PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saxena, S; Roselli, F; Singh, K; Leptien, K; Julien, JP; Gros-Louis, F; Caroni, P				Saxena, Smita; Roselli, Francesco; Singh, Katyayani; Leptien, Kerstin; Julien, Jean-Pierre; Gros-Louis, Francois; Caroni, Pico			Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; LUMBAR MOTONEURONS; ER STRESS; WILD-TYPE; CALCIUM; DEATH	Delaying clinical disease onset would greatly reduce neurodegenerative disease burden, but the mechanisms influencing early preclinical progression are poorly understood. Here, we show that in mouse models of familial motoneuron (MN) disease, SOD1 mutants specifically render vulnerable MNs dependent on endogenous neuroprotection signaling involving excitability and mammalian target of rapamycin (mTOR). The most vulnerable low-excitability FF MNs already exhibited evidence of pathology and endogenous neuroprotection recruitment early postnatally. Enhancing MN excitability promoted MN neuroprotection and reversed misfolded SOD1 (misfSOD1) accumulation and MN pathology, whereas reducing MN excitability augmented misfS0D1 accumulation and accelerated disease. Inhibiting metabotropic cholinergic signaling onto MNs reduced ER stress, but enhanced. misfS0D1 accumulation and prevented mTOR activation in alpha-MNs. Modulating excitability and/or alpha-MN mTOR activity had comparable effects on the progression rates of motor dysfunction, denervation, and death. Therefore, excitability and mTOR are key endogenous neuroprotection mechanisms in motoneurons to counteract clinically important disease progression in ALS.	[Saxena, Smita; Roselli, Francesco; Leptien, Kerstin; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Saxena, Smita; Singh, Katyayani] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Gros-Louis, Francois] Univ Laval, CHU Quebec Res Ctr, Ctr LOEX, Quebec City, PQ G1V 0A6, Canada; [Gros-Louis, Francois] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ G1V 0A6, Canada; [Julien, Jean-Pierre] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ G1V 0A6, Canada	Friedrich Miescher Institute for Biomedical Research; University of Bern; Laval University; Laval University; Laval University	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	roselli, francesco/O-8847-2019; roselli, francesco/G-6701-2013	roselli, francesco/0000-0001-9935-6899; Saxena, Smita/0000-0003-4574-4591; Singh, Katyayani/0000-0002-3287-1885	Novartis Research Foundation; EMBO; Canadian Institutes of Health Research	Novartis Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to K. McAllister and C. Gee (Novartis Institutes for Biomedical Research, Basel) for suggestions and help with the original AMPA receptor antagonist experiments and to S. Sternson (Janelia Farms) for the pharmacogenetic reagents. The Friedrich Miescher Institute for Biomedical Research is supported by the Novartis Research Foundation. F.R. was supported by an EMBO long-term fellowship; F. G.-L. and J.-P. J. were supported by the Canadian Institutes of Health Research.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bories C, 2007, EUR J NEUROSCI, V25, P451, DOI 10.1111/j.1460-9568.2007.05306.x; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Gleichmann M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.012; Gordon T, 2010, NEUROBIOL DIS, V37, P412, DOI 10.1016/j.nbd.2009.10.021; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Herron LR, 2012, NEUROSCIENCE, V226, P313, DOI 10.1016/j.neuroscience.2012.09.031; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kanekura K, 2009, MOL NEUROBIOL, V39, P81, DOI 10.1007/s12035-009-8054-3; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim SR, 2012, MOL THER, V20, P275, DOI 10.1038/mt.2011.213; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Martin LJ, 2012, MOL NEUROBIOL, V45, P30, DOI 10.1007/s12035-011-8217-x; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Piotrkiewicz M, 2011, J PHYSIOL-LONDON, V589, P2745, DOI 10.1113/jphysiol.2011.204891; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Pullen AH, 2009, EUR J NEUROSCI, V29, P551, DOI 10.1111/j.1460-9568.2008.06602.x; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Shen WW, 2011, BIOL CELL, V103, P365, DOI 10.1042/BC20100152; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Taguchi J, 2000, ACTA NEUROPATHOL, V100, P153, DOI 10.1007/s004019900165; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541	51	177	178	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					80	96		10.1016/j.neuron.2013.07.027	http://dx.doi.org/10.1016/j.neuron.2013.07.027			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094105	Bronze			2022-12-25	WOS:000326305300010
J	Jacobs, J; Weidemann, CT; Miller, JF; Solway, A; Burke, JF; Wei, XX; Suthana, N; Sperling, MR; Sharan, AD; Fried, I; Kahana, MJ				Jacobs, Joshua; Weidemann, Christoph T.; Miller, Jonathan F.; Solway, Alec; Burke, John F.; Wei, Xue-Xin; Suthana, Nanthia; Sperling, Michael R.; Sharan, Ashwini D.; Fried, Itzhak; Kahana, Michael J.			Direct recordings of grid-like neuronal activity in human spatial navigation	NATURE NEUROSCIENCE			English	Article							ENTORHINAL CORTEX; CELLS; HIPPOCAMPUS; REPRESENTATION; MEMORY; MAP; EXPERIENCE; NETWORK; PLACE; SPACE	Grid cells in the entorhinal cortex appear to represent spatial location via a triangular coordinate system. Such cells, which have been identified in rats, bats and monkeys, are believed to support a wide range of spatial behaviors. Recording neuronal activity from neurosurgical patients performing a virtual-navigation task, we identified cells exhibiting grid-like spiking patterns in the human brain, suggesting that humans and simpler animals rely on homologous spatial-coding schemes.	[Jacobs, Joshua; Miller, Jonathan F.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Solway, Alec] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Burke, John F.; Wei, Xue-Xin; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Sperling, Michael R.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Sharan, Ashwini D.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Drexel University; Swansea University; Princeton University; University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Jefferson University; Jefferson University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Jacobs, J (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	joshua.jacobs@drexel.edu; ifried@mednet.ucla.edu	Jacobs, Joshua/E-9500-2013; Weidemann, Christoph T./E-8857-2011	Jacobs, Joshua/0000-0003-1807-6882; Weidemann, Christoph T./0000-0002-4280-2744; Burke, John/0000-0002-6190-5116; Suthana, Nanthia/0000-0002-8796-3277	US National Institutes of Health [MH061975, NS033221]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084017, R56NS033221, R01NS033221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients for participating in our study. We thank K. Lee, D. Wyeth, E. Wyeth, D. Pourshaban, E. Behnke and T. Fields for technical assistance. This work was supported by US National Institutes of Health grants MH061975 and NS033221.	Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	22	266	274	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1188	1190		10.1038/nn.3466	http://dx.doi.org/10.1038/nn.3466			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912946	Green Accepted			2022-12-25	WOS:000323597500009
J	Hess, ME; Hess, S; Meyer, KD; Verhagen, LAW; Koch, L; Bronneke, HS; Dietrich, MO; Jordan, SD; Saletore, Y; Elemento, O; Belgardt, BF; Franz, T; Horvath, TL; Ruther, U; Jaffrey, SR; Kloppenburg, P; Bruning, JC				Hess, Martin E.; Hess, Simon; Meyer, Kate D.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Dietrich, Marcelo O.; Jordan, Sabine D.; Saletore, Yogesh; Elemento, Olivier; Belgardt, Bengt F.; Franz, Thomas; Horvath, Tamas L.; Ruether, Ulrich; Jaffrey, Samie R.; Kloppenburg, Peter; Bruening, Jens C.			The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry	NATURE NEUROSCIENCE			English	Article							SUBSTANTIA-NIGRA; D2 RECEPTORS; MICE LACKING; ADDICTION; COCAINE; REWARD; BRAIN; RNA; CHILDHOOD; NEURONS	Dopaminergic (DA) signaling governs the control of complex behaviors, and its deregulation has been implicated in a wide range of diseases. Here we demonstrate that inactivation of the Fto gene, encoding a nucleic acid demethylase, impairs dopamine receptor type 2 (D2R) and type 3 (D3R) (collectively, 'D2-like receptor')-dependent control of neuronal activity and behavioral responses. Conventional and DA neuron-specific Fto knockout mice show attenuated activation of G protein-coupled inwardly-rectifying potassium (GIRK) channel conductance by cocaine and quinpirole. Impaired D2-like receptor-mediated autoinhibition results in attenuated quinpirole-mediated reduction of locomotion and an enhanced sensitivity to the locomotor-and reward-stimulatory actions of cocaine. Analysis of global N-6-methyladenosine (m(6)A) modification of mRNAs using methylated RNA immunoprecipitation coupled with next-generation sequencing in the midbrain and striatum of Fto-deficient mice revealed increased adenosine methylation in a subset of mRNAs important for neuronal signaling, including many in the DA signaling pathway. Several proteins encoded by these mRNAs had altered expression levels. Collectively, FTO regulates the demethylation of specific mRNAs in vivo, and this activity relates to the control of DA transmission.	[Hess, Martin E.; Verhagen, Linda A. W.; Broenneke, Hella S.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Ctr Mol Med Cologne, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Hess, Simon; Kloppenburg, Peter] Univ Cologne, Inst Zool, Cologne, Germany; [Meyer, Kate D.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Broenneke, Hella S.] CECAD, Mouse Phenotyping Facil, Cologne, Germany; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Saletore, Yogesh; Elemento, Olivier] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Franz, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany; [Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Cornell University; University of Cologne; Yale University; Yale University; Yale University; Cornell University; Max Planck Society; Heinrich Heine University Dusseldorf	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221; Koch, Linda/0000-0002-2943-1993; Jaffrey, Samie/0000-0003-3615-6958; Meyer, Kate/0000-0001-7197-4054; Belgardt, Bengt-Frederik/0000-0003-4537-9002	US National Institutes of Health [R01 NS056306]; Deutsche Forschungsgemeinschaft [Br1492-7/1, KL 762/2-2]; Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ) [01GI1122A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Alber, B. Hampel, H. Wratil and Y. Masekowitz for excellent technical assistance. We also thank C. Mason for assistance with MeRIP-Seq peak calling. We thank the European Conditional Mouse Mutagenesis Program (EUCOMM) for providing mice with knock in of the beta-galactosidase gene into the Fto gene and N.G. Larsson (Max Planck Institute for Biology of Ageing, Cologne, Germany) for providing Dat-Cre mice. This work was supported by US National Institutes of Health grant R01 NS056306 (S. R. J.), the Deutsche Forschungsgemeinschaft (Br1492-7/1 to J. C. B. and KL 762/2-2 to P. K.) and the Kompetenznetz Adipositas (Competence Network for Obesity) funded by the German Federal Ministry of Education and Research (FKZ: 01GI1122A to J.C.B.).	Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Choudhry Z, 2013, OBESITY, V21, pE738, DOI 10.1002/oby.20444; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garcia-Tornadu I, 2010, FRONT HORM RES, V38, P59, DOI 10.1159/000318495; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Yeo GSH, 2012, J NEUROENDOCRINOL, V24, P393, DOI 10.1111/j.1365-2826.2011.02254.x	41	325	337	3	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1042	U96		10.1038/nn.3449	http://dx.doi.org/10.1038/nn.3449			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817550				2022-12-25	WOS:000322323000014
J	Myant, KB; Cammareri, P; McGhee, EJ; Ridgway, RA; Huels, DJ; Cordero, JB; Schwitalla, S; Kalna, G; Ogg, EL; Athineos, D; Timpson, P; Vidal, M; Murray, GI; Greten, FR; Anderson, KI; Sansom, OJ				Myant, Kevin B.; Cammareri, Patrizia; McGhee, Ewan J.; Ridgway, Rachel A.; Huels, David J.; Cordero, Julia B.; Schwitalla, Sarah; Kalna, Gabriela; Ogg, Erinn-Lee; Athineos, Dimitris; Timpson, Paul; Vidal, Marcos; Murray, Graeme I.; Greten, Florian R.; Anderson, Kurt I.; Sansom, Owen J.			ROS Production and NF-kappa B Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation	CELL STEM CELL			English	Article							BETA-CATENIN; MOUSE MODEL; TUMOR PROGRESSION; GENE-EXPRESSION; APC DEFICIENCY; IN-VIVO; COLON; TUMORIGENESIS; MUTATIONS; PROTEIN	The Adenomatous Polyposis Coli (APC) gene is mutated in the majority of colorectal cancers (CRCs). Loss of APC leads to constitutively active WNT signaling, hyperproliferation, and tumorigenesis. Identification of pathways that facilitate tumorigenesis after APC loss is important for therapeutic development. Here, we show that RAC1 is a critical mediator of tumorigenesis after APC loss. We find that RAC1 is required for expansion of the LGR5 intestinal stem cell (ISC) signature, progenitor hyperproliferation, and transformation. Mechanistically, RAC1-driven ROS and NF-kappa B signaling mediate these processes. Together, these data highlight that ROS production and NF-kappa B activation triggered by RAC1 are critical events in CRC initiation.	[Myant, Kevin B.; Cammareri, Patrizia; McGhee, Ewan J.; Ridgway, Rachel A.; Huels, David J.; Cordero, Julia B.; Kalna, Gabriela; Ogg, Erinn-Lee; Athineos, Dimitris; Timpson, Paul; Vidal, Marcos; Anderson, Kurt I.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Schwitalla, Sarah; Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Murray, Graeme I.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Dept Pathol, Aberdeen AB25 2ZD, Scotland	Beatson Institute; Technical University of Munich; University of Aberdeen	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Timpson, Paul/A-9429-2016; Greten, Florian R/AAF-5196-2020; Sch/AAA-9548-2021	Greten, Florian R/0000-0002-3928-6080; Cammareri, Patrizia/0000-0002-5888-6903; Cordero, Julia/0000-0003-1701-9480; Athineos, Dimitris/0000-0001-5298-7941; Sansom, Owen J./0000-0001-9540-3010; Huels, David/0000-0001-6154-1183; Anderson, Kurt/0000-0002-9324-9598; Timpson, Paul/0000-0002-5514-7080; myant, kevin/0000-0001-8017-1093	Cancer Research UK; AICR grant; European Union [278568]; Cancer Research UK [12481, 15565] Funding Source: researchfish; National Centre for the Replacement [G1000078/1] Funding Source: researchfish; Worldwide Cancer Research [10-0643] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR grant; European Union(European Commission); Cancer Research UK(Cancer Research UK); National Centre for the Replacement; Worldwide Cancer Research	All authors are supported by Cancer Research UK. K.B.M. is funded by an AICR grant. The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 278568. Thanks to histology, microscopy, and the BSU for enabling this work to be performed and Florian Greten for discussions. We thank Victor Tybulewicz for Rac1 flox and Ian Tomlinson for Apc<SUP>1322T/+</SUP> mice. The ROSA-tdRFP mice were imported from the EMMA repository (strain 02112) and were a kind gift from Hans Jorg Fehling. We thank David Tuveson and Tim Humpton for help with ROS staining. We thank Bryan Miller for help preparing the manuscript. O.J.S., K.B.M., and F.R.G. conceived and designed the project. K.B.M., P.C., E.J.M., R.A.R., D.J.H., S.S., G.K., E.-L.O., D.A., and P.T. performed the experiments and analyzed the data. K.B.M., O.J.S., P.C., D.J.H., E.J.M., and K.I.A.interpreted the data. O.J.S, K.B.M., P.C., and R.A.R. wrote the manuscript.	Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BROMBERG Y, 1994, J BIOL CHEM, V269, P7055; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Espina C, 2008, AM J PATHOL, V172, P156, DOI 10.2353/ajpath.2008.070561; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gold DL, 2007, BRIEF BIOINFORM, V8, P71, DOI 10.1093/bib/bbl019; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Li A, 2012, J INVEST DERMATOL, V132, P2610, DOI 10.1038/jid.2012.186; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Obrador-Hevia A, 2010, J PATHOL, V221, P57, DOI 10.1002/path.2685; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Samuel MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017143; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99	62	274	285	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					761	773		10.1016/j.stem.2013.04.006	http://dx.doi.org/10.1016/j.stem.2013.04.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23665120	Green Published, hybrid			2022-12-25	WOS:000329569900018
J	Guenthner, CJ; Miyamichi, K; Yang, HH; Heller, HC; Luo, LQ				Guenthner, Casey J.; Miyamichi, Kazunari; Yang, Helen H.; Heller, H. Craig; Luo, Liqun			Permanent Genetic Access to Transiently Active Neurons via TRAP: Targeted Recombination in Active Populations	NEURON			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; RAT VISUAL-CORTEX; C-FOS EXPRESSION; BARREL CORTEX; NULL MUTATION; IN-VIVO; FUNCTIONAL-ORGANIZATION; TRANSCRIPTION FACTORS; SYNAPTIC ACTIVATION	Targeting genetically encoded tools for neural circuit dissection to relevant cellular populations is a major challenge in neurobiology. We developed an approach, targeted recombination in active populations (TRAP), to obtain genetic access to neurons that were activated by defined stimuli. This method utilizes mice in which the tamoxifen-dependent recombinase CreER(T2) is expressed in an activity-dependent manner from the loci of the immediate early genes Arc and Fos. Active cells that express CreER(T2) can only undergo recombination when tamoxifen is present, allowing genetic access to neurons that are active during a time window of less than 12 hr. We show that TRAP can provide selective access to neurons activated by specific somatosensory, visual, and auditory stimuli and by experience in a novel environment. When combined with tools for labeling, tracing, recording, and manipulating neurons, TRAP offers a powerful approach for understanding how the brain processes information and generates behavior.	[Guenthner, Casey J.; Miyamichi, Kazunari; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Guenthner, Casey J.; Miyamichi, Kazunari; Heller, H. Craig; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Guenthner, Casey J.; Yang, Helen H.; Heller, H. Craig; Luo, Liqun] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.ed	Miyamichi, Kazunari/AAO-3705-2021	Luo, Liqun/0000-0001-5467-9264; Heller, H Craig/0000-0003-4479-5880; Yang, Helen/0000-0001-5140-9664	National Institutes of Health (NIH) [R01-NS050835, TR01MH099647]; Simons Foundation; Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award; U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program; Human Frontier Science Program Organization [LT00300/2007-L]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award; U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program; Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Huberman, A. Mizrahi, and C. Ran for advice; members of the Heller lab for help with preliminary experiments; B. Tasic for DNA constructs and advice; C. Manalac and K. DeLoach for technical assistance; the Stanford Transgenic Facility for help in generating mice; K. Beier, K. Deisseroth, L. DeNardo, X. Gao, C. Golgi, A. Huberman, N. Makki, A. Mizrahi, T. Mosca, L. Schwarz, and B. Weissbourd for helpful comments on the manuscript; and members of the Luo lab for helpful discussion. This work was supported by grants from the National Institutes of Health (NIH; R01-NS050835 and TR01MH099647), the Simons Foundation, and by a Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award. C.J.G. is supported by the U.S. Department of Defense through the National Defense Science and Engineering Graduate Fellowship program. H.H.Y. is a Stanford Graduate Fellow. K.M. was supported by the Human Frontier Science Program Organization (LT00300/2007-L). K.M. is a research specialist and L.L. is an investigator of the HHMI.	Amir S, 1996, BRAIN RES, V716, P213, DOI 10.1016/0006-8993(96)00025-X; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Deng XL, 1999, J NEUROSCI, V19, P10107; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Glazewski S, 2001, NEUROPHARMACOLOGY, V41, P771, DOI 10.1016/S0028-3908(01)00097-1; Hess US, 1995, J NEUROSCI, V15, P7796; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; LUCKMAN SM, 1994, J NEUROSCI, V14, P4825; Luo F, 2009, HEARING RES, V257, P75, DOI 10.1016/j.heares.2009.08.002; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Saint Marie RL, 1999, J COMP NEUROL, V404, P258, DOI 10.1002/(SICI)1096-9861(19990208)404:2<258::AID-CNE9>3.0.CO;2-U; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Van der Gucht E, 2002, EUR J NEUROSCI, V16, P1620, DOI 10.1046/j.1460-9568.2002.02226.x; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Watanabe Y, 1996, J NEUROSCI, V16, P3827; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Young E. D., 2004, J NEUROSCI; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	45	298	312	7	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					773	784		10.1016/j.neuron.2013.03.025	http://dx.doi.org/10.1016/j.neuron.2013.03.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764283	Bronze, Green Accepted			2022-12-25	WOS:000320743400005
J	Badura, A; Schonewille, M; Voges, K; Galliano, E; Renier, N; Gao, ZY; Witter, L; Hoebeek, FE; Chedotal, A; De Zeeuw, CI				Badura, Aleksandra; Schonewille, Martijn; Voges, Kai; Galliano, Elisa; Renier, Nicolas; Gao, Zhenyu; Witter, Laurens; Hoebeek, Freek E.; Chedotal, Alain; De Zeeuw, Chris I.			Climbing Fiber Input Shapes Reciprocity of Purkinje Cell Firing	NEURON			English	Article							MOLECULAR LAYER INTERNEURONS; INFERIOR OLIVARY COMPLEX; SYNAPTIC INHIBITION; MOSSY FIBERS; SIMPLE SPIKE; CEREBELLUM; PLASTICITY; FLOCCULUS; ORGANIZATION; OUTPUT	The cerebellum fine-tunes motor activity via its Purkinje cell output. Purkinje cells produce two different types of spikes, complex spikes and simple spikes, which often show reciprocal activity: a periodical increase in complex spikes is associated with a decrease in simple spikes, and vice versa. This reciprocal firing is thought to be essential for coordinated motor behavior, yet how it is accomplished is debated. Here, we show in Ptf1a::cre;Robo3(lox/lox) mice that selectively rerouting the climbing fibers from a contralateral to an ipsilateral projection reversed the complex-spike modulation during sensory stimulation. Strikingly, modulation of simple spikes, which is supposed to be controlled by mossy fibers, reversed as well. Climbing fibers enforce this reciprocity in part by influencing activity of inhibitory interneurons, because the phase of their activity was also converted. Ptf1a::cre;Robo3(lox/lox) mice showed severe ataxia highlighting that climbing fiber input and its impact on reciprocity of Purkinje cell firing play an important role in motor coordination.	[Badura, Aleksandra; Schonewille, Martijn; Voges, Kai; Galliano, Elisa; Gao, Zhenyu; Hoebeek, Freek E.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; [Witter, Laurens; De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci KNAW, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Renier, Nicolas; Chedotal, Alain] INSERM, U968, F-75012 Paris, France; [Renier, Nicolas; Chedotal, Alain] UPMC Univ Paris 06, UMR S 968, Inst Vis, F-75012 Paris, France; [Chedotal, Alain] CNRS, UMR 7210, F-75012 Paris, France	Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Witter, Laurens/AAB-1461-2019; Galliano, Elisa/AAP-6700-2020; Schonewille, Martijn/E-6170-2013; Chedotal, Alain/F-2750-2017; Badura, Aleksandra/ABC-5427-2020; Renier, Nicolas/E-1855-2018	Witter, Laurens/0000-0003-2357-0578; Galliano, Elisa/0000-0002-6941-766X; Chedotal, Alain/0000-0001-7577-3794; Badura, Aleksandra/0000-0002-0119-5108; Renier, Nicolas/0000-0003-2642-4402	Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (Neuro-Basic); Erasmus University; ERC; CEREBNET; European Community; "fondation pour le recherche medicale" - programme Equipe FRM; Association Francaise contre les Myopathies - AFM [ASS-SUB06-00123]; Labex lifesenses; Agence Nationale de la Recherche [ANR-2011 8SV40091]	Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (Neuro-Basic); Erasmus University; ERC(European Research Council (ERC)European Commission); CEREBNET; European Community(European Commission); "fondation pour le recherche medicale" - programme Equipe FRM; Association Francaise contre les Myopathies - AFM(Association Francaise contre les Myopathies); Labex lifesenses; Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank E. Haasdijk, R. de Avila Freire, E. Goedknegt, and M. Rutteman for their technical assistance; C.V. Wright (Vanderbilt Univerisity) for providing the Ptf1a::Cre mice; and we thank the Dutch Organization for Medical Sciences (ZonMw; C.I.D.Z., F.E.H.), Life Sciences (ALW; M.S., C.I.D.Z., F.E.H.), Senter (Neuro-Basic; C.I.D.Z.), Erasmus University Fellowship (M.S., F.E.H.), the ERC, CEREBNET, and C7 programs of the European Community (C.I.D.Z.), the "fondation pour le recherche medicale" - programme Equipe FRM (A.C.), the Association Francaise contre les Myopathies - AFM, ASS-SUB06-00123 (A.G.), the Labex lifesenses (A.C.), and the Agence Nationale de la Recherche ANR-2011 8SV40091(A.C.) for their financial support. A.B. is currently a postdoctoral research associate at the Department of Molecular Biology and Princeton Neuroscience Institute, Princeton University, Princeton, NJ, USA. C.I.D.Z. conceived the project. A.B. and M.S. obtained and analyzed the in vivo electrophysiological, behavioral, and histological data. K.V. designed Mat Lab software for spiking and eye movement analysis and analyzed in vivo electrophysiological data. L.W. performed in vivo patch-clamp recordings, Z.G., E.G., and F.E.H. performed the in vitro experiments in slice preparation. N.R. and A.C engineered and analyzed the Ptf1a and Robo mutants. A.B., M.S., A.G., and C.I.D.Z. designed the experiments, discussed the results, and prepared the manuscript.	Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Batschelet E, 1981, CIRCULAR STAT BIOL; Bosley TM, 2005, NEUROLOGY, V64, P1196, DOI 10.1212/01.WNL.0000156349.01765.2B; Bosman LWJ, 2010, J PHYSIOL-LONDON, V588, P3757, DOI 10.1113/jphysiol.2010.195180; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; DEZEEUW CI, 1995, J NEUROPHYSIOL, V74, P2051, DOI 10.1152/jn.1995.74.5.2051; Ebner TJ, 2002, ANN NY ACAD SCI, V978, P205, DOI 10.1111/j.1749-6632.2002.tb07568.x; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Fujita H, 2012, J COMP NEUROL, V520, P656, DOI 10.1002/cne.22760; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Gebre SA, 2012, BRAIN STRUCT FUNCT, V217, P165, DOI 10.1007/s00429-011-0339-4; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; GRAF W, 1988, J NEUROPHYSIOL, V60, P2091, DOI 10.1152/jn.1988.60.6.2091; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, BEHAV BRAIN SCI, V19, P354, DOI 10.1017/S0140525X00081450; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Leonard C.S., 1986, SIMPLE SPIKE MODULAT; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; Mathews PJ, 2012, J NEUROSCI, V32, P17988, DOI 10.1523/JNEUROSCI.3916-12.2012; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; Morara S, 2001, NEUROSCIENCE, V108, P655, DOI 10.1016/S0306-4522(01)00433-X; Peltier AC, 1999, NEUROSCI RES, V34, P177, DOI 10.1016/S0168-0102(99)00045-0; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Raman IM, 1999, J NEUROSCI, V19, P1663; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rizzolatti G, 2005, CURR OPIN NEUROBIOL, V15, P623, DOI 10.1016/j.conb.2005.10.018; Ruigrok TJH, 2003, J COMP NEUROL, V466, P278, DOI 10.1002/cne.10889; RUIGROK TJH, 1995, J NEUROSCI METH, V61, P127, DOI 10.1016/0165-0270(94)00034-E; Ruigrok TJH, 2007, NAT PROTOC, V2, P1869, DOI 10.1038/nprot.2007.264; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Schmahmann J.D., 2012, HDB CEREBELLUM CEREB, V3, P1717; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Tian JB, 2008, NEUROSCIENCE, V153, P308, DOI 10.1016/j.neuroscience.2008.01.076; Timmann D, 2012, FORTSCHR NEUROL PSYC, V80, P44, DOI 10.1055/s-0031-1282022; Van Alphen AM, 2002, ANN NY ACAD SCI, V978, P413; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Voogd J, 2006, PROG BRAIN RES, V151, P231, DOI 10.1016/S0079-6123(05)51008-2; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Yakhnitsa V, 2006, NEUROSCIENCE, V143, P615, DOI 10.1016/j.neuroscience.2006.08.006; Yamada M, 2007, J NEUROSCI, V27, P10924, DOI 10.1523/JNEUROSCI.1423-07.2007	61	90	90	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					700	713		10.1016/j.neuron.2013.03.018	http://dx.doi.org/10.1016/j.neuron.2013.03.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23643935	Bronze			2022-12-25	WOS:000319491200013
J	Foldy, C; Malenka, RC; Sudhof, TC				Foeldy, Csaba; Malenka, Robert C.; Suedhof, Thomas C.			Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling	NEURON			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; HIPPOCAMPAL GABAERGIC SYNAPSES; PERISOMATIC INHIBITION; RECEPTOR ACTIVATION; FAST-SPIKING; RELEASE; CANNABINOIDS; MODULATION; NEUREXINS; GABA	Neuroligins are postsynaptic cell-adhesion molecules that interact with presynaptic neurexins. Rare mutations in neuroligins and neurexins predispose to autism, including a neuroligin-3 amino acid substitution (R451C) and a neuroligin-3 deletion. Previous analyses showed that neuroligin-3 R451C-knockin mice exhibit robust synaptic phenotypes but failed to uncover major changes in neuroligin-3 knockout mice, questioning the notion that a common synaptic mechanism mediates autism pathogenesis in patients with these mutations. Here, we used paired recordings in mice carrying these mutations to measure synaptic transmission at GABAergic synapses formed by hippocampal parvalbumin- and cholecystokinin-expressing basket cells onto pyramidal neurons. We demonstrate that in addition to unique gain-of-function effects produced by the neuroligin-3 R451C-knockin but not the neuroligin-3 knockout mutation, both mutations dramatically impaired tonic but not phasic endocannabinoid signaling. Our data thus suggest that neuroligin-3 is specifically required for tonic endocannabinoid signaling, raising the possibility that alterations in endocannabinoid signaling may contribute to autism pathophysiology.	[Foeldy, Csaba; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Foeldy, Csaba; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Malenka, Robert C.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Foldy, C (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	foldy@stanford.edu; tcs1@stanford.edu		Foldy, Csaba/0000-0001-8709-8490	Simons Foundation [177850]; NIMH [P50 MH086403]; NIDA [K99DA034029]; NINDS [NS069375]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA034029, R01DA030379] Funding Source: NIH RePORTER	Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Nathan Huang, Scarlett Fang, Ayeh Darvishzadeh, and Shaon Ghosh for technical assistance, and Dr. Jason Aoto for advice. This study was supported by grants from the Simons Foundation (177850 to T.C.S.), the NIMH (P50 MH086403 to R.C.M. and T.C.S.), the NIDA (K99DA034029 to C.F.), and the NINDS (NS069375 to the Stanford Neuroscience Microscopy Service).	Alger BE, 2002, PROG NEUROBIOL, V68, P247; Alger BE, 2012, J PHYSIOL-LONDON, V590, P2203, DOI 10.1113/jphysiol.2011.220855; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Ali AB, 2010, EUR J NEUROSCI, V31, P1196, DOI 10.1111/j.1460-9568.2010.07165.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; De Jaco A, 2010, CHEM-BIOL INTERACT, V187, P56, DOI 10.1016/j.cbi.2010.03.012; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PITLER TA, 1994, NEURON, V13, P1447; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szabo GG, 2010, EUR J NEUROSCI, V31, P2234, DOI 10.1111/j.1460-9568.2010.07292.x; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	51	185	185	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					498	509		10.1016/j.neuron.2013.02.036	http://dx.doi.org/10.1016/j.neuron.2013.02.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23583622	Bronze, Green Accepted			2022-12-25	WOS:000318961700011
J	Ueno, M; Fujita, Y; Tanaka, T; Nakamura, Y; Kikuta, J; Ishii, M; Yamashita, T				Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Kikuta, Junichi; Ishii, Masaru; Yamashita, Toshihide			Layer V cortical neurons require microglial support for survival during postnatal development	NATURE NEUROSCIENCE			English	Article							PROJECTION NEURONS; CELL-DEATH; MACROPHAGES; ACTIVATION; GROWTH; RECEPTOR; CALLOSAL; PROLIFERATION; DEGENERATION; EXPRESSION	Neurons require trophic support during neural circuit formation; however, how the cellular milieu contributes to neuronal survival remains unclear. We found that layer V cortical neurons require support from microglia for survival during postnatal development. Specifically, we found that microglia accumulated close to the subcerebral and callosal projection axons in the postnatal brain. Inactivation of microglia by minocycline treatment or transient ablation of microglia in CD11b-DTR transgenic mice led to increased apoptosis, specifically in layer V subcerebral and callosal projection neurons. CX3CR1 in microglia was required for the survival of layer V neurons. Microglia consistently promoted the survival of cortical neurons in vitro. In addition, we identified microglia-derived IGF1 as a trophic factor that maintained neuronal survival. Our results highlight a neuron-glia interaction that is indispensable for network formation during a specific period in the developing brain.	[Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Ueno, Masaki; Fujita, Yuki; Nakamura, Yuka; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Tanaka, Tatsuhide] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Sapporo, Hokkaido, Japan; [Kikuta, Junichi; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Lab Cellular Dynam, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University	Ueno, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	ms-ueno@umin.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Kikuta, Junichi/HHS-8875-2022; Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Tanaka, Tatsuhide/0000-0002-3373-9093; Yamashita, Toshihide/0000-0003-4559-7018	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Ozawa for experimental technical support, M.K. Yamada (University of Tokyo), P. Osten (Cold Spring Harbor Laboratory) and H. Miyoshi (RIKEN) for their kind gift of the lentivirus plasmid and helpful suggestions, and Y. Yoshida (Cincinnati Children's Hospital Medical Center) for critical comments on the manuscript. This work was supported by a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) to T.Y. and a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science to M.U.	Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Antony JM, 2011, J NEUROSCI RES, V89, P286, DOI 10.1002/jnr.22533; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Canty AJ, 2008, PROG NEUROBIOL, V85, P214, DOI 10.1016/j.pneurobio.2008.02.001; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chesik D, 2004, NEUROREPORT, V15, P1033, DOI 10.1097/00001756-200404290-00020; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Ling E A, 2001, Prog Brain Res, V132, P61; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Murase S, 1998, J NEUROSCI, V18, P10481; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Oppenheim R. W., 2003, PROGRAMMED CELL DEAT; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Ueno Masaki, 2008, Biologics, V2, P253; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	51	474	484	6	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					543	+		10.1038/nn.3358	http://dx.doi.org/10.1038/nn.3358			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525041				2022-12-25	WOS:000318029300010
J	Gilad, A; Meirovithz, E; Slovin, H				Gilad, Ariel; Meirovithz, Elhanan; Slovin, Hamutal			Population Responses to Contour Integration: Early Encoding of Discrete Elements and Late Perceptual Grouping	NEURON			English	Article							PRIMARY VISUAL-CORTEX; FIGURE-GROUND SEGREGATION; SPATIOTEMPORAL PATTERNS; FUNCTIONAL ARCHITECTURE; CORTICAL DYNAMICS; RECEPTIVE-FIELD; STRIATE CORTEX; SUPPRESSION; V1; MONKEY	The neuronal mechanisms underlying perceptual grouping of discrete, similarly oriented elements are not well understood. To investigate this, we measured neural population responses using voltage-sensitive dye imaging in V1 of monkeys trained on a contour-detection task. By mapping the contour and background elements onto V1, we could study their neural processing. Population response early in time showed activation patches corresponding to the contour/background individual elements. However, late increased activity in the contour elements, along with suppressed activity in the background elements, enabled us to visualize in single trials a salient continuous contour "popping out" from a suppressed background. This modulated activity in the contour and in background extended beyond the cortical representation of individual contour or background elements. Finally, the late modulation was correlated with behavioral performance of contour saliency and the monkeys' perceptual report. Thus, opposing responses in the contour and background may underlie perceptual grouping in V1.	[Gilad, Ariel; Meirovithz, Elhanan; Slovin, Hamutal] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, IL-52900 Ramat Gan, Israel	Bar Ilan University	Slovin, H (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, IL-52900 Ramat Gan, Israel.	hamutal.slovin@biu.ac.il		Slovin, Hamutal/0000-0001-6350-8141	DFG [185/1-1]; Israel Science Foundation	DFG(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the DFG: Program of German-Israeli Project cooperation (DIP grant, ref: 185/1-1) and the Israel Science Foundation. We are grateful to Ray Shamir and Uri Werner-Reiss for helping with the experiments, and to Inbal Ayzenshtat for invaluable comments and discussions throughout the course of this study.	Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Ayzenshtat I, 2012, J NEUROSCI, V32, P13971, DOI 10.1523/JNEUROSCI.1596-12.2012; Ayzenshtat I, 2010, J NEUROSCI, V30, P11232, DOI 10.1523/JNEUROSCI.5177-09.2010; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bauer R, 2002, EXP BRAIN RES, V147, P145, DOI 10.1007/s00221-002-1178-6; Braun J, 1999, SPATIAL VISION, V12, P211, DOI 10.1163/156856899X00120; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P313; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chisum HJ, 2003, J NEUROSCI, V23, P2947; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A., 1999, MODERN TECHNIQUES NE, P893, DOI DOI 10.1007/978-3-642-58552-4_34; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Libedinsky C, 2009, J VISION, V9, DOI 10.1167/9.1.14; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Poort J, 2012, NEURON, V75, P143, DOI 10.1016/j.neuron.2012.04.032; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TSO DY, 1986, J NEUROSCI, V6, P1160; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Zipser K, 1996, J NEUROSCI, V16, P7376	49	53	54	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					389	402		10.1016/j.neuron.2013.02.013	http://dx.doi.org/10.1016/j.neuron.2013.02.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622069	Bronze			2022-12-25	WOS:000318202200017
J	Song, YY; Kirkpatrick, LL; Schilling, AB; Helseth, DL; Chabot, N; Keillor, JW; Johnson, GVW; Brady, ST				Song, Yuyu; Kirkpatrick, Laura L.; Schilling, Alexander B.; Helseth, Donald L.; Chabot, Nicolas; Keillor, Jeffrey W.; Johnson, Gail V. W.; Brady, Scott T.			Transglutaminase and Polyamination of Tubulin: Posttranslational Modification for Stabilizing Axonal Microtubules	NEURON			English	Article							TISSUE TRANSGLUTAMINASE; NEURODEGENERATIVE DISEASES; ALPHA-TUBULIN; ORNITHINE DECARBOXYLASE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; CULTURED-CELLS; CROSS-LINKING; BRAIN; PROTEINS	Neuronal microtubules support intracellular transport, facilitate axon growth, and form a basis for neuronal morphology. While microtubules in non-neuronal cells are depolymerized by cold, Ca2+, or antimitotic drugs, neuronal microtubules are unusually stable. Such stability is important for normal axon growth and maintenance, while hyperstability may compromise neuronal function in aging and degeneration. Though mechanisms for stability are unclear, studies suggest that stable microtubules contain biochemically distinct tubulins that are more basic than conventional tubulins. Transglutaminase-catalyzed posttranslational incorporation of polyamines is one of the few modifications of intracellular proteins that add positive charges. Here we show that neuronal tubulin can be polyaminated by transglutaminase. Endogenous brain transglutaminase-catalyzed polyaminated tubulins have the biochemical characteristics of neuronal stable microtubules. Inhibiting polyamine synthesis or transglutaminase activity significantly decreases microtubule stability in vitro and in vivo. Together, these findings suggest that transglutaminase-catalyzed polyamination of tubulins stabilizes microtubules essential for unique neuronal structures and functions.	[Song, Yuyu; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Kirkpatrick, Laura L.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Schilling, Alexander B.; Helseth, Donald L.] Univ Illinois, CBC RRC Prote & Informat Serv Facil, Chicago, IL 60612 USA; [Chabot, Nicolas; Keillor, Jeffrey W.] Univ Ottawa, Dept Chem, Ottawa, ON K1N 6N5, Canada; [Johnson, Gail V. W.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lexicon Pharmaceuticals; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Ottawa; University of Rochester	Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	stbrady@uic.edu	Song, Yuyu/J-8939-2019	Song, Yuyu/0000-0002-9196-1610	NINDS [NS23868, NS23320]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R56NS023868, R01NS023320] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Brady and Johnson Laboratories for their general support; Dr. Hua Xu for help with MassMatrix data analysis; Dr. Robert Graham for generating the TG2 KO mouse; Gerardo Morfini, Gustavo Pigino, Hanwu Liu, Bin Wang, and Bao-shiang Lee for advice and encouragement; and Nicholas Kanaan for assistance with electron microscopy. The work was funded in part by grants from NINDS (NS23868, NS23320) to S.T.B.	AMBRON RT, 1982, P NATL ACAD SCI-BIOL, V79, P3442, DOI 10.1073/pnas.79.11.3442; Bailey CDC, 2005, PROG EXP TUMOR RES, V38, P139; Bailey CDC, 2004, J NEUROCHEM, V91, P1369, DOI 10.1111/j.1471-4159.2004.02825.x; Basso M, 2012, J NEUROSCI, V32, P6561, DOI 10.1523/JNEUROSCI.3353-11.2012; Brady Scott T., 1993, P7; BRADY ST, 1982, METHOD CELL BIOL, V25, P365, DOI 10.1016/S0091-679X(08)61434-X; BRADY ST, 1986, ANN NY ACAD SCI, V466, P199, DOI 10.1111/j.1749-6632.1986.tb38395.x; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; CACERES A, 1984, J NEUROSCI, V4, P394; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chabot N, 2010, CHEM BIOL, V17, P1143, DOI 10.1016/j.chembiol.2010.06.019; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Cooper AJL, 2002, NEUROCHEM INT, V40, P1, DOI 10.1016/S0197-0186(01)00055-9; Dai Y, 2008, J PHARMACOL EXP THER, V326, P153, DOI 10.1124/jpet.107.135046; DANZIN C, 1979, LIFE SCI, V24, P519, DOI 10.1016/0024-3205(79)90173-5; De Vivo G, 2009, CURR MED CHEM, V16, P4767, DOI 10.2174/092986709789909594; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Facchiano F, 2010, AMINO ACIDS, V39, P257, DOI 10.1007/s00726-009-0436-3; FALCONER MM, 1994, NEUROTOXICOLOGY, V15, P109; FOLK JE, 1980, J BIOL CHEM, V255, P3695; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HAND D, 1993, INT J DEV NEUROSCI, V11, P709, DOI 10.1016/0736-5748(93)90060-Q; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Kirkpatrick LL, 2001, J NEUROSCI, V21, P2288, DOI 10.1523/JNEUROSCI.21-07-02288.2001; KIRKPATRICK LL, 1994, J NEUROSCI, V14, P7440; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Lesort M, 2000, PROG NEUROBIOL, V61, P439, DOI 10.1016/S0301-0082(99)00052-0; LORAND L, 1971, ANAL BIOCHEM, V44, P221, DOI 10.1016/0003-2697(71)90363-0; Luduena RF, 1998, INT REV CYTOL, V178, P207; MACCIONI RB, 1986, MOL CELL BIOCHEM, V69, P161; Mahoney SA, 2000, NEUROSCIENCE, V101, P141, DOI 10.1016/S0306-4522(00)00324-9; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Mehta K, 2006, FRONT BIOSCI-LANDMRK, V11, P173, DOI 10.2741/1789; MELINO G, 1988, EXP CELL RES, V179, P429, DOI 10.1016/0014-4827(88)90281-9; MILLER CCJ, 1986, J NEUROCHEM, V46, P1912; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PEGG AE, 1988, ISI ATLAS-BIOCHEM, V1, P11; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; POHJANPELTO P, 1981, NATURE, V293, P475, DOI 10.1038/293475a0; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; SAHENK Z, 1987, CELL MOTIL CYTOSKEL, V8, P155, DOI 10.1002/cm.970080207; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; SHAW GG, 1973, J NEUROCHEM, V20, P1225, DOI 10.1111/j.1471-4159.1973.tb00091.x; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113	55	132	134	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2013	78	1					109	123		10.1016/j.neuron.2013.01.036	http://dx.doi.org/10.1016/j.neuron.2013.01.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583110	Bronze, Green Accepted			2022-12-25	WOS:000317556000011
J	Puehringer, D; Orel, N; Luningschror, P; Subramanian, N; Herrmann, T; Chao, MV; Sendtner, M				Puehringer, Dirk; Orel, Nadiya; Lueningschroer, Patrick; Subramanian, Narayan; Herrmann, Thomas; Chao, Moses V.; Sendtner, Michael			EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons	NATURE NEUROSCIENCE			English	Article							PROGENITOR-CELL PROLIFERATION; GROWTH-FACTOR; NEUROTROPHIN RECEPTORS; MICE LACKING; N-GLYCOSYLATION; NERVOUS-SYSTEM; DIFFERENTIATION; MEMBRANE; GUIDANCE; SURVIVAL	The development of neuronal networks in the neocortex depends on control mechanisms for mitosis and migration that allow newborn neurons to find their accurate position. Multiple mitogens, neurotrophic factors, guidance molecules and their corresponding receptors are involved in this process, but the mechanisms by which these signals are integrated are only poorly understood. We found that TrkB and TrkC, the receptors for brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are activated by epidermal growth factor receptor (EGFR) signaling rather than by BDNF or NT-3 in embryonic mouse cortical precursor cells. This transactivation event regulated migration of early neuronal cells to their final position in the developing cortex. Transactivation by EGF led to membrane translocation of TrkB, promoting its signaling responsiveness. Our results provide genetic evidence that TrkB and TrkC activation in early cortical neurons do not depend on BDNF and NT-3, but instead on transactivation by EGFR signaling.	[Puehringer, Dirk; Orel, Nadiya; Lueningschroer, Patrick; Subramanian, Narayan; Herrmann, Thomas; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Chao, Moses V.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY USA	University of Wurzburg; New York University	Sendtner, M (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	sendtner_m@klinik.uni-wuerzburg.de	Sendtner, Michael/M-8137-2014; Subramanian, Narayan/H-7449-2019; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Subramanian, Narayan/0000-0002-0234-9092; Sendtner, Michael/0000-0002-4737-2974; Chao, Moses/0000-0002-6969-3744; Luningschror, Patrick/0000-0002-3883-6554	Deutsche Forschungsgemeinschaft [SFB 487, C4, SFB 581, B4]; ForNeuroCell; US National Institutes of Health [NS21072-24]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ForNeuroCell; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank M. Sibilia (Medical University of Vienna) for providing Egfr<SUP>-/-</SUP> mice, Y.A. Barde (University of Basel) for the HA-TrkB construct, K. Walter for excellent technical assistance, and W. Fouquet and S. Sigrist for their help in STED microscopy. This work was supported by the Deutsche Forschungsgemeinschaft, grants SFB 487, C4 (N.O.) and SFB 581, B4 (D.P. and M.S.), ForNeuroCell (M.S.) and by US National Institutes of Health grant NS21072-24 (M.V.C.).	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bayer S.A., 1991, NEOCORTICAL DEV; Behar TN, 1997, EUR J NEUROSCI, V9, P2561, DOI 10.1111/j.1460-9568.1997.tb01685.x; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dontchev VD, 2002, J NEUROSCI, V22, P6659; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lotto RB, 2001, J NEUROSCI, V21, P3904, DOI 10.1523/JNEUROSCI.21-11-03904.2001; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Qiu LH, 2006, INT J ONCOL, V29, P1003; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rajagopal R, 2006, MOL CELL NEUROSCI, V33, P36, DOI 10.1016/j.mcn.2006.06.002; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rohrer B, 1999, J NEUROSCI, V19, P8919, DOI 10.1523/JNEUROSCI.19-20-08919.1999; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tropepe V, 1997, J NEUROSCI, V17, P7850; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8	54	61	62	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					407	U63		10.1038/nn.3333	http://dx.doi.org/10.1038/nn.3333			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416450	Green Accepted			2022-12-25	WOS:000316723700010
J	Korkut, C; Li, YH; Koles, K; Brewer, C; Ashley, J; Yoshihara, M; Budnik, V				Korkut, Ceren; Li, Yihang; Koles, Kate; Brewer, Cassandra; Ashley, James; Yoshihara, Motojiro; Budnik, Vivian			Regulation of Postsynaptic Retrograde Signaling by Presynaptic Exosome Release	NEURON			English	Article							SYNAPTOTAGMIN-IV; SYNAPTIC FUNCTION; DROSOPHILA; CELLS	Retrograde signals from postsynaptic targets are critical during development and plasticity of synaptic connections. These signals serve to adjust the activity of presynaptic cells according to postsynaptic cell outputs and to maintain synaptic function within a dynamic range. Despite their importance, the mechanisms that trigger the release of retrograde signals and the role of presynaptic cells in this signaling event are unknown. Here we show that a retrograde signal mediated by Synaptotagmin 4 (Syt4) is transmitted to the postsynaptic cell through anterograde delivery of Syt4 via exosomes. Thus, by transferring an essential component of retrograde signaling through exosomes, presynaptic cells enable retrograde signaling.	[Korkut, Ceren; Li, Yihang; Koles, Kate; Brewer, Cassandra; Ashley, James; Yoshihara, Motojiro; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu		Tezer, Ceren/0000-0001-9276-3264; Ashley, James/0000-0002-6693-1014	NIH [MH070000, MH85958]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000, R01MH085958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Budnik laboratory for helpful discussions. We also thank Dr. Troy Littleton, Dr. Michael Boutros, Dr. Patrick Emery, Dr. Carl Deisseroth, and the Vienna Drosophila RNAi Center for generous reagent sharing. We thank John Nunnari and the core electron microscopy facility at UMass Medical School. This work was supported by NIH grants MH070000 to V.B. and MH85958 to M.Y. Authors contribution is as follows: C.K. carried out most of the experiments, generated the chicken Syt4 antibody, coordinated the project, contributed intellectually to experimental design and interpretation, and contributed to writing the manuscript; Y.L. carried out immunoprecipitations and anatomical analysis, contributed intellectually to experimental design and interpretation, and coordinated the project in its last stages; C.B. carried out electrophysiological experiments; K.K. performed the purification of the exosomal fraction, immunoelectron microscopy of exosomes, and exosome uptake assays in myotubes from gastrula embryos and the CNS cell line; J.A. carried out electrophysiology and immunoelectron microscopy; M.Y. contributed to the initial observation of trans-synaptic Syt4 transfer, generation of the chicken Syt4 antibody, and to helpful discussions; and V.B. directed the project, experimental design, and interpretations and wrote the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; Barber CF, 2009, J CELL BIOL, V187, P295, DOI 10.1083/jcb.200903098; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Ferguson GD, 2001, MOL NEUROBIOL, V23, P173; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Li H, 2002, NEUROSCIENCE, V115, P505, DOI 10.1016/S0306-4522(02)00380-9; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	27	152	157	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2013	77	6					1039	1046		10.1016/j.neuron.2013.01.013	http://dx.doi.org/10.1016/j.neuron.2013.01.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522040	Green Accepted, Bronze			2022-12-25	WOS:000316645000006
J	Liu, KC; Jiang, M; Lu, Y; Chen, H; Sun, J; Wu, SP; Ku, WY; Nakagawa, H; Kita, Y; Natsugoe, S; Peters, JH; Rustgi, AK; Onaitis, MW; Kiernan, A; Chen, XX; Que, JW				Liu, Kuancan; Jiang, Ming; Lu, Yun; Chen, Hao; Sun, Jun; Wu, Shaoping; Ku, Wei-Yao; Nakagawa, Hiroshi; Kita, Yoshiaki; Natsugoe, Shoji; Peters, Jeffrey H.; Rustgi, Anil K.; Onaitis, Mark W.; Kiernan, Amy; Chen, Xiaoxin; Que, Jianwen			Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; ESOPHAGEAL EPITHELIUM; ANTERIOR FOREGUT; MOUSE TRACHEA; CANCER; REFLUX; TUMOR; DIFFERENTIATION; PROLIFERATION	Sox2 regulates the self-renewal of multiple types of stem cells. Recent studies suggest it also plays oncogenic roles in the formation of squamous carcinoma in several organs, including the esophagus where Sox2 is predominantly expressed in the basal progenitor cells of the stratified epithelium. Here, we use mouse genetic models to reveal a mechanism by which Sox2 cooperates with microenvironmental signals to malignantly transform epithelial progenitor cells. Conditional overexpression of Sox2 in basal cells expands the progenitor population in both the esophagus and forestomach. Significantly, carcinoma only develops in the forestomach, where pathological progression correlates with inflammation and nuclear localization of Stat3 in progenitor cells. Importantly, co-overexpression of Sox2 and activated Stat3 (Stat3C) also transforms esophageal basal cells but not the differentiated suprabasal cells. These findings indicate that basal stem/progenitor cells are the cells of origin of squamous carcinoma and that cooperation between Sox2 and microenvironment-activated Stat3 is required for Sox2-driven tumorigenesis.	[Liu, Kuancan; Jiang, Ming; Ku, Wei-Yao; Que, Jianwen] Univ Rochester, Dept Biomed Genet, Rochester, NY 14642 USA; [Que, Jianwen] Univ Rochester, Stem Cell & Regenerat Med Inst, Rochester, NY 14642 USA; [Peters, Jeffrey H.] Univ Rochester, Dept Surg, Rochester, NY 14642 USA; [Kiernan, Amy] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Chen, Hao; Chen, Xiaoxin] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Onaitis, Mark W.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Sun, Jun; Wu, Shaoping] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Rustgi, Anil K.] Univ Penn, Sch Med, Abramson Canc Ctr, Div Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Sch Med, Abramson Canc Ctr, Div Dept Genet, Philadelphia, PA 19104 USA; [Lu, Yun] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Kita, Yoshiaki; Natsugoe, Shoji] Kagoshima Univ, Dept Digest Surg, Kagoshima 8908520, Japan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of North Carolina; North Carolina Central University; Duke University; Rush University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tsinghua University; Kagoshima University	Que, JW (corresponding author), Univ Rochester, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	jianwen_que@urmc.rochester.edu	liu, kuancan/AAE-4400-2020; Sun, Jun/S-7440-2019	liu, kuancan/0000-0002-2470-7479; Sun, Jun/0000-0001-7465-3133	NIDDK [K99/R00 DK082650]; NCI [U54 CA156735, P01-CA098101, U01-CA143056]; American Cancer Society; NATIONAL CANCER INSTITUTE [P01CA098101, U01CA143056, U54CA156735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK082650, K99DK082650] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was initiated in Dr. Brigid Hogan's laboratory at the Department of Cell Biology, Duke University. We are grateful to Dr. Brigid Hogan and Dr. Mark Noble, Dr. Hartmut Land, Dr. Craig Jordan, and Dr. Dirk Bohmann at the Department of Biomedical Genetics in the University of Rochester for helpful discussion and critical reading of the manuscript. We also wish to thank Ian Jacobs and other members of the Que laboratory for discussion and technical assistance. This work was supported by the following grants: NIDDK K99/R00 DK082650 (J.Q.), NCI U54 CA156735 (X. C.), NCI P01-CA098101 (and its Molecular Pathology/Imaging and Molecular Biology Core Facilities, A. R.), NCI U01-CA143056 (A. R.), and American Cancer Society (A.R.).	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chen KH, 2007, ANTICANCER RES, V27, P175; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gen Y., 2010, CANCER GENET CYTOGEN, V202, P82; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-59; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jacobs IJ, 2012, DEV BIOL, V369, P54, DOI 10.1016/j.ydbio.2012.06.016; Jovov B, 2011, AM J GASTROENTEROL, V106, P1039, DOI 10.1038/ajg.2011.102; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; Pandeya N, 2010, GUT, V59, P31, DOI 10.1136/gut.2009.190827; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Souza RF, 2010, BIOCHEM SOC T, V38, P348, DOI 10.1042/BST0380348; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Taccioli C, 2012, ONCOGENE, V31, P4550, DOI 10.1038/onc.2011.592; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Uno K, 2011, AM J GASTROENTEROL, V106, P1923, DOI 10.1038/ajg.2011.282; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026	45	136	139	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					304	315		10.1016/j.stem.2013.01.007	http://dx.doi.org/10.1016/j.stem.2013.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472872	Green Accepted, Bronze			2022-12-25	WOS:000329569400009
J	Cao, E; Cordero-Morales, JF; Liu, BY; Qin, F; Julius, D				Cao, Erhu; Cordero-Morales, Julio F.; Liu, Beiying; Qin, Feng; Julius, David			TRPV1 Channels Are Intrinsically Heat Sensitive and Negatively Regulated by Phosphoinositide Lipids	NEURON			English	Article							PROTEIN-KINASE-C; CAPSAICIN RECEPTOR; PHOSPHOLIPASE-C; ION CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DROSOPHILA PHOTORECEPTORS; VANILLOID RECEPTOR; TRPM8 CHANNELS; MEMBRANE-PROTEINS; PIP2 ACTIVATION	The capsaicin receptor, TRPV1, is regulated by phosphatidylinosito1-4,5-bisphosphate (PIP2), although the precise nature of this effect (i.e., positive or negative) remains controversial. Here, we reconstitute purified TRPV1 into artificial liposomes, where it is gated robustly by capsaicin, protons, spider toxins, and, notably, heat, demonstrating intrinsic sensitivity of the channel to both chemical and thermal stimuli. TRPV1 is fully functional in the absence of phosphoinositides, arguing against their proposed obligatory role in channel activation. Rather, introduction of various phosphoinositides, including PIP2, PI4P, and phosphatidylinositol, inhibits TRPV1, supporting a model whereby phosphoinositide turnover contributes to thermal hyperalgesia by disinhibiting the channel. Using an orthogonal chemical strategy, we show that association of the TRPV1 C terminus with the bilayer modulates channel gating, consistent with phylogenetic data implicating this domain as a key regulatory site for tuning stimulus sensitivity. Beyond TRPV1, these findings are relevant to understanding how membrane lipids modulate other "receptor-operated" TRP channels.	[Cao, Erhu; Cordero-Morales, Julio F.; Julius, David] Univ Calif San Francisco, Dept Phys, San Francisco, CA 94143 USA; [Liu, Beiying; Qin, Feng] SUNY Buffalo, Dept Physiol & Biophys Sci, Buffalo, NY 14214 USA	University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Julius, D (corresponding author), Univ Calif San Francisco, Dept Phys, San Francisco, CA 94143 USA.	david.julius@ucsf.edu		Cordero Morales, Julio/0000-0002-6505-5403	Lilly Research Laboratory; National Institutes of Health [GM65994, NS047723, NS065071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065994, R01GM104521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS065071, R01NS065071, R01NS047723, R37NS047723] Funding Source: NIH RePORTER	Lilly Research Laboratory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Avi Priel and other members of the Julius Lab for helpful discussion and suggestions. E.C. was a fellow of the Damon Runyon Cancer Research Foundation and J.F.C.-M. is a fellow of the Life Science Research Foundation (sponsored by the Lilly Research Laboratory). This work was supported by grants from the National Institutes of Health, including GM65994 (F.Q.) and NS047723 and NS065071 (D.J.).	Albert AP, 2008, J PHYSIOL-LONDON, V586, P3087, DOI 10.1113/jphysiol.2008.153676; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Ferreira J, 2004, BRIT J PHARMACOL, V141, P787, DOI 10.1038/sj.bjp.0705546; Gamper Nikita, 2012, Subcell Biochem, V59, P289, DOI 10.1007/978-94-007-3015-1_10; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hardie RC, 2012, SCIENCE, V338, P260, DOI 10.1126/science.1222376; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kaczmarek JS, 2012, P NATL ACAD SCI USA, V109, P7888, DOI 10.1073/pnas.1205869109; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lemonnier L, 2008, CELL CALCIUM, V43, P506, DOI 10.1016/j.ceca.2007.09.001; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Minke B, 2001, CELL MOL NEUROBIOL, V21, P629, DOI 10.1023/A:1015191702536; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin F., 2007, V179, P509; Raghu P, 2009, CELL CALCIUM, V45, P566, DOI 10.1016/j.ceca.2009.03.005; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum EE, 2011, NEURON, V72, P602, DOI 10.1016/j.neuron.2011.09.016; Rosenbaum Tamara, 2007, P69; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	68	217	220	5	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					667	679		10.1016/j.neuron.2012.12.016	http://dx.doi.org/10.1016/j.neuron.2012.12.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439120	Bronze, Green Accepted			2022-12-25	WOS:000315561300010
J	Ouyang, Q; Lizarraga, SB; Schmidt, M; Yang, U; Gong, JY; Ellisor, D; Kauer, JA; Morrow, EM				Ouyang, Qing; Lizarraga, Sofia B.; Schmidt, Michael; Yang, Unikora; Gong, Jingyi; Ellisor, Debra; Kauer, Julie A.; Morrow, Eric M.			Christianson Syndrome Protein NHE6 Modulates TrkB Endosomal Signaling Required for Neuronal Circuit Development	NEURON			English	Article							NA+/H+ EXCHANGER ISOFORM-6; MENTAL-RETARDATION; SODIUM/PROTON EXCHANGER; NEUROTROPHIC FACTOR; ANGELMAN-SYNDROME; AUTISM; MECHANISMS; CELLS; YEAST; PH	Neuronal arborization is regulated by cell-autonomous and nonautonomous mechanisms including endosomal signaling via BDNF/TrkB. The endosomal Na+/H+ exchanger 6 (NHE6) is mutated in a new autism-related disorder. NHE6 functions to permit proton leak from endosomes, yet the mechanisms causing disease are unknown. We demonstrate that loss of NHE6 results in overacidification of the endosomal compartment and attenuated TrkB signaling. Mouse brains with disrupted NHE6 display reduced axonal and dendritic branching, synapse number, and circuit strength. Site-directed mutagenesis shows that the proton leak function of NHE6 is required for neuronal arborization. We find that TrkB receptor colocalizes to NHE6-associated endosomes. TrkB protein and phosphorylation are reduced in NHE6 mutant neurons in response to BDNF signaling. Finally, exogenous BDNF rescues defects in neuronal arborization. We propose that NHE6 mutation leads to circuit defects that are in part due to impoverished neuronal arborization that may be treatable by enhanced TrkB signaling.	[Ouyang, Qing; Lizarraga, Sofia B.; Schmidt, Michael; Yang, Unikora; Gong, Jingyi; Ellisor, Debra; Morrow, Eric M.] Brown Univ, Dept Mol Biol, Mol Med Lab, Providence, RI 02903 USA; [Ouyang, Qing; Lizarraga, Sofia B.; Schmidt, Michael; Yang, Unikora; Gong, Jingyi; Ellisor, Debra; Morrow, Eric M.] Brown Univ, Dept Cell Biol, Mol Med Lab, Providence, RI 02903 USA; [Ouyang, Qing; Lizarraga, Sofia B.; Schmidt, Michael; Yang, Unikora; Gong, Jingyi; Ellisor, Debra; Morrow, Eric M.] Brown Univ, Dept Biochem, Mol Med Lab, Providence, RI 02903 USA; [Ouyang, Qing; Lizarraga, Sofia B.; Schmidt, Michael; Yang, Unikora; Gong, Jingyi; Ellisor, Debra; Morrow, Eric M.] Brown Univ, Inst Brain Sci, Mol Med Lab, Providence, RI 02903 USA; [Kauer, Julie A.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Kauer, Julie A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Morrow, Eric M.] Brown Univ, Sch Med, Emma Pendleton Bradley Hosp, Dev Disorders Genet Res Program, East Providence, RI 02915 USA; [Morrow, Eric M.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, East Providence, RI 02915 USA	Brown University; Brown University; Brown University; Brown University; Brown University; Brown University; Brown University; Brown University	Morrow, EM (corresponding author), Brown Univ, Dept Mol Biol, Mol Med Lab, 70 Ship St, Providence, RI 02903 USA.	eric_morrow@brown.edu	Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520; Kauer, Julie/0000-0002-3362-1642	Career Award in Medical Science; Burroughs Wellcome Fund; NIH NIGMS COBRE [8P20GM103537-10]; NIH [5T32MH019118-21]; Simons Foundation [SFARI 239834]; Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103537, P30GM103410, P20GM103645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH080954, T32MH019118] Funding Source: NIH RePORTER	Career Award in Medical Science; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH NIGMS COBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Robbed Creton at Brown University Leduc Bioimaging Facility for advice regarding microscopy and Dr. Peter Davies for the kind gift of Phospho-Tau1 antibody. E.M.M. has received support from Career Award in Medical Science, Burroughs Wellcome Fund, and NIH NIGMS COBRE 8P20GM103537-10. S.B.L. has received support from NIH 5T32MH019118-21. This work was supported by a grant from the Simons Foundation (SFARI 239834 to E.M.M.) and also generous support to E.M.M. from the Nancy Lurie Marks Foundation.	Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chao MV, 2004, J ALZHEIMERS DIS, V6, pS7; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Danzer SC, 2002, J NEUROSCI, V22, P9754; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Goh GY, 2011, NAT NEUROSCI, V14, P1285, DOI 10.1038/nn.2898; Gorski JA, 2003, J NEUROSCI, V23, P6856; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; MELLMAN I, 1992, J EXP BIOL, V172, P39; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Ohgaki R, 2008, J BIOL CHEM, V283, P4417, DOI 10.1074/jbc.M705146200; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; Overly CC, 1996, J NEUROSCI, V16, P6056; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schroer RJ, 2010, AM J MED GENET A, V152A, P2775, DOI 10.1002/ajmg.a.33093; Schwede M, 2014, MOL PSYCHIATR, V19, P277, DOI 10.1038/mp.2013.28; Stromme P., 2011, BRAIN, V134, P3369; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wu CB, 2009, J PROTEOMICS, V72, P46, DOI 10.1016/j.jprot.2008.10.007; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	44	85	85	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					97	112		10.1016/j.neuron.2013.07.043	http://dx.doi.org/10.1016/j.neuron.2013.07.043			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24035762	Green Accepted, Bronze			2022-12-25	WOS:000326305300011
J	Vilberg, KL; Davachi, L				Vilberg, Kaia L.; Davachi, Lila			Perirhinal-Hippocampal Connectivity during Reactivation Is a Marker for Object-Based Memory Consolidation	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; DECLARATIVE MEMORIES; RETROGRADE-AMNESIA; SLEEP; CORTEX; RETRIEVAL; REPLAY; RECOLLECTION; HUMANS	The present study utilized event-related fMRI to address the role of the human perirhinal cortex (PRC), and its interactions with the hippocampus, in memory consolidation. Participants encoded object-based and scene-based associations and then restudied them either after a "long" or "short" delay during which consolidation could occur. We found that BOLD activation in left PRC and hippocampal-PRC functional connectivity were significantly enhanced during the restudy of the long versus short delay word-object pairs. Secondly, hippocampal-PRC connectivity during restudy of the long delay word-object pairs predicted a subsequent reduction in associative forgetting. By contrast, hippocampal-PRC connectivity did not predict subsequent resistance to forgetting for the short delay or novel associations. Together, these results provide evidence for perirhinal-hippocampal interactions in the selective consolidation of object-based associative memories and provide support for the notion that, during early stages of consolidation, memories become more distributed across brain regions.	[Vilberg, Kaia L.] Univ Texas Dallas, Ctr Vital Longev, Dallas, TX 75235 USA; [Vilberg, Kaia L.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75235 USA; [Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; New York University; New York University	Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lila.davachi@nyy.edu		Davachi, Lila/0000-0003-4317-0889	NIMH [RO1-MH074692]; Dart Neuroscience; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dart Neuroscience; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIMH RO1-MH074692 and Dart Neuroscience to L.D.	Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Larkin AE, 2008, BRAIN RES, V1199, P126, DOI 10.1016/j.brainres.2008.01.019; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Litman L, 2008, LEARN MEMORY, V15, P711, DOI 10.1101/lm.1132008; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Milton F, 2011, MEMORY, V19, P733, DOI 10.1080/09658211.2011.552185; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oudiette D, 2013, J NEUROSCI, V33, P6672, DOI 10.1523/JNEUROSCI.5497-12.2013; Oudiette D, 2013, TRENDS COGN SCI, V17, P142, DOI 10.1016/j.tics.2013.01.006; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Paz R, 2007, J NEUROSCI, V27, P6542, DOI 10.1523/JNEUROSCI.1077-07.2007; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Ramos JMJ, 2008, LEARN MEMORY, V15, P587, DOI 10.1101/lm.1036308; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Staresina BP, 2011, J NEUROSCI, V31, P8739, DOI 10.1523/JNEUROSCI.4978-10.2011; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wimber M, 2012, CURR BIOL, V22, P1482, DOI 10.1016/j.cub.2012.05.054; Winters BD, 2005, J NEUROSCI, V25, P4243, DOI 10.1523/JNEUROSCI.0480-05.2005; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	54	47	47	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1232	1242		10.1016/j.neuron.2013.07.013	http://dx.doi.org/10.1016/j.neuron.2013.07.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	23993700	Green Accepted, Bronze			2022-12-25	WOS:000330329600019
J	Miron, VE; Boyd, A; Zhao, JW; Yuen, TJ; Ruckh, JM; Shadrach, JL; van Wijngaarden, P; Wagers, AJ; Williams, A; Franklin, RJM; Ffrench-Constant, C				Miron, Veronique E.; Boyd, Amanda; Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; Shadrach, Jennifer L.; van Wijngaarden, Peter; Wagers, Amy J.; Williams, Anna; Franklin, Robin J. M.; Ffrench-Constant, Charles			M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination	NATURE NEUROSCIENCE			English	Article							GADOLINIUM CHLORIDE; PROGENITOR CELLS; GENE-EXPRESSION; ACTIVIN-A; IDENTIFICATION; MONOCYTES; INJURY; BETA; REGENERATION; PROGRESSION	The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination. This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2). We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started. Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion. M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination. Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures. Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.	[Miron, Veronique E.; Boyd, Amanda; Yuen, Tracy J.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, MRC Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England; [Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Shadrach, Jennifer L.; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA	University of Edinburgh; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.	Miron, VE (corresponding author), Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	vmiron@staffmail.ed.ac.uk	Zhao, Jing-Wei/L-9964-2014; Zhao, Jing-Wei/A-6887-2012; Miron, Veronique E./H-4280-2019	Zhao, Jing-Wei/0000-0002-1135-9743; Miron, Veronique E./0000-0003-1738-0647; Williams, Anna/0000-0002-6329-382X; Franklin, Robin/0000-0001-6522-2104; van Wijngaarden, Peter/0000-0002-8800-7834; Yuen, Tracy/0000-0002-3451-9279	UK Multiple Sclerosis Society; Wellcome Trust; Multiple Sclerosis Society of Canada; Medical Research Council [MR/K017047/1B, G0300336, G0802545] Funding Source: researchfish; MRC [G0802545, G0300336] Funding Source: UKRI	UK Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); Multiple Sclerosis Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Multiple Sclerosis Tissue Bank for providing human brain tissue, F. Roncaroli (Imperial College London) for neuropathological diagnosis of lesions and R. Nicholas (Imperial College London) for providing clinical history of patients. We also thank W. Mungall, J. Huang, M. Harrisingh, A. Jarjour, M. Bechler, M. Swire, A.-C. Nunes-Fonseca, D. Morrison, and C. Watkins for technical assistance. This work was funded by the UK Multiple Sclerosis Society (R.J.M.F. and C.ff.-C.) and the Wellcome Trust (A.W. and C.ff.-C.), and V.E.M. holds a post-doctoral fellowship from the Multiple Sclerosis Society of Canada.	Abdel-Zaher AO, 2007, TOXICOLOGY, V234, P124, DOI 10.1016/j.tox.2007.02.014; Ahn M, 2012, BRAIN RES, V1453, P77, DOI 10.1016/j.brainres.2012.03.023; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Attisano L, 1996, MOL CELL BIOL, V16, P1066; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; CASH E, 1993, CELL IMMUNOL, V147, P129, DOI 10.1006/cimm.1993.1053; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MATZUK MM, 1995, TRENDS ENDOCRIN MET, V6, P120, DOI 10.1016/1043-2760(95)00032-D; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189, DOI 10.1002/jlb.59.2.189; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; PENDINO KJ, 1995, AM J RESP CELL MOL, V13, P125, DOI 10.1165/ajrcmb.13.2.7542894; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sakai T, 2012, CELL TRANSPLANT, V21, P355, DOI 10.3727/096368911X580545; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Voss EV, 2012, NEUROBIOL DIS, V45, P519, DOI 10.1016/j.nbd.2011.09.008; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	48	1054	1084	12	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1211	U75		10.1038/nn.3469	http://dx.doi.org/10.1038/nn.3469			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872599	Green Accepted			2022-12-25	WOS:000323597500012
J	Goldman, O; Han, SY; Sourrisseau, M; Dziedzic, N; Hamou, W; Corneo, B; D'Souza, S; Sato, T; Kotton, DN; Bissig, KD; Kalir, T; Jacobs, A; Evans, T; Evans, MJ; Gouon-Evans, V				Goldman, Orit; Han, Songyan; Sourrisseau, Marion; Dziedzic, Noelle; Hamou, Wissam; Corneo, Barbara; D'Souza, Sunita; Sato, Thomas; Kotton, Darrell N.; Bissig, Karl-Dimiter; Kalir, Tamara; Jacobs, Adam; Evans, Todd; Evans, Matthew J.; Gouon-Evans, Valerie			KDR Identifies a Conserved Human and Murine Hepatic Progenitor and Instructs Early Liver Development	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HEPATOCYTE-LIKE CELLS; C VIRUS-INFECTION; EFFICIENT DIFFERENTIATION; DEFINITIVE ENDODERM; FUNCTIONAL HEPATOCYTES; MOUSE-LIVER; IN-VIVO; FETAL; EXPRESSION	Understanding the fetal hepatic niche is essential for optimizing the generation of functional hepatocyte-like cells (hepatic cells) from human embryonic stem cells (hESCs). Here, we show that KDR (VEGFR2/FLK-1), previously assumed to be mostly restricted to mesodermal lineages, marks a hESCderived hepatic progenitor. hESC-derived endoderm cells do not express KDR but, when cultured in media supporting hepatic differentiation, generate KDR+ hepatic progenitors and KDR-hepatic cells. KDR+ progenitors require active KDR signaling both to instruct their own differentiation into hepatic cells and to non-cell-autonomously support the functional maturation of cocultured KDR-hepatic cells. Analysis of human fetal livers suggests that similar progenitors are present in human livers. Lineage tracing in mice provides in vivo evidence of a KDR+ hepatic progenitor for fetal hepatoblasts, adult hepatocytes, and adult cholangiocytes. Altogether, our findings reveal that KDR is a conserved marker for endoderm- derived hepatic progenitors and a functional receptor instructing early liver development.	[Goldman, Orit; Han, Songyan; Dziedzic, Noelle; Hamou, Wissam; D'Souza, Sunita; Gouon-Evans, Valerie] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Sourrisseau, Marion; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Kalir, Tamara] Icahn Sch Med Mt Sinai, Div Gynecol Pathol, New York, NY 10029 USA; [Jacobs, Adam] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Corneo, Barbara] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Sato, Thomas] Nara Inst Sci & Technol, Nara 6300101, Japan; [Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA; [Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Dept Mol & Cellular Biol, Stem Cells & Regenerat Med Ctr, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Nara Institute of Science & Technology; Boston University; Boston Medical Center; Baylor College of Medicine; Cornell University	Gouon-Evans, V (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	valerie.gouon-evans@mssm.edu	Han, Songyan/D-8351-2012	Gouon-Evans, Valerie/0000-0001-5424-6573; Evans, Matthew/0000-0002-4991-3877; Kotton, Darrell/0000-0002-9604-8476; Corneo, Barbara/0000-0001-5189-6749; hamou, wissam/0000-0002-0731-9386	Black Family Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087867-01]; American Cancer Society [RSG-12-176-01-MPC]; Pew Charitable Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087867, R01DK095125] Funding Source: NIH RePORTER	Black Family Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Pew Charitable Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Black Family Stem Cell Institute, the National Institute of Diabetes and Digestive and Kidney Diseases for the mouse study (R01DK087867-01 to V.G.E.), the Robin Chemers Neustein Postdoctoral Fellowship (M.S.), the American Cancer Society (RSG-12-176-01-MPC to M.J.E.), and the Pew Charitable Funds (M.J.E.).	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Han S., 2012, J STEM CELL RES TH S, VS10; Han SY, 2011, STEM CELLS, V29, P217, DOI 10.1002/stem.576; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kopper O, 2012, STEM CELL RES, V8, P335, DOI 10.1016/j.scr.2011.12.006; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Mahieu-Caputo D, 2004, HUM GENE THER, V15, P1219, DOI 10.1089/hum.2004.15.1219; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; MIGLIACCIO G, 1986, J CLIN INVEST, V78, P51, DOI 10.1172/JCI112572; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nierhoff D, 2007, HEPATOLOGY, V46, P535, DOI 10.1002/hep.21721; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Nowak G, 2005, GUT, V54, P972, DOI 10.1136/gut.2005.064477; Nyamath P, 2007, WORLD J GASTROENTERO, V13, P2319, DOI 10.3748/wjg.v13.i16.2319; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shulla A, 2012, CURR OPIN VIROL, V2, P725, DOI 10.1016/j.coviro.2012.09.013; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sondell M, 2001, NEUROREPORT, V12, P105, DOI 10.1097/00001756-200101220-00028; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Terrace JD, 2007, STEM CELLS DEV, V16, P771, DOI 10.1089/scd.2007.0016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Yoshida T, 2011, BIOCHEM BIOPH RES CO, V416, P119, DOI 10.1016/j.bbrc.2011.11.007	55	41	45	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					748	760		10.1016/j.stem.2013.04.026	http://dx.doi.org/10.1016/j.stem.2013.04.026			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746980	Bronze, Green Accepted			2022-12-25	WOS:000329569900017
J	Cvetkovska, V; Hibbert, AD; Emran, F; Chen, BE				Cvetkovska, Vedrana; Hibbert, Alexa D.; Emran, Farida; Chen, Brian E.			Overexpression of Down syndrome cell adhesion molecule impairs precise synaptic targeting	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; DSCAM; FMRP; REGION; DIVERSITY; BINDING	Fragile X syndrome is caused by the loss of Fragile X mental retardation protein (FMRP), an RNA-binding protein that suppresses protein translation. We found that FMRP binds to Down syndrome cell adhesion molecule (Dscam) RNA, a molecule that is involved in neural development and has been implicated in Down syndrome. Elevated Dscam protein levels in FMRP null Drosophila and in flies with three copies of the Dscam gene both produced specific and similar synaptic targeting errors in a hard-wired neural circuit, which impaired the flies' sensory perception. Reducing Dscam levels in FMRP null flies reduced synaptic targeting errors and rescued behavioral responses. Our results indicate that excess Dscam protein may be a common molecular mechanism underlying altered neural wiring in intellectual disabilities such as Fragile X and Down syndromes.	[Cvetkovska, Vedrana; Hibbert, Alexa D.; Emran, Farida; Chen, Brian E.] McGill Univ, Ctr Res Neurosci, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada; [Chen, Brian E.] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada; [Chen, Brian E.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Chen, BE (corresponding author), McGill Univ, Ctr Res Neurosci, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada.	brian.chen@mcgill.ca		Cvetkovska, Vedrana/0000-0002-8876-6662	Alfred P. Sloan Research Fellowship; Canada Research Chair grant [950-212462]; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre	Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Canada Research Chair grant(Canada Research Chairs); Department of Medicine at McGill University; Research Institute of the McGill University Health Centre	The authors thank T.-J. Lin, I. Kays and V. Stoudenikina for assistance with experiments, R. Suciu for assistance in pyrosequencing analysis, A. Staffa and the Massively Parallel Sequencing Unit at Genome Quebec for pyrosequencing assistance, and B. Douba for graphic arts assistance in the fly drawing. This work was supported by an Alfred P. Sloan Research Fellowship and a Canada Research Chair grant 950-212462 (to B.E.C.) and by funds from the Department of Medicine at McGill University and the Research Institute of the McGill University Health Centre.	Alves-Sampaio A, 2010, J NEUROSCI, V30, P13537, DOI 10.1523/JNEUROSCI.3457-10.2010; Antonarakis SE, 1998, GENOMICS, V51, P1, DOI 10.1006/geno.1998.5335; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blank M, 2011, J NEUROSCI, V31, P5764, DOI 10.1523/JNEUROSCI.6015-10.2011; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Canal I, 1998, J NEUROSCI, V18, P999; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; CORFAS G, 1989, J NEUROSCI, V9, P56; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; Grossman TR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002344; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hildmann T, 1999, GENOME RES, V9, P360; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Li HL, 2009, NEURON, V61, P527, DOI 10.1016/j.neuron.2009.01.010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Neufeld SQ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-15; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PHILLIS RW, 1993, GENETICS, V133, P581; Rachidi M, 2007, NEUROSCI RES, V59, P349, DOI 10.1016/j.neures.2007.08.007; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; VANDERVORST P, 1980, NATURE, V286, P65, DOI 10.1038/286065a0; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	49	48	49	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					677	U36		10.1038/nn.3396	http://dx.doi.org/10.1038/nn.3396			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666178	Green Accepted			2022-12-25	WOS:000319509600008
J	Julian, LM; Vandenbosch, R; Pakenham, CA; Andrusiak, MG; Nguyen, AP; McClellan, KA; Svoboda, DS; Lagace, DC; Park, DS; Leone, G; Blais, A; Slack, RS				Julian, Lisa M.; Vandenbosch, Renaud; Pakenham, Catherine A.; Andrusiak, Matthew G.; Nguyen, Angela P.; McClellan, Kelly A.; Svoboda, Devon S.; Lagace, Diane C.; Park, David S.; Leone, Gustavo; Blais, Alexandre; Slack, Ruth S.			Opposing Regulation of Sox2 by Cell-Cycle Effectors E2f3a and E2f3b in Neural Stem Cells	CELL STEM CELL			English	Article							MITOTIC SPINDLE ORIENTATION; PROGENITOR CELLS; TRANSCRIPTION FACTORS; PRECURSOR CELLS; MAMMALIAN BRAIN; DIFFERENTIATION; MOUSE; GENE; EXPRESSION; NEURONS	The mechanisms through which cell-cycle control and cell-fate decisions are coordinated in proliferating stem cell populations are largely unknown. Here, we show that E2f3 isoforms, which control cell-cycle progression in cooperation with the retinoblastoma protein (pRb), have critical effects during developmental and adult neurogenesis. Loss of either E2f3 isoform disrupts Sox2 gene regulation and the balance between precursor maintenance and differentiation in the developing cortex. Both isoforms target the Sox2 locus to maintain baseline levels of Sox2 expression but antagonistically regulate Sox2 levels to instruct fate choices. E2f3-mediated regulation of Sox2 and precursor cell fate extends to the adult brain, where E2f3a loss results in defects in hippocampal neurogenesis and memory formation. Our results demonstrate a mechanism by which E2f3a and E2f3b differentially regulate Sox2 dosage in neural precursors, a finding that may have broad implications for the regulation of diverse stem cell populations.	[Julian, Lisa M.; Vandenbosch, Renaud; Pakenham, Catherine A.; Andrusiak, Matthew G.; Nguyen, Angela P.; McClellan, Kelly A.; Svoboda, Devon S.; Lagace, Diane C.; Park, David S.; Slack, Ruth S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Blais, Alexandre] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Blais, Alexandre] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Leone, Gustavo] Ohio State Univ, Solid Tumor Biol Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Genet, Columbus, OH 43210 USA	University of Ottawa; University of Ottawa; University of Ottawa; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Blais, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	alexandre.blais@uottawa.ca; rslack@uottawa.ca		Blais, Alexandre/0000-0003-2446-1883; Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784	Canadian Institutes of Health Research (CIHR); CIHR Canada Graduate Scholarships; Ontario Graduate Scholarship (OGS); OGSST studentships; OGS; Heart and Stroke Foundation of Canada (HSFC) scholarships; Alzheimer Society of Canada; HSFC; University of Ottawa; Fonds Leon Fredericq (University of Liege, Belgium)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); OGSST studentships; OGS(Ontario Graduate Scholarship); Heart and Stroke Foundation of Canada (HSFC) scholarships; Alzheimer Society of Canada; HSFC(Heart & Stroke Foundation of Canada); University of Ottawa; Fonds Leon Fredericq (University of Liege, Belgium)	We thank Drs. Valerie Wallace, Rod Bremner, Marc Germain, and Mireille Khacho for critical review of the manuscript, as well as Jason MacLaurin, Linda Jui, Mirela Hasu, Alysen Clark, and Delphie Dugal-Tessier for excellent technical assistance. We also thank Yubing Liu for help with ChIP-on-chip experiments and Drs. Juliette Godin and Sandrine Humbert for assistance with the spindle-pole analysis. This work was funded by Canadian Institutes of Health Research (CIHR) grants to R. S. S.; and also by CIHR Canada Graduate Scholarships to L.M.J. and K. A. M.; Ontario Graduate Scholarship (OGS) and OGSST studentships to C. A. P. and L.M.J.; OGS and Heart and Stroke Foundation of Canada (HSFC) scholarships to M. G. A.; and fellowships from the Alzheimer Society of Canada, HSFC, University of Ottawa Vision 2010, and a travel award from Fonds Leon Fredericq (University of Liege, Belgium) to R.V.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Callaghan DA, 1999, DEV BIOL, V207, P257, DOI 10.1006/dbio.1998.9162; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; King JC, 2008, CELL CYCLE, V7, P3775, DOI 10.4161/cc.7.23.7240; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Connor MD, 2011, EXP HEMATOL, V39, P866, DOI 10.1016/j.exphem.2011.05.008; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Ruzhynsky VA, 2007, J NEUROSCI, V27, P5926, DOI 10.1523/JNEUROSCI.1538-07.2007; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	39	55	56	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					440	452		10.1016/j.stem.2013.02.001	http://dx.doi.org/10.1016/j.stem.2013.02.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23499385	Bronze			2022-12-25	WOS:000329569500011
J	Schulz, A; Baader, SL; Niwa-Kawakita, M; Jung, MJ; Bauer, R; Garcia, C; Zoch, A; Schacke, S; Hagel, C; Mautner, VF; Hanemann, CO; Dun, XP; Parkinson, DB; Weis, J; Schroder, JM; Gutmann, DH; Giovannini, M; Morrison, H				Schulz, Alexander; Baader, Stephan L.; Niwa-Kawakita, Michiko; Jung, Marie Juliane; Bauer, Reinhard; Garcia, Cynthia; Zoch, Ansgar; Schacke, Stephan; Hagel, Christian; Mautner, Victor-Felix; Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.; Weis, Joachim; Schroeder, J. Michael; Gutmann, David H.; Giovannini, Marco; Morrison, Helen			Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy	NATURE NEUROSCIENCE			English	Article							SUPPRESSOR GENE-PRODUCT; NEUROFILAMENT; MICE; RHO; EXPRESSION; NEURONS; PHOSPHORYLATION; PROTEIN; GTPASES; GROWTH	The autosomal dominant disorder neurofibromatosis type 2 (NF2) is a hereditary tumor syndrome caused by inactivation of the NF2 tumor suppressor gene, encoding merlin. Apart from tumors affecting the peripheral and central nervous systems, most NF2 patients develop peripheral neuropathies. This peripheral nerve disease can occur in the absence of nerve-damaging tumors, suggesting an etiology that is independent of gross tumor burden. We discovered that merlin isoform 2 (merlin-iso2) has a specific function in maintaining axonal integrity and propose that reduced axonal NF2 gene dosage leads to NF2-associated polyneuropathy. We identified a merlin-iso2-dependent complex that promotes activation of the GTPase RhoA, enabling downstream Rho-associated kinase to promote neurofilament heavy chain phosphorylation. Merlin-iso2-deficient mice exhibited impaired locomotor capacities, delayed sensory reactions and electrophysiological signs of axonal neuropathy. Sciatic nerves from these mice and sural nerve biopsies from NF2 patients revealed reduced phosphorylation of the neurofilament H subunit, decreased interfilament spacings and irregularly shaped axons.	[Schulz, Alexander; Jung, Marie Juliane; Zoch, Ansgar; Schacke, Stephan; Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Baader, Stephan L.] Univ Bonn, Inst Anat Anat & Cell Biol, Bonn, Germany; [Niwa-Kawakita, Michiko] Univ Paris, INSERM, U674, F-75252 Paris, France; [Bauer, Reinhard] Univ Jena, Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Bauer, Reinhard] Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Garcia, Cynthia; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Neuropathol, Hamburg, Germany; [Mautner, Victor-Felix] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England; [Weis, Joachim; Schroeder, J. Michael] Rhein Westfal TH Aachen, Univ Hosp Aachen, Inst Neuropathol, D-52062 Aachen, Germany; [Giovannini, Marco] Ctr Neural Tumor Res, House Ear Inst, Los Angeles, CA USA	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Washington University (WUSTL); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Plymouth; University of Plymouth; RWTH Aachen University; RWTH Aachen University Hospital; House Research Institute	Morrison, H (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.	helen@fli-leibniz.de	Morrison, Helen/B-3984-2017; Weis, Joachim/G-1984-2014; Hanemann, C Oliver/AAV-6257-2020; Morrison, Helen/F-9748-2014	Morrison, Helen/0000-0003-4938-1409; Weis, Joachim/0000-0003-3280-6773; Hanemann, C Oliver/0000-0002-1951-1025; Morrison, Helen/0000-0003-4938-1409; Zoch, Ansgar/0000-0003-2071-1590; Gutmann, David/0000-0002-3127-5045; Dun, Xin-peng/0000-0003-2837-4672; Kawakita, Michiko/0000-0002-9450-583X	Deutsche Forschungsgemeinschaft [MO 1421/2-1]; Children's Tumor Foundation;  [Sonderforschungsbereich 604];  [Krebshilfe 107089]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Children's Tumor Foundation; ; 	The authors would like to thank U. Petz, C. Poser and S. Ramrath for their expert technical assistance, H. Rosemann, F. Kaufmann and D. Galendo for their skilled breeding and husbandry of animals, and R.E. Ferner for discussions and support. Mpz-cre mice were kindly provided M.L. Feltri (Hunter James Kelly Research Institute). This work was supported by Sonderforschungsbereich 604, Deutsche Forschungsgemeinschaft MO 1421/2-1 and Krebshilfe 107089. A.S. is recipient of a Young Investigator Award from the Children's Tumor Foundation.	Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Baader SL, 1996, J NEUROSCI, V16, P1440; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dubois M, 2005, J NEUROSCI RES, V80, P751, DOI 10.1002/jnr.20493; Elder GA, 1999, J CELL BIOL, V146, P181; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Gianola S, 2001, J COMP NEUROL, V430, P101, DOI 10.1002/1096-9861(20010129)430:1<101::AID-CNE1017>3.0.CO;2-Z; Giovannini M, 2000, GENE DEV, V14, P1617; Hagel C, 2002, ACTA NEUROPATHOL, V104, P179, DOI 10.1007/s00401-002-0535-7; Hanemann CO, 2007, BRAIN PATHOL, V17, P371, DOI 10.1111/j.1750-3639.2007.00086.x; Hashimoto R, 1998, BIOCHEM BIOPH RES CO, V245, P407, DOI 10.1006/bbrc.1998.8446; Iseki Chifumi, 2009, Rinsho Shinkeigaku, V49, P419; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jankowski J, 2009, CEREBELLUM, V8, P277, DOI 10.1007/s12311-009-0093-9; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; MORRISON JH, 1987, BRAIN RES, V416, P331, DOI 10.1016/0006-8993(87)90914-0; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Mundegar RR, 2008, J HISTOCHEM CYTOCHEM, V56, P969, DOI 10.1369/jhc.2008.950105; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Scherer SS, 1996, J NEUROSCI RES, V46, P595, DOI 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.3.CO;2-2; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Sperfeld AD, 2002, BRAIN, V125, P996, DOI 10.1093/brain/awf115; Watanabe SY, 1999, NEUROSCI RES, V33, P71, DOI 10.1016/S0168-0102(98)00113-8; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	35	44	44	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					426	U86		10.1038/nn.3348	http://dx.doi.org/10.1038/nn.3348			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455610				2022-12-25	WOS:000316723700012
J	Parnaudeau, S; O'Neill, PK; Bolkan, SS; Ward, RD; Abbas, AI; Roth, BL; Balsam, PD; Gordon, JA; Kellendonk, C				Parnaudeau, Sebastien; O'Neill, Pia-Kelsey; Bolkan, Scott S.; Ward, Ryan D.; Abbas, Atheir I.; Roth, Bryan L.; Balsam, Peter D.; Gordon, Joshua A.; Kellendonk, Christoph			Inhibition of Mediodorsal Thalamus Disrupts Thalamofrontal Connectivity and Cognition	NEURON			English	Article							SHORT-TERM-MEMORY; SEROTONERGIC NEURON INHIBITION; PROTEIN-COUPLED RECEPTORS; BODY-TEMPERATURE CONTROL; PREFRONTAL CORTEX; WORKING-MEMORY; OSCILLATORY SYNCHRONY; ORBITOFRONTAL CORTEX; SPATIAL MEMORY; SCHIZOPHRENIA	Cognitive deficits are central to schizophrenia, but the underlying mechanisms still remain unclear. Imaging studies performed in patients point to decreased activity in the nnediodorsal thalamus (MD) and reduced functional connectivity between the MD and prefrontal cortex (PFC) as candidate mechanisms. However, a causal link is still missing. We used a pharmacogenetic approach in mice to diminish MD neuron activity and examined the behavioral and physiological consequences. We found that a subtle decrease in MD activity is sufficient to trigger selective impairments in prefrontal-dependent cognitive tasks. In vivo recordings in behaving animals revealed that MD-PFC beta-range synchrony is enhanced during acquisition and performance of a working memory task. Decreasing MD activity interfered with this task-dependent modulation of MD-PFC synchrony, which correlated with impaired working memory. These findings suggest that altered MD activity is sufficient to disrupt prefrontal-dependent cognitive behaviors and could contribute to the cognitive symptoms observed in schizophrenia.	[Parnaudeau, Sebastien; O'Neill, Pia-Kelsey; Bolkan, Scott S.; Ward, Ryan D.; Abbas, Atheir I.; Balsam, Peter D.; Gordon, Joshua A.; Kellendonk, Christoph] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Parnaudeau, Sebastien; Bolkan, Scott S.; Kellendonk, Christoph] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Parnaudeau, Sebastien; Bolkan, Scott S.; Kellendonk, Christoph] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [O'Neill, Pia-Kelsey; Bolkan, Scott S.; Abbas, Atheir I.; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; New York State Psychiatry Institute; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jg343@columbia.edu; ck491@columbia.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020; Kellendonk, Christoph/O-7229-2018; Abbas, Atheir/AAI-2158-2019	Roth, Bryan/0000-0002-0561-6520; Kellendonk, Christoph/0000-0003-3302-2188; Abbas, Atheir/0000-0002-7080-3509	NINDS; Anonymous Foundation; NARSAD; International Mental Health Research Organization; Hope for Depression Research Foundation; NIH [R21 MH093887, R01 MH081968, U19MH82441]; Fondation Fyssen Fellowship;  [R25 MH086466]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093887, U19MH082441, R01MH096274, R01MH081968, R01MH061887, R25MH086466] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Anonymous Foundation; NARSAD(NARSAD); International Mental Health Research Organization; Hope for Depression Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Fyssen Fellowship; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Neil Harrison for advising on in vitro slice physiology and Mariya Shegda for excellent technical help. CNO was obtained from the NIH as part of the Rapid Access to Investigative Drug Program funded by the NINDS. This work was supported by grants from "Anonymous Foundation" and NARSAD to C.K., from the International Mental Health Research Organization; the Hope for Depression Research Foundation, and the NIH (R21 MH093887 and R01 MH081968) to J.A.G, U19MH82441 to B.L.R., and a Fondation Fyssen Fellowship to S.P. A.I.A. is a Leon Levy Foundation Resident Fellow and is supported by R25 MH086466. S.P. designed and performed the experiments, conducted the data analysis, and wrote the paper. P.K.O. performed the in vivo recordings experiment and conducted the analysis. S.S.B. and R.D.W. helped with behavior experiments. A.I.A. assisted in the analysis of the in vivo recordings. B.L.R. provided the DREADD system. P.B. supervised and designed behavioral experiments. JAG. and C.K. designed and supervised the performance of the experiments and data analysis and wrote the paper.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Andrews J, 2006, AM J PSYCHIAT, V163, P463, DOI 10.1176/appi.ajp.163.3.463; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bailey KR, 2005, BEHAV NEUROSCI, V119, P410, DOI 10.1037/0735-7044.119.2.410; Bechara A, 1998, J NEUROSCI, V18, P428; BERACOCHEA DJ, 1989, BEHAV NEURAL BIOL, V51, P364, DOI 10.1016/S0163-1047(89)91000-5; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Block AE, 2007, CEREB CORTEX, V17, P1625, DOI 10.1093/cercor/bhl073; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Byne W, 2009, ACTA NEUROPATHOL, V117, P347, DOI 10.1007/s00401-008-0404-0; Chudasama Y, 2001, EUR J NEUROSCI, V14, P1009, DOI 10.1046/j.0953-816x.2001.01607.x; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Floresco SB, 1999, J NEUROSCI, V19, P11061, DOI 10.1523/JNEUROSCI.19-24-11061.1999; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Green MF, 1996, AM J PSYCHIAT, V153, P321; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Hunt PR, 1998, J NEUROSCI, V18, P10045; HUNT PR, 1991, BEHAV NEURAL BIOL, V55, P227, DOI 10.1016/0163-1047(91)80141-Z; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JANN MW, 1994, ARCH INT PHARMACOD T, V328, P243; Jones E.G., 2012, THALAMUS; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kuroda M, 1998, PROG NEUROBIOL, V54, P417, DOI 10.1016/S0301-0082(97)00070-1; Lavin A, 1998, NEUROPSYCHOPHARMACOL, V18, P352; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; Loffler S, 2012, SCIENCE, V337, DOI 10.1126/science.1221810; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; McOmish CE, 2012, NEUROPSYCHOPHARMACOL, V37, P2747, DOI 10.1038/npp.2012.139; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Mitelman SA, 2005, AM J PSYCHIAT, V162, P1733, DOI 10.1176/appi.ajp.162.9.1733; NEAVE N, 1993, BEHAV BRAIN RES, V55, P39, DOI 10.1016/0166-4328(93)90005-B; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rygula R, 2010, J NEUROSCI, V30, P14552, DOI 10.1523/JNEUROSCI.2631-10.2010; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vinck M, 2012, J COMPUT NEUROSCI, V33, P53, DOI 10.1007/s10827-011-0374-4; Watanabe Y, 2012, NEUROSCI BIOBEHAV R, V36, P134, DOI 10.1016/j.neubiorev.2011.05.003; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808	58	239	241	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1151	1162		10.1016/j.neuron.2013.01.038	http://dx.doi.org/10.1016/j.neuron.2013.01.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522049	Green Accepted, Bronze, Green Published			2022-12-25	WOS:000316645000015
J	Mizumoto, K; Shen, K				Mizumoto, Kota; Shen, Kang			Interaxonal Interaction Defines Tiled Presynaptic Innervation in C. elegans	NEURON			English	Article							DROSOPHILA VISUAL-SYSTEM; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE SEMAPHORINS; EPIDERMAL MORPHOGENESIS; MEMBRANE EXTENSION; SYNAPSE FORMATION; F-ACTIN; GENE; HIPPOCAMPUS; NEURONS	Cellular interactions between neighboring axons are essential for global topographic map formation. Here we show that axonal interactions also precisely instruct the location of synapses. Motoneurons form en passant synapses in Caenorhabditis elegans. Although axons from the same neuron class significantly overlap, each neuron innervates a unique and tiled segment of the muscle field by restricting its synapses to a distinct subaxonal domain a phenomenon we term synaptic tiling. Using DA8 and DA9 motoneurons, we found that the synaptic tiling requires the PlexinA4 homolog, PLX-1, and two transmembrane semaphorins. In the plexin or semaphorin mutants, synaptic domains from both neurons expand and overlap with each other without guidance defects. In a semaphorin-dependent manner, PLX-1 is concentrated at the synapse-free axonal segment, delineating the tiling border. Furthermore, plexin inhibits presynapse formation by suppressing synaptic F-actin through its cytoplasmic GTPase-activating protein (GAP) domain. Hence, contact-dependent, intra-axonal plexin signaling specifies synaptic circuits by inhibiting synapse formation at the subcellular loci.	[Mizumoto, Kota; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu		Mizumoto, Kota/0000-0001-8091-4483	Human Frontier Science Program fellowship; Japan Society for the Promotion of Science; Howard Hughes Medical Institute; Human Frontier Science Foundation; W. Keck Foundation; Leave-a-Nest grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Human Frontier Science Program fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Foundation(Human Frontier Science Program); W. Keck Foundation(W.M. Keck Foundation); Leave-a-Nest grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kolodkin for sharing unpublished results and critical comments on the manuscript, D. Hall for the EM image, and the International Caenorhabditis Genetic Center, S. Mitani (National BioResource Project, Japan), and G. Garriga for strains. We also thank A. Howell, M. Klassen, O. Liu, and G. Maro for comments on the manuscript. This work is supported by the Human Frontier Science Program fellowship (KM.), the Japan Society for the Promotion of Science (KM.), the Howard Hughes Medical Institute (KS.), the Human Frontier Science Foundation (KS.), and the W. Keck Foundation (K.S.). K.M. is also supported partly by the Leave-a-Nest grant.	Alexander M, 2009, DEVELOPMENT, V136, P911, DOI 10.1242/dev.030759; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BRENNER S, 1974, GENETICS, V77, P71; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003; Dixon SJ, 2006, DEVELOPMENT, V133, P1263, DOI 10.1242/dev.02300; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fujii T, 2002, DEVELOPMENT, V129, P2053; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HAN M, 1991, GENE DEV, V5, P2188, DOI 10.1101/gad.5.12a.2188; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Liu ZC, 2005, DEV BIOL, V282, P138, DOI 10.1016/j.ydbio.2005.03.002; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nukazuka A, 2008, GENE DEV, V22, P1025, DOI 10.1101/gad.1644008; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/NMETH.1929, 10.1038/nmeth.1929]; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yaron A, 2012, TRENDS NEUROSCI, V35, P230, DOI 10.1016/j.tins.2011.12.003; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	56	43	44	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					655	666		10.1016/j.neuron.2012.12.031	http://dx.doi.org/10.1016/j.neuron.2012.12.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439119	Bronze, Green Accepted			2022-12-25	WOS:000315561300009
J	Osterweil, EK; Chuang, SC; Chubykin, AA; Sidorov, M; Bianchi, R; Wong, RKS; Bear, MF				Osterweil, Emily K.; Chuang, Shih-Chieh; Chubykin, Alexander A.; Sidorov, Michael; Bianchi, Riccardo; Wong, Robert K. S.; Bear, Mark F.			Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome	NEURON			English	Article							EPILEPTIFORM DISCHARGES; MENTAL-RETARDATION; EPILEPSY; SUPPRESSION; INDUCTION; MGLUR5; MICE; SEIZURES; STATIN	Many neuropsychiatric symptoms of fragile X syndrome (FXS) are believed to be a consequence of altered regulation of protein synthesis at synapses. We discovered that lovastatin, a drug that is widely prescribed for the treatment of high cholesterol, can correct excess hippocampal protein synthesis in the mouse model of FXS and can prevent one of the robust functional consequences of increased protein synthesis in FXS, epileptogenesis. These data suggest that lovastatin is potentially disease modifying and could be a viable prophylactic treatment for epileptogenesis in FXS.	[Osterweil, Emily K.; Chubykin, Alexander A.; Sidorov, Michael; Bear, Mark F.] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Chuang, Shih-Chieh; Bianchi, Riccardo; Wong, Robert K. S.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Chuang, Shih-Chieh; Bianchi, Riccardo; Wong, Robert K. S.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbear@mit.edu	Bianchi, Riccardo/GLT-3136-2022	Bianchi, Riccardo/0000-0002-1656-4455; Bear, Mark/0000-0002-9903-2541; Chubykin, Alexander/0000-0001-8224-9296; Osterweil, Emily/0000-0003-0582-2284	FRAXA; NIMH; NICHD; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090452] Funding Source: NIH RePORTER	FRAXA; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	For excellent technical and administrative support and for valuable discussions, we thank D. D. Krueger, K. Dram, S. Meagher, A. Heynen, E. Sklar, E. Greene-Colozzi, K. Reinhold, G. Conley, E. Gisin, S. Lacy, L Khibnik, B. Dolan, B. D. Auerbach, R. W. Schecter, S. F. Cooke, and J. Gavornik. This work was supported in part by grants from FRAXA, NIMH, NICHD, and the Simons Foundation. M.F.B. discloses a financial interest in Seaside Therapeutics.	Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Choi CH, 2011, BRAIN RES, V1380, P106, DOI 10.1016/j.brainres.2010.11.032; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; Gegg ME, 2005, J IMMUNOL, V174, P2327, DOI 10.4049/jimmunol.174.4.2327; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kanner L, 1943, NERV CHILD, V2, P217; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kloog, 1999, Expert Opin Investig Drugs, V8, P2121, DOI 10.1517/13543784.8.12.2121; Krab LC, 2008, TRENDS GENET, V24, P498, DOI 10.1016/j.tig.2008.07.005; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Makovski V, 2012, INT J CANCER, V130, P1420, DOI 10.1002/ijc.26139; MENDOLA CE, 1990, CELL GROWTH DIFFER, V1, P499; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; Musumeci SA, 1999, EPILEPSIA, V40, P1092, DOI 10.1111/j.1528-1157.1999.tb00824.x; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Raisinghani M, 2003, BRAIN RES, V967, P113, DOI 10.1016/S0006-8993(02)04232-4; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; Serbanescu I, 2004, J LIPID RES, V45, P2038, DOI 10.1194/jlr.M400097-JLR200; Taylor GW, 1995, J NEUROSCI, V15, P8039; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; van Vliet EA, 2011, EPILEPSIA, V52, P1319, DOI 10.1111/j.1528-1167.2011.03073.x; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Yamada T, 2000, J INHERIT METAB DIS, V23, P607, DOI 10.1023/A:1005634130286; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Zhao WF, 2004, J NEUROSCI, V24, P76, DOI 10.1523/JNEUROSCI.4515-03.2004	34	161	166	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 23	2013	77	2					243	250		10.1016/j.neuron.2012.01.034	http://dx.doi.org/10.1016/j.neuron.2012.01.034			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352161	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000314199400007
J	Qiu, F; Rebolledo, S; Gonzalez, C; Larsson, HP				Qiu, Feng; Rebolledo, Santiago; Gonzalez, Carlos; Larsson, H. Peter			Subunit Interactions during Cooperative Opening of Voltage-Gated Proton Channels	NEURON			English	Article							DEPENDENT K+ CHANNEL; HV1; PORE; PH; TRANSITIONS; DOMAIN; SENSOR	Voltage-gated proton (Hv1) channels are dimers, where each subunit has a separate permeation pathway. However, opening of the two pathways is highly cooperative. It is unclear how Hv1 channels open their permeation pathways, because Hv1 channels lack a classic pore domain. Using voltage-clamp fluorometry, we here detect two conformational changes reported by a fluorophore attached to the voltage sensor S4 in Hv1 channels. The first is voltage dependent and precedes channel opening, with properties consistent with reporting on independent S4 charge movements in the two subunits. The second is less voltage dependent and closely correlates with channel opening. Mutations that reduce dimerization or alter the intersubunit interface affect both the second conformational change and channel opening. These observations suggest that, following an initial S4 charge movement in the two subunits, there is a second, cooperative conformational change, involving interactions between subunits, that opens both pathways in Hv1 channels.	[Qiu, Feng; Rebolledo, Santiago; Larsson, H. Peter] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Gonzalez, Carlos] Univ Valparaiso, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2366103, Chile	University of Miami; Universidad de Valparaiso	Larsson, HP (corresponding author), Univ Miami, Dept Physiol & Biophys, 1600 NW 10th Ave,RMSB 5123, Miami, FL 33136 USA.	plarsson@med.miami.edu	Gonzalez, Carlos/V-7628-2019		NHLBI [R01-HL095920]; fondecyt [1120802, ACT 1104]; CINV as Millennium Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095920] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CINV as Millennium Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs. Rene Barro-Soria, Fredrik Elinder, Karl Magleby, Wolfgang Nonner, and Ramon Latorre for comments on the manuscript. This work was partially funded by a grant from NHLBI (R01-HL095920) to H.P.L., and fondecyt 1120802 and ACT 1104 and CINV as Millennium Institute to C.G.	Berger TK, 2011, NEURON, V72, P991, DOI 10.1016/j.neuron.2011.11.014; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2010, PHYSIOLOGY, V25, P27, DOI 10.1152/physiol.00039.2009; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Hong L, 2013, NEURON, V77, P274, DOI 10.1016/j.neuron.2012.11.013; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sakata S, 2010, P NATL ACAD SCI USA, V107, P2313, DOI 10.1073/pnas.0911868107; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	30	51	51	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 23	2013	77	2					288	298		10.1016/j.neuron.2012.12.021	http://dx.doi.org/10.1016/j.neuron.2012.12.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352165	Bronze, Green Accepted			2022-12-25	WOS:000314199400011
J	Rouault-Pierre, K; Lopez-Onieva, L; Foster, K; Anjos-Afonso, F; Lamrissi-Garcia, I; Serrano-Sanchez, M; Mitter, R; Ivanovic, Z; de Verneuil, H; Gribben, J; Taussig, D; Rezvani, HR; Mazurier, F; Bonnet, D				Rouault-Pierre, Kevin; Lopez-Onieva, Lourdes; Foster, Katie; Anjos-Afonso, Fernando; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; Mitter, Richard; Ivanovic, Zoran; de Verneuil, Hubert; Gribben, John; Taussig, David; Rezvani, Hamid Reza; Mazurier, Frederic; Bonnet, Dominique			HIF-2 alpha Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress	CELL STEM CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR; STEM-CELLS; BONE-MARROW; CHUVASH POLYCYTHEMIA; RECEPTOR CXCR4; NICHE; HIF-1-ALPHA; MICE; ERYTHROPOIESIS; HOMEOSTASIS	Hematopoietic stem and progenitor cells (HSPCs) are exposed to low levels of oxygen in the bone marrow niche, and hypoxia-inducible factors (HIFs) are the main regulators of cellular responses to oxygen variation. Recent studies using conditional knockout mouse models have unveiled a major role for HIF-1 alpha in the maintenance of murine HSCs; however, the role of HIF-2 alpha is still unclear. Here, we show that knockdown of HIF-2 alpha, and to a much lesser extent HIF-1 alpha, impedes the long-term repopulating ability of human CD34(+) umbilical cord blood cells. HIF-2 alpha-deficient HSPCs display increased production of reactive oxygen species (ROS), which subsequently stimulates endoplasmic reticulum (ER) stress and triggers apoptosis by activation of the unfolded-protein-response (UPR) pathway. HIF-2 alpha deregulation also significantly decreased engraftment ability of human acute myeloid leukemia (AML) cells. Overall, our data demonstrate a key role for HIF-2 alpha in the maintenance of human HSPCs and in the survival of primary AML cells.	[Rouault-Pierre, Kevin; Lopez-Onieva, Lourdes; Foster, Katie; Anjos-Afonso, Fernando; Bonnet, Dominique] Canc Res UK, Haematopoiet Stem Cell Lab, London Res Inst, London WC2A 3LY, England; [Rouault-Pierre, Kevin; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; de Verneuil, Hubert; Rezvani, Hamid Reza; Mazurier, Frederic] INSERM, U1035, F-33076 Bordeaux, France; [Rouault-Pierre, Kevin; Lamrissi-Garcia, Isabelle; Serrano-Sanchez, Martin; Ivanovic, Zoran; de Verneuil, Hubert; Rezvani, Hamid Reza; Mazurier, Frederic] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Mitter, Richard] Canc Res UK, Bioinformat & Biostat Dept, London Res Inst, London WC2A 3LY, England; [Ivanovic, Zoran] Etab Francais Sang Aquitaine Limousin, F-33000 Bordeaux, France; [Ivanovic, Zoran] CNRS UMR 5164, F-33076 Bordeaux, France; [Gribben, John; Taussig, David] Queen Mary Univ London, Barts Canc Inst, Dept Haematooncol, London EC1M 6BQ, England	Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of London; Queen Mary University London	Mazurier, F (corresponding author), INSERM, U1035, F-33076 Bordeaux, France.	mazurier@u-bordeaux2.fr; dominique.bonnet@cancer.org.uk	Ivanovic, Zoran/ABC-7667-2020; López-Onieva, Lourdes/A-6475-2019; Mazurier, FrÃ©dÃ©ric/O-1619-2018; Rezvani, Hamid Reza/G-3734-2013	Ivanovic, Zoran/0000-0001-6158-0270; López-Onieva, Lourdes/0000-0001-5509-3804; Rezvani, Hamid Reza/0000-0001-8067-1338; Mazurier, Frederic/0000-0002-6984-7096; Mitter, Richard/0000-0002-1279-3760; Anjos-Afonso, Fernando/0000-0003-4392-488X; Rouault-Pierre, Kevin/0000-0001-7671-7364	Cancer Research UK; COST Action [TD0901]; French Ministere de l'Enseignement Superieur et de la Recherche (MESR); Marie Curie fellowship; French Association of Cancer Research (ARC)	Cancer Research UK(Cancer Research UK); COST Action(European Cooperation in Science and Technology (COST)); French Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Marie Curie fellowship(European Commission); French Association of Cancer Research (ARC)	The authors extend their thanks to all the staff at the Maison de Sante Protestante de Bordeaux-Bagatelle (Bordeaux, France), to Ms Besky at the Royal London Hospital for providing cord blood samples, and to the laboratory of virology headed by Professor Fleury. The authors are grateful to the Biological Resource Units, B. Rousseau (University of Bordeaux) for his valuable expertise, Dr. V. Pitard and the Flow Cytometry core facility members at LRI, and Gavin Kelly of the Bioinformatics Department at LRI for their expertise in sorting and statistical analysis. We would also like to thanks the electron microscopy core facility members at LRI for their help. This work was funded in part by Cancer Research UK to D.B. and by the COST Action TD0901 to FM. K.R.P. was financed in part by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche (MESR) and by Cancer Research UK; L.L.O., by a Marie Curie fellowship; and M.S.S. by a fellowship from the French Association of Cancer Research (ARC).	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Giuntoli S, 2007, STEM CELLS, V25, P1119, DOI 10.1634/stemcells.2006-0637; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu YL, 2006, CANCER BIOL THER, V5, P1320, DOI 10.4161/cbt.5.10.3162; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Piccoli C, 2007, FEBS LETT, V581, P3111, DOI 10.1016/j.febslet.2007.05.077; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	47	127	131	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					549	563		10.1016/j.stem.2013.08.011	http://dx.doi.org/10.1016/j.stem.2013.08.011			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24095676	Bronze			2022-12-25	WOS:000329571500008
J	Hansen, DV; Lui, JH; Flandin, P; Yoshikawa, K; Rubenstein, JL; Alvarez-Buylla, A; Kriegstein, AR				Hansen, David V.; Lui, Jan H.; Flandin, Pierre; Yoshikawa, Kazuaki; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.			Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences	NATURE NEUROSCIENCE			English	Article							FATE MAPPING REVEALS; GABAERGIC NEURONS; NEOCORTICAL INTERNEURONS; MOLECULAR SPECIFICATION; SUBVENTRICULAR ZONE; GLOBUS-PALLIDUS; VISUAL-CORTEX; RADIAL GLIA; MIGRATION; ORIGINS	GABAergic cortical interneurons underlie the complexity of neural circuits and are particularly numerous and diverse in humans. In rodents, cortical interneurons originate in the subpallial ganglionic eminences, but their developmental origins in humans are controversial. We characterized the developing human ganglionic eminences and found that the subventricular zone (SVZ) expanded massively during the early second trimester, becoming densely populated with neural stem cells and intermediate progenitor cells. In contrast with the cortex, most stem cells in the ganglionic eminence SVZ did not maintain radial fibers or orientation. The medial ganglionic eminence exhibited unique patterns of progenitor cell organization and clustering, and markers revealed that the caudal ganglionic eminence generated a greater proportion of cortical interneurons in humans than in rodents. On the basis of labeling of newborn neurons in slice culture and mapping of proliferating interneuron progenitors, we conclude that the vast majority of human cortical interneurons are produced in the ganglionic eminences, including an enormous contribution from non-epithelial SVZ stem cells.	[Hansen, David V.; Lui, Jan H.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hansen, David V.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Flandin, Pierre; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Osaka University; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	john.rubenstein@ucsf.edu; abuylla@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Hansen, David/0000-0001-9679-7189; Alvarez-Buylla, Arturo/0000-0003-4426-8925	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health; National Institute of Mental Health of the US National Institutes of Health; California Institute for Regenerative Medicine; John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human fetal tissue. We thank S. Davis and co-workers at the California National Primate Research Center for providing fixed brain tissue from fetal macaques. We also thank W Walantus, K. Wang, S. Wang, Y. Wang and other University of California at San Francisco personnel for technical and administrative support. We are very grateful to J. Kohtz (Northwestern University) for sharing her final aliquot of pan-Dlx antibody. The NKX2-2 antibody developed by T. Jessell and S. Brenner-Morton was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology. This work was supported by grants from the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health of the US National Institutes of Health, California Institute for Regenerative Medicine, John G. Bowes Research Fund and from Bernard Osher.	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Battista D, 2010, J NEUROSCI, V30, P3995, DOI 10.1523/JNEUROSCI.4382-09.2010; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; CONNOR JR, 1984, NEUROSCIENCE, V12, P1027, DOI 10.1016/0306-4522(84)90002-2; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; delRio MR, 1997, J CHEM NEUROANAT, V13, P243, DOI 10.1016/S0891-0618(97)00050-1; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jones EG, 2009, CEREB CORTEX, V19, P1953, DOI 10.1093/cercor/bhp088; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2000, J NEUROSCI, V20, P6063; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Sussel L, 1999, DEVELOPMENT, V126, P3359; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wu SX, 2011, DEVELOPMENT, V138, P2499, DOI 10.1242/dev.063032; Xu Q, 2003, CEREB CORTEX, V13, P670, DOI 10.1093/cercor/13.6.670; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yun K, 2002, DEVELOPMENT, V129, P5029; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812	50	184	185	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1576	1587		10.1038/nn.3541	http://dx.doi.org/10.1038/nn.3541			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097039	Green Accepted			2022-12-25	WOS:000326205700015
J	Hauner, KK; Howard, JD; Zelano, C; Gottfried, JA				Hauner, Katherina K.; Howard, James D.; Zelano, Christina; Gottfried, Jay A.			Stimulus-specific enhancement of fear extinction during slow-wave sleep	NATURE NEUROSCIENCE			English	Article							MEMORY; CONTEXT; HIPPOCAMPUS; HUMANS	Sleep can strengthen memory for emotional information, but whether emotional memories can be specifically targeted and modified during sleep is unknown. In human subjects who underwent olfactory contextual fear conditioning, re-exposure to the odorant context in slow-wave sleep promoted stimulus-specific fear extinction, with parallel reductions of hippocampal activity and reorganization of amygdala ensemble patterns. Thus, fear extinction may be selectively enhanced during sleep, even without re-exposure to the feared stimulus itself.	[Hauner, Katherina K.; Howard, James D.; Zelano, Christina; Gottfried, Jay A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hauner, KK (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	hauner@u.northwestern.edu			US National Institutes of Health [F32MH091967, T32NS047987, R01DC010014, R21DC012014]; Northwestern University Center for Translational Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH091967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC013500, R21DC012014, R01DC010014] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Center for Translational Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank P. Zee, C. Westerberg and K.N. Wu for technical assistance, and J. Radulovic and K. Paller for insightful discussions. Support was provided from the US National Institutes of Health to K.K.H. (F32MH091967, T32NS047987) and to J.A.G. (R01DC010014, R21DC012014), and from the Northwestern University Center for Translational Imaging.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Arzi A, 2012, NAT NEUROSCI, V15, P1460, DOI 10.1038/nn.3193; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Stout SC, 2004, BEHAV PROCESS, V66, P7, DOI 10.1016/j.beproc.2003.11.003; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wang SH, 2009, NAT NEUROSCI, V12, P253, DOI 10.1038/nn.2263	20	110	114	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1553	1555		10.1038/nn.3527	http://dx.doi.org/10.1038/nn.3527			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056700	Green Accepted			2022-12-25	WOS:000326205700012
J	Jego, S; Glasgow, SD; Herrera, CG; Ekstrand, M; Reed, SJ; Boyce, R; Friedman, J; Burdakov, D; Adamantidis, AR				Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Ekstrand, Mats; Reed, Sean J.; Boyce, Richard; Friedman, Jeffrey; Burdakov, Denis; Adamantidis, Antoine R.			Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus	NATURE NEUROSCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; PARADOXICAL REM SLEEP; STEM GABAERGIC NEURONS; LOCUS-COERULEUS; GLUTAMATERGIC TRANSMISSION; OREXIN NEURONS; WAKING CYCLE; RAT-BRAIN; IN-SITU; MICE	Rapid-eye movement (REM) sleep correlates with neuronal activity in the brainstem, basal forebrain and lateral hypothalamus. Lateral hypothalamus melanin-concentrating hormone (MCH)-expressing neurons are active during sleep, but their effects on REM sleep remain unclear. Using optogenetic tools in newly generated Tg(Pmch-cre) mice, we found that acute activation of MCH neurons (ChETA, SSFO) at the onset of REM sleep extended the duration of REM, but not non-REM, sleep episodes. In contrast, their acute silencing (eNpHR3.0, archaerhodopsin) reduced the frequency and amplitude of hippocampal theta rhythm without affecting REM sleep duration. In vitro activation of MCH neuron terminals induced GABA(A)-mediated inhibitory postsynaptic currents in wake-promoting histaminergic neurons of the tuberomammillary nucleus (TMN), and in vivo activation of MCH neuron terminals in TMN or medial septum also prolonged REM sleep episodes. Collectively, these results suggest that activation of MCH neurons maintains REM sleep, possibly through inhibition of arousal circuits in the mammalian brain.	[Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Reed, Sean J.; Boyce, Richard; Adamantidis, Antoine R.] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada; [Ekstrand, Mats; Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; [Burdakov, Denis] Natl Inst Med Res, MRC, London NW7 1AA, England; [Burdakov, Denis] Kings Coll London, London WC2R 2LS, England	McGill University; Howard Hughes Medical Institute; Rockefeller University; MRC National Institute for Medical Research; University of London; King's College London	Adamantidis, AR (corresponding author), McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada.	antoine.adamantidis@mcgill.ca		Burdakov, Denis/0000-0002-9134-9165; Gutierrez Herrera, Carolina/0000-0002-7916-3341; Glasgow, Stephen/0000-0002-9809-4812; Adamantidis, Antoine/0000-0003-2531-5175	Fonds de la Recherche du Quebec - Sante; Human Frontier Science Program; Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research; Natural Science and Engineering Council of Canada; Medical Research Council [MC_UP_1202/2] Funding Source: researchfish; MRC [MC_UP_1202/2] Funding Source: UKRI	Fonds de la Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Jones, M.E. Carter and L. de Lecea for helpful comments on a previous version of the manuscript. We thank the members of the Adamantidis laboratory for their technical help and comments. Optogenetic plasmids were kindly provided by K. Deisseroth (Stanford University). S.D.G. was supported by the Fonds de la Recherche du Quebec - Sante. D.B. and A.R.A. were supported by the Human Frontier Science Program. A.R.A. was supported by the Douglas Foundation, McGill University, Canadian Fund for Innovation, Canadian Research Chair (Tier 2), Canadian Institute for Health Research and the Natural Science and Engineering Council of Canada.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Chee MJS, 2013, J COMP NEUROL, V521, P2208, DOI 10.1002/cne.23273; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; del Cid-Pellitero E, 2012, NEUROSCIENCE, V223, P269, DOI 10.1016/j.neuroscience.2012.07.072; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JOUVET M, 1962, Arch Ital Biol, V100, P125; Konadhode RR, 2013, J NEUROSCI, V33, P10257, DOI 10.1523/JNEUROSCI.1225-13.2013; Lagos P, 2011, BRAIN RES, V1369, P112, DOI 10.1016/j.brainres.2010.11.027; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lu ZH, 2013, PEPTIDES, V44, P32, DOI 10.1016/j.peptides.2013.03.015; Luppi P.-H., 2013, CURR OPIN NEUROBIOL, DOI [10.1016/j.conb.2013.02.006, DOI 10.1016/J.C0NB.2013.02.006]; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Monti JM, 2013, SLEEP MED REV, V17, P293, DOI 10.1016/j.smrv.2012.10.002; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Pachoud B, 2010, J NEUROPHYSIOL, V104, P1417, DOI 10.1152/jn.01052.2009; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	253	260	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1637	1643		10.1038/nn.3522	http://dx.doi.org/10.1038/nn.3522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056699	Green Accepted			2022-12-25	WOS:000326205700021
J	Laurens, J; Meng, H; Angelaki, DE				Laurens, Jean; Meng, Hui; Angelaki, Dora E.			Computation of linear acceleration through an internal model in the macaque cerebellum	NATURE NEUROSCIENCE			English	Article							VISUAL GRAVITATIONAL MOTION; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULAR SIGNALS; INERTIAL MOTION; EYE-MOVEMENTS; CORIOLIS; NEURONS; OTOLITH; STIMULATION	A combination of theory and behavioral findings support a role for internal models in the resolution of sensory ambiguities and sensorimotor processing. Although the cerebellum has been proposed as a candidate for implementation of internal models, concrete evidence from neural responses is lacking. Using unnatural motion stimuli, which induce incorrect self-motion perception and eye movements, we explored the neural correlates of an internal model that has been proposed to compensate for Einstein's equivalence principle and generate neural estimates of linear acceleration and gravity. We found that caudal cerebellar vermis Purkinje cells and cerebellar nuclei neurons selective for actual linear acceleration also encoded erroneous linear acceleration, as would be expected from the internal model hypothesis, even when no actual linear acceleration occurred. These findings provide strong evidence that the cerebellum might be involved in the implementation of internal models that mimic physical principles to interpret sensory signals, as previously hypothesized.	[Laurens, Jean] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Meng, Hui; Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Washington University (WUSTL); Baylor College of Medicine	Angelaki, DE (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	angelaki@bcm.edu			US National Institutes of Health [EY12814]; NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank E. Klier, P. Blazquez and T. Yakusheva for critically reading the manuscript. This work was supported by a grant from the US National Institutes of Health (EY12814).	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Angelaki DE, 2009, ANN NY ACAD SCI, V1164, P19, DOI 10.1111/j.1749-6632.2009.03939.x; Barmack NH, 1995, J NEUROPHYSIOL, V74, P2573, DOI 10.1152/jn.1995.74.6.2573; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bles W, 1998, BRAIN RES BULL, V47, P543, DOI 10.1016/S0361-9230(98)00089-6; Bo J, 2008, J NEUROPHYSIOL, V100, P2825, DOI 10.1152/jn.90221.2008; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Cullen KE, 2011, EXP BRAIN RES, V210, P377, DOI 10.1007/s00221-011-2555-9; DIZIO P, 1987, AVIAT SPACE ENVIR MD, V58, pA218; FERNANDEZ C, 1972, J NEUROPHYSIOL, V35, P978, DOI 10.1152/jn.1972.35.6.978; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Green AM, 1998, J NEUROPHYSIOL, V80, P2222, DOI 10.1152/jn.1998.80.4.2222; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S02; GUEDRY FE, 1961, AEROSPACE MED, V32, P487; HESS BJM, 1993, EXP BRAIN RES, V95, P77; Holly JE, 2004, J VESTIBUL RES-EQUIL, V14, P443; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kennedy R.S., 1965, RES REP US NAV SCH A, V18, P1; KORTE GE, 1979, J COMP NEUROL, V184, P265, DOI 10.1002/cne.901840204; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; Laurens J, 2011, J NEUROSCI, V31, P8093, DOI 10.1523/JNEUROSCI.5900-10.2011; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; Laurens J, 2010, J NEUROPHYSIOL, V104, P1370, DOI 10.1152/jn.00143.2010; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Liu S, 2011, CEREB CORTEX, V21, P563, DOI 10.1093/cercor/bhq123; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; MERFELD DM, 1995, EXP BRAIN RES, V106, P123; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; Raphan T, 1977, CONTROL GAZE BRAIN S, V1, P37; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shaikh AG, 2005, CURR BIOL, V15, P1657, DOI 10.1016/j.cub.2005.08.009; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; Shaikh AG, 2004, J NEUROSCI, V24, P4491, DOI 10.1523/JNEUROSCI.0109-04.2004; Tribukait A, 2006, J VESTIBUL RES-EQUIL, V16, P105; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yakusheva T, 2008, J NEUROSCI, V28, P9997, DOI 10.1523/JNEUROSCI.2232-08.2008; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	50	55	55	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1701	1708		10.1038/nn.3530	http://dx.doi.org/10.1038/nn.3530			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077562	Green Accepted			2022-12-25	WOS:000326205700029
J	Lee, Y; Karuppagounder, SS; Shin, JH; Lee, YI; Ko, HS; Swing, D; Jiang, HS; Kang, SU; Lee, BD; Kang, HC; Kim, D; Tessarollo, L; Dawson, VL; Dawson, TM				Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Swing, Debbie; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Tessarollo, Lino; Dawson, Valina L.; Dawson, Ted M.			Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss	NATURE NEUROSCIENCE			English	Article							RNA SYNTHETASE COMPLEX; POLYMERASE-1-DEPENDENT CELL-DEATH; APOPTOSIS-INDUCING FACTOR; PARKINSONS-DISEASE; S-NITROSYLATION; ALPHA-SYNUCLEIN; PHOSPHORYLATION; UBIQUITINATION; EXPRESSION; BINDING	The defining pathogenic feature of Parkinson's disease is the age-dependent loss of dopaminergic neurons. Mutations and inactivation of parkin, an ubiquitin E3 ligase, induce Parkinson's disease through accumulation of pathogenic substrates. We found that transgenic overexpression of a parkin substrate, aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2), led to a selective, age-dependent, progressive loss of dopaminergic neurons via activation of poly(ADP-ribose) polymerase-1 (PARP1). AIMP2 accumulation in vitro and in vivo resulted in PARP1 overactivation and dopaminergic cell toxicity via direct association of these proteins in the nucleus, providing a path to PARP1 activation other than DNA damage. Inhibition of PARP1 through gene deletion or drug inhibition reversed behavioral deficits and protected against dopamine neuron death in AIMP2 transgenic mice. These data indicate that brain-permeable PARP inhibitors could effectively delay or prevent disease progression in Parkinson's disease.	[Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA; [Lee, Yunjong] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Jiang, Haisong; Kang, Sung-Ung; Dawson, Valina L.; Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [Shin, Joo-Ho] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol,Dept Mol Cell Biol, Suwon, South Korea; [Ko, Han Seok; Kim, Donghoon] Diana Helis Henry Med Res Fdn, New Orleans, LA USA; [Swing, Debbie; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Lee, Byoung Dae] Kyung Hee Univ, Dept Neurosci, Age Related & Brain Dis Res Ctr, Seoul, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 441749, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyung Hee University; Ajou University; Ajou University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA.	vdawson@jhmi.edu; tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Karuppagounder, Senthilkumar/I-6752-2013; Shin, Joo-Ho/P-1417-2018	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Dawson, Valina/0000-0002-2915-3970; Lee, Yunjong/0000-0003-0182-2279	US National Institutes of Health [NS38377]; JPB Foundation; Samsung Scholarship Foundation; Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067525, P50NS038377] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Samsung Scholarship Foundation(Samsung); Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (NS38377) and the JPB Foundation. Y.-I.L. was supported by the Samsung Scholarship Foundation. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors acknowledge the joint participation and support by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. D.S. and L.T. were supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, US National Institutes of Health.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2006, J NEURAL TRANSM-SUPP, P209; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009324; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; MacCallum PR, 2006, J GEN VIROL, V87, P3251, DOI 10.1099/vir.0.82051-0; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sprengel R, 2007, Handb Exp Pharmacol, P49; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	52	148	154	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1392	+		10.1038/nn.3500	http://dx.doi.org/10.1038/nn.3500			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974709	Green Accepted			2022-12-25	WOS:000324795300011
J	Huang, F; Wang, XD; Ostertag, EM; Nuwal, T; Huang, B; Jan, YN; Basbaum, AI; Jan, LY				Huang, Fen; Wang, Xidao; Ostertag, Eric M.; Nuwal, Tulip; Huang, Bo; Jan, Yuh-Nung; Basbaum, Allan I.; Jan, Lily Yeh			TMEM16C facilitates Na+-activated K+ currents in rat sensory neurons and regulates pain processing	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; CHLORIDE CHANNEL ACTIVITY; PRIMARY AFFERENT NEURONS; SODIUM-CHANNELS; MOLECULAR-MECHANISMS; POTASSIUM CHANNEL; CALCIUM-CHANNELS; FAMILY; SLACK; ELECTROGENESIS	TMEM16C belongs to the TMEM16 family, which includes the Ca2+-activated Cl- channels TMEM16A and TMEM16B and a small-conductance, Ca2+-activated, nonselective cation channel (SCAN), TMEM16F. We found that in rat dorsal root ganglia (DRG) TMEM16C was expressed mainly in the IB4-positive, non-peptidergic nociceptors that also express the sodium-activated potassium (K-Na) channel Slack. Together these channel proteins promote K-Na channel activity and dampen neuronal excitability. DRG from TMEM16C knockout rats had diminished Slack expression, broadened action potentials and increased excitability. Moreover, the TMEM16C knockout rats, as well as rats with Slack knockdown by intrathecal injection of short interfering RNA, exhibited increased thermal and mechanical sensitivity. Experiments involving heterologous expression in HEK293 cells further showed that TMEM16C modulated the single-channel activity of Slack channels and increased its sodium sensitivity. Our study thus reveals that TMEM16C enhances K-Na channel activity in DRG neurons and regulates the processing of pain messages.	[Huang, Fen; Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Huang, Fen; Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ostertag, Eric M.] Transposagen Biopharmaceut Inc, Lexington, KY USA; [Nuwal, Tulip; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	US National Institutes of Health (NIH); NIH; Commonwealth of Kentucky; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Tynan La Fontaine and D. Wang for the assistance with the rodent genotyping and husbandry. We thank T. Jin, H. Yang, W. Zhang, W. Ge, T. Wang, C. Peters, S. Xiao, T. Cheng, J. Berg and Z. Guan for technical help and discussions. We thank J. Crawford at Transposagen for administrative assistance. This study is supported by grants from the US National Institutes of Health (NIH) to L.Y.J. and A. I. B. and grants from the NIH and the Commonwealth of Kentucky to E.M.O. Y.-N.J. and L.Y.J. are supported by the Howard Hughes Medical Institute.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blair NT, 2002, J NEUROSCI, V22, P10277; Briones N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-7; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fang X, 2002, J NEUROSCI, V22, P7425; Heninger A. K., 2007, CSH PROTOC, V2007; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; HUANG Y, 1989, BIOPHYS J, V56, P1023, DOI 10.1016/S0006-3495(89)82747-X; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kamiyama D, 2012, DEV CELL, V23, P1103, DOI 10.1016/j.devcel.2012.10.003; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kuo CC, 2002, J GEN PHYSIOL, V120, P159, DOI 10.1085/jgp.20018536; Leffler A, 2005, PFLUG ARCH EUR J PHY, V451, P454, DOI 10.1007/s00424-005-1463-x; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stucky CL, 1999, J NEUROSCI, V19, P6497; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Vivancos GG, 2004, BRAZ J MED BIOL RES, V37, P391, DOI 10.1590/S0100-879X2004000300017; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	52	86	90	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1284	U166		10.1038/nn.3468	http://dx.doi.org/10.1038/nn.3468			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872594	Green Submitted, Green Accepted			2022-12-25	WOS:000323597500020
J	Lee, SH; Kravitz, DJ; Baker, CI				Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.			Goal-dependent dissociation of visual and prefrontal cortices during working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; NEURAL FRAMEWORK; CORTEX; OBJECTS; REPRESENTATIONS; VISUALIZATION; INFORMATION; AREAS	To determine the specific contribution of brain regions to working memory, human participants performed two distinct tasks on the same visually presented objects. During the maintenance of visual properties, object identity could be decoded from extrastriate, but not prefrontal, cortex, whereas the opposite held for nonvisual properties. Thus, the ability to maintain information during working memory is a general and flexible cortical property, with the role of individual regions being goal-dependent.	[Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lee, SH (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	sue-hyun.lee@nih.gov	Baker, Chris/P-8442-2019; Kravitz, Dwight/AAO-5860-2020; Lee, Sue-Hyun/F-5490-2015	Baker, Chris/0000-0001-6861-8964; Kravitz, Dwight/0000-0002-8108-1329; Lee, Sue-Hyun/0000-0002-5318-5657	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institute of Mental Health Intramural Research Program. Thanks to S. Marrett and S. Inati for help with data acquisition, E. Bilger and E. Aguila for data collection, A. Harel and A. Martin for comments and members of the Laboratory of Brain and Cognition for discussion.	Brady MJ, 2003, J VISION, V3, P413, DOI 10.1167/3.6.2; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee SH, 2012, NEUROIMAGE, V59, P4064, DOI 10.1016/j.neuroimage.2011.10.055; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Lewis-Peacock JA, 2012, NEUROPSYCHOLOGIA, V50, P470, DOI 10.1016/j.neuropsychologia.2011.11.006; Linden DEJ, 2012, J NEUROPHYSIOL, V107, P628, DOI 10.1152/jn.00105.2011; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Romero L, 2006, J COGNITIVE NEUROSCI, V18, P1147, DOI 10.1162/jocn.2006.18.7.1147; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Sligte IG, 2013, J NEUROSCI, V33, P1293, DOI 10.1523/JNEUROSCI.4860-12.2013; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009	25	120	120	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					997	U35		10.1038/nn.3452	http://dx.doi.org/10.1038/nn.3452			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817547	Green Accepted			2022-12-25	WOS:000322323000008
J	Faddah, DA; Wang, HY; Cheng, AW; Katz, Y; Buganim, Y; Jaenisch, R				Faddah, Dina A.; Wang, Haoyi; Cheng, Albert Wu; Katz, Yarden; Buganim, Yosef; Jaenisch, Rudolf			Single-Cell Analysis Reveals that Expression of Nanog Is Biallelic and Equally Variable as that of Other Pluripotency Factors in Mouse ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; AUTOREPRESSION; HETEROGENEITY	The homeodomain transcription factor Nanog is a central part of the core pluripotency transcriptional network and plays a critical role in embryonic stem cell (ESC) self-renewal. Several reports have suggested that Nanog expression is allelically regulated and that transient downregulation of Nanog in a subset of pluripotent cells predisposes them toward differentiation. Using single-cell gene expression analyses combined with different reporters for the two alleles of Nanog, we show that Nanog is biallelically expressed in ESCs independently of culture condition. We also show that the overall variation in endogenous Nanog expression in ESCs is very similar to that of several other pluripotency markers. Our analysis suggests that reporter-based studies of gene expression in pluripotent cells can be significantly influenced by the gene-targeting strategy and genetic background employed.	[Faddah, Dina A.; Wang, Haoyi; Cheng, Albert Wu; Katz, Yarden; Buganim, Yosef; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert Wu] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Katz, Yarden] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Cheng, Albert/0000-0003-2653-5743	National Science Foundation Graduate Research Fellowship; Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; National Institutes of Health (NIH) Kirschstein National Research Service Award [1 F32 GM099153-01A1]; NIH [HD 045022, R37CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; National Institutes of Health (NIH) Kirschstein National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Smith for sharing TNGA cells; B. Carey, M. Dawlaty, F. Soldner, and A. Salama for helpful discussions; T. Theunissen for help with sorting; and A. van Oudenaarden and S. Klemm for insightful discussions and Stella probe. D. A. F. is a Vertex scholar and was supported by a National Science Foundation Graduate Research Fellowship and a Jerome and Florence Brill Graduate Student Fellowship. A. W. C. was supported by a Croucher and Ludwig Research Fellowship. Y.B. was supported by a National Institutes of Health (NIH) Kirschstein National Research Service Award (1 F32 GM099153-01A1). This work was supported by NIH grants HD 045022 and R37CA084198 to R.J. R.J. is a cofounder of Fate Therapeutics and an advisor to Stemgent.	Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Fischer Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012533; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	22	90	91	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					23	29		10.1016/j.stem.2013.04.019	http://dx.doi.org/10.1016/j.stem.2013.04.019			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827708	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000329570100009
J	Aly, M; Ranganath, C; Yonelinas, AP				Aly, Mariam; Ranganath, Charan; Yonelinas, Andrew P.			Detecting Changes in Scenes: The Hippocampus Is Critical for Strength-Based Perception	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; VISUAL-DISCRIMINATION PERFORMANCE; HIGH-RESOLUTION FMRI; RECOGNITION MEMORY; PATTERN SEPARATION; WORKING-MEMORY; NEURAL SYSTEM; RECOLLECTION; FAMILIARITY; AMNESIA	Recent findings have ignited a controversy over whether the hippocampus is critical for visual perception as well as memory. Some studies have shown that hippocampal damage impairs perception of scenes, but others found no evidence for hippocampal involvement. These studies measured perception as a unitary phenomenon, but recent findings indicate that perceptual discriminations can be based on two kinds of information: states of perceiving local differences or global strength of relational match. In the current study, we separated state- and strength-based perception using a change detection paradigm with scenes. Patients with selective hippocampal damage exhibited significant reductions in strength-based perception but showed spared state-based responses. In a follow-up neuroinnaging study, hippocampal activation linearly tracked confidence in strength-based perception, and was not differentially associated with state-based responses. The hippocampus therefore plays a selective role in perception, contributing high-resolution strength information possibly through its role in the representation of relational information.	[Aly, Mariam; Ranganath, Charan; Yonelinas, Andrew P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Ranganath, Charan] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Yonelinas, Andrew P.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Aly, M (corresponding author), Univ Calif Davis, Dept Psychol, 135 Young Hall,1 Shields Ave, Davis, CA 95616 USA.	mariam.s.aly@gmail.com		Yonelinas, Andrew/0000-0002-9580-4997; Aly, Mariam/0000-0003-4033-6134	 [MH59352];  [MH083734]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083734, R01MH059352] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants MH59352 and MH083734. We would like to thank Maureen Ritchey, Iain Harlow, Luke Jenkins, and the UC Davis Memory Group for helpful advice, and Maria Montchal and Wei-chun Wang for the hippocampal tracings. M.A., C.R., and A.P.Y. conceived and designed the experiments. M.A. performed the experiments and analyzed the data. M.A., C.R., and A.P.Y. wrote the paper.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Aly M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030231; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barense MD, 2010, HIPPOCAMPUS, V20, P389, DOI 10.1002/hipo.20641; Baxter MG, 2009, NEURON, V61, P667, DOI 10.1016/j.neuron.2009.02.007; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chadwick MJ, 2013, CORTEX, V49, P2067, DOI 10.1016/j.cortex.2012.11.010; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Duvernoy HM, 1998, HUMAN HIPPOCAMPUS FU; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Elfman KW, 2008, J EXP PSYCHOL LEARN, V34, P752, DOI 10.1037/0278-7393.34.4.752; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Graham KS, 2010, NEUROPSYCHOLOGIA, V48, P831, DOI 10.1016/j.neuropsychologia.2010.01.001; Green DM, 1966, SIGNAL DETECTION THE; Harlow IM, 2013, PSYCHON B REV, V20, P318, DOI 10.3758/s13423-012-0340-9; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Kim S, 2011, J NEUROSCI, V31, P2624, DOI 10.1523/JNEUROSCI.5954-10.2011; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Knutson AR, 2012, P NATL ACAD SCI USA, V109, P13106, DOI 10.1073/pnas.1208876109; KONO E, 1983, ARCH PSYCHIAT NERVEN, V233, P271, DOI 10.1007/BF00345797; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Lee ACH, 2005, NEUROPSYCHOLOGIA, V43, P1, DOI 10.1016/j.neuropsychologia.2004.07.017; Lee ACH, 2005, HIPPOCAMPUS, V15, P782, DOI 10.1002/hipo.20101; Lee ACH, 2008, CEREB CORTEX, V18, P683, DOI 10.1093/cercor/bhm104; Lee ACH, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00091; Lee ACH, 2010, J COGNITIVE NEUROSCI, V22, P2823, DOI 10.1162/jocn.2009.21396; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Macmillan N. A., 2005, DETECTION THEORY USE; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mullally SL, 2012, CURR BIOL, V22, P261, DOI 10.1016/j.cub.2012.01.001; Mundy ME, 2012, NEUROPSYCHOLOGIA, V50, P3053, DOI 10.1016/j.neuropsychologia.2012.07.006; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsen RK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00146; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Parks CM, 2011, J EXP PSYCHOL LEARN, V37, P861, DOI 10.1037/a0022798; Parks CM, 2009, P NATL ACAD SCI USA, V106, P11515, DOI 10.1073/pnas.0905505106; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rensink RA, 2004, PSYCHOL SCI, V15, P27, DOI 10.1111/j.0963-7214.2004.01501005.x; Saksida LM, 2010, NEUROPSYCHOLOGIA, V48, P2370, DOI 10.1016/j.neuropsychologia.2010.02.026; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2006, J NEUROSCI, V26, P2235, DOI 10.1523/JNEUROSCI.4792-05.2006; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Warren DE, 2012, HIPPOCAMPUS, V22, P1577, DOI 10.1002/hipo.21000; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yonelinas AP, 2010, HIPPOCAMPUS, V20, P1178, DOI 10.1002/hipo.20864; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061	71	81	81	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1127	1137		10.1016/j.neuron.2013.04.018	http://dx.doi.org/10.1016/j.neuron.2013.04.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	172TD	23791201	Bronze, Green Accepted			2022-12-25	WOS:000321026900017
J	Zhang, YS; Pak, C; Han, Y; Ahlenius, H; Zhang, ZJ; Chanda, S; Marro, S; Patzke, C; Acuna, C; Covy, J; Xu, W; Yang, N; Danko, T; Chen, L; Wernig, M; Sudhof, TC				Zhang, Yingsha; Pak, ChangHui; Han, Yan; Ahlenius, Henrik; Zhang, Zhenjie; Chanda, Soham; Marro, Samuele; Patzke, Christopher; Acuna, Claudio; Covy, Jason; Xu, Wei; Yang, Nan; Danko, Tamas; Chen, Lu; Wernig, Marius; Suedhof, Thomas C.			Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells	NEURON			English	Article							HOMEOSTATIC SYNAPTIC PLASTICITY; HUMAN FIBROBLASTS; HUMAN ES; DIRECT CONVERSION; DOPAMINERGIC-NEURONS; HIGHLY EFFICIENT; RETINOIC ACID; IPS CELLS; DISEASE; DIFFERENTIATION	Available methods for differentiating human embryonic stem cells (ESCs) and induced pluripotent cells (iPSCs) into neurons are often cumbersome, slow, and variable. Alternatively, human fibroblasts can be directly converted into induced neuronal (IN) cells. However, with present techniques conversion is inefficient, synapse formation is limited, and only small amounts of neurons can be generated. Here, we show that human ESCs and iPSCs can be converted into functional IN cells with nearly 100% yield and purity in less than 2 weeks by forced expression of a single transcription factor. The resulting ES-iN or iPS-iN cells exhibit quantitatively reproducible properties independent of the cell line of origin, form mature pre- and postsynaptic specializations, and integrate into existing synaptic networks when transplanted into mouse brain. As illustrated by selected examples, our approach enables large-scale studies of human neurons for questions such as analyses of human diseases, examination of human-specific genes, and drug screening.	[Zhang, Yingsha; Pak, ChangHui; Han, Yan; Chanda, Soham; Patzke, Christopher; Acuna, Claudio; Covy, Jason; Xu, Wei; Danko, Tamas; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ahlenius, Henrik; Chanda, Soham; Marro, Samuele; Yang, Nan; Danko, Tamas; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Ahlenius, Henrik; Chanda, Soham; Marro, Samuele; Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Zhang, Zhenjie; Chen, Lu; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Marro, Samuele G./I-4493-2014; Han, Yan/G-6027-2014; Ahlenius, Henrik/L-8660-2015; Ahlenius, Henrik/GPG-1120-2022; Patzke, Christopher/J-5679-2019	Marro, Samuele G./0000-0002-9326-6945; Ahlenius, Henrik/0000-0001-8958-6148; Ahlenius, Henrik/0000-0001-8958-6148; Patzke, Christopher/0000-0001-7293-8936; Chanda, Soham/0000-0002-2327-6224; Yang, Nan/0000-0003-3663-1288; xu, wei/0000-0003-0987-2481; Chen, Lu/0000-0002-8097-2699	Ellison Medical Foundation [AG-NS-0709-10]; NIH [P50 AG010770-18A1, R01 MH092931, P50 MH086403]; California Institute for Regenerative Medicine [RT2-02061]; Department of Defense [PR100175P1]; Berry Foundation; Swedish Research Council; Swedish Society for Medical Research; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091193, P50MH086403, R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Department of Defense(United States Department of Defense); Berry Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Drs. V. Sebastiano, B. Haddad, and B. Berninger for advice and reagents. This study was supported by grants from the Ellison Medical Foundation (AG-NS-0709-10 M.W.), the NIH (P50 AG010770-18A1 and R01 MH092931 to M.W. and T.C.S., and P50 MH086403 to L.C. and T.C.S.), the California Institute for Regenerative Medicine (RT2-02061 to MM. and T.C.S.), and the Department of Defense (PR100175P1 to M.W.). M.W. is a New York Stem Cell Foundation-Robertson Investigator. N.Y. was supported by a fellowship from the Berry Foundation, H.A. by a fellowship from the Swedish Research Council and the Swedish Society for Medical Research, and C.P. by a fellowship from the Deutsche Forschungsgemeinschaft.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Blanpain C, 2012, NAT REV MOL CELL BIO, V13, P471, DOI 10.1038/nrm3371; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Franke B, 1998, HISTOCHEM CELL BIOL, V110, P595, DOI 10.1007/s004180050322; Hamada M, 2006, NEUROBIOL DIS, V22, P509, DOI 10.1016/j.nbd.2005.12.020; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Marchetto MC, 2012, CELL STEM CELL, V10, P642, DOI 10.1016/j.stem.2012.05.008; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Ming GL, 2011, J NEUROSCI, V31, P16070, DOI 10.1523/JNEUROSCI.4218-11.2011; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Pavone P, 2012, BRAIN DEV-JPN, V34, P459, DOI 10.1016/j.braindev.2011.09.004; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sugimoto Y, 2009, CELL BIOL INT, V33, P174, DOI 10.1016/j.cellbi.2008.10.010; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	53	696	714	9	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					785	798		10.1016/j.neuron.2013.05.029	http://dx.doi.org/10.1016/j.neuron.2013.05.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764284	Bronze, Green Accepted			2022-12-25	WOS:000320743400006
J	Brandon, MP; Bogaard, AR; Schultheiss, NW; Hasselmo, ME				Brandon, Mark P.; Bogaard, Andrew R.; Schultheiss, Nathan W.; Hasselmo, Michael E.			Segregation of cortical head direction cell assemblies on alternating theta cycles	NATURE NEUROSCIENCE			English	Article							FREELY MOVING RATS; PHASE PRECESSION; GABAERGIC MODULATION; MEMORY IMPAIRMENTS; GRID CELLS; HIPPOCAMPAL; OSCILLATIONS; PLACE; RHYTHM; POSTSUBICULUM	High-level cortical systems for spatial navigation, including entorhinal grid cells, critically depend on input from the head direction system. We examined spiking rhythms and modes of synchrony between neurons participating in head direction networks for evidence of internal processing, independent of direct sensory drive, which may be important for grid cell function. We found that head direction networks of rats were segregated into at least two populations of neurons firing on alternate theta cycles (theta cycle skipping) with fixed synchronous or anti-synchronous relationships. Pairs of anti-synchronous theta cycle skipping neurons exhibited larger differences in head direction tuning, with a minimum difference of 40 degrees of head direction. Septal inactivation preserved the head direction signal, but eliminated theta cycle skipping of head direction cells and grid cell spatial periodicity. We propose that internal mechanisms underlying cycle skipping in head direction networks may be critical for downstream spatial computation by grid cells.	[Brandon, Mark P.; Bogaard, Andrew R.; Schultheiss, Nathan W.; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Grad Program Neurosci, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Brandon, MP (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	mbrandon@ucsd.edu		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health [R01 MH60013, MH61492]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-10-1-0936]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060013, R01MH061492] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We kindly thank S. Gillet, J. Hinman, E. Newman and L. Ewell for their invaluable consultations and comments on previous versions of this manuscript, as well as M. Connerney, S. Eriksson, C. Libby and T. Ware for technical assistance and behavioral training. This work was supported by grants from the National Institute of Mental Health (R01 MH60013 and MH61492) and the Office of Naval Research Multidisciplinary University Research Initiative (N00014-10-1-0936).	Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2012, HIPPOCAMPUS, V22, P604, DOI 10.1002/hipo.20924; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GIVENS B, 1995, NEUROBIOL LEARN MEM, V63, P269, DOI 10.1006/nlme.1995.1031; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	51	64	64	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					739	+		10.1038/nn.3383	http://dx.doi.org/10.1038/nn.3383			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603709	Green Accepted			2022-12-25	WOS:000319509600016
J	Hughes, EG; Kang, SH; Fukaya, M; Bergles, DE				Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.			Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain	NATURE NEUROSCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCAN; NG2-POSITIVE CELLS; GLIAL PROGENITORS; PRECURSOR CELLS; WHITE-MATTER; NG2 CELLS; LONG-TERM; PROLIFERATION; DYNAMICS; ORIGIN	The adult CNS contains an abundant population of oligodendrocyte precursor cells (NG2(+) cells) that generate oligodendrocytes and repair myelin, but how these ubiquitous progenitors maintain their density is unknown. We generated NG2-mEGFP mice and used in vivo two-photon imaging to study their dynamics in the adult brain. Time-lapse imaging revealed that NG2(+) cells in the cortex were highly dynamic; they surveyed their local environment with motile filopodia, extended growth cones and continuously migrated. They maintained unique territories though self-avoidance, and NG2(+) cell loss though death, differentiation or ablation triggered rapid migration and proliferation of adjacent cells to restore their density. NG2(+) cells recruited to sites of focal CNS injury were similarly replaced by a proliferative burst surrounding the injury site. Thus, homeostatic control of NG2(+) cell density through a balance of active growth and self-repulsion ensures that these progenitors are available to replace oligodendrocytes and participate in tissue repair.	[Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Hughes, Ethan/0000-0003-3243-7429	Kirschstein National Research Service Award grant from the US National Institutes of Health [F32NS076098]; US National Institutes of Health [NS051509, NS050274]; Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R01NS051509, F32NS076098] Funding Source: NIH RePORTER	Kirschstein National Research Service Award grant from the US National Institutes of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pucak, N. Ye and T. Lee for technical assistance, B. Cudmore (Johns Hopkins University) and S. Wang (Princeton University) for advice on cranial window implantation, W.-B. Gan (New York University) for advice on preparing thinned skull windows, and members of the Bergles laboratory for discussions. E.G.H. was supported by a Kirschstein National Research Service Award grant from the US National Institutes of Health (F32NS076098). Funding was provided by grants from the US National Institutes of Health (NS051509, NS050274) and the Brain Science Institute at Johns Hopkins University.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Chung SH, 2009, APPL PHYS A-MATER, V96, P335, DOI 10.1007/s00339-009-5201-7; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haber M, 2009, GLIA, V57, P1000, DOI 10.1002/glia.20824; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; MOORE BR, 1980, BIOMETRIKA, V67, P175; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Spassky N, 2002, J NEUROSCI, V22, P5992; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang H, 1996, J NEUROSCI, V16, P6886; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	468	475	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					668	+		10.1038/nn.3390	http://dx.doi.org/10.1038/nn.3390			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624515	Green Accepted			2022-12-25	WOS:000319509600007
J	Monosov, IE; Hikosaka, O				Monosov, Ilya E.; Hikosaka, Okihide			Selective and graded coding of reward uncertainty by neurons in the primate anterodorsal septal region	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; RISK; CONNECTIONS; ANXIETY; MONKEY; REPRESENTATION; INFORMATION; PROJECTIONS; DISTINCT	Natural environments are uncertain. Uncertainty of emotional outcomes can induce anxiety and raise vigilance, promote and signal the opportunity for learning, modulate economic choice and regulate risk-seeking. Here we demonstrate that a subset of neurons in the anterodorsal region of the primate septum (ADS) are primarily devoted to processing uncertainty in a highly specific manner. Those neurons were selectively activated by visual cues indicating probabilistic delivery of reward (for example, 25%, 50% and 75% reward) and did not respond to cues indicating certain outcomes (0% and 100% reward). The average ADS uncertainty response was graded with the magnitude of reward uncertainty and selectively signaled uncertainty about rewards rather than punishments. The selective and graded information about reward uncertainty encoded by many neurons in the ADS may underlie modulation of uncertainty of value-and sensorimotor-related areas to regulate goal-directed behavior.	[Monosov, Ilya E.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Monosov, IE (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	ilya.monosov@gmail.com			Intramural NIH HHS [ZIA EY000415-11] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anselme P, 2010, BEHAV BRAIN RES, V208, P291, DOI 10.1016/j.bbr.2009.12.020; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Daye PM, 2013, J NEUROSCI METH, V213, P123, DOI 10.1016/j.jneumeth.2012.12.012; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Hirsh JB, 2012, PSYCHOL REV, V119, P304, DOI 10.1037/a0026767; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Menard J, 1996, PHYSIOL BEHAV, V60, P845; Monosov IE, 2012, J NEUROSCI, V32, P10318, DOI 10.1523/JNEUROSCI.1801-12.2012; Neuringer A, 2002, PSYCHON B REV, V9, P672, DOI 10.3758/BF03196324; Nishijo H, 1997, HIPPOCAMPUS, V7, P536, DOI 10.1002/(SICI)1098-1063(1997)7:5<536::AID-HIPO9>3.0.CO;2-E; Nishijo H, 1997, HIPPOCAMPUS, V7, P460, DOI 10.1002/(SICI)1098-1063(1997)7:5<460::AID-HIPO2>3.0.CO;2-L; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Ogawa M, 2013, NEURON, V77, P251, DOI 10.1016/j.neuron.2012.11.006; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; POWELL EW, 1973, EXP BRAIN RES, V17, P394; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; STAIGER JF, 1991, CELL TISSUE RES, V264, P415, DOI 10.1007/BF00319032; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VOGT BA, 1987, J COMP NEUROL, V262, P256, DOI 10.1002/cne.902620207; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	49	51	51	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					756	+		10.1038/nn.3398	http://dx.doi.org/10.1038/nn.3398			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666181	Green Accepted			2022-12-25	WOS:000319509600018
J	Li, WH; Prazak, L; Chatterjee, N; Gruninger, S; Krug, L; Theodorou, D; Dubnau, J				Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Grueninger, Servan; Krug, Lisa; Theodorou, Delphine; Dubnau, Josh			Activation of transposable elements during aging and neuronal decline in Drosophila	NATURE NEUROSCIENCE			English	Article							L1 RETROTRANSPOSITION; OLFACTORY MEMORY; GYPSY	We found that several transposable elements were highly active in Drosophila brain during normal aging. In addition, we found that mutations in Drosophila Argonaute 2 (Ago2) resulted in exacerbated transposon expression in the brain, progressive and age-dependent memory impairment, and shortened lifespan. These findings suggest that transposon activation may contribute to age-dependent loss of neuronal function.	[Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Dubnau, Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Li, Wanhe] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Grueninger, Servan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Grueninger, Servan; Krug, Lisa; Dubnau, Josh] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Theodorou, Delphine] Univ Paris Diderot, Magistere Genet Grad Program, Paris, France	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Zurich; Cold Spring Harbor Laboratory; UDICE-French Research Universities; Universite Paris Cite	Dubnau, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.edu		Dubnau, Josh/0000-0002-9285-7444; Gruninger, Servan/0000-0003-2900-1376	US National Institutes of Health [TR01(5R01NS067690-03)]; DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Czech and G. Hannon (Cold Spring Harbor Laboratory) for the Ago2<SUP>414</SUP> and loki RNAi fly lines, F.-B. Gao (University of Massachusetts Medical School) for the Ago2<SUP>51B</SUP> fly line, B. Dickson (Institute of Molecular Pathology) for the UAS::Ago2 transgenic fly line, M. Welte (University of Rochester) for the Ago2<SUP>454</SUP> fly line, T. Lee (Janelia Farm Research Campus) for the pTub-GAL80 in Casper4 plasmid, J. Boek (Johns Hopkins University School of Medicine) for the 7B3 hybridoma cell line, and C. Bautista at the Cold Spring Harbor Laboratory shared resources for ascites production. We thank T. Russel for technical assistance in construction of the gypsy reporter system. We also are grateful to S. Waddell, J. Beshel, M. Cressy, B. Czech, G. Hannon, K. Honegger, J. Huang, M. Kernan, R. Martienssen, H. Qin, C. Sandoval, Y. Shuai, G. Turner, T. Zador and Y. Zhong for helpful discussions or comments on the manuscript. This work was supported by US National Institutes of Health grant TR01(5R01NS067690-03) and DART NeuroScience LLC awarded to J.D. S.G. received additional support from the Shakespeare Fellowship and the Ernst Gohner Foundation.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Dubnau J, 2013, CURR OPIN NEUROBIOL, V23, P84, DOI 10.1016/j.conb.2012.09.006; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Jeong BH, 2010, J CLIN VIROL, V47, P136, DOI 10.1016/j.jcv.2009.11.016; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Labrador M, 2008, GENETICS, V180, P1367, DOI 10.1534/genetics.108.094318; Lathe R, 2009, J MOL BIOL, V392, P813, DOI 10.1016/j.jmb.2009.07.045; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; Tan HP, 2012, HUM MOL GENET, V21, P57, DOI 10.1093/hmg/ddr437; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0	24	195	204	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					529	+		10.1038/nn.3368	http://dx.doi.org/10.1038/nn.3368			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563579	Green Accepted			2022-12-25	WOS:000318029300008
J	Wamsteeker Cusulin, JI; Fuzesi, T; Inoue, W; Bains, JS				Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.			Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE RELEASE; ACUTE STRESS; ENKEPHALIN; TRANSMISSION; ACTIVATION; INHIBITION; EXPRESSION; PLASTICITY	Stressful experience initiates a neuroendocrine response culminating in the release of glucocorticoid hormones into the blood. Glucocorticoids feed back to the brain, causing adaptations that prevent excessive hormone responses to subsequent challenges. How these changes occur remains unknown. We found that glucocorticoid receptor activation in rodent hypothalamic neuroendocrine neurons following in vivo stress is a metaplastic signal that allows GABA synapses to undergo activity-dependent long-term depression (LTDGABA). LTDGABA was unmasked through glucocorticoid receptor-dependent inhibition of Regulator of G protein Signaling 4 (RGS4), which amplified signaling through postsynaptic metabotropic glutamate receptors. This drove somatodendritic opioid release, resulting in a persistent retrograde suppression of synaptic transmission through presynaptic mu receptors. Together, our data provide new evidence for retrograde opioid signaling at synapses in neuroendocrine circuits and represent a potential mechanism underlying glucocorticoid contributions to stress adaptation.	[Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Bains, JS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca	Inoue, Wataru/M-2163-2015	Inoue, Wataru/0000-0002-2438-5123; Bains, Jaideep/0000-0002-3634-6463	Canadian Institutes of Health Research [MOP 86501]; Alberta Innovates-Health Solutions; Hotchkiss Brain Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Hotchkiss Brain Institute	We acknowledge members of the Bains laboratory for thoughtful discussion and C. Sank and R. Cantrup for technical assistance. We thank Q. Pittman and K. Iremonger for helpful comments on the manuscript, and K. Sharkey (University of Calgary) for providing Cnr1<SUP>-/-</SUP> mice. We thank the Hotchkiss Brain Institute support of the optogenetics core. J.S.B. is an Alberta Innovates-Health Solutions Senior Scholar. This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP 86501 to J.S.B.). W.I. and T.F. are supported by postdoctoral fellowships, and J.I.W.C. by a PhD scholarship from Alberta Innovates-Health Solutions. W.I. and J.I.W.C. also received fellowship and scholarship support from the Hotchkiss Brain Institute.	Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BUCKINGHAM JC, 1982, NEUROENDOCRINOLOGY, V35, P111, DOI 10.1159/000123364; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DECAVEL C, 1992, J COMP NEUROL, V316, P104, DOI 10.1002/cne.903160109; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Dumont EC, 2000, J NEUROCHEM, V75, P2200, DOI 10.1046/j.1471-4159.2000.0752200.x; Garcia-Garcia L, 1998, BRAIN RES, V786, P215, DOI 10.1016/S0006-8993(97)01416-9; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Inoue W, 2013, NAT NEUROSCI, V16, P605, DOI 10.1038/nn.3373; Iremonger KJ, 2011, J NEUROSCI, V31, P12011, DOI 10.1523/JNEUROSCI.2925-11.2011; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kim G, 2010, MOL CELLS, V30, P161, DOI 10.1007/s10059-010-0102-3; KIRITSYROY JA, 1986, J PHARMACOL EXP THER, V239, P814; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lafourcade CA, 2008, PSYCHOPHARMACOLOGY, V198, P539, DOI 10.1007/s00213-007-1040-4; LARSEN PJ, 1994, PEPTIDES, V15, P783, DOI 10.1016/0196-9781(94)90030-2; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; LIGHTMAN SL, 1989, P NATL ACAD SCI USA, V86, P4306, DOI 10.1073/pnas.86.11.4306; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Ni YG, 1999, J NEUROSCI, V19, P3674; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; PRETEL S, 1990, J COMP NEUROL, V294, P192, DOI 10.1002/cne.902940204; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Saugstad JA, 1998, J NEUROSCI, V18, P905; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Verkuyl JM, 2005, EUR J NEUROSCI, V21, P113, DOI 10.1111/j.1460-9568.2004.03846.x; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	50	44	44	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					596	+		10.1038/nn.3374	http://dx.doi.org/10.1038/nn.3374			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563581	Green Accepted			2022-12-25	WOS:000318029300016
J	Hafed, ZM				Hafed, Ziad M.			Alteration of Visual Perception prior to Microsaccades	NEURON			English	Article							PERI-SACCADIC PERCEPTION; SUPERIOR-COLLICULUS; RECEPTIVE-FIELDS; EYE-MOVEMENTS; PSYCHOMETRIC FUNCTION; ATTENTION IMPROVES; REPRESENTATIONS; NEURONS; COMPRESSION; SENSITIVITY	Gaze fixation is an active process, with the incessant occurrence of tiny eye movements, including microsaccades. While the retinal consequences of microsaccades may be presumed minimal because of their minute size, a significant perceptual consequence of these movements can also stem from active extraretinal mechanisms associated with corollaries of their motor generation. Here I show that prior to microsaccade onset, spatial perception is altered in a very specific manner: foveal stimuli are erroneously perceived as more eccentric, whereas peripheral stimuli are rendered more foveal. The mechanism for this perceptual "compression of space" is consistent with a spatially specific gain modulation of visual representations caused by the upcoming eye movements, as is hypothesized to happen for much larger saccades. I then demonstrate that this perimicrosaccadic perceptual alteration has at least one important functional consequence: it mediates visual-performance alterations similar to ones classically attributed to the cognitive process of covert visual attention.	[Hafed, Ziad M.] Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Hafed, Ziad M.] Univ Tubingen, Inst Neurobiol, Anim Physiol Unit, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hafed, ZM (corresponding author), Werner Reichardt Ctr Integrat Neurosci, Otfried Muller Str 25, D-72076 Tubingen, Germany.	ziad.m.hafed@cin.uni-tuebingen.de			Werner Reichardt Centre for Integrative Neuroscience, Tuebingen, Germany	Werner Reichardt Centre for Integrative Neuroscience, Tuebingen, Germany	I thank A. Ruch for help in setting up the laboratory, A. Zaidi for help in some initial data collection, and C. Engesser for help in recruiting subjects. I am also grateful to M. Hated and A. Nieder for reading an earlier version of the manuscript. This work was funded by the Werner Reichardt Centre for Integrative Neuroscience, Tuebingen, Germany.	BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BERLUCCHI G, 1987, NEUROPSYCHOLOGIA, V25, P1, DOI 10.1016/0028-3932(87)90038-8; Boehnke SE, 2008, CURR OPIN NEUROBIOL, V18, P544, DOI 10.1016/j.conb.2008.11.004; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Conner CE, 1997, J NEUROSCI, V17, P3201; Corneil BD, 2008, NAT NEUROSCI, V11, P13, DOI 10.1038/nn2023; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Goffart L, 2012, J NEUROSCI, V32, P10627, DOI 10.1523/JNEUROSCI.0696-12.2012; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Hafed Z.M., 2013, EUR J NEUROSCI; Hafed ZM, 2008, J NEUROSCI, V28, P9426, DOI 10.1523/JNEUROSCI.1313-08.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hafed ZM, 2012, J NEUROPHYSIOL, V107, P1904, DOI 10.1152/jn.01125.2011; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Hafed ZM, 2011, EUR J NEUROSCI, V33, P2101, DOI 10.1111/j.1460-9568.2011.07694.x; Hafed ZM, 2010, J NEUROSCI, V30, P9542, DOI 10.1523/JNEUROSCI.1137-10.2010; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koenig-Robert R, 2011, J VISION, V11, DOI 10.1167/11.14.12; Krauzlis RJ, 2004, J NEUROPHYSIOL, V92, P949, DOI 10.1152/jn.00830.2003; Kuang XT, 2012, CURR BIOL, V22, P510, DOI 10.1016/j.cub.2012.01.050; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Lavergne L, 2010, J VISION, V10, DOI 10.1167/10.14.17; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Li XB, 2008, J NEUROSCI, V28, P4561, DOI 10.1523/JNEUROSCI.5683-07.2008; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Richard A, 2009, J NEUROSCI, V29, P10160, DOI 10.1523/JNEUROSCI.0511-09.2009; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Van Wetter SMCI, 2008, J VISION, V8, DOI 10.1167/8.14.8; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; VERHEIJEN F J, 1961, Opt Acta (Lond), V8, P309; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	57	97	98	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2013	77	4					775	786		10.1016/j.neuron.2012.12.014	http://dx.doi.org/10.1016/j.neuron.2012.12.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439128	Bronze			2022-12-25	WOS:000315561300018
J	Seib, DRM; Corsini, NS; Ellwanger, K; Plaas, C; Mateos, A; Pitzer, C; Niehrs, C; Celikel, T; Martin-Villalba, A				Seib, Desiree R. M.; Corsini, Nina S.; Ellwanger, Kristina; Plaas, Christian; Mateos, Alvaro; Pitzer, Claudia; Niehrs, Christof; Celikel, Tansu; Martin-Villalba, Ana			Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PATTERN SEPARATION; GRANULE CELLS; NEURONS; BRAIN; MODEL; DIFFERENTIATION	Memory impairment has been associated with age-related decline in adult hippocampal neurogenesis. Although Notch, bone morphogenetic protein, and Wnt signaling pathways are known to regulate multiple aspects of adult neural stem cell function, the molecular basis of declining neurogenesis in the aging hippocampus remains unknown. Here, we show that expression of the Wnt antagonist Dickkopf-1 (Dkk1) increases with age and that its loss enhances neurogenesis in the hippocampus. Neural progenitors with inducible loss of Dkk1 increase their Wnt activity, which leads to enhanced self-renewal and increased generation of immature neurons. This Wnt-expanded progeny subsequently matures into glutamatergic granule neurons with increased dendritic complexity. As a result, mice deficient in Dkk1 exhibit enhanced spatial working memory and memory consolidation and also show improvements in affective behavior. Taken together, our findings show that upregulating Wnt signaling by reducing Dkk1 expression can counteract age-related decrease in neurogenesis and its associated cognitive decline.	[Seib, Desiree R. M.; Corsini, Nina S.; Mateos, Alvaro; Martin-Villalba, Ana] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Neurobiol, D-69120 Heidelberg, Germany; [Ellwanger, Kristina; Niehrs, Christof] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [Plaas, Christian; Pitzer, Claudia] SYGNIS Biosci, D-69120 Heidelberg, Germany; [Celikel, Tansu] Univ So Calif, Lab Neural Circuits & Plast, Los Angeles, CA 90089 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California	Martin-Villalba, A (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Neurobiol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de	Seib, Desiree/AAF-2801-2021; Celikel, Tansu/P-4235-2018	Seib, Desiree/0000-0001-9953-8270; Martin-Villalba, Ana/0000-0002-9405-8910; Corsini, Nina/0000-0001-6731-3544	DKFZ Light Microscopy Facility; Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG) [SFB873]; Federal Ministry of Education and Research (BMBF independent research group); German Cancer Research Center (DKFZ)	DKFZ Light Microscopy Facility; Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF independent research group); German Cancer Research Center (DKFZ)(Helmholtz Association)	We thank Gunther Schutz for the Nestin-Cre and Nestin-CreER<SUP>T2</SUP> mouse lines and Roel Nusse for the 7TGC plasmid. Automatized analysis of behavioral experiments was performed with SYGNIS TRACKER V4.1.14, SYGNIS Bioscience, Heidelberg. Support by the DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg is gratefully acknowledged. We thank Carmen Ruiz de Almodovar for help with in situ hybridization and discussion of the data. We thank Lola Buades for help with the design of the GA. We also thank Lothar Pilz and Simone Braun for help with statistical analysis. In addition, we thank Jennifer Hermes, Carina Konrad, Stefanie Limpert, Katrin Volk, Michaela Muller, and Christin Hannusch for experimental support. This work was funded by the German Research Foundation (DFG) (SFB873), the Federal Ministry of Education and Research (BMBF independent research group), and the German Cancer Research Center (DKFZ).	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee SW, 2012, BEHAV BRAIN RES, V227, P497, DOI 10.1016/j.bbr.2011.10.009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Matrisciano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016447; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108	51	212	220	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					204	214		10.1016/j.stem.2012.11.010	http://dx.doi.org/10.1016/j.stem.2012.11.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395445	Bronze			2022-12-25	WOS:000329569300011
J	Mueller, S; Wang, DH; Fox, MD; Yeo, BTT; Sepulcre, J; Sabuncu, MR; Shafee, R; Lu, J; Liu, HS				Mueller, Sophia; Wang, Danhong; Fox, Michael D.; Yeo, B. T. Thomas; Sepulcre, Jorge; Sabuncu, Mert R.; Shafee, Rebecca; Lu, Jie; Liu, Hesheng			Individual Variability in Functional Connectivity Architecture of the Human Brain	NEURON			English	Article							SURFACE-BASED ANALYSIS; CEREBRAL-CORTEX; INTERSUBJECT VARIABILITY; GENETIC INFLUENCES; PREFRONTAL CORTEX; EVOLUTION; TOPOGRAPHY; ASYMMETRY; TALAIRACH; EXPANSION	The fact that people think or behave differently from one another is rooted in individual differences in brain anatomy and connectivity. Here, we used repeated-measurement resting-state functional MRI to explore intersubject variability in connectivity. Individual differences in functional connectivity were heterogeneous across the cortex, with significantly higher variability in heteromodal association cortex and lower variability in unimodal cortices. Intersubject variability in connectivity was significantly correlated with the degree of evolutionary cortical expansion, suggesting a potential evolutionary root of functional variability. The connectivity variability was also related to variability in sulcal depth but not cortical thickness, positively correlated with the degree of long-range connectivity but negatively correlated with local connectivity. A meta-analysis further revealed that regions predicting individual differences in cognitive domains are predominantly located in regions of high connectivity variability. Our findings have potential implications for understanding brain evolution and development, guiding intervention, and interpreting statistical maps in neuroimaging.	[Mueller, Sophia; Wang, Danhong; Yeo, B. T. Thomas; Sepulcre, Jorge; Sabuncu, Mert R.; Liu, Hesheng] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Mueller, Sophia; Sepulcre, Jorge; Shafee, Rebecca] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Mueller, Sophia] Univ Munich, Inst Clin Radiol, D-81377 Munich, Germany; [Fox, Michael D.] Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Yeo, B. T. Thomas] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore 169857, Singapore; [Sepulcre, Jorge] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA; [Sepulcre, Jorge] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lu, Jie] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing 100053, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; University of Munich; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Capital Medical University	Lu, J (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing 100053, Peoples R China.	jielu@nmr.mgh.harvard.edu; hesheng@nmr.mgh.harvard.edu	Sabuncu, Mert Rory/ABE-2284-2021; Lu, Jie/GNW-3367-2022; Sepulcre, Jorge/ABE-6375-2020; Fox, Michael D./AAZ-3928-2020; Yeo, B.T. Thomas/X-2860-2019; Liu, Hesheng/D-1115-2018	Fox, Michael D./0000-0001-8848-6399; Yeo, B.T. Thomas/0000-0002-0119-3276; Liu, Hesheng/0000-0002-7233-1509; Sepulcre, Jorge/0000-0002-4199-2304; Sabuncu, Mert/0000-0002-7068-719X	NINDS [K25NS069805]; NARSAD; German Research Foundation [MU 3222/2-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS069805] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NARSAD(NARSAD); German Research Foundation(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant K25NS069805, NARSAD Young Investigator Grant, and a research grant from the German Research Foundation (MU 3222/2-1). The authors would like to thank Drs. Randy L. Buckner and Bruce Fischl for discussions and comments on the manuscript.	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Brett M, 2001, NEUROIMAGE, V13, pS85; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Chen CH, 2011, NEURON, V72, P537, DOI 10.1016/j.neuron.2011.08.021; Clancy B, 2000, DEVELOPMENTAL SCI, V3, P57, DOI 10.1111/1467-7687.00100; CONNOLLY KJ, 1992, NEUROPSYCHOLOGIA, V30, P13, DOI 10.1016/0028-3932(92)90010-J; Diedrichsen J., 2005, SURFACE STAT USING C; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Elston GN, 2009, J NEUROSCI, V29, P3271, DOI 10.1523/JNEUROSCI.5216-08.2009; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Glendenning KK, 1998, BRAIN BEHAV EVOLUT, V51, P59, DOI 10.1159/000006530; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Jacobs B, 1997, J COMP NEUROL, V386, P661; Kaas JH, 2005, J BIOSCIENCES, V30, P155, DOI 10.1007/BF02703695; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Liu HS, 2009, J NEUROSURG, V111, P746, DOI 10.3171/2008.10.JNS08846; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Preuss Todd M., 1995, P1227; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rimol LM, 2010, BIOL PSYCHIAT, V67, P493, DOI 10.1016/j.biopsych.2009.09.032; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Seung S., 2012, CONNECTOME BRAINS WI; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smaers JB, 2011, BRAIN BEHAV EVOLUT, V77, P67, DOI 10.1159/000323671; Sugiura M, 2007, HUM BRAIN MAPP, V28, P49, DOI 10.1002/hbm.20256; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2012, CEREB CORTEX, V22, P2227, DOI 10.1093/cercor/bhr290; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Yakovlev PI, 1967, MYELOGENETIC CYCLES; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yeo BTT, 2010, IEEE T MED IMAGING, V29, P1424, DOI 10.1109/TMI.2010.2049497; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zilles K, 1997, HUM BRAIN MAPP, V5, P218, DOI 10.1002/(SICI)1097-0193(1997)5:4<218::AID-HBM2>3.0.CO;2-6	64	563	574	13	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					586	595		10.1016/j.neuron.2012.12.028	http://dx.doi.org/10.1016/j.neuron.2012.12.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395382	Green Accepted, Bronze			2022-12-25	WOS:000317030800018
J	Yanamandra, K; Kfoury, N; Jiang, H; Mahan, TE; Ma, SM; Maloney, SE; Wozniak, DF; Diamond, MI; Holtzman, DM				Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Maloney, Susan E.; Wozniak, David F.; Diamond, Marc I.; Holtzman, David M.			Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo	NEURON			English	Article							A-BETA BURDEN; MOUSE MODEL; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PASSIVE-IMMUNIZATION; PROTEIN; IMMUNOTHERAPY; PROPAGATION; ACTIVATION; TAUOPATHY	Tau aggregation occurs in neurodegenerative diseases including Alzheimer's disease and many other disorders collectively termed tauopathies. trans-cellular propagation of tau pathology, mediated by extracellular tau aggregates, may underlie pathogenesis of these conditions. P301S tau transgenic mice express mutant human tau protein and develop progressive tau pathology. Using a cell-based biosensor assay, we screened anti-tau monoclonal antibodies for their ability to block seeding activity present in P301S brain lysates. We infused three effective antibodies or controls into the lateral ventricle of P301S mice for 3 months. The antibodies markedly reduced hyperphosphorylated, aggregated, and insoluble tau. They also blocked development of tau seeding activity detected in brain lysates using the biosensor assay, reduced microglial activation, and improved cognitive deficits. These data imply a central role for extracellular tau aggregates in the development of pathology. They also suggest that immunotherapy specifically designed to block trans-cellular aggregate propagation will be a productive treatment strategy.	[Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Yanamandra, Kiran; Kfoury, Najla; Jiang, Hong; Mahan, Thomas E.; Ma, Shengmei; Diamond, Marc I.; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Maloney, Susan E.; Wozniak, David F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MI (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	diamondm@neuro.wustl.edu; holtzman@neuro.wustl.edu	Yanamandra, Kiran/M-4037-2014	Yanamandra, Kiran/0000-0002-4908-5848; Mahan, Thomas/0000-0001-9811-7490; Maloney, Ph.D., Susan E./0000-0001-5585-4722	Tau consortium; C2N Diagnostics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071835] Funding Source: NIH RePORTER	Tau consortium; C2N Diagnostics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was from the Tau consortium (D.M.H. and M.I.D.) and from a research grant from C2N Diagnostics (D.M.H. and M.I.D.). D.M.H. is a cofounder and has ownership interests in C2N Diagnostics. We thank Floy Stewart and Mary Beth Finn for expert technical advice and assistance.	Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Sato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048180; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	55	397	438	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					402	414		10.1016/j.neuron.2013.07.046	http://dx.doi.org/10.1016/j.neuron.2013.07.046			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24075978	Bronze, Green Accepted			2022-12-25	WOS:000326196400021
J	Yu, XZ; Wang, G; Gilmore, A; Yee, AX; Li, X; Xu, TH; Smith, SJ; Chen, L; Zuo, Y				Yu, Xinzhu; Wang, Gordon; Gilmore, Anthony; Yee, Ada Xin; Li, Xiang; Xu, Tonghui; Smith, Stephen J.; Chen, Lu; Zuo, Yi			Accelerated Experience-Dependent Pruning of Cortical Synapses in Ephrin-A2 Knockout Mice	NEURON			English	Article							DENDRITIC SPINE MORPHOLOGY; NMDA RECEPTOR; GLUTAMATE TRANSPORTERS; SYNAPTIC FUNCTIONS; VISUAL-CORTEX; IN-VIVO; PLASTICITY; ELIMINATION; ASTROCYTES; MECHANISMS	Refinement of mammalian neural circuits involves substantial experience-dependent synapse elimination. Using in vivo two-photon imaging, we found that experience-dependent elimination of postsynaptic dendritic spines in the cortex was accelerated in ephrin-A2 knockout (KO) mice, resulting in fewer adolescent spines integrated into adult circuits. Such increased spine removal in ephrin-A2 KOs depended on activation of glutamate receptors, as blockade of the N-methyl-D-aspartate (NMDA) receptors eliminated the difference in spine loss between wild-type and KO mice. We also showed that ephrin-A2 in the cortex colocalized with glial glutamate transporters, which were significantly downregulated in ephrin-A2 KOs. Consistently, glial glutamate transport was reduced in ephrin-A2 KOs, resulting in an accumulation of synaptic glutamate. Finally, inhibition of glial glutamate uptake promoted spine elimination in wild-type mice, resembling the phenotype of ephrin-A2 KOs. Together, our results suggest that ephrin-A2 regulates experience-dependent, NMDA receptor-mediated synaptic pruning through glial glutamate transport during maturation of the mouse cortex.	[Yu, Xinzhu; Gilmore, Anthony; Xu, Tonghui; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Wang, Gordon; Smith, Stephen J.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Yee, Ada Xin; Chen, Lu] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Li, Xiang] Columbia Univ, Dept Neurosci, New York, NY 10032 USA	University of California System; University of California Santa Cruz; Stanford University; Stanford University; Columbia University	Zuo, Y (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	yizuo@ucsc.edu	Yee, Ada/GRX-9171-2022	Smith, Stephen/0000-0002-2290-8701; Wang, Gordon/0000-0002-2707-7118; Chen, Lu/0000-0002-8097-2699; Zuo, Yi/0000-0001-9020-0003	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016, R56MH094449, R01MH094449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075252] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank David Feldheim for providing ephrin-A2 and ephrin-A3 KO mice; Jeffrey Rothstein for providing GLAST and GLT-1 antibodies; Yi Qin, Ju Lu, and David States for critical comments on the manuscript; Shinya Ito for help with spine lifetime analysis; and Shibo Li, Zhuojun Guo, Maria Ximena Silveyra, Michael Robinson, Benjamin Abrams, Adam Aharon, James Perna, Rebecca Roberts, Andrew Perlik, and Jonathan Zweig for suggestions and assistance with experiments. This work was supported by grants from the National Institute of Mental Health to Y.Z. S.J.S. is a founder of Aratome and chair of its scientific advisory board.	Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Koeberle PD, 2008, CELL DEATH DIFFER, V15, P471, DOI 10.1038/sj.cdd.4402281; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zimmer G, 2007, J NEUROSCI, V27, P5643, DOI 10.1523/JNEUROSCI.0954-07.2007; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	44	38	39	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					64	71		10.1016/j.neuron.2013.07.014	http://dx.doi.org/10.1016/j.neuron.2013.07.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094103	Bronze, Green Accepted			2022-12-25	WOS:000326305300008
J	del Pino, I; Garcia-Frigola, C; Dehorter, N; Brotons-Mas, JR; Alvarez-Salvado, E; de Lagran, MM; Ciceri, G; Gabaldon, MV; Moratal, D; Dierssen, M; Canals, S; Marin, O; Rico, B				del Pino, Isabel; Garcia-Frigola, Cristina; Dehorter, Nathalie; Brotons-Mas, Jorge R.; Alvarez-Salvado, Efren; Martinez de Lagran, Maria; Ciceri, Gabriele; Victoria Gabaldon, Maria; Moratal, David; Dierssen, Mara; Canals, Santiago; Marin, Oscar; Rico, Beatriz			Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes	NEURON			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; CORTICAL GABAERGIC INTERNEURONS; GLUTAMIC-ACID DECARBOXYLASE; NEUREGULIN 3 NRG3; PREFRONTAL CORTEX; GENE-EXPRESSION; CEREBRAL-CORTEX; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; PSYCHIATRIC-DISORDERS	Genetic variation in neuregulin and its ErbB4 receptor has been linked to schizophrenia, although little is known about how they contribute to the disease process. Here, we have examined conditional Erbb4 mouse mutants to study how disruption of specific inhibitory circuits in the cerebral cortex may cause large-scale functional deficits. We found that deletion of ErbB4 from the two main classes of fast-spiking interneurons, chandelier and basket cells, causes relatively subtle but consistent synaptic defects. Surprisingly, these relatively small wiring abnormalities boost cortical excitability, increase oscillatory activity, and disrupt synchrony across cortical regions. These functional deficits are associated with increased locomotor activity, abnormal emotional responses, and impaired social behavior and cognitive function. Our results reinforce the view that dysfunction of cortical fast-spiking interneurons might be central to the pathophysiology of schizophrenia.	[del Pino, Isabel; Garcia-Frigola, Cristina; Dehorter, Nathalie; Brotons-Mas, Jorge R.; Alvarez-Salvado, Efren; Ciceri, Gabriele; Canals, Santiago; Marin, Oscar; Rico, Beatriz] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [del Pino, Isabel; Garcia-Frigola, Cristina; Dehorter, Nathalie; Brotons-Mas, Jorge R.; Alvarez-Salvado, Efren; Ciceri, Gabriele; Canals, Santiago; Marin, Oscar; Rico, Beatriz] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Martinez de Lagran, Maria; Dierssen, Mara] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Martinez de Lagran, Maria; Dierssen, Mara] CIBERER, Barcelona 08003, Spain; [Victoria Gabaldon, Maria; Moratal, David] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat Politecnica de Valencia	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es; brico@umh.es	Marin, Oscar/F-3856-2012; del Pino, Isabel/A-6072-2018; Canals, Santiago/N-5838-2014; Moratal, David/D-1853-2010; Dierssen, Mara/G-3552-2015; martinez de lagran, maria/L-2027-2015	Marin, Oscar/0000-0001-6264-7027; del Pino, Isabel/0000-0002-8672-926X; Canals, Santiago/0000-0003-2175-8139; Moratal, David/0000-0002-2825-3646; Dierssen, Mara/0000-0003-0853-6865; Dehorter, Nathalie/0000-0001-7599-2866; Rico, Beatriz/0000-0002-0581-851X; Ciceri, Gabriele/0000-0002-8481-9771; Garcia-Frigola, Cristina/0000-0003-2434-3879; martinez de lagran, maria/0000-0002-0836-6491	Spanish Government [SAF2010-21723, CONSOLIDER CSD2007-00023, SAF2010-16427, CSD2007-00023, BFU2009-09938, PIM2010ERN-00679]; Spanish Government (part of the ERANET NEURON TRANSALC project); Fundacion Alicia Koplowitz; Lilly Research Awards Program; Fundacio la Marato	Spanish Government(Spanish GovernmentEuropean Commission); Spanish Government (part of the ERANET NEURON TRANSALC project); Fundacion Alicia Koplowitz; Lilly Research Awards Program; Fundacio la Marato	We thank D. Baeza and M. Fernandez-Otero for excellent technical assistance, A. Casillas, T. Gil, and M. Perez for general laboratory support, G. Fishell (New York University), K. Lloyd (University College Dublin), and N. Kessaris (University College London) for RCE, Erbb4, and Lhx6-Cre mouse strains, respectively, and J-M. Fritschy (University of Zurich) for GABA receptor antibodies. We are also grateful to members of the Borrell, Mann, and Rico laboratories for stimulating discussions and ideas. Supported by grants from the Spanish Government to B.R. (SAF2010-21723 and CONSOLIDER CSD2007-00023), O.M. (CSD2007-00023), M.D. (SAF2010-16427), and S.C. (CSD2007-00023, BFU2009-09938 and PIM2010ERN-00679, part of the ERANET NEURON TRANSALC project), from Fundacion Alicia Koplowitz to B.R., from the Lilly Research Awards Program to B.R. and O.M., and from Fundacio la Marato to O.M., B.R., and M.D. B.R. is an EMBO Young Investigator.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Brotons-Mas JR, 2010, EUR J NEUROSCI, V32, P648, DOI 10.1111/j.1460-9568.2010.07308.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cano-Colino M, 2012, PHARMACOPSYCHIATRY, V45, pS49, DOI 10.1055/s-0032-1306314; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Chacon MR, 2012, DEVELOPMENT, V139, P3200, DOI 10.1242/dev.080564; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; Curley AA, 2012, J PHYSIOL-LONDON, V590, P715, DOI 10.1113/jphysiol.2011.224659; Curley AA, 2011, AM J PSYCHIAT, V168, P921, DOI 10.1176/appi.ajp.2011.11010052; Di Lazzaro V, 2003, J PHYSIOL-LONDON, V547, P485, DOI 10.1113/jphysiol.2002.030486; Duncan CE, 2010, J PSYCHIATR RES, V44, P673, DOI 10.1016/j.jpsychires.2009.12.007; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Hirano S, 2008, J NEUROSCI, V28, P4897, DOI 10.1523/JNEUROSCI.5031-07.2008; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Inda M, 2009, CEREB CORTEX, V19, P41, DOI 10.1093/cercor/bhn057; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2001, AM J PSYCHIAT, V158, P1411, DOI 10.1176/appi.ajp.158.9.1411; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Loup F, 1998, J HISTOCHEM CYTOCHEM, V46, P1129, DOI 10.1177/002215549804601005; Luykx JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2088, DOI 10.1038/npp.2012.57; Marenco S, 2011, J NEUROSCI, V31, P11628, DOI 10.1523/JNEUROSCI.1529-11.2011; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Minzenberg MJ, 2012, TRENDS COGN SCI, V16, P35, DOI 10.1016/j.tics.2011.11.017; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Morar B, 2011, MOL PSYCHIATR, V16, P860, DOI 10.1038/mp.2010.70; Mulle JG, 2012, CURR OPIN GENET DEV, V22, P238, DOI 10.1016/j.gde.2012.02.011; Neddens J, 2011, BIOL PSYCHIAT, V70, P636, DOI 10.1016/j.biopsych.2011.04.016; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Rico B, 2011, CURR OPIN GENET DEV, V21, P262, DOI 10.1016/j.gde.2010.12.010; Rymar VV, 2007, J COMP NEUROL, V501, P369, DOI 10.1002/cne.21250; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sullivan EM, 2012, SCHIZOPHRENIA BULL, V38, P373, DOI 10.1093/schbul/sbs052; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Suzuki Y, 2002, NEUROSCIENCE, V114, P769, DOI 10.1016/S0306-4522(02)00298-1; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wang YC, 2008, BIOL PSYCHIAT, V64, P1093, DOI 10.1016/j.biopsych.2008.07.012; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	89	196	196	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1152	1168		10.1016/j.neuron.2013.07.010	http://dx.doi.org/10.1016/j.neuron.2013.07.010			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050403	Bronze			2022-12-25	WOS:000330329600013
J	Khodosevich, K; Lazarini, F; von Engelhardt, J; Kaneko, H; Liedo, PM; Monyer, H				Khodosevich, Konstantin; Lazarini, Francoise; von Engelhardt, Jakob; Kaneko, Hiroshi; Liedo, Pierre-Marie; Monyer, Hannah			Connective Tissue Growth Factor Regulates Interneuron Survival and Information Processing in the Olfactory Bulb	NEURON			English	Article							ROSTRAL MIGRATORY STREAM; EXTERNAL TUFTED CELLS; ADULT-BORN NEURONS; NEURAL STEM-CELLS; GENE-EXPRESSION; FACTOR CTGF; NEUROGENESIS; RECEPTOR; SYNCHRONIZATION; DISCRIMINATION	Neurogenesis underlies plastic changes in defined neuronal circuits in the postnatal and adult brain. Here we identify connective tissue growth factor (CTGF) as a critical factor in the mouse olfactory bulb (OB) in determining the efficiency of incorporation of postnatally born inhibitory neurons, thus gating the output of glomeruli, the first relay station of olfactory processing in the brain. In the OB, CTGF expression was restricted to prenatally born external tufted cells. CTGF enhanced the proapoptotic activity of glial-derived TGF-beta 2, decreasing the survival of periglomerular inhibitory neurons. Changes in CTGF expression levels in the OB led to modifications in local neuronal circuitry and olfactory behaviors. We show that the odorant-specific recruitment of distinct glomeruli resulted in enhanced local CTGF expression levels in the activated glomeruli. Collectively our data reveal a molecular mechanism controlling the survival of defined postnatally born neurons, thus adapting neuronal integration to the sensory experiences.	[Khodosevich, Konstantin; Kaneko, Hiroshi; Monyer, Hannah] Heidelberg Univ, Med Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [Khodosevich, Konstantin; Kaneko, Hiroshi; Monyer, Hannah] German Ctr Canc Res DKFZ, Dept Clin Neurobiol A230, D-69120 Heidelberg, Germany; [von Engelhardt, Jakob] German Ctr Canc Res DKFZ, D-69120 Heidelberg, Germany; [Lazarini, Francoise; Liedo, Pierre-Marie] Inst Pasteur, Lab Percept & Memory, F-75015 Paris, France; [Lazarini, Francoise; Liedo, Pierre-Marie] CNRS, Unite Mixte Rech UMR3571, F-75015 Paris, France; [von Engelhardt, Jakob] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Monyer, H (corresponding author), Heidelberg Univ, Med Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de	von Engelhardt, Jakob/AAD-4920-2021; von Engelhardt, Jakob/G-7397-2015	von Engelhardt, Jakob/0000-0003-3861-3294; von Engelhardt, Jakob/0000-0003-3861-3294; Monyer, Hannah/0000-0002-9332-5749; Lazarini, Francoise/0000-0001-5572-6982; Khodosevich, Konstantin/0000-0001-7232-5558	NIH [NS39055, NS057098]; Schilling Foundation; DFG [SFB488, FOR643]; AG2R-La Mondiale; Agence Nationale de la Recherche [ANR-BLAN-SVSE4-LS-110624, ANR-09-NEUR-004]; European Commission	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schilling Foundation; DFG(German Research Foundation (DFG)); AG2R-La Mondiale; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank U. Amtmann, R. Hinz-Herkommer, I. Preugschat-Gumprecht, D. van der Giezen, and N. Torquet for technical assistance; C. Le Magueresse and P. Seeburg for critical reading of the manuscript; R. Goldschmeding for Ctgf knockout mice; K. Krieglstein and Bjorn Spittau for Tgfbr2 knockout mice; P. Mombaerts for MOR23-IRES-tauGFP mice; M. Ehlers for the pSPORT-mTgfbr1 plasmid; W. Kelsch for the retroviral EGFP-T2A-Cre plasmid; and University of Pennsylvania Vector Core team for the AAV rh43 helper plasmid. The GFAP promoter was provided by M. Brenner (Alabama Neuroscience Blueprint Core, NIH grants NS39055 and NS057098). This work was supported by the Schilling Foundation and DFG (SFB488 and FOR643 grants) to H.M. The laboratory of P.-M.L. is supported by the life insurance company "AG2R-La Mondiale," the Agence Nationale de la Recherche "ANR-BLAN-SVSE4-LS-110624," and "ANR-09-NEUR-004" in the frame of "ERA-NET NEURON" of the FP7 program by the European Commission.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Buonviso N, 2000, NEUROSCIENCE, V95, P325; Dalton P, 1996, PERCEPT PSYCHOPHYS, V58, P781, DOI 10.3758/BF03213109; De Saint Jan D, 2009, J NEUROSCI, V29, P2043, DOI 10.1523/JNEUROSCI.5317-08.2009; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; Friedrichsen S, 2005, GROWTH FACTORS, V23, P43, DOI 10.1080/08977190512331340566; Giridhar S, 2011, P NATL ACAD SCI USA, V108, P5843, DOI 10.1073/pnas.1015165108; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; JOHNSON BA, 1995, BRAIN RES, V699, P192, DOI 10.1016/0006-8993(95)00896-X; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; Khankan R, 2011, INVEST OPHTH VIS SCI, V52, P5068, DOI 10.1167/iovs.11-7191; Khodosevich K, 2012, P NATL ACAD SCI USA, V109, P20107, DOI 10.1073/pnas.1217103109; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Khodosevich K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.007.2009; Khodosevich K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001151; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kraemer S, 2004, PHYSIOL BEHAV, V81, P435, DOI 10.1016/j.physbeh.2004.01.012; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P755, DOI 10.1093/ndt/gfn530; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Ohmomo H, 2009, NEUROSCIENCE, V160, P419, DOI 10.1016/j.neuroscience.2009.02.048; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Petreanu L, 2002, J NEUROSCI, V22, P6106; Rey N.L., 2012, NEUROBIOL AGING, V33, P626, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.03.026; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shipley MT, 1996, J NEUROBIOL, V30, P123; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Williams EO, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-48; Yokoyama TK, 2011, NEURON, V71, P883, DOI 10.1016/j.neuron.2011.05.046	57	42	43	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1136	1151		10.1016/j.neuron.2013.07.011	http://dx.doi.org/10.1016/j.neuron.2013.07.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	23993699	Green Published, Bronze			2022-12-25	WOS:000330329600012
J	Cole, MW; Reynolds, JR; Power, JD; Repovs, G; Anticevic, A; Braver, TS				Cole, Michael W.; Reynolds, Jeremy R.; Power, Jonathan D.; Repovs, Grega; Anticevic, Alan; Braver, Todd S.			Multi-task connectivity reveals flexible hubs for adaptive task control	NATURE NEUROSCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PSYCHOPHYSIOLOGICAL INTERACTIONS; COGNITIVE CONTROL; HUMAN BRAIN; NETWORK; REGIONS; RULES; REPRESENTATION	Extensive evidence suggests that the human ability to adaptively implement a wide variety of tasks is preferentially a result of the operation of a fronto-parietal brain network (FPN). We hypothesized that this network's adaptability is made possible by flexible hubs: brain regions that rapidly update their pattern of global functional connectivity according to task demands. Using recent advances in characterizing brain network organization and dynamics, we identified mechanisms consistent with the flexible hub theory. We found that the FPN's brain-wide functional connectivity pattern shifted more than those of other networks across a variety of task states and that these connectivity patterns could be used to identify the current task. Furthermore, these patterns were consistent across practiced and novel tasks, suggesting that reuse of flexible hub connectivity patterns facilitates adaptive (novel) task performance. Together, these findings support a central role for fronto-parietal flexible hubs in cognitive control and adaptive implementation of task demands.	[Cole, Michael W.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Reynolds, Jeremy R.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Power, Jonathan D.] Washington Univ, Dept Psychol, St Louis, MO USA; [Repovs, Grega] Univ Ljubljana, Dept Psychol, Ljubljana 61000, Slovenia; [Anticevic, Alan] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Anticevic, Alan] Yale Univ, Abraham Ribicoff Res Facil, New Haven, CT USA; [Anticevic, Alan] Natl Inst Alcohol Abuse, New Haven, CT USA; [Anticevic, Alan] Alcoholism Ctr Translat Neurosci Alcoholism, New Haven, CT USA	Washington University (WUSTL); University of Denver; Washington University (WUSTL); University of Ljubljana; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Cole, MW (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	mwcole@mwcole.net	Cole, Michael W/G-1056-2010	Cole, Michael W/0000-0003-4329-438X; Power, Jonathan/0000-0002-6922-100X; Braver, Todd/0000-0002-2631-3393; Repovs, Grega/0000-0003-1837-3879	US National Institutes of Health [K99MH096801, DP5OD012109-01]; Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH066078, R00MH096801, K99MH096801] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012109] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Petersen, D. Bassett and J. Etzel for helpful feedback and suggestions during preparation of this manuscript. We also thank W. Schneider for access to data from his laboratory. Our work was supported by the US National Institutes of Health under awards K99MH096801 (M.W.C.), DP5OD012109-01 (A.A.) and a Brain and Behavior Research Foundation (NARSAD) Young Investigator Award (A.A.).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cole MW, 2013, COGN AFFECT BEHAV NE, V13, P1, DOI 10.3758/s13415-012-0125-7; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Cole MW, 2010, J NEUROSCI, V30, P14245, DOI 10.1523/JNEUROSCI.1662-10.2010; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dumontheil I, 2011, J COGNITIVE NEUROSCI, V23, P168, DOI 10.1162/jocn.2010.21439; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; HEBB D. O., 1949; Heinzle J, 2012, J NEUROSCI, V32, P9960, DOI 10.1523/JNEUROSCI.1604-12.2012; Kim J, 2008, MAGN RESON IMAGING, V26, P583, DOI 10.1016/j.mri.2007.10.011; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niendam T.A., 2012, COGN AFFECT BEHAV NE; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Repovs G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00137; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schneider W., 2002, E PRIME USERS GUIDE; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; SINGLEY MK, 1985, INT J MAN MACH STUD, V22, P403, DOI 10.1016/S0020-7373(85)80047-X; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Urfer-Parnas A, 2010, PSYCHOL MED, V40, P547, DOI 10.1017/S0033291709990754; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Woolgar A, 2011, NEUROIMAGE, V56, P744, DOI 10.1016/j.neuroimage.2010.04.035; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	58	908	918	14	199	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1348	U247		10.1038/nn.3470	http://dx.doi.org/10.1038/nn.3470			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892552	Green Published, Green Accepted			2022-12-25	WOS:000323597500028
J	Kornblith, S; Cheng, XQ; Ohayon, S; Tsao, DY				Kornblith, Simon; Cheng, Xueqi; Ohayon, Shay; Tsao, Doris Y.			A Network for Scene Processing in the Macaque Temporal Lobe	NEURON			English	Article							PARAHIPPOCAMPAL PLACE AREA; CORTICAL CONNECTIONS; RHESUS-MONKEY; VISUAL-CORTEX; FMRI; REPRESENTATION; NAVIGATION; OBJECT; SYSTEM; CELLS	Spatial navigation is a complex process, but one that is essential for any mobile organism. We localized a region in the macaque occipitotemporal sulcus that responds preferentially to images of scenes. Single-unit recording revealed that this region, which we term the lateral place patch (LPP), contained a large concentration of scene-selective single units. These units were not modulated by spatial layout alone but were instead modulated by a combination of spatial and nonspatial factors, with individual units coding specific scene parts. We further demonstrate by ' microstimulation that LPP is connected with extrastriate visual areas V4V and DP and a scene-selective medial place patch in the parahippocampal gyrus, revealing a ventral network for visual scene processing in the macaque.	[Kornblith, Simon; Cheng, Xueqi; Ohayon, Shay; Tsao, Doris Y.] CALTECH, Div Biol & Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology	Tsao, DY (corresponding author), CALTECH, Div Biol & Computat & Neural Syst, Pasadena, CA 91125 USA.	dortsao@caltech.edu		Kornblith, Simon/0000-0002-9088-2443	DARPA Young Faculty Award; Sloan Scholar Award; Searle Scholar Award; NSF Graduate Research Fellowship; Direct For Biological Sciences [0922982] Funding Source: National Science Foundation	DARPA Young Faculty Award; Sloan Scholar Award; Searle Scholar Award; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by DARPA Young Faculty, Sloan Scholar, and Searle Scholar Awards to D.Y.T. and an NSF Graduate Research Fellowship to S.K. We wish to thank Margaret Livingstone and three anonymous reviewers for their helpful comments on the manuscript and the Massachusetts General Hospital R.F. Coil Laboratory for manufacturing and maintaining our imaging coils.	Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Blatt GJ, 2003, J COMP NEUROL, V466, P161, DOI 10.1002/cne.10866; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cant JS, 2012, J NEUROSCI, V32, P7685, DOI 10.1523/JNEUROSCI.3325-11.2012; Cant JS, 2011, J NEUROSCI, V31, P8248, DOI 10.1523/JNEUROSCI.6113-10.2011; Dilks DD, 2011, J NEUROSCI, V31, P11305, DOI 10.1523/JNEUROSCI.1935-11.2011; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2008, J NEUROPHYSIOL, V99, P2877, DOI 10.1152/jn.90376.2008; Freeman WJ, 2004, CLIN NEUROPHYSIOL, V115, P2077, DOI 10.1016/j.clinph.2004.02.029; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Mendez MF, 2003, NEUROPSYCHOLOGIA, V41, P1387, DOI 10.1016/S0028-3932(03)00041-1; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Park S, 2009, NEUROIMAGE, V47, P1747, DOI 10.1016/j.neuroimage.2009.04.058; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Saleem KS, 2007, J COMP NEUROL, V500, P973, DOI 10.1002/cne.21141; Saleem KS, 2012, COMBINED MRI HISTOLO; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Takahashi N, 1997, NEUROLOGY, V49, P464, DOI 10.1212/WNL.49.2.464; TAUBE JS, 1990, J NEUROSCI, V10, P436; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Yoder RM, 2011, TRENDS NEUROSCI, V34, P561, DOI 10.1016/j.tins.2011.08.004	43	92	93	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 21	2013	79	4					766	781		10.1016/j.neuron.2013.06.015	http://dx.doi.org/10.1016/j.neuron.2013.06.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23891401	Green Accepted, Bronze			2022-12-25	WOS:000323587000015
J	Gil-Sanz, C; Franco, SJ; Martinez-Garay, I; Espinosa, A; Harkins-Perry, S; Muller, U				Gil-Sanz, Cristina; Franco, Santos J.; Martinez-Garay, Isabel; Espinosa, Ana; Harkins-Perry, Sarah; Mueller, Ulrich			Cajal-Retzius Cells Instruct Neuronal Migration by Coincidence Signaling between Secreted and Contact-Dependent Guidance Cues	NEURON			English	Article							DOUBLECORTIN-LIKE-KINASE; RADIAL MIGRATION; CEREBRAL-CORTEX; E-CADHERIN; ADHESION MOLECULES; NEURAL PROGENITORS; ADHERENS JUNCTIONS; NERVOUS-SYSTEM; AXON OUTGROWTH; RAT NEOCORTEX	Cajal-Retzius (CR) cells are a transient cell population of the CNS that is critical for brain development. In the neocortex, CR cells secrete reelin to instruct the radial migration of projection neurons. It has remained unexplored, however, whether CR cells provide additional molecular cues important for brain development. Here, we show that CR cells express the immunoglobulin-like adhesion molecule nectin1, whereas neocortical projection neurons express its preferred binding partner, nectin3. We demonstrate that nectin1- and nectin3-mediated interactions between CR cells and migrating neurons are critical for radial migration. Furthermore, reelin signaling to Rap1 promotes neuronal Cdh2 function via nectin3 and afadin, thus directing the broadly expressed homophilic cell adhesion molecule Cdh2 toward mediating heterotypic cell-cell interactions between neurons and CR cells. Our findings identify nectins and afadin as components of the reelin signaling pathway and demonstrate that coincidence signaling between CR cell-derived secreted and short-range guidance cues direct neuronal migration.	[Gil-Sanz, Cristina; Franco, Santos J.; Martinez-Garay, Isabel; Espinosa, Ana; Harkins-Perry, Sarah; Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Martinez-Garay, Isabel] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	Scripps Research Institute; University of Oxford	Muller, U (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	umueller@scripps.edu	Espinosa Martínez, Ana Belén/AAD-4487-2021; Gil-Sanz, Cristina/K-9859-2017; Garay, Isabel Martinez/AAI-8951-2021; Franco, Santos/V-3413-2019; Gil-Sanz, Cristina/AAX-3558-2021	Espinosa Martínez, Ana Belén/0000-0002-3738-3514; Gil-Sanz, Cristina/0000-0002-7827-5480; Garay, Isabel Martinez/0000-0001-6849-7496; Franco, Santos/0000-0002-4478-5634; Gil-Sanz, Cristina/0000-0002-7827-5480	NIH [NS060355, NS046456, MH078833, HD070494]; Dorris Neurscience Center; Skaggs Institute for Chemical Biology; CIRM; Ministerio de Educacion [EX2009-0416, FU-2006-1238]; Generalitat Valenciana [APOSTD/2010/064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060355, R01NS046456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris Neurscience Center; Skaggs Institute for Chemical Biology; CIRM(California Institute for Regenerative Medicine); Ministerio de Educacion; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Spencer for help with microscopy; C. Ramos, G. Martin, and S. Kupriyanov for assistance with generating mice; and the Polleux laboratory for reagents. This work was supported by funding from the NIH (NS060355 to S.J.F.; NS046456, MH078833, and HD070494 to U.M.), the Dorris Neurscience Center (U.M.), the Skaggs Institute for Chemical Biology (U.M.), CIRM (I.M.-G. and A.E.), Ministerio de Educacion (EX2009-0416 to C.G.-S.; FU-2006-1238 to I.M.-G.), and Generalitat Valenciana (APOSTD/2010/064 to C.G.-S.).	Aguilo A, 1999, J NEUROSCI, V19, P10856, DOI 10.1523/JNEUROSCI.19-24-10856.1999; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Brakeman PR, 2009, AM J PHYSIOL-RENAL, V296, pF564, DOI 10.1152/ajprenal.90328.2008; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Griveau A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000440; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Louvi A, 2007, J COMP NEUROL, V504, P550, DOI 10.1002/cne.21461; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Radnikow G, 2002, J NEUROSCI, V22, P6908; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soda T, 2003, J NEUROSCI, V23, P6272; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Super H, 1998, J NEUROSCI, V18, P4616; Tabata H, 2003, J NEUROSCI, V23, P9996; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Togashi H, 2011, SCIENCE, V333, P1144, DOI 10.1126/science.1208467; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; WEISENHORN DMV, 1994, DEV BRAIN RES, V82, P293; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042	53	94	94	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					461	477		10.1016/j.neuron.2013.06.040	http://dx.doi.org/10.1016/j.neuron.2013.06.040			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23931996	Bronze, Green Accepted			2022-12-25	WOS:000323085100008
J	Harnett, MT; Xu, NL; Magee, JC; Williams, SR				Harnett, Mark T.; Xu, Ning-Long; Magee, Jeffrey C.; Williams, Stephen R.			Potassium Channels Control the Interaction between Active Dendritic Integration Compartments in Layer 5 Cortical Pyramidal Neurons	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; RAT VIBRISSAL CORTEX; ACTION-POTENTIALS; APICAL DENDRITES; HIGH-FREQUENCY; VISUAL-CORTEX; K+ CHANNELS; INPUT; PROPAGATION; MORPHOLOGY	Active dendritic synaptic integration enhances the computational power of neurons. Such nonlinear processing generates an object-localization signal in the apical dendritic tuft of layer 5B cortical pyramidal neurons during sensory-motor behavior. Here, we employ electrophysiological and optical approaches in brain slices and behaving animals to investigate how excitatory synaptic input to this distal dendritic compartment influences neuronal output. We find that active dendritic integration throughout the apical dendritic tuft is highly compartmentalized by voltage-gated potassium (K-V) channels. A high density of both transient and sustained K-V channels was observed in all apical dendritic compartments. These channels potently regulated the interaction between apical dendritic tuft, trunk, and axosomatic integration zones to control neuronal output in vitro as well as the engagement of dendritic nonlinear processing in vivo during sensory-motor behavior. Thus, K-V channels dynamically tune the interaction between active dendritic integration compartments in layer 5B pyramidal neurons to shape behaviorally relevant neuronal computations.	[Harnett, Mark T.; Xu, Ning-Long; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Williams, Stephen R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	Howard Hughes Medical Institute; University of Queensland	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org; srw@ug.edu.au	Xu, Ning-long/U-8665-2019	Xu, Ning-long/0000-0002-1651-401X; Williams, Stephen/0000-0001-5352-7947	Australian Research Council [FT100100502]; National Health and Medical Research Council [APP1004575]; Howard Hughes Medical Institute	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Milstein and M. Roberts for help in creating analysis tools. This work was supported by the Australian Research Council (FT100100502), the National Health and Medical Research Council (APP1004575), and the Howard Hughes Medical Institute.	Atkinson SE, 2009, J NEUROPHYSIOL, V102, P735, DOI 10.1152/jn.00083.2009; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CAULLER LJ, 1994, J NEUROSCI, V14, P751; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; IMAIZUMI Y, 1987, AM J PHYSIOL, V253, pH704, DOI 10.1152/ajpheart.1987.253.3.H704; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rall W, 1964, NEURAL THEORY MODELI, P73; Schaefer AT, 2007, J PHYSIOL-LONDON, V579, P737, DOI 10.1113/jphysiol.2006.122564; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 2007, J PHYSIOL-LONDON, V585, P759, DOI 10.1113/jphysiol.2007.138453; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yue LX, 2000, CARDIOVASC RES, V46, P151, DOI 10.1016/S0008-6363(99)00430-7	43	92	94	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					516	529		10.1016/j.neuron.2013.06.005	http://dx.doi.org/10.1016/j.neuron.2013.06.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23931999	Bronze, Green Accepted			2022-12-25	WOS:000323085100012
J	Nicholls, H				Nicholls, Henry			VSELs: Is Ideology Overtaking Science?	CELL STEM CELL			English	News Item												henry@henrynicholls.com						[Anonymous], 2013, NATURE, V496, P269; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; Havens AM, 2013, STEM CELLS DEV, V22, P622, DOI 10.1089/scd.2012.0327; Kassmer SH, 2013, STEM CELLS, V31, P2759, DOI 10.1002/stem.1413; Miyanishi M, 2013, STEM CELL REP, V1, P198, DOI 10.1016/j.stemcr.2013.07.001; Szade K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063329	6	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					143	144		10.1016/j.stem.2013.07.003	http://dx.doi.org/10.1016/j.stem.2013.07.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	24066359	Bronze			2022-12-25	WOS:000329570600007
J	Freeman, J; Ziemba, CM; Heeger, DJ; Simoncelli, EP; Movshon, A				Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony			A functional and perceptual signature of the second visual area in primates	NATURE NEUROSCIENCE			English	Article							HUMAN OCCIPITAL CORTEX; NATURAL SCENES; BORDER OWNERSHIP; V2; MOTION; CELLS; REPRESENTATION; SELECTIVITY; STATISTICS; MODELS	There is no generally accepted account of the function of the second visual cortical area (V2), partly because no simple response properties robustly distinguish V2 neurons from those in primary visual cortex (V1). We constructed synthetic stimuli replicating the higher-order statistical dependencies found in natural texture images and used them to stimulate macaque V1 and V2 neurons. Most V2 cells responded more vigorously to these textures than to control stimuli lacking naturalistic structure; V1 cells did not. Functional magnetic resonance imaging (fMRI) measurements in humans revealed differences between V1 and V2 that paralleled the neuronal measurements. The ability of human observers to detect naturalistic structure in different types of texture was well predicted by the strength of neuronal and fMRI responses in V2 but not in V1. Together, these results reveal a particular functional role for V2 in the representation of natural image structure.	[Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Dept Psychol, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Freeman, J (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	freemanj11@janelia.hhmi.org	Ziemba, Corey/AAE-1531-2022	Ziemba, Corey/0000-0002-6808-2087; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY04440]; Howard Hughes Medical Institute; New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships; NATIONAL EYE INSTITUTE [R37EY004440, R01EY022428, R01EY004440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Boynton for discussions, to M. Landy for comments on the manuscript, to M. Brotzmang for help programming the Mechanical Turk experiments and to members of the Movshon laboratory for help with physiological experiments. This work was supported by US National Institutes of Health grant EY04440, the Howard Hughes Medical Institute, the New York University Center for Brain Imaging and US National Science Foundation Graduate Research Fellowships to J.F. and C.M.Z.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Angelucci A, 2002, J NEUROSCI, V22, P8633; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; Dawidt A. Philip, 1979, APPL STAT, P20, DOI [DOI 10.2307/2346806, 10.2307/2346806]; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Fang F, 2009, J NEUROSCI, V29, P460, DOI 10.1523/JNEUROSCI.4628-08.2009; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Heeger D.J., 1995, P 22 ANN C COMP GRAP, P229, DOI DOI 10.1145/218380.218446; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCHILLER PH, 1977, BRAIN RES, V126, P366, DOI 10.1016/0006-8993(77)90734-X; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli E.P., 1997, 31 AS C SIGN SYST CO, V1, P673, DOI DOI 10.1109/ACSSC.1997.680530; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Thomson MGA, 2000, PERCEPTION, V29, P1057, DOI 10.1068/p2867; Vintch Brett, 2012, Adv Neural Inf Process Syst, V25, P3113; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	54	172	172	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					974	+		10.1038/nn.3402	http://dx.doi.org/10.1038/nn.3402			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685719	Green Accepted			2022-12-25	WOS:000321180900033
J	Haddad, R; Lanjuin, A; Madisen, L; Zeng, HK; Murthy, VN; Uchida, N				Haddad, Rafi; Lanjuin, Anne; Madisen, Linda; Zeng, Hongkui; Murthy, Venkatesh N.; Uchida, Naoshige			Olfactory cortical neurons read out a relative time code in the olfactory bulb	NATURE NEUROSCIENCE			English	Article							LIGHT-INDUCED ACTIVATION; ODOR REPRESENTATIONS; TRANSGENIC MICE; TEMPORAL STRUCTURE; CORTEX; INHIBITION; INPUT; CELLS; CIRCUITS; DISCRIMINATION	Odor stimulation evokes complex spatiotemporal activity in the olfactory bulb, suggesting that both the identity of activated neurons and the timing of their activity convey information about odors. However, whether and how downstream neurons decipher these temporal patterns remains unknown. We addressed this question by measuring the spiking activity of downstream neurons while optogenetically stimulating two foci in the olfactory bulb with varying relative timing in mice. We found that the overall spike rates of piriform cortex neurons (PCNs) were sensitive to the relative timing of activation. Posterior PCNs showed higher sensitivity to relative input times than neurons in the anterior piriform cortex. In contrast, olfactory bulb neurons rarely showed such sensitivity. Thus, the brain can transform a relative time code in the periphery into a firing rate-based representation in central brain areas, providing evidence for the relevance of a relative time-based code in the olfactory bulb.	[Haddad, Rafi; Lanjuin, Anne; Murthy, Venkatesh N.; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA	Harvard University; Allen Institute for Brain Science	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Uchida, Naoshige/0000-0002-5755-9409; Murthy, Venkatesh/0000-0003-2443-4252	Human Frontier Science Program; Howard Hughes Medical Institute Collaborative Innovation Award; Smith Family New Investigator Award; Alfred Sloan Foundation; US National Institutes of Health; Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Howard Hughes Medical Institute Collaborative Innovation Award(Howard Hughes Medical Institute); Smith Family New Investigator Award; Alfred Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Dulac (Harvard University) for sharing resources generously, comments on the manuscript and providing Tbet-cre; ChR2<SUP>loxP/loxP</SUP> mice (generated by A.L.). We thank E. Soucy and T. Sato for technical support and D. F. Albeanu and A.K. Dhawale for technical advice. We thank Y. Ben-Shaul, C. Poo, N. Eshel and J.Y. Cohen for their comments on the manuscript. This work was supported by Human Frontier Science Program (R.H.), a Howard Hughes Medical Institute Collaborative Innovation Award, a Smith Family New Investigator Award, the Alfred Sloan Foundation and the Milton Fund (N.U.), and a grant from the US National Institutes of Health (V.N.M.).	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Angelo K, 2012, NATURE, V488, P375, DOI 10.1038/nature11291; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; HABERLY LB, 1973, J NEUROPHYSIOL, V36, P775, DOI 10.1152/jn.1973.36.4.775; Hagiwara A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00018; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Mouly AM, 1998, EUR J NEUROSCI, V10, P1128, DOI 10.1046/j.1460-9568.1998.00126.x; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Oswald AMM, 2012, J NEUROSCI, V32, P6092, DOI 10.1523/JNEUROSCI.6285-11.2012; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2011, NEURON, V72, P41, DOI 10.1016/j.neuron.2011.08.015; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; SATOU M, 1983, J NEUROPHYSIOL, V50, P89, DOI 10.1152/jn.1983.50.1.89; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Suzuki N, 2012, J NEUROSCI, V32, P919, DOI 10.1523/JNEUROSCI.4112-11.2012; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	54	114	116	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					949	U227		10.1038/nn.3407	http://dx.doi.org/10.1038/nn.3407			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685720	Green Submitted, Green Accepted			2022-12-25	WOS:000321180900030
J	Kim, JH; Wang, X; Coolon, R; Ye, B				Kim, Jung Hwan; Wang, Xin; Coolon, Rosemary; Ye, Bing			Dscam Expression Levels Determine Presynaptic Arbor Sizes in Drosophila Sensory Neurons	NEURON			English	Article							FRAGILE-X-SYNDROME; FIBER SYNAPTIC REORGANIZATION; DOWN-SYNDROME; SELF-AVOIDANCE; LOCAL TRANSLATION; MESSENGER-RNAS; REQUIRE DSCAM; AXONAL INJURY; MOUSE RETINA; KINASE	Expression of the Down syndrome cell-adhesion molecule (Dscam) is increased in the brains of patients with several neurological disorders. Although Dscam is critically involved in many aspects of neuronal development, little is known about either the mechanism that regulates its expression or the functional consequences of dysregulated Dscam expression. Here, we show that Dscam expression levels serve as an instructive code for the size control of presynaptic arbor. Two convergent pathways, involving dual leucine zipper kinase (DLK) and fragile X mental retardation protein (FMRP), control Dscam expression through protein translation. Defects in this regulation of Dscam translation lead to exuberant presynaptic arbor growth in Drosophila somatosensory neurons. Our findings uncover a function of Dscam in presynaptic size control and provide in-sights into how dysregulated Dscam may contribute to the pathogenesis of neurological disorders.	[Kim, Jung Hwan; Wang, Xin; Coolon, Rosemary; Ye, Bing] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Kim, Jung Hwan; Wang, Xin; Coolon, Rosemary; Ye, Bing] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Wang, Xin] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ye, B (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	bingye@umich.edu	Ye, Bing/V-1306-2018	Ye, Bing/0000-0002-8828-4065; Kim, Jung Hwan/0000-0001-8548-4435	NIH [R00MH080599, R01MH091186]; Whitehall Foundation; Pew Scholars Program in the Biological Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091186, R00MH080599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Pew Scholars Program in the Biological Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Tzumin Lee, Dr. Larry Zipursky, Dr. Catherine Collins, Dr. Chunlai Wu, Dr. Kendal Broadie, Dr. Chun Han, Dr. Liqun Luo, and Dr. Yuh Nung Jan for generously sharing reagents, Dr. Ting Han and Dr. John Kim for their help on the RNA-IP experiments, the members of Dr. Jiandie Lin's laboratory for helping us to set up the real-time PCR experiments. We also thank Dr. Catherine Collins, Dr. Tzumin Lee, Dr. Hisashi Umemori, and Gabriella Sterne for critical comments on earlier versions of the manuscript. This work was supported by grants from NIH (R00MH080599 and R01MH091186), the Whitehall Foundation, and the Pew Scholars Program in the Biological Sciences to B.Y.	Alves-Sampaio A, 2010, J NEUROSCI, V30, P13537, DOI 10.1523/JNEUROSCI.3457-10.2010; Amano K, 2008, PSYCHIAT GENET, V18, P1, DOI 10.1097/YPG.0b013e3281ac238e; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Blank M, 2011, J NEUROSCI, V31, P5764, DOI 10.1523/JNEUROSCI.6015-10.2011; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; HOUSER CR, 1990, J NEUROSCI, V10, P267; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Larsen DD, 2006, J COMP NEUROL, V494, P398, DOI 10.1002/cne.20754; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Maynard KR, 2012, J NEUROSCI, V32, P16637, DOI 10.1523/JNEUROSCI.2811-12.2012; Millard SS, 2008, CURR OPIN NEUROBIOL, V18, P84, DOI 10.1016/j.conb.2008.05.005; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; Musumeci SA, 1999, EPILEPSIA, V40, P1092, DOI 10.1111/j.1528-1157.1999.tb00824.x; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Saito Y, 2000, ACTA NEUROPATHOL, V100, P654, DOI 10.1007/s004010000230; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Shen L, 2011, SYNAPSE, V65, P975, DOI 10.1002/syn.20924; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; STAFSTROM CE, 1993, AM J MENT RETARD, V98, P12; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Ye B, 2011, J NEUROSCI, V31, P3309, DOI 10.1523/JNEUROSCI.6307-10.2011; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	62	54	54	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					827	838		10.1016/j.neuron.2013.05.020	http://dx.doi.org/10.1016/j.neuron.2013.05.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764288	Bronze, Green Accepted			2022-12-25	WOS:000320743400010
J	Xu, RS; Serritella, AV; Sen, T; Farook, JM; Sedlak, TW; Baraban, J; Snyder, SH; Sen, N				Xu, Risheng; Serritella, Anthony V.; Sen, Tanusree; Farook, Justin M.; Sedlak, Thomas W.; Baraban, Jay; Snyder, Solomon H.; Sen, Nilkantha			Behavioral Effects of Cocaine Mediated by Nitric Oxide-GAPDH Transcriptional Signaling	NEURON			English	Article							NEUROTRANSMITTER TRANSPORTERS; HISTONE METHYLTRANSFERASE; S-NITROSYLATION; NEUROPROTECTION; EXPRESSION; RECEPTORS; NEURONS; CASCADE; TCH346; REWARD	Cocaine's behavioral-stimulant effects derive from potentiation of synaptic signaling by dopamine and serotonin leading to transcriptional alterations in postsynaptic cells. We report that a signaling cascade involving nitric oxide (NO) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mediates cocaine's transcriptional and behavioral actions. Lower, behavioral-stimulant doses enhance the cAMP response element-binding (CREB) signaling system, while higher, neurotoxic doses stimulate the p53 cytotoxic system. The drug CGP3466B, which potently and selectively blocks GAPDH nitrosylation and GAPDH-Siah binding, prevents these actions as well as behavioral effects of cocaine providing a strategy for anticocaine therapy.	[Xu, Risheng; Serritella, Anthony V.; Sedlak, Thomas W.; Baraban, Jay; Snyder, Solomon H.; Sen, Nilkantha] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Xu, Risheng; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Xu, Risheng; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Xu, Risheng] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Sen, Tanusree; Farook, Justin M.; Sen, Nilkantha] Georgia Regents Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA 30912 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Georgia; Augusta University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu; nsen@gru.edu	Sen, Nilkantha/AAW-9788-2020	Baraban, Jay/0000-0002-8165-2638	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS057824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [P50 DA000266, DA-000266] Funding Source: Medline; NINDS NIH HHS [K08 NS057824] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Larson EB, 2010, J NEUROCHEM, V115, P112, DOI 10.1111/j.1471-4159.2010.06907.x; Leigh PN, 2004, AMYOTROPH LATERAL SC, V5, P84, DOI 10.1080/14660820410020187; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; LeWitt PA, 2004, NEUROLOGY, V63, pS23, DOI 10.1212/WNL.63.7_suppl_2.S23; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Meinen S, 2011, EMBO MOL MED, V3, P465, DOI 10.1002/emmm.201100151; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Noda Y, 2004, ANN NY ACAD SCI, V1025, P62, DOI 10.1196/annals.1316.008; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Taniguchi M, 2012, NEURON, V73, P108, DOI 10.1016/j.neuron.2011.10.032; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Waldmeier PC, 2000, N-S ARCH PHARMACOL, V362, P526, DOI 10.1007/s002100000300; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	29	24	24	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					623	630		10.1016/j.neuron.2013.03.021	http://dx.doi.org/10.1016/j.neuron.2013.03.021			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719162	Bronze, Green Accepted			2022-12-25	WOS:000319491200007
J	Ngo, HVV; Martinetz, T; Born, J; Molle, M				Ngo, Hong-Viet V.; Martinetz, Thomas; Born, Jan; Moelle, Matthias			Auditory Closed-Loop Stimulation of the Sleep Slow Oscillation Enhances Memory	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; K-COMPLEX REPRESENTS; CORTICAL DOWN-STATE; EYE-MOVEMENT SLEEP; ELECTRICAL-STIMULATION; NEURONAL PLASTICITY; SPINDLES; WAVES; CONSOLIDATION; EEG	Brain rhythms regulate information processing in different states to enable learning and memory formation. The <1 Hz sleep slow oscillation hallmarks slow-wave sleep and is critical to memory consolidation. Here we show in sleeping humans that auditory stimulation in phase with the ongoing rhythmic occurrence of slow oscillation up states profoundly enhances the slow oscillation rhythm, phase-coupled spindle activity, and, consequently, the consolidation of declarative memory. Stimulation out of phase with the ongoing slow oscillation rhythm remained ineffective. Closed-loop in-phase stimulation provides a straight-forward tool to enhance sleep rhythms and their functional efficacy.	[Ngo, Hong-Viet V.; Born, Jan; Moelle, Matthias] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany; [Ngo, Hong-Viet V.; Born, Jan; Moelle, Matthias] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Ngo, Hong-Viet V.; Martinetz, Thomas] Med Univ Lubeck, Inst Neuro & Bioinformat, D-23538 Lubeck, Germany; [Ngo, Hong-Viet V.] Med Univ Lubeck, Grad Sch Comp Med & Life Sci, D-23538 Lubeck, Germany; [Born, Jan; Moelle, Matthias] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Lubeck; University of Lubeck; University of Lubeck	Born, J (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany.	jan.born@uni-tuebingen.de	Ngo, Hong-Viet/AAL-1457-2021; Born, Jan/K-2596-2016	Ngo, Hong-Viet/0000-0001-5828-5588; Born, Jan/0000-0002-1847-6248	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 654 and Graduate School 235). We are grateful to J. Beyer and S. Janz for conducting parts of the experiments. H.-V.V.N.. and M.M. performed the experiments and related analysis. H.-V.V.N., J.B., and M.M. designed the experiments. H.-V.V.N., T.M., J.B., and M.M. interpreted the data and contributed to writing the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 2010, SCIENCE, V330, DOI 10.1126/science.1182138; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bergmann TO, 2012, J NEUROSCI, V32, P243, DOI 10.1523/JNEUROSCI.4792-11.2012; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Landsness EC, 2009, SLEEP, V32, P1273; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2011, PROG BRAIN RES, V193, P93, DOI 10.1016/B978-0-444-53839-0.00007-7; Molle M, 2002, J NEUROSCI, V22, P10941; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Riemann D, 2011, PHARMACOPSYCHIATRY, V44, P1, DOI 10.1055/s-0030-1267978; Rosanova M, 2005, J PHYSIOL-LONDON, V562, P569, DOI 10.1113/jphysiol.2004.071381; Ruch S, 2012, NEUROPSYCHOLOGIA, V50, P2389, DOI 10.1016/j.neuropsychologia.2012.06.008; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Timofeev I, 2002, J PHYSIOL-LONDON, V542, P583, DOI 10.1113/jphysiol.2001.013479; Timofeev I, 2011, PROG BRAIN RES, V193, P121, DOI 10.1016/B978-0-444-53839-0.00009-0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G., 2010, MEDICAMUNDI, V54, P82, DOI DOI 10.3389/FNSYS.2014.00208; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	40	429	451	11	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2013	78	3					545	553		10.1016/j.neuron.2013.03.006	http://dx.doi.org/10.1016/j.neuron.2013.03.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23583623	Bronze			2022-12-25	WOS:000318961700015
J	Kreiner, T; Irion, S				Kreiner, Thane; Irion, Stefan			Whole-Genome Analysis, Stem Cell Research, and the Future of Biobanks	CELL STEM CELL			English	Editorial Material							ISSUES	The convergence of the genomic revolution and biobanking with rapid progress in stem cell research holds vast potential for personalized medicine and novel therapies. In this Forum, we explore social and ethical considerations emerging from strategies to realize the promise of these remarkable technologies.	[Kreiner, Thane; Irion, Stefan] Santa Clara Univ, Ctr Sci Technol & Soc, Santa Clara, CA 95053 USA	Santa Clara University	Kreiner, T (corresponding author), Santa Clara Univ, Ctr Sci Technol & Soc, Santa Clara, CA 95053 USA.	tkreiner@scu.edu						Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cambon-Thomsen A, 2004, NAT REV GENET, V5, P866, DOI 10.1038/nrg1473; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knoppers BM, 2012, ANNU REV GENOM HUM G, V13, P395, DOI 10.1146/annurev-genom-090711-163834; Mathews DJH, 2013, CELL STEM CELL, V12, P508, DOI 10.1016/j.stem.2013.04.015; Sullivan GJ, 2010, MOL HUM REPROD, V16, P880, DOI 10.1093/molehr/gaq091; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	10	10	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					513	516		10.1016/j.stem.2013.04.024	http://dx.doi.org/10.1016/j.stem.2013.04.024			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642361	Bronze			2022-12-25	WOS:000329569600007
J	Ramos, AD; Diaz, A; Nellore, A; Delgado, RN; Park, KY; Gonzales-Roybal, G; Oldham, MC; Song, JS; Lim, DA				Ramos, Alexander D.; Diaz, Aaron; Nellore, Abhinav; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Oldham, Michael C.; Song, Jun S.; Lim, Daniel A.			Integration of Genome-wide Approaches Identifies lncRNAs of Adult Neural Stem Cells and Their Progeny In Vivo	CELL STEM CELL			English	Article							LONG NONCODING RNAS; RETINAL DEVELOPMENT; GENE-EXPRESSION; MOUSE-BRAIN; CHROMATIN; DIFFERENTIATION; REVEALS; NEUROGENESIS; LINCRNAS; LINEAGE	Long noncoding RNAs (lncRNAs) have been described in cell lines and various whole tissues, but lncRNA analysis of development in vivo is limited. Here, we comprehensively analyze lncRNA expression for the adult mouse subventricular zone neural stem cell lineage. We utilize complementary genome-wide techniques including RNA-seq, RNA CaptureSeq, and ChIP-seq to associate specific lncRNAs with neural cell types, developmental processes, and human disease states. By integrating data from chromatin state maps, custom microarrays, and FACS purification of the subventricular zone lineage, we stringently identify lncRNAs with potential roles in adult neurogenesis. shRNA-mediated knockdown of two such lncRNAs, Six3os and Dlx1as, indicate roles for lncRNAs in the glial-neuronal lineage specification of multipotent adult stem cells. Our data and workflow thus provide a uniquely coherent in vivo lncRNA analysis and form the foundation of a user-friendly online resource for the study of lncRNAs in development and disease.	[Ramos, Alexander D.; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Delgado, Ryan N.; Park, Ki-Youb; Gonzales-Roybal, Gabriel; Oldham, Michael C.; Song, Jun S.; Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ramos, Alexander D.; Delgado, Ryan N.] Univ Calif San Francisco, Med Scientist Training Program, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Diaz, Aaron; Nellore, Abhinav; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Lim, Daniel A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu	Song, Jun S/E-2526-2016	Song, Jun S/0000-0002-0422-2175; Lim, Daniel/0000-0001-7221-3425; Nellore, Abhinav/0000-0001-8145-1484	NIH [DP2-OD006505-01, R01CA163336]; VA [1I01 BX000252-01]; Sontag Foundation; Sandler Foundation; NIH GMS [K12-GM081266]; California Institute for Regenerative Medicine (CIRM); UCSF Program for Breakthrough Biomedical Research; MSTP [2T32GM007618-34]; NATIONAL CANCER INSTITUTE [R01CA163336, R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, K12GM081266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006505] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Sontag Foundation; Sandler Foundation; NIH GMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCSF Program for Breakthrough Biomedical Research; MSTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by NIH DP2-OD006505-01, VA 1I01 BX000252-01, and the Sontag Foundation to D.A.L., NIH R01CA163336 and the Sontag Foundation to J.S.S., the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation, to M.C.O., NIH GMS K12-GM081266 to G.G.-R., a training grant from the California Institute for Regenerative Medicine (CIRM) to A.D.R., MSTP training grant 2T32GM007618-34 to A.D.R. and R.N.D, and facilities and resources provided by the San Francisco Veterans Affairs Medical Center.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Rapicavoli NA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-32; Rapicavoli NA, 2009, DEV DYNAM, V238, P2103, DOI 10.1002/dvdy.21844; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas EA, 2011, HUM MOL GENET, V20, P1049, DOI 10.1093/hmg/ddq548; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	185	192	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					616	628		10.1016/j.stem.2013.03.003	http://dx.doi.org/10.1016/j.stem.2013.03.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23583100	Green Accepted, Bronze, Green Published			2022-12-25	WOS:000329569600016
J	Dolev, I; Fogel, H; Milshtein, H; Berdichevsky, Y; Lipstein, N; Brose, N; Gazit, N; Slutsky, I				Dolev, Iftach; Fogel, Hilla; Milshtein, Hila; Berdichevsky, Yevgeny; Lipstein, Noa; Brose, Nils; Gazit, Neta; Slutsky, Inna			Spike bursts increase amyloid-beta 40/42 ratio by inducing a presenilin-1 conformational change	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; RELEASE PROBABILITY; PROTEIN-PRECURSOR; TALKING POINT; CELL BIOLOGY; IN-VIVO; MUTATIONS; PEPTIDE; SYNAPSES; HIPPOCAMPUS	Accumulated genetic evidence suggests that attenuation of the ratio between cerebral amyloid-beta A beta 40 and A beta 42 isoforms is central to familial Alzheimer's disease (FAD) pathogenesis. However, FAD mutations account for only 1-2% of Alzheimer's disease cases, leaving the experience-dependent mechanisms regulating A beta 40/42 an enigma. Here we explored regulation of A beta 40/42 ratio by temporal spiking patterns in the rodent hippocampus. Spike bursts boosted A beta 40/42 through a conformational change in presenilin1 (PS1), the catalytic subunit of gamma-secretase, and subsequent increase in A beta 40 production. Conversely, single spikes did not alter basal PS1 conformation and A beta 40/42. Burst-induced PS1 conformational shift was mediated by means of Ca2+-dependent synaptic vesicle exocytosis. Presynaptic inhibition in vitro and visual deprivation in vivo augmented synaptic and A beta 40/42 facilitation by bursts in the hippocampus. Thus, burst probability and transfer properties of synapses represent fundamental features regulating A beta 40/42 by experience and may contribute to the initiation of the common, sporadic Alzheimer's disease.	[Dolev, Iftach; Fogel, Hilla; Milshtein, Hila; Berdichevsky, Yevgeny; Gazit, Neta; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Milshtein, Hila; Gazit, Neta; Slutsky, Inna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lipstein, Noa; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Max Planck Society	Slutsky, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	islutsky@post.tau.ac.il		Berdichevsky, Yevgeny/0000-0002-5038-6816; Lipstein, Noa/0000-0002-0755-5899; Slutsky, Inna/0000-0002-0700-2266	European Research Council [281403]; Legacy Heritage Biomedical Program of the Israel Science Foundation [1925/08]; Alzheimer's Association [NIRG-10-172308]; Israel Science Foundation [993/08, 170/08]; SynSys Consortia [FP7-HEALTH-F2-2009-241498, FP7-HEALTH-F2-2009-242167]; Center for Nanoscience and Nanotechnology of Tel Aviv University; Azrieli Foundation; EUROSPIN	European Research Council(European Research Council (ERC)European Commission); Legacy Heritage Biomedical Program of the Israel Science Foundation; Alzheimer's Association(Alzheimer's Association); Israel Science Foundation(Israel Science Foundation); SynSys Consortia; Center for Nanoscience and Nanotechnology of Tel Aviv University; Azrieli Foundation; EUROSPIN	We thank B. De Strooper for discussions, O. Berezovska (Harvard Medical School) for providing GFP-PS1-RFP cDNA, S. Frere for comments on the manuscript, Y. Amitai for suggestions on an early version of the manuscript and all laboratory members for discussions. This work was supported by European Research Council (281403), Legacy Heritage Biomedical Program of the Israel Science Foundation (1925/08), Alzheimer's Association (NIRG-10-172308) and Israel Science Foundation (993/08 and 170/08) grants to I.S. and EUROSPIN and SynSys Consortia (FP7-HEALTH-F2-2009-241498 and FP7-HEALTH-F2-2009-242167) grants to N.B.I.D. is grateful to the Center for Nanoscience and Nanotechnology of Tel Aviv University and Azrieli Foundation for the award of doctoral fellowships.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herring A, 2011, NEUROBIOL DIS, V42, P530, DOI 10.1016/j.nbd.2011.03.007; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Laviv T, 2011, J NEUROSCI, V31, P12523, DOI 10.1523/JNEUROSCI.1527-11.2011; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	64	66	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					587	+		10.1038/nn.3376	http://dx.doi.org/10.1038/nn.3376			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563578				2022-12-25	WOS:000318029300015
J	Stroh, A; Adelsberger, H; Groh, A; Ruhlmann, C; Fischer, S; Schierloh, A; Deisseroth, K; Konnerth, A				Stroh, Albrecht; Adelsberger, Helmuth; Groh, Alexander; Ruehlmann, Charlotta; Fischer, Sebastian; Schierloh, Anja; Deisseroth, Karl; Konnerth, Arthur			Making Waves: Initiation and Propagation of Corticothalamic Ca2+ Waves In Vivo	NEURON			English	Article							LESS-THAN-1 HZ OSCILLATION; NEOCORTICAL NETWORKS; NEURONAL-ACTIVITY; CORTICAL ACTIVITY; SLOW OSCILLATION; NEURAL CIRCUITRY; AUDITORY-CORTEX; BEHAVING MICE; VISUAL-CORTEX; SLEEP	Corticothalamic slow oscillations of neuronal activity determine internal brain states. At least in the cortex, the electrical activity is associated with large neuronal Ca2+ transients. Here we implemented an optogenetic approach to explore causal features of the generation of slow oscillation-associated Ca2+ waves in the in vivo mouse brain. We demonstrate that brief optogenetic stimulation (3-20 ms) of a local group of layer 5 cortical neurons is sufficient for the induction of global brain Ca2+ waves. These Ca2+ waves are evoked in an all-or-none manner, exhibit refractoriness during repetitive stimulation, and propagate over long distances. By local optogenetic stimulation, we demonstrate that evoked Ca2+ waves initially invade the cortex, followed by a secondary recruitment of the thalamus. Together, our results establish that synchronous activity in a small cluster of layer 5 cortical neurons can initiate a global neuronal wave of activity suited for long-range corticothalamic integration.	[Stroh, Albrecht; Adelsberger, Helmuth; Groh, Alexander; Ruehlmann, Charlotta; Fischer, Sebastian; Schierloh, Anja; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Stroh, Albrecht; Adelsberger, Helmuth; Konnerth, Arthur] Munich Cluster Syst Neurol SyNergy, D-80802 Munich, Germany; [Stroh, Albrecht; Adelsberger, Helmuth; Konnerth, Arthur] Ctr Integrated Prot Sci Munich, D-80802 Munich, Germany; [Stroh, Albrecht] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Inst Microscop Anat & Neurobiol, D-55128 Mainz, Germany; [Deisseroth, Karl] Stanford Univ, HHMI, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Technical University of Munich; University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Howard Hughes Medical Institute; Stanford University; Stanford University	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteiner Str 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tu-muenchen.de	Stroh, Albrecht/AAE-8004-2021	Stroh, Albrecht/0000-0001-9410-4086; Groh, Alexander/0000-0002-5308-5971	Friedrich Schiedel Foundation; European Commission; DFG [IRTG 1373]	Friedrich Schiedel Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); DFG(German Research Foundation (DFG))	The authors thank Jia Lou for help with preparing the figures, Sarah Bechtold and Rosa Karl for virus preparation, Rebecca Mease for help with data analysis, Rita Forster for perfusion of mice, and the other laboratory members for critical comments on the manuscript. This work was supported by the Friedrich Schiedel Foundation and by the European Commission under the 7th Framework Programme, Project Corticonic. S. Fischer and C. Ruhlmann were supported by the DFG (IRTG 1373). A. Konnerth designed the study. A. Stroh and C. Ruhlmann performed the viral construct injections and confocal imaging. A. Stroh, C. Ruhlmann, A. Schierloh, and H. Adelsberger performed the optical fiber recordings. S. Fischer and H. Adelsberger conducted and analyzed the camera recordings. A. Groh and A. Stroh conducted the electrophysiological measurements. A. Stroh and K. Deisseroth established the optogenetic procedures. A. Konnerth and A. Stroh wrote the manuscript.	Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gao LX, 2009, J NEUROSCI, V29, P6013, DOI 10.1523/JNEUROSCI.5733-08.2009; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Garaschuk O, 2006, PFLUG ARCH EUR J PHY, V453, P385, DOI 10.1007/s00424-006-0150-x; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grienberger C, 2012, J PHYSIOL-LONDON, V590, P899, DOI 10.1113/jphysiol.2011.222513; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; He JF, 2003, J NEUROSCI, V23, P8281; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Landsness EC, 2009, SLEEP, V32, P1273; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rigas P, 2007, J NEUROSCI, V27, P4261, DOI 10.1523/JNEUROSCI.0003-07.2007; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	49	160	161	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1136	1150		10.1016/j.neuron.2013.01.031	http://dx.doi.org/10.1016/j.neuron.2013.01.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522048	Bronze			2022-12-25	WOS:000316645000014
J	Reinhardt, P; Schmid, B; Burbulla, LF; Schondorf, DC; Wagner, L; Glatza, M; Hoing, S; Hargus, G; Heck, SA; Dhingra, A; Wu, GM; Muller, S; Brockmann, K; Kluba, T; Maisel, M; Kruger, R; Berg, D; Tsytsyura, Y; Thiel, CS; Psathaki, OE; Klingauf, J; Kuhlmann, T; Klewin, M; Muller, H; Gasser, T; Scholer, HR; Sterneckert, J				Reinhardt, Peter; Schmid, Benjamin; Burbulla, Lena F.; Schoendorf, David C.; Wagner, Lydia; Glatza, Michael; Hoeing, Susanne; Hargus, Gunnar; Heck, Susanna A.; Dhingra, Ashutosh; Wu, Guangming; Mueller, Stephan; Brockmann, Kathrin; Kluba, Torsten; Maisel, Martina; Krueger, Rejko; Berg, Daniela; Tsytsyura, Yaroslav; Thiel, Cora S.; Psathaki, Olympia-Ekaterini; Klingauf, Juergen; Kuhlmann, Tanja; Klewin, Marlene; Mueller, Heiko; Gasser, Thomas; Schoeler, Hans R.; Sterneckert, Jared			Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; ALPHA-SYNUCLEIN; KINASE-ACTIVITY; SH-SY5Y CELLS; LEWY BODIES; DISEASE; NEUROPATHOLOGY; INDUCTION; DEGENERATION; INHIBITION	The LRRK2 mutation G2019S is the most common genetic cause of Parkinson's disease (PD). To better understand the link between mutant LRRK2 and PD pathology, we derived induced pluripotent stem cells from PD patients harboring LRRK2 G2019S and then specifically corrected the mutant LRRK2 allele. We demonstrate that gene correction resulted in phenotypic rescue in differentiated neurons and uncovered expression changes associated with LRRK2 G2019S. We found that LRRK2 G2019S induced dysregulation of CPNE8, MAP7, UHRF2, ANXA1, and CADPS2. Knockdown experiments demonstrated that four of these genes contribute to dopaminergic neurodegeneration. LRRK2 G2019S induced increased extracellular-signal-regulated kinase 1/2 (ERK) phosphorylation. Transcriptional dysregulation of CADPS2, CPNE8, and UHRF2 was dependent on ERK activity. We show that multiple PD-associated phenotypes were ameliorated by inhibition of ERK. Therefore, our results provide mechanistic insight into the pathogenesis induced by mutant LRRK2 and pointers for the development of potential new therapeutics.	[Reinhardt, Peter; Glatza, Michael; Hoeing, Susanne; Hargus, Gunnar; Wu, Guangming; Psathaki, Olympia-Ekaterini; Schoeler, Hans R.; Sterneckert, Jared] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schmid, Benjamin; Burbulla, Lena F.; Schoendorf, David C.; Heck, Susanna A.; Dhingra, Ashutosh; Brockmann, Kathrin; Maisel, Martina; Krueger, Rejko; Berg, Daniela; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Mueller, Stephan] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Epileptol, D-72076 Tubingen, Germany; German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schoendorf, David C.; Hargus, Gunnar] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Dhingra, Ashutosh] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72076 Tubingen, Germany; [Kluba, Torsten] Univ Tubingen, Dept Orthopaed Surg, D-72076 Tubingen, Germany; [Tsytsyura, Yaroslav; Thiel, Cora S.] Univ Munster, Inst Med Phys & Biophys, Cellular Biophys Grp, D-41849 Munster, Germany; [Klewin, Marlene; Mueller, Heiko] Lead Discovery Ctr GmbH, Dept Pharmacol, D-44227 Dortmund, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Munster; Lead Discovery Center GmbH (LDC); University of Munster	Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany.	thomas.gasser@uni-tuebingen.de; office@mpi-muenster.mpg.de	Gasser, Thomas/GNH-5293-2022; Berg, Daniela/A-8728-2019; Sterneckert, Jared/E-6802-2015; , HS/AAB-4434-2019	Gasser, Thomas/0000-0002-1069-1146; Berg, Daniela/0000-0001-5796-5442; , HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609; Sterneckert, Jared/0000-0002-7688-3124; Krueger, Rejko/0000-0003-4258-6241	German Research [WO 1610/2-1, KR2119/8-1]; Fortuene [1831-0-0-0-0]; German Research Council (DFG) [KR2119/8-1]; Fritz Thyssen Foundation [10.11.2.153]; Michael J. Fox Foundation (LRRK2 Biology LEAPS); charitable Hertie Foundation	German Research; Fortuene; German Research Council (DFG)(German Research Foundation (DFG)); Fritz Thyssen Foundation; Michael J. Fox Foundation (LRRK2 Biology LEAPS); charitable Hertie Foundation	This work was supported by grants from the German Research (WO 1610/2-1 to M. M. and T. G.; KR2119/8-1 to R. K. and T. G.); Fortuene (Nr. 1831-0-0-0-0 to M. M.); the German Research Council (DFG, KR2119/8-1 to R. K. and T. G.); Fritz Thyssen Foundation (10.11.2.153 to R. K.); the Michael J. Fox Foundation (LRRK2 Biology LEAPS Award, 2012); and by a doctoral scholarship from the charitable Hertie Foundation (to L. F. B.). Plasmids for reprogramming were obtained from Addgene: Addgene plasmids 8449, 8454, 17217, 17218, 17219, and 17220. We would like to acknowledge Ann-Kathrin Hauser for the sequencing analysis. We would like to thank Kerstin Hergarten and Rhea Brintrup for excellent technical support.	Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Botta-Orfila T, 2012, J MOL NEUROSCI, V48, P245, DOI 10.1007/s12031-012-9820-7; Bravo-San Pedro JM, 2013, CELL MOL LIFE SCI, V70, P121, DOI 10.1007/s00018-012-1061-y; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; European Brain Council, 2011, PARK DIS FACT SHEET; Fu XP, 2011, MOL BIOL CELL, V22, P3684, DOI 10.1091/mbc.E11-04-0308; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Golub Y, 2009, PARKINSONISM RELAT D, V15, P539, DOI 10.1016/j.parkreldis.2008.10.008; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maldonado H, 2011, J NEUROSCI RES, V89, P1489, DOI 10.1002/jnr.22678; Maldonado H, 2008, BIOL RES, V41, P239, DOI [/S0716-97602008000300001, 10.4067/S0716-97602008000300001]; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	361	381	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					354	367		10.1016/j.stem.2013.01.008	http://dx.doi.org/10.1016/j.stem.2013.01.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472874	Bronze			2022-12-25	WOS:000329569400013
J	Young, KM; Psachoulia, K; Tripathi, RB; Dunn, SJ; Cossell, L; Attwell, D; Tohyama, K; Richardson, WD				Young, Kaylene M.; Psachoulia, Konstantina; Tripathi, Richa B.; Dunn, Sara-Jane; Cossell, Lee; Attwell, David; Tohyama, Koujiro; Richardson, William D.			Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling	NEURON			English	Article							OPTIC-NERVE; PRECURSOR CELLS; PROGENITOR CELLS; CORPUS-CALLOSUM; GLIA GENERATE; WHITE-MATTER; MICE; AXONS; AGE; DEMYELINATION	Oligodendrocyte precursors (OPs) continue to proliferate and generate myelinating oligodendrocytes (OLs) well into adulthood. It is not known whether adult-born OLs ensheath previously unmyelinated axons or remodel existing myelin. We quantified OP division and OL production in different regions of the adult mouse CNS including the 4-month-old optic nerve, in which practically all axons are already myelinated. Even there, all OPs were dividing and generating new OLs and myelin at a rate higher than can be explained by first-time myelination of naked axons. We conclude that adult-born OLs in the optic nerve are engaged in myelin remodeling, either replacing OLs that die in service or intercalating among existing myelin sheaths. The latter would predict that average internode length should decrease with age. Consistent with that, we found that adult-born OLs elaborated much shorter but many more internodes than OLs generated during early postnatal life.	[Young, Kaylene M.; Psachoulia, Konstantina; Tripathi, Richa B.; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Young, Kaylene M.; Psachoulia, Konstantina; Tripathi, Richa B.; Richardson, William D.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Young, Kaylene M.; Cossell, Lee; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Young, Kaylene M.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Dunn, Sara-Jane] Microsoft Res Cambridge, Cambridge CB3 0FB, England; [Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Morioka, Iwate 0208505, Japan	University of London; University College London; University of London; University College London; University of London; University College London; University of Tasmania; Microsoft; Iwate Medical University	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Mortimer St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk	Attwell, David/ABE-6750-2020; Richardson FMedSci FRS, William D/C-1762-2008	Young, Kaylene/0000-0002-1686-3463; Tripathi, Richa/0000-0002-3810-0328; Richardson FMedSci FRS, William D/0000-0001-7261-2485	UK Medical Research Council; Wellcome Trust; National Institutes of Health (USA); Alzheimer's Society UK; BUPA Foundation; Multiple Sclerosis Research Australia; Australian National Health and Medical Research Council; Japanese Ministry of Education, Culture, Sports, Science and Technology; MRC [G0800575] Funding Source: UKRI; Medical Research Council [G0800575] Funding Source: researchfish; Wellcome Trust [100269/Z/12/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Society UK; BUPA Foundation; Multiple Sclerosis Research Australia; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Ben Emery (University of Melbourne), Sarah Jolly (University College London [UCL]), and Lorena Arancibia (UCL) for experimental help and/or advice. We also thank Ms. Eri Matsuura, Mr. Katsutoshi Ogasawara, and the other staff of the Center for Electron Microscopy and Bio-Imaging Research, Iwate Medical University, as well as Uila Dennehy and Sabrina Pacheco (both UCL) for excellent technical support. K.P. held a studentship from the UK Medical Research Council. The work was also supported by the UK Medical Research Council, the Wellcome Trust, the National Institutes of Health (USA), the Alzheimer's Society UK, the BUPA Foundation, Multiple Sclerosis Research Australia, the Australian National Health and Medical Research Council and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akagi T, 2006, J NEUROSCI METH, V153, P276, DOI 10.1016/j.jneumeth.2005.11.007; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bartsch S, 1997, BRAIN RES, V762, P231, DOI 10.1016/S0006-8993(97)00484-8; BLAKEMORE WF, 1981, J NEUROL SCI, V49, P273, DOI 10.1016/0022-510X(81)90084-8; BUTT AM, 1994, J NEUROCYTOL, V23, P469, DOI 10.1007/BF01184071; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Dangata YY, 1996, J ANAT, V189, P117; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HONJIN R, 1977, ARCH HISTOL JAPON, V40, P321, DOI 10.1679/aohc1950.40.321; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kimura F, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.012.2009; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; McIver SR, 2005, J NEUROSCI RES, V82, P397, DOI 10.1002/jnr.20626; Murtie JC, 2007, J NEUROSCI RES, V85, P2080, DOI 10.1002/jnr.21339; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Raz N, 2012, ANN NEUROL, V71, P531, DOI 10.1002/ana.22692; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Richter-Landsberg C, 1999, J NEUROSCI RES, V56, P259, DOI 10.1002/(SICI)1097-4547(19990501)56:3<259::AID-JNR5>3.0.CO;2-N; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sandell JH, 2002, J COMP NEUROL, V445, P13, DOI 10.1002/cne.10162; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Vinet J, 2010, EUR J NEUROSCI, V31, P425, DOI 10.1111/j.1460-9568.2010.07082.x; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	53	557	565	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					873	885		10.1016/j.neuron.2013.01.006	http://dx.doi.org/10.1016/j.neuron.2013.01.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473318	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000316162600009
J	Rizzoti, K; Akiyama, H; Lovell-Badge, R				Rizzoti, Karine; Akiyama, Haruhiko; Lovell-Badge, Robin			Mobilized Adult Pituitary Stem Cells Contribute to Endocrine Regeneration in Response to Physiological Demand	CELL STEM CELL			English	Article							RAT ANTERIOR-PITUITARY; PROGENITOR CELLS; ESTROGEN; SOX2; GONADECTOMY; LINEAGES; AXIS	Pituitary hormone deficiencies, with Growth Hormone deficiency being most frequent (1 in 3,50010,000 births), cause significant morbidity. Regeneration of missing endocrine cells would be a significant improvement over hormone replacement therapies, which incur side effects and do not mimic physiological secretion patterns. Recent in vitro studies have identified a population of adult pituitary progenitors that express the HMG box transcription factors SOX2 and SOX9. Here, we apply cell-lineage tracing analysis to demonstrate that SOX2- and SOX9-expressing progenitors can self-renew and give rise to endocrine cells in vivo, suggesting that they are tissue stem cells. Moreover, we show that they can become mobilized and differentiate into the appropriate endocrine cell types in response to physiological stress. Our results highlight the pituitary as a model for exploring how physiological changes influence stem cell behavior and suggest that manipulation of endogenous pituitary stem cells is a potential therapeutic strategy for pituitary deficiencies.	[Rizzoti, Karine; Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan	MRC National Institute for Medical Research; Kyoto University	Rizzoti, K (corresponding author), MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England.	krizzot@nimr.mrc.ac.uk	Rizzoti, Karine/AAW-1090-2021	Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179	UK Medical Research Council [U117512772]; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Konrad Hochedlinger (Harvard University) for the Sox2<SUP>CreERT2</SUP> mice and to Larysa Pevny (University of North Carolina) for the Sox2<SUP>EGFP</SUP> animals. We thank Iain Robinson (NIMR), Paul Burgoyne (NIMR), Andy Levy (Bristol University), and Paul LeTissier (NIMR) for helpful discussions. We are indebted to Danielle Carmignac, Confocal Microscopy (Donald Bell and Yan Gu) and Flow Cytometry (Graeme Preece and Bhavik Patel) platforms, and Biological Services for animal husbandry. We would like to thank members of the Lovell-Badge's lab for help and support. This work was supported by the UK Medical Research Council (U117512772). K. R. and R. L.-B. designed the study and wrote the manuscript. K. R performed and analyzed experiments. H. A. provided the Sox9<SUP>ires-CreERT2/+</SUP> mice. The authors declare no competing financial interests with this paper.	Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Budry L, 2011, P NATL ACAD SCI USA, V108, P12515, DOI 10.1073/pnas.1105929108; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; IBRAHIM SN, 1986, ENDOCRINOLOGY, V119, P629, DOI 10.1210/endo-119-2-629; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kominami R, 2003, HISTOCHEM CELL BIOL, V120, P223, DOI 10.1007/s00418-003-0565-9; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Nolan LA, 2006, J NEUROENDOCRINOL, V18, P655, DOI 10.1111/j.1365-2826.2006.01459.x; Nolan LA, 2009, J NEUROENDOCRINOL, V21, P457, DOI 10.1111/j.1365-2826.2009.01864.x; Nolan LA, 2006, J ENDOCRINOL, V188, P387, DOI 10.1677/joe.1.06508; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Rizzoti K, 2010, EUR J NEUROSCI, V32, P2053, DOI 10.1111/j.1460-9568.2010.07524.x; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subburaju S, 2007, ENDOCRINOLOGY, V148, P3102, DOI 10.1210/en.2007-0103; Zhu D, 2010, METHODS MOL BIOL, V616, P207, DOI 10.1007/978-1-60761-461-6_14	33	113	114	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					419	432		10.1016/j.stem.2013.07.006	http://dx.doi.org/10.1016/j.stem.2013.07.006			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094323	hybrid, Green Published			2022-12-25	WOS:000329571100011
J	Brockie, PJ; Jensen, M; Mellem, JE; Jensen, E; Yamasaki, T; Wang, R; Maxfield, D; Thacker, C; Hoerndli, F; Dunn, PJ; Tomita, S; Madsen, DM; Maricq, AV				Brockie, Penelope J.; Jensen, Michael; Mellem, Jerry E.; Jensen, Erica; Yamasaki, Tokiwa; Wang, Rui; Maxfield, Dane; Thacker, Colin; Hoerndli, Frederic; Dunn, Patrick J.; Tomita, Susumu; Madsen, David M.; Maricq, Andres V.			Cornichons Control ER Export of AMPA Receptors to Regulate Synaptic Excitability	NEURON			English	Article							C-ELEGANS; GLUTAMATE RECEPTORS; AUXILIARY SUBUNITS; PROTEIN; TRAFFICKING; PLASTICITY; TARPS; SOL-1; RECONSTITUTION; MODULATION	The strength of synaptic communication at central synapses depends on the number of ionotropic glutamate receptors, particularly the class gated by the agonist AMPA (AMPARs). Cornichon proteins, evolutionarily conserved endoplasmic reticulum cargo adaptors, modify the properties of vertebrate AMPARs when coexpressed in heterologous cells. However, the contribution of cornichons to behavior and in vivo nervous system function has yet to be determined. Here, we take a genetic approach to these questions by studying CNI-1-the sole cornichon homolog in C. elegans. cni-1 mutants hyperreverse, a phenotype associated with increased glutamatergic synaptic transmission. Consistent with this behavior, we find larger glutamate-gated currents in cni-1 mutants with a corresponding increase in AMPAR number. Furthermore, we observe opposite phenotypes in transgenic worms that overexpress CNI-1 or vertebrate homologs. In reconstitution studies, we provide support for an evolutionarily conserved role for cornichons in regulating the export of vertebrate and invertebrate AMPARs.	[Brockie, Penelope J.; Jensen, Michael; Mellem, Jerry E.; Jensen, Erica; Wang, Rui; Maxfield, Dane; Thacker, Colin; Hoerndli, Frederic; Madsen, David M.; Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Yamasaki, Tokiwa; Dunn, Patrick J.; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, CNNR, New Haven, CT 06510 USA	Utah System of Higher Education; University of Utah; Yale University	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu	Wang, Rui/C-8424-2011	jensen, michael/0000-0002-4517-822X; Hoerndli, Frederic/0000-0001-6838-0386	NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH [NS35812, MH077939]; Program for Young Researcher Overseas Visits, Graduate School of Pharmaceutical Science, The University of Tokyo; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH077939, R01MH077939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Young Researcher Overseas Visits, Graduate School of Pharmaceutical Science, The University of Tokyo; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Maricq laboratory and Marcus Babst for comments on the manuscript, Craig Walker for the preliminary analysis of cni-1 mutants and Aleksander Maricq for assistance writing the MATLAB script. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This research was made possible by support from NIH Grants NS35812 (A.V.M.) and MH077939 (S.T.). T.Y. is supported by the Program for Young Researcher Overseas Visits, Graduate School of Pharmaceutical Science, The University of Tokyo.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Brockie PJ, 2006, BIOCHEM SOC T, V34, P64, DOI 10.1042/BST0340064; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Coombs ID, 2012, J NEUROSCI, V32, P9796, DOI 10.1523/JNEUROSCI.0345-12.2012; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gill MB, 2012, EUR J NEUROSCI, V35, P182, DOI 10.1111/j.1460-9568.2011.07948.x; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Harmel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030681; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Herzig Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001329; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Leber A, 1995, FEBS LETT, V377, P271, DOI 10.1016/0014-5793(95)01361-X; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Lofke C, 2008, BIOCHEM J, V413, P115, DOI 10.1042/BJ20071371; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Orsborn AM, 2007, DEVELOPMENT, V134, P3383, DOI 10.1242/dev.005181; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10787, DOI 10.1073/pnas.0604520103; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10781, DOI 10.1073/pnas.0604482103; Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023; Wang R, 2012, NEURON, V75, P838, DOI 10.1016/j.neuron.2012.06.038; Wright A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00034; Yan D, 2012, J PHYSIOL-LONDON, V590, P21, DOI 10.1113/jphysiol.2011.213868; Zhang D, 2012, J CELL BIOL, V196, P85, DOI 10.1083/jcb.201104141; Zheng Y, 2006, P NATL ACAD SCI USA, V103, P1100, DOI 10.1073/pnas.0504612103; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	57	36	41	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					129	142		10.1016/j.neuron.2013.07.028	http://dx.doi.org/10.1016/j.neuron.2013.07.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094107	Green Accepted, Bronze			2022-12-25	WOS:000326305300013
J	Day, JJ; Childs, D; Guzman-Karlsson, MC; Kibe, M; Moulden, J; Song, E; Tahir, A; Sweatt, JD				Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David			DNA methylation regulates associative reward learning	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; VENTRAL TEGMENTAL AREA; EPIGENETIC MECHANISMS; GENE-TRANSCRIPTION; EXPRESSION; DOPAMINE; BEHAVIOR; NEURONS; ADDICTION; AMYGDALA	Reward-related memories are essential for adaptive behavior and evolutionary fitness, but they are also a core component of maladaptive brain diseases such as addiction. Reward learning requires dopamine neurons located in the ventral tegmental area (VTA), which encode relationships between predictive cues and future rewards. Recent evidence suggests that epigenetic mechanisms, including DNA methylation, are essential regulators of neuronal plasticity and experience-driven behavioral change. However, the role of epigenetic mechanisms in reward learning is poorly understood. Here we show that the formation of reward-related associative memories in rats upregulates key plasticity genes in the VTA, which are correlated with memory strength and associated with gene-specific changes in DNA methylation. Moreover, DNA methylation in the VTA is required for the formation of stimulus-reward associations. These results provide the first evidence that that activity-dependent methylation and demethylation of DNA is an essential substrate for the behavioral and neuronal plasticity driven by reward-related experiences.	[Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X; Childs, Daniel/0000-0001-7643-2836	US National Institute on Drug Abuse [DA029419]; US National Institutes of Mental Health [MH091122, MH057014]; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091122, R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank all members of the Sweatt laboratory, particularly G. Kaas and I. Zovkic, for comments and suggestions during the completion of these studies. We would also like to thank the Intellectual and Developmental Disabilities Research Core at the University of Alabama at Birmingham for assistance with cell culture experiments. This work is supported by the US National Institute on Drug Abuse (DA029419 to J.J.D.), the US National Institutes of Mental Health (MH091122 and MH057014 to J.D.S.) and the Evelyn F. McKnight Brain Research Foundation.	Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lamprecht R, 1996, LEARN MEMORY, V3, P31, DOI 10.1101/lm.3.1.31; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Saunders BT, 2013, NEUROSCI BIOBEHAV R, V37, P1955, DOI 10.1016/j.neubiorev.2013.02.008; Saunders BT, 2013, NEUROPSYCHOPHARMACOL, V38, P249, DOI 10.1038/npp.2012.161; Schirrmacher E, 2006, BIOCONJUGATE CHEM, V17, P261, DOI 10.1021/bc050300b; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	53	155	159	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1445	+		10.1038/nn.3504	http://dx.doi.org/10.1038/nn.3504			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974711	Green Accepted			2022-12-25	WOS:000324795300017
J	Lin, JY; Knutsen, PM; Muller, A; Kleinfeld, D; Tsien, RY				Lin, John Y.; Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David; Tsien, Roger Y.			ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX; FACIAL NUCLEUS; IN-VITRO; WHISKER; STIMULATION; MOVEMENTS; ACTIVATION; CHANNEL; CELLS	Channelrhodopsins (ChRs) are used to optogenetically depolarize neurons. We engineered a variant of ChR, denoted red-activatable ChR (ReaChR), that is optimally excited with orange to red light (lambda similar to 590-630 nm) and offers improved membrane trafficking, higher photocurrents and faster kinetics compared to existing red-shifted ChRs. Red light is less scattered by tissue and is absorbed less by blood than the blue to green wavelengths that are required by other ChR variants. We used ReaChR expressed in the vibrissa motor cortex to drive spiking and vibrissa motion in awake mice when excited with red light through intact skull. Precise vibrissa movements were evoked by expressing ReaChR in the facial motor nucleus in the brainstem and illumination with red light through the external auditory canal. Thus, ReaChR enables transcranial optical activation of neurons in deep brain structures without the need to surgically thin the skull, form a transcranial window or implant optical fibers.	[Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Howard Hughes Med Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Lin, JY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j8lin@ucsd.edu		Lin, John/0000-0002-1723-4597	Foundation of Research, Science and Technology New Zealand; Human Frontier Science Program (HFSP); US National Institutes of Health [NS027177, DA029706, OD006831, NS058668]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, DP1NS082097, R01NS027177, R01NS058668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Foundation of Research, Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology); Human Frontier Science Program (HFSP)(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.Y.L. was funded by the Foundation of Research, Science and Technology New Zealand, and P.M.K. was supported by a long-term fellowship from the Human Frontier Science Program (HFSP). The project was supported by grants to R.Y.T. from the US National Institutes of Health (NS027177) and the Howard Hughes Medical Institute and grants to D.K. from the US National Institutes of Health (DA029706, OD006831 and NS058668). We thank P. Tsai for suggesting the name ReaChR. We thank K. Deisseroth (Stanford University) for the hChR2<SUP>H134R</SUP>-eYFP construct, K. Svoboda (Howard Hughes Medical Institute Janelia Farm Research Campus) for the CAG promoter vector, E. Boyden (Massachusetts Institute of Technology) for the lentiviral vector, L. Tian (Howard Hughes Medical Institute Janelia Farm Research Campus) for the AAV2 vector and D. Trono (Ecole Polytechnique Federale De Lausane) for the psPAX2 and pMD2.G lentivirus packaging vectors. AAV2-ReaChR-Citrine and pLenti-ReaChR-Citrine constructs can be requested from http://tsienlab.ucsd.edu/Samples.htm.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; DORFL J, 1982, J ANAT, V135, P147; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; MARTIN MR, 1977, BRAIN RES, V123, P1, DOI 10.1016/0006-8993(77)90639-4; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; SHICHIDA Y, 1983, BIOCHIM BIOPHYS ACTA, V723, P240, DOI 10.1016/0005-2728(83)90123-8; Sohler TP, 1941, J PHARMACOL EXP THER, V71, P325; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	40	492	514	3	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1499	+		10.1038/nn.3502	http://dx.doi.org/10.1038/nn.3502			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995068	Green Accepted, Green Submitted			2022-12-25	WOS:000324795300024
J	Fisher, D; Olasagasti, T; Tank, DW; Aksay, ERF; Goldman, MS				Fisher, Dimitry; Olasagasti, Teas; Tank, David W.; Aksay, Emre R. F.; Goldman, Mark S.			A Modeling Framework for Deriving the Structural and Functional Architecture of a Short-Term Memory Microcircuit	NEURON			English	Article							PERSISTENT NEURAL ACTIVITY; EYE-POSITION; RECURRENT NETWORK; WORKING-MEMORY; INTEGRATOR; DENDRITES; PERTURBATION; DISCHARGE; NEURONS; SIGNALS	Although many studies have identified neural correlates of memory, relatively little is known about the circuit properties connecting single-neuron physiology to behavior. Here we developed a modeling framework to bridge this gap and identify circuit interactions capable of maintaining short-term memory. Unlike typical studies that construct a phenomenological model and test whether it reproduces select aspects of neuronal data, we directly fit the synaptic connectivity of an oculomotor memory circuit to a broad range of anatomical, electrophysiological, and behavioral data. Simultaneous fits to all data, combined with sensitivity analyses, revealed complementary roles of synaptic and neuronal recruitment thresholds in providing the nonlinear interactions required to generate the observed circuit behavior. This work provides a methodology for identifying the cellular and synaptic mechanisms underlying short-term memory and demonstrates how the anatomical structure of a circuit may belie its functional organization.	[Fisher, Dimitry; Goldman, Mark S.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Olasagasti, Teas] Univ Zurich Hosp, Dept Neurol, CH-8006 Zurich, Switzerland; [Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Aksay, Emre R. F.] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Aksay, Emre R. F.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Neurobiol, Davis, CA 95618 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Physiol, Davis, CA 95618 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Behav, Davis, CA 95618 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Ophthalmol & Visual Sci, Davis, CA 95618 USA	University of California System; University of California Davis; University of Zurich; University Zurich Hospital; Princeton University; Princeton University; Cornell University; Cornell University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Aksay, ERF (corresponding author), Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA.	ema2004@med.cornell.edu; msgoldman@ucdavis.edu		Olasagasti, Itsaso/0000-0002-5172-5373; Aksay, Emre/0000-0002-4561-4175	NSF [IIS-1208218-0]; NIH [R01 MH069726]; Sloan Foundation Research Fellowship; Burroughs Wellcome Collaborative Research Travel Grant; UC Davis Ophthalmology Research to Prevent Blindness grant; Wellesley College Brachmann-Hoffman Fellowship; Burroughs Wellcome Career Award at the Scientific Interface; Searle Scholars program; Div Of Information & Intelligent Systems [1208088] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069726] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); Burroughs Wellcome Collaborative Research Travel Grant; UC Davis Ophthalmology Research to Prevent Blindness grant; Wellesley College Brachmann-Hoffman Fellowship; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars program; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NSF grant IIS-1208218-0 (M.S.G., E.R.F.A.), NIH grant R01 MH069726 (M.S.G.), a Sloan Foundation Research Fellowship (M.S.G.), a Burroughs Wellcome Collaborative Research Travel Grant (M.S.G.), a UC Davis Ophthalmology Research to Prevent Blindness grant (M.S.G.), a Wellesley College Brachmann-Hoffman Fellowship (M.S.G.), a Burroughs Wellcome Career Award at the Scientific Interface (E.R.F.A.), and the Searle Scholars program (E.R.F.A.). We thank Guy Major, Jennifer Raymond, Sukbin Lim, Andrew Miri, Brian Mulloney, Michael Wright, Melanie Lee, and Jochen Ditterich for helpful comments on this work and Melanie Lee for computational assistance.	Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2003, J NEUROSCI, V23, P10852; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Chichilnisky EJ, 2005, J NEUROSCI, V25, P318, DOI 10.1523/JNEUROSCI.2339-04.2005; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Debowy O, 2011, J NEUROPHYSIOL, V105, P896, DOI 10.1152/jn.00313.2010; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Eliasmith C, 2003, NEURAL ENG; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman M.S., 2009, ENCYCL NEUROSCI, V6, P165, DOI DOI 10.1016/B978-008045046-9.01434-0; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Hastie T., 2009, UNSUPERVISED LEARNIN; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Machens CK, 2008, NEURAL COMPUT, V20, P452, DOI 10.1162/neco.2007.07-06-297; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miri A, 2011, NAT NEUROSCI, V14, P1150, DOI 10.1038/nn.2888; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz Astrid A, 2007, Methods Mol Biol, V401, P167, DOI 10.1007/978-1-59745-520-6_10; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; Sklavos SG, 2002, BIOL CYBERN, V86, P97, DOI 10.1007/S004220100281; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198	44	40	40	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					987	1000		10.1016/j.neuron.2013.06.041	http://dx.doi.org/10.1016/j.neuron.2013.06.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012010	Bronze, Green Accepted			2022-12-25	WOS:000330269100015
J	Liang, L; Li, YL; Potter, CJ; Yizhar, O; Deisseroth, K; Tsien, RW; Luo, LQ				Liang, Liang; Li, Yulong; Potter, Christopher J.; Yizhar, Ofer; Deisseroth, Karl; Tsien, Richard W.; Luo, Liqun			GABAergic Projection Neurons Route Selective Olfactory Inputs to Specific Higher-Order Neurons	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; COURTSHIP BEHAVIOR; PRESYNAPTIC INHIBITION; NEURAL CIRCUITRY; MOSAIC ANALYSIS; MUSHROOM BODY; GAIN-CONTROL; PHEROMONE; RECEPTOR; REPRESENTATION	We characterize an inhibitory circuit motif in the Drosophila olfactory system, parallel inhibition, which differs from feedforward or feedback inhibition. Excitatory and GABAergic inhibitory projection neurons (ePNs and iPNs) each receive input from antennal lobe glomeruli and send parallel output to the lateral horn, a higher center implicated in regulating innate olfactory behavior. Ca2+ imaging of specific lateral horn neurons as an olfactory readout revealed that iPNs selectively suppressed food-related odor responses, but spared signal transmission from pheromone channels. Coapplying food odorant did not affect pheromone signal transmission, suggesting that the differential effects likely result from connection specificity of iPNs, rather than a generalized inhibitory tone. Ca2+ responses in the ePN axon terminals show no detectable suppression by iPNs, arguing against presynaptic inhibition as a primary mechanism. The parallel inhibition motif may provide specificity in inhibition to funnel specific olfactory information, such as food and pheromone, into distinct downstream circuits.	[Liang, Liang; Potter, Christopher J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Liang, Liang; Potter, Christopher J.; Yizhar, Ofer; Deisseroth, Karl; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Liang, Liang] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	YIZHAR, OFER/AAV-8497-2021; Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112; Yizhar, Ofer/0000-0003-4228-1448; Li, Yulong/0000-0002-9166-9919; Liang, Liang/0000-0001-5718-0717; Luo, Liqun/0000-0001-5467-9264	NIH [R01-DC005982]; Stanford Graduate Fellowship; Lubert Stryer Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Lubert Stryer Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Y. Chou, B. Dickson, V. Jayaraman, T. Lee, L. Looger, K. Wehner, X. Yu, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the Developmental Studies Hybridoma Bank, and the BACPAC Resources Center for fly stocks, reagents, and antibodies; S. Sinha, D. Profitt, and D. Luginbuhl for technical assistance; K. Beier, X. Chen, T. Clandinin, X. Gao, N. Makki, A. Mizrahi, T. Mosca, and R. Wilson for providing critiques of the manuscript; M. Schnitzer for support; and G. Miesenbock for communicating data prior to publication. This work is supported by an NIH grant (R01-DC005982 to L. Luo). L. Liang has been supported by a Stanford Graduate Fellowship and a Lubert Stryer Stanford Interdisciplinary Graduate Fellowship. L Luo is an investigator of the Howard Hughes Medical Institute.	Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Higo S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.025.2009; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Kuppers B, 2003, J NEUROCHEM, V84, P939, DOI 10.1046/j.1471-4159.2003.01554.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liang L, 2010, SCI CHINA LIFE SCI, V53, P472, DOI 10.1007/s11427-010-0099-z; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	55	73	73	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					917	931		10.1016/j.neuron.2013.06.014	http://dx.doi.org/10.1016/j.neuron.2013.06.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012005	Green Accepted, Bronze			2022-12-25	WOS:000330269100010
J	Wang, ZP; Hou, YL; Guo, X; van der Voet, M; Boxem, M; Dixon, JE; Chisholm, AD; Jin, YS				Wang, Zhiping; Hou, Yanli; Guo, Xing; van der Voet, Monique; Boxem, Mike; Dixon, Jack E.; Chisholm, Andrew D.; Jin, Yishi			The EBAX-type Cullin-RING E3 Ligase and Hsp90 Guard the Protein Quality of the SAX-3/Robo Receptor in Developing Neurons	NEURON			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; CONTROL DEGRADATION; UBIQUITIN LIGASES; MOTOR NEUROPATHY; AXON GUIDANCE; HOT-SPOT; SLIT; ROBO; AGGREGATION	Although protein quality control (PQC) is generally perceived as important for the development of the nervous system, the specific mechanisms of neuronal PQC have remained poorly understood. Here, we report that C. elegans Elongin BC-binding axon regulator (EBAX-1), a conserved BC-box protein, regulates axon guidance through PQC of the SAX-3/Robo receptor. EBAX-1 buffers guidance errors against temperature variations. As a substrate-recognition subunit in the Elongin BC-containing Cullin-RING ubiquitin ligase (CRL), EBAX-1 also binds to DAF-21, a cytosolic Hsp90 chaperone. The EBAX-type CRL and DAF-21 collaboratively regulate SAX-3-mediated axon pathfinding. Biochemical and imaging assays indicate that EBAX-1 specifically recognizes misfolded SAX-3 and promotes its degradation in vitro and in vivo. Importantly, vertebrate EBAX also shows substrate preference toward aberrant Robo3 implicated in horizontal gaze palsy with progressive scoliosis (HGPPS). Together, our findings demonstrate a triage PQC mechanism mediated by the EBAX-type CRL and DAF-21/Hsp90 that maintains the accuracy of neuronal wiring.	[Wang, Zhiping; Chisholm, Andrew D.; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Guo, Xing; Dixon, Jack E.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.; Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Hou, Yanli] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [van der Voet, Monique; Boxem, Mike] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; Utrecht University	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	yijin@ucsd.edu	van der Voet, Monique/F-5772-2012; Boxem, Mike/B-8857-2011	van der Voet, Monique/0000-0002-8829-1767; Jin, Yishi/0000-0002-9371-9860; Chisholm, Andrew/0000-0001-5091-0537	Jane Coffin Childs Memorial Fund for Medical Research; Susan G. Komen breast cancer foundation; National Institutes of Health [R01 NS057317, R01 NS 035546]; Netherlands Organization for Scientific Research Vidi grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057317, R01NS035546] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Susan G. Komen breast cancer foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research Vidi grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Larry Zipursky for generously sharing unpublished results of Drosophila CG34401 mutants, leading us to work on ebax-1 in C. elegans, and to Aljoscha Nern and Marta Morey-Ramonell for personal communications. We thank David King at the Howard Hughes Medical Institute Mass Spectrometry Lab at UC Berkeley for mass spectrometry analyses. Shohei Mitani, the C. elegans Gene Knockout Consortium, and the Caenorhabditis Genetics Center provided mutant strains. We thank Cori Bargmann, Gian Garriga, Ian Chin-Sang, Ed Kipreos, William Wadsworth, Xiaofeng Xin, and Charlie Boone for reagents. We value discussions with Randy Hampton, James Moresco, and our lab members. Z.W. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research, and X.G. was supported by a postdoctoral fellowship from the Susan G. Komen breast cancer foundation. This work was partly supported by awards from the National Institutes of Health (R01 NS057317 to A.D.C.; Y.J.; R01 NS 035546 to Y.J.). M.B. was supported by a Netherlands Organization for Scientific Research Vidi grant. Y. J. is an investigator of the Howard Hughes Medical Institute.	Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kjaer S, 2003, HUM MOL GENET, V12, P2133, DOI 10.1093/hmg/ddg227; Lee DY, 2012, BIOL CHEM, V393, P441, DOI 10.1515/hsz-2012-0120; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Najarro EH, 2012, J NEUROSCI, V32, P4196, DOI 10.1523/JNEUROSCI.3094-11.2012; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Voss AK, 2000, DEVELOPMENT, V127, P1; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yochem J, 1998, GENETICS, V149, P1323; Yuasa-Kawada J, 2009, NAT NEUROSCI, V12, P1087, DOI 10.1038/nn.2382; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	48	21	25	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					903	916		10.1016/j.neuron.2013.06.035	http://dx.doi.org/10.1016/j.neuron.2013.06.035			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012004	Bronze, Green Accepted			2022-12-25	WOS:000330269100009
J	Power, JD; Schlaggar, BL; Lessov-Schlaggar, CN; Petersen, SE				Power, Jonathan D.; Schlaggar, Bradley L.; Lessov-Schlaggar, Christina N.; Petersen, Steven E.			Evidence for Hubs in Human Functional Brain Networks	NEURON			English	Article							MODULAR ORGANIZATION; SMALL-WORLD; COMMUNITY STRUCTURE; CONNECTIVITY; CORTEX	Hubs integrate and distribute information in powerful ways due to the number and positioning of their contacts in a network. Several resting-state functional connectivity MRI reports have implicated regions of the default mode system as brain hubs; we demonstrate that previous degree-based approaches to hub identification may have identified portions of large brain systems rather than critical nodes of brain networks. We utilize two methods to identify hub-like brain regions: (1) finding network nodes that participate in multiple subnetworks of the brain, and (2) finding spatial locations in which several systems are represented within a small volume. These methods converge on a distributed set of regions that differ from previous reports on hubs. This work identifies regions that support multiple systems, leading to spatially constrained predictions about brain function that may be tested in terms of lesions, evoked responses, and dynamic patterns of activity.	[Power, Jonathan D.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Sch Med St Louis, Dept Neurol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Radiol, Sch Med St Louis, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, Sch Med St Louis, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Anat & Neurobiol, Sch Med St Louis, St Louis, MO 63110 USA; [Lessov-Schlaggar, Christina N.] Washington Univ, Dept Psychiat, Sch Med St Louis, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Neurosurg, Sch Med St Louis, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Petersen, Steven E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Power, JD (corresponding author), Washington Univ, Sch Med St Louis, Dept Neurol, 660 South Euclid Ave, St Louis, MO 63110 USA.	powerj@wusm.wustl.edu	Petersen, Steve/ABF-1368-2020; Schlaggar, Bradley/AAZ-4153-2020	Power, Jonathan/0000-0002-6922-100X	NIH [F30 MH940322, R21NS061144, 5R01 HD057076-03-S1, R01HD057076, K12 EY16336, K01DA027046]; McDonnell Foundation Collaborative Action Award; Simons Foundation Award [95177]; NSF IGERT [DGE-0548890]; Barnes-Jewish Hospital Foundation; McDonnell Center for Systems Neuroscience at Washington University; Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand) [P30 CA91842]; Intellectual and Developmental Disabilities Research Center at Washington University [NIH/NICHD P30 HD062171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057076, P30HD062171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH094032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation Collaborative Action Award; Simons Foundation Award; NSF IGERT(National Science Foundation (NSF)); Barnes-Jewish Hospital Foundation; McDonnell Center for Systems Neuroscience at Washington University; Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand); Intellectual and Developmental Disabilities Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The impetus to write this paper came from discussions during the 2011 Summer Institute for Cognitive Neuroscience. We thank Tom Pearce, Steve Nelson, Chris Fetsch, and Brad Miller for comments on an earlier version of the manuscript, and Jessica Church, Joe Dubis, Eric Feczko, Katie Ihnen, Maital Neta, and Alecia Vogel for data contribution. This work was funded by NIH F30 MH940322 (J.D.P.), NIH R21NS061144 (S.E.P.), a McDonnell Foundation Collaborative Action Award (S.E.P.), Simons Foundation Award 95177 (S.E.P.), NIH 5R01 HD057076-03-S1 (B.L.S.), NIH R01HD057076 (B.L.S.), and NSF IGERT DGE-0548890 (Kurt Thoroughman). Data were acquired with the support of NIH K12 EY16336 (John Pruett), NIH K01DA027046 (C.N.L.-S.), the Barnes-Jewish Hospital Foundation (C.N.L.-S.), the McDonnell Center for Systems Neuroscience at Washington University (C.N.L.-S.), and the Alvin J. Siteman Cancer Center (via NCI Cancer Center Support Grand P30 CA91842) (C.N.L.-S.). This project was supported by the Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD P30 HD062171).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Chang C, 2010, FILM COMMENT, V46, P81; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frank A., 2010, CEREB CORTEX; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser P., 2003, COMMUNITY STRUCTURE; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Knuth DE., 1993, STANFORD GRAPH BASE; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	57	445	451	6	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					798	813		10.1016/j.neuron.2013.07.035	http://dx.doi.org/10.1016/j.neuron.2013.07.035			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972601	Bronze, Green Accepted			2022-12-25	WOS:000323587000017
J	Lu, L; Leutgeb, JK; Tsao, A; Henriksen, EJ; Leutgeb, S; Barnes, CA; Witter, MP; Moser, MB; Moser, EI				Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.			Impaired hippocampal rate coding after lesions of the lateral entorhinal cortex	NATURE NEUROSCIENCE			English	Article							PLACE CELLS; GRID CELLS; SPATIAL REPRESENTATION; MEMORY REPRESENTATIONS; DENTATE GYRUS; ORGANIZATION; DYNAMICS; MAP; TRANSFORMATION; CORTICES	In the hippocampus, spatial and non-spatial parameters may be represented by a dual coding scheme, in which coordinates in space are expressed by the collective firing locations of place cells and the diversity of experience at these locations is encoded by orthogonal variations in firing rates. Although the spatial signal may reflect input from medial entorhinal cortex, the sources of the variations in firing rate have not been identified. We found that rate variations in rat CA3 place cells depended on inputs from the lateral entorhinal cortex (LEC). Hippocampal rate remapping, induced by changing the shape or the color configuration of the environment, was impaired by lesions in those parts of the ipsilateral LEC that provided the densest input to the hippocampal recording position. Rate remapping was not observed in LEC itself. The findings suggest that LEC inputs are important for efficient rate coding in the hippocampus.	[Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, N-7034 Trondheim, Norway; [Leutgeb, Jill K.; Leutgeb, Stefan] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Leutgeb, Jill K.; Leutgeb, Stefan] Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol Sci, La Jolla, CA 92093 USA; [Barnes, Carol A.] Univ Arizona, Evelyn F McKnight Brain Inst, Div Neural Syst Memory & Aging, Tucson, AZ USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego; University of California System; University of California San Diego; University of Arizona	Lu, L (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	li.lu@ntnu.no; jleutgeb@ucsd.edu; edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X	Kavli Foundation; Centre of Excellence from Research Council of Norway	Kavli Foundation; Centre of Excellence from Research Council of Norway	We thank A. M. Amundgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng and H. Waade for technical assistance. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Research Council of Norway.	Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Burke SN, 2012, HIPPOCAMPUS, V22, P2032, DOI 10.1002/hipo.22060; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Deshmukh SS, 2012, HIPPOCAMPUS, V22, P2045, DOI 10.1002/hipo.22046; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; ITO HT, 2013, SOC NEUROSCI; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; Navawongse R, 2013, J NEUROSCI, V33, P1002, DOI 10.1523/JNEUROSCI.3891-12.2013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; ROOM P, 1985, J COMP NEUROL, V242, P40, DOI 10.1002/cne.902420104; RUTH RE, 1988, J COMP NEUROL, V270, P506, DOI 10.1002/cne.902700404; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Young BJ, 1997, J NEUROSCI, V17, P5183; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	51	66	66	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1085	U153		10.1038/nn.3462	http://dx.doi.org/10.1038/nn.3462			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852116				2022-12-25	WOS:000322323000019
J	Pagan, M; Urban, LS; Wohl, MP; Rust, NC				Pagan, Marino; Urban, Luke S.; Wohl, Margot P.; Rust, Nicole C.			Signals in inferotemporal and perirhinal cortex suggest an untangling of visual target information	NATURE NEUROSCIENCE			English	Article							INVARIANT OBJECT RECOGNITION; INFERIOR TEMPORAL CORTEX; MACAQUE AREA V4; PARAHIPPOCAMPAL CORTICES; PREFRONTAL CORTEX; NEURAL MECHANISMS; SENSORY STIMULI; MEMORY; MONKEY; RESPONSES	Finding sought visual targets requires our brains to flexibly combine working memory information about what we are looking for with visual information about what we are looking at. To investigate the neural computations involved in finding visual targets, we recorded neural responses in inferotemporal cortex (IT) and perirhinal cortex (PRH) as macaque monkeys performed a task that required them to find targets in sequences of distractors. We found similar amounts of total task-specific information in both areas; however, information about whether a target was in view was more accessible using a linear read-out or, equivalently, was more untangled in PRH. Consistent with the flow of information from IT to PRH, we also found that task-relevant information arrived earlier in IT. PRH responses were well-described by a functional model in which computations in PRH untangle input from IT by combining neurons with asymmetric tuning correlations for target matches and distractors.	[Pagan, Marino; Urban, Luke S.; Wohl, Margot P.; Rust, Nicole C.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rust, NC (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	nrust@sas.upenn.edu			National Eye Institute of the US National Institutes of Health [R01EY020851]; Sloan Foundation; National Eye Institute [P30EY001583]; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020851] Funding Source: NIH RePORTER	National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Sloan Foundation(Alfred P. Sloan Foundation); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Y. Cohen, J.A. Movshon, E. Simoncelli and A. Stocker for helpful discussions. We are especially grateful to D. Brainard and J. Gold for detailed comments on the work and on the manuscript. We also thank J. Deutsch for technical assistance and C. Veeder for veterinary support. This work was supported by the National Eye Institute of the US National Institutes of Health (award number R01EY020851), a Sloan Foundation award to N.C.R. and contributions from a National Eye Institute core grant (award number P30EY001583).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Buffalo EA, 2000, LEARN MEMORY, V7, P375, DOI 10.1101/lm.32100; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Edmonds J., 1970, COMB STRUCT THEIR AP; Efron B, 1994, INTRO BOOSTRAP; Engel TA, 2011, J NEUROSCI, V31, P6982, DOI 10.1523/JNEUROSCI.6150-10.2011; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Marr D., 1982, VISION; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2009, SPR SER COMPUT NEURO, V3, P121, DOI 10.1007/978-1-4419-0389-1_7; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085	44	69	69	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1132	U217		10.1038/nn.3433	http://dx.doi.org/10.1038/nn.3433			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792943	Green Accepted			2022-12-25	WOS:000322323000025
J	Seif, T; Chang, SJ; Simms, JA; Gibb, SL; Dadgar, J; Chen, BT; Harvey, BK; Ron, D; Messing, RO; Bonci, A; Hopf, FW				Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Chen, Billy T.; Harvey, Brandon K.; Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward			Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake	NATURE NEUROSCIENCE			English	Article							CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; GABA(A) RECEPTORS; ETHANOL-CONSUMPTION; ANIMAL-MODEL; RATS; CORE; ADDICTION	Compulsive drinking despite serious adverse medical, social and economic consequences is a characteristic of alcohol use disorders in humans. Although frontal cortical areas have been implicated in alcohol use disorders, little is known about the molecular mechanisms and pathways that sustain aversion-resistant intake. Here, we show that nucleus accumbens core (NAcore) NMDA-type glutamate receptors and medial prefrontal (mPFC) and insula glutamatergic inputs to the NAcore are necessary for aversion-resistant alcohol consumption in rats. Aversion-resistant intake was associated with a new type of NMDA receptor adaptation, in which hyperpolarization-active NMDA receptors were present at mPFC and insula but not amygdalar inputs in the NAcore. Accordingly, inhibition of Grin2c NMDA receptor subunits in the NAcore reduced aversion-resistant alcohol intake. None of these manipulations altered intake when alcohol was not paired with an aversive consequence. Our results identify a mechanism by which hyperpolarization-active NMDA receptors under mPFC- and insula-to-NAcore inputs sustain aversion-resistant alcohol intake.	[Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Ron, Dorit; Messing, Robert O.; Hopf, F. Woodward] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Chen, Billy T.; Harvey, Brandon K.; Bonci, Antonello] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Hopf, FW (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	antonello.bonci@nih.gov; woody@gallo.ucsf.edu	Harvey, Brandon Keith/AAY-4080-2021; Messing, Robert/D-3642-2015	Harvey, Brandon Keith/0000-0002-4036-1383; Messing, Robert/0000-0002-5345-4431	NIAAA [RO1AA015358]; National Institute on Drug Abuse [F32DA028065]; NIAAA/NIH [RO1A/MH13438]; State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015358, P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000526, ZIADA000579, ZICDA000555, F32DA028065] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Kharazia and the Gallo Center P50 National Institute on Alcohol Abuse and Alcoholism (NIAAA) AA017072 Histology Core for assistance with histology and R. Maiya for shRNA assistance. Supported by NIAAA RO1AA015358 (F.W.H.), National Institute on Drug Abuse F32DA028065 (T.S.), NIAAA/NIH RO1A/MH13438 (D.R.) and funds provided by the State of California for medical research for alcohol substance abuse through the University of California San Francisco (D.R., A.B., R.O.M.).	Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Breese GR, 2011, PHARMACOL THERAPEUT, V129, P149, DOI 10.1016/j.pharmthera.2010.09.007; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Chaudhri N, 2009, PSYCHOPHARMACOLOGY, V207, P303, DOI 10.1007/s00213-009-1657-6; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Cooper A, 2007, PSYCHOPHARMACOLOGY, V194, P117, DOI 10.1007/s00213-007-0827-7; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; da Cunha IC, 2008, BEHAV BRAIN RES, V188, P91, DOI 10.1016/j.bbr.2007.10.023; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Di Pietro NC, 2006, EUR J NEUROSCI, V24, P3285, DOI 10.1111/j.1460-9568.2006.05193.x; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Gibb SL, 2011, J NEUROSCI, V31, P2180, DOI 10.1523/JNEUROSCI.5540-10.2011; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hagino Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013722; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; June HL, 2001, J NEUROSCI, V21, P2166, DOI 10.1523/JNEUROSCI.21-06-02166.2001; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; MALDONADOIRIZARRY CS, 1994, PSYCHOPHARMACOLOGY, V116, P65, DOI 10.1007/BF02244872; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Obiang P, 2012, J NEUROSCI, V32, P12726, DOI 10.1523/JNEUROSCI.6202-11.2012; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Raeder H, 2008, DRUG ALCOHOL DEPEN, V96, P16, DOI 10.1016/j.drugalcdep.2007.12.013; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Roberts AJ, 1996, ALCOHOL CLIN EXP RES, V20, P1289, DOI 10.1111/j.1530-0277.1996.tb01125.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shi MM, 2011, NEUROREPORT, V22, P762, DOI 10.1097/WNR.0b013e32834ae32e; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sinclair CM, 2012, PHARMACOL BIOCHEM BE, V101, P329, DOI 10.1016/j.pbb.2012.01.014; Singh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00126; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wolffgramm J, 2000, J NEURAL TRANSM, V107, P649, DOI 10.1007/s007020070067; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009	60	192	196	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1094	U162		10.1038/nn.3445	http://dx.doi.org/10.1038/nn.3445			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817545	Green Accepted			2022-12-25	WOS:000322323000020
J	Schneider, DM; Woolley, SMN				Schneider, David M.; Woolley, Sarah M. N.			Sparse and Background-Invariant Coding of Vocalizations in Auditory Scenes	NEURON			English	Article							COCKTAIL PARTY PROBLEM; PRIMARY VISUAL-CORTEX; NEURONS; SONG; NOISE; SEGREGATION; INHIBITION; PATHWAYS; DISCRIMINATION; MECHANISMS	Vocal communicators such as humans and songbirds readily recognize individual vocalizations, even in distracting auditory environments. This perceptual ability is likely subserved by auditory neurons whose spiking responses to individual vocalizations are minimally affected by background sounds. However, auditory neurons that produce background-invariant responses to vocalizations in auditory scenes have not been found. Here, we describe a population of neurons in the zebra finch auditory cortex that represent vocalizations with a sparse code and that maintain their vocalization-like firing patterns in levels of background sound that permit behavioral recognition. These same neurons decrease or stop spiking in levels of background sound that preclude behavioral recognition. In contrast, upstream neurons represent vocalizations with dense and background-corrupted responses. We provide experimental evidence suggesting that sparse coding is mediated by feedforward suppression. Finally, we show through simulations that feedforward inhibition can transform a dense representation of vocalizations into a sparse and background-invariant representation.	[Schneider, David M.; Woolley, Sarah M. N.] Columbia Univ, Program Neurobiol & Behav, New York, NY 10032 USA; [Woolley, Sarah M. N.] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University; Columbia University	Woolley, SMN (corresponding author), Columbia Univ, Program Neurobiol & Behav, New York, NY 10032 USA.	sw2277@columbia.edu			NIH [F31-DC010301, R01-DC009810]; NSF [IOS-0920081]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009810, F31DC010301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Moore, J. Schumacher, and A. Calabrese for critical comments on the manuscript and for their input on experimental design and data analysis; G. Pollak generously donated equipment used for the pharmacology experiments. D.M.S. was supported by the NIH (F31-DC010301), and S.M.N.W. was supported by the NIH (R01-DC009810) and the NSF (IOS-0920081).	Asari H, 2006, J NEUROSCI, V26, P7477, DOI 10.1523/JNEUROSCI.1563-06.2006; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Boumans T, 2008, J NEUROPHYSIOL, V99, P931, DOI 10.1152/jn.00483.2007; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; GERHARDT HC, 1988, ANIM BEHAV, V36, P1247, DOI 10.1016/S0003-3472(88)80090-3; Gess A, 2011, ANIM BEHAV, V82, P285, DOI 10.1016/j.anbehav.2011.05.003; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HOWARDJONES PA, 1993, J ACOUST SOC AM, V93, P2915, DOI 10.1121/1.405811; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hulse SH, 1997, J COMP PSYCHOL, V111, P3, DOI 10.1037/0735-7036.111.1.3; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Joris PX, 2006, HEARING RES, V216, P19, DOI 10.1016/j.heares.2006.03.010; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Meliza CD, 2012, J NEUROSCI, V32, P15158, DOI 10.1523/JNEUROSCI.0845-12.2012; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Narayan R, 2007, NAT NEUROSCI, V10, P1601, DOI 10.1038/nn2009; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Schumacher JW, 2011, J NEUROPHYSIOL, V106, P500, DOI 10.1152/jn.01072.2010; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thompson JV, 2013, J NEUROPHYSIOL, V109, P721, DOI 10.1152/jn.00262.2012; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	44	74	74	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					141	152		10.1016/j.neuron.2013.04.038	http://dx.doi.org/10.1016/j.neuron.2013.04.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849201	Bronze, Green Accepted			2022-12-25	WOS:000321802000015
J	Tuthill, JC; Nern, A; Holtz, SL; Rubin, GM; Reiser, MB				Tuthill, John C.; Nern, Aljoscha; Holtz, Stephen L.; Rubin, Gerald M.; Reiser, Michael B.			Contributions of the 12 Neuron Classes in the Fly Lamina to Motion Vision	NEURON			English	Article							RECEPTIVE-FIELD ORGANIZATION; LARGE MONOPOLAR CELLS; VISUAL-SYSTEM; DROSOPHILA-MELANOGASTER; OPTOMOTOR RESPONSES; OPTIC FLOW; DIRECTION SELECTIVITY; BLOWFLY CALLIPHORA; MOVEMENT DETECTORS; DETECTION CIRCUITS	Motion detection is a fundamental neural computation performed by many sensory systems. In the fly, local motion computation is thought to occur within the first two layers of the visual system, the lamina and medulla. We constructed specific genetic driver lines for each of the 12 neuron classes in the lamina. We then depolarized and hyperpolarized each neuron type and quantified fly behavioral responses to a diverse set of motion stimuli. We found that only a small number of lamina output neurons are essential for motion detection, while most neurons serve to sculpt and enhance these feedforward pathways. Two classes of feedback neurons (C2 and C3), and lamina output neurons (L2 and L4), are required for normal detection of directional motion stimuli. Our results reveal a prominent role for feedback and lateral interactions in motion processing and demonstrate that motion-dependent behaviors rely on contributions from nearly all lamina neuron classes. .	[Tuthill, John C.; Nern, Aljoscha; Holtz, Stephen L.; Rubin, Gerald M.; Reiser, Michael B.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Reiser, MB (corresponding author), HHMI Janelia Farm Res Campus, 19700 Helix Dr, Ashburn, VA 20147 USA.	reiserm@janelia.hhmi.org		Reiser, Michael/0000-0002-4108-4517; Rubin, Gerald/0000-0001-8762-8703; Tuthill, John/0000-0002-5689-5806	HHMI	HHMI(Howard Hughes Medical Institute)	We thank Barret Pfeiffer, Heather Dionne, and Chris Murphy for molecular biology of Split-GAL4 constructs, Ted Ngo and Ming Wu for assistance with Split-GAL4 screening, the Janelia Fly Core for assistance with Drosophila care, the Janelia Fly Light Project for providing images of the primary GAL4 lines and of C2 single neurons, the Janelia Fly Light Scientific Computing Team for image processing software, Matt Smear and Stephen Huston for assistance with stimulus design, Damon Clark for discussions of L1- and L2-inactivation phenotypes, and Magnus Karlsson and Jinyang Liu for continued development and support of the visual display system. The Iso-D1 and the two L1 stocks used in Figure S6 were a gift from Tom Clandinin. We also thank Larry Zipursky, Alla Karpova, Stefan Pulver, Vivek Jayaraman, Anthony Leonardo, and members of the Reiser, Jayaraman, Card, and Rubin laboratories. This project was supported by HHMI.	ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRAITENB.V, 1974, J COMP PHYSIOL, V90, P25, DOI 10.1007/BF00698364; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Buchner E., 1971, THESIS U TUBINGEN TU; Buchner E, 1984, PLENUM, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; Carver S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040032; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; COOMBE PE, 1989, J COMP PHYSIOL A, V166, P23, DOI 10.1007/BF00190206; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; Duistermars BJ, 2007, J COMP PHYSIOL A, V193, P787, DOI 10.1007/s00359-007-0233-y; Duistermars BJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00006; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Farrow K, 2006, NAT NEUROSCI, V9, P1312, DOI 10.1038/nn1769; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1987, J EXP BIOL, V128, P35; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARDIE RC, 1990, J COMP PHYSIOL A, V167, P723, DOI 10.1007/BF00189763; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Hassenstein V., 1956, Z NATURFORSCH B, V11, P513; HAUSEN K, 1989, J NEUROSCI, V9, P3828; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HEISENBERG M, 1972, J COMP PHYSIOL, V80, P119, DOI 10.1007/BF00696485; Heisenberg M., 1984, VISION DROSOPHILA GE; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Single S, 1997, J NEUROSCI, V17, P6023; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STRAUSFELD NJ, 1973, BRAIN RES, V59, P97, DOI 10.1016/0006-8993(73)90254-0; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Theobald JC, 2010, J EXP BIOL, V213, P1366, DOI 10.1242/jeb.037945; Tuthill JC, 2011, P NATL ACAD SCI USA, V108, P9685, DOI 10.1073/pnas.1100062108; Zabala F, 2012, CURR BIOL, V22, P1344, DOI 10.1016/j.cub.2012.05.024; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	76	118	118	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					128	140		10.1016/j.neuron.2013.05.024	http://dx.doi.org/10.1016/j.neuron.2013.05.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849200	Green Accepted, Bronze			2022-12-25	WOS:000321802000014
J	Song, SJ; Ito, K; Ala, U; Kats, L; Webster, K; Sun, SM; Jongen-Lavrencic, M; Manova-Todorova, K; Teruya-Feldstein, J; Avigan, DE; Delwel, R; Pandolfi, PP				Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Sun, Su Ming; Jongen-Lavrencic, Mojca; Manova-Todorova, Katia; Teruya-Feldstein, Julie; Avigan, David E.; Delwel, Ruud; Pandolfi, Pier Paolo			The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; DNA METHYLATION; MUTANT TET2; MALIGNANCIES; MUTATIONS; LNA; DIFFERENTIATION; EXPRESSION; CANCERS	MicroRNAs are frequently deregulated in cancer. Here we show that miR-22 is upregulated in myelodysplastic syndrome (MDS) and leukemia and its aberrant expression correlates with poor survival. To explore its role in hematopoietic stem cell function and malignancy, we generated transgenic mice conditionally expressing miR-22 in the hematopoietic compartment. These mice displayed reduced levels of global 5-hydroxymethylcytosine (5-hmC) and increased hematopoietic stem cell self-renewal-accompanied by defective differentiation. Conversely, miR-22 inhibition blocked proliferation in both mouse and human leukemic cells. Over time, miR-22 transgenic mice developed MDS and hematological malignancies. We also identify TET2 as a key target of miR-22 in this context. Ectopic expression of TET2 suppressed the miR-22-induced phenotypes. Downregulation of TET2 protein also correlated with poor clinical outcomes and miR-22 overexpression in MDS patients. Our results therefore identify miR-22 as a potent proto-oncogene and suggest that aberrations in the miR-22/TET2 regulatory network are common in hematopoietic malignancies.	[Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Genet,Dept Med, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Song, Su Jung; Ito, Keisuke; Ala, Ugo; Kats, Lev; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Genet, Boston, MA 02215 USA; [Avigan, David E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA; [Sun, Su Ming; Jongen-Lavrencic, Mojca; Delwel, Ruud] Erasmus MC, Inst Hematol, NL-5201 Rotterdam, Netherlands; [Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Ala, Ugo/K-2029-2016; Kats, Lev/AAW-3252-2021	Ala, Ugo/0000-0001-5408-6397; Kats, Lev/0000-0001-8742-8138; Webster, Kaitlyn/0000-0001-9902-0500; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH [R00CA139009, R01DK10068901]; NHMRC Overseas Biomedical Fellowship;  [CA141457-03 NIH]; NATIONAL CANCER INSTITUTE [R00CA139009, P30CA008748, U01CA141457, R01CA082328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the members of the Pandolfi laboratory for their comments and discussion. We are grateful to Thomas Garvey and Min Sup Song for critical editing of the manuscript. We are also especially thankful to Akinobu Matsumoto, Dina Stroopinsky, and Mesruh Turkekul for technical support and help on in situ hybridization; to Lourdes Mendez for comments and help on hematological analysis; to Aviv Bergman for comments and support on statistical analysis of human patients' data; and to Miriam Fayad for support on cohort study of patients with hematological malignancies. K. I. was supported by NIH grants R00CA139009 and R01DK10068901. L. K. was supported by an NHMRC Overseas Biomedical Fellowship. This work was supported by CA141457-03 NIH grants to P.P.P.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Liu TC, 2000, AM J HEMATOL, V63, P170, DOI 10.1002/(SICI)1096-8652(200004)63:4<170::AID-AJH2>3.0.CO;2-0; Merkerova MD, 2011, EUR J HUM GENET, V19, P313, DOI 10.1038/ejhg.2010.209; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Song S.J., 2013, CELL IN PRESS, V154, DOI DOI 10.1016/J.CELL.2013.06.026; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Wang J, 2012, BIOTECHNOL LETT, V34, P2007, DOI 10.1007/s10529-012-1018-0; Yamazaki J, 2012, EPIGENETICS-US, V7, P201, DOI 10.4161/epi.7.2.19015; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	47	237	244	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					87	101		10.1016/j.stem.2013.06.003	http://dx.doi.org/10.1016/j.stem.2013.06.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827711	Green Accepted, Bronze			2022-12-25	WOS:000329570100015
J	Zhang, H; Jiao, WW; Sun, L; Fan, JY; Chen, MF; Wang, H; Xu, XY; Shen, AD; Li, T; Niu, BB; Ge, SF; Li, W; Cui, JW; Wang, GJ; Sun, JN; Fan, XQ; Hu, X; Mrsny, RJ; Hoffman, AR; Hu, JF				Zhang, He; Jiao, Weiwei; Sun, Lin; Fan, Jiayan; Chen, Mengfei; Wang, Hong; Xu, Xiaoyi; Shen, Adong; Li, Tao; Niu, Beibei; Ge, Shengfang; Li, Wei; Cui, Jiuwei; Wang, Guanjun; Sun, Jingnan; Fan, Xianqun; Hu, Xiang; Mrsny, Randall J.; Hoffman, Andrew R.; Hu, Ji-Fan			Intrachromosomal Looping Is Required for Activation of Endogenous Pluripotency Genes during Reprogramming	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; DEFINED FACTORS; EXPRESSION; CHROMATIN; BINDING; NETWORK; OCT4	Generation of induced pluripotent stem cells (iPSCs) by defined factors is an extremely inefficient process, because there is a strong epigenetic block preventing cells from achieving pluripotency. Here we report that virally expressed factors bound to the promoters of their target genes to the same extent in both iPSCs and unreprogrammed cells (URCs). However, expression of endogenous pluripotentcy genes was observed only in iPSCs. Comparison of local chromatin structure of the OCT4 locus revealed that there was a cohesin-complex-mediated intrachromosomal loop that juxtaposes a downstream enhancer to the gene's promoter, enabling activation of endogenous stemness genes. None of these long-range interactions were observed in URCs. Knockdown of the cohesin-complex gene SMC1 by RNAi abolished the intrachromosomal interaction and affected pluripotency. These findings highlight the importance of the SMC1-orchestrated intrachromosomal loop as a critical epigenetic barrier to the induction of pluripotency.	[Wang, Hong; Xu, Xiaoyi; Li, Wei; Cui, Jiuwei; Wang, Guanjun; Sun, Jingnan; Hu, Ji-Fan] Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130021, Peoples R China; [Zhang, He; Fan, Jiayan; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200025, Peoples R China; [Jiao, Weiwei; Sun, Lin; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Inst, Beijing 100045, Peoples R China; [Chen, Mengfei; Li, Tao; Hu, Xiang] Shenzhen Beike Cell Engn Res Inst, Shenzhen 518057, Peoples R China; [Zhang, He; Jiao, Weiwei; Sun, Lin; Fan, Jiayan; Niu, Beibei; Hoffman, Andrew R.; Hu, Ji-Fan] Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Mrsny, Randall J.; Hu, Ji-Fan] GMR Epigenet, Palo Alto, CA 94303 USA; [Mrsny, Randall J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	Jilin University; Shanghai Jiao Tong University; Capital Medical University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Bath	Hu, JF (corresponding author), Jilin Univ, Affiliated Hosp 1, Stem Cell & Canc Ctr, Changchun 130021, Peoples R China.	fanxq@sh163.net; arhoffman@stanford.edu; jifan@stanford.edu	Hu, Jifan/Q-3003-2019; Chen, Mengfei/T-7020-2018; Chen, Mengfei/N-2474-2019	Chen, Mengfei/0000-0001-6922-1221; Hoffman, Andrew/0000-0002-0145-1917; ZHANG, HE/0000-0001-9954-4451; HU, Jifan/0000-0002-2174-0361	California Institute of Regenerative Medicine (CIRM) [RT2-01942]; Jilin International Collaboration Grant [20120720]; NSFC [81272294, 81172323]; Jilin Science and Technique Program grant [11GG003]; Merit Review grant from the Medical Research Service of the Department of Veterans Affairs; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040411]; Shanghai Leading Academic Discipline Project [S30205]	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jilin International Collaboration Grant; NSFC(National Natural Science Foundation of China (NSFC)); Jilin Science and Technique Program grant; Merit Review grant from the Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the California Institute of Regenerative Medicine (CIRM) (grant RT2-01942), a Jilin International Collaboration Grant (20120720), and an NSFC grant (81272294) to J.F.H; a Jilin Science and Technique Program grant (11GG003) to W. L.; a Merit Review grant from the Medical Research Service of the Department of Veterans Affairs to A. R. H.; an NSFC grant (81172323) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040411) to S. F. G; and a Shanghai Leading Academic Discipline Project grant (S30205) to X. Q. F. H.Z. is an Early Career Scientist of Shanghai JiaoTong University School of Medicine.	Apostolou E, 2013, CELL STEM CELL, V13, P1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; IMAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4503, DOI 10.1093/nar/19.16.4503; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simonsson S, 2005, CELL CYCLE, V4, P513, DOI 10.4161/cc.4.4.1581; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	17	103	110	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					30	35		10.1016/j.stem.2013.05.012	http://dx.doi.org/10.1016/j.stem.2013.05.012			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23747202	Bronze			2022-12-25	WOS:000329570100010
J	Coddington, LT; Rudolph, S; Vande Lune, P; Overstreet-Wadiche, L; Wadiche, JI				Coddington, Luke T.; Rudolph, Stephanie; Vande Lune, Patrick; Overstreet-Wadiche, Linda; Wadiche, Jacques I.			Spillover-Mediated Feedforward Inhibition Functionally Segregates Interneuron Activity	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; METABOTROPIC GLUTAMATE RECEPTORS; PYRAMIDAL CELLS; CLIMBING FIBERS; EXTRASYNAPTIC GLUTAMATE; PARALLEL FIBER; EXCITATORY TRANSMISSION; MULTIVESICULAR RELEASE; HIPPOCAMPAL SYNAPSES; SYNAPTIC INTEGRATION	Neurotransmitter spillover represents a form of neural transmission not restricted to morphologically defined synaptic connections. Communication between climbing fibers (CFs) and molecular layer interneurons (MLIs) in the cerebellum is mediated exclusively by glutamate spillover. Here, we show how CF stimulation functionally segregates MLIs based on their location relative to glutamate release. Excitation of MLIs that reside within the domain of spillover diffusion coordinates inhibition of MLIs outside the diffusion limit. CF excitation of MLIs is dependent on extrasynaptic NMDA receptors that enhance the spatial and temporal spread of CF signaling. Activity mediated by functionally segregated MLIs converges onto neighboring Purkinje cells (PCs) to generate a long-lasting biphasic change in inhibition. These data demonstrate how glutamate release from single CFs modulates excitability of neighboring PCs, thus expanding the influence of CFs on cerebellar cortical activity in a manner not predicted by anatomical connectivity.	[Coddington, Luke T.; Rudolph, Stephanie; Vande Lune, Patrick; Overstreet-Wadiche, Linda; Wadiche, Jacques I.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Coddington, Luke T.; Rudolph, Stephanie; Vande Lune, Patrick; Overstreet-Wadiche, Linda; Wadiche, Jacques I.] Univ Alabama Birmingham, Evelyn McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Overstreet-Wadiche, L (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	lwadiche@uab.edu; jwadiche@uab.edu		Coddington, Luke/0000-0002-0785-4231; Rudolph, Stephanie/0000-0003-0388-7762; Wadiche, Jacques/0000-0001-8180-2061; Wadiche, Linda/0000-0001-7367-5998	NIH [NS064025, NS065920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065920, R01NS064025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NS064025 (L.O.-W.) and NS065920 (J.I.W.). We thank Kamran Khodakhah, Ming-Chi Tsai, Anastassios Tzingounis, and members of the Wadiche laboratories for discussions and reading the manuscript.	Abrahamsson T, 2012, NEURON, V73, P1159, DOI 10.1016/j.neuron.2012.01.027; Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Barmack NH, 2011, J NEUROSCI, V31, P9824, DOI 10.1523/JNEUROSCI.1738-11.2011; Barmack NH, 2003, J NEUROSCI, V23, P7904; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; BLOEDEL JR, 1983, J NEUROPHYSIOL, V50, P220, DOI 10.1152/jn.1983.50.1.220; Borst JGG, 2010, TRENDS NEUROSCI, V33, P259, DOI 10.1016/j.tins.2010.03.003; Bosman LWJ, 2010, J PHYSIOL-LONDON, V588, P3757, DOI 10.1113/jphysiol.2010.195180; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Brown KM, 2012, J NEUROSCI, V32, P14670, DOI 10.1523/JNEUROSCI.2018-12.2012; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chalifoux JR, 2011, J NEUROSCI, V31, P16435, DOI 10.1523/JNEUROSCI.2777-11.2011; Chavas J, 2003, J NEUROSCI, V23, P2019; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; EBNER TJ, 1983, J NEUROPHYSIOL, V50, P205, DOI 10.1152/jn.1983.50.1.205; Fuxe K, 1991, VOLUME TRANSMISSION; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jarolimek W, 1999, J NEUROSCI, V19, P4695; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Mathews PJ, 2012, J NEUROSCI, V32, P17988, DOI 10.1523/JNEUROSCI.3916-12.2012; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Palay S. L., 1974, CEREBELLAR CORTEX CY; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Rudolph S, 2011, NEURON, V70, P991, DOI 10.1016/j.neuron.2011.03.029; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; Szmajda BA, 2011, J NEUROSCI, V31, P13431, DOI 10.1523/JNEUROSCI.2105-11.2011; Tsai MC, 2012, J NEUROSCI, V32, P1528, DOI 10.1523/JNEUROSCI.5232-11.2012; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	72	47	47	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 19	2013	78	6					1050	1062		10.1016/j.neuron.2013.04.019	http://dx.doi.org/10.1016/j.neuron.2013.04.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23707614	Green Accepted, Bronze			2022-12-25	WOS:000321026900011
J	Wang, Z; Chen, LM; Negyessy, L; Friedman, RM; Mishra, A; Gore, JC; Roe, AW				Wang, Zheng; Chen, Li Min; Negyessy, Laszlo; Friedman, Robert M.; Mishra, Arabinda; Gore, John C.; Roe, Anna W.			The Relationship of Anatomical and Functional Connectivity to Resting-State Connectivity in Primate Somatosensory Cortex	NEURON			English	Article							HUMAN BRAIN; STRUCTURAL CONNECTIVITY; MONKEYS; ORGANIZATION; RESPONSES; AREAS; V2; REPRESENTATION; ARCHITECTURE; SPECIFICITY	Studies of resting-state activity in the brain have provoked critical questions about the brain's functional organization, but the biological basis of this activity is not clear. Specifically, the relationships between interregional correlations in resting-state measures of activity, neuronal functional connectivity and anatomical connectivity are much debated. To investigate these relationships, we have examined both anatomical and steady-state functional connectivity within the hand representation of primary somatosensory cortex (areas 3b and 1) in anesthetized squirrel monkeys. The comparison of three data sets (fMRI, electrophysiological, and anatomical) indicate two primary axes of information flow within the SI: prominent interdigit interactions within area 3b and predominantly homotopic interactions between area 3b and area 1. These data support a strikingly close relationship between baseline functional connectivity and anatomical connections. This study extends findings derived from large-scale cortical networks to the realm of local millimeter-scale networks.	[Wang, Zheng; Friedman, Robert M.; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37232 USA; [Chen, Li Min; Mishra, Arabinda; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA; [Negyessy, Laszlo] Hungarian Acad Sci, Wigner Res Ctr Phys, Dept Theory, H-1051 Budapest, Hungary; [Negyessy, Laszlo] Semmelweis Univ, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Chen, Li Min; Mishra, Arabinda; Gore, John C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Semmelweis University; Vanderbilt University	Gore, JC (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA.	john.gore@vanderbilt.edu; anna.roe@vanderbilt.edu	Wang, Zheng/GRE-7739-2022; Chen, Li Min/C-3554-2011; Négyessy, László/G-6283-2019	Négyessy, László/0000-0002-4369-0406; Wang, Zheng/0000-0001-5943-344X; Roe, Anna Wang/0000-0003-4146-9705; Wang, Zheng/0000-0001-7138-8581	FIRCA [NS059061]; NIH [NS044375, NS069909, NS078680]; Dana Foundation; Vanderbilt Core Grant [P30EY008126]; Hungarian Scientific Research Fund OTKA [NN79366]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081437, R01NS078680, R03NS059061, R01NS044375, R56NS044375, R01NS069909] Funding Source: NIH RePORTER	FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Vanderbilt Core Grant; Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from FIRCA (NS059061 to A.W.R.) and NIH (NS044375 to A.W.R., NS069909 to L.M.C., and NS078680 to J.C.G.), and the Dana Foundation (to L.M.C.), a Vanderbilt Core Grant (P30EY008126), and the Hungarian Scientific Research Fund OTKA NN79366 (L.N.). The technical assistance of Chang Cu, Yan Yan Chu, and Alyssa Zuehl is highly appreciated. We thank Maria Ashaber, Emese Palfi, and Cory Palmer for help with anatomical data analyses, Hui-Xin Qi for assistance in some electrophysiology mapping experiments, and Baxter Rogers for guidance with fMRI analysis.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brody CD, 1999, NEURAL COMPUT, V11, P1527, DOI 10.1162/089976699300016124; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101; Friedman RM, 2008, J NEUROPHYSIOL, V100, P3185, DOI 10.1152/jn.90278.2008; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; Hung C. P., 2010, DYNAMIC BRAIN EXPLOR, P83; Hung CP, 2007, NAT NEUROSCI, V10, P1185, DOI 10.1038/nn1948; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kaskan PM, 2009, CEREB CORTEX, V19, P1394, DOI 10.1093/cercor/bhn178; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Lipton ML, 2010, J NEUROSCI, V30, P15895, DOI 10.1523/JNEUROSCI.4765-09.2010; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P2830; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Manger PR, 1997, J NEUROSCI, V17, P6338; Matsui T, 2011, CEREB CORTEX, V21, P2348, DOI 10.1093/cercor/bhr019; Negyessy L, 2013, J COMP NEUROL, V521, P2798, DOI 10.1002/cne.23317; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reed JL, 2008, P NATL ACAD SCI USA, V105, P10233, DOI 10.1073/pnas.0803800105; Roe AW, 1999, J NEUROPHYSIOL, V82, P2719, DOI 10.1152/jn.1999.82.5.2719; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; TSO DY, 1988, J NEUROSCI, V8, P1712; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	47	140	142	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1116	1126		10.1016/j.neuron.2013.04.023	http://dx.doi.org/10.1016/j.neuron.2013.04.023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791200	Green Accepted, Bronze			2022-12-25	WOS:000321026900016
J	Benraiss, A; Toner, MJ; Xu, QW; Bruel-Jungerman, E; Rogers, EH; Wang, FS; Economides, AN; Davidson, BL; Kageyama, R; Nedergaard, M; Goldman, SA				Benraiss, Abdellatif; Toner, Michael J.; Xu, Qiwu; Bruel-Jungerman, Elodie; Rogers, Eloise H.; Wang, Fushun; Economides, Aris N.; Davidson, Beverly L.; Kageyama, Ryoichiro; Nedergaard, Maiken; Goldman, Steven A.			Sustained Mobilization of Endogenous Neural Progenitors Delays Disease Progression in a Transgenic Model of Huntington's Disease	CELL STEM CELL			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; STEM-CELLS; ADULT FOREBRAIN; SPINY NEURONS; GENE-THERAPY; MOUSE MODEL; BRAIN; MICE; NEUROGENESIS; EXPRESSION	Huntington's disease (HD) is a neurodegenerative disease characterized in part by the loss of striatopallidal medium spiny projection neurons (MSNs). Expression of BDNF and noggin via intracerebroventricular (ICV) delivery in an adenoviral vector triggers the addition of new neurons to the neostriatum. In this study, we found that a single ICV injection of the adeno-associated viruses AAV4-BDNF and AAV4-noggin triggered the sustained recruitment of new MSNs in both wild-type and R6/2 mice, a model of HD. Mice treated with AAV4-BDNF/noggin or with BDNF and noggin proteins actively recruited subependymal progenitor cells to form new MSNs that matured and achieved circuit integration. Importantly, the AAV4-BDNF/noggin-treated R6/2 mice showed delayed deterioration of motor function and substantially increased survival. In addition, squirrel monkeys given ICV injections of adenoviral BDNF/ noggin showed similar addition of striatal neurons. Induced neuronal addition may therefore represent a promising avenue for disease amelioration in HD.	[Benraiss, Abdellatif; Toner, Michael J.; Bruel-Jungerman, Elodie; Rogers, Eloise H.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Benraiss, Abdellatif; Toner, Michael J.; Xu, Qiwu; Wang, Fushun; Nedergaard, Maiken; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Xu, Qiwu; Bruel-Jungerman, Elodie; Wang, Fushun; Nedergaard, Maiken; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Davidson, Beverly L.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	University of Rochester; University of Rochester; University of Rochester; Regeneron; University of Iowa; Kyoto University	Benraiss, A (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	abdellatif_benraiss@urmc.rochester.edu; steven_goldman@urmc.rochester.edu	Benraiss, Abdellatif/AAI-8584-2021	Benraiss, Abdellatif/0000-0002-0325-6234; Economides, Aris/0000-0002-6508-8942; Goldman, Steven/0000-0002-5498-4303; Davidson, Beverly/0000-0002-3715-6290	NINDS [R01NS52534, R37NS29813]; Hereditary Disease Foundation; CHDI; New York State Stem Cell Research Program (NYSTEM); Davidson laboratory [DK54759, NS34568, HD3353]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029813, R01NS078304, R01NS034568, R01NS078167, R01NS075177, R01NS075345, R01NS052534] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation; CHDI; New York State Stem Cell Research Program (NYSTEM); Davidson laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS R01NS52534 and R37NS29813, the Hereditary Disease Foundation, CHDI, and the New York State Stem Cell Research Program (NYSTEM). Work in the Davidson laboratory was supported by DK54759, NS34568, and HD3353. We thank Dr. Louis DiVincenti, Jr. for his veterinary expertise and assistance with the squirrel monkey arm of this project. We also thank the referees for their consistently helpful critiques and suggestions during the progression of this study. Dr. Goldman and colleagues have received the following patents relevant to this study: "Gene-therapymediated induction of neurogenesis in the adult brain,'' U.S. Patent 7,037,493, and "Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of BDNF and an inhibitor of a progliogenic bone morphogenetic protein,'' U. S. Patent 7,576,065. These patents are owned by the Cornell University Center for Technology Enterprise; neither Dr. Goldman nor any coauthors have received income from these patents.	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Benraiss A, 2012, GENE THER, V19, P483, DOI 10.1038/gt.2011.114; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 2002, HUNTINGTONS DIS, P251; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu G, 2005, GENE THER, V12, P1503, DOI 10.1038/sj.gt.3302554; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	44	41	45	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					787	799		10.1016/j.stem.2013.04.014	http://dx.doi.org/10.1016/j.stem.2013.04.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746982	Bronze, Green Accepted			2022-12-25	WOS:000329569900020
J	McGinty, VB; Lardeux, S; Taha, SA; Kim, JJ; Nicola, SM				McGinty, Vincent B.; Lardeux, Sylvie; Taha, Sharif A.; Kim, James J.; Nicola, Saleem M.			Invigoration of Reward Seeking by Cue and Proximity Encoding in the Nucleus Accumbens	NEURON			English	Article							VENTRAL STRIATUM; BASOLATERAL AMYGDALA; NEURONS ENCODE; REACTION-TIME; HIPPOCAMPAL; DOPAMINE; NAVIGATION; AFFERENTS; BEHAVIOR; STIMULI	A key function of the nucleus accumbens is to promote vigorous reward seeking, but the corresponding neural mechanism has not been identified despite many years of research. Here, we study cued flexible approach behavior, a form of reward seeking that strongly depends on the accumbens, and we describe a robust, single-cell neural correlate of behavioral vigor in the excitatory response of accumbens neurons to reward-predictive cues. Well before locomotion begins, this cue-evoked excitation predicts both the movement initiation latency and the speed of subsequent flexible approach responses, but not those of stereotyped, inflexible responses. Moreover, the excitation simultaneously signals the subject's proximity to the approach target, a signal that appears to mediate greater response vigor on trials that begin with the subject closer to the target. These results demonstrate a neural Mechanism for response invigoration whereby accumbens neuronal encoding of reward availability and target proximity together drive the onset and speed of reward-seeking locomotion.	[McGinty, Vincent B.; Lardeux, Sylvie; Kim, James J.; Nicola, Saleem M.] Yeshiva Univ Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA; [McGinty, Vincent B.; Lardeux, Sylvie; Kim, James J.; Nicola, Saleem M.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Taha, Sharif A.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Utah System of Higher Education; University of Utah	Nicola, SM (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA.	saleem.nicola@einstein.yu.edu			NIH [DA019473, MH092757, MH094870]; NARSAD; Klarman Family Foundation; Peter F. McManus Charitable Trust; Hilda and Preston Davis Foundation; Tourette Syndrome Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092757, R01MH094870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019473] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Klarman Family Foundation; Peter F. McManus Charitable Trust; Hilda and Preston Davis Foundation; Tourette Syndrome Association; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Morrison, J. du Hoffmann, K. Caref, K. Wright, D. Moorman, P. W. German, F. Ambroggi, and H. Fields for comments on the manuscript. This work was supported by grants from the NIH (DA019473 and MH092757 to S.M.N. and MH094870 to S.A.T.); from NARSAD, the Klarman Family Foundation, and the Peter F. McManus Charitable Trust (to S.M.N.); from the Hilda and Preston Davis Foundation (to S.L.); and from the Tourette Syndrome Association (to V.B.M.).	AMALRIC M, 1987, J NEUROSCI, V7, P2129; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Ambroggi F, 2011, J NEUROSCI, V31, P6820, DOI 10.1523/JNEUROSCI.6491-10.2011; Brown VJ, 1995, EUR J NEUROSCI, V7, P2479, DOI 10.1111/j.1460-9568.1995.tb01046.x; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Cacciapaglia F, 2011, J NEUROSCI, V31, P13860, DOI 10.1523/JNEUROSCI.1340-11.2011; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; German PW, 2007, J NEUROPHYSIOL, V97, P2094, DOI 10.1152/jn.00304.2006; Ghods-Sharifi S, 2010, BEHAV NEUROSCI, V124, P179, DOI 10.1037/a0018932; Giertler C, 2004, BEHAV PHARMACOL, V15, P55, DOI 10.1097/00008877-200402000-00007; Goldstein BL, 2012, J NEUROSCI, V32, P2027, DOI 10.1523/JNEUROSCI.5349-11.2012; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Lansink CS, 2012, J NEUROSCI, V32, P12444, DOI 10.1523/JNEUROSCI.0593-12.2012; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; LAVOIE AM, 1994, BRAIN RES, V638, P157, DOI 10.1016/0006-8993(94)90645-9; Mulder AB, 2004, EUR J NEUROSCI, V19, P1923, DOI 10.1111/j.1460-9568.2004.03301.x; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nicola SM, 2007, PSYCHOPHARMACOLOGY, V191, P521, DOI 10.1007/s00213-006-0510-4; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nicola SM, 2004, J NEUROPHYSIOL, V91, P1840, DOI 10.1152/jn.00657.2003; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Roesch MR, 2009, J NEUROSCI, V29, P13365, DOI 10.1523/JNEUROSCI.2572-09.2009; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Sharp PE, 1996, HIPPOCAMPUS, V6, P720, DOI 10.1002/(SICI)1098-1063(1996)6:6<720::AID-HIPO14>3.0.CO;2-2; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Taha SA, 2007, J PHYSIOL-LONDON, V584, P801, DOI 10.1113/jphysiol.2007.140236; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	38	85	85	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2013	78	5					910	922		10.1016/j.neuron.2013.04.010	http://dx.doi.org/10.1016/j.neuron.2013.04.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764290	Bronze, Green Accepted			2022-12-25	WOS:000320743400016
J	Komura, Y; Nikkuni, A; Hirashima, N; Uetake, T; Miyamoto, A				Komura, Yutaka; Nikkuni, Akihiko; Hirashima, Noriko; Uetake, Teppei; Miyamoto, Aki			Responses of pulvinar neurons reflect a subject's confidence in visual categorization	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; SPATIAL ATTENTION; BEHAVING MACAQUE; RHESUS-MONKEY; CORTEX; THALAMUS; DECISION; CONSCIOUSNESS; AWARENESS; HUMANS	When we recognize a sensory event, we experience a confident feeling that we certainly know the perceived world 'here and now'. However, it is unknown how and where the brain generates such 'perceptual confidence'. Here we found neural correlates of confidence in the primate pulvinar, a visual thalamic nucleus that has been expanding markedly through evolution. During a categorization task, the majority of pulvinar responses did not correlate with any 'perceptual content'. During an opt-out task, pulvinar responses decreased when monkeys chose 'escape' options, suggesting less confidence in their perceptual categorization. Functional silencing of the pulvinar increased monkeys' escape choices in the opt-out task without affecting categorization performance; this effect was specific to the contralateral visual target. These data were supported by a theoretical model of confidence, indicating that pulvinar activities encode a subject's certainty of visual categorization and contribute to perceptual confidence.	[Komura, Yutaka; Nikkuni, Akihiko; Hirashima, Noriko; Uetake, Teppei; Miyamoto, Aki] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Komura, Yutaka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Komura, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	komura-y@aist.go.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Kawano, S. Dehaene, R. Kanai and S. Phillips for valuable comments and critical discussions; R. Tamura and K. Numata for continuous encouragement; T.Mega and A.Muramatsu for technical help and animal care. This work was supported in part by Precursory Research for Embryonic Science and Technology program from Japan Science and Technology Agency, Grant-in-Aids for Young Scientists (A) and Scientific Research on Innovative Areas from Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.K.).	Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; BENEVENTO LA, 1995, VISUAL NEUROSCI, V12, P523, DOI 10.1017/S0952523800008439; Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Casanova C., 2003, VISUAL NEUROSCIENCES, P592; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Gutierrez C, 2000, J COMP NEUROL, V419, P61, DOI 10.1002/(SICI)1096-9861(20000327)419:1<61::AID-CNE4>3.0.CO;2-I; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Imura K, 2006, J COMP NEUROL, V498, P649, DOI 10.1002/cne.21085; Inaba N, 2007, J NEUROPHYSIOL, V97, P3473, DOI 10.1152/jn.01054.2006; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Koch C, 2007, NAT NEUROSCI, V10, P140, DOI 10.1038/nn0207-140; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Kusama T., 1970, STEREOTAXIC ATLAS BR; LABERGE D, 1990, J NEUROSCI, V10, P613; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; olszewski j, 1952, THALAMUS MACACA MULA; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Pierce CS., 1885, MEMOIRS NATL ACAD SC, V3, P73; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; ROBINSON DL, 1990, EXP BRAIN RES, V82, P235; Romanski LM, 1997, J COMP NEUROL, V379, P313; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sahraie A, 1998, BEHAV BRAIN RES, V96, P71, DOI 10.1016/S0166-4328(97)00194-0; Seth AK, 2005, CONSCIOUS COGN, V14, P119, DOI 10.1016/j.concog.2004.08.006; Shields WE, 2005, J GEN PSYCHOL, V132, P165; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Wilke M, 2009, P NATL ACAD SCI USA, V106, P9465, DOI 10.1073/pnas.0900714106; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZIHL J, 1979, BRAIN, V102, P835, DOI 10.1093/brain/102.4.835	52	116	116	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					749	+		10.1038/nn.3393	http://dx.doi.org/10.1038/nn.3393			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666179				2022-12-25	WOS:000319509600017
J	Clark, DA; Freifeld, L; Clandininz, TR				Clark, Damon A.; Freifeld, Limor; Clandininz, Thomas R.			Mapping and Cracking Sensorimotor Circuits in Genetic Model Organisms	NEURON			English	Review							WHITE-NOISE ANALYSIS; CAENORHABDITIS-ELEGANS; VISUAL-SYSTEM; FUNCTIONAL SPECIALIZATION; CONTRAST ADAPTATION; RECEPTIVE-FIELDS; VIRTUAL-REALITY; SEXUAL-BEHAVIOR; OPTICAL CONTROL; FLIGHT SPEED	One central goal of systems neuroscience is to understand how neural circuits implement the computations that link sensory inputs to behavior. Work combining electrophysiological and imaging-based approaches to measure neural activity with pharmacological and electrophysiological manipulations has provided fundamental insights. More recently, genetic approaches have been used to monitor and manipulate neural activity, opening up new experimental opportunities and challenges. Here, we discuss issues associated with applying genetic approaches to circuit dissection in sensorimotor transformations, outlining important considerations for experimental design and considering how modeling can complement experimental approaches.	[Freifeld, Limor] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Clark, Damon A.; Clandininz, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Clandininz, TR (corresponding author), Stanford Univ, Dept Neurobiol, 299 W Campus Dr, Stanford, CA 94305 USA.	trc@stanford.edu		Clark, Damon/0000-0001-8487-700X; Freifeld, Limor/0000-0002-0739-6947	NIH [DP1 OD003530]; NEI [R01 EY022638]; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Justin Ales, Rave da Silveira, Liqun Luo, Aravi Samuel, Nirao Shah, and Clandinin laboratory members for helpful discussions and comments. Work on neural circuits in the Clandinin laboratory is supported by an NIH Director's Pioneer Award (DP1 OD003530) and by R01 EY022638 (NEI).	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Aptekar JW, 2012, CURR BIOL, V22, P482, DOI 10.1016/j.cub.2012.01.044; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Atick JJ, 2011, NETWORK, V22, P213; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Boeddeker N, 2005, J COMP PHYSIOL A, V191, P1143, DOI 10.1007/s00359-005-0038-9; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Braun E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009361; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Bullock TH, 1997, ELECTROEN CLIN NEURO, V103, P661, DOI 10.1016/S0013-4694(97)00087-4; Burgess HA, 2010, CURR BIOL, V20, P381, DOI 10.1016/j.cub.2010.01.022; CAMPBELL FW, 1969, J PHYSIOL-LONDON, V203, P223, DOI 10.1113/jphysiol.1969.sp008861; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chow DM, 2011, J NEUROSCI, V31, P15035, DOI 10.1523/JNEUROSCI.1736-11.2011; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; DALY SJ, 1985, VISION RES, V25, P1197, DOI 10.1016/0042-6989(85)90034-3; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Duistermars BJ, 2008, CURR BIOL, V18, P270, DOI 10.1016/j.cub.2008.01.027; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; England PM, 2010, CHEM BIOL, V17, P607, DOI 10.1016/j.chembiol.2010.06.001; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fry SN, 2004, J NEUROSCI METH, V135, P149, DOI 10.1016/j.jneumeth.2003.12.012; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Frye MA, 2003, J EXP BIOL, V206, P843, DOI 10.1242/jeb.00175; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; GRUNER JA, 1980, EXP BRAIN RES, V40, P374; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hecht S, 1934, J GEN PHYSIOL, V17, P517, DOI 10.1085/jgp.17.4.517; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ibanez-Tallon I, 2012, CURR OPIN NEUROBIOL, V22, P72, DOI 10.1016/j.conb.2011.11.003; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JULESZ B, 1978, BIOL CYBERN, V31, P137, DOI 10.1007/BF00336998; Jung SN, 2011, J NEUROSCI, V31, P9231, DOI 10.1523/JNEUROSCI.1138-11.2011; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kern R, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-08-j0001.2001; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOZAK W, 1965, J NEUROPHYSIOL, V28, P19, DOI 10.1152/jn.1965.28.1.19; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Lewi J, 2011, J COMPUT NEUROSCI, V30, P181, DOI 10.1007/s10827-010-0248-1; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Machens CK, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228104; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; Marr D., 1982, VISION COMPUTATIONAL; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MCCANN GD, 1974, J NEUROPHYSIOL, V37, P869, DOI 10.1152/jn.1974.37.5.869; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; POGGIO T, 1980, BIOL CYBERN, V37, P167, DOI 10.1007/BF00355455; POGGIO T, 1973, KYBERNETIK, V13, P223, DOI 10.1007/BF00274887; Portugues R, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00072; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Rajan K, 2012, ARXIV12010321; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rohrseitz N, 2011, J R SOC INTERFACE, V8, P171, DOI 10.1098/rsif.2010.0225; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Ryu WS, 2002, J NEUROSCI, V22, P5727; SAKAI HM, 1988, VISUAL NEUROSCI, V1, P287, DOI 10.1017/S0952523800001942; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Schuster S, 2002, CURR BIOL, V12, P1591, DOI 10.1016/S0960-9822(02)01141-7; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stone CP, 1922, J COMP PSYCHOL, V2, P95, DOI 10.1037/h0075931; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Tammero LF, 2002, J EXP BIOL, V205, P327; Theobald JC, 2010, J EXP BIOL, V213, P1366, DOI 10.1242/jeb.037945; Tinbergen N., 1977, STUDY INSTINCT; Tu MS, 1996, J COMP PHYSIOL A, V178, P813, DOI 10.1007/BF00225830; VANABEELEN JHF, 1963, GENETICA, V34, P270, DOI 10.1007/BF01664196; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; WALD G., 1949, DOCUMENTA OPHTHALMOL, V3, P94, DOI 10.1007/BF00162600; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; White BH, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.020.2009; ZANKER JM, 1990, PHILOS T ROY SOC B, V327, P19, DOI 10.1098/rstb.1990.0041	140	18	18	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					583	595		10.1016/j.neuron.2013.05.006	http://dx.doi.org/10.1016/j.neuron.2013.05.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719159	Green Accepted, Bronze			2022-12-25	WOS:000319491200004
J	Griciuc, A; Serrano-Pozo, A; Parrado, AR; Lesinski, AN; Asselin, CN; Mullin, K; Hooli, B; Choi, SH; Hyman, BT; Tanzil, RE				Griciuc, Ana; Serrano-Pozo, Alberto; Parrado, Antonio R.; Lesinski, Andrea N.; Asselin, Caroline N.; Mullin, Kristina; Hooli, Basavaraj; Choi, Se Hoon; Hyman, Bradley T.; Tanzil, Rudolph E.			Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta	NEURON			English	Article							GENOME-WIDE ASSOCIATION; A-BETA; APOLIPOPROTEIN-E; IDENTIFIES VARIANTS; MYELOID-LEUKEMIA; COMMON VARIANTS; IN-VIVO; SIGLECS; HYPOTHESIS; DEPOSITION	The transmembrane protein CD33 is a sialic acid-binding immunoglobulin-like lectin that regulates innate immunity but has no known functions in the brain. We have previously shown that the CD33 gene is a risk factor for Alzheimer's disease (AD). Here, we observed increased expression of CD33 in microglial cells in AD brain. The minor allele of the CD33 SNP rs3865444, which confers protection against AD, was associated with reductions in both CD33 expression and insoluble amyloid beta 42 (A beta 42) levels in AD brain. Furthermore, the numbers of CD33-immunoreactive microglia were positively correlated with insoluble A beta 42 levels and plaque burden in AD brain. CD33 inhibited uptake and clearance of A beta 42 in microglial cell cultures. Finally, brain levels of insoluble A beta 42 as well as amyloid plaque burden were markedly reduced in APP(Swe)/PS1(Delta E9)/CD33(-/-) mice. Therefore, CD33 inactivation mitigates A beta pathology and CD33 inhibition could represent a novel therapy for AD.	[Griciuc, Ana; Parrado, Antonio R.; Lesinski, Andrea N.; Asselin, Caroline N.; Mullin, Kristina; Hooli, Basavaraj; Choi, Se Hoon; Tanzil, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Serrano-Pozo, Alberto; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA; [Serrano-Pozo, Alberto; Hyman, Bradley T.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Tanzil, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Serrano-Pozo, Alberto/L-1519-2019	Tanzi, Rudolph/0000-0002-7032-1454; Serrano-Pozo, Alberto/0000-0003-0899-7530	National Institutes of Health [5R37MH060009, 5P01AG15379, AG08487, P50AG05134]; Cure Alzheimer's Fund; Deutsche Forschungsgemeinschaft (Germany); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009, R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, R29AG008487, P50AG005134, T32AG000222, P01AG015379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ronald B. Walter (Fred Hutchinson Cancer Research Center, Seattle, WA, USA) for the CD33 plasmids and Linda Van Eldik (University of Kentucky, Lexington, KY, USA) for the BV2 microglial cell line. We thank Karlotta Fitch for assistance with tissue sectioning. We thank Lars Bertram, Zhongcong Xie, Jaehong Suh, Can Zhang, and Doo Kim for stimulating discussions. This work was supported by grants from the National Institutes of Health (5R37MH060009 and 5P01AG15379 to R.E.T. and AG08487 and P50AG05134 to B.T.H.), and Cure Alzheimer's Fund. A.G. is supported by a fellowship from the Deutsche Forschungsgemeinschaft (Germany). B.T.H. is on the Scientific Advisory Board of Neurophage, which was not involved in this study.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Brinkman-Vand der Linden ECM, 2003, MOL CELL BIOL, V23, P4199, DOI 10.1128/MCB.23.12.4199-4206.2003; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hoyer JD, 2008, AM J CLIN PATHOL, V129, P316, DOI 10.1309/E36008Y2H08Q1AYY; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jurcic JG, 2012, CURR HEMATOL MALIG R, V7, P65, DOI 10.1007/s11899-011-0103-0; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Liu CC, 2013, NAT REV NEUROL, V9, P184, DOI 10.1038/nrneurol.2013.32; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Perez-Oliva AB, 2011, GLYCOBIOLOGY, V21, P757, DOI 10.1093/glycob/cwq220; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; R Development Core Team, 2009, R LANG ENV STAT COMP; Reilly JF, 2003, P NATL ACAD SCI USA, V100, P4837, DOI 10.1073/pnas.0330745100; Ricart AD, 2011, CLIN CANCER RES, V17, P6417, DOI 10.1158/1078-0432.CCR-11-0486; Rollins-Raval MA, 2012, HISTOPATHOLOGY, V60, P933, DOI 10.1111/j.1365-2559.2012.04175.x; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Walter RB, 2008, TRAFFIC, V9, P267, DOI 10.1111/j.1600-0854.2007.00682.x; Wang YJ, 2011, J NEUROSCI, V31, P2292, DOI 10.1523/JNEUROSCI.2733-10.2011; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	57	608	632	9	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2013	78	4					631	643		10.1016/j.neuron.2013.04.014	http://dx.doi.org/10.1016/j.neuron.2013.04.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23623698	Bronze, Green Accepted			2022-12-25	WOS:000319491200008
J	Yu, XMM; Gutman, I; Mosca, TJ; Iram, T; Ozkan, E; Garcia, KC; Luo, LQ; Schuldiner, O				Yu, Xiaomeng M.; Gutman, Itai; Mosca, Timothy J.; Iram, Tal; Oezkan, Engin; Garcia, K. Christopher; Luo, Liqun; Schuldiner, Oren			Plum, an Immunoglobulin Superfamily Protein, Regulates Axon Pruning by Facilitating TGF-beta Signaling	NEURON			English	Article							DROSOPHILA MUSHROOM BODIES; SYNAPSE STABILIZATION; GLIAL-CELLS; IN-VIVO; METAMORPHOSIS; EXPRESSION; RECEPTOR; DEGENERATION; MELANOGASTER; MECHANISMS	Axon pruning during development is essential for proper wiring of the mature nervous system, but its regulation remains poorly understood. We have identified an immunoglobulin superfamily (IgSF) transmembrane protein, Plum, that is cell autonomously required for axon pruning of mushroom body (MB) gamma neurons and for ectopic synapse refinement at the developing neuromuscular junction in Drosophila. Plum promotes MB gamma neuron axon pruning by regulating the expression of Ecdysone Receptor-B1, a key initiator of axon pruning. Genetic analyses indicate that Plum acts to facilitate signaling of Myoglianin, a glial-derived TGF-beta, on MB gamma neurons upstream of the type-I TGF-beta receptor Baboon. Myoglianin, Baboon, and Ecdysone Receptor-B1 are also required for neuromuscular junction ectopic synapse refinement. Our study highlights both IgSF proteins and TGF-beta facilitation as key promoters of developmental axon elimination and demonstrates a mechanistic conservation between MB axon pruning during metamorphosis and the refinement of ectopic larval neuromuscular connections.	[Yu, Xiaomeng M.; Mosca, Timothy J.; Luo, Liqun] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94303 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94303 USA; [Gutman, Itai; Iram, Tal; Schuldiner, Oren] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Weizmann Institute of Science	Luo, LQ (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94303 USA.	lluo@stanford.edu; oren.schuldiner@weizmann.ac.il	Iram, Tal/GSE-3876-2022; Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Ozkan, Engin/0000-0002-0263-6729; Luo, Liqun/0000-0001-5467-9264; Mosca, Timothy/0000-0003-3485-0719	National Institute of Child Health and Human Development; National Institutes of Health (NIH) [R37-NSO41044]; Israel Science Foundation [1864/08, 683/11]; Irving B. Harrison foundation; Estate of Florence and Charles Cuevas; Adelis Foundation; Epilepsy, Neonatology, and Developmental Biology Training grants (NIH [5132 NS 007280, HD007249]; Damon Runyon Cancer Research Foundation [DRG1993-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280, R37NS041044] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Irving B. Harrison foundation; Estate of Florence and Charles Cuevas; Adelis Foundation; Epilepsy, Neonatology, and Developmental Biology Training grants (NIH; Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Attisano, T. Lee, M. B. O'Connor, N. Reist, the Vienna Drosophila RNAI Center, and the Bloomington stock center for reagents; the Fasll (1D4) and Brp (nc82) monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa. We also thank R. Watts and E. Hoopfer for many hours of joint screening, N. Goriatcheva, D. Luginbuhl, N. Issman, and O. Fuchs for technical assistance, O. Golani for help with MATLAB programming, M. Hortsch and M. Serpe for discussions, and K. Shen, A. Yaron, M. Schuldiner, and members of the Luo and Schuldiner labs for discussions and their critical reading of our manuscript. This work was supported by a grant from the National Institutes of Health (NIH) (R37-NSO41044) (to L.L.), by grants from the Israel Science Foundation (1864/08 and 683/11) (Bio-med Legacy program), funds from the Irving B. Harrison foundation, the Estate of Florence and Charles Cuevas, and the Adelis Foundation (to O.S.). L.L. and K.C.G. are investigators of the Howard Hughes Medical Institute. O.S. is the incumbent of the Rothstein Career Development Chair of Genetic Diseases. T.J.M. was supported by Epilepsy, Neonatology, and Developmental Biology Training grants (NIH) (5132 NS 007280 and HD007249). X.M.Y. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG1993-08).	Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Boulanger A, 2011, NAT NEUROSCI, V14, P37, DOI 10.1038/nn.2700; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; Carrillo RA, 2010, NEURON, V68, P32, DOI 10.1016/j.neuron.2010.09.005; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; HALPERN ME, 1991, J NEUROSCI, V11, P3227; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Ito K, 1997, DEVELOPMENT, V124, P761; Jarecki J, 1995, J NEUROSCI, V15, P8177; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massaro CM, 2009, J CELL BIOL, V187, P101, DOI 10.1083/jcb.200903166; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Salbaum JM, 2000, GENOMICS, V64, P15, DOI 10.1006/geno.2000.6114; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wong YH, 2010, J NEUROSCI, V30, P4428, DOI 10.1523/JNEUROSCI.0473-10.2010; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; YANG MY, 1995, NEURON, V15, P45; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	60	34	34	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2013	78	3					456	468		10.1016/j.neuron.2013.03.004	http://dx.doi.org/10.1016/j.neuron.2013.03.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664613	Bronze, Green Accepted			2022-12-25	WOS:000318961700008
J	Dus, M; Ai, MR; Suh, GSB				Dus, Monica; Ai, Minrong; Suh, Greg S. B.			Taste-independent nutrient selection is mediated by a brain-specific Na+/solute co-transporter in Drosophila	NATURE NEUROSCIENCE			English	Article							GLUCOSE; MIDGUT; MEMORY; SUGAR	Animals can determine the nutritional value of sugar without the influence of taste. We examined a Drosophila mutant that is insensitive to the nutritional value of sugars, responding only to the concentration (that is, sweetness). The affected gene encodes a sodium/solute co-transporter-like protein, designated SLC5A11 (or cupcake), which is structurally similar to mammalian sodium/glucose co-transporters that transport sugar across the intestinal and renal lumen. However, SLC5A11 was prominently expressed in 10-13 pairs of R4 neurons of the ellipsoid body in the brain and functioned in these neurons for selecting appropriate foods.	[Dus, Monica; Ai, Minrong; Suh, Greg S. B.] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA	New York University	Suh, GSB (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA.	greg.suh@med.nyu.edu	Suh, Seong Bae/K-2434-2016	Suh, Greg/0000-0003-4381-658X	Hilda and Preston Davis Foundation; Ruth L. Kirschstein National Research Service Award; Klarman Foundation; Hirschl/Caulier Trust award; US National Institutes of Health grants from the National Institute of General Medical Sciences; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK097141, K99DK097141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012791] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Foundation; Hirschl/Caulier Trust award; US National Institutes of Health grants from the National Institute of General Medical Sciences; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Perdigoto for assistance with gut immunohistochemistry, members of the Suh laboratory, R. Davis, S. Burden and N. Ringstad for comments on the manuscript, and the Belasco laboratory and the New York University fly community at Skirball Institute for sharing their equipment. Financial support was provided by the Hilda and Preston Davis Foundation (M.D.), Ruth L. Kirschstein National Research Service Award (M.A.), the Klarman Foundation, a Hirschl/Caulier Trust award, and US National Institutes of Health RO1 grants from the National Institute of General Medical Sciences and the National Institute on Deafness and Other Communication Disorders (G.S.B.S.).	BOGDANOVE EM, 1950, P SOC EXP BIOL MED, V75, P77; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Malley D, 2006, DIABETES, V55, P3381, DOI 10.2337/db06-0531; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Renn SCP, 1999, J NEUROBIOL, V41, P189; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009	18	80	81	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					526	+		10.1038/nn.3372	http://dx.doi.org/10.1038/nn.3372			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542692	Green Accepted			2022-12-25	WOS:000318029300007
J	Khoutorsky, A; Yanagiya, A; Gkogkas, CG; Fabian, MR; Prager-Khoutorsky, M; Cao, RF; Gamache, K; Bouthiette, F; Parsyan, A; Sorge, RE; Mogil, JS; Nader, K; Lacaille, JC; Sonenberg, N				Khoutorsky, Arkady; Yanagiya, Akiko; Gkogkas, Christos G.; Fabian, Marc R.; Prager-Khoutorsky, Masha; Cao, Ruifeng; Gamache, Karine; Bouthiette, Frederic; Parsyan, Armen; Sorge, Robert E.; Mogil, Jeffrey S.; Nader, Karim; Lacaille, Jean-Claude; Sonenberg, Nahum			Control of Synaptic Plasticity and Memory via Suppression of Poly(A)-Binding Protein	NEURON			English	Article							POLY(A) BINDING-PROTEIN; LONG-TERM POTENTIATION; CALMODULIN KINASE-II; CAMKII MESSENGER-RNA; TRANSLATIONAL CONTROL; ALPHA; CALPAIN; INITIATION; PABP; PHOSPHORYLATION	Control of protein synthesis is critical for synaptic plasticity and memory formation. However, the molecular mechanisms linking neuronal activity to activation of mRNA translation are not fully understood. Here, we report that the translational repressor poly(A)-binding protein (PABP)-interacting protein 2A (PAIP2A), an inhibitor of PABP, is rapidly proteolyzed by calpains in stimulated neurons and following training for contextual memory. Paip2a knockout mice exhibit a lowered threshold for the induction of sustained long-term potentiation and an enhancement of long-term memory after weak training. Translation of CaMKII alpha mRNA is enhanced in Paip2a(-/-) slices upon tetanic stimulation and in the hippocampus of Paip2a(-/-) mice following contextual fear learning. We demonstrate that activity-dependent degradation of PAIP2A relieves translational inhibition of memory-related genes through PABP reactivation and conclude that PAIP2A is a pivotal translational regulator of synaptic plasticity and-memory.	[Khoutorsky, Arkady; Yanagiya, Akiko; Gkogkas, Christos G.; Cao, Ruifeng; Parsyan, Armen; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Khoutorsky, Arkady; Yanagiya, Akiko; Gkogkas, Christos G.; Cao, Ruifeng; Parsyan, Armen; Sonenberg, Nahum] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Fabian, Marc R.] McGill Univ, Jewish Gen Hosp, Dept Oncol, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Prager-Khoutorsky, Masha] McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; [Gamache, Karine; Sorge, Robert E.; Mogil, Jeffrey S.; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; [Bouthiette, Frederic; Lacaille, Jean-Claude] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Bouthiette, Frederic; Lacaille, Jean-Claude] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Sorge, Robert E.; Mogil, Jeffrey S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	jean-claude.lacaille@umontreal.ca; nahum.sonenberg@mcgill.ca	Cao, Ruifeng/K-8894-2013; Gkogkas, Christos/GQH-2659-2022; Cao, Ruifeng/P-3819-2019; Mogil, Jeffrey/AAA-9611-2019; Gkogkas, Christos/GLR-5348-2022	Gkogkas, Christos/0000-0001-6281-3419; Cao, Ruifeng/0000-0001-5105-7726; Mogil, Jeffrey/0000-0003-1359-5720; Khoutorsky, Arkady/0000-0003-3846-8728; Yanagiya, Akiko/0000-0002-5553-0311	National Institutes of Health [2R01GM066157]; Canadian Institutes of Health Research (CIHR) [MOP-10848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Wayne Sossin and Valerie Henderson for excellent comments; Annie Sylvestre, Sandra Perreault, and Colin Lister for technical assistance; and Isabel Laplante for assistance with immunostaining. This work was supported by National Institutes of Health Grant 2R01GM066157 and a Canadian Institutes of Health Research (CIHR) grant to Nahum Sonenberg and CIHR Grant MOP-10848 to J.C.L. J.C.L. is the recipient of the Canada Research Chair in Cellular and Molecular Neurophysiology.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Assini FL, 2009, BEHAV BRAIN RES, V204, P206, DOI 10.1016/j.bbr.2009.06.005; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Berlanga JJ, 2006, RNA, V12, P1556, DOI 10.1261/rna.106506; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; DELCERRO S, 1990, BRAIN RES, V530, P91; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; Derry MC, 2006, COLD SPRING HARB SYM, V71, P537, DOI 10.1101/sqb.2006.71.061; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vanderklish P, 1996, LEARN MEMORY, V3, P209, DOI 10.1101/lm.3.2-3.209; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yanagiya A, 2010, J CLIN INVEST, V120, P3389, DOI 10.1172/JCI43350; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1	58	52	52	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					298	311		10.1016/j.neuron.2013.02.025	http://dx.doi.org/10.1016/j.neuron.2013.02.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622065	Bronze, Green Published			2022-12-25	WOS:000318202200010
J	Mysore, SP; Knudsen, EI				Mysore, Shreesh P.; Knudsen, Eric I.			A shared inhibitory circuit for both exogenous and endogenous control of stimulus selection	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; TOP-DOWN CONTROL; WORKING-MEMORY; FLEXIBLE CATEGORIZATION; ATTENTIONAL MODULATION; SURROUND SUPPRESSION; NORMALIZATION MODEL; VISUAL-ATTENTION; MIDBRAIN NETWORK	The mechanisms by which the brain suppresses distracting stimuli to control the locus of attention are unknown. We found that focal, reversible inactivation of a single inhibitory circuit in the barn owl midbrain tegmentum, the nucleus isthmi pars magnocellularis (Imc), abolished both stimulus-driven (exogenous) and internally driven (endogenous) competitive interactions in the optic tectum (superior colliculus in mammals), which are vital to the selection of a target among distractors in behaving animals. Imc neurons transformed spatially precise multisensory and endogenous input into powerful inhibitory output that suppressed competing representations across the entire tectal space map. We identified a small, but highly potent, circuit that is employed by both exogenous and endogenous signals to exert competitive suppression in the midbrain selection network. Our findings reveal, to the best of our knowledge, for the first time, a neural mechanism for the construction of a priority map that is critical for the selection of the most important stimulus for gaze and attention.	[Mysore, Shreesh P.; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Mysore, SP (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	shreesh@stanford.edu		Mysore, Shreesh/0000-0002-7781-8252	US National Institutes of Health [9R01 EY019179]; NATIONAL EYE INSTITUTE [R01EY019179] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Knudsen for the immunohistochemistry. We are grateful to A. Asadollahi, A. Bryant, A. Goddard, J. Schwarz and N. Steinmetz for critically reading the manuscript. This work was supported by funding from the US National Institutes of Health (9R01 EY019179, E.I.K.).	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Bair W, 2003, J NEUROSCI, V23, P7690; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1993, VISUAL NEUROSCI, V10, P159, DOI 10.1017/S095252380000328X; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mysore SP, 2012, NEURON, V73, P193, DOI 10.1016/j.neuron.2011.10.037; Mysore SP, 2011, CURR OPIN NEUROBIOL, V21, P653, DOI 10.1016/j.conb.2011.05.024; Mysore SP, 2011, J NEUROSCI, V31, P7745, DOI 10.1523/JNEUROSCI.5425-10.2011; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Nummela SU, 2010, J NEUROPHYSIOL, V104, P1538, DOI 10.1152/jn.00406.2010; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; SCHALL JD, 1995, J NEUROSCI, V15, P6905; STANTON GB, 1988, J COMP NEUROL, V271, P493, DOI 10.1002/cne.902710403; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Winkowski DE, 2008, NEURON, V60, P698, DOI 10.1016/j.neuron.2008.09.013; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411; Witten IB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010396; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497	48	69	70	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					473	U143		10.1038/nn.3352	http://dx.doi.org/10.1038/nn.3352			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23475112	Green Accepted			2022-12-25	WOS:000316723700018
J	Herring, BE; Shi, Y; Suh, YH; Zheng, CY; Blankenship, SM; Roche, KW; Nicoll, RA				Herring, Bruce E.; Shi, Yun; Suh, Young Ho; Zheng, Chan-Ying; Blankenship, Sabine M.; Roche, Katherine W.; Nicoll, Roger A.			Cornichon Proteins Determine the Subunit Composition of Synaptic AMPA Receptors	NEURON			English	Article							GLUTAMATE RECEPTORS; TARPS; TRAFFICKING; EXPRESSION; PLASTICITY; NEURONS	Cornichon-2 and cornichon-3 (CNIH-2/-3) are AMPA receptor (AMPAR) binding proteins that promote receptor trafficking and markedly slow AMPAR deactivation in heterologous cells, but their role in neurons is unclear. Using CNIH-2 and CNIH-3 conditional knockout mice, we find a profound reduction of AMPAR synaptic transmission in the hippocampus. This deficit is due to the selective loss of surface GluA1-containing AMPARs (GluA1A2 heteromers), leaving a small residual pool of synaptic GluA2A3 heteromers. The kinetics of AMPARs in neurons lacking CNIH-2/-3 are faster than those in WT neurons due to the fast kinetics of GluA2A3 heteromers. The remarkably selective effect of CNIHs on the GluA1 subunit is probably mediated by TARP gamma-8, Which prevents a functional association of CNIHs with non-GluA1 subunits. These results point to a sophisticated interplay between CNIHs and gamma-8 that dictates subunit-specific AMPAR trafficking and the strength and kinetics of synaptic AMPAR-mediated transmission.	[Herring, Bruce E.; Shi, Yun; Blankenship, Sabine M.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Herring, Bruce E.; Shi, Yun; Blankenship, Sabine M.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Suh, Young Ho] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Dept Pharmacol, Suwon 443721, South Korea; [Zheng, Chan-Ying; Roche, Katherine W.] NINDS, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ajou University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Suh, YH (corresponding author), Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Dept Pharmacol, Suwon 443721, South Korea.	suhy@ajou.ac.kr; roger.nicoll@ucsf.edu	Shi, Yun S/T-8845-2018; Suh, Young Ho/AAJ-6405-2021; Roche, Katherine/W-9893-2019; Herring, Bruce/AAL-4218-2021; Shi, Yun/B-5623-2009	Suh, Young Ho/0000-0003-3979-1615; Shi, Yun/0000-0002-8842-9818; Roche, Katherine/0000-0001-7282-6539	US NIMH; NARSAD grant from the Brain and Behavior Research Fund; Intramural Research Program of NINDS; Basic Science Research Program [2011-0011694]; MRC through the National Research Foundation of Korea [2012048183]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957, R01MH080379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, ZIANS002994] Funding Source: NIH RePORTER	US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD grant from the Brain and Behavior Research Fund; Intramural Research Program of NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Basic Science Research Program; MRC through the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the US NIMH to R.A.N. and a NARSAD grant from the Brain and Behavior Research Fund to B.E.H. C.-Y.Z. and K.W.R. were supported by the Intramural Research Program of NINDS. Y.H.S. was supported by the Basic Science Research Program (2011-0011694) and MRC (2012048183) through the National Research Foundation of Korea.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; Diaz E, 2010, EUR J NEUROSCI, V32, P261, DOI 10.1111/j.1460-9568.2010.07357.x; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Gill MB, 2012, EUR J NEUROSCI, V35, P182, DOI 10.1111/j.1460-9568.2011.07948.x; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Harmel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030681; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	27	93	95	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2013	77	6					1083	1096		10.1016/j.neuron.2013.01.017	http://dx.doi.org/10.1016/j.neuron.2013.01.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522044	Green Accepted, Bronze			2022-12-25	WOS:000316645000010
J	Lomniczi, A; Loche, A; Castellano, JM; Ronnekleiv, OK; Bosch, M; Kaidar, G; Knoll, JG; Wright, H; Pfeifer, GP; Ojeda, SR				Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Bosch, Martha; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Pfeifer, Gerd P.; Ojeda, Sergio R.			Epigenetic control of female puberty	NATURE NEUROSCIENCE			English	Article							ARCUATE NUCLEUS; HORMONE NEURONS; HYPOGONADOTROPIC HYPOGONADISM; NEUROKININ B; LIFE-SPAN; CHROMATIN; KISSPEPTIN; COMPLEX; GENE; MECHANISMS	The timing of puberty is controlled by many genes. The elements coordinating this process have not, however, been identified. Here we show that an epigenetic mechanism of transcriptional repression times the initiation of female puberty in rats. We identify silencers of the Polycomb group (PcG) as principal contributors to this mechanism and show that PcG proteins repress Kiss1, a puberty-activating gene. Hypothalamic expression of two key PcG genes, Eed and Cbx7, decreased and methylation of their promoters increased before puberty. Inhibiting DNA methylation blocked both events and resulted in pubertal failure. The pubertal increase in Kiss1 expression was accompanied by EED loss from the Kiss1 promoter and enrichment of histone H3 modifications associated with gene activation. Preventing the eviction of EED from the Kiss1 promoter disrupted pulsatile gonadotropin-releasing hormone release, delayed puberty and compromised fecundity. Our results identify epigenetic silencing as a mechanism underlying the neuroendocrine control of female puberty.	[Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Ojeda, Sergio R.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Ronnekleiv, Oline K.; Bosch, Martha] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; City of Hope; Beckman Research Institute of City of Hope	Lomniczi, A (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA.	lomniczi@ohsu.edu; ojedas@ohsu.edu	Castellano, Juan Manuel/AAI-2052-2019	Castellano, Juan Manuel/0000-0003-3981-6683; Loche, Alberto/0000-0001-5974-6008; Lomniczi, Alejandro/0000-0003-4535-0103	US National Institute of Health (NIH) [HD025123-ARRA, 8P51OD011092]; US National Science Foundation [IOS1121691]; NIH [NS43330, DK68098]; European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007133] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M.E. Costa for technical assistance with the in situ hybridization procedures and the preparation of ovaries for morphological observation. This work was supported by US National Institute of Health (NIH; HD025123-ARRA and 8P51OD011092) and US National Science Foundation (IOS1121691) grants to S.R.O. and by NIH grants NS43330 and DK68098 to O.K.R., and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2010-IOF) to J.M.C.	Bedecarrats GY, 2007, SEMIN REPROD MED, V25, P368, DOI 10.1055/s-2007-984743; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; Christian CA, 2009, BIOL REPROD, V80, P1128, DOI 10.1095/biolreprod.108.075077; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Iremonger KJ, 2010, BRAIN RES, V1364, P35, DOI 10.1016/j.brainres.2010.08.071; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; Kurian JR, 2010, ENDOCRINOLOGY, V151, P5359, DOI 10.1210/en.2010-0555; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Neill JD, 1994, PHYSL REPRODUCTION, V1, P1621; NOWAK KW, 1995, LIFE SCI, V57, P833, DOI 10.1016/0024-3205(95)02015-B; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Ojeda SR, 2010, EUR J NEUROSCI, V32, P2003, DOI 10.1111/j.1460-9568.2010.07515.x; Ojeda SR, 2010, BRAIN RES, V1364, P164, DOI 10.1016/j.brainres.2010.09.039; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Plant TM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2177; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 2001, ENDOCRINOLOGY, V142, P2173, DOI 10.1210/en.142.6.2173; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Suter KJ, 2004, NEUROSCIENCE, V128, P443, DOI 10.1016/j.neuroscience.2004.06.044; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	50	182	188	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					281	289		10.1038/nn.3319	http://dx.doi.org/10.1038/nn.3319			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354331	Green Accepted			2022-12-25	WOS:000315474800010
J	Stanley, GB				Stanley, Garrett B.			Reading and writing the neural code	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; HIPPOCAMPAL PLACE CELLS; RETINAL GANGLION-CELLS; EARLY VISUAL-SYSTEM; PSYCHOPHYSICAL PERFORMANCE; NEURONAL POPULATION; THALAMIC SYNCHRONY; NATURAL SCENES; CORTEX; INFORMATION	It has been more than 20 years since Bialek and colleagues published a landmark paper asking a seemingly innocuous question: what can we extract about the outside world from the spiking activity of sensory neurons? Can we read the neural code? Although this seemingly simple question has helped us shed light on the neural code, we still do not understand the anatomical and neurophysiological constraints that enable these codes to propagate across synapses and form the basis for computations that we need to interact with our environment. The sensitivity of neuronal activity to the timing of synaptic inputs naturally suggests that synchrony determines the form of the neural code, and, in turn, regulation of synchrony is a critical element in 'writing' the neural code through the artificial control of microcircuits to activate downstream structures. In this way, reading and writing the neural code are inextricably linked.	[Stanley, Garrett B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Stanley, Garrett B.] Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706	US National Science Foundation [IIS-0904630, IOS-1131948]; US National Institutes of Health National Institute of Neurological Disorders and Stroke [2R01NS048285]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048285] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I would like to thank D.A. Butts, J.-M. Alonso, C. Schwarz and D.C. Millard for comments on the manuscript. G.B.S. was supported by US National Science Foundation Collaborative Research in Computational Neuroscience grants IIS-0904630 and IOS-1131948, and US National Institutes of Health National Institute of Neurological Disorders and Stroke grant 2R01NS048285.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bernstein JG, 2008, PROC SPIE, V6854, DOI 10.1117/12.768798; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brown EN, 1998, J NEUROSCI, V18, P7411; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; CREUTZFELDT OD, 1978, NATURWISSENSCHAFTEN, V65, P307, DOI 10.1007/BF00368371; Desbordes G, 2008, PLOS BIOL, V6, P2672, DOI 10.1371/journal.pbio.0060324; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Masquelier T, 2012, J COMPUT NEUROSCI, V32, P425, DOI 10.1007/s10827-011-0361-9; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Schneidman E, 2003, J NEUROSCI, V23, P11539; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Stoelzel CR, 2009, J NEUROSCI, V29, P6851, DOI 10.1523/JNEUROSCI.5983-08.2009; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wang Q, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026008; Wang Q, 2010, NAT NEUROSCI, V13, P1534, DOI 10.1038/nn.2670; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	63	65	0	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					259	263		10.1038/nn.3330	http://dx.doi.org/10.1038/nn.3330			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23434978				2022-12-25	WOS:000315474800005
J	Nahm, M; Lee, MJ; Parkinson, W; Lee, M; Kim, H; Kim, YJ; Kim, S; Cho, YS; Min, BM; Bae, YC; Broadie, K; Lee, S				Nahm, Minyeop; Lee, Min-Jung; Parkinson, William; Lee, Mihye; Kim, Haeran; Kim, Yoon-Jung; Kim, Sungdae; Cho, Yi Sul; Min, Byung-Moo; Bae, Yong Chul; Broadie, Kendal; Lee, Seungbok			Spartin Regulates Synaptic Growth and Neuronal Survival by Inhibiting BMP-Mediated Microtubule Stabilization	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; HEREDITARY SPASTIC PARAPLEGIA; MENTAL-RETARDATION PROTEIN; TROYER-SYNDROME; NEURODEGENERATIVE DISEASES; DENDRITIC GROWTH; II RECEPTOR; INTERACTS; ARCHITECTURE; FUTSCH	Troyer syndrome is a hereditary spastic paraplegia caused by human spartin (SPG20) gene mutations. We have generated a Drosophila disease model showing that Spartin functions presynaptically with endocytic adaptor Eps15 to regulate synaptic growth and function. Spartin inhibits bone morphogenetic protein (BMP) signaling by promoting endocytic degradation of BMP receptor wishful thinking (Wit). Drosophila fragile X mental retardation protein (dFMRP) and Futsch/MAP1B are downstream effectors of Spartin and BMP signaling in regulating microtubule stability and synaptic growth. Loss of Spartin or elevation of BMP signaling induces age-dependent progressive defects resembling hereditary spastic paraplegias, including motor dysfunction and brain neurodegeneration. Null spartin phenotypes are prevented by administration of the microtubule-destabilizing drug vinblastine. Together, these results demonstrate that Spartin regulates both synaptic development and neuronal survival by controlling microtubule stability via the BMP-dFMRP-Futsch pathway, suggesting that impaired regulation of microtubule stability is a core pathogenic component in Troyer syndrome.	[Nahm, Minyeop; Lee, Min-Jung; Lee, Mihye; Kim, Haeran; Kim, Yoon-Jung; Kim, Sungdae; Lee, Seungbok] Seoul Natl Univ, Dent Res Inst, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Min, Byung-Moo] Seoul Natl Univ, Dent Res Inst, Dept Oral Biochem, Seoul 110749, South Korea; [Parkinson, William; Broadie, Kendal] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Inst Brain, Dept Biol Sci, Nashville, TN 37232 USA; [Parkinson, William; Broadie, Kendal] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Inst Brain, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Cho, Yi Sul; Bae, Yong Chul] Kyungpook Natl Univ, Dept Oral Anat & Neurobiol, Taegu 700412, South Korea	Seoul National University (SNU); Seoul National University (SNU); Vanderbilt University; Vanderbilt University; Kyungpook National University	Lee, S (corresponding author), Seoul Natl Univ, Dent Res Inst, Dept Cell & Dev Biol, Seoul 110749, South Korea.	seunglee@snu.ac.kr	Min, Byung-Moo/F-2854-2012; Lee, Seungbok/AAS-1529-2021	Lee, Seungbok/0000-0002-6620-6269; Lee, Mihye/0000-0001-9689-6937; Kim, Sungdae/0000-0002-6617-7322	National Research Foundation of Korea [2011-0019228, 2010-0029398, 2009-0071481]; Brain Research Center of the 21st Century Frontier Research Program [2011K000281]; National Institutes of Health [R01 MH096832]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096832] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Adachi-Yamada, H. Bellen, M. Gonzalez-Gaitan, T. Tabata, K. Wharton, and the Bloomington Stock Center for reagents and fly stocks, and S. Choi and F. Yu for helpful discussion. This work was supported by grants from the National Research Foundation of Korea (grant numbers 2011-0019228, 2010-0029398, and 2009-0071481) and the Brain Research Center of the 21st Century Frontier Research Program (grant number 2011K000281) (to S.L.) and from the National Institutes of Health (R01 MH096832) (to K.B.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Coffee RL, 2010, DIS MODEL MECH, V3, P471, DOI 10.1242/dmm.004598; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; Falnikar A, 2009, RESULTS PROBL CELL D, V48, P47, DOI 10.1007/400_2009_2; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Gatto CL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.008.2009; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; JORDAN MA, 1992, J CELL SCI, V102, P401; Joshi DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019290; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Manzini MC, 2010, ANN NEUROL, V67, P516, DOI 10.1002/ana.21923; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Orso G, 2005, J CLIN INVEST, V115, P3026, DOI 10.1172/JCI24694; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	47	80	83	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					680	695		10.1016/j.neuron.2012.12.015	http://dx.doi.org/10.1016/j.neuron.2012.12.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439121	Bronze, Green Accepted			2022-12-25	WOS:000315561300011
J	Wang, S; Bates, J; Li, XJ; Schanz, S; Chandler-Militello, D; Levine, C; Maherali, N; Studer, L; Hochedlinger, K; Windrem, M; Goldman, SA				Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Maherali, Nimet; Studer, Lorenz; Hochedlinger, Konrad; Windrem, Martha; Goldman, Steven A.			Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital Hypomyelination	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; HUMAN ES; DIFFERENTIATION; DISEASE; LINEAGE; BRAIN; FETAL; IDENTIFICATION; REMYELINATE	Neonatal engraftment by oligodendrocyte progenitor cells (OPCs) permits the myelination of the congenitally dysmyelinated brain. To establish a potential autologous source of these cells, we developed a strategy by which to differentiate human induced pluripotent stem cells (hiPSCs) into OPCs. From three hiPSC lines, as well as from human embryonic stem cells (hESCs), we generated highly enriched OLIG2(+)/PDGFR alpha(+)/NKX2.2(+)/SOX10(+) human OPCs, which could be further purified using fluorescence-activated cell sorting. hiPSC OPCs efficiently differentiated into both myelinogenic oligodendrocytes and astrocytes, in vitro and in vivo. Neonatally engrafted hiPSC OPCs robustly myelinated the brains of myelin-deficient shiverer mice and substantially increased their survival. The speed and efficiency of myelination by hiPSC OPCs was higher than that previously observed using fetal-tissue-derived OPCs, and no tumors from these grafts were noted as long as 9 months after transplant. These results suggest the potential utility of hiPSC-derived OPCs in treating disorders of myelin loss.	[Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Windrem, Martha; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Wang, Su; Bates, Janna; Li, Xiaojie; Schanz, Steven; Chandler-Militello, Devin; Levine, Corri; Windrem, Martha; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Cambridge, MA 02138 USA; [Maherali, Nimet; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu	Levine, Corri/AAI-6980-2020; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Levine, Corri/0000-0003-0405-5191; Goldman, Steven/0000-0002-5498-4303	New York State Stem Cell Science (NYSTEM); National Multiple Sclerosis Society; NIH [R01NS75345, R01NS39559]; G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039559, R01NS075345] Funding Source: NIH RePORTER	New York State Stem Cell Science (NYSTEM); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by New York State Stem Cell Science (NYSTEM); the National Multiple Sclerosis Society; NIH grants R01NS75345 and R01NS39559; the G. Harold and Leila Y. Mathers Charitable Foundation; and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. We thank Karen Bentley and Gayle Schneider for their assistance in electron microscopy.	Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Qi YC, 2001, DEVELOPMENT, V128, P2723; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	29	383	405	0	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					252	264		10.1016/j.stem.2012.12.002	http://dx.doi.org/10.1016/j.stem.2012.12.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395447	Green Accepted, Bronze			2022-12-25	WOS:000329569300015
J	Pecot, MY; Tadros, W; Nern, A; Bader, M; Chen, Y; Zipursky, SL				Pecot, Matthew Y.; Tadros, Wael; Nern, Aljoscha; Bader, Maya; Chen, Yi; Zipursky, S. Lawrence			Multiple Interactions Control Synaptic Layer Specificity in the Drosophila Visual System	NEURON			English	Article							TARGETED GENE-EXPRESSION; N-CADHERIN; AXON GUIDANCE; PHOTORECEPTOR AXONS; RECEPTOR; MELANOGASTER; VERSATILE; CNS; TRANSMEMBRANE; MOLECULES	How neurons form synapses within specific layers remains poorly understood. In the Drosophila medulla, neurons target to discrete layers in a precise fashion. Here we demonstrate that the targeting of L3 neurons to a specific layer occurs in two steps. Initially, L3 growth cones project to a common domain in the outer medulla, overlapping with the growth cones of other neurons destined for a different layer through the redundant functions of N-Cadherin (CadN) and Semaphorin-1 a (Sema-1a). CadN mediates adhesion within the domain and Sema-1a mediates repulsion through Plexin A (PlexA) expressed in an adjacent region. Subsequently, L3 growth cones segregate from the domain into their target layer in part through Sema-1a/PlexA-dependent remodeling. Together, our results and recent studies argue that the early medulla is organized into common domains, comprising processes bound for different layers, and that discrete layers later emerge through successive interactions between processes within domains and developing layers.	[Pecot, Matthew Y.; Tadros, Wael; Bader, Maya; Chen, Yi; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nern, Aljoscha] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu		Zipursky, Stephen/0000-0001-5630-7181; Tadros, Wael/0000-0001-8703-2803	Jane Coffin Childs Medical Memorial Research Fund; Human Frontiers Science Program; Howard Hughes Medical Institute	Jane Coffin Childs Medical Memorial Research Fund; Human Frontiers Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Alex Kolodkin and Zhuhao Wu for providing Sema-1a and Plexin A antibodies and a PlexA BAC, Liqun Luo for flies used in genetic mosaic analyses involving sema-1a and plexA RNAi experiments, Yong Rao for flies used in sema-1a rescue experiments, and Koen Venken for providing reagents for the tagging of endogenous Sema-1a and CadN. For critical reading of the manuscript, we would also like to thank Alex Kolodkin, Kelsey Martin, Sean Millard, Alvaro Sagasti, Kota Saito, and members of the S.L.Z. laboratory. This work was supported by the Jane Coffin Childs Medical Memorial Research Fund, the Human Frontiers Science Program, and the Howard Hughes Medical Institute.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	34	45	45	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 23	2013	77	2					299	310		10.1016/j.neuron.2012.11.007	http://dx.doi.org/10.1016/j.neuron.2012.11.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352166	Bronze, Green Accepted			2022-12-25	WOS:000314199400012
J	Denholtz, M; Bonora, G; Chronis, C; Splinter, E; de Laat, W; Ernst, J; Pellegrini, M; Plath, K				Denholtz, Matthew; Bonora, Giancarlo; Chronis, Constantinos; Splinter, Erik; de Laat, Wouter; Ernst, Jason; Pellegrini, Matteo; Plath, Kathrin			Long-Range Chromatin Contacts in Embryonic Stem Cells Reveal a Role for Pluripotency Factors and Polycomb Proteins in Genome Organization	CELL STEM CELL			English	Article							GENE-EXPRESSION; NANOG LOCUS; DOMAINS; INACTIVATION; ARCHITECTURE; PRINCIPLES; LANDSCAPE; MEDIATOR	The relationship between 3D organization of the genome and gene-regulatory networks is poorly understood. Here, we examined long-range chromatin interactions genome-wide in mouse embryonic stem cells (ESCs), iPSCs, and fibroblasts and uncovered a pluripotency-specific genome organization that is gradually reestablished during reprogramming. Our data confirm that long-range chromatin interactions are primarily associated with the spatial segregation of open and closed chromatin, defining overall chromosome conformation. Additionally, we identified two further levels of genome organization in ESCs characterized by colocalization of regions with high pluripotency factor occupancy and strong enrichment for Polycomb proteins/H3K27me3, respectively. Underlining the independence of these networks and their functional relevance for genome organization, loss of the Polycomb protein Eed diminishes interactions between Polycomb-regulated regions without altering overarching chromosome conformation. Together, our data highlight a pluripotency-specific genome organization in which pluripotency factors such as Nanog and H3K27me3 occupy distinct nuclear spaces and reveal a role for cell-type-specific gene-regulatory networks in genome organization.	[Denholtz, Matthew; Bonora, Giancarlo; Chronis, Constantinos; Ernst, Jason; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Splinter, Erik; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; de Laat, Wouter] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Pellegrini, M (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; kplath@mednet.ucla.edu		Plath, Kathrin/0000-0001-7796-3372; Pellegrini, Matteo/0000-0001-9355-9564; de Laat, Wouter/0000-0002-6393-595X; chronis, Constantinos/0000-0002-7783-8202	UCLA Broad Center of Regenerative Medicine and Stem Cell Research; NIH [DP2OD001686, P01GM099134]; CIRM [RN1-00564]; NSF [HYS-1066293]; Whitcome Pre-doctoral Training Program; UCLA Graduate Division; CIRM; Leukemia and Lymphoma Research [10040]; UCLA David Geffen School of Medicine; ERC [209700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, P01GM081621] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	UCLA Broad Center of Regenerative Medicine and Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Whitcome Pre-doctoral Training Program; UCLA Graduate Division; CIRM(California Institute for Regenerative Medicine); Leukemia and Lymphoma Research; UCLA David Geffen School of Medicine; ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Shawn Cokus for advice, Sanjeet Patel for RNA-seq data analysis, and Terry Magnuson for Eed<SUP>-/-</SUP> ESCs. K.P. is supported by the UCLA Broad Center of Regenerative Medicine and Stem Cell Research, NIH (DP2OD001686; P01GM099134), and CIRM (RN1-00564); M.P., by NIH (P01GM099134), NSF (HYS-1066293), and the hospitality of the Aspen Center for Physics; G.B., by the Whitcome Pre-doctoral Training Program; M.D., by fellowships from the UCLA Broad Center of Regenerative Medicine and Stem Cell Research, the UCLA Graduate Division, and CIRM; C.C., by a Leukemia and Lymphoma Research Fellowship 10040; J.E., by funds from the UCLA David Geffen School of Medicine; and W.d.L., by an ERC Starting Grant (209700). M.D. and G.B. designed research, performed experiments, analyzed data, and wrote the paper; C.C. performed experiments; E.S. and W.d.L. trained M.D. in 4C-seq library preparation in 2008; J.E. provided analytic tools; M.P. offered supervision and data analysis; and K.P. designed research, analyzed data, wrote the paper, and supervised the overall project.	Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denholtz M, 2012, CURR OPIN CELL BIOL, V24, P793, DOI 10.1016/j.ceb.2012.11.001; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Hakim O, 2013, GENOME RES, V23, P462, DOI 10.1101/gr.147652.112; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	40	196	197	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					602	616		10.1016/j.stem.2013.08.013	http://dx.doi.org/10.1016/j.stem.2013.08.013			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24035354	Green Accepted, Bronze			2022-12-25	WOS:000329571500012
J	Goldmann, T; Wieghofer, P; Muller, PF; Wolf, Y; Varol, D; Yona, S; Brendecke, SM; Kierdorf, K; Staszewski, O; Datta, M; Luedde, T; Heikenwalder, M; Jung, S; Prinz, M				Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Wolf, Yochai; Varol, Diana; Yona, Simon; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Luedde, Tom; Heikenwalder, Mathias; Jung, Steffen; Prinz, Marco			A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; ANTIGEN-PRESENTING CELLS; FRACTALKINE RECEPTOR; MYELOID CELLS; T-CELLS; ACTIVATION; MACROPHAGES; MONOCYTES; ENCEPHALOMYELITIS	Microglia are brain macrophages and, as such, key immune-competent cells that can respond to environmental changes. Understanding the mechanisms of microglia-specific responses during pathologies is hence vital for reducing disease burden. The definition of microglial functions has so far been hampered by the lack of genetic in vivo approaches that allow discrimination of microglia from closely related peripheral macrophage populations in the body. Here we introduce a mouse experimental system that specifically targets microglia to examine the role of a mitogen-associated protein kinase kinase kinase (MAP3K), transforming growth factor (TGF)-beta-activated kinase 1 (TAK1), during autoimmune inflammation. Conditional depletion of TAK1 in microglia only, not in neuroectodermal cells, suppressed disease, significantly reduced CNS inflammation and diminished axonal and myelin damage by cell-autonomous inhibition of the NE-kappa B, JNK and ERK1/2 pathways. Thus, we found TAK1 to be pivotal in CNS autoimmunity, and we present a tool for future investigations of microglial function in the CNS.	[Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Wolf, Yochai; Varol, Diana; Yona, Simon; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Luedde, Tom] Univ Hosp Rhein Westfal TH Aachen, Dept Internal Med 3, Aachen, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; Weizmann Institute of Science; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	s.jung@weizmann.ac.il; marco.prinz@uniklinik-freiburg.de	Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012; Heikenwalder, Mathias/AAA-2269-2020; Luedde, Tom/AAE-9135-2022; Wieghofer, Peter/AAV-9572-2020; Kierdorf, Katrin/AAO-6288-2021; Datta, Moumita/AAU-8006-2021	Jung, Steffen/0000-0003-4290-5716; Luedde, Tom/0000-0002-6288-8821; Yona, Simon/0000-0002-3984-2008; Staszewski, Ori/0000-0002-0579-6701; Pohlmann, Philippe-Fabian/0000-0001-8578-7452; Wolf, Yochai/0000-0003-0270-2025; Goldmann, Tobias/0000-0001-9754-9144; Kierdorf, Katrin/0000-0002-9272-4780	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB 992, FOR1336, PR 577/8-1]; Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec; Helmholtz Foundation; European Research Council; Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation;  [SFB620];  [SFB-TR36]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec(Biogen); Helmholtz Foundation(Helmholtz Association); European Research Council(European Research Council (ERC)European Commission); Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation(Israel Science Foundation); ; 	We thank M. Oberle, C. Fix and S. Gaupp for excellent technical assistance. Special thanks to M. Olschewski for help with the thorough statistical analysis of our data. M.P. was supported by the Bundesministerium fur Bildung und Forschung-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (KNDD), the Deutsche Forschungsgemeinschaft (SFB 992, FOR1336, PR 577/8-1), the Fritz-Thyssen Foundation, the Gemeinnutzige Hertie Foundation (GHST) and Biogen Idec. P.F.M. was supported by an MD educational grant of the SFB620. M.H. was funded by the Helmholtz Foundation, the SFB-TR36, a European Research Council starting grant and the Helmholtz Alliance Preclinical Comprehensive Cancer Center. S.J. was supported by the Deutsche Forschungsgemeinschaft (FOR1336) and by the Israel Science Foundation.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; FORD AL, 1995, J IMMUNOL, V154, P4309; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pfrieger FW, 2012, GLIA, V60, P681, DOI 10.1002/glia.22283; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Rajasekaran K, 2011, J BIOL CHEM, V286, P31213, DOI 10.1074/jbc.M111.261917; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Siao CJ, 2003, J NEUROSCI, V23, P3234; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zehntner SP, 2003, FASEB J, V17, P1910, DOI 10.1096/fj.03-0199fje	47	440	444	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1618	1626		10.1038/nn.3531	http://dx.doi.org/10.1038/nn.3531			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077561				2022-12-25	WOS:000326205700019
J	Guo, GJ; Luc, S; Marco, E; Lin, TW; Peng, C; Kerenyi, MA; Beyaz, S; Kim, W; Xu, J; Das, PP; Neff, T; Zou, KY; Yuan, GC; Orkin, SH				Guo, Guoji; Luc, Sidinh; Marco, Eugenio; Lin, Ta-Wei; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Neff, Tobias; Zou, Keyong; Yuan, Guo-Cheng; Orkin, Stuart H.			Mapping Cellular Hierarchy by Single-Cell Analysis of the Cell Surface Repertoire	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION ANALYSIS; ACUTE MYELOID-LEUKEMIA; MOUSE BONE-MARROW; MESSENGER-RNA-SEQ; TRANSCRIPTION FACTOR; PROGENITOR CELLS; IDENTIFICATION; GATA-1; LINEAGES	Stem cell differentiation pathways are most often studied at the population level, whereas critical decisions are executed at the level of single cells. We have established a highly multiplexed, quantitative PCR assay to profile in an unbiased manner a panel of all commonly used cell surface markers (280 genes) from individual cells. With this method, we analyzed over 1,500 single cells throughout the mouse hematopoietic system and illustrate its utility for revealing important biological insights. The comprehensive single cell data set permits mapping of the mouse hematopoietic stem cell differentiation hierarchy by computational lineage progression analysis. Further profiling of 180 intracellular regulators enabled construction of a genetic network to assign the earliest differentiation event during hematopoietic lineage specification. Analysis of acute myeloid leukemia elicited by MLL-AF9 uncovered a distinct cellular hierarchy containing two independent self-renewing lineages with different clonal activities. The strategy has broad applicability in other cellular systems.	[Guo, Guoji; Luc, Sidinh; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Guo, Guoji; Luc, Sidinh; Peng, Cong; Kerenyi, Marc A.; Beyaz, Semir; Kim, Woojin; Xu, Jian; Das, Partha Pratim; Orkin, Stuart H.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Lin, Ta-Wei] Childrens Hosp, Mol Genet Core Facil, Boston, MA 02115 USA; [Neff, Tobias] Univ Colorado, Pediat Hematol Oncol BMT, Aurora, CO 80045 USA; [Zou, Keyong] Boston Open Labs, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Marco, Eugenio/F-4583-2011	Guo, Guoji/0000-0002-1716-4621; Luc, Sidinh/0000-0001-7006-6169; Neff, Tobias/0000-0002-0188-8393; Marco, Eugenio/0000-0002-3675-263X; Beyaz, Semir/0000-0003-4730-4012; Das, Partha Pratim/0000-0003-3544-2629	National Institutes of Health; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [K08CA154777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K01DK093543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Skaletsky from Whitehead Institute for extensive help on the multiplexed primer design; Y. Fujiwara, E. Baena, O. Yilmaz, M. Nguyen, X. Han, V. Bragt, D. Linn, and J. Buchman for help with different parts of the sample preparations; and H. Huang, Z. Li, D. Scadden, H. Xie, and H. Hock for insightful discussions on the project. This work was supported by funding from the National Institutes of Health and the Harvard Stem Cell Institute (S. H. O). S. H. O. is an investigator of the Howard Hughes Medical Institute.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cavalli G, 2012, SCIENCE, V338, P1430, DOI 10.1126/science.1232332; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai L, 1998, J IMMUNOL, V160, P3861; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016	41	173	175	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					492	505		10.1016/j.stem.2013.07.017	http://dx.doi.org/10.1016/j.stem.2013.07.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24035353	Green Accepted, Bronze			2022-12-25	WOS:000329571100017
J	Lee, S; Song, B; Kim, J; Park, K; Hong, I; An, B; Song, S; Lee, J; Park, S; Kim, J; Park, D; Lee, CJ; Kim, K; Shin, KS; Tsien, RW; Choi, S				Lee, Sukwon; Song, Beomjong; Kim, Jeongyeon; Park, Kyungjoon; Hong, Ingie; An, Bobae; Song, Sangho; Lee, Jiwon; Park, Sungmo; Kim, Jihye; Park, Dongeun; Lee, C. Justin; Kim, Kyungjin; Shin, Ki Soon; Tsien, Richard W.; Choi, Sukwoo			GluA1 phosphorylation at serine 831 in the lateral amygdala is required for fear renewal	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT NEURONAL-ACTIVITY; AMPA RECEPTOR ENDOCYTOSIS; SYNAPTIC PLASTICITY; CONDITIONED FEAR; GLUTAMATE RECEPTORS; CHANNEL CONDUCTANCE; KINASE-II; EXTINCTION; MEMORY	Fear renewal, a widely pursued model of post-traumatic stress disorder and phobias, refers to the context-specific relapse of conditioned fear after extinction. However, its molecular mechanisms are largely unknown. We found that renewal-inducing stimuli, generally believed to be insufficient to induce synaptic plasticity, enhanced excitatory synaptic strength, activity of synaptic GluA2-lacking AMPA receptors and Ser831 phosphorylation of synaptic surface GluA1 in the lateral nucleus of the amygdala (LAn) of fear-extinguished rats. Consistently, the induction threshold for LAn synaptic potentiation was considerably lowered after extinction, and renewal occluded this low-threshold potentiation. The low-threshold potentiation (a potential cellular substrate for renewal), but not long-term potentiation, was attenuated by dialysis into LAn neurons of a GluA1-derived peptide that competes with Ser831-phosphorylated GluA1. Microinjections of the same peptide into the LAn attenuated fear renewal, but not fear learning. Our findings suggest that GluA1 phosphorylation constitutes a promising target for clinical treatment of aberrant fear-related disorders.	[Lee, Sukwon; Song, Beomjong; Hong, Ingie; An, Bobae; Song, Sangho; Lee, Jiwon; Park, Sungmo; Kim, Jihye; Park, Dongeun; Kim, Kyungjin; Choi, Sukwoo] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jeongyeon; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Kim, Jeongyeon; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Park, Kyungjoon; Shin, Ki Soon] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Park, Kyungjoon; Shin, Ki Soon] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Tsien, Richard W.] NYU, Langone Med Ctr, Inst Neurosci, Dept Physiol & Neurosci, New York, NY USA	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Kyung Hee University; Kyung Hee University; New York University; NYU Langone Medical Center	Choi, S (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	kyungjin@snu.ac.kr; kisoon_shin@khu.ac.kr; sukwoo12@snu.ac.kr	Park, Kyungjoon/AAL-8086-2020; Lee, C. Justin/AAC-1663-2019; Shin, Ki Soon/AAK-1939-2020; Lee, Sukwon/I-7375-2013	Park, Kyungjoon/0000-0002-7518-636X; Shin, Ki Soon/0000-0002-5701-3596; Lee, Sukwon/0000-0001-7654-5769; Hong, Ingie/0000-0002-7246-9233; Song, Beomjong/0000-0001-8820-7310; Lee, C Justin/0000-0002-3555-0980; Park, Sung Mo/0000-0001-8352-3533	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0018209, 2011-0019226]; Original Technology Research Program for Brain Science through the National Research Foundation of Korea; Korean World Class Institute program; Brain Korea 21 Research Fellowships from the Korean Ministry of Education	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Original Technology Research Program for Brain Science through the National Research Foundation of Korea(National Research Foundation of Korea); Korean World Class Institute program; Brain Korea 21 Research Fellowships from the Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This paper is dedicated in loving memory to Sang-Soon Choi. We thank P. Sah for his valuable comments on our manuscript. This work was supported by a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (No. 2011-0018209, S.C.), by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (No. 2011-0019226, S.C.) and by the Korean World Class Institute program (C.J.L.). B.S., Jeongyeon Kim, K.P., I.H., B.A., S.S., J.L., S.P. and Jihye Kim were supported by Brain Korea 21 Research Fellowships from the Korean Ministry of Education.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; BOUTON ME, 1988, BEHAV RES THER, V26, P137, DOI 10.1016/0005-7967(88)90113-1; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Crombag HS, 2008, BEHAV BRAIN RES, V191, P178, DOI 10.1016/j.bbr.2008.03.026; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2007, BIOCHEM BIOPH RES CO, V355, P188, DOI 10.1016/j.bbrc.2007.01.125; Kim J, 2010, J NEUROSCI, V30, P9631, DOI 10.1523/JNEUROSCI.0940-10.2010; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mao SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059580; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; RACHMAN S, 1989, CLIN PSYCHOL REV, V9, P147, DOI 10.1016/0272-7358(89)90025-1; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Selvakumar B, 2013, P NATL ACAD SCI USA, V110, P1077, DOI 10.1073/pnas.1221295110; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Woods AM, 2006, BEHAV NEUROSCI, V120, P1159, DOI 10.1037/0735-7044.120.5.1159	54	35	36	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1436	+		10.1038/nn.3491	http://dx.doi.org/10.1038/nn.3491			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974710				2022-12-25	WOS:000324795300016
J	Leinwand, SG; Chalasani, SH				Leinwand, Sarah G.; Chalasani, Sreekanth H.			Neuropeptide signaling remodels chemosensory circuit composition in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; LIFE-SPAN; INSULIN; CHEMOTAXIS; GENE; MODULATION; BEHAVIOR; CELL; IDENTIFICATION; INHIBITION	Neural circuits detect environmental changes and drive behavior. The routes of information flow through dense neural networks are dynamic, but the mechanisms underlying this circuit flexibility are poorly understood. Here, we define a sensory context-dependent and neuropeptide-regulated switch in the composition of a C. elegans salt sensory circuit. The primary salt detectors, ASE sensory neurons, used BLI-4 endoprotease-dependent cleavage to release the insulin-like peptide INS-6 in response to large, but not small, changes in external salt stimuli. Insulins, signaling through the insulin receptor DAF-2, functionally switched the AWC olfactory sensory neuron into an interneuron in the salt circuit. Worms with disrupted insulin signaling had deficits in salt attraction, suggesting that peptidergic signaling potentiates responses to high salt stimuli, which may promote ion homeostasis. Our results indicate that sensory context and neuropeptide signaling modify neural networks and suggest general mechanisms for generating flexible behavioral outputs by modulating neural circuit composition.	[Leinwand, Sarah G.; Chalasani, Sreekanth H.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Leinwand, Sarah G.; Chalasani, Sreekanth H.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Chalasani, SH (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	schalasani@salk.edu		Leinwand, Sarah/0000-0001-5328-0462	Searle Scholars Program; March of Dimes; Whitehall Foundation; Rita Allen Foundation; US National Institutes of Health [R01MH096881-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061847] Funding Source: NIH RePORTER	Searle Scholars Program; March of Dimes(March of Dimes); Whitehall Foundation; Rita Allen Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center, the National Brain Research Project (Japan), C. Bargmann, P. Sengupta, P. Sternberg and A. Zaslaver for worm strains, M. Ailion for unc-31 cDNA, and Y. Jin, C. Stevens, T. Sejnowski, E.J. Chichilnisky and H. Karten for helpful discussions. We also acknowledge J. Fitzpatrick and J. Kasuboski of the Waitt Advanced Biophotonics Center for providing the resources and training to perform confocal imaging and J. Simon for help with the illustrations. We are grateful to A. Tong, C. Yang and other members of the Chalasani laboratory for critical help, advice and insights. This work was funded by grants from The Searle Scholars Program, March of Dimes, Whitehall Foundation, Rita Allen Foundation and US National Institutes of Health grant R01MH096881-01A1 (S.H.C.). S.G.L. holds a graduate research fellowship from the NSF.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Collet J, 1998, GENETICS, V148, P187; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; DORMAN JB, 1995, GENETICS, V141, P1399; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; HOOPER SL, 1989, SCIENCE, V244, P1587, DOI 10.1126/science.2740903; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hung WL, 2013, EMBO J, V32, P1745, DOI 10.1038/emboj.2013.91; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; THACKER C, 1995, GENE DEV, V9, P956, DOI 10.1101/gad.9.8.956; Thiele TR, 2009, J NEUROSCI, V29, P11904, DOI 10.1523/JNEUROSCI.0594-09.2009; Tissenbaum HA, 2012, J GERONTOL A-BIOL, V67, P503, DOI 10.1093/gerona/gls088; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia XB, 2004, VISUAL NEUROSCI, V21, P791, DOI 10.1017/S0952523804215127	53	59	64	0	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1461	+		10.1038/nn.3511	http://dx.doi.org/10.1038/nn.3511			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013594	Green Accepted			2022-12-25	WOS:000324795300019
J	Zhang, YV; Raghuwanshi, RP; Shen, WL; Montell, C				Zhang, Yali V.; Raghuwanshi, Rakesh P.; Shen, Wei L.; Montell, Craig			Food experience-induced taste desensitization modulated by the Drosophila TRPL channel	NATURE NEUROSCIENCE			English	Article							RECEPTOR POTENTIAL CHANNEL; ANGELMAN-SYNDROME; GUSTATORY SYSTEM; BINDING PROTEIN; BITTER TASTE; IN-VIVO; GENE; PLASTICITY; PHOTOTRANSDUCTION; ADAPTATION	Animals tend to reject bitter foods. However, long-term exposure to some unpalatable tastants increases acceptance of these foods. Here we show that dietary exposure to an unappealing but safe additive, camphor, caused the fruit fly Drosophila melanogaster to decrease camphor rejection. The transient receptor potential-like (TRPL) cation channel was a direct target for camphor in gustatory receptor neurons, and long-term feeding on a camphor diet led to reversible downregulation of TRPL protein concentrations. The turnover of TRPL was controlled by an E3 ubiquitin ligase, Ube3a. The decline in TRPL levels and increased acceptance of camphor reversed after returning the flies to a camphor-free diet long term. We propose that dynamic regulation of taste receptors by ubiquitin-mediated protein degradation comprises an important molecular mechanism that allows an animal to alter its taste behavior in response to a changing food environment.	[Zhang, Yali V.; Raghuwanshi, Rakesh P.; Shen, Wei L.; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	Johns Hopkins University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021; Raghuwanshi, Rakesh/AAS-3918-2020	Montell, Craig/0000-0001-5637-1482; Zhang, Yali/0000-0003-4083-4352	US National Institute on Deafness and Other Communication Disorders [DC007864]; US National Eye Institute [EY010852]; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Fischer (University of Texas at Austin), K. Scott (University of California, Berkeley) and the Bloomington Stock Center for providing fly stocks, FlyBase for genomic information and B. Minke (Hebrew University, Jerusalem) for the pMT-trpl-eGFP construct. This work was supported by grants to C.M. from the US National Institute on Deafness and Other Communication Disorders (DC007864) and the US National Eye Institute (EY010852).	Ackroff K, 2012, PHYSIOL BEHAV, V107, P207, DOI 10.1016/j.physbeh.2012.06.022; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cooke L, 2007, J HUM NUTR DIET, V20, P294, DOI 10.1111/j.1365-277X.2007.00804.x; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; del Campo ML, 2009, INSECT TASTE, P205; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Elkobi A, 2008, NAT NEUROSCI, V11, P1149, DOI 10.1038/nn.2190; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Galindo MM, 2012, PROG MOL BIOL TRANSL, V108, P383, DOI 10.1016/B978-0-12-398397-8.00015-0; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 2001, J EXP BIOL, V204, P3355; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Mennella JA, 2012, ANN NUTR METAB, V60, P40, DOI 10.1159/000335337; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shuler MG, 2004, J COMP NEUROL, V472, P183, DOI 10.1002/cne.11017; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	57	53	55	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1468	+		10.1038/nn.3513	http://dx.doi.org/10.1038/nn.3513			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013593	Green Accepted, Green Submitted			2022-12-25	WOS:000324795300020
J	Schepers, K; Pietras, EM; Reynaud, D; Flach, J; Binnewies, M; Garg, T; Wagers, AJ; Hsiao, EC; Passegue, E				Schepers, Koen; Pietras, Eric M.; Reynaud, Damien; Flach, Johanna; Binnewies, Mikhail; Garg, Trit; Wagers, Amy J.; Hsiao, Edward C.; Passegue, Emmanuelle			Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; OSTEOBLASTIC CELLS; PRIMARY MYELOFIBROSIS; IN-VIVO; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION; MAINTENANCE	Multipotent stromal cells (MSCs) and their osteoblastic lineage cell (OBC) derivatives are part of the bone marrow (BM) niche and contribute to hematopoietic stem cell (HSC) maintenance. Here, we show that myeloproliferative neoplasia (MPN) progressively remodels the endosteal BM niche into a self-reinforcing leukemic niche that impairs normal hematopoiesis, favors leukemic stem cell (LSC) function, and contributes to BM fibrosis. We show that leukemic myeloid cells stimulate MSCs to overproduce functionally altered OBCs, which accumulate in the BM cavity as inflammatory myelofibrotic cells. We identify roles for thrombopoietin, CCL3, and direct cell-cell interactions in driving OBC expansion, and for changes in TGF-beta, Notch, and inflammatory signaling in OBC remodeling. MPN-expanded OBCs, in turn, exhibit decreased expression of many HSC retention factors and severely compromised ability to maintain normal HSCs, but effectively support LSCs. Targeting this pathological interplay could represent a novel avenue for treatment of MPN-affected patients and prevention of myelofibrosis.	[Schepers, Koen; Pietras, Eric M.; Reynaud, Damien; Flach, Johanna; Binnewies, Mikhail; Garg, Trit; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, San Francisco, CA 94143 USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Inst Human Genet, Div Endocrinol & Metab, San Francisco, CA 94143 USA; [Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Howard Hughes Medical Institute; Harvard University	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Div Hematol Oncol, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu	Schepers, Koen/H-7108-2013	Schepers, Koen/0000-0003-2442-242X; Reynaud, Damien/0000-0001-8765-8419; Passegue, Emmanuelle/0000-0002-3516-297X	NWO Rubicon fellowship; KWF fellowship; NIH [F32 HL106989, U01 HL100402, K08 AR056299, R01 HL092471]; CIRM New Faculty Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL092471, F32HL106989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER	NWO Rubicon fellowship(Netherlands Organization for Scientific Research (NWO)); KWF fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Paul Frenette (Einstein College of Medicine) for Nes-gfp mice, Dr. Takashi Nagasawa (Kyoto University) for Cxcl12-gfp mice, Dr. Zena Werb (UCSF) for Osx-gfp mice, the UCSF Mouse Pathology and Genomics core facilities, the San Francisco VA Histomorphometry Core, Michael Kissner for management of our Flow Cytometry Core facility, Daniel Carlin for help with the microarray analyses, Zhiqiang Cheng for help with TRAP staining, Stephanie Leong for help with the mouse colonies, and all members of the Passegue laboratory for critical insights and suggestions. This work was supported by NWO Rubicon and KWF fellowships to K.S., NIH F32 HL106989 to E.M.P., NIH U01 HL100402 to A.J.W., NIH K08 AR056299 to E.C.H., and a CIRM New Faculty Award and NIH R01 HL092471 to E.P.	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chitteti BR, 2010, J CELL BIOCHEM, V111, P284, DOI 10.1002/jcb.22694; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Okamoto H, 2008, FEBS J, V275, P4463, DOI 10.1111/j.1742-4658.2008.06582.x; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Thiele J, 2006, HISTOL HISTOPATHOL, V21, P1367, DOI 10.14670/HH-21.1367; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Varricchio L, 2009, EXPERT REV HEMATOL, V2, P315, DOI 10.1586/EHM.09.17; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	40	411	420	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					285	299		10.1016/j.stem.2013.06.009	http://dx.doi.org/10.1016/j.stem.2013.06.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850243	Green Accepted, Bronze			2022-12-25	WOS:000329570800007
J	Yu, B; He, ZY; You, P; Han, QW; Xiang, D; Chen, F; Wang, MJ; Liu, CC; Lin, XW; Borjigin, U; Zi, XY; Li, JX; Zhu, HY; Li, WL; Han, CS; Wangensteen, KJ; Shi, YF; Hui, LJ; Wang, X; Hu, YP				Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Lin, Xi-Wen; Borjigin, Uyunbilig; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Han, Chun-Sheng; Wangensteen, Kirk J.; Shi, Yufang; Hui, Li-Jian; Wang, Xin; Hu, Yi-Ping			Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors	CELL STEM CELL			English	Article							LIVER PROGENITOR CELLS; DIRECT CONVERSION; MOUSE FIBROBLASTS; CARDIOMYOCYTES; REGENERATION; REPOPULATION; DYSFUNCTION; GENERATION; NEURONS; ALPHA	Recent studies have demonstrated direct reprogramming of fibroblasts into a range of somatic cell types, but to date stem or progenitor cells have only been reprogrammed for the blood and neuronal lineages. We previously reported generation of induced hepatocyte-like (iHep) cells by transduction of Gata4, Hnf1 alpha, and Foxa3 in p19 Arf null mouse embryonic fibroblasts (MEFs). Here, we show that Hnf1 beta and Foxa3, liver organogenesis transcription factors, are sufficient to reprogram MEFs into induced hepatic stem cells (iHepSCs). iHepSCs can be stably expanded in vitro and possess the potential of bidirectional differentiation into both hepatocytic and cholangiocytic lineages. In the injured liver of fumarylacetoacetate hydrolase (Fah)-deficient mice, repopulating iHepSCs become hepatocyte-like cells. They also engraft as cholangiocytes into bile ducts of mice with DDC-induced bile ductular injury. Lineage conversion into bipotential expandable iHepSCs provides a strategy to enable efficient derivation of both hepatocytes and cholangiocytes for use in disease modeling and tissue engineering.	[Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Yu, Bing; He, Zhi-Ying; You, Pu; Han, Qing-Wang; Xiang, Dao; Chen, Fei; Wang, Min-Jun; Liu, Chang-Cheng; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhu, Hai-Ying; Li, Wen-Lin; Hu, Yi-Ping] Second Mil Med Univ, Grad Sch, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China; [Lin, Xi-Wen; Han, Chun-Sheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Borjigin, Uyunbilig; Wang, Xin] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China; [Wangensteen, Kirk J.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Shi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China; [Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ 08901 USA; [Hui, Li-Jian; Wang, Xin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Lab Mol Cell Biol, Shanghai 200031, Peoples R China; [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Inner Mongolia University; University of Pennsylvania; Chinese Academy of Sciences; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities	Wang, X (corresponding author), Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China.	wangxin_cn@imu.edu.cn; yphu@smmu.edu.cn	Yu, Bing/GSD-3362-2022; Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; Yu, Bing/0000-0002-3421-8601; li, wenlin/0000-0002-0842-222X; Wangensteen, Kirk/0000-0001-6042-6490	National Key Basic Research and Development Program of China [2010CB945600, 2009CB941100, 2011CB966200]; National Natural Science Foundation of China [31171309, 31271474, 31271469, 31271042, 31100996]; Scientific Innovation Project of the Chinese Academy of Science [XDA01040000]; International Science & Technology Cooperation Program of China [2011DFB30010]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Project of the Chinese Academy of Science; International Science & Technology Cooperation Program of China	We thank Dr. Fuming Li (Chinese Academy of Sciences, China) for helpful discussion and critical reading of the manuscript and Dr. Pengyu Huang (Chinese Academy of Sciences, China) for excellent technical support. We thank Professors Yi Sun and Jun Xu (Tongji University, China) for helpful discussion and technical support in laser-capture microdissection, Professors Minghua Zhu and Zhenghua Xiang (Second Military Medical University, China) for histochemical assistance. We thank Professors Joseph T.Y. Lau (Roswell Park Cancer Institute, USA), Gang Wang (Chinese Academy of Sciences, China), and Lixin Feng (Shanghai Jiao Tong University School of Medicine) for helpful discussion. This work was funded by National Key Basic Research and Development Program of China (2010CB945600, 2009CB941100, 2011CB966200), National Natural Science Foundation of China (31171309, 31271474, 31271469, 31271042, 31100996), Scientific Innovation Project of the Chinese Academy of Science (XDA01040000), and International Science & Technology Cooperation Program of China (2011DFB30010).	Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Coffinier C, 2002, DEVELOPMENT, V129, P1829; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He ZY, 2012, INT J BIOCHEM CELL B, V44, P648, DOI 10.1016/j.biocel.2012.01.002; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li WL, 2006, STEM CELLS, V24, P322, DOI 10.1634/stemcells.2005-0108; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Moritoki Y, 2006, LIVER INT, V26, P457, DOI 10.1111/j.1478-3231.2006.01250.x; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Preisegger KH, 1999, LAB INVEST, V79, P103; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shafritz D.A., 2002, EINSTEIN Q J BIOL ME, V19, P20; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	51	120	139	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					328	340		10.1016/j.stem.2013.06.017	http://dx.doi.org/10.1016/j.stem.2013.06.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871605	Bronze			2022-12-25	WOS:000329570800010
J	Stansbury, DE; Naselaris, T; Gallant, JL				Stansbury, Dustin E.; Naselaris, Thomas; Gallant, Jack L.			Natural Scene Statistics Account for the Representation of Scene Categories in Human Visual Cortex	NEURON			English	Article							HUMAN BRAIN ACTIVITY; HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; CORTICAL REPRESENTATION; OBJECTS; PERCEPTION; IMAGES; FMRI; ORGANIZATION; PATTERNS	During natural vision, humans categorize the scenes they encounter: an office, the beach, and so on. These categories are informed by knowledge of the way that objects co-occur in natural scenes. How does the human brain aggregate information about objects to represent scene categories? To explore this issue, we used statistical learning methods to learn categories that objectively capture the co-occurrence statistics of objects in a large collection of natural scenes. Using the learned categories, we modeled fMRI brain signals evoked in human subjects when viewing images of scenes. We find that evoked activity across much of anterior visual cortex is explained by the learned categories. Furthermore, a decoder based on these scene categories accurately predicts the categories and objects comprising novel scenes from brain activity evoked by those scenes. These results suggest that the human brain represents scene categories that capture the co-occurrence statistics of objects in the world.	[Stansbury, Dustin E.; Gallant, Jack L.] Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA; [Naselaris, Thomas; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA.	gallant@berkeley.edu			National Eye Institute [EY019684]; National Institute of Mental Health [MH66990]; National Science Foundation Center for the Science of Information [CCF-0939370]; NATIONAL EYE INSTITUTE [F32EY016941, R01EY019684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066990] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation Center for the Science of Information; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants to J.L.G. from the National Eye Institute (EY019684), the National Institute of Mental Health (MH66990, and the National Science Foundation Center for the Science of Information (CCF-0939370). We thank An Vu for data collection assistance and Tom Griffiths, Shinji Nishimoto, Tolga Cukur, Mark Lescoarte, Michael Oliver, Alex Huth, James Gao, Natalia Bilenko, Anwar Nunez, Ben Dichter, and Melanie Miller for helpful discussions and comments.	BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BIEDERMAN I, 1973, J EXP PSYCHOL, V97, P22, DOI 10.1037/h0033776; Biederman I., 1981, PERCEPTUAL ORG, P213, DOI 10.4324/9781315512372-8; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Buxton R.B., 2002, INTRODUCTION TO FUNC; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Green C, 2006, J EXP PSYCHOL HUMAN, V32, P1107, DOI 10.1037/0096-1523.32.5.1107; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Hastie T., 2008, THE ELEMENTS OF STAT, P219; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kay KN, 2008, HUM BRAIN MAPP, V29, P142, DOI 10.1002/hbm.20379; Kim JG, 2011, CEREB CORTEX, V21, P1738, DOI 10.1093/cercor/bhq240; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Naselaris T, 2012, J PHYSIOL-PARIS, V106, P239, DOI 10.1016/j.jphysparis.2012.02.001; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Yao B, 2007, LECT NOTES COMPUT SC, V4679, P169	43	83	86	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					1025	1034		10.1016/j.neuron.2013.06.034	http://dx.doi.org/10.1016/j.neuron.2013.06.034			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	23932491	Green Accepted, Bronze			2022-12-25	WOS:000330269100018
J	Jeong, YT; Shim, J; Oh, SR; Yoon, HI; Kim, CH; Moon, SJ; Montell, C				Jeong, Yong Taek; Shim, Jaewon; Oh, So Ra; Yoon, Hong In; Kim, Chul Hoon; Moon, Seok Jun; Montell, Craig			An Odorant-Binding Protein Required for Suppression of Sweet Taste by Bitter Chemicals	NEURON			English	Article							PHEROMONE-BINDING; OLFACTORY RECEPTORS; MOLECULAR EVOLUTION; GUSTATORY RECEPTORS; CAFFEINE RESPONSE; DROSOPHILA; EXPRESSION; FAMILY; GENES; MUTANTS	Animals often must decide whether or not to consume a diet that contains competing attractive and aversive compounds. Here, using the fruit fly, Drosophila melanogaster, we describe a mechanism that influences this decision. Addition of bitter compounds to sucrose suppressed feeding behavior, and this inhibition depended on an odorant-binding protein (OBP) termed OBP49a. In wild-type flies, bitter compounds suppressed sucrose-induced action potentials, and the inhibition was impaired in Obp49a mutants. However, loss of OBP49a did not affect action potentials in sugar- or bitter-activated gustatory receptor neurons (GRNs) when the GRNs were presented with just one type of tastant. OBP49a was expressed in accessory cells and acted non-cell-autonomously to attenuate nerve firings in sugar-activated GRNs when bitter compounds were combined with sucrose. These findings demonstrate an unexpected role for an OBP in taste and identify a molecular player involved in the integration of opposing attractive and aversive gustatory inputs.	[Jeong, Yong Taek; Shim, Jaewon; Moon, Seok Jun] Yonsei Univ, Coll Dent, Dept Oral Biol, Project BK21, Seoul 120752, South Korea; [Oh, So Ra; Yoon, Hong In; Kim, Chul Hoon] Yonsei Univ, Coll Med, Dept Pharmacol, Project BK21, Seoul 120752, South Korea; [Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93110 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Moon, SJ (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol, Project BK21, 250 Seongsanno, Seoul 120752, South Korea.	sjmoon@yuhs.ac; craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Jeong, Yong Taek/0000-0003-0067-6396; Moon, Seok Jun/0000-0001-7282-2888; Yoon, Hong In/0000-0002-2106-6856; Kim, Chul Hoon/0000-0002-7360-429X	NICHD; NIDCD [DC007864]; Converging Research Center Program; Ministry of Education, Science, and Technology [2012K001350, 2009-0075341, 2012R1A1A1012081]; Basic Science Research Program through National Research Foundation of Korea; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Converging Research Center Program; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank FlyBase, the Bloomington Stock Center and Drs. K. Scott, L. Vosshall, J.W. Posakony, and Y.D. Chung for fly stocks, and Dr. C.Y. Park and Mr. J. Song at the Surface Plasmon Resonance Facility, UNIST, for technical help. The tubulin monoclonal antibody developed by Drs. J. Frankel and E.M. Nelsen was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology, University of Iowa (Iowa City, IA). This work was supported by a grant to C.M. from the NIDCD (DC007864) and by grants to S.J.M. from the Converging Research Center Program funded by the Ministry of Education, Science, and Technology (2012K001350) and from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0075341 and 2012R1A1A1012081).	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Formaker BK, 1997, BRAIN RES, V772, P239, DOI 10.1016/S0006-8993(97)00845-7; Galindo K, 2001, GENETICS, V159, P1059; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Glendinning JI, 2007, BIOL BULL-US, V213, P252, DOI 10.2307/25066643; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Koganezawa M, 2002, CHEM SENSES, V27, P319, DOI 10.1093/chemse/27.4.319; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Ogawa K, 1997, BRAIN RES, V769, P263, DOI 10.1016/S0006-8993(97)00729-4; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Vandenbeuch A, 2004, NEUROSCI LETT, V358, P137, DOI 10.1016/j.neulet.2004.01.013; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	56	141	146	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					725	737		10.1016/j.neuron.2013.06.025	http://dx.doi.org/10.1016/j.neuron.2013.06.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972598	Green Accepted, Bronze			2022-12-25	WOS:000323587000012
J	Smith, CJ; O'Brien, T; Chatzigeorgiou, M; Spencer, WC; Feingold-Link, E; Husson, SJ; Hori, S; Mitani, S; Gottschalk, A; Schafer, WR; Miller, DM				Smith, Cody J.; O'Brien, Timothy; Chatzigeorgiou, Marios; Spencer, W. Clay; Feingold-Link, Elana; Husson, Steven J.; Hori, Sayaka; Mitani, Shohei; Gottschalk, Alexander; Schafer, William R.; Miller, David M., III			Sensory Neuron Fates Are Distinguished by a Transcriptional Switch that Regulates Dendrite Branch Stabilization	NEURON			English	Article							ARYL-HYDROCARBON RECEPTOR; NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; MECHANOSENSORY NEURONS; NERVOUS-SYSTEM; NUCLEAR TRANSLOCATOR; MOLECULAR-MECHANISMS; HOMEODOMAIN PROTEIN; TOUCH SENSATION; GENE-EXPRESSION	Sensory neurons adopt distinct morphologies and functional modalities to mediate responses to specific stimuli. Transcription factors and their downstream effectors orchestrate this outcome but are incompletely defined. Here, we show that different classes of mechanosensory neurons in C. elegans are distinguished by the combined action of the transcription factors MEC-3, AHR-1, and ZAG-1. Low levels of MEC-3 specify the elaborate branching pattern of PVD nociceptors, whereas high MEC-3 is correlated with the simple morphology of AVM and PVM touch neurons. AHR-1 specifies AVM touch neuron fate by elevating MEC-3 while simultaneously blocking expression of nociceptive genes such as the MEC-3 target, the claudin-like membrane protein HPO-30, that promotes the complex dendritic branching pattern of PVD. ZAG-1 exercises a parallel role to prevent PVM from adopting the PVD fate. The conserved dendritic branching function of the Drosophila AHR-1 homolog, Spineless, argues for similar pathways in mammals.	[Smith, Cody J.; O'Brien, Timothy; Spencer, W. Clay; Feingold-Link, Elana; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Chatzigeorgiou, Marios; Schafer, William R.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 0QH, England; [Husson, Steven J.; Gottschalk, Alexander] Katholieke Univ Leuven, Dept Biol, B-3000 Louvain, Belgium; [Husson, Steven J.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Hori, Sayaka; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan; [Miller, David M., III] Vanderbilt Univ, Neurosci Program, Nashville, TN 37232 USA; [Miller, David M., III] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37203 USA	Vanderbilt University; MRC Laboratory Molecular Biology; KU Leuven; Goethe University Frankfurt; Tokyo Women's Medical University; Vanderbilt University; Vanderbilt University	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	david.miller@vanderbilt.edu	Sayaka, Hori/AAU-7866-2020; Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Tal, Elana/0000-0001-7065-8121; Schafer, William/0000-0002-6676-8034	National Institutes of Health (NIH) National Center for Research Resources; NIH [R01 NS26115, R01 NS079611, R21 N206882, U01 HG004263, F31 NS071801]; Deutsche Forschungsgemeinschaft [EXC115, GO1011/3-1, GO1011/4-1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079611, R01NS026115, F31NS071801, R21NS066882] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185857] Funding Source: researchfish; MRC [MC_U105185857] Funding Source: UKRI	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Powell-Coffman for pJ360 and ZG628 and O. Hobert for otls181, otls236, and advice. Some of the strains used in this work were provided by the C. elegans Genetics Center, which is supported by the National Institutes of Health (NIH) National Center for Research Resources. This work was supported by NIH Grants R01 NS26115, R01 NS079611, R21 N206882, and U01 HG004263 to D.M.M.; NIH Grant F31 NS071801 to C.J.S.; and Deutsche Forschungsgemeinschaft Grants EXC115, GO1011/3-1, and GO1011/4-1 to A.G. S.J.H. was a Long-Term fellow of the Human Frontiers Science Program Organization. C.J.S.,.T.O., and D.M.M. designed experiments; C.J.S. and T.O. performed experiments with advice from D.M.M.; W.C.S. helped with microarray data analysis; E.F.-L. helped with phenotypic analysis of ahr-1 and zag-1 strains and FISH experiments; M.O. and W.R.S. performed calcium imaging experiments; S.H. and S.M. generated deletion alleles of T24F1.4; S.J.H. and A.G. performed optogenetic experiments; and C.J.S., T.O., and D.M.M. wrote the paper with input from coauthors.	Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chatzigeorgiou M, 2011, NEURON, V70, P299, DOI 10.1016/j.neuron.2011.02.046; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Huang X, 2004, DEVELOPMENT, V131, P819, DOI 10.1242/dev.00959; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Karim MR, 2011, J NEUROSCI, V31, P17017, DOI 10.1523/JNEUROSCI.2815-11.2011; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Labouesse Michel, 2006, WormBook, P1; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Siegel DA, 2002, INT J DEV NEUROSCI, V20, P373, DOI 10.1016/S0736-5748(02)00055-2; Simske JS, 2011, METHODS MOL BIOL, V762, P147, DOI 10.1007/978-1-61779-185-7_11; Smith CJ, 2012, NAT NEUROSCI, V15, P731, DOI 10.1038/nn.3065; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; STRUHL G, 1982, GENETICS, V102, P737; Sulkowski MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022611; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Topalidou I, 2011, P NATL ACAD SCI USA, V108, P19258, DOI 10.1073/pnas.1111684108; Topalidou I, 2011, P NATL ACAD SCI USA, V108, P4063, DOI 10.1073/pnas.1101329108; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson CL, 1998, TOXICOL PATHOL, V26, P657, DOI 10.1177/019262339802600510; Wood WB, 1988, NEMATODE CAENORHABDI, P1; Wu J, 2001, GENE DEV, V15, P789, DOI 10.1101/gad.857401; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	65	69	75	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					266	280		10.1016/j.neuron.2013.05.009	http://dx.doi.org/10.1016/j.neuron.2013.05.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889932	Green Accepted, Bronze			2022-12-25	WOS:000322426200007
J	Smith, KS; Graybiel, AM				Smith, Kyle S.; Graybiel, Ann M.			A Dual Operator View of Habitual Behavior Reflecting Cortical and Striatal Dynamics	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; BASAL GANGLIA; DORSOLATERAL STRIATUM; NEURAL MECHANISMS; INFRALIMBIC CORTEX; DORSAL STRIATUM; RAT; ADDICTION; NEURONS; CIRCUITS	Habits are notoriously difficult to break and, if broken, are usually replaced by new routines. To examine the neural basis of these characteristics, we recorded spike activity in cortical and striatal habit sites as rats learned maze tasks. Overtraining induced a shift from purposeful to habitual behavior. This shift coincided with the activation of neuronal ensembles in the infralimbic neocortex and the sensorimotor striatum, which became engaged simultaneously but developed changes in spike activity with distinct time courses and stability. The striatum rapidly acquired an action-bracketing activity pattern insensitive to reward devaluation but sensitive to running automaticity. A similar pattern developed in the upper layers of the infralimbic cortex, but it formed only late during overtraining and closely tracked habit states. Selective optogenetic disruption of infralimbic activity during overtraining prevented habit formation. We suggest that learning-related spiking dynamics of both striatum and neocortex are necessary, as dual operators, for habit crystallization.	[Smith, Kyle S.; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Smith, Kyle S.; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Smith, KS (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kyle.s.smith@dartmouth.edu; graybiel@mit.edu		Graybiel, Ann/0000-0002-4326-7720	NIH [R01 MH060379, F32 MH085454]; Office of Naval Research grant [N00014-04-1-0208]; Stanley H. and Sheila G. Sydney Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060379, F32MH085454] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research grant(Office of Naval Research); Stanley H. and Sheila G. Sydney Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Christine Keller-McGandy, Alex McWhinnie, Dr. Daniel J. Gibson, and Henry F. Hall; Dr. Marshall Shuler, Dr. Catherine Thorn and Dr. Yasuo Kubota; and Karen Sittig, Arti Virkud, and Dordaneh Sugano for their help and advice. This work was supported by NIH grants R01 MH060379 (A.M.G.) and F32 MH085454 (K.S.S.), by Office of Naval Research grant N00014-04-1-0208 (A.M.G.), by the Stanley H. and Sheila G. Sydney Fund (A.M.G.), and by funding from Mr. R. Pourian and Julia Madadi (A.M.G.).	ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; Aldridge JW, 2004, CAN J PHYSIOL PHARM, V82, P732, DOI 10.1139/Y04-061; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Carelli RM, 1997, J NEUROSCI, V17, P1804; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; Daw N. D., 2005, RECENT BREAKTHROUGHS, P91; de Wit S, 2011, J COGNITIVE NEUROSCI, V23, P1218, DOI 10.1162/jocn.2010.21514; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Elsevier Inc, 2013, NEURON, V79, P361; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Fujimoto H, 2011, J NEUROSCI, V31, P10023, DOI 10.1523/JNEUROSCI.1606-11.2011; Garcia J, 1968, Recent Adv Biol Psychiatry, V10, P284; Ghazizadeh A, 2012, J NEUROSCI, V32, P726, DOI 10.1523/JNEUROSCI.3891-11.2012; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; Holtzheimer PE, 2011, ANNU REV NEUROSCI, V34, P289, DOI 10.1146/annurev-neuro-061010-113638; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kimchi EY, 2009, J NEUROPHYSIOL, V102, P475, DOI 10.1152/jn.00262.2009; Kubota Y, 2009, J NEUROPHYSIOL, V102, P2142, DOI 10.1152/jn.00522.2009; Lingawi NW, 2012, J NEUROSCI, V32, P1073, DOI 10.1523/JNEUROSCI.4806-11.2012; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Muenzinger KF, 1938, PEDAGOG SEMIN J GEN, V53, P75; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rhodes SEV, 2004, LEARN MEMORY, V11, P611, DOI 10.1101/lm.79704; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Root DH, 2010, BEHAV BRAIN RES, V211, P23, DOI 10.1016/j.bbr.2010.03.001; Smith KS, 2012, P NATL ACAD SCI USA, V109, P18932, DOI 10.1073/pnas.1216264109; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tang CK, 2007, EUR J NEUROSCI, V25, P1212, DOI 10.1111/j.1460-9568.2007.05353.x; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	56	187	187	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					361	374		10.1016/j.neuron.2013.05.038	http://dx.doi.org/10.1016/j.neuron.2013.05.038			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23810540	Green Accepted, Bronze, Green Published			2022-12-25	WOS:000322426200014
J	Esposti, F; Johnston, J; Rosa, JM; Leung, KM; Lagnado, L				Esposti, Federico; Johnston, Jamie; Rosa, Juliana M.; Leung, Kin-Mei; Lagnado, Leon			Olfactory Stimulation Selectively Modulates the OFF Pathway in the Retina of Zebrafish	NEURON			English	Article							TERMINAL NERVE; BIPOLAR CELLS; VISUAL SENSITIVITY; INTERPLEXIFORM CELLS; MELATONIN RECEPTORS; POTASSIUM CURRENTS; DOPAMINE-RECEPTORS; CIRCADIAN CLOCK; GANGLION-CELLS; CHANNELS	Cross-modal regulation of visual performance by olfactory stimuli begins in the retina, where dopaminergic interneurons receive projections from the olfactory bulb. However, we do not understand how olfactory stimuli alter the processing of visual signals within the retina. We investigated this question by in vivo imaging activity in transgenic zebrafish expressing SyGCaMP2 in bipolar cell terminals and GCaMP3.5 in ganglion cells. The food-related amino acid methionine reduced the gain and increased sensitivity of responses to luminance and contrast transmitted through OFF bipolar cells but not ON. The effects of olfactory stimulus were blocked by inhibiting dopamine uptake and release. Activation of dopamine receptors increased the gain of synaptic transmission in vivo and potentiated synaptic calcium currents in isolated bipolar cells. These results indicate that olfactory stimuli alter the sensitivity of the retina through the dopaminergic regulation of presynaptic calcium channels that control the gain of synaptic transmission through OFF bipolar cells.	[Esposti, Federico; Johnston, Jamie; Rosa, Juliana M.; Leung, Kin-Mei; Lagnado, Leon] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Lagnado, Leon] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	MRC Laboratory Molecular Biology; University of Sussex	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ll1@mrc-lmb.cam.ac.uk	Rosa, Juliana M/P-6969-2017	Rosa, Juliana M/0000-0003-0857-3746; Esposti, Federico/0000-0002-0033-3118; Johnston, Jamie/0000-0002-9928-989X	Wellcome Trust [083220]; MRC [MC_U105178794] Funding Source: UKRI; Medical Research Council [MC_U105178794] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank all of the members of the Lagnado laboratory for discussions that contributed to this work. We also thank the Wellcome Trust for funding (grant 083220). Experiments were designed by F.E., J.J., J.M.R., and L.L. and performed by F.E., J.J., and J.M.R. Analysis was carried out by F.E., J.J., and L.L. eno2::GCamp3.5 fish were generated and characterized by K.-M.L. The manuscript was written by F.E., J.J., and L.L.	Abe H, 2007, FISH PHYSIOL, V25, P455, DOI 10.1016/S1546-5098(06)25011-8; Baden T, 2011, CURR BIOL, V21, P1859, DOI 10.1016/j.cub.2011.09.042; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Behrens U, 2004, MICROSC RES TECHNIQ, V65, P25, DOI 10.1002/jemt.20108; Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101; Bourne JA, 2001, CNS DRUG REV, V7, P399; Burgess HA, 2010, CURR BIOL, V20, P381, DOI 10.1016/j.cub.2010.01.022; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Cajal SR, 1894, RETINA WIRBELTHIERE; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Connaughton VP, 2000, J PHYSIOL-LONDON, V524, P135, DOI 10.1111/j.1469-7793.2000.t01-1-00135.x; DEMSKI LS, 1993, ACTA ANAT, V148, P81; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; DOWLING JE, 1991, VISUAL NEUROSCI, V7, P87, DOI 10.1017/S0952523800010968; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Fan SF, 2005, VISUAL NEUROSCI, V22, P55, DOI 10.1017/S0952523805221089; FEIGENSPAN A, 1994, P NATL ACAD SCI USA, V91, P10893, DOI 10.1073/pnas.91.23.10893; HEIDELBERGER R, 1994, NEUROREPORT, V5, P729, DOI 10.1097/00001756-199402000-00018; Huang LX, 2005, J PHYSIOL-LONDON, V569, P939, DOI 10.1113/jphysiol.2005.099531; IUVONE PM, 1995, J NEUROSCI, V15, P2179, DOI 10.1523/JNEUROSCI.15-03-02179.1995; JENSEN RJ, 1992, VISUAL NEUROSCI, V8, P463, DOI 10.1017/S095252380000496X; JENSEN RJ, 1984, J NEUROSCI, V4, P2972; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; Kubrusly RCC, 2008, NEUROCHEM INT, V53, P63, DOI 10.1016/j.neuint.2008.05.002; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2000, J NEUROSCI, V20, P1893; Li L, 2007, FISH PHYSIOL, V25, P179, DOI 10.1016/S1546-5098(06)25005-2; LIMA L, 1994, NEUROCHEM RES, V19, P249, DOI 10.1007/BF00971572; LIN ZS, 1994, VISUAL NEUROSCI, V11, P683, DOI 10.1017/S0952523800002996; LoGiudice L, 2006, MOL VIS, V12, P184; Maaswinkel H, 2003, J EXP BIOL, V206, P2201, DOI 10.1242/jeb.00397; MAGUIRE G, 1994, J NEUROSCI, V14, P6094; MCMAHON DG, 1994, J NEUROSCI, V14, P1722, DOI 10.1523/JNEUROSCI.14-03-01722.1994; Mora-Ferrer C, 2000, VISUAL NEUROSCI, V17, P177, DOI 10.1017/S0952523800171196; MoraFerrer C, 1996, VISION RES, V36, P4035, DOI 10.1016/S0042-6989(96)00173-3; Nelson RF, 2004, INVEST OPHTH VIS SCI, V45, pU343; Nusslein-Volhard C, 2001, ZEBRAFISH PRACTICAL; Odermatt B, 2012, NEURON, V73, P758, DOI 10.1016/j.neuron.2011.12.023; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; REITH MEA, 1994, EUR J PHARMACOL, V253, P175, DOI 10.1016/0014-2999(94)90774-9; Reperant J, 2007, BRAIN RES REV, V53, P161, DOI 10.1016/j.brainresrev.2006.08.004; REPERANT J, 1989, INT REV CYTOL, V118, P115, DOI 10.1016/S0074-7696(08)60874-8; Ribelayga C, 2002, J PHYSIOL-LONDON, V544, P801, DOI 10.1113/jphysiol.2002.023671; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; ROTHMAN RB, 1991, PHARMACOL BIOCHEM BE, V40, P387, DOI 10.1016/0091-3057(91)90570-R; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Schlicker E, 1996, N-S ARCH PHARMACOL, V354, P791, DOI 10.1007/BF00166907; Singh S, 2000, CHEM REV, V100, P925, DOI 10.1021/cr9700538; SPRINGER AD, 1983, J COMP NEUROL, V214, P404, DOI 10.1002/cne.902140405; Stella SL, 2000, EUR J NEUROSCI, V12, P3537, DOI 10.1046/j.1460-9568.2000.00235.x; Stephenson JF, 2011, ZEBRAFISH, V8, P17, DOI 10.1089/zeb.2010.0671; UMINO O, 1991, J NEUROSCI, V11, P3034; Wang XK, 2011, J CELL PHYSIOL, V226, P608, DOI 10.1002/jcp.22369; Wiechmann AF, 2012, J COMP NEUROL, V520, P1115, DOI 10.1002/cne.22783; Yamamoto N, 2000, J COMP NEUROL, V428, P355, DOI 10.1002/1096-9861(20001211)428:2<355::AID-CNE12>3.0.CO;2-W; Yu CJ, 2005, J NEUROSCI RES, V82, P368, DOI 10.1002/jnr.20637; ZUCKER CL, 1987, NATURE, V330, P166, DOI 10.1038/330166a0	61	30	31	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					97	110		10.1016/j.neuron.2013.05.001	http://dx.doi.org/10.1016/j.neuron.2013.05.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849198	Green Published, hybrid			2022-12-25	WOS:000321802000012
J	Zhang, C; Mejia, LA; Huang, J; Valnegri, P; Bennett, EJ; Anckar, J; Jahani-Asl, A; Gallardo, G; Ikeuchi, Y; Yamada, T; Rudnicki, M; Harper, JW; Bonni, A				Zhang, Chi; Mejia, Luis A.; Huang, Ju; Valnegri, Pamela; Bennett, Eric J.; Anckar, Julius; Jahani-Asl, Arezu; Gallardo, Gilbert; Ikeuchi, Yoshiho; Yamada, Tomoko; Rudnicki, Michael; Harper, J. Wade; Bonni, Azad			The X-Linked Intellectual Disability Protein PHF6 Associates with the PAF1 Complex and Regulates Neuronal Migration in the Mammalian Brain	NEURON			English	Article							RNA-POLYMERASE-II; NEUROGLYCAN-C; EXPRESSION; NEUREGULIN; MUTATIONS; GENES	Intellectual disability is a prevalent disorder that remains incurable. Mutations of the X-linked protein PHF6 cause the intellectual disability disorder Borjeson-Forssman-Lehmann syndrome (BFLS). However, the biological role of PHF6 relevant to BFLS pathogenesis has remained unknown. We report that knockdown of PHF6 profoundly impairs neuronal migration in the mouse cerebral cortex in vivo, leading to the formation of white matter heterotopias displaying neuronal hyperexcitability. We find that PHF6 physically associates with the PAF1 transcription elongation complex, and inhibition of PAF1 phenocopies the PHF6 knockdown-induced migration phenotype in vivo. We also identify Neuroglycan C/Chondroitin sulfate proteoglycan 5 (NGC/CSPG5), a potential schizophrenia susceptibility gene, as a critical downstream target of PHF6 in the control of neuronal migration. These findings define PHF6, PAF1, and NGC/CSPG5 as components of a cell-intrinsic transcriptional pathway that orchestrates neuronal migration in the brain, with important implications for the pathogenesis of developmental disorders of cognition.	[Zhang, Chi; Mejia, Luis A.; Huang, Ju; Valnegri, Pamela; Anckar, Julius; Jahani-Asl, Arezu; Gallardo, Gilbert; Ikeuchi, Yoshiho; Yamada, Tomoko; Bonni, Azad] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mejia, Luis A.; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Chi] Harvard Univ, Sch Dent Med, Program Biol Sci Dent Med, Boston, MA 02115 USA; [Huang, Ju; Valnegri, Pamela; Gallardo, Gilbert; Ikeuchi, Yoshiho; Yamada, Tomoko; Bonni, Azad] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Jahani-Asl, Arezu; Rudnicki, Michael] Ottawa Hosp Res Inst Ottawa, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Washington University (WUSTL); University of Ottawa; Ottawa Hospital Research Institute	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bonni@wustl.edu	ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Huang, Ju/I-4327-2015	ikeuchi, yoshiho/0000-0002-2829-3840; Jahani-Asl, Arezu/0000-0003-4002-3381; Harper, Jeffrey/0000-0002-6944-7236; Rudnicki, Michael/0000-0002-3866-5249	NIH [NS041021, GM054137, AG011085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085, T32AG000222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Bonni laboratory for helpful discussions and critical reading of the manuscript. This work was supported by NIH grants NS041021 (A.B.), GM054137 (J.W.H), and AG011085 (J.W.H).	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berland S, 2010, MOL SYNDROMOL, V1, P294, DOI 10.1159/000330111; Bhasin Tanya Karapurkar, 2006, Morbidity and Mortality Weekly Report, V55, P1; BRUN A, 1974, J MENT DEFIC RES, V18, P317; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kinugasa Y, 2004, BIOCHEM BIOPH RES CO, V321, P1045, DOI 10.1016/j.bbrc.2004.07.066; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; So HC, 2010, AM J MED GENET B, V153B, P103, DOI 10.1002/ajmg.b.30961; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110	30	69	69	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					986	993		10.1016/j.neuron.2013.04.021	http://dx.doi.org/10.1016/j.neuron.2013.04.021			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791194	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000321026900006
J	Morimoto, H; Iwata, K; Ogonuki, N; Inoue, K; Atsuo, O; Kanatsu-Shinohara, M; Morimoto, T; Yabe-Nishimura, C; Shinohara, T				Morimoto, Hiroko; Iwata, Kazumi; Ogonuki, Narumi; Inoue, Kimiko; Atsuo, Ogura; Kanatsu-Shinohara, Mito; Morimoto, Takeshi; Yabe-Nishimura, Chihiro; Shinohara, Takashi			ROS Are Required for Mouse Spermatogonial Stem Cell Self-Renewal	CELL STEM CELL			English	Article							OXIDATIVE STRESS; UNDIFFERENTIATED SPERMATOGONIA; NEUROTROPHIC FACTOR; P38 MAPK; OXYGEN; PROLIFERATION; MICE; ATM; SPERMATOGENESIS; OXIDASE	Reactive oxygen species (ROS) generation is implicated in stem cell self-renewal in several tissues but is thought to be detrimental for spermatogenesis as well as spermatogonial stem cells (SSCs). Using cultured SSCs, we show that ROS are generated via the AKT and MEK signaling pathways under conditions where the growth factors glial cell linederived neurotrophic factor and fibroblast growth factor 2 drive SSC self-renewal and, instead, stimulate self-renewal at physiological levels. SSCs depleted of ROS stopped proliferating, but they showed enhanced self-renewal when ROS levels were increased by the addition of hydrogen peroxide, which induced the phosphorylation of stress kinases p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (JNK). Moreover, ROS depletion in vivo decreased SSC number in the testis, and NADPH oxidase 1 (Nox1)-deficient SSCs exhibited reduced self-renewal division upon serial transplantation. These results suggest that ROS generated by Nox1 play critical roles in SSC selfrenewal via the activation of the p38 MAPK and JNK pathways.	[Morimoto, Hiroko; Kanatsu-Shinohara, Mito; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Iwata, Kazumi; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto 6028566, Japan; [Ogonuki, Narumi; Inoue, Kimiko; Atsuo, Ogura] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Morimoto, Takeshi] Kinki Univ, Sch Med, Ctr Gen Int Med & Emergency Care, Osaka 5898511, Japan; [Shinohara, Takashi] Japan Sci & Technol Agcy, CREST, Kyoto 6068501, Japan	Kyoto University; Kyoto Prefectural University of Medicine; RIKEN; Kindai University (Kinki University); Japan Science & Technology Agency (JST)	Shinohara, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	tshinoha@virus.kyoto-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988; Iwata, Kazumi/0000-0002-9595-7782	Japan Science and Technology Agency (CREST); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [25293067] Funding Source: KAKEN	Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Ogata for technical assistance. This research was supported by the Japan Science and Technology Agency (CREST) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Rooij DG, 2000, J ANDROL, V21, P776; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, BIOL REPROD, V75, P68, DOI 10.1095/biolreprod.106.051193; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng XJ, 2001, CANCER RES, V61, P3267; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; MULLANEY BP, 1992, ENDOCRINOLOGY, V131, P2928, DOI 10.1210/en.131.6.2928; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Piccoli C, 2007, BIOCHEM BIOPH RES CO, V353, P965, DOI 10.1016/j.bbrc.2006.12.148; Sato K, 2008, J NEUROSCI RES, V86, P2179, DOI 10.1002/jnr.21668; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Takubo K, 2006, BIOCHEM BIOPH RES CO, V351, P993, DOI 10.1016/j.bbrc.2006.10.145	46	152	166	4	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					774	786		10.1016/j.stem.2013.04.001	http://dx.doi.org/10.1016/j.stem.2013.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746981	Bronze, Green Published			2022-12-25	WOS:000329569900019
J	Wang, XD; Su, YA; Wagner, KV; Avrabos, C; Scharf, SH; Hartmann, J; Wolf, M; Liebl, C; Kuhne, C; Wurst, W; Holsboer, F; Eder, M; Deussing, JM; Muller, MB; Schmidt, MV				Wang, Xiao-Dong; Su, Yun-Ai; Wagner, Klaus V.; Avrabos, Charilaos; Scharf, Sebastian H.; Hartmann, Jakob; Wolf, Miriam; Liebl, Claudia; Kuehne, Claudia; Wurst, Wolfgang; Holsboer, Florian; Eder, Matthias; Deussing, Jan M.; Mueller, Marianne B.; Schmidt, Mathias V.			Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING HORMONE; EARLY-LIFE STRESS; ANXIETY-RELATED BEHAVIOR; CELL-ADHESION MOLECULES; COGNITIVE DEFICITS; DENDRITIC SPINES; RECEPTOR 1; HIPPOCAMPUS; MAINTENANCE; MECHANISMS	Stress impairs cognition via corticotropin-releasing hormone receptor 1 (CRHR1), but the molecular link between abnormal CRHR1 signaling and stress-induced cognitive impairments remains unclear. We investigated whether the cell adhesion molecule nectin-3 is required for the effects of CRHR1 on cognition and structural remodeling after early-life stress exposure. Postnatally stressed adult mice had decreased hippocampal nectin-3 levels, which could be attenuated by CRHR1 inactivation and mimicked by corticotropin-releasing hormone (CRH) overexpression in forebrain neurons. Acute stress dynamically reduced hippocampal nectin-3 levels, which involved CRH-CRHR1, but not glucocorticoid receptor, signaling. Suppression of hippocampal nectin-3 caused spatial memory deficits and dendritic spine loss, whereas enhancing hippocampal nectin-3 expression rescued the detrimental effects of early-life stress on memory and spine density in adulthood. Our findings suggest that hippocampal nectin-3 is necessary for the effects of stress on memory and structural plasticity and indicate that the CRH-CRHR1 system interacts with the nectin-afadin complex to mediate such effects.	[Wang, Xiao-Dong; Su, Yun-Ai; Wagner, Klaus V.; Avrabos, Charilaos; Scharf, Sebastian H.; Hartmann, Jakob; Wolf, Miriam; Liebl, Claudia; Kuehne, Claudia; Wurst, Wolfgang; Holsboer, Florian; Eder, Matthias; Deussing, Jan M.; Mueller, Marianne B.; Schmidt, Mathias V.] Max Planck Inst Psychiat, Munich, Germany; [Wurst, Wolfgang] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmidt, MV (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	mschmidt@mpipsykl.mpg.de	Müller, Marianne B./AAL-8911-2021; Wang, Xiao-Dong/A-9610-2010; Deussing, Jan M/ABB-5993-2021; Hartmann, Jakob/GPF-5919-2022	Müller, Marianne B./0000-0002-0269-6131; Wang, Xiao-Dong/0000-0001-7730-3710; Hartmann, Jakob/0000-0002-1960-8177; Eder, Matthias/0000-0002-2579-2628; Wurst, Wolfgang/0000-0003-4422-7410; Scharf, Sebastian/0000-0002-9129-4723; Deussing, Jan/0000-0002-9329-5252; SU, YUNAI/0000-0001-8445-9633; Schmidt, Mathias/0000-0002-3788-2268				Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Heck N, 2012, BRAIN STRUCT FUNCT, V217, P421, DOI 10.1007/s00429-011-0340-y; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kuhne C, 2012, J COMP NEUROL, V520, P3150, DOI 10.1002/cne.23082; Li YW, 2003, J PHARMACOL EXP THER, V305, P86, DOI 10.1124/jpet.102.045914; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lu A, 2008, MOL PSYCHIATR, V13, P1028, DOI 10.1038/mp.2008.51; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Schmidt MV, 2010, J NEUROSCI, V30, P16949, DOI 10.1523/JNEUROSCI.4668-10.2010; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Wagner KV, 2013, J NEUROSCI, V33, P3857, DOI 10.1523/JNEUROSCI.4333-12.2013; Wagner KV, 2012, NEUROPSYCHOPHARMACOL, V37, P2797, DOI 10.1038/npp.2012.150; Wang XD, 2012, EUR J NEUROSCI, V36, P2360, DOI 10.1111/j.1460-9568.2012.08148.x; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008	46	89	93	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					706	+		10.1038/nn.3395	http://dx.doi.org/10.1038/nn.3395			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644483				2022-12-25	WOS:000319509600012
J	Galashan, FO; Sassen, HC; Kreiter, AK; Wegener, D				Galashan, F. Orlando; Sassen, Hanna C.; Kreiter, Andreas K.; Wegener, Detlef			Monkey Area MT Latencies to Speed Changes Depend on Attention and Correlate with Behavioral Reaction Times	NEURON			English	Article							TEMPORAL VISUAL AREA; CORTICAL AREA; SPATIAL ATTENTION; SELECTIVE ATTENTION; RESPONSE LATENCIES; NEURONAL RESPONSES; CONTRAST SENSITIVITY; INDIVIDUAL NEURONS; STIMULUS DIRECTION; NEURAL MECHANISMS	Selective visual attention is known to be associated with characteristic modulations of neuronal activity in early visual cortex, but there is only rare evidence showing that these neuronal modulations are directly related to attention-dependent behavioral improvements. Here, we describe a strong, transient increase in the response of neurons in the mediotemporal (MT) area to behaviorally relevant speed changes that is not only modulated by attention but also highly correlated with the animal's performance. In trials with fast reaction time (RT), this transient component occurs with short latency, whereas latency increases monotonically with slower RT. Importantly, RTs are related not to the firing rate modulation during sustained attentive tracking of the target prior to the speed change but to the variability of the neuronal response. Our findings suggest a direct link between attention-dependent response modulations in early visual cortex and improved behavioral performance.	[Galashan, F. Orlando; Sassen, Hanna C.; Kreiter, Andreas K.; Wegener, Detlef] Univ Bremen, Ctr Cognit Sci, Brain Res Inst, D-28334 Bremen, Germany	University of Bremen	Wegener, D (corresponding author), Univ Bremen, Ctr Cognit Sci, Brain Res Inst, POB 33 04 40, D-28334 Bremen, Germany.	wegener@brain.uni-bremen.de	Wegener, Detlef/Q-5965-2019	Wegener, Detlef/0000-0002-9507-0188	DFG [KR 1844/1-2]; University of Bremen [02/117/06]; German National Academic Foundation	DFG(German Research Foundation (DFG)); University of Bremen; German National Academic Foundation	This work was supported by DFG grant KR 1844/1-2, ZF grant 02/117/06 from the University of Bremen, and a scholarship from the German National Academic Foundation. The authors would like to thank Katrin Thoss and Ramazani Hakazimani for animal care, Peter Bujotzek and Alexandra Nadolski for general technical support, Sunita Mandon for support during surgeries, and Udo Ernst for critical comments on the manuscript.	Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Bosking WH, 2011, J NEUROSCI, V31, P8230, DOI 10.1523/JNEUROSCI.0126-11.2011; Box GE., 1978, STAT EXPT; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cook EP, 2004, J NEUROSCI, V24, P7964, DOI 10.1523/JNEUROSCI.5102-03.2004; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Galashan FO, 2011, J NEUROPHYSIOL, V105, P3092, DOI 10.1152/jn.00508.2010; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Green DM, 1966, SIGNAL DETECTION THE; Grothe I, 2012, J NEUROSCI, V32, P16172, DOI 10.1523/JNEUROSCI.0890-12.2012; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Krekelberg B, 2001, TRENDS NEUROSCI, V24, P335, DOI 10.1016/S0166-2236(00)01795-1; Lee J, 2007, J NEUROSCI, V27, P9632, DOI 10.1523/JNEUROSCI.2734-07.2007; Lee J, 2010, J NEUROPHYSIOL, V104, P960, DOI 10.1152/jn.01019.2009; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Sundberg KA, 2012, J NEUROSCI, V32, P16040, DOI 10.1523/JNEUROSCI.0489-12.2012; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Traschutz A, 2012, VISION RES, V72, P1, DOI 10.1016/j.visres.2012.08.019; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wegener D, 2004, J NEUROSCI, V24, P6106, DOI 10.1523/JNEUROSCI.1459-04.2004; Wegener D, 2006, VISION RES, V46, P3563, DOI 10.1016/j.visres.2006.06.008; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2008, J NEUROSCI, V28, P8934, DOI 10.1523/JNEUROSCI.4030-07.2008; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	57	29	29	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2013	78	4					740	750		10.1016/j.neuron.2013.03.014	http://dx.doi.org/10.1016/j.neuron.2013.03.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719167	Bronze			2022-12-25	WOS:000319491200016
J	Todd, PK; Oh, SY; Krans, A; He, F; Sellier, C; Frazer, M; Renoux, AJ; Chen, KC; Scaglione, KM; Basrur, V; Elenitoba-Johnson, K; Vonsattel, JP; Louis, ED; Sutton, MA; Taylor, JP; Mills, RE; Charlet-Berguerand, N; Paulson, HL				Todd, Peter K.; Oh, Seok Yoon; Krans, Amy; He, Fang; Sellier, Chantal; Frazer, Michelle; Renoux, Abigail J.; Chen, Kai-chun; Scaglione, K. Matthew; Basrur, Venkatesha; Elenitoba-Johnson, Kojo; Vonsattel, Jean P.; Louis, Elan D.; Sutton, Michael A.; Taylor, J. Paul; Mills, Ryan E.; Charlet-Berguerand, Nicholas; Paulson, Henry L.			CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome	NEURON			English	Article							MESSENGER-RNA; INTRANUCLEAR INCLUSIONS; TREMOR/ATAXIA SYNDROME; HEXANUCLEOTIDE REPEAT; DROSOPHILA MODEL; RCGG REPEATS; IN-VIVO; FMR1; C9ORF72; INITIATION	Fragile X-associated tremor ataxia syndrome (FXTAS) results from a CGG repeat expansion in the 5' UTR of FMR1. This repeat is thought to elicit toxicity as RNA, yet disease brains contain ubiquitin-positive neuronal inclusions, a pathologic hallmark of protein-mediated neurodegeneration. We explain this paradox by demonstrating that CGG repeats trigger repeat-associated non-AUG-initiated (RAN) translation of a cryptic polyglycine-containing protein, FMRpolyG. FMRpolyG accumulates in ubiquitin-positive inclusions in Drosophila, cell culture, mouse disease models, and FXTAS patient brains. CGG RAN translation occurs in at least two of three possible reading frames at repeat sizes ranging from normal (25) to pathogenic (90), but inclusion formation only occurs with expanded repeats. In Drosophila, CGG repeat toxicity is suppressed by eliminating RAN translation and enhanced by increased polyglycine protein production. These studies expand the growing list of nucleotide repeat disorders in which RAN translation occurs and provide evidence that RAN translation contributes to neurodegeneration.	[Todd, Peter K.; Oh, Seok Yoon; Krans, Amy; He, Fang; Frazer, Michelle; Renoux, Abigail J.; Chen, Kai-chun; Scaglione, K. Matthew; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Renoux, Abigail J.; Sutton, Michael A.] Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Elenitoba-Johnson, Kojo] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Mills, Ryan E.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Mills, Ryan E.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Sellier, Chantal; Charlet-Berguerand, Nicholas] IGBMC, Dept Translat Med, F-67400 Illkirch Graffenstaden, France; [Sellier, Chantal] Coll France, F-75000 Paris, France; [Vonsattel, Jean P.] Columbia Univ, Taub Inst, New York, NY 10032 USA; [Vonsattel, Jean P.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Louis, Elan D.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Taylor, J. Paul] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Columbia University; Columbia University; Columbia University; St Jude Children's Research Hospital	Todd, PK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	petertod@umich.edu; henryp@umich.edu	Charlet-Berguerand, Nicolas/GZM-6636-2022; He, Fang/H-1545-2015; Taylor, J. Paul/N-2482-2018; Mills, Ryan/F-4225-2010; Todd, Peter/AAH-2463-2020; Charlet-Berguerand, Nicolas/I-6727-2016	Charlet-Berguerand, Nicolas/0000-0002-4423-4920; He, Fang/0000-0002-0944-3364; Taylor, J. Paul/0000-0002-5794-0349; Mills, Ryan/0000-0003-3425-6998; Todd, Peter/0000-0003-4781-6376; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Sutton, Michael/0000-0002-0692-6459; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Scaglione, Kenneth/0000-0002-3858-9418	NAF postdoctoral fellowship; Michigan Alzheimer's Disease Center;  [KNS069809A];  [RO1 NS038712];  [RO1 AG034228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH097451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936, K99NS073936, K08NS069809, R01NS038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034228] Funding Source: NIH RePORTER	NAF postdoctoral fellowship; Michigan Alzheimer's Disease Center; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Peng Jin for providing (CGG)<INF>90</INF> GFP fly lines, Karen Usdin for providing (CGG)<INF>120</INF> KI "NIH" mice, and David Nelson and the Fragile X mutant mouse facility for providing (CGG)<INF>160</INF> KI "Dutch" mice (originally generated by Rob Willemsen in Erasmus, the Netherlands), Paul Hagerman for sharing plasmids and patient tissue samples, and Zhe Han and Jinghan Cheng for fly resources and technical assistance. This work was funded by KNS069809A to P.K.T. NAF postdoctoral fellowship to F.H. and RO1 NS038712, RO1 AG034228, and research funds from the Michigan Alzheimer's Disease Center to H.L.P.	Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Beerman RW, 2011, NEUROSCIENCE, V181, P48, DOI 10.1016/j.neuroscience.2011.02.029; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brouwer JR, 2008, J NEUROCHEM, V107, P1671, DOI 10.1111/j.1471-4159.2008.05747.x; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Entezam A, 2007, GENE, V395, P125, DOI 10.1016/j.gene.2007.02.026; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Handa V, 2005, FEBS LETT, V579, P2702, DOI 10.1016/j.febslet.2005.04.004; Hashem V, 2009, HUM MOL GENET, V18, P2443, DOI 10.1093/hmg/ddp182; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; HUBER TW, 1970, J BACTERIOL, V103, P116, DOI 10.1128/JB.103.1.116-119.1970; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Leehey MA, 2008, NEUROLOGY, V70, P1397, DOI 10.1212/01.wnl.0000281692.98200.f5; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Louis E, 2006, MOVEMENT DISORD, V21, P420, DOI 10.1002/mds.20753; Ludwig AL, 2011, J MOL BIOL, V407, P21, DOI 10.1016/j.jmb.2011.01.006; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Napierala M, 2005, NUCLEIC ACIDS RES, V33, P451, DOI 10.1093/nar/gki186; Oma Y, 2004, J BIOL CHEM, V279, P21217, DOI 10.1074/jbc.M309887200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stochmanski SJ, 2012, HUM MOL GENET, V21, P2211, DOI 10.1093/hmg/dds036; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Todd PK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001240; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	49	314	318	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					440	455		10.1016/j.neuron.2013.03.026	http://dx.doi.org/10.1016/j.neuron.2013.03.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23602499	Green Accepted, Bronze			2022-12-25	WOS:000318961700007
J	Lu, BX; Al-Ramahi, I; Valencia, A; Wang, Q; Berenshteyn, F; Yang, HD; Gallego-Flores, T; Ichcho, S; Lacoste, A; Hild, M; DiFiglia, M; Botas, J; Palacino, J				Lu, Boxun; Al-Ramahi, Ismael; Valencia, Antonio; Wang, Qiong; Berenshteyn, Frada; Yang, Haidi; Gallego-Flores, Tatiana; Ichcho, Salah; Lacoste, Arnaud; Hild, Marc; DiFiglia, Marian; Botas, Juan; Palacino, James			Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance	NATURE NEUROSCIENCE			English	Article							IN MOUSE MODEL; PROTEASOMAL DEGRADATION; DISEASE; CELLS; NEDD8; MODIFIERS; MOTOR; NEUROPATHOLOGY; INACTIVATION; PROTEOLYSIS	Huntington's disease is caused by expanded CAG repeats in HTT, conferring toxic gain of function on mutant HTT (mHTT) protein. Reducing mHTT amounts is postulated as a strategy for therapeutic intervention. We conducted genome-wide RNA interference screens for genes modifying mHTT abundance and identified 13 hits. We tested 10 in vivo in a Drosophila melanogaster Huntington's disease model, and 6 exhibited activity consistent with the in vitro screening results. Among these, negative regulator of ubiquitin-like protein 1 (NUB1) overexpression lowered mHTT in neuronal models and rescued mHTT-induced death. NUB1 reduces mHTT amounts by enhancing polyubiquitination and proteasomal degradation of mHTT protein. The process requires CUL3 and the ubiquitin-like protein NEDD8 necessary for CUL3 activation. As a potential approach to modulating NUB1 for treatment, interferon-beta lowered mHTT and rescued neuronal toxicity through induction of NUB1. Thus, we have identified genes modifying endogenous mHTT using high-throughput screening and demonstrate NUB1 as an exemplar entry point for therapeutic intervention of Huntington's disease.	[Lu, Boxun] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lu, Boxun; Wang, Qiong; Berenshteyn, Frada; Yang, Haidi; Ichcho, Salah; Lacoste, Arnaud; Hild, Marc; Palacino, James] Novartis Inst BioMed Res Inc, Dev & Mol Pathways, Cambridge, MA USA; [Al-Ramahi, Ismael; Gallego-Flores, Tatiana; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Al-Ramahi, Ismael; Gallego-Flores, Tatiana; Botas, Juan] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Valencia, Antonio; DiFiglia, Marian] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Valencia, Antonio; DiFiglia, Marian] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	Fudan University; Novartis; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Palacino, J (corresponding author), Novartis Inst BioMed Res Inc, Dev & Mol Pathways, Cambridge, MA USA.	luboxun@fudan.edu.cn; james.palacino@novartis.com	Al-Ramahi, Ismael/B-4000-2017	Al-Ramahi, Ismael/0000-0002-1275-1114; Gallego, Tatiana/0000-0003-0773-0578	John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation; Hereditary Disease Foundation; US National Institutes of Health grant [NS074381]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS074381] Funding Source: NIH RePORTER	John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation; Hereditary Disease Foundation; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank D. Curtis for discussions and suggestions during the project, X. Shi for performing the control screening on SMN level changes, C. Mazur for assistance with cloning and sample processing, P. Manos and C. Littlefield for assistance with the hESC and human iPSC experiments, and E. Kim for assistance with the fly experiments. I.A. was funded by a John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation. A.V. was funded by the Hereditary Disease Foundation. M.D. was funded by US National Institutes of Health grant NS074381.	Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacDonald ME, 1996, COLD SPRING HARB SYM, V61, P627; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nagashima Y, 2011, J BIOL CHEM, V286, P29594, DOI 10.1074/jbc.M111.261032; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Tanji K, 2007, ACTA NEUROPATHOL, V114, P365, DOI 10.1007/s00401-007-0238-1; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	51	71	73	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					562	+		10.1038/nn.3367	http://dx.doi.org/10.1038/nn.3367			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525043				2022-12-25	WOS:000318029300012
J	Boyken, J; Gronborg, M; Riedel, D; Urlaub, H; Jahn, R; Chua, JJE				Boyken, Janina; Gronborg, Mads; Riedel, Dietmar; Urlaub, Henning; Jahn, Reinhard; Chua, John Jia En			Molecular Profiling of Synaptic Vesicle Docking Sites Reveals Novel Proteins but Few Differences between Glutamatergic and GABAergic Synapses	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRESYNAPTIC ACTIVE ZONE; RAT-BRAIN; POSTSYNAPTIC DENSITY; PROTEOMICS ANALYSIS; ADHESION MOLECULES; NERVE-TERMINALS; TRANSPORTER; EXPRESSION; MEMBRANES	Neurotransmission involves calcium-triggered fusion of docked synaptic vesicles at specialized presynaptic release sites. While many of the participating proteins have been identified, the molecular composition of these sites has not been characterized comprehensively. Here, we report a procedure to biochemically isolate fractions highly enriched in docked synaptic vesicles. The fraction is largely free of postsynaptic proteins and most other organelles while containing most known synaptic vesicle and active zone proteins. Numerous presynaptic transmembrane proteins were also identified, together with over 30 uncharacterized proteins, many of which are evolutionarily conserved. Quantitative proteomic comparison of glutamate- and GABA-specific docking complexes revealed that, except of neurotransmitter-specific enzymes and transporters, only few proteins were selectively enriched in either fraction. We conclude that the core machinery involved in vesicle docking and exocytosis does not show compositional differences between the two types of synapses.	[Boyken, Janina; Gronborg, Mads; Jahn, Reinhard; Chua, John Jia En] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Gronborg, Mads; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Chem, D-37075 Gottingen, Germany; [Gronborg, Mads] Hagedorn Res Inst, DK-2820 Gentofte, Denmark	Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen; University of Groningen; Novo Nordisk; Hagedorn Research Institute	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	889, CRC/L-1607-2018; Chua, John Jia En/G-8639-2012	889, CRC/0000-0002-6678-3138; Chua, John Jia En/0000-0002-5615-1014; Jahn, Reinhard/0000-0003-1542-3498	European Union [HEALTH-F2-2009-241498]; Deutsche Forschungsgemeinschaft [SFB 889, TP4]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Prof. Silvio Rizzoli for providing the MatLab program and Maria Druminski for excellent technical assistance. The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement no. HEALTH-F2-2009-241498 ("EUROSPIN") to R.J. and of the Deutsche Forschungsgemeinschaft (SFB 889, TP4) to R.J. and H.U.	Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Bukalo O, 2012, ADV EXP MED BIOL, V970, P97, DOI 10.1007/978-3-7091-0932-8_5; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Cooper B, 2008, BRAIN RES, V1197, P1, DOI 10.1016/j.brainres.2007.11.066; Craig AM, 1996, J NEUROSCI, V16, P3166; DAVIS GA, 1973, BRAIN RES, V62, P135, DOI 10.1016/0006-8993(73)90624-0; FISZER SARA, 1967, BRAIN RES, V5, P31, DOI 10.1016/0006-8993(67)90217-X; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; GRAY EG, 1963, J ANAT, V97, P101; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; JONES EG, 1994, J NEUROSCI, V14, P611; Knaus HG, 1996, J NEUROSCI, V16, P955; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Morciano M, 2009, J NEUROCHEM, V108, P662, DOI 10.1111/j.1471-4159.2008.05824.x; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Muto Y, 2008, CELL CYCLE, V7, P2738, DOI 10.4161/cc.7.17.6591; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Phillips GR, 2005, J NEUROSCI RES, V81, P762, DOI 10.1002/jnr.20614; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x	47	102	102	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					285	297		10.1016/j.neuron.2013.02.027	http://dx.doi.org/10.1016/j.neuron.2013.02.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622064	Green Published, Bronze			2022-12-25	WOS:000318202200009
J	Vincent, JJ; Huang, Y; Chen, PY; Feng, SH; Calvopina, JH; Nee, K; Lee, SA; Le, T; Yoon, AJ; Faull, K; Fan, GP; Rao, A; Jacobsen, SE; Pellegrini, M; Clark, AT				Vincent, John J.; Huang, Yun; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Nee, Kevin; Lee, Serena A.; Thuc Le; Yoon, Alexander J.; Faull, Kym; Fan, Guoping; Rao, Anjana; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.			Stage-Specific Roles for Tet1 and Tet2 in DNA Demethylation in Primordial Germ Cells	CELL STEM CELL			English	Article							IMPRINT ERASURE; MOUSE EMBRYO; METHYLATION; DYNAMICS; GENOME; 5-HYDROXYMETHYLCYTOSINE; LINEAGES	Primordial germ cells (PGCs) undergo dramatic rearrangements to their methylome during embryogenesis, including initial genome-wide DNA demethylation that establishes the germline epigenetic ground state. The role of the 5-methylcytosine (5mC) dioxygenases Tet1 and Tet2 in the initial genome-wide DNA demethylation process has not been examined directly. Using PGCs differentiated from either control or Tet2(-/-); Tet1 knockdown embryonic stem cells (ESCs), we show that in vitro PGC (iPGC) formation and genome-wide DNA demethylation are unaffected by the absence of Tet1 and Tet2, and thus 5-hydroxymethylcytosine (5hmC). However, numerous promoters and gene bodies were hypermethylated in mutant iPGCs, which is consistent with a role for 5hmC as an intermediate in locus-specific demethylation. Altogether, our results support a revised model of PGC DNA demethylation in which the first phase of comprehensive 5mC loss does not involve 5hmC. Instead, Tet1 and Tet2 have a locus-specific role in shaping the PGC epigenome during subsequent development.	[Vincent, John J.; Yoon, Alexander J.; Faull, Kym; Fan, Guoping; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Nee, Kevin; Lee, Serena A.; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Chen, Pao-Yang; Feng, Suhua; Calvopina, Joseph H.; Fan, Guoping; Jacobsen, Steven E.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Thuc Le; Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Thuc Le; Yoon, Alexander J.; Faull, Kym] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Huang, Yun; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Chen, Pao-Yang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Academia Sinica - Taiwan	Clark, AT (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu	Chen, Pao-Yang/ABG-9939-2020	Chen, Pao-Yang/0000-0002-7402-3075; Huang, Yun/0000-0001-5950-9168; Fan, Guoping/0000-0001-5235-6410; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health (NIH) [R01HD058047]; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research; NIH [R01 HD065812, CA151535]; UCLA; Leukemia & Lymphoma Society; California Institute for Regenerative Medicine [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047, R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grant R01HD058047 from the National Institutes of Health (NIH) and a Research Award from the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research to A. T. C. and NIH grants R01 HD065812 and CA151535 to A. R. The sequencing and FACS experiments were performed at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research Sequencing Center and FACS facility. J.J.V. is supported by a Dissertation Year Fellowship from UCLA. Y.H. and S. F. are supported by postdoctoral fellowships from the Leukemia & Lymphoma Society and J.H.C. is supported by fellowship TG2-01169 from the California Institute for Regenerative Medicine. Requests for Tet2<SUP>-/-</SUP> ESCs should be directed to A. R. at the La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.	Ambartsumyan G, 2010, HUM MOL GENET, V19, P3970, DOI 10.1093/hmg/ddq312; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lei H, 1996, DEVELOPMENT, V122, P3195; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MONK M, 1987, DEVELOPMENT, V99, P371; Ohinata Y, 2006, E SCHERING RES FDN W, V60, P143; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thuc L, 2011, ANAL BIOCHEM, V412, P203, DOI 10.1016/j.ab.2011.01.026; Vincent JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028960; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	40	135	138	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					470	478		10.1016/j.stem.2013.01.016	http://dx.doi.org/10.1016/j.stem.2013.01.016			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23415914	Green Accepted, Bronze			2022-12-25	WOS:000329569500013
J	Brocard, F; Shevtsova, NA; Bouhadfane, M; Tazerart, S; Heinemann, U; Rybak, IA; Vinay, L				Brocard, Frederic; Shevtsova, Natalia A.; Bouhadfane, Mouloud; Tazerart, Sabrina; Heinemann, Uwe; Rybak, Ilya A.; Vinay, Laurent			Activity-Dependent Changes in Extracellular Ca2+ and K+ Reveal Pacemakers in the Spinal Locomotor-Related Network	NEURON			English	Article							PERSISTENT SODIUM CURRENT; RESPIRATORY RHYTHM GENERATION; CENTRAL PATTERN GENERATOR; PRE-BOTZINGER COMPLEX; CORD IN-VITRO; NEONATAL-RAT; HB9 INTERNEURONS; POTASSIUM CONCENTRATION; VOLTAGE OSCILLATIONS; FICTIVE LOCOMOTION	Changes in the extracellular ionic concentrations occur as a natural consequence of firing activity in large populations of neurons. The extent to which these changes alter the properties of individual neurons and the operation of neuronal networks remains unknown. Here, we show that the locomotorlike activity in the isolated neonatal rodent spinal cord reduces the extracellular calcium ([Ca2+](o)) to 0.9 mM and increases the extracellular potassium ([K+](o)) to 6 mM. Such changes in [Ca2+](o) and [K+](o) trigger pacemaker activities in interneurons considered to be part of the locomotor network. Experimental data and a modeling study show that the emergence of pacemaker properties critically involves a [Ca2+](o)-dependent activation of the persistent sodium current (I-NaP). These results support a concept for locomotor rhythm generation in which I-NaP-dependent pacemaker properties in spinal interneurons are switched on and tuned by activity-dependent changes in [Ca2+](o) and [K+](o).	[Brocard, Frederic; Bouhadfane, Mouloud; Tazerart, Sabrina; Vinay, Laurent] CNRS, UMR 7289, Inst Neurosci Timone, Team P3M, F-13385 Marseille, France; [Brocard, Frederic; Bouhadfane, Mouloud; Tazerart, Sabrina; Vinay, Laurent] Aix Marseille Univ, F-13385 Marseille, France; [Shevtsova, Natalia A.; Rybak, Ilya A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; [Heinemann, Uwe] Charite Univ Med Berlin, Neurowissensch Forschungszentrum, D-14195 Berlin, Germany; [Heinemann, Uwe] Charite Univ Med Berlin, Inst Neurophysiol, D-14195 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Drexel University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brocard, F (corresponding author), CNRS, UMR 7289, Inst Neurosci Timone, Team P3M, F-13385 Marseille, France.	frederic.brocard@univ-amu.fr		Brocard, Frederic/0000-0001-9444-9586	French Agence Nationale pour la Recherche; Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); Fondation pour la Recherche Medicale (FRM); National Institutes of Health [R01 NS081713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081713, R01NS048844, R01NS057815, R01NS069220] Funding Source: NIH RePORTER	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the French Agence Nationale pour la Recherche (ANR to L.V.), the Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME to L.V. and F.B.). S.T. received a grant from the Fondation pour la Recherche Medicale (FRM). I.A.R. and N.A.S. were supported by the National Institutes of Health grant R01 NS081713. F.B. designed and supervised the overall project, performed and analyzed in vitro experiments, and wrote the manuscript. S.T. performed and analyzed some in vitro experiments in Figure 1 and Figure S3. M.B. performed and analyzed some experiments in Figure 1 and Figure S3. N.A.S. designed, performed, and analyzed the modeling study and wrote the manuscript. I.A.R. supervised the modeling investigation and wrote the manuscript. U.H. provided valuable expertise for the ion-sensitive microelectrode techniques. L.V. contributed to the design and supervision of the project and wrote the manuscript.	Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Anderson TM, 2012, J NEUROPHYSIOL, V107, P103, DOI 10.1152/jn.00583.2011; Armstrong CM, 1999, P NATL ACAD SCI USA, V96, P4158, DOI 10.1073/pnas.96.7.4158; Brocard F, 2006, J NEUROPHYSIOL, V96, P2410, DOI 10.1152/jn.00352.2006; Brocard F, 2010, NEUROSCIENTIST, V16, P139, DOI 10.1177/1073858409346339; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; Cowley KC, 2005, J NEUROPHYSIOL, V94, P3805, DOI 10.1152/jn.00016.2005; GRILLNER S, 1985, NEUROSCI LETT, V60, P289, DOI 10.1016/0304-3940(85)90592-0; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; HEINEMANN U, 1981, NEUROSCI LETT, V21, P87, DOI 10.1016/0304-3940(81)90063-X; HEINEMANN U, 1990, EXP BRAIN RES, V79, P283, DOI 10.1007/BF00608237; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P2559, DOI 10.1152/jn.1994.72.5.2559; Hsiao CF, 2002, J NEUROPHYSIOL, V87, P1318, DOI 10.1152/jn.00469.2001; JENDELOVA P, 1991, GLIA, V4, P56, DOI 10.1002/glia.440040107; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kiehn O, 2010, BIOCHEM BIOPH RES CO, V396, P11, DOI 10.1016/j.bbrc.2010.02.107; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KRIZ N, 1974, J PHYSIOL-LONDON, V238, P1; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; Li WC, 2010, J NEUROSCI, V30, P16609, DOI 10.1523/JNEUROSCI.3695-10.2010; LOTHMAN EW, 1975, J PHYSIOL-LONDON, V252, P115, DOI 10.1113/jphysiol.1975.sp011137; Marchetti C, 2001, NEUROSCI LETT, V304, P77, DOI 10.1016/S0304-3940(01)01777-3; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; McCrea DA, 2007, PROG BRAIN RES, V165, P235, DOI 10.1016/S0079-6123(06)65015-2; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Pace RW, 2007, J PHYSIOL-LONDON, V580, P485, DOI 10.1113/jphysiol.2006.124602; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Rybak IA, 2003, EUR J NEUROSCI, V18, P239, DOI 10.1046/j.1460-9568.2003.02739.x; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P641, DOI 10.1113/jphysiol.2006.118711; Ryczko D, 2010, J NEUROPHYSIOL, V104, P2677, DOI 10.1152/jn.00479.2010; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; SYKOVA E, 1987, CAN J PHYSIOL PHARM, V65, P1058, DOI 10.1139/y87-167; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Tazerart S, 2007, J NEUROPHYSIOL, V98, P613, DOI 10.1152/jn.00316.2007; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Vargova L, 2001, J CEREBR BLOOD F MET, V21, P1077, DOI 10.1097/00004647-200109000-00005; WALLEN P, 1984, ACTA PHYSIOL SCAND, V120, P457, DOI 10.1111/j.1748-1716.1984.tb07406.x; WALTON KD, 1988, NEUROSCIENCE, V25, P983, DOI 10.1016/0306-4522(88)90051-6; Zhong GS, 2007, J NEUROSCI, V27, P4507, DOI 10.1523/JNEUROSCI.0124-07.2007; Ziskind-Conhaim L, 2008, J NEUROPHYSIOL, V100, P2254, DOI 10.1152/jn.90437.2008	44	58	61	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1047	1054		10.1016/j.neuron.2013.01.026	http://dx.doi.org/10.1016/j.neuron.2013.01.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522041	Green Accepted, Bronze			2022-12-25	WOS:000316645000007
J	Goff, DJ; Recart, AC; Sadarangani, A; Chun, HJ; Barrett, CL; Krajewska, M; Leu, H; Low-Marchelli, J; Ma, WX; Shih, AY; Wei, J; Zhai, DY; Geron, I; Pu, MY; Bao, L; Chuang, R; Balaian, L; Gotlib, J; Minden, M; Martinelli, G; Rusert, J; Dao, KH; Shazand, K; Wentworth, P; Smith, KM; Jamieson, CAM; Morris, SR; Messer, K; Goldstein, LSB; Hudson, TJ; Marra, M; Frazer, KA; Pellecchia, M; Reed, JC; Jamieson, CHM				Goff, Daniel J.; Recart, Angela Court; Sadarangani, Anil; Chun, Hye-Jung; Barrett, Christian L.; Krajewska, Maryla; Leu, Heather; Low-Marchelli, Janine; Ma, Wenxue; Shih, Alice Y.; Wei, Jun; Zhai, Dayong; Geron, Ifat; Pu, Minya; Bao, Lei; Chuang, Ryan; Balaian, Larisa; Gotlib, Jason; Minden, Mark; Martinelli, Giovanni; Rusert, Jessica; Dao, Kim-Hien; Shazand, Kamran; Wentworth, Peggy; Smith, Kristen M.; Jamieson, Christina A. M.; Morris, Sheldon R.; Messer, Karen; Goldstein, Lawrence S. B.; Hudson, Thomas J.; Marra, Marco; Frazer, Kelly A.; Pellecchia, Maurizio; Reed, John C.; Jamieson, Catriona H. M.			A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition	CELL STEM CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCL-2 FAMILY PROTEINS; BLAST-CRISIS CML; IN-VIVO; REDUCES PROLIFERATION; HEMATOPOIETIC-CELLS; CANCER-THERAPY; CD34(+) CELLS; CYCLE CONTROL	Leukemia stem cells (LSCs) play a pivotal role in the resistance of chronic myeloid leukemia (CML) to tyrosine kinase inhibitors (TKIs) and its progression to blast crisis (BC), in part, through the alternative splicing of self-renewal and survival genes. To elucidate splice-isoform regulators of human BC LSC maintenance, we performed whole-transcriptome RNA sequencing, splice-isoform-specific quantitative RT-PCR (qRT-PCR), nanoproteomics, stromal coculture, and BC LSC xenotransplantation analyses. Cumulatively, these studies show that the alternative splicing of multiple prosurvival BCL2 family genes promotes malignant transformation of myeloid progenitors into BC LSCS that are quiescent in the marrow niche and that contribute to therapeutic resistance. Notably, sabutoclax, a pan-BCL2 inhibitor, renders marrow-niche-resident BC LSCs sensitive to TKIs at doses that spare normal progenitors. These findings underscore the importance of alternative BCL2 family splice-isoform expression in BC LSC maintenance and suggest that the combinatorial inhibition of prosurvival BCL2 family proteins and BCR-ABL may eliminate dormant LSCs and obviate resistance.	[Goff, Daniel J.; Recart, Angela Court; Sadarangani, Anil; Leu, Heather; Low-Marchelli, Janine; Ma, Wenxue; Shih, Alice Y.; Geron, Ifat; Pu, Minya; Bao, Lei; Chuang, Ryan; Balaian, Larisa; Wentworth, Peggy; Smith, Kristen M.; Jamieson, Christina A. M.; Morris, Sheldon R.; Messer, Karen; Jamieson, Catriona H. M.] Univ Calif San Diego, Moores Canc Ctr, Dept Med, Stem Cell Program, La Jolla, CA 92093 USA; [Barrett, Christian L.; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, Div Genome Informat Sci, La Jolla, CA 92093 USA; [Rusert, Jessica; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Rusert, Jessica; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chun, Hye-Jung; Marra, Marco] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Krajewska, Maryla; Wei, Jun; Zhai, Dayong; Pellecchia, Maurizio; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92093 USA; [Gotlib, Jason] Stanford Med Ctr, Div Hematol, Stanford, CA 94305 USA; [Minden, Mark] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Martinelli, Giovanni] Univ Bologna, Inst Hematol & Med Oncol, I-40126 Bologna, Italy; [Dao, Kim-Hien] Oregon Hlth & Sci Univ, Div Bone Marrow Transplantat, Portland, OR 97239 USA; [Shazand, Kamran; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; British Columbia Cancer Agency; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bologna; Oregon Health & Science University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Jamieson, CHM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Med, Stem Cell Program, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu	Ma, Wenxue/A-6344-2012; Ma, Wenxue/D-5383-2019; Pellecchia, Maurizio/Y-7072-2018; Martinelli, Giovanni/AAK-9211-2020; Marra, Marco A/B-5987-2008	Ma, Wenxue/0000-0001-9228-6162; Ma, Wenxue/0000-0001-9228-6162; Martinelli, Giovanni/0000-0002-1025-4210; Marra, Marco A/0000-0001-7146-7175; Goff, Daniel/0000-0003-2109-1696; Hudson, Thomas/0000-0002-1376-4849; Frazer, Kelly/0000-0002-6060-8902; Smith, Kristen/0000-0003-0960-0937	Ratner Family Fund; California Institute for Regenerative Medicine (CIRM) [RN2-00910-1, RS1-00228-1, TR2-01789, DR1-01430]; CIRM UCSD Stem Cell Training Grant II; UCSD Cancer Training Grant; National Cancer Institute (NCI) [CA-55164]; National Institutes of Health (NIH) [CA-149668]; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Government of Canada through Ontario Genomics Institute [OGI-047]; Government of Canada through Canadian Institute of Health Research [CSC-105367]; NATIONAL CANCER INSTITUTE [R01CA149668, P01CA055164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524, T32GM007198] Funding Source: NIH RePORTER	Ratner Family Fund; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM UCSD Stem Cell Training Grant II; UCSD Cancer Training Grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Government of Canada through Ontario Genomics Institute; Government of Canada through Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dennis Carson for his continuous advice and mentorship, Dennis Young for his expert assistance on all FACS experiments, Ida Deichaite for her excellent assistance with material transfer and industry relations, Jennifer Black and Rusty Wall for their help with sample preparation and mouse experiments, Isabel Newton for her advice and help with DiR studies, Derrick Duarte for his assistance with immunohistochemistry studies, Jerry Wu for his assistance with FACS cell-cycle experiments, and Kimberly Wilson for her assistance with grant and manuscript preparation and submission. This work was generously supported by the Ratner Family Fund and by the California Institute for Regenerative Medicine (CIRM; grants RN2-00910-1, RS1-00228-1, TR2-01789, and DR1-01430). D.J.G. was supported by the CIRM UCSD Stem Cell Training Grant II and the UCSD Cancer Training Grant. This work was also funded by the National Cancer Institute (NCI; no. CA-55164) and the National Institutes of Health (NIH; no. CA-149668), and supported by the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation and the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and through the Canadian Institute of Health Research (CSC-105367). J.C.R., J.W., and M. P. are coinventors of sabutoclax and related compounds, licensed by the SBMRI to Oncothyreon (Seattle). The Oncothyreon license entitles J.C.R. to milestone and royalty payments for studies advancing to clinic. He does not receive consulting fees or lab support, nor does he have stock or stock options.	Abe A, 2008, INT J HEMATOL, V88, P471, DOI 10.1007/s12185-008-0221-1; Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chomel JC, 2011, ONCOTARGET, V2, P713; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger Michael, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS11; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; ESFAHANI MK, 2006, CURR TREAT OPTION ON, V7, P189; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goldman DA, 2000, STAT MED, V19, P1081, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1081::AID-SIM406>3.0.CO;2-A; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Konopleva M, 2002, BRIT J HAEMATOL, V118, P521, DOI 10.1046/j.1365-2141.2002.03637.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mak DH, 2012, LEUKEMIA, V26, P788, DOI 10.1038/leu.2011.285; MARTIN PJ, 1980, NATURE, V287, P49, DOI 10.1038/287049a0; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meng Y, 2007, LEUKEMIA LYMPHOMA, V48, P2204, DOI 10.1080/10428190701583991; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OReilly LA, 1997, J IMMUNOL, V159, P2301; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Slape CI, 2012, BLOOD, V120, P2475, DOI 10.1182/blood-2012-05-430736; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Tauchi T, 2003, CLIN CANCER RES, V9, P4267; Vairo G, 1996, ONCOGENE, V13, P1511; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Wei J, 2009, J MED CHEM, V52, P4511, DOI 10.1021/jm900472s; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	71	141	144	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					316	328		10.1016/j.stem.2012.12.011	http://dx.doi.org/10.1016/j.stem.2012.12.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333150	Bronze, Green Accepted			2022-12-25	WOS:000329569400010
J	Golumbic, EMZ; Ding, N; Bickel, S; Lakatos, P; Schevon, CA; McKhann, GM; Goodman, RR; Emerson, R; Mehta, AD; Simon, JZ; Poeppel, D; Schroeder, CE				Golumbic, Elena M. Zion; Ding, Nai; Bickel, Stephan; Lakatos, Peter; Schevon, Catherine A.; McKhann, Guy M.; Goodman, Robert R.; Emerson, Ronald; Mehta, Ashesh D.; Simon, Jonathan Z.; Poeppel, David; Schroeder, Charles E.			Mechanisms Underlying Selective Neuronal Tracking of Attended Speech at a "Cocktail Party"	NEURON			English	Article							HUMAN AUDITORY-CORTEX; RECEPTIVE-FIELDS; CORTICAL NETWORK; PHASE PATTERNS; ATTENTION; FREQUENCY; OSCILLATIONS; RESPONSES; DYNAMICS; NOISE	The ability to focus on and understand one talker in a noisy social environment is a critical social-cognitive capacity, whose underlying neuronal mechanisms are unclear. We investigated the manner in which speech streams are represented in brain activity and the way that selective attention governs the brain's representation of speech using a "Cocktail Party" paradigm, coupled with direct recordings from the cortical surface in surgical epilepsy patients. We find that brain activity dynamically tracks speech streams using both low-frequency phase and high-frequency amplitude fluctuations and that optimal encoding likely combines the two. In and near low-level auditory cortices, attention "modulates" the representation by enhancing cortical tracking of attended speech streams, but ignored speech remains represented. In higher-order regions, the representation appears to become more "selective," in that there is no detectable tracking of ignored speech. This selectivity itself seems to sharpen as a sentence unfolds.	[Golumbic, Elena M. Zion; Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Schevon, Catherine A.; Emerson, Ronald] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [McKhann, Guy M.; Goodman, Robert R.] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, New York, NY 10032 USA; [Golumbic, Elena M. Zion; Lakatos, Peter; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Ding, Nai; Simon, Jonathan Z.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20740 USA; [Ding, Nai; Simon, Jonathan Z.] Univ Maryland, Dept Biol, College Pk, MD 20740 USA; [Bickel, Stephan; Mehta, Ashesh D.] North Shore Long Isl Jewish Hlth Syst, Dept Neurol, New Hyde Pk, NY 11040 USA; [Bickel, Stephan; Mehta, Ashesh D.] North Shore Long Isl Jewish Hlth Syst, Dept Neurosurg, New Hyde Pk, NY 11040 USA; [Bickel, Stephan; Mehta, Ashesh D.] Hofstra Univ, Sch Med, Feinstein Inst Med Res, Manhasset, NY 11549 USA; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Columbia University; Columbia University; Columbia University; Nathan Kline Institute for Psychiatric Research; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Northwell Health; Northwell Health; Hofstra University; Northwell Health; New York University	Schroeder, CE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	schrod@nki.rfmh.org	Simon, Jonathan Z/A-8196-2008	Simon, Jonathan Z/0000-0003-0858-0698; Lakatos, Peter/0000-0003-0221-4021	 [MH093061];  [MH60358];  [MH086385];  [DC008342];  [DC05660]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060358, F32MH093061, P50MH086385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012947, R01DC005660, R01DC008342, R56DC005660] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by MH093061, MH60358, MH086385, DC008342, and DC05660. We thank Dr. Joseph Isler and the other members of the Columbia Oscillations Journal Club for critical comments and advice on this work.	Ahissar E, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P295; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Ding N, 2012, J NEUROPHYSIOL, V107, P78, DOI 10.1152/jn.00297.2011; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Golumbic EMZ, 2012, BRAIN LANG, V122, P151, DOI 10.1016/j.bandl.2011.12.010; Golumbic EZ, 2013, J NEUROSCI, V33, P1417, DOI 10.1523/JNEUROSCI.3675-12.2013; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Greenberg S, 2006, LISTENING SPEECH AUD; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Kayser C, 2007, J NEUROPHYSIOL, V98, P1806, DOI 10.1152/jn.00358.2007; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Xiang JJ, 2010, J NEUROSCI, V30, P12084, DOI 10.1523/JNEUROSCI.0827-10.2010	49	458	462	6	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					980	991		10.1016/j.neuron.2012.12.037	http://dx.doi.org/10.1016/j.neuron.2012.12.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473326	Green Accepted, Bronze			2022-12-25	WOS:000316162600017
J	Lakatos, P; Musacchia, G; O'Connel, MN; Falchier, AY; Javitt, DC; Schroeder, CE				Lakatos, Peter; Musacchia, Gabriella; O'Connel, Monica N.; Falchier, Arnaud Y.; Javitt, Daniel C.; Schroeder, Charles E.			The Spectrotemporal Filter Mechanism of Auditory Selective Attention	NEURON			English	Article							THALAMIC RETICULAR NUCLEUS; GAMMA-BAND SYNCHRONIZATION; NEURONAL OSCILLATIONS; PREFRONTAL CORTEX; CORTICAL REPRESENTATION; STREAM SEGREGATION; RECEPTIVE-FIELDS; DYNAMICS; PROJECTIONS; MODULATION	Although we have convincing evidence that attention to auditory stimuli modulates neuronal responses at or before the level of primary auditory cortex (A1), the underlying physiological mechanisms are unknown. We found that attending to rhythmic auditory streams resulted in the entrainment of ongoing oscillatory activity reflecting rhythmic excitability fluctuations in A1. Strikingly, although the rhythm of the entrained oscillations in A1 neuronal ensembles reflected the temporal structure of the attended stream, the phase depended on the attended frequency content. Counter-phase entrainment across differently tuned A1 regions resulted in both the amplification and sharpening of responses at attended time points, in essence acting as a spectrotemporal filter mechanism. Our data suggest that selective attention generates a dynamically evolving model of attended auditory stimulus streams in the form of modulatory subthreshold oscillations across tonotopically organized neuronal ensembles in A1 that enhances the representation of attended stimuli.	[Lakatos, Peter; O'Connel, Monica N.; Falchier, Arnaud Y.; Javitt, Daniel C.; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Lakatos, Peter; Javitt, Daniel C.; Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Musacchia, Gabriella] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Nathan Kline Institute for Psychiatric Research; Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Lakatos, P (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	plakatos@nki.rfmh.org	Musacchia, Gabriella Andrea-Eugenia/AAN-5493-2020; Javitt, Daniel/U-6015-2019	Musacchia, Gabriella Andrea-Eugenia/0000-0001-8895-9096; Lakatos, Peter/0000-0003-0221-4021; Falchier, Arnaud/0000-0003-2426-3975	NIH from the NIDCD [DC010415, DC011490]; NIMH [MH060358, MH086385, MH49334]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012947, R01DC011490, R21DC010415] Funding Source: NIH RePORTER	NIH from the NIDCD; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for this work was provided by NIH grant DC010415 and DC011490 from the NIDCD, and grants, MH060358, MH086385 and MH49334 from the NIMH.	Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; BARTUS RT, 1977, BRAIN RES, V119, P233, DOI 10.1016/0006-8993(77)90103-2; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; BRAGIN A, 1995, J NEUROSCI, V15, P47; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cason N, 2012, NEUROPSYCHOLOGIA, V50, P2652, DOI 10.1016/j.neuropsychologia.2012.07.018; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fritz J, 2005, HEARING RES, V206, P159, DOI 10.1016/j.heares.2005.01.015; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; HASHIKAWA T, 1991, BRAIN RES, V544, P335, DOI 10.1016/0006-8993(91)90076-8; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Izumi A, 2002, COGNITION, V82, pB113, DOI 10.1016/S0010-0277(01)00161-5; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG., 1998, ADV NEUROL, V77, P72; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kosaki H, 1997, J COMP NEUROL, V386, P304; Kubovy M, 2001, COGNITION, V80, P97, DOI 10.1016/S0010-0277(00)00155-4; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lehiste I., 1977, J PHONET, V5, P253, DOI [DOI 10.1016/S0095-4470, 10.1016/S0095-4470]; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; MOLINARI M, 1995, J COMP NEUROL, V362, P171, DOI 10.1002/cne.903620203; O'Connell MN, 2011, NEURON, V69, P805, DOI 10.1016/j.neuron.2011.01.012; Obleser J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00250; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P1643, DOI 10.1097/WNR.0b013e328333b0c6; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; van Noorden L. P. A. S., 1975, THESIS TH EINDHOVEN; Viaene AN, 2011, J NEUROPHYSIOL, V105, P279, DOI 10.1152/jn.00747.2010; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zikopoulos B, 2007, REV NEUROSCIENCE, V18, P417; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	72	280	284	5	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2013	77	4					750	761		10.1016/j.neuron.2012.11.034	http://dx.doi.org/10.1016/j.neuron.2012.11.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439126	Green Accepted, Bronze			2022-12-25	WOS:000315561300016
J	Engelhard, B; Ozeri, N; Israel, Z; Bergman, H; Vaadia, E				Engelhard, Ben; Ozeri, Nofar; Israel, Zvi; Bergman, Hagai; Vaadia, Eilon			Inducing Gamma Oscillations and Precise Spike Synchrony by Operant Conditioning via Brain-Machine Interface	NEURON			English	Article							FIELD POTENTIAL OSCILLATIONS; PRIMATE MOTOR CORTEX; SENSORIMOTOR CORTEX; NEURONAL OSCILLATIONS; VISUAL-CORTEX; EEG; DYNAMICS; SCALE; NEUROFEEDBACK; INTERNEURONS	Neural oscillations in the low-gamma range (3050 Hz) have been implicated in neuronal synchrony, computation, behavior, and cognition. Abnormal low-gamma activity, hypothesized to reflect impaired synchronization, has been evidenced in several brain disorders. Thus, understanding the relations between gamma oscillations, neuronal synchrony and behavior is a major research challenge. We used a brain-machine interface (BMI) to train monkeys to specifically increase low-gamma power in selected sites of motor cortex to move a cursor and obtain a reward. The monkeys learned to robustly generate oscillatory gamma waves, which were accompanied by a dramatic increase of spiking synchrony of highly precise spatiotemporal patterns. The findings link volitional control of LFP oscillations, neuronal synchrony, and the behavioral outcome. Subjects' ability to directly modulate specific patterns of neuronal synchrony provides a powerful approach for understanding neuronal processing in relation to behavior and for the use of BMIs in a clinical setting.	[Engelhard, Ben; Ozeri, Nofar; Bergman, Hagai; Vaadia, Eilon] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Israel, Zvi] Hadassah Univ Hosp, Dept Neurosurg, Ctr Funct & Restorat Neurosurg, IL-91120 Jerusalem, Israel; [Engelhard, Ben; Bergman, Hagai; Vaadia, Eilon] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Engelhard, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel.	ben.engelhard@mail.huji.ac.il	Bergman, Hagai/AAI-4683-2021; Israel, Zvi/S-5814-2016	Bergman, Hagai/0000-0002-2402-6673; Israel, Zvi/0000-0002-0060-5769	Binational Science Foundation (BSF); Israel Science Foundation; Rosetrees Trust; Gatsby Charitable Foundation; Ida Baruch Fund; Felix M. Katar fund; Rosetrees Trust [M14-F1] Funding Source: researchfish	Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Gatsby Charitable Foundation; Ida Baruch Fund; Felix M. Katar fund; Rosetrees Trust(Rosetrees Trust)	We thank I. Novick for help with the EMG recordings; E. Ahissar, I. Novick, and M. London for their helpful comments; A. Raz for help with the surgeries; and S. Freeman and A. Shapochnikov for technical assistance. This work was supported in part by the Binational Science Foundation (BSF), the Israel Science Foundation, special contributions from the Rosetrees Trust, the Gatsby Charitable Foundation, and the Ida Baruch Fund. B.E. was partly supported by the Felix M. Katar fund. This work is dedicated to the memory of Dr. Dmitry Davidov. The authors are currently preparing a patent application that is partly based on the results of this study.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Angelakis E, 2007, CLIN NEUROPSYCHOL, V21, P110, DOI 10.1080/13854040600744839; APOSTOL G, 1974, BRAIN RES, V67, P65, DOI 10.1016/0006-8993(74)90298-4; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar E, 2008, BRAIN RES, V1235, P172, DOI 10.1016/j.brainres.2008.06.103; BIRD BL, 1978, BIOFEEDBACK SELF-REG, V3, P1, DOI 10.1007/BF00998559; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Denker M, 2011, CEREB CORTEX, V21, P2681, DOI 10.1093/cercor/bhr040; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Keizer AW, 2010, INT J PSYCHOPHYSIOL, V75, P25, DOI 10.1016/j.ijpsycho.2009.10.011; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Loo SK, 2005, APPL NEUROPSYCHOL, V12, P64, DOI 10.1207/s15324826an1202_2; MacKay WA, 2005, FRON NEUROS, P181; Moriyama TS, 2012, NEUROTHERAPEUTICS, V9, P588, DOI 10.1007/s13311-012-0136-7; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nunez PL, 2010, BRAIN STRUCT FUNCT, V215, P67, DOI 10.1007/s00429-010-0277-6; Palanca BJA, 2005, NEURON, V46, P333, DOI 10.1016/j.neuron.2005.03.002; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Ros T, 2010, EUR J NEUROSCI, V31, P770, DOI 10.1111/j.1460-9568.2010.07100.x; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shmiel T, 2005, P NATL ACAD SCI USA, V102, P18655, DOI 10.1073/pnas.0509346102; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; STERIADE M, 1995, J COMP NEUROL, V354, P57, DOI 10.1002/cne.903540106; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	58	77	77	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					361	375		10.1016/j.neuron.2012.11.015	http://dx.doi.org/10.1016/j.neuron.2012.11.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352171	Bronze			2022-12-25	WOS:000314199400017
J	Wang, BS; Feng, L; Liu, MN; Liu, XR; Cang, JH				Wang, Bor-Shuen; Feng, Liang; Liu, Mingna; Liu, Xiaorong; Cang, Jianhua			Environmental Enrichment Rescues Binocular Matching of Orientation Preference in Mice that Have a Precocious Critical Period	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; VISUAL CORTICAL PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; HISTONE DEACETYLASE INHIBITORS; MULTIPLE SENSITIVE PERIODS; RECEPTIVE-FIELDS; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; MEMORY FORMATION	Experience shapes neural circuits during critical periods in early life. The timing of critical periods is regulated by both genetics and the environment. Here we study the functional significance of such temporal regulations in the mouse primary visual cortex, where critical period plasticity drives binocular matching of orientation preference. We find that the binocular matching is permanently disrupted in mice that have a precocious critical period due to genetically enhanced inhibition. The disruption is specific to one type of neuron, the complex cells, which, as we reveal, normally match after the simple cells. Early environmental enrichment completely rescues the deficit by inducing histone acetylation and consequently advancing the matching process to coincide with the precocious plasticity. Our experiments thus demonstrate that the proper timing of the critical period is essential for establishing normal binocularity and the detrimental impact of its genetic nnisregulation can be ameliorated by environmental manipulations via epigenetic mechanisms.	[Wang, Bor-Shuen; Liu, Mingna; Liu, Xiaorong; Cang, Jianhua] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Feng, Liang; Liu, Xiaorong] Northwestern Univ, Dept Ophthalmol, Evanston, IL 60208 USA; [Wang, Bor-Shuen] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Liu, XR (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	xiaorong-liu@northwestern.edu; cang@northwestern.edu	Liu, Mingna/E-9088-2013; Liu, Xiaorong/R-3787-2019; Liu, Mingna/F-6299-2014	Liu, Mingna/0000-0001-7060-0288; Liu, Xiaorong/0000-0002-7655-6342; Liu, Mingna/0000-0001-7060-0288	U.S. National Institutes of Health (NIH) [EY020950, EY019034]; Sloan Research Fellowship; Klingenstein Fellowship Award in Neurosciences; NATIONAL EYE INSTITUTE [R01EY020950, R01EY019034] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship Award in Neurosciences(Klingenstein Philanthropies); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Yong-Chao Ma and Rashmi Sarnaik for help with experiments; David Ferster, Josh Huang, Hermann Riecke, and members of the Gang laboratory for discussions and comments on early versions of the manuscript. This work was supported by U.S. National Institutes of Health (NIH) grants (EY020950 to J.C. and EY019034 to XL), a Sloan Research Fellowship, and a Klingenstein Fellowship Award in Neurosciences to J.C.	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Baroncelli L, 2010, EXP NEUROL, V226, P100, DOI 10.1016/j.expneurol.2010.08.009; Begenisic T, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00029; Brainard MS, 1998, J NEUROSCI, V18, P3929; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Carro E, 2000, J NEUROSCI, V20, P2926; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; CYNADER M, 1976, EXP BRAIN RES, V25, P139; Daw NW, 1997, OPTOMETRY VISION SCI, V74, P690, DOI 10.1097/00006324-199709000-00002; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; EMERSON VF, 1982, EXP BRAIN RES, V45, P168; Erwin E, 1999, J NEUROSCI, V19, P7212, DOI 10.1523/JNEUROSCI.19-16-07212.1999; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; HARWERTH RS, 1990, BEHAV BRAIN RES, V41, P179, DOI 10.1016/0166-4328(90)90107-P; HARWERTH RS, 1986, SCIENCE, V232, P235, DOI 10.1126/science.3952507; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, BRAIN RES, V122, P336, DOI 10.1016/0006-8993(77)90299-2; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; JONES KR, 1984, J NEUROSCI, V4, P2543; Kanold PO, 2009, J PHYSIOL-LONDON, V587, P2857, DOI 10.1113/jphysiol.2009.171215; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Landi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000346; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lewis TL, 2009, OPTOMETRY VISION SCI, V86, P640, DOI 10.1097/OPX.0b013e3181a7296b; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Li YT, 2012, J NEUROSCI, V32, P3981, DOI 10.1523/JNEUROSCI.5514-11.2012; Liu XR, 2007, J NEUROSCI, V27, P7256, DOI 10.1523/JNEUROSCI.0779-07.2007; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; Morales B, 2002, J NEUROSCI, V22, P8084; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sarnaik R., 2013, CEREB CORTEX, DOI DOI 10.1093/CERC0R/BHT027; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Scali M, 2012, EXP GERONTOL, V47, P337, DOI 10.1016/j.exger.2012.01.007; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; VANSLUYTERS RC, 1974, EXP BRAIN RES, V19, P196, DOI 10.1007/BF00238534; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	80	45	45	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					198	209		10.1016/j.neuron.2013.07.023	http://dx.doi.org/10.1016/j.neuron.2013.07.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24012279	Bronze, Green Accepted			2022-12-25	WOS:000326305300018
J	Zembrzycki, A; Chou, SJ; Ashery-Padan, R; Stoykova, A; O'Leary, DDM				Zembrzycki, Andreas; Chou, Shen-Ju; Ashery-Padan, Ruth; Stoykova, Anastassia; O'Leary, Dennis D. M.			Sensory cortex limits cortical maps and drives top-down plasticity in thalamocortical circuits	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; RAT SOMATOSENSORY CORTEX; HUMAN VISUAL-CORTEX; CEREBRAL-CORTEX; BARREL CORTEX; EVOLUTION; COMPLEX; PAX6; NEOCORTEX; MAMMALS	The primary somatosensory cortex (S1) contains a complete body map that mirrors the subcortical maps developed by peripheral sensory input projecting to the sensory hindbrain, the thalamus and then S1. Peripheral changes during development alter these maps through 'bottom-up' plasticity. Unknown is how S1 size influences map organization and whether an altered S1 map feeds back to affect subcortical maps. We show that the size of S1 in mice is significantly reduced by cortex-specific deletion of Pax6, resulting in a reduced body map and loss of body representations by an exclusion of later-differentiating sensory thalamocortical input. An initially normal sensory thalamus was repatterned to match the aberrant S1 map by apoptotic deletion of thalamic neurons representing body parts with axons excluded from S1. Deleted representations were rescued by altering competition between thalamocortical axons using sensory deprivation or increasing the size of S1. Thus, S1 size determined the resolution and completeness of body maps and engaged 'top-down' plasticity that repatterned the sensory thalamus to match S1.	[Zembrzycki, Andreas; Chou, Shen-Ju; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Ashery-Padan, Ruth; Stoykova, Anastassia] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Salk Institute; Max Planck Society	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	doleary@salk.edu	Zembrzycki, Andreas/D-7607-2013	Zembrzycki, Andreas/0000-0001-8468-4195	US National Institutes of Health [R01 NS31558, R01 MH086147]; Vincent J. Coates Chair of Molecular Neurobiology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS031558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent J. Coates Chair of Molecular Neurobiology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Higgins and H. Gutierrez for technical assistance, J. Simon (Salk Institute MultiMedia Resources) for help making Adobe Illustrator schematics, Y. Dayn (Salk Institute Transgenic Core) for help producing the nestin-Pax6TG conditional transgenic mice, K. Jones (University of Colorado) for the Emx1-IRES-cre mice, M. Goulding (Salk Institute) for the ROSA26-GAP43-eGFP mice and members of the O'Leary lab for discussion. This work was supported by US National Institutes of Health grants R01 NS31558 and R01 MH086147 and the Vincent J. Coates Chair of Molecular Neurobiology (D.D.M.O.).	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; DURHAM D, 1984, J COMP NEUROL, V223, P424, DOI 10.1002/cne.902230308; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053; Higginbotham H, 2011, CEREB CORTEX, V21, P1465, DOI 10.1093/cercor/bhq197; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; KAAS JH, 1989, J EXP BIOL, V146, P165; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Krubitzer L, 2003, PROG NEUROBIOL, V70, P33, DOI 10.1016/S0301-0082(03)00088-1; Krubitzer L, 2009, ANN NY ACAD SCI, V1156, P44, DOI 10.1111/j.1749-6632.2009.04421.x; Krubitzer LA, 2012, P NATL ACAD SCI USA, V109, P10647, DOI 10.1073/pnas.1201891109; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; MA PM, 1984, BRAIN RES, V306, P374, DOI 10.1016/0006-8993(84)90390-1; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinon MC, 2008, J NEUROSCI, V28, P8724, DOI 10.1523/JNEUROSCI.2565-08.2008; Rasband W., 2006, IMAGEJ; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tamura R, 2010, PSYCHIAT RES-NEUROIM, V184, P186, DOI 10.1016/j.pscychresns.2010.07.001; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; WAITE PME, 1992, NEUROREPORT, V3, P485, DOI 10.1097/00001756-199206000-00007; Wallace H, 1999, J NEUROBIOL, V41, P58, DOI 10.1002/(SICI)1097-4695(199910)41:1<58::AID-NEU8>3.0.CO;2-F; White LE, 1997, CEREB CORTEX, V7, P31, DOI 10.1093/cercor/7.1.31; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zhou LB, 2010, J NEUROSCI, V30, P7928, DOI 10.1523/JNEUROSCI.6005-09.2010	50	48	48	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1060	1067		10.1038/nn.3454	http://dx.doi.org/10.1038/nn.3454			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23831966	Green Accepted			2022-12-25	WOS:000322323000016
J	Benucci, A; Saleem, AB; Carandini, M				Benucci, Andrea; Saleem, Aman B.; Carandini, Matteo			Adaptation maintains population homeostasis in primary visual cortex	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; CORTICAL-NEURONS; RAPID ADAPTATION; AUDITORY-CORTEX; IN-VIVO; ORIENTATION; PLASTICITY; INFORMATION; MOTION; SENSITIVITY	Sensory systems exhibit mechanisms of neural adaptation, which adjust neuronal activity on the basis of recent stimulus history. In primary visual cortex (V1) in particular, adaptation controls the responsiveness of individual neurons and shifts their visual selectivity. What benefits does adaptation confer on a neuronal population? We measured adaptation in the responses of populations of cat V1 neurons to stimulus ensembles with markedly different statistics of stimulus orientation. We found that adaptation served two homeostatic goals. First, it maintained equality in the time-averaged responses across the population. Second, it maintained independence in selectivity across the population. Adaptation scaled and distorted population activity according to a simple multiplicative rule that depended on neuronal orientation preference and on stimulus orientation. We conclude that adaptation in V1 acts as a mechanism of homeostasis, enforcing a tendency toward equality and independence in neural activity across the population.	[Benucci, Andrea; Saleem, Aman B.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England	University of London; University College London	Benucci, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	a.benucci@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Benucci, Andrea/N-6361-2015	Carandini, Matteo/0000-0003-4880-7682; Benucci, Andrea/0000-0002-7698-6289; Saleem, Aman/0000-0002-7100-1954	US National Institutes of Health; European Research Council; Wellcome Trust; NATIONAL EYE INSTITUTE [R01EY017396] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Busse and S. Katzner for help with data acquisition, and numerous colleagues for useful suggestions. This work was supported by the US National Institutes of Health, the European Research Council and the Wellcome Trust. M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; BARLOW H, 1989, COMP NEUR S, P54; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 2001, NEUROCOMPUTING, V38, P141, DOI 10.1016/S0925-2312(01)00550-1; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Dayan P., 2001, THEORETICAL NEUROSCI; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gardner JL, 2004, J NEUROSCI, V24, P9035, DOI 10.1523/JNEUROSCI.0337-04.2004; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEKULER R, 1967, VISION RES, V7, P427, DOI 10.1016/0042-6989(67)90050-8; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Stocker AA, 2009, J VISION, V9, DOI 10.1167/9.9.9; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; ULLMAN S, 1982, PROC R SOC SER B-BIO, V216, P299, DOI 10.1098/rspb.1982.0076; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Wissig SC, 2012, J NEUROPHYSIOL, V107, P3370, DOI 10.1152/jn.00739.2011; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101	49	99	100	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					724	+		10.1038/nn.3382	http://dx.doi.org/10.1038/nn.3382			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603708	Green Accepted			2022-12-25	WOS:000319509600014
J	Bagdasarian, K; Szwed, M; Knutsen, PM; Deutsch, D; Derdikman, D; Pietr, M; Simony, E; Ahissar, E				Bagdasarian, Knarik; Szwed, Marcin; Knutsen, Per Magne; Deutsch, Dudi; Derdikman, Dori; Pietr, Maciej; Simony, Erez; Ahissar, Ehud			Pre-neuronal morphological processing of object location by individual whiskers	NATURE NEUROSCIENCE			English	Article							RADIAL DISTANCE DETERMINATION; TRIGEMINAL GANGLION NEURONS; FUNCTIONAL PLASTICITY; VIBRISSAL SYSTEM; BARREL CORTEX; RAT-VIBRISSAE; WHISKING; LOCALIZATION; RESPONSES; MOVEMENTS	In the vibrissal system, touch information is conveyed by a receptorless whisker hair to follicle mechanoreceptors, which then provide input to the brain. We examined whether any processing, that is, meaningful transformation, occurs in the whisker itself. Using high-speed videography and tracking the movements of whiskers in anesthetized and behaving rats, we found that whisker-related morphological phase planes, based on angular and curvature variables, can represent the coordinates of object position after contact in a reliable manner, consistent with theoretical predictions. By tracking exposed follicles, we found that the follicle-whisker junction is rigid, which enables direct readout of whisker morphological coding by mechanoreceptors. Finally, we found that our behaving rats pushed their whiskers against objects during localization in a way that induced meaningful morphological coding and, in parallel, improved their localization performance, which suggests a role for pre-neuronal morphological computation in active vibrissal touch.	[Bagdasarian, Knarik; Deutsch, Dudi; Pietr, Maciej; Ahissar, Ehud] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Szwed, Marcin] Jagiellonian Univ, Inst Psychol, Psychophysiol Lab, Krakow, Poland; [Knutsen, Per Magne] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Derdikman, Dori] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Simony, Erez] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Simony, Erez] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA	Weizmann Institute of Science; Jagiellonian University; University of California System; University of California San Diego; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Princeton University; Princeton University	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il	simony, erez/AAA-9757-2020		Israel Science Foundation [749/10]; Minerva Foundation; Federal German Ministry for Education and Research; United States-Israel Binational Science Foundation [2011432]; Ministry of Science and Technology (Israel); Ministry of Research (Taiwan); Israeli Ministry of Health; KAMEA program; Long-Term Fellowship from the Human Frontier Science Program	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Science and Technology (Israel); Ministry of Research (Taiwan)(Ministry of Education, Taiwan); Israeli Ministry of Health; KAMEA program; Long-Term Fellowship from the Human Frontier Science Program(Human Frontier Science Program)	We thank D. Goldian and S. Haidarliu for technical assistance, N. Rubin for programming, B. Schick for reviewing, M. Hartmann and J. Solomon for critically reading the manuscript and for extensive and helpful discussions, and C. Moore, J. Ritt, L. Gomez, S. Barash and G. Bi for helpful suggestions. The article is dedicated to our late friend and colleague Maciej Pietr for his significant contribution to this work. This work was supported by the Israel Science Foundation (grant 749/10), the Minerva Foundation funded by the Federal German Ministry for Education and Research, the United States-Israel Binational Science Foundation (grant 2011432), the Ministry of Science and Technology (Israel), the Ministry of Research (Taiwan), and the Chief Scientist, Israeli Ministry of Health. K.B. acknowledges support by the KAMEA program administered by the Ministry of Absorption (Israel). P.M.K. was supported by a Long-Term Fellowship from the Human Frontier Science Program. E.A. holds the Helen Diller Family Professorial Chair of Neurobiology.	Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Boubenec Y, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00074; Chiel HJ, 2009, J NEUROSCI, V29, P12807, DOI 10.1523/JNEUROSCI.3338-09.2009; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Deutsch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044272; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Euler L., 1744, ENESTROM 65 METHODUS; Gordon G, 2012, NEURAL NETWORKS, V32, P119, DOI 10.1016/j.neunet.2012.02.024; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Horev G, 2011, PHILOS T R SOC B, V366, P3070, DOI 10.1098/rstb.2011.0157; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lottem E, 2008, J NEUROPHYSIOL, V100, P2852, DOI 10.1152/jn.90302.2008; Lottem E, 2011, J NEUROSCI, V31, P8520, DOI 10.1523/JNEUROSCI.6695-10.2011; Mitchinson B, 2004, P ROY SOC B-BIOL SCI, V271, P2509, DOI 10.1098/rspb.2004.2882; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pammer L., 2013, J NEUROSCI IN PRESS; Pearson MJ, 2011, PHILOS T R SOC B, V366, P3085, DOI 10.1098/rstb.2011.0164; Pfeifer R, 2009, LECT NOTES ARTIF INT, V5436, P66, DOI 10.1007/978-3-642-00616-6_5; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Prescott TJ, 2009, IEEE ROBOT AUTOM MAG, V16, P42, DOI 10.1109/MRA.2009.933624; Quist BW, 2012, J NEUROPHYSIOL, V107, P2298, DOI 10.1152/jn.00372.2011; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Saig A, 2012, J NEUROSCI, V32, P14022, DOI 10.1523/JNEUROSCI.2432-12.2012; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Solomon JH, 2011, PHILOS T R SOC B, V366, P3049, DOI 10.1098/rstb.2011.0166; Stuttgen MC, 2008, J NEUROPHYSIOL, V100, P1879, DOI 10.1152/jn.90511.2008; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Towal RB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001120; Weisstein JS, 2005, J AM ACAD ORTHOP SUR, V13, P544, DOI 10.5435/00124635-200512000-00007; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215	52	64	64	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					622	+		10.1038/nn.3378	http://dx.doi.org/10.1038/nn.3378			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563582				2022-12-25	WOS:000318029300019
J	Dupret, D; O'Neill, J; Csicsvari, J				Dupret, David; O'Neill, Joseph; Csicsvari, Jozsef			Dynamic Reconfiguration of Hippocampal Interneuron Circuits during Spatial Learning	NEURON			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL CELLS; PHASE PRECESSION; PLACE CELLS; MEMORY; REACTIVATION; PLASTICITY; MAPS; REPRESENTATION; POPULATIONS	In the hippocampus, cell assemblies forming mnemonic representations of space are thought to arise as a result of changes in functional connections of pyramidal cells. We have found that CA1 interneuron circuits are also reconfigured during goal-oriented spatial learning through modification of inputs from pyramidal cells. As learning progressed, new pyramidal assemblies expressed in theta cycles alternated with previously established ones, and eventually overtook them. The firing patterns of interneurons developed a relationship to new, learning-related assemblies: some interneurons associated their activity with new pyramidal assemblies while some others dissociated from them. These firing associations were explained by changes in the weight of monosynaptic inputs received by interneurons from new pyramidal assemblies, as these predicted the associational changes. Spatial learning thus engages circuit modifications in the hippocampus that incorporate a redistribution of inhibitory activity that might assist in the segregation of competing pyramidal cell assembly patterns in space and time.	[Dupret, David; O'Neill, Joseph; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; [O'Neill, Joseph; Csicsvari, Jozsef] IST Austria, A-3400 Klosterneuburg, Austria	University of Oxford; Institute of Science & Technology - Austria	Dupret, D (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	david.dupret@pharm.ox.ac.uk; jozsef.csicsvari@ist.ac.at		Dupret, David/0000-0002-0040-1766	MRC [U138197111]; European Research Council [281511]; Saint Edmund Hall College, University of Oxford; Medical Research Council [MC_UU_12020/7, MC_U138197111] Funding Source: researchfish; MRC [MC_UU_12020/7, MC_U138197111] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Saint Edmund Hall College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Somogyi, P. Jonas, K. Allen, and D. Dickerson for their constructive comments on a previous version of the manuscript and K. Lamsa for helpful discussions; N. Campo-Urriza and L. Norman for their technical assistance. D.D. and J.C. were supported by a MRC Intramural Programme Grant (U138197111) and J.C. by a European Research Council Starter Grant (281511). D.D. currently holds a Research Fellowship in Neuroscience from Saint Edmund Hall College, University of Oxford. D.D. conducted the experiments. D.D. and J.O. carried out the data analysis. D.D. and J.C. wrote the manuscript. J.C. supervised the project. All authors discussed the results and commented on the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Assisi C, 2011, NEURON, V69, P373, DOI 10.1016/j.neuron.2010.12.019; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 2011, J NEUROSCI, V31, P2938, DOI 10.1523/JNEUROSCI.5037-10.2011; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Jackson J, 2007, HIPPOCAMPUS, V17, P1209, DOI 10.1002/hipo.20359; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kelemen E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000403; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; Kruskal PB, 2007, STAT MED, V26, P3997, DOI 10.1002/sim.2946; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1989, J NEUROSCI, V9, P4101; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zar JH, 1999, BIOSTATISTICAL ANAL	52	80	81	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2013	78	1					166	180		10.1016/j.neuron.2013.01.033	http://dx.doi.org/10.1016/j.neuron.2013.01.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23523593	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000317556000015
J	Gao, YW; Chen, JY; Li, K; Wu, T; Huang, B; Liu, WQ; Kou, XC; Zhang, Y; Huang, H; Jiang, YH; Yao, C; Liu, XL; Lu, ZW; Xu, ZJ; Kang, L; Chen, J; Wang, HL; Cai, T; Gao, SR				Gao, Yawei; Chen, Jiayu; Li, Ke; Wu, Tong; Huang, Bo; Liu, Wenqiang; Kou, Xiaochen; Zhang, Yu; Huang, Hua; Jiang, Yonghua; Yao, Chao; Liu, Xiaolei; Lu, Zhiwei; Xu, Zijian; Kang, Lan; Chen, Jun; Wang, Hailin; Cai, Tao; Gao, Shaorong			Replacement of Oct4 by Tet1 during iPSC Induction Reveals an Important Role of DNA Methylation and Hydroxymethylation in Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; MOUSE; GENOME; 5-METHYLCYTOSINE; FIBROBLASTS; MICE; REGULATORS	DNA methylation and demethylation have been proposed to play an important role in somatic cell reprogramming. Here, we demonstrate that the DNA hydroxylase Tet1 facilitates pluripotent stem cell induction by promoting Oct4 demethylation and reactivation. Moreover, Tet1 (T) can replace Oct4 and initiate somatic cell reprogramming in conjunction with Sox2 (S), Klf4 (K), and c-Myc (M). We established an efficient TSKM secondary reprogramming system and used it to characterize the dynamic profiles of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), and gene expression during reprogramming. Our analysis revealed that both 5mC and 5hmC modifications increased at an intermediate stage of the process, correlating with a transition in the transcriptional profile. We also found that 5hmC enrichment is involved in the demethylation and reactivation of genes and regulatory regions that are important for pluripotency. Our data indicate that changes in DNA methylation and hydroxymethylation play important roles in genome-wide epigenetic remodeling during reprogramming.	[Gao, Yawei; Chen, Jiayu; Gao, Shaorong] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Gao, Yawei; Chen, Jiayu; Li, Ke; Wu, Tong; Huang, Bo; Liu, Wenqiang; Kou, Xiaochen; Zhang, Yu; Jiang, Yonghua; Yao, Chao; Liu, Xiaolei; Lu, Zhiwei; Xu, Zijian; Kang, Lan; Chen, Jun; Cai, Tao; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Huang, Hua; Wang, Hailin] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Cai, T (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	caitao@nibs.ac.cn; gaoshaorong@nibs.ac.cn	huang, bo/A-2690-2017; Li, Ke/I-7327-2019; Chen, Jiayu/ABF-3722-2021	Li, Ke/0000-0002-0737-1045; Chen, Jiayu/0000-0003-4755-8901; CHen, Jun/0000-0002-4493-9082; huang, hua/0000-0002-9881-4197; gao, yawei/0000-0001-8946-9697	Ministry of Science and Technology [2010CB944900, 2011CB812700, 2011CB964800]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank Professor Rudolf Jaenisch from the Whitehead Institute of MIT for generously supplying the lentiviral vectors containing the cDNAs of the original four transcription factors. We thank Dr. Guo-Liang Xu from the Shanghai Institute of Biological Sciences for providing the Tet1 antibody. We thank Dr. Lijun Liu from Lanzhou University for assistance with the karyotype analysis of the TSKM-iPS8 cells. We thank Mr. Ning Yang for assistance with the design of the schematic model. We thank Dr. Bing Zhu and Dr. Dangsheng Li for their comments. We are also grateful to our laboratory colleagues for their assistance with experiments and in the preparation of the manuscript. This work was supported by the Ministry of Science and Technology (grants 2010CB944900, 2011CB812700, and 2011CB964800).	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Costa Y., 2013, NATURE; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Kang L, 2011, CELL RES, V21, P546, DOI 10.1038/cr.2010.164; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kou ZH, 2010, BIOL REPROD, V83, P238, DOI 10.1095/biolreprod.110.084731; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vincent J.J., 2013, CELL STEM CELL; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	51	263	287	3	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					453	469		10.1016/j.stem.2013.02.005	http://dx.doi.org/10.1016/j.stem.2013.02.005			17	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23499384	Green Published, Bronze			2022-12-25	WOS:000329569500012
J	Shonesy, BC; Wang, XH; Rose, KL; Ramikie, TS; Cavener, VS; Rentz, T; Baucum, AJ; Jalan-Sakrikar, N; Mackie, K; Winder, DG; Patel, S; Colbran, RJ				Shonesy, Brian C.; Wang, Xiaohan; Rose, Kristie L.; Ramikie, Teniel S.; Cavener, Victoria S.; Rentz, Tyler; Baucum, Anthony J., II; Jalan-Sakrikar, Nidhi; Mackie, Ken; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.			CaMKII regulates diacylglycerol lipase-alpha and striatal endocannabinoid signaling	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; DEPOLARIZED POSTSYNAPTIC NEURONS; LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; SYNAPTIC PLASTICITY; DOPAMINERGIC CONTROL; MOTOR DEFICITS; RECEPTOR; MODULATION	The endocannabinoid 2-arachidonoylglycerol (2-AG) mediates activity-dependent depression of excitatory neurotransmission at central synapses, but the molecular regulation of 2-AG synthesis is not well understood. Here we identify a functional interaction between the 2-AG synthetic enzyme diacylglycerol lipase-alpha (DGL alpha) and calcium/calmodulin dependent protein kinase II (CaMKII). Activated CaMKII interacted with the C-terminal domain of DGL alpha, phosphorylated two serine residues and inhibited DGL alpha activity. Consistent with an inhibitory role for CaMKII in 2-AG synthesis, in vivo genetic inhibition of CaMKII increased striatal DGL activity and basal levels of 2-AG, and CaMKII inhibition augmented short-term retrograde endocannabinoid signaling at striatal glutamatergic synapses. Lastly, blockade of 2-AG breakdown using concentrations of JZL-184 that have no effect in wild-type mice produced a hypolocomotor response in mice with reduced CaMKII activity. These findings provide mechanistic insights into the molecular regulation of striatal endocannabinoid signaling with implications for physiological control of motor function.	[Shonesy, Brian C.; Rentz, Tyler; Baucum, Anthony J., II; Jalan-Sakrikar, Nidhi; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Shonesy, Brian C.; Wang, Xiaohan; Ramikie, Teniel S.; Cavener, Victoria S.; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Wang, Xiaohan] Vanderbilt Univ, Sch Med, Vanderbilt Int Scholar Program, Nashville, TN 37212 USA; [Rose, Kristie L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Ramikie, Teniel S.; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Mackie, Ken] Indiana Univ, Gill Ctr, Bloomington, IN USA; [Mackie, Ken] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	sachin.patel@vanderbilt.edu; roger.colbran@vanderbilt.edu	Patel, Sachin/E-5608-2012; Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013; Mackie, Ken/E-3715-2013; Shonesy, Brian/AAP-7569-2021; Wang, Xiaohan/V-3920-2019; Winder, Danny G./H-4857-2013; Jalan-Sakrikar, Nidhi/S-8653-2019	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Mackie, Ken/0000-0001-8501-6199; Wang, Xiaohan/0000-0001-7895-2333; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121; Shonesy, Brian/0000-0003-3791-9339	US National Institutes of Health [T32-NS007491, T32-MH065215, K01-NS073700, K05-DA021696, R01-DA011322, R01-AA019455, K08-MH090412, R01-MH063232, R01-NS078291]; Michael J. Fox Foundation; Luton Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232, K08MH090412, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491, K01NS073700, R01NS078291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Luton Society; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health (T32-NS007491 and T32-MH065215 to B.C.S.; K01-NS073700 to A.J.B.; K05-DA021696 and R01-DA011322 to K.M.; R01-AA019455 to D.G.W.; K08-MH090412 to S.P.; and R01-MH063232 and R01-NS078291 to R.J.C.), the Michael J. Fox Foundation (R.J.C.) and the Luton Society (S.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. Behavioral studies were performed in the Murine Neurobehavior Core and mass spectrometry and proteomics studies were performed at the Mass Spectrometry Research Center, both at Vanderbilt University Medical Center. We thank B. Cravatt (The Scripps Research Institute) for plasmids encoding DGL alpha-V5 and DGL beta-V5.	Ade KK, 2007, J NEUROSCI, V27, P2403, DOI 10.1523/JNEUROSCI.2916-06.2007; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2011, BRAIN, V134, P119, DOI 10.1093/brain/awq278; Brown AM, 2005, EUR J NEUROSCI, V22, P247, DOI 10.1111/j.1460-9568.2005.04190.x; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Di Filippo M, 2008, CURR PHARM DESIGN, V14, P2337, DOI 10.2174/138161208785740072; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jung KM, 2007, MOL PHARMACOL, V72, P612, DOI 10.1124/mol.107.037796; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Keimpema E, 2010, J NEUROSCI, V30, P13992, DOI 10.1523/JNEUROSCI.2126-10.2010; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Muller-Vahl KR, 1999, AM J PSYCHIAT, V156, P495; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Ohno-Shosaku T, 2005, CELL CALCIUM, V38, P369, DOI 10.1016/j.ceca.2005.06.014; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oudin MJ, 2011, EUR J NEUROSCI, V34, P1634, DOI 10.1111/j.1460-9568.2011.07831.x; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shen YS, 2005, J COMPUT NEUROSCI, V18, P25, DOI 10.1007/s10827-005-5475-5; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshino H, 2011, J PHYSIOL-LONDON, V589, P4857, DOI 10.1113/jphysiol.2011.212225; Zhang L, 2011, PLOS ONE, V6	57	52	52	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					456	U124		10.1038/nn.3353	http://dx.doi.org/10.1038/nn.3353			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23502535	Green Accepted			2022-12-25	WOS:000316723700016
J	Gutierrez, GJ; O'Leary, T; Marder, E				Gutierrez, Gabrielle J.; O'Leary, Timothy; Marder, Eve			Multiple Mechanisms Switch an Electrically Coupled, Synaptically Inhibited Neuron between Competing Rhythmic Oscillators	NEURON			English	Article							LOBSTER STOMATOGASTRIC GANGLION; UNDERLYING PATTERN GENERATION; MOTOR-PATTERN; SELECTIVE INACTIVATION; IDENTIFIED NEURONS; NETWORK; SYNAPSES; CIRCUIT; MODEL; FREQUENCY	Rhythmic oscillations are common features of nervous systems. One of the fundamental questions posed by these rhythms is how individual neurons or groups of neurons are recruited into different network oscillations. We modeled competing fast and slow oscillators connected to a hub neuron with electrical and inhibitory synapses. We explore the patterns of coordination shown in the network as a function of the electrical coupling and inhibitory synapse strengths with the help of a novel visualization method that we call the "parameterscape." The hub neuron can be switched between the fast and slow oscillators by multiple network mechanisms, indicating that a given change in network state can be achieved by degenerate cellular mechanisms. These results have importance for interpreting experiments employing optogenetic, genetic, and pharmacological manipulations to understand circuit dynamics.	[Gutierrez, Gabrielle J.; O'Leary, Timothy; Marder, Eve] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Gutierrez, Gabrielle J.; O'Leary, Timothy; Marder, Eve] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, 415 South St, Waltham, MA 02454 USA.	marder@brandeis.edu	Gutierrez, Gabrielle/AAC-5102-2021; Gutierrez, Gabrielle/B-6612-2009	Gutierrez, Gabrielle/0000-0002-2350-1559; Gutierrez, Gabrielle/0000-0002-2350-1559; O'Leary, Timothy/0000-0002-1029-0158	National Institutes of Health [NS17813, MH46742]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017813, R37NS017813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grants NS17813 and MH46742. Author contributions: G.J.G. constructed the network model and developed the parameterscape method. G.J.G. and T.O. performed simulations and analyzed data. G.J.G., T.O., and E.M. designed the study and wrote the manuscript.	Ainsworth M, 2011, J NEUROSCI, V31, P17040, DOI 10.1523/JNEUROSCI.2209-11.2011; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Bem T, 2005, EUR J NEUROSCI, V22, P2661, DOI 10.1111/j.1460-9568.2005.04405.x; Bem T, 2004, J NEUROPHYSIOL, V91, P693, DOI 10.1152/jn.00783.2003; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bennett MVL, 2000, NAT NEUROSCI, V3, P7, DOI 10.1038/71082; Bennett MVL, 2000, BRAIN RES REV, V32, P16, DOI 10.1016/S0165-0173(99)00065-X; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Bucher D, 2006, J NEUROPHYSIOL, V95, P3617, DOI 10.1152/jn.00004.2006; Buschges A, 2004, EUR J NEUROSCI, V19, P1856, DOI 10.1111/j.1460-9568.2004.03312.x; Clapp WC, 2011, P NATL ACAD SCI USA, V108, P7212, DOI 10.1073/pnas.1015297108; Connors BW, 2010, NEURON, V67, P354, DOI 10.1016/j.neuron.2010.07.024; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Griffith LC, 2012, CURR OPIN NEUROBIOL, V22, P609, DOI 10.1016/j.conb.2012.01.002; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Haas JS, 2012, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00031; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; Heerebout BT, 2010, COGN AFFECT BEHAV NE, V10, P217, DOI 10.3758/CABN.10.2.217; HOOPER SL, 1989, SCIENCE, V244, P1587, DOI 10.1126/science.2740903; HOOPER SL, 1990, J NEUROPHYSIOL, V64, P1555, DOI 10.1152/jn.1990.64.5.1555; HOOPER SL, 1990, J NEUROPHYSIOL, V64, P1574, DOI 10.1152/jn.1990.64.5.1574; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; KATZ PS, 1991, J NEUROPHYSIOL, V65, P1442, DOI 10.1152/jn.1991.65.6.1442; KEPLER TB, 1990, SCIENCE, V248, P83, DOI 10.1126/science.2321028; Kopell N, 1998, PHYSICA D, V121, P367, DOI 10.1016/S0167-2789(98)00031-1; Lamb DG, 2012, CURR OPIN NEUROBIOL, V22, P670, DOI 10.1016/j.conb.2012.01.010; Lamb Damon G, 2011, Neural Syst Circuits, V1, P13, DOI 10.1186/2042-1001-1-13; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 1998, CURR BIOL, V8, pR795, DOI 10.1016/S0960-9822(07)00502-7; MARDER E, 1984, J EXP BIOL, V112, P147; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; MAYERI E, 1973, J GEN PHYSIOL, V62, P448, DOI 10.1085/jgp.62.4.448; MEYRAND P, 1994, J NEUROSCI, V14, P630; MEYRAND P, 1991, NATURE, V351, P60, DOI 10.1038/351060a0; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1378, DOI 10.1152/jn.1982.48.6.1378; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Mulloney B, 2003, J NEUROSCI, V23, P5953; PEARSON KG, 1985, J NEUROPHYSIOL, V53, P910, DOI 10.1152/jn.1985.53.4.910; Pereda AE, 2013, BBA-BIOMEMBRANES, V1828, P134, DOI 10.1016/j.bbamem.2012.05.026; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; RUSSELL DF, 1985, J EXP BIOL, V114, P71; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; SKINNER FK, 1993, BIOL CYBERN, V69, P375, DOI 10.1007/BF00199437; Soto-Trevino C, 2005, J NEUROPHYSIOL, V94, P590, DOI 10.1152/jn.00013.2005; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1995, J COMPUT NEUROSCI, V2, P283, DOI 10.1007/BF00961440; Traub RD, 2011, NEURAL NETWORKS, V24, P515, DOI 10.1016/j.neunet.2010.11.007; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1999, NEUROSCIENCE, V89, P347, DOI 10.1016/S0306-4522(98)00315-7; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	71	95	96	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					845	858		10.1016/j.neuron.2013.01.016	http://dx.doi.org/10.1016/j.neuron.2013.01.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473315	Green Accepted, Bronze			2022-12-25	WOS:000316162600006
J	Whitaker, LR; Degoulet, M; Morikawa, H				Whitaker, Leslie R.; Degoulet, Mickael; Morikawa, Hitoshi			Social Deprivation Enhances VTA Synaptic Plasticity and Drug-Induced Contextual Learning	NEURON			English	Article							ISOLATION-REARED RATS; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; INOSITOL 1,4,5-TRISPHOSPHATE; GLUTAMATE RECEPTORS; NEURAL MECHANISMS; NMDA RECEPTORS; COCAINE; AMPHETAMINE; ACQUISITION	Drug addiction is driven, in part, by powerful drug-related memories. Deficits in social life, particularly during adolescence, increase addiction vulnerability. Social isolation in rodents has been used extensively to model the effects of deficient social experience, yet its impact on learning and memory processes underlying addiction remains elusive. Here, we show that social isolation of rats during a critical period of adolescence (postnatal days 21-42) enhances long-term potentiation of NMDA receptor (NMDAR)-mediated glutamatergic transmission in the ventral tegmental area (VTA). This enhancement, which is caused by an increase in metabotropic glutamate receptor-dependent Ca2+ signaling, cannot be reversed by subsequent resocialization. Notably, memories of amphetamine- and ethanol-paired contextual stimuli are acquired faster and, once acquired, amphetamine-associated contextual memory is more resistant to extinction in socially isolated rats. We propose that NMDAR plasticity in the VTA may represent a neural substrate by which early life deficits in social experience increase addiction vulnerability.	[Whitaker, Leslie R.; Degoulet, Mickael; Morikawa, Hitoshi] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Whitaker, Leslie R.; Degoulet, Mickael; Morikawa, Hitoshi] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Whitaker, Leslie R.; Degoulet, Mickael; Morikawa, Hitoshi] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Morikawa, H (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, 2400 Speedway, Austin, TX 78712 USA.	morikawa@utexas.edu		Ramsey, Leslie/0000-0001-8129-612X; Degoulet, Mickael/0000-0002-4268-5795	NIH [DA015687, AA015521]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015687] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Kamran Khodakhah for the generous gift of caged IP<INF>3</INF> made in his lab. We also thank Dr. Yavin Shaham for discussions regarding CPP data analysis, Drs. Mark Harnett and Nikolai Dembrow for comments on the manuscript, Claire Stelly for assistance with animal housing, and Kavita Thakkar for assistance with histological verification of intracranial injections sites. This work was funded by NIH grants DA015687 and AA015521.	Ahn KC, 2010, J NEUROSCI, V30, P6689, DOI 10.1523/JNEUROSCI.4453-09.2010; Bernier BE, 2011, J NEUROSCI, V31, P5205, DOI 10.1523/JNEUROSCI.5282-10.2011; BOWLING SL, 1994, PHARMACOL BIOCHEM BE, V48, P459, DOI 10.1016/0091-3057(94)90553-3; Brenes JC, 2008, NEUROSCI LETT, V436, P278, DOI 10.1016/j.neulet.2008.03.045; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Cilia J, 2001, PSYCHOPHARMACOLOGY, V156, P327, DOI 10.1007/s002130100786; Cui GH, 2007, J NEUROSCI, V27, P4776, DOI 10.1523/JNEUROSCI.0139-07.2007; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; EINON DF, 1977, DEV PSYCHOBIOL, V10, P123, DOI 10.1002/dev.420100205; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fabricius K, 2011, INT J DEV NEUROSCI, V29, P347, DOI 10.1016/j.ijdevneu.2010.09.003; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Guatteo E, 1999, J NEUROPHYSIOL, V82, P1974, DOI 10.1152/jn.1999.82.4.1974; Harmer CJ, 1998, PHYSIOL BEHAV, V63, P177, DOI 10.1016/S0031-9384(97)00417-4; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Howes SR, 2000, PSYCHOPHARMACOLOGY, V151, P55, DOI 10.1007/s002130000451; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koulchitsky S, 2012, NEUROPSYCHOPHARMACOL, V37, P1559, DOI 10.1038/npp.2011.339; Lu L, 2003, NEUROSCI BIOBEHAV R, V27, P457, DOI 10.1016/S0149-7634(03)00073-3; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Lukkes JL, 2009, NEUROSCIENCE, V158, P845, DOI 10.1016/j.neuroscience.2008.10.036; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; Luo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012141; Maffei A, 2008, PROG BRAIN RES, V169, P211, DOI 10.1016/S0079-6123(07)00012-X; Mauk MD, 2004, LEARN MEMORY, V11, P566, DOI 10.1101/lm.83504; MCCRAY JA, 1980, P NATL ACAD SCI-BIOL, V77, P7237, DOI 10.1073/pnas.77.12.7237; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quan MN, 2010, NEUROSCIENCE, V169, P214, DOI 10.1016/j.neuroscience.2010.04.048; Riegel AC, 2008, NEURON, V57, P559, DOI 10.1016/j.neuron.2007.12.029; Robbins TW, 1996, J PSYCHOPHARMACOL, V10, P39, DOI 10.1177/026988119601000107; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SCHENK S, 1986, PHARMACOL BIOCHEM BE, V24, P1793, DOI 10.1016/0091-3057(86)90523-X; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Serra M, 2005, STRESS, V8, P259, DOI 10.1080/10253890500495244; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Smith JK, 1997, PSYCHOPHARMACOLOGY, V131, P23, DOI 10.1007/s002130050261; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; Stuber GD, 2010, CURR TOP BEHAV NEURO, V3, P3, DOI 10.1007/7854_2009_23; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; WOLFFGRAMM J, 1990, PSYCHOPHARMACOLOGY, V101, P233, DOI 10.1007/BF02244132; WRIGHT IK, 1991, PHYSIOL BEHAV, V50, P1129, DOI 10.1016/0031-9384(91)90572-6; Zakharova E, 2009, NEUROSCIENCE, V163, P890, DOI 10.1016/j.neuroscience.2009.06.068; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	55	103	103	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					335	345		10.1016/j.neuron.2012.11.022	http://dx.doi.org/10.1016/j.neuron.2012.11.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352169	Bronze, Green Accepted			2022-12-25	WOS:000314199400015
J	Angueyra, JM; Rieke, F				Angueyra, Juan M.; Rieke, Fred			Origin and effect of phototransduction noise in primate cone photoreceptors	NATURE NEUROSCIENCE			English	Article							MONKEY MACACA-FASCICULARIS; ROD OUTER SEGMENTS; LIGHT ADAPTATION; DARK NOISE; ABSOLUTE THRESHOLD; VISUAL-ADAPTATION; RETINAL CONES; SENSITIVITY; VISION; MECHANISMS	Noise in the responses of cone photoreceptors sets a fundamental limit on visual sensitivity, yet the origin of noise in mammalian cones and its relation to behavioral sensitivity are poorly understood. Our work here on primate cones improves understanding of these issues in three ways. First, we found that cone noise was not dominated by spontaneous photopigment activation or by quantal fluctuations in photon absorption, but was instead dominated by other sources, namely channel noise and fluctuations in cyclic GMP. Second, adaptation in cones, unlike that in rods, affected signal and noise differently. This difference helps to explain why thresholds for rod- and cone-mediated signals have different dependencies on background light level. Third, past estimates of noise in mammalian cones are too high to explain behavioral sensitivity. Our measurements indicate a lower level of cone noise and therefore help to reconcile physiological and behavioral estimates of cone noise and sensitivity.	[Angueyra, Juan M.; Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.	rieke@uw.edu	Angueyra, Juan/HCI-8722-2022	Angueyra, Juan/0000-0002-9217-3069	Howard Hughes Medical Institute; National Eye Institute of the US National Institutes of Health [RO1EY11850]; US National Institutes of Health grant [RR00166]; National Center for Research Resources; Office of Research Infrastructure Programs of the National Institutes of Health [P51 OD 010425]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Asbury, F. Dunn, G. Horwitz and R. Sinha for helpful comments on an earlier version of the paper, and M. Cafaro and P. Newman for excellent technical assistance. Color scales were developed and made freely available for Matlab by M. Niccoli. Support was provided by the Howard Hughes Medical Institute (F.R.) and the National Eye Institute of the US National Institutes of Health (RO1EY11850 to ER.). Retinas were obtained from the Washington National Primate Research Center at the University of Washington, US National Institutes of Health grant RR00166, and from the National Center for Research Resources and the Office of Research Infrastructure Programs of the National Institutes of Health through grant Number P51 OD 010425.	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Borghuis BG, 2009, J NEUROSCI, V29, P3045, DOI 10.1523/JNEUROSCI.5071-08.2009; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DONNER K, 1990, J GEN PHYSIOL, V95, P733, DOI 10.1085/jgp.95.4.733; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Holcman D, 2005, J GEN PHYSIOL, V125, P641, DOI 10.1085/jgp.200509277; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Koenig D, 2011, J VISION, V11, DOI 10.1167/11.1.21; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; SWARUP G, 1983, BIOCHEMISTRY-US, V22, P1102, DOI 10.1021/bi00274a017; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0	30	51	51	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1692	1700		10.1038/nn.3534	http://dx.doi.org/10.1038/nn.3534			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097042	Green Accepted			2022-12-25	WOS:000326205700028
J	Shao, YR; Isett, BR; Miyashita, T; Chung, J; Pourzia, O; Gasperini, RJ; Feldman, DE				Shao, Yu R.; Isett, Brian R.; Miyashita, Toshio; Chung, Jason; Pourzia, Olivia; Gasperini, Robert J.; Feldman, Daniel E.			Plasticity of Recurrent L2/3 Inhibition and Gamma Oscillations by Whisker Experience	NEURON			English	Article							RAT SOMATOSENSORY CORTEX; CRITICAL PERIOD PLASTICITY; DEVELOPING VISUAL-CORTEX; CORTICAL MAP PLASTICITY; 2/3 PYRAMIDAL NEURONS; BARREL CORTEX; IN-VIVO; DEPENDENT PLASTICITY; SENSORY DEPRIVATION; AXONAL ARBORS	Local recurrent networks in neocortex are critical nodes for sensory processing, but their regulation by experience is much less understood than for long-distance (translaminar or cross-columnar) projections. We studied local L2/3 recurrent networks in rat somatosensory cortex during deprivation-induced whisker map plasticity, by expressing channelrhodopsin-2 (ChR2) in L2/3 pyramidal cells and measuring light-evoked synaptic currents in ex vivo Si slices. In columns with intact whiskers, brief light impulses evoked recurrent excitation and supralinear inhibition. Deprived columns showed modestly reduced excitation and profoundly reduced inhibition, providing a circuit locus for disinhibition of whisker-evoked responses observed in L2/3 in vivo. Slower light ramps elicited sustained gamma frequency oscillations, which were nearly abolished in deprived columns. Reduction in gamma power was also observed in spontaneous LFP oscillations in L2/3 of deprived columns in vivo. Thus, L2/3 recurrent networks are a powerful site for homeostatic modulation of excitation-inhibition balance and regulation of gamma oscillations.	[Shao, Yu R.; Isett, Brian R.; Miyashita, Toshio; Chung, Jason; Pourzia, Olivia; Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Shao, Yu R.; Isett, Brian R.; Miyashita, Toshio; Chung, Jason; Pourzia, Olivia; Feldman, Daniel E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Gasperini, Robert J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Tasmania; Menzies Institute for Medical Research	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu	Gasperini, Rob/J-7804-2014	Gasperini, Rob/0000-0001-6859-1247; Isett, Brian/0000-0002-1581-0706	National Institutes of Health [1R01 NS073912]; National Science Foundation (NSF) [SMA 1041755]; NSF Science of Learning Center; National Science Foundation [DGE 1106400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Prof. K. Deisseroth (Stanford University) for the ChR2-H134R-EYFP-WPRE construct. This work was supported by grants from the National Institutes of Health (1R01 NS073912) and the National Science Foundation (NSF) (# SMA 1041755) to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. B.R.I. was supported by National Science Foundation predoctoral fellowship (DGE 1106400).	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Broser P, 2008, CEREB CORTEX, V18, P1588, DOI 10.1093/cercor/bhm189; Bruno RM, 2009, J NEUROSCI, V29, P3172, DOI 10.1523/JNEUROSCI.5911-08.2009; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cheetham CEJ, 2008, J NEUROSCI, V28, P9249, DOI 10.1523/JNEUROSCI.2974-08.2008; Cheetham CEJ, 2007, J NEUROSCI, V27, P3456, DOI 10.1523/JNEUROSCI.5143-06.2007; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Drew PJ, 2009, CEREB CORTEX, V19, P331, DOI 10.1093/cercor/bhn085; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gentet LJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00052; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hardingham N, 2008, NEURON, V60, P861, DOI 10.1016/j.neuron.2008.10.018; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; Miyashita T, 2010, CEREB CORTEX, V20, P229, DOI 10.1093/cercor/bhp093; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Paik SB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000927; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wen JA, 2011, J NEUROSCI, V31, P4456, DOI 10.1523/JNEUROSCI.6042-10.2011; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	73	25	25	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					210	222		10.1016/j.neuron.2013.07.026	http://dx.doi.org/10.1016/j.neuron.2013.07.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094112	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000326305300019
J	Rash, JE; Curti, S; Vanderpool, KG; Kamasawa, N; Nannapaneni, S; Palacios-Prado, N; Flores, CE; Yasumura, T; O'Brien, J; Lynn, BD; Bukauskas, FF; Nagy, JI; Pereda, AE				Rash, John E.; Curti, Sebastian; Vanderpool, Kimberly G.; Kamasawa, Naomi; Nannapaneni, Srikant; Palacios-Prado, Nicolas; Flores, Carmen E.; Yasumura, Thomas; O'Brien, John; Lynn, Bruce D.; Bukauskas, Feliksas F.; Nagy, James I.; Pereda, Alberto E.			Molecular and Functional Asymmetry at a Vertebrate Electrical Synapse	NEURON			English	Article							GAP-JUNCTION CHANNELS; RECTIFYING ELECTROTONIC SYNAPSE; SUBTHRESHOLD SODIUM CURRENT; GOLDFISH MAUTHNER CELL; NEURONAL CONNEXIN36; ZONULA OCCLUDENS-1; MIXED SYNAPSES; HETEROTYPIC CHANNELS; AUDITORY AFFERENTS; MAMMALIAN BRAIN	Electrical synapses are abundant in the vertebrate brain, but their functional and molecular complexities are still poorly understood. We report here that electrical synapses between auditory afferents and goldfish Mauthner cells are constructed by apposition of hemichannels formed by two homologs of mammalian connexin 36 (Cx36) and that, while Cx35 is restricted to presynaptic hemiplaques, Cx34.7 is restricted to postsynaptic hemiplaques, forming heterotypic junctions. This molecular asymmetry is associated with rectification of electrical transmission that may act to promote cooperativity between auditory afferents. Our data suggest that, in similarity to pre- and postsynaptic sites at chemical synapses, one side in electrical synapses should not necessarily be considered the mirror image of the other. While asymmetry based on the presence of two Cx36 homologs is restricted to teleost fish, it might also be based on differences in posttranslational modifications of individual connexins or in the complement of gap junction-associated proteins.	[Rash, John E.; Vanderpool, Kimberly G.; Yasumura, Thomas] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Curti, Sebastian; Nannapaneni, Srikant; Palacios-Prado, Nicolas; Flores, Carmen E.; Bukauskas, Feliksas F.; Pereda, Alberto E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Curti, Sebastian] Univ Republica, Fac Med, Dept Fisiol, Lab Neurofisiol Celular, Montevideo 11800, Uruguay; [Kamasawa, Naomi] Max Planck Florida Inst, Jupiter, FL 33458 USA; [O'Brien, John] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Lynn, Bruce D.; Nagy, James I.] Univ Manitoba, Dept Physiol, Winnipeg, MB R3E 0J9, Canada	Colorado State University; Yeshiva University; Albert Einstein College of Medicine; Universidad de la Republica, Uruguay; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; University of Manitoba	Pereda, AE (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA.	alberto.pereda@einstein.yu.edu	O'Brien, John/G-2522-2013; Vanderpool, Kimberly/M-2620-2014	O'Brien, John/0000-0002-0270-3442; Vanderpool, Kimberly/0000-0002-8295-6553; Palacios-Prado, Nicolas/0000-0002-3411-8002; Nagy, James Imre/0000-0003-2753-091X	National Institutes of Health [S10RR05831, S10RR08329, NS044395, NS044010, EY012857, RO1NS072238]; Canadian Institute for Health Research; NIH [DC03186, DC011099, R21NS055726, NS0552827]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008329, S10RR005831] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS044395, R21NS055726, R01NS052827, R01NS072238, R01NS044395, R01NS044010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003186, R01DC011099, R56DC003186, R29DC003186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Michael V.L. Bennett and Peter Sterling for their comments on the manuscript. This research was supported by National Institutes of Health grants S10RR05831, S10RR08329, NS044395, and NS044010 (to J.E.R.), EY012857 (to J.O.), RO1NS072238 (to F.F.B.), Canadian Institute for Health Research (to J.I.N.), and by NIH grants DC03186, DC011099, R21NS055726, and NS0552827 (to A.E.P.).	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; AUERBACH AA, 1969, J GEN PHYSIOL, V53, P211, DOI 10.1085/jgp.53.2.211; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Bennett M., 1977, HDB PHYSL          1, P357; BENNETT MVL, 1966, ANN NY ACAD SCI, V137, P509, DOI 10.1111/j.1749-6632.1966.tb50178.x; BUKAUSKAS FF, 1995, PFLUG ARCH EUR J PHY, V429, P870, DOI 10.1007/BF00374812; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Cachope R, 2007, NEURON, V56, P1034, DOI 10.1016/j.neuron.2007.11.014; Ciolofan C, 2006, NEUROSCIENCE, V140, P433, DOI 10.1016/j.neuroscience.2006.02.032; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruciani V, 2007, BIOL CHEM, V388, P253, DOI 10.1515/BC.2007.028; Curti S, 2004, J NEUROSCI, V24, P3999, DOI 10.1523/JNEUROSCI.0077-04.2004; Curti S, 2008, J NEUROPHYSIOL, V99, P1683, DOI 10.1152/jn.01173.2007; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; Elenes S, 2001, BIOPHYS J, V81, P1406, DOI 10.1016/S0006-3495(01)75796-7; Faber DS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P73; Flores CE, 2008, P NATL ACAD SCI USA, V105, P12545, DOI 10.1073/pnas.0804793105; Flores CE, 2012, P NATL ACAD SCI USA, V109, pE573, DOI 10.1073/pnas.1121557109; Flores CE, 2010, J NEUROSCI, V30, P9488, DOI 10.1523/JNEUROSCI.4466-09.2010; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; FUKAMI Y, 1965, J GEN PHYSIOL, V48, P581, DOI 10.1085/jgp.48.4.581; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; FURSHPAN EJ, 1962, J NEUROPHYSIOL, V25, P732, DOI 10.1152/jn.1962.25.6.732; GIAUME C, 1987, J PHYSIOL-LONDON, V386, P91, DOI 10.1113/jphysiol.1987.sp016524; GIAUME C, 1984, J PHYSIOL-LONDON, V356, P151, DOI 10.1113/jphysiol.1984.sp015458; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; Herberholz J, 2002, J NEUROSCI, V22, P9078; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Li XB, 2004, EUR J NEUROSCI, V19, P2132, DOI 10.1111/j.0953-816X.2004.03283.x; Li XB, 2009, NEUROCHEM INT, V54, P393, DOI 10.1016/j.neuint.2009.01.003; LIN JW, 1983, BRAIN RES, V274, P319, DOI 10.1016/0006-8993(83)90710-2; LIN JW, 1988, J NEUROSCI, V8, P1302; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; Musa H, 2003, BIOPHYS J, V84, P205, DOI 10.1016/S0006-3495(03)74843-7; O'Brien J, 1998, J NEUROSCI, V18, P7625; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Palacios-Prado N, 2013, J NEUROSCI, V33, P4741, DOI 10.1523/JNEUROSCI.2825-12.2013; Palacios-Prado N, 2009, P NATL ACAD SCI USA, V106, P14855, DOI 10.1073/pnas.0901923106; Pereda A, 2003, J NEUROSCI, V23, P7489; Pereda AE, 2004, BRAIN RES REV, V47, P227, DOI 10.1016/j.brainresrev.2004.06.010; PEREDA AE, 1995, J NEUROSCI, V15, P5943; Pereda AE, 1996, J NEUROSCI, V16, P983; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Rash JE, 2010, NEUROSCIENCE, V168, P982, DOI 10.1016/j.neuroscience.2009.10.028; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Shore L, 2001, BIOCHEM J, V357, P489, DOI 10.1042/0264-6021:3570489; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; TUTTLE R, 1986, J COMP NEUROL, V246, P202, DOI 10.1002/cne.902460206; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007	58	65	65	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					957	969		10.1016/j.neuron.2013.06.037	http://dx.doi.org/10.1016/j.neuron.2013.06.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012008	Green Accepted, Bronze			2022-12-25	WOS:000330269100013
J	Ciceri, G; Dehorter, N; Sols, I; Huang, ZJ; Maravall, M; Marin, O				Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Huang, Z. Josh; Maravall, Miguel; Marin, Oscar			Lineage-specific laminar organization of cortical GABAergic interneurons	NATURE NEUROSCIENCE			English	Article							CAUDAL GANGLIONIC EMINENCE; FATE MAPPING REVEALS; CEREBRAL-CORTEX; IMMUNOREACTIVE NEURONS; INHIBITORY INTERNEURONS; MONKEY NEOCORTEX; BASAL FOREBRAIN; MIGRATION; SUBTYPES; CELLS	In the cerebral cortex, pyramidal cells and interneurons are generated in distant germinal zones, and so the mechanisms that control their precise assembly into specific microcircuits remain an enigma. Here we report that cortical interneurons labeled at the clonal level do not distribute randomly but rather have a strong tendency to cluster in the mouse neocortex. This behavior is common to different classes of interneurons, independently of their origin. Interneuron clusters are typically contained within one or two adjacent cortical layers, are largely formed by isochronically generated neurons and populate specific layers, as revealed by unbiased hierarchical clustering methods. Our results suggest that different progenitor cells give rise to interneurons populating infra- and supragranular cortical layers, which challenges current views of cortical neurogenesis. Thus, specific lineages of cortical interneurons seem to be produced to primarily mirror the laminar structure of the cerebral cortex, rather than its columnar organization.	[Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Maravall, Miguel; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain; [Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Maravall, Miguel; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant, Spain; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Cold Spring Harbor Laboratory	Maravall, M (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain.	mmaravall@umh.es; o.marin@umh.es	Marin, Oscar/F-3856-2012; Maravall, Miguel/AAW-4328-2021	Marin, Oscar/0000-0001-6264-7027; Maravall, Miguel/0000-0002-8869-7206; Huang, Z. Josh/0000-0003-0592-028X; Dehorter, Nathalie/0000-0001-7599-2866; Ciceri, Gabriele/0000-0002-8481-9771	Spanish Ministry of Economy and Innovation (MINECO) [SAF2011-28845, BFU2011-23049]; CONSOLIDER [CSD2007-00023]; European Research Council [ERC-2011-AdG 293683]; MINECO; European Molecular Biology Organization (EMBO)	Spanish Ministry of Economy and Innovation (MINECO)(Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We thank A. Casillas, T. Gil and M. Perez for excellent technical assistance, D. Gelman for contributing to the development of conditional retroviruses, S. A. Anderson (University of Pennsylvania School of Medicine; Nkx2-1-Cre), S. Arber (University of Basel; PV-Cre), and A. Barco (Instituto de Neurociencias; Nestin-Cre) for mouse strains, F.H. Gage (The Salk Institute for Biological Studies) for retroviral vectors and N. Tamamaki (Kumamoto University) for the CAG-Fucci-G plasmid. We are grateful to members of the Marin and Rico laboratories for discussions and ideas. Supported by grants from Spanish Ministry of Economy and Innovation (MINECO) SAF2011-28845 to O.M., BFU2011-23049 to M.M. and CONSOLIDER CSD2007-00023 to O.M. and M. M., and from the European Research Council (ERC-2011-AdG 293683) to O.M. G.C. and I.S. are recipients of "Formacion de Personal Investigador" (FPI) fellowships from the MINECO. N.D. is the recipient of a European Molecular Biology Organization (EMBO) long-term fellowship.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carugo O, 2010, METHODS MOL BIOL, V609, P175, DOI 10.1007/978-1-60327-241-4_11; CAVANAGH ME, 1989, J COMP NEUROL, V284, P637, DOI 10.1002/cne.902840410; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; HENDRY SHC, 1984, J NEUROSCI, V4, P2497; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jones EG, 2010, CEREB CORTEX, V20, P2261, DOI 10.1093/cercor/bhq127; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lodato S, 2011, NEURON, V69, P763, DOI 10.1016/j.neuron.2011.01.015; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rymar VV, 2007, J COMP NEUROL, V501, P369, DOI 10.1002/cne.21250; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Valcanis H, 2003, J NEUROSCI, V23, P5113; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	59	91	91	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1199	U64		10.1038/nn.3485	http://dx.doi.org/10.1038/nn.3485			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933753				2022-12-25	WOS:000323597500011
J	Ding, L; Gold, JI				Ding, Long; Gold, Joshua I.			The Basal Ganglia's Contributions to Perceptual Decision Making	NEURON			English	Review							NIGRA PARS RETICULATA; FRONTAL EYE FIELD; LATERAL INTRAPARIETAL AREA; MONKEY CAUDATE NEURONS; PRIMATE SUPERIOR COLLICULUS; SUBSTANTIA-NIGRA; PARIETAL CORTEX; OCULOMOTOR FUNCTIONS; FUNCTIONAL-PROPERTIES; DISCRIMINATION TASK	Perceptual decision making is a computationally demanding process that requires the brain to interpret incoming sensory information in the context of goals, expectations, preferences, and other factors. These integrative processes engage much of cortex but also require contributions from subcortical structures to affect behavior. Here we summarize recent evidence supporting specific computational roles of the basal ganglia in perceptual decision making. These roles probably share common mechanisms with the basal ganglia's other, more well-established functions in motor control, learning, and other aspects of cognition and thus can provide insights into the general roles of this important subcortical network in higher brain function.	[Ding, Long; Gold, Joshua I.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Ding, L (corresponding author), Univ Penn, Dept Neurosci, 111 Johnson Pavil,3600 Hamilton Walk, Philadelphia, PA 19104 USA.	lding@mail.med.upenn.edu; jigold@mail.med.upenn.edu			National Eye Institute [R01 EY022411, R01 EY015260]; NATIONAL EYE INSTITUTE [R01EY022411, R01EY015260] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by the National Eye Institute R01 EY022411 (L.D. and J.I.G.) and R01 EY015260 (J.I.G.). We thank Dr. Kensaku Nomoto and Dr. Masamichi Sakagami for sharing their dopamine neuron data and Yin Li and Dr. Takahiro Doi for helpful comments on the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; Beiser, 1995, MODELS INFORM PROCES, P215; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Berns GS, 1995, NEUROBIOLOGY DECISIO, P101; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Denny-Brown D., 1962, BASAL GANGLIA THEIR; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Ferrier D, 1873, J Anat Physiol, V8, P152; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Gibson JJ., 1966, SENSES CONSIDERED PE; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gold JI, 2013, PROG NEUROBIOL, V103, P98, DOI 10.1016/j.pneurobio.2012.05.008; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1254, DOI 10.1152/jn.1983.49.5.1254; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Houk JC, 1995, MODELS INFORMATION P, P249; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Krauzlis RJ, 2004, J NEUROPHYSIOL, V92, P949, DOI 10.1152/jn.00830.2003; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lepora NF, 2012, NEURAL COMPUT, V24, P2924, DOI 10.1162/NECO_a_00360; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Macmillan N. A., 2004, DETECTION THEORY USE; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MORGAN MJ, 1980, VISION RES, V20, P431, DOI 10.1016/0042-6989(80)90033-4; Mulder MJ, 2012, J NEUROSCI, V32, P2335, DOI 10.1523/JNEUROSCI.4156-11.2012; Nagano-Saito A, 2012, J NEUROPHYSIOL, V108, P501, DOI 10.1152/jn.00592.2011; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rao RPN, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00146; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Smith Y, 1998, NEUROSCIENCE, V86, P353; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Wickens J., 1993, THEORY STRIATUM; Wilson S. A. K., 1914, BRAIN, V36, P427	92	101	102	2	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 21	2013	79	4					640	649		10.1016/j.neuron.2013.07.042	http://dx.doi.org/10.1016/j.neuron.2013.07.042			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972593	Green Accepted, Bronze			2022-12-25	WOS:000323587000005
J	Oh, P; Lobry, C; Gao, J; Tikhonova, A; Loizou, E; Manent, J; van Handel, B; Ibrahim, S; Greve, J; Mikkola, H; Artavanis-Tsakonas, S; Aifantis, I				Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Manent, Jan; van Handel, Ben; Ibrahim, Sherif; Greve, Jeffrey; Mikkola, Hanna; Artavanis-Tsakonas, Spyros; Aifantis, Iannis			In Vivo Mapping of Notch Pathway Activity in Normal and Stress Hematopoiesis	CELL STEM CELL			English	Article							ZONE B-CELLS; SELF-RENEWAL; ACTIVATION; LINEAGE; MICE; ERYTHROPOIETIN; MAINTENANCE; EXPRESSION; DISEASE; ANEMIA	Accumulating evidence suggests that Notch signaling is active at multiple points during hematopoiesis. Until recently, the majority of such studies focused on Notch signaling in lymphocyte differentiation and knowledge of individual Notch receptor roles has been limited due to a paucity of genetic tools available. In this manuscript we generate and describe animal models to identify and fate-map stem and progenitor cells expressing each Notch receptor, delineate Notch pathway activation, and perform in vivo gain- and loss-of-function studies dissecting Notch signaling in early hematopoiesis. These models provide comprehensive genetic maps of lineage-specific Notch receptor expression and activation in hematopoietic stem and progenitor cells. Moreover, they establish a previously unknown role for Notch signaling in the commitment of blood progenitors toward the erythrocytic lineage and link Notch signaling to optimal organismal response to stress erythropoiesis.	[Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Oh, Philmo; Lobry, Camille; Gao, Jie; Tikhonova, Anastasia; Loizou, Evangelia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Ibrahim, Sherif] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Manent, Jan; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [van Handel, Ben; Mikkola, Hanna] Univ Calif Los Angeles, Eli & Edythe Broad Stem Cell Res Ctr, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Greve, Jeffrey] Exelixis Inc, San Francisco, CA 94080 USA; [Artavanis-Tsakonas, Spyros] Coll France, F-75231 Paris 05, France	Howard Hughes Medical Institute; New York University; New York University; New York University; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Exelixis, Inc.; UDICE-French Research Universities; PSL Research University Paris; College de France	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	lobry, camille/A-6188-2015; Tikhonova, Anastasia/F-1186-2015	lobry, camille/0000-0003-0550-4921; Manent, Jan/0000-0001-9152-5459	NIH/NCI [P30 CA016087-30, 5 P30CA16087-31]; NYU Cancer Institute Center [5P30CA16087-31]; National Institutes of Health [RO1CA133379, RO1CA105129, RO1CA149655, RO1GM088847]; Leukemia & Lymphoma Society (TRP program grants); V Foundation for Cancer Research; Irma T. Hirschl Trust; St. Baldrick's Foundation for Cancer Research; NYU MSTP Program; Helen and Martin Kimmel Center for Stem Cell Research; NIH [RO1 CA 098402]; NATIONAL CANCER INSTITUTE [R01CA133379, R01CA105129, R01CA149655, R01CA098402, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Cancer Institute Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society (TRP program grants); V Foundation for Cancer Research; Irma T. Hirschl Trust; St. Baldrick's Foundation for Cancer Research; NYU MSTP Program; Helen and Martin Kimmel Center for Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to H.-J. Fehling for the ROSA26-RFP mice and Linheng Li, Paul Frenette, and Amy Wagers for sharing experimental tools and advice. We would like to thank the NYU Genome Technology Center (supported in part by NIH/NCI P30 CA016087-30 grant) for expert assistance with microarray experiments; the NYU Flow Cytometry facility (supported in part by NIH/NCI 5 P30CA16087-31) for expert cell sorting; the NYU Histology Core (5P30CA16087-31); the Transgenic Mouse Core (NYU Cancer Institute Center Grant (5P30CA16087-31); and Jacquelyn Freund for technical assistance. I. A. is supported by the National Institutes of Health (RO1CA133379, RO1CA105129, RO1CA149655, and RO1GM088847), the Leukemia & Lymphoma Society (TRP program grants), The V Foundation for Cancer Research, the Irma T. Hirschl Trust, and the St. Baldrick's Foundation for Cancer Research. P.O. was supported by the NYU MSTP Program. C. L. was supported by the Helen and Martin Kimmel Center for Stem Cell Research and is currently a Leukemia and Lymphoma Society Fellow. The research in the S.A.-T. laboratory was supported by the NIH (RO1 CA 098402). I. A. is a Howard Hughes Medical Institute Early Career Scientist. Hes1<SUP>GFP</SUP> and Notch(1-4)<SUP>CreER</SUP> mice are available upon request to Dr. Artavanis-Tsakonas.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; JACKSON CW, 1973, BLOOD, V42, P413, DOI 10.1182/blood.V42.3.413.413; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Melnikova I, 2006, NAT REV DRUG DISCOV, V5, P627, DOI 10.1038/nrd2113; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peslak SA, 2012, BLOOD, V120, P2501, DOI 10.1182/blood-2011-11-394304; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sekine C, 2009, INT IMMUNOL, V21, P295, DOI 10.1093/intimm/dxn148; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Van der Putten K, 2008, NAT CLIN PRACT NEPHR, V4, P47, DOI 10.1038/ncpneph0655; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868	40	68	69	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					190	204		10.1016/j.stem.2013.05.015	http://dx.doi.org/10.1016/j.stem.2013.05.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23791481	Green Accepted, Bronze			2022-12-25	WOS:000329570600012
J	Pereira, CF; Chang, B; Qiu, JJ; Niu, XH; Papatsenko, D; Hendry, CE; Clark, NR; Nomura-Kitabayashi, A; Kovacic, JC; Ma'ayan, A; Schaniel, C; Lemischka, IR; Moore, K				Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Clark, Neil R.; Nomura-Kitabayashi, Aya; Kovacic, Jason C.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.; Moore, Kateri			Induction of a Hemogenic Program in Mouse Fibroblasts	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; MICE LACKING; IN-VIVO; C-FOS; HAEMOGENIC ENDOTHELIUM; DIRECT CONVERSION; AGM REGION; BLOOD STEM; GATA-2	Definitive hematopoiesis emerges during embryogenesis via an endothelial-to-hematopoietic transition. We attempted to induce this process in mouse fibroblasts by screening a panel of factors for hemogenic activity. We identified a combination of four transcription factors, Gata2, Gfi1b, cFos, and Etv6, that efficiently induces endothelial-like precursor cells, with the subsequent appearance of hematopoietic cells. The precursor cells express a human CD34 reporter, Sca1, and Prominin1 within a global endothelial transcription program. Emergent hematopoietic cells possess nascent hematopoietic stem cell gene-expression profiles and cell-surface phenotypes. After transgene silencing and reaggregation culture, the specified cells generate hematopoietic colonies in vitro. Thus, we show that a simple combination of transcription factors is sufficient to induce a complex, dynamic, and multistep developmental program in vitro. These findings provide insights into the specification of definitive hemogenesis and a platform for future development of patient-specific stem and progenitor cells, as well as more-differentiated blood products.	[Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Lemischka, Ihor R.; Moore, Kateri] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Clark, Neil R.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Pereira, Carlos-Filipe; Chang, Betty; Qiu, Jiajing; Niu, Xiaohong; Papatsenko, Dmitri; Hendry, Caroline E.; Clark, Neil R.; Ma'ayan, Avi; Schaniel, Christoph; Lemischka, Ihor R.; Moore, Kateri] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Nomura-Kitabayashi, Aya; Kovacic, Jason C.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Chang, Betty; Qiu, Jiajing] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Pereira, CF (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, 1 Gustave L Levy Pl,Box 1496, New York, NY 10029 USA.	filipe.pereira@mssm.edu; kateri.moore@mssm.edu	Schaniel, Chrisoph/C-9655-2012; Pereira, Carlos-Filipe/B-8438-2013; Papatsenko, Dmitri/G-7375-2016; Ma'ayan, Avi/AAG-3131-2019; Schaniel, Christoph/P-3836-2019	Pereira, Carlos-Filipe/0000-0002-9724-1382; Papatsenko, Dmitri/0000-0002-4390-5446; Ma'ayan, Avi/0000-0002-6904-1017; Schaniel, Christoph/0000-0002-1343-4858; Kovacic, Jason/0000-0003-4555-769X	NIH [5K08HL111330, 5T32HL007824-15]; EMBO Long-term Postdoctoral Fellowship;  [R01GM098316];  [R01DK088541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058739, K08HL111330, T32HL007824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM098316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Tenen (Harvard Medical School) for the huCD34tTa transgenic mouse. We thank D. F. Lee, Y.S. Ang, S. Mulero-Navarro, A. Freire, and the members of the Lemischka/Moore laboratory for useful discussions and Y. Liu for laboratory management. We would like to thank M. Rendl and V. Gouon-Evans and their laboratories for their assistance. We thank T. Schroeder and K. Kokkaliaris for advice with live imaging and F. Gonzalez for inducible vectors. We thank M. Baron and S. Ghaffari for critical reading of the manuscript. We would also like to thank the Mount Sinai hESC/hiPSC Shared Resource Facility and S. D'Souza for help with materials and protocols and the Mount Sinai Genomics, Flow Cytometry, and Mouse facilities. C. F. P. is a recipient of an EMBO Long-term Postdoctoral Fellowship. J.C.K. and A.N.K are supported by the NIH grants 5K08HL111330 and 5T32HL007824-15; A. M. by R01GM098316 and R01DK088541.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma GT, 1997, DEVELOPMENT, V124, P907; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Minehata K, 2002, BLOOD, V99, P2360, DOI 10.1182/blood.V99.7.2360; Moepps B, 2000, EUR J IMMUNOL, V30, P2924, DOI 10.1002/1521-4141(200010)30:10<2924::AID-IMMU2924>3.0.CO;2-Y; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; North T, 1999, DEVELOPMENT, V126, P2563; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Pereira CF, 2012, ANN NY ACAD SCI, V1266, P7, DOI 10.1111/j.1749-6632.2012.06508.x; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Radomska HS, 2002, BLOOD, V100, P4410, DOI 10.1182/blood-2002-02-0355; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schaniel C, 2009, ANN NY ACAD SCI, V1176, P26, DOI 10.1111/j.1749-6632.2009.04608.x; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Sinka L, 2012, BLOOD, V119, P3712, DOI 10.1182/blood-2010-11-314781; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	156	166	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					205	218		10.1016/j.stem.2013.05.024	http://dx.doi.org/10.1016/j.stem.2013.05.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23770078	Bronze, Green Accepted			2022-12-25	WOS:000329570600013
J	Robertson, SD; Plummer, NW; de Marchena, J; Jensen, P				Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia			Developmental origins of central norepinephrine neuron diversity	NATURE NEUROSCIENCE			English	Article							DOPAMINE-BETA-HYDROXYLASE; LOCUS-COERULEUS NEURONS; NORADRENERGIC NEURONS; RAT-BRAIN; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; MESSENGER-RNA; EXPOSURE; MICE; DISEASE	Central norepinephrine-producing neurons comprise a diverse population of cells differing in anatomical location, connectivity, function and response to disease and environmental insult. The mechanisms that generate this diversity are unknown. Here we elucidate the lineal relationship between molecularly distinct progenitor populations in the developing mouse hindbrain and mature norepinephrine neuron subtype identity. We have identified four genetically separable subpopulations of mature norepinephrine neurons differing in their anatomical location, axon morphology and efferent projection pattern. One of the subpopulations showed an unexpected projection to the prefrontal cortex, challenging the long-held belief that the locus coeruleus is the sole source of norepinephrine projections to the cortex. These findings reveal the embryonic origins of central norepinephrine neurons and provide multiple molecular points of entry for future study of individual norepinephrine circuits in complex behavioral and physiological processes including arousal, attention, mood, memory, appetite and homeostasis.	[Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jensen, P (corresponding author), NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	patricia.jensen@nih.gov	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289; Robertson, Sabrina/0000-0003-4598-6929; /0000-0003-2971-814X	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences [ZIA-ES-102805]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES102805] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Dymecki (Harvard Medical School) for Hoxa2-cre and RC:: FrePe mice and P. Charnay (INSERM) for Krox20cre mice. We thank T. Wolfgang, G. Keeley and the National Institute of Environmental Health Sciences Fluorescence Microscopy, Vivarium, Knockout Mice and Statistics services for assistance. This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (ZIA-ES-102805).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Aroca P, 2006, J COMP NEUROL, V496, P802, DOI 10.1002/cne.20957; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Benarroch EE, 2008, ACTA NEUROPATHOL, V115, P629, DOI 10.1007/s00401-008-0351-9; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bertrand E, 1997, FOLIA NEUROPATHOL, V35, P80; Brunnstrom H, 2011, CLIN NEUROPATHOL, V30, P104, DOI 10.5414/NPP30104; Busch C, 1997, NEUROBIOL AGING, V18, P401, DOI 10.1016/S0197-4580(97)00035-3; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Champagnat J, 2009, PHILOS T R SOC B, V364, P2469, DOI 10.1098/rstb.2009.0090; Chandler D, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00020; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Del Pino J, 2011, TOXICOLOGY, V287, P145, DOI 10.1016/j.tox.2011.06.009; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Forray MI, 2000, BRAIN RES BULL, V52, P163, DOI 10.1016/S0361-9230(00)00229-X; FRITSCHY JM, 1990, J COMP NEUROL, V293, P616, DOI 10.1002/cne.902930407; Garel S, 2000, DEVELOPMENT, V127, P5297; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; GRZANNA R, 1991, PROG BRAIN RES, V88, P89; HOKFELT T, 1973, ACTA PHYSIOL SCAND, V89, P286, DOI 10.1111/j.1748-1716.1973.tb05522.x; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jin SH, 2004, J COMP NEUROL, V477, P300, DOI 10.1002/cne.20263; Kimmel RA, 2000, GENE DEV, V14, P1377; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LORANG D, 1994, J NEUROSCI, V14, P4903; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mejias-Aponte CA, 2009, J NEUROSCI, V29, P3613, DOI 10.1523/JNEUROSCI.4632-08.2009; Miller MA, 1999, J NEUROCHEM, V73, P2028; Mohideen SS, 2011, TOXICOLOGY, V285, P67, DOI 10.1016/j.tox.2011.04.005; Myers EA, 2005, J COMP NEUROL, V492, P426, DOI 10.1002/cne.20727; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schofield Brett R, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0117s43; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Slotkin TA, 2011, BRAIN RES BULL, V86, P435, DOI 10.1016/j.brainresbull.2011.08.009; Soulage C, 2004, NEUROCHEM INT, V45, P979, DOI 10.1016/j.neuint.2004.06.015; SWANSON LW, 1976, BRAIN RES, V110, P39, DOI 10.1016/0006-8993(76)90207-9; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	57	149	151	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1016	U65		10.1038/nn.3458	http://dx.doi.org/10.1038/nn.3458			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852112	Green Accepted			2022-12-25	WOS:000322323000011
J	Bradfield, LA; Bertran-Gonzalez, J; Chieng, B; Balleine, BW				Bradfield, Laura A.; Bertran-Gonzalez, Jesus; Chieng, Billy; Balleine, Bernard W.			The Thalamostriatal Pathway and Cholinergic Control of Goal-Directed Action: Interlacing New with Existing Learning in the Striatum	NEURON			English	Article							PARAFASCICULAR THALAMIC NUCLEUS; VIVO ACETYLCHOLINE-RELEASE; RIBOSOMAL-PROTEIN S6; DORSOMEDIAL STRIATUM; BASAL GANGLIA; RAT STRIATUM; IN-VIVO; BEHAVIORAL FLEXIBILITY; DORSAL STRIATUM; SPINY NEURONS	The capacity for goal-directed action depends on encoding specific action-outcome associations, a learning process mediated by the posterior dorsomedial striatum (pDMS). In a changing environment, plasticity has to remain flexible, requiring interference between new and existing learning to be minimized, yet it is not known how new and existing learning are interlaced in this way. Here we investigated the role of the thalamostriatal pathway linking the parafascicular thalamus (Pf) with cholinergic interneurons (CINs) in the pDMS in this process. Removing the excitatory input from Pf to the CINs was found to reduce the firing rate and intrinsic activity of these neurons and produced an enduring deficit in goal-directed learning after changes in the action-outcome contingency. Disconnection of the Pf-pDMS pathway produced similar behavioral effects. These data suggest that CINs reduce interference between new and existing learning, consistent with claims that the thalamostriatal pathway exerts state control over learning-related plasticity.	[Bradfield, Laura A.; Bertran-Gonzalez, Jesus; Chieng, Billy; Balleine, Bernard W.] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney	Balleine, BW (corresponding author), Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia.	bernard.balleine@sydney.edu.au	Bertran-Gonzalez, J/L-1410-2017	Bertran-Gonzalez, J/0000-0002-3794-1782; Chieng, Billy/0000-0003-0222-8001; Balleine, Bernard/0000-0001-8618-7950; Bradfield, Laura/0000-0003-3921-0745	National Institute of Mental Health [MH56446]; National Health & Medical Research Council of Australia [633267]; Australian Research Council [FL0992409]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056446, R29MH056446] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research reported in the manuscript was supported by grants from the National Institute of Mental Health MH56446, the National Health & Medical Research Council of Australia 633267, and a Laureate Fellowship from the Australian Research Council, FL0992409. The authors thank Amir Dezfouli for his comments on the manuscript.	Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bernard V, 1998, J NEUROSCI, V18, P10207; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bertran-Gonzalez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053195; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Bonsi P, 2008, J NEUROSCI, V28, P6258, DOI 10.1523/JNEUROSCI.1678-08.2008; Brown HD, 2010, J NEUROSCI, V30, P14390, DOI 10.1523/JNEUROSCI.2167-10.2010; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; Consolo S, 1996, EUR J NEUROSCI, V8, P2702, DOI 10.1111/j.1460-9568.1996.tb01565.x; Consolo S, 1996, NEUROSCIENCE, V71, P157, DOI 10.1016/0306-4522(95)00421-1; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; CORNWALL J, 1988, BRAIN RES BULL, V20, P139, DOI 10.1016/0361-9230(88)90171-2; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; Dempster F.N., 1995, INTERFERENCE INHIBIT; Deschenes M, 1996, EUR J NEUROSCI, V8, P329, DOI 10.1111/j.1460-9568.1996.tb01217.x; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Ellender TJ, 2013, J PHYSIOL-LONDON, V591, P257, DOI 10.1113/jphysiol.2012.245233; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; FRENCH RM, 1991, PROGRAM OF THE THIRTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P173; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Goldberg Joshua A, 2012, Handb Exp Pharmacol, P223, DOI 10.1007/978-3-642-23274-9_10; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; HERSCH SM, 1994, J NEUROSCI, V14, P3351; Kimura M, 2004, NEUROSCI RES, V48, P355, DOI 10.1016/j.neures.2003.12.002; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; Linster C, 1999, J NEUROPHYSIOL, V81, P2737, DOI 10.1152/jn.1999.81.6.2737; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Ostlund SB, 2007, LEARN BEHAV, V35, P43; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Ragozzino ME, 2009, NEUROBIOL LEARN MEM, V91, P13, DOI 10.1016/j.nlm.2008.09.008; Rescorla RA, 1996, ANIM LEARN BEHAV, V24, P450, DOI 10.3758/BF03199016; RESCORLA RA, 1991, J EXP PSYCHOL ANIM B, V17, P465, DOI 10.1037/0097-7403.17.4.465; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shiflett MW, 2011, PROG NEUROBIOL, V95, P1, DOI 10.1016/j.pneurobio.2011.05.007; Shiflett MW, 2011, BEHAV BRAIN RES, V218, P240, DOI 10.1016/j.bbr.2010.12.010; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; SORIMACHI M, 1975, BRAIN RES, V94, P325, DOI 10.1016/0006-8993(75)90065-7; Stalnaker TA, 2012, J NEUROSCI, V32, P10296, DOI 10.1523/JNEUROSCI.0832-12.2012; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Threlfell S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00011; UNDERWOOD BJ, 1957, PSYCHOL REV, V64, P49, DOI 10.1037/h0044616; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	65	183	186	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					153	166		10.1016/j.neuron.2013.04.039	http://dx.doi.org/10.1016/j.neuron.2013.04.039			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23770257	Green Accepted, Bronze			2022-12-25	WOS:000321802000016
J	Silies, M; Gohl, DM; Fisher, YE; Freifeld, L; Clark, DA; Clandinin, TR				Silies, Marion; Gohl, Daryl M.; Fisher, Yvette E.; Freifeld, Limor; Clark, Damon A.; Clandinin, Thomas R.			Modular Use of Peripheral Input Channels Tunes Motion-Detecting Circuitry	NEURON			English	Article							RECEPTIVE-FIELD ORGANIZATION; VISUAL FLIGHT ORIENTATION; WHITE-NOISE ANALYSIS; DROSOPHILA-MELANOGASTER; OPTOMOTOR RESPONSES; OPTIC FLOW; TRANSGENE EXPRESSION; FINE-STRUCTURE; YAW TORQUE; WILD-TYPE	In the visual system, peripheral processing circuits are often tuned to specific stimulus features. How this selectivity arises and how these circuits are organized to inform specific visual behaviors is incompletely understood. Using forward genetics and quantitative behavioral studies, we uncover an input channel to motion detecting circuitry in Drosophila. The second-order neuron L3 acts combinatorially with two previously known inputs, L1 and L2, to inform circuits specialized to detect moving light and dark edges. In vivo calcium imaging of L3, combined with neuronal silencing experiments, suggests a neural mechanism to achieve selectivity for moving dark edges. We further demonstrate that different innate behaviors, turning and forward movement, can be independently modulated by visual motion. These two behaviors make use of different combinations of input channels. Such modular use of input channels to achieve feature extraction and behavioral specialization likely represents a general principle in sensory systems.	[Silies, Marion; Gohl, Daryl M.; Fisher, Yvette E.; Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Freifeld, Limor] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu		Freifeld, Limor/0000-0002-0739-6947; Fisher, Yvette/0000-0001-8445-9625; Gohl, Daryl/0000-0002-4434-2788	Jane Coffin Childs Memorial Fund for Medical Research; National Eye Institute [F32EY020040]; NIH Neuroscience Research Training grant [5 T32 MH020016-14]; Fulbright International Science and Technology Scholarship; Bio-X Stanford Interdisciplinary Graduate Fellowship; NIH T32 Postdoctoral Training Grant; National Institutes of Health Director's Pioneer Award [DP1 OD003530];  [R01 EY022638]; NATIONAL EYE INSTITUTE [R01EY022638, F32EY020040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Neuroscience Research Training grant; Fulbright International Science and Technology Scholarship; Bio-X Stanford Interdisciplinary Graduate Fellowship; NIH T32 Postdoctoral Training Grant; National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Nirao Shah, Liqun Luo, Christian Klambt, David Kastner, Girish Deshpande, Saskia de Vries, Jennifer Esch, and Tina Schwabe for critical comments on the manuscript. We thank Georg Dietzl and Sheetal Bhalerao for providing the phototaxis assay, Christoph Scheper and Ya-Hui Chou for brain dissections, and Alexander Katsov for help with the high-throughput behavioral assay. M.S. and D.A.C. acknowledge postdoctoral fellowships from the Jane Coffin Childs Memorial Fund for Medical Research. D.M.G was supported by a Ruth L Kirschstein NRSA Postdoctoral Fellowship (F32EY020040) from the National Eye Institute. Y.E.F. acknowledges an NIH Neuroscience Research Training grant (5 T32 MH020016-14), and L.F. was supported by a Fulbright International Science and Technology Scholarship and a Bio-X Stanford Interdisciplinary Graduate Fellowship (Bruce and Elizabeth Dunlevie fellow). D.A.C also received support from an NIH T32 Postdoctoral Training Grant. This work was funded by a National Institutes of Health Director's Pioneer Award DP1 OD003530 (T.R.C.) and by R01 EY022638.	BARNES WJP, 1990, J EXP BIOL, V154, P99; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRAITENBERG V, 1970, KYBERNETIK, V7, P235; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; Duistermars BJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00006; Egelhaaf M, 2002, TRENDS NEUROSCI, V25, P96, DOI 10.1016/S0166-2236(02)02063-5; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; Hecht S, 1934, J GEN PHYSIOL, V17, P517, DOI 10.1085/jgp.17.4.517; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JUNGER W, 1991, J COMP PHYSIOL A, V169, P641; KALMUS H, 1949, PHYS COMP OECOL, V1, P127; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; SAKAI HM, 1988, VISUAL NEUROSCI, V1, P287, DOI 10.1017/S0952523800001942; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; STRAUSFELD NJ, 1973, BRAIN RES, V59, P97, DOI 10.1016/0006-8993(73)90254-0; STRAUSFELD NJ, 1977, SCIENCE, V195, P894, DOI 10.1126/science.841315; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Theobald JC, 2010, J EXP BIOL, V213, P1366, DOI 10.1242/jeb.037945; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tinbergen, 1951, STUDY INSTINCT; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	65	84	84	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					111	127		10.1016/j.neuron.2013.04.029	http://dx.doi.org/10.1016/j.neuron.2013.04.029			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849199	Bronze, Green Accepted			2022-12-25	WOS:000321802000013
J	Herrero, JL; Gieselmann, MA; Sanayei, M; Thiele, A				Herrero, Jose L.; Gieselmann, Marc A.; Sanayei, Mehdi; Thiele, Alexander			Attention-Induced Variance and Noise Correlation Reduction in Macaque V1 Is Mediated by NMDA Receptors	NEURON			English	Article							PRIMARY VISUAL-CORTEX; SELECTIVE ATTENTION; NEURONAL OSCILLATIONS; SPATIAL INTEGRATION; WORKING-MEMORY; NETWORK MODEL; AREA; MODULATION; INFORMATION; VARIABILITY	Attention improves perception by affecting different aspects of the neuronal code. It enhances firing rates, it reduces firing rate variability and noise correlations of neurons, and it alters the strength of oscillatory activity. Attention-induced rate enhancement in striate cortex requires cholinergic mechanisms. The neuropharmacological mechanisms responsible for attention-induced variance and noise correlation reduction or those supporting changes in oscillatory activity are unknown. We show that ionotropic glutamatergic receptor activation is required for attention-induced rate variance, noise correlation, and LFP gamma power reduction in macaque V1, but not for attention-induced rate modulations. NMDA receptors mediate attention-induced variance reduction and attention-induced noise correlation reduction. Our results demonstrate that attention improves sensory processing by a variety of mechanisms that are dissociable at the receptor level.	[Herrero, Jose L.; Gieselmann, Marc A.; Sanayei, Mehdi; Thiele, Alexander] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk		Thiele, Alexander/0000-0003-4894-0213	BBSRC; MRC; Wellcome Trust; BBSRC [BB/F021399/1] Funding Source: UKRI; MRC [MR/K013785/1, G0700976] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021399/1] Funding Source: researchfish; Medical Research Council [G0700976, MR/K013785/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the staff of the Comparative Biology Centre (Newcastle University) for excellent technical support. The work was supported by the BBSRC, MRC, and the Wellcome Trust. We would like to thank K. Harris and C.E. Schroeder for their valuable comments on earlier versions of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Deco G, 2011, EUR J NEUROSCI, V34, P146, DOI 10.1111/j.1460-9568.2011.07749.x; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Niebergall R, 2011, J NEUROSCI, V31, P15499, DOI 10.1523/JNEUROSCI.2822-11.2011; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Rasch MJ, 2011, J NEUROPHYSIOL, V105, P757, DOI 10.1152/jn.00845.2009; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Rowland LM, 2005, NEUROPSYCHOPHARMACOL, V30, P633, DOI 10.1038/sj.npp.1300642; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shima K, 1998, JPN J PHYSIOL, V48, P275, DOI 10.2170/jjphysiol.48.275; SHIMA K, 1993, CEREB CORTEX, V3, P330, DOI 10.1093/cercor/3.4.330; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Turchi J, 2001, NEUROSCIENCE, V104, P407, DOI 10.1016/S0306-4522(01)00089-6; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	55	106	106	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					729	739		10.1016/j.neuron.2013.03.029	http://dx.doi.org/10.1016/j.neuron.2013.03.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719166	Green Published, hybrid			2022-12-25	WOS:000319491200015
J	Guha, P; Morgan, JW; Mostoslavsky, G; Rodrigues, NP; Boyd, AS				Guha, Prajna; Morgan, John W.; Mostoslavsky, Gustavo; Rodrigues, Neil P.; Boyd, Ashleigh S.			Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							MOUSE	The prospects for using autologous induced pluripotent stem cells (iPSCs) in cell replacement therapy have been tempered by evidence that undifferentiated, syngeneic mouse iPSCs are immunogenic upon transplantation. However, the immunogenicity of more therapeutically relevant differentiated cells remains unexplored. Here, we differentiated mouse iPSCs into embryoid bodies (EBs) or representative cell types spanning the three embryonic germ layers and assessed their immunogenicity in vitro and after their transplantation into syngeneic recipients. We found no evidence of increased T cell proliferation in vitro, rejection of syngeneic iPSC-derived EBs/tissue-specific cells (TSCs) after transplantation, or an antigen-specific secondary immune response. Thus, differentiated cells derived from syngeneic iPSCs do not appear to be rejected after transplantation. We also found little evidence of an immune response to undifferentiated, syngeneic iPSCs. Our data support the idea that differentiated cells generated from autologous iPSCs could be applied for cell replacement therapy without eliciting immune rejection.	[Guha, Prajna; Morgan, John W.; Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Roger Williams Med Ctr, NIH Ctr Biomed Res Excellence COBRE Stem Cell Bio, Providence, RI 02908 USA; [Mostoslavsky, Gustavo; Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Rodrigues, Neil P.; Boyd, Ashleigh S.] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Roger Williams Medical Center; Boston University; Boston University	Boyd, AS (corresponding author), Boston Univ, Sch Med, Roger Williams Med Ctr, NIH Ctr Biomed Res Excellence COBRE Stem Cell Bio, Providence, RI 02908 USA.	asboyd@bu.edu		Mostoslavsky, Gustavo/0000-0002-0784-2169; Rodrigues, Neil/0000-0002-1925-7733	NIH [P20RR018757]; Rhode Island Foundation; BD Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; BD Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH Grant P20RR018757 (A. S. B. and N.P.R.), the Rhode Island Foundation (A. S. B.), and BD Biosciences (N.P.R.). Additional support to A. S. B. and N.P.R. laboratories was provided by the administrative, imaging, and flow cytometry cores within the NIH COBRE at Roger Williams Medical Center. The authors thank Dr. Yang Xu for generously sharing the episomal iPSC line used in this study, Dr. Darrell Kotton for his advice on derivation of mouse iPSCs, Anthony Berghelli for editorial and technical assistance, and Jasmine Sayegh and Dr. Murugabaskar Balan for technical assistance. The authors declare no conflict of interest. P. G. performed experiments, acquired and analyzed data, and prepared figures; J.W.M. performed cell sorting and assisted with flow cytometry analysis; G. M. contributed vital reagents and advice on derivation of iPSC lines and reviewed the manuscript; N.P.R. conceived the project, designed experiments, analyzed and interpreted data, and wrote the manuscript; and A. S. B. conceived the project, designed experiments, contributed to derivation of iPSC lines, analyzed and interpreted data, and wrote the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Boyd AS, 2008, STEM CELLS, V26, P1128, DOI 10.1634/stemcells.2007-0762; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	17	251	260	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					407	412		10.1016/j.stem.2013.01.006	http://dx.doi.org/10.1016/j.stem.2013.01.006			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23352605	Bronze			2022-12-25	WOS:000329569500008
J	van Spronsen, M; Mikhaylova, M; Lipka, J; Schlager, MA; van den Heuve, DJ; Kuijpers, M; Wulf, PS; Keijzer, N; Demmers, J; Kapitein, LC; Jaarsma, D; Gerritsen, HC; Akhmanova, A; Hoogenraad, CC				van Spronsen, Myrrhe; Mikhaylova, Marina; Lipka, Joanna; Schlager, Max A.; van den Heuve, Dave J.; Kuijpers, Marijn; Wulf, Phebe S.; Keijzer, Nanda; Demmers, Jeroen; Kapitein, Lukas C.; Jaarsma, Dick; Gerritsen, Hans C.; Akhmanova, Anna; Hoogenraad, Casper C.			TRAK/Milton Motor-Adaptor Proteins Steer Mitochondrial Trafficking to Axons and Dendrites	NEURON			English	Article							COIL DOMAIN PROTEINS; KINESIN HEAVY-CHAIN; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; HIPPOCAMPAL-NEURONS; DYNEIN; SYNAPSES; LOCALIZATION; MICROTUBULES; ORGANELLE	In neurons, the distinct molecular composition of axons and dendrites is established through polarized targeting mechanisms, but it is currently unclear how nonpolarized cargoes, such as mitochondria, become uniformly distributed over these specialized neuronal compartments. Here, we show that TRAK family adaptor proteins, TRAK1 and TRAK2, which link mitochondria to microtubule-based motors, are required for axonal and dendritic mitochondrial motility and utilize different transport machineries to steer mitochondria into axons and dendrites. TRAK1 binds to both kinesin-1 and dynein/dynactin, is prominently localized in axons, and is needed for normal axon outgrowth, whereas TRAK2 predominantly interacts with dynein/dynactin, is more abundantly present in dendrites, and is required for dendritic development. These functional differences follow from their distinct conformations: TRAK2 preferentially adopts a head-to-tail interaction, which interferes with kinesin-1 binding and axonal transport. Our study demonstrates how the molecular interplay between bidirectional adaptor proteins and distinct microtubule-based motors drives polarized mitochondria! transport.	[van Spronsen, Myrrhe; Mikhaylova, Marina; Lipka, Joanna; Kuijpers, Marijn; Wulf, Phebe S.; Kapitein, Lukas C.; Akhmanova, Anna; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands; [van den Heuve, Dave J.; Gerritsen, Hans C.] Univ Utrecht, Fac Sci, Dept Phys & Astron, NL-3584 CH Utrecht, Netherlands; [van Spronsen, Myrrhe; Schlager, Max A.; Keijzer, Nanda; Jaarsma, Dick; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Mikhaylova, Marina] Leibniz Inst Neurobiol, RG Neuroplast, D-39118 Magdeburg, Germany; [Lipka, Joanna] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Utrecht University; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leibniz Institut fur Neurobiologie (LIN); Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Hoogenraad, CC (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands.	c.hoogenraad@uu.nl	Hoogenraad, Casper/B-8866-2011; Demmers, Jeroen AA/F-4046-2016; kuijpers, marijn/F-2248-2013; Gerritsen, Hans c/B-6303-2008; Mikhaylova, Marina/AAM-4368-2020; Kapitein, Lukas C/J-4776-2016	Hoogenraad, Casper/0000-0002-2666-0758; Demmers, Jeroen AA/0000-0002-8757-9611; kuijpers, marijn/0000-0003-1187-0290; Mikhaylova, Marina/0000-0001-7646-1346; Kapitein, Lukas C/0000-0001-9418-6739; Schlager, Max/0000-0003-3558-7078	International PhD Projects Programme of Foundation for Polish Science; European Union-Regional Development Fund; European Molecular Biology Organization (EMBO) [EMBO ALTF 884-2011]; European Commission [GA-2010-267146]; Marie Curie Actions; Erasmus Medical Center (EMC); Netherlands Organisation for Scientific Research (NWO-VENI); Netherlands Organisation for Scientific Research (NWO-ALW-VICI); Netherlands Organisation for Health Research and Development (ZonMW-TOP); European Science Foundation (EURYI); EMBO Young Investigators Program; Human Frontier Science Program (HFSP-CDA)	International PhD Projects Programme of Foundation for Polish Science; European Union-Regional Development Fund(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Actions(European Commission); Erasmus Medical Center (EMC); Netherlands Organisation for Scientific Research (NWO-VENI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO-ALW-VICI); Netherlands Organisation for Health Research and Development (ZonMW-TOP); European Science Foundation (EURYI)(European Science Foundation (ESF)); EMBO Young Investigators Program(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP-CDA)(Human Frontier Science Program)	We thank Dr. David Stephens for GFP-p150Glued, Dr. Richard Vallee for Flag-DHC-FL, Dr. Pontus Aspenstrom for myc-Miro-1, Karel Bezstarosti for help with mass spectrometry analyses, and Dr. Esther de Graaff for TRAK antibody-blocking experiments. J.L. is supported by International PhD Projects Programme of Foundation for Polish Science (studies of nucleic acids and proteins-from basic to applied research) cofinanced by the European Union-Regional Development Fund and cosupervised by Dr. Jacek Jaworski. M.M. is a recipient of a European Molecular Biology Organization (EMBO) Long-Term Fellowship (EMBO ALTF 884-2011) cofunded by the European Commission (EMBOCOFUND2010, GA-2010-267146) and Marie Curie Actions. This work was supported by the Erasmus Medical Center (EMC fellowship to L.C.K.), the Netherlands Organisation for Scientific Research (NWO-VENI to L.C.K. and NWO-ALW-VICI to A.A. and C.C.H.), the Netherlands Organisation for Health Research and Development (ZonMW-TOP to C.C.H.), the European Science Foundation (EURYI to C.C.H.), EMBO Young Investigators Program (to C.C.H.), and the Human Frontier Science Program (HFSP-CDA to C.C.H.).	Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Rolls MM, 2011, DEV NEUROBIOL, V71, P419, DOI 10.1002/dneu.20836; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wiggins LM, 2012, J COMP NEUROL, V520, P2757, DOI 10.1002/cne.23085; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	34	244	244	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					485	502		10.1016/j.neuron.2012.11.027	http://dx.doi.org/10.1016/j.neuron.2012.11.027			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395375	Bronze			2022-12-25	WOS:000317030800011
J	Hong, L; Pathak, MM; Kim, IH; Ta, D; Tombola, F				Hong, Liang; Pathak, Medha M.; Kim, Iris H.; Ta, Dennis; Tombola, Francesco			Voltage-Sensing Domain of Voltage-Gated Proton Channel Hv1 Shares Mechanism of Block with Pore Domains	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; GATING PORE; K+ CHANNEL; ION-PERMEATION; SUBUNIT STOICHIOMETRY; SODIUM-CHANNELS; BREAST-CANCER; SENSOR; INACTIVATION; CHARGE	Voltage-gated sodium, potassium, and calcium channels are made of a pore domain (PD) controlled by four voltage-sensing domains (VSDs). The PD contains the ion permeation pathway and the activation gate located on the intracellular side of the membrane. A large number of small molecules are known to inhibit the PD by acting as open channel blockers. The voltage-gated proton channel Hv1 is made of two VSDs and lacks the PD. The location of the activation gate in the VSD is unknown and open channel blockers for VSDs have not yet been identified. Here, we describe a class of small molecules which act as open channel blockers on the Hv1 VSD and find that a highly conserved phenylalanine in the charge transfer center of the VSD plays a key role in blocker binding. We then use one of the blockers to show that Hv1 contains two intracellular and allosterically coupled gates.	[Hong, Liang; Pathak, Medha M.; Kim, Iris H.; Ta, Dennis; Tombola, Francesco] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Tombola, F (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	ftombola@uci.edu	Tombola, Francesco/ABA-6002-2020; Hong, Liang/C-4251-2008; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Hong, Liang/0000-0001-8152-5631; 	National Institute of Health [R01GM098973]; American Heart Association [09BGIA2160044]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098973] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D.E. Clapham for the cDNA of the h-Hv1 channel, Y. Okamura for the cDNAs of Ci-VSP and Ci-VSOP, and C. Brownlee and G. Wheeler for the cDNA of Eh-HVCN1. We thank M.L. Wood and D.J. Tobias for the Hv1-R1 and Hv1-R2 structural models superimposed in Si. This work was supported by the National Institute of Health (grant R01GM098973 to ET.), the American Heart Association (WSA grant 09BGIA2160044 to F.T.), and the Helen Hay Whitney Foundation (postdoctoral fellowship to M.M.P.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRON.CM, 1968, NATURE, V219, P1262, DOI 10.1038/2191262a0; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Berger TK, 2011, NEURON, V72, P991, DOI 10.1016/j.neuron.2011.11.014; Capasso M, 2011, TRENDS CELL BIOL, V21, P20, DOI 10.1016/j.tcb.2010.09.006; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2007, CURR PHARM DESIGN, V13, P2406; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kalia J, 2011, MOL PHARMACOL, V80, P1085, DOI 10.1124/mol.111.074989; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lacroix JJ, 2011, P NATL ACAD SCI USA, V108, P6444, DOI 10.1073/pnas.1103397108; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Macey R., 2009, BERKELEY MADONNA USE; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; NARAHASHI T, 1969, NATURE, V223, P748, DOI 10.1038/223748a0; Okamura Y, 2007, PFLUG ARCH EUR J PHY, V454, P361, DOI 10.1007/s00424-007-0222-6; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Struyk AF, 2007, J GEN PHYSIOL, V130, P11, DOI 10.1085/jgp.200709755; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Wang YF, 2011, BIOCHEM BIOPH RES CO, V412, P353, DOI 10.1016/j.bbrc.2011.07.102; Wood ML, 2012, BBA-BIOMEMBRANES, V1818, P286, DOI 10.1016/j.bbamem.2011.07.045; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	53	70	71	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					274	287		10.1016/j.neuron.2012.11.013	http://dx.doi.org/10.1016/j.neuron.2012.11.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352164	Green Accepted, Bronze			2022-12-25	WOS:000314199400010
J	Okamoto, M; Namba, T; Shinoda, T; Kondo, T; Watanabe, T; Inoue, Y; Takeuchi, K; Enomoto, Y; Ota, K; Oda, K; Wada, Y; Sagou, K; Saito, K; Sakakibara, A; Kawaguchi, A; Nakajima, K; Adachi, T; Fujimori, T; Ueda, M; Hayashi, S; Kaibuchi, K; Miyata, T				Okamoto, Mayumi; Namba, Takashi; Shinoda, Tomoyasu; Kondo, Takefumi; Watanabe, Tadashi; Inoue, Yasuhiro; Takeuchi, Kosei; Enomoto, Yukiko; Ota, Kumiko; Oda, Kanako; Wada, Yoshino; Sagou, Ken; Saito, Kanako; Sakakibara, Akira; Kawaguchi, Ayano; Nakajima, Kazunori; Adachi, Taiji; Fujimori, Toshihiko; Ueda, Masahiro; Hayashi, Shigeo; Kaibuchi, Kozo; Miyata, Takaki			TAG-1-assisted progenitor elongation streamlines nuclear migration to optimize subapical crowding	NATURE NEUROSCIENCE			English	Article							DEVELOPING MOUSE NEOCORTEX; OUTER SUBVENTRICULAR ZONE; ASYMMETRIC INHERITANCE; MAMMALIAN NEUROGENESIS; NEURAL PROGENITORS; PLANAR DIVISIONS; CEREBRAL-CORTEX; CELL-MIGRATION; NEURONS; BRAIN	Neural progenitors exhibit cell cycle-dependent interkinetic nuclear migration (INM) along the apicobasal axis. Despite recent advances in understanding its underlying molecular mechanisms, the processes to which INM contributes mechanically and the regulation of INM by the apicobasally elongated morphology of progenitors remain unclear. We found that knockdown of the cell-surface molecule TAG-1 resulted in retraction of neocortical progenitors' basal processes. Highly shortened stem-like progenitors failed to undergo basalward INM and became overcrowded in the periventricular (subapical) space. Surprisingly, the overcrowded progenitors left the apical surface and migrated into basal neuronal territories. These observations, together with the results of in toto imaging and physical tests, suggest that progenitors may sense and respond to excessive mechanical stress. Although, unexpectedly, the heterotopic progenitors remained stem-like and continued to sequentially produce neurons until the late embryonic period, histogenesis was severely disrupted. Thus, INM is essential for preventing overcrowding of nuclei and their somata, thereby ensuring normal brain histogenesis.	[Okamoto, Mayumi; Shinoda, Tomoyasu; Enomoto, Yukiko; Ota, Kumiko; Sagou, Ken; Saito, Kanako; Sakakibara, Akira; Kawaguchi, Ayano; Miyata, Takaki] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Nagoya, Aichi 4648601, Japan; [Namba, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Kondo, Takefumi; Hayashi, Shigeo] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Kobe, Hyogo, Japan; [Watanabe, Tadashi; Inoue, Yasuhiro; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Dept Biomech, Kyoto, Japan; [Takeuchi, Kosei; Oda, Kanako; Wada, Yoshino] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Niigata, Japan; [Takeuchi, Kosei] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Oda, Kanako] Brain Res Inst, Dept Comparat & Expt Med, Niigata, Japan; [Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan; [Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan; [Ueda, Masahiro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Ueda, Masahiro] Japan Sci & Technol Agcy, CREST, Toyonaka, Osaka, Japan; [Ueda, Masahiro] RIKEN, Quantitat Biol Ctr, Lab Cell Signaling Dynam, Suita, Osaka, Japan	Nagoya University; Nagoya University; RIKEN; Kyoto University; Niigata University; Niigata University; Keio University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Osaka University; Japan Science & Technology Agency (JST); RIKEN	Miyata, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Nagoya, Aichi 4648601, Japan.	tmiyata@med.nagoya-u.ac.jp	Hayashi, Shigeo/J-9628-2019; Nakajima, Kazunori/L-3396-2013; Takeuchi, Kosei/AAV-3577-2021; MIYATA, TAKAKI/I-7066-2014; Fujimori, Toshihiko/L-7711-2016; Namba, Takashi/AAE-4439-2022; Namba, Takashi/ABF-4571-2020; Adachi, Taiji/P-8981-2016; Kaibuchi, Kozo/M-4887-2014; Inoue, Yasuhiro/AAE-3409-2019; Kawaguchi, Ayano/I-7286-2014	Hayashi, Shigeo/0000-0001-7785-1290; Nakajima, Kazunori/0000-0003-1864-9425; Takeuchi, Kosei/0000-0001-6397-2243; Fujimori, Toshihiko/0000-0001-5200-4634; Namba, Takashi/0000-0003-4875-666X; Adachi, Taiji/0000-0001-5280-4156; Kaibuchi, Kozo/0000-0003-0714-1992; Inoue, Yasuhiro/0000-0002-1968-8883; Kawaguchi, Ayano/0000-0002-0339-3992; Kondo, Takefumi/0000-0001-8127-1141; Ueda, Masahiro/0000-0002-9354-3404	Japan Ministry of Education, Culture, Sports, Science and Technology [22111006]; Japan Society for the Promotion of Science (JSPS) [21240027, 23700378]; MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders"	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders"	We thank T. Shimogori for instruction in utero electroporation at E10; S. Nakagawa (RIKEN Advanced Science Institute), K. Ohta (Kumamoto University), S. Takada (Japan National Institute for Basic Biology), F. Matsuzaki (RIKEN Center for Developmental Biology), H. Kimura (Osaka University), S. Okabe (University of Tokyo) and T. Sapir (Weizmann Institute of Science) for plasmids; Y. Itoh and Y. Gotoh (both University of Tokyo) for antibodies; F. Matsuzaki and M. Ogawa for critical reading of an earlier version of the manuscript; S. Okuda, H. Takagi, K. Nagayama, T. Matsumoto for suggestions; members of the Matsuzaki, Nakajima and Ueda laboratories for discussions; and M. Masaoka, T. Kawaue, J. Yamada and N. Noguchi for excellent technical assistance. This work was supported by Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas "Cross-talk between moving cells and microenvironment as a basis of emerging order" 22111006 (T.M.), Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) 21240027 (T.M.), MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders" (T.M.), and JSPS Grant-in-Aid for Young Scientists (B) 23700378 (M.O.).	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bayer S.A., 2006, ATLAS HUMAN CENTRAL, V4; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fitzgerald MP, 2011, NEUROSCIENCE, V176, P455, DOI 10.1016/j.neuroscience.2010.12.003; Fukamauchi F, 2001, BIOCHEM BIOPH RES CO, V281, P220, DOI 10.1006/bbrc.2001.4334; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; Miyanaga Y, 2009, METHODS MOL BIOL, V571, P417, DOI 10.1007/978-1-60761-198-1_28; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2007, CURR BIOL, V17, P146, DOI 10.1016/j.cub.2006.11.023; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nishizawa Y, 2007, DEV DYNAM, V236, P3061, DOI 10.1002/dvdy.21351; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Reiner O, 2012, J MOL NEUROSCI, V46, P516, DOI 10.1007/s12031-011-9633-0; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaper A, 1897, SCIENCE, V5, P430; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Sittaramane V, 2009, DEV BIOL, V325, P363, DOI 10.1016/j.ydbio.2008.10.030; SMART IHM, 1965, J ANAT, V99, P941; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zedevic N., 1993, EARLY HUM DEV, V32, P131	50	66	66	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1556	1566		10.1038/nn.3525	http://dx.doi.org/10.1038/nn.3525			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056697				2022-12-25	WOS:000326205700013
J	Rudenko, A; Dawlaty, MM; Seo, J; Cheng, AW; Meng, J; Le, T; Faull, KF; Jaenisch, R; Tsai, LH				Rudenko, Andrii; Dawlaty, Meelad M.; Seo, Jinsoo; Cheng, Albert W.; Meng, Jia; Le, Thuc; Faull, Kym F.; Jaenisch, Rudolf; Tsai, Li-Huei			Tet1 Is Critical for Neuronal Activity-Regulated Gene Expression and Memory Extinction	NEURON			English	Article							LONG-TERM DEPRESSION; DNA METHYLATION; PROTEIN-SYNTHESIS; FEAR EXTINCTION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DEMETHYLATION; ACQUISITION; ROLES; 5HMC	The ten-eleven translocation (Tet) family of methylcytosine dioxygenases catalyze oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and promote DNA demethylation. Despite the abundance of 5hmC and Tet proteins in the brain, little is known about the functions of the neuronal Tet enzymes. Here, we analyzed Tet1 knockout mice (Tet1KO) and found downregulation of multiple neuronal activity-regulated genes, including Npas4, c-Fos, and Arc. Furthermore, Tet1KO animals exhibited abnormal hippocannpal long-term depression and impaired memory extinction. Analysis of the key regulatory gene, Npas4, indicated that its promoter region, containing multiple CpG dinucleotides, is hypermethylated in both naive Tet1KO mice and after extinction training. Such hypermethylation may account for the diminished expression of Npas4 itself and its downstream targets, impairing transcriptional programs underlying cognitive processes. In summary, we show that neuronal Tet1 regulates normal DNA methylation levels, expression of activity-regulated genes, synaptic plasticity, and memory extinction.	[Rudenko, Andrii; Seo, Jinsoo; Meng, Jia; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Rudenko, Andrii; Seo, Jinsoo; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Rudenko, Andrii; Seo, Jinsoo; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Tsai, Li-Huei] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dawlaty, Meelad M.; Cheng, Albert W.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Le, Thuc; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Le, Thuc; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; lhtsai@mit.edu	Seo, Jinsoo/AAD-4950-2019; Rudenko, Andrey/AAG-4696-2020	Seo, Jinsoo/0000-0001-6432-6964; Rudenko, Andrey/0000-0001-6858-3650; Meng, Jia/0000-0003-3455-205X; Cheng, Albert/0000-0003-2653-5743	NARSAD Young Investigator Award; Croucher scholarship; UCLA Molecular, Cellular and Neurobiology Training Grant; UCLA Mental Retardation Training Grant; Eugene V. Cota-Robles Fellowship; Simons Foundation; NIH RO1 grant [NS078839];  [HD 045022];  [R37CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046174] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); Croucher scholarship; UCLA Molecular, Cellular and Neurobiology Training Grant; UCLA Mental Retardation Training Grant; Eugene V. Cota-Robles Fellowship; Simons Foundation; NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Dr. Tracy Petryshen and Dr. Mike Lewis for the valuable advice on behavioral assays; Dr. Yingxi Lin for providing Npas4 anti-body; Lin laboratory members for discussion; Dr. Alison Mungenast and Dr. Alexi Nott for helpful comments on the manuscript; Dr. Susan C. Su for the help with histological preparations; and all members of Tsai and Jaenisch laboratories for advice and discussion. We would like to thank Mali Taylor, Ruth Flannery, and Kibibi Ganz for help with animal care, J. Kwon and J. Love from the Whitehead Genome Technology Core for help with microarrays, and A. Yoon for help with mass spectrometry. A.R is supported by NARSAD Young Investigator Award; M.M.D. is a Damon Runyon Postdoctoral Fellow; A.W.C is supported by a Croucher scholarship; T.L. is supported by a UCLA Molecular, Cellular and Neurobiology Training Grant, a UCLA Mental Retardation Training Grant, and a Eugene V. Cota-Robles Fellowship. Work in R.J. laboratory is supported by grants from National Institutes of Health (HD 045022 and R37CA084198) and the Simons Foundation. L-H.T. is an investigator of the Howard Hughes Medical Institute. This work is partially supported by an NIH RO1 grant (NS078839) to L.H.-T.	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; American Psychiatric Association, 2000, DSM 4 TR; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cain CK, 2003, J EXP PSYCHOL ANIM B, V29, P323, DOI 10.1037/0097-7403.29.4.323; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2007, NEUROBIOL LEARN MEM, V87, P149, DOI 10.1016/j.nlm.2006.08.003; Floresco SB, 2011, NEUROPSYCHOPHARMACOL, V36, P227, DOI 10.1038/npp.2010.158; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Keifer J, 2008, NEUROBIOL LEARN MEM, V90, P301, DOI 10.1016/j.nlm.2008.04.011; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lattal KM, 2003, BEHAV NEUROSCI, V117, P1017, DOI 10.1037/0735-7044.117.5.1017; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Polack CW, 2012, LEARN BEHAV, V40, P24, DOI 10.3758/s13420-011-0039-1; Porter RS, 2011, MERCK MANUAL DIAGNOS; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rudenko A, 2014, NEUROSCIENCE, V264, P51, DOI 10.1016/j.neuroscience.2012.12.034; Ryu J, 2008, J NEUROSCI, V28, P8178, DOI 10.1523/JNEUROSCI.1944-08.2008; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Smith ZD, 2013, EMBO J, V32, P318, DOI 10.1038/emboj.2012.349; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Tsetsenis T, 2011, P NATL ACAD SCI USA, V108, P14300, DOI 10.1073/pnas.1112237108; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2527; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011	71	312	325	4	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1109	1122		10.1016/j.neuron.2013.08.003	http://dx.doi.org/10.1016/j.neuron.2013.08.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050401	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000330329600010
J	Yonehara, K; Farrow, K; Ghanem, A; Hillier, D; Balint, K; Teixeira, M; Juttner, J; Noda, M; Neve, RL; Conzelmann, KK; Roska, B				Yonehara, Keisuke; Farrow, Karl; Ghanem, Alexander; Hillier, Daniel; Balint, Kamill; Teixeira, Miguel; Juettner, Josephine; Noda, Masaharu; Neve, Rachael L.; Conzelmann, Karl-Klaus; Roska, Botond			The First Stage of Cardinal Direction Selectivity Is Localized to the Dendrites of Retinal Ganglion Cells	NEURON			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; MOUSE RETINA; RABIES VIRUS; IMAGE MOTION; BIPOLAR CELLS; IDENTIFICATION; MECHANISMS; CIRCUITS; COMPUTATION	Inferring the direction of image motion is a fundamental component of visual computation and essential for visually guided behavior. In the retina, the direction of image motion is computed in four cardinal directions, but it is not known at which circuit location along the flow of visual information the cardinal direction selectivity first appears. We recorded the concerted activity of the neuronal circuit elements of single direction-selective (DS) retinal ganglion cells at subcellular resolution by combining GCaMP3-functionalized transsynaptic viral tracing and two-photon imaging. While the visually evoked activity of the dendritic segments of the DS cells were direction selective, direction-selective activity was absent in the axon terminals of bipolar cells. Furthermore, the glutamate input to DS cells, recorded using a genetically encoded glutamate sensor, also lacked direction selectivity. Therefore, the first stage in which extraction of a cardinal motion direction occurs is the dendrites of DS cells.	[Yonehara, Keisuke; Farrow, Karl; Hillier, Daniel; Balint, Kamill; Teixeira, Miguel; Juettner, Josephine; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Ghanem, Alexander; Conzelmann, Karl-Klaus] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; [Ghanem, Alexander; Conzelmann, Karl-Klaus] Univ Munich, Gene Ctr, D-80336 Munich, Germany; [Teixeira, Miguel] Univ Basel, CH-4003 Basel, Switzerland; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Neve, Rachael L.] MIT, Viral Gene Transfer Core, Cambridge, MA 02139 USA	Friedrich Miescher Institute for Biomedical Research; University of Munich; University of Munich; University of Basel; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Massachusetts Institute of Technology (MIT)	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Farrow, Karl/C-6215-2008; Conzelmann, Karl-Klaus/L-7239-2013; Noda, Masaharu/D-7146-2016; Roska, Botond/AAD-7268-2021	Noda, Masaharu/0000-0002-3796-524X; Yonehara, Keisuke/0000-0001-9541-6671; Hillier, Daniel/0000-0003-0453-9049; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Farrow, Karl/0000-0003-1409-096X	Friedrich Miescher Institute for Biomedical Research; Gebert-Ruf Foundation; Swiss National Science Foundation; European Research Council; SEEBETTER grant from the European Union; TREATRUSH grant from the European Union; OPTONEURO grant from the European Union; 3X3D Imaging grant from the European Union; EMBO Long-Term Fellowship; JSPS; EMBO Long-Term Fellowships; Marie Curie Postdoctoral Fellowships; DFG [SBF 870]	Friedrich Miescher Institute for Biomedical Research; Gebert-Ruf Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); SEEBETTER grant from the European Union; TREATRUSH grant from the European Union; OPTONEURO grant from the European Union; 3X3D Imaging grant from the European Union; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO Long-Term Fellowships; Marie Curie Postdoctoral Fellowships; DFG(German Research Foundation (DFG))	We thank B.G. Scherf, S. Djaffer, and N. Zapf for technical assistance and S. Oakeley, A. Drinnenberg, F. Esposti, and S. Trenholm for their comments on the manuscript. We thank Z. Raics for developing software for two-photon imaging and electrophysiology. We thank A. Borst and D. Reiff for sharing their ideas and providing hardware for asynchronous visual stimulation during two-photon recordings. The study was supported by the Friedrich Miescher Institute for Biomedical Research, the Gebert-Ruf Foundation, the Swiss National Science Foundation, the European Research Council, and SEEBETTER, TREATRUSH, OPTONEURO, and 3X3D Imaging grants from the European Union to B.R., an EMBO Long-Term Fellowship and a JSPS Postdoctoral Fellowship for Research Abroad to K.Y., EMBO Long-Term Fellowships and Marie Curie Postdoctoral Fellowships to K.F. and D.H., and a DFG SBF 870 grant to K.-K.C. K.Y. performed and designed all retinal experiments, performed in vivo injections, developed all plasmids, analyzed anatomical data, and wrote the paper. K.F, designed and performed two-photon experiments, analyzed two-photon and confocal data, and helped write the paper. A.G. and K.-K.C. made the GCaMP3- and iGluSnFR-expressing rabies viruses. D.H. developed software for two-photon data analysis and helped write the paper. K.B. grew and titred rabies viruses. M.T. helped with in vivo injections. J.J. made AAV viruses. M.N. developed Spig1-GFP mice. R.L.N. made herpes viruses. B.R. designed experiments, analyzed data, and wrote the paper.	Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Borst A, 2001, NAT NEUROSCI, V4, P119, DOI 10.1038/83927; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Chiao CC, 2003, NAT NEUROSCI, V6, P1251, DOI 10.1038/nn1147; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Poleg-Polsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019463; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Shi ZW, 2011, J NEUROSCI, V31, P13118, DOI 10.1523/JNEUROSCI.2331-11.2011; Sivyer B, 2010, J PHYSIOL-LONDON, V588, P3243, DOI 10.1113/jphysiol.2010.192716; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Ugolini G, 2011, ADV VIRUS RES, V79, P165, DOI 10.1016/B978-0-12-387040-7.00010-X; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wright LL, 1997, VISUAL NEUROSCI, V14, P473, DOI 10.1017/S0952523800012141; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	47	99	102	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1078	1085		10.1016/j.neuron.2013.08.005	http://dx.doi.org/10.1016/j.neuron.2013.08.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	23973208	Bronze			2022-12-25	WOS:000330329600007
J	Mazzoni, EO; Mahony, S; Peljto, M; Patel, T; Thornton, SR; McCuine, S; Reeder, C; Boyer, LA; Young, RA; Gifford, DK; Wichterle, H				Mazzoni, Esteban O.; Mahony, Shaun; Peljto, Mirza; Patel, Tulsi; Thornton, Seraphim R.; McCuine, Scott; Reeder, Christopher; Boyer, Laurie A.; Young, Richard A.; Gifford, David K.; Wichterle, Hynek			Saltatory remodeling of Hox chromatin in response to rostrocaudal patterning signals	NATURE NEUROSCIENCE			English	Article							POLYCOMB GROUP PROTEINS; RETINOIC ACID; GENE-EXPRESSION; NUCLEAR REORGANIZATION; COLUMNAR ORGANIZATION; POOL IDENTITY; STEM-CELLS; COMPLEX; BINDING; CDX2	Hox genes controlling motor neuron subtype identity are expressed in rostrocaudal patterns that are spatially and temporally collinear with their chromosomal organization. Here we demonstrate that Hox chromatin is subdivided into discrete domains that are controlled by rostrocaudal patterning signals that trigger rapid, domain-wide clearance of repressive histone H3 Lys27 trimethylation (H3K27me3) polycomb modifications. Treatment of differentiating mouse neural progenitors with retinoic acid leads to activation and binding of retinoic acid receptors (RARs) to the Hox1-Hox5 chromatin domains, which is followed by a rapid domain-wide removal of H3K27me3 and acquisition of cervical spinal identity. Wnt and fibroblast growth factor (FGF) signals induce expression of the Cdx2 transcription factor that binds and clears H3K27me3 from the Hox1-Hox9 chromatin domains, leading to specification of brachial or thoracic spinal identity. We propose that rapid clearance of repressive modifications in response to transient patterning signals encodes global rostrocaudal neural identity and that maintenance of these chromatin domains ensures the transmission of positional identity to postmitotic motor neurons later in development.	[Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA; [Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY USA; [Mazzoni, Esteban O.] NYU, Dept Biol, New York, NY 10003 USA; [Mahony, Shaun; Reeder, Christopher; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mahony, Shaun] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Thornton, Seraphim R.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA USA; [McCuine, Scott; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Columbia University; Columbia University; Columbia University; New York University; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Mazzoni, EO (corresponding author), Columbia Univ, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA.	eom204@nyu.edu; gifford@mit.edu; hw350@columbia.edu	Young, Richard A/F-6495-2012; Mahony, Shaun/C-5699-2014	Young, Richard A/0000-0001-8855-8647; Mahony, Shaun/0000-0002-2641-1807; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health [P01 NS055923, R01 NS058502, NS078097]; Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R56NS078097, R01NS078097, R01NS058502] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Korinek (Institute of Molecular Genetics, Prague) for purified Wnt3A protein, G. Daley (Harvard Medical School) for the Cdx2 construct, M. Kyba (University of Minnesota) for sharing reagents for construction of the inducible Cdx2 ESC line and T. Jessell (Columbia University) and J. Dasen (New York University) for sharing antibodies and for constructive discussion of our findings. E.O.M. was the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07), and this work was supported by The Leona M. and Harry B. Helmsley Charitable Trust, US National Institutes of Health grants P01 NS055923 (D.K.G. and H.W.) and R01 NS058502 and NS078097 (H.W.) and The Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts (L.A.B.).	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bickmore WA, 2004, COLD SPRING HARB SYM, V69, P251, DOI 10.1101/sqb.2004.69.251; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Ensini M, 1998, DEVELOPMENT, V125, P969; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Golden MG, 2012, GENE DEV, V26, P2236, DOI 10.1101/gad.199133.112; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimizu T, 2006, DEVELOPMENT, V133, P4709, DOI 10.1242/dev.02660; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	50	101	101	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1191	U50		10.1038/nn.3490	http://dx.doi.org/10.1038/nn.3490			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955559	Green Accepted, Green Submitted			2022-12-25	WOS:000323597500010
J	Pfeffer, CK; Xue, MS; He, M; Huang, ZJ; Scanziani, M				Pfeffer, Carsten K.; Xue, Mingshan; He, Miao; Huang, Z. Josh; Scanziani, Massimo			Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; GREEN FLUORESCENT PROTEIN; GABAERGIC CELL SUBTYPES; RAT FRONTAL-CORTEX; CEREBRAL-CORTEX; JUVENILE RAT; TRANSGENIC MICE; LAYER 2/3; NEURONS; NEOCORTEX	Cortical inhibitory neurons contact each other to form a network of inhibitory synaptic connections. Our knowledge of the connectivity pattern underlying this inhibitory network is, however, still incomplete. Here we describe a simple and complementary interaction scheme between three large, molecularly distinct interneuron populations in mouse visual cortex: parvalbumin-expressing interneurons strongly inhibit one another but provide little inhibition to other populations. In contrast, somatostatin-expressing interneurons avoid inhibiting one another yet strongly inhibit all other populations. Finally, vasoactive intestinal peptide-expressing interneurons preferentially inhibit somatostatin-expressing interneurons. This scheme occurs in supragranular and infragranular layers, suggesting that inhibitory networks operate similarly at the input and output of the visual cortex. Thus, as the specificity of connections between excitatory neurons forms the basis for the cortical canonical circuit, the scheme described here outlines a standard connectivity pattern among cortical inhibitory neurons.	[Pfeffer, Carsten K.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [He, Miao; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Pfeffer, CK (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	cpfeffer10@gmail.com; massimo@ucsd.edu	He, Miao/AAQ-1044-2020	He, Miao/0000-0003-0731-6801; Huang, Z. Josh/0000-0003-0592-028X; Xue, Mingshan/0000-0003-1463-8884	National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [NS047101]; European Molecular Biology Organization [EMBO LTF 1114_2009]; Howard Hughes Medical Institute; Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Evora for help with genotyping and mouse husbandry, M. Chan for immunohistochemical labeling, J. Isaacson for critical reading of the manuscript and the members of the Scanziani and Isaacson laboratories for advice during the course of the study. This work was supported in part by grants from the National Alliance for Research on Schizophrenia and Depression and US National Institutes of Health (NS047101). C. K. P. was supported by a European Molecular Biology Organization long-term fellowship (EMBO LTF 1114_2009) and the Howard Hughes Medical Institute. M. X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M. S. was supported by the Gatsby charitable foundation and the Howard Hughes Medical Institute.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Caputi A, 2009, CEREB CORTEX, V19, P1345, DOI 10.1093/cercor/bhn175; Cauli B, 1997, J NEUROSCI, V17, P3894; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kaneko T, 1998, NEUROSCIENCE, V86, P765, DOI 10.1016/S0306-4522(98)00036-0; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Ma YY, 2012, J NEUROSCI, V32, P983, DOI 10.1523/JNEUROSCI.5007-11.2012; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Staiger JF, 1997, EUR J NEUROSCI, V9, P2259, DOI 10.1111/j.1460-9568.1997.tb01644.x; Staiger JF, 2004, J COMP NEUROL, V468, P179, DOI 10.1002/cne.10953; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229	54	752	759	9	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1068	U130		10.1038/nn.3446	http://dx.doi.org/10.1038/nn.3446			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817549	Green Accepted, Green Submitted			2022-12-25	WOS:000322323000017
J	Lilley, BN; Pan, YA; Sanes, JR				Lilley, Brendan N.; Pan, Y. Albert; Sanes, Joshua R.			SAD Kinases Sculpt Axonal Arbors of Sensory Neurons through Long- and Short-Term Responses to Neurotrophin Signals	NEURON			English	Article							DORSAL-ROOT-GANGLIA; SPINAL-CORD; NERVOUS-SYSTEM; IN-VIVO; PROTEIN-KINASE; TGF-BETA; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; POLARIZATION	Extrinsic cues activate intrinsic signaling mechanisms to pattern neuronal shape and connectivity. We showed previously that three cytoplasmic Ser/Thr kinases, LKB1, SAD-A, and SAD-B, control early axon-dendrite polarization in forebrain neurons. Here, we assess their role in other neuronal types. We found that all three kinases are dispensable for axon formation outside of the cortex but that SAD kinases are required for formation of central axonal arbors by subsets of sensory neurons. The requirement for SAD kinases is most prominent in NT-3 dependent neurons. SAD kinases transduce NT-3 signals in two ways through distinct pathways. First, sustained NT-3/TrkC signaling increases SAD protein levels. Second, short-duration NT-3/TrkC signals transiently activate SADs by inducing dephosphorylation of C-terminal domains, thereby allowing activating phosphorylation of the kinase domain. We propose that SAD kinases integrate long- and short-duration signals from extrinsic cues to sculpt axon arbors within the CNS.	[Lilley, Brendan N.; Pan, Y. Albert; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lilley, Brendan N.; Pan, Y. Albert; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu			NIH [R01 NS029169, R21 NS076880]; Damon Runyon Cancer Research Foundation [DRG-1914-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS019195, R01NS029169, R21NS076880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marian Carlson, Susan Dymecki, Tom Jessell, Louis Reichardt, Michael Schneider, William Sellers, Li-Huei Tsai, Sander van den Heuvel, and Hans Widlund for mouse strains, antibodies, and plasmids used in this study; Debbie Pelusi for excellent technical assistance; Arjun Krishnaswamy and members of the Sanes lab for helpful suggestions. This work was supported by grants from the NIH (R01 NS029169 and R21 NS076880). B.N.L. was supported by a fellowship from the Damon Runyon Cancer Research Foundation (DRG-1914-06).	Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Chen XY, 2012, J BIOL CHEM, V287, P30368, DOI 10.1074/jbc.M112.375618; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CHUNG K, 1988, NEUROSCI LETT, V90, P27, DOI 10.1016/0304-3940(88)90781-1; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Ding YQ, 2005, DEVELOPMENT, V132, P2047, DOI 10.1242/dev.01798; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Genc B, 2004, PLOS BIOL, V2, P2112, DOI 10.1371/journal.pbio.0020403; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jadrich JL, 2003, GENE EXPR PATTERNS, V3, P131, DOI 10.1016/S1567-133X(03)00012-7; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kim JSM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-23; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lentz SI, 1999, J NEUROSCI, V19, P1038; Li RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045932; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MATSUDA S, 1984, CELL TISSUE RES, V235, P13; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Oakley RA, 1997, J NEUROSCI, V17, P4262; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Ozdinler PH, 2004, DEV BRAIN RES, V151, P55, DOI 10.1016/j.devbrainres.2004.03.017; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Philippidou P, 2012, NAT NEUROSCI, V15, P1636, DOI 10.1038/nn.3242; Puram SV, 2011, SEMIN CELL DEV BIOL, V22, P586, DOI 10.1016/j.semcdb.2011.03.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Schmidt H, 2010, BIOESSAYS, V32, P977, DOI 10.1002/bies.201000054; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; SMITH CL, 1986, J COMP NEUROL, V245, P541, DOI 10.1002/cne.902450409; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Usui N, 2012, DEVELOPMENT, V139, P1125, DOI 10.1242/dev.069997; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WEINBERG RJ, 1990, J COMP NEUROL, V300, P113, DOI 10.1002/cne.903000108; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	69	44	44	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					39	53		10.1016/j.neuron.2013.05.017	http://dx.doi.org/10.1016/j.neuron.2013.05.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23790753	Green Accepted, Bronze			2022-12-25	WOS:000321802000008
J	Pozzorini, C; Naud, R; Mensi, S; Gerstner, W				Pozzorini, Christian; Naud, Richard; Mensi, Skander; Gerstner, Wulfram			Temporal whitening by power-law adaptation in neocortical neurons	NATURE NEUROSCIENCE			English	Article							MULTIPLE TIME SCALES; PYRAMIDAL NEURONS; SLOW INACTIVATION; MODEL; DECORRELATION; MOUSE; MECHANISMS; HISTORY; ENERGY	Spike-frequency adaptation (SFA) is widespread in the CNS, but its function remains unclear. In neocortical pyramidal neurons, adaptation manifests itself by an increase in the firing threshold and by adaptation currents triggered after each spike. Combining electrophysiological recordings in mice with modeling, we found that these adaptation processes lasted for more than 20 s and decayed over multiple timescales according to a power law. The power-law decay associated with adaptation mirrored and canceled the temporal correlations of input current received in vivo at the somata of layer 2/3 somatosensory pyramidal neurons. These findings suggest that, in the cortex, SFA causes temporal decorrelation of output spikes (temporal whitening), an energy-efficient coding procedure that, at high signal-to-noise ratio, improves the information transfer.	[Pozzorini, Christian] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pozzorini, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland.	christian.pozzorini@epfl.ch	Naud, Richard/V-2586-2019	Naud, Richard/0000-0001-7383-3095	Swiss National Science Foundation [200020 132871/1]; European Community's Seventh Framework Program (BrainScaleS) [269921]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Program (BrainScaleS)	We thank C.C.H. Petersen, B.N. Lundstrom, G. Hennequin and A. Seeholzer for helpful discussions. We are also grateful to S. Crochet for sharing in vivo recordings and to B.N. Lundstrom for sharing the data that inspired this work. Finally, we thank S. Naskar for his help with the in vitro recordings. This project was funded by the Swiss National Science Foundation (grant no. 200020 132871/1; C.P. and S.M.) and by the European Community's Seventh Framework Program (BrainScaleS, grant no. 269921; S.M. and R.N.).	Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Bohte S.M., 2010, ADV NEURAL INFORM PR, V23, P253; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2008, NEURON, V59, P379, DOI 10.1016/j.neuron.2008.06.021; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Dan Y, 1996, J NEUROSCI, V16, P3351; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Gerstner W., 2002, SPIKING NEURON MODEL; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jolivet R, 2008, BIOL CYBERN, V99, P417, DOI 10.1007/s00422-008-0261-x; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; La Camera G, 2006, J NEUROPHYSIOL, V96, P3448, DOI 10.1152/jn.00453.2006; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lowen SB, 1999, PHYS REV E, V59, P5970, DOI 10.1103/PhysRevE.59.5970; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Melnick IV, 2004, J PHYSIOL-LONDON, V559, P383, DOI 10.1113/jphysiol.2004.066415; Mensi S, 2012, J NEUROPHYSIOL, V107, P1756, DOI 10.1152/jn.00408.2011; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Naud R, 2011, NEURAL COMPUT, V23, P3016, DOI 10.1162/NECO_a_00208; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2005, NEUROCOMPUTING, V65, P379, DOI 10.1016/j.neucom.2004.10.032; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pitkow X, 2012, NAT NEUROSCI, V15, P628, DOI 10.1038/nn.3064; Rieke F., 1999, SPIKES EXPLORING NEU; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; Shin JH, 2001, NEURAL NETWORKS, V14, P907, DOI 10.1016/S0893-6080(01)00077-6; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P591, DOI 10.1113/jphysiol.1991.sp018488; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Toib A, 1998, J NEUROSCI, V18, P1893; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001	55	108	108	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					942	U216		10.1038/nn.3431	http://dx.doi.org/10.1038/nn.3431			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749146	Green Published			2022-12-25	WOS:000321180900029
J	Hunt, RF; Girskis, KM; Rubenstein, JL; Alvarez-Buylla, A; Baraban, SC				Hunt, Robert F.; Girskis, Kelly M.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Baraban, Scott C.			GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; TEMPORAL-LOBE EPILEPSY; OPTOGENETIC CONTROL; PILOCARPINE MODEL; INHIBITION; PRECURSORS; ORIGINS; NEURONS; MICE	Impaired GABA-mediated neurotransmission has been implicated in many neurologic diseases, including epilepsy, intellectual disability and psychiatric disorders. We found that inhibitory neuron transplantation into the hippocampus of adult mice with confirmed epilepsy at the time of grafting markedly reduced the occurrence of electrographic seizures and restored behavioral deficits in spatial learning, hyperactivity and the aggressive response to handling. In the recipient brain, GABA progenitors migrated up to 1,500 mu m from the injection site, expressed genes and proteins characteristic for interneurons, differentiated into functional inhibitory neurons and received excitatory synaptic input. In contrast with hippocampus, cell grafts into basolateral amygdala rescued the hyperactivity deficit, but did not alter seizure activity or other abnormal behaviors. Our results highlight a critical role for interneurons in epilepsy and suggest that interneuron cell transplantation is a powerful approach to halting seizures and rescuing accompanying deficits in severely epileptic mice.	[Hunt, Robert F.; Girskis, Kelly M.; Baraban, Scott C.] Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA; [Hunt, Robert F.; Girskis, Kelly M.; Alvarez-Buylla, Arturo; Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hunt, RF (corresponding author), Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA.	robert.huntiii@ucsf.edu; scott.baraban@ucsf.edu	Ritter, Stefanie L/D-9312-2012	Baraban, Scott/0000-0003-1975-9781; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Hunt, Robert/0000-0003-4490-8718	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke [RO1-NS071785, F32-NS077747]; California Institute of Regenerative Medicine [TR2-01749]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077747, R01NS071785] Funding Source: NIH RePORTER	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Dinday and W. Hindle-Katel for assistance with pilocarpine injections, J. Sebe for tissue dissection training, G. Hortopan for advice on the single-cell RT-PCR procedure, R. Palmiter for the ZnT3 antibody, and S. Canchola for training on behavior assays. This work was supported by funding from US National Institutes of Health grants from the National Institute of Neurological Disorders and Stroke (RO1-NS071785 to S.C.B., J.L.R. and A.A.-B., and F32-NS077747 to R.F.H.), and a grant from the California Institute of Regenerative Medicine (#TR2-01749 to A.A.-B. and S.C.B.).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; [Anonymous], 2012, EPILEPSY FACT SHEET; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Clasadonte J., 2012, JASPERS BASIC MECH E; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Loscher W., 2012, JASPERS BASIC MECH E, Vfourth; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; Marchenko Steven, 2007, J Vis Exp, P262, DOI 10.3791/262; Mortazavi F, 2005, EPILEPSY BEHAV, V7, P629, DOI 10.1016/j.yebeh.2005.08.019; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vignoli T, 2012, BRAIN RES, V1450, P125, DOI 10.1016/j.brainres.2012.02.028; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	42	203	205	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					692	+		10.1038/nn.3392	http://dx.doi.org/10.1038/nn.3392			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644485	Green Submitted, Green Accepted			2022-12-25	WOS:000319509600010
J	Susuki, K; Chang, KJ; Zollinger, DR; Liu, YH; Ogawa, Y; Eshed-Eisenbach, Y; Dours-Zimmermann, MT; Oses-Prieto, JA; Burlingame, AL; Seidenbecher, CI; Zimmermann, DR; Oohashi, T; Peles, E; Rasband, MN				Susuki, Keiichiro; Chang, Kae-Jiun; Zollinger, Daniel R.; Liu, Yanhong; Ogawa, Yasuhiro; Eshed-Eisenbach, Yael; Dours-Zimmermann, Maria T.; Oses-Prieto, Juan A.; Burlingame, Alma L.; Seidenbecher, Constanze I.; Zimmermann, Dieter R.; Oohashi, Toshitaka; Peles, Elior; Rasband, Matthew N.			Three Mechanisms Assemble Central Nervous System Nodes of Ranvier	NEURON			English	Article							AXON INITIAL SEGMENTS; BETA-IV-SPECTRIN; EXTRACELLULAR-MATRIX; DIFFUSION BARRIER; GLIA INTERACTIONS; LATERAL MOBILITY; ANKYRIN BINDING; NEUROFASCIN; DOMAINS; GLIOMEDIN	Rapid action potential propagation in myelinated axons requires N+ channel clustering at nodes of Ranvier. However, the mechanism of clustering at CNS nodes remains poorly understood. Here, we show that the assembly of nodes of Ranvier in the CNS involves three mechanisms: a glia-derived extracellular matrix (ECM) complex containing proteoglycans and adhesion molecules that cluster NF186, paranodal axoglial junctions that function as barriers to restrict the position of nodal proteins, and axonal cytoskeletal scaffolds (CSs) that stabilize nodal N+ channels. We show that while mice with a single disrupted mechanism had mostly normal nodes, disruptions of the ECM and paranodal barrier, the ECM and CS, or the paranodal barrier and CS all lead to juvenile lethality, profound motor dysfunction, and significantly reduced N+ channel clustering. Our results demonstrate that ECM, paranodal, and axonal cytoskeletal mechanisms ensure robust CNS nodal N+ channel clustering.	[Susuki, Keiichiro; Zollinger, Daniel R.; Liu, Yanhong; Ogawa, Yasuhiro; Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chang, Kae-Jiun; Rasband, Matthew N.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Eshed-Eisenbach, Yael; Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Seidenbecher, Constanze I.] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Oohashi, Toshitaka] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Biol & Biochem, Okayama 7008558, Japan	Baylor College of Medicine; Baylor College of Medicine; Weizmann Institute of Science; University of Zurich; University Zurich Hospital; University of California System; University of California San Francisco; Leibniz Institut fur Neurobiologie (LIN); Okayama University	Rasband, MN (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	rasband@bcm.edu	liu, yan/HCI-5542-2022; Oohashi, Toshitaka/B-1599-2011	Rasband, Matthew/0000-0001-8184-2477; Oses-Prieto, Juan/0000-0003-4759-2341; Seidenbecher, Constanze/0000-0002-7433-2716; Oohashi, Toshitaka/0000-0002-9302-1913; Chang, Kae-Jiun/0000-0002-3656-7725; Peles, Elior/0000-0002-3325-0597	NIH [NS069688, NS044916, NS50220]; Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ministry of Education, Culture, Sports Science, and Technology (ME)(1) of Japan [24107516]; U.S.-Israel Binational Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069688, R01NS044916, R37NS044916, R01NS050220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ministry of Education, Culture, Sports Science, and Technology (ME)(1) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Debra Townley (Integrated Microscopy Core, Baylor College of Medicine) and Marlesa Godoy (Department of Neuroscience, Baylor College of Medicine) for technical assistance. This work was supported by grants from the NIH (NS069688 and NS044916 to M.N.R., and NS50220 to E.P.); the Dr. Miriam and Sheldon Adelson Medical Research Foundation; the Ministry of Education, Culture, Sports Science, and Technology (ME)(1) of Japan (24107516 to T.O.); and the U.S.-Israel Binational Science Foundation. E.P. is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience.	Bekku Y, 2010, ARCH HISTOL CYTOL, V73, P95, DOI 10.1679/aohc.73.95; Bekku Y, 2010, J NEUROSCI, V30, P3113, DOI 10.1523/JNEUROSCI.5598-09.2010; Bekku Y, 2009, J NEUROCHEM, V108, P1266, DOI 10.1111/j.1471-4159.2009.05873.x; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang KJ, 2010, J NEUROSCI, V30, P14476, DOI 10.1523/JNEUROSCI.1698-10.2010; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; Dupree JL, 2010, PROSTAG OTH LIPID M, V91, P118, DOI 10.1016/j.prostaglandins.2009.04.005; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; GIRARD N, 1992, HISTOCHEM J, V24, P21, DOI 10.1007/BF01043283; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Oohashi T, 2002, MOL CELL NEUROSCI, V19, P43, DOI 10.1006/mcne.2001.1061; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Poliak S, 2001, J NEUROSCI, V21, P7568, DOI 10.1523/JNEUROSCI.21-19-07568.2001; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Rios JC, 2003, J NEUROSCI, V23, P7001, DOI 10.1523/JNEUROSCI.23-18-07001.2003; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Schafer DP, 2006, CURR OPIN NEUROBIOL, V16, P508, DOI 10.1016/j.conb.2006.08.003; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Susuki K, 2011, P NATL ACAD SCI USA, V108, P8009, DOI 10.1073/pnas.1019600108; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Thaxton C, 2011, NEURON, V69, P244, DOI 10.1016/j.neuron.2010.12.016; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	54	115	115	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					469	482		10.1016/j.neuron.2013.03.005	http://dx.doi.org/10.1016/j.neuron.2013.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664614	Bronze, Green Accepted			2022-12-25	WOS:000318961700009
J	Rose, T; Schoenenberger, P; Jezek, K; Oertner, TG				Rose, Tobias; Schoenenberger, Philipp; Jezek, Karel; Oertner, Thomas G.			Developmental Refinement of Vesicle Cycling at Schaffer Collateral Synapses	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIVITY-DEPENDENT CONTROL; KISS-AND-RUN; SYNAPTIC VESICLES; 3-DIMENSIONAL RECONSTRUCTION; RELEASE PROBABILITY; RESTING POOL; 2 MODES; KINETICS; CALYX	At synapses formed between dissociated neurons, about half of all synaptic vesicles are refractory to evoked release, forming the so-called "resting pool." Here, we use optical measurements of vesicular pH to study developmental changes in pool partitioning and vesicle cycling in cultured hippocampal slices. Two-photon imaging of a genetically encoded two-color release sensor (ratio-sypHy) allowed us to perform calibrated measurements at individual Schaffer collateral boutons. Mature boutons released a large fraction of their vesicles during simulated place field activity, and vesicle retrieval rates were 7-fold higher compared to immature boutons. Saturating stimulation mobilized essentially all vesicles at mature synapses. Resting pool formation and a concomitant reduction in evoked release was induced by chronic depolarization but not by acute inhibition of the protein phosphatase calcineurin. We conclude that synapses in CA1 undergo a prominent refinement of vesicle use during early postnatal development that is not recapitulated in dissociated neuronal culture.	[Rose, Tobias; Schoenenberger, Philipp; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Jezek, Karel] NTNU, CNC, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway	Friedrich Miescher Institute for Biomedical Research; Norwegian University of Science & Technology (NTNU)	Rose, T (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	trose@neuro.mpg.de; thomas.oertner@zmnh.uni-hamburg.de	Jezek, Karel/A-9581-2012; Oertner, Thomas/F-2214-2010; Rose, Tobias/H-5388-2019	Jezek, Karel/0000-0001-7559-3689; Oertner, Thomas/0000-0002-2312-7528; Rose, Tobias/0000-0002-7156-4714	Novartis Research Foundation; SystemsX.ch; Kavli Foundation	Novartis Research Foundation; SystemsX.ch; Kavli Foundation	This work was supported by the Novartis Research Foundation, SystemsX.ch, and the Kavli Foundation. The authors thank Daniela Gerosa for excellent technical assistance; Yongling Zhu and Charles F. Stevens for the gift of sypHluorin-1X; Roger Y. Tsien for tdimer2; and Corette Wierenga, Volker Scheuss, and the members of the Oertner lab for critically reading the manuscript.	Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Armbruster M, 2011, NAT NEUROSCI, V14, P824, DOI 10.1038/nn.2828; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2010, J STRUCT BIOL, V172, P203, DOI 10.1016/j.jsb.2009.10.014; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Feldmeyer D, 2009, J PHYSIOL-LONDON, V587, P1889, DOI 10.1113/jphysiol.2009.169458; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P2945, DOI 10.1073/pnas.0811017106; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PAPA M, 1995, J NEUROSCI, V15, P1; Peng XY, 2012, J NEUROPHYSIOL, V107, P2430, DOI 10.1152/jn.00615.2011; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ratnayaka A, 2012, J PHYSIOL-LONDON, V590, P1585, DOI 10.1113/jphysiol.2011.226688; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Reyes A, 1999, J NEUROSCI, V19, P3827; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Satzler K, 2002, J NEUROSCI, V22, P10567; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sonntag M, 2011, J NEUROSCI, V31, P6699, DOI 10.1523/JNEUROSCI.0575-11.2011; SORRA KE, 1993, J NEUROSCI, V13, P3736; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Varshney LR, 2006, NEURON, V52, P409, DOI 10.1016/j.neuron.2006.10.017; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yamashita T, 2010, NAT NEUROSCI, V13, P838, DOI 10.1038/nn.2576; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	62	34	34	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2013	77	6					1109	1121		10.1016/j.neuron.2013.01.021	http://dx.doi.org/10.1016/j.neuron.2013.01.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522046	Bronze			2022-12-25	WOS:000316645000012
J	Haimes, E; Skene, L; Ballantyne, AJ; Caulfield, T; Goldstein, LS; Hyun, I; Kimmelman, J; Robert, JS; Roxland, BE; Scott, CT; Solbakk, JH; Sugarman, J; Taylor, PL; Testa, G				Haimes, Erica; Skene, Loane; Ballantyne, Angela J.; Caulfield, Timothy; Goldstein, Lawrence S.; Hyun, Insoo; Kimmelman, Jonathan; Robert, Jason S.; Roxland, Beth E.; Scott, Christopher T.; Solbakk, Jan Helge; Sugarman, Jeremy; Taylor, Patrick L.; Testa, Giuseppe			Position Statement on the Provision and Procurement of Human Eggs for Stem Cell Research	CELL STEM CELL			English	Editorial Material							FRESH EMBRYO DONATION; NUCLEAR TRANSFER; OOCYTES; COMPENSATION	The nature of compensation for women who donate eggs (oocytes) for research remains a contentious issue internationally. This position paper lays out the arguments for, and discusses the arrangements in which, a modest payment might be ethically justifiable.	[Haimes, Erica] Newcastle Univ, PEALS Policy Eth & Life Sci Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skene, Loane] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic 3010, Australia; [Ballantyne, Angela J.] Wellington Sch Med & Hlth Sci, Wellington 6242, New Zealand; [Caulfield, Timothy] Univ Alberta, Fac Law, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2H5, Canada; [Goldstein, Lawrence S.] Univ Calif San Diego, Sch Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 0G4, Canada; [Robert, Jason S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Scott, Christopher T.] Ctr Biomed Eth, Stanford Program Stem Cells Soc, Palo Alto, CA 94304 USA; [Solbakk, Jan Helge] Univ Oslo, Inst Hlth & Soc, Fac Med, Ctr Med Eth, NO-0316 Oslo, Norway; [Sugarman, Jeremy] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21218 USA; [Taylor, Patrick L.] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Boston, MA 02138 USA; [Testa, Giuseppe] European Inst Oncol, I-20139 Milan, Italy	Newcastle University - UK; University of Melbourne; University of Otago; University of Alberta; University of Alberta; University of California System; University of California San Diego; Case Western Reserve University; McGill University; Arizona State University; Arizona State University-Tempe; University of Oslo; Johns Hopkins University; Harvard University; IRCCS European Institute of Oncology (IEO)	Haimes, E (corresponding author), Newcastle Univ, PEALS Policy Eth & Life Sci Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	erica.haimes@newcastle.ac.uk	Ballantyne, Angela/AAN-1757-2020	Ballantyne, Angela/0000-0003-2666-9557; Sugarman, Jeremy/0000-0001-7022-8332; Robert, Jason/0000-0002-5346-0575; Testa, Giuseppe/0000-0002-9104-0918	Medical Research Council [G0701109] Funding Source: Medline; MRC [G0701109] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BALLANTYNE A, 2008, INT J FEM APPROACHES, V1, P145; Caulfield T, 2012, EMBO REP, V13, P12, DOI 10.1038/embor.2011.232; Choudhary M, 2012, CELL STEM CELL, V10, P239, DOI 10.1016/j.stem.2012.02.001; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Haimes E, 2009, HUM REPROD, V24, P2142, DOI 10.1093/humrep/dep124; Haimes E, 2012, SOCIOL HEALTH ILL, V34, P1199, DOI 10.1111/j.1467-9566.2012.01467.x; Haimes E, 2011, BIOETHICS, V25, P334, DOI 10.1111/j.1467-8519.2009.01792.x; Haimes E, 2011, CELL STEM CELL, V8, P613, DOI 10.1016/j.stem.2011.05.005; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; Isasi RM, 2007, STEM CELL RES, V1, P37, DOI 10.1016/j.scr.2007.09.003; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nuffield Council on Bioethics, 2011, HUM BOD DON MED RES; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Roxland BE, 2012, REGEN MED, V7, P397, DOI [10.2217/rme.12.20, 10.2217/RME.12.20]; Skene L., 2009, MONASH BIOETHICS REV, V28, P281; SKENE L, 2010, IND J GLOBAL LEGAL S, V17, P211; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Waldby C, 2008, NEW GENET SOC, V27, P19, DOI 10.1080/14636770701843576; Widdows H., 2009, INT J FEM APPROACHES, V2, P5	25	8	8	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					285	291		10.1016/j.stem.2013.02.002	http://dx.doi.org/10.1016/j.stem.2013.02.002			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472870	Bronze			2022-12-25	WOS:000329569400006
J	Kheirbek, MA; Drew, LJ; Burghardt, NS; Costantini, DO; Tannenholz, L; Ahmari, SE; Zeng, HK; Fenton, AA; Hen, R				Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Costantini, Daniel O.; Tannenholz, Lindsay; Ahmari, Susanne E.; Zeng, Hongkui; Fenton, Andre A.; Hen, Rene			Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus	NEURON			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; POSTTRAUMATIC-STRESS-DISORDER; PATTERN SEPARATION; VENTRAL HIPPOCAMPUS; DOUBLE DISSOCIATION; CONTEXTUAL FEAR; SPATIAL MEMORY; DORSAL HIPPOCAMPUS; NMDA RECEPTORS; CA3	The dentate gyrus (DG), in addition to its role in learning and memory, is increasingly implicated in the pathophysiology of anxiety disorders. Here, we show that, dependent on their position along the dorsoventral axis of the hippocampus, DG granule cells (GCs) control specific features of anxiety and contextual learning. Using optogenetic techniques to either elevate or decrease GC activity, we demonstrate that GCs in the dorsal DG control exploratory drive and encoding, not retrieval, of contextual fear memories. In contrast, elevating the activity of GCs in the ventral DG has no effect on contextual learning but powerfully suppresses innate anxiety. These results suggest that strategies aimed at modulating the excitability of the ventral DG may be beneficial for the treatment of anxiety disorders.	[Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Ahmari, Susanne E.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Ahmari, Susanne E.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Tannenholz, Lindsay; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Kheirbek, Mazen A.; Drew, Liam J.; Burghardt, Nesha S.; Costantini, Daniel O.; Tannenholz, Lindsay; Ahmari, Susanne E.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fenton, Andre A.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Allen Institute for Brain Science; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hen, R (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	rh95@columbia.edu	Ahmari, Susanne E./J-5812-2013; Kheirbek, Mazen A/J-3656-2015	Ahmari, Susanne E./0000-0003-4576-076X; Kheirbek, Mazen A/0000-0001-9157-7363; Fenton, Andre/0000-0002-5063-1156	NIMH [1K01MH099371-01]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; Sackler Institute Award; Kavli Institute postdoctoral fellowship; NARSAD; New York Stem Cell Initiative [NYSTEM C026430]; NIH [R37 MH068542]; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099371, T32MH015174, K08MH087718, R37MH068542] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); Sackler Institute Award; Kavli Institute postdoctoral fellowship; NARSAD(NARSAD); New York Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Ledoux and A. Losonczy for comments on previous versions of this manuscript, G. Stuber, J. Britt, and A. Bond for assistance in optogenetic manipulation, S. Tonegawa for POMC-Cre mice, K. Deisseroth for ChR2 and eNpHR constructs, and C. Dupre, A. Goldberg and E. Balough for technical assistance. This work was supported by NIMH 1K01MH099371-01, a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and a Sackler Institute Award (M.A.K.); a Kavli Institute postdoctoral fellowship (L.J.D.), and NARSAD, the New York Stem Cell Initiative (NYSTEM C026430), NIH R37 MH068542, and Hope for Depression Research Foundation grants (R.H.). R.H. receives compensation as a consultant for Lundbeck and Roche.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kishi T, 2006, J COMP NEUROL, V496, P349, DOI 10.1002/cne.20919; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McNish KA, 1997, J NEUROSCI, V17, P9353; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang SH, 2012, HIPPOCAMPUS, V22, P2157, DOI 10.1002/hipo.22036; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	65	425	428	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					955	968		10.1016/j.neuron.2012.12.038	http://dx.doi.org/10.1016/j.neuron.2012.12.038			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473324	Green Accepted, Bronze			2022-12-25	WOS:000316162600015
J	Rishel, CA; Huang, G; Freedman, DJ				Rishel, Chris A.; Huang, Gang; Freedman, David J.			Independent Category and Spatial Encoding in Parietal Cortex	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; PREFRONTAL CORTEX; SINGLE NEURONS; VISUAL-CORTEX; ATTENTION; MONKEY; CATEGORIZATION; REPRESENTATION; INFORMATION; INTENTION	The posterior parietal cortex plays a central role in spatial functions, such as spatial attention and saccadic eye movements. However, recent work has increasingly focused on the role of parietal cortex in encoding nonspatial cognitive factors such as visual categories, learned stimulus associations, and task rules. The relationship between spatial encoding and nonspatial cognitive signals in parietal cortex, and whether cognitive signals are robustly encoded in the presence of strong spatial neuronal responses, is unknown. We directly compared nonspatial cognitive and spatial encoding in the lateral intraparietal (LIP) area by training monkeys to perform a visual categorization task during which they made saccades toward or away from LIP response fields (RFs). Here we show that strong saccade-related responses minimally influence robustly encoded category signals in LIP. This suggests that cognitive and spatial signals are encoded independently in LIP and underscores the role of parietal cortex in nonspatial cognitive functions.	[Rishel, Chris A.; Huang, Gang; Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu	Rishel, Chris/J-1435-2018	Rishel, Chris/0000-0002-2098-6562	NIH [R01 EY019041]; NSF CAREER award; McKnight Scholar award; Alfred P. Sloan Foundation; Brain Research Foundation; NATIONAL EYE INSTITUTE [R01EY019041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); McKnight Scholar award; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Brain Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Jonathan Hodnefield, Adam Stevenson, Steve McClellan, Navaneethan Santhanam, and Stephanie Thomas for technical assistance and the staff of The University of Chicago Animal Resources Center for expert veterinary assistance. We also thank the following for helpful discussions and/or comments on this manuscript: John Assad, Jamie Fitzgerald, Jared Clemens, Nicolas Masse, Doug Ruff, Sruthi Swaminathan, and Jonathan Wallis. This work was supported by NIH R01 EY019041. Additional support was provided by an NSF CAREER award, a McKnight Scholar award, the Alfred P. Sloan Foundation, and The Brain Research Foundation. D.J.F. and C.A.R. designed the experiments and wrote the manuscript. CAR. trained the animals and performed all neurophysiological recordings and data analysis. D.J.F. assisted in animal training, neurophysiological recordings, and data analysis. G.H. assisted in animal training, neurophysiological recordings, behavioral data analysis, and edited the manuscript.	Asaad WF, 2008, J NEUROSCI METH, V174, P245, DOI 10.1016/j.jneumeth.2008.07.014; Asaad WF, 2013, J NEUROPHYSIOL, V109, P249, DOI 10.1152/jn.00527.2012; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goodwin SJ, 2012, J NEUROSCI, V32, P3499, DOI 10.1523/JNEUROSCI.3585-11.2012; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Green DM, 1966, SIGNAL DETECTION THE; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Rao V, 2012, J NEUROSCI, V32, P10063, DOI 10.1523/JNEUROSCI.5948-11.2012; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Thiele A, 2009, CEREB CORTEX, V19, P2970, DOI 10.1093/cercor/bhp070; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081	37	53	53	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 6	2013	77	5					969	979		10.1016/j.neuron.2013.01.007	http://dx.doi.org/10.1016/j.neuron.2013.01.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473325	Green Accepted, Bronze			2022-12-25	WOS:000316162600016
J	Chen, SK; Chew, KS; McNei, DS; Keeley, PW; Ecker, JL; Mao, BQQ; Pahlberg, J; Kim, B; Lee, SCS; Fox, MA; Guido, W; Wong, KY; Sampath, AP; Reese, BE; Kuruvilla, R; Hattar, S				Chen, Shih-Kuo; Chew, Kylie S.; McNei, David S.; Keeley, Patrick W.; Ecker, Jennifer L.; Mao, Buqing Q.; Pahlberg, Johan; Kim, Bright; Lee, Sammy C. S.; Fox, Michael A.; Guido, William; Wong, Kwoon Y.; Sampath, Alapakkam P.; Reese, Benjamin E.; Kuruvilla, Rejji; Hattar, Samer			Apoptosis Regulates ipRGC Spacing Necessary for Rods and Cones to Drive Circadian Photoentrainment	NEURON			English	Article							RETINAL GANGLION-CELL; DOPAMINERGIC AMACRINE CELLS; PUPILLARY LIGHT REFLEX; DOUBLE REPORTER; NEURONAL DEATH; MELANOPSIN; BAX; POPULATIONS; PROJECTIONS; DIVERSITY	The retina consists of ordered arrays of individual types of neurons for processing vision. Here, we show that such order is necessary for intrinsically photosensitive retinal ganglion cells (ipRGCs) to function as irradiance detectors. We found that during development, ipRGCs undergo proximity-dependent Bax-mediated apoptosis. Box mutant mice exhibit disrupted ipRGC spacing and dendritic stratification with an increase in abnormally localized synapses. ipRGCs are the sole conduit for light input to circadian photoentrainment, and either their melanopsin-based photosensitivity or ability to relay rod/cone input is sufficient for circadian photoentrainment. Remarkably, the disrupted ipRGC spacing does not affect melanopsin-based circadian photoentrainment but severely impairs rod/cone-driven photoentrainment. We demonstrate reduced rod/cone-driven cFos activation and electrophysiological responses in ipRGCs, suggesting that impaired synaptic input to ipRGCs underlies the photoentrainment deficits. Thus, for irradiance detection, developmental apoptosis is necessary for the spacing and connectivity of ipRGCs that underlie their functioning within a neural network.	[Chen, Shih-Kuo; Chew, Kylie S.; McNei, David S.; Ecker, Jennifer L.; Kuruvilla, Rejji; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Keeley, Patrick W.; Lee, Sammy C. S.; Reese, Benjamin E.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Keeley, Patrick W.; Lee, Sammy C. S.; Reese, Benjamin E.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Keeley, Patrick W.; Lee, Sammy C. S.; Reese, Benjamin E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Mao, Buqing Q.; Pahlberg, Johan; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Kim, Bright; Wong, Kwoon Y.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Fox, Michael A.; Guido, William] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Hattar, Samer] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Southern California; University of Michigan System; University of Michigan; Virginia Commonwealth University; Johns Hopkins University	Kuruvilla, R (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	rkuruvilla@jhu.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Pahlberg, Johan/0000-0002-4038-9693; Wong, Kwoon/0000-0001-9279-7827; Fox, Michael/0000-0002-1649-7782; CHEN, SHIH-KUO/0000-0002-7921-1358; Lee, Sammy Chi Sam/0000-0001-9220-6097; Kuruvilla, Rejji/0000-0002-2851-675X; Chew, Kylie/0000-0003-4752-009X	Johns Hopkins University-Dean's office funds; David and Lucile Packard Foundation Fellowship; Alfred P. Sloan Fellowship; National Institutes of Health [R01-GM076430, R01-EY019053, R01-MH080738, R01-EY019968, R01-EY17606, RO1-EY021222, -EY012716, R00-EY18863]; Whitehall Foundation; McKnight Endowment Fund for Neuroscience; Research to Prevent Blindness; Kellogg Eye Center [P30-EY007003]; NATIONAL EYE INSTITUTE [R01EY019053, R01EY019968, P30EY007003, R01EY012716, R01EY017606, R00EY018863, R01EY021222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073751] Funding Source: NIH RePORTER	Johns Hopkins University-Dean's office funds; David and Lucile Packard Foundation Fellowship(The David & Lucile Packard Foundation); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; McKnight Endowment Fund for Neuroscience; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Kellogg Eye Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Cara Altimus for help performing and analyzing wheel-running experiments, Andy Huberman for help with density recovery profile analysis, Richard Youle for antibody against activated Bax, Robert Margolskee for the antibody against gamma 13, and the late Dr. Stanley J. Korsmeyer for conditional Bax mice. Funding was provided by The Johns Hopkins University-Dean's office funds, The David and Lucile Packard Foundation Fellowship, The Alfred P. Sloan Fellowship, National Institutes of Health Grants R01-GM076430 and R01-EY019053 (to S.H.), National Institutes of Health Grant R01-MH080738 and a Whitehall Foundation Award (to R.K.), National Institutes of Health Grant R01-EY019968 (to B.E.R.), National Institutes of Health Grant R01-EY17606 and the McKnight Endowment Fund for Neuroscience (to A.P.S.), National Institutes of Health RO1-EY021222 (to M.A.F.) and -EY012716 (to W.G.), and a Scientific Career Development Award from Research to Prevent Blindness, National Institutes of Health Grant R00-EY18863, and the Kellogg Eye Center Core Grant P30-EY007003 (to K.Y.W.).	Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Cellerino A, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0002.2000; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Contini M, 2003, P NATL ACAD SCI USA, V100, P1358, DOI 10.1073/pnas.0337681100; Cook JE, 1998, NATO ADV SCI I A-LIF, V299, P91; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; DREHER B, 1983, NEUROSCI LETT, V36, P255, DOI 10.1016/0304-3940(83)90009-5; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Galli-Resta L, 2002, TRENDS NEUROSCI, V25, P638, DOI 10.1016/S0166-2236(02)02279-8; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hirasawa H, 2009, J NEUROPHYSIOL, V102, P146, DOI 10.1152/jn.00130.2009; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Jonas EA, 2005, ANTIOXID REDOX SIGN, V7, P1092, DOI 10.1089/ars.2005.7.1092; Keeley PW, 2012, J COMP NEUROL, V520, P1349, DOI 10.1002/cne.23033; Keeley PW, 2010, J COMP NEUROL, V518, P1220, DOI 10.1002/cne.22270; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ogilvie JM, 1998, INVEST OPHTH VIS SCI, V39, P1713; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Reese B.E., 2008, EYE RETINA VISUAL SY, P147; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; White FA, 1998, J NEUROSCI, V18, P1428; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005	47	29	29	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					503	515		10.1016/j.neuron.2012.11.028	http://dx.doi.org/10.1016/j.neuron.2012.11.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395376	Bronze, Green Accepted			2022-12-25	WOS:000317030800012
J	Lattal, KM; Wood, MA				Lattal, K. Matthew; Wood, Marcelo A.			Epigenetics and persistent memory: implications for reconsolidation and silent extinction beyond the zero	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; FEAR EXTINCTION; HISTONE ACETYLATION; MECHANISMS; INHIBITORS; ENHANCEMENT; HDAC3	Targeting epigenetic mechanisms during initial learning or memory retrieval can lead to persistent memory. Retrieval induces plasticity that may result in reconsolidation of the original memory, in which critical molecular events are needed to stabilize the memory, or extinction, in which new learning during the retrieval trial creates an additional memory that reflects the changed environmental contingencies. A canonical feature of extinction is that the original response is temporarily suppressed, but returns under various conditions. These characteristics have defined whether a given manipulation alters extinction (when persistence does not occur) or reconsolidation (when persistence does occur). A problem arises with these behavioral definitions when considering the potential for persistent memory of extinction. Recent studies have found that epigenetic modulation of memory processes leads to surprisingly robust and persistent extinction. We discuss evidence from behavioral epigenetic approaches that forces a re-evaluation of widely used behavioral definitions of extinction and reconsolidation.	[Lattal, K. Matthew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wood, Marcelo A.] Univ Calif Irvine, Irvine, CA USA	Oregon Health & Science University; University of California System; University of California Irvine	Lattal, KM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	lattalm@ohsu.edu; mwood@uci.edu	Lattal, K/W-8386-2019		US National Institutes of Health [DA018165, DA025922, DA031989, MH077111, MH081004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081004, R01MH077111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025922, R21DA031989, P50DA018165] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Bieszczad and M. Malvaez for helpful comments. Preparation of this manuscript was supported by grants from the US National Institutes of Health (DA018165, DA025922, DA031989, MH077111 and MH081004). The order of authorship was determined by lot.	Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Baker KD, 2012, LEARN MEMORY, V19, P461, DOI 10.1101/lm.026674.112; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brogden WJ, 1938, AM J PSYCHOL, V51, P109, DOI 10.2307/1416419; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Delamater AR, 2012, BEHAV PROCESS, V90, P9, DOI 10.1016/j.beproc.2012.03.006; Denniston JC, 2003, LEARN MOTIV, V34, P68, DOI 10.1016/S0023-9690(02)00508-8; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kramar EA, 2012, P NATL ACAD SCI USA, V109, P5121, DOI 10.1073/pnas.1120700109; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lattal KM, 2012, BEHAV PROCESS, V90, P1, DOI 10.1016/j.beproc.2012.03.009; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Leung HT, 2008, J EXP PSYCHOL-ANIM B, V34, P461, DOI 10.1037/0097-7403.34.4.461; Lynch G, 2013, NEUROPHARMACOLOGY, V64, P27, DOI 10.1016/j.neuropharm.2012.07.006; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Marek R, 2011, J NEUROSCI, V31, P7486, DOI 10.1523/JNEUROSCI.0133-11.2011; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Qi ZH, 2009, LEARN MEMORY, V16, P308, DOI 10.1101/lm.1333409; Quirk GJ, 2010, J NEUROSCI, V30, P14993, DOI 10.1523/JNEUROSCI.4268-10.2010; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 2006, J EXP PSYCHOL ANIM B, V32, P135, DOI 10.1037/0097-7403.32.2.135; REYNOLDS GS, 1964, J EXP ANAL BEHAV, V7, P173, DOI 10.1901/jeab.1964.7-173; Stafford JM, 2012, BIOL PSYCHIAT, V72, P25, DOI 10.1016/j.biopsych.2011.12.012; Stafford JM, 2011, NEUROBIOL LEARN MEM, V96, P35, DOI 10.1016/j.nlm.2011.04.012; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Torregrossa MM, 2013, PSYCHOPHARMACOLOGY, V226, P659, DOI 10.1007/s00213-012-2750-9; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vogel-Ciernia A, 2012, REV NEUROSCIENCE, V23, P607, DOI 10.1515/revneuro-2012-0050; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; Wei W, 2012, J NEUROSCI, V32, P11930, DOI 10.1523/JNEUROSCI.0178-12.2012; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	50	78	79	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					124	129		10.1038/nn.3302	http://dx.doi.org/10.1038/nn.3302			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354385	Green Accepted			2022-12-25	WOS:000314260200007
J	Pettem, KL; Yokomaku, D; Luo, L; Linhoff, MW; Prasad, T; Connor, SA; Siddiqui, TJ; Kawabe, H; Chen, F; Zhang, L; Rudenko, G; Wang, YT; Brose, N; Craig, AM				Pettem, Katherine L.; Yokomaku, Daisaku; Luo, Lin; Linhoff, Michael W.; Prasad, Tuhina; Connor, Steven A.; Siddiqui, Tabrez J.; Kawabe, Hiroshi; Chen, Fang; Zhang, Ling; Rudenko, Gabby; Wang, Yu Tian; Brose, Nils; Craig, Ann Marie			The Specific alpha-Neurexin Interactor Calsyntenin-3 Promotes Excitatory and Inhibitory Synapse Development	NEURON			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MEMBRANE-PROTEINS; AXONAL-TRANSPORT; CA2+ CHANNELS; PTP-SIGMA; NEUROLIGINS; AUTISM; FAMILY; DELETIONS; SPECTRUM	Perturbations of cell surface synapse-organizing proteins, particularly alpha-neurexins, contribute to neurodevelopmental and psychiatric disorders. From an unbiased screen, we identify calsyntenin-3 (alcadein-beta) as a synapse-organizing protein unique in binding and recruiting alpha-neurexins, but not beta-neurexins. Calsyntenin-3 is present in many pyramidal neurons throughout cortex and hippocampus but is most highly expressed in interneurons. The transmembrane form of calsyntenin-3 can trigger excitatory and inhibitory presynapse differentiation in contacting axons. However, calsyntenin-3-shed ectodomain, which represents about half the calsyntenin-3 pool in brain, suppresses the ability of multiple alpha-neurexin partners including neuroligin 2 and LRRTM2 to induce presynapse differentiation. Cistn3(-/-) mice show reductions in excitatory and inhibitory synapse density by confocal and electron microscopy and corresponding deficits in synaptic transmission. These results identify calsyntenin-3 as an alpha-neurexin-specific binding partner required for normal functional GABAergic and glutamatergic synapse development.	[Pettem, Katherine L.; Yokomaku, Daisaku; Luo, Lin; Linhoff, Michael W.; Prasad, Tuhina; Connor, Steven A.; Siddiqui, Tabrez J.; Zhang, Ling; Wang, Yu Tian; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Pettem, Katherine L.; Yokomaku, Daisaku; Luo, Lin; Linhoff, Michael W.; Prasad, Tuhina; Connor, Steven A.; Siddiqui, Tabrez J.; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Connor, Steven A.; Zhang, Ling; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada; [Kawabe, Hiroshi; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Chen, Fang; Rudenko, Gabby] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Chen, Fang; Rudenko, Gabby] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of British Columbia; University of British Columbia; University of British Columbia; Max Planck Society; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.	acraig@mail.ubc.ca	Connor, Steven/AAD-6261-2021; Craig, Ann Marie/M-2054-2014; Rudenko, Gabrielle (Gabby)/O-7938-2018; Wang, Yu Tian/J-8255-2015; Kawabe, Hiroshi/U-7325-2018	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Siddiqui, Tabrez/0000-0002-6938-7827; Kawabe, Hiroshi/0000-0001-5650-8696	National Institutes of Health [MH070860, MH077303]; Canada Research Chair salary award; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship; Michael Smith Foundation for Health Research Fellowships; German Research Foundation [SPP1365/KA3423/1-1]; Fritz Thyssen Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077303, R01MH070860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair salary award; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Fellowships; German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Xiling Zhou and Nazarine Fernandes for excellent technical assistance, Vivian Lam and Sarah Au-Yeung for contributions for the western blot analysis, Fergil Mills and Dr. Shernaz Bamji for experimental advice and Derrick Home and Bradford Ross of the Bioimaging Facility for technical assistance with electron microscopy, Michiko Takeda for contributions to mouse colony management, Mika Kishimoto-Suga for experimental advice with antibody generation, and Dr. Robert Holt and team at the Michael Smith Genome Sciances Centre for arraying the cDNA subpool and preparing DNA in 384-well format. This work was supported by the National Institutes of Health (MH070860) and Canada Research Chair salary award to A.M.C., a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship to K.L.P., Michael Smith Foundation for Health Research Fellowships to K.L.P. and T.J.S., the German Research Foundation (SPP1365/KA3423/1-1) to H.K, and N.B., the Fritz Thyssen Foundation to H.K., and the National Institutes of Health (MH077303) to G.R.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Ito-Ishida A, 2012, NEURON, V76, P549, DOI 10.1016/j.neuron.2012.07.027; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Johnston D., 1995, FDN CELLULAR NEUROPH; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Maruta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043058; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Schaaf CP, 2012, EUR J HUM GENET, V20, P1240, DOI 10.1038/ejhg.2012.95; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Uchida Y, 2011, FEBS LETT, V585, P651, DOI 10.1016/j.febslet.2011.01.025; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	55	96	99	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					113	128		10.1016/j.neuron.2013.07.016	http://dx.doi.org/10.1016/j.neuron.2013.07.016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094106	Green Accepted, Bronze			2022-12-25	WOS:000326305300012
J	Munoz-Cuevas, FJ; Athilingam, J; Piscopo, D; Wilbrecht, L				Munoz-Cuevas, Francisco Javier; Athilingam, Jegath; Piscopo, Denise; Wilbrecht, Linda			Cocaine-induced structural plasticity in frontal cortex correlates with conditioned place preference	NATURE NEUROSCIENCE			English	Article							NEOCORTEX IN-VIVO; DENDRITIC SPINES; PREFRONTAL CORTEX; CORTICAL CIRCUITS; NUCLEUS-ACCUMBENS; LONG-TERM; MORPHOLOGY; TRANSIENT; STABILITY; RATS	Contextual cues associated with previous drug exposure can trigger drug craving and seeking, and form a substantial obstacle in substance use recovery. Using in vivo imaging in mice, we found that cocaine administration induced a rapid increase in the formation and accumulation of new dendritic spines, and that measures of new persistent spine gain correlated with cocaine conditioned place preference. Our data suggest that new persistent spine formation in the frontal cortex may be involved in stimulant-related learning driving appetitive behavior.	[Munoz-Cuevas, Francisco Javier; Athilingam, Jegath; Piscopo, Denise; Wilbrecht, Linda] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA USA; [Piscopo, Denise] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Wilbrecht, Linda] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Oregon; University of California System; University of California Berkeley	Wilbrecht, L (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA USA.	wilbrecht@berkeley.edu			National Institute on Drug Abuse [R01DA029150]; State of California, University of California San Francisco; P. Royer and K. Clayton Family; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029150] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); State of California, University of California San Francisco; P. Royer and K. Clayton Family; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Whistler, P. Janak, S. Jurado, C. Johnson and C. Bates for comments on the manuscript. This work was supported by the National Institute on Drug Abuse (R01DA029150), the State of California, University of California San Francisco, and the P. Royer and K. Clayton Family.	Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	17	60	61	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1367	+		10.1038/nn.3498	http://dx.doi.org/10.1038/nn.3498			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974707	Green Accepted, Green Submitted			2022-12-25	WOS:000324795300007
J	Toth, AB; Terauchi, A; Zhang, LY; Johnson-Venkatesh, EM; Larsen, DJ; Sutton, MA; Umemori, H				Toth, Anna B.; Terauchi, Akiko; Zhang, Lily Y.; Johnson-Venkatesh, Erin M.; Larsen, David J.; Sutton, Michael A.; Umemori, Hisashi			Synapse maturation by activity-dependent ectodomain shedding of SIRP alpha	NATURE NEUROSCIENCE			English	Article							SIGNAL REGULATORY PROTEINS; PRESYNAPTIC ORGANIZING MOLECULES; NEURONAL-ACTIVITY; DEFICIENT MICE; MECHANISMS; BRAIN; METALLOPROTEINASES; DIFFERENTIATION; NEUROLIGIN-1; LOCALIZATION	Formation of appropriate synaptic connections is critical for proper functioning of the brain. After initial synaptic differentiation, active synapses are stabilized by neural activity-dependent signals to establish functional synaptic connections. However, the molecular mechanisms underlying activity-dependent synapse maturation remain to be elucidated. Here we show that activity-dependent ectodomain shedding of signal regulatory protein-alpha (SIRP alpha) mediates presynaptic maturation. Two target-derived molecules, fibroblast growth factor 22 and SIRP alpha, sequentially organize the glutamatergic presynaptic terminals during the initial synaptic differentiation and synapse maturation stages, respectively, in the mouse hippocampus. SIRP alpha drives presynaptic maturation in an activity-dependent fashion. Remarkably, neural activity cleaves the extracellular domain of SIRP alpha, and the shed ectodomain in turn promotes the maturation of the presynaptic terminal. This process involves calcium/calmodulin-dependent protein kinase, matrix metalloproteinases and the presynaptic receptor CD47. Finally, SIRP alpha-dependent synapse maturation has an impact on synaptic function and plasticity. Thus, ectodomain shedding of SIRP alpha is an activity-dependent trans-synaptic mechanism for the maturation of functional synapses.	[Toth, Anna B.; Terauchi, Akiko; Zhang, Lily Y.; Johnson-Venkatesh, Erin M.; Larsen, David J.; Sutton, Michael A.; Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	umemoh@umich.edu		Sutton, Michael/0000-0002-0692-6459; Umemori, Hisashi/0000-0001-7198-2062	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation; Whitehall Foundation; US National Institutes of Health [MH091429, NS070005, MH092614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092614, R01MH091429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070005] Funding Source: NIH RePORTER	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation(March of Dimes); Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Sanes for critical comments on the manuscript; H. Enomoto for pSV loxP sv40 intron polyA EGFP FRTneo plasmid; A. Murayama and L. Kee for plasmid construction; E. Gibbs for help with in situ hybridization; D. Sorenson for help with electron microscopy; M. Zhang, R. Carson and A. Williams for technical assistance; and E. Hughes, Y. Qu, K. Childs, G. Gavrilina, D. Vanheyningen and the Transgenic Animal Model Core of the University of Michigan for preparation of SIRP alpha knockout mice. Core support was provided by the University of Michigan Center for Organogenesis. This work was supported by the Ester A. & Joseph Klingenstein Fund, the Edward Mallinckrodt Jr. Foundation, the March of Dimes Foundation, the Whitehall Foundation and US National Institutes of Health grants MH091429, NS070005 and MH092614 (H.U.).	Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bleckert A, 2011, BIOESSAYS, V33, P61, DOI 10.1002/bies.201000095; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hahn CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005251; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kay L, 2011, NAT NEUROSCI, V14, P688, DOI 10.1038/nn.2826; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lipska BK, 2002, J NEUROSCI, V22, P2835, DOI 10.1523/JNEUROSCI.22-07-02835.2002; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	49	37	38	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1417	+		10.1038/nn.3516	http://dx.doi.org/10.1038/nn.3516			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036914	Green Accepted			2022-12-25	WOS:000324795300014
J	Koralek, AC; Costa, RM; Carmena, JM				Koralek, Aaron C.; Costa, Rui M.; Carmena, Jose M.			Temporally Precise Cell-Specific Coherence Develops in Corticostriatal Networks during Learning	NEURON			English	Article							PARIETAL CORTEX; NEURONAL SYNCHRONIZATION; CORTICAL NETWORKS; HIGH-FREQUENCY; OSCILLATIONS; PLASTICITY; RAT; MODULATION; BRAIN; COORDINATION	It has been postulated that selective temporal coordination between neurons and development of functional neuronal assemblies are fundamental for brain function and behavior. Still, there is little evidence that functionally relevant coordination emerges preferentially in neuronal assemblies directly controlling behavioral output. We investigated coherence between primary motor cortex and the dorsal striatum as rats learn an abstract operant task. Striking coherence developed between these regions during learning. Interestingly, coherence was selectively increased in cells controlling behavioral output relative to adjacent cells. Furthermore, the temporal offset of these interactions aligned closely with corticostriatal conduction delays, demonstrating highly precise timing. Spikes from either region were followed by a consistent phase in the other, suggesting that network feedback reinforces coherence. Together, these results demonstrate that temporally precise coherence develops during learning specifically in output-relevant neuronal populations and further suggest that correlations in oscillatory activity serve to synchronize widespread brain networks to produce behavior.	[Koralek, Aaron C.; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Joint Grad Grp Bioengn UCB UCSF, Berkeley, CA 94720 USA; [Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Fundacao Champalimaud	Carmena, JM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	jcarmena@berkeley.edu		Koralek, Aaron/0000-0001-5205-0171; Costa, Rui M./0000-0003-0495-8374	National Science Foundation CAREER Award [0954243]; Multiscale Systems Research Center; Defense Advanced Research Projects Agency [N66001-10-C-2008]; International Early Career Scientists Grant from the Howard Hughes Medical Institute; Marie Curie International Reintegration Grant [239527]; European Research Council STG [243393]	National Science Foundation CAREER Award(National Science Foundation (NSF)); Multiscale Systems Research Center; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); International Early Career Scientists Grant from the Howard Hughes Medical Institute; Marie Curie International Reintegration Grant(European Commission); European Research Council STG(European Research Council (ERC))	We thank J.D. Long II for technical support and R.T. Canolty for helpful discussion. This work was supported by the National Science Foundation CAREER Award 0954243, the Multiscale Systems Research Center, and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 to J.M.C., and the International Early Career Scientists Grant from the Howard Hughes Medical Institute, the Marie Curie International Reintegration Grant 239527, and European Research Council STG 243393 to R.M.C.	Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Bragin A, 2010, CURR OPIN NEUROL, V23, P151, DOI 10.1097/WCO.0b013e3283373ac8; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Castro-Alamancos MA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00021; Colgin L.L., 2009, NATURE, V462, P353; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dean HL, 2012, NEURON, V73, P829, DOI 10.1016/j.neuron.2011.12.035; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Kandel A, 1997, J NEUROSCI, V17, P6783; Kerr JND, 2004, J NEUROSCI, V24, P877, DOI 10.1523/JNEUROSCI.4475-03.2004; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lepage KQ, 2011, NEURAL COMPUT, V23, P2209, DOI 10.1162/NECO_a_00169; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Tiesinga PHE, 2001, NEUROCOMPUTING, V38, P397, DOI 10.1016/S0925-2312(01)00464-7; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; van der Meer MAA, 2011, J NEUROSCI, V31, P2843, DOI 10.1523/JNEUROSCI.4869-10.2011; VANDERMAELEN CP, 1980, BRAIN RES BULL, V5, P725, DOI 10.1016/0361-9230(80)90212-9; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zeitler M, 2008, J COMPUT NEUROSCI, V25, P89, DOI 10.1007/s10827-007-0066-2; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	47	80	80	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					865	872		10.1016/j.neuron.2013.06.047	http://dx.doi.org/10.1016/j.neuron.2013.06.047			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	23954030	Bronze			2022-12-25	WOS:000330269100006
J	Studniarczyk, D; Coombs, I; Cull-Candy, SG; Farrant, M				Studniarczyk, Dorota; Coombs, Ian; Cull-Candy, Stuart G.; Farrant, Mark			TARP gamma-7 selectively enhances synaptic expression of calcium-permeable AMPARs	NATURE NEUROSCIENCE			English	Article							2 DISTINCT MECHANISMS; RECEPTOR SUBUNIT; GLUTAMATE RECEPTORS; AUXILIARY SUBUNITS; CA2+ PERMEABILITY; MOUSE STARGAZER; MESSENGER-RNAS; PLASTICITY; TRAFFICKING; CHANNELS	Regulation of calcium-permeable AMPA receptors (CP-AMPARs) is crucial in normal synaptic function and neurological disease states. Although transmembrane AMPAR regulatory proteins (TARPs) such as stargazin (gamma-2) modulate the properties of calciumimpermeable AMPARs (CI-AMPARs) and promote their synaptic targeting, the TARP-specific rules governing CP-AMPAR synaptic trafficking remain unclear. We used RNA interference to manipulate AMPAR-subunit and TARP expression in gamma-2-lacking stargazer cerebellar granule cells-the classic model of TARP deficiency. We found that TARP gamma-7 selectively enhanced the synaptic expression of CP-AMPARs and suppressed CI-AMPARs, identifying a pivotal role of gamma-7 in regulating the prevalence of CP-AMPARs. In the absence of associated TARPs, both CP-AMPARs and CI-AMPARs were able to localize to synapses and mediate transmission, although their properties were altered. Our results also establish that TARPed synaptic receptors in granule cells require both gamma-2 and gamma-7 and reveal an unexpected basis for the loss of AMPAR-mediated transmission in stargazer mice.	[Studniarczyk, Dorota; Coombs, Ian; Cull-Candy, Stuart G.; Farrant, Mark] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	s.cull-candy@ucl.ac.uk; m.farrant@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326; Coombs, Ian/0000-0003-1006-7471; Studniarczyk, Dorota/0000-0003-4109-7956; Farrant, Mark/0000-0002-9918-0376	Wellcome Trust; Medical Research Council; MRC [MR/J002976/1] Funding Source: UKRI; Medical Research Council [MR/J002976/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Programme Grants from the Wellcome Trust and the Medical Research Council (S.G.C.-C. and M. F.). We thank M. Watanabe for antibodies against gamma-2 and gamma-7, R. Nicoll for TARP gamma-2 cDNA, C. Bats for invaluable discussions and M. Zonouzi and M. Watanabe for advice on coimmunoprecipitation.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bats C, 2012, NAT NEUROSCI, V15, P853, DOI 10.1038/nn.3107; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Bowie D, 1998, J NEUROSCI, V18, P8175; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Chung CH, 2008, J NEUROPHYSIOL, V100, P2089, DOI 10.1152/jn.90404.2008; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GALLO V, 1992, J NEUROSCI, V12, P1010; Gangadharan V, 2011, J CLIN INVEST, V121, P1608, DOI 10.1172/JCI44911; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kott S, 2009, NEUROSCIENCE, V158, P78, DOI 10.1016/j.neuroscience.2007.12.047; Kudoh SN, 2002, BIOSENS BIOELECTRON, V17, P773, DOI 10.1016/S0956-5663(02)00053-2; Kunert R, 2005, P NATL ACAD SCI USA, V102, P5826, DOI 10.1073/pnas.0501316102; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maechler M., 2012, CLUSTER ANAL BASICS; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Yan D, 2012, J PHYSIOL-LONDON, V590, P21, DOI 10.1113/jphysiol.2011.213868	58	38	38	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1266	U146		10.1038/nn.3473	http://dx.doi.org/10.1038/nn.3473			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872597	Green Submitted, Green Accepted			2022-12-25	WOS:000323597500018
J	Oguro, H; Ding, L; Morrison, SJ				Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.			SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors	CELL STEM CELL			English	Article							SELF-RENEWAL; DIFFERENTIATION; LINEAGE; IDENTIFICATION; FETAL; MICE; RECONSTITUTION; HETEROGENEITY; PURIFICATION; EXPRESSION	Hematopoietic stem cells (HSCs) and multipotent hematopoietic progenitors (MPPs) are routinely isolated using various markers but remain heterogeneous. Here we show that four SLAM family markers, CD150, CD48, CD229, and CD244, can distinguish HSCs and MPPs from restricted progenitors and subdivide them into a hierarchy of functionally distinct subpopulations with stepwise changes in cell-cycle status, self-renewal, and reconstituting potential. CD229 expression largely distinguished lymphoid-biased HSCs from rarely dividing myeloid-biased HSCs, enabling prospective enrichment of these HSC subsets. Differences in CD229 and CD244 expression resolved CD150(-)CD48(-/low) Lineage(-/low)Sca-1(+)c-Kit(+) cells into a hierarchy of highly purified MPPs that retained erythroid and platelet potential but exhibited progressive changes in mitotic activity and reconstituting potential. Use of these markers, and reconstitution assays, showed that conditional deletion of Scf from endothelial cells and perivascular stromal cells eliminated the vast majority of bone marrow HSCs, including nearly all CD229(-/low) HSCs, demonstrating that quiescent HSCs are maintained by a perivascular niche.	[Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Oguro, Hideyuki; Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Oguro, Hideyuki/Q-5478-2019; Morrison, Sean/ABD-5326-2021	Oguro, Hideyuki/0000-0002-9070-4575; Morrison, Sean/0000-0003-1587-8329	National Heart, Lung and Blood Institute [HL097760]; Howard Hughes Medical Institute (HHMI); Cancer Prevention and Research Institute of Texas; Helen Hay Whitney Foundation; HHMI; Japanese Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas; Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung and Blood Institute (HL097760), the Howard Hughes Medical Institute (HHMI), and the Cancer Prevention and Research Institute of Texas. L. D. was supported by the Helen Hay Whitney Foundation and by HHMI. H.O. was supported by postdoctoral fellowships from the Japanese Society for the Promotion of Science and from the Uehara Memorial Foundation. H.O. performed most experiments. H.O and L. D. performed experiments in Figures 7C-7E and S7A-S7D. H.O. and S.J.M. designed and interpreted all experiments and wrote the manuscript. The University of Michigan has patented the use of SLAM family markers for the isolation of hematopoietic stem cells.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; UCHIDA N, 1994, BLOOD, V83, P3758; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106	47	391	401	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					102	116		10.1016/j.stem.2013.05.014	http://dx.doi.org/10.1016/j.stem.2013.05.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827712	Bronze, Green Accepted			2022-12-25	WOS:000329570100016
J	Chan, SSK; Shi, XZ; Toyama, A; Arpke, RW; Dandapat, A; Iacovino, M; Kang, J; Le, G; Hagen, HR; Garry, DJ; Kyba, M				Chan, Sunny Sun-Kin; Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Dandapat, Abhijit; Iacovino, Michelina; Kang, Jinjoo; Le, Gengyun; Hagen, Hannah R.; Garry, Daniel J.; Kyba, Michael			Mesp1 Patterns Mesoderm into Cardiac, Hematopoietic, or Skeletal Myogenic Progenitors in a Context-Dependent Manner	CELL STEM CELL			English	Article							STEM-CELL DIFFERENTIATION; EARLY MOUSE EMBRYO; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; GENE-EXPRESSION; IN-VITRO; HUMAN ES; SPECIFICATION; BLOOD; HEAD	Mesp1 is regarded as the master regulator of cardiovascular development, initiating the cardiac transcription factor cascade to direct the generation of cardiac mesoderm. To define the early embryonic cell population that responds to Mesp1, we performed pulse inductions of gene expression over tight temporal windows following embryonic stem cell differentiation. Remarkably, instead of promoting cardiac differentiation in the initial wave of mesoderm, Mesp1 binds to the Tal1 (Scl) +40 kb enhancer and generates Flk-1+ precursors expressing Etv2 (ER71) and Tal1 that undergo hematopoietic differentiation. The second wave of mesoderm responds to Mesp1 by differentiating into PDGFR alpha+ precursors that undergo cardiac differentiation. Furthermore, in the absence of serum-derived factors, Mesp1 promotes skeletal myogenic differentiation. Lineage tracing revealed that the majority of yolk sac and many adult hematopoietic cells derive from Mesp1+ precursors. Thus, Mesp1 is a context-dependent determination factor, integrating the stage of differentiation and the signaling environment to specify different lineage outcomes.	[Chan, Sunny Sun-Kin; Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Dandapat, Abhijit; Iacovino, Michelina; Kang, Jinjoo; Le, Gengyun; Hagen, Hannah R.; Garry, Daniel J.; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Chan, Sunny Sun-Kin; Dandapat, Abhijit; Kang, Jinjoo; Le, Gengyun; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Shi, Xiaozhong; Toyama, Akira; Arpke, Robert W.; Iacovino, Michelina; Garry, Daniel J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kyba, M (corresponding author), Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA.	kyba@umn.edu		Kyba, Michael/0000-0002-5579-7534; iacovino, michelina/0000-0002-1076-3146; Arpke, Robert W/0000-0002-0876-078X	NIH [U01 HL100407, R01 AR055685, T32 AR007612, T32 HL069764]; American Heart Association-Jon Holden DeHaan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069764, U01HL100407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055685, T32AR007612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Nardina Nash and Cara-lin Lonetree for animal husbandry and genotyping and Si Ho Choi for technical assistance in ChIP analysis. This work was supported by NIH grants U01 HL100407 and R01 AR055685 and by the American Heart Association-Jon Holden DeHaan Foundation. R. A. and A. T. were supported by NIH grants T32 AR007612 and T32 HL069764.	Ackerman KG, 2007, AM J MED GENET C, V145C, P109, DOI 10.1002/ajmg.c.30128; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Arpke RW, 2013, STEM CELLS, V31, P1611, DOI 10.1002/stem.1402; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bothe I, 2011, DEVELOPMENT, V138, P2807, DOI 10.1242/dev.062737; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai M, 2012, BLOOD, V120, P335, DOI 10.1182/blood-2012-01-403139; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Duchenne G., 1868, ARCH GEN MED, V11, P305; Duchenne G., 1868, ARCH GEN MED 6 SER, V11, P179; Duchenne G., 1868, ARCH GEN MED, V11, P421; Duchenne G., 1868, ARCH GEN MED, V11, P5; Duchenne G., 1868, ARCH GEN MED, V11, P552; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Hirata H, 2007, J BIOSCI BIOENG, V103, P412, DOI 10.1263/jbb.103.412; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Landouzy L, 1885, REV MED, V5, P253; Landouzy L, 1885, REV MED, V5, P81; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Palis J, 1999, DEVELOPMENT, V126, P5073; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Shih HP, 2008, ACTA HISTOCHEM, V110, P97, DOI 10.1016/j.acthis.2007.08.004; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	74	119	122	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					587	601		10.1016/j.stem.2013.03.004	http://dx.doi.org/10.1016/j.stem.2013.03.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642367	Green Accepted, Bronze			2022-12-25	WOS:000329569600014
J	Karwacki-Neisius, V; Goke, J; Osorno, R; Halbritter, F; Ng, JH; Weisse, AY; Wong, FCK; Gagliardi, A; Mullin, NP; Festuccia, N; Colby, D; Tomlinson, SR; Ng, HH; Chambers, I				Karwacki-Neisius, Violetta; Goeke, Jonathan; Osorno, Rodrigo; Halbritter, Florian; Ng, Jia Hui; Weisse, Andrea Y.; Wong, Frederick C. K.; Gagliardi, Alessia; Mullin, Nicholas P.; Festuccia, Nicola; Colby, Douglas; Tomlinson, Simon R.; Ng, Huck-Hui; Chambers, Ian			Reduced Oct4 Expression Directs a Robust Pluripotent State with Distinct Signaling Activity and Increased Enhancer Occupancy by Oct4 and Nanog	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE ES CELLS; GENE-EXPRESSION; GROUND-STATE; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; PREVENT DIFFERENTIATION; PRIMITIVE ENDODERM; RAT BLASTOCYSTS; EPIBLAST	Embryonic stem cell (ESC) pluripotency is governed by a gene regulatory network centered on the transcription factors Oct4 and Nanog. To date, robust self-renewing ESC states have only been obtained through the chemical inhibition of signaling pathways or enforced transgene expression. Here, we show that ESCs with reduced Oct4 expression resulting from heterozygosity also exhibit a stabilized pluripotent state. Despite having reduced Oct4 expression, Oct4(+/-) ESCs show increased genome-wide binding of Oct4, particularly at pluripotency-associated enhancers, homogeneous expression of pluripotency transcription factors, enhanced self-renewal efficiency, and delayed differentiation kinetics. Cells also exhibit increased Wnt expression, enhanced leukemia inhibitory factor (LIF) sensitivity, and reduced responsiveness to fibroblast growth factor. Although they are able to maintain pluripotency in the absence of bone morphogenetic protein, removal of LIF destabilizes pluripotency. Our findings suggest that cells with a reduced Oct4 concentration range are maintained in a robust pluripotent state and that the wild-type Oct4 concentration range enables effective differentiation.	[Karwacki-Neisius, Violetta; Osorno, Rodrigo; Halbritter, Florian; Wong, Frederick C. K.; Gagliardi, Alessia; Mullin, Nicholas P.; Festuccia, Nicola; Colby, Douglas; Tomlinson, Simon R.; Chambers, Ian] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH16 4UU, Midlothian, Scotland; [Weisse, Andrea Y.] Univ Edinburgh, SyntheSys Synthet & Syst Biol, Sch Biol Sci, Edinburgh EH9 3JD, Midlothian, Scotland; [Goeke, Jonathan; Ng, Jia Hui; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Dept Biol Sci, Singapore 117597, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	University of Edinburgh; University of Edinburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chambers, I (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	ichambers@ed.ac.uk	Ng, Huck Hui/A-1135-2009; Halbritter, Florian/AAI-1000-2019	Halbritter, Florian/0000-0003-2452-4784; Chambers, Ian/0000-0003-2605-1597; Goke, Jonathan/0000-0002-0825-4991; Mullin, Nicholas/0000-0003-4802-440X; NG, HUCK HUI/0000-0001-6352-8417	Medical Research Council of the UK; EU; Wellcome Trust; Human Frontier Sciences Program; Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education); el Consejo Nacional de Ciencia y Tecnologia; Biomedical Research Council; A*STAR; German Academic Exchange Service; MRC [G0901533] Funding Source: UKRI; Medical Research Council [G0700711B, G0901533] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Wellcome Trust(Wellcome Trust); Human Frontier Sciences Program(Human Frontier Science Program); Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); el Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR(Agency for Science Technology & Research (A*STAR)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are particularly indebted to V. Wilson for stimulating discussions and to S. Lowell and P. Navarro for comments on the manuscript. We are grateful to S. Monard and V. Berno for advice on FACS and microscopy, respectively, to M. Tyers and J. Wildenhain for access to and advice on the use of image analysis software, and to L. Robertson, C. Manson and staff for animal husbandry. Research in I.C.'s lab and in S.R.T.'s lab was supported by the Medical Research Council of the UK and the EU Framework 7 project EuroSyStem. I.C.'s lab is also supported by the Wellcome Trust, the Human Frontier Sciences Program, and studentships from Biotechnology and Biological Sciences Research Council (a Council for Advancement and Support of Education award to V.K.-N.) and el Consejo Nacional de Ciencia y Tecnologia (R.O.). Research in H.-H.N.'s lab is supported by the Biomedical Research Council, A*STAR, and by a fellowship from the German Academic Exchange Service (J.G.).	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I., 2005, REND FIS ACC LINCEI, V16, P83, DOI [10.1007/BF02904758, DOI 10.1007/BF02904758]; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gilchrist DS, 2003, GENESIS, V36, P168, DOI 10.1002/gene.10209; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Mountford P, 1998, REPROD FERT DEVELOP, V10, P527, DOI 10.1071/RD98087; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yuan H., 1996, GENE DEV, V9, P2635	55	129	134	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					531	545		10.1016/j.stem.2013.04.023	http://dx.doi.org/10.1016/j.stem.2013.04.023			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642364	hybrid, Green Published			2022-12-25	WOS:000329569600010
J	McCoy, ES; Taylor-Blake, B; Street, SE; Pribisko, AL; Zheng, JH; Zylka, MJ				McCoy, Eric S.; Taylor-Blake, Bonnie; Street, Sarah E.; Pribisko, Alaine L.; Zheng, Jihong; Zylka, Mark J.			Peptidergic CGRP alpha Primary Sensory Neurons Encode Heat and Itch and Tonically Suppress Sensitivity to Cold	NEURON			English	Article							PRIMARY AFFERENT NEURONS; RECEPTOR POTENTIAL VANILLOID-1; MOUSE GLABROUS SKIN; SUBSTANTIA-GELATINOSA; BEHAVIORAL-RESPONSES; NOCICEPTIVE NEURONS; SPINAL-CORD; PAIN; TRPM8; CAPSAICIN	Calcitonin gene-related peptide (CGRP) is a classic molecular marker of peptidergic primary somatosensory neurons. Despite years of research, it is unknown whether these neurons are required to sense pain or other sensory stimuli. Here, we found that genetic ablation of CGRP alpha-expressing sensory neurons reduced sensitivity to noxious heat, capsaicin, and itch (histamine and chloroquine) and impaired thermoregulation but did not impair mechanosensation or beta-alanine itch-stimuli associated with nonpeptidergic sensory neurons. Unexpectedly, ablation enhanced behavioral responses to cold stimuli and cold mimetics without altering peripheral nerve responses to cooling. Mechanistically, ablation reduced tonic and evoked activity in postsynaptic spinal neurons associated with TRPV1/heat, while profoundly increasing tonic and evoked activity in spinal neurons associated with TRPM8/cold. Our data reveal that CGRP alpha sensory neurons encode heat and itch and tonically cross-inhibit cold-responsive spinal neurons. Disruption of this crosstalk unmasks cold hypersensitivity, with mechanistic implications for neuropathic pain and temperature perception.	[McCoy, Eric S.; Taylor-Blake, Bonnie; Street, Sarah E.; Pribisko, Alaine L.; Zheng, Jihong; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, CB 7545, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022		The Searle Scholars Program; The Klingenstein Foundation; The Rita Allen Foundation; NINDS [R01NS060725, R01NS067688, P30NS045892]; NICHD [P30HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, P30NS045892, R01NS060725] Funding Source: NIH RePORTER	The Searle Scholars Program; The Klingenstein Foundation(Klingenstein Philanthropies); The Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank JrGang Cheng at the University of North Carolina BAC Core for generating the CGRP alpha targeting arms, Megumi Aita for performing in situ hybridization, Fan Wang at Duke University for providing Advillin-Cre mice, Edward Perl for allowing us to use his skin-nerve electrophysiology rig, Sarah Shoemaker for mouse colony management, Brendan Fitzpatrick for performing surgeries, Kenji Kohno for providing hDTR (pTRECK1) plasmid, and Masatoshi Takeichi for providing TRPM8 antibody. This work was supported by grants to M.J.Z. from The Searle Scholars Program, The Klingenstein Foundation, The Rita Allen Foundation, and NINDS (R01NS060725, R01NS067688). The BAC Core, Confocal Imaging Core, and In Situ Hybridization Core are funded by grants from NINDS (P30NS045892) and NICHD (P30HD03110).	Banik RK, 2008, PAIN, V138, P380, DOI 10.1016/j.pain.2008.01.017; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; OCHOA JL, 1994, BRAIN, V117, P185, DOI 10.1093/brain/117.1.185; Prescott SA, 2012, CURR OPIN NEUROBIOL, V22, P631, DOI 10.1016/j.conb.2012.02.010; Pribisko AL, 2011, J NEUROSCI METH, V194, P235, DOI 10.1016/j.jneumeth.2010.10.013; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Sikand P, 2011, PAIN, V152, P2485, DOI 10.1016/j.pain.2011.06.001; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; WAHREN LK, 1989, PAIN, V38, P313, DOI 10.1016/0304-3959(89)90218-2; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yang K, 1998, NEUROSCI LETT, V255, P135, DOI 10.1016/S0304-3940(98)00730-7; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x; Zheng JH, 2010, J PHYSIOL-LONDON, V588, P2065, DOI 10.1113/jphysiol.2010.188052; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	56	171	173	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2013	78	1					138	151		10.1016/j.neuron.2013.01.030	http://dx.doi.org/10.1016/j.neuron.2013.01.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23523592	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000317556000013
J	Trovo, L; Ahmed, T; Callaerts-Vegh, Z; Buzzi, A; Bagni, C; Chuah, M; VandenDriessche, T; D'Hooge, R; Balschun, D; Dotti, CG				Trovo, Laura; Ahmed, Tariq; Callaerts-Vegh, Zsuzsanna; Buzzi, Andrea; Bagni, Claudia; Chuah, Marinee; VandenDriessche, Thierry; D'Hooge, Rudi; Balschun, Detlef; Dotti, Carlos G.			Low hippocampal PI(4,5)P-2 contributes to reduced cognition in old mice as a result of loss of MARCKS	NATURE NEUROSCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE-C; NEURONAL EXCITABILITY; SYNAPTIC PLASTICITY; AKT PHOSPHORYLATION; ALZHEIMERS-DISEASE; CHOLESTEROL LOSS; MEMBRANE-LIPIDS; MUTANT MICE; HUMAN BRAIN	Cognitive and motor performances decline during aging. Although it is clear that such signs reflect synaptic compromise, the underlying mechanisms have not been defined. We found that the levels and activity of the synaptic plasticity modulators phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P-2) and phospholipase C gamma (PLC gamma) were substantially reduced in hippocampal synaptic membranes from old mice. In addition, these membranes contained reduced levels of the PI(4,5)P-2-clustering molecule myristoylated alanine-rich C kinase substrate (MARCKS). Consistent with a cause-effect relationship, raising MARCKS levels in the brain of old mice led to increased synaptic membrane clustering of PI(4,5)P-2 and to PLC gamma activation. MARCKS overexpression in the hippocampus of old mice or intraventricular perfusion of MARCKS peptide resulted in enhanced long-term potentiation and improved memory. These results reveal one of the mechanisms involved in brain dysfunction during aging.	[Trovo, Laura; Buzzi, Andrea; Bagni, Claudia; Dotti, Carlos G.] VIB Ctr Biol Dis, Louvain, Belgium; [Trovo, Laura; Buzzi, Andrea; Bagni, Claudia; Dotti, Carlos G.] Katholieke Univ Leuven, Univ Louvain, Ctr Human Genet, Louvain, Belgium; [Ahmed, Tariq; Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi; Balschun, Detlef] Univ Louvain, Fac Psychol & Educ Sci, Lab Biol Psychol, Louvain, Belgium; [Chuah, Marinee; VandenDriessche, Thierry] Free Univ Brussels, Univ Med Ctr, Fac Med & Pharm, Dept Gene Therapy & Regenerat Med, Brussels, Belgium; [Chuah, Marinee; VandenDriessche, Thierry] Univ Louvain, Dept Mol & Cellular Med, Louvain, Belgium; [Dotti, Carlos G.] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	cdotti@cbm.uam.es	Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Vandendriessche, Thierry/0000-0003-4230-745X; Trovo, Laura/0000-0002-8227-3429; Chuah, Marinee/0000-0001-8569-0175; Ahmed, Tariq/0000-0002-0998-1103; Bagni, Claudia/0000-0002-4419-210X	Fund for Scientific Research Flanders (FWO); Federal Office for Scientific Affairs [IUAP P6/43]; Flemish Government; Belgian Government [IAP 7/16]; Spanish Ministry of Science and Innovation [CSD2010-00064, SAF2010-14906]; Katholieke University of Leuven; K.U. Leuven GOA [12/008]	Fund for Scientific Research Flanders (FWO)(FWO); Federal Office for Scientific Affairs; Flemish Government(European Commission); Belgian Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Katholieke University of Leuven; K.U. Leuven GOA(KU Leuven)	We thank K. Vennekens for technical assistance and P.J. Blackshear (National Institute of Environmental Health) for the MARCKS plasmids. This research was supported by the Fund for Scientific Research Flanders (FWO), the Federal Office for Scientific Affairs (IUAP P6/43), the Flemish Government's Methusalem Grant, a NEUROBRAINNET grant from the Belgian Government (IAP 7/16), and grants from the Spanish Ministry of Science and Innovation Ingenio-Consolider (CSD2010-00064 and SAF2010-14906) to C.G.D. L.T. is the recipient of a BOF-Post Doctoral Fellowship from the Research Fund of Katholieke University of Leuven. D.B. and R.D. are supported by a K.U. Leuven GOA (12/008) grant.	Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Gong LW, 2008, P NATL ACAD SCI USA, V105, P17561, DOI 10.1073/pnas.0809221105; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hetman M, 2000, J NEUROSCI, V20, P2567; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Koch M, 2012, BBA-MOL CELL BIOL L, V1821, P1114, DOI 10.1016/j.bbalip.2012.02.008; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Lukowski S, 1998, BIOCHEM BIOPH RES CO, V248, P278, DOI 10.1006/bbrc.1998.8942; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Murray CA, 1998, J NEUROSCI, V18, P2974; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rivera GM, 2009, MOL CELL, V36, P525, DOI 10.1016/j.molcel.2009.10.025; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P2051, DOI 10.1111/j.1471-4159.1991.tb03466.x; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Thelen KM, 2006, NEUROSCI LETT, V403, P15, DOI 10.1016/j.neulet.2006.04.034; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Trovo L, 2011, J CELL SCI, V124, P1308, DOI 10.1242/jcs.078766; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822	57	45	47	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					449	U114		10.1038/nn.3342	http://dx.doi.org/10.1038/nn.3342			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434911				2022-12-25	WOS:000316723700015
J	de Nooij, JC; Doobar, S; Jessell, TM				de Nooij, Joriene C.; Doobar, Staceyann; Jessell, Thomas M.			Etv1 Inactivation Reveals Proprioceptor Subclasses that Reflect the Level of NT3 Expression in Muscle Targets	NEURON			English	Article							MOTOR-NEURON POOLS; SPINDLE AFFERENTS; SENSORY NEURONS; SPINAL-CORD; CUTANEOUS MECHANORECEPTORS; SYNAPTIC ACTIONS; CELL-DEATH; NEUROTROPHIN-3; CONNECTIONS; DIFFERENTIATION	The organization of spinal reflex circuits relies on the specification of distinct classes of proprioceptive sensory neurons (pSN), but the factors that drive such diversity remain unclear. We report here that pSNs supplying distinct skeletal muscles differ in their dependence on the ETS transcription factor Etv1 for their survival and differentiation. The status of Etv1-dependence is linked to the location of proprioceptor muscle targets: pSNs innervating hypaxial and axial muscles depend critically on Etv1 for survival, whereas those innervating certain limb muscles are resistant to Etv1 inactivation. The level of NT3 expression in individual muscles correlates with Etv1-dependence and the loss of pSNs triggered by Etv1 inactivation can be prevented by elevating the level of muscle-derived NT3 revealing a TrkC-activated Etv1-bypass pathway. Our findings support a model in which the specification of aspects of pSN subtype character is controlled by variation in the level of muscle NT3 expression and signaling.	[de Nooij, Joriene C.; Doobar, Staceyann; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [de Nooij, Joriene C.; Doobar, Staceyann; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu			Helen Hay Whitney Foundation; NIH [NS033245]; Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033245, R01NS033245] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Y. Mathers Foundation; Project A.L.S.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Andy Liu and Ira Schieren for technical help, Barbara Han, Susan Brenner-Morton, Monica Mendelsohn, and Jennifer Kirkland for help with generation of antibodies and mouse strains, Neil Shneider for providing the hEGR3 promoter construct and information on its MS expression, and Stephane Nedelec and Annina DeLeo for advice on qRT-PCR experiments. We are grateful to S. Arber, D. Wright, W. Snider, and S. Dufour for mouse strains, and to Eiman Azim, Jay Bikoff, Nikolaos Balaskas, George Mentis, Sebastian Poliak, and Niccolo Zampieri for comments on the manuscript. J.C.N. was supported by a Helen Hay Whitney Foundation fellowship. T.M.J. was supported by NIH grant NS033245, the Harold and Leila Y. Mathers Foundation, and Project A.L.S. T.M.J. is an HHMI Investigator.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Banks RW, 2009, J ANAT, V214, P859, DOI 10.1111/j.1469-7580.2009.01072.x; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Brown AG, 1981, ORG SPINAL CORD; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; Demireva EY, 2011, CELL, V147, P641, DOI 10.1016/j.cell.2011.09.037; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ECCLES RM, 1958, J PHYSIOL-LONDON, V144, P271, DOI 10.1113/jphysiol.1958.sp006101; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; HINTERBERGER TJ, 1991, DEV BIOL, V147, P144, DOI 10.1016/S0012-1606(05)80014-4; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Iscoe S, 2000, RESP PHYSIOL, V122, P27, DOI 10.1016/S0034-5687(00)00138-9; JANKOWSKA E, 1980, BRAIN RES, V194, P65, DOI 10.1016/0006-8993(80)91319-0; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lallemend F, 2012, EMBO J, V31, P3718, DOI 10.1038/emboj.2012.228; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045551; Levine AJ, 2012, CURR OPIN NEUROBIOL, V22, P812, DOI 10.1016/j.conb.2012.07.002; Li LY, 2006, DEV DYNAM, V235, P3039, DOI 10.1002/dvdy.20964; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matthews P. B. C., 1972, MAMMALIAN MUSCLE REC; Mears SC, 1997, J NEUROSCI, V17, P3128; MENDELSON B, 1991, J NEUROSCI, V11, P1390; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; MOLANDER C, 1986, NEUROSCIENCE, V19, P297, DOI 10.1016/0306-4522(86)90023-0; Nakayama K, 1998, J COMP NEUROL, V398, P459; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; SEARS TA, 1964, J PHYSIOL-LONDON, V175, P386, DOI 10.1113/jphysiol.1964.sp007523; Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; White FA, 1998, J NEUROSCI, V18, P1428; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; Zhao J, 2006, GENESIS, V44, P364, DOI 10.1002/dvg.20224	55	65	65	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1055	1068		10.1016/j.neuron.2013.01.015	http://dx.doi.org/10.1016/j.neuron.2013.01.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522042	Green Accepted, Bronze			2022-12-25	WOS:000316645000008
J	Han, XN; Chen, M; Wang, FS; Windrem, M; Wang, S; Shanz, S; Xu, QW; Oberheim, NA; Bekar, L; Betstadt, S; Silva, AJ; Takano, T; Goldman, SA; Nedergaard, M				Han, Xiaoning; Chen, Michael; Wang, Fushun; Windrem, Martha; Wang, Su; Shanz, Steven; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Betstadt, Sarah; Silva, Alcino J.; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken			Forebrain Engraftment by Human Glial Progenitor Cells Enhances Synaptic Plasticity and Learning in Adult Mice	CELL STEM CELL			English	Article							AMPA-RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; TNF-ALPHA; AREA CA1; D-SERINE; ASTROCYTES; BRAIN; HIPPOCAMPUS; MEMORY; EXCITABILITY	Human astrocytes are larger and more complex than those of infraprimate mammals, suggesting that their role in neural processing has expanded with evolution. To assess the cell-autonomous and species-selective properties of human glia, we engrafted human glial progenitor cells (GPCs) into neonatal immunodeficient mice. Upon maturation, the recipient brains exhibited large numbers and high proportions of both human glial progenitors and astrocytes. The engrafted human glia were gap-junction-coupled to host astroglia, yet retained the size and pleomorphism of hominid astroglia, and propagated Ca2+ signals 3-fold faster than their hosts. Long-term potentiation (LTP) was sharply enhanced in the human glial chimeric mice, as was their learning, as assessed by Barnes maze navigation, object-location memory, and both contextual and tone fear conditioning. Mice allografted with murine GPCs showed no enhancement of either LTP or learning. These findings indicate that human glia differentially enhance both activity-dependent plasticity and learning in mice.	[Han, Xiaoning; Chen, Michael; Wang, Fushun; Windrem, Martha; Wang, Su; Shanz, Steven; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Han, Xiaoning; Chen, Michael; Wang, Fushun; Xu, Qiwu; Oberheim, Nancy Ann; Bekar, Lane; Takano, Takahiro; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Windrem, Martha; Wang, Su; Shanz, Steven; Goldman, Steven A.; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Betstadt, Sarah] Univ Rochester, Med Ctr, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Psychiat, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA 90095 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu; nedergaard@urmc.rochester.edu	Silva, Alcino/ABD-7684-2021; Bekar, Lane K./AAI-2645-2021	Silva, Alcino/0000-0002-1587-4558; Bekar, Lane/0000-0001-5083-0967; Silva, Alcino/0000-0001-5525-0494; Takano, Takahiro/0000-0002-6235-6673; Goldman, Steven/0000-0002-5498-4303	G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Multiple Sclerosis Society; NIMH; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078304, R01NS078167, R01NS075345, R01NS075177, R01NS052534] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the National Multiple Sclerosis Society, NIMH, and NINDS. We thank R. Malenka for valuable comments on the manuscript. Drs. Goldman and Windrem have a patent on the generation and use of glial chimeric mice, entitled, "Non-human animals with human glial chimeric brains," US patent no. 7,524,491. They receive no income or financial consideration from this patent.	Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Colombo J. A., 2001, Neurobiology (Budapest), V9, P1, DOI 10.1556/Neurob.9.2001.1.1; Colombo JA, 1996, ACTA ANAT, V155, P57; COLOMBO JA, 1995, J NEUROSCI RES, V40, P551, DOI 10.1002/jnr.490400414; COTRINA M, 2005, INTRACELLULAR CALCIU; Dawitz J, 2011, J VIS EXP, V56; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Fields RD, 2004, SCI AM, V290, P54, DOI 10.1038/scientificamerican0404-54; GROVER LM, 1993, NEUROSCI LETT, V154, P39, DOI 10.1016/0304-3940(93)90166-I; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangin JM, 2011, ASN NEURO, V3, P37, DOI 10.1042/AN20110001; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Ni YC, 2009, GLIA, V57, P1296, DOI 10.1002/glia.20849; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2012, NEUROCHEM INT, V61, P610, DOI 10.1016/j.neuint.2011.12.001; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI 10.1177/1073858410387304; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Windrem M.S., 2009, NEONATALLY IMPLANTED; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	39	388	400	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					342	353		10.1016/j.stem.2012.12.015	http://dx.doi.org/10.1016/j.stem.2012.12.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23472873	Bronze, Green Accepted			2022-12-25	WOS:000329569400012
J	Xie, RY; Everett, LJ; Lim, HW; Patel, NA; Schug, J; Kroon, E; Kelly, OG; Wang, A; D'Amour, KA; Robins, AJ; Won, KJ; Kaestner, KH; Sander, M				Xie, Ruiyu; Everett, Logan J.; Lim, Hee-Woong; Patel, Nisha A.; Schug, Jonathan; Kroon, Evert; Kelly, Olivia G.; Wang, Allen; D'Amour, Kevin A.; Robins, Allan J.; Won, Kyoung-Jae; Kaestner, Klaus H.; Sander, Maike			Dynamic Chromatin Remodeling Mediated by Polycomb Proteins Orchestrates Pancreatic Differentiation of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							GENOME-WIDE MAPS; INSULIN-SECRETION; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; HISTONE MODIFICATIONS; IN-VIVO; LINEAGE; ISLETS; GENES	Embryonic development is characterized by dynamic changes in gene expression, yet the role of chromatin remodeling in these cellular transitions remains elusive. To address this question, we profiled the transcriptome and select chromatin modifications at defined stages during pancreatic endocrine differentiation of human embryonic stem cells. We identify removal of Polycomb group (PcG)-mediated repression on stage-specific genes as a key mechanism for the induction of developmental regulators. Furthermore, we discover that silencing of transitory genes during lineage progression associates with reinstatement of PcG-dependent repression. Significantly, in vivo-but not in vitro-differentiated endocrine cells exhibit close similarity to primary human islets in regard to transcriptome and chromatin structure. We further demonstrate that endocrine cells produced in vitro do not fully eliminate PcG-mediated repression on endocrine-specific genes, probably contributing to their malfunction. These studies reveal dynamic chromatin remodeling during developmental lineage progression and identify possible strategies for improving cell differentiation in culture.	[Xie, Ruiyu; Patel, Nisha A.; Wang, Allen; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Everett, Logan J.; Lim, Hee-Woong; Schug, Jonathan; Won, Kyoung-Jae; Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Everett, Logan J.; Lim, Hee-Woong; Schug, Jonathan; Won, Kyoung-Jae; Kaestner, Klaus H.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kroon, Evert; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.] ViaCyte Inc, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of Pennsylvania; University of Pennsylvania	Sander, M (corresponding author), Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA.	masander@ucsd.edu	Sander, Maike/N-6615-2016; Lim, Hee Woong/AAX-6835-2021; Everett, Logan/AAK-1523-2021; Lim, HW/GRY-3517-2022	Sander, Maike/0000-0001-5308-7785; Lim, Hee Woong/0000-0001-8599-1808; KROON, EVERT/0000-0002-4069-3644; Xie, Ruiyu/0000-0003-0518-2897; Won, Kyoung Jae/0000-0002-2924-9630	National Institutes of Health [U01-DK089567, R01-DK07243, U01-DK089529, R01-DK088383, P30-DK19525]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078803, P30DK019525, R01DK088383, U01DK089529, U01DK089567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Wright (Vanderbilt University) and K. Miyabayashi (Kyushu University) for antibodies; T. Harper for lentivirus preparation; N. Shah and E. Lee for technical assistance; and E. Baetge and members of the M. S. laboratory for helpful discussions. We acknowledge use of human fetal pancreas provided by the Birth Defects Research Laboratory of the University of Washington. We are grateful to E. O'Connor for his help with FACS. This work was supported by National Institutes of Health grants U01-DK089567 and R01-DK07243 to M. S., U01-DK089529 and R01-DK088383 to K. H. K., and P30-DK19525 to K.-J.W.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu HL, 2011, ACTA HISTOCHEM, V113, P340, DOI 10.1016/j.acthis.2010.01.005; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Luco RF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000079; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750	38	174	185	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					224	237		10.1016/j.stem.2012.11.023	http://dx.doi.org/10.1016/j.stem.2012.11.023			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23318056	Bronze, Green Accepted			2022-12-25	WOS:000329569300013
J	Ninkovic, J; Steiner-Mezzadri, A; Jawerka, M; Akinci, U; Messerdotti, G; Petricca, S; Fischer, J; von Holst, A; Beckers, J; Lie, CD; Petrik, D; Miller, E; Tang, J; Wu, J; Lefebvre, V; Demmers, J; Eisch, A; Metzger, D; Crabtree, G; Irmler, M; Poot, R; Gotz, M				Ninkovic, Jovica; Steiner-Mezzadri, Andrea; Jawerka, Melanie; Akinci, Umut; Messerdotti, Giacomo; Petricca, Stefania; Fischer, Judith; von Holst, Alexander; Beckers, Johanes; Lie, Chichung D.; Petrik, David; Miller, Erik; Tang, Jiong; Wu, Jiang; Lefebvre, Veronique; Demmers, Jeroen; Eisch, Amelia; Metzger, Daniel; Crabtree, Gerald; Irmler, Martin; Poot, Raymond; Goetz, Magdalena			The BAF Complex Interacts with Pax6 in Adult Neural Progenitors to Establish a Neurogenic Cross-Regulatory Transcriptional Network	CELL STEM CELL			English	Article							CHROMATIN-REMODELING COMPLEXES; SCHWANN-CELL DIFFERENTIATION; MOUSE CEREBRAL-CORTEX; STEM-CELLS; OLFACTORY-BULB; RADIAL GLIA; IN-VITRO; EXPRESSION; GENES; NEURONS	Numerous transcriptional regulators of neurogenesis have been identified in the developing and adult brain, but how neurogenic fate is programmed at the epigenetic level remains poorly defined. Here, we report that the transcription factor Pax6 directly interacts with the Brg1-containing BAF complex in adult neural progenitors. Deletion of either Brg1 or Pax6 in the subependymal zone (SEZ) causes the progeny of adult neural stem cells to convert to the ependymal lineage within the SEZ while migrating neuroblasts convert to different glial lineages en route to or in the olfactory bulb (OB). Genome-wide analyses reveal that the majority of genes downregulated in the Brg1 null SEZ and OB contain Pax6 binding sites and are also downregulated in Pax6 null SEZ and OB. Downstream of the Pax6-BAF complex, we find that Sox11, Nfib, and Pou3f4 form a transcriptional cross-regulatory network that drives neurogenesis and can convert postnatal glia into neurons. Taken together, elements of our work identify a tripartite effector network activated by Pax6-BAF that programs neuronal fate.	[Ninkovic, Jovica; Steiner-Mezzadri, Andrea; Messerdotti, Giacomo; Petricca, Stefania; Fischer, Judith; Goetz, Magdalena] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Lie, Chichung D.] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Beckers, Johanes; Irmler, Martin] Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Ninkovic, Jovica; Jawerka, Melanie; Messerdotti, Giacomo; Goetz, Magdalena] Univ Munich, Fac Med, D-80633 Munich, Germany; [Akinci, Umut; Poot, Raymond] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [von Holst, Alexander] Heidelberg Univ, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; [von Holst, Alexander] Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany; [Beckers, Johanes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Lie, Chichung D.] Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany; [Petrik, David; Eisch, Amelia] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Wu, Jiang] Univ Texas SW Med Ctr Dallas, Dept Physiol & Dev Biol, Dallas, TX 75390 USA; [Miller, Erik; Tang, Jiong; Crabtree, Gerald] Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B211, Stanford, CA 94305 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol NC10, Cleveland, OH 44195 USA; [Metzger, Daniel] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Goetz, Magdalena] Univ Munich, Munich Cluster Syst Neurol EXC SyNergy 1010, D-80539 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Erlangen Nuremberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Stanford University; Cleveland Clinic Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich	Gotz, M (corresponding author), Helmholtz Ctr Munich German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	magdalena.goetz@helmholtz-muenchen.de	Lie, Dieter Chichung/AAS-8604-2020; Demmers, Jeroen AA/F-4046-2016; Beckers, Johannes/K-7237-2012; Irmler, Martin/B-3317-2013; Ninkovic, Jovica/AAH-5220-2019; von Holst, Alexander/I-3061-2014; Lie, Dieter Chichung/S-7914-2017	Lie, Dieter Chichung/0000-0002-6035-6442; Demmers, Jeroen AA/0000-0002-8757-9611; Beckers, Johannes/0000-0001-7874-3822; Irmler, Martin/0000-0003-3169-479X; Ninkovic, Jovica/0000-0002-4381-0041; Lie, Dieter Chichung/0000-0002-6035-6442; Eisch, Amelia/0000-0001-6476-5385; Metzger, Daniel/0000-0002-5555-046X; Petrik, David/0000-0003-3026-0770; Crabtree, Robert/0000-0002-6639-8707; Fischer-Sternjak, Judith/0000-0003-0398-7720	German Research foundation (DFG) [SFB 870]; German Research foundation (DFG) by SPP "Integrative Analysis of Olfaction"; Leibniz Prize; Munich Cluster for Systems Neurology [EXC 1010 SyNergy]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016765, K02DA023555] Funding Source: NIH RePORTER	German Research foundation (DFG)(German Research Foundation (DFG)); German Research foundation (DFG) by SPP "Integrative Analysis of Olfaction"; Leibniz Prize(German Research Foundation (DFG)); Munich Cluster for Systems Neurology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We want to thank Peter Becker, Ales Cvekl, and Maren Eckey for help with establishment of ChIP experiments, and Karel Bezstarosti for help with the mass spectrometry analysis. We are also thankful to Timucin Ozturk, Emily Violette-Baumgardt, and Angelika Waiser for excellent technical help, Alexandra Lepier for the viral vector production, Jelena Ninkovic for the help with statistical analysis, and Leda Dimou for critical reading of the manuscript. We also gratefully acknowledge funding to J.N. from the German Research foundation (DFG) by the SFB 870 and SPP "Integrative Analysis of Olfaction," and to M. G. from the German Research foundation (DFG) by the SFB 870, the Leibniz Prize, and the Munich Cluster for Systems Neurology (EXC 1010 SyNergy).	Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Baker NE, 2001, BIOESSAYS, V23, P763, DOI 10.1002/bies.1110; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Cuddapah S, 2009, COLD SPRING HARB PRO, V2009; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Limpert AS, 2013, J NEUROSCI, V33, P2388, DOI 10.1523/JNEUROSCI.3223-12.2013; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yip DJ, 2012, DEV CELL, V22, P871, DOI 10.1016/j.devcel.2012.01.020; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	52	138	139	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					403	418		10.1016/j.stem.2013.07.002	http://dx.doi.org/10.1016/j.stem.2013.07.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23933087	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000329571100010
J	Toyoizumi, T; Miyamoto, H; Yazaki-Sugiyama, Y; Atapour, N; Hensch, TK; Miller, KD				Toyoizumi, Taro; Miyamoto, Hiroyuki; Yazaki-Sugiyama, Yoko; Atapour, Nafiseh; Hensch, Takao K.; Miller, Kenneth D.			A Theory of the Transition to Critical Period Plasticity: Inhibition Selectively Suppresses Spontaneous Activity	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; PRIMARY VISUAL-CORTEX; LONG-TERM POTENTIATION; NR2A SUBUNIT EXPRESSION; DEVELOPMENTAL PLASTICITY; ORIENTATION SELECTIVITY; CORTICAL INHIBITION; OTX2 HOMEOPROTEIN; SENSITIVE PERIODS	What causes critical periods (CPs) to open? For the best-studied case, ocular dominance plasticity in primary visual cortex in response to monocular deprivation (MD), the maturation of inhibition is necessary and sufficient. How does inhibition open the CP? We present a theory: the transition from pre-CP to CP plasticity arises because inhibition preferentially suppresses responses to spontaneous relative to visually driven input activity, switching learning cues from internal to external sources. This differs from previous proposals in (1) arguing that the CP can open without changes in plasticity mechanisms when activity patterns become more sensitive to sensory experience through circuit development, and (2) explaining not simply a transition from no plasticity to plasticity, but a change in outcome of MD-induced plasticity from pre-CP to CP. More broadly, hierarchical organization of sensory-motor pathways may develop through a cascade of CPs induced as circuit maturation progresses from "lower" to "higher" cortical areas.	[Toyoizumi, Taro; Miller, Kenneth D.] Columbia Univ, Coll Phys & Surg, Ctr Theoret Neurosci, New York, NY 10032 USA; [Toyoizumi, Taro; Miller, Kenneth D.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Miller, Kenneth D.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Toyoizumi, Taro; Miyamoto, Hiroyuki; Yazaki-Sugiyama, Yoko; Atapour, Nafiseh; Hensch, Takao K.] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Toyoizumi, Taro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268503, Japan; [Hensch, Takao K.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Columbia University; Columbia University; Columbia University; RIKEN; Tokyo Institute of Technology; Harvard University	Toyoizumi, T (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Theoret Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	taro.toyoizumi@brain.riken.jp	Hensch, Takao/L-4182-2019; Toyoizumi, Taro/G-5632-2015; Yazaki-Sugiyama, Yoko/G-4950-2015	Toyoizumi, Taro/0000-0001-5444-8829; Yazaki-Sugiyama, Yoko/0000-0003-2052-4162; Atapour, Nafiseh/0000-0002-8773-9283	Japan Society for the Promotion of Science (JSPS); Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Bank of America; Trustee; Special Postdoctoral Researchers Program of RIKEN; RIKEN Brain Science Institute; Japan Science and Technology Agency; National Eye Institute (NEI) [R01-EY11001]; Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University;  [1806772]; NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Bank of America; Trustee; Special Postdoctoral Researchers Program of RIKEN; RIKEN Brain Science Institute; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank M. Eisele and X. Pitkow for helpful discussions and C. Yokoyama for comments on the manuscript. T.T. was supported by The Japan Society for the Promotion of Science (JSPS), Grant-in-Aid 1806772 for JSPS fellows, The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship, Bank of America, Trustee, The Special Postdoctoral Researchers Program of RIKEN, and RIKEN Brain Science Institute. The Japan Science and Technology Agency supported H.M. (PRESTO), Y.Y-S., and T.K.H. (CREST). N.A. and T.K.H. were further supported by RIKEN Brain Science Institute. K.D.M. was supported by R01-EY11001 from the National Eye Institute (NEI) and by the Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University. T.T. and K.D.M. developed the theory in discussion with Y.Y-S. T.T. simulated the model in discussion with K.D.M. H.M. and T.K.H. designed the tetrode experiment. H.M. recorded the data. T.T. and H.M. analyzed the experimental data. N.A. provided the two pathway LTD experiment. T.T., T.K.H., and K.D.M. wrote the manuscript.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dayan P., 2001, THEORETICAL NEUROSCI; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Failor S, 2010, J NEUROSCI, V30, P81, DOI 10.1523/JNEUROSCI.5656-08.2010; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gerstner W., 2002, SPIKING NEURON MODEL; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hebb Donald O., 1949, ORG BEHAV; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hernandez AE, 2007, PSYCHOL BULL, V133, P638, DOI 10.1037/0033-2909.133.4.638; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Kanold PO, 2009, J PHYSIOL-LONDON, V587, P2857, DOI 10.1113/jphysiol.2009.171215; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Kuhlman SJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000797; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Miller K. D, 1990, NEUROSCIENCE CONNECT, P267; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Morales B, 2002, J NEUROSCI, V22, P8084; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nishie H, 2012, NEUROSCI RES, V73, P292, DOI 10.1016/j.neures.2012.05.006; Ohshiro T, 2006, NAT NEUROSCI, V9, P1541, DOI 10.1038/nn1799; PARKINSON D, 1988, EXP BRAIN RES, V73, P553, DOI 10.1007/BF00406614; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Robinson K, 1998, INT J PEDIATR OTORHI, V46, P71, DOI 10.1016/S0165-5876(98)00125-6; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Scott LS, 2007, CURR DIR PSYCHOL SCI, V16, P197, DOI 10.1111/j.1467-8721.2007.00503.x; Sharpee TO, 2011, CURR OPIN NEUROBIOL, V21, P761, DOI 10.1016/j.conb.2011.05.027; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Werker JF, 2009, PHILOS T R SOC B, V364, P3649, DOI 10.1098/rstb.2009.0105; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wyatt RM, 2012, NAT NEUROSCI, V15, P949, DOI 10.1038/nn.3134; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	116	87	87	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					51	63		10.1016/j.neuron.2013.07.022	http://dx.doi.org/10.1016/j.neuron.2013.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094102	Green Accepted, Bronze			2022-12-25	WOS:000326305300007
J	Guzman, YF; Tronson, NC; Jovasevic, V; Sato, K; Guedea, AL; Mizukami, H; Nishimori, K; Radulovic, J				Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Sato, Keisuke; Guedea, Anita L.; Mizukami, Hiroaki; Nishimori, Katsuhiko; Radulovic, Jelena			Fear-enhancing effects of septal oxytocin receptors	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT; MICE; STRESS; VASOPRESSIN; RELEASE; NEURONS; ANXIETY	The nonapeptide oxytocin is considered beneficial to mental health due to its anxiolytic, prosocial and antistress effects, but evidence for anxiogenic actions of oxytocin in humans has recently emerged. Using region-specific manipulations of the mouse oxytocin receptor (Oxtr) gene (Oxtr), we identified the lateral septum as the brain region mediating fear-enhancing effects of Oxtr. These effects emerge after social defeat and require Oxtr specifically coupled to the extracellular signal-regulated protein kinase pathway.	[Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Guedea, Anita L.; Radulovic, Jelena] Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Tronson, Natalie C.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Sato, Keisuke; Nishimori, Katsuhiko] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 980, Japan; [Mizukami, Hiroaki] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan	Northwestern University; University of Michigan System; University of Michigan; Tohoku University; Jichi Medical University	Radulovic, J (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	j-radulovic@northwestern.edu	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X; Guzman, Yomayra F./0000-0003-4802-8304; Tronson, Natalie/0000-0001-5676-1579; Radulovic, Jelena/0000-0002-0268-2426	US National Institutes of Health [R01 MH078064, MH092065]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073669, R01MH078064, F31MH092065] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH078064 (J.R.) and MH092065 (Y.F.G.). Part of this study carried out by K.N. and K.S. was the result of "Molecular study of the functional mechanism of oxytocin in brain" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank P. Osten (Cold Spring Harbor) for providing the rAAV-Cre vector, and L. Li and W. G. Tourtellotte (Department of Pathology, Northwestern University) for providing B6.129S4-Gt(ROSA) mice and their help with the beta-galactosidase staining.	Ayers LW, 2011, NEUROPSYCHOPHARMACOL, V36, P2488, DOI 10.1038/npp.2011.138; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Devost D, 2008, PROG BRAIN RES, V170, P167, DOI 10.1016/S0079-6123(08)00415-9; Ebner K, 2000, BRAIN RES, V872, P87, DOI 10.1016/S0006-8993(00)02464-1; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Grillon C., 2012, MOL PSYCHIATR, DOI [10.1038/mp.2012.156, DOI 10.1038/MP.2012.156.(13]; IsHak WW, 2011, J AFFECT DISORDERS, V130, P1, DOI 10.1016/j.jad.2010.06.001; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Pagani JH, 2011, GENES BRAIN BEHAV, V10, P710, DOI 10.1111/j.1601-183X.2011.00709.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Radulovic J, 1999, J NEUROSCI, V19, P5016; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; ROCHE KE, 1979, SCIENCE, V204, P1343, DOI 10.1126/science.221973; Sato K, 2009, BIOSCI BIOTECH BIOCH, V73, P2145, DOI 10.1271/bbb.90287; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Striepens N, 2012, P NATL ACAD SCI USA, V109, P18144, DOI 10.1073/pnas.1208852109; Tabak BA, 2011, PSYCHONEUROENDOCRINO, V36, P115, DOI 10.1016/j.psyneuen.2010.07.004; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; Tronson NC, 2008, NEUROPSYCHOPHARMACOL, V33, P1570, DOI 10.1038/sj.npp.1301550; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	27	151	155	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1185	U36		10.1038/nn.3465	http://dx.doi.org/10.1038/nn.3465			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872596	Green Accepted			2022-12-25	WOS:000323597500008
J	Stoll, G; Pietilainen, OPH; Linder, B; Suvisaari, J; Brosi, C; Hennah, W; Leppa, V; Torniainen, M; Ripatti, S; Ala-Mello, S; Plottner, O; Rehnstrom, K; Tuulio-Henriksson, A; Varilo, T; Tallila, J; Kristiansson, K; Isohanni, M; Kaprio, J; Eriksson, JG; Raitakari, OT; Lehtimaki, T; Jarvelin, MR; Salomaa, V; Hurles, M; Stefansson, H; Peltonen, L; Sullivan, PF; Paunio, T; Lonnqvist, J; Daly, MJ; Fischer, U; Freimer, NB; Palotie, A				Stoll, Georg; Pietilainen, Olli P. H.; Linder, Bastian; Suvisaari, Jaana; Brosi, Cornelia; Hennah, William; Leppa, Virpi; Torniainen, Minna; Ripatti, Samuli; Ala-Mello, Sirpa; Plottner, Oliver; Rehnstrom, Karola; Tuulio-Henriksson, Annamari; Varilo, Teppo; Tallila, Jonna; Kristiansson, Kati; Isohanni, Matti; Kaprio, Jaakko; Eriksson, Johan G.; Raitakari, Olli T.; Lehtimaki, Terho; Jarvelin, Marjo-Riitta; Salomaa, Veikko; Hurles, Matthew; Stefansson, Hreinn; Peltonen, Leena; Sullivan, Patrick F.; Paunio, Tiina; Lonnqvist, Jouko; Daly, Mark J.; Fischer, Utz; Freimer, Nelson B.; Palotie, Aarno			Deletion of TOP3 beta, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders	NATURE NEUROSCIENCE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; DIGEORGE-SYNDROME; RNA; JUNCTION; SCHIZOPHRENIA; COMPLEX; PATTERNS	Implicating particular genes in the generation of complex brain and behavior phenotypes requires multiple lines of evidence. The rarity of most high-impact genetic variants typically precludes the possibility of accruing statistical evidence that they are associated with a given trait. We found that the enrichment of a rare chromosome 22q11.22 deletion in a recently expanded Northern Finnish sub-isolate enabled the detection of association between TOP3B and both schizophrenia and cognitive impairment. Biochemical analysis of TOP3 beta revealed that this topoisomerase was a component of cytosolic messenger ribonucleoproteins (mRNPs) and was catalytically active on RNA. The recruitment of TOP3 beta to mRNPs was independent of RNA cis-elements and was coupled to the co-recruitment of FMRP, the disease gene product in fragile X mental retardation syndrome. Our results indicate a previously unknown role for TOP3 beta in mRNA metabolism and suggest that it is involved in neurodevelopmental disorders.	Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Pietilainen, Olli P. H.; Ripatti, Samuli; Rehnstrom, Karola; Tallila, Jonna; Hurles, Matthew; Peltonen, Leena; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Hennah, William; Leppa, Virpi; Ripatti, Samuli; Kaprio, Jaakko; Paunio, Tiina; Palotie, Aarno] Inst Mol Med Finland, Helsinki, Finland; [Pietilainen, Olli P. H.; Varilo, Teppo; Peltonen, Leena; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Suvisaari, Jaana; Hennah, William; Torniainen, Minna; Tuulio-Henriksson, Annamari; Kaprio, Jaakko; Lonnqvist, Jouko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Suvisaari, Jaana; Hennah, William; Torniainen, Minna; Tuulio-Henriksson, Annamari; Kaprio, Jaakko; Lonnqvist, Jouko] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland; [Ala-Mello, Sirpa; Lonnqvist, Jouko] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Plottner, Oliver] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Isohanni, Matti] Univ Oulu, Dept Psychiat, Inst Clin Med, Oulu, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf Chron Dis Epidemiol & Preve, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol Nucl Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ, Cent Hosp, Turku, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Imperial Coll London, MRC HPA Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Stefansson, Hreinn] deCODE Genet, Reykjavik, Iceland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat & Epidemiol, Chapel Hill, NC USA; [Paunio, Tiina] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Daly, Mark J.] Massachusetts Gen Hosp, Anal & Translat Genet Unit, Boston, MA 02114 USA; [Daly, Mark J.; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Freimer, Nelson B.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA	University of Wurzburg; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Roche Holding; University of Oulu; University of Helsinki; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Imperial College London; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles	Freimer, NB (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de; nfreimer@mednet.ucla.edu	Daly, Mark J/B-2453-2017; Lehtimäki, Terho/AAD-1094-2022; Kaprio, Jaakko/A-1820-2008; Raitakari, Olli/AAQ-7389-2021; Linder, Bastian/G-5111-2012; Linder, Bastian/W-4923-2019; Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016; Ripatti, Samuli/H-9446-2014	Daly, Mark J/0000-0002-0949-8752; Lehtimäki, Terho/0000-0002-2555-4427; Kaprio, Jaakko/0000-0002-3716-2455; Linder, Bastian/0000-0003-1203-3136; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Ripatti, Samuli/0000-0002-0504-1202; Eriksson, Johan/0000-0002-2516-2060; Suvisaari, Jaana/0000-0001-7167-0990; Hennah, William/0000-0002-4462-4208; Stefansson, Hreinn/0000-0002-9331-6666; Tuulio-Henriksson, Annamari/0000-0002-3580-3693; Kristiansson, Kati/0000-0003-4688-107X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Leppa, Virpi/0000-0003-2942-2656; Palotie, Aarno/0000-0002-2527-5874; Varilo, Teppo/0000-0002-5839-8854; Holm, Minna/0000-0003-2149-855X	Wellcome Trust [WT089062, WT098051]; Academy of Finland [200923, 251704, 136635, 128504, 132071]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; EuroHead project [LSM-CT-2004-504837]; European Community's Seventh Framework Programme; ENGAGE Consortium [HEALTH-F4-2007-201413]; EU/SYNSYS-Synaptic Systems [242167]; National Alliance for Research in Schizophrenia and Depression; Sigrid Juselius Foundation; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; US National Institutes of Health [RL1MH083268, P30NS062691]; DFG [FOR 855]; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); EuroHead project(European Commission); European Community's Seventh Framework Programme(European Commission); ENGAGE Consortium; EU/SYNSYS-Synaptic Systems; National Alliance for Research in Schizophrenia and Depression(NARSAD); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Durbin for providing genotype data from the 173 individuals who constitute the sub-isolate population sample, C. Sabatti for helpful suggestions, and B. Laggerbauer and A. Hirmer for critically reading the manuscript. This work was supported by The Wellcome Trust (grant numbers WT089062 and WT098051 to A.P.), the Academy of Finland (project grants 200923 and 251704 to A. P., 136635 to V.S., 128504 to W.H., and 132071 to M.I.), the Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers 213506 and 129680 to A.P. and J. K.), the EuroHead project (LSM-CT-2004-504837), the European Community's Seventh Framework Programme (FP7/2007-2013), the ENGAGE Consortium (grant agreement HEALTH-F4-2007-201413), EU/SYNSYS-Synaptic Systems (grant number 242167 to A.P.), the National Alliance for Research in Schizophrenia and Depression, Sigrid Juselius Foundation (to J. L. and A. P.), the Biomedicum Helsinki Foundation (to O.P.H.P.), the Jalmari and Rauha Ahokas Foundation (to O.P.H.P.), the Paivikki and Sakari Sohlberg Foundation (to A. P.), the Orion Farmos Research Foundation (to W.H.), grants RL1MH083268 and P30NS062691 from the US National Institutes of Health (to N.B.F.), and grants of the RVZ-network and the DFG (FOR 855) to U.F.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Haukka J, 2001, PSYCHOL MED, V31, P1045, DOI 10.1017/S0033291701004299; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Jaaskelainen A., 2005, INT J OBES LOND, V35, P1289; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jelenkovic A, 2011, AM J HUM BIOL, V23, P764, DOI 10.1002/ajhb.21208; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Palmgren K., 1964, PUBLICATIONS NATL A, VA15; Palotie A, 2013, NEW BIOTECHNOL, V30, P291, DOI 10.1016/j.nbt.2012.11.013; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Perala J, 2008, SCHIZOPHR RES, V106, P337, DOI 10.1016/j.schres.2008.08.017; Pietilainen OPH, 2011, HUM MOL GENET, V20, P2686, DOI 10.1093/hmg/ddr162; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tan TY, 2011, AM J MED GENET A, V155A, P1623, DOI 10.1002/ajmg.a.34051; The Social Insurance Institution of Finland, 2011, OFF STAT FINL 2011; Toulopoulou T, 2010, ARCH GEN PSYCHIAT, V67, P905, DOI 10.1001/archgenpsychiatry.2010.99; Tuulio-Henriksson A, 2004, BRIT J PSYCHIAT, V185, P215, DOI 10.1192/bjp.185.3.215; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yu Michael C, 2011, Mol Biol Int, V2011, P163827, DOI 10.4061/2011/163827	61	109	110	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1228	U99		10.1038/nn.3484	http://dx.doi.org/10.1038/nn.3484			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912948	Green Accepted, Green Submitted			2022-12-25	WOS:000323597500014
J	de Wit, J; O'Sullivan, ML; Savas, JN; Condomitti, G; Caccese, MC; Vennekens, KM; Yates, JR; Ghosh, A				de Wit, Joris; O'Sullivan, Matthew L.; Savas, Jeffrey N.; Condomitti, Giuseppe; Caccese, Max C.; Vennekens, Kristel M.; Yates, John R., III; Ghosh, Anirvan			Unbiased Discovery of Glypican as a Receptor for LRRTM4 in Regulating Excitatory Synapse Development	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; NERVOUS-SYSTEM; ADHESION MOLECULES; DENDRITIC SPINES; EXPRESSION; AMPA; PROTEINS; FAMILY; LIGAND; AXONS	Leucine-rich repeat (LRR) proteins have recently been identified as important regulators of synapse development and function, but for many LRR proteins the ligand-receptor interactions are not known. Here we identify the heparan sulfate (HS) proteoglycan glypican as a receptor for LRRTM4 using an unbiased proteomics-based approach. Glypican binds LRRTM4, but not LRRTM2, in an HS-dependent manner. Glypican 4 (GPC4) and LRRTM4 localize to the pre- and postsynaptic membranes of excitatory synapses, respectively. Consistent with a trans-synaptic interaction, LRRTM4 triggers GPC4 clustering in contacting axons and GPC4 induces clustering of LRRTM4 in contacting dendrites in an HS-dependent manner. LRRTM4 positively regulates excitatory synapse development in cultured neurons and in vivo, and the synaptogenic activity of LRRTM4 requires the presence of HS on the neuronal surface. Our results identify glypican as an LRRTM4 receptor and indicate that a trans-synaptic glypican-LRRTM4 interaction regulates excitatory synapse development.	[de Wit, Joris; O'Sullivan, Matthew L.; Caccese, Max C.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Ghosh, Anirvan] F Hoffmann La Roche, Neurosci Discovery, CH-4070 Basel, Switzerland; [de Wit, Joris; Condomitti, Giuseppe; Vennekens, Kristel M.] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [de Wit, Joris; Condomitti, Giuseppe; Vennekens, Kristel M.] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	University of California System; University of California San Diego; Scripps Research Institute; Roche Holding; Flanders Institute for Biotechnology (VIB); KU Leuven	de Wit, J (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.	joris.dewit@cme.vib-kuleuven.be; anirvan.ghosh@roche.com		de Wit, Joris/0000-0003-1120-1089; Condomitti, Giuseppe/0000-0003-1374-1038; O'Sullivan, Matthew/0000-0003-2201-0106	NARSAD Young Investigator Award from the Brain and Behavior Research Foundation; ERC Starting Grant [311083]; FWO Odysseus Grant; National Institute on Aging NRSA Fellowship [1F32AG039127]; NIH grants [P41 GM103533, R01 MH067880, R01 NS064124, NS067216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064124, R01NS067216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	NARSAD Young Investigator Award from the Brain and Behavior Research Foundation(NARSAD); ERC Starting Grant; FWO Odysseus Grant(FWO); National Institute on Aging NRSA Fellowship; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Ghosh laboratory for discussion and Laura DeNardo, Emily Sylwestrak, and Guido David for critical reading of the manuscript. We thank Katie Tiglio, Christine Wu, Christopher Sanchez, Merve Oney, Joseph Antonios, Tev Stachniak, and Stefanie Otto for help with in situ hybridizations, recombinant protein, and virus production and Stephane Baudouin (Scheiffele laboratory, Biozentrum, University of Basel) for advice on immunohistochemistry. The LRRTM4 monoclonal antibody N205B/22 was developed with the UC Davis/NIH NeuroMab Facility. Mono- and disaccharide analysis of GPC4-Fc was performed by the UCSD Glycotechnology Core. This work was supported by a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation, an ERC Starting Grant (311083) and FWO Odysseus Grant (J.d.W.), National Institute on Aging NRSA Fellowship 1F32AG039127 (J.N.S.), and NIH grants P41 GM103533, R01 MH067880 (J.R.Y.), and R01 NS064124 and NS067216 (A.G.).	Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Calboli FCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011504; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dani N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003031; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; de Wit J, 2007, ADV EXP MED BIOL, V600, P73; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ivins JK, 1997, DEV BIOL, V184, P320, DOI 10.1006/dbio.1997.8532; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; LITWACK ED, 1994, J NEUROSCI, V14, P3713; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Siebertz B, 1999, BIOCHEM J, V344, P937, DOI 10.1042/0264-6021:3440937; STIPP CS, 1994, J CELL BIOL, V124, P149, DOI 10.1083/jcb.124.1.149; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459	51	102	102	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 21	2013	79	4					696	711		10.1016/j.neuron.2013.06.049	http://dx.doi.org/10.1016/j.neuron.2013.06.049			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23911103	Green Accepted, Bronze			2022-12-25	WOS:000323587000010
J	Lopour, BA; Tavassoli, A; Fried, I; Ringach, DL				Lopour, Beth A.; Tavassoli, Abtine; Fried, Itzhak; Ringach, Dario L.			Coding of Information in the Phase of Local Field Potentials within Human Medial Temporal Lobe	NEURON			English	Article							HUMAN NEOCORTICAL OSCILLATIONS; MEMORY; CORTEX; PARAHIPPOCAMPAL; MECHANISMS; RESPONSES; DYNAMICS; OBJECT; SYNCHRONIZATION; ATTENTION	There is increasing evidence that the phase of ongoing oscillations plays a role in neural coding, but its relative importance throughout the brain has yet to be understood. We assessed single-trial phase coding in four temporal lobe and four frontal lobe regions of the human brain using local field potentials (LFPs) recorded during a card-matching task. In the temporal lobe, classification of correct/incorrect matches based on LFP phase was significantly better than classification based on amplitude and comparable to the full LFP signal. Surprisingly, in these regions, the correct/incorrect mean phases became aligned to one another before they diverged and coded for trial outcome. Neural responses in the amygdala were consistent with a mechanism of phase resetting, while parahippocampal gyrus activity was indicative of evoked potentials. These findings highlight the importance of phase coding in human medial temporal lobe and suggest that different brain regions may represent information in diverse ways.	[Lopour, Beth A.; Tavassoli, Abtine; Ringach, Dario L.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Fried, Itzhak] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lopour, BA (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	bethlopour@ucla.edu	Tavassoli, Abtine/S-3560-2019		National Institutes of Health [NS033221]; University of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084017, R01NS033221, T32NS058280, R56NS033221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Eric Behnke and Tony Fields for technical assistance and Nanthia Suthana for electrode localizations. This work was supported by a grant from the National Institutes of Health (NS033221) as well as a University of California President's Postdoctoral Fellowship (awarded to B.A.L.).	Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Bellgowan PSF, 2009, LEARN MEMORY, V16, P433, DOI 10.1101/lm.1357309; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Donoho D., 2005, WAVELAB VERSION 850; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fell J, 2008, NEUROIMAGE, V43, P410, DOI 10.1016/j.neuroimage.2008.07.021; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kreiman G., 2004, Physics of Life Reviews, V1, P71, DOI 10.1016/j.plrev.2004.06.001; Krieg J, 2011, NEUROIMAGE, V55, P67, DOI 10.1016/j.neuroimage.2010.11.058; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Malkova L, 2003, J NEUROSCI, V23, P1956; Miller KJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00197; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Ng BSW, 2013, CEREB CORTEX, V23, P389, DOI 10.1093/cercor/bhs031; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rousselet GA, 2007, NEUROIMAGE, V36, P843, DOI 10.1016/j.neuroimage.2007.02.052; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schiff SJ, 2005, NEUROINFORMATICS, V3, P315, DOI 10.1385/NI:3:4:315; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; Tsunada J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00217; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x; Zaveri HP, 2006, CLIN NEUROPHYSIOL, V117, P2102, DOI 10.1016/j.clinph.2006.05.032	38	29	29	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					594	606		10.1016/j.neuron.2013.06.001	http://dx.doi.org/10.1016/j.neuron.2013.06.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23932002	Bronze, Green Accepted			2022-12-25	WOS:000323085100018
J	Wilson, NH; Stoeckli, ET				Wilson, Nicole H.; Stoeckli, Esther T.			Sonic Hedgehog Regulates Its Own Receptor on Postcrossing Commissural Axons in a Glypican1-Dependent Manner	NEURON			English	Article							HEPARAN-SULFATE; SPINAL-CORD; DALLY-LIKE; NEURAL DEVELOPMENT; SIGNALING PATHWAY; GUIDANCE; MIDLINE; PROTEIN; GLYPICAN; SWITCH	Upon reaching their intermediate target, the floor-plate, commissural axons acquire responsiveness to repulsive guidance cues, allowing the axons to exit the midline and adopt a contralateral, longitudinal trajectory. The molecular mechanisms that regulate this switch from attraction to repulsion remain poorly defined. Here, we show that the heparan sulfate proteoglycan Glypican1 (GPC1) is required as a coreceptor for the Shh-dependent induction of Hedgehog-interacting protein (Hhip) in commissural neurons. In turn, Hhip is required for postcrossing axons to respond to a repulsive anteroposterior Shh gradient. Thus, Shh is a cue with dual function. In precrossing axons it acts as an attractive guidance molecule in a transcription-independent manner. At the same time, Shh binds to GPC1 to induce the expression of its own receptor, Hhip, which mediates the repulsive response of postcrossing axons to Shh. Our study characterizes a molecular mechanism by which navigating axons switch their responsiveness at intermediate targets.	[Wilson, Nicole H.; Stoeckli, Esther T.] Univ Zurich, Neurosci Ctr Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Stoeckli, ET (corresponding author), Univ Zurich, Neurosci Ctr Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	esther.stoeckli@imls.uzh.ch		Stoeckli, Esther/0000-0002-8485-0648	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Silvia Arber (University of Basel), Avihu Klar (Hebrew University), Cathy Krull (University of Michigan), Andrew McMahon (Harvard University), and James Briscoe (NIMR) for constructs. We thank Irwin Andermatt for input, discussion, and his critical reading of the manuscript. This work was supported by a grant from the Swiss National Science Foundation (to E.S.).	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Barik Sailen, 2002, Methods Mol Biol, V192, P189, DOI 10.1385/1-59259-177-9:189; Beckett K, 2008, TRENDS CELL BIOL, V18, P360, DOI 10.1016/j.tcb.2008.06.001; Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Domanitskaya E, 2010, J NEUROSCI, V30, P11167, DOI 10.1523/JNEUROSCI.1488-10.2010; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Joset P, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-22; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mauti O, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-32; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; Niederkofler V, 2010, DEVELOPMENT, V137, P427, DOI 10.1242/dev.042515; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Parra LM, 2010, NAT NEUROSCI, V13, P29, DOI 10.1038/nn.2457; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Rikin A., 2010, J VIS EXP, V42, pe2020; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Smart AD, 2011, DEV NEUROBIOL, V71, P608, DOI 10.1002/dneu.20854; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Wilson NH, 2012, JOVE-J VIS EXP, DOI 10.3791/4384; Wilson NH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr628; Yam PT, 2012, NEURON, V76, P735, DOI 10.1016/j.neuron.2012.09.017; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	53	58	58	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 7	2013	79	3					478	491		10.1016/j.neuron.2013.05.025	http://dx.doi.org/10.1016/j.neuron.2013.05.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23931997	Green Accepted, Bronze			2022-12-25	WOS:000323085100009
J	Zhao, XL; Tang, ZX; Zhang, HK; Atianjoh, FE; Zhao, JY; Liang, LL; Wang, W; Guan, XW; Kao, SC; Tiwari, V; Gao, YJ; Hoffman, PN; Cui, HM; Li, M; Dong, XZ; Tao, YX				Zhao, Xiuli; Tang, Zongxiang; Zhang, Hongkang; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Gao, Yong-Jing; Hoffman, Paul N.; Cui, Hengmi; Li, Min; Dong, Xinzhong; Tao, Yuan-Xiang			A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; ALPHA-GENE EXPRESSION; POTASSIUM CHANNELS; DOWN-REGULATION; MESSENGER-RNA; NERVE INJURY; DORSAL-HORN; RAT; CONDUCTANCE	Neuropathic pain is a refractory disease characterized by maladaptive changes in gene transcription and translation in the sensory pathway. Long noncoding RNAs (lncRNAs) are emerging as new players in gene regulation, but how lncRNAs operate in the development of neuropathic pain is unclear. Here we identify a conserved lncRNA, named Kcna2 antisense RNA, for a voltage-dependent potassium channel mRNA, Kcna2, in first-order sensory neurons of rat dorsal root ganglion (DRG). Peripheral nerve injury increased Kcna2 antisense RNA expression in injured DRG through activation of myeloid zinc finger protein 1, a transcription factor that binds to the Kcna2 antisense RNA gene promoter. Mimicking this increase downregulated Kcna2, reduced total voltage-gated potassium current, increased excitability in DRG neurons and produced neuropathic pain symptoms. Blocking this increase reversed nerve injury-induced downregulation of DRG Kcna2 and attenuated development and maintenance of neuropathic pain. These findings suggest endogenous Kcna2 antisense RNA as a therapeutic target for the treatment of neuropathic pain.	[Zhao, Xiuli; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Tao, Yuan-Xiang] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Tang, Zongxiang] Nanjing Univ Chinese Med, Coll Basic Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongkang; Li, Min; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Yong-Jing] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Inst Naut Med, Nantong, Peoples R China; [Hoffman, Paul N.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cui, Hengmi] Yangzhou Univ, Biomed Innovat Inst, Yangzhou, Peoples R China; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Nanjing University of Chinese Medicine; Johns Hopkins University; Nantong University; Johns Hopkins University; Yangzhou University; Howard Hughes Medical Institute; Johns Hopkins University	Tao, YX (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	ytao1@jhmi.edu	Core, Vector/CAF-4832-2022; TIWARI, VINOD K/L-9595-2019; Gao, Yong-Jing/E-6939-2015	TIWARI, VINOD K/0000-0001-9244-8889; Gao, Yong-Jing/0000-0002-7432-7458; Tiwari, Vinod/0000-0002-8491-2255; Zhao, Jian-Yuan/0000-0001-9861-0330	Howard Hughes Medical Institute; US National Institutes of Health (NIH) [NS054791, GM087369]; NIH [MH084691, GM078579, DA033390, NS072206]; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791, R01NS094664, R01NS072206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033390] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R.J. Samulski (University of North Carolina) for the rAAV5 plasmid, J. Zhou (Institute of Biochemistry of Cell Biology, Chinese Academy of Sciences) for the full-length EGFP-MZF1 plasmid and D.Y.H. Tuan (Georgia Health Sciences University) for MZF1 antibody. We thank C. F. Levine for editorial assistance. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health (NIH) grants (NS054791 and GM087369) to X. D., by NIH grants (MH084691 and GM078579) to M. L. and by NIH grants (DA033390, NS072206) and the grants from the Rita Allen Foundation to Y.-X.T.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Cardenas CG, 1999, J PHYSIOL-LONDON, V518, P507, DOI 10.1111/j.1469-7793.1999.0507p.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; CHABAL C, 1989, PAIN, V36, P321, DOI 10.1016/0304-3959(89)90091-2; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Chung Jin Mo, 2002, Pain Pract, V2, P87, DOI 10.1046/j.1533-2500.2002.02011.x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DEVOR M, 1983, NEUROSCI LETT, V40, P181, DOI 10.1016/0304-3940(83)90299-9; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dodson PD, 2002, J NEUROSCI, V22, P6953; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; Everill B, 2000, NEUROSCIENCE, V100, P417, DOI 10.1016/S0306-4522(00)00263-3; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; Gallagher PE, 2001, METH MOLEC MED, V51, P205, DOI 10.1385/1-59259-087-X:205; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guan XW, 2009, N-S ARCH PHARMACOL, V380, P459, DOI 10.1007/s00210-009-0451-7; Han PJ, 2004, EXP NEUROL, V189, P293, DOI 10.1016/j.expneurol.2004.03.010; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Kim YI, 1998, NEUROSCIENCE, V86, P301, DOI 10.1016/S0306-4522(98)00022-0; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liang LL, 2013, J PAIN, V14, P638, DOI 10.1016/j.jpain.2013.01.778; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Nehme B, 2011, J NEUROSCI METH, V196, P281, DOI 10.1016/j.jneumeth.2011.01.018; Nicol GD, 1997, J NEUROPHYSIOL, V77, P167, DOI 10.1152/jn.1997.77.1.167; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Park SY, 2003, MOL CELLS, V16, P256; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Tal M, 1999, BRAIN RES, V824, P218, DOI 10.1016/S0006-8993(99)01190-7; TARG EF, 1986, BRAIN RES, V363, P1, DOI 10.1016/0006-8993(86)90652-9; Vacher H, 2011, PFLUG ARCH EUR J PHY, V462, P631, DOI 10.1007/s00424-011-1004-8; Visan V, 2004, MOL PHARMACOL, V66, P1103, DOI 10.1124/mol.104.002774; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Weissner W, 2006, J COMP NEUROL, V497, P78, DOI 10.1002/cne.20981; Xu JT, 2010, BRAIN RES, V1336, P46, DOI 10.1016/j.brainres.2010.04.010; Xu Y, 2003, P NATL ACAD SCI USA, V100, P6204, DOI 10.1073/pnas.0930324100; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zheng Q, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-24	52	243	256	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1024	U76		10.1038/nn.3438	http://dx.doi.org/10.1038/nn.3438			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792947	Green Accepted			2022-12-25	WOS:000322323000012
J	Kishimoto, N; Asakawa, K; Madelaine, R; Blader, P; Kawakami, K; Sawamoto, K				Kishimoto, Norihito; Asakawa, Kazuhide; Madelaine, Romain; Blader, Patrick; Kawakami, Koichi; Sawamoto, Kazunobu			Interhemispheric asymmetry of olfactory input-dependent neuronal specification in the adult brain	NATURE NEUROSCIENCE			English	Article							GENE TRAP APPROACH; NEURAL STEM-CELLS; ZEBRAFISH; NEUROGENESIS; BULB; RESPONSES; CIRCUITS; NOTCH	The vertebrate brain is anatomically and functionally asymmetric. The left and right cerebral hemispheres harbor neural stem cell niches at the ventricular-subventricular zone (V-SVZ) of the ventricular walls, where new neurons are continuously generated throughout life. However, any interhemispheric asymmetry of neural stem cell niches remains unclear. We performed gene-trap screens in adult zebrafish to identify genes that are differentially expressed in the two hemispheres and found that adult-born neurons expressing the neural zinc-finger protein Myt1 exist predominantly in the left V-SVZ. This lateralization could be reversed by left olfactory sensory deprivation-induced inactivation of Notch signaling. The olfactory behavioral preference for attractive amino acids was also impaired by sensory deprivation of the left olfactory system, but not of the right olfactory system. Our findings suggest that olfactory input generates interhemispheric differences in the fate of adult-born neurons in the zebrafish brain.	[Kishimoto, Norihito; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan; [Asakawa, Kazuhide; Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Div Mol & Dev Biol, Natl Inst Genet, Mishima, Shizuoka, Japan; [Asakawa, Kazuhide; Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Madelaine, Romain; Blader, Patrick] Univ Toulouse, UPS, Ctr Biol Dev, Toulouse, France; [Madelaine, Romain; Blader, Patrick] Ctr Dev Biol, CNRS, UMR 5547, Toulouse, France	Nagoya City University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sawamoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan.	sawamoto@med.nagoya-cu.ac.jp	Kawakami, Koichi/AAF-1380-2019; Asakawa, Kazuhide/ABD-2065-2020	Asakawa, Kazuhide/0000-0003-0628-1176; Blader, Patrick/0000-0003-3299-6108; Sawamoto, Kazunobu/0000-0003-1984-5129	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science [LS104]; National BioResource Project; Ministry of Education, Culture, Sports, Science and Technology [20509005, 23241063]	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science; National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Seki (Tokyo Medical University) for the antibody to PSA-NCAM, U. Strahle (Karlsruhe Institute of Technology) for the Tg(neurog1:gfp) fish, A. Alvarez-Buylla and Y. Yoshihara for helpful comments on the manuscript, and members of the Sawamoto laboratory for discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (LS104 to K.S.), the National BioResource Project (K.K.), a Grant-in-Aid for Scientific Research (C) (20509005 to N.K.) and a Grant-in-Aid for Scientific Research (A) (23241063 to K.K.) from the Ministry of Education, Culture, Sports, Science and Technology.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Byrd CA, 2000, BRAIN RES, V866, P92, DOI 10.1016/S0006-8993(00)02252-6; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kishimoto N, 2011, J COMP NEUROL, V519, P3549, DOI 10.1002/cne.22722; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; Liang JO, 2000, DEVELOPMENT, V127, P5101; Lindsay SM, 2004, CHEM SENSES, V29, P93, DOI 10.1093/chemse/bjh009; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Roussigne M, 2009, DEVELOPMENT, V136, P1549, DOI 10.1242/dev.034793; Scheer N, 2001, DEVELOPMENT, V128, P1099; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Westerfield M, 1995, ZEBRAFISH BOOK	25	11	11	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					884	U139		10.1038/nn.3409	http://dx.doi.org/10.1038/nn.3409			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685722				2022-12-25	WOS:000321180900021
J	Wentzel, C; Sommer, JE; Nair, R; Stiefvater, A; Sibarita, JB; Scheiffele, P				Wentzel, Corinna; Sommer, Julia E.; Nair, Ramya; Stiefvater, Adeline; Sibarita, Jean-Baptiste; Scheiffele, Peter			mSYD1A, a Mammalian Synapse-Defective-1 Protein, Regulates Synaptogenic Signaling and Vesicle Docking	NEURON			English	Article							LIPRIN-ALPHA FAMILY; ACTIVE ZONE; MOLECULAR-MECHANISMS; PTP-SIGMA; EXPRESSION; RECEPTOR; DYNAMICS; SYD-1; LOCALIZATION; MEMBRANE	Structure and function of presynaptic terminals are critical for the transmission and processing of neuronal signals. Trans-synaptic signaling systems instruct the differentiation and function of presynaptic release sites, but their downstream mediators are only beginning to be understood. Here, we identify the intracellular mSYD1A (mouse Synapse-Defective-1A) as a regulator of presynaptic function in mice. mSYD1A forms a complex with presynaptic receptor tyrosine phosphatases and controls tethering of synaptic vesicles at synapses. mSYD1A function relies on an intrinsically disordered domain that interacts with multiple structurally unrelated binding partners, including the active zone protein liprin-alpha 2 and nsec1/munc18-1. In mSYD1A knockout mice, synapses assemble in normal numbers but there is a significant reduction in synaptic vesicle docking at the active zone and an impairment of synaptic transmission. Thus, mSYD1A is a regulator of presynaptic release sites at central synapses.	[Wentzel, Corinna; Sommer, Julia E.; Nair, Ramya; Stiefvater, Adeline; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Sibarita, Jean-Baptiste] Univ Bordeaux, Interdisciplinary Inst Neurosci, F-33400 Bordeaux, France; [Sibarita, Jean-Baptiste] CNRS, UMR 5297, F-33000 Bordeaux, France	University of Basel; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch		Sibarita, Jean-Baptiste/0000-0002-9920-7700; Scheiffele, Peter/0000-0002-9516-9399	Werner-Siemens Foundation; Boehringer Ingelheim Fund; Swiss National Science Foundation; F. Hoffmann La Roche; National Institute on Drug Abuse; Kanton Basel-Stadt; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020844] Funding Source: NIH RePORTER	Werner-Siemens Foundation; Boehringer Ingelheim Fund(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); F. Hoffmann La Roche(Hoffmann-La Roche); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Kanton Basel-Stadt; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Yves Barde, Casper Hoogenraad, Eunjoon Kim, Thi-Minh Nguyen, Olivier Pertz, Susanne Schoch, Dietmar Schreiner, Tim Sharpe, Stephan Sigrist, Matthijs Verhage, and Mingjie Zhang for valuable reagents and advice. We thank Ursula Sauder and the Zentrum fur Mikroskopie for excellent support with the electron microscopy and Daniela Klewe-Nebenius and the Transgenic Mouse Core Facility for help in generating the mSYD1A<SUP>KO</SUP> mice. This work was supported by a fellowship from the Werner-Siemens Foundation to C.W., an award from the Boehringer Ingelheim Fund to J.E.S., funds to P.S. from the Swiss National Science Foundation, F. Hoffmann La Roche, the National Institute on Drug Abuse, and the Kanton Basel-Stadt.	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheadle L, 2012, J CELL BIOL, V199, P985, DOI 10.1083/jcb.201205041; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Johnson EL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000193; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Owald D, 2012, NAT NEUROSCI, V15, P1219, DOI 10.1038/nn.3183; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spangler SA, 2011, J COMP NEUROL, V519, P3040, DOI 10.1002/cne.22665; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370; Zurner M, 2011, J COMP NEUROL, V519, P3019, DOI 10.1002/cne.22664; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	52	34	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1012	1023		10.1016/j.neuron.2013.05.010	http://dx.doi.org/10.1016/j.neuron.2013.05.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791195	Green Accepted, Bronze			2022-12-25	WOS:000321026900008
J	Yin, DM; Chen, YJ; Lu, YS; Bean, JC; Sathyamurthy, A; Shen, CY; Liu, XH; Lin, TW; Smith, CA; Xiong, WC; Mei, L				Yin, Dong-Min; Chen, Yong-Jun; Lu, Yi-Sheng; Bean, Jonathan C.; Sathyamurthy, Anupama; Shen, Chengyong; Liu, Xihui; Lin, Thiri W.; Smith, Clifford A.; Xiong, Wen-Cheng; Mei, Lin			Reversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1	NEURON			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LIM-KINASE 1; LONG-TERM POTENTIATION; SUBUNIT MESSENGER-RNA; GABAERGIC INTERNEURONS; COMMON VARIANTS; MUTANT MICE; SCHIZOPHRENIA; EXPRESSION; ERBB4	Neuregulin 1 (Nrg1) is a susceptibility gene of schizophrenia, a disabling mental illness that affects 1 % of the general population. Here, we show that ctoNrg1 mice, which mimic high levels of NRG1 observed in forebrain regions of schizophrenic patients, exhibit behavioral deficits and hypofunction of glutamatergic and GABAergic pathways. Intriguingly, these deficits were diminished when NRG1 expression returned to normal in adult mice, suggesting that damage which occurred during development is recoverable. Conversely, increase of NRG1 in adulthood was sufficient to cause glutamatergic impairment and behavioral deficits. We found that the glutamatergic impairment by NRG1 overexpression required LIM domain kinase 1 (LIMK1), which was activated in mutant mice, identifying a pathological mechanism. These observations demonstrate that synaptic dysfunction and behavioral deficits in ctoNrg1 mice require continuous NRG1 abnormality in adulthood, suggesting that relevant schizophrenia may benefit from therapeutic intervention to restore NRG1 signaling.	[Yin, Dong-Min; Chen, Yong-Jun; Lu, Yi-Sheng; Bean, Jonathan C.; Sathyamurthy, Anupama; Shen, Chengyong; Liu, Xihui; Lin, Thiri W.; Smith, Clifford A.; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Xiong, Wen-Cheng; Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA 30901 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mei, L (corresponding author), Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	lmei@gru.edu	Liu, Xihui/H-1960-2012	Liu, Xihui/0000-0002-9716-1032; Bean, Jonathan/0000-0002-8007-2383	NARSAD; National Institute of Mental Health, NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH083563, R01MH083317] Funding Source: NIH RePORTER	NARSAD(NARSAD); National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported in part by grants from NARSAD and National Institute of Mental Health, NIH. L.M. is a NARSAD Distinguished Investigator. D.-M.Y. and Y.-S.L. are NARSAD Young Investigators. We are grateful to Dr. Douglas Falls for original NRG1 constructs, Dr. Joe Tsien for the pMM400 plasmid, Dr. Richard Huganir for antibodies against GluR1, GluR2/3, NR2A, and NR2B, and Dr. Cary Lai for the anti-ErbB4 antibody. We thank Dr. Kathleen Yee and Dr. Martin Gassmann for providing ErbB4 null mutant mice, Dr. Alvin Terry and Dr. Patrick Callahan of the Small Animal Behavioral Core at GRU for assistance in behavioral analysis, and Dr. Alexis Stranaha for advice and assistance in stereology analysis.	Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Beneyto M, 2011, CEREB CORTEX, V21, P999, DOI 10.1093/cercor/bhq169; Bertram I, 2007, ANN NY ACAD SCI, V1096, P147, DOI 10.1196/annals.1397.080; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Cahill ME, 2012, MOL PSYCHIATR, V17, P99, DOI 10.1038/mp.2011.35; Chang Q, 2006, J NEUROSCI, V26, P11295, DOI 10.1523/JNEUROSCI.1794-06.2006; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Deakin IH, 2012, CEREB CORTEX, V22, P1520, DOI 10.1093/cercor/bhr223; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Glausier JR, 2011, NEUROPSYCHOPHARMACOL, V36, P2103, DOI 10.1038/npp.2011.102; Gonzalez-Islas C, 2009, J NEUROPHYSIOL, V101, P507, DOI 10.1152/jn.90986.2008; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hodges H, 1996, COGNITIVE BRAIN RES, V3, P167, DOI 10.1016/0926-6410(96)00004-3; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014185; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murray CJ, 1996, GLOBAL BURDEN DIS; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Parlapani E, 2010, WORLD J BIOL PSYCHIA, V11, P243, DOI 10.3109/15622970802022376; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; Rimer M, 2005, NEUROREPORT, V16, P271, DOI 10.1097/00001756-200502280-00014; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SNYDER SH, 1973, AM J PSYCHIAT, V130, P61, DOI 10.1176/ajp.130.1.61; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stranahan AM, 2012, J COMP NEUROL, V520, P1318, DOI 10.1002/cne.22790; Tan GH, 2012, NAT NEUROSCI, V15, P258, DOI 10.1038/nn.3005; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Wang JY, 1998, J BIOL CHEM, V273, P20525, DOI 10.1074/jbc.273.32.20525; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Weickert CS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.25; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yildirim M, 2008, NEUROSCIENCE, V152, P360, DOI 10.1016/j.neuroscience.2008.01.004; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	77	95	100	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					644	657		10.1016/j.neuron.2013.03.028	http://dx.doi.org/10.1016/j.neuron.2013.03.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719163	Green Accepted, Bronze			2022-12-25	WOS:000319491200009
J	Bardehle, S; Kruger, M; Buggenthin, F; Schwausch, J; Ninkovic, J; Clevers, H; Snippert, HJ; Theis, FJ; Meyer-Luehmann, M; Bechmann, I; Dimou, L; Gotz, M				Bardehle, Sophia; Krueger, Martin; Buggenthin, Felix; Schwausch, Julia; Ninkovic, Jovica; Clevers, Hans; Snippert, Hugo J.; Theis, Fabian J.; Meyer-Luehmann, Melanie; Bechmann, Ingo; Dimou, Leda; Goetz, Magdalena			Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation	NATURE NEUROSCIENCE			English	Article							IN-VITRO; MOUSE MODEL; RHO-GTPASE; GLIA; CELLS; CDC42; TOOL; REGENERATION; EXPRESSION; DELETION	Astrocytes are thought to have important roles after brain injury, but their behavior has largely been inferred from postmortem analysis. To examine the mechanisms that recruit astrocytes to sites of injury, we used in vivo two-photon laser-scanning microscopy to follow the response of GFP-labeled astrocytes in the adult mouse cerebral cortex over several weeks after acute injury. Live imaging revealed a marked heterogeneity in the reaction of individual astrocytes, with one subset retaining their initial morphology, another directing their processes toward the lesion, and a distinct subset located at juxtavascular sites proliferating. Although no astrocytes actively migrated toward the injury site, selective proliferation of juxtavascular astrocytes was observed after the introduction of a lesion and was still the case, even though the extent was reduced, after astrocyte-specific deletion of the RhoGTPase Cdc42. Thus, astrocyte recruitment after injury relies solely on proliferation in a specific niche.	[Bardehle, Sophia; Dimou, Leda; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Bardehle, Sophia; Schwausch, Julia; Ninkovic, Jovica; Dimou, Leda; Goetz, Magdalena] Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany; [Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Buggenthin, Felix; Theis, Fabian J.] Helmholtz Zentrum Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Buggenthin, Felix; Theis, Fabian J.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany; [Clevers, Hans; Snippert, Hugo J.] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Connecticut Utrecht, Netherlands; [Clevers, Hans; Snippert, Hugo J.] Univ Med Ctr Utrecht, Connecticut Utrecht, Netherlands; [Meyer-Luehmann, Melanie] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Neuroctr, Freiburg, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Munich; University of Freiburg; University of Munich	Gotz, M (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Ninkovic, Jovica/AAH-5220-2019; Dimou, Leda/E-7968-2012; Theis, Fabian J/ABD-5212-2021	Ninkovic, Jovica/0000-0002-4381-0041; Theis, Fabian J/0000-0002-2419-1943; Meyer-Luehmann, Melanie/0000-0003-3661-2220	DFG (German Research foundation) [SFB 870, SPP1356, DFG-FOR 1336]; BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG [ME 3542/1-1]; European Research Council; Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	DFG (German Research foundation)(German Research Foundation (DFG)); BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	We are indebted to C. Brakebusch for the Cdc42<SUP>loxP/loxP</SUP> mice, S. Robel for initial help in setting up the two-photon live-imaging procedure, and C. Straube and S. Falkner for sharing their imaging expertise. We would also like to thank R. Waberer, C. Meyer, D. Franzen, I. Muhlhahn and G. Jager for technical assistance, and M. Hubener, D.E. Bergles, J. McCarter and P. Hardy for critical comments on the manuscript. We thank the DFG (German Research foundation) whose support (particularly via the Leibniz Prize and SFB 870) allowed us to invest into this new experimental area and for funding M.G. and F.J.T. by SPP1356 and I.B. by DFG-FOR 1336. In addition, this work was supported by the BMBF (Ministry of Science and Education) to M.G. and F.J.T., the Helmholtz Association (Helmholtz Alliance ICEMED to M.G., I.B. and F.J.T.; Helmholtz Alliance on Systems Biology to M.G. and F.J.T.), the Emmy Noether Program of the DFG (ME 3542/1-1 to M.M.-L.), the European Research Council (starting grant 'LatentCauses' to F.J.T.) and Munich Cluster for Systems Neurology. The Initial Training Network Edu-GLIA (PITN-GA-2009-237956) funded by the European Commission under the Seventh Framework Program (FP7) provided a wonderful discussion platform for glial research.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Fuchs S, 2009, CELL STEM CELL, V4, P236, DOI 10.1016/j.stem.2009.01.017; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S., 2013, CELL STEM C IN PRESS; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	46	261	266	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					580	+		10.1038/nn.3371	http://dx.doi.org/10.1038/nn.3371			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542688				2022-12-25	WOS:000318029300014
J	Li, PC; Zhu, SD; Chen, M; Han, C; Xu, HR; Hu, JM; Fang, Y; Lu, HDD				Li, Peichao; Zhu, Shude; Chen, Ming; Han, Chao; Xu, Haoran; Hu, Jiaming; Fang, Yang; Lu, Haidong D.			A Motion Direction Preference Map in Monkey V4	NEURON			English	Article							VISUAL AREA MT; KINETICALLY DEFINED BOUNDARIES; INFERIOR TEMPORAL NEURONS; MACAQUE MONKEY; FUNCTIONAL-ORGANIZATION; STRIATE CORTEX; EXTRASTRIATE CORTEX; SELECTIVE NEURONS; SHAPE SELECTIVITY; RECEPTIVE-FIELDS	In the primate visual system, area V4 is located in the ventral pathway and is traditionally thought to be involved in processing color and form information. However, little is known about its functional role in processing motion information. Using intrinsic signal optical imaging over large fields of view in V1, V2, and V4, we mapped the direction of motion responses in anesthetized macaques. We found that V4 contains direction-preferring domains that are preferentially activated by stimuli moving in one direction. These direction-preferring domains normally occupy several restricted regions of V4 and tend to overlap with orientation- and color-preferring domains. Single-cell recordings targeting these direction-preferring domains also showed a clustering, as well as a columnar organization of V4 direction-selective neurons. These data suggest that, in contrast to the classical view, motion information is also processed in ventral pathway regions such as area V4.	[Li, Peichao; Zhu, Shude; Chen, Ming; Han, Chao; Xu, Haoran; Hu, Jiaming; Fang, Yang; Lu, Haidong D.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Peichao; Zhu, Shude; Chen, Ming; Han, Chao; Xu, Haoran; Hu, Jiaming; Fang, Yang; Lu, Haidong D.] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lu, HDD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	haidong@ion.ac.cn		Li, Peichao/0000-0001-5761-9435; Han, Chao/0000-0003-3923-8537	National Basic Research Program in China (973 Program) [2011CBA00400]; Chinese Academy of Sciences	National Basic Research Program in China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Dr. Anna W. Roe for valuable comments. We also thank Jingwei Pan, Junjie Cai, Cheng Xu, Zhongchao Tan, and Jie Lu for technical assistance. This work was supported by grants from National Basic Research Program in China (973 Program 2011CBA00400); and the Hundred Talent Program of the Chinese Academy of Sciences.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Bosking WH, 1997, J NEUROSCI, V17, P2112; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2009, P NATL ACAD SCI USA, V106, P18034, DOI 10.1073/pnas.0810943106; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; FERRERA VP, 1994, J NEUROSCI, V14, P2080; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Ferrera VP, 2005, NAT NEUROSCI, V8, P1125, DOI 10.1038/nn0905-1125a; Fisher NI, 1995, STAT ANAL CIRCULAR D; GATTASS R, 1988, J NEUROSCI, V8, P1831; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Handa T, 2010, NEUROREPORT, V21, P532, DOI 10.1097/WNR.0b013e3283393a5f; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Kaskan PM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00023; Kotake Y, 2009, J NEUROPHYSIOL, V102, P15, DOI 10.1152/jn.90624.2008; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Lu HD, 2007, CEREB CORTEX, V17, P2675, DOI 10.1093/cercor/bhl177; Lu HDD, 2010, NEURON, V68, P1002, DOI 10.1016/j.neuron.2010.11.020; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; MARCAR VL, 1995, J NEUROPHYSIOL, V74, P1258, DOI 10.1152/jn.1995.74.3.1258; Marcar VL, 2000, J NEUROPHYSIOL, V84, P2786, DOI 10.1152/jn.2000.84.6.2786; Mardia K., 1972, STAT DIRECTIONAL DAT, V37, DOI 10.2307/2984782; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Mysore SG, 2008, CEREB CORTEX, V18, P1429, DOI 10.1093/cercor/bhm176; Mysore SG, 2006, J NEUROPHYSIOL, V95, P1864, DOI 10.1152/jn.00627.2005; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; ROE AW, 1995, J NEUROSCI, V15, P3689; SARY G, 1995, J NEUROPHYSIOL, V73, P1341, DOI 10.1152/jn.1995.73.4.1341; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Shmuel A, 1996, J NEUROSCI, V16, P6945; Stepniewska I, 2005, CEREB CORTEX, V15, P809, DOI 10.1093/cercor/bhh182; TANAKA M, 1986, EXP BRAIN RES, V65, P11; Tanigawa H, 2010, NAT NEUROSCI, V13, P1542, DOI 10.1038/nn.2676; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Xu XM, 2004, P NATL ACAD SCI USA, V101, P2566, DOI 10.1073/pnas.0308745101; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P71, DOI 10.1016/0166-4328(95)00184-0; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	64	45	46	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2013	78	2					376	388		10.1016/j.neuron.2013.02.024	http://dx.doi.org/10.1016/j.neuron.2013.02.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622068	Bronze			2022-12-25	WOS:000318202200016
J	Kondo, T; Asai, M; Tsukita, K; Kutoku, Y; Ohsawa, Y; Sunada, Y; Imamura, K; Egawa, N; Yahata, N; Okita, K; Takahashi, K; Asaka, I; Aoi, T; Watanabe, A; Watanabe, K; Kadoya, C; Nakano, R; Watanabe, D; Maruyama, K; Hori, O; Hibino, S; Choshi, T; Nakahata, T; Hioki, H; Kaneko, T; Naitoh, M; Yoshikawa, K; Yamawaki, S; Suzuki, S; Hata, R; Ueno, S; Seki, T; Kobayashi, K; Toda, T; Murakami, K; Irie, K; Klein, WL; Mori, H; Asada, T; Takahashi, R; Iwata, N; Yamanaka, S; Inoue, H				Kondo, Takayuki; Asai, Masashi; Tsukita, Kayoko; Kutoku, Yumiko; Ohsawa, Yutaka; Sunada, Yoshihide; Imamura, Keiko; Egawa, Naohiro; Yahata, Naoki; Okita, Keisuke; Takahashi, Kazutoshi; Asaka, Isao; Aoi, Takashi; Watanabe, Akira; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Watanabe, Dai; Maruyama, Kei; Hori, Osamu; Hibino, Satoshi; Choshi, Tominari; Nakahata, Tatsutoshi; Hioki, Hiroyuki; Kaneko, Takeshi; Naitoh, Motoko; Yoshikawa, Katsuhiro; Yamawaki, Satoko; Suzuki, Shigehiko; Hata, Ryuji; Ueno, Shu-ichi; Seki, Tsuneyoshi; Kobayashi, Kazuhiro; Toda, Tatsushi; Murakami, Kazuma; Irie, Kazuhiro; Klein, William L.; Mori, Hiroshi; Asada, Takashi; Takahashi, Ryosuke; Iwata, Nobuhisa; Yamanaka, Shinya; Inoue, Haruhisa			Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular A beta and Differential Drug Responsiveness	CELL STEM CELL			English	Article							OXIDATIVE STRESS; PROTEIN; OLIGOMERS; NEURODEGENERATION; GENERATION; BRAIN	Oligomeric forms of amyloid-beta peptide (A beta) are thought to play a pivotal role in the pathogenesis of Alzheimer's disease (AD), but the mechanism involved is still unclear. Here, we generated induced pluripotent stem cells (iPSCs) from familial and sporadic AD patients and differentiated them into neural cells. A beta oligomers accumulated in iPSC-derived neurons and astrocytes in cells from patients with a familial amyloid precursor protein (APP)-E693 Delta mutation and sporadic AD, leading to endoplasmic reticulum (ER) and oxidative stress. The accumulated A beta oligomers were not proteolytically resistant, and docosahexaenoic acid (DHA) treatment alleviated the stress responses in the AD neural cells. Differential manifestation of ER stress and DHA responsiveness may help explain variable clinical results obtained with the use of DHA treatment and suggests that DHA may in fact be effective for a subset of patients. It also illustrates how patient-specific iPSCs can be useful for analyzing AD pathogenesis and evaluating drugs.	[Kondo, Takayuki; Tsukita, Kayoko; Imamura, Keiko; Egawa, Naohiro; Yahata, Naoki; Okita, Keisuke; Takahashi, Kazutoshi; Asaka, Isao; Aoi, Takashi; Watanabe, Akira; Nakahata, Tatsutoshi; Yamanaka, Shinya; Inoue, Haruhisa] Kyoto Univ, Ctr IPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Kondo, Takayuki; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Med, Dept Biol Sci, Kyoto 6068507, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto 6068507, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto 6068507, Japan; [Naitoh, Motoko; Yoshikawa, Katsuhiro; Yamawaki, Satoko; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan; [Murakami, Kazuma; Irie, Kazuhiro] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068507, Japan; [Kondo, Takayuki; Asai, Masashi; Tsukita, Kayoko; Yahata, Naoki; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Iwata, Nobuhisa; Inoue, Haruhisa] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Inoue, Haruhisa] Japan Sci & Technol Agcy JST, Yamanaka IPS Cell Special Project, Saitama 3320012, Japan; [Asai, Masashi; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Saitama 3500495, Japan; [Asai, Masashi; Watanabe, Kaori; Kadoya, Chie; Nakano, Rie; Iwata, Nobuhisa] Nagasaki Univ, Lab Mol Biol & Biotechnol, Dept Mol Med Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Kutoku, Yumiko; Ohsawa, Yutaka; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Okayama 7010192, Japan; [Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat Biotargeting, Kanazawa, Ishikawa 9208640, Japan; [Hibino, Satoshi; Choshi, Tominari] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan; [Hata, Ryuji] Ehime Univ, Grad Sch Med, Dept Funct Histol, Matsuyama, Ehime 7910295, Japan; [Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Psychiat, Matsuyama, Ehime 7910295, Japan; [Seki, Tsuneyoshi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Mori, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Neurosci, Osaka 5458585, Japan; [Asada, Takashi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Ibaraki 3058577, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Saitama Medical University; Nagasaki University; Kawasaki Medical School; Kanazawa University; Fukuyama University; Ehime University; Ehime University; Kobe University; Northwestern University; Osaka Metropolitan University; University of Tsukuba	Iwata, N (corresponding author), Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan.	iwata-n@nagasaki-u.ac.jp; haruhisa@cira.kyoto-u.ac.jp	Hioki, Hiroyuki/J-9412-2017; Asai, Masashi/AAB-7672-2022; Takahashi, Kazutoshi/ABE-5504-2020; Murakami, Kazuma/GQA-7062-2022; Yoshikawa, Katsuhiro/X-1186-2019; Irie, Kazuhiro/A-6121-2014; Kobayashi, Kazuhiro/AAH-8638-2021	Hioki, Hiroyuki/0000-0002-0152-7854; Asai, Masashi/0000-0001-6392-0910; Takahashi, Kazutoshi/0000-0002-5329-8395; Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568; Kobayashi, Kazuhiro/0000-0001-7801-147X; Okita, Keisuke/0000-0001-5806-1090; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science (JSPS); Alzheimer's Association [IIRG-09-132098]; JST Yamanaka iPS Cell Special Project; CREST; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [22110007]; Japan Research Foundation for Clinical Pharmacology; Grants-in-Aid for Scientific Research [24700367, 24590040, 21248015, 23592093] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association(Alzheimer's Association); JST Yamanaka iPS Cell Special Project(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Foundation for Clinical Pharmacology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to express our sincere gratitude to all our coworkers and collaborators, Mari Ohnuki, Megumi Kumazaki, Mitsuyo Kawada, Fumihiko Adachi, Takako Enami, and Misato Funayama for technical assistance; Nobuya Inagaki and Norio Harada for technical advice; and Kazumi Murai for editing the manuscript. This research was funded in part by a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS) to S.Y., from the Alzheimer's Association (IIRG-09-132098) to H. M., from the JST Yamanaka iPS Cell Special Project to S.Y. and H. I., from CREST to H. I., H. M., N.I., and T. T., from a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan to H. I., from a Grant-in-Aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" (22110007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H. I. and N.I., and from the Japan Research Foundation for Clinical Pharmacology to H. I. H. I. conceived the project; T. K., N.I., M. A., and H. I. designed the experiments; T. K., N.I., M. A., K. W., C. K., R.N., N.E., N.Y. and K. Tsukita performed the experiments; T. K., N.I., M. A., and H. I. analyzed the data; K.O., I. A., K. M., T.N., K. I., W. L. K., O.H., S. H., and T. C. contributed reagents, materials and analysis tools; Y.K., Y.O., Y.S., M.N., K.Y., S.Y., S. S., T. A., R. H., and S. U. recruited the patients; R. T., H. M., and S.Y. provided critical reading and scientific discussions; T. S., K. K., T. T., and K. Takahashi performed microarray analysis; T. A. performed karyotyping; A. W. performed bisulfite genomic sequencing; K. I. and D. W. performed electrophysiology; K. Tsukita, T. K., and H. H. produced the lentivirus; H. I., N.I., M. A., and T. K. wrote the paper. The experimental protocols dealing with human or animal subjects were approved by the institutional review board at each institute. S.Y. is a member without salary of the scientific advisory boards of iPierian, iPS Academia Japan, Megakaryon Corporation, and Retina Institute Japan.	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimada H, 2011, DEMENT GERIATR COGN, V32, P45, DOI 10.1159/000330017; Takano K, 2007, AM J PHYSIOL-CELL PH, V293, pC1884, DOI 10.1152/ajpcell.00305.2007; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	30	505	534	10	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					487	496		10.1016/j.stem.2013.01.009	http://dx.doi.org/10.1016/j.stem.2013.01.009			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23434393	Bronze, Green Submitted			2022-12-25	WOS:000329569500015
J	Hao, JZ; Padilla, F; Dandonneau, M; Lavebratt, C; Lesage, F; Noel, J; Delmas, P				Hao, Jizhe; Padilla, Francoise; Dandonneau, Mathieu; Lavebratt, Catharina; Lesage, Florian; Noel, Jacques; Delmas, Patrick			Kv1.1 Channels Act as Mechanical Brake in the Senses of Touch and Pain	NEURON			English	Article							GATED POTASSIUM CHANNELS; MECHANOSENSITIVE CURRENTS; MOLECULAR-MECHANISMS; NEURONS; MECHANOTRANSDUCTION; EXPRESSION; CELLS; BRAIN; TRANSDUCTION; RECEPTORS	Molecular determinants of threshold sensitivity of mammalian mechanoreceptors are unknown. Here, we identify a nnechanosensitive (MS) K+ current (I-Kmech) that governs mechanical threshold and adaptation of distinct populations of mechanoreceptors. Toxin profiling and transgenic mouse studies indicate that I-Kmech is carried by Kv1.1-Kv1.2 heteromers. Mechanosensitivity is attributed to Kv1.1 subunits, through facilitation of voltage-dependent open probability. I-Kmech is expressed in high-threshold C-mechano-nociceptors (C-HTMRs) and A beta-mechanoreceptors, but not in low-threshold C-mechanoreceptors. I-Kmech opposes depolarization induced by slow/ultraslow MS cation currents in C-HTMRs, thereby shifting mechanical threshold for firing to higher values. However, due to kinetics mismatch with rapidly-adapting MS cation currents, I-Kmech tunes firing adaptation but not mechanical threshold in A beta-mechanoreceptors. Expression of Kv1.1 dominant negative or inhibition of Kv1.1/I-Kmech caused severe mechanical allodynia but not heat hyperalgesia. By balancing the activity of excitatory mechanotransducers, Kv1.1 acts as a mechanosensitive brake that regulates mechanical sensitivity of fibers associated with mechanical perception.	[Hao, Jizhe; Padilla, Francoise; Dandonneau, Mathieu; Delmas, Patrick] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286,CS80011, F-13344 Marseille 15, France; [Lesage, Florian; Noel, Jacques] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel,UMR 6097, F-06560 Valbonne, France; [Lavebratt, Catharina] Karolinska Inst, Ctr Mol Med, SE-17177 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Karolinska Institutet	Delmas, P (corresponding author), Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286,CS80011, Blvd Pierre Dramard, F-13344 Marseille 15, France.	patrick.delmas@univ-amu.fr	Lesage, Florian/D-5097-2011; Noël, Jacques/K-7967-2012; Lesage, Florian/P-9780-2019; hao, jizhe/AFS-9867-2022	Lesage, Florian/0000-0002-4406-7106; Noël, Jacques/0000-0003-4017-2352; Lesage, Florian/0000-0002-4406-7106; Lavebratt, Catharina/0000-0003-4987-2718	CNRS; ANR; IRME; FRM; Institut UPSA; SFETD; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); IRME; FRM(Fondation pour la Recherche Medicale); Institut UPSA; SFETD; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We are grateful to Professor Roderick MacKinnon and Dr. Marcel Crest for discussion and to Professor Baldomero M. Olivera and Dr. Marie-France Martin-Eauclaire for the gift of some toxins. We thank Axel Fernandez for excellent technical assistance. This work was supported by grants from the CNRS, ANR, IRME, FRM, Institut UPSA, and SFETD. J.H. was supported by a PhD studentship from the French Ministry of Research and the FRM.	Abbas N, 2008, BIOCHEM BIOPH RES CO, V376, P525, DOI 10.1016/j.bbrc.2008.09.033; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Ferber M, 2004, TOXICON, V43, P915, DOI 10.1016/j.toxicon.2003.12.010; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Haeberle H, 2008, CHEMOSENS PERCEPT, V1, P110, DOI 10.1007/s12078-008-9012-6; Hao JZ, 2011, NAT PROTOC, V6, P979, DOI 10.1038/nprot.2011.343; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; Hatton WJ, 2001, J PHYSIOL-LONDON, V533, P315, DOI 10.1111/j.1469-7793.2001.0315a.x; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; Imperial JS, 2008, J BIOL CHEM, V283, P23026, DOI 10.1074/jbc.M800084200; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kawakubo T, 1999, AM J PHYSIOL-HEART C, V276, pH1827, DOI 10.1152/ajpheart.1999.276.6.H1827; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Perl ER, 1996, PROG BRAIN RES, V113, P21, DOI 10.1016/S0079-6123(08)61079-1; Persson AS, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-65; Petersson S, 2003, EUR J NEUROSCI, V18, P3231, DOI 10.1111/j.1460-9568.2003.03044.x; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Saal HP, 2009, J NEUROSCI, V29, P8022, DOI 10.1523/JNEUROSCI.0665-09.2009; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sokolov MV, 2007, NEUROPHARMACOLOGY, V53, P272, DOI 10.1016/j.neuropharm.2007.05.008; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Wang FC, 1999, EUR J BIOCHEM, V263, P230, DOI 10.1046/j.1432-1327.1999.00493.x	54	89	95	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					899	914		10.1016/j.neuron.2012.12.035	http://dx.doi.org/10.1016/j.neuron.2012.12.035			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473320	Bronze			2022-12-25	WOS:000316162600011
J	Labouebe, G; Liu, S; Dias, C; Zou, HY; Wong, JCY; Karunakaran, S; Clee, SM; Phillips, AG; Boutrel, B; Borgland, SL				Labouebe, Gwenael; Liu, Shuai; Dias, Carine; Zou, Haiyan; Wong, Jovi C. Y.; Karunakaran, Subashini; Clee, Susanne M.; Phillips, Anthony G.; Boutrel, Benjamin; Borgland, Stephanie L.			Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; INTRAVENTRICULAR INSULIN; NUCLEUS-ACCUMBENS; SUCROSE INTAKE; FOOD-INTAKE; LEPTIN; BRAIN; RATS; TRANSMISSION	The prevalence of obesity has markedly increased over the past few decades. Exploration of how hunger and satiety signals influence the reward system can help us understand non-homeostatic feeding. Insulin may act in the ventral tegmental area (VIA), a critical site for reward-seeking behavior, to suppress feeding. However, the neural mechanisms underlying insulin effects in the VIA remain unknown. We demonstrate that insulin, a circulating catabolic peptide that inhibits feeding, can induce long-term depression (LTD) of mouse excitatory synapses onto VIA dopamine neurons. This effect requires endocannabinoid-mediated presynaptic inhibition of glutamate release. Furthermore, after a sweetened high-fat meal, which elevates endogenous insulin, insulin-induced LTD is occluded. Finally, insulin in the VIA reduces food anticipatory behavior in mice and conditioned place preference for food in rats. Taken together, these results suggest that insulin in the VIA suppresses excitatory synaptic transmission and reduces anticipatory activity and preference for food-related cues.	[Labouebe, Gwenael; Liu, Shuai; Zou, Haiyan; Wong, Jovi C. Y.; Borgland, Stephanie L.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Labouebe, Gwenael; Boutrel, Benjamin] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Lausanne, Switzerland; [Liu, Shuai; Borgland, Stephanie L.] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Dias, Carine; Phillips, Anthony G.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Karunakaran, Subashini; Clee, Susanne M.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Fudan University; University of British Columbia; University of British Columbia	Borgland, SL (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	borgland@mail.ubc.ca	Borgland, Stephanie/GPC-5260-2022; Clee, Susanne/AAC-4278-2020; Clee, Susanne/F-7312-2010; Borgland, Stephanie/M-2936-2016	Borgland, Stephanie/0000-0001-7546-5687; Clee, Susanne/0000-0001-7946-688X; Borgland, Stephanie/0000-0001-7546-5687; Wong, Jovi/0000-0001-7980-9352; Boutrel, Benjamin/0000-0003-4988-759X	Canadian Institute of Health Research [102617]; Swiss National Science Foundation [31003A-133056]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors would like to thank K. Lee for performing the insulin measurements and K. Haas, B. MacVicar and Y.T. Wang for suggestions on the manuscript. This research was supported by a Canadian Institute of Health Research operating grant (102617) and a Canadian Institute of Health Research new investigator award to S.L.B. G.L. was supported by a Swiss National Science Foundation postdoctoral fellowship. Behavioral experiments done in B.B.'s laboratory were supported by the Swiss National Science Foundation (31003A-133056).	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahn S, 1999, J NEUROSCI, V19; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Bruijnzeel AW, 2011, BEHAV BRAIN RES, V219, P254, DOI 10.1016/j.bbr.2011.01.020; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Sipols AJ, 2002, PEPTIDES, V23, P2181, DOI 10.1016/S0196-9781(02)00246-2; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vigneri R, 2010, ACTA DIABETOL, V47, P271, DOI 10.1007/s00592-010-0215-3; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006	50	164	168	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					300	308		10.1038/nn.3321	http://dx.doi.org/10.1038/nn.3321			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354329	Green Accepted, Green Submitted			2022-12-25	WOS:000315474800012
J	Zhu, PX; Frank, T; Friedrich, RW				Zhu, Peixin; Frank, Thomas; Friedrich, Rainer W.			Equalization of odor representations by a network of electrically coupled inhibitory interneurons	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH OLFACTORY-BULB; DROSOPHILA ANTENNAL LOBE; MAMMALIAN NEURONS; IN-VIVO; SYSTEM; RESPONSES; EXPRESSION; GLOMERULI; CELLS; CHANNELRHODOPSIN-2	Robustness of neuronal activity patterns against variations in input intensity is critical for neuronal computations. We found that odor representations in the olfactory bulb were stabilized by interneurons that were densely coupled to the output neurons by electrical and GABAergic synapses. This interneuron network modulated responses of output neurons as a function of stimulus intensity in two ways: it globally boosted responses to weak odors, but attenuated responses to strong odors, and it increased the sensitivity of some output neurons, but decreased the sensitivity of others. These effects are closely related to strategies used in engineering to increase dynamic range. Together, they maintained not only the mean, but also the distribution, of activity across the population of output neurons within narrow limits, which is important for pattern classification. Neuronal circuits in the olfactory bulb therefore stabilize combinatorial sensory representations against variations in stimulus intensity by generic mechanisms.	[Zhu, Peixin; Frank, Thomas; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Friedrich, Rainer W.] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	rainer.friedrich@fmi.ch	Frank, Thomas/F-5273-2012	Frank, Thomas/0000-0002-5113-176X; Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; European Molecular Biology Organization; Human Frontiers Science Program; Swiss National Science Foundation	Novartis Research Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank G. Jacobson, I. Namekawa, G. Keller and F. Albeanu for comments on the manuscript and members of the Friedrich laboratory for fruitful discussions. We are grateful to K. Deisseroth (Stanford University) for DNA constructs containing NpHR3.0-YFP and ChR2-YFP, and to E. Callaway (Salk Institute) for DNA constructs containing AlstR. This work was supported by the Novartis Research Foundation, the European Molecular Biology Organization, the Human Frontiers Science Program and the Swiss National Science Foundation.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Bundschuh ST, 2012, J NEUROSCI, V32, P6830, DOI 10.1523/JNEUROSCI.6026-11.2012; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Christiani N., 2000, INTRO SUPPORT VECTOR; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Friedrich RW, 2013, ANNU REV NEUROSCI, V36, P383, DOI 10.1146/annurev-neuro-062111-150504; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Huang J, 2010, NEURON, V67, P1021, DOI 10.1016/j.neuron.2010.08.025; Kastner DB, 2011, NAT NEUROSCI, V14, P1317, DOI 10.1038/nn.2906; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Kosaka T, 2005, NEUROSCIENCE, V131, P611, DOI 10.1016/j.neuroscience.2004.11.050; Kosaka T, 2008, NEUROSCI RES, V60, P349, DOI 10.1016/j.neures.2007.11.012; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Luo SX, 2010, P NATL ACAD SCI USA, V107, P10713, DOI 10.1073/pnas.1005635107; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; PINCHING AJ, 1971, J CELL SCI, V9, P347; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sato Y, 2005, J NEUROSCI, V25, P4889, DOI 10.1523/JNEUROSCI.0679-05.2005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhang CB, 2003, J COMP NEUROL, V459, P426, DOI 10.1002/cne.10617; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zhu PX, 2012, NAT PROTOC, V7, P1410, DOI 10.1038/nprot.2012.072; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	50	41	42	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1678	1686		10.1038/nn.3528	http://dx.doi.org/10.1038/nn.3528			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077563				2022-12-25	WOS:000326205700026
J	Kadohisa, M; Petrov, P; Stokes, M; Sigala, N; Buckley, M; Gaffan, D; Kusunoki, M; Duncan, J				Kadohisa, Mikiko; Petrov, Philippe; Stokes, Mark; Sigala, Natasha; Buckley, Mark; Gaffan, David; Kusunoki, Makoto; Duncan, John			Dynamic Construction of a Coherent Attentional State in a Prefrontal Cell Population	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; FRONTAL EYE FIELDS; VISUAL-SEARCH; SELECTIVE REPRESENTATION; NEURAL MECHANISMS; COGNITIVE CONTROL; COVERT SHIFTS; MONKEY; MACAQUE; INFORMATION	Prefrontal cortex has been proposed to show highly adaptive information coding, with neurons dynamically allocated to processing task-relevant information. To track this dynamic allocation in monkey prefrontal cortex, we used time-resolved measures of neural population activity in a simple case of competition between target (behaviorally critical) and nontarget objects in opposite visual hemifields. Early in processing, there were parallel responses to competing inputs, with neurons in each hemisphere dominated by the contralateral stimulus. Later, the nontarget lost control of neural activity, with emerging global control by the behaviorally critical target. The speed of transition reflected the competitive weights of different display elements, occurring most rapidly when relative behavioral significance was well established by training history. In line with adaptive coding, the results show widespread reallocation of prefrontal processing resources as an attentional focus is established.	[Kadohisa, Mikiko; Kusunoki, Makoto; Duncan, John] MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Petrov, Philippe; Stokes, Mark; Buckley, Mark; Gaffan, David; Duncan, John] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Sigala, Natasha] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9RR, E Sussex, England; [Sigala, Natasha] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton BN1 9RR, E Sussex, England	University of Oxford; University of Brighton; University of Sussex; University of Sussex	Kadohisa, M (corresponding author), MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England.	miki.kadohisa@psy.ox.ac.uk; john.duncan@mrc-cbu.cam.ac.uk	Sigala, Natasha/ABH-3181-2020; Sigala, Natasha/K-1750-2013	Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; Duncan, John/0000-0002-9695-2764	MRC [MC-A060-5PQ14]; James S. McDonnell Foundation [220020081]; MRC; National Institute for Health Research (NIHR); Oxford Biomedical Research Centre based at Oxford University Hospitals Trust, Oxford University; MRC [G0400593, MC_U105580448, MC_qA137504, MR/J009024/1] Funding Source: UKRI; Medical Research Council [G0400593, MC_U105580448, MC_qA137504, MR/J009024/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S. McDonnell Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxford Biomedical Research Centre based at Oxford University Hospitals Trust, Oxford University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC intramural programme MC-A060-5PQ14 and research award 220020081 from the James S. McDonnell Foundation. The work of M.S. is supported by an MRC Career Development Fellowship, the National Institute for Health Research (NIHR), and Oxford Biomedical Research Centre based at Oxford University Hospitals Trust, Oxford University. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broadbent D.E., 1958, PSYCHOL REV; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J., 2002, PRINCIPLES FRONTAL L, P278, DOI DOI 10.1093/ACPROF:OSO/9780195; EGETH H, 1991, J EXP PSYCHOL HUMAN, V17, P551, DOI 10.1037/0096-1523.17.2.551; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kahneman D., 1973, PLOS BIOL; Kusunoki M, 2009, CEREB CORTEX, V19, P2522, DOI 10.1093/cercor/bhp005; Kusunoki M, 2010, J COGNITIVE NEUROSCI, V22, P751, DOI 10.1162/jocn.2009.21216; Kyllingsbaek S, 2007, J EXP PSYCHOL HUMAN, V33, P64, DOI 10.1037/0096-1523.33.1.64; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Norman D., 1980, 8006 ERIC CLEAR; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pandya DN, 1996, PHILOS T ROY SOC B, V351, P1423, DOI 10.1098/rstb.1996.0127; PASHLER H, 1993, J EXP PSYCHOL HUMAN, V19, P315, DOI 10.1037/0096-1523.19.2.315; Pucak ML, 1996, J COMP NEUROL, V376, P614, DOI 10.1002/(SICI)1096-9861(19961223)376:4<614::AID-CNE9>3.0.CO;2-4; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903	43	33	33	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					235	246		10.1016/j.neuron.2013.07.041	http://dx.doi.org/10.1016/j.neuron.2013.07.041			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24035763	hybrid, Green Published			2022-12-25	WOS:000326305300021
J	Fischer, AG; Ullsperger, M				Fischer, Adrian G.; Ullsperger, Markus			Real and Fictive Outcomes Are Processed Differently but Converge on a Common Adaptive Mechanism	NEURON			English	Article							MEDIAL FRONTAL-CORTEX; BRAIN POTENTIALS; PREDICTION ERROR; DECISION-MAKING; PARIETAL CORTEX; FEEDBACK; CONNECTIONS; PERFORMANCE; SIGNATURE; COMPONENT	The ability to learn not only from experienced but also from merely fictive outcomes without direct rewarding or punishing consequences should improve learning and resulting value-guided choice. Using an instrumental learning task in combination with multiple single-trial regression of predictions derived from a computational reinforcement-learning model on human EEG, we found an early temporospatial double dissociation in the processing of fictive and real feedback. Thereafter, real and fictive feedback processing converged at a common final path, reflected in parietal EEG activity that was predictive of future choices. In the choice phase, similar parietal EEG activity related to certainty of the impending response was predictive for the decision on the next trial as well. These parietal EEG effects may reflect a common adaptive cortical mechanism of updating or strengthening of stimulus values by integrating outcomes, learning rate, and certainty, which is active during both decision making and evaluation. Neuronal processing of real (rewarding, punishing) and fictive action outcomes (which would have happened had one acted differently) differs for 400 ms and then converges on a common adaptive mechanism driving future decision making and learning.	[Fischer, Adrian G.; Ullsperger, Markus] Otto Von Guericke Univ, Inst Neuropsychol, D-39106 Magdeburg, Germany; [Ullsperger, Markus] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 HR Nijmegen, Netherlands; [Fischer, Adrian G.; Ullsperger, Markus] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Ullsperger, Markus] Ctr Behav Brain Sci, D-39106 Magdeburg, Germany	Otto von Guericke University; Radboud University Nijmegen; Max Planck Society	Fischer, AG (corresponding author), Otto Von Guericke Univ, Inst Neuropsychol, D-39106 Magdeburg, Germany.	adrian.fischer@ovgu.de	Ullsperger, Markus/I-4760-2019; Fischer, Adrian G/A-2575-2015; Ullsperger, Markus/E-2797-2010	Ullsperger, Markus/0000-0003-3970-1982; Fischer, Adrian G/0000-0001-8779-9051; Ullsperger, Markus/0000-0003-3970-1982	German Ministry of Education and Research (BMBF) [01GW0722]; German Research Foundation (DFG) [SFB 779 A 12]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank Gerhard Jocham, Theo O.J. Grill-Idler, and Tanja Endrass for fruitful discussions on the presented data and Sabrina Doring for support in data collection. This work was supported by grants of the German Ministry of Education and Research (BMBF, 01GW0722) and from the German Research Foundation (DFG, SFB 779 A 12) to M.U.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Benjamini Y, 2001, ANN STAT, V29, P1165; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Caplin A, 2008, CURR OPIN NEUROBIOL, V18, P197, DOI 10.1016/j.conb.2008.07.007; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; Ferdinand NK, 2012, J NEUROSCI, V32, P12087, DOI 10.1523/JNEUROSCI.1410-12.2012; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mars RB, 2008, J NEUROSCI, V28, P12539, DOI 10.1523/JNEUROSCI.2925-08.2008; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Philiastides MG, 2010, NEUROIMAGE, V53, P221, DOI 10.1016/j.neuroimage.2010.05.052; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Talmi D, 2012, NEUROIMAGE, V59, P635, DOI 10.1016/j.neuroimage.2011.06.051; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; ULLSPERGER P, 1988, BIOL PSYCHOL, V26, P299, DOI 10.1016/0301-0511(88)90025-7; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50	53	103	103	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1243	1255		10.1016/j.neuron.2013.07.006	http://dx.doi.org/10.1016/j.neuron.2013.07.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	298NC	24050408	Green Published, Bronze			2022-12-25	WOS:000330329600020
J	Folgueras, AR; Guo, XY; Pasolli, HA; Stokes, N; Polak, L; Zheng, DY; Fuchs, E				Folgueras, Alicia R.; Guo, Xingyi; Pasolli, H. Amalia; Stokes, Nicole; Polak, Lisa; Zheng, Deyou; Fuchs, Elaine			Architectural Niche Organization by LHX2 Is Linked to Hair Follicle Stem Cell Function	CELL STEM CELL			English	Article							LIM-HOMEOBOX GENE; SELF-RENEWAL; DIFFERENTIATION; LINEAGE; HOMEOSTASIS; ACTIVATION; CONTRIBUTE; PROGENY; DEFINES; ROLES	In adult skin, self-renewing, undifferentiated hair follicle stem cells (HF-SCs) reside within a specialized niche, where they spend prolonged times as a single layer of polarized, quiescent epithelial cells. When sufficient activating signals accumulate, HF-SCs become mobilized to fuel tissue regeneration and hair growth. Here, we show that architectural organization of the HF-SC niche by transcription factor LHX2 plays a critical role in HF-SC behavior. Using genome-wide chromatin and transcriptional profiling of HF-SCs in vivo, we show that LHX2 directly transactivates genes that orchestrate cytoskeletal dynamics and adhesion. Conditional ablation of LHX2 results in gross cellular disorganization and HF-SC polarization within the niche. LHX2 loss leads to a failure to maintain HF-SC quiescence and hair anchoring, as well as progressive transformation of the niche into a sebaceous gland. These findings suggest that niche organization underlies the requirement for LHX2 in hair follicle structure and function.	[Folgueras, Alicia R.; Pasolli, H. Amalia; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Folgueras, Alicia/B-3281-2017; Fuchs, Elaine/G-1565-2016	Folgueras, Alicia/0000-0003-3426-9502; Pasolli, Hilda Amalia/0000-0003-3899-3530; Zheng, Deyou/0000-0003-4354-5337	EMBO Postdoctoral Fellowship; National Institutes of Health NIAMS [R01AR31737]; New York State Department of Health [NYSTEM/C026427]; NIH/NIMH [R21MH099452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	EMBO Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York State Department of Health; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Dewell for assistance in high-throughput sequencing and analysis (RU Genomics Resource Center); S. Mazel, L. Li, S. Semova, and S. Tadesse for FACS sorting (RU FACS facility); the RU Bioimaging Center for advice on image acquisition; and the MSKCC Genomics Core Facility for RNA and microarray processing. We thank E.F.' laboratory members D. Oristian and A. Aldeguer for assistance in mouse research; E. Heller for advice on image analyses and quantifications; M. Nikolova, J. Racelis, S. Chai, E. Wong, and P. Janki for technical assistance; and W.-H. Lien, C. Luxenburg, M. Kadaja, B. Keyes, and C.P. Lu for valuable discussions. A.R.F. was supported by an EMBO Postdoctoral Fellowship. E.F. is an HHMI Investigator. This work was supported by grants to E.F. (National Institutes of Health NIAMS R01AR31737 and New York State Department of Health NYSTEM/C026427) and to D.Z. (NIH/NIMH R21MH099452).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bertrand V, 2009, DEV CELL, V16, P563, DOI 10.1016/j.devcel.2009.02.011; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 1999, DEVELOPMENT, V126, P4557; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Niemann C, 2002, DEVELOPMENT, V129, P95; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Porter FD, 1997, DEVELOPMENT, V124, P2935; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rodriguez-Esteban C, 1998, DEVELOPMENT, V125, P3925; Subramanian L, 2011, P NATL ACAD SCI USA, V108, pE265, DOI 10.1073/pnas.1101109108; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Xie YS, 2012, J INVEST DERMATOL, V132, P547, DOI 10.1038/jid.2011.381; Xu XM, 2007, DEV BIOL, V312, P484, DOI 10.1016/j.ydbio.2007.09.052; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YG, 2010, DEV BIOL, V337, P313, DOI 10.1016/j.ydbio.2009.11.002	51	62	65	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					314	327		10.1016/j.stem.2013.06.018	http://dx.doi.org/10.1016/j.stem.2013.06.018			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	24012369	Green Accepted, Bronze			2022-12-25	WOS:000329570800009
J	Perisse, E; Yin, Y; Lin, AC; Lin, SW; Huetteroth, W; Waddell, S				Perisse, Emmanuel; Yin, Yan; Lin, Andrew C.; Lin, Suewei; Huetteroth, Wolf; Waddell, Scott			Different Kenyon Cell Populations Drive Learned Approach and Avoidance in Drosophila	NEURON			English	Article							LONG-TERM-MEMORY; MUSHROOM BODY; COURTSHIP BEHAVIOR; NEURAL CIRCUIT; GAMMA NEURONS; ODOR MEMORY; EXPRESSION; DOPAMINE; REWARD; TRACE	In Drosophila, anatomically discrete dopamine neurons that innervate distinct zones of the mushroom body (MB) assign opposing valence to odors during olfactory learning. Subsets of MB neurons have temporally unique roles in memory processing, but valence-related organization has not been demonstrated. We functionally subdivided the alpha beta neurons, revealing a value-specific role for the similar to 160 alpha beta core (alpha beta(c)) neurons. Blocking neurotransmission from alpha beta surface (alpha beta(s)) neurons revealed a requirement during retrieval of aversive and appetitive memory, whereas blocking alpha beta(c) only impaired appetitive memory. The alpha beta(c) were also required to express memory in a differential aversive paradigm demonstrating a role in relative valuation and approach behavior. Strikingly, both reinforcing dopamine neurons and efferent pathways differentially innervate alpha beta(c) and alpha beta(s) in the MB lobes. We propose that conditioned approach requires pooling synaptic outputs from across the alpha beta ensemble but only from the alpha beta(s) for conditioned aversion.	[Perisse, Emmanuel; Lin, Andrew C.; Lin, Suewei; Huetteroth, Wolf; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England; [Perisse, Emmanuel; Yin, Yan; Huetteroth, Wolf; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Waddell, S (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	scott.waddell@cncb.ox.ac.uk	Huetteroth, Wolf/I-6661-2015; Lin, Suewei/AAA-3962-2021; Huetteroth, Wolf/L-5252-2019	Lin, Suewei/0000-0001-7079-7818; Huetteroth, Wolf/0000-0003-3421-9935; Perisse, Emmanuel/0000-0002-0830-0687; Waddell, Scott/0000-0003-4503-6229; Lin, Andrew/0000-0001-6310-9765	Sir Henry Wellcome Postdoctoral Fellowship; EMBO Long-Term Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences; National Institutes of Health [MH081982]; Gatsby Charitable Foundation; Oxford Martin School; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081982] Funding Source: NIH RePORTER	Sir Henry Wellcome Postdoctoral Fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Oxford Martin School; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank David Owald, Daryl Gohl, Marion Sillies, Tom Clandinin, and Ulrike Heberlein for flies. We also thank Peter Dayan, Gero Miesenbock, and members of the Waddell and Miesenbock laboratories for discussion. E.P. thanks the Philippe and Bettencourt-Schueller Foundations. A.C.L. and S.L. are supported by a Sir Henry Wellcome Postdoctoral Fellowship and an EMBO Long-Term Fellowship, respectively. S.W. is funded by a Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences, grant MH081982 from the National Institutes of Health, and by funds from the Gatsby Charitable Foundation and Oxford Martin School.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Barberini CL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00170; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Huang C, 2012, CURR BIOL, V22, P1981, DOI 10.1016/j.cub.2012.08.048; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Motanis H, 2014, CEREB CORTEX, V24, P1075, DOI 10.1093/cercor/bhs394; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Pai TP, 2013, P NATL ACAD SCI USA, V110, P7898, DOI 10.1073/pnas.1216336110; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Trannoy S, 2011, CURR BIOL, V21, P1647, DOI 10.1016/j.cub.2011.08.032; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yin Y, 2009, EUR J NEUROSCI, V30, P279, DOI 10.1111/j.1460-9568.2009.06821.x; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	55	76	76	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					945	956		10.1016/j.neuron.2013.07.045	http://dx.doi.org/10.1016/j.neuron.2013.07.045			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012007	Green Published, hybrid			2022-12-25	WOS:000330269100012
J	Ishii, T; Pera, RAR; Greely, HT				Ishii, Tetsuya; Pera, Renee A. Reijo; Greely, Henry T.			Ethical and Legal Issues Arising in Research on Inducing Human Germ Cells from Pluripotent Stem Cells	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; EMBRYOS	Derivation of eggs or sperm from pluripotent stem cells or direct reprogramming from somatic cells would have huge effects on assisted reproductive technology. Here we discuss important ethical, legal, and social issues that would be raised by the development of such female or male gametes for clinical use.	[Ishii, Tetsuya] Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan; [Pera, Renee A. Reijo] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Law Sch, Stanford, CA 94305 USA	Hokkaido University; Stanford University; Stanford University	Ishii, T (corresponding author), Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido 0600808, Japan.	tishii@general.hokudai.ac.jp		Ishii, Tetsuya/0000-0002-7085-7750; Reijo Pera, Renee/0000-0002-6487-1329				Easley CA, 2012, CELL REP, V2, P440, DOI 10.1016/j.celrep.2012.07.015; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Lomax GP, 2013, NAT BIOTECHNOL, V31, P288, DOI 10.1038/nbt.2541; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The President's Council on Bioethics, 2002, HUM CLON HUM DIGN ET; Trounson A, 2013, CELL STEM CELL, V12, P636, DOI 10.1016/j.stem.2013.05.022	9	32	32	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					145	148		10.1016/j.stem.2013.07.005	http://dx.doi.org/10.1016/j.stem.2013.07.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910081	Bronze, Green Submitted			2022-12-25	WOS:000329570600008
J	Payzan-LeNestour, E; Dunne, S; Bossaerts, P; O'Doherty, JP				Payzan-LeNestour, Elise; Dunne, Simon; Bossaerts, Peter; O'Doherty, John P.			The Neural Representation of Unexpected Uncertainty during Value-Based Decision Making	NEURON			English	Article							LOCUS-COERULEUS; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; SELECTIVE ATTENTION; REWARD; PREDICTION; RISK; ACTIVATION; RESPONSES	Uncertainty is an inherent property of the environment and a central feature of models of decision-making and learning. Theoretical propositions suggest that one form, unexpected uncertainty, may be used to rapidly adapt to changes in the environment, while being influenced by two other forms: risk and estimation uncertainty. While previous studies have reported neural representations of estimation uncertainty and risk, relatively little is known about unexpected uncertainty. Here, participants performed a decision-making task while undergoing functional magnetic resonance imaging (fMRI), which, in combination with a Bayesian model-based analysis, enabled us to separately examine each form of uncertainty examined. We found representations of unexpected uncertainty in multiple cortical areas, as well as the noradrenergic brainstem nucleus locus coeruleus. Other unique cortical regions were found to encode risk, estimation uncertainty, and learning rate. Collectively, these findings support theoretical models in which several formally separable uncertainty computations determine the speed of learning.	[Payzan-LeNestour, Elise] Univ New S Wales, Sch Banking & Finance, Australian Sch Business, Sydney, NSW 2052, Australia; [Payzan-LeNestour, Elise; Dunne, Simon; Bossaerts, Peter; O'Doherty, John P.] CALTECH, Pasadena, CA 91125 USA; [O'Doherty, John P.] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland	University of New South Wales Sydney; California Institute of Technology; Trinity College Dublin	Payzan-LeNestour, E (corresponding author), Univ New S Wales, Sch Banking & Finance, Australian Sch Business, Sydney, NSW 2052, Australia.	elise@elisepayzan.com; sdunne@caltech.edu	Bossaerts, Peter/AAZ-9851-2020; O'Doherty, John P/F-1204-2013; Bossaerts, Peter/O-9964-2015	Bossaerts, Peter/0000-0003-2308-2603; Payzan-LeNestour, Elise/0000-0001-8658-3208; Dunne, Simon/0000-0003-4875-7953	Science Foundation Ireland [08/IN.1/B1844]; European Research Council; Swiss Finance Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swiss Finance Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Science Foundation Ireland grant 08/IN.1/B1844 and a European Research Council grant (to J.O.D). P.B. and E.P.L.N. acknowledge the support of the Swiss Finance Institute to the Ecole Polytechnique Federale Lausanne.	ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Aston-Jones G., 2002, SOC NEUR ABSTR, V2002, P86; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bach DR, 2011, J NEUROSCI, V31, P4811, DOI 10.1523/JNEUROSCI.1452-10.2011; Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bland AR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00085; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Bruguier AJ, 2010, J FINANC, V65, P1703, DOI 10.1111/j.1540-6261.2010.01591.x; Callan AM, 2009, HUM BRAIN MAPP, V30, P2804, DOI 10.1002/hbm.20710; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cavanagh JF, 2012, CEREB CORTEX, V22, P2575, DOI 10.1093/cercor/bhr332; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Chumbley JR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002346; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; d'Acremont M, 2009, NEUROIMAGE, V47, P1929, DOI 10.1016/j.neuroimage.2009.04.096; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; McGaughy J, 2008, NEUROSCIENCE, V153, P63, DOI 10.1016/j.neuroscience.2008.01.064; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Payzan-Lenestour Elise, 2012, Front Neurosci, V6, P150, DOI 10.3389/fnins.2012.00150; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Prevost C, 2011, EUR J NEUROSCI, V34, P134, DOI 10.1111/j.1460-9568.2011.07686.x; Rajkowski J., 1992, SOC NEUR ABSTR, V18, P538; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Schlund MW, 2010, NEUROSCIENCE, V165, P151, DOI 10.1016/j.neuroscience.2009.10.014; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Talsma D, 2010, J COGNITIVE NEUROSCI, V22, P761, DOI 10.1162/jocn.2009.21223; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Vercauteren T., 2007, DIFFEOMORPHIC DEMONS; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Yu AJ, 2012, NAT NEUROSCI, V15, P933, DOI 10.1038/nn.3150	70	135	136	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					191	201		10.1016/j.neuron.2013.04.037	http://dx.doi.org/10.1016/j.neuron.2013.04.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849203	Green Accepted, Bronze			2022-12-25	WOS:000321802000019
J	Wang, H; Duclot, F; Liu, Y; Wang, ZX; Kabbaj, M				Wang, Hui; Duclot, Florian; Liu, Yan; Wang, Zuoxin; Kabbaj, Mohamed			Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles	NATURE NEUROSCIENCE			English	Article							PAIR-BOND FORMATION; ESTROGEN-RECEPTOR-ALPHA; MICROTUS-OCHROGASTER; NUCLEUS-ACCUMBENS; MATERNAL-CARE; AFFILIATIVE BEHAVIOR; SOCIAL-ORGANIZATION; DNA METHYLATION; OXYTOCIN; VASOPRESSIN	In the socially monogamous prairie vole (Microtus ochrogaster), mating induces enduring pair-bonds that are initiated by partner preference formation and regulated by a variety of neurotransmitters, including oxytocin, vasopressin and dopamine. We examined potential epigenetic mechanisms mediating pair-bond regulation and found that the histone deacetylase inhibitors sodium butyrate and trichostatin A (TSA) facilitated partner preference formation in female prairie voles in the absence of mating. This was associated with a specific upregulation of oxytocin receptor (OTR, oxtr) and vasopressin V1a receptor (V1aR, avpr1a) in the nucleus accumbens (NAcc), through an increase in histone acetylation at their respective promoters. Furthermore, TSA-facilitated partner preference was prevented by OTR or V1aR blockade in the NAcc. Notably, mating-induced partner preference triggered the same epigenetic regulation of oxtr and avpr1a gene promoters as TSA. These observations indicate that TSA and mating facilitate partner preference through epigenetic events, providing, to the best of our knowledge, the first direct evidence for epigenetic regulation of pair-bonding.	[Wang, Hui; Duclot, Florian; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Wang, Hui; Duclot, Florian; Liu, Yan; Wang, Zuoxin; Kabbaj, Mohamed] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Wang, Hui; Liu, Yan; Wang, Zuoxin] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Kabbaj, M (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	zwang@psy.fsu.edu; mohamed.kabbaj@med.fsu.edu	Duclot, Florian/E-4669-2013; Kabbaj, Mohamed/M-9240-2016	Duclot, Florian/0000-0003-0121-5807; 	National Institute of Mental Health [MHR21-083128, MHR01-058616]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058616, R21MH083128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023048] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We also thank M. Manning for the generous gift of the OTR antagonist OTA(T) (University of Toledo). This work was supported by grants from the National Institute of Mental Health (MHR21-083128 to M.K. and Z.W., and MHR01-058616 to Z.W.).	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bonthuis PJ, 2011, ENDOCRINOLOGY, V152, P3172, DOI 10.1210/en.2010-1001; Bora E, 2009, CURR OPIN PSYCHIATR, V22, P320, DOI 10.1097/YCO.0b013e328329e970; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; GETZ LL, 1986, BEHAV ECOL SOCIOBIOL, V18, P275, DOI 10.1007/BF00300004; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Halsall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033453; Hawk JD, 2011, LEARN MEMORY, V18, P367, DOI 10.1101/lm.2097411; Hollis F, 2011, HORM BEHAV, V59, P331, DOI 10.1016/j.yhbeh.2010.09.005; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Ito K, 2002, MOL BIOTECHNOL, V20, P99, DOI 10.1385/MB:20:1:099; Keebaugh AC, 2011, HORM BEHAV, V60, P498, DOI 10.1016/j.yhbeh.2011.07.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Liu Y, 2010, P NATL ACAD SCI USA, V107, P1217, DOI 10.1073/pnas.0911998107; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; Mariadason JM, 2000, CANCER RES, V60, P4561; Molfese DL, 2011, DEV NEUROPSYCHOL, V36, P810, DOI 10.1080/87565641.2011.606395; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; THOMAS JA, 1979, BEHAV ECOL SOCIOBIOL, V5, P171, DOI 10.1007/BF00293304; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Veenema AH, 2012, HORM BEHAV, V61, P304, DOI 10.1016/j.yhbeh.2011.12.002; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; WITT DM, 1991, ENDOCRINOLOGY, V128, P3269, DOI 10.1210/endo-128-6-3269; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 1996, J NEUROENDOCRINOL, V8, P777, DOI 10.1046/j.1365-2826.1996.05188.x; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	50	85	85	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					919	U184		10.1038/nn.3420	http://dx.doi.org/10.1038/nn.3420			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727821	Green Accepted			2022-12-25	WOS:000321180900026
J	Mi, D; Carr, CB; Georgala, PA; Huang, YT; Manuel, MN; Jeanes, E; Niisato, E; Sansom, SN; Livesey, FJ; Theil, T; Hasenpusch-Theil, K; Simpson, TI; Mason, JO; Price, DJ				Mi, Da; Carr, Catherine B.; Georgala, Petrina A.; Huang, Yu-Ting; Manuel, Martine N.; Jeanes, Emily; Niisato, Emi; Sansom, Stephen N.; Livesey, Frederick J.; Theil, Thomas; Hasenpusch-Theil, Kerstin; Simpson, T. Ian; Mason, John O.; Price, David J.			Pax6 Exerts Regional Control of Cortical Progenitor Proliferation via Direct Repression of Cdk6 and Hypophosphorylation of pRb	NEURON			English	Article							GENOME-WIDE CHARACTERIZATION; CELL-CYCLE; IN-VIVO; RETINOBLASTOMA PROTEIN; PAIRED DOMAIN; DNA-BINDING; FOREBRAIN; PHOSPHORYLATION; EXPRESSION; DIVISION	The mechanisms by which early spatiotemporal expression patterns of transcription factors such as Pax6 regulate cortical progenitors in a region-specific manner are poorly understood. Pax6 is expressed in a gradient across the developing cortex and is essential for normal corticogenesis. We found that constitutive or conditional loss of Pax6 increases cortical progenitor proliferation by amounts that vary regionally with normal Pax6 levels. We compared the gene expression profiles of equivalent Pax6-expressing progenitors isolated from Pax6(+/+) and Pax6(-/-) cortices and identified many negatively regulated cell-cycle genes, including Cyclins and Cdks. Biochemical assays indicated that Pax6 directly represses Cdk6 expression. Cyclin/Cdk repression inhibits retinoblastoma protein (pRb) phosphorylation, thereby limiting the transcription of genes that directly promote the mechanics of the cell cycle, and we found that Pax6 inhibits pRb phosphorylation and represses genes involved in DNA replication. Our results indicate that Pax6's modulation of cortical progenitor cell cycles is regional and direct.	[Mi, Da; Carr, Catherine B.; Georgala, Petrina A.; Huang, Yu-Ting; Manuel, Martine N.; Jeanes, Emily; Niisato, Emi; Theil, Thomas; Hasenpusch-Theil, Kerstin; Simpson, T. Ian; Mason, John O.; Price, David J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Sansom, Stephen N.; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Edinburgh; University of Cambridge	Mason, JO (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	john.mason@ed.ac.uk; david.price@ed.ac.uk	Simpson, Ian/AAG-8830-2021; Mason, John O/A-1926-2010; Simpson, Ian/B-4722-2011	Simpson, Ian/0000-0003-0495-7187; Mason, John O/0000-0002-0489-2400; Simpson, Ian/0000-0003-0495-7187; Theil, Thomas/0000-0001-6590-8309; Livesey, Rick/0000-0001-6128-3372; Mi, Da/0000-0002-7829-1923; Manuel, Martine/0000-0001-7674-8785; Price, David/0000-0002-5318-307X	MRC; Wellcome Trust; MRC [MR/J003662/1, G0800429, G0801359] Funding Source: UKRI; Medical Research Council [MR/J003662/1, G0800429, G0801359] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Alan Ross for carrying out array hybridizations, Thorsten Forster for statistical analyses, Trudi Gillespie (IMPACT Facility) for help with imaging, Malgorzata (Gosia) Borkowska for doing the electroporations, and David Santamaria for the Cdk6 knockout mice, and Nicoletta Kessaris for the Emx1-creER<SUP>T2</SUP> mice. This work was supported by the MRC and the Wellcome Trust.	Appolloni I, 2012, INT J CANCER, V131, pE1078, DOI 10.1002/ijc.27606; Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Castro DS, 2011, CELL CYCLE, V10, P4026, DOI 10.4161/cc.10.23.18578; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cram EJ, 2001, J BIOL CHEM, V276, P22332, DOI 10.1074/jbc.M010539200; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Einarson MB, 2004, MOL CELL BIOL, V24, P3957, DOI 10.1128/MCB.24.9.3957-3971.2004; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Goto Y, 2006, BBA-GENE STRUCT EXPR, V1759, P60, DOI 10.1016/j.bbaexp.2006.02.004; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knockleby JW, 2010, CELL CYCLE, V9, P4487, DOI 10.4161/cc.9.22.14047; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miyake T, 2012, ONCOGENE, V31, P1431, DOI 10.1038/onc.2011.332; Pilaz LJ, 2009, P NATL ACAD SCI USA, V106, P21924, DOI 10.1073/pnas.0909894106; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Satyanarayana A, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-9; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Tomita Y, 2011, CANCER SCI, V102, P697, DOI 10.1111/j.1349-7006.2011.01865.x; Tuoc TC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-23; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0	58	51	53	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					269	284		10.1016/j.neuron.2013.02.012	http://dx.doi.org/10.1016/j.neuron.2013.02.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622063	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000318202200008
J	Kennedy, PJ; Feng, J; Robison, AJ; Maze, I; Badimon, A; Mouzon, E; Chaudhury, D; Damez-Werno, DM; Haggarty, SJ; Han, MH; Bassel-Duby, R; Olson, EN; Nestler, EJ				Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Maze, Ian; Badimon, Ana; Mouzon, Ezekiell; Chaudhury, Dipesh; Damez-Werno, Diane M.; Haggarty, Stephen J.; Han, Ming-Hu; Bassel-Duby, Rhonda; Olson, Eric N.; Nestler, Eric J.			Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; DEACETYLASE INHIBITORS; DELTA-FOSB; AMPHETAMINE; EXPRESSION; ACETYLATION; ACTIVATION; GLUTAMATE; MECHANISM	Induction of histone acetylation in the nucleus accumbens (NAc), a key brain reward region, promotes cocaine-induced alterations in gene expression. Histone deacetylases (HDACs) tightly regulate the acetylation of histone tails, but little is known about the functional specificity of different HDAC isoforms in the development and maintenance of cocaine-induced plasticity, and previous studies of HDAC inhibitors report conflicting effects on cocaine-elicited behavioral adaptations. Here we demonstrate that specific and prolonged blockade of HDAC1 in NAc of mice increased global levels of histone acetylation, but also induced repressive histone methylation and antagonized cocaine-induced changes in behavior, an effect mediated in part through a chromatin-mediated suppression of GABA(A) receptor subunit expression and inhibitory tone on NAc neurons. Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction.	[Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Maze, Ian] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Chaudhury, Dipesh; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Dept Neurol, Boston, MA USA; [Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Maze, Ian/P-8077-2018; Han, Ming-Hu/G-8836-2012; Robison, Alfred J/P-8521-2018; Haggarty, Stephen J/M-9495-2016	Robison, Alfred J/0000-0002-4150-9570; Haggarty, Stephen J/0000-0002-7872-168X; Maze, Ian/0000-0003-1490-7781	US National Institute on Drug Abuse; US National Institute of Mental Health; Canadian Institutes for Health Research [MFE 90086]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301, R01DA007359, P01DA008227] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank R. Neve (Massachusetts Institute of Technology) for viral vectors and M. Baxter for statistical expertise. This work was supported by grants from the US National Institute on Drug Abuse and National Institute of Mental Health (E.J.N.) and the Canadian Institutes for Health Research (P.J.K.; MFE 90086).	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kalda A, 2007, BEHAV BRAIN RES, V181, P76, DOI 10.1016/j.bbr.2007.03.027; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim WY, 2008, NEUROSCI LETT, V432, P54, DOI 10.1016/j.neulet.2007.12.005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pierce RC, 1996, J NEUROSCI, V16, P1550; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HY, 2008, NEUROSCIENCE, V157, P644, DOI 10.1016/j.neuroscience.2008.09.019; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445	45	122	127	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					434	U95		10.1038/nn.3354	http://dx.doi.org/10.1038/nn.3354			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23475113	Green Accepted, Green Submitted			2022-12-25	WOS:000316723700013
J	Kikuta, S; Fletcher, ML; Homma, R; Yamasoba, T; Nagayama, S				Kikuta, Shu; Fletcher, Max L.; Homma, Ryota; Yamasoba, Tatsuya; Nagayama, Shin			Odorant Response Properties of Individual Neurons in an Olfactory Glomerular Module	NEURON			English	Article							NEIGHBORING MITRAL/TUFTED CELLS; EXTERNAL PLEXIFORM LAYER; TUFTED CELLS; MITRAL CELLS; BULB GLOMERULI; GRANULE CELLS; FUNCTIONAL-ORGANIZATION; COLUMNAR ORGANIZATION; ACTION-POTENTIALS; NETWORK ACTIVITY	Neuronal networks that are directly associated with glomeruli in the olfactory bulb are thought to comprise functional modules. However, this has not yet been experimentally proven. In this study, we explored the anatomical and functional architecture of glomerular modules using in vivo two-photon calcium imaging. Surprisingly, the deep portions of the glonnerular modules showed considerable spatial overlap with other modules. Juxtaglomerular cells showed similar excitatory odorant response profiles to presynaptic olfactory sensory neuron inputs. Mitral cells exhibited a more sharply tuned molecular receptive range compared to juxtaglonnerular cells, and their odorant response profiles varied depending on their interneuronal horizontal distances. These data suggest that glomerular modules are composed of functionally distinct neurons, and that homogenous odor inputs to each glomerulus may be parsed and processed in different fashions within the modules before being sent to higher olfactory centers.	[Kikuta, Shu; Homma, Ryota; Nagayama, Shin] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Kikuta, Shu; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Tokyo 1138655, Japan; [Fletcher, Max L.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA	University of Texas System; University of Texas Health Science Center Houston; University of Tokyo; University of Tennessee System; University of Tennessee Health Science Center	Nagayama, S (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA.	shin.nagayama@uth.tmc.edu		Homma, Ryota/0000-0003-3329-7958	NIH [DC010057, DC009666, DC009853]; Japan Society for Promotion of Science [24791753]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010057, R03DC009853, R01DC009666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Wei Chen for support, critical suggestions, and comments. We also thank Gordon M. Shepherd (Yale University) and Kensaku Mori (University of Tokyo) for comments on this manuscript. This work was supported by multiple NIH grants (DC010057 and DC009666 to S.N.; DC009853 to M.L.F.). S.K. was supported by multiple grants of the Japan Society for Promotion of Science (Institutional Program for Young Researcher Overseas Visits, and Young' Investigator Grants [24791753]).	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Fukunaga I, 2012, NEURON, V75, P320, DOI 10.1016/j.neuron.2012.05.017; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Griff ER, 2008, CHEM SENSES, V33, P793, DOI 10.1093/chemse/bjn040; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kim DH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00005; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; Linden JF, 2003, CEREB CORTEX, V13, P1; Liu SL, 2008, J NEUROSCI, V28, P1625, DOI 10.1523/JNEUROSCI.3906-07.2008; Lowe G, 2002, J NEUROPHYSIOL, V88, P64, DOI 10.1152/jn.2002.88.1.64; Ma J, 2010, NEUROSCIENCE, V169, P1715, DOI 10.1016/j.neuroscience.2010.06.033; MACRIDES F, 1985, CHEM SENSES, V10, P175, DOI 10.1093/chemse/10.2.175; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Naritsuka H, 2009, J COMP NEUROL, V515, P409, DOI 10.1002/cne.22063; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Shipley MT, 1996, J NEUROBIOL, V30, P123; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091	63	62	62	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1122	1135		10.1016/j.neuron.2013.01.022	http://dx.doi.org/10.1016/j.neuron.2013.01.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522047	Bronze, Green Accepted			2022-12-25	WOS:000316645000013
J	Xie, L; Gao, SB; Alcaire, SM; Aoyagi, K; Wang, Y; Griffin, JK; Stagljar, I; Nagamatsu, S; Zhen, M				Xie, Lin; Gao, Shangbang; Alcaire, Salvador M.; Aoyagi, Kyota; Wang, Ying; Griffin, Jennifer K.; Stagljar, Igor; Nagamatsu, Shinya; Zhen, Mei			NLF-1 Delivers a Sodium Leak Channel to Regulate Neuronal Excitability and Modulate Rhythmic Locomotion	NEURON			English	Article							CATION CHANNEL; ENDOPLASMIC-RETICULUM; PROTEIN INTERACTIONS; GENETIC-ANALYSIS; SPLIT-UBIQUITIN; IONIC CURRENTS; TRAFFICKING; ELEGANS; SUBUNIT; MUTATIONS	A cation channel NCA/UNC-79/UNC-80 affects neuronal activity. We report here the identification of a conserved endoplasmic reticulum protein NLF-1 (NCA localization factor-1) that regulates neuronal excitability and locomotion through the NCA channel. In C. elegans, the loss of either NLF-1 or NCA leads to a reduced sodium leak current, and a hyperpolarized resting membrane potential in premotor interneurons. This results in a decreased premotor interneuron activity that reduces the initiation and sustainability of rhythmic locomotion. NLF-1 promotes axonal localization of all NCA reporters. Its mouse homolog mNLF-1 functionally substitutes for NLF-1 in C. elegans, interacts with the mammalian sodium leak channel NALCN in vitro, and potentiates sodium leak currents in primary cortical neuron cultures. Taken together, an ER protein NLF-1 delivers a sodium leak channel to maintain neuronal excitability and potentiates a premotor interneuron network critical for C. elegans rhythmic locomotion.	[Xie, Lin; Alcaire, Salvador M.; Zhen, Mei] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Xie, Lin; Gao, Shangbang; Alcaire, Salvador M.; Wang, Ying; Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Aoyagi, Kyota; Nagamatsu, Shinya] Kyorin Univ, Sch Med, Dept Biochem, Tokyo 1818611, Japan; [Griffin, Jennifer K.] Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Stagljar, Igor] Univ Toronto, Dept Biochem, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Stagljar, Igor; Zhen, Mei] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Zhen, Mei] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Kyorin University; University of Toronto; University of Toronto; University of Toronto	Zhen, M (corresponding author), Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada.	zhen@lunenfeld.ca	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Gao, Shangbang/0000-0001-5431-4628	National Sciences and Engineering Research Council; Canadian Institute of Health Research [MOP74530, MOP123250]	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the Caenorhabditis Genetics Center and National Bioresource Project for strains, Cori Bargmann for ER and Golgi markers and UNC-2 cDNA, Mario de Bono for EGL-19::GFP strains, Mike Nonet for UNC-10 antibodies, and Dejian Ren for NALCN and mUNC-80 cDNAs. We thank Sharon Ng, Hang Li, Taizo Kawano, Zhi Xu, and Dan Zu for technical and programming support, Victoria Wong and Ria Lim for advice on MYTH and shRNA knockdown, respectively, and H. McNeill and S. Cordes for access to equipments and reagents. S.M.A. was supported by a National Sciences and Engineering Research Council postgraduate fellowship. This work was supported by the Canadian Institute of Health Research grants (MOP74530 and MOP123250) to M.Z. I.S. received Canadian Institute of Health Research grants.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Arellano-Carbajal F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001341; Basham SE, 2001, DEVELOPMENT, V128, P4645; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nicholls J., 2001, NEURON BRAIN; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Raman IM, 2000, J NEUROSCI, V20, P9004; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056	50	54	59	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2013	77	6					1069	1082		10.1016/j.neuron.2013.01.018	http://dx.doi.org/10.1016/j.neuron.2013.01.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522043	Green Submitted, Bronze			2022-12-25	WOS:000316645000009
J	Miyamoto, K; Osada, T; Adachi, Y; Matsui, T; Kimura, HM; Miyashita, Y				Miyamoto, Kentaro; Osada, Takahiro; Adachi, Yusuke; Matsui, Teppei; Kimura, Hiroko M.; Miyashita, Yasushi			Functional Differentiation of Memory Retrieval Network in Macaque Posterior Parietal Cortex	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; RECORDING SITES; CEREBRAL-CORTEX; WORKING-MEMORY; MONKEY BRAIN; MRI; REPRESENTATION	Human fMRI studies revealed involvement of the posterior parietal cortex (PPC) during memory retrieval. However, corresponding memory-related regions in macaque PPC have not been established. In this monkey fMRI study, comparisons of cortical activity during correct recognition of previously seen items and rejection of unseen items revealed two major PPC activation sites that were differentially characterized by a serial probe recognition paradigm: area PG/PGOp in inferior parietal lobule, along with the hippocampus, was more active for initial item retrieval, while area PEa/DIP in intraparietal sulcus was for the last item. Effective connectivity analyses revealed that connectivity from hippocampus to PG/PGOp, but not to PEa/DIP, increased during initial item retrieval. The two parietal areas with differential serial probe recognition profiles were embedded in two different subnetworks of the brain-wide retrieval-related regions. These functional dissociations in the macaque PPC imply the functional correspondence of retrieval-related PPC networks in macaques and humans.	[Miyamoto, Kentaro; Osada, Takahiro; Adachi, Yusuke; Matsui, Teppei; Kimura, Hiroko M.; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; [Matsui, Teppei; Miyashita, Yasushi] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Miyashita, Yasushi] JST, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Osada, Takahiro/GLU-9088-2022; Miyashita, Yasushi/B-7171-2019; ADACHI, Yusuke/O-5316-2016	Osada, Takahiro/0000-0002-3743-3200; Miyashita, Yasushi/0000-0003-3496-8637; ADACHI, Yusuke/0000-0001-8697-994X; Miyamoto, Kentaro/0000-0003-1386-0045	MEXT/JSPS KAKENHI [19002010, 24220008]; CREST, Japan Science and Technology Agency; Takeda Science Foundation; Japan Society for the Promotion of Science [234682, 201204982]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by MEXT/JSPS KAKENHI Grant Numbers 19002010 and 24220008 to Y.M., by CREST, Japan Science and Technology Agency to Y.M., by a grant from Takeda Science Foundation to Y.M., and by Japan Society for the Promotion of Science Research Fellowships for Young Scientists to K.M. (234682) and T.M. (201204982). One Japanese monkey used in this research was provided by NBRP "Japanese Monkeys" through the National BioResource Project of the MEXT. We thank Tomomi Watanabe for technical assistance and Seiki Konishi and Takamitsu Watanabe for helpful comments on the manuscript.	Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Baldo J.V., 2002, HDB MEMORY DISORDERS, P363; Basile BM, 2010, BEHAV PROCESS, V83, P183, DOI 10.1016/j.beproc.2009.12.013; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Davidson PSR, 2008, NEUROPSYCHOLOGIA, V46, P1743, DOI 10.1016/j.neuropsychologia.2008.01.011; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Huijbers W, 2010, NEUROPSYCHOLOGIA, V48, P491, DOI 10.1016/j.neuropsychologia.2009.10.006; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Kagan I, 2010, P NATL ACAD SCI USA, V107, P7933, DOI 10.1073/pnas.1002825107; Kamigaki T, 2009, NEURON, V61, P941, DOI 10.1016/j.neuron.2009.01.028; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Koyano KW, 2011, J NEUROPHYSIOL, V105, P1380, DOI 10.1152/jn.00358.2010; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Matsui T, 2007, NAT METHODS, V4, P161, DOI 10.1038/nmeth987; Matsui T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047515; Matsui T, 2011, CEREB CORTEX, V21, P2348, DOI 10.1093/cercor/bhr019; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Nelissen K, 2011, J NEUROSCI, V31, P3743, DOI 10.1523/JNEUROSCI.4803-10.2011; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Talmi D, 2005, PSYCHOL SCI, V16, P716, DOI 10.1111/j.1467-9280.2005.01601.x; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; WRIGHT AA, 1985, SCIENCE, V229, P287, DOI 10.1126/science.9304205; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	60	24	24	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					787	799		10.1016/j.neuron.2012.12.019	http://dx.doi.org/10.1016/j.neuron.2012.12.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439129	Bronze			2022-12-25	WOS:000315561300019
J	Chen, ZN; Hendricks, M; Cornils, A; Maier, W; Alcedo, J; Zhang, Y				Chen, Zhunan; Hendricks, Michael; Cornils, Astrid; Maier, Wolfgang; Alcedo, Joy; Zhang, Yun			Two Insulin-like Peptides Antagonistically Regulate Aversive Olfactory Learning in C. elegans	NEURON			English	Article							LONG-RANGE ACTION; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; NERVOUS-SYSTEM; NEURAL CIRCUIT; FAMILY-MEMBER; RECEPTOR; GROWTH; LONGEVITY	The insulin/insulin-like peptides (ILPs) regulate key events in physiology, including neural plasticity. However, the cellular and circuit mechanisms whereby ILPs regulate learning remain largely unknown. Here, we characterize two ILPs that play antagonistic roles in aversive olfactory learning of C. elegans. We show that the I LP ins-6 acts from ASI sensory neurons to enable learning by repressing the transcription of another ILP, ins-7, specifically in URX neurons. A high level of INS-7 from URX disrupts learning by antagonizing the insulin receptor-like homolog DAF-2 in the postsynaptic neurons RIA, which play an essential role in the neural circuit underlying olfactory learning. We also show that increasing URX-generated INS-7 and loss of INS-6, both of which abolish learning, alter RIA neuronal property. Together, our results reveal an "ILP-to-ILP" pathway that links environment-sensing neurons, ASI and URX, to the key neuron, RIA, of a network that underlies olfactory plasticity and modulates its activity.	[Chen, Zhunan; Hendricks, Michael; Zhang, Yun] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Cornils, Astrid; Maier, Wolfgang; Alcedo, Joy] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Alcedo, Joy] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Harvard University; Friedrich Miescher Institute for Biomedical Research; Wayne State University	Zhang, Y (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	yzhang@oeb.harvard.edu		Alcedo, Joy/0000-0002-5279-6640; Maier, Wolfgang/0000-0002-9464-6640; Hendricks, Michael/0000-0002-3408-3858	NIH Office of Research Infrastructure [P40 OD010440]; Novartis Research Foundation; Wayne State University; Esther A. and Joseph Klingenstein Fund; March of Dimes Foundation; Alfred P. Sloan Foundation; John Merck Fund; NIH [R01 DC009852]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009852] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure; Novartis Research Foundation; Wayne State University; Esther A. and Joseph Klingenstein Fund(Klingenstein Philanthropies); March of Dimes Foundation(March of Dimes); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); John Merck Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure (P40 OD010440), for strains, S. Mitani for tm2416, tm2001, tm1907, and tm2308, G. Ruvkun for GR1333, C. Kenyon for the daf-16::gfp strain, and I. Katic and J.-L. Bessereau for daf-2 cDNA constructs. This work was supported by funding from the Novartis Research Foundation and Wayne State University to J.A. and The Esther A. and Joseph Klingenstein Fund, March of Dimes Foundation, The Alfred P. Sloan Foundation, The John Merck Fund and NIH (R01 DC009852) to Y.Z. Y.Z. conceived of the study; Z.C., M.H., J.A., and Y.Z. designed experiments, analyzed data, and co-wrote the paper; all authors performed the experiments.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alvino CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027488; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Edwards RH, 1998, CURR BIOL, V8, pR883, DOI 10.1016/S0960-9822(07)00551-9; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu Changlu, 2008, V46, P213, DOI 10.1007/400_2007_055; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	57	65	71	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					572	585		10.1016/j.neuron.2012.11.025	http://dx.doi.org/10.1016/j.neuron.2012.11.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395381	Green Accepted, Bronze			2022-12-25	WOS:000317030800017
J	Villar-Cervino, V; Molano-Mazon, M; Catchpole, T; Valdeolmillos, M; Henkemeyer, M; Martinez, LM; Borrell, V; Marin, O				Villar-Cervino, Verona; Molano-Mazon, Manuel; Catchpole, Timothy; Valdeolmillos, Miguel; Henkemeyer, Mark; Martinez, Luis M.; Borrell, Victor; Marin, Oscar			Contact Repulsion Controls the Dispersion and Final Distribution of Cajal-Retzius Cells	NEURON			English	Article							DEVELOPING CEREBRAL-CORTEX; EPH RECEPTORS; AXON GUIDANCE; GABAERGIC INTERNEURONS; DEVELOPING NEOCORTEX; COMMISSURAL AXONS; ONE CENTURY; SHORT-RANGE; MIGRATION; NEURONS	Cajal-Retzius (CR) cells play a fundamental role in the development of the mammalian cerebral cortex. They control the formation of cortical layers by regulating the migration of pyramidal cells through the release of Reelin. The function of CR cells critically depends on their regular distribution throughout the surface of the cortex, but little is known about the events controlling this phenomenon. Using time-lapse video microscopy in vivo and in vitro, we found that movement of CR cells is regulated by repulsive interactions, which leads to their random dispersion throughout the cortical surface. Mathematical modeling reveals that contact repulsion is both necessary and sufficient for this process, which demonstrates that complex neuronal assemblies may emerge during development through stochastic events. At the molecular level, we found that contact repulsion is mediated by Eph/ephrin interactions. Our observations reveal a mechanism that controls the even distribution of neurons in the developing brain.	[Villar-Cervino, Verona; Molano-Mazon, Manuel; Valdeolmillos, Miguel; Martinez, Luis M.; Borrell, Victor; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Villar-Cervino, Verona; Molano-Mazon, Manuel; Valdeolmillos, Miguel; Martinez, Luis M.; Borrell, Victor; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Catchpole, Timothy; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Catchpole, Timothy; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es	Borrell, Victor/U-1802-2017; Villar-Cerviño, Verona/K-6380-2014; Valdeolmillos, Miguel/G-3223-2015; Marin, Oscar/F-3856-2012	Borrell, Victor/0000-0002-7833-3978; Valdeolmillos, Miguel/0000-0001-9885-6699; Marin, Oscar/0000-0001-6264-7027; Molano Mazon, Manuel/0000-0002-9140-3571; Henkemeyer, Mark/0000-0002-7525-1061	Spanish Ministry of Science and Innovation [SAF2011-28845, CSD2007-00023]; National Institutes of Health [R01 MH66332]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Casillas for excellent technical assistance, T. Gil and M. Perez for lab support, U. Drescher, E. Herrera, J.L R. Rubenstein, A. Wanaka, and D. Wilkinson for plasmids, and G. Fishell (RCE) and J.Z. Huang (Calretinin-Cre) for mouse colonies. We are grateful to B. Hassan, M. Maravall, M.A. Nieto for critical reading of the manuscript and members of the Borrell, Mann, and Rico laboratories for stimulating discussions and ideas. This work was supported by grants from Spanish Ministry of Science and Innovation SAF2011-28845 and CONSOLIDER CSD2007-00023 to O.M. and from the National Institutes of Health (R01 MH66332) to M.H. V.V.-C. was a "Junta de Ampliacion de Estudios" (JAE) postdoctoral fellow from the Consejo Superior de Investigaciones Cientificas and is now a "Juan de la Cierva" postdoctoral fellow from the Ministerio de Economia e Innovacion.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Alcantara S, 2006, CEREB CORTEX, V16, P487, DOI 10.1093/cercor/bhi128; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Espinosa A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.027.2009; Fairen A, 2002, PROG BRAIN RES, V136, P281; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; GalliResta L, 1997, J NEUROSCI, V17, P7831; Griveau A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000440; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Kao TJ, 2012, SEMIN CELL DEV BIOL, V23, P83, DOI 10.1016/j.semcdb.2011.10.016; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Martini FJ, 2009, DEVELOPMENT, V136, P41, DOI 10.1242/dev.025502; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Suetterlin P, 2012, SEMIN CELL DEV BIOL, V23, P1, DOI 10.1016/j.semcdb.2011.10.015; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Teddy JM, 2004, DEVELOPMENT, V131, P6141, DOI 10.1242/dev.01534; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209	58	72	72	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 6	2013	77	3					457	471		10.1016/j.neuron.2012.11.023	http://dx.doi.org/10.1016/j.neuron.2012.11.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395373	Green Accepted, Bronze			2022-12-25	WOS:000317030800009
J	Wragg, RT; Snead, D; Dong, YM; Ramlall, TF; Menon, I; Bai, JH; Eliezer, D; Dittman, JS				Wragg, Rachel T.; Snead, David; Dong, Yongming; Ramlall, Trudy F.; Menon, Indu; Bai, Jihong; Eliezer, David; Dittman, Jeremy S.			Synaptic Vesicles Position Complexin to Block Spontaneous Fusion	NEURON			English	Article							TRANSMISSION; SYNAPTOTAGMIN; ABUNDANCE; PROTEINS; SYNAPTOBREVIN; LOCALIZATION; RECEPTORS; SYNAPSES; RELEASE; BINDING	Synapses continually replenish their synaptic vesicle (SV) pools while suppressing spontaneous fusion events, thus maintaining a high dynamic range in response to physiological stimuli. The presynaptic protein complexin can both promote and inhibit fusion through interactions between its a-helical domain and the SNARE complex. In addition, complexin's C-terminal half is required for the inhibition of spontaneous fusion in worm, fly, and mouse, although the molecular mechanism remains unexplained. We show here that complexin's C-terminal domain binds lipids through a novel protein motif, permitting complexin to inhibit spontaneous exocytosis in vivo by targeting complexin to SVs. We propose that the SV pool serves as a platform to sequester and position complexin where it can intercept the rapidly assembling SNAREs and control the rate of spontaneous fusion.	[Wragg, Rachel T.; Snead, David; Ramlall, Trudy F.; Menon, Indu; Eliezer, David; Dittman, Jeremy S.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Dong, Yongming; Bai, Jihong] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Cornell University; Fred Hutchinson Cancer Center	Dittman, JS (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	jed2019@med.cornell.edu	Dong, Yongming/H-9502-2013	Dong, Yongming/0000-0002-6510-0913; Dittman, Jeremy S./0000-0002-3850-9078	National Institutes of Health [R01-GM095674, R00-MH085039, R37-AG019391, 5R01GM71041, MSTP GM07739]; Rita Allen Foundation [188423]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095674, T32GM007739, R01GM071041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Tim Ryan, Anant Menon, Josh Kaplan, Daniel Radoff, Richard Komuniecki, and Michael Hoppa for advice and for critically reading the manuscript, as well as the anonymous reviewers for their helpful suggestions. This work was supported by National Institutes of Health grants R01-GM095674 (J.S.D.), R00-MH085039 (J.B.), R37-AG019391 (D.E.), 5R01GM71041(I.M.), MSTP GM07739 (D.S.), a gift from Herbert and Ann Siegel (D.E.), and the Rita Allen Foundation Award 188423 (J.S.D.).	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chicka MC, 2009, BIOCHEMISTRY-US, V48, P657, DOI 10.1021/bi801962d; Cho RW, 2010, MOL CELL NEUROSCI, V45, P389, DOI 10.1016/j.mcn.2010.07.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hobson RJ, 2011, CURR BIOL, V21, P106, DOI 10.1016/j.cub.2010.12.015; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaeser-Woo YJ, 2012, J NEUROSCI, V32, P2877, DOI 10.1523/JNEUROSCI.3360-11.2012; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Krishnakumar SS, 2011, NAT STRUCT MOL BIOL, V18, P934, DOI 10.1038/nsmb.2103; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Landgraf I, 2012, EUR J NEUROSCI, V36, P2470, DOI 10.1111/j.1460-9568.2012.08149.x; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Nonet ML, 1998, J NEUROSCI, V18, P70; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Prescott ED, 2005, CURR OPIN NEUROBIOL, V15, P431, DOI 10.1016/j.conb.2005.07.005; RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2009, J CELL SCI, V122, P1352, DOI 10.1242/jcs.045401; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seiler F, 2009, FEBS LETT, V583, P2343, DOI 10.1016/j.febslet.2009.06.025; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Wichmann C, 2010, J NEUROGENET, V24, P133, DOI 10.3109/01677063.2010.489626; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	50	60	62	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					323	334		10.1016/j.neuron.2012.11.005	http://dx.doi.org/10.1016/j.neuron.2012.11.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352168	Bronze, Green Accepted			2022-12-25	WOS:000314199400014
J	Crowe, DA; Goodwin, SJ; Blackman, RK; Sakellaridi, S; Sponheim, SR; MacDonald, AW; Chafee, MV				Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Sakellaridi, Sofia; Sponheim, Scott R.; MacDonald, Angus W., III; Chafee, Matthew V.			Prefrontal neurons transmit signals to parietal neurons that reflect executive control of cognition	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL; CORTICOCORTICAL CONNECTIONS; DECISION-MAKING; NEURAL ACTIVITY; WORKING-MEMORY; RHESUS-MONKEY; CORTEX; ATTENTION; REPRESENTATION; CORTICES	Prefrontal cortex influences behavior largely through its connections with other association cortices; however, the nature of the information conveyed by prefrontal output signals and what effect these signals have on computations performed by target structures is largely unknown. To address these questions, we simultaneously recorded the activity of neurons in prefrontal and posterior parietal cortices of monkeys performing a rule-based spatial categorization task. Parietal cortex receives direct prefrontal input, and parietal neurons, like their prefrontal counterparts, exhibit signals that reflect rule-based cognitive processing in this task. By analyzing rapid fluctuations in the cognitive information encoded by activity in the two areas, we obtained evidence that signals reflecting rule-dependent categories were selectively transmitted in a top-down direction from prefrontal to parietal neurons, suggesting that prefrontal output is important for the executive control of distributed cognitive processing.	[Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Chafee, Matthew V.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Sakellaridi, Sofia; Sponheim, Scott R.; Chafee, Matthew V.] Vet Affairs Med Ctr, Brain Sci Ctr, Minneapolis, MN USA; [Crowe, David A.] Augsburg Coll, Dept Biol, Minneapolis, MN USA; [Blackman, Rachael K.] Univ Minnesota, Med Scientist Training Program MD PhD, Minneapolis, MN USA; [Sakellaridi, Sofia; MacDonald, Angus W., III; Chafee, Matthew V.] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN USA; [Sponheim, Scott R.; MacDonald, Angus W., III] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [MacDonald, Angus W., III] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Augsburg University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chafee, MV (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	chafe001@umn.edu	MacDonald, Angus/M-9855-2016; Sponheim, Scott/J-3857-2017	MacDonald, Angus/0000-0003-4588-931X; Sponheim, Scott/0000-0002-2782-0856; Goodwin, Shikha/0000-0001-9935-4359	US National Institutes of Health [R01 MH077779, R24MH069675, T32 GM008244]; Department of Veterans Affairs; American Legion Brain Sciences Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077779, R24MH069675] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Legion Brain Sciences Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Georgopoulos for fundamental intellectual contributions to, and longstanding support of, this work. We thank P. Goldman-Rakic for critical insights into the network basis of prefrontal cortex function that strongly influenced this study. We thank D. Evans and D. Boeff for excellent technical assistance. We thank J. Ortiz and S. Te Nelson for assistance in training of nonhuman primates. Supported by the US National Institutes of Health (grant R01 MH077779 and R24MH069675), the Department of Veterans Affairs and the American Legion Brain Sciences Chair. R.K. Blackman was supported by US National Institutes of Health grant T32 GM008244. The views and opinions expressed in this work are those of the authors solely and not those of the United States Federal Government.	ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Christova P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046025; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fitzgerald JK, 2013, NEURON, V77, P180, DOI 10.1016/j.neuron.2012.11.014; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Goodwin SJ, 2012, J NEUROSCI, V32, P3499, DOI 10.1523/JNEUROSCI.3585-11.2012; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Granger C. W. J., 1986, FORECASTING EC TIME, DOI 10.1016/B978-0-12-295183-1.50013-3; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Medalla M, 2006, EUR J NEUROSCI, V23, P161, DOI 10.1111/j.1460-9568.2005.04522.x; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Nee DE, 2013, CEREB CORTEX, V23, P2146, DOI 10.1093/cercor/bhs194; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Qi XL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00012; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Vallentin D, 2010, EUR J NEUROSCI, V32, P1380, DOI 10.1111/j.1460-9568.2010.07427.x	34	96	96	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1484	+		10.1038/nn.3509	http://dx.doi.org/10.1038/nn.3509			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995071	Green Accepted			2022-12-25	WOS:000324795300022
J	Wang, WY; Pan, L; Su, SC; Quinn, EJ; Sasaki, M; Jimenez, JC; Mackenzie, IRA; Huang, EJ; Tsai, LH				Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Mackenzie, Ian R. A.; Huang, Eric J.; Tsai, Li-Huei			Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PRO-ONCOPROTEIN TLS/FUS; STRAND BREAK REPAIR; RNA-BINDING PROTEIN; GENOMIC STABILITY; DENDRITIC SPINES; MAMMALIAN-CELLS; DISEASE; CHROMATIN; MICE	Defects in DNA repair have been extensively linked to neurodegenerative diseases, but the exact mechanisms remain poorly understood. We found that FUS, an RNA/DNA-binding protein that has been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, is important for the DNA damage response (DDR). The function of FUS in DDR involved a direct interaction with histone deacetylase 1 (HDAC1), and the recruitment of FUS to double-stranded break sites was important for proper DDR signaling. Notably, FUS proteins carrying familial ALS mutations were defective in DDR and DNA repair and showed a diminished interaction with HDAC1. Moreover, we observed increased DNA damage in human ALS patients harboring FUS mutations. Our findings suggest that an impaired DDR and DNA repair may contribute to the pathogenesis of neurodegenerative diseases linked to FUS mutations.	[Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mackenzie, Ian R. A.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Huang, Eric J.] VA Med Ctr, Pathol Serv, San Francisco, CA USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; University of British Columbia; University of California System; University of California San Francisco	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Huang, Eric J./AAH-7997-2019; Pan, Ling/K-9333-2013	Huang, Eric J./0000-0002-5381-3801; Pan, Ling/0000-0001-9947-9071	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke [NS078839]; Department of Veterans Affairs [BX001108]; Muscular Dystrophy Association [MDA217592]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD011915] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001108, I21BX001625] Funding Source: NIH RePORTER	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Muscular Dystrophy Association(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank T. Misteli (National Cancer Institute) for kindly providing the NIH2/4 cell line and Lac-R constructs, M. Dobbin (Massachusetts Institute of Technology) for technical assistance on microirradiation experiments, A. Mungenast, R. Madabhushi, A. Bero, J. Penney and A. Nott for critical reading of the manuscript, and other members of the Tsai and Huang laboratories for helpful discussions. We also thank R.H. Brown Jr and L.J. Hayward for insightful discussions. W.-Y.W. was supported by a Postdoctoral Fellowship from the Simons Foundation, J.C.J. was supported by the Howard Hughes Medical Institute Exceptional Research Opportunities Program. This work is also supported by grants from National Institute of Neurological Disorders and Stroke (NS078839 to L.-H.T.), the Department of Veterans Affairs (BX001108 to E.J.H.) and the Muscular Dystrophy Association (MDA217592 to E.J.H.). L.-H.T. is a member of the Neurodegeneration Consortium. E.J.H. is a member of the Consortium for Frontotemporal Dementia Research. L.-H.T. receives funding from the Howard Hughes Medical Institute.	Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Keramaris E, 2003, J BIOL CHEM, V278, P37782, DOI 10.1074/jbc.M304049200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Millecamps S, 2012, J MED GENET, V49, P258, DOI 10.1136/jmedgenet-2011-100699; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.001; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	50	257	260	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1383	+		10.1038/nn.3514	http://dx.doi.org/10.1038/nn.3514			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036913	Green Accepted			2022-12-25	WOS:000324795300010
J	Mazzoni, EO; Mahony, S; Closser, M; Morrison, CA; Nedelec, S; Williams, DJ; An, DS; Gifford, DK; Wichterle, H				Mazzoni, Esteban O.; Mahony, Shaun; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Williams, Damian J.; An, Disi; Gifford, David K.; Wichterle, Hynek			Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; DIRECT CONVERSION; SPINAL-CORD; HUMAN FIBROBLASTS; DEFINED FACTORS; PHOX2 GENES; EXPRESSION; MOUSE; MOTONEURONS; DIFFERENTIATION	Efficient transcriptional programming promises to open new frontiers in regenerative medicine. However, mechanisms by which programming factors transform cell fate are unknown, preventing more rational selection of factors to generate desirable cell types. Three transcription factors, Ngn2, Isl1 and Lhx3, were sufficient to program rapidly and efficiently spinal motor neuron identity when expressed in differentiating mouse embryonic stem cells. Replacement of Lhx3 by Phox2a led to specification of cranial, rather than spinal, motor neurons. Chromatin immunoprecipitation-sequencing analysis of Isl1, Lhx3 and Phox2a binding sites revealed that the two cell fates were programmed by the recruitment of Isl1-Lhx3 and Isl1-Phox2a complexes to distinct genomic locations characterized by a unique grammar of homeodomain binding motifs. Our findings suggest that synergistic interactions among transcription factors determine the specificity of their recruitment to cell type-specific binding sites and illustrate how a single transcription factor can be repurposed to program different cell types.	[Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurol,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurosci,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; An, Disi] NYU, Dept Biol, New York, NY 10003 USA; [Mahony, Shaun; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mahony, Shaun] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Williams, Damian J.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University; Columbia University; New York University; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University	Mazzoni, EO (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA.	eom204@nyu.edu; gifford@mit.edu; hw350@columbia.edu	Mahony, Shaun/C-5699-2014; Young, Richard A/F-6495-2012; Nedelec, Stéphane/G-8469-2017; Williams, Damian/K-4023-2014; Martinat, Cecile/F-6777-2010	Mahony, Shaun/0000-0002-2641-1807; Young, Richard A/0000-0001-8855-8647; Nedelec, Stéphane/0000-0001-8044-2498; Martinat, Cecile/0000-0002-5234-1064; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080; Williams, Damian/0000-0001-5891-6300; An, Disi/0000-0002-3821-7497	Damon Runyon Cancer Research Foundation [DRG-1937-07]; Project ALS foundation; US National Institutes of Health [P01 NS055923, R01 NS078097]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R01NS078097] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Project ALS foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank I. Lieberam (King's College) for assistance introducing the Hb9-GFP transgene, members of the Wichterle laboratory for helpful comments, S. Brenner-Morton and T. Jessell (Columbia University) for sharing clones of Isl monoclonal antibodies, J.-F. Brunet for Phox2a and Phox2b antibodies, and I. Schieren for technical assistance with flow cytometry. E.O.M. receives funding from the Damon Runyon Cancer Research Foundation (DRG-1937-07). Personnel and work were supported by the Project ALS foundation and US National Institutes of Health grants P01 NS055923 (D.K.G. and H.W.) and R01 NS078097 (H.W.).	Albuquerque C., 2009, COLD SPRING HARBOR P, V8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Grillet N, 2003, J NEUROSCI, V23, P10613; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hasan KB, 2010, DEVELOPMENT, V137, P1205, DOI 10.1242/dev.041251; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hirsch MR, 2007, DEV BIOL, V303, P687, DOI 10.1016/j.ydbio.2006.12.006; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2012, P NATL ACAD SCI USA, V109, P3383, DOI 10.1073/pnas.1114515109; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2009, V482, P171, DOI 10.1007/978-1-59745-060-7_11; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	49	132	136	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1219	U86		10.1038/nn.3467	http://dx.doi.org/10.1038/nn.3467			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872598	Green Accepted, Green Published			2022-12-25	WOS:000323597500013
J	Xiong, XRR; Liang, FX; Li, HF; Mesik, L; Zhang, KK; Polley, DB; Tao, HZW; Xiao, ZJ; Zhang, LI				Xiong, Xiaorui R.; Liang, Feixue; Li, Haifu; Mesik, Lukas; Zhang, Ke K.; Polley, Daniel B.; Tao, Huizhong W.; Xiao, Zhongju; Zhang, Li I.			Interaural Level Difference-Dependent Gain Control and Synaptic Scaling Underlying Binaural Computation	NEURON			English	Article							SOUND PRESSURE LEVEL; INFERIOR COLLICULUS; INTRACELLULAR-RECORDINGS; CENTRAL NUCLEUS; FREQUENCY REPRESENTATION; ASCENDING PROJECTIONS; INTENSITY DISPARITIES; RESPONSE PROPERTIES; AUDITORY MIDBRAIN; TUNING CURVES	Binaural integration in the central nucleus of inferior colliculus (ICC) plays a critical role in sound localization. However, its arithmetic nature and underlying synaptic mechanisms remain unclear. Here, we showed in mouse ICC neurons that the contralateral dominance is created by a "push-pull"-like mechanism, with contralaterally dominant excitation and more bilaterally balanced inhibition. Importantly, binaural spiking response is generated apparently from an ipsilaterally mediated scaling of contralateral response, leaving frequency tuning unchanged. This scaling effect is attributed to a divisive attenuation of contralaterally evoked synaptic excitation onto ICC neurons with their inhibition largely unaffected. Thus, a gain control mediates the linear transformation from monaural to binaural spike responses. The gain value is modulated by interaural level difference (ILD) primarily through scaling excitation to different levels. The ILD-dependent synaptic scaling and gain adjustment allow ICC neurons to dynamically encode interaural sound localization cues while maintaining an invariant representation of other independent sound attributes.	[Xiong, Xiaorui R.; Mesik, Lukas; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Xiong, Xiaorui R.; Mesik, Lukas] Univ So Calif, Keck Sch Med, Neurosci Grad Program, Los Angeles, CA 90033 USA; [Xiong, Xiaorui R.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Liang, Feixue; Li, Haifu; Xiao, Zhongju] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China; [Polley, Daniel B.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; [Zhang, Ke K.] Univ N Dakota, Dept Pathol, Grand Forks, ND 58202 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Southern Medical University - China; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; University of North Dakota Grand Forks	Xiao, ZJ (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China.	xiaozj@fimmu.com; liizhang@usc.edu	Tao, Huizhong W/HDM-9767-2022; Li, Haifu/AAI-5869-2020	Polley, Daniel/0000-0002-5120-2409	US National Institutes of Health (NIH) [R01DC008983]; David and Lucile Packard Foundation; NIH [R01EY019049, R01DC009836, P20RR016471, P20GM103442]; China NSF [31228013, 31171059, 31200831]; 973 program [2014CB943002]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016471] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983, R01DC009836] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China NSF(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to L.I.Z. from the US National Institutes of Health (NIH; R01DC008983) and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). H.W.T. was supported by an NIH grant R01EY019049. D.B.P was supported by an NIH grant R01DC009836. K.K.Z was supported by NIH grants P20RR016471 and P20GM103442. Z.X., L.I.Z., and F.L. were supported by China NSF grants (31228013, 31171059, 31200831) and a 973 program (2014CB943002).	ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; CANT NB, 1986, J COMP NEUROL, V247, P457, DOI 10.1002/cne.902470406; Carandini M, 1997, J NEUROSCI, V17, P8621; Casseday JH, 2005, INFERIOR COLLICULUS, P626, DOI 10.1007/0-387-27083-3_22; Casseday JH, 2002, SPR HDB AUD, V15, P238; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chase SM, 2005, J NEUROSCI, V25, P7575, DOI 10.1523/JNEUROSCI.0915-05.2005; Covey E, 1996, J NEUROSCI, V16, P3009; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; Efron B., 1994, INTRO BOOTSTRAP; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HELFERT RH, 1997, CENTRAL AUDITORY SYS, P193; Hines M., 1993, NEURON PROGRAM SIMUL; IRVINE DRF, 1990, J NEUROPHYSIOL, V63, P570, DOI 10.1152/jn.1990.63.3.570; KAVANAGH GL, 1992, J NEUROPHYSIOL, V67, P1643, DOI 10.1152/jn.1992.67.6.1643; KELLY JB, 1991, HEARING RES, V56, P273, DOI 10.1016/0378-5955(91)90177-B; KELLY JB, 1991, HEARING RES, V55, P39, DOI 10.1016/0378-5955(91)90089-R; Kudo M, 1987, AUDITORY PATHWAY STR, P171; Kuo RI, 2012, NEURON, V73, P1016, DOI 10.1016/j.neuron.2011.11.035; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; Kuwada S, 1997, J NEUROSCI, V17, P7565; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li N, 2013, J NEUROSCI, V33, P6367, DOI 10.1523/JNEUROSCI.5735-12.2013; Li N, 2010, J NEUROSCI, V30, P14573, DOI 10.1523/JNEUROSCI.2228-10.2010; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; MOORE MJ, 1983, J NEUROSCI, V3, P237; OLIVER DL, 1991, J COMP NEUROL, V303, P75, DOI 10.1002/cne.903030108; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Peterson DC, 2008, J NEUROPHYSIOL, V100, P629, DOI 10.1152/jn.90390.2008; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Pollak GD, 2012, HEARING RES, V288, P47, DOI 10.1016/j.heares.2012.01.011; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Priebe NJ, 2008, J NEUROSCI, V28, P8553, DOI 10.1523/JNEUROSCI.2182-08.2008; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; ROSS LS, 1989, J NEUROSCI, V9, P2819; ROTH GL, 1978, J COMP NEUROL, V182, P661, DOI 10.1002/cne.901820407; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Schumacher JW, 2011, J NEUROPHYSIOL, V106, P500, DOI 10.1152/jn.01072.2010; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; SEMPLE MN, 1985, J NEUROPHYSIOL, V53, P1467, DOI 10.1152/jn.1985.53.6.1467; SEMPLE MN, 1987, J NEUROPHYSIOL, V57, P1130, DOI 10.1152/jn.1987.57.4.1130; STIEBLER I, 1985, J COMP NEUROL, V238, P65, DOI 10.1002/cne.902380106; Stuart G, 1998, J NEUROSCI, V18, P3501; Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; VATER M, 1992, J COMP PHYSIOL A, V171, P541; WENSTRUP JJ, 1988, J NEUROPHYSIOL, V60, P1369, DOI 10.1152/jn.1988.60.4.1369; WILLOTT JF, 1984, BRAIN RES, V309, P159, DOI 10.1016/0006-8993(84)91022-9; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zhou M, 2012, J NEUROSCI, V32, P18068, DOI 10.1523/JNEUROSCI.3647-12.2012; Zhou Y, 2012, J NEUROSCI, V32, P9969, DOI 10.1523/JNEUROSCI.1384-12.2012; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	64	50	50	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					738	753		10.1016/j.neuron.2013.06.012	http://dx.doi.org/10.1016/j.neuron.2013.06.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972599	Green Accepted, Bronze			2022-12-25	WOS:000323587000013
J	Kastner, DB; Baccus, SA				Kastner, David B.; Baccus, Stephen A.			Spatial Segregation of Adaptation and Predictive Sensitization in Retinal Ganglion Cells	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; SLOW CONTRAST ADAPTATION; NATURAL IMAGES; VARIANCE ADAPTATION; VISUAL-SYSTEM; BIPOLAR CELLS; AMACRINE CELL; NEURONS; OBJECT; FIELD	Sensory systems change their sensitivity based on recent stimuli to adjust their response range to the range of inputs and to predict future sensory input. Here, we report the presence of retinal ganglion cells that have antagonistic plasticity, showing central adaptation and peripheral sensitization. Ganglion cell responses were captured by a spatiotemporal model with independently adapting excitatory and inhibitory subunits, and sensitization requires GABAergic inhibition. Using a simple theory of signal detection, we show that the sensitizing surround conforms to an optimal inference model that continually updates the prior signal probability. This indicates that small receptive field regions have dual functionality to adapt to the local range of signals but sensitize based upon the probability of the presence of that signal. Within this framework, we show that sensitization predicts the location of a nearby object, revealing prediction as a functional role for adapting inhibition in the nervous system.	[Kastner, David B.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Baccus, Stephen A.] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Baccus, SA (corresponding author), Stanford Univ, Sch Med, Neurosci Program, 299 Campus Dr West, Stanford, CA 94305 USA.	baccus@stanford.edu		Kastner, David/0000-0001-9681-425X	National Eye Institute; Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Alfred P. Sloan Foundation; E. Matilda Ziegler Foundation; Stanford Medical Scientist Training Program; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY022933] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); E. Matilda Ziegler Foundation; Stanford Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Baylor, R.W. Tsien, B. Wendell, A.L. Fairhall, and P. Jadzinsky for helpful discussions. This work was supported by grants from the National Eye Institute, Pew Charitable Trusts, the McKnight Endowment Fund for Neuroscience, the Alfred P. Sloan Foundation, and the E. Matilda Ziegler Foundation (S.A.B.); by the Stanford Medical Scientist Training Program, and a National Science Foundation Integrative Graduate Education and Research Traineeship graduate fellowship (D.B.K.). D.B.K. and S.A.B. designed the study, D.B.K. performed the experiments and analysis, and D.B.K. and S.A.B. wrote the manuscript.	Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Bolinger D, 2012, NEURON, V73, P333, DOI 10.1016/j.neuron.2011.10.039; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; BOWER TGR, 1967, PERCEPT PSYCHOPHYS, V2, P411, DOI 10.3758/BF03208778; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Camp AJ, 2009, J NEUROSCI, V29, P5009, DOI 10.1523/JNEUROSCI.0219-09.2009; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; de Vries SEJ, 2011, J NEUROSCI, V31, P8595, DOI 10.1523/JNEUROSCI.5662-10.2011; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Garvert MM, 2013, NEURON, V77, P915, DOI 10.1016/j.neuron.2012.12.030; Geisler WS, 2009, VISUAL NEUROSCI, V26, P109, DOI 10.1017/S0952523808080875; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jarsky T, 2011, J NEUROSCI, V31, P11003, DOI 10.1523/JNEUROSCI.2631-11.2011; Kastner DB, 2011, NAT NEUROSCI, V14, P1317, DOI 10.1038/nn.2906; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Li GL, 2007, J NEUROSCI, V27, P7377, DOI 10.1523/JNEUROSCI.0410-07.2007; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1202, DOI 10.1523/JNEUROSCI.14-03-01202.1994; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Manu M, 2011, P NATL ACAD SCI USA, V108, P18447, DOI 10.1073/pnas.1107994108; Nikolaev A., 2013, NAT NEUROSCI; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Ozuysal Y, 2012, NEURON, V73, P1002, DOI 10.1016/j.neuron.2011.12.029; Pitkow X, 2012, NAT NEUROSCI, V15, P628, DOI 10.1038/nn.3064; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Sagdullaev BT, 2011, J NEUROSCI, V31, P15102, DOI 10.1523/JNEUROSCI.1801-11.2011; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; Stocker A., 2006, ADV NEURAL INFORM PR, V18, P1289; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Wissig SC, 2012, J NEUROPHYSIOL, V107, P3370, DOI 10.1152/jn.00739.2011; Zaghloul KA, 2003, J NEUROSCI, V23, P2645; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	57	32	32	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					541	554		10.1016/j.neuron.2013.06.011	http://dx.doi.org/10.1016/j.neuron.2013.06.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23932000	Green Accepted, Bronze			2022-12-25	WOS:000323085100014
J	Soler-Llavina, GJ; Arstikaitis, P; Morishita, W; Ahmad, M; Sudhof, TC; Malenka, RC				Soler-Llavina, Gilberto J.; Arstikaitis, Pamela; Morishita, Wade; Ahmad, Mohiuddin; Suedhof, Thomas C.; Malenka, Robert C.			Leucine-Rich Repeat Transmembrane Proteins Are Essential for Maintenance of Long-Term Potentiation	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; EXCITATORY SYNAPSE FORMATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; NMDA-RECEPTOR; LTP REQUIRES; PLASTICITY; MEMORY; NEUROLIGINS; NEUREXINS	Leucine-rich repeat transmembrane proteins (LRRTMs) are synaptic cell adhesion molecules that trigger excitatory synapse assembly in cultured neurons and influence synaptic function in vivo, but their role in synaptic plasticity is unknown. shRNA-mediated knockdown (KD) of LRRTM1 and LRRTM2 in vivo in CA1 pyramidal neurons of newborn mice blocked long-term potentiation (LTP) in acute hippocampal slices. Molecular replacement experiments revealed that the LRRTM2 extracellular domain is sufficient for LTP, probably because it mediates binding to neurexins (Nrxs). Examination of surface expression of endogenous AMPA receptors (AMPARs) in cultured neurons suggests that LRRTMs maintain newly delivered AMPARs at synapses after LTP induction. LRRTMs are also required for LTP of mature synapses on adult CA1 pyramidal neurons, indicating that the block of LTP in neonatal synapses by LRRTM1 and LRRTM2 KD is not due to impairment of synapse maturation.	[Soler-Llavina, Gilberto J.; Arstikaitis, Pamela; Morishita, Wade; Ahmad, Mohiuddin; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Arstikaitis, Pamela; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Ahmad, Mohiuddin/H-7295-2015	Ahmad, Mohiuddin/0000-0002-0976-9620	NIH [MH063394, MH086403]; CIHR; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403, R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank members of the Malenka and Sudhof laboratories and Dr. Lu Chen for helpful comments and advice and Dr. Paul Temkin for providing the GluA1-FLAG construct. This work was funded by NIH grants MH063394 (to R.C.M.) and MH086403 (to R.C.M. and T.C.S.). P.A. is supported by a postdoctoral research fellowship from CIHR. G.J.S.-L. constructed plasmids, generated lentiviruses, injected these in PO mice, and performed and analyzed agonist-evoked currents in outside out patches. G.J.S.-L and W.M. performed and analyzed long-term plasticity experiments in acute slices and injected lentiviruses in P21 mice. P.A. performed and analyzed all GluA1 surface expression assays in hippocampal cultures. M.A. performed immunoprecipitation assay. G.J.S.-L., P.A., T.C.S., and R.C.M. wrote the manuscript and all authors approved the final version.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ahmad M, 2012, NEURON, V73, P260, DOI 10.1016/j.neuron.2011.11.020; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shipman SL, 2012, NEURON, V76, P309, DOI 10.1016/j.neuron.2012.07.024; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sousa I, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-7; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sumioka A, 2011, NAT NEUROSCI, V14, P1410, DOI 10.1038/nn.2952; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802	49	53	55	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					439	446		10.1016/j.neuron.2013.06.007	http://dx.doi.org/10.1016/j.neuron.2013.06.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23931994	Green Accepted, Bronze			2022-12-25	WOS:000323085100006
J	Dobbin, MM; Madabhushi, R; Pan, L; Chen, Y; Kim, D; Gao, J; Ahanonu, B; Pao, PC; Qiu, Y; Zhao, YM; Tsai, LH				Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Chen, Yue; Kim, Dohoon; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Qiu, Yi; Zhao, Yingming; Tsai, Li-Huei			SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons	NATURE NEUROSCIENCE			English	Article							DNA-DAMAGE; CROSS-LINKING; STRAND BREAKS; I-TASSER; CHROMATIN; ACTIVATION; ACETYLATION; PROTEINS; REPAIR; P53	Defects in DNA repair have been linked to cognitive decline with age and neurodegenerative disease, yet the mechanisms that protect neurons from genotoxic stress remain largely obscure. We sought to characterize the roles of the NAD+-dependent deacetylase SIRT1 in the neuronal response to DNA double-strand breaks (DSBs). We found that SIRT1 was rapidly recruited to DSBs in postmitotic neurons, where it showed a synergistic relationship with ataxia telangiectasia mutated (ATM). SIRT1 recruitment to breaks was ATM dependent; however, SIRT1 also stimulated ATM autophosphorylation and activity and stabilized ATM at DSB sites. After DSB induction, SIRT1 also bound the neuroprotective class I histone deacetylase HDAC1. We found that SIRT1 deacetylated HDAC1 and stimulated its enzymatic activity, which was necessary for DSB repair through the nonhomologous end-joining pathway. HDAC1 mutations that mimic a constitutively acetylated state rendered neurons more susceptible to DNA damage, whereas pharmacological SIRT1 activators that promoted HDAC1 deacetylation also reduced DNA damage in two mouse models of neurodegeneration. We propose that SIRT1 is an apical transducer of the DSB response and that SIRT1 activation offers an important therapeutic avenue in neurodegeneration.	[Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chen, Yue; Zhao, Yingming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Kim, Dohoon] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University System of Florida; University of Florida	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Pan, Ling/K-9333-2013; Pao, Ping-Chieh/AAG-9742-2019; Ahanonu, Biafra/AAY-8776-2020	Pan, Ling/0000-0001-9947-9071; Pao, Ping-Chieh/0000-0001-6788-7185; Ahanonu, Biafra/0000-0002-2021-5848; , Yi/0000-0002-3282-6072	US National Institutes of Health (NIH) [AG27916]; Howard Hughes Medical Institute; Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH [R01 HL095674, U54 RR020389, T32 GM007484, T32 MH081728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R36MH081728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG046174] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. W. Alt (Harvard Medical School) and E.N. Olson (University of Texas Southwestern Medical Center) for providing the Sirt1<SUP>loxP/loxP</SUP> and Hdac1<SUP>loxP/loxP</SUP> mice, respectively; R. Huganir (Johns Hopkins University) for providing the lentiviral Cre constructs; V. Suri, J. Ellis and G. Vlasuk (Sirtris) for providing compound # 10 and, together with J. Graff, for critical comments on the manuscript; M. Kastan (St. Jude's Medical Research Hospital) for gifting the I-PpoI-ER construct; and V. Gorbunova (University of Rochester) for providing the NHEJ constructs. This work was supported by funding from US National Institutes of Health (NIH) PO1 grant AG27916, the Howard Hughes Medical Institute, the Neurodegeneration Consortium and the Glenn award for research in biological mechanisms of aging to L.-H. T., NIH grant R01 HL095674 to Y.Q. and NIH grant U54 RR020389 to Y.Z.M.M.D. was supported by NIH training grants T32 GM007484 and T32 MH081728.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Ball AR, 2011, CURR OPIN CELL BIOL, V23, P277, DOI 10.1016/j.ceb.2011.03.012; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Dundr M, 2003, CURR PROTOC CELL BIO; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	50	164	171	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1008	U54		10.1038/nn.3460	http://dx.doi.org/10.1038/nn.3460			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852118	Green Accepted, Green Submitted			2022-12-25	WOS:000322323000010
J	Parent, AV; Russ, HA; Khan, IS; LaFlam, TN; Metzger, TC; Anderson, MS; Hebrok, M				Parent, Audrey V.; Russ, Holger A.; Khan, Imran S.; LaFlam, Taylor N.; Metzger, Todd C.; Anderson, Mark S.; Hebrok, Matthias			Generation of Functional Thymic Epithelium from Human Embryonic Stem Cells that Supports Host T Cell Development	CELL STEM CELL			English	Article							FETAL THYMUS; NUDE-MICE; ENDODERM; MOUSE; EXPRESSION; MATURATION; TOLERANCE; BMP4; MICROENVIRONMENTS; DIFFERENTIATION	Inducing immune tolerance to prevent rejection is a key step toward successful engraftment of stem-cell-derived tissue in a clinical setting. Using human pluripotent stem cells to generate thymic epithelial cells (TECs) capable of supporting T cell development represents a promising approach to reach this goal; however, progress toward generating functional TECs has been limited. Here, we describe a robust in vitro method to direct differentiation of human embryonic stem cells (hESCs) into thymic epithelial progenitors (TEPs) by precise regulation of TGF beta, BMP4, RA, Wnt, Shh, and FGF signaling. The hESC-derived TEPs further mature into functional TECs that support T cell development upon transplantation into thymus-deficient mice. Importantly, the engrafted TEPs produce T cells capable of in vitro proliferation as well as in vivo immune responses. Thus, hESC-derived TEP grafts may have broad applications for enhancing engraftment in cell-based therapies as well as restoring age- and stress-related thymic decline.	[Parent, Audrey V.; Russ, Holger A.; Khan, Imran S.; LaFlam, Taylor N.; Metzger, Todd C.; Anderson, Mark S.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu; mhebrok@diabetes.ucsf.edu		Khan, Imran/0000-0003-4570-4143	Canadian Institutes of Health Research fellowship; Richard G. Klein fellowship; JDRF fellowship [3-2012-266]; CIRM grant [CIRM RM1-01702]; UCSF Diabetes and Endocrinology Research Center (DERC); UCSF Flow Cytometry Core; NATIONAL CANCER INSTITUTE [F30CA174154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Richard G. Klein fellowship; JDRF fellowship; CIRM grant; UCSF Diabetes and Endocrinology Research Center (DERC); UCSF Flow Cytometry Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Anderson and Hebrok laboratories for helpful discussion. We thank Na Li, Kellsey Johannes, Debbie Ngow, and Jennifer Ringler for technical help; C. Stoddart and J. Rivera for help with kidney capsule transplantations; J. Puck and Y. Wang for help with analysis of the spectratyping data; Q. Tang and K. Lee for help with skin transplantations; and Viacyte for providing the CyT49 cell line. A. V. P. was supported by a Canadian Institutes of Health Research fellowship, H. A. R by a Richard G. Klein fellowship and JDRF fellowship (3-2012-266), and I. S. K. and T.N.L. by the UCSF Medical Scientist Training Program. Research in M.S.A.'s and M.H.'s laboratories was supported by a CIRM grant (CIRM RM1-01702). Imaging and flow cytometry experiments were supported by resources from the UCSF Diabetes and Endocrinology Research Center (DERC) and UCSF Flow Cytometry Core.	Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Currier Jeffrey R, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1028s38; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Frank DU, 2002, DEVELOPMENT, V129, P4591; Fudaba Y, 2008, J IMMUNOL, V181, P7649, DOI 10.4049/jimmunol.181.11.7649; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2010, DEV BIOL, V339, P141, DOI 10.1016/j.ydbio.2009.12.026; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KOLLMANN TR, 1993, J EXP MED, V177, P821, DOI 10.1084/jem.177.3.821; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Neves H, 2012, DEV BIOL, V361, P208, DOI 10.1016/j.ydbio.2011.10.022; Nobori S, 2006, P NATL ACAD SCI USA, V103, P19081, DOI 10.1073/pnas.0605159103; Patel SR, 2006, GENE EXPR PATTERNS, V6, P794, DOI 10.1016/j.modgep.2006.01.011; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Russ H.A., 2011, CELL TRANSPLANTATION; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; TAGUCHI O, 1986, J EXP MED, V164, P60, DOI 10.1084/jem.164.1.60; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	33	100	104	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					219	229		10.1016/j.stem.2013.04.004	http://dx.doi.org/10.1016/j.stem.2013.04.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23684540	Green Accepted, Bronze			2022-12-25	WOS:000329570600014
J	Bradshaw, EM; Chibnik, LB; Keenan, BT; Ottoboni, L; Raj, T; Tang, A; Rosenkrantz, LL; Imboywa, S; Lee, M; Von Korff, A; Morris, MC; Evans, DA; Johnson, K; Sperling, RA; Schneider, JA; Bennett, DA; De Jager, PL				Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; Morris, Martha C.; Evans, Denis A.; Johnson, Keith; Sperling, Reisa A.; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.		Alzheimer's Dis Neuroimaging Initi	CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; COMMON VARIANTS; EPHA1; PET; DEMENTIA; BINDING; CD2AP; BETA	In our functional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs3865444(C) risk allele was associated with greater cell surface expression of CD33 in the monocytes ( t(50) = 10.06, P-joint = 1.3 x 10(-13)) of young and older individuals. It was also associated with diminished internalization of amyloid-beta 42 peptide, accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging, and increased numbers of activated human microglia.	[Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Ottoboni, Linda; Raj, Towfique; Johnson, Keith; Sperling, Reisa A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Morris, Martha C.; Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sperling, Reisa A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimers Res & Treatment, Boston, MA 02115 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	De Jager, PL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	pdejager@partners.org	Raj, Towfique/ABD-7620-2021; Ottoboni, Linda/AAC-4508-2022; Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Saykin, Andrew/A-1318-2007	Ottoboni, Linda/0000-0001-5412-7785; Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Saykin, Andrew/0000-0002-1376-8532; Chibnik, Lori/0000-0001-6293-806X; Ponto, Laura/0000-0003-1197-6714	US National Institutes of Health [R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161, R01 AG11101]; Illinois Department of Public Health; JDRF; American Diabetes Association; Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center;  [R01 NS067305];  [RC2 GM093080];  [R01 AG043617]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM076321, RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010161, K25AG041906, P50AG008702, R01AG043617, P30AG008051, R01AG036042, P30AG013846, R01AG015819, R01AG031553, R01AG011101, P50AG005138, R01AG017917, R01AG030146, U24AG021886] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; JDRF(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to the participants of the ROS, MAP, CHAP, Harvard Aging Brain Study (HAB) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Data used in preparation of this article were obtained from the ADNI database (http://adni.loni.ucla.edu/). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. We also thank the participants of the Brigham and Women's PhenoGenetic Project. This work is supported by the US National Institutes of Health (grants R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161 and R01 AG11101) and the Illinois Department of Public Health. This work was supported by grants R01 NS067305, RC2 GM093080 and R01 AG043617. E.M.B. receives support from the JDRF, American Diabetes Association, Boston Area Diabetes and Endocrinology Research Center and the Harvard NeuroDiscovery Center.	[Anonymous], 1997, Neurobiol Aging, V18, pS1; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hollingworth P, 2011, INT J GERIATR PSYCH, V26, P793, DOI 10.1002/gps.2628; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D, 1987, WMS R WECHSLER MEMOR; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	41	371	383	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					848	U92		10.1038/nn.3435	http://dx.doi.org/10.1038/nn.3435			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708142	Green Accepted, Green Submitted			2022-12-25	WOS:000321180900016
J	Asada, N; Katayama, Y; Sato, M; Minagawa, K; Wakahashi, K; Kawano, H; Kawano, Y; Sada, A; Ikeda, K; Matsui, T; Tanimoto, M				Asada, Noboru; Katayama, Yoshio; Sato, Mari; Minagawa, Kentaro; Wakahashi, Kanako; Kawano, Hiroki; Kawano, Yuko; Sada, Akiko; Ikeda, Kyoji; Matsui, Toshimitsu; Tanimoto, Mitsune			Matrix-Embedded Osteocytes Regulate Mobilization of Hematopoietic Stem/Progenitor Cells	CELL STEM CELL			English	Article							STEM-CELLS; RECEPTOR; RELEASE; NICHE	The bone marrow (BM) niche comprises multiple cell types that regulate hematopoietic stem/progenitor cell (HSPC) migration out of the niche and into the circulation. Here, we demonstrate that osteocytes, the major cellular component of mature bone, are regulators of HSPC egress. Granulocyte colony-stimulating factor (G-CSF), used clinically to mobilize HSPCs, induces changes in the morphology and gene expression of the osteocytic network that precedes changes in osteoblasts. This rapid response is likely under control of the sympathetic nervous system, since osteocytes express the b2-adrenergic receptor and surgical sympathectomy prevents it. Mice with targeted ablation of osteocytes or a disrupted osteocyte network have comparable numbers of HSPCs in the BM but fail to mobilize HSPCs in response to G-CSF. Taken together, these results indicate that the BM/bone niche interface is critically controlled from inside of the bone matrix and establish an important physiological role for skeletal tissues in hematopoietic function.	[Asada, Noboru; Tanimoto, Mitsune] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Asada, Noboru; Katayama, Yoshio; Sato, Mari; Minagawa, Kentaro; Wakahashi, Kanako; Kawano, Hiroki; Kawano, Yuko; Sada, Akiko; Matsui, Toshimitsu] Kobe Univ, Grad Sch Med, Dept Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Katayama, Yoshio] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ikeda, Kyoji] NCGG, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan	Okayama University; Kobe University; Japan Science & Technology Agency (JST)	Katayama, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	katayama@med.kobe-u.ac.jp		Minagawa, Kentaro/0000-0003-1740-7109; Matsui, Toshimitsu/0000-0002-2536-7584	Japan Society for the Promotion of Science [23390251]; Ministry of Education, Culture, Sports, Science and Technology in Japan [23118517]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We would like to thank the following: Drs. Hidetsugu Tsujigiwa and Hitoshi Nagatsuka (Okayama University) for the technical help and valuable suggestions on immunohistological analysis of bone; Dr. Hiroshi Kamioka (Okayama University) for the superb advice about osteocyte staining and for stimulating discussions; and Dr. Toshitaka Oohashi (Okayama University) for the technical help on making frozen sections. This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (# 23390251 to Y. Katayama) and for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan (# 23118517 to Y. Katayama). N.A. performed all experiments and wrote the manuscript; M.S., K.M., K.W., H.K., Y. Kawano, and A. S. helped with animal maintenance, tissue sample preparation, and qRT-PCR; K.I. and T.M. supervised the studies for DMP-1 DTR Tg mice; M.T. supervised the studies for surgical denervation and kl/kl mice; and Y. Katayama supervised all experiments and wrote the manuscript. The authors declare no competing financial interests.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Calvi LM, 2012, BLOOD, V119, P2489, DOI 10.1182/blood-2011-06-360933; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	38	110	115	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					737	747		10.1016/j.stem.2013.05.001	http://dx.doi.org/10.1016/j.stem.2013.05.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746979	Green Submitted, Bronze			2022-12-25	WOS:000329569900016
J	Garbern, JC; Lee, RT				Garbern, Jessica C.; Lee, Richard T.			Cardiac Stem Cell Therapy and the Promise of Heart Regeneration	CELL STEM CELL			English	Review							ACUTE MYOCARDIAL-INFARCTION; CARDIOSPHERE-DERIVED CELLS; PROGENITOR CELLS; SMOOTH-MUSCLE; CARDIOMYOCYTE PROLIFERATION; FUNCTIONAL CARDIOMYOCYTES; ISCHEMIC CARDIOMYOPATHY; MITOTIC DIVISION; DNA-SYNTHESIS; FIBROBLASTS	Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. Yet as clinical trials proceed, our incomplete understanding of stem cell behavior is made evident by numerous unresolved matters, such as the mechanisms of cardiomyocyte turnover or the optimal therapeutic strategies to achieve clinical efficacy. In this Perspective, we consider how cardiac stem cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration.	[Garbern, Jessica C.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Brigham Regenerat Med Ctr, Boston, MA 02115 USA; [Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Lee, Richard T.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, RT (corresponding author), Brigham & Womens Hosp, Harvard Stem Cell Inst, 75 Francis St, Boston, MA 02115 USA.	rlee@partners.org		Lee, Richard/0000-0003-4687-1381	NIH [R01 AG032977, 1R01 AG040019]; NATIONAL INSTITUTE ON AGING [R01AG032977, R01AG040019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by grants from NIH (R01 AG032977 1R01 AG040019) to R.T.L. The authors thank Sean M. Wu of Stanford University for his helpful comments. R. L. is cofounder and coowner of Provasculon, Inc. R. L. is a paid consultant to the company and serves on the company's Board of Directors. Provasculon has interests in regenerative cell therapy, an area related to this work. R. L.'s interests were reviewed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their institutional policies.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Aguirre A, 2013, CELL STEM CELL, V12, P275, DOI 10.1016/j.stem.2013.02.008; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Baffour R, 2006, CARDIOVASC REVASCULA, V7, P222, DOI 10.1016/j.carrev.2006.06.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Davis RP, 2012, CIRCULATION, V125, P3079, DOI 10.1161/CIRCULATIONAHA.111.066092; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Govaert JA, 2009, J HEART LUNG TRANSPL, V28, P1158, DOI 10.1016/j.healun.2009.06.018; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kajstura J, 2012, CIRCULATION, V126, P1869, DOI 10.1161/CIRCULATIONAHA.112.118380; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kantrowitz A, 1998, ASAIO J, V44, P244, DOI 10.1097/00002480-199807000-00003; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Limbourg FP, 2005, CIRC RES, V96, P6, DOI 10.1161/01.RES.0000153667.26414.10; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Marban E, 2012, JAMA-J AM MED ASSOC, V308, P2405, DOI 10.1001/jama.2012.64751; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Ohnishi S, 2007, INT J HEMATOL, V86, P17, DOI 10.1532/IJH97.07041; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; RUMYANTSEV PP, 1974, VIRCHOWS ARCH B, V15, P357; Schmidt D, 2007, CIRCULATION, V116, pI64, DOI 10.1161/CIRCULATIONAHA.106.6806637; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAUSSIG HB, 1969, J AMER MED ASSOC, V207, P951, DOI 10.1001/jama.1969.03150180081020; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, J MOL CELL CARDIOL, V52, P43, DOI 10.1016/j.yjmcc.2011.08.020; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	86	280	290	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					689	698		10.1016/j.stem.2013.05.008	http://dx.doi.org/10.1016/j.stem.2013.05.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746978	Green Accepted, Bronze			2022-12-25	WOS:000329569900012
J	Longordo, F; To, MS; Ikeda, K; Stuart, GJ				Longordo, Fabio; To, Minh-Son; Ikeda, Kaori; Stuart, Greg J.			Sublinear integration underlies binocular processing in primary visual cortex	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; IN-VIVO; CORTICAL-NEURONS; COMPLEX CELLS; ORIENTATION SELECTIVITY; DENDRITIC INTEGRATION; SYNAPTIC INPUTS; BARREL CORTEX; SUMMATION; ORGANIZATION	Although we know much about the capacity of neurons to integrate synaptic inputs in vitro, less is known about synaptic integration in vivo. Here we address this issue by investigating the integration of inputs from the two eyes in mouse primary visual cortex. We find that binocular inputs to layer 2/3 pyramidal neurons are integrated sublinearly in an amplitude-dependent manner. Sublinear integration was greatest when binocular responses were largest, as occurs at the preferred orientation and binocular disparity, and highest contrast. Using voltage-clamp experiments and modeling, we show that sublinear integration occurs postsynaptically. The extent of sublinear integration cannot be accounted for solely by nonlinear integration of excitatory inputs, even when they are activated closely in space and time, but requires balanced recruitment of inhibition. Finally, we show that sublinear binocular integration acts as a divisive form of gain control, linearizing the output of binocular neurons and enhancing orientation selectivity.	[Longordo, Fabio; To, Minh-Son; Ikeda, Kaori; Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [To, Minh-Son] Flinders Univ Adelaide, Dept Human Physiol, Adelaide, SA, Australia; [To, Minh-Son] Flinders Univ Adelaide, Ctr Neurosci, Adelaide, SA, Australia	Australian National University; John Curtin School of Medical Research; Flinders University South Australia; Flinders University South Australia	Longordo, F (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia.	fabio.longordo@anu.edu.au; greg.stuart@anu.edu.au		stuart, greg/0000-0001-9395-2219	European Community's Seventh Framework Program (FP7) [201600]; Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ) [01GS08151, 01GS08155]; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]	European Community's Seventh Framework Program (FP7); Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ); Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society	We are grateful to D. Harbich and B. Schmid for technical assistance. This work was supported by the European Community's Seventh Framework Program (FP7, Project No. 201600), the Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ: 01GS08151 and 01GS08155) and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215).	Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Enoki R, 2002, NEUROSCIENCE, V113, P1003, DOI 10.1016/S0306-4522(02)00169-0; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Medini P, 2011, J NEUROSCI, V31, P17134, DOI 10.1523/JNEUROSCI.2951-11.2011; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Ringach DL, 2002, J NEUROSCI, V22, P5639; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Ziburkus J, 2006, J NEUROPHYSIOL, V96, P2775, DOI 10.1152/jn.01321.2004	55	41	42	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					714	+		10.1038/nn.3394	http://dx.doi.org/10.1038/nn.3394			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644484	Green Submitted			2022-12-25	WOS:000319509600013
J	Sekine, SU; Haraguchi, S; Chao, KH; Kato, T; Luo, LQ; Miura, M; Chihara, T				Sekine, Sayaka U.; Haraguchi, Shuka; Chao, Kinhong; Kato, Tomoko; Luo, Liqun; Miura, Masayuki; Chihara, Takahiro			Meigo governs dendrite targeting specificity by modulating Ephrin level and N-glycosylation	NATURE NEUROSCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; OLFACTORY PROJECTION NEURONS; DROSOPHILA EMBRYONIC CNS; REPRESSIBLE CELL MARKER; ENDOPLASMIC-RETICULUM; WIRING SPECIFICITY; HEPARAN-SULFATE; TRANSCRIPTIONAL CONTROL; TERMINAL ARBORIZATION; MOSAIC ANALYSIS	Neural circuit assembly requires precise dendrite and axon targeting. We identified an evolutionarily conserved endoplasmic reticulum (ER) protein, Meigo, from a mosaic genetic screen in Drosophila melanogaster. Meigo was cell-autonomously required in olfactory receptor neurons and projection neurons to target their axons and dendrites to the lateral antennal lobe and to refine projection neuron dendrites into individual glomeruli. Loss of Meigo induced an unfolded protein response and reduced the amount of neuronal cell surface proteins, including Ephrin. Ephrin overexpression specifically suppressed the projection neuron dendrite refinement defect present in meigo mutant flies, and ephrin knockdown caused a similar projection neuron dendrite refinement defect. Meigo positively regulated the level of Ephrin N-glycosylation, which was required for its optimal function in vivo. Thus, Meigo, an ER-resident protein, governs neuronal targeting specificity by regulating ER folding capacity and protein N-glycosylation. Furthermore, Ephrin appears to be an important substrate that mediates Meigo's function in refinement of glomerular targeting.	[Sekine, Sayaka U.; Haraguchi, Shuka; Chao, Kinhong; Kato, Tomoko; Miura, Masayuki; Chihara, Takahiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Miura, Masayuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Chihara, Takahiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan	University of Tokyo; Howard Hughes Medical Institute; Stanford University; Stanford University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Chihara, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan.	tchihara@mol.f.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019	Chihara, Takahiro/0000-0001-9989-3619; Sekine, Sayaka/0000-0001-5656-2959	Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; US National Institutes of Health [R01 DC005982]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.B. Thomas, Bloomington and the Kyoto Drosophila Stock Center for fly stocks, A.H. Brand (University of Cambridge) for the Ephrin antibody and fly stocks, S. Goto (Rikkyo University) for the dGLG1 (120 kDa) antibody, C. Field (Harvard University) for the Lava Lamp antibody, T. Uemura (Kyoto University) for the UAS-DNcadherin plasmid, H.D. Ryoo (New York University) and P.M. Domingos (Instituto de Tecnologia Quimica e Biologica) for xbp1:EGFP-related reagents and the Hsc3 antibody, C.-H. Chen for advice on constructing shRNAs, G. Thomas and M. Khanna for advice on performing OptiPrep density gradient centrifugation, and all of the members of the Miura and Luo laboratories for comments on this study. We especially thank T. Mosca for improving the manuscript and M. Okumura and T.C. for the blind test. L.L. is funded by the Howard Hughes Medical Institute. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan to M.M. and T.C., the Japan Society for the Promotion of Science to S.U.S., M.M. and T.C., the Japan Science and Technology Agency to M.M. and T.C., and the US National Institutes of Health (R01 DC005982) to L.L.	Bossing T, 2002, DEVELOPMENT, V129, P4205; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910; Cudna RE, 2003, BIOTECHNOL BIOENG, V81, P56, DOI 10.1002/bit.10445; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Haecker A, 2008, DEVELOPMENT, V135, P1745, DOI 10.1242/dev.020891; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Khanna MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-302; Kobayashi T, 2006, BIOCHEM J, V400, P281, DOI 10.1042/BJ20060429; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nakanishi H, 2001, YEAST, V18, P543, DOI 10.1002/yea.707; Newsome TP, 2000, DEVELOPMENT, V127, P851; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Reyes F, 2010, PLANT J, V61, P423, DOI 10.1111/j.1365-313X.2009.04066.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yamamoto-Hino M, 2012, CELL STRUCT FUNCT, V37, P55, DOI 10.1247/csf.11037; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	54	21	21	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					683	+		10.1038/nn.3389	http://dx.doi.org/10.1038/nn.3389			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624514	Green Accepted			2022-12-25	WOS:000319509600009
J	Calhoon, GG; O'Donnell, P				Calhoon, Gwendolyn G.; O'Donnell, Patricio			Closing the Gate in the Limbic Striatum: Prefrontal Suppression of Hippocampal and Thalamic Inputs	NEURON			English	Article							NUCLEUS-ACCUMBENS NEURONS; IN-VIVO; PROJECTION NEURONS; VENTRAL STRIATUM; RAT STRIATUM; HETEROSYNAPTIC DEPRESSION; SYNAPTIC-INTERACTIONS; DECISION-MAKING; CORTICAL INPUTS; REWARD	Many brain circuits control behavior by integrating information arising from separate inputs onto a common target neuron. Neurons in the ventral striatum (VS) receive converging excitatory afferents from the prefrontal cortex (PFC), hippocampus (HP), and thalamus, among other structures, and the integration of these inputs is critical for goal-directed behaviors. Although HP inputs have been described as gating PFC throughput in the VS, recent data reveal that the VS desynchronizes from the HP during epochs of burst-like PFC activity related to decision making. It is therefore possible that PFC inputs locally attenuate responses to other glutamatergic inputs to the VS. Here, we found that delivering trains of stimuli to the PFC suppresses HP- and thalamus-evoked synaptic responses in the VS, in part through activation of inhibitory processes. This interaction may enable the PFC to exert influence on basal ganglia loops during decision-making instances with minimal disturbance from ongoing contextual inputs.	[Calhoon, Gwendolyn G.; O'Donnell, Patricio] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Calhoon, Gwendolyn G.; O'Donnell, Patricio] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [O'Donnell, Patricio] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	O'Donnell, P (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	podon002@umaryland.edu		O'Donnell, Patricio/0000-0001-7788-624X	National Institutes of Health [R01 MH060131, R31 MH092043]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH092043, R01MH060131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (R01 MH060131) to P.O.'D. and (R31 MH092043) to G.G.C.	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; AKAIKE N, 1985, J PHYSIOL-LONDON, V360, P367, DOI 10.1113/jphysiol.1985.sp015622; ALGER BE, 1978, BRAIN RES BULL, V3, P181, DOI 10.1016/0361-9230(78)90045-X; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Brady AM, 2004, J NEUROSCI, V24, P1040, DOI 10.1523/JNEUROSCI.4178-03.2004; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; Cohen MX, 2009, NEUROPSYCHOPHARMACOL, V34, P1649, DOI 10.1038/npp.2008.222; CUPELLO A, 1991, CELL MOL NEUROBIOL, V11, P333, DOI 10.1007/BF00713277; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; Fuentealba P, 2004, J NEUROPHYSIOL, V91, P1990, DOI 10.1152/jn.01105.2003; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Goto Y, 2001, J NEUROSCI, V21; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Gruber AJ, 2009, SYNAPSE, V63, P173, DOI 10.1002/syn.20593; Hjelmstad GO, 2003, J NEUROPHYSIOL, V89, P2389, DOI 10.1152/jn.01115.2002; Hjelmstad GO, 2001, J NEUROPHYSIOL, V85, P1153, DOI 10.1152/jn.2001.85.3.1153; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; INOMATA N, 1988, NEUROSCI RES, V6, P72, DOI 10.1016/0168-0102(88)90007-7; JAEGER D, 1994, J NEUROPHYSIOL, V72, P2555, DOI 10.1152/jn.1994.72.5.2555; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; LAVOIE AM, 1994, BRAIN RES, V638, P157, DOI 10.1016/0006-8993(94)90645-9; Lovinger David M, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS132, DOI 10.1016/S1353-8020(11)70041-4; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; MEREDITH GE, 1990, BRAIN RES, V513, P329, DOI 10.1016/0006-8993(90)90476-R; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Peters YM, 2005, SYNAPSE, V56, P74, DOI 10.1002/syn.20129; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; St Onge JR, 2012, J NEUROSCI, V32, P2886, DOI 10.1523/JNEUROSCI.5625-11.2012; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Taverna S, 2007, BRAIN RES, V1152, P49, DOI 10.1016/j.brainres.2007.03.053; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tunstall MJ, 2002, J NEUROPHYSIOL, V88, P1263, DOI 10.1152/jn.2002.88.3.1263; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wolf JA, 2009, J PHYSIOL-LONDON, V587, P1695, DOI 10.1113/jphysiol.2008.168369	49	33	33	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2013	78	1					181	190		10.1016/j.neuron.2013.01.032	http://dx.doi.org/10.1016/j.neuron.2013.01.032			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583113	Green Accepted, Bronze			2022-12-25	WOS:000317556000016
J	Schmidt-Hieber, C; Hausser, M				Schmidt-Hieber, Christoph; Haeusser, Michael			Cellular mechanisms of spatial navigation in the medial entorhinal cortex	NATURE NEUROSCIENCE			English	Article							GRID CELLS; STELLATE CELLS; SUBTHRESHOLD OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; LAYER-II; THETA; INTERFERENCE; ORGANIZATION; FREQUENCY	Neurons in the medial entorhinal cortex exhibit a grid-like spatial pattern of spike rates that has been proposed to represent a neural code for path integration. To understand how grid cell firing arises from the combination of intrinsic conductances and synaptic input in medial entorhinal stellate cells, we performed patch-clamp recordings in mice navigating in a virtual-reality environment. We found that the membrane potential signature of stellate cells during firing field crossings consisted of a slow depolarization driving spike output. This was best predicted by network models in which neurons receive sustained depolarizing synaptic input during a field crossing, such as continuous attractor network models of grid cell firing. Another key feature of the data, phase precession of intracellular theta oscillations and spiking with respect to extracellular theta oscillations, was best captured by an oscillatory interference model. Thus, these findings provide crucial new information for a quantitative understanding of the cellular basis of spatial navigation in the entorhinal cortex.	[Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Schmidt-Hieber, C (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	c.schmidt-hieber@ucl.ac.uk; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Schmidt-Hieber, Christoph/0000-0002-5328-9704	Wellcome Trust; European Research Council; Gatsby Charitable Foundation; Alexander von Humboldt Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Gatsby Charitable Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We are grateful to N. Burgess, B. Clark, P. Dayan, K. Harris, P. Latham, J. O'Keefe, A. Packer, A. Roth, S. Turaga and C. Wilms for helpful discussions and for comments on the manuscript, and to A. Naeem for assistance with histology. This work was supported by grants from the Wellcome Trust, European Research Council and Gatsby Charitable Foundation, and by a fellowship to C. S.-H. from the Alexander von Humboldt Foundation.	ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	36	186	188	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					325	331		10.1038/nn.3340	http://dx.doi.org/10.1038/nn.3340			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396102				2022-12-25	WOS:000315474800015
J	Ash, PEA; Bieniek, KF; Gendron, TF; Caulfield, T; Lin, WL; DeJesus-Hernandez, M; van Blitterswijk, MM; Jansen-West, K; Paul, JW; Rademakers, R; Boylan, KB; Dickson, DW; Petrucelli, L				Ash, Peter E. A.; Bieniek, Kevin F.; Gendron, Tania F.; Caulfield, Thomas; Lin, Wen-Lang; DeJesus-Hernandez, Mariely; van Blitterswijk, Marka M.; Jansen-West, Karen; Paul, Joseph W., III; Rademakers, Rosa; Boylan, Kevin B.; Dickson, Dennis W.; Petrucelli, Leonard			Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS	NEURON			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT EXPANSION; RNA; INCLUSIONS; DISORDERS; SPECTRUM; FTD; ALS	Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are devastating neurodegenerative disorders with clinical, genetic, and neuropathological overlap. Hexanucleotide (GGGGCC) repeat expansions in a noncoding region of C9ORF72 are the major genetic cause of FTD and ALS (c9FTD/ALS). The RNA structure of GGGGCC repeats renders these transcripts susceptible to an unconventional mechanism of translation repeat-associated non-ATG (RAN) translation. Antibodies generated against putative GGGGCC repeat RAN-translated peptides (anti-C9RANT) detected high molecular weight, insoluble material in brain homogenates, and neuronal inclusions throughout the CNS of c9FTD/ALS cases. C9RANT immunoreactivity was not found in other neurodegenerative diseases, including GAG repeat disorders, or in peripheral tissues of c9FTD/ALS. The specificity of C9RANT for c9FTD/ALS is a potential biomarker for this most common cause of FTD and ALS. These findings have significant implications for treatment strategies directed at RAN-translated peptides and their aggregation and the RNA structures necessary for their production.	[Ash, Peter E. A.; Bieniek, Kevin F.; Gendron, Tania F.; Caulfield, Thomas; Lin, Wen-Lang; DeJesus-Hernandez, Mariely; van Blitterswijk, Marka M.; Jansen-West, Karen; Paul, Joseph W., III; Rademakers, Rosa; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA; [Boylan, Kevin B.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL 32224 USA; [Ash, Peter E. A.; Bieniek, Kevin F.; DeJesus-Hernandez, Mariely] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Petrucelli, L (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	van Blitterswijk, Marka/AAL-4126-2021; van Blitterswijk, Marka/H-7274-2012	van Blitterswijk, Marka/0000-0002-3054-7053; van Blitterswijk, Marka/0000-0002-3054-7053; Caulfield, Thomas/0000-0002-1055-3069; Bieniek, Kevin/0000-0003-4922-864X; Dickson, Dennis W/0000-0001-7189-7917	Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging [R01 AG026251, P01 AG003949, P50 AG016574]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R21 NS074121-01, R01 NS080882, R01 NS063964, R01 NS077402, P50 NS72187]; National Institute of Environmental Health Services [R01 ES20395]; Amyotrophic Lateral Sclerosis Association; ALS Therapy Alliance; Department of Defense [W81XWH-10-1-0512-1, W81XWH-09-1-0315AL093108]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063964, R01NS080882, R21NS074121, P50NS072187, R01NS077402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, R01AG026251, P01AG003949] Funding Source: NIH RePORTER	Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Amyotrophic Lateral Sclerosis Association; ALS Therapy Alliance; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to all patients, family members, and caregivers who agreed to brain donation, without which these studies would have been impossible. We also acknowledge expert technical assistance of Linda Rousseau, Virginia Phillips, and Monica Castanedes-Casey for histology and John Gonzalez, Beth Marten, Pamela Desaro, and Amelia Johnston for brain banking. This work was supported by Mayo Clinic Foundation, National Institutes of Health/National Institute on Aging (R01 AG026251 [L.P., R.R.], P01 AG003949 [D.W.D.], P50 AG016574 [D.W.D., R.R.]), National Institutes of Health/National Institute of Neurological Disorders and Stroke (R21 NS074121-01 [T.F.G., K.B.B.], R01 NS080882 [R.R.], R01 NS063964 [L.P.], R01 NS077402 [L.P.], P50 NS72187 [D.W.D., R.R.]), National Institute of Environmental Health Services (R01 ES20395 [L.P.]), Amyotrophic Lateral Sclerosis Association (K.B.B., L.P.), ALS Therapy Alliance (R.R.), and Department of Defense (W81XWH-10-1-0512-1 [L.P.], W81XWH-09-1-0315AL093108 [L.P.]). R.R. and M.D.-H. have a patent on the discovery of the hexanucleotide repeat expansion in the C9ORF72 gene.	Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Bieniek KF, 2013, ACTA NEUROPATHOL, V125, P289, DOI 10.1007/s00401-012-1048-7; Bigio E.H., 2012, NEUROPATHOLOGY; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Garden GA, 2012, NEURON, V73, P886, DOI 10.1016/j.neuron.2012.02.017; Gardner DP, 2011, J MOL BIOL, V413, P473, DOI 10.1016/j.jmb.2011.08.033; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Levine T.P., 2013, BIOINFORMATICS; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Pikkarainen M, 2008, J NEUROPATH EXP NEUR, V67, P280, DOI 10.1097/NEN.0b013e31816a1da2; Pikkarainen M, 2010, NEUROPATHOLOGY, V30, P197, DOI 10.1111/j.1440-1789.2009.01043.x; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; van Blitterswijk M, 2012, CURR OPIN NEUROL, V25, P689, DOI 10.1097/WCO.0b013e32835a3efb; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	20	753	775	3	83	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					639	646		10.1016/j.neuron.2013.02.004	http://dx.doi.org/10.1016/j.neuron.2013.02.004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23415312	Bronze, Green Accepted			2022-12-25	WOS:000315561300007
J	Haefner, RM; Gerwinn, S; Macke, JH; Bethge, M				Haefner, Ralf M.; Gerwinn, Sebastian; Macke, Jakob H.; Bethge, Matthias			Inferring decoding strategies from choice probabilities in the presence of correlated variability	NATURE NEUROSCIENCE			English	Article							DECISION-RELATED ACTIVITY; AREA MT; SENSORY NEURONS; CORTICAL AREA; POPULATION CODE; TASK STRATEGY; VISUAL-CORTEX; SINGLE-NEURON; V2 NEURONS; MACAQUE MT	The activity of cortical neurons in sensory areas covaries with perceptual decisions, a relationship that is often quantified by choice probabilities. Although choice probabilities have been measured extensively, their interpretation has remained fraught with difficulty. We derive the mathematical relationship between choice probabilities, read-out weights and correlated variability in the standard neural decision-making model. Our solution allowed us to prove and generalize earlier observations on the basis of numerical simulations and to derive new predictions. Notably, our results indicate how the read-out weight profile, or decoding strategy, can be inferred from experimentally measurable quantities. Furthermore, we developed a test to decide whether the decoding weights of individual neurons are optimal for the task, even without knowing the underlying correlations. We confirmed the practicality of our approach using simulated data from a realistic population model. Thus, our findings provide a theoretical foundation for a growing body of experimental results on choice probabilities and correlations.	[Haefner, Ralf M.; Macke, Jakob H.] Max Planck Inst Biol Cybernet, Neural Computat & Behav Grp, D-72076 Tubingen, Germany; [Haefner, Ralf M.; Macke, Jakob H.; Bethge, Matthias] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Haefner, Ralf M.] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA USA; [Gerwinn, Sebastian; Macke, Jakob H.; Bethge, Matthias] Werner Reichhardt Ctr Integrat Neurosci, Tubingen, Germany; [Gerwinn, Sebastian] Inst Informat Technol OFFIS, R&D Div Transportat, Oldenburg, Germany; [Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany	Max Planck Society; Brandeis University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Haefner, RM (corresponding author), Max Planck Inst Biol Cybernet, Neural Computat & Behav Grp, Spemannstr 38, D-72076 Tubingen, Germany.	ralf.haefner@gmail.com	Bethge, Matthias/B-1554-2008	Haefner, Ralf M/0000-0002-5031-0379	German Ministry of Education, Science, Research and Technology through the Bernstein Award [FKZ 01GQ0601]; Bernstein Center for Computational Neuroscience [FKZ 01GQ1002]; German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen [EXC307]; European Commission [FP7-ICT-257005]; Swartz Foundation	German Ministry of Education, Science, Research and Technology through the Bernstein Award; Bernstein Center for Computational Neuroscience; German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen; European Commission(European CommissionEuropean Commission Joint Research Centre); Swartz Foundation	We thank A. Ecker and P. Berens for stimulating discussions and detailed comments on an earlier version of the manuscript, and H. Nienborg and B.G. Cumming for many helpful conversations. This work was partially supported by the German Ministry of Education, Science, Research and Technology through the Bernstein Award (FKZ 01GQ0601) (M.B.), the Bernstein Center for Computational Neuroscience (FKZ 01GQ1002), the German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen (EXC307) and the European Commission (FP7-ICT-257005). R.M.H. acknowledges the hospitality of the Fiser laboratory at Brandeis University where this study was completed and financial support from the Swartz Foundation. Part of this research was done while J.H.M. was at the Gatsby Computational Neuroscience Unit, University College London.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bishop C.M., 2006, PATTERN RECOGNITION; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grunewald A, 2002, J NEUROSCI, V22, P6195; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Jazayeri M, 2008, CURR OPIN NEUROBIOL, V18, P431, DOI 10.1016/j.conb.2008.09.004; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034	41	100	100	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					235	242		10.1038/nn.3309	http://dx.doi.org/10.1038/nn.3309			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313912				2022-12-25	WOS:000314260200021
J	Turner, M; Leslie, S; Martin, NG; Peschanski, M; Rao, M; Taylor, CJ; Trounson, A; Turner, D; Yamanaka, S; Wilmut, I				Turner, Marc; Leslie, Stephen; Martin, Nicholas G.; Peschanski, Marc; Rao, Mahendra; Taylor, Craig J.; Trounson, Alan; Turner, David; Yamanaka, Shinya; Wilmut, Ian			Toward the Development of a Global Induced Pluripotent Stem Cell Library	CELL STEM CELL			English	Editorial Material							IPS CELLS; TRANSPLANTATION; BANKING	The ability to preselect the donor genotype of iPSC lines provides important opportunities for immunematching in cell therapy. Here we propose that an international assessment should be made of how immune incompatibility can best be managed and how a network of GMP HLA homozygous haplobanks could be operated.	[Turner, Marc] SNBTS HeadQuarters, Edinburgh EH17 7QT, Midlothian, Scotland; [Leslie, Stephen] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld Q4029, Australia; [Peschanski, Marc] INSERM UMR861, AFM, F-91030 Evry, France; [Peschanski, Marc] UEVE UMR861, F-91030 Evry, France; [Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Taylor, Craig J.] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Tissue Typing Lab, Cambridge CB2 0QQ, England; [Trounson, Alan] Calif Inst Regenerat Med, San Francisco, CA 94107 USA; [Turner, David] Royal Infirm Edinburgh NHS Trust, SNBTS, Edinburgh EH16 4SA, Midlothian, Scotland; [Yamanaka, Shinya] Kyoto Univ, Ctr IPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Wilmut, Ian] Univ Edinburgh, Edinburgh BioQuarter, Scottish Ctr Regenerat Med, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Infirmary of Edinburgh; University of Edinburgh; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Edinburgh	Wilmut, I (corresponding author), Univ Edinburgh, Edinburgh BioQuarter, Scottish Ctr Regenerat Med, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	ian.wilmut@ed.ac.uk	Peschanski, Marc/N-5769-2017; Martin, Nicholas/R-9235-2019	Martin, Nicholas/0000-0003-4069-8020; Trounson, Alan/0000-0001-5469-0500; Turner, David/0000-0003-4007-6248	Medical Research Council [G0700711B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014	10	156	159	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					382	384		10.1016/j.stem.2013.08.003	http://dx.doi.org/10.1016/j.stem.2013.08.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094319	Bronze			2022-12-25	WOS:000329571100006
J	Donahue, CH; Seo, H; Lee, D				Donahue, Christopher H.; Seo, Hyojung; Lee, Daeyeol			Cortical Signals for Rewarded Actions and Strategic Exploration	NEURON			English	Article							SUPPLEMENTARY EYE FIELD; ANTERIOR CINGULATE CORTEX; CONDITIONAL OCULOMOTOR ASSOCIATIONS; PREFRONTAL CORTEX; DECISION-MAKING; NEURONAL-ACTIVITY; PARIETAL CORTEX; FRONTAL-CORTEX; REINFORCEMENT; PERFORMANCE	In stable environments, decision makers can exploit their previously learned strategies for optimal outcomes, while exploration might lead to better options in unstable environments. Here, to investigate the cortical contributions to exploratory behavior, we analyzed single-neuron activity recorded from four different cortical areas of monkeys performing a matching-pennies task and a visual search task, which encouraged and discouraged exploration, respectively. We found that neurons in multiple regions in the frontal and parietal cortex tended to encode signals related to previously rewarded actions more reliably than unrewarded actions. In addition, signals for rewarded choices in the supplementary eye field were attenuated during the visual search task and were correlated with the tendency to switch choices during the matching-pennies task. These results suggest that the supplementary eye field might play a unique role in encouraging animals to explore alternative decision-making strategies.	[Donahue, Christopher H.; Seo, Hyojung; Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Lee, Daeyeol] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Lee, Daeyeol] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Lee, D (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	daeyeol.lee@yale.edu	Donahue, Christopher/T-1778-2019; Lee, Daeyeol/A-6794-2008	Donahue, Christopher/0000-0003-1574-1162; Lee, Daeyeol/0000-0003-3474-019X	National Institute of Drug Abuse [R01 DA029330]; National Institute of Neurological Disorders and Stroke [T32 NS007224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dominic Barraclough and Ben McGreevy for their help with data collection. This study was supported by the National Institute of Drug Abuse (R01 DA029330), and C.D. was supported by a training grant from the National Institute of Neurological Disorders and Stroke (T32 NS007224).	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166, DOI 10.1152/jn.1997.78.2.1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim H, 2013, J NEUROSCI, V33, P52, DOI 10.1523/JNEUROSCI.2422-12.2013; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Lee H, 2012, NEW YORK REV BOOKS, V59, P32; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Middlebrooks PG, 2012, NEURON, V75, P517, DOI 10.1016/j.neuron.2012.05.028; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Olson CR, 2000, J NEUROPHYSIOL, V84, P1369, DOI 10.1152/jn.2000.84.3.1369; Parton A, 2007, NEUROPSYCHOLOGIA, V45, P997, DOI 10.1016/j.neuropsychologia.2006.09.007; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Purcell BA, 2012, J NEUROSCI, V32, P10273, DOI 10.1523/JNEUROSCI.6386-11.2012; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Stuphorn V, 2010, J NEUROPHYSIOL, V103, P801, DOI 10.1152/jn.00221.2009; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; Thevarajah D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.057.2009; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wirth S, 2009, NEURON, V61, P930, DOI 10.1016/j.neuron.2009.01.012; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	59	38	38	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					223	234		10.1016/j.neuron.2013.07.040	http://dx.doi.org/10.1016/j.neuron.2013.07.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24012280	Bronze, Green Accepted			2022-12-25	WOS:000326305300020
J	Hayama, T; Noguchi, J; Watanabe, S; Takahashi, N; Hayashi-Takagi, A; Ellis-Davies, GCR; Matsuzaki, M; Kasai, H				Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Ellis-Davies, Graham C. R.; Matsuzaki, Masanori; Kasai, Haruo			GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signaling	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; TIMING-DEPENDENT PLASTICITY; CRITICAL PERIOD PLASTICITY; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CALCIUM-BINDING; 2-PHOTON; GLUTAMATE; MEMORY; LTD	Activity-dependent competition of synapses plays a key role in neural organization and is often promoted by GABA; however, its cellular bases are poorly understood. Excitatory synapses of cortical pyramidal neurons are formed on small protrusions known as dendritic spines, which exhibit structural plasticity. We used two-color uncaging of glutamate and GABA in rat hippocampal CA1 pyramidal neurons and found that spine shrinkage and elimination were markedly promoted by the activation of GABA(A) receptors shortly before action potentials. GABA(ergic) inhibition suppressed bulk increases in cytosolic Ca2+ concentrations, whereas it preserved the Ca2+ nanodomains generated by NMDA-type receptors, both of which were necessary for spine shrinkage. Unlike spine enlargement, spine shrinkage spread to neighboring spines (< 15 mu m) and competed with their enlargement, and this process involved the actin-depolymerizing factor ADF/cofilin. Thus, GABA(ergic) inhibition directly suppresses local dendritic Ca2+ transients and strongly promotes the competitive selection of dendritic spines.	[Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan; [Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Matsuzaki, Masanori; Kasai, Haruo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hayashi-Takagi, Akiko; Matsuzaki, Masanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Matsuzaki, Masanori] Grad Univ Adv Studies Sokendai, Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Icahn School of Medicine at Mount Sinai; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kasai, H (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan.	hkasai@m.u-tokyo.ac.jp	Takahashi, Noriko/AAL-1011-2020	Noguchi, Jun/0000-0002-8350-791X; Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21000009, 21500367, 20021008, 19680020, 22115005]; US National Institutes of Health [GM53395, NS69720]; Mitsubishi Foundation; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21000009, 24116003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mizuno, K. Ohashi, G.J. Augustine, C.O'Donnell, S. Okabe and J. Eilers for discussions and C. Maeda, M. Ogasawara, H. Ohno, M. Ishikawa and K. Tamura for technical assistance. This work was supported by Grants-in-Aid for Specially Promoted Area (no. 21000009 to H.K.), Scientific Research (C) (no. 21500367 to J.N.), Scientific Research on Priority Areas ('Elucidation of neural network function in the brain', no. 20021008 to M.M.), Young Scientist (A) (no. 19680020 to M.M.), Scientific Research on Innovative Areas 'Mesoscopic Neurocircuitry' (no. 22115005 to M.M.), the Global COE Program ('Integrative Life Science based on the study of Biosignaling Mechanisms' to H.K.) and the Strategic Research Program for Brain Sciences ('Neuroinformatics of Emotion' to H.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the US National Institutes of Health (grants GM53395 and NS69720 to G.C.R.E.-D.). In addition, this work was supported by a Mitsubishi Foundation grant to M.M. and a Research Grant from the Human Frontier Science Program to H.K.	ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ADLER EM, 1991, J NEUROSCI, V11, P1496; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Ellis-Davies GCR, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.193; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kanemoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022652; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M., 2011, COLD SPRING HARBOR P; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nishiyama Makoto, 2010, Front Synaptic Neurosci, V2, P22, DOI 10.3389/fnsyn.2010.00022; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	55	127	127	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1409	+		10.1038/nn.3496	http://dx.doi.org/10.1038/nn.3496			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974706	Green Accepted			2022-12-25	WOS:000324795300013
J	Mohajerani, MH; Chan, AW; Mohsenvand, M; LeDue, J; Liu, R; McVea, DA; Boyd, JD; Wang, YT; Reimers, M; Murphy, TH				Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Reimers, Mark; Murphy, Timothy H.			Spontaneous cortical activity alternates between motifs defined by regional axonal projections	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; DYNAMICS; STATE; FLUCTUATIONS; INTEGRATION; RESOLUTION; RESPONSES; NETWORKS; WAVES	Using millisecond-timescale voltage-sensitive dye imaging in lightly anesthetized or awake adult mice, we show that a palette of sensory-evoked and hemisphere-wide activity motifs are represented in spontaneous activity. These motifs can reflect multiple modes of sensory processing, including vision, audition and touch. We found similar cortical networks with direct cortical activation using channelrhodopsin-2. Regional analysis of activity spread indicated modality-specific sources, such as primary sensory areas, a common posterior-medial cortical sink where sensory activity was extinguished within the parietal association area and a secondary anterior medial sink within the cingulate and secondary motor cortices for visual stimuli. Correlation analysis between functional circuits and intracortical axonal projections indicated a common framework corresponding to long-range monosynaptic connections between cortical regions. Maps of intracortical monosynaptic structural connections predicted hemisphere-wide patterns of spontaneous and sensory-evoked depolarization. We suggest that an intracortical monosynaptic connectome shapes the ebb and flow of spontaneous cortical activity.	[Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Murphy, Timothy H.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Murphy, Timothy H.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Reimers, Mark] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Murphy, Timothy H.] Univ British Columbia, Dep Cellular & Physiol Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Virginia Commonwealth University; University of British Columbia	Murphy, TH (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	thmurphy@mail.ubc.ca	Liu, Rui/AAC-5111-2020; Wang, Yu Tian/J-8255-2015; Chan, Allen/AAF-4718-2020; Murphy, Timothy H/I-4982-2014; LeDue, Jeffrey/C-9230-2012; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490; Liu, Rui/0000-0002-3634-0344; Mohajerani, Majid H./0000-0003-0964-2977	Canadian Institutes of Health Research (CIHR) [MOP-12675]; Human Frontier Science Program; Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-12675 (T.H.M.), a Human Frontier Science Program grant (T.H.M.), Michael Smith Foundation for Health Research postdoctoral fellowships (M.H.M. and A.W.C.), a CIHR Operating Grant (Y.T.W.), Heart and Stroke Foundation of Canada postdoctoral fellowships (M.H.M. and A.W.C.) and a CIHR Focus on Stroke postdoctoral fellowship (M.H.M.). We thank the Allen Institute for Brain Science for providing a database of axonal projections. We thank P. Wang and C. Jiang for surgical assistance.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Allen Institute for Brain Science, 2012, ALL MOUS BRAIN CONN; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azin M, 2011, IEEE T BIO-MED ENG, V58, P2589, DOI 10.1109/TBME.2011.2159603; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Grandy TH, 2012, J NEUROPHYSIOL, V108, P2931, DOI 10.1152/jn.00512.2011; Grienberger C, 2012, J PHYSIOL-LONDON, V590, P899, DOI 10.1113/jphysiol.2011.222513; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Liu C., 2009, PIXELS EXPLORING NEW; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Polack PO, 2012, J NEUROSCI, V32, P11120, DOI 10.1523/JNEUROSCI.6304-11.2012; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reid RC, 2012, NEURON, V75, P209, DOI 10.1016/j.neuron.2012.06.031; Sato TK, 2012, NEURON, V75, P218, DOI 10.1016/j.neuron.2012.06.029; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Takagaki K, 2011, J NEUROSCI METH, V200, P207, DOI 10.1016/j.jneumeth.2011.05.023; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	52	224	228	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1426	+		10.1038/nn.3499	http://dx.doi.org/10.1038/nn.3499			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974708	Green Accepted			2022-12-25	WOS:000324795300015
J	Maruyama, M; Shimada, H; Suhara, T; Shinotoh, H; Ji, B; Maeda, J; Zhang, MR; Trojanowski, JQ; Lee, VMY; Ono, M; Masamoto, K; Takano, H; Sahara, N; Iwata, N; Okamura, N; Furumoto, S; Kudo, Y; Chang, Q; Saido, TC; Takashima, A; Lewis, J; Jang, MK; Aoki, I; Ito, H; Higuchi, M				Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M. -Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto			Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls	NEURON			English	Article							IN-VIVO DETECTION; AMYLOID-BETA; DISEASE; PET; BINDING; DISORDERS; PLAQUES; TANGLES; LIGAND; TRACER	Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders. In vivo optical and positron emission tomographic (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs. A pyridinated PBB, [C-11]PBB3, was next applied in a clinical PET study, and its robust signal in the AD hippocampus wherein tau pathology is enriched contrasted strikingly with that of a senile plaque radioligand, [C-11]Pittsburgh Compound-B ([C-11]PIB. [C-11]PBB3-PET data were also consistent with the spreading of tau pathology with AD progression. Furthermore, increased [C-11]PBB3 signals were found in a corticobasal syndrome patient negative for [C-11]PIB-PET.	[Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Sahara, Naruhiko; Takashima, Akihiko] RIKEN Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Sahara, Naruhiko; Lewis, Jada] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Sahara, Naruhiko; Lewis, Jada] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Okamura, Nobuyuki; Furumoto, Shozo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kudo, Yukitsuka] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Chang, Qing; Jang, Ming-Kuei] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77054 USA	National Institutes for Quantum Science & Technology; University of Pennsylvania; Pennsylvania Medicine; RIKEN; RIKEN; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Tohoku University; Tohoku University; University of Texas System; UTMD Anderson Cancer Center	Higuchi, M (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	mhiguchi@nirs.go.jp	Aoki, Ichio/G-2529-2011; Okamura, Nobuyuki/C-3541-2017; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Aoki, Ichio/ABF-7336-2020	Aoki, Ichio/0000-0002-4429-5053; Okamura, Nobuyuki/0000-0002-5991-7812; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; SHIMADA, Hitoshi/0000-0002-7139-7178; Furumoto, Shozo/0000-0002-9296-3079	National Institute on Aging of the National Institutes of Health [AG10124, AG17586]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21791158, 23390235, 23111009]; Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida; Belfer Neurodegeneration Consortium; Grants-in-Aid for Scientific Research [23591735] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida; Belfer Neurodegeneration Consortium; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Mr. T. Minamihisamatsu and Mr. Y. Matsuba for technical assistance, the staff of the Molecular Probe Group, National Institute of Radiological Sciences, for support with radiosynthesis, Dr. Y. Yoshiyama at National Hospital Organization Chiba-East Hospital for his support on clinical PET studies, and Dr. T. Iwatsubo at the University of Tokyo and Dr. H. Inoue at Kyoto University for their critical discussions. This work was supported in part by grants from the National Institute on Aging of the National Institutes of Health (AG10124 and AG17586) (to J.Q.T. and V. M.-Y.L.), Grants-in-Aid for Japan Advanced Molecular Imaging Program, Young Scientists (21791158) (to M.M.), Scientific Research (B) (23390235) (to M.H.), Core Research for Evolutional Science and Technology (to T.S.), Scientific Research on Innovative Areas ("Brain Environment") (23111009) (to M.H.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Thomas H. Maren Junior Investigator Fund from College of Medicine, University of Florida (to N.S.), and research fund of Belfer Neurodegeneration Consortium (to Q.C. and M.-K.J.). M.M., H. Shimada, T.S., M.-R.Z., and M.H. are named as inventors on a patent application 0749006WO1, claiming subject matter related to the results described in this paper.	Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hintersteiner M, 2005, NAT BIOTECHNOL, V23, P577, DOI 10.1038/nbt1085; Klunk WE, 2003, J NEUROSCI, V23, P2086; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Maeda J, 2011, J NEUROSCI, V31, P4720, DOI 10.1523/JNEUROSCI.3076-10.2011; Marx J, 2007, SCIENCE, V316, P1416, DOI 10.1126/science.316.5830.1416; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHMIDT ML, 1988, ANN NEUROL, V23, P184, DOI 10.1002/ana.410230212; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Suzuki K., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS658; Thompson PW, 2009, J NEUROCHEM, V109, P623, DOI 10.1111/j.1471-4159.2009.05996.x; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	27	522	544	3	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1094	1108		10.1016/j.neuron.2013.07.037	http://dx.doi.org/10.1016/j.neuron.2013.07.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050400	Green Accepted, Bronze			2022-12-25	WOS:000330329600009
J	Younger, MA; Muller, M; Tong, A; Pym, EC; Davis, GW				Younger, Meg A.; Mueller, Martin; Tong, Amy; Pym, Edward C.; Davis, Graeme W.			A Presynaptic ENaC Channel Drives Homeostatic Plasticity	NEURON			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; RAT BRAIN-STEM; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; SOMATIC DEPOLARIZATION; GENETIC-ANALYSIS; QUANTAL CONTENT; DROSOPHILA; CALCIUM; DEG/ENAC	An electrophysiology-based forward genetic screen has identified two genes, pickpocket11 (ppk11) and pickpocket16 (ppk16), as being necessary for the homeostatic modulation of presynaptic neurotransmitter release at the Drosophila neuromuscular junction (NMJ). Pickpocket genes encode Degenerin/Epithelial Sodium channel subunits (DEG/ENaC). We demonstrate thatppk11 and ppk16 are necessary in presynaptic motoneurons for both the acute induction and long-term maintenance of synaptic homeostasis. We show that ppk11 and ppk16 are co-transcribed as a single mRNA that is upregulated during homeostatic plasticity. Acute pharmacological inhibition of a PPK11- and PPK16-containing channel abolishes the expression of short- and long-term homeostatic plasticity without altering baseline presynaptic neurotransmitter release, indicating remarkable specificity for homeostatic plasticity rather than NMJ development. Finally, presynaptic calcium imaging experiments support a model in which a PPK11- and PPK16-containing DEG/ENaC channel modulates presynaptic membrane voltage and, thereby, controls calcium channel activity to homeostatically regulate neurotransmitter release.	[Younger, Meg A.; Mueller, Martin; Tong, Amy; Pym, Edward C.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	graeme.davis@ucsf.edu		Younger, Meg/0000-0003-4967-7939	NIH [NS39313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grant number NS39313 to G.W.D. We thank Li Liu for sending Drosophila stocks and Susan Younger, Phil Parker, Kevin Ford, and members of the Davis laboratory for help and advice.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bergquist S, 2010, NEURON, V66, P220, DOI 10.1016/j.neuron.2010.03.023; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Bouhours B, 2011, J NEUROSCI, V31, P5804, DOI 10.1523/JNEUROSCI.5127-10.2011; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Chu YX, 2012, J NEUROSCI, V32, P13796, DOI 10.1523/JNEUROSCI.2158-12.2012; CUTHBERT AW, 1978, BRIT J PHARMACOL, V63, P139, DOI 10.1111/j.1476-5381.1978.tb07783.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gonzalez-Islas C, 2010, J NEUROSCI, V30, P13016, DOI 10.1523/JNEUROSCI.1659-10.2010; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Muller M, 2012, J NEUROSCI, V32, P16574, DOI 10.1523/JNEUROSCI.0981-12.2012; Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; WOJTOWICZ JM, 1983, J NEUROBIOL, V14, P385, DOI 10.1002/neu.480140506; WOJTOWICZ JM, 1984, J NEUROPHYSIOL, V52, P99, DOI 10.1152/jn.1984.52.1.99; Zhao CJ, 2011, J NEUROSCI, V31, P7492, DOI 10.1523/JNEUROSCI.6636-10.2011	64	62	64	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1183	1196		10.1016/j.neuron.2013.06.048	http://dx.doi.org/10.1016/j.neuron.2013.06.048			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	23973209	Green Accepted, Bronze			2022-12-25	WOS:000330329600015
J	Parnas, M; Lin, AC; Huetteroth, W; Miesenbock, G				Parnas, Moshe; Lin, Andrew C.; Huetteroth, Wolf; Miesenboeck, Gero			Odor Discrimination in Drosophila: From Neural Population Codes to Behavior	NEURON			English	Article							ANTENNAL LOBE; OLFACTORY SYSTEM; GAIN-CONTROL; FLY BRAIN; NEURONS; INHIBITION; CIRCUIT; MELANOGASTER; RESPONSES; MAP	Taking advantage of the well-characterized olfactory system of Drosophila, we derive a simple quantitative relationship between patterns of odorant receptor activation, the resulting internal representations of odors, and odor discrimination. Second-order excitatory and inhibitory projection neurons (ePNs and iPNs) convey olfactory information to the lateral horn, a brain region implicated in innate odor-driven behaviors. We show that the distance between ePN activity patterns is the main determinant of a fly's spontaneous discrimination behavior. Manipulations that silence subsets of ePNs have graded behavioral consequences, and effect sizes are predicted by changes in ePN distances. ePN distances predict only innate, not learned, behavior because the latter engages the mushroom body, which enables differentiated responses to even very similar odors. Inhibition from iPNs, which scales with olfactory stimulus strength, enhances innate discrimination of closely related odors, by imposing a high-pass filter on transmitter release from ePN terminals that increases the distance between odor representations.	[Parnas, Moshe; Lin, Andrew C.; Huetteroth, Wolf; Miesenboeck, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	gero.miesenboeck@cncb.ox.ac.uk	Huetteroth, Wolf/L-5252-2019; Huetteroth, Wolf/I-6661-2015	Huetteroth, Wolf/0000-0003-3421-9935; Lin, Andrew/0000-0001-6310-9765; Miesenboeck, Gero/0000-0003-2940-3228; Parnas, Moshe/0000-0001-9726-1511	Wellcome Trust; Gatsby Charitable Foundation; Medical Research Council; National Institutes of Health; Oxford Martin School; European Molecular Biology Organization; Edmond and Lily Safra Center for Brain Sciences; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish; MRC [G0700888, G0701225] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Gatsby Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Martin School; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Edmond and Lily Safra Center for Brain Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Alexei Bygrave and Ruth Brain for generating QUAS-spH flies; Liqun Luo for communicating unpublished results; Bassem Hassan, Kei Ito, Toshi Kitamoto, Tzumin Lee, David Owald, Joachim Urban, Jing Wang, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, and the Kyoto Drosophila Genetic Resource Center for fly strains; and Loren Looger for GCaMP3. This work was supported by grants (to G.M.) from the Wellcome Trust, the Gatsby Charitable Foundation, the Medical Research Council, the National Institutes of Health, and the Oxford Martin School. M.P. received postdoctoral fellowships from the European Molecular Biology Organization and the Edmond and Lily Safra Center for Brain Sciences. A.C.L. was a Sir Henry Wellcome Postdoctoral Fellow. M.P. and G.M. conceived and designed the study; M.P. performed and analyzed all experiments; and M.P., A.C.L., and G.M. interpreted the results and wrote the paper. A.C.L. provided fly strains and image analysis scripts. W.H. performed structural imaging.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GOOD IJ, 1985, BAYESIAN STATISTICS, V2, P249; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gupta N, 2012, J NEUROSCI, V32, P8138, DOI 10.1523/JNEUROSCI.1066-12.2012; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Legenstein R, 2008, NEURAL COMPUT, V20, P288, DOI 10.1162/neco.2008.20.1.288; Liang L, 2013, NEURON, V79, P917, DOI 10.1016/j.neuron.2013.06.014; Luo SX, 2010, P NATL ACAD SCI USA, V107, P10713, DOI 10.1073/pnas.1005635107; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mysore SP, 2012, NEURON, V73, P193, DOI 10.1016/j.neuron.2011.10.037; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005	52	80	80	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					932	944		10.1016/j.neuron.2013.08.006	http://dx.doi.org/10.1016/j.neuron.2013.08.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012006	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330269100011
J	McIlroy, G; Foldi, I; Aurikko, J; Wentzell, JS; Lim, MA; Fenton, JC; Gay, NJ; Hidalgo, A				McIlroy, Graham; Foldi, Istvan; Aurikko, Jukka; Wentzell, Jill S.; Lim, Mei Ann; Fenton, Janine C.; Gay, Nicholas J.; Hidalgo, Alicia			Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS	NATURE NEUROSCIENCE			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; CYSTINE-KNOT PROTEIN; AXON GUIDANCE; IMMUNE-RESPONSE; GROWTH-FACTOR; SPATZLE; MECHANISM; SURVIVAL	Neurotrophin receptors corresponding to vertebrate Trk, p75(NTR) or Sortilin have not been identified in Drosophila, thus it is unknown how neurotrophism may be implemented in insects. Two Drosophila neurotrophins, DNT1 and DNT2, have nervous system functions, but their receptors are unknown. The Toll receptor superfamily has ancient evolutionary origins and a universal function in innate immunity. Here we show that Toll paralogs unrelated to the mammalian neurotrophin receptors function as neurotrophin receptors in fruit flies. Toll-6 and Toll-7 are expressed in the CNS throughout development and regulate locomotion, motor axon targeting and neuronal survival. DNT1 (also known as NT1 and spz2) and DNT2 (also known as NT2 and spz5) interact genetically with Toll-6 and Toll-7, and DNT1 and DNT2 bind to Toll-6 and Toll-7 promiscuously and are distributed in vivo in domains complementary to or overlapping with those of Toll-6 and Toll-7. We conclude that in fruit flies, Tolls are not only involved in development and immunity but also in neurotrophism, revealing an unforeseen relationship between the neurotrophin and Toll protein families.	[McIlroy, Graham; Foldi, Istvan; Wentzell, Jill S.; Lim, Mei Ann; Fenton, Janine C.; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Aurikko, Jukka; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Birmingham; University of Cambridge	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	McIlroy, Graham/HIA-0680-2022; Hidalgo, Alicia/F-5930-2015	McIlroy, Graham/0000-0002-4731-1784; Hidalgo, Alicia/0000-0001-8041-5764; Lim, Mei Ann/0000-0001-9060-0058	UK Medical Research Council Career Establishment Grant [MRCG0200140]; Wellcome Trust [WT094175/Z/10/Z]; Wellcome Trust equipment grant [WT073228/Z/03/Z]; Wellcome Trust programme grant [WT081744MA]; European Union Marie Curie International Incoming Fellowship [PIIF-GA-2010-274193-NPN]; UK Medical Research Council studentship; Brunei government studentship; MRC [G1000133] Funding Source: UKRI; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish	UK Medical Research Council Career Establishment Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust equipment grant(Wellcome Trust); Wellcome Trust programme grant(Wellcome Trust); European Union Marie Curie International Incoming Fellowship; UK Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brunei government studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Arnot, J. Wen and M. Wheatley for advice; S. Jondhale, J. Ng and S. Quayle for technical help; S. Bishop and K. Kato for comments on the manuscript; A. J. Courey (University of California, Los Angeles), J. L. Imler (Institut de Biologie Moleculaire et Cellulaire, CNRS, Strasbourg), T. Ip (University of Massachusetts), J. M. Reichhart (Institut de Biologie Moleculaire et Cellulaire, CNRS, Strasbourg), S. Sanyal (Emory University), R. Baines (University of Manchester), M. Freeman (University of Oxford), K. Ito (University of Tokyo), A. Chiba (University of Miami), B. Pfeiffer (Janelia Farm), M. Landgraf (University of Cambridge), C. Basler (University of Zurich), H. Broihier (Case Western Reserve University), D. Ferrandon (CNRS, Strasbourg), the Bloomington Stock Center and Iowa Hybridoma Bank for reagents; the Birmingham Mass Spectrometry Facility (Birmingham Science City, Advantage West Midlands); and Len Packman for mass spectrometry and Edman sequencing in Cambridge. The LTQ Orbitrap Velos ETD mass spectrometer used in this research was obtained through the Birmingham Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM). This work was funded by a UK Medical Research Council Career Establishment Grant (MRCG0200140) to A.H., Wellcome Trust project grant (WT094175/Z/10/Z) to A.H. and N.J.G., Wellcome Trust equipment grant (WT073228/Z/03/Z) to A.H., Wellcome Trust programme grant (WT081744MA) to N.J.G., European Union Marie Curie International Incoming Fellowship (PIIF-GA-2010-274193-NPN) to J.S.W., UK Medical Research Council studentship to G.M. and Brunei government studentship to M.A.L.	Arnot CJ, 2010, J BIOL CHEM, V285, P19502, DOI 10.1074/jbc.M109.098186; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bothwell M, 2006, BRAIN BEHAV EVOLUT, V68, P124, DOI 10.1159/000094082; Broihier HT, 2002, NEURON, V35, P39, DOI 10.1016/S0896-6273(02)00743-2; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Foehr ED, 2000, J NEUROSCI, V20, P7556; Forero MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005441; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; Hidalgo A, 2001, DEV CELL, V1, P679, DOI 10.1016/S1534-5807(01)00074-0; Hidalgo A, 2011, GLIA, V59, P1296, DOI 10.1002/glia.21092; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Levi-Montalcini R, 1990, PROG NEUROENDOCRINOL, V3, P1; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Newquist G, 2013, CELL REP, V3, P595, DOI 10.1016/j.celrep.2013.02.017; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Sossin WS, 2006, BRAIN BEHAV EVOLUT, V68, P145, DOI 10.1159/000094084; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	53	66	72	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1248	U124		10.1038/nn.3474	http://dx.doi.org/10.1038/nn.3474			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892553	Green Accepted, Green Published			2022-12-25	WOS:000323597500016
J	Pan, BF; Geleoc, GS; Asai, Y; Horwitz, GC; Kurima, K; Ishikawa, K; Kawashima, Y; Griffith, AJ; Holt, JR				Pan, Bifeng; Geleoc, Gwenaelle S.; Asai, Yukako; Horwitz, Geoffrey C.; Kurima, Kiyoto; Ishikawa, Kotaro; Kawashima, Yoshiyuki; Griffith, Andrew J.; Holt, Jeffrey R.			TMC1 and TMC2 Are Components of the Mechanotransduction Channel in Hair Cells of the Mammalian Inner Ear	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCER CHANNELS; MECHANOSENSITIVE CHANNELS; FUNCTIONAL MATURATION; SENSORY TRANSDUCTION; MOUSE COCHLEA; C. ELEGANS; ADAPTATION; CALCIUM; DOMINANT; DEAFNESS	Sensory transduction in auditory and vestibular hair cells requires expression of transmembrane channel-like (Tmc) 1 and 2 genes, but the function of these genes is unknown. To investigate the hypothesis that TMC1 and TMC2 proteins are components of the mechanosensitive ion channels that convert mechanical information into electrical signals, we recorded whole-cell and single-channel currents from mouse hair cells that expressed Tmc1, Tmc2, or mutant Tmc1. Cells that expressed Tmc2 had high calcium permeability and large single-channel currents, while cells with mutant Tmc1 had reduced calcium permeability and reduced single-channel currents. Cells that expressed Tmc1 and Tmc2 had a broad range of single-channel currents, suggesting multiple heteromeric assemblies of TMC subunits. The data demonstrate TMC1 and TMC2 are components of hair cell transduction channels and contribute to permeation properties. Gradients in TMC channel composition may also contribute to variation in sensory transduction along the tonotopic axis of the mammalian cochlea.	[Pan, Bifeng; Geleoc, Gwenaelle S.; Asai, Yukako; Horwitz, Geoffrey C.; Holt, Jeffrey R.] Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Otolaryngol,FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Kurima, Kiyoto; Ishikawa, Kotaro; Kawashima, Yoshiyuki; Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Rockville, MD 20850 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Griffith, AJ (corresponding author), Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, 5 Res Court,Room 2B-29, Rockville, MD 20850 USA.	griffita@nidcd.nih.gov; jeffrey.holt@childrens.harvard.edu			NIDCD [Z01-DC000060-10]; NIH [R01-DC05439, R01-DC008853]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005439, Z01DC000060, ZIADC000060, R01DC008853, R01DC013521] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Erin Child for technical assistance, Lin Huang for assistance with statistical analysis, and Martin Hrabe de Angelis and Helmut Fuchs for providing Beethoven mice. We thank John Assad, David Clapham, David Corey, Tom Friedman, Matt Kelley, Tom Schwarz, and Clifford Woolf for helpful discussions and critical review of an earlier version of the manuscript. This work was supported by NIDCD intramural research funds Z01-DC000060-10 (A.J.G.); NIH grants R01-DC05439 (J.R.H.) and R01-DC008853 (G.S.G.). K.K. and A.J.G. hold US Patents: 7,166,433 (Transductin-2 and Applications to Hereditary Deafness; abandoned in 2009), 7,192,705 (Transductin-1 and Applications to Hereditary Deafness), and 7,659,115 (Nucleic Acid Encoding Human Transductin-1 Polypeptide). These patents have never been licensed and generate no income or royalties. B.P. collected all electrophysiology data from inner hair cells and helped analyze data. G.S.G. collected electrophysiology data from vestibular hair cells and helped analyze the data. G.C.H. collected electrophysiology data from vestibular hair cells, performed ABRs, and helped analyze data. Y.A. generated adenoviral vectors and performed qRT-PCR experiments. K.K. generated Tmc constructs. K.I. performed cell count analysis of Tmc1 mutant mice. Y.K. acquired SEM images of hair cells. A.J.G. contributed to conception of the study and provided critical comments on the data and manuscript. J.R.H. conceived and designed the experiments, analyzed the data, generated the figures, and wrote the paper. All authors provided comments and approved the final submission of the manuscript.	Amalfitano A, 1998, J VIROL, V72, P926, DOI 10.1128/JVI.72.2.926-933.1998; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; ASSAD JA, 1992, J NEUROSCI, V12, P3291; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chatzigeorgiou M, 2013, NATURE, V494, P95, DOI 10.1038/nature11845; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Esterberg R, 2013, J NEUROSCI, V33, P7513, DOI 10.1523/JNEUROSCI.4559-12.2013; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Hodges BL, 2000, J GENE MED, V2, P250, DOI 10.1002/1521-2254(200007/08)2:4<250::AID-JGM113>3.0.CO;2-3; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; RUSCH A, 1994, J PHYSIOL-LONDON, V474, P75; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; STEEL KP, 1989, DEVELOPMENT, V107, P453; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yang T, 2010, CLIN GENET, V77, P395, DOI 10.1111/j.1399-0004.2009.01338.x	40	257	261	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					504	515		10.1016/j.neuron.2013.06.019	http://dx.doi.org/10.1016/j.neuron.2013.06.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23871232	Green Accepted, Bronze			2022-12-25	WOS:000323085100011
J	Reimann, MW; Anastassiou, CA; Perin, R; Hill, SL; Markram, H; Koch, C				Reimann, Michael W.; Anastassiou, Costas A.; Perin, Rodrigo; Hill, Sean L.; Markram, Henry; Koch, Christof			A Biophysically Detailed Model of Neocortical Local Field Potentials Predicts the Critical Role of Active Membrane Currents	NEURON			English	Article							LONG-TERM POTENTIATION; LESS-THAN-1 HZ OSCILLATION; SOURCE-DENSITY METHOD; IN-VIVO; PYRAMIDAL CELLS; POSITIVE PHASE; THETA; NEURONS; CORTEX; FREQUENCY	Brain activity generates extracellular voltage fluctuations recorded as local field potentials (LFPs). It is known that the relevant microvariables, the ionic currents across membranes, jointly generate the macrovariables, the extracellular voltage, but neither the detailed biophysical knowledge nor the required computational power have been available to model these processes. We simulated the LFP in a model of the rodent neocortical column composed of >12,000 reconstructed, multicompartmental, and spiking cortical layer 4 and 5 pyramidal neurons and basket cells, including five million dendritic and somatic compartments with voltage- and ion-dependent currents, realistic connectivity, and probabilistic AMPA, NMDA, and GABA synapses. We found that, depending on a number of factors, the LFP reflects local and cross-layer processing. Active currents dominate the generation of LFPs, not synaptic ones. Spike-related currents impact the LFP not only at higher frequencies but below 50 Hz. This work calls for re-evaluating the genesis of LFPs.	[Reimann, Michael W.; Perin, Rodrigo; Hill, Sean L.; Markram, Henry] Ecole Polytech Fed Lausanne, Blue Brain Project, CH-1015 Lausanne Vd, CH, Switzerland; [Anastassiou, Costas A.; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anastassiou, Costas A.; Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98103 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; California Institute of Technology; Allen Institute for Brain Science	Anastassiou, CA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	costasa@alleninstitute.org	Perin, Rodrigo/G-7691-2015	Perin, Rodrigo/0000-0001-5756-3769; Koch, Christof/0000-0001-6482-8067	National Institute of Neurological Disorders and Stroke; Human Frontier Science Program; Swiss National Science Foundation; Allen Institute for Brain Science; Mathers Charitable Foundation; ETH Board; EPFL; Canton of Geneva; Canton of Vaud; Hans Wilsdorf Foundation; Louis-Jeantet Foundation; University of Geneva; University of Lausanne; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Allen Institute for Brain Science; Mathers Charitable Foundation; ETH Board; EPFL; Canton of Geneva; Canton of Vaud; Hans Wilsdorf Foundation; Louis-Jeantet Foundation; University of Geneva; University of Lausanne; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, Human Frontier Science Program, Swiss National Science Foundation, the Allen Institute for Brain Science, and the Mathers Charitable Foundation and by funding to the Blue Brain Project by the ETH Board and EPFL. Financial support for the CADMOS Blue Gene/P system was provided by the Canton of Geneva, Canton of Vaud, Hans Wilsdorf Foundation, Louis-Jeantet Foundation, University of Geneva, University of Lausanne, and EPFL. Special thanks goes to G. Buzsaki, E. Schomburg, A. Shai, Y. Billeh, J. Taxidis, and members of the Blue Brain Consortium, in particular, Michael Hines, James King, Eilif Muller, Srikant Ramaswamy, Felix Schurmann, and Werner van Geit.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Bedard C, 2009, BIOPHYS J, V96, P2589, DOI 10.1016/j.bpj.2008.12.3951; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Buzsaki G, 1996, EPILEPSY COMPREHENSI; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Elul R, 1971, Int Rev Neurobiol, V15, P227; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gold C, 2007, J COMPUT NEUROSCI, V23, P39, DOI 10.1007/s10827-006-0018-2; Goto T, 2010, J NEUROPHYSIOL, V104, P3388, DOI 10.1152/jn.00122.2010; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Hines ML, 2008, J COMPUT NEUROSCI, V25, P203, DOI 10.1007/s10827-007-0073-3; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holscher C, 1997, J NEUROSCI, V17, P6470; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Hyman JM, 2003, J NEUROSCI, V23, P11725; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Koch Christof, 1999, P1; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Miller K, 2009, AM PHILOS QUART, V46, P1; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Nunez P.L., 2006, ELECT FIELDS BRAIN; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pettersen KH, 2008, J COMPUT NEUROSCI, V24, P291, DOI 10.1007/s10827-007-0056-4; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; PRITCHARD WS, 1992, INT J NEUROSCI, V66, P119, DOI 10.3109/00207459208999796; Ramaswamy S, 2012, J PHYSIOL-LONDON, V590, P737, DOI 10.1113/jphysiol.2011.219576; Rasch M, 2009, J NEUROSCI, V29, P13785, DOI 10.1523/JNEUROSCI.2390-09.2009; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Riera JJ, 2012, J NEUROPHYSIOL, V108, P956, DOI 10.1152/jn.00098.2011; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	69	157	160	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					375	390		10.1016/j.neuron.2013.05.023	http://dx.doi.org/10.1016/j.neuron.2013.05.023			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889937	Green Accepted, Bronze			2022-12-25	WOS:000322426200015
J	Son, SJ; Filosa, JA; Potapenko, ES; Biancardi, VC; Zheng, H; Patel, KP; Tobin, VA; Ludwig, M; Stern, JE				Son, Sook Jin; Filosa, Jessica A.; Potapenko, Evgeniy S.; Biancardi, Vinicia C.; Zheng, Hong; Patel, Kaushik P.; Tobin, Vicky A.; Ludwig, Mike; Stern, Javier E.			Dendritic Peptide Release Mediates Interpopulation Crosstalk between Neurosecretory and Preautonomic Networks	NEURON			English	Article							RAT SUPRAOPTIC NUCLEUS; VASOPRESSIN NEURONS; PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM; IN-VIVO; DEPOLARIZING AFTERPOTENTIALS; CENTRAL HYPEROSMOLALITY; MAGNOCELLULAR NEURONS; HYPERTENSIVE-RATS; CATION CHANNELS	Although communication between neurons is considered a function of the synapse, neurons also release neurotransmitter from their dendrites. We found that dendritic transmitter release coordinates activity across distinct neuronal populations to generate integrative homeostatic responses. We show that activity-dependent vasopressin release from hypothalamic neuroendocrine neurons in the paraventricular nucleus stimulates neighboring (similar to 100 mu m soma-to-soma) presynnpathetic neurons, resulting in a sympathoexcitatory population response. This interpopulation crosstalk was engaged by an NMDA-mediated increase in dendritic Ca2+, influenced by vasopressin's ability to diffuse in the extracellular space, and involved activation of CAN channels at the target neurons. Furthermore, we demonstrate that this interpopulation crosstalk plays a pivotal role in the generation of a systemic, polymodal neurohumoral response to a hyperosmotic challenge. Because dendritic release is emerging as a widespread process, our results suggest that a similar mechanism could mediate interpopulation crosstalk in other brain systems, particularly those involved in generating complex behaviors.	[Son, Sook Jin; Filosa, Jessica A.; Potapenko, Evgeniy S.; Biancardi, Vinicia C.; Stern, Javier E.] Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA; [Zheng, Hong; Patel, Kaushik P.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA; [Tobin, Vicky A.; Ludwig, Mike] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University System of Georgia; Augusta University; University of Nebraska System; University of Nebraska Medical Center; University of Edinburgh	Stern, JE (corresponding author), Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA.	jstern@gru.edu	Biancardi, Vinicia Campana/N-1108-2017; Filosa, Jessica Andrea/ABG-4524-2020	Biancardi, Vinicia Campana/0000-0001-7301-1702; Filosa, Jessica Andrea/0000-0001-7536-2039	NIH [R01-HL090948-01]; BBSRC [BB/J004723/1]; Biotechnology and Biological Sciences Research Council [BB/J004723/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Professor Rainer Landgraf for analyzing the microdialysis samples, Dr. Ryoichi Teruyama for the kind donation of the TRPM4 antibody, and Professor Gareth Leng for critical reading of the manuscript. This work was supported by NIH R01-HL090948-01 (to J.E.S.) and BBSRC BB/J004723/1 (to M.L.).	Antunes VR, 2006, J PHYSIOL-LONDON, V576, P569, DOI 10.1113/jphysiol.2006.115766; Armstrong WE, 2010, J NEUROENDOCRINOL, V22, P330, DOI 10.1111/j.1365-2826.2010.01989.x; Biancardi VC, 2011, HYPERTENSION, V58, P454, DOI 10.1161/HYPERTENSIONAHA.111.175810; Biancardi VC, 2010, J COMP NEUROL, V518, P567, DOI 10.1002/cne.22256; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Brown CH, 1998, J NEUROSCI, V18, P9480, DOI 10.1523/jneurosci.18-22-09480.1998; Buijs RM, 2000, PROG BRAIN RES, V126, P117; Chen QH, 2001, AM J PHYSIOL-REG I, V281, pR1844, DOI 10.1152/ajpregu.2001.281.6.R1844; Chen XH, 1999, J NEUROPHYSIOL, V82, P1689, DOI 10.1152/jn.1999.82.4.1689; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; de Kock CPJ, 2006, J PHYSIOL-LONDON, V577, P891, DOI 10.1113/jphysiol.2006.115311; de Kock CPJ, 2004, J PHYSIOL-LONDON, V561, P53, DOI 10.1113/jphysiol.2004.069005; Ely DL, 1995, ANN NY ACAD SCI, V771, P594, DOI 10.1111/j.1749-6632.1995.tb44712.x; ESLER MD, 1995, CLIN EXP HYPERTENS, V17, P409, DOI 10.3109/10641969509087081; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Ghamari-Langroudi M, 2002, J PHYSIOL-LONDON, V545, P537, DOI 10.1113/jphysiol.2002.033589; Gouzenes L, 1998, J NEUROSCI, V18, P1879; Guan JL, 2005, REGUL PEPTIDES, V126, P73, DOI 10.1016/j.regpep.2004.08.011; HATTON GI, 1985, BRAIN RES BULL, V14, P123, DOI 10.1016/0361-9230(85)90072-3; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LANDGRAF R, 1995, EUR J NEUROSCI, V7, P592, DOI 10.1111/j.1460-9568.1995.tb00663.x; Leng G, 2001, J NEUROSCI, V21, P6967, DOI 10.1523/JNEUROSCI.21-17-06967.2001; Leng G, 2008, J PHYSIOL-LONDON, V586, P5625, DOI 10.1113/jphysiol.2008.159103; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Ludwig M, 1998, J NEUROENDOCRINOL, V10, P881; Ludwig M, 1997, EUR J NEUROSCI, V9, P2532, DOI 10.1111/j.1460-9568.1997.tb01682.x; MCBEAN GJ, 1994, BRIT J PHARMACOL, V113, P536, DOI 10.1111/j.1476-5381.1994.tb17022.x; MENS WBJ, 1983, BRAIN RES, V262, P143, DOI 10.1016/0006-8993(83)90478-X; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; Petersen OH, 2002, CURR BIOL, V12, pR520, DOI 10.1016/S0960-9822(02)01027-8; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; PITTMAN QJ, 1982, PEPTIDES, V3, P515, DOI 10.1016/0196-9781(82)90118-8; Pliquett RU, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-4; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Shi P, 2007, AM J PHYSIOL-REG I, V293, pR2279, DOI 10.1152/ajpregu.00160.2007; Sonner PM, 2011, J PHYSIOL-LONDON, V589, P667, DOI 10.1113/jphysiol.2010.198556; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1980, BRAIN RES, V198, P190, DOI 10.1016/0006-8993(80)90354-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Teruyama R, 2011, J NEUROENDOCRINOL, V23, P1204, DOI 10.1111/j.1365-2826.2011.02211.x; Teruyama R, 2007, J NEUROPHYSIOL, V98, P2612, DOI 10.1152/jn.00599.2007; Tobin VA, 2010, NATURE, V464, P413, DOI 10.1038/nature08826; Toney GM, 2010, J PHYSIOL-LONDON, V588, P3375, DOI 10.1113/jphysiol.2010.191940; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Xu HL, 2008, AM J PHYSIOL-HEART C, V294, pH622, DOI 10.1152/ajpheart.00530.2007; Zingg HH, 1996, BAILLIERE CLIN ENDOC, V10, P75, DOI 10.1016/S0950-351X(96)80314-4	54	113	114	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 19	2013	78	6					1036	1049		10.1016/j.neuron.2013.04.025	http://dx.doi.org/10.1016/j.neuron.2013.04.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791197	Green Accepted, Bronze			2022-12-25	WOS:000321026900010
J	Joo, WJ; Sweeney, LB; Liang, L; Luo, LQ				Joo, William J.; Sweeney, Lora B.; Liang, Liang; Luo, Liqun			Linking Cell Fate, Trajectory Choice, and Target Selection: Genetic Analysis of Sema-2b in Olfactory Axon Targeting	NEURON			English	Article							RECEPTOR NEURONS; CIS INTERACTION; DROSOPHILA CNS; ANTENNAL LOBE; MAP; SYSTEM; SPECIFICITY; ESTABLISHES; EXPRESSION; GUIDANCE	Neural circuit assembly requires selection of specific cell fates, axonal trajectories, and synaptic targets. By analyzing the function of a secreted semaphorin, Sema-2b, in Drosophila olfactory receptor neuron (ORN) development, we identified multiple molecular and cellular mechanisms that link these events. Notch signaling limits Sema-2b expression to ventromedial ORN classes, within which Sema-2b cell-autonomously sensitizes ORN axons to external semaphorins. Central-brain-derived Sema-2a and Sema-2b attract Sema-2b-expressing axons to the ventromedial trajectory. In addition, Sema-2b/PlexB-mediated axon-axon interactions consolidate this trajectory choice and promote ventromedial axon-bundle formation. Selecting the correct developmental trajectory is ultimately essential for proper target choice. These findings demonstrate that Sema-2b couples ORN axon guidance to postsynaptic target neuron dendrite patterning well before the final target selection phase, and exemplify how a single guidance molecule can drive consecutive stages of neural circuit assembly with the help of sophisticated spatial and temporal regulation.	[Joo, William J.; Sweeney, Lora B.; Liang, Liang; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Joo, William J.; Sweeney, Lora B.; Liang, Liang; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Joo, William J.; Sweeney, Lora B.; Luo, Liqun] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA; [Sweeney, Lora B.] Stanford Univ, Applied Phys Grad Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Liang, Liang/0000-0001-5718-0717; Sweeney, Lora/0000-0001-9242-5601	Stanford Neurosciences Graduate Program; Kendall Fund; NIH NRSA Predoctoral Fellowship [5 F31 NS071697]; NIH [R01-DC005982]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Stanford Neurosciences Graduate Program; Kendall Fund; NIH NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Chris Potter for sharing unpublished Orco-GAL80 transgenic flies, Alex Kolodkin and Zhuhao Wu for reagents and discussions, and Thomas Clandinin, Kang Shen, and members of the Luo lab for comments on the manuscript. W.J.J. was supported by the Stanford Neurosciences Graduate Program, the Kendall Fund, and an NIH NRSA Predoctoral Fellowship (5 F31 NS071697), and dedicates this work to A. Wittstruck. This work was supported by NIH grant R01-DC005982 (to L.L.). L.L. is an investigator at the Howard Hughes Medical Institute.	Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chou YH, 2010, CELL, V142, P954, DOI 10.1016/j.cell.2010.08.015; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jukam D, 2010, CURR OPIN NEUROBIOL, V20, P6, DOI 10.1016/j.conb.2009.11.002; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Langen M, 2013, ELIFE, V2, DOI 10.7554/eLife.00337; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li PP, 2013, ELIFE, V2, DOI 10.7554/eLife.00378; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Yaron A, 2012, TRENDS NEUROSCI, V35, P230, DOI 10.1016/j.tins.2011.12.003	38	39	39	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					673	686		10.1016/j.neuron.2013.03.022	http://dx.doi.org/10.1016/j.neuron.2013.03.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719164	Green Accepted, Bronze			2022-12-25	WOS:000319491200011
J	Yan, D; Yamasaki, M; Straub, C; Watanabe, M; Tomita, S				Yan, Dan; Yamasaki, Miwako; Straub, Christoph; Watanabe, Masahiko; Tomita, Susumu			Homeostatic Control of Synaptic Transmission by Distinct Glutamate Receptors	NEURON			English	Article							MOSSY FIBER SYNAPSES; HETEROMERIC KAINATE RECEPTORS; SUBUNIT MESSENGER-RNAS; HIPPOCAMPAL INTERNEURONS; AMPA RECEPTORS; AUXILIARY SUBUNIT; MOUSE STARGAZER; SPINAL-CORD; TIME COURSE; RAT-BRAIN	Glutamate is the most abundant excitatory neurotransmitter in the brain, and distinct classes of glutamate receptors coordinate synaptic transmission and spike generation upon various levels of neuronal activity. However, the mechanisms remain unclear. Here, we found that loss of synaptic AMPA receptors increased kainate receptor activity in cerebellar granule cells without changing NMDA receptors. The augmentation of kainate receptor-mediated currents in the absence of AMPA receptor activity is required for spike generation and is mediated by the increased expression of the GluK5 high-affinity kainate receptor subunit. Increase in GluK5 expression is sufficient to enhance kainate receptor activity by modulating receptor channel properties, but not localization. Furthermore, we demonstrate that the combined loss of the AMPA receptor auxiliary TARP gamma-2 subunit and the GluK5 subunit leads to early mouse lethality. Our findings reveal mechanisms mediated by distinct classes of postsynaptic glutamate receptors for the homeostatic maintenance of the neuronal activity.	[Yan, Dan; Straub, Christoph; Tomita, Susumu] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06504 USA; [Yan, Dan; Straub, Christoph; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06504 USA; [Yamasaki, Miwako; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Yale University; Yale University; Hokkaido University	Tomita, S (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06504 USA.	susumu.tomita@yale.edu	Yamasaki, Miwako/I-8053-2014; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	Yamasaki, Miwako/0000-0003-4974-9349; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138	NIH/NIMH [R01 MH085080, MH077939]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19100005]; Boehringer-Ingelheim; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH077939, R01MH085080, R01MH077939] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Boehringer-Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the members of the Tomita lab and Dr. James Howe (Yale Pharmacology) for helpful discussions. We thank Mr. Gerard Somers for maintaining the mouse colonies, Mr. Kwang S. Kim for preliminary studies, Dr. S.F. Heinemann (Salk Institute) for generating the GluK2 mice, Deltagen and Jackson for generating and maintaining GluK5 mice, and Dr. Hyoungseok Ju and Dr. Janghoo Lim for their valuable comments on the qPCR and real-time PCR equipment. S.T. is supported by NIH/NIMH R01 MH085080 and MH077939. M.W. is supported by Grants-in-Aid for Scientific Research (19100005) provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. C.S. is supported by a Boehringer-Ingelheim Fonds PhD fellowship.	AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; BAHN S, 1994, J NEUROSCI, V14, P5525; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Fernandes HB, 2009, NEURON, V63, P818, DOI 10.1016/j.neuron.2009.08.010; Frerking M, 2002, J NEUROSCI, V22, P7434; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Fukaya M, 2000, J COMP NEUROL, V426, P572; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lemon RN, 2010, BRAIN, V133, P652, DOI 10.1093/brain/awq030; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Menuz K, 2008, J NEUROSCI, V28, P10599, DOI 10.1523/JNEUROSCI.2732-08.2008; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pinheiro PS, 2007, P NATL ACAD SCI USA, V104, P12181, DOI 10.1073/pnas.0608891104; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tomita S, 2012, J PHYSIOL-LONDON, V590, P2217, DOI 10.1113/jphysiol.2011.221101; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wondolowski J, 2009, J NEUROSCI, V29, P563, DOI 10.1523/JNEUROSCI.4788-08.2009; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	69	23	23	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2013	78	4					687	699		10.1016/j.neuron.2013.02.031	http://dx.doi.org/10.1016/j.neuron.2013.02.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719165	Green Accepted, Bronze			2022-12-25	WOS:000319491200012
J	Bateup, HS; Johnson, CA; Denefrio, CL; Saulnier, JL; Kornacker, K; Sabatini, BL				Bateup, Helen S.; Johnson, Caroline A.; Denefrio, Cassandra L.; Saulnier, Jessica L.; Kornacker, Karl; Sabatini, Bernardo L.			Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis	NEURON			English	Article							NEURODEVELOPMENTAL DISORDERS; AMPA RECEPTORS; AUTISM; EPILEPSY; NEURONS; COMPLEX; TSC1; INHIBITION; TRANSLATION; SUPPRESSION	Neural circuits are regulated by activity-dependent feedback systems that tightly control network excitability and which are thought to be crucial for proper brain development. Defects in the ability to establish and maintain network homeostasis may be central to the pathogenesis of neurodevelopmental disorders. Here, we examine the function of the tuberous sclerosis complex (TSC)-mTOR signaling pathway, a common target of mutations associated with epilepsy and autism spectrum disorder, in regulating activity-dependent processes in the mouse hippocampus. We find that the TSC-mTOR pathway is a central component of a positive feedback loop that promotes network activity by repressing inhibitory synapses onto excitatory neurons. In Tsc1 KO neurons, weakened inhibition caused by deregulated mTOR alters the balance of excitatory and inhibitory synaptic transmission, leading to hippocampal hyperexcitability. These findings identify the TSC-mTOR pathway as a regulator of neural network activity and have implications for the neurological dysfunction in disorders exhibiting deregulated mTOR signaling.	[Bateup, Helen S.; Johnson, Caroline A.; Denefrio, Cassandra L.; Saulnier, Jessica L.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Kornacker, Karl] Ohio State Univ, Div Sensory Biophys, Columbus, OH 43210 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University System of Ohio; Ohio State University	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Denefrio, Cassandra/AAV-2261-2021	Johnson, Caroline/0000-0001-5770-6176	NINDS grant [NS052707]; Nancy Lurie Marks postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052707] Funding Source: NIH RePORTER	NINDS grant; Nancy Lurie Marks postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini lab for helpful comments and critically reading our manuscript. This work was supported by an NINDS grant (NS052707) (to B.L.S.) and a Nancy Lurie Marks postdoctoral fellowship (to H.S.B.).	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P1101, DOI 10.1016/j.nbd.2011.12.028; Cudmore RH, 2010, J NEUROSCI, V30, P12885, DOI 10.1523/JNEUROSCI.0740-10.2010; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Vries PJ, 2010, NEUROTHERAPEUTICS, V7, P275, DOI 10.1016/j.nurt.2010.05.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035003, 10.1371/journal.pone.0050716]; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Meador KJ, 2007, EPILEPSIA, V48, P23, DOI 10.1111/j.1528-1167.2007.01396.x; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Mori K, 2012, BRAIN DEV-JPN, V34, P478, DOI 10.1016/j.braindev.2011.09.001; Morrison RS, 1996, J NEUROSCI, V16, P1337; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Prather P, 2004, J CHILD NEUROL, V19, P666, DOI 10.1177/08830738040190090601; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Talos DM, 2012, ANN NEUROL, V71, P539, DOI 10.1002/ana.22696; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Wong M, 2012, JASPERS BASIC MECH E; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	47	213	217	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2013	78	3					510	522		10.1016/j.neuron.2013.03.017	http://dx.doi.org/10.1016/j.neuron.2013.03.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664616	Green Accepted, Bronze			2022-12-25	WOS:000318961700012
J	Maus, GW; Fischer, J; Whitney, D				Maus, Gerrit W.; Fischer, Jason; Whitney, David			Motion-Dependent Representation of Space in Area MT	NEURON			English	Article							MIDDLE TEMPORAL AREA; VISUAL-MOTION; PERCEIVED POSITION; PSYCHOMETRIC FUNCTION; RECEPTIVE-FIELDS; FLASH-LAG; PSYCHOPHYSICS; RETINOTOPY; MOVEMENTS; OBJECTS	How is visual space represented in cortical area MT+? At a relatively coarse scale, the organization of MT+ is debated; retinotopic, spatiotopic, or mixed representations have all been proposed. However, none of these representations entirely explain the perceptual localization of objects at a fine spatial scale-a scale relevant for tasks like navigating or manipulating objects. For example, perceived positions of objects are strongly modulated by visual motion; stationary flashes appear shifted in the direction of nearby motion. Does spatial coding in MT+ reflect these shifts in perceived position? We performed an fMRI experiment employing this "flash-drag" effect and found that flashes presented near motion produced patterns of activity similar to physically shifted flashes in the absence of motion. This reveals a motion-dependent change in the neural representation of object position in human MT+, a process that could help compensate for perceptual and motor delays in localizing objects in dynamic scenes.	[Maus, Gerrit W.; Fischer, Jason; Whitney, David] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Maus, Gerrit W.; Fischer, Jason; Whitney, David] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95618 USA; [Fischer, Jason] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Fischer, Jason] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Maus, GW (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	maus@berkeley.edu	Maus, Gerrit W/A-7542-2011	Maus, Gerrit W/0000-0003-4843-3748	National Institutes of Health [EY018216]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Parts of this work were presented at the European Conference on Visual Perception and the Annual Meeting of the Society for Neuroscience in 2009. The authors would like to thank E. Sheykhani and N. Wurnitsch for help with data collection and analysis. This research was supported by grant number EY018216 from the National Institutes of Health.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Au RKC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00058; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crespi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021661; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Fischer J, 2011, J COGNITIVE NEUROSCI, V23, P119, DOI 10.1162/jocn.2010.21417; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; Golomb JD, 2011, CEREB CORTEX, V21, P2094, DOI [10.1093/cercor/bhq292, 10.1093/cercor/bhr357]; Hartmann TS, 2011, J NEUROSCI, V31, P10437, DOI 10.1523/JNEUROSCI.5590-10.2011; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huk AC, 2002, J NEUROSCI, V22, P7195; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kosovicheva AA, 2012, J VISION, V12, DOI 10.1167/12.8.7; Krekelberg B, 2001, TRENDS NEUROSCI, V24, P335, DOI 10.1016/S0166-2236(00)01795-1; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maus GW, 2013, CEREB CORTEX, V23, P241, DOI 10.1093/cercor/bhs021; Maus GW, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00186; McGraw PV, 2004, CURR BIOL, V14, P1090, DOI 10.1016/j.cub.2004.06.028; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Morris AP, 2010, J NEUROSCI, V30, P9821, DOI 10.1523/JNEUROSCI.1705-10.2010; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Ong WS, 2011, J NEUROSCI, V31, P10432, DOI 10.1523/JNEUROSCI.5589-10.2011; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Schwartz G, 2007, NEURON, V55, P958, DOI 10.1016/j.neuron.2007.07.042; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Tse PU, 2011, J VISION, V11, DOI 10.1167/11.3.12; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Whitney D, 2003, NATURE, V423, P869, DOI 10.1038/nature01693; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D., 2010, SPACE TIME PERCEPTIO, P121; Whitney D, 2008, BEHAV BRAIN SCI, V31, P220, DOI 10.1017/S0140525X08004044; Whitney D, 2007, CEREB CORTEX, V17, P2644, DOI 10.1093/cercor/bhl172; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Womelsdorf T, 2008, J NEUROSCI, V28, P8934, DOI 10.1523/JNEUROSCI.4030-07.2008; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zimmermann E, 2012, J VISION, V12, DOI 10.1167/12.2.10	52	41	41	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					554	562		10.1016/j.neuron.2013.03.010	http://dx.doi.org/10.1016/j.neuron.2013.03.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664618	Green Accepted, Bronze			2022-12-25	WOS:000318961700016
J	Wakao, H; Yoshikiyo, K; Koshimizu, U; Furukawa, T; Enomoto, K; Matsunaga, T; Tanaka, T; Yasutomi, Y; Yamada, T; Minakami, H; Tanaka, J; Oda, A; Sasaki, T; Wakao, R; Lantz, O; Udagawa, T; Sekiya, Y; Higuchi, K; Harada, N; Nishimura, K; Ohtaka, M; Nakanishi, M; Fujita, H				Wakao, Hiroshi; Yoshikiyo, Kazunori; Koshimizu, Uichi; Furukawa, Tomoko; Enomoto, Kei; Matsunaga, Tomomi; Tanaka, Tomofumi; Yasutomi, Yusuke; Yamada, Takashi; Minakami, Hisanori; Tanaka, Jyunji; Oda, Atsushi; Sasaki, Tomoyuki; Wakao, Rika; Lantz, Olivier; Udagawa, Tadashi; Sekiya, Yukie; Higuchi, Kazue; Harada, Nobuyuki; Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito; Fujita, Hiroyoshi			Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN PERIPHERAL-BLOOD; ANTIMICROBIAL ACTIVITY; IN-VITRO; INDUCTION; GENERATION; MR1; LYMPHOCYTES; GRANULYSIN; EXPRESSION	Mucosal-associated invariant T (MAIT) cells play an important physiological role in host pathogen defense and may also be involved in inflammatory disorders and multiple sclerosis. The rarity and inefficient expansion of these cells have hampered detailed analysis and application. Here, we report an induced pluripotent stem cell (iPSC)-based reprogramming approach for the expansion of functional MAIT cells. We found that human MAIT cells can be reprogrammed into iPSCs using a Sendai virus harboring standard reprogramming factors. Under T cell-permissive conditions, these iPSCs efficiently redifferentiate into MAIT-like lymphocytes expressing the T cell receptor V alpha 7.2, CD161, and interleukin-18 receptor chain alpha. Upon incubation with bacteria-fed monocytes, the derived MAIT cells show enhanced production of a broad range of cytokines. Following adoptive transfer into immunocompromised mice, these cells migrate to the bone marrow, liver, spleen, and intestine and protect against Mycobacterium abscessus. Our findings pave the way for further functional analysis of MAIT cells and determination of their therapeutic potential.	[Wakao, Hiroshi; Furukawa, Tomoko; Matsunaga, Tomomi; Oda, Atsushi; Sasaki, Tomoyuki; Fujita, Hiroyoshi] Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan; [Yamada, Takashi; Minakami, Hisanori] Hokkaido Univ, Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Jyunji] Hokkaido Univ, Sch Med, Dept Hematol, Sapporo, Hokkaido 0608638, Japan; [Yoshikiyo, Kazunori; Koshimizu, Uichi; Enomoto, Kei; Tanaka, Tomofumi; Yasutomi, Yusuke] Asubio Pharma, Kobe, Hyogo 6500047, Japan; [Wakao, Rika] Pharmaceut & Med Devices Agcy, Secur Dept, Tokyo 1000013, Japan; [Lantz, Olivier] Inst Curie, Immunol Lab, F-75005 Paris, France; [Udagawa, Tadashi; Sekiya, Yukie; Higuchi, Kazue; Harada, Nobuyuki] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose 2048533, Japan; [Nishimura, Ken] Univ Tsukuba, Sch Med, Lab Gene Regulat, Tsukuba, Ibaraki 3058575, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Tsukuba Cent Res, Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Asubio Pharma Co., Ltd.; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Wakao, H (corresponding author), Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan.	hwakao@med.hokudai.ac.jp	Nishimura, KEN/HGC-6147-2022; Enomoto, Kei/GQP-7270-2022; Nakanishi, Mahito/I-9888-2018	Enomoto, Kei/0000-0001-6210-8699; Nakanishi, Mahito/0000-0002-7068-7587; Lantz, olivier/0000-0003-3161-7719	Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency); Suzuken Memorial Foundation; Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University	Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency); Suzuken Memorial Foundation; Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (KAKENHI; H.F. and H.W.), by a Grant-in-Aid for Scientific Research (C) (KAKENHI; H.W.), by a Grant-in-Aid for Challenging Exploratory Research (KAKENHI; H.F.), by the Adaptable and Seamless Technology Transfer Program through target-driven R&D (Japan Science and Technology Agency; H.W.), by a grant (A) (Hokkaido Translational Research; H.W.), and by the Suzuken Memorial Foundation (H.W.). The earliest phase of the work was supported in part by the Cooperative Research Program of the Institute for Frontier Medical Sciences, Kyoto University (H.W.). We thank the Hokkaido Cord Blood Bank for providing CB for RNA expression and Bio-Plex analysis. The experimental protocol on human subjects was approved by the Ethical Committee at the School of Medicine, Hokkaido University. All mouse experiments were approved by the Hokkaido University Animal Committee and by the Animal Committee of the Japan Anti-Tuberculosis Association (JATA). The entire work was performed in compliance with the Declaration of Helsinki.	Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Kronenberg M, 2009, CURR OPIN IMMUNOL, V21, P391, DOI 10.1016/j.coi.2009.07.002; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lengner CJ, 2010, ANN NY ACAD SCI, V1192, P38, DOI 10.1111/j.1749-6632.2009.05213.x; Liu ZW, 2009, J IMMUNOL, V183, P3616, DOI 10.4049/jimmunol.0804336; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wakao H, 2008, FASEB J, V22, P2223, DOI 10.1096/fj.07-104687; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	42	65	72	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					546	558		10.1016/j.stem.2013.03.001	http://dx.doi.org/10.1016/j.stem.2013.03.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23523177	Bronze			2022-12-25	WOS:000329569600011
J	Figee, M; Luigjes, J; Smolders, R; Valencia-Alfonso, CE; van Wingen, G; de Kwaasteniet, B; Mantione, M; Ooms, P; de Koning, P; Vulink, N; Levar, N; Droge, L; van den Munckhof, P; Schuurman, PR; Nederveen, A; van den Brink, W; Mazaheri, A; Vink, M; Denys, D				Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Munckhof, Pepijn; Schuurman, P. Richard; Nederveen, Aart; van den Brink, Wim; Mazaheri, Ali; Vink, Matthijs; Denys, Damiaan			Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY	Little is known about the underlying neural mechanism of deep brain stimulation (DBS). We found that DBS targeted at the nucleus accumbens (NAc) normalized NAc activity, reduced excessive connectivity between the NAc and prefrontal cortex, and decreased frontal low-frequency oscillations during symptom provocation in patients with obsessive-compulsive disorder. Our findings suggest that DBS is able to reduce maladaptive activity and connectivity of the stimulated region.	[Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Brink, Wim; Mazaheri, Ali; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Figee, Martijn; Luigjes, Judy; Smolders, Ruud; van Wingen, Guido; de Kwaasteniet, Bart; Levar, Nina; Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Valencia-Alfonso, Carlos-Eduardo; Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [van den Munckhof, Pepijn; Schuurman, P. Richard] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands; [Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Vink, Matthijs] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Figee, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.figee@amc.nl; ddenys@gmail.com	Smolders, Ruud/H-4771-2013; de Koning, Pelle/F-2599-2013; Schuurman, Rick/ABE-9100-2021; Figee, Martijn/N-5659-2019; van Wingen, Guido/AAK-8462-2021; luigjes, judy/P-5161-2014; van den Munckhof, Pepijn/AAY-9259-2020; Figee, Martijn/C-7581-2012	Smolders, Ruud/0000-0002-1976-3775; Figee, Martijn/0000-0003-3679-284X; van Wingen, Guido/0000-0003-3076-5891; Figee, Martijn/0000-0003-3679-284X; Vink, Matthijs/0000-0002-1235-8347; Mazaheri, Ali/0000-0001-5732-7555; Vulink, Nienke/0000-0001-8991-9627	Netherlands Organization for Scientific Research ZON-MW VENI program [916.66.095]; VENI grant from the Netherlands Organization for Scientific Research [016.115.196]	Netherlands Organization for Scientific Research ZON-MW VENI program; VENI grant from the Netherlands Organization for Scientific Research	This study was supported by grant 916.66.095 from the Netherlands Organization for Scientific Research ZON-MW VENI program. A.M. was supported from a VENI grant 016.115.196 from the Netherlands Organization for Scientific Research.	Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Lang P.J., 2008, A8 U FLOR; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pogarell O, 2006, INT J PSYCHOPHYSIOL, V62, P87, DOI 10.1016/j.ijpsycho.2006.02.002; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Laere K, 2006, J NUCL MED, V47, P740	20	274	277	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					386	U195		10.1038/nn.3344	http://dx.doi.org/10.1038/nn.3344			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434914				2022-12-25	WOS:000316723700006
J	Orenstein, SJ; Kuo, SH; Tasset, I; Arias, E; Koga, H; Fernandez-Carasa, I; Cortes, E; Honig, LS; Dauer, W; Consiglio, A; Raya, A; Sulzer, D; Cuervo, AM				Orenstein, Samantha J.; Kuo, Sheng-Han; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Fernandez-Carasa, Irene; Cortes, Etty; Honig, Lawrence S.; Dauer, William; Consiglio, Antonella; Raya, Angel; Sulzer, David; Cuervo, Ana Maria			Interplay of LRRK2 with chaperone-mediated autophagy	NATURE NEUROSCIENCE			English	Article							ALPHA-SYNUCLEIN; LYSOSOMAL DEGRADATION; PEPTIDE SEQUENCES; DISEASE; MUTANT; PROTEINS; LOCALIZATION; RECEPTOR; MICRODOMAINS; MUTATIONS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. We found LRRK2 to be degraded in lysosomes by chaperone-mediated autophagy (CMA), whereas the most common pathogenic mutant form of LRRK2, G2019S, was poorly degraded by this pathway. In contrast to the behavior of typical CMA substrates, lysosomal binding of both wild-type and several pathogenic mutant LRRK2 proteins was enhanced in the presence of other CMA substrates, which interfered with the organization of the CMA translocation complex, resulting in defective CMA. Cells responded to such LRRK2-mediated CMA compromise by increasing levels of the CMA lysosomal receptor, as seen in neuronal cultures and brains of LRRK2 transgenic mice, induced pluripotent stem cell-derived dopaminergic neurons and brains of Parkinson's disease patients with LRRK2 mutations. This newly described LRRK2 self-perpetuating inhibitory effect on CMA could underlie toxicity in Parkinson's disease by compromising the degradation of alpha-synuclein, another Parkinson's disease-related protein degraded by this pathway.	[Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA; [Kuo, Sheng-Han; Cortes, Etty; Honig, Lawrence S.; Sulzer, David] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Fernandez-Carasa, Irene; Consiglio, Antonella] Univ Barcelona, Institute Biomed IBUB, Barcelona, Spain; [Cortes, Etty; Honig, Lawrence S.] Columbia Univ, Sch Med, Taub Inst, New York, NY USA; [Dauer, William] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Raya, Angel] Inst Bioengn Catalonia IBEC, Control Stem Cell Potency Grp, Barcelona, Spain; [Raya, Angel] ICREA, Barcelona, Spain; [Raya, Angel] Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Barcelona, Spain; [Sulzer, David] Columbia Univ, Dept Psychiat, Sch Med, New York, NY USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; University of Barcelona; Columbia University; University of Michigan System; University of Michigan; University of Brescia; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ICREA; Columbia University; Columbia University	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ds43@columbia.edu; ana-maria.cuervo@einstein.yu.edu	Raya, Angel/E-6205-2010; consiglio, antonella/AAA-5864-2019; Fernandez-Carasa, Irene/R-4421-2018; Cuevas, Inmaculada Tasset/R-4509-2019; consiglio, antonella/G-1815-2016	Raya, Angel/0000-0003-2189-9775; consiglio, antonella/0000-0002-3988-6254; Fernandez-Carasa, Irene/0000-0002-8195-3510; Cuevas, Inmaculada Tasset/0000-0003-0730-6750; consiglio, antonella/0000-0002-3988-6254; Cuervo, Ana Maria/0000-0002-0771-700X; Arias, Esperanza/0000-0002-7836-5072; Dauer, William/0000-0003-1775-7504; Kuo, Sheng-Han/0000-0002-9412-931X	US National Institutes of Health National Institute on Aging [AG031782, AG038072, AG08702, T32AG023475]; MINECO [SAF2012-33526, PLE2009-0144, ACI2010-1117, RyC-2008-02772, BFU2010-21823]; Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370, K08NS083738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, R37AG021904, P50AG008702, T32AG023475, P01AG031782, R01AG021904] Funding Source: NIH RePORTER	US National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MINECO(Spanish Government); Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; ICREA(ICREA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Michael J. Fox Foundation for kindly providing some of the LRRK2 antibodies, C. Calatayud for help with neuronal differentiation of iPSC, D. Arduino and B. Caballero for their help with the generation of the LRRK2 knockdown cells, J.P. Vonsattel and R. Alcalay for assistance with human tissue and A. Diaz and B. Patel for technical assistance in several aspects of this work. This work was supported by grants from the US National Institutes of Health National Institute on Aging (AG031782 and AG038072 (A.M.C.) and AG08702 (Alzheimer's Disease Research Center at Columbia University)), MINECO (SAF2012-33526, PLE2009-0144 and ACI2010-1117 (A.R.); RyC-2008-02772 and BFU2010-21823 (A.C.)), the Beatrice and Roy Backus Foundation (A.M.C.), the Rainwaters Foundation (A.M.C.), a Robert and Renee Belfer gift (A.M.C.), the JPB Foundation (D.S.), the Parkinson's Disease Foundation (D.S. and S.-H.K.), Fondazione Guido Berlucchi (A.C.), a CIBERNED Cooperative Project (A.R.), a US National Institute of Neurological Disorders and Stroke Udall Center of Excellence (A.M.C. and D.S.) and a Hirschl/Weill-Caulier Career Scientist Award (A.M.C.). S.J.O. was supported by US National Institutes of Health National Institute on Aging training grant T32AG023475 and S.-H.K. by an American Academy of Neurology Research Fellowship.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; LOWRY CC, 1951, AM J SURG, V81, P676, DOI 10.1016/0002-9610(51)90161-4; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Michael A.C., 2007, ELECTROCHEMICAL METH; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhu JH, 2003, BRAIN PATHOL, V13, P473	54	410	421	7	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					394	U52		10.1038/nn.3350	http://dx.doi.org/10.1038/nn.3350			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455607	Green Accepted			2022-12-25	WOS:000316723700009
J	Visser, RM; Scholte, HS; Beemsterboer, T; Kindt, M				Visser, Renee M.; Scholte, H. Steven; Beemsterboer, Tinka; Kindt, Merel			Neural pattern similarity predicts long-term fear memory	NATURE NEUROSCIENCE			English	Article								Although certain changes in the brain may reflect fear learning, there are no known markers that indicate whether an aversive experience will develop into fear memory. We examined the moment-to-moment dynamics of human fear learning by applying multi-voxel pattern analysis to single-trial blood oxygen level-dependent magnetic resonance imaging data. We found that the long-term behavioral expression of fear memory could be predicted from neural patterns at the time of learning.	[Visser, Renee M.; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Visser, Renee M.; Scholte, H. Steven; Kindt, Merel] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Scholte, H. Steven; Beemsterboer, Tinka] Univ Amsterdam, Dept Brain & Cognit, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	m.kindt@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788; Visser, Renee/0000-0003-0376-8165	Vici grant from the Netherlands Organization for Scientific Research	Vici grant from the Netherlands Organization for Scientific Research	The authors thank J. Wijnen and M. Spaan for technical assistance. This work was supported by a Vici grant (M.K.) from the Netherlands Organization for Scientific Research.	Bach DR, 2011, J NEUROSCI, V31, P9383, DOI 10.1523/JNEUROSCI.1524-11.2011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Peterson RA., 1992, ANXIETY SENSITIVITY; Reinhard G, 2006, PSYCHOPHYSIOLOGY, V43, P73, DOI 10.1111/j.1469-8986.2006.00374.x; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Spielberger C., 1983, MANUAL STATE TRAIT I; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Visser RM, 2011, J NEUROSCI, V31, P12021, DOI 10.1523/JNEUROSCI.2178-11.2011; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125	18	69	69	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					388	U200		10.1038/nn.3345	http://dx.doi.org/10.1038/nn.3345			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434912				2022-12-25	WOS:000316723700007
J	Arsenault, JT; Nelissen, K; Jarraya, B; Vanduffel, W				Arsenault, John T.; Nelissen, Koen; Jarraya, Bechir; Vanduffel, Wim			Dopaminergic Reward Signals Selectively Decrease fMRI Activity in Primate Visual Cortex	NEURON			English	Article							NEURONAL-ACTIVITY; CONTRAST AGENT; HUMAN BRAIN; ATTENTION; RESPONSES; DORSAL; REPRESENTATIONS; REINFORCERS; PREDICTION; MOTIVATION	Stimulus-reward coupling without attention can induce highly specific perceptual learning effects, suggesting that reward triggers selective plasticity within visual cortex. Additionally, dopamine-releasing events temporally surrounding stimulus-reward associations selectively enhance memory. These forms of plasticity may be evoked by selective modulation of stimulus representations during dopamine-inducing events. However, it remains to be shown whether dopaminergic signals can selectively modulate visual cortical activity. We measured fMRI activity in monkey visual cortex during reward-only trials apart from intermixed cue-reward trials. Reward without visual stimulation selectively decreased fMRI activity within the cue representations that had been paired with reward during other trials. Behavioral tests indicated that these same uncued reward trials strengthened cue-reward associations. Furthermore, such spatially-specific activity modulations depended on prediction error, as shown by manipulations of reward magnitude, cue-reward probability, cue-reward familiarity, and dopamine signaling. This cue-selective negative reward signal offers a mechanism for selectively gating sensory cortical plasticity.	[Arsenault, John T.; Nelissen, Koen; Jarraya, Bechir; Vanduffel, Wim] KU Leuven Med Sch, Lab Neuro & Psychophysiol, B-3000 Louvain, Belgium; [Arsenault, John T.; Jarraya, Bechir; Vanduffel, Wim] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Vanduffel, Wim] Harvard Univ, Sch Med, Dept Radiol, Charlestown, MA 02129 USA	KU Leuven; Harvard University; Massachusetts General Hospital; Harvard University	Vanduffel, W (corresponding author), KU Leuven Med Sch, Lab Neuro & Psychophysiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	wim@nmr.mgh.harvard.edu	Jarraya, Bechir/R-6023-2019	Jarraya, Bechir/0000-0003-0878-763X	Inter-University Attraction Pole [PFV10/008]; Geconcerteerde Onderzoeks Actie 10/19; Impulsfinanciering Zware Apparatuur; Katholieke Universiteit Leuven; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G062208.10, G083111.10, G.0719.12, G0888.13]; National Center for Research Resources [P41RR14075]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER	Inter-University Attraction Pole(Belgian Federal Science Policy Office); Geconcerteerde Onderzoeks Actie 10/19; Impulsfinanciering Zware Apparatuur; Katholieke Universiteit Leuven(KU Leuven); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank C. Fransen, C. Van Eupen, and A. Coeman for animal training and care; D. Mantini, O. Joly, H. Kolster, W. Depuydt, G. Meulemans, P. Kayenbergh, M. De Paep, M. Docx, and I. Puttemans for technical assistance; and P. Roelfsema, T Knapen, T, Donner, and S. Raiguel for their comments on the manuscript. This work received support from Inter-University Attraction Pole 7/11, Programme Financing PFV10/008, Geconcerteerde Onderzoeks Actie 10/19, Impulsfinanciering Zware Apparatuur and Hercules funding of the Katholieke Universiteit Leuven, Fonds Wetenschappelijk Onderzoek-Vlaanderen G062208.10, G083111.10 and G.0719.12, and G0888.13. K.N. is postdoctoral fellow of the Fonds Wetenschappelijk Onderzoek-Vlaanderen. The Martinos Center for Biomedical Imaging is supported by National Center for Research Resources grant P41RR14075.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Blaiss CA, 2007, NEUROBIOL LEARN MEM, V87, P644, DOI 10.1016/j.nlm.2006.12.007; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Engelmann JB, 2007, EMOTION, V7, P668, DOI 10.1037/1528-3542.7.3.668; Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fize D, 2003, J NEUROSCI, V23, P7395; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; HIETALA J, 1992, PSYCHOPHARMACOLOGY, V106, P455, DOI 10.1007/BF02244814; Hitchcott PK, 1998, PSYCHOPHARMACOLOGY, V140, P458, DOI 10.1007/s002130050790; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; LINDVALL O, 1974, BRAIN RES, V81, P325, DOI 10.1016/0006-8993(74)90947-0; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; MESSIER C, 1984, PHYSIOL BEHAV, V32, P195, DOI 10.1016/0031-9384(84)90129-X; Nelissen K, 2012, BIOL PSYCHIAT, V72, P422, DOI 10.1016/j.biopsych.2012.02.021; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; OSCOS A, 1988, PSYCHOPHARMACOLOGY, V95, P132; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pleger B, 2008, J NEUROSCI, V28, P8161, DOI 10.1523/JNEUROSCI.1093-08.2008; Pleger B, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000164; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; SALEEM KS, 2006, COMBINED MRI HISTOLO; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Sylvester CM, 2007, J NEUROSCI, V27, P14424, DOI 10.1523/JNEUROSCI.3759-07.2007; Tan CO, 2009, J NEUROPHYSIOL, V101, P2738, DOI 10.1152/jn.00141.2009; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P147, DOI 10.1002/cne.902480202; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Weil RS, 2010, J NEUROPHYSIOL, V104, P1746, DOI 10.1152/jn.00870.2009; WHITE N, 1978, PHARMACOL BIOCHEM BE, V8, P565, DOI 10.1016/0091-3057(78)90389-1; WHITE NM, 1992, ANNU REV PSYCHOL, V43, P443; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhao YQ, 2002, J PHYSIOL-LONDON, V539, P223, DOI 10.1113/jphysiol.2001.012721	59	78	78	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1174	1186		10.1016/j.neuron.2013.01.008	http://dx.doi.org/10.1016/j.neuron.2013.01.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522051	Green Accepted, Bronze			2022-12-25	WOS:000316645000017
J	Ziv, Y; Burns, LD; Cocker, ED; Hamel, EO; Ghosh, KK; Kitch, LJ; El Gamal, A; Schnitzer, MJ				Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Ghosh, Kunal K.; Kitch, Lacey J.; El Gamal, Abbas; Schnitzer, Mark J.			Long-term dynamics of CA1 hippocampal place codes	NATURE NEUROSCIENCE			English	Article							SPATIAL INFORMATION; STABILITY; MEMORY; CELLS; MICE; REPRESENTATION; EXPERIENCE	Using Ca2+ imaging in freely behaving mice that repeatedly explored a familiar environment, we tracked thousands of CA1 pyramidal cells' place fields over weeks. Place coding was dynamic, as each day the ensemble representation of this environment involved a unique subset of cells. However, cells in the similar to 15-25% overlap between any two of these subsets retained the same place fields, which sufficed to preserve an accurate spatial representation across weeks.	[Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Kitch, Lacey J.; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Ghosh, Kunal K.; El Gamal, Abbas] Stanford Univ, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yziv@stanford.edu; mschnitz@stanford.edu	Core, Vector/CAF-4832-2022		US National Science Foundation; Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health [DP1OD003560, R21AG038771, R21MH099469]; Div Of Biological Infrastructure [1063292] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038771] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003560] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Looger (Janelia Farm Research Campus) for GCaMP3 plasmid, and A. Attardo, T. Davidson, J. Fitzgerald, J. Li, J.Z. Li, A. Lui, C. Ramachandran, O. Yizhar and T. Zhang for conversations and assistance. We appreciate fellowships from the US National Science Foundation (L.D.B., L.J.K.), the Simons (L.J.K.) and Machiah (Y.Z.) Foundations and research funding to M.J.S. from the Paul G. Allen Family Foundation and the US National Institutes of Health (grants DP1OD003560, R21AG038771 and R21MH099469).	Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MULLER RU, 1987, J NEUROSCI, V7, P1935; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398	19	550	555	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					264	266		10.1038/nn.3329	http://dx.doi.org/10.1038/nn.3329			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396101	Green Accepted			2022-12-25	WOS:000315474800006
J	Jia, XX; Tanabe, S; Kohn, A				Jia, Xiaoxuan; Tanabe, Seiji; Kohn, Adam			Gamma and the Coordination of Spiking Activity in Early Visual Cortex	NEURON			English	Article							OSCILLATORY RESPONSES; NEURONAL-ACTIVITY; CORTICAL ACTIVITY; MACAQUE; SYNCHRONIZATION; FREQUENCY; STRIATE; AREAS; INFORMATION; INTEGRATION	Gamma components of the local field potential (LFP) are elevated during cognitive and perceptual processes. It has been suggested that gamma power indicates the strength of neuronal population synchrony, which influences the relaying of signals between cortical areas. However, the relationship between coordinated spiking activity and gamma remains unclear, and the influence on corticocortical signaling largely untested. We investigated these issues by recording from neuronal populations in areas V1 and V2 of anesthetized macaque monkeys. We found that visual stimuli that induce a strong, coherent gamma rhythm result in enhanced pairwise and higher-order V1 synchrony. This is associated with stronger coupling of V1-V2 spiking activity, in a retinotopically specific manner. Coupling is more strongly related to the gamma modulation of V1 firing than to the downstream V2 rhythm. Our results thus show that elevated gamma power is associated with stronger coordination of spiking activity both within and between cortical areas.	[Jia, Xiaoxuan; Tanabe, Seiji; Kohn, Adam] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10461 USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Ophthalmol & Vis Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jia, XX (corresponding author), MIT, McGoven Inst Brain Res, Cambridge, MA 02139 USA.	jxiaoxuan@gmail.com; adam.kohn@einstein.yu.edu	Jia, Xiaoxuan/P-5588-2014	Jia, Xiaoxuan/0000-0001-5484-9331	National Institutes of Health [EY016774, P30HD071593]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health (EY016774 and P30HD071593) and Research to Prevent Blindness. We thank Douglas McLelland and Steve Gotts for comments on an earlier version of this manuscript. We thank Amin Zandvakili for help with V1-V2 recordings and analysis.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GIRARD P, 1989, J NEUROPHYSIOL, V62, P1287, DOI 10.1152/jn.1989.62.6.1287; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Ito J, 2011, CEREB CORTEX, V21, P2482, DOI 10.1093/cercor/bhr020; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; ROCKLAND KS, 1992, CEREB CORTEX, V2, P38, DOI 10.1093/cercor/2.1.38; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Samonds JM, 2005, J NEUROPHYSIOL, V93, P223, DOI 10.1152/jn.00548.2004; Schmid MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005527; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Smith M.A., 2012, J NEUROPHYSIOL; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	47	108	108	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2013	77	4					762	774		10.1016/j.neuron.2012.12.036	http://dx.doi.org/10.1016/j.neuron.2012.12.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439127	Green Accepted, Bronze			2022-12-25	WOS:000315561300017
J	Mehta, B; Snellman, J; Chen, S; Li, W; Zenisek, D				Mehta, Bhupesh; Snellman, Josefin; Chen, Shan; Li, Wei; Zenisek, David			Synaptic Ribbons Influence the Size and Frequency of Miniature-like Evoked Postsynaptic Currents	NEURON			English	Article							MULTIVESICULAR RELEASE; SPONTANEOUS NEUROTRANSMISSION; TRANSMITTER RELEASE; BIPOLAR CELLS; MOUSE RETINA; RAT RETINA; SYNAPSES; ROD; EXOCYTOSIS; LUMINANCE	Nonspiking cells of several sensory systems respond to stimuli with graded changes in neurotransmitter release and possess specialized synaptic ribbons. Here, we show that manipulations to synaptic ribbons caused dramatic effects on mEPSC-like (mIEPSC) amplitude and frequency. Damage to rod-bipolar cell ribbons using fluorophore-assisted light inactivation resulted in the immediate reduction of mIEPSC amplitude and frequency, whereas the first evoked response after damage remained largely intact. The reduction in amplitude could not be recovered by increasing release frequency after ribbon damage. In parallel experiments, we looked at mIEPSCs from cones of hibernating ground squirrels, which exhibit dramatically smaller ribbons than awake animals. Fewer and smaller mIEPSCs were observed postsynaptic to cones from hibernating animals, although depolarized cones were able to generate larger mIEPSCs. Our results indicate that ribbon size may influence mIEPSC frequency and support a role for ribbons in coordinating multivesicular release.	[Mehta, Bhupesh; Snellman, Josefin; Zenisek, David] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Zenisek, David] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; [Zenisek, David] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Chen, Shan; Li, Wei] NEI, Unit Retinal Neurophysiol, Intramural Res Program, NIH, Bethesda, MD 20892 USA	Yale University; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Li, W (corresponding author), NEI, Unit Retinal Neurophysiol, Intramural Res Program, NIH, 35 Convent Dr,Room 2A-108, Bethesda, MD 20892 USA.	liwei2@nei.nih.gov; david.zenisek@yale.edu		Li, Wei/0000-0002-2897-649X	National Institutes of Health [EY014990]; National Eye Institute Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000488, R01EY014990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health (grant no. EY014990, to D.Z.) and the National Eye Institute Intramural Research Program (W.L.).	Allwardt BA, 2001, J NEUROSCI, V21, P2330, DOI 10.1523/JNEUROSCI.21-07-02330.2001; Auger C, 1998, J NEUROSCI, V18, P4532; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Grant L, 2010, J NEUROSCI, V30, P4210, DOI 10.1523/JNEUROSCI.4439-09.2010; Graydon CW, 2011, J NEUROSCI, V31, P16637, DOI 10.1523/JNEUROSCI.1866-11.2011; Hoffman-Kim D, 2007, METHOD CELL BIOL, V82, P335, DOI 10.1016/S0091-679(06)82011-X; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jarsky T, 2011, J NEUROSCI, V31, P11003, DOI 10.1523/JNEUROSCI.2631-11.2011; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kirischuk S, 1999, P NATL ACAD SCI USA, V96, P7520, DOI 10.1073/pnas.96.13.7520; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Oesch NW, 2011, NAT NEUROSCI, V14, P1555, DOI 10.1038/nn.2945; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815; Sara Y, 2011, J NEUROSCI, V31, P5378, DOI 10.1523/JNEUROSCI.5234-10.2011; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Snellman J, 2011, NAT NEUROSCI, V14, P1135, DOI 10.1038/nn.2870; Snellman J, 2009, J PHYSIOL-LONDON, V587, P2443, DOI 10.1113/jphysiol.2008.165241; STERLING P, 1988, J NEUROSCI, V8, P623; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	47	46	47	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 6	2013	77	3					516	527		10.1016/j.neuron.2012.11.024	http://dx.doi.org/10.1016/j.neuron.2012.11.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395377	Green Accepted, Bronze			2022-12-25	WOS:000317030800013
J	Ma, T; Wang, CM; Wang, L; Zhou, X; Tian, M; Zhang, QQ; Zhang, Y; Li, JW; Liu, ZD; Cai, YQ; Liu, F; You, Y; Chen, C; Campbell, K; Song, HJ; Ma, L; Rubenstein, JL; Yang, ZG				Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Chen, Chao; Campbell, Kenneth; Song, Hongjun; Ma, Lan; Rubenstein, John L.; Yang, Zhengang			Subcortical origins of human and monkey neocortical interneurons	NATURE NEUROSCIENCE			English	Article							LATERAL/CAUDAL GANGLIONIC EMINENCE; COUP-TFII; CORTICAL INTERNEURONS; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; RADIAL GLIA; EXPRESSION; SUBPOPULATION; DIVERSITY; NKX2-1	Cortical GABAergic inhibitory interneurons have crucial roles in the development and function of the cerebral cortex. In rodents, nearly all neocortical interneurons are generated from the subcortical ganglionic eminences. In humans and nonhuman primates, however, the developmental origin of neocortical GABAergic interneurons remains unclear. Here we show that the expression patterns of several key transcription factors in the developing primate telencephalon are very similar to those in rodents, delineating the three main subcortical progenitor domains (the medial, lateral and caudal ganglionic eminences) and the interneurons tangentially migrating from them. On the basis of the continuity of Sox6, COUP-TFII and Sp8 transcription factor expression and evidence from cell migration and cell fate analyses, we propose that the majority of primate neocortical GABAergic interneurons originate from ganglionic eminences of the ventral telencephalon. Our findings reveal that the mammalian neocortex shares basic rules for interneuron development, substantially reshaping our understanding of the origin and classification of primate neocortical interneurons.	[Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Wang, Lei] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Hebei, Peoples R China; [Chen, Chao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China; [Campbell, Kenneth] Univ Cincinnati, Med Ctr, Coll Med, Childrens Hosp,Div Dev Biol, Cincinnati, OH 45267 USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	Fudan University; Fudan University; Hebei Medical University; Fudan University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Yang, ZG (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	yangz@fudan.edu.cn	Ma, Lan/B-9295-2009; Campbell, Kenneth/ABC-3570-2021	Ma, Lan/0000-0001-9034-5472; Wang, Lei/0000-0003-0741-8170; Li, Jiwen/0000-0002-1332-4763	National Basic Research Program of China [2011CB504400, 2010CB945500]; National Natural Science Foundation of China [30990261, 31028009, 31121061, 91232723]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB504400 and 2010CB945500) and the National Natural Science Foundation of China (30990261, 31028009, 31121061 and 91232723). We thank the staff at the Chinese Brain Bank Center, Wuhan, China and the Red Cross Society of China, Shanghai Branch at Fudan University for providing access to donated adult human brains.	Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Bayer SA, 2005, HUMAN BRAIN 2 TRIMES; Borello U, 2014, CEREB CORTEX, V24, P1409, DOI 10.1093/cercor/bhs412; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cai YQ, 2013, STEM CELLS, V31, P1193, DOI 10.1002/stem.1363; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Long JE, 2009, CEREB CORTEX S1, V19, P196; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reinchisi G, 2012, CEREB CORTEX, V22, P2820, DOI 10.1093/cercor/bhr359; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Stenman J, 2003, J NEUROSCI, V23, P167; Sussel L, 1999, DEVELOPMENT, V126, P3359; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wang B, 2013, J COMP NEUROL, V521, P1561, DOI 10.1002/cne.23242; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	50	188	189	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1588	1597		10.1038/nn.3536	http://dx.doi.org/10.1038/nn.3536			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097041				2022-12-25	WOS:000326205700016
J	Page, ME; Lombard, P; Ng, F; Gottgens, B; Jensen, KB				Page, Mahalia E.; Lombard, Patrick; Ng, Felicia; Goettgens, Berthold; Jensen, Kim B.			The Epidermis Comprises Autonomous Compartments Maintained by Distinct Stem Cell Populations	CELL STEM CELL			English	Article							HAIR FOLLICLE; PROGENITOR CELLS; SEBACEOUS GLAND; MOUSE EPIDERMIS; WOUND REPAIR; SKIN; LRIG1; HOMEOSTASIS; KERATINOCYTES; MAINTENANCE	The complex anatomy of the epidermis contains multiple adult stem cell populations, but the extent to which they functionally overlap during homeostasis, wound healing, and tumor initiation remains poorly defined. Here, we demonstrate that Lrig1(+ve) cells are highly proliferative epidermal stem cells. Longterm clonal analysis reveals that Lrig1(+ve) cells maintain the upper pilosebaceous unit, containing the infundibulum and sebaceous gland as independent compartments, but contribute to neither the hair follicle nor the interfollicular epidermis, which are maintained by distinct stem cell populations. In contrast, upon wounding, stem cell progeny from multiple compartments acquire lineage plasticity and make permanent contributions to regenerating tissue. We further show that oncogene activation in Lrig1(+ve) cells drives hyperplasia but requires auxiliary stimuli for tumor formation. In summary, our data demonstrate that epidermal stem cells are lineage restricted during homeostasis and suggest that compartmentalization may constitute a conserved mechanism underlying epithelial tissue maintenance.	[Page, Mahalia E.; Lombard, Patrick; Ng, Felicia; Goettgens, Berthold; Jensen, Kim B.] Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Page, Mahalia E.; Jensen, Kim B.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Lombard, Patrick; Ng, Felicia; Goettgens, Berthold] Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Jensen, Kim B.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark	University of Cambridge; University of Cambridge; University of Copenhagen	Jensen, KB (corresponding author), Wellcome Trust Med Res Council Cambridge Stem Cel, Tennis Court Rd, Cambridge CB2 1QR, England.	kim.jensen@bric.ku.dk	Jensen, Kim/F-5333-2014	Gottgens, Berthold/0000-0001-6302-5705; Jensen, Kim/0000-0001-6569-1664	UK Medical Research Council (MRC); Wellcome Trust; Lundbeck Foundation; Danish Medical Research Council; MRC; BBSRC [BB/I00050X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Lundbeck Foundation [R105-2011-9755] Funding Source: researchfish; Medical Research Council [MC_PC_12009, 979886] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We thank Fiona Watt for assistance in generating the Lrig1 KI mouse model; Tyler Jacks and Guoqiang Gu for making their mouse models available; the Cambridge Stem Cell Institute core facilities and the Cambridge Genomics Services for technical assistance; Michaela Frye for excellent suggestions; and Austin Smith, Kristian Helin, and members of the Jensen laboratory for comments on the manuscript. We acknowledge Ferda Oeztuerk-Winder and Juan Jose Ventura for tissue from the Lgr6 mouse, and Clare Blackburn for the Plet1 antibody. This work was supported by the UK Medical Research Council (MRC), the Wellcome Trust, the Lundbeck Foundation, and the Danish Medical Research Council. K.J. is a Wellcome Trust Career Development fellow (WT088454MA). M. E. P. and F.N. are funded by an MRC PhD studentship and a Yousef Jameel Scholarship, respectively. M. E. P. and K.B.J. conceived and designed the study, performed experiments, analyzed the data, and wrote the manuscript. P. L., F.N., and B. G. performed the bioinformatics analysis of the microarray data. All authors commented on the manuscript. K.B.J. supervised the project.	Alcolea MP, 2013, NAT REV CANCER, V13, P161, DOI 10.1038/nrc3460; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cottle DL, 2013, CELL REP, V3, P427, DOI 10.1016/j.celrep.2013.01.013; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Frances D, 2012, DEV BIOL, V363, P138, DOI 10.1016/j.ydbio.2011.12.028; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Weyden LD, 2011, J PATHOL, V224, P22, DOI 10.1002/path.2853; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	51	204	206	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					471	482		10.1016/j.stem.2013.07.010	http://dx.doi.org/10.1016/j.stem.2013.07.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23954751	hybrid, Green Published			2022-12-25	WOS:000329571100015
J	Basu, J; Srinivas, KV; Cheung, SK; Taniguchi, H; Huang, ZJ; Siegelbaum, SA				Basu, Jayeeta; Srinivas, Kalyan V.; Cheung, Stephanie K.; Taniguchi, Hiroki; Huang, Z. Josh; Siegelbaum, Steven A.			A Cortico-Hippocampal Learning Rule Shapes Inhibitory Microcircuit Activity to Enhance Hippocampal Information Flow	NEURON			English	Article							LONG-LASTING POTENTIATION; ENTORHINAL CORTEX; AREA CA1; SYNAPTIC PLASTICITY; GABAERGIC NEURONS; PYRAMIDAL NEURONS; TIMING DEPENDENCE; GABA RELEASE; INPUT; INTERNEURONS	How does coordinated activity between distinct brain regions implement a set of learning rules to sculpt information processing in a given neural circuit? Using interneuron cell-type-specific optical activation and pharmacogenetic silencing in vitro, we show that temporally precise pairing of direct entorhinal perforant path (PP) and hippocampal Schaffer collateral (SC) inputs to CA1 pyramidal cells selectively suppresses SC-associated perisomatic inhibition from cholecystokinin (CCK)-expressing interneurons. The CCK interneurons provide a surprisingly strong feedforward inhibitory drive to effectively control the coincident excitation of CA1 pyramidal neurons by convergent inputs. Thus, in-phase cortico-hippocampal activity provides a powerful heterosynaptic learning rule for long-term gating of information flow through the hippocampal excitatory macrocircuit by the silencing of the CCK inhibitory microcircuit.	[Basu, Jayeeta; Srinivas, Kalyan V.; Cheung, Stephanie K.; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Srinivas, Kalyan V.; Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Cold Spring Harbor Laboratory	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu		Huang, Z. Josh/0000-0003-0592-028X; Basu, Jayeeta/0000-0002-7559-0936	NARSAD Young Investigator grant; Columbia University Undergraduate WEP grant; Howard Hughes Medical Institute;  [5U01 MH078844-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER	NARSAD Young Investigator grant(NARSAD); Columbia University Undergraduate WEP grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Deisseroth, G. Fishell, and S. Sternson for generously providing reagents; V. Chevaleyre, J. Dudman, M. Larkum, M. Lovett-Barron, R. Piskorowski, H. Takahashi, P. Trifilieff, and T. Younts for technical advice; and K. Franks, F. Hitti, V. Johnstone, J. Kupferman, A. Losonczy, Z. Rosen, M. Russo, and B. Santoro for helpful comments on previous versions of the manuscript. This work was supported by a NARSAD Young Investigator grant (J.B.), a Columbia University Undergraduate WEP grant (S.K.C.), a 5U01 MH078844-05 grant (Z.J.H.), and the Howard Hughes Medical Institute (S.A.S.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cho JH, 2012, NAT NEUROSCI, V15, P113, DOI 10.1038/nn.2993; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Han EB, 2013, J NEUROSCI, V33, P1314, DOI 10.1523/JNEUROSCI.3219-12.2013; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kajiwara R, 2008, HIPPOCAMPUS, V18, P266, DOI 10.1002/hipo.20385; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wohrl R, 2007, EUR J NEUROSCI, V25, P251, DOI 10.1111/j.1460-9568.2006.05274.x; Xu JY, 2012, J PHYSIOL-LONDON, V590, P2305, DOI 10.1113/jphysiol.2011.223511; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	56	78	79	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1208	1221		10.1016/j.neuron.2013.07.001	http://dx.doi.org/10.1016/j.neuron.2013.07.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050406	Bronze, Green Accepted			2022-12-25	WOS:000330329600017
J	Um, JW; Kaufman, AC; Kostylev, M; Heiss, JK; Stagi, M; Takahashi, H; Kerrisk, ME; Vortmeyer, A; Wisniewski, T; Koleske, AJ; Gunther, EC; Nygaard, HB; Strittmatter, SM				Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Kerrisk, Meghan E.; Vortmeyer, Alexander; Wisniewski, Thomas; Koleske, Anthony J.; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.			Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer A beta Oligomer Bound to Cellular Prion Protein	NEURON			English	Article							LONG-TERM POTENTIATION; AMYLOID-PRECURSOR PROTEIN; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; DENDRITIC SPINES; DISEASE BRAIN; UP-REGULATION; MOUSE MODELS; FYN KINASE; IN-VIVO	Soluble amyloid-beta oligomers (A beta o) trigger Alzheimer's disease (AD) pathophysiology and bind with high affinity to cellular prion protein (PrPC). At the postsynaptic density (PSD), extracellular A beta o bound to lipid-anchored PrPC activates intracellular Fyn kinase to disrupt synapses. Here, we screened transmembrane PSD proteins heterologously for the ability to couple A beta o-PrPC with Fyn. Only coexpression of the metabotropic glutamate receptor, mGluR5, allowed PrPC-bound A beta o to activate Fyn. PrPC and mGluR5 interact physically, and cytoplasmic Fyn forms a complex with mGluR5. A beta o-PrPC generates mGluR5-mediated increases of intracellular calcium in Xenopus oocytes and in neurons, and the latter is also driven by human AD brain extracts. In addition, signaling by A beta o-PrPC-mGluR5 complexes mediates eEF2 phosphorylation and dendritic spine loss. For mice expressing familial AD transgenes, mGluR5 antagonism reverses deficits in learning, memory, and synapse density. Thus, A beta o-PrPC complexes at the neuronal surface activate mGluR5 to disrupt neuronal function.	[Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA; [Um, Ji Won; Kaufman, Adam C.; Kostylev, Mikhail; Heiss, Jacqueline K.; Stagi, Massimiliano; Takahashi, Hideyuki; Gunther, Erik C.; Nygaard, Haakon B.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06536 USA; [Kerrisk, Meghan E.; Koleske, Anthony J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06536 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA	Yale University; Yale University; Yale University; Yale University; New York University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Wisniewski, Thomas/Q-6525-2019; Stagi, Massimiliano/ABF-5894-2020; Strittmatter, Stephen/F-5739-2011	Wisniewski, Thomas/0000-0002-3379-8966; Stagi, Massimiliano/0000-0002-5827-902X; Strittmatter, Stephen/0000-0001-8188-3092; Kostylev, Mikhail/0000-0003-0435-8141	National Institutes of Health; Falk Medical Research Trust; Alzheimer's Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074319, R01NS073502, R01NS080388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P30AG008051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Yiguang Fu and Stefano Sodi for excellent technical support. We thank Xinran Liu of the Yale Center for Cell Imaging for advice on synapse ultrastructure analysis. S.M.S. is a cofounder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics. H.B.N. is an Ellison Medical Foundation AFAR Postdoctoral Fellow and S.M.S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge support from the National Institutes of Health to S.M.S., A.J.K., and T.W., and from the Falk Medical Research Trust and the Alzheimer's Association to S.M.S.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bizat N, 2010, J NEUROSCI, V30, P5394, DOI 10.1523/JNEUROSCI.5831-09.2010; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Heidinger V, 2002, J NEUROSCI, V22, P5452; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Menard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shinoda Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010390; Simonyi A, 2010, EUR J PHARMACOL, V639, P17, DOI 10.1016/j.ejphar.2009.12.039; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; STRITTMATTER SM, 1993, P NATL ACAD SCI USA, V90, P5327, DOI 10.1073/pnas.90.11.5327; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	61	398	405	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					887	902		10.1016/j.neuron.2013.06.036	http://dx.doi.org/10.1016/j.neuron.2013.06.036			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012003	Green Accepted, Bronze			2022-12-25	WOS:000330269100008
J	Xu, DY; Shen, WP; Guo, R; Xue, YT; Peng, W; Sima, J; Yang, J; Sharov, A; Srikantan, S; Yang, JD; Fox, D; Qian, Y; Martindale, JL; Piao, YL; Machamer, J; Joshi, SR; Mohanty, S; Shaw, AC; Lloyd, TE; Brown, GW; Ko, MSH; Gorospe, M; Zou, SG; Wang, WD				Xu, Dongyi; Shen, Weiping; Guo, Rong; Xue, Yutong; Peng, Wei; Sima, Jian; Yang, Jay; Sharov, Alexei; Srikantan, Subramanya; Yang, Jiandong; Fox, David, III; Qian, Yong; Martindale, Jennifer L.; Piao, Yulan; Machamer, James; Joshi, Samit R.; Mohanty, Subhasis; Shaw, Albert C.; Lloyd, Thomas E.; Brown, Grant W.; Ko, Minoru S. H.; Gorospe, Myriam; Zou, Sige; Wang, Weidong			Top3 beta is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; FOCAL ADHESION KINASE; MESSENGER-RNA; III-ALPHA; DNA-DAMAGE; FMRP; TRANSLATION; COMPLEX; EXPRESSION; HOMOLOG	Topoisomerases are crucial for solving DNA topological problems, but they have not been linked to RNA metabolism. Here we show that human topoisomerase 3 beta (Top3 beta) is an RNA topoisomerase that biochemically and genetically interacts with FMRP, a protein that is deficient in fragile X syndrome and is known to regulate the translation of mRNAs that are important for neuronal function, abnormalities of which are linked to autism. Notably, the FMRP-Top3 beta interaction is abolished by a disease-associated mutation of FMRP, suggesting that Top3 beta may contribute to the pathogenesis of mental disorders. Top3 beta binds multiple mRNAs encoded by genes with neuronal functions linked to schizophrenia and autism. Expression of one such gene, that encoding protein tyrosine kinase 2 (ptk2, also known as focal adhesion kinase or FAK), is reduced in the neuromuscular junctions of Top3 beta mutant flies. Synapse formation is defective in Top3 beta mutant flies and mice, as well as in FMRP mutant flies and mice. Our findings suggest that Top3 beta acts as an RNA topoisomerase and works with FMRP to promote the expression of mRNAs that are crucial for neurodevelopment and mental health.	[Xu, Dongyi; Shen, Weiping; Guo, Rong; Xue, Yutong; Peng, Wei; Yang, Jiandong; Fox, David, III; Wang, Weidong] NIA, Genome Instabil & Chromatin Remodeling Sect, NIH, Baltimore, MD 21224 USA; [Xu, Dongyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Sima, Jian] NIA, Human Genet Sect, NIH, Baltimore, MD 21224 USA; [Yang, Jay; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Sharov, Alexei; Qian, Yong; Piao, Yulan; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, NIH, Baltimore, MD 21224 USA; [Srikantan, Subramanya; Martindale, Jennifer L.; Gorospe, Myriam] NIA, RNA Regulat Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Machamer, James; Lloyd, Thomas E.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD USA; [Joshi, Samit R.; Mohanty, Subhasis; Shaw, Albert C.] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Zou, Sige] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Zou, SG (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	zous@mail.nih.gov; wangw@grc.nia.nih.gov	Martindale, Jennifer Luethy/AAD-1963-2022; Ko, Minoru S. H./B-7969-2009; Wang, Weidong/AAV-2446-2021; Shaw, Albert/AAD-2567-2021	Martindale, Jennifer Luethy/0000-0002-3234-6861; Ko, Minoru S. H./0000-0002-3530-3015; Shaw, Albert/0000-0003-4970-7640; Xu, Dongyi/0000-0001-5711-2618; Wang, Weidong/0000-0002-0658-7928; Brown, Grant/0000-0002-9002-5003; Lloyd, Thomas/0000-0003-4756-3700; Sima, Jian/0000-0002-4127-1638; srikantan, subramanya/0000-0003-1810-6519	Intramural Research Program of the NIA [Z01 AG000657-08]; NIH; Johns Hopkins Center for Neuroscience Research [NS050274]; Canadian Institutes of Health research grant [MOP-79368]; National Basic Research Program of China [2013CB911002]; National Natural Science Foundation of China [31271435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R01NS082563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000518, ZIAAG000657, ZIAAG000702, ZIAAG000365, K24AG042489, Z01AG000657, ZIAAG000689] Funding Source: NIH RePORTER	Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Center for Neuroscience Research; Canadian Institutes of Health research grant(Canadian Institutes of Health Research (CIHR)); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Hsieh (Duke University) for Drosophila Top3 beta reagents; J.C. Wang (Harvard University) for Top3 beta knockout mice; D. Zarnescu (University of Illinois), T. Jongens (University of Pennsylvania) and G. Dreyfuss (University of Pennsylvania) for dfmr1 fly strains and antibodies; S. Warren (Emory University), S. Ceman (University of Illinois) and Y. Feng (Emory University) for vectors of FMR1 variants; U. Fischer (University of Wuerzburg) for vectors of TDRD3 and FMR1 orthologs; A. Hoogeveen (Erasmus University) for FXR1 and FXR2 antibodies; R. Hynes (Massachusetts Institute of Technology) and R. Palmer (Umea University) for FAK reagents; T. Enomoto (Tohoku University) for Top3b<SUP>-/-</SUP>DT40 cells; and R. Hanai (Rikkyo University) for the Top3 beta vector. We thank E. Chen, D.J. Pan and Y. Feng for advice and assistance, S. K. Lee for assistance and D. Schlessinger for support and critical reading of the manuscript. This work is supported in part by the Intramural Research Program of the NIA (Z01 AG000657-08), the NIH, the Johns Hopkins Center for Neuroscience Research (NS050274), Canadian Institutes of Health research grant MOP-79368 (to G. W. B.), the National Basic Research Program of China (2013CB911002) and the National Natural Science Foundation of China (31271435). This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH, Bethesda, Maryland, USA (http://biowulf.nih.gov).	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chandrasekaran S., 2012, NETWORK BIOL, V2, P16; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Cziko AMJ, 2009, GENETICS, V182, P1051, DOI 10.1534/genetics.109.103234; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Gaengel Konstantin, 2008, V420, P277, DOI 10.1007/978-1-59745-583-1_17; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Kim Yun-Gi, 2012, Exp Neurobiol, V21, P61, DOI 10.5607/en.2012.21.2.61; Kwan KY, 2007, P NATL ACAD SCI USA, V104, P9242, DOI 10.1073/pnas.0703587104; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mohanty S, 2008, P NATL ACAD SCI USA, V105, P5063, DOI 10.1073/pnas.0801235105; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wu JH, 2006, DEV BIOL, V296, P219, DOI 10.1016/j.ydbio.2006.04.459; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	63	93	93	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1238	U112		10.1038/nn.3479	http://dx.doi.org/10.1038/nn.3479			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912945	Green Accepted			2022-12-25	WOS:000323597500015
J	Crockett, MJ; Braams, BR; Clark, L; Tobler, PN; Robbins, TW; Kalenscher, T				Crockett, Molly J.; Braams, Barbara R.; Clark, Luke; Tobler, Philippe N.; Robbins, Trevor W.; Kalenscher, Tobias			Restricting Temptations: Neural Mechanisms of Precommitment	NEURON			English	Article							INTERTEMPORAL DECISION-MAKING; PREFRONTAL CORTEX AREA-10; SELF-CONTROL; RESPONSE-INHIBITION; FRONTAL-CORTEX; ACTIVATION; CHOICE; DELAY; REPRESENTATION; GRATIFICATION	Humans can resist temptations by exerting willpower, the effortful inhibition of impulses. But willpower can be disrupted by emotions and depleted over time. Luckily, humans can deploy alternative self-control strategies like precommitment, the voluntary restriction of access to temptations. Here, we examined the neural mechanisms of willpower and precommitment using fMRI. Behaviorally, precommitment facilitated choices for large delayed rewards, relative to willpower, especially in more impulsive individuals. While willpower was associated with activation in dorsolateral prefrontal cortex (DLPFC), posterior parietal cortex (PPC), and inferior frontal gyrus, precommitment engaged lateral frontopolar cortex (LFPC). During precommitment, LFPC showed increased functional connectivity with DLPFC and PPC, especially in more impulsive individuals, and the relationship between impulsivity and LFPC connectivity was mediated by value-related activation in ventromedial PFC. Our findings support a hierarchical model of self-control in which LFPC orchestrates precommitment by controlling action plans in more caudal prefrontal regions as a function of expected value.	[Crockett, Molly J.; Clark, Luke; Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB1 3EB, England; [Crockett, Molly J.; Clark, Luke; Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge CB1 3EB, England; [Crockett, Molly J.; Tobler, Philippe N.] Univ Zurich, Lab Social & Neural Syst Res, Dept Econ, CH-8006 Zurich, Switzerland; [Crockett, Molly J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Braams, Barbara R.] Leiden Univ, Inst Psychol, NL-2311 EZ Leiden, Netherlands; [Kalenscher, Tobias] Univ Dusseldorf, Inst Expt Psychol, D-40225 Dusseldorf, Germany; [Kalenscher, Tobias] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	University of Cambridge; University of Cambridge; University of Zurich; University of London; University College London; Leiden University; Leiden University - Excl LUMC; Heinrich Heine University Dusseldorf; University of Amsterdam	Crockett, MJ (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB1 3EB, England.	molly.crockett@ucl.ac.uk	Braams, Barbara/ABB-6422-2020; Robbins, Trevor W/A-7551-2008; Kalenscher, Tobias/U-8438-2019; Crockett, Molly/F-8217-2014	Braams, Barbara/0000-0002-8688-5959; Kalenscher, Tobias/0000-0002-0358-9020; Crockett, Molly/0000-0001-8800-410X; Clark, Luke/0000-0003-1103-2422; Robbins, Trevor/0000-0003-0642-5977; Tobler, Philippe/0000-0002-4915-9448	Sir Henry Wellcome Postdoctoral Fellowship; VENI grant from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [016.081.144]; Amsterdam graduate school for the neurosciences (ONWA); University Research Fellowship of the Royal Society [UF080591]; Swiss National Science Foundation [PP00P1_128574, CRSII3_141965]; Medical Research Council [G00001354]; Wellcome Trust [G00001354]; MRC [G1000183] Funding Source: UKRI; Medical Research Council [G0001354, G0001354B, G1000183B, G1000183] Funding Source: researchfish	Sir Henry Wellcome Postdoctoral Fellowship; VENI grant from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Amsterdam graduate school for the neurosciences (ONWA); University Research Fellowship of the Royal Society(Royal Society of London); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M.J.C. is supported by the Sir Henry Wellcome Postdoctoral Fellowship. T.K. was supported by a VENI grant from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO; grant 016.081.144). Scanning costs were in part funded by the Amsterdam graduate school for the neurosciences (ONWA). P.N.T. was supported by a University Research Fellowship of the Royal Society (UF080591) and by the Swiss National Science Foundation (Grants PP00P1_128574 and CRSII3_141965). Study 1 was completed at the Behavioural and Clinical Neuroscience Institute, University of Cambridge, which is supported by a joint award from the Medical Research Council and Wellcome Trust (G00001354). We thank Anna Barnes for assistance with image preprocessing, Todd Hare for comments on the manuscript and assistance with the PPI analysis, Zeb Kurth-Nelson for comments on the manuscript, and our three anonymous reviewers for helpful feedback and suggestions.	AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; Ali SN, 2011, Q J ECON, V126, P857, DOI 10.1093/qje/qjr014; Ariely D, 2002, PSYCHOL SCI, V13, P219, DOI 10.1111/1467-9280.00441; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Cohen J.R, 2012, PRINCIPLES FRONTAL L, P417; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Elster J., 2000, ULYSSES UNBOUND STUD; Essex BG, 2012, J NEUROSCI, V32, P15403, DOI 10.1523/JNEUROSCI.6106-11.2012; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fujita K, 2011, PERS SOC PSYCHOL REV, V15, P352, DOI 10.1177/1088868311411165; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kurth-Nelson Z, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00138; Kurth-Nelson Z, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00184; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Loewenstein G, 2004, ANIMAL SPIRITS AFFEC; Luo S, 2012, NEUROIMAGE, V59, P1469, DOI 10.1016/j.neuroimage.2011.08.004; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Thaler R.H., 2021, NUDGE FINAL EDITION; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Wertenbroch K, 1998, MARKET SCI, V17, P317, DOI 10.1287/mksc.17.4.317	44	77	82	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					391	401		10.1016/j.neuron.2013.05.028	http://dx.doi.org/10.1016/j.neuron.2013.05.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	191PX	23889938	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000322426200016
J	Lipstein, N; Sakaba, T; Cooper, BH; Lin, KH; Strenzke, N; Ashery, U; Rhee, JS; Taschenberger, H; Neher, E; Brose, N				Lipstein, Noa; Sakaba, Takeshi; Cooper, Benjamin H.; Lin, Kun-Han; Strenzke, Nicola; Ashery, Uri; Rhee, Jeong-Seop; Taschenberger, Holger; Neher, Erwin; Brose, Nils			Dynamic Control of Synaptic Vesicle Replenishment and Short-Term Plasticity by Ca2+-Calmodulin-Munc13-1 Signaling	NEURON			English	Article							READILY RELEASABLE POOL; DEVELOPMENTAL-CHANGES; TRANSMITTER RELEASE; RAT CALYX; PRESYNAPTIC DEPRESSION; CALCIUM-DEPENDENCE; QUANTAL PARAMETERS; RAPID RECRUITMENT; CALMODULIN; CA2+	Short-term synaptic plasticity, the dynamic alteration of synaptic strength during high-frequency activity, is a fundamental characteristic of all synapses. At the calyx of Held, repetitive activity eventually results in short-term synaptic depression, which is in part due to the gradual exhaustion of releasable synaptic vesicles. This is counterbalanced by Ca2+-dependent vesicle replenishment, but the molecular mechanisms of this replenishment are largely unknown. We studied calyces of Held in knockin mice that express a Ca2+-Calmodulin insensitive Munc13-1(W464R) variant of the synaptic vesicle priming protein Munc13-1. Calyces of these mice exhibit a slower rate of synaptic vesicle replenishment, aberrant short-term depression and reduced recovery from synaptic depression after high-frequency stimulation. Our data establish Munc13-1 as a major presynaptic target of Ca2+-Calmodulin signaling and show that the Ca2+-Calmodulin-Munc13-1 complex is a pivotal component of the molecular machinery that determines short-term synaptic plasticity characteristics.	[Lipstein, Noa; Cooper, Benjamin H.; Rhee, Jeong-Seop; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Lipstein, Noa; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Microbiol, IL-69978 Tel Aviv, Israel; [Sakaba, Takeshi; Lin, Kun-Han; Taschenberger, Holger; Neher, Erwin] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Sakaba, Takeshi] Doshisha Univ, Grad Sch Brain Sci, Kizugawa 6190225, Japan; [Strenzke, Nicola] Univ Gottingen, Dept Otolaryngol, Auditory Syst Physiol Grp, D-37075 Gottingen, Germany; [Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Max Planck Society; Tel Aviv University; Max Planck Society; Doshisha University; University of Gottingen; Tel Aviv University	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de	889, CRC/L-1607-2018; Strenzke, Nicola/AAP-5349-2021	889, CRC/0000-0002-6678-3138; Strenzke, Nicola/0000-0003-1673-1046; Ashery, Uri/0000-0001-6338-7888; Cooper, Benjamin/0000-0003-2374-9922; Sakaba, Takeshi/0000-0003-0688-7717; Taschenberger, Holger/0000-0003-3186-3231; Lipstein, Noa/0000-0002-0755-5899	Max Planck Society; German Research Foundation [SFB889/B1, SFB889/A6]; European Commission (EUROSPIN); European Commission (SynSys); Uehara Foundation; Toray Foundation; Japanese Ministry of Education, Sports, and Culture [24300144]; Minerva Foundation	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); European Commission (EUROSPIN); European Commission (SynSys)(European CommissionEuropean Commission Joint Research Centre); Uehara Foundation(Uehara Memorial Foundation); Toray Foundation; Japanese Ministry of Education, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Minerva Foundation	This work was supported by the Max Planck Society (N.B., E.N.), the German Research Foundation (SFB889/B1, J.-S.R., N.B.; SFB889/A6, N.S.), the European Commission (EUROSPIN, E.N., N.B.; SynSys, N.B.), the Uehara Foundation (T.S.), the Toray Foundation (T.S.), and Grants-in-Aid for Scientific Research of the Japanese Ministry of Education, Sports, and Culture (Number 24300144, to T.S.). N.L. was a recipient of a Feodor Lynen Fellowship of the Minerva Foundation. We are grateful to A. Betz and A. Ivanovic for discussions and advice, to F. Benseler, I. Thanhauser, D. Schwerdtfeger, and S. Thom for excellent technical support, and to the staff of the MPIEM animal facility for the management of mouse colonies.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Crins TTH, 2011, J NEUROSCI, V31, P11706, DOI 10.1523/JNEUROSCI.1995-11.2011; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; Dimova K, 2009, BIOCHEMISTRY-US, V48, P5908, DOI 10.1021/bi900300r; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Erazo-Fischer E, 2007, J NEUROSCI, V27, P1725, DOI 10.1523/JNEUROSCI.4116-06.2007; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee JS, 2008, J NEUROSCI, V28, P7945, DOI 10.1523/JNEUROSCI.2165-08.2008; Lee JS, 2012, P NATL ACAD SCI USA, V109, pE765, DOI 10.1073/pnas.1114072109; Lipstein N, 2012, MOL CELL BIOL, V32, P4628, DOI 10.1128/MCB.00933-12; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Nadim F, 2000, CURR OPIN NEUROBIOL, V10, P683, DOI 10.1016/S0959-4388(00)00159-8; Nakamura T, 2008, J PHYSIOL-LONDON, V586, P2253, DOI 10.1113/jphysiol.2007.142521; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pan B, 2009, NEURON, V62, P539, DOI 10.1016/j.neuron.2009.03.025; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Sonntag M, 2011, J NEUROSCI, V31, P6699, DOI 10.1523/JNEUROSCI.0575-11.2011; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2006, P NATL ACAD SCI USA, V103, P2880, DOI 10.1073/pnas.0511300103; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 2008, J NEUROSCI, V28, P14450, DOI 10.1523/JNEUROSCI.4245-08.2008; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weis S, 1999, BIOPHYS J, V77, P2418, DOI 10.1016/S0006-3495(99)77079-7; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	69	105	106	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					82	96		10.1016/j.neuron.2013.05.011	http://dx.doi.org/10.1016/j.neuron.2013.05.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23770256	Bronze			2022-12-25	WOS:000321802000011
J	Lee, HK; Cording, A; Vielmetter, J; Zinn, K				Lee, Hyung-Kook (Peter); Cording, Amy; Vielmetter, Jost; Zinn, Kai			Interactions between a Receptor Tyrosine Phosphatase and a Cell Surface Ligand Regulate Axon Guidance and Glial-Neuronal Communication	NEURON			English	Article							DROSOPHILA EMBRYO; OLFACTORY MAP; IN-VIVO; VE-PTP; PROTEINS; MIDLINE; GENES; PHOSPHORYLATION; EXPRESSION; SELECTION	We developed a screening method for orphan receptor ligands, in which cell-surface proteins are expressed in Drosophila embryos from GAL4-dependent insertion lines and ligand candidates identified by the presence of ectopic staining with receptor fusion proteins. Stranded at second (Sas) binds to the receptor tyrosine phosphatase Ptp1 OD in embryos and in vitro. Sas and Ptp1 OD can interact in trans when expressed in cultured cells. Interactions between Sas and Ptp1 OD on longitudinal axons are required to prevent them from abnormally crossing the midline. Sas is expressed on both neurons and glia, whereas Ptp1 OD is restricted to CNS axons. We conducted epistasis experiments by overexpressing Sas in glia and examining how the resulting phenotypes are changed by removal of Ptp1 OD from neurons. We find that neuronal Ptp1 OD restrains signaling by overexpressed glial Sas, which would otherwise produce strong glial and axonal phenotypes.	[Lee, Hyung-Kook (Peter); Cording, Amy; Vielmetter, Jost; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Zinn, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu			NIH [NS28182]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182, R37NS028182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Woj Wojtowicz (University of California, Berkeley) for Dscam fusion proteins, DNA constructs, antibodies, and advice on ELISAs; Engin Ozkan and Chris Garcia (Stanford) for Unc5-Fc and Fasll-Fc; Douglas Cavener (Penn State) for anti-Sas, and Hermann Aberle for Fasll-GAL4. We thank Violana Nesterova for help with figure preparation. Protein expression was done at the Caltech Protein Expression Center. This work was supported by an NIH RO1 grant (NS28182) to K.Z.	Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Dudanova I, 2011, NEURON, V71, P1, DOI 10.1016/j.neuron.2011.06.030; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Griffiths RC, 2007, NEURON GLIA BIOL, V3, P75, DOI 10.1017/S1740925X07000610; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; Hancock ML, 2011, DEVELOPMENT, V138, P4887, DOI 10.1242/dev.072306; Hidalgo A, 2004, CELL CYCLE, V3, P1118; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hower AE, 2009, J NEUROCHEM, V110, P1635, DOI 10.1111/j.1471-4159.2009.06261.x; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jeon M, 2012, BIOL OPEN, V1, P548, DOI 10.1242/bio.2012471; Jeon M, 2009, DEVELOPMENT, V136, P3121, DOI 10.1242/dev.033597; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kato K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001133; Kinrade EFV, 2004, NEURON GLIA BIOL, V1, P101, DOI 10.1017/S1740925X04000225; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Kurusu M, 2008, MOL CELL NEUROSCI, V38, P53, DOI 10.1016/j.mcn.2008.01.015; Lee HY, 2009, J VIS EXP; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; OON SH, 1993, J BIOL CHEM, V268, P23964; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Sun Q, 2000, DEVELOPMENT, V127, P801; Sun Q, 2001, MOL CELL NEUROSCI, V17, P274, DOI 10.1006/mcne.2000.0939; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Thomas GB, 2007, DEVELOPMENT, V134, P591, DOI 10.1242/dev.02754; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wright AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012288; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4	53	24	25	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2013	78	5					813	826		10.1016/j.neuron.2013.04.001	http://dx.doi.org/10.1016/j.neuron.2013.04.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764287	Bronze, Green Accepted			2022-12-25	WOS:000320743400009
J	MacGillavry, HD; Song, Y; Raghavachari, S; Blanpied, TA				MacGillavry, Harold D.; Song, Yu; Raghavachari, Sridhar; Blanpied, Thomas A.			Nanoscale Scaffolding Domains within the Postsynaptic Density Concentrate Synaptic AMPA Receptors	NEURON			English	Article							QUANTAL TRANSMISSION; RELEASE PROBABILITY; DENDRITIC SPINES; SYNAPSES; PSD-95; ORGANIZATION; PROTEINS; TRAFFICKING; PLASTICITY; STARGAZIN	Scaffolding molecules at the postsynaptic membrane form the foundation of excitatory synaptic transmission by establishing the architecture of the postsynaptic density (PSD), but the small size of the synapse has precluded measurement of PSD organization in live cells. We measured the internal structure of the PSD in live neurons at approximately 25 nm resolution using photoactivated localization microscopy (PALM). We found that four major PSD scaffold proteins were each organized in distinctive similar to 80 nm ensembles able to undergo striking changes over time. Bidirectional PALM and single-molecule immunolabeling showed that dense nano-domains of PSD-95 were preferentially enriched in AMPA receptors more than NMDA receptors. Chronic suppression of activity triggered changes in PSD interior architecture that may help amplify synaptic plasticity. The observed clustered architecture of the PSD controlled the amplitude and variance of simulated postsynaptic currents, suggesting several ways in which PSD interior organization may regulate the strength and plasticity of neurotransmission.	[MacGillavry, Harold D.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [MacGillavry, Harold D.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Song, Yu] Duke Univ, Dept Phys, Durham, NC 27710 USA; [Raghavachari, Sridhar] Duke Univ, Dept Neurobiol, Med Ctr, Durham, NC 27710 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Duke University; Duke University	Blanpied, TA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	tblanpied@som.umaryland.edu		MacGillavry, Harold/0000-0002-6153-3586; Blanpied, Thomas/0000-0003-4957-557X	NIH [MH080046]; NIH (CRCNS) [MH096376, DA027807]; Dana Foundation; Broad Foundation; Katherine D. and Theodore J. Carski Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096376, R01MH080046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (CRCNS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Broad Foundation; Katherine D. and Theodore J. Carski Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Scott Thompson, John Lisman, and members of the Blanpied Laboratory for helpful discussions and critical evaluation of the manuscript, Nick Frost for help designing the microscope and analysis software, and Tamar Davis and Minerva Contreras for excellent technical support. This work was supported by the NIH (MH080046 to T.A.B. and CRCNS grants MH096376 and DA027807 to S.R.), the Dana Foundation (to T.A.B.), the Broad Foundation (to S.R. and T.A.B.), and the Katherine D. and Theodore J. Carski Fund (to T.A.B.).	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Burette AC, 2012, J COMP NEUROL, V520, P2697, DOI 10.1002/cne.23067; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; DeGiorgis JA, 2006, BRAIN CELL BIOL, V35, P239, DOI 10.1007/s11068-007-9017-0; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Franks KM, 2003, J NEUROSCI, V23, P3186; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Ripley B, 2011, P NATL ACAD SCI USA, V108, P367, DOI 10.1073/pnas.1015163108; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Santamaria F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000780; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Schikorski T, 1997, J NEUROSCI, V17, P5858; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Swulius MT, 2010, J COMP NEUROL, V518, P4243, DOI 10.1002/cne.22451; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	46	255	257	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					615	622		10.1016/j.neuron.2013.03.009	http://dx.doi.org/10.1016/j.neuron.2013.03.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23719161	Bronze, Green Accepted			2022-12-25	WOS:000319491200006
J	Cai, X; Kallarackal, AJ; Kvarta, MD; Goluskin, S; Gaylor, K; Bailey, AM; Lee, HK; Huganir, RL; Thompson, SM				Cai, Xiang; Kallarackal, Angy J.; Kvarta, Mark D.; Goluskin, Sasha; Gaylor, Kaitlin; Bailey, Aileen M.; Lee, Hey-Kyoung; Huganir, Richard L.; Thompson, Scott M.			Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression	NATURE NEUROSCIENCE			English	Article							PHOSPHORYLATION SITES; NUCLEUS-ACCUMBENS; RECEPTOR AGONIST; BEHAVIOR; STRESS; HIPPOCAMPUS; ACTIVATION; FLUOXETINE; CA1; NEUROGENESIS	The causes of major depression remain unknown. Antidepressants elevate concentrations of monoamines, particularly serotonin, but it remains uncertain which downstream events are critical to their therapeutic effects. We found that endogenous serotonin selectively potentiated excitatory synapses formed by the temporoammonic pathway with CA1 pyramidal cells via activation of serotonin receptors (5-HT(1B)Rs), without affecting nearby Schaffer collateral synapses. This potentiation was expressed postsynaptically by AMPA-type glutamate receptors and required calmodulin-dependent protein kinase-mediated phosphorylation of GluA1 subunits. Because they share common expression mechanisms, long-term potentiation and serotonin-induced potentiation occluded each other. Long-term consolidation of spatial learning, a function of temporoammonic-CA1 synapses, was enhanced by 5-HT1BR antagonists. Serotonin-induced potentiation was quantitatively and qualitatively altered in a rat model of depression, restored by chronic antidepressants, and required for the ability of chronic antidepressants to reverse stress-induced anhedonia. Changes in serotonin-mediated potentiation, and its recovery by antidepressants, implicate excitatory synapses as a locus of plasticity in depression.	[Cai, Xiang; Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Program Membrane Biol, Baltimore, MD 21201 USA; [Kvarta, Mark D.] Univ Maryland, Sch Med, Med Scientist Training Program, Baltimore, MD 21201 USA; [Goluskin, Sasha; Gaylor, Kaitlin; Bailey, Aileen M.] St Marys Coll Maryland, Dept Psychol, St Marys City, MD 20686 USA; [Lee, Hey-Kyoung] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Thompson, Scott M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Kvarta, Mark/ABF-6151-2021; Thompson, Scott M/K-8921-2015; Cai, Xiang/AAD-8012-2021	Kvarta, Mark/0000-0002-1093-1648; Lee, Hey-Kyoung/0000-0002-5554-983X	Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression; Howard Hughes Medical Institute; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Ahmari and R. Hen (Columbia University) for providing Hrt1b<SUP>-/-</SUP> mice, B. Alger, T. Blanpied, T. Gould, J. Kim and M. McCarthy for their comments, S. Aungst for advice on immunohistochemistry, and H. Zimmerman, L. Mok and M. Taylor for technical assistance. This work was funded by a Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression Young Investigator Award (X.C.), the Howard Hughes Medical Institute (R.L.H.) and the US National Institutes of Health (R.L.H., H.-K.L., X.C. and S.M.T.).	AMARA DA, 1995, BRAIN RES BULL, V38, P17, DOI 10.1016/0361-9230(95)00066-N; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bechtholt AJ, 2008, PHYSIOL BEHAV, V93, P659, DOI 10.1016/j.physbeh.2007.11.006; BILLINGS AG, 1983, J ABNORM PSYCHOL, V92, P119, DOI 10.1037/0021-843X.92.2.119; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Boulenguez P, 1996, NEUROPHARMACOLOGY, V35, P1521, DOI 10.1016/S0028-3908(96)00099-8; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Buhot MC, 2003, LEARN MEMORY, V10, P466, DOI 10.1101/lm.60203; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chourbaji S, 2008, FASEB J, V22, P3129, DOI 10.1096/fj.08-106450; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DEWAR KM, 1992, J NEUROCHEM, V58, P250, DOI 10.1111/j.1471-4159.1992.tb09303.x; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Gaster LM, 1998, J MED CHEM, V41, P1218, DOI 10.1021/jm970457s; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GOTHERT M, 1995, BRIT J PHARMACOL, V114, P269; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hsu EH, 2001, J PHARMACOL EXP THER, V298, P825; IHARA N, 1988, ACTA ANAT, V132, P335; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krugers Harmen J, 2010, Front Synaptic Neurosci, V2, P24, DOI 10.3389/fnsyn.2010.00024; Lambe EK, 2000, CEREB CORTEX, V10, P974, DOI 10.1093/cercor/10.10.974; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Neill MF, 2001, NEUROPSYCHOPHARMACOL, V24, P391, DOI 10.1016/S0893-133X(00)00196-2; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sari Y, 1999, NEUROSCIENCE, V88, P899, DOI 10.1016/S0306-4522(98)00256-5; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SHARP T, 1989, BRIT J PHARMACOL, V96, P283, DOI 10.1111/j.1476-5381.1989.tb11815.x; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Tatarczynska E, 2004, BEHAV PHARMACOL, V15, P523, DOI 10.1097/00008877-200412000-00001; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033	50	105	134	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					464	U135		10.1038/nn.3355	http://dx.doi.org/10.1038/nn.3355			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23502536	Green Accepted			2022-12-25	WOS:000316723700017
J	Huang, W; Zhu, PJ; Zhang, SX; Zhou, HY; Stoica, L; Galiano, M; Krnjevic, K; Roman, G; Costa-Mattioli, M				Huang, Wei; Zhu, Ping Jun; Zhang, Shixing; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Krnjevic, Kresimir; Roman, Gregg; Costa-Mattioli, Mauro			mTORC2 controls actin polymerization required for consolidation of long-term memory	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; AKT; PHOSPHORYLATION; RICTOR; DYNAMICS; REVEALS; DISEASE; GROWTH	A major goal of biomedical research is the identification of molecular and cellular mechanisms that underlie memory storage. Here we report a previously unknown signaling pathway that is necessary for the conversion from short- to long-term memory. The mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor (rapamycin-insensitive companion of mTOR), was discovered only recently and little is known about its function. We found that conditional deletion of Rictor in the postnatal murine forebrain greatly reduced mTORC2 activity and selectively impaired both long-term memory (LTM) and the late phase of hippocampal long-term potentiation (L-LTP). We also found a comparable impairment of LTM in dTORC2-deficient flies, highlighting the evolutionary conservation of this pathway. Actin polymerization was reduced in the hippocampus of mTORC2-deficient mice and its restoration rescued both L-LTP and LTM. Moreover, a compound that promoted mTORC2 activity converted early LTP into late LTP and enhanced LTM. Thus, mTORC2 could be a therapeutic target for the treatment of cognitive dysfunction.	[Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Costa-Mattioli, Mauro] Baylor Coll Med, Ctr Addict Learning & Memory, Houston, TX 77030 USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Biol Behav Inst, Houston, TX USA; [Stoica, Loredana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699; Galiano, Mauricio/0000-0002-8245-1715	National Institute of Mental Health [MH 096816]; National Institute of Neurological Disorders and Stroke [NS 076708]; Searle award [09-SSP-211]; George and Cynthia Mitchell Foundation; US National Institutes of Health [MH091305]; Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Searle award; George and Cynthia Mitchell Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Magnuson (Vanderbilt University), I. Dragatsis (University of Tennessee) and K. Tolias (Baylor College of Medicine) who generously provided Rictor<SUP>loxP/loxP</SUP> mice, Camk2a-Cre mice and the Tiam1 constructs, respectively. We also thank A. Placzek and W. Sossin for comments on an early version of the manuscript. This work was supported by grants to M.C.-M. (National Institute of Mental Health grant MH 096816, National Institute of Neurological Disorders and Stroke grant NS 076708, Searle award grant 09-SSP-211, Whitehall award, grants from the George and Cynthia Mitchell Foundation) and G.R. (US National Institutes of Health grant MH091305 and a Texas Norman Hackerman Advanced Research Program award).	BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choe G, 2003, CANCER RES, V63, P2742; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Van Horck FPG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.18pe11; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	55	203	208	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					441	U105		10.1038/nn.3351	http://dx.doi.org/10.1038/nn.3351			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455608	Green Accepted			2022-12-25	WOS:000316723700014
J	Boiers, C; Carrelha, J; Lutteropp, M; Luc, S; Green, JCA; Azzoni, E; Woll, PS; Mead, AJ; Hultquist, A; Swiers, G; Perdiguero, EG; Macaulay, IC; Melchiori, L; Luis, TC; Kharazi, S; Bouriez-Jones, T; Deng, QL; Ponten, A; Atkinson, D; Jensen, CT; Sitnicka, E; Geissmann, F; Godin, I; Sandberg, R; de Bruijn, MFTR; Jacobsen, SEW				Boiers, Charlotta; Carrelha, Joana; Lutteropp, Michael; Luc, Sidinh; Green, Joanna C. A.; Azzoni, Emanuele; Woll, Petter S.; Mead, Adam J.; Hultquist, Anne; Swiers, Gemma; Perdiguero, Elisa Gomez; Macaulay, Iain C.; Melchiori, Luca; Luis, Tiago C.; Kharazi, Shabnam; Bouriez-Jones, Tiphaine; Deng, Qiaolin; Ponten, Annica; Atkinson, Deborah; Jensen, Christina T.; Sitnicka, Ewa; Geissmann, Frederic; Godin, Isabelle; Sandberg, Rickard; de Bruijn, Marella F. T. R.; Jacobsen, Sten Eirik W.			Lymphomyeloid Contribution of an Immune-Restricted Progenitor Emerging Prior to Definitive Hematopoietic Stem Cells	CELL STEM CELL			English	Article							T-CELL; B-CELL; BONE-MARROW; AGM REGION; YOLK-SAC; MULTIPOTENT PROGENITORS; LYMPHOID PROGENITORS; LINEAGE COMMITMENT; FETAL LIVER; MOUSE	In jawed vertebrates, development of an adaptive immune-system is essential for protection of the born organism against otherwise life-threatening pathogens. Myeloid cells of the innate immune system are formed early in development, whereas lymphopoiesis has been suggested to initiate much later, following emergence of definitive hematopoietic stem cells (HSCs). Herein, we demonstrate that the embryonic lymphoid commitment process initiates earlier than previously appreciated, prior to emergence of definitive HSCs, through establishment of a previously unrecognized entirely immune-restricted and lymphoid-primed progenitor. Notably, this immune-restricted progenitor appears to first emerge in the yolk sac and contributes physiologically to the establishment of lymphoid and some myeloid components of the immune-system, establishing the lymphomyeloid lineage restriction process as an early and physiologically important line-age-commitment step in mammalian hematopoiesis.	[Boiers, Charlotta; Hultquist, Anne; Kharazi, Shabnam; Sitnicka, Ewa] Lund Univ, Lund Stem Cell Ctr, Haematopoiet Stem Cell Lab, S-22184 Lund, Sweden; [Boiers, Charlotta] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Carrelha, Joana; Lutteropp, Michael; Luc, Sidinh; Green, Joanna C. A.; Woll, Petter S.; Mead, Adam J.; Macaulay, Iain C.; Melchiori, Luca; Luis, Tiago C.; Bouriez-Jones, Tiphaine; Atkinson, Deborah; Jensen, Christina T.; Jacobsen, Sten Eirik W.] Univ Oxford, Haematopoiet Stem Cell Lab, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Azzoni, Emanuele; Swiers, Gemma; de Bruijn, Marella F. T. R.; Jacobsen, Sten Eirik W.] Univ Oxford, MRC Mol Haematol Unit, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Deng, Qiaolin; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Ponten, Annica] Lund Univ, Lund Stem Cell Ctr, Cardiovasc Grp, S-22184 Lund, Sweden; [Godin, Isabelle] Univ Paris 11, INSERM 1009, Inst Natl Sante & Rech Med, F-94805 Villejuif, France; [Jacobsen, Sten Eirik W.] Karolinska Inst, Dept Cell & Mol Biol, Wallenberg Inst Regenerat Med, S-17177 Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, S-17177 Stockholm, Sweden	Lund University; Lund University; University of Oxford; University of Oxford; University of London; King's College London; Karolinska Institutet; Lund University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Karolinska Institutet	Jacobsen, SEW (corresponding author), Univ Oxford, Haematopoiet Stem Cell Lab, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	sten.jacobsen@imm.ox.ac.uk	Mead, Adam/A-8796-2012; Azzoni, Emanuele/AAE-8064-2022; Jacobsen, Sten Eirik W/D-3974-2018; Perdiguero, Elisa Gomez/U-2120-2018; Deng, Qiaolin/AAD-6905-2020; GODIN, Isabelle/K-5769-2013	Mead, Adam/0000-0001-8522-1002; Azzoni, Emanuele/0000-0002-4572-5692; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Macaulay, Iain/0000-0002-6761-757X; geissmann, frederic/0000-0001-5029-2468; Deng, Qiaolin/0000-0001-5934-7816; Sandberg, Rickard/0000-0001-6473-1740; GODIN, Isabelle/0000-0001-8577-8388; Woll, Petter S./0000-0002-2340-2526; Luc, Sidinh/0000-0001-7006-6169; Cunha Luis, Tiago/0000-0002-6305-1257; Carrelha, Joana/0000-0002-0324-2617; Boiers, Charlotta/0000-0002-4876-1218	Medical Research Council UK [H4RPLK0]; Knut och Alice Wallenberg Foundation (WIRM); StratRegen, KI; EU; ALF; Swedish Research Council Linnaeus; MRC Molecular Haematology Unit; Leukaemia and Lymphoma Research; Swedish Cancer foundation; Swedish Society of Medicine; Crafoord Foundation; Georg Danielsson's foundation; Medical Research Council [G84/6443, MC_U137970202, MC_UU_12009/2, G1000801h, MC_UU_12009/5, G0501838, G0900867, G0801073] Funding Source: researchfish; MRC [G84/6443, G0900867, G0801073, MC_UU_12009/5, MC_UU_12009/2, G0501838, MC_U137970202] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Knut och Alice Wallenberg Foundation (WIRM); StratRegen, KI; EU(European Commission); ALF; Swedish Research Council Linnaeus(Swedish Research Council); MRC Molecular Haematology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; Swedish Cancer foundation; Swedish Society of Medicine; Crafoord Foundation; Georg Danielsson's foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Lilian Wittmann, Ingbritt Astrand-Grundstrom, and Hanane Boukarabila for skillful technical assistance, the Biomedical Services at Oxford University for expert animal support, and Sally-Ann Clark, Paul Sopp, and the WIMM FACS facility for FACS support. Asa Bjorklund, Daniel Ramskold, and Ersen Kavak are thanked for skillful technical assistance with the RNA sequencing. This work was supported by a programme grant (H4RPLK0) from the Medical Research Council UK (S.E.W.J.), Knut och Alice Wallenberg Foundation (WIRM; S.E.W.J.), StratRegen, KI (S.E.W.J.), EU-FP7 EuroSyStem Integrated projects (S.E.W.J.), ALF (Government Public Health Grant; C.B.), the Hemato-Linne grant (Swedish Research Council Linnaeus; S.E.W.J.), the MRC Molecular Haematology Unit core award (M.F.T.R.d.-B., E.A., S.E.W.J.), a Leukaemia and Lymphoma Research project grant (M.B., G.S.), Swedish Cancer foundation (A.H.), Swedish Society of Medicine (A.H.), Crafoord Foundation (A.H.), Georg Danielsson's foundation (A.H.), and the Leukaemia and Lymphoma Research Senior Bennett Fellowship (A.J.M.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bene MC, 2009, HAEMATOL-HEMATOL J, V94, P891, DOI 10.3324/haematol.2009.007799; Boyer SW, 2012, CELL CYCLE, V11, P3180, DOI 10.4161/cc.21279; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Ohmura K, 1999, J IMMUNOL, V163, P4788; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	52	162	167	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					535	548		10.1016/j.stem.2013.08.012	http://dx.doi.org/10.1016/j.stem.2013.08.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24054998	Green Submitted, Bronze			2022-12-25	WOS:000329571500007
J	De Rubeis, S; Pasciuto, E; Li, KW; Fernandez, E; Di Marino, D; Buzzi, A; Ostroff, LE; Klann, E; Zwartkruis, FJT; Komiyama, NH; Grant, SGN; Poujol, C; Choquet, D; Achsel, T; Posthuma, D; Smit, AB; Bagni, C				De Rubeis, Silvia; Pasciuto, Emanuela; Li, Ka Wan; Fernandez, Esperanza; Di Marino, Daniele; Buzzi, Andrea; Ostroff, Linnaea E.; Klann, Eric; Zwartkruis, Fried J. T.; Komiyama, Noboru H.; Grant, Seth G. N.; Poujol, Christel; Choquet, Daniel; Achsel, Tilmann; Posthuma, Danielle; Smit, August B.; Bagni, Claudia			CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation	NEURON			English	Article							FRAGILE-X-SYNDROME; LOCAL PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; CRITICAL REGION; MOUSE MODEL; RAC1; FMRP; MECHANISMS; AUTISM	The CYFIP1/SRA1 gene is located in a chromosomal region linked to various neurological disorders, including intellectual disability, autism, and schizophrenia. CYFIP1 plays a dual role in two apparently unrelated processes, inhibiting local protein synthesis and favoring actin remodeling. Here, we show that brain-derived neurotrophic factor (BDNF)-driven synaptic signaling releases CYFIP1 from the translational inhibitory complex, triggering translation of target mRNAs and shifting CYFIP1 into the WAVE regulatory complex. Active Rac1 alters the CYFIP1 conformation, as demonstrated by intramolecular FRET, and is key in changing the equilibrium of the two complexes. CYFIP1 thus orchestrates the two molecular cascades, protein translation and actin polymerization, each of which is necessary for correct spine morphology in neurons. The CYFIP1 interactome reveals many interactors associated with brain disorders, opening new perspectives to define regulatory pathways shared by neurological disabilities characterized by spine dysmorphogenesis.	[De Rubeis, Silvia; Pasciuto, Emanuela; Fernandez, Esperanza; Di Marino, Daniele; Buzzi, Andrea; Achsel, Tilmann; Bagni, Claudia] KULeuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [De Rubeis, Silvia; Pasciuto, Emanuela; Fernandez, Esperanza; Di Marino, Daniele; Buzzi, Andrea; Achsel, Tilmann; Bagni, Claudia] KULeuven, Ctr Human Genet, B-3000 Leuven, Belgium; [De Rubeis, Silvia; Pasciuto, Emanuela; Fernandez, Esperanza; Di Marino, Daniele; Buzzi, Andrea; Achsel, Tilmann; Bagni, Claudia] KULeuven, LIND, B-3000 Leuven, Belgium; [Li, Ka Wan; Smit, August B.] VU Univ Med Ctr Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] VU Univ Med Ctr Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] VU Univ Med Ctr Amsterdam, Ctr Neurogen & Cognit Res, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Ostroff, Linnaea E.; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Zwartkruis, Fried J. T.] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Zwartkruis, Fried J. T.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Komiyama, Noboru H.; Grant, Seth G. N.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Komiyama, Noboru H.; Grant, Seth G. N.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Poujol, Christel] CNRS, Bordeaux Imaging Ctr, UMS 3420, F-33000 Bordeaux, France; [Poujol, Christel] Univ Bordeaux, UMS 3420, F-33077 Bordeaux, France; [Choquet, Daniel] CNRS, Interdisciplinary Inst Neurosci, IINS, UMR 5297, F-33000 Bordeaux, France; [Choquet, Daniel] Univ Bordeaux, UMR 5297, F-33077 Bordeaux, France; [Posthuma, Danielle] Erasmus Univ, Sophia Child Hosp, Dept Child & Adolescent Psychiat, Med Ctr, NL-3000 CB Rotterdam, Netherlands; [Bagni, Claudia] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; New York University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Edinburgh; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Erasmus University Rotterdam; Erasmus MC; University of Rome Tor Vergata	Bagni, C (corresponding author), KULeuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium.	claudia.bagni@cme.vib-kuleuven.be	Di Marino, Daniele/AAB-9653-2019; Choquet, Daniel/GOJ-8825-2022; De Rubeis, Silvia/E-9852-2013; Pasciuto, Emanuela/AAP-2982-2020; Di Marino, Daniele/ABB-2333-2020; Choquet, Daniel/K-7893-2018	Di Marino, Daniele/0000-0001-6961-3129; Choquet, Daniel/0000-0003-4726-9763; De Rubeis, Silvia/0000-0001-9383-6883; Choquet, Daniel/0000-0003-4726-9763; Pasciuto, Emanuela/0000-0002-5391-9585; Ostroff, Linnaea/0000-0002-3348-342X; Posthuma, Danielle/0000-0001-7582-2365; Bagni, Claudia/0000-0002-4419-210X; Grant, Seth/0000-0001-8732-8735; li, ka wan/0000-0001-6983-5055; Poujol, Christel/0000-0002-5222-9064	Associazione Italiana Sindrome X Fragile; Fonds Wetenschappelijk Onderzoek (FWO) [FWO G.0705.11]; FWO; FWO [FWO G.0705.11]; Intra-European Marie Curie Fellowship FP7; Queen Elisabeth Foundation (Belgium); CARIPLO; VIB; Telethon [GGP10150]; FP7 GENCODYS; EU-FP7 "EUROSPIN"; Wellcome Trust; Center for Medical Systems Biology (CMSB);  [HEALTH-2009-2.1.2-1 EU-FP7 "SynSys"]	Associazione Italiana Sindrome X Fragile; Fonds Wetenschappelijk Onderzoek (FWO)(FWO); FWO(FWO); FWO(FWO); Intra-European Marie Curie Fellowship FP7; Queen Elisabeth Foundation (Belgium); CARIPLO(Fondazione Cariplo); VIB; Telethon(Fondazione Telethon); FP7 GENCODYS; EU-FP7 "EUROSPIN"; Wellcome Trust(Wellcome TrustEuropean Commission); Center for Medical Systems Biology (CMSB); 	We thank Ilaria Napoli and Tiziana Girardi for preliminary data. We are grateful to Evita Mohr and Joachim Kremerskothen for the PABP1 and SYNCRIP antibodies. We are grateful to Elien Theuns, Jonathan Royaert, Karin Jonkers, Ingeborg Beheydt, and Roel van der Schors for technical help and to Bing Yen for viral production. We are thankful to Paul Woolley, Carolina Barillas, and Giovanni Chillemi for comments on the manuscript and to Sebastian Munck, coordinator of LiMoNe, for his advice. S.D.R. was supported by the Associazione Italiana Sindrome X Fragile and by a Fonds Wetenschappelijk Onderzoek (FWO) grant to C.B. (FWO G.0705.11); E.P. was supported by an FWO (aspirant fellowship); D.D.M was supported by an FWO grant to C.B. (FWO G.0705.11); E.F. was supported by an Intra-European Marie Curie Fellowship FP7. We are indebted to the Schizophrenia subgroup of the Psychiatric Genetics Consortium for providing access to the results of their meta-analysis. This work was supported by grants from the following agencies: Queen Elisabeth Foundation (Belgium), CARIPLO, FWO (FWO G.0705.11), VIB, and Telethon (GGP10150) to C.B.; HEALTH-2009-2.1.2-1 EU-FP7 "SynSys" to A.B.S., S.G.N.G., and C.B.; FP7 GENCODYS and EU-FP7 "EUROSPIN" to A.B.S. and S.G.N.G.; Wellcome Trust to S.G.N.G.; and the Center for Medical Systems Biology (CMSB) to A.B.S. Nikon microscope used in this study was acquired through a Hercules Type 1 AKUL/09/037 to Wim Annaert. We are very grateful to Eef Lemmens for administrative support.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ehninger D, 2009, NAT MED, V15, P849, DOI 10.1038/nm0809-849; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; PAPA M, 1995, J NEUROSCI, V15, P1; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petroulakis E, 2002, J BIOL CHEM, V277, P18718, DOI 10.1074/jbc.M111782200; REISS AL, 1986, AM J MED GENET, V23, P393, DOI 10.1002/ajmg.1320230131; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sahoo T, 2006, J MED GENET, V43, P512, DOI 10.1136/jmg.2005.036913; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Turk J, 2011, CURR OPIN PSYCHIATR, V24, P387, DOI 10.1097/YCO.0b013e328349bb77; Valnegri P, 2012, ADV EXP MED BIOL, V970, P433, DOI 10.1007/978-3-7091-0932-8_19; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von der Lippe C, 2011, EUR J MED GENET, V54, P357, DOI 10.1016/j.ejmg.2010.12.008; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang H, 2013, MOL PSYCHIATR, V18, P471, DOI 10.1038/mp.2012.80; Zhao Q., 2012, SCHIZOPHR B, V39, P712, DOI [10.1093/schbul/sbr197, DOI 10.1093/SCHBUL/SBR]	78	170	172	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1169	1182		10.1016/j.neuron.2013.06.039	http://dx.doi.org/10.1016/j.neuron.2013.06.039			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050404	hybrid, Green Published			2022-12-25	WOS:000330329600014
J	Lau, AY; Salazar, H; Blachowicz, L; Ghisi, V; Plested, AJR; Roux, B				Lau, Albert Y.; Salazar, Hector; Blachowicz, Lydia; Ghisi, Valentina; Plested, Andrew J. R.; Roux, Benoit			A Conformational Intermediate in Glutamate Receptor Activation	NEURON			English	Article							LIGAND-BINDING DOMAIN; NETWORK MODEL; DESENSITIZATION; MECHANISM; BEHAVIOR	Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an similar to 30 degrees rotation of the LBD dinners relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state.	[Lau, Albert Y.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Salazar, Hector; Ghisi, Valentina; Plested, Andrew J. R.] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Salazar, Hector; Ghisi, Valentina; Plested, Andrew J. R.] Charite, D-10117 Berlin, Germany; [Blachowicz, Lydia; Roux, Benoit] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Johns Hopkins University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago	Lau, AY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	alau@jhmi.edu; plested@fmp-berlin.de; roux@uchicago.edu		Plested, Andrew/0000-0001-6062-0832; Lau, Albert/0000-0002-0967-7558	NIH [GM094495, GM062342]; DFG [EXC 257, PI-619]; HFSP Long-Term Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342, R01GM094495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); HFSP Long-Term Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Gouaux for providing the GluR2-S1S2J plasmid; C. Ogata, K. Perry, and K. Rajashankar for providing helpful advice with X-ray diffraction data collection at APS; B. Ziervogel and B. Dhakshnamoorthy for assisting with data collection; J. Baranovic for comments on the manuscript; and M. Wietstruk for providing technical assistance. This work was funded by NIH grant GM094495 (to A.Y.L.), DFG grants EXC 257 (NeuroCure) and PI-619 (to A.J.R.P.), and NIH grant GM062342 (to B.R.). H.S. is the recipient of a HFSP Long-Term Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Echeverria Riesco I., 2011, THESIS J HOPKINS U B; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103	37	34	34	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 7	2013	79	3					492	503		10.1016/j.neuron.2013.06.003	http://dx.doi.org/10.1016/j.neuron.2013.06.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23931998	Green Accepted, Bronze			2022-12-25	WOS:000323085100010
J	Rocca, DL; Amici, M; Antoniou, A; Suarez, EB; Halemani, N; Murk, K; McGarvey, J; Jaafari, N; Mellor, JR; Collingridge, GL; Hanley, JG				Rocca, Daniel L.; Amici, Mascia; Antoniou, Anna; Suarez, Elena Blanco; Halemani, Nagaraj; Murk, Kai; McGarvey, Jennifer; Jaafari, Nadia; Mellor, Jack R.; Collingridge, Graham L.; Hanley, Jonathan G.			The Small GTPase Arf1 Modulates Arp2/3-Mediated Actin Polymerization via PICK1 to Regulate Synaptic Plasticity	NEURON			English	Article							AMPA-RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; ADP-RIBOSYLATION FACTORS; ARP2/3 COMPLEX; PDZ DOMAIN; DENDRITIC SPINES; PROTEIN PICK1; ENDOCYTOSIS; DYNAMICS; CYTOSKELETON	Inhibition of Arp2/3-mediated actin polymerization by PICK1 is a central mechanism to AMPA receptor (AMPAR) internalization and long-term depression (LTD), although the signaling pathways that modulate this process in response to NMDA receptor (NMDAR) activation are unknown. Here, we define a function for the GTPase Arf1 in this process. We show that Arf1-GTP binds PICK1 to limit PICK1-mediated inhibition of Arp2/3 activity. Expression of mutant Arf1 that does not bind PICK1 leads to reduced surface levels of GluA2-containing AMPARs and smaller spines in hippocampal neurons, which occludes subsequent NMDA-induced AMPAR internalization and spine shrinkage. In organotypic slices, NMDAR-dependent LTD of AMPAR excitatory postsynaptic currents is abolished in neurons expressing mutant Arf1. Furthermore, NMDAR stimulation downregulates Arf1 activation and binding to PICK1 via the Arf-GAP GIT1. This study defines Arf1 as a critical regulator of actin dynamics and synaptic function via modulation of PICK1.	[Rocca, Daniel L.; Antoniou, Anna; Suarez, Elena Blanco; Halemani, Nagaraj; Murk, Kai; McGarvey, Jennifer; Jaafari, Nadia; Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Amici, Mascia; McGarvey, Jennifer; Mellor, Jack R.; Collingridge, Graham L.] Univ Bristol, Sch Physiol & Pharmacol, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Collingridge, Graham L.] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul 151746, South Korea	University of Bristol; University of Bristol; Seoul National University (SNU)	Hanley, JG (corresponding author), Univ Bristol, Sch Biochem, Ctr Synapt Plast, Med Sci Bldg & Dorothy Hodgkin Bldg, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk	collingridge, graham/AAI-8362-2020; Antoniou, Anna/J-3523-2017; Antoniou, Anna/AAA-2809-2021; MELLOR, Jack/B-4548-2019; Amici, Mascia/L-3842-2019; Collingridge, Graham L/C-4605-2015	Antoniou, Anna/0000-0002-3907-2330; Antoniou, Anna/0000-0002-3907-2330; MELLOR, Jack/0000-0002-7706-8105; Amici, Mascia/0000-0001-8548-4179; Collingridge, Graham L/0000-0002-9572-5359; Murk, Kai/0000-0002-6573-4529; McGarvey, Jennifer/0000-0001-8782-267X; Hanley, Jonathan/0000-0003-1704-4707; Blanco-Suarez, Elena/0000-0002-2131-6376	BBSRC; MRC; Wellcome Trust; WCU Program (Korea); Biotechnology and Biological Sciences Research Council [BB/H014284/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0601813, G0501455, G0601841B] Funding Source: researchfish; BBSRC [BB/H014284/1] Funding Source: UKRI; MRC [MC_G1000734, G0501455, G0601813] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); WCU Program (Korea); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Rubin and P. Tidball for technical assistance, R. Kahn for Arf1 plasmids, and T. Bouschet for Arf6 plasmids. This work was funded by BBSRC, MRC, The Wellcome Trust, and the WCU Program (Korea). D.L.R. designed the research and performed all biochemistry experiments and some imaging experiments; M.A. designed the research and performed all electrophysiology experiments; A.A. performed live imaging experiments; E.B.S., N.H., J.M., and N.J. performed imaging experiments; KM. performed molecular biology; J.R.M. advised electrophysiology experiments; G.L.C. designed research and supervised electrophysiology experiments; J.G.H. designed the research, supervised the biochemistry and imaging experiments, performed imaging experiments, supervised the project, and wrote the paper.	Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bortolotto Z.A, 2011, CURR PROTOC NEUROSCI; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Harris BZ, 2001, J CELL SCI, V114, P3219; Heuvingh J, 2007, P NATL ACAD SCI USA, V104, P16928, DOI 10.1073/pnas.0704749104; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Ko J, 2003, J NEUROSCI, V23, P1667; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	43	63	66	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					293	307		10.1016/j.neuron.2013.05.003	http://dx.doi.org/10.1016/j.neuron.2013.05.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889934	hybrid, Green Published			2022-12-25	WOS:000322426200009
J	Sivachenko, A; Li, Y; Abruzzi, KC; Rosbash, M				Sivachenko, Anna; Li, Yue; Abruzzi, Katharine C.; Rosbash, Michael			The Transcription Factor Mef2 Links the Drosophila Core Clock to Fas2, Neuronal Morphology, and Circadian Behavior	NEURON			English	Article							GENE-EXPRESSION; STRUCTURAL PLASTICITY; OPTIC NEUROPIL; TARGET GENES; MELANOGASTER; SYNAPSE; CELLS; SLEEP; DIFFERENTIATION; ORGANIZATION	The transcription factor Mef2 regulates activity-dependent neuronal plasticity and morphology in mammals, and clock neurons are reported to experience activity-dependent circadian remodeling in Drosophila. We show here that Mef2 is required for this daily fasciculation-defasciculation cycle. Moreover, the master circadian transcription complex CLK/CYC directly regulates Mef2 transcription. ChIP-Chip analysis identified numerous Mef2 target genes implicated in neuronal plasticity, including the cell-adhesion gene Fas2. Genetic epistasis experiments support this transcriptional regulatory hierarchy, CLK/CYC- > Mef2- > Fas2, indicate that it influences the circadian fasciculation cycle within pacemaker neurons, and suggest that this cycle also contributes to circadian behavior. Mef2 therefore transmits clock information to machinery involved in neuronal remodeling, which contributes to locomotor activity rhythms.	[Sivachenko, Anna; Li, Yue; Abruzzi, Katharine C.; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Dept Biol, 415 South St, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [T32 NS007292] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Behrens UD, 1996, VISION RES, V36, P3901, DOI 10.1016/S0042-6989(96)00139-3; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Blanchard FJ, 2010, J NEUROSCI, V30, P5855, DOI 10.1523/JNEUROSCI.2688-09.2010; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Bushey D, 2011, INT REV NEUROBIOL, V99, P213, DOI 10.1016/B978-0-12-387003-2.00009-4; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chen SX, 2012, CELL, V151, P41, DOI 10.1016/j.cell.2012.08.028; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Depetris-Chauvin A, 2011, CURR BIOL, V21, P1783, DOI 10.1016/j.cub.2011.09.027; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Junion G, 2005, P NATL ACAD SCI USA, V102, P18479, DOI 10.1073/pnas.0507030102; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; LAVAIL MM, 1976, INVEST OPHTH VISUAL, V15, P64; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Moncalvo VGR, 2005, DEV BIOL, V286, P549, DOI 10.1016/j.ydbio.2005.08.030; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nojima M, 2008, J MOL BIOL, V382, P275, DOI 10.1016/j.jmb.2008.07.017; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; PYZA E, 1995, J NEUROSCI, V15, P407; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; Tavosanis G, 2012, DEV NEUROBIOL, V72, P73, DOI 10.1002/dneu.20951; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wijnen H, 2005, METHOD ENZYMOL, V393, P341, DOI 10.1016/S0076-6879(05)93015-2; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	52	56	56	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					281	292		10.1016/j.neuron.2013.05.015	http://dx.doi.org/10.1016/j.neuron.2013.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889933	Green Accepted, Bronze			2022-12-25	WOS:000322426200008
J	Feng, WJ; Khan, MA; Bellvis, P; Zhu, Z; Bernhardt, O; Herold-Mende, C; Liu, HK				Feng, Weijun; Khan, Muhammad Amir; Bellvis, Pablo; Zhu, Zhe; Bernhardt, Olga; Herold-Mende, Christel; Liu, Hai-Kun			The Chromatin Remodeler CHD7 Regulates Adult Neurogenesis via Activation of SoxC Transcription Factors	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; NUCLEAR RECEPTOR TAILLESS; DE-NOVO MUTATIONS; CHARGE-SYNDROME; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; ANALYSIS REVEALS; GENES; EXPANSION; PROTEIN	Chromatin factors that regulate neurogenesis in the central nervous system remain to be explored. Here, we demonstrate that the chromatin remodeler chromodomain-helicase-DNA-binding protein 7 (CHD7), a protein frequently mutated in human CHARGE syndrome, is a master regulator of neurogenesis in mammalian brain. CHD7 is selectively expressed in actively dividing neural stem cells (NSCs) and progenitors. Genetic inactivation of CHD7 in NSCs leads to a reduction of neuronal differentiation and aberrant dendritic development of newborn neurons. Strikingly, physical exercise can rescue the CHD7 mutant phenotype in the adult hippocampal dentate gyrus. We further show that in NSCs, CHD7 stimulates the expression of Sox4 and Sox11 genes via remodeling their promoters to an open chromatin state. Our study demonstrates an essential role of CHD7 in activation of the neuronal differentiation program in NSCs, thus providing insights into epigenetic regulation of stem cell differentiation and molecular mechanism of human CHARGE syndrome.	[Feng, Weijun; Khan, Muhammad Amir; Bellvis, Pablo; Zhu, Zhe; Bernhardt, Olga; Liu, Hai-Kun] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Helmholtz Young Investigator Grp Normal & Neoplas, D-69120 Heidelberg, Germany; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Liu, HK (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Helmholtz Young Investigator Grp Normal & Neoplas, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	l.haikun@dkfz-heidelberg.de	Zhu, Zhe/H-6009-2019	Zhu, Zhe/0000-0002-5385-948X; liu, hai-kun/0000-0003-3338-4066	Helmholtz Young Investigator Award [VH-NG-702]; Deutsche Forschungsgemeinschaft [LI 2140/1-1, LI2140/2-1]; Deutsche Krebshilfe [110226]; Helmholtz Alliance PCCC; DKFZ Intramural Grant Program	Helmholtz Young Investigator Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Alliance PCCC; DKFZ Intramural Grant Program	We thank Ingrid Grummt for her constructive comments. We thank Gunther Schutz, Patricia Rusu, and Monika Bock for their critical reading of the manu-script. We thank the Imaging Facility of the DKFZ and the Carl Zeiss Imaging Center in the DKFZ for their support with image acquisition. This work was supported by the Helmholtz Young Investigator Award (VH-NG-702), the Deutsche Forschungsgemeinschaft (LI 2140/1-1 and LI2140/2-1), the Deutsche Krebshilfe (110226), the Helmholtz Alliance PCCC, and the DKFZ Intramural Grant Program.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blustajn J, 2008, AM J NEURORADIOL, V29, P1266, DOI 10.3174/ajnr.A1099; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hartshorne TS, 2005, AM J MED GENET A, V133A, P257, DOI 10.1002/ajmg.a.30545; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	49	103	105	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					62	72		10.1016/j.stem.2013.05.002	http://dx.doi.org/10.1016/j.stem.2013.05.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827709	Bronze			2022-12-25	WOS:000329570100013
J	Blinder, P; Tsai, PS; Kaufhold, JP; Knutsen, PM; Suhl, H; Kleinfeld, D				Blinder, Pablo; Tsai, Philbert S.; Kaufhold, John P.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David			The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; FUNCTIONAL ARCHITECTURE; PENETRATING ARTERIOLES; NEURONAL-ACTIVITY; INTRINSIC SIGNAL; VISUAL-CORTEX; LASER-PULSES; BRAIN; OCCLUSION; MICROVASCULATURE	What is the nature of the vascular architecture in the cortex that allows the brain to meet the energy demands of neuronal computations? We used high-throughput histology to reconstruct the complete angioarchitecture and the positions of all neuronal somata of multiple cubic millimeter regions of vibrissa primary sensory cortex in mouse. Vascular networks were derived from the reconstruction. In contrast with the standard model of cortical columns that are tightly linked with the vascular network, graph-theoretical analyses revealed that the subsurface microvasculature formed interconnected loops with a topology that was invariant to the position and boundary of columns. Furthermore, the calculated patterns of blood flow in the networks were unrelated to location of columns. Rather, blood sourced by penetrating arterioles was effectively drained by the penetrating venules to limit lateral perfusion. This analysis provides the underpinning to understand functional imaging and the effect of penetrating vessels strokes on brain viability.	[Blinder, Pablo; Tsai, Philbert S.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kaufhold, John P.] Sci Applicat Int Corp Intelligent Syst Div, Arlington, VA USA; [Kleinfeld, David] Univ Calif San Diego, Sect Neurobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Science Applications International Corporation (SAIC); University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Blinder, Pablo/AAX-7980-2020; Blinder, Pablo/D-2472-2009; Blinder, Pablo/GQI-2237-2022	Blinder, Pablo/0000-0002-4042-214X; Kaufhold, John/0000-0002-2236-7909	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health [EB003832, MH085499, MH072570, OD006831]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085499, R21MH072570] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Lee for assistance in the analysis of the surface vasculature, J.D. Driscoll for assistance with the imaging acquisition software, N. Nishimura and C.B. Schaffer for sharing their data logs, S. Chien, W. Denk, P.J. Drew, A.L. Fairhall, B. Friedman, R.D. Frostig, H.J. Karten, H.S. Seung, T.W. Secomb, A.Y. Shih and B. Weber for critical discussions. This work was supported by the Israeli Science Foundation (Bikura fellowship to P.B.) and the US National Institutes of Health (grants EB003832, MH085499, MH072570 and OD006831).	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Brundel M, 2012, J CEREBR BLOOD F MET, V32, P425, DOI 10.1038/jcbfm.2011.200; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Cserti J, 2000, AM J PHYS, V68, P896, DOI 10.1119/1.1285881; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Derdikman D, 2003, J NEUROSCI, V23, P3100; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Eppihimer MJ, 1996, MICROVASC RES, V51, P187, DOI 10.1006/mvre.1996.0020; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Guibert R, 2010, J CEREBR BLOOD F MET, V30, P1860, DOI 10.1038/jcbfm.2010.105; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kaufhold JP, 2012, MED IMAGE ANAL, V16, P1241, DOI 10.1016/j.media.2012.06.004; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Kohn A, 2000, NEUROSCIENCE, V95, P51; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAYHAN WG, 1986, CIRC RES, V59, P216, DOI 10.1161/01.RES.59.2.216; Mchedlishvili G., 1963, ARTERIAL BEHAV BLOOD; NAKAI K, 1981, STROKE, V12, P653, DOI 10.1161/01.STR.12.5.653; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Oraevsky AA, 1996, IEEE J SEL TOP QUANT, V2, P801, DOI 10.1109/2944.577302; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Vazquez AL, 2012, J CEREBR BLOOD F MET, V32, P745, DOI 10.1038/jcbfm.2011.198; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu FY, 2004, J PHYS A-MATH GEN, V37, P6653, DOI 10.1088/0305-4470/37/26/004; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	330	341	2	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					889	U150		10.1038/nn.3426	http://dx.doi.org/10.1038/nn.3426			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749145	Green Accepted			2022-12-25	WOS:000321180900022
J	Chesi, A; Staahl, BT; Jovicic, A; Couthouis, J; Fasolino, M; Raphael, AR; Yamazaki, T; Elias, L; Polak, M; Kelly, C; Williams, KL; Fifita, JA; Maragakis, NJ; Nicholson, GA; King, OD; Reed, R; Crabtree, GR; Blair, IP; Glass, JD; Gitler, AD				Chesi, Alessandra; Staahl, Brett T.; Jovicic, Ana; Couthouis, Julien; Fasolino, Maria; Raphael, Alya R.; Yamazaki, Tomohiro; Elias, Laura; Polak, Meraida; Kelly, Crystal; Williams, Kelly L.; Fifita, Jennifer A.; Maragakis, Nicholas J.; Nicholson, Garth A.; King, Oliver D.; Reed, Robin; Crabtree, Gerald R.; Blair, Ian P.; Glass, Jonathan D.; Gitler, Aaron D.			Exome sequencing to identify de novo mutations in sporadic ALS trios	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; PRION-LIKE DOMAINS; SODIUM PHENYLBUTYRATE; HEXANUCLEOTIDE REPEAT; GENE; COMPLEX; EXPRESSION; FRAMEWORK; PARADIGM	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease whose causes are still poorly understood. To identify additional genetic risk factors, we assessed the role of de novo mutations in ALS by sequencing the exomes of 47 ALS patients and both of their unaffected parents (n = 141 exomes). We found that amino acid-altering de novo mutations were enriched in genes encoding chromatin regulators, including the neuronal chromatin remodeling complex (nBAF) component SS18L1 (also known as CREST). CREST mutations inhibited activity-dependent neurite outgrowth in primary neurons, and CREST associated with the ALS protein FUS. These findings expand our understanding of the ALS genetic landscape and provide a resource for future studies into the pathogenic mechanisms contributing to sporadic ALS.	[Chesi, Alessandra; Jovicic, Ana; Couthouis, Julien; Raphael, Alya R.; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Staahl, Brett T.; Elias, Laura; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Staahl, Brett T.; Elias, Laura; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Fasolino, Maria] Univ Penn, Neurosci Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yamazaki, Tomohiro; Reed, Robin] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Polak, Meraida; Kelly, Crystal; Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Williams, Kelly L.; Fifita, Jennifer A.; Nicholson, Garth A.; Blair, Ian P.] Australian & New Zealand Army Corps Res Inst, Northcott Neurosci Lab, Sydney, NSW, Australia; [Williams, Kelly L.; Nicholson, Garth A.; Blair, Ian P.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Williams, Kelly L.; Fifita, Jennifer A.; Blair, Ian P.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [King, Oliver D.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Emory University; University of Sydney; Macquarie University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Gitler, AD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	chesi@stanford.edu; agitler@stanford.edu	Chesi, Alessandra/AAT-8248-2020; Williams, Kelly L/A-5545-2010; COUTHOUIS, Julien/G-3895-2012; Chesi, Alessandra/N-7693-2017	Williams, Kelly L/0000-0001-6319-9473; COUTHOUIS, Julien/0000-0002-2378-4595; Blair, Ian/0000-0003-3083-0075; Gitler, Aaron/0000-0001-8603-1526; Fifita, Jennifer/0000-0002-0814-0118; Crabtree, Robert/0000-0002-6639-8707; Chesi, Alessandra/0000-0002-0954-7446; Nicholson, Garth/0000-0001-9694-066X	National Health and Medical Research Council of Australia [1004670, 511941]; Motor Neurone Disease Research Institute of Australia; US National Institutes of Health Director's New Innovator Award [1DP2OD004417]; US National Institutes of Health [1R01NS065317, R01NS046789, 5U01NS062713]; Department of Defense ALS Research Program; Biogen Idec ALS genome sequencing consortium; Pew Charitable Trusts; Rita Allen Foundation; Howard Hughes Medical Institute; Packard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R01NS065317, R37NS046789, U01NS062713, R01NS073660] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia; US National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense ALS Research Program(United States Department of Defense); Biogen Idec ALS genome sequencing consortium; Pew Charitable Trusts; Rita Allen Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a US National Institutes of Health Director's New Innovator Award 1DP2OD004417 (A.D.G.), grants from the US National Institutes of Health (1R01NS065317 to A.D.G., R01NS046789 to G.R.C. and 5U01NS062713 to N.J.M.) and the Department of Defense ALS Research Program (N.J.M.). A.D.G. received funding from the Biogen Idec ALS genome sequencing consortium. A.D.G. received funding from The Pew Charitable Trusts and the Rita Allen Foundation. G.R.C. receives funding from the Howard Hughes Medical Institute. A.D.G. and J.D.G. are supported by the Packard Center for ALS Research at Johns Hopkins. This work was also supported by the National Health and Medical Research Council of Australia (1004670, 511941) and the Motor Neurone Disease Research Institute of Australia.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Alexander MD, 2002, ANN NEUROL, V52, P680, DOI 10.1002/ana.10369; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Folco EG, 2012, JOVE-J VIS EXP, DOI 10.3791/4140; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gil OD, 1998, J NEUROSCI, V18, P9312; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Lule D, 2008, MED HYPOTHESES, V70, P1133, DOI 10.1016/j.mehy.2007.11.002; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wolff D, 2011, MOL SYNDROMOL, V2, P237, DOI 10.1159/000337323; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	55	104	104	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					851	U98		10.1038/nn.3412	http://dx.doi.org/10.1038/nn.3412			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708140	Green Submitted, Green Accepted			2022-12-25	WOS:000321180900017
J	Laje, R; Buonomano, DV				Laje, Rodrigo; Buonomano, Dean V.			Robust timing and motor patterns by taming chaos in recurrent neural networks	NATURE NEUROSCIENCE			English	Article							TEMPORAL INFORMATION; TRANSIENT DYNAMICS; TIME; MODEL; CEREBELLUM; SEQUENCES; VARIABILITY; MECHANISMS; SYSTEMS; MEMORY	The brain's ability to tell time and produce complex spatiotemporal motor patterns is critical for anticipating the next ring of a telephone or playing a musical instrument. One class of models proposes that these abilities emerge from dynamically changing patterns of neural activity generated in recurrent neural networks. However, the relevant dynamic regimes of recurrent networks are highly sensitive to noise; that is, chaotic. We developed a firing rate model that tells time on the order of seconds and generates complex spatiotemporal patterns in the presence of high levels of noise. This is achieved through the tuning of the recurrent connections. The network operates in a dynamic regime that exhibits coexisting chaotic and locally stable trajectories. These stable patterns function as 'dynamic attractors' and provide a feature that is characteristic of biological systems: the ability to 'return' to the pattern being generated in the face of perturbations.	[Laje, Rodrigo; Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA.	dbuono@ucla.edu	Laje, Rodrigo/AAI-9793-2020	Laje, Rodrigo/0000-0003-1481-303X	US National Institutes of Health [NS077340]; National Science Foundation [II-1114833]; Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS077340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Garfinkel and R. Huerta for helpful discussions and comments on the manuscript. This work was supported by the US National Institutes of Health (NS077340), the National Science Foundation (II-1114833), the Pew Charitable Trusts, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Ahrens MB, 2011, CURR BIOL, V21, P200, DOI 10.1016/j.cub.2010.12.043; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Boffetta G, 2001, PHYSICA D, V159, P58, DOI 10.1016/S0167-2789(01)00330-X; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Haykin S., 2002, ADAPTIVE FILTER THEO; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H, 2001, BONN GER GER NATL RE, V148, P13; Jaeger H, 2007, NEURAL NETWORKS, V20, P287, DOI 10.1016/j.neunet.2007.04.001; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Li JX, 2011, NEURON, V69, P159, DOI 10.1016/j.neuron.2010.11.043; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Monteforte M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	55	238	238	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					925	U196		10.1038/nn.3405	http://dx.doi.org/10.1038/nn.3405			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708144	Green Accepted, Green Submitted			2022-12-25	WOS:000321180900027
J	Wu, YE; Huo, L; Maeder, CI; Feng, W; Shen, K				Wu, Ye E.; Huo, Lin; Maeder, Celine I.; Feng, Wei; Shen, Kang			The Balance between Capture and Dissociation of Presynaptic Proteins Controls the Spatial Distribution of Synapses	NEURON			English	Article							ACTIVE ZONE; SYNAPTIC VESICLES; AXONAL-TRANSPORT; LYSOSOMAL TRAFFICKING; SIGNAL-TRANSDUCTION; MEMBRANE-TRANSPORT; JNK PATHWAY; KINESIN; NEURONS; RPM-1	The location, size, and number of synapses critically influence the specificity and strength of neural connections. In axons, synaptic vesicle (SV) and active zone (AZ) proteins are transported by molecular motors and accumulate at discrete presynaptic loci. Little is known about the mechanisms coordinating presynaptic protein transport and deposition to achieve proper distribution of synaptic material. Here we show that SV and AZ proteins exhibit extensive cotransport and undergo frequent pauses. At the axonal and synaptic pause sites, the balance between the capture and dissociation of mobile transport packets determines the extent of presynaptic assembly. The small G protein ARL-8 inhibits assembly by promoting dissociation, while a JNK kinase pathway and AZ assembly proteins inhibit dissociation. Furthermore, ARL-8 directly binds to the UNC-104/KIF1A motor to limit the capture efficiency. Together, molecular regulation of the dichotomy between axonal trafficking and local assembly controls vital aspects of synapse formation and maintenance.	[Wu, Ye E.; Maeder, Celine I.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wu, Ye E.; Maeder, Celine I.; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Huo, Lin; Feng, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Howard Hughes Medical Institute; Stanford University; Stanford University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kangshen@stanford.edu	HUO, LIN/A-6673-2012		Howard Hughes Medical Institute; National Institutes of Health NIH [5R01 NS048392]; National Major Basic Research Program of China [2011CB910503]; National Natural Science Foundation of China [31070657, 31190062]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health NIH 5R01 NS048392, the National Major Basic Research Program of China (2011CB910503), and the National Natural Science Foundation of China (31070657 and 31190062). We thank the Caenorhabditis Genetics Center, the National Bioresource Project (Japan), G. Maro, P. Kurshan, and the laboratories of J. Bessereau, K. Kontani, S. Mitani, Y. Jin, M. Nachury, and S. Munro for strains and reagents. We also thank S. Shaham for help with the analysis of the whole-genome sequencing data, C. Gao and Y. Fu for technical assistance, and A. McAllister, M. Klassen, and P. Kushan for thoughtful comments on the manuscript. Y.E.W. and K.S. designed experiments and wrote the paper. C.I.M. built some transgenes for dynamic imaging. L.H. and W.F. performed the experiments in Figure 8. Y.E.W. performed the other experiments and analyzed the data.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Bury LAD, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-24; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Gally C, 2003, J NEUROSCI, V23, P2591; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hellman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024562; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Huo L, 2012, STRUCTURE, V20, P1550, DOI 10.1016/j.str.2012.07.002; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee JR, 2004, EMBO J, V23, P1506, DOI 10.1038/sj.emboj.7600164; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tao-Cheng JH, 2007, NEUROSCIENCE, V150, P575, DOI 10.1016/j.neuroscience.2007.09.031; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Wagner O.I., 2009, NAT NEUROSCI, V106, P19605; Weston CR, 2003, GENE DEV, V17, P1271, DOI 10.1101/gad.1087303; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	56	80	84	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					994	1011		10.1016/j.neuron.2013.04.035	http://dx.doi.org/10.1016/j.neuron.2013.04.035			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23727120	Bronze, Green Accepted			2022-12-25	WOS:000321026900007
J	Engle, SJ; Puppala, D				Engle, Sandra J.; Puppala, Dinesh			Integrating Human Pluripotent Stem Cells into Drug Development	CELL STEM CELL			English	Review							RESEARCH-AND-DEVELOPMENT; PHARMACEUTICAL RESEARCH; IPS CELLS; HUMAN ES; DIFFERENTIATION; INDUCTION; LINES; DISCOVERY; MEDICINES; PARADIGM	Integration of physiologically relevant in vitro assays at the earliest stages of drug discovery may improve the likelihood of successfully translating preclinical discoveries to the clinic. Assays based on in vitro-differentiated, human pluripotent stem cell (IVD hPSC)-derived cells, which may better model human physiology, are starting to impact the drug discovery process, but their implementation has been slower than originally anticipated. In this Perspective, we discuss imperatives for incorporating IVD hPSCs into drug discovery and the associated challenges.	[Engle, Sandra J.] Pfizer Inc, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; [Puppala, Dinesh] Pfizer Inc, Compound Safety Predict, Groton, CT 06340 USA	Pfizer; Pfizer	Engle, SJ (corresponding author), Pfizer Inc, Pharmacokinet Dynam & Metab, Eastern Point Rd, Groton, CT 06340 USA.	sandra.j.engle@pfizer.com						Allen MJ, 2010, CLIN CHEM, V56, P1675, DOI 10.1373/clinchem.2010.150672; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Baker MH, 2012, RICHMOND THEATER FIRE: EARLY AMERICA'S FIRST GREAT DISASTER, P215; Campbell Angela, 2005, Med Law Int, V7, P113; Cezar GG, 2007, CURR OPIN CHEM BIOL, V11, P405, DOI 10.1016/j.cbpa.2007.05.033; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Cheng LT, 2012, GENES CELLS, V17, P431, DOI 10.1111/j.1365-2443.2012.01599.x; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; De Trizio Ella, 2004, J Biolaw Bus, V7, P14; Dolsten M, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-7; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; Eglen RM, 2008, COMB CHEM HIGH T SCR, V11, P560, DOI 10.2174/138620708785204144; Fakunle ES, 2012, TRENDS MOL MED, V18, P709, DOI 10.1016/j.molmed.2012.10.007; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Georgieva BP, 2010, REGEN MED, V5, P581, DOI 10.2217/RME.10.43; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Goldbard S, 2006, CURR OPIN DRUG DISC, V9, P110; Goldin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029861; Greek R, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-40; Gulbrandsen C, 2007, NAT BIOTECHNOL, V25, P387, DOI 10.1038/nbt0407-387; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; Knight A, 2007, ALTEX-ALTERN TIEREXP, V24, P320, DOI 10.14573/altex.2007.4.320; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; LEONARDBARTON D, 1985, HARVARD BUS REV, V63, P102; Levine AD, 2011, NAT BIOTECHNOL, V29, P1079, DOI 10.1038/nbt.2029; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Lodge AP, 2010, J BIOMOL SCREEN, V15, P159, DOI 10.1177/1087057109355468; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Munos BH, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000155; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; President's Council of Advisors on Science and Technology (PCAST), 2008, PRIOR PERS MED REP P; Puppala D, 2013, TOXICOL SCI, V131, P292, DOI 10.1093/toxsci/kfs282; Rao M, 2013, CELL STEM CELL, V12, P149, DOI 10.1016/j.stem.2013.01.010; Rowntree RK, 2010, REGEN MED, V5, P557, DOI [10.2217/rme.10.36, 10.2217/RME.10.36]; Sahi Jasminder, 2010, Curr Drug Discov Technol, V7, P188; Sams-Dodd F, 2013, DRUG DISCOV TODAY, V18, P211, DOI 10.1016/j.drudis.2012.10.010; Sandusky G, 2009, VET PATHOL, V46, P2, DOI 10.1354/vp.46-1-2; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; Vidal R, 2011, CURR PHARM DESIGN, V17, P521, DOI 10.2174/138161211795164086; Vieira C, 2010, INT J DEV BIOL, V54, P7, DOI 10.1387/ijdb.092853cv; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	69	99	103	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					669	677		10.1016/j.stem.2013.05.011	http://dx.doi.org/10.1016/j.stem.2013.05.011			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746976	Bronze			2022-12-25	WOS:000329569900010
J	Yang, YM; Gupta, SK; Kim, KJ; Powers, BE; Cerqueira, A; Wainger, BJ; Ngo, HD; Rosowski, KA; Schein, PA; Ackeifi, CA; Arvanites, AC; Davidow, LS; Woolf, CJ; Rubin, LL				Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Wainger, Brian J.; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Arvanites, Anthony C.; Davidow, Lance S.; Woolf, Clifford J.; Rubin, Lee L.			A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOUSE MODEL; C-JUN; MATRIX METALLOPROTEINASES; DISEASE PROGRESSION; PROTEIN-KINASE; SURVIVAL; TDP-43; DEATH	Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease, characterized by motor neuron (MN) death, for which there are no truly effective treatments. Here, we describe a new small molecule survival screen carried out using MNs from both wild-type and mutant SOD1 mouse embryonic stem cells. Among the hits we found, kenpaullone had a particularly impressive ability to prolong the healthy survival of both types of MNs that can be attributed to its dual inhibition of GSK-3 and HGK kinases. Furthermore, kenpaullone also strongly improved the survival of human MNs derived from ALS-patient-induced pluripotent stem cells and was more active than either of two compounds, olesoxime and dexpramipexole, that recently failed in ALS clinical trials. Our studies demonstrate the value of a stem cell approach to drug discovery and point to a new paradigm for identification and preclinical testing of future ALS therapeutics.	[Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yang, Yin M.; Gupta, Shailesh K.; Kim, Kevin J.; Powers, Berit E.; Cerqueira, Antonio; Ngo, Hien D.; Rosowski, Kathryn A.; Schein, Pamela A.; Ackeifi, Courtney A.; Arvanites, Anthony C.; Davidow, Lance S.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Rosowski, Kathryn A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Harvard University; Yale University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu	Wainger, Brian/L-7553-2017; Woolf, Clifford/A-9784-2010	Kim, Kevin/0000-0002-7015-5871; Ackeifi, Courtney/0000-0002-7110-5841; Rubin, Lee/0000-0002-8658-841X	ALS Association; New York Stem Cell Foundation; NINDS [P01NS066888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	ALS Association; New York Stem Cell Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to K. Eggan for providing mouse ESCs and human ESCs and iPSCs, G. Daley for providing the TDP-43 human iPSCs, and B. Doble and J. Woodgett for providing mouse GSK-KO ESC lines. We would also like to thank B. Tilton and P. Rogers for assistance with FACS; K. Kotkow, A. D. Sinor-Anderson, N. Makhortova, M. Hayhurst, K. Krumholz, G. Boulting, J. Ichida, E. Kiskinis, and A. Blumenstein for providing reagents and helpful discussions; and J. LaLonde for editorial assistance. This work was supported by the ALS Association, the New York Stem Cell Foundation, NINDS (P01NS066888), and the Harvard Stem Cell Institute. L.L.R. is a founder of iPierian Inc. and a member of its Scientific Advisory Board.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Dewil M, 2007, NEUROPATH APPL NEURO, V33, P499, DOI 10.1111/j.1365-2990.2007.00850.x; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Gribkoff VK, 2008, CNS NEUROSCI THER, V14, P215, DOI 10.1111/j.1755-5949.2008.00048.x; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim K, 2006, EUR J PHARMACOL, V542, P100, DOI 10.1016/j.ejphar.2006.05.025; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; Koh SH, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/205761; Koh SH, 2004, TOXICOLOGY, V202, P213, DOI 10.1016/j.tox.2004.05.008; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lorenzl S, 2006, EXP NEUROL, V200, P166, DOI 10.1016/j.expneurol.2006.01.026; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Martin LJ, 2001, INT J MOL MED, V7, P455; Mattson MP, 1997, APOPTOSIS, V2, P257, DOI 10.1023/A:1026433019210; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Shoemaker JL, 2007, J NEUROCHEM, V101, P87, DOI 10.1111/j.1471-4159.2006.04346.x; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sunyach C, 2012, NEUROPHARMACOLOGY, V62, P2346, DOI 10.1016/j.neuropharm.2012.02.013; Tradewell ML, 2010, NEUROREPORT, V21, P976, DOI 10.1097/WNR.0b013e32833ddd45; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang LJ, 2010, J NEUROCHEM, V113, P166, DOI 10.1111/j.1471-4159.2010.06594.x; Watson A, 1998, J NEUROSCI, V18, P751; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	58	216	230	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					713	726		10.1016/j.stem.2013.04.003	http://dx.doi.org/10.1016/j.stem.2013.04.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23602540	Bronze, Green Accepted			2022-12-25	WOS:000329569900014
J	Gantz, SC; Bunzow, JR; Williams, JT				Gantz, Stephanie C.; Bunzow, James R.; Williams, John T.			Spontaneous Inhibitory Synaptic Currents Mediated by a G Protein-Coupled Receptor	NEURON			English	Article							SOMATODENDRITIC DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; SUBSTANTIA-NIGRA; DIFFERENTIAL ACTIVATION; NEURONS; RAT; TRANSMISSION; SLICES; TRANSMITTER	G protein-coupled receptors (GPCRs) affect many physiological processes by modulating both intrinsic membrane conductances and synaptic transmission. This study describes spontaneous miniature inhibitory postsynaptic currents mediated by vesicular dopamine release acting locally on metabotropic D-2 receptors leading to the activation of a G protein-coupled inwardly rectifying potassium conductance. Thus, individual exocytotic events result in spontaneous GPCR-mediated transmission, similar to synaptic activation of classical ligand-gated ion channels.	[Gantz, Stephanie C.; Bunzow, James R.; Williams, John T.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Williams, JT (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	williamj@ohsu.edu	Gantz, Stephanie/AAF-4473-2021	Gantz, Stephanie/0000-0002-1800-4400	NIH [DA04523]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. C.P. Ford for comments on the work and manuscript. Supported by NIH DA04523.	ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; BAYER VE, 1990, J NEUROSCI, V10, P2996; Beckstead MJ, 2007, EUR J NEUROSCI, V26, P1479, DOI 10.1111/j.1460-9568.2007.05775.x; Beckstead MJ, 2007, J NEUROSCI, V27, P2074, DOI 10.1523/JNEUROSCI.3251-06.2007; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; BOBKER DH, 1989, J PHARMACOL EXP THER, V250, P37; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Courtney NA, 2012, J NEUROSCI, V32, P13520, DOI 10.1523/JNEUROSCI.2745-12.2012; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Ford CP, 2009, J NEUROSCI, V29, P13344, DOI 10.1523/JNEUROSCI.3546-09.2009; Fortin GD, 2006, J NEUROCHEM, V96, P1740, DOI 10.1111/j.1471-4159.2006.03699.x; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Gantz SC, 2011, J NEUROSCI, V31, P12629, DOI 10.1523/JNEUROSCI.0684-11.2011; GROVES PM, 1983, EXP BRAIN RES, V49, P209; HEERINGA MJ, 1995, J NEUROCHEM, V65, P192; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jaffe EH, 1998, J NEUROSCI, V18, P3548; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Mendez JA, 2011, J BIOL CHEM, V286, P23928, DOI 10.1074/jbc.M111.218032; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; Patel JC, 2009, J NEUROSCI, V29, P6568, DOI 10.1523/JNEUROSCI.0181-09.2009; Pothos EN, 1998, J NEUROSCI, V18, P4106; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31	32	62	63	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					807	812		10.1016/j.neuron.2013.04.013	http://dx.doi.org/10.1016/j.neuron.2013.04.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764286	Green Accepted, Bronze			2022-12-25	WOS:000320743400008
J	Michalski, N; Babai, N; Renier, N; Perkel, DJ; Chedotal, A; Schneggenburger, R				Michalski, Nicolas; Babai, Norbert; Renier, Nicolas; Perkel, David J.; Chedotal, Alain; Schneggenburger, Ralf			Robo3-Driven Axon Midline Crossing Conditions Functional Maturation of a Large Commissural Synapse	NEURON			English	Article							VENTRAL COCHLEAR NUCLEUS; PRESYNAPTIC ACTIVE ZONE; HORIZONTAL GAZE PALSY; NERVOUS-SYSTEM; HELD SYNAPSE; POSTTETANIC POTENTIATION; NEUROTRANSMITTER RELEASE; PROGRESSIVE SCOLIOSIS; DEVELOPMENTAL-CHANGES; AUDITORY SYNAPSE	During the formation of neuronal circuits, axon pathfinding decisions specify the location of synapses on the correct brain side and in correct target areas. We investigated a possible link between axon midline crossing and the subsequent development of output synapses formed by these axons. Conditional knockout of Robo3 in the auditory system forced a large commissural synapse, the calyx of Held, to be exclusively formed on the wrong, ipsilateral side. lpsilateral calyx of Held synapses showed strong transmission defects, with reduced and desynchronized transmitter release, fewer fast-releasable vesicles, and smaller and more variable presynaptic Ca2+ currents. Transmission defects were not observed in a downstream inhibitory synapse, and some defects persisted into adulthood. These results suggest that axon midline crossing conditions functional maturation of commissural synapses, thereby minimizing the impact of mislocalized synapses on information processing. This mechanism might be relevant to human disease caused by mutations in the ROBO3 gene.	[Michalski, Nicolas; Babai, Norbert; Perkel, David J.; Schneggenburger, Ralf] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland; [Renier, Nicolas; Chedotal, Alain] INSERM, U968, F-75012 Paris, France; [Renier, Nicolas; Chedotal, Alain] Univ Paris 06, UPMC, UMR S 968, Inst Vis, F-75012 Paris, France; [Renier, Nicolas; Chedotal, Alain] CNRS, UMR 7210, F-75012 Paris, France; [Perkel, David J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Perkel, David J.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Schneggenburger, R (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland.	ralf.schneggenburger@epfl.ch	Babai, Norbert/T-2952-2019; Renier, Nicolas/E-1855-2018; Chedotal, Alain/F-2750-2017	Renier, Nicolas/0000-0003-2642-4402; Chedotal, Alain/0000-0001-7577-3794; michalski, nicolas/0000-0002-1287-2709	Marie Curie post-doctoral fellowship [IEF-235223-Calyx-MMFF]; Swiss National Science Foundation (SNF) [CRSI33_127440/1]; National Center of Competence in Research (NCCR) of the SNF "Synaptic Bases of Mental Disease"; Fondation pour recherche medicale (FRM); Association Francaise contre les Myopathies (AFM) [ASS-SUB06-00123]; Labex lifesenses; Agence Nationale de la Recherche [ANR-2011 BSV 40091]	Marie Curie post-doctoral fellowship(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); National Center of Competence in Research (NCCR) of the SNF "Synaptic Bases of Mental Disease"(Swiss National Science Foundation (SNSF)); Fondation pour recherche medicale (FRM); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Labex lifesenses; Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank Jessica Dupasquier, Coraly Pernet, Heather Murray, and Nicolas Rama for expert technical assistance, Enida Gjoni for help with LSO recordings, and Jean-Pierre Hardelin for critical comments on the manuscript. This research was supported by a Marie Curie post-doctoral fellowship (IEF-235223-Calyx-MMFF to N.M.), the Swiss National Science Foundation (SNF; Sinergia grant CRSI33_127440/1 to R.S.), the National Center of Competence in Research (NCCR) of the SNF "Synaptic Bases of Mental Disease," the Fondation pour recherche medicale (FRM; to A.C.), the Association Francaise contre les Myopathies (AFM, ASS-SUB06-00123; to A.C.), the Labex lifesenses (to A.C.), and the Agence Nationale de la Recherche (ANR-2011 BSV 40091; to A.C.)	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Amoiridis G, 2006, J NEUROL NEUROSUR PS, V77, P1047, DOI 10.1136/jnnp.2006.088435; Bergsman JB, 2004, J NEUROPHYSIOL, V92, P545, DOI 10.1152/jn.00927.2003; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Chuhma N, 2001, J PHYSIOL-LONDON, V530, P93, DOI 10.1111/j.1469-7793.2001.0093m.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ehret G, 1976, J Am Audiol Soc, V1, P179; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Guo C., 2002, GENESIS, V32, P8; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Haller S, 2008, NEURORADIOLOGY, V50, P453, DOI 10.1007/s00234-007-0359-1; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Howell DM, 2007, J COMP NEUROL, V504, P533, DOI 10.1002/cne.21443; Hsieh CY, 2007, J COMP NEUROL, V504, P508, DOI 10.1002/cne.21465; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Miko IJ, 2007, J COMP NEUROL, V505, P669, DOI 10.1002/cne.21530; Nakamura PA, 2011, HEARING RES, V276, P70, DOI 10.1016/j.heares.2010.11.004; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rodriguez-Contreras A, 2008, P NATL ACAD SCI USA, V105, P5603, DOI 10.1073/pnas.0801395105; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Xiao L., NAT NEUROSCI; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511	59	24	24	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					855	868		10.1016/j.neuron.2013.04.006	http://dx.doi.org/10.1016/j.neuron.2013.04.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23664551	Bronze			2022-12-25	WOS:000320743400012
J	Beerman, I; Bock, C; Garrison, BS; Smith, ZD; Gu, HC; Meissner, A; Rossi, DJ				Beerman, Isabel; Bock, Christoph; Garrison, Brian S.; Smith, Zachary D.; Gu, Hongcang; Meissner, Alexander; Rossi, Derrick J.			Proliferation-Dependent Alterations of the DNA Methylation Landscape Underlie Hematopoietic Stem Cell Aging	CELL STEM CELL			English	Article							SELF-RENEWAL CAPACITY; AGE; DIFFERENTIATION; TRANSPLANTATION; FREQUENCY; SUBTYPES; LOCUS; BLOOD	The functional potential of hematopoietic stem cells (HSCs) declines during aging, and in doing so, significantly contributes to hematopoietic pathophysiology in the elderly. To explore the relationship between age-associated HSC decline and the epigenome, we examined global DNA methylation of HSCs during ontogeny in combination with functional analysis. Although the DNA methylome is generally stable during aging, site-specific alterations of DNA methylation occur at genomic regions associated with hematopoietic lineage potential and selectively target genes expressed in downstream progenitor and effector cells. We found that age-associated HSC decline, replicative limits, and DNA methylation are largely dependent on the proliferative history of HSCs, yet appear to be telomere-length independent. Physiological aging and experimentally enforced proliferation of HSCs both led to DNA hypermethylation of genes regulated by Polycomb Repressive Complex 2. Our results provide evidence that epigenomic alterations of the DNA methylation landscape contribute to the functional decline of HSCs during aging.	[Beerman, Isabel; Garrison, Brian S.; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Beerman, Isabel; Garrison, Brian S.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beerman, Isabel; Bock, Christoph; Garrison, Brian S.; Smith, Zachary D.; Meissner, Alexander; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Smith, Zachary D.; Gu, Hongcang; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Meissner, Alexander; Rossi, Derrick J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	alexander_meissner@harvard.edu; derrick.rossi@childrens.harvard.edu	Beerman, Isabel/AAN-4216-2020; Beerman, Isabel/Y-2555-2019; Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088; Gu, Hongcang/0000-0002-1439-7606; Beerman, Isabel/0000-0002-7758-8231	Harvard Stem Cell Institute; Pew Charitable Trusts	Harvard Stem Cell Institute; Pew Charitable Trusts	We would like to thank A. Zguro, R. Gazit, L. Fang, and M. Ziller for technical assistance; P. Mandal for helpful discussions; and E. Beerman for editorial help. This work was supported by a grant from the Harvard Stem Cell Institute. A. M. is supported by the Pew Charitable Trusts. D.J.R. and A. M. are New York Stem Cell Foundation, Robertson Investigators.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; EWING KL, 1964, J GERONTOL, V19, P165, DOI 10.1093/geronj/19.2.165; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fukumoto JS, 2005, CRIT REV ONCOL HEMAT, V56, P179, DOI 10.1016/j.critrevonc.2005.04.006; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Norddahl GL, 2012, AGING CELL, V11, P1128, DOI 10.1111/j.1474-9726.2012.00863.x; Oh IH, 2012, STEM CELLS, V30, P82, DOI 10.1002/stem.776; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weinhofer I., 2010, PLOS GENET, V6, P6; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050	60	305	309	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					413	425		10.1016/j.stem.2013.01.017	http://dx.doi.org/10.1016/j.stem.2013.01.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23415915	Bronze			2022-12-25	WOS:000329569500009
J	Bonnevie, T; Dunn, B; Fyhn, M; Hafting, T; Derdikman, D; Kubie, JL; Roudi, Y; Moser, EI; Moser, MB				Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Kubie, John L.; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt			Grid cells require excitatory drive from the hippocampus	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; SPATIAL REPRESENTATION SYSTEM; PLACE CELLS; THETA OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; COGNITIVE MAP; RAT; NEURONS; FIELDS	To determine how hippocampal backprojections influence spatially periodic firing in grid cells, we recorded neural activity in the medial entorhinal cortex (MEC) of rats after temporary inactivation of the hippocampus. We report two major changes in entorhinal grid cells. First, hippocampal inactivation gradually and selectively extinguished the grid pattern. Second, the same grid cells that lost their grid fields acquired substantial tuning to the direction of the rat's head. This transition in firing properties was contingent on a drop in the average firing rate of the grid cells and could be replicated by the removal of an external excitatory drive in an attractor network model in which grid structure emerges by velocity-dependent translation of activity across a network with inhibitory connections. These results point to excitatory drive from the hippocampus, and possibly other regions, as one prerequisite for the formation and translocation of grid patterns in the MEC.	[Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Ctr Biol Memory, Norwegian Brain Ctr, Trondheim, Norway; [Kubie, John L.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Moser, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway.	edvard.moser@ntnu.no; maybm@ntnu.no		Roudi, Yasser/0000-0002-6989-3420; Hafting, Torkel/0000-0002-0928-3487	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT')	We thank R. Skjerpeng for programming, M.P. Witter and C.B. Boccara for advice on tetrode locations, M. Mehta and M.P. Witter for discussion, N. Burgess for sharing code for dynamic autocorrelation analyses and A.M. Amundsgard, K. Haugen, K. Jenssen; E. Krakvik and H. Waade for technical assistance. This work was supported by the Kavli Foundation, a studentship to T.B. from the Faculty of Medicine at NTNU, a Centre of Excellence grant from the Research Council of Norway and an Advanced Investigator Grant to E.I.M. from the European Research Council ('CIRCUIT', grant agreement 232608).	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Monaco JD, 2011, J NEUROSCI, V31, P11096; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Samu D, 2009, BIOL CYBERN, V101, P19, DOI 10.1007/s00422-009-0311-z; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yoshida M, 2011, J NEUROSCI, V31, P12683, DOI 10.1523/JNEUROSCI.1654-11.2011; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	42	227	232	0	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					309	317		10.1038/nn.3311	http://dx.doi.org/10.1038/nn.3311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334581				2022-12-25	WOS:000315474800013
J	Li, HH; Penzo, MA; Taniguchi, H; Kopec, CD; Huang, ZJ; Li, B				Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Kopec, Charles D.; Huang, Z. Josh; Li, Bo			Experience-dependent modification of a central amygdala fear circuit	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; RECEPTOR TRAFFICKING; CONDITIONED FEAR; PROJECTIONS; NEURONS; RAT; EXPRESSION; COMPLEX; CONNECTIONS	The amygdala is essential for fear learning and expression. The central amygdala (CeA), once viewed as a passive relay between the amygdala complex and downstream fear effectors, has emerged as an active participant in fear conditioning. However, the mechanism by which CeA contributes to the learning and expression of fear is unclear. We found that fear conditioning in mice induced robust plasticity of excitatory synapses onto inhibitory neurons in the lateral subdivision of the CeA (CeL). This experience-dependent plasticity was cell specific, bidirectional and expressed presynaptically by inputs from the lateral amygdala. In particular, preventing synaptic potentiation onto somatostatin-positive neurons impaired fear memory formation. Furthermore, activation of these neurons was necessary for fear memory recall and was sufficient to drive fear responses. Our findings support a model in which fear conditioning-induced synaptic modifications in CeL favor the activation of somatostatin-positive neurons, which inhibit CeL output, thereby disinhibiting the medial subdivision of CeA and releasing fear expression.	[Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Huang, Z. Josh; Li, Bo] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kopec, Charles D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Cold Spring Harbor Laboratory; Princeton University	Li, B (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	bli@cshl.edu	Core, Vector/CAF-4832-2022; Penzo, Mario/AAP-8789-2021	Li, Bo/0000-0002-0154-3088; Huang, Z. Josh/0000-0003-0592-028X	US National Institutes of Health [5R01MH091903-03, 5U01MH078844-05]; Dana Foundation; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091903, U01MH078844] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R.H. Paik for expert technical assistance, K. Deisseroth and M. Mirrione for the initial help with optogenetic methods, M. Luo (National Institute of Biological Sciences, Beijing) and S.H. Shi (Memorial Sloan-Kettering Cancer Center) for the AAV-DIO-hM4Di-mCherry construct, W Wei for help with the focal optogenetic stimulation, A. Zador (Cold Spring Harbor Laboratory) for sharing the AAV-DIO-ChR2(H134R)-YFP and AAV-DIO-Arch-GFP viruses, A. Reid (Cold Spring Harbor Laboratory) for sharing the Ai32 mice, and K. Pradhan for advice on statistic analysis. We thank S. Shea, L. Van Aelst and R. Malinow for critical reading of the manuscript, and members of the Li laboratory for discussions. This study was supported by the US National Institutes of Health (5R01MH091903-03 to B.L. and 5U01MH078844-05 to Z.J.H.), the Dana Foundation (B.L.) and the National Alliance for Research on Schizophrenia and Depression (B.L. and Z.J.H.).	Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; CASSELL MD, 1989, J COMP NEUROL, V281, P320, DOI 10.1002/cne.902810212; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M., 2000, AMYGDALA, P213; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; OTTERSEN OP, 1979, J COMP NEUROL, V187, P401, DOI 10.1002/cne.901870209; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	296	298	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					332	339		10.1038/nn.3322	http://dx.doi.org/10.1038/nn.3322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354330	Green Accepted			2022-12-25	WOS:000315474800016
J	Shin, JB; Krey, JF; Hassan, A; Metlagel, Z; Tauscher, AN; Pagana, JM; Sherman, NE; Jeffery, ED; Spinelli, KJ; Zhao, HY; Wilmarth, PA; Choi, D; David, LL; Auer, M; Barr-Gillespie, PG				Shin, Jung-Bum; Krey, Jocelyn F.; Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Pagana, James M.; Sherman, Nicholas E.; Jeffery, Erin D.; Spinelli, Kateri J.; Zhao, Hongyu; Wilmarth, Phillip A.; Choi, Dongseok; David, Larry L.; Auer, Manfred; Barr-Gillespie, Peter G.			Molecular architecture of the chick vestibular hair bundle	NATURE NEUROSCIENCE			English	Article							SCAFFOLDING PROTEIN EBP50; CELL STEREOCILIA; INNER-EAR; SENSORY EPITHELIA; ACTIN; LOCALIZATION; PHOSPHORYLATION; ROOTLETS; TURNOVER; DYNAMICS	Hair bundles of the inner ear have a specialized structure and protein composition that underlies their sensitivity to mechanical stimulation. Using mass spectrometry, we identified and quantified >1,100 proteins, present from a few to 400,000 copies per stereocilium, from purified chick bundles; 336 of these were significantly enriched in bundles. Bundle proteins that we detected have been shown to regulate cytoskeleton structure and dynamics, energy metabolism, phospholipid synthesis and cell signaling. Three-dimensional imaging using electron tomography allowed us to count the number of actin-actin cross-linkers and actin-membrane connectors; these values compared well to those obtained from mass spectrometry. Network analysis revealed several hub proteins, including RDX (radixin) and SLC9A3R2 (NHERF2), which interact with many bundle proteins and may perform functions essential for bundle structure and function. The quantitative mass spectrometry of bundle proteins reported here establishes a framework for future characterization of dynamic processes that shape bundle structure and function.	[Shin, Jung-Bum; Pagana, James M.] Univ Virginia, Dept Neurosci, Charlottesville, VA USA; [Shin, Jung-Bum; Krey, Jocelyn F.; Pagana, James M.; Spinelli, Kateri J.; Zhao, Hongyu; Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Sherman, Nicholas E.; Jeffery, Erin D.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA; [Wilmarth, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Virginia; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Virginia; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Barr-Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Choi, Dongseok/0000-0002-1552-4072; Jeffery, Erin/0000-0001-9511-7719; Spinelli, Kateri/0000-0002-6290-0886; Barr-Gillespie, Peter/0000-0002-9787-5860; Sherman, Nicholas/0000-0003-3206-3113	US National Institutes of Health (NIH) National Center for Research Resources [RR017573]; National Center for Research Resources (NIH) [S10 RR023432, S10 RR025440]; NIH [K99/R00 DC009412, F32 DC012455, R01 DC002368, R01 DC011034, P30 DC005983, R01 EY007755, P30 EY10572, P01 GM051487]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, S10RR025440, S10RR023432] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572, R01EY007755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, P01GM051487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009412, P30DC005983, R01DC011034, K99DC009412, R21DC008801, R21DC006097, R01DC002368, F32DC012455] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Mass spectrometry was carried out by the W.M. Keck Biomedical Mass Spectrometry Laboratory and The University of Virginia Biomedical Research Facility. We thank K. McDonald, R. Zalpuri and G. Min of the University of California Berkeley Electron Microscopy Laboratory for assistance with high-pressure freezing and imaging; D. Jorgens provided mentoring in high-pressure freezing. We would like to thank A. Cheng, B. Carragher and C. Potter for help with electron microscopy data collection at the National Resource for Automated Molecular Microscopy, supported by US National Institutes of Health (NIH) National Center for Research Resources grant RR017573. For technical assistance, we acknowledge A. Snyder of the Advanced Light Microscopy Core at The Jungers Center (Oregon Health & Science University), supported by shared instrumentation grants S10 RR023432 and S10 RR025440 from the National Center for Research Resources (NIH). Work described here was supported by NIH grants K99/R00 DC009412 (J.B.S.), F32 DC012455 (J.F.K.), R01 DC002368 (P.G.B.-G.), R01 DC011034 (P.G.B.-G.), P30 DC005983 (P.G.B.-G.), R01 EY007755 (L.L.D.), P30 EY10572 (L L D) and P01 GM051487 (M.A.).	Auer M, 2008, JARO-J ASSOC RES OTO, V9, P215, DOI 10.1007/s10162-008-0114-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURNHAM JA, 1984, J NEUROCYTOL, V13, P617, DOI 10.1007/BF01148082; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Jones SM, 2000, JARO-J ASSOC RES OTO, V1, P232, DOI 10.1007/s101620010026; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kruger RP, 1999, J NEUROSCI, V19, P4815; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P1787, DOI 10.1177/37.12.2685109; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Steel KP, 2007, GENES AND COMMON DISEASES: GENETICS IN MODERN MEDICINE, P505; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012	50	122	124	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					365	374		10.1038/nn.3312	http://dx.doi.org/10.1038/nn.3312			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334578	Green Accepted			2022-12-25	WOS:000315474800020
J	Smear, M; Resulaj, A; Zhang, JJ; Bozza, T; Rinberg, D				Smear, Matthew; Resulaj, Admir; Zhang, Jingji; Bozza, Thomas; Rinberg, Dmitry			Multiple perceptible signals from a single olfactory glomerulus	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURON INPUT; ODOR DISCRIMINATION; BULB GLOMERULI; DROSOPHILA; MOUSE; MAP; ACCURACY; SPEED; REPRESENTATIONS; ORGANIZATION	Glomeruli are functional units in the olfactory system. The mouse olfactory bulb contains roughly 2,000 glomeruli, each receiving inputs from olfactory sensory neurons (OSNs) that express a specific odorant receptor gene. Odors typically activate many glomeruli in complex combinatorial patterns and it is unknown which features of neuronal activity in individual glomeruli contribute to odor perception. To address this, we used optogenetics to selectively activate single, genetically identified glomeruli in behaving mice. We found that mice could perceive the stimulation of a single glomerulus. Single-glomerulus stimulation was also detected on an intense odor background. In addition, different input intensities and the timing of input relative to sniffing were discriminated through one glomerulus. Our data suggest that each glomerulus can transmit odor information using identity, intensity and temporal coding cues. These multiple modes of information transmission may enable the olfactory system to efficiently identify and localize odor sources.	[Smear, Matthew; Resulaj, Admir; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA USA; [Resulaj, Admir; Rinberg, Dmitry] NYU, Langone Med Ctr, New York Univ Neurosci Inst, New York, NY USA; [Zhang, Jingji; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	Howard Hughes Medical Institute; New York University; NYU Langone Medical Center; Northwestern University	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	bozza@northwestern.edu; dmitry.rinberg@nyumc.org			National Institute on Deafness and Other Communication Disorders [R01DC009640, R21DC010911]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010911, R01DC009640] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Guo and the gene targeting facility at Janelia Farm for generation of chimeric mice, B. Weiland for technical help with cloning and gene targeting, M. Karlsson for designing the behavioral controller box, and K. Svoboda, G. Fishell, R. Egnor and Y. Sirotin for comments on the manuscript. This work was supported by the Visiting Scientist Program at the Janelia Farm Research Center. T.B. was supported by funding from the National Institute on Deafness and Other Communication Disorders (R01DC009640 and R21DC010911), the Whitehall Foundation and the Brain Research Foundation.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Zhang J., 2012, MOL CELL NEUROSCI	37	71	72	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1687	1691		10.1038/nn.3519	http://dx.doi.org/10.1038/nn.3519			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056698				2022-12-25	WOS:000326205700027
J	Picard, N; Matsuzaka, Y; Strick, PL				Picard, Nathalie; Matsuzaka, Yoshiya; Strick, Peter L.			Extended practice of a motor skill is associated with reduced metabolic activity in M1	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; LONG-TERM PRACTICE; CORTICAL REPRESENTATION; NEURONAL-ACTIVITY; FUNCTIONAL MRI; SOMATOSENSORY CORTEX; MOVEMENT PARAMETERS; SYNAPTIC ACTIVITY; PIANO PLAYERS; NON-MUSICIANS	How does long-term training and the development of motor skills modify the activity of the primary motor cortex (M1)? To address this issue, we trained monkeys for similar to 1-6 years to perform visually guided and internally generated sequences of reaching movements. Then, we used [C-14] 2-deoxyglucose (2DG) uptake and single-neuron recording to measure metabolic and neuron activity in M1. After extended practice, we observed a profound reduction of metabolic activity in M1 for the performance of internally generated compared to visually guided tasks. In contrast, measures of neuron firing displayed little difference during the two tasks. These findings suggest that the development of skill through extended practice results in a reduction in the synaptic activity required to produce internally generated, but not visually guided, sequences of movements. Thus, practice leading to skilled performance results in more efficient generation of neuronal activity in M1.	[Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Syst Neurosci Inst, Pittsburgh, PA USA; [Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Strick, Peter L.] Dept Vet Affairs Med Ctr, Res Serv, Pittsburgh, PA USA; [Strick, Peter L.] Univ Pittsburgh, Sch Med, Dept Psychiat & Neurol Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	strickp@pitt.edu			Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health [R01 NS24328, P30 NS076405, P01 NS044393]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076405, R01NS024328, P01NS044393] Funding Source: NIH RePORTER	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This material is based on work supported in part by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health grants R01 NS24328 (P.L.S.), P30 NS076405 (P.L.S.) and P01 NS044393 (P.L.S.). The contents do not represent the views of the Department of Veterans Affairs or the US Government. We are grateful to M. Page for the development of computer programs, and to M. O'Malley and K. McDonald for their expert technical assistance.	ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Ben-Shaul Y, 2004, J NEUROPHYSIOL, V91, P1748, DOI 10.1152/jn.00957.2003; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Devor A, 2008, J NEUROSCI, V28, P14347, DOI 10.1523/JNEUROSCI.4307-08.2008; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Gaser C, 2003, J NEUROSCI, V23, P9240; Gregoriou GG, 2005, NEUROIMAGE, V27, P442, DOI 10.1016/j.neuroimage.2005.02.038; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; JULIANO SL, 1987, J COMP NEUROL, V263, P514, DOI 10.1002/cne.902630405; KARNI A, 1995, NATURE, V377, P155; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kilavik BE, 2009, J NEUROSCI, V29, P12653, DOI 10.1523/JNEUROSCI.1554-09.2009; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Landau SM, 2006, COGN AFFECT BEHAV NE, V6, P246, DOI 10.3758/CABN.6.3.246; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MATSUNAMI K, 1995, NEUROSCI RES, V23, P365, DOI 10.1016/0168-0102(95)00964-U; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSHIAKE H, 1993, J NEUROPHYSIOL, V70, P2660, DOI 10.1152/jn.1993.70.6.2660; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; NUDO RJ, 1986, J COMP NEUROL, V245, P553, DOI 10.1002/cne.902450410; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Proctor R. W., 1995, SKILL ACQUISITION HU; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Savaki HE, 1999, PROG NEUROBIOL, V58, P473, DOI 10.1016/S0301-0082(98)00080-X; Schwenkreis P, 2007, EUR J NEUROSCI, V26, P3291, DOI 10.1111/j.1460-9568.2007.05894.x; Shulman RG, 1999, P NATL ACAD SCI USA, V96, P3245, DOI 10.1073/pnas.96.6.3245; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1993, DEV NEUROSCI-BASEL, V15, P194, DOI 10.1159/000111335; Stark E, 2007, EUR J NEUROSCI, V26, P1055, DOI 10.1111/j.1460-9568.2007.05711.x; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Turner RS, 2003, J NEUROPHYSIOL, V90, P3958, DOI 10.1152/jn.00323.2003; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016	59	73	73	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1340	U237		10.1038/nn.3477	http://dx.doi.org/10.1038/nn.3477			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912947	Green Accepted			2022-12-25	WOS:000323597500027
J	Felix-Ortiz, AC; Beyeler, A; Seo, C; Leppla, CA; Wildes, CP; Tye, KM				Felix-Ortiz, Ada C.; Beyeler, Anna; Seo, Changwoo; Leppla, Christopher A.; Wildes, Craig P.; Tye, Kay M.			BLA to vHPC Inputs Modulate Anxiety-Related Behaviors	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; VENTRAL HIPPOCAMPUS; CONDITIONED FEAR; PLUS-MAZE; AMYGDALA; PROJECTIONS; CIRCUITS; DEPENDS; LESIONS	The basolateral amygdala (BLA) and ventral hippocampus (vHPC) have both been implicated in mediating anxiety-related behaviors, but the functional contribution of BLA inputs to the vHPC has never been directly investigated. Here we show that activation of BLA-vHPC synapses acutely and robustly increased anxiety-related behaviors, while inhibition of BLA-vHPC synapses decreased anxiety-related behaviors. We combined optogenetic approaches with in vivo pharmacological manipulations and ex vivo whole-cell patch-clamp recordings to dissect the local circuit mechanisms, demonstrating that activation of BLA terminals in the vHPC provided monosynaptic, glutamatergic inputs to vHPC pyramidal neurons. Furthermore, BLA inputs exerted polysynaptic, inhibitory effects mediated by local interneurons in the vHPC that may serve to balance the circuit locally. These data establish a role for BLA-vHPC synapses in bidirectionally controlling anxiety-related behaviors in an immediate, yet reversible, manner and a model for the local circuit mechanism of BLA inputs in the vHPC.	[Felix-Ortiz, Ada C.; Beyeler, Anna; Seo, Changwoo; Leppla, Christopher A.; Wildes, Craig P.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	kaytye@mit.edu	Core, Vector/CAF-4832-2022; Beyeler, Anna/V-9934-2019; Tye, Kay/J-6158-2013	Tye, Kay/0000-0002-2435-0182; /0000-0003-2371-5706	JPB Foundation; Picower Institute Innovation Funds; Whitehall Foundation; Klingenstein Foundation; Picower Institute for Learning and Memory; Department of Brain and Cognitive Sciences at MIT; Swiss National Science Foundation (SNSF) [PBSKP3_143586]; MIT; HHMI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441] Funding Source: NIH RePORTER	JPB Foundation; Picower Institute Innovation Funds; Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Picower Institute for Learning and Memory; Department of Brain and Cognitive Sciences at MIT; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); MIT; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Namburi for sharing the cell-counting software, K. Kohara for the biocytin-streptavidin protocol, and all members of the Tye Laboratory for their helpful discussion. We would like to thank M. Dobbins, L.-H. Tsai, K. Jones, W. Xu, Q. Zhang, and G. Feng for providing access to their confocal microscopes. We acknowledge Dr. R.J. Samulski and the UNC Vector Core for gene transfer vectors preparation. This work was supported by funds from the JPB Foundation, Picower Institute Innovation Funds, The Whitehall Foundation, The Klingenstein Foundation, and startup funds provided by the Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences at MIT (K.M.T). A.B. was supported by a postdoctoral fellowship for prospective researchers from the Swiss National Science Foundation (SNSF; Project number: PBSKP3_143586). C.A.L. was supported by the MIT Summer Research Program and by HHMI undergraduate education grant.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P739; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Buchel C, 1999, J NEUROSCI, V19, P10869; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P123, DOI 10.1016/0091-3057(95)02108-6; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Somerville LH, 2004, BIOL PSYCHIAT, V55, P897, DOI 10.1016/j.biopsych.2004.01.007; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Tye KM, 2010, J NEUROSCI, V30, P116, DOI 10.1523/JNEUROSCI.4240-09.2010; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018739	25	305	311	3	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 21	2013	79	4					658	664		10.1016/j.neuron.2013.06.016	http://dx.doi.org/10.1016/j.neuron.2013.06.016			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972595	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000323587000007
J	Rudebeck, PH; Saunders, RC; Prescott, AT; Chau, LS; Murray, EA				Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.			Prefrontal mechanisms of behavioral flexibility, emotion regulation and value updating	NATURE NEUROSCIENCE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; DECISION-MAKING; RHESUS-MONKEYS; BASOLATERAL AMYGDALA; FRONTAL-CORTEX; FIBER PATHWAYS; REWARD VALUE; REVERSAL; LESIONS; NEURONS	Two ideas have dominated neuropsychology concerning the orbitofrontal cortex (OFC). One holds that OFC regulates emotion and enhances behavioral flexibility through inhibitory control. The other ascribes to OFC a role in updating valuations on the basis of current motivational states. Neuroimaging, neurophysiological and clinical observations are consistent with either or both hypotheses. Although these hypotheses are compatible in principle, we present results supporting the latter view of OFC function and arguing against the former. We found that excitotoxic, fiber-sparing lesions confined to OFC in monkeys did not alter either behavioral flexibility, as measured by object reversal learning, or emotion regulation, as assessed by fear of snakes. A follow-up experiment indicated that a previously reported loss of inhibitory control resulted from damage to nearby fiber tracts and not from OFC dysfunction. Thus, OFC has a more specialized role in reward-guided behavior and emotion than has been thought, a function that includes value updating.	[Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.] NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rudebeck, PH (corresponding author), NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	rudebeckp@mail.nih.gov	Murray, Elisabeth A./X-2051-2019	Rudebeck, Peter/0000-0002-1411-7555; Murray, Elisabeth/0000-0003-1450-1642	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002887] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Lundgren and E. Howland for assistance with data collection and R. Reoli for help performing surgery. We also thank S. Wise and M. Walton for comments on an earlier version of the manuscript. This work was supported by the Intramural Research Program of the US National Institute of Mental Health.	Baxter MG, 2009, EUR J NEUROSCI, V29, P2049, DOI 10.1111/j.1460-9568.2009.06740.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blair RJR, 2010, BRIT J PSYCHOL, V101, P383, DOI 10.1348/000712609X418480; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Chudasama Y., 2012, CEREB, DOI DOI 10.1093/CERC0R/BHS266; Chudasama Y, 2009, EUR J NEUROSCI, V30, P2327, DOI 10.1111/j.1460-9568.2009.07012.x; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; KITT CA, 1987, BRAIN RES, V406, P192, DOI 10.1016/0006-8993(87)90783-9; Mineka S., 1987, THEORETICAL FDN BEHA; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROLLS ET, 1999, BRAIN EMOTION; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016	49	251	255	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1140	U225		10.1038/nn.3440	http://dx.doi.org/10.1038/nn.3440			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792944	Green Accepted			2022-12-25	WOS:000322323000026
J	Gu, Y; Huang, SY; Chang, MC; Worley, P; Kirkwood, A; Quinlan, EM				Gu, Yu; Huang, Shiyong; Chang, Michael C.; Worley, Paul; Kirkwood, Alfredo; Quinlan, Elizabeth M.			Obligatory Role for the Immediate Early Gene NARP in Critical Period Plasticity	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; PRIMARY VISUAL-CORTEX; LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; MONOCULAR DEPRIVATION; INTRACORTICAL INHIBITION; GABAERGIC TRANSMISSION; SYNAPTIC PLASTICITY; CORTICAL INHIBITION; ADULT MICE	The immediate early gene neuronal activity-regulated pentraxin (NARP)is an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) binding protein that is specifically enriched at excitatory synapses onto fast-spiking parvalbumin-positive interneurons (FS [PV] INs). Here, we show that transgenic deletion of NARP decreases the number of excitatory synaptic inputs onto FS (PV) INs and reduces net excitatory synaptic drive onto FS (PV) Accordingly, the visual cortex of NARP(-/-) mice is hyperexcitable and unable to express ocular dominance plasticity, although many aspects of visual function are unimpaired. Importantly, the number and strength of inhibitory synaptic contacts from FS (PV) INs onto principle neurons in the visual cortex is normal in NARP(-/-) mice, and enhancement of this output recovers the expression of experience-dependent synaptic plasticity. Thus the recruitment of inhibition from FS (PV) INs plays a central role in enabling the critical period for ocular dominance plasticity.	[Gu, Yu; Quinlan, Elizabeth M.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Huang, Shiyong; Quinlan, Elizabeth M.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Kirkwood, Alfredo] Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; [Chang, Michael C.; Worley, Paul; Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University	Kirkwood, A (corresponding author), Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA.	kirkwood@jhu.edu; equinlan@umd.edu	Huang, Shiyong/D-5211-2009	Huang, Shiyong/0000-0003-2976-5798; Gu, Yu/0000-0001-7882-5422	NIH [R01EY016431, R01EY012124]; NATIONAL EYE INSTITUTE [R01EY012124, R01EY016431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01EY016431 (to E.M.Q.) and R01EY012124 (to A.K.).	ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Beste C, 2011, CURR BIOL, V21, P876, DOI 10.1016/j.cub.2011.03.065; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Choi SY, 2002, J NEUROSCI, V22, P5271; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang SY, 2010, J NEUROSCI, V30, P16636, DOI 10.1523/JNEUROSCI.4384-10.2010; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jang HJ, 2009, J NEUROPHYSIOL, V101, P269, DOI 10.1152/jn.90900.2008; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Kuhlman SJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000797; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Morales B, 2002, J NEUROSCI, V22, P8084; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Ranson A, 2012, P NATL ACAD SCI USA, V109, P1311, DOI 10.1073/pnas.1112204109; Ross RM, 2008, BRAIN RES BULL, V76, P97, DOI 10.1016/j.brainresbull.2008.01.021; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Scheuss V, 2001, BIOPHYS J, V81, P1970, DOI 10.1016/S0006-3495(01)75848-1; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Toyoizumi T, 2009, J NEUROSCI, V29, P6514, DOI 10.1523/JNEUROSCI.0492-08.2009; Tsui CC, 1996, J NEUROSCI, V16, P2463; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	61	85	86	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 24	2013	79	2					335	346		10.1016/j.neuron.2013.05.016	http://dx.doi.org/10.1016/j.neuron.2013.05.016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889936	Green Accepted, Bronze			2022-12-25	WOS:000322426200012
J	Apostolou, E; Ferrari, F; Walsh, RM; Bar-Nur, O; Stadtfeld, M; Cheloufi, S; Stuart, HT; Polo, JM; Ohsumi, TK; Borowsky, ML; Kharchenko, PV; Park, PJ; Hochedlinger, K				Apostolou, Effie; Ferrari, Francesco; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Ohsumi, Toshiro K.; Borowsky, Mark L.; Kharchenko, Peter V.; Park, Peter J.; Hochedlinger, Konrad			Genome-wide Chromatin Interactions of the Nanog Locus in Pluripotency, Differentiation, and Reprogramming	CELL STEM CELL			English	Article							CHROMOSOMAL REARRANGEMENTS; TRANSCRIPTIONAL NETWORK; GENE; ORGANIZATION; EXPRESSION; MEDIATOR; COMPLEX; MED12; ESTABLISHMENT; MAINTENANCE	The chromatin state of pluripotency genes has been studied extensively in embryonic stem cells (ESCs) and differentiated cells, but their potential interactions with other parts of the genome remain largely unexplored. Here, we identified a genome-wide, pluripotency-specific interaction network around the Nanog promoter by adapting circular chromosome conformation capture sequencing. This network was rearranged during differentiation and restored in induced pluripotent stem cells. A large fraction of Nanog-interacting loci were bound by Mediator or cohesin in pluripotent cells. Depletion of these proteins from ESCs resulted in a disruption of contacts and the acquisition of a differentiation-specific interaction pattern prior to obvious transcriptional and phenotypic changes. Similarly, the establishment of Nanog interactions during reprogramming often preceded transcriptional upregulation of associated genes, suggesting a causative link. Our results document a complex, pluripotency-specific chromatin "interactome'' for Nanog and suggest a functional role for long-range genomic interactions in the maintenance and induction of pluripotency.	[Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Apostolou, Effie; Walsh, Ryan M.; Bar-Nur, Ori; Stadtfeld, Matthias; Cheloufi, Sihem; Stuart, Hannah T.; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ferrari, Francesco; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kharchenko, Peter V.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.	peter_park@harvard.edu; khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020; Ferrari, Francesco/H-5007-2012; Bar-Nur, Ori/GWQ-5917-2022	Ferrari, Francesco/0000-0002-9811-3753; Polo, Jose M/0000-0002-2531-778X; Stuart, Hannah/0000-0001-9563-9760; Stadtfeld, Matthias/0000-0002-5852-9906; Park, Peter/0000-0001-9378-960X; Cheloufi, Sihem/0000-0002-1726-4796	JCCF; HHMI; NIH [RC2HL102815, K25AG037596, DP2OD003266, R01HD058013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	JCCF; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge Peter Fraser, Frank Grosveld, Jane Skok, and Job Dekker for comments and suggestions. We thank Mariann Miscinai and Triantiafyllos Paparountas for discussing bioinformatics analysis, Eda Yildirim and Berni Peyer for advice about FISH experiments, and all members of the Hochedlinger and Park groups for suggestions. E.A. was supported by post-doctoral fellowships from JCCF and HHMI. P.J.P. was supported by a Sloan Research Fellowship and NIH (RC2HL102815), P.V.K was supported by NIH (K25AG037596), and K.H. was supported by NIH (DP2OD003266 and R01HD058013).	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rocha PP, 2012, MOL CELL, V47, P873, DOI 10.1016/j.molcel.2012.06.036; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; SCHARDIN M, 1985, HUM GENET, V71, P281, DOI 10.1007/BF00388452; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M., 2012, NAT GENET, V44, pS1, DOI DOI 10.1038/NG.1110; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	62	153	157	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					699	712		10.1016/j.stem.2013.04.013	http://dx.doi.org/10.1016/j.stem.2013.04.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23665121	Bronze, Green Accepted			2022-12-25	WOS:000329569900013
J	Bui, TV; Akay, T; Loubani, O; Hnasko, TS; Jessell, TM; Brownstone, RM				Bui, Tuan V.; Akay, Turgay; Loubani, Osama; Hnasko, Thomas S.; Jessell, Thomas M.; Brownstone, Robert M.			Circuits for Grasping: Spinal dI3 Interneurons Mediate Cutaneous Control of Motor Behavior	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; DORSAL-ROOT GANGLIA; STUMBLING CORRECTIVE REACTION; PRIMARY AFFERENT SYNAPSES; PRECISION GRIP; MERKEL CELLS; HUMAN HAND; REFLEX PATHWAYS; SENSORY NEURONS; IN-VIVO	Accurate motor performance depends on the integration in spinal microcircuits of sensory feedback information. Hand grasp is a skilled motor behavior known to require cutaneous sensory feedback, but spinal microcircuits that process and relay this feedback to the motor system have not been defined. We sought to define classes of spinal interneurons involved in the cutaneous control of hand grasp in mice and to show that dI3 interneurons, a class of dorsal spinal interneurons marked by the expression of Isl1, convey input from low threshold cutaneous afferents to motoneurons. Mice in which the output of dI3 interneurons has been inactivated exhibit deficits in motor tasks that rely on cutaneous afferent input. Most strikingly, the ability to maintain grip strength in response to increasing load is lost following genetic silencing of dI3 interneuron output. Thus, spinal microcircuits that integrate cutaneous feedback crucial for paw grip rely on the intermediary role of dI3 interneurons.	[Brownstone, Robert M.] Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS B3H 4R2, Canada; [Bui, Tuan V.; Loubani, Osama; Brownstone, Robert M.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada; [Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Akay, Turgay] Columbia Univ, Dept Neurol Surg, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Hnasko, Thomas S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Dalhousie University; Dalhousie University; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; University of California System; University of California San Diego	Brownstone, RM (corresponding author), Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS B3H 4R2, Canada.	rob.brownstone@dal.ca		Akay, Turgay/0000-0002-0466-2285; Brownstone, Robert/0000-0001-5135-2725; Bui, Tuan/0000-0003-0024-1544; Hnasko, Thomas/0000-0001-6176-8513	Nova Scotia Health Research Foundation; Canadian Institutes of Health Research (CIHR); National Institutes of Health [R01-NS033245]; Harold and Leila Mathers Foundation; Project A.L.S.; CIHR [FRN 79413]; Canada Research Chairs program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R37NS033245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Mathers Foundation; Project A.L.S.; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Angelita Alcoa, Bithika Ray, Apiraami Thana, and Nadia Farbstein for excellent technical assistance; Joshua Sanes and Silvia Arber for the generous contribution of mouse strains; Natalie Parks and Dan Marsh for assistance with chronic spinalization; Jason Meissner and Allison Reid for aid with the von Frey test; Anatoliy Voskresenskiy and Leigh Sadler for work with the horizontal ladder experiments; Jonathan Carp and Jonathan Wolpaw for their suggestions in designing the nerve cuff electrodes; Patrick Whelan and Meggie Reardon for help with the isolated spinal cord preparation with sural nerve in continuity; Frederic Bretzner, Pratip Mitra, Philippe Magown, Izabela Panek, and Sabrina Tazerart for discussions; and Kevin Bourke for photography. We also thank patient D.F., whose disabling grasp reflex led to a portion of the work described. T.V.B. was supported by a Nova Scotia Health Research Foundation fellowship and a Canadian Institutes of Health Research (CIHR) Fellowship. T.M.J. is an investigator of the Howard Hughes Medical Institute and was supported by the National Institutes of Health (R01-NS033245), Project A.L.S., and the Harold and Leila Mathers Foundation. This research was funded by a grant to R.M.B. from the CIHR (FRN 79413) and was undertaken thanks, in part, to funding to R.M.B. from the Canada Research Chairs program.	Abdala V, 2009, ANAT REC, V292, P842, DOI 10.1002/ar.20909; Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Alstermark B, 2011, J NEUROPHYSIOL, V106, P122, DOI 10.1152/jn.00089.2011; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Baker SN, 2011, J PHYSIOL-LONDON, V589, P5603, DOI 10.1113/jphysiol.2011.215160; BROWN AG, 1981, J PHYSIOL-LONDON, V316, P469, DOI 10.1113/jphysiol.1981.sp013801; Brownstone RM, 2010, PROG BRAIN RES, V187, P81, DOI [10.1016/S0079-6123(10)87006-2, 10.1016/B978-0-444-53613-6.00006-X]; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; DUYSENS J, 1976, EXP BRAIN RES, V24, P245; EGGER MD, 1971, J PHYSIOL-LONDON, V216, P483, DOI 10.1113/jphysiol.1971.sp009536; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Erlanger J, 1930, AM J PHYSIOL, V92, P43, DOI 10.1152/ajplegacy.1930.92.1.43; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Fetz EE, 2002, BRAIN RES REV, V40, P53, DOI 10.1016/S0165-0173(02)00188-1; FORSSBERG H, 1979, J NEUROPHYSIOL, V42, P936, DOI 10.1152/jn.1979.42.4.936; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Fuglevand AJ, 2011, J PHYSIOL-LONDON, V589, P5595, DOI 10.1113/jphysiol.2011.215236; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halverson HM, 1937, PEDAGOG SEMIN J GEN, V51, P371; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; HONGO T, 1989, BRAIN RES, V505, P163, DOI 10.1016/0006-8993(89)90131-5; HONGO T, 1989, BRAIN RES, V505, P167, DOI 10.1016/0006-8993(89)90132-7; Hooker D., 1938, P AM PHILOS SOC, V79, P587; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Jennings E, 1998, J PHYSIOL-LONDON, V509, P859, DOI 10.1111/j.1469-7793.1998.859bm.x; Johansson R.S., 1984, EXP BRAIN RES, V56, P550; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Li WC, 2004, J NEUROPHYSIOL, V92, P895, DOI 10.1152/jn.00024.2004; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; Mears SC, 1997, J NEUROSCI, V17, P3128; Mentis GZ, 2006, J NEUROSCI, V26, P13297, DOI 10.1523/JNEUROSCI.2945-06.2006; Mestre T, 2010, MOVEMENT DISORD, V25, P2479, DOI 10.1002/mds.23059; Monzee J, 2003, J NEUROPHYSIOL, V89, P672, DOI 10.1152/jn.00434.2001; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; PAULSON G, 1968, BRAIN, V91, P37, DOI 10.1093/brain/91.1.37; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PEYRONNARD JM, 1982, MUSCLE NERVE, V5, P654, DOI 10.1002/mus.880050811; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; POLLACK SL, 1960, ARCH NEUROL-CHICAGO, V3, P574, DOI 10.1001/archneur.1960.00450050094011; Quevedo J, 2005, J NEUROPHYSIOL, V94, P2045, DOI 10.1152/jn.00175.2005; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; RUSHWORTH G, 1959, J NEUROL NEUROSUR PS, V22, P91, DOI 10.1136/jnnp.22.2.91; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Schieber MH, 2011, J PHYSIOL-LONDON, V589, P5613, DOI 10.1113/jphysiol.2011.215814; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Walshe FMR, 1936, BRAIN, V59, P315, DOI 10.1093/brain/59.3.315; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	75	90	90	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2013	78	1					191	204		10.1016/j.neuron.2013.02.007	http://dx.doi.org/10.1016/j.neuron.2013.02.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583114	Green Accepted, Bronze			2022-12-25	WOS:000317556000017
J	Sirko, S; Behrendt, G; Johansson, PA; Tripathi, P; Costa, MR; Bek, S; Heinrich, C; Tiedt, S; Colak, D; Dichgans, M; Fischer, IR; Plesnila, N; Staufenbiel, M; Haass, C; Snapyan, M; Saghatelyan, A; Tsai, LH; Fischer, A; Grobe, K; Dimou, L; Gotz, M				Sirko, Swetlana; Behrendt, Gwendolyn; Johansson, Pia Annette; Tripathi, Pratibha; Costa, Marcos Romualdo; Bek, Sarah; Heinrich, Christophe; Tiedt, Steffen; Colak, Dilek; Dichgans, Martin; Fischer, Isabel Rebekka; Plesnila, Nikolaus; Staufenbiel, Matthias; Haass, Christian; Snapyan, Marina; Saghatelyan, Armen; Tsai, Li-Huei; Fischer, Andre; Grobe, Kay; Dimou, Leda; Goetz, Magdalena			Reactive Glia in the Injured Brain Acquire Stem Cell Properties in Response to Sonic Hedgehog	CELL STEM CELL			English	Article							NEURAL STEM/PROGENITOR CELLS; IN-VITRO; ASTROCYTE PROLIFERATION; SUBVENTRICULAR ZONE; SELF-RENEWAL; RADIAL GLIA; SPINAL-CORD; ADULT; DIFFERENTIATION; REGENERATION	As a result of brain injury, astrocytes become activated and start to proliferate in the vicinity of the injury site. Recently, we had demonstrated that these reactive astrocytes, or glia, can form self-renewing and multipotent neurospheres in vitro. In the present study, we demonstrate that it is only invasive injury, such as stab wounding or cerebral ischemia, and not noninvasive injury conditions, such as chronic amyloidosis or induced neuronal death, that can elicit this increase in plasticity. Furthermore, we find that Sonic hedgehog (SHH) is the signal that acts directly on the astrocytes and is necessary and sufficient to elicit the stem cell response both in vitro and in vivo. These findings provide a molecular basis for how cells with neural stem cell lineage emerge at sites of brain injury and imply that the high levels of SHH known to enter the brain from extraneural sources after invasive injury can trigger this response.	[Sirko, Swetlana; Behrendt, Gwendolyn; Bek, Sarah; Heinrich, Christophe; Tiedt, Steffen; Dimou, Leda; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80336 Munich, Germany; [Haass, Christian] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Sirko, Swetlana; Johansson, Pia Annette; Tripathi, Pratibha; Costa, Marcos Romualdo; Bek, Sarah; Colak, Dilek; Dimou, Leda; Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Colak, Dilek] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Dichgans, Martin; Fischer, Isabel Rebekka; Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Dichgans, Martin; Plesnila, Nikolaus; Haass, Christian; Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Staufenbiel, Matthias] Novartis Pharma AG, Dept Neurosci, Inst Biomed Res, CH-4057 Basel, Switzerland; [Snapyan, Marina; Saghatelyan, Armen] Univ Laval, Cellular Neurobiol Unit, Inst Univ Sante Mentale Quebec, Quebec City, PQ G1J 2G3, Canada; [Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA; [Fischer, Andre] Univ Med Ctr, Dept Psychiat & Psychotherapy, D-37077 Gottingen, Germany; [Fischer, Andre] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Cornell University; University of Munich; University of Munich; Novartis; Universita della Svizzera Italiana; Laval University; Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster	Gotz, M (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Dichgans, Martin/HCH-3247-2022; Grobe, Kay/F-2399-2011; Fischer, Andre/AAU-7487-2021; Plesnila, Nikolaus/T-7522-2019; Costa, Marcos R/F-8071-2012; Dimou, Leda/E-7968-2012; Fischer, Isabel/GRX-2167-2022; HEINRICH, Christophe/K-1300-2017; Sirko, Swetlana/O-5725-2019	Dichgans, Martin/0000-0002-0654-387X; Costa, Marcos R/0000-0002-4928-2163; HEINRICH, Christophe/0000-0003-1266-718X; Sirko, Swetlana/0000-0001-5950-616X; Fischer, Andre/0000-0001-8546-1161; Johansson, Pia/0000-0002-6938-4060; Saghatelyan, Armen/0000-0003-4962-0465	Graduate School of Systemic Neurosciences; DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration [SFB 596, SFB 870]; Hans and Ilse Breuer Foundation; German Federal Ministry for Education and Research (BMBF); DFG [GO640/6-1, GO640/7-1, GO640/8-1]; Friedrich Baur Foundation; Alexander von Humboldt Foundation; EU; NIH [NS051874]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	Graduate School of Systemic Neurosciences; DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration; Hans and Ilse Breuer Foundation; German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Friedrich Baur Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are particularly grateful to Andreas Faissner for providing the 473HD antibody and would like to thank Gabi Jager, Angelika Waiser, Ines Muhlhahn, Andrea Steiner, Tatjana Simon-Ebert, and Uta Mamrak for excellent technical assistance, and Timucin Ozturk and Detlef Franzen for help with the colony of Smoothened floxed mice. It is a pleasure to thank Benedikt Berninger, Marisa Karow, Jovica Ninkovic, Stefanie Robel, and Paul Hardy for excellent comments on the manuscript and the Graduate School of Systemic Neurosciences for support. Funding to M. G. was provided by SFB 596 (DFG Collaborative Research Center on Molecular Mechanisms of Neurodegeneration), SFB 870, the award of the Breuer Prize 2008 by the Hans and Ilse Breuer Foundation, the German Federal Ministry for Education and Research (BMBF), and DFG grants GO640/6-1, 7-1, and 8-1. S. S. was supported by a grant from the Friedrich Baur Foundation, M. C. by a Research Fellowship from the Alexander von Humboldt Foundation, and N.P. by an EU MicroFlow grant. L.-H. T. is an Investigator of the Howard Hughes Medical Institute and acknowledges support from NIH (RO1 Grant NS051874).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; El-Zaatari M, 2012, PANCREAS, V41, P1019, DOI 10.1097/MPA.0b013e31824a0eeb; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Long FX, 2001, DEVELOPMENT, V128, P5099; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Sehgal R, 2009, DEV BIOL, V332, P429, DOI 10.1016/j.ydbio.2009.05.579; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010	54	258	271	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					426	439		10.1016/j.stem.2013.01.019	http://dx.doi.org/10.1016/j.stem.2013.01.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561443	Bronze, Green Published			2022-12-25	WOS:000329569500010
J	Lagadinou, ED; Sach, A; Callahan, K; Rossi, RM; Neering, SJ; Minhajuddin, M; Ashton, JM; Pei, SS; Grose, V; O'Dwyer, KM; Liesveld, JL; Brookes, PS; Becker, MW; Jordan, CT				Lagadinou, Eleni D.; Sach, Alexander; Callahan, Kevin; Rossi, Randall M.; Neering, Sarah J.; Minhajuddin, Mohammad; Ashton, John M.; Pei, Shanshan; Grose, Valerie; O'Dwyer, Kristen M.; Liesveld, Jane L.; Brookes, Paul S.; Becker, Michael W.; Jordan, Craig T.			BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; CANCER-CELLS; APOPTOSIS; STATE; AML; MECHANISMS; EXPRESSION; RESISTANCE; NICHE	Most forms of chemotherapy employ mechanisms involving induction of oxidative stress, a strategy that can be effective due to the elevated oxidative state commonly observed in cancer cells. However, recent studies have shown that relative redox levels in primary tumors can be heterogeneous, suggesting that regimens dependent on differential oxidative state may not be uniformly effective. To investigate this issue in hematological malignancies, we evaluated mechanisms controlling oxidative state in primary specimens derived from acute myelogenous leukemia (AML) patients. Our studies demonstrate three striking findings. First, the majority of functionally defined leukemia stem cells (LSCs) are characterized by relatively low levels of reactive oxygen species (termed "ROS-low"). Second, ROS-low LSCs aberrantly overexpress BCL-2. Third, BCL-2 inhibition reduced oxidative phosphorylation and selectively eradicated quiescent LSCs. Based on these findings, we propose a model wherein the unique physiology of ROS-low LSCs provides an opportunity for selective targeting via disruption of BCL-2-dependent oxidative phosphorylation.	[Lagadinou, Eleni D.; Sach, Alexander; Callahan, Kevin; Rossi, Randall M.; Neering, Sarah J.; Minhajuddin, Mohammad; Ashton, John M.; Pei, Shanshan; Grose, Valerie; O'Dwyer, Kristen M.; Liesveld, Jane L.; Becker, Michael W.; Jordan, Craig T.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [O'Dwyer, Kristen M.; Liesveld, Jane L.; Becker, Michael W.; Jordan, Craig T.] Univ Rochester, Med Ctr, Div Hematol Oncol, Rochester, NY 14642 USA; [Pei, Shanshan; Jordan, Craig T.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Brookes, Paul S.] Univ Rochester, Med Ctr, Anesthesiol Dept, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Jordan, CT (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	Minhajuddin, Mohammad/AAC-9227-2022; PEI, SHANSHAN/D-8200-2016; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; Brookes, Paul/0000-0002-8639-8413; Ashton, John/0000-0001-9875-5994; jordan, craig/0000-0003-0869-3465; Becker, Michael/0000-0001-9890-8815	Leukemia and Lymphoma Society [6230-11, 6133-12]; NYSTEM [CO24964]; US National Institutes of Health [HL-071158]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NYSTEM; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge critical review and comments by Drs. Fay Young, H. Leighton Grimes, Martin Carroll, and Helene McMurray, and technical assistance by the Functional Genomics Center of the University of Rochester. Craig Jordan is supported by an endowed chair generously provided by Philip and Marilyn Wehrheim. Research studies described in this manuscript were supported by grants from the Leukemia and Lymphoma Society (6230-11 and 6133-12, C.T.J.), NYSTEM (CO24964, C.T.J.), and the US National Institutes of Health (HL-071158, P.S.B.).	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen ZX, 2007, CELL DEATH DIFFER, V14, P1617, DOI 10.1038/sj.cdd.4402165; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; DELIA D, 1992, BLOOD, V79, P1291, DOI 10.1182/blood.V79.5.1291.bloodjournal7951291; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Nakajima EC, 2012, MOL CARCINOG; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013	25	765	785	5	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					329	341		10.1016/j.stem.2012.12.013	http://dx.doi.org/10.1016/j.stem.2012.12.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333149	Bronze, Green Accepted			2022-12-25	WOS:000329569400011
J	Viader, A; Sasaki, Y; Kim, S; Strickland, A; Workman, CS; Yang, K; Gross, RW; Milbrandt, J				Viader, Andreu; Sasaki, Yo; Kim, Sungsu; Strickland, Amy; Workman, Cayce S.; Yang, Kui; Gross, Richard W.; Milbrandt, Jeffrey			Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy	NEURON			English	Article							MULTIDIMENSIONAL MASS-SPECTROMETRY; LONG-CHAIN ACYLCARNITINE; TRANSCRIPTION FACTOR; STRESS; MYELIN; IDENTIFICATION; ACID; MICE; MOLECULES	Mitochondrial dysfunction is a common cause of peripheral neuropathy. Much effort has been devoted to examining the role played by neuronal/axonal mitochondria, but how mitochondrial deficits in peripheral nerve glia (Schwann cells [SCs]) contribute to peripheral nerve diseases remains unclear. Here, we investigate a mouse model of peripheral neuropathy secondary to SC mitochondria! dysfunction (Tfam-SCKOs). We show that disruption of SC mitochondria activates a maladaptive integrated stress response (ISR) through the actions of heme-regulated inhibitor (H RI) kinase, and causes a shift in lipid metabolism away from fatty acid synthesis toward oxidation. These alterations in SC lipid metabolism result in depletion of important myelin lipid components as well as in accumulation of acylcarnitines (ACs), an intermediate of fatty acid beta-oxidation. Importantly, we show that ACs are released from SCs and induce axonal degeneration. A maladaptive ISR as well as altered SC lipid metabolism are thus underlying pathological mechanisms in mitochondria-related peripheral neuropathies.	[Viader, Andreu; Sasaki, Yo; Kim, Sungsu; Strickland, Amy; Workman, Cayce S.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	NCI Cancer Center [P30 CA91842]; ICTS/CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH) [UL1RR024992]; NIH Roadmap for Medical Research; NIH Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders, National Institutes of Health [AG13730]; Muscular Dystrophy Association [237041]; Amyotrophic Lateral Sclerosis Foundation [57696]; PPG [2P01 HL057278]; LipoSpectrum; Platomics Inc.; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, RF1AG013730] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroscience Blueprint Center; HOPE Center for Neurological Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis Foundation; PPG; LipoSpectrum; Platomics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Michael A. Kiebish, Nina Pachenko, Kelli Simburger, and members of the Milbrandt laboratory for experimental assistance, comments on the manuscript, and helpful discussions; Dennis Dietzen and the St. Louis Children's Hospital Metabolic Genetics Section Core laboratory for help with AC release measurements; Nils-Goran Larsson for the Tfam<SUP>loxP</SUP> mice; Lawrence Wrabetz and Albee Messing for the P<INF>o</INF>-Cre mice; the Genome Technology Access Center (GTAC) in the Department of Genetics for help with genomic analysis; the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital (St. Louis, MO) for the use of the Biomedical Informatics Core (BMC), which provided the in silico analysis service, especially Nobish Varghese. Both GTAC and BMC are partially supported by NCI Cancer Center grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant UL1RR024992 from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This work was also supported by NIH Neuroscience Blueprint Center core grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, National Institutes of Health Grant AG13730 (J.M.), Muscular Dystrophy Association grant 237041 (J.M.), Amyotrophic Lateral Sclerosis Foundation grant 57696 (J.M.), and PPG 2P01 HL057278 (R.W.G). R.W.G. has financial relationships with LipoSpectrum and Platomics Inc.	Atkinson D.E., 1968, NEUROSCIENTIST, V7, P4030; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Dalton LE, 2012, PROG MOL BIOL TRANSL, V106, P189, DOI 10.1016/B978-0-12-396456-4.00003-1; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Gately DP, 1996, BRIT J CANCER, V73, P18, DOI 10.1038/bjc.1996.4; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Hoshi T, 2007, GLIA, V55, P584, DOI 10.1002/glia.20487; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; MARBACH EP, 1967, CLIN CHEM, V13, P314; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Schaefer J, 1996, ANN NEUROL, V40, P597, DOI 10.1002/ana.410400409; SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamada KA, 2000, J CARDIOVASC PHARM, V36, P14, DOI 10.1097/00005344-200007000-00002; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	40	149	154	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					886	898		10.1016/j.neuron.2013.01.012	http://dx.doi.org/10.1016/j.neuron.2013.01.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473319	Bronze, Green Accepted			2022-12-25	WOS:000316162600010
J	Feinstein, JS; Buzza, C; Hurlemann, R; Follmer, RL; Dahdaleh, NS; Coryell, WH; Welsh, MJ; Tranel, D; Wemmie, JA				Feinstein, Justin S.; Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Dahdaleh, Nader S.; Coryell, William H.; Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.			Fear and panic in humans with bilateral amygdala damage	NATURE NEUROSCIENCE			English	Article							DOUBLE DISSOCIATION; CARBON-DIOXIDE; DISORDER; RECOGNITION; EMOTION; FMRI	Decades of research have highlighted the amygdala's influential role in fear. We found that inhalation of 35% CO2 evoked not only fear, but also panic attacks, in three rare patients with bilateral amygdala damage. These results indicate that the amygdala is not required for fear and panic, and make an important distinction between fear triggered by external threats from the environment versus fear triggered internally by CO2.	[Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Coryell, William H.; Wemmie, John A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Hurlemann, Rene] Univ Bonn, Dept Psychiat, Bonn, Germany; [Dahdaleh, Nader S.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Bonn; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Tranel, D (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	daniel.tranel@uiowa.edu; john-wemmie@uiowa.edu	Hurlemann, Rene/AAL-5515-2020; Hurlemann, Rene/G-4164-2012	Hurlemann, Rene/0000-0003-2628-565X; Hurlemann, Rene/0000-0003-2628-565X; Wemmie, John/0000-0001-7531-9065; Tranel, Daniel/0000-0002-1338-1389; coryell, william/0000-0003-3989-7276; Welsh, Michael/0000-0002-1646-6206	Doris Duke Clinical Research Fellowship; National Institute of Neurological Disorders and Stroke [P50 NS19632]; Department of Veterans Affairs; National Institutes of Mental Health [5RO1MH085724]; McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632, P50NS019632] Funding Source: NIH RePORTER	Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Wunsch for technical support and M. Coryell and J. Potash for critically reading this manuscript. C.B. was supported by a Doris Duke Clinical Research Fellowship. D.T. was supported by the National Institute of Neurological Disorders and Stroke (P50 NS19632). J.A.W. was supported by the Department of Veterans Affairs (Merit Award), the National Institutes of Mental Health (5RO1MH085724) and a McKnight Neuroscience of Brain Disorders Award. R.H. was supported by a Starting Independent Researcher Grant (NEMO-Neuromodulation of Emotion) jointly provided by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT) and the University of Bonn. M.J.W. receives funding from the Howard Hughes Medical Institute.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Del-Ben CM, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/108135; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Ottaviani C, 2012, PSYCHIAT RES-NEUROIM, V203, P159, DOI 10.1016/j.pscychresns.2011.12.010; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Rassovsky Y, 2003, J ANXIETY DISORD, V17, P1, DOI 10.1016/S0887-6185(02)00181-0; Wemmie John A, 2011, Dialogues Clin Neurosci, V13, P475; Wiest G, 2006, ARCH NEUROL-CHICAGO, V63, P1798, DOI 10.1001/archneur.63.12.1798; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	20	167	171	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					270	272		10.1038/nn.3323	http://dx.doi.org/10.1038/nn.3323			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	097LE	23377128	Green Accepted, Green Submitted			2022-12-25	WOS:000315474800008
J	Lim, ET; Raychaudhuri, S; Sanders, SJ; Stevens, C; Sabo, A; MacArthur, DG; Neale, BM; Kirby, A; Ruderfer, DM; Fromer, M; Lek, M; Liu, L; Flannick, J; Ripke, S; Nagaswamy, U; Muzny, D; Reid, JG; Hawes, A; Newsham, I; Wu, YQ; Lewis, L; Dinh, H; Gross, S; Wang, LS; Lin, CF; Valladares, O; Gabriel, SB; dePristo, M; Altshuler, DM; Purcell, SM; State, MW; Boerwinkle, E; Buxbaum, JD; Cook, EH; Gibbs, RA; Schellenberg, GD; Sutcliffe, JS; Devlin, B; Roeder, K; Daly, MJ				Lim, Elaine T.; Raychaudhuri, Soumya; Sanders, Stephan J.; Stevens, Christine; Sabo, Aniko; MacArthur, Daniel G.; Neale, Benjamin M.; Kirby, Andrew; Ruderfer, Douglas M.; Fromer, Menachem; Lek, Monkol; Liu, Li; Flannick, Jason; Ripke, Stephan; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Hawes, Alicia; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Dinh, Huyen; Gross, Shannon; Wang, Li-San; Lin, Chiao-Feng; Valladares, Otto; Gabriel, Stacey B.; dePristo, Mark; Altshuler, David M.; Purcell, Shaun M.; State, Matthew W.; Boerwinkle, Eric; Buxbaum, Joseph D.; Cook, Edwin H.; Gibbs, Richard A.; Schellenberg, Gerard D.; Sutcliffe, James S.; Devlin, Bernie; Roeder, Kathryn; Daly, Mark J.		NHLBI Exome Sequencing Project	Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders	NEURON			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; CANDIDATE GENES; GENOME; EXOME; VARIANTS; ASSOCIATION; FAMILIES; TOOL	To characterize the role of rare complete human knockouts in autism spectrum disorders (ASDs), we identify genes with homozygous or compound heterozygous loss-of-function (LoF) variants (defined as nonsense and essential splice sites) from exome sequencing of 933 cases and 869 controls. We identify a 2-fold increase in complete knockouts of autosomal genes with low rates of LoF variation (<= 5% frequency) in cases and estimate a 3% contribution to ASD risk by these events, confirming this observation in an independent set of 563 probands and 4,605 controls. Outside the pseudoautosomal regions on the X chromosome, we similarly observe a significant 1.5-fold increase in rare hemizygous knockouts in males, contributing to another 2% of ASDs in males. Taken together, these results provide compelling evidence that rare autosomal and X chromosome complete gene knockouts are important inherited risk factors for ASD.	[Lim, Elaine T.; MacArthur, Daniel G.; Neale, Benjamin M.; Kirby, Andrew; Ruderfer, Douglas M.; Fromer, Menachem; Lek, Monkol; Flannick, Jason; Ripke, Stephan; Altshuler, David M.; Purcell, Shaun M.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ruderfer, Douglas M.; Fromer, Menachem; Purcell, Shaun M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Lim, Elaine T.; Raychaudhuri, Soumya; Stevens, Christine; MacArthur, Daniel G.; Neale, Benjamin M.; Kirby, Andrew; Ruderfer, Douglas M.; Fromer, Menachem; Lek, Monkol; Flannick, Jason; Ripke, Stephan; Gabriel, Stacey B.; dePristo, Mark; Altshuler, David M.; Purcell, Shaun M.; Daly, Mark J.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lim, Elaine T.; Neale, Benjamin M.; Ruderfer, Douglas M.; Fromer, Menachem; Ripke, Stephan; Purcell, Shaun M.; Daly, Mark J.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Lim, Elaine T.; Raychaudhuri, Soumya; MacArthur, Daniel G.; Neale, Benjamin M.; Kirby, Andrew; Ruderfer, Douglas M.; Fromer, Menachem; Lek, Monkol; Flannick, Jason; Altshuler, David M.; Purcell, Shaun M.; Daly, Mark J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lim, Elaine T.; Raychaudhuri, Soumya; MacArthur, Daniel G.; Neale, Benjamin M.; Kirby, Andrew; Ruderfer, Douglas M.; Fromer, Menachem; Lek, Monkol; Flannick, Jason; Altshuler, David M.; Purcell, Shaun M.; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lim, Elaine T.] Harvard Univ, Sch Med, Program Genet & Genom Biol & Biomed Sci, Boston, MA 02115 USA; [Ruderfer, Douglas M.; Fromer, Menachem; Purcell, Shaun M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Immunol Allergy & Rheumatol, Boston, MA 02115 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT 06520 USA; [Sanders, Stephan J.; State, Matthew W.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Sabo, Aniko; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Hawes, Alicia; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Dinh, Huyen; Gross, Shannon; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ruderfer, Douglas M.; Fromer, Menachem; Purcell, Shaun M.] Mt Sinai Sch Med, Div Psychiat Genom, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Ruderfer, Douglas M.; Fromer, Menachem; Purcell, Shaun M.; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Ruderfer, Douglas M.; Fromer, Menachem; Purcell, Shaun M.; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Liu, Li; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Liu, Li; Roeder, Kathryn] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Wang, Li-San; Lin, Chiao-Feng; Valladares, Otto] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Cook, Edwin H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Psychiat, Nashville, TN 37232 USA; [Devlin, Bernie] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA 15260 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	mjdaly@atgu.mgh.harvard.edu	Ripke, Stephan/AAK-5486-2021; Buxbaum, Joseph D/G-6001-2010; Altshuler, David M/A-4476-2009; State, Matthew/W-2256-2019; Daly, Mark J/B-2453-2017; Lim, Elaine/H-9032-2016; Ruderfer, Douglas M/M-5795-2016; Liu, Li/G-1897-2015; Sanders, Stephan/S-8645-2019; Sutcliffe, James S/C-1348-2012; Fromer, Menachem/G-2116-2012	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Sutcliffe, James S/0000-0001-5200-6007; Sanders, Stephan/0000-0001-9112-5148; ripke, stephan/0000-0003-3622-835X; Roeder, Kathryn/0000-0002-8869-6254; Buxbaum, Joseph/0000-0001-8898-8313; Stevens, Christine/0000-0002-2621-2234; Fromer, Menachem/0000-0003-3749-4342; MacArthur, Daniel/0000-0002-5771-2290; Lin, Chiao-Feng/0000-0002-6177-8807; Raychaudhuri, Soumya/0000-0002-1901-8265; Lim, Teng Ting/0000-0003-3651-0654; Walston, Shannon/0000-0002-7268-8313; State, Matthew/0000-0003-1624-8302	National Institute of Mental Health (NIMH) repository [U24MH068457]; Autism Genetic Resource Exchange (AGRE) Consortium [1U24MH081810]; Autism Speaks; Simons Foundation; Autism Consortium; NIH [R01MH089208, R01MH089025, R01MH089004, R01MH089175, R01MH089482, P50HD055751, R01MH057881, R01MH061009]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010];  [U54 HG003273];  [U54 HG003067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, UC2HL102926, RC2HL102924, RC2HL102925, UC2HL103010, UC2HL102923, UC2HL102925, RC2HL102923, RC2HL103010, UC2HL102924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089208, R01MH057881, R01MH089482, R01MH089004, R01MH061009, R01MH089175, R01MH089025, U24MH068457, R37MH057881, U24MH081810] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH) repository; Autism Genetic Resource Exchange (AGRE) Consortium; Autism Speaks; Simons Foundation; Autism Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge the following resources and families who contributed to them: the National Institute of Mental Health (NIMH) repository (U24MH068457); Autism Genetic Resource Exchange (AGRE) Consortium, a program of Autism Speaks (1U24MH081810 to Clara M. Lajonchere); The Autism Simplex Collection (TASC) (grant from Autism Speaks); Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (grant from the Simons Foundation); The Autism Consortium (grant from the Autism Consortium). For full citation of resources, please see Supplemental Information. This work was directly supported by NIH grants R01MH089208 (M.J.D.), R01MH089025 (J.D.B.), R01MH089004 (G.D.S.), R01MH089175 (R.A.G.), and R01MH089482 (J.S.S.) and supported in part by NIH grants P50HD055751 (E.H.C.), R01MH057881 (S.D.), and R01MH061009 (J.S.S.). We acknowledge partial support from U54 HG003273 (R.A.G.) and U54 HG003067 (E. Lander). We thank Thomas Lehner (NIMH), Adam Felsenfeld (NHGRI), and Patrick Bender (NIMH) for their support and contribution to the project. E.B., J.D.B., S.D., M.J.D., R.A.G., K.R., A.S., G.D.S., and J.S.S. are lead investigators in the ARRA Autism Sequencing Collaboration (AASC). We would also like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Baio J., 2012, MORBIDITY MORTALITY, V61; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Constantino J.N., 2012, MOL PSYCHIAT; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ishikawa T, 2012, NEUROSCIENCE, V214, P181, DOI 10.1016/j.neuroscience.2012.04.030; Johansson M, 2010, RES DEV DISABIL, V31, P9, DOI 10.1016/j.ridd.2009.07.011; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renieri A, 2009, BRAIN DEV-JPN, V31, P208, DOI 10.1016/j.braindev.2008.04.007; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Speevak MD, 2011, AM J MED GENET B, V156B, P484, DOI 10.1002/ajmg.b.31186; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	42	181	187	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					235	242		10.1016/j.neuron.2012.12.029	http://dx.doi.org/10.1016/j.neuron.2012.12.029			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352160	Green Accepted, Bronze			2022-12-25	WOS:000314199400006
J	Chittajallu, R; Craig, MT; McFarland, A; Yuan, XQ; Geffen, S; Tricoire, L; Erkkila, B; Barron, SC; Lopez, CM; Liang, BJ; Jeffries, BW; Pelkey, KA; McBain, CJ				Chittajallu, Ramesh; Craig, Michael T.; McFarland, Ashley; Yuan, Xiaoqing; Geffen, Scott; Tricoire, Ludovic; Erkkila, Brian; Barron, Sean C.; Lopez, Carla M.; Liang, Barry J.; Jeffries, Brian W.; Pelkey, Kenneth A.; McBain, Chris J.			Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT3AR expression	NATURE NEUROSCIENCE			English	Article							OSCILLATIONS IN-VITRO; STRATUM-ORIENS INTERNEURONS; CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; NETWORK OSCILLATIONS; RAT HIPPOCAMPUS; PERISOMATIC INHIBITION; RECEPTOR ACTIVATION; TRANSGENIC MICE; BASKET CELLS	Forebrain circuits rely upon a relatively small but remarkably diverse population of GABAergic interneurons to bind and entrain large principal cell assemblies for network synchronization and rhythmogenesis. Despite the high degree of heterogeneity across cortical interneurons, members of a given subtype typically exhibit homogeneous developmental origins, neuromodulatory response profiles, morphological characteristics, neurochemical signatures and electrical features. Here we report a surprising divergence among hippocampal oriens-lacunosum moleculare (O-LM) projecting interneurons that have hitherto been considered a homogeneous cell population. Combined immunocytochemical, anatomical and electrophysiological interrogation of Htr3a-GFP and Nkx2-1-cre:RCE mice revealed that O-LM cells parse into a caudal ganglionic eminence-derived subpopulation expressing 5-HT3A receptors (5-HT(3A)Rs) and a medial ganglionic eminence-derived subpopulation lacking 5-HT(3A)Rs. These two cohorts differentially participate in network oscillations, with 5-HT3AR-containing O-LM cell recruitment dictated by serotonergic tone. Thus, members of a seemingly uniform interneuron population can exhibit unique circuit functions and neuromodulatory properties dictated by disparate developmental origins.	[Chittajallu, Ramesh; Craig, Michael T.; McFarland, Ashley; Yuan, Xiaoqing; Geffen, Scott; Tricoire, Ludovic; Erkkila, Brian; Barron, Sean C.; Lopez, Carla M.; Liang, Barry J.; Jeffries, Brian W.; Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pelkey, KA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA.	pelkeyk2@mail.nih.gov	Chittajallu, Ramesh/AAX-3749-2020; Craig, Michael/E-7070-2011; Craig, Michael/O-8267-2019	Chittajallu, Ramesh/0000-0002-9794-0052; Craig, Michael/0000-0001-8481-6709; Craig, Michael/0000-0001-8481-6709	NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Abebe for expert technical assistance. We are grateful to S. Anderson (University of Pennsylvania) and a Fishell (New York University) for providing the Nkx2-1-cre and the RCE reporter mouse lines, respectively. The GENSAT BAC-Cre driver line (Htr3a-NO152) mice were obtained from C. Gerfen (National Institute of Mental Health). We would also like to thank E. Mann (University of Oxford) for providing the code for the wavelet analyses. This work was supported by an NICHD intramural award to C.J.M.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Ferraguti F, 2004, HIPPOCAMPUS, V14, P193, DOI 10.1002/hipo.10163; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Fuentealba P, 2010, J NEUROSCI, V30, P1595, DOI 10.1523/JNEUROSCI.4199-09.2010; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; HALASY K, 1992, EUR J NEUROSCI, V4, P144, DOI 10.1111/j.1460-9568.1992.tb00861.x; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lawrence JJ, 2006, J PHYSIOL-LONDON, V571, P555, DOI 10.1113/jphysiol.2005.103218; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maccaferri G, 2005, J PHYSIOL-LONDON, V562, P73, DOI 10.1113/jphysiol.2004.077081; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Reznic J, 1997, J NEUROPHYSIOL, V77, P517, DOI 10.1152/jn.1997.77.1.517; Rio CACD, 2012, J PHYSIOL-LONDON, V590, P695, DOI 10.1113/jphysiol.2011.225342; ROPERT N, 1991, J PHYSIOL-LONDON, V441, P121, DOI 10.1113/jphysiol.1991.sp018742; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Spampanato J, 2007, J NEUROPHYSIOL, V98, P96, DOI 10.1152/jn.00188.2007; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Verney C, 2000, DEV NEUROSCI-BASEL, V22, P125, DOI 10.1159/000017434; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Wierenga CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015915; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	50	77	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1598	1607		10.1038/nn.3538	http://dx.doi.org/10.1038/nn.3538			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097043	Green Accepted			2022-12-25	WOS:000326205700017
J	Andoniadou, CL; Matsushima, D; Gharavy, SNM; Signore, M; Mackintosh, AI; Schaeffer, M; Gaston-Massuet, C; Mollard, P; Jacques, TS; Le Tissier, P; Dattani, MT; Pevny, LH; Martinez-Barbera, JP				Andoniadou, Cynthia Lilian; Matsushima, Danielle; Gharavy, Seyedeh Neda Mousavy; Signore, Massimo; Mackintosh, Albert Ian; Schaeffer, Marie; Gaston-Massuet, Carles; Mollard, Patrice; Jacques, Thomas Stanley; Le Tissier, Paul; Dattani, Mehul Tulsidas; Pevny, Larysa Halyna; Martinez-Barbera, Juan Pedro			Sox2(+) Stem/Progenitor Cells in the Adult Mouse Pituitary Support Organ Homeostasis and Have Tumor-Inducing Potential	CELL STEM CELL			English	Article							CANCER STEM-CELLS; BETA-CATENIN; ANTERIOR-PITUITARY; DIFFERENTIATION; PATHOGENESIS; MUTATIONS; GROWTH; CRANIOPHARYNGIOMAS; IDENTIFICATION; TRANSFORMATION	Sox2(+) adult mouse pituitary cells can self-renew and terminally differentiate in vitro, but their physiological role in vivo and possible contribution to oncogenesis remain largely unknown. Using genetic lineage tracing, we show here that the Sox2(+) cell compartment of both the embryonic and adult pituitary contains stem/progenitor cells that are able to differentiate into all hormone-producing lineages and contribute to organ homeostasis during postnatal life. In addition, we show that targeted expression of oncogenic beta-catenin in Sox2(+) cells gives rise to pituitary tumors, but, unexpectedly, the tumor mass is not derived from the Sox2(+) mutation-sustaining cells, suggesting a paracrine role of Sox2(+) cells in pituitary oncogenesis. Our data therefore provide in vivo evidence of a role for Sox2(+) stem/progenitor cells in long-term physiological maintenance of the adult pituitary, and highlight an unexpected non-cell-autonomous role for these cells in the induction of pituitary tumors.	[Andoniadou, Cynthia Lilian; Gharavy, Seyedeh Neda Mousavy; Signore, Massimo; Mackintosh, Albert Ian; Gaston-Massuet, Carles; Jacques, Thomas Stanley; Le Tissier, Paul; Martinez-Barbera, Juan Pedro] UCL Inst Child Hlth, Neural Dev Unit, Birth Defects Res Ctr, London WC1N 1EH, England; [Matsushima, Danielle; Pevny, Larysa Halyna] Univ N Carolina, Ctr Neurosci, Dept Genet, Chapel Hill, NC 27599 USA; [Schaeffer, Marie; Mollard, Patrice] CNRS, Inst Genom Fonct, UMR 5203, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] INSERM, U661, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] Univ Montpellier I, UMR 5203, F-34000 Montpellier, France; [Schaeffer, Marie; Mollard, Patrice] Univ Montpellier 2, UMR 5203, F-34000 Montpellier, France; [Jacques, Thomas Stanley] Great Ormond St Hosp Children NHS Fdn Trust, Dept Histopathol, London WC1N 3JH, England; [Dattani, Mehul Tulsidas] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London WC1N 1EH, England; [Dattani, Mehul Tulsidas] Great Ormond St Hosp Children NHS Fdn Trust, Dept Endocrinol, London WC1N 1EH, England	University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Andoniadou, CL (corresponding author), UCL Inst Child Hlth, Neural Dev Unit, Birth Defects Res Ctr, London WC1N 1EH, England.	cynthia.andoniadou@kcl.ac.uk; j.martinez-barbera@ucl.ac.uk	Schaeffer, Marie/C-9815-2019; Jacques, Thomas/C-2209-2008; Martinez-Barbera, Juan Pedro/AAE-9284-2020	Schaeffer, Marie/0000-0002-2063-5324; Jacques, Thomas/0000-0002-7833-2158; Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Matsushima, Danielle/0000-0002-4538-2992; Andoniadou, Cynthia/0000-0003-4311-5855; Le Tissier, Paul/0000-0002-7220-5705	UCL Institute of Child Health; Great Ormond Street Hospital Flow Cytometry Core Facility; Montpellier RIO Imaging Cytometry Facility; UCL Genomics; ICH Embryonic Stem Cell/Chimera Production Facility; UCL Biological Services Unit; UCL Cancer Institute; WIBR Scientific Support Services; Wellcome Trust [086545, 084361]; Great Ormond Street Children's Hospital Charity; Medical Research Council [MC_U117570590] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1255, W1055] Funding Source: researchfish; MRC [MC_U117570590] Funding Source: UKRI	UCL Institute of Child Health; Great Ormond Street Hospital Flow Cytometry Core Facility; Montpellier RIO Imaging Cytometry Facility; UCL Genomics; ICH Embryonic Stem Cell/Chimera Production Facility; UCL Biological Services Unit; UCL Cancer Institute; WIBR Scientific Support Services; Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Children's Hospital Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was carried out with the support of the UCL Institute of Child Health and Great Ormond Street Hospital Flow Cytometry Core Facility, the Montpellier RIO Imaging Cytometry Facility, UCL Genomics, the ICH Embryonic Stem Cell/Chimera Production Facility, UCL Biological Services Unit, and UCL Cancer Institute and WIBR Scientific Support Services. We thank Dr. JrGang Cheng and the BAC Recombineering Core Facility at UNC Chapel Hill, C. Legraverend for providing the S100beta-eGFP transgenic mice, and the Developmental Studies Hybridoma Bank (University of Iowa) and the National Hormone and Peptide Program (Harbor-UCLA Medical Center) for providing some of the antibodies used in this study. We thank Gabriella Carreno and Mario Gonzalez-Meljem for technical assistance; Prof. Jacques Drouin and Prof. Simon Rhodes for TPIT and PIT1 antibodies, respectively; and Prof. Sally Camper, Prof. Steve Jones, and Prof. Gregory Shackleford for Wnt6, Wnt5a, and Wnt10a probes, respectively. This work was supported by grants 086545 and 084361 from The Wellcome Trust. M. T. D. is funded by the Great Ormond Street Children's Hospital Charity.	Alatzoglou KS, 2011, HUM MUTAT, V32, P1376, DOI 10.1002/humu.21606; ALLAERTS W, 1990, MOL CELL ENDOCRINOL, V71, P73, DOI 10.1016/0303-7207(90)90244-3; Andoniadou CL, 2007, DEVELOPMENT, V134, P1499, DOI 10.1242/dev.02829; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; BORSON S, 1994, NEUROENDOCRINOLOGY, V59, P466, DOI 10.1159/000126693; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Castinetti F, 2011, ENDOCR REV, V32, P453, DOI 10.1210/er.2010-0011; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Devnath S, 2008, J NEUROENDOCRINOL, V20, P687, DOI 10.1111/j.1365-2826.2008.01716.x; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dworakowska D, 2012, MINERVA ENDOCRINOL, V37, P157; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Florio T, 2011, NEUROENDOCRINOLOGY, V94, P265, DOI 10.1159/000330857; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Gueorguiev M, 2011, NAT REV ENDOCRINOL, V7, P71, DOI 10.1038/nrendo.2010.233; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hofmann BM, 2006, AM J SURG PATHOL, V30, P1595, DOI 10.1097/01.pas.0000213328.64121.12; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Labeur M, 2010, MOL CELL ENDOCRINOL, V326, P85, DOI 10.1016/j.mce.2010.04.006; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Levy A, 2008, J NEUROENDOCRINOL, V20, P139; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Muller HL, 2010, NAT REV ENDOCRINOL, V6, P609, DOI 10.1038/nrendo.2010.168; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Pevny L, 2003, TRENDS NEUROSCI, V26, P351, DOI 10.1016/S0166-2236(03)00169-3; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taniguchi Y, 2002, ANAT EMBRYOL, V206, P1, DOI 10.1007/s00429-002-0271-8; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	66	186	188	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					433	445		10.1016/j.stem.2013.07.004	http://dx.doi.org/10.1016/j.stem.2013.07.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094324	Green Published, Bronze			2022-12-25	WOS:000329571100012
J	Kessenbrock, K; Dijkgraaf, GJP; Lawson, DA; Littlepage, LE; Shahi, P; Pieper, U; Werb, Z				Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Pieper, Ursula; Werb, Zena			A Role for Matrix Metalloproteinases in Regulating Mammary Stem Cell Function via the Wnt Signaling Pathway	CELL STEM CELL			English	Article							BRANCHING MORPHOGENESIS; GLAND DEVELOPMENT; TGF-BETA; HEMOPEXIN DOMAIN; PROGENITOR CELLS; CANCER; PROTEINS; GROWTH; SUBPOPULATIONS; STROMELYSIN	The microenvironment provides cues that control the behavior of epithelial stem and progenitor cells. Here, we identify matrix metalloproteinase-3 (MMP3) as a regulator of Wnt signaling and mammary stem cell (MaSC) activity. We show that MMP3 overexpression promotes hyperplastic epithelial growth, surprisingly, in a nonproteolytic manner via its hemopexin (HPX) domain. We demonstrate that MMP3-HPX specifically binds and inactivates Wnt5b, a noncanonical Wnt ligand that inhibits canonical Wnt signaling and mammary epithelial outgrowth in vivo. Indeed, transplants overexpressing MMP3 display increased canonical Wnt signaling, demonstrating that MMP3 is an extracellular regulator of the Wnt signaling pathway. MMP3-deficient mice exhibit decreased MaSC populations and diminished mammary-reconstituting activity, whereas MMP3 overexpression elevates MaSC function, indicating that MMP3 is necessary for the maintenance of MaSCs. Our study reveals a mechanism by a microenvironmental protease that regulates Wnt signaling and impacts adult epithelial stem cell function.	[Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kessenbrock, Kai; Dijkgraaf, Gerrit J. P.; Lawson, Devon A.; Littlepage, Laurie E.; Shahi, Payam; Werb, Zena] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Pieper, Ursula] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu	Kessenbrock, Kai/B-6936-2011	Pieper, Ursula/0000-0002-3168-8122	National Cancer Institute [R01 CA057621]; Komen Foundation; American Cancer Society; Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense [DAMD-17-02-1-0333, W81XWH-11-1-0742]; NATIONAL CANCER INSTITUTE [T32CA108462, K99CA181490, R01CA057621] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Howard Bussey (McGill University, Canada) for Y2H reagents and Dr. Sandra Werner (Institute of Molecular Health Sciences, Switzerland) for the murine MMP10 cDNA. We thank Markus Brown, Ying Yu, and Elena Atamuniac for technical assistance. This work was supported by a grant from the National Cancer Institute (R01 CA057621 to Z.W.), postdoctoral fellowships from the Komen Foundation (to K.K.), the American Cancer Society (to L.E.L.), and the Congressionally Directed Breast Cancer Research Program, U.S. Department of Defense (DAMD-17-02-1-0333 to G.J.P.D. and W81XWH-11-1-0742 to D.A.L.).	BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Correia AL, 2013, GENE DEV, V27, P805, DOI 10.1101/gad.211383.112; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Ji H, 2011, PROTEOMICS, V11, P4029, DOI 10.1002/pmic.201100102; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mudgett JS, 1998, ARTHRITIS RHEUM-US, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030814; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Witty Jean P., 1995, Molecular Biology of the Cell, V6, P1287; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	47	101	103	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					300	313		10.1016/j.stem.2013.06.005	http://dx.doi.org/10.1016/j.stem.2013.06.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871604	Bronze, Green Accepted			2022-12-25	WOS:000329570800008
J	Lien, AD; Scanziani, M				Lien, Anthony D.; Scanziani, Massimo			Tuned thalamic excitation is amplified by visual cortical circuits	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; SIMPLE CELLS; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; CONNECTIONS; INPUT; SPECIFICITY	Cortical neurons in thalamic recipient layers receive excitation from the thalamus and the cortex. The relative contribution of these two sources of excitation to sensory tuning is poorly understood. We optogenetically silenced the visual cortex of mice to isolate thalamic excitation onto layer 4 neurons during visual stimulation. Thalamic excitation contributed to a third of the total excitation and was organized in spatially offset, yet overlapping, ON and OFF receptive fields. This receptive field structure predicted the orientation tuning of thalamic excitation. Finally, both thalamic and total excitation were similarly tuned to orientation and direction and had the same temporal phase relationship to the visual stimulus. Our results indicate that tuning of thalamic excitation is unlikely to be imparted by direction- or orientation-selective thalamic neurons and that a principal role of cortical circuits is to amplify tuned thalamic excitation.	[Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Lien, AD (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	anthony.d.lien@gmail.com; massimo@ucsd.edu		Lien, Anthony/0000-0003-3989-3881	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Evora for help with genotyping and mouse husbandry, J. Isaacson, E. Chichilnisky and the members of the Scanziani and Isaacson laboratories for helpful discussions of this project, and S. Olsen and K. Reinhold for help with dLGN recordings. This project was supported by the Gatsby charitable foundation, the Brain and Behavior Research Foundation and the Howard Hughes Medical Institute.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lien AD, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00016; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000	39	201	202	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1315	U207		10.1038/nn.3488	http://dx.doi.org/10.1038/nn.3488			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933748	Green Submitted, Green Accepted			2022-12-25	WOS:000323597500024
J	Olcese, U; Lurilli, G; Medini, P				Olcese, Umberto; lurilli, Giuliano; Medini, Paolo			Cellular and Synaptic Architecture of Multisensory Integration in the Mouse Neocortex	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; VISUAL CORTICAL AREAS; RAT BARREL CORTEX; PARIETAL CORTEX; FUNCTIONAL SPECIALIZATION; SOMATOSENSORY CORTEX; SUPERIOR COLLICULUS; GABAERGIC NEURONS; PYRAMIDAL NEURONS; BEHAVING MICE	Multisensory integration (MI) is crucial for sensory processing, but it is unclear how MI is organized in cortical microcircuits. Whole-cell recordings in a mouse visuotactile area located between primary visual and somatosensory cortices revealed that spike responses were less bimodal than synaptic responses but displayed larger multisensory enhancement. MI was layer and cell type specific, with multisensory enhancement being rare in the major class of inhibitory interneurons and in the output infragranular layers. Optogenetic manipulation of parvalbumin-positive interneuron activity revealed that the scarce MI of interneurons enables MI in neighboring pyramids. Finally, single-cell resolution calcium imaging revealed a gradual merging of modalities: unisensory neurons had higher densities toward the borders of the primary cortices, but were located in unimodal clusters in the middle of the cortical area. These findings reveal the role of different neuronal subcircuits in the synaptic process of MI in the rodent parietal cortex.	[Olcese, Umberto; lurilli, Giuliano; Medini, Paolo] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Medini, P (corresponding author), Umea Univ, Mol Biol & Integrat Med Biol Physiol Sect, S-90187 Umea, Sweden.	paolo.medini@iit.it	Medini, Paolo/R-7504-2018; Medini, Paolo/GWC-1936-2022	Iurilli, Giuliano/0000-0001-9037-2489; Olcese, Umberto/0000-0001-6968-2503				Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; Foxworthy WA, 2013, J COMP NEUROL, V521, P1867, DOI 10.1002/cne.23264; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; Higley MJ, 2005, J NEUROPHYSIOL, V93, P1920, DOI 10.1152/jn.00917.2004; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jiang W, 2001, J NEUROPHYSIOL, V85, P506, DOI 10.1152/jn.2001.85.2.506; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Medini P, 2011, J NEUROSCI, V31, P17134, DOI 10.1523/JNEUROSCI.2951-11.2011; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; PINTOHAMUY T, 1987, BEHAV BRAIN RES, V25, P221, DOI 10.1016/0166-4328(87)90070-2; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Roth MM, 2012, J NEUROSCI, V32, P9716, DOI 10.1523/JNEUROSCI.0110-12.2012; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 1996, PROG BRAIN RES, V112, P289; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Torrealba F, 2008, BIOL RES, V41, P369, DOI [10.4067/S0716-97602008000400002, /S0716-97602008000400002]; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	50	112	113	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					579	593		10.1016/j.neuron.2013.06.010	http://dx.doi.org/10.1016/j.neuron.2013.06.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23850594	Bronze			2022-12-25	WOS:000323085100017
J	Guezguez, B; Campbell, CJV; Boyd, AL; Karanu, F; Casado, FL; Di Cresce, C; Collins, TJ; Shapovalova, Z; Xenocostas, A; Bhatia, M				Guezguez, Borhane; Campbell, Clinton J. V.; Boyd, Allison L.; Karanu, Francis; Casado, Fanny L.; Di Cresce, Christine; Collins, Tony J.; Shapovalova, Zoya; Xenocostas, Anargyros; Bhatia, Mickie			Regional Localization within the Bone Marrow Influences the Functional Capacity of Human HSCs	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELL; CORD BLOOD TRANSPLANTATION; NOTCH LIGAND JAGGED1; NOD-SCID MICE; PROGENITOR CELLS; SELF-RENEWAL; INTRAFEMORAL TRANSPLANTATION; MURINE BONE; IN-VIVO; NICHE	Numerous studies have shown that the bone marrow (BM) niche plays a key role in mouse hematopoietic stem cell (HSC) function and involves contributions from a broad array of cell types. However, the composition and role of the human BM HSC niche have not been investigated. Here, using human bone biopsy specimens, we provide evidence of HSC propensity to localize to endosteal regions of the trabecular bone area (TBA). Through functional xenograft transplantation, we found that human HSCs localizing to the TBA have superior regenerative and self-renewal capacity and are molecularly distinct from those localizing to the long bone area (LBA). In addition, osteoblasts in the TBA possess unique characteristics and express a key network of factors that regulate TBA-versus LBA-localized human HSCs in vivo. Our study reveals that BM localization and architecture play a critical role in defining the functional and molecular properties of human HSCs.	[Guezguez, Borhane; Campbell, Clinton J. V.; Boyd, Allison L.; Karanu, Francis; Casado, Fanny L.; Collins, Tony J.; Shapovalova, Zoya; Bhatia, Mickie] McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Campbell, Clinton J. V.; Boyd, Allison L.; Bhatia, Mickie] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Di Cresce, Christine] Univ Western Ontario, Lawson Hlth Res Inst, London, ON N6A 5C1, Canada; [Di Cresce, Christine] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Xenocostas, Anargyros] Univ Western Ontario, London Hlth Sci Ctr, London, ON N6A 5C1, Canada; [Xenocostas, Anargyros] Univ Western Ontario, Schulich Sch Med, London, ON N6A 5C1, Canada	McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Xenocostas, Anargyros/G-3358-2011; Casado, Fanny L/D-8266-2015; Campbell, Clinton/Z-1986-2019	Casado, Fanny L/0000-0002-8791-626X; Campbell, Clinton/0000-0002-8896-1134; Guezguez, Borhane/0000-0002-1474-8074	Canadian Institutes of Health Research (CIHR); Ontario Cancer Research Institute (OICR); Canadian Research Chair Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Cancer Research Institute (OICR); Canadian Research Chair Program(Canada Research Chairs)	We thank J. McNicol and J. Russell for imaging scanning and analysis assistance; David Carter (LRGC, Robarts Research Institute) for the quality of the probes and arrays; A. Fiebig-Comyn, Claudia I. Hopkins, and Monica Graham for general technical assistance; M. Levadoux-Martin for FACS analysis and cell sorting; Mary-Jo Smith for histology assistance and troubleshooting of in situ staining; and Drs. Kristin Hope, T. Ogilvie Werbowetski, and B. McIntyre for critical review of the manuscript prior to submission. We also thank members of the Labor and Delivery ward at the McMaster Children's Hospital for supplying human cord blood samples. Funding for this research was provided by a research grant from the Canadian Institutes of Health Research (CIHR) and the Ontario Cancer Research Institute (OICR). M. B. is supported by the Canadian Research Chair Program and holds a chair in human stem cell biology. B. G. designed and performed experiments, analyzed and interpreted data, and wrote manuscript draft; Z.S. performed bioinformatic and gene expression analysis; T.J.C. wrote the image processing and analysis scripts; C.J.V.C. performed experiments, analyzed and interpreted data, and edited the manuscript; F. C. and A. B. performed and assisted with the human biopsy analysis and transplant experiments; F. K. performed the Notch-HSC-related experiments; and M. B. designed the experiments, interpreted data, and wrote the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Blank U, 2006, BLOOD, V108, P4246, DOI 10.1182/blood-2006-02-005611; Bowman Teresa V., 2007, V134, P1; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Christianson SW, 1997, J IMMUNOL, V158, P3578; Chung YJ, 2006, BLOOD, V108, P1208, DOI 10.1182/blood-2006-01-010199; Colvin GA, 2010, J CELL PHYSIOL, V222, P57, DOI 10.1002/jcp.21918; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Guezguez B, 2008, CURR OPIN ORGAN TRAN, V13, P44, DOI 10.1097/MOT.0b013e3282f42486; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Hodby K, 2011, STEM CELLS, V29, P1322, DOI 10.1002/stem.689; Hope K, 2011, NAT METHODS, V8, pS36, DOI [10.1038/NMETH.1590, 10.1038/nmeth.1590]; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jansen M, 2005, STEM CELLS, V23, P335, DOI 10.1634/stemcells.2004-0216; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kelly SS, 2010, CYTOTHERAPY, V12, P121, DOI 10.3109/14653240903440111; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naresh KN, 2006, J CLIN PATHOL, V59, P903, DOI 10.1136/jcp.2004.020610; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schoemans H, 2006, BONE MARROW TRANSPL, V38, P83, DOI 10.1038/sj.bmt.1705403; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	73	78	78	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					175	189		10.1016/j.stem.2013.06.015	http://dx.doi.org/10.1016/j.stem.2013.06.015			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910084	Bronze			2022-12-25	WOS:000329570600011
J	Hohl, SS; Chaisanguanthum, KS; Lisberger, SG				Hohl, Sonja S.; Chaisanguanthum, Kris S.; Lisberger, Stephen G.			Sensory Population Decoding for Visually Guided Movements	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; CORTICAL AREA MT; MACAQUE MONKEYS; ATTENTIONAL MODULATION; BEHAVIORAL-RESPONSES; INDIVIDUAL NEURONS; TIME-COURSE; MOTION; DIRECTION; SIGNALS	We have used a new approach to study the neural decoding function that converts the population response in extrastriate area MT into estimates of target motion to drive smooth pursuit eye movement. Experiments reveal significant trial-by-trial correlations between the responses of MT neurons and the initiation of pursuit. The preponderance of significant correlations and the relatively low reduction in noise between MT and the behavioral output support the hypothesis of a sensory origin for at least some of the trial-by-trial variation in pursuit initiation. The finding of mainly positive MT-pursuit correlations, whether the target speed is faster or slower than the neuron's preferred speed, places strong constraints on the neural decoding computation. We propose that decoding is based on normalizing a weighted population vector of opponent motion responses; normalization comes from neurons uncorrelated with those used to compute the weighted population vector.	[Lisberger, Stephen G.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lisberger, Stephen G.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Hohl, Sonja S.; Chaisanguanthum, Kris S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Hohl, Sonja S.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Chaisanguanthum, Kris S.] Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; [Hohl, Sonja S.; Chaisanguanthum, Kris S.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	Duke University; Howard Hughes Medical Institute; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lisberger, SG (corresponding author), Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA.	lisberger@neuro.duke.edu			Howard Hughes Medical Institute; Swartz Foundation; NIH [EY03878, T32 EY007120]; NATIONAL EYE INSTITUTE [T32EY007120, R37EY003878, R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swartz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Mehrdad Jazayeri for insightful comments on an earlier version of the manuscript and Mark Churchland for clarity on issues of population decoding. We are grateful to Lisberger lab members, as well as Jonathan Pillow, Peter Latham, Surya Ganguli, and Valerio Mante for valuable discussions. We also thank Drs. Allison Doupe, Philip Sabes, Christoph Schreiner, and Yang Dan for helpful comments on the PhD thesis that turned into this paper. We thank Stefanie Tokiyama, Elizabeth Montgomery, Karen MacLeod, Dirk Kleinhesselink, Scott Ruffner, David Wolfgang-Kimball, Darrell Floyd, and Ken McGary for technical assistance. Research supported by the Howard Hughes Medical Institute, the Swartz Foundation, and NIH grants EY03878 and T32 EY007120.	Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Carey MR, 2005, NAT NEUROSCI, V8, P813, DOI 10.1038/nn1470; Chaisanguanthum KS, 2011, J NEUROSCI, V31, P4868, DOI 10.1523/JNEUROSCI.6776-10.2011; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cook EP, 2004, J NEUROSCI, V24, P7964, DOI 10.1523/JNEUROSCI.5102-03.2004; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Fallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037888; GOLDREICH D, 1992, J NEUROPHYSIOL, V67, P625, DOI 10.1152/jn.1992.67.3.625; Groh JM, 1997, J NEUROSCI, V17, P4312; Groh JM, 2001, BIOL CYBERN, V85, P159, DOI 10.1007/s004220100249; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HEEGER DJ, 1993, J NEUROPHYSIOL, V70, P1885, DOI 10.1152/jn.1993.70.5.1885; Hohl SS, 2011, J NEUROSCI, V31, P16561, DOI 10.1523/JNEUROSCI.3166-11.2011; Hu XT, 2007, P NATL ACAD SCI USA, V104, P8137, DOI 10.1073/pnas.0702799104; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Krauzlis RJ, 1996, EXP BRAIN RES, V109, P289; Krekelberg B, 2006, J NEUROSCI, V26, P8988, DOI 10.1523/JNEUROSCI.1983-06.2006; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Lisberger SG, 1997, J NEUROSCI, V17, P7490; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Niu YQ, 2011, J NEUROPHYSIOL, V106, P741, DOI 10.1152/jn.01025.2010; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Schoppik D, 2008, NEURON, V58, P248, DOI 10.1016/j.neuron.2008.02.015; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Smith JET, 2011, J NEUROSCI, V31, P13458, DOI 10.1523/JNEUROSCI.1347-11.2011; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Yang J, 2012, J NEUROSCI, V32, P17632, DOI 10.1523/JNEUROSCI.1163-12.2012; Yang J, 2009, J NEUROPHYSIOL, V101, P2693, DOI 10.1152/jn.00061.2009	49	27	27	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					167	179		10.1016/j.neuron.2013.05.026	http://dx.doi.org/10.1016/j.neuron.2013.05.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849202	Bronze, Green Accepted			2022-12-25	WOS:000321802000017
J	Freifeld, L; Clark, DA; Schnitzer, MJ; Horowitz, MA; Clandinin, TR				Freifeld, Limor; Clark, Damon A.; Schnitzer, Mark J.; Horowitz, Mark A.; Clandinin, Thomas R.			GABAergic Lateral Interactions Tune the Early Stages of Visual Processing in Drosophila	NEURON			English	Article							FLY MOTION VISION; CENTER-SURROUND ORGANIZATION; GAIN-CONTROL MECHANISM; RETINAL BIPOLAR CELLS; BLOWFLY COMPOUND EYE; FIRST OPTIC NEUROPIL; RECEPTIVE-FIELDS; PRESYNAPTIC INHIBITION; SIGNALING COMPONENTS; RESPONSE PROPERTIES	Early stages of visual processing must capture complex, dynamic inputs. While peripheral neurons often implement efficient encoding by exploiting natural stimulus statistics, downstream neurons are specialized to extract behaviorally relevant features. How do these specializations arise? We use two-photon imaging in Drosophila to characterize a first-order interneuron, L2, that provides input to a pathway specialized for detecting moving dark edges. GABAergic interactions, mediated in part presynaptically, create an antagonistic and anisotropic center-surround receptive field. This receptive field is spatiotemporally coupled, applying differential temporal processing to large and small dark objects, achieving significant specialization. GABAergic circuits also mediate OFF responses and balance these with responses to ON stimuli. Remarkably, the functional properties of L2 are strikingly similar to those of bipolar cells, yet emerge through different molecular and circuit mechanisms. Thus, evolution appears to have converged on a common strategy for processing visual information at the first synapse.	[Freifeld, Limor; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Yale University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu		Freifeld, Limor/0000-0002-0739-6947; Clark, Damon/0000-0001-8487-700X	Fulbright Science and Technology Fellowship; Bio-X Bruce and Elizabeth Dunlevie Stanford Interdisciplinary Graduate Fellowship; Jane Coffin Child's Postdoctoral fellowship; NIH [DP1 OD003530, R01EY022638]; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	Fulbright Science and Technology Fellowship; Bio-X Bruce and Elizabeth Dunlevie Stanford Interdisciplinary Graduate Fellowship; Jane Coffin Child's Postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Stephen Baccus, Saskia DeVries, Daryl Gohl, Marion Shies, Tina Schwab, Jennifer Esch, and Helen Yang for helpful comments on the manuscript. We would also like to thank Daryl Gohl and Xiaojing Gao (Luo laboratory) for providing fly stocks. This work was supported by a Fulbright Science and Technology Fellowship and a Bio-X Bruce and Elizabeth Dunlevie Stanford Interdisciplinary Graduate Fellowship (L.F.), a Jane Coffin Child's Postdoctoral fellowship (D.A.C.), and a NIH Director's Pioneer Award DP1 OD003530 (T.R.C.) and NIH R01EY022638 (T.R.C.).	ARNETT DW, 1972, J NEUROPHYSIOL, V35, P429, DOI 10.1152/jn.1972.35.4.429; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW RB, 1969, J GEN PHYSIOL, V54, P383, DOI 10.1085/jgp.54.3.383; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BLAGBURN JM, 1987, J EXP BIOL, V127, P135; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; BURROWS M, 1994, J NEUROSCI, V14, P272; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; DAVIS GW, 1980, J NEUROPHYSIOL, V43, P807, DOI 10.1152/jn.1980.43.3.807; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; DUBS A, 1982, J COMP PHYSIOL, V146, P321, DOI 10.1007/BF00612703; DUBS A, 1981, J PHYSIOL-LONDON, V317, P317, DOI 10.1113/jphysiol.1981.sp013827; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Fahey PK, 2003, VISUAL NEUROSCI, V20, P1, DOI 10.1017/S0952523803201012; Fleet D.J., 1985, COMPUT INTELL, V1, P89; FLEET DJ, 1985, BIOL CYBERN, V52, P153; GLANTZ RM, 1994, J NEUROPHYSIOL, V71, P2168, DOI 10.1152/jn.1994.71.6.2168; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JOHNSTON D, 1976, J GEN PHYSIOL, V67, P1, DOI 10.1085/jgp.67.1.1; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 1995, J NEUROPHYSIOL, V74, P2538, DOI 10.1152/jn.1995.74.6.2538; KANEKO A, 1986, J PHYSIOL-LONDON, V373, P443, DOI 10.1113/jphysiol.1986.sp016057; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KENNEDY D, 1974, SCIENCE, V186, P451, DOI 10.1126/science.186.4162.451; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1974, J COMP PHYSIOL, V92, P377, DOI 10.1007/BF00694708; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; LAUGHLIN SB, 1974, J COMP PHYSIOL, V92, P357, DOI 10.1007/BF00694707; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MIMURA K, 1976, J COMP PHYSIOL, V105, P65, DOI 10.1007/BF01380054; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; OWEN WG, 1989, NEUROSCI RES, pS77; Pitkow X, 2012, NAT NEUROSCI, V15, P628, DOI 10.1038/nn.3064; RATLIFF F, 1963, J OPT SOC AM, V53, P110, DOI 10.1364/JOSA.53.000110; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; RICHTER J, 1982, BIOL CYBERN, V43, P127, DOI 10.1007/BF00336975; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; SHAW SR, 1975, NATURE, V255, P480, DOI 10.1038/255480a0; Shields CR, 2000, J NEUROSCI, V20, P2673; SRINIVASAN MV, 1980, J COMP PHYSIOL, V140, P1, DOI 10.1007/BF00613743; SRINIVASAN MV, 1990, PROC R SOC SER B-BIO, V240, P279, DOI 10.1098/rspb.1990.0038; SRINIVASAN MV, 1990, BIOL CYBERN, V63, P421, DOI 10.1007/BF00199574; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; TOYODA J, 1983, VISION RES, V23, P1143, DOI 10.1016/0042-6989(83)90028-7; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; Vigh J, 2011, J NEUROSCI, V31, P15884, DOI 10.1523/JNEUROSCI.2959-11.2011; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; WECKSTROM M, 1989, J EXP BIOL, V144, P147; Weckstrom M, 2010, J NEUROSCI, V30, P9557, DOI 10.1523/JNEUROSCI.6122-09.2010; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Zanker JM, 1999, BIOL CYBERN, V80, P109, DOI 10.1007/s004220050509; Zhang AJ, 2009, J NEUROSCI, V29, P789, DOI 10.1523/JNEUROSCI.4984-08.2009	90	53	53	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1075	1089		10.1016/j.neuron.2013.04.024	http://dx.doi.org/10.1016/j.neuron.2013.04.024			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791198	Bronze, Green Accepted			2022-12-25	WOS:000321026900013
J	Bock, R; Shin, JH; Kaplan, AR; Dobi, A; Markey, E; Kramer, PF; Gremel, CM; Christensen, CH; Adrover, MF; Alvarez, VA				Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.			Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use	NATURE NEUROSCIENCE			English	Article							D2-LIKE AGONISTS; OPTOGENETIC CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE D1-LIKE; DISTINCT ROLES; D2 RECEPTORS; ADDICTION; REWARD; RATS; IMPULSIVITY	A hallmark of addiction is the loss of control over drug intake, which is seen in only a fraction of those exposed to stimulant drugs such as cocaine. The cellular mechanisms underlying vulnerability or resistance to compulsive drug use remain unknown. We found that individual variability in the development of highly motivated and perseverative behavior toward cocaine is associated with synaptic plasticity in medium spiny neurons expressing dopamine D2 receptors (D2-MSNs) in the nucleus accumbens (NAc) of mice. Potentiation of glutamatergic inputs onto indirect pathway D2-MSNs was associated with resilience toward compulsive cocaine seeking. Inhibition of D2-MSNs using a chemicogenetic approach enhanced the motivation to obtain cocaine, whereas optogenetic activation of D2-MSNs suppressed cocaine self-administration. These results indicate that recruitment of D2-MSNs in NAc functions to restrain cocaine self-administration and serves as a natural protective mechanism in drug-exposed individuals.	[Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.] NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA; [Alvarez, Veronica A.] NINDS, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Alvarez, VA (corresponding author), NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA.	alvarezva@mail.nih.gov	Alvarez, Veronica A/E-9745-2015; Bock, Roland/G-2982-2016; Core, Vector/CAF-4832-2022	Alvarez, Veronica A/0000-0003-2611-8675; Bock, Roland/0000-0002-8654-1080; Kramer, Paul/0000-0002-0095-3712; Kaplan, Alanna/0000-0002-2612-4736	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke [ZIA-AA000421]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000421] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to the staff of Fishers Lane Animal Center and to L. Chedester for technical support. We thank the members of the Alvarez laboratory, J.T. Williams, D.M. Lovinger and B.L. Sabatini for helpful comments on the manuscript. We also thank B. Roth (University of North Carolina) and K. Deisseroth (Stanford University) for their generosity in providing the constructs for hM4Di and ChR2, respectively, and B. Harvey (Optogenetics and Transgenic Technology Core at the National Institute on Drug Abuse) for the viral vector preparation. This study was funded by the Intramural Programs of the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Neurological Disorders and Stroke (ZIA-AA000421).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Barrett AC, 2004, NEUROPHARMACOLOGY, V47, P256, DOI 10.1016/j.neuropharm.2004.07.007; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Caine SB, 1999, J PHARMACOL EXP THER, V291, P353; Corbit LH, 2010, EUR J NEUROSCI, V31, P1312, DOI 10.1111/j.1460-9568.2010.07153.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ralph RJ, 2005, J PHARMACOL EXP THER, V312, P733, DOI 10.1124/jpet.104.074468; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Root DH, 2013, J COMP NEUROL, V521, P558, DOI 10.1002/cne.23191; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Thomsen Morgane, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0920s32; Torregrossa MM, 2008, NEUROSCI LETT, V438, P142, DOI 10.1016/j.neulet.2008.04.016; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137	36	212	216	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					632	+		10.1038/nn.3369	http://dx.doi.org/10.1038/nn.3369			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542690	Green Accepted			2022-12-25	WOS:000318029300020
J	Garvert, MM; Gollisch, T				Garvert, Mona M.; Gollisch, Tim			Local and Global Contrast Adaptation in Retinal Ganglion Cells	NEURON			English	Article							NONLINEAR SPATIAL SUMMATION; GAIN-CONTROL; FUNCTIONAL CIRCUITRY; TEMPORAL CONTRAST; RECEPTIVE-FIELD; BIPOLAR CELLS; STIMULUS STATISTICS; SALAMANDER RETINA; VISUAL-ADAPTATION; DYNAMIC STIMULI	Retinal ganglion cells react to changes in visual contrast by adjusting their sensitivity and temporal filtering characteristics. This contrast adaptation has primarily been studied under spatially homogeneous stimulation. Yet, ganglion cell receptive fields are often characterized by spatial subfields, providing a substrate for nonlinear spatial processing. This raises the question whether contrast adaptation follows a similar subfield structure or whether it occurs globally over the receptive field even for local stimulation. We therefore recorded ganglion cell activity in isolated salamander retinas while locally changing visual contrast. Ganglion cells showed primarily global adaptation characteristics, with notable exceptions in certain aspects of temporal filtering. Surprisingly, some changes in filtering were most pronounced for locations where contrast did not change. This seemingly paradoxical effect can be explained by a simple computational model, which emphasizes the importance of local nonlinearities in the retina and suggests a reevaluation of previously reported local contrast adaptation.	[Garvert, Mona M.; Gollisch, Tim] Max Planck Inst Neurobiol, Visual Coding Grp, D-82152 Martinsried, Germany; [Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, D-37073 Gottingen, Germany; [Gollisch, Tim] Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Gollisch, T (corresponding author), Max Planck Inst Neurobiol, Visual Coding Grp, D-82152 Martinsried, Germany.	tim.gollisch@med.uni-goettingen.de	889, CRC/L-1607-2018; Garvert, Mona/GXV-5608-2022	889, CRC/0000-0002-6678-3138; Garvert, Mona/0000-0002-8678-5536; Gollisch, Tim/0000-0003-3998-533X	Max Planck Society; German Initiative of Excellence; International Human Frontier Science Program Organization; Deutsche Forschungsgemeinschaft [DFG-SFB 889]	Max Planck Society(Max Planck Society); German Initiative of Excellence; International Human Frontier Science Program Organization(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max Planck Society, the German Initiative of Excellence, the International Human Frontier Science Program Organization, and the Deutsche Forschungsgemeinschaft (DFG-SFB 889).	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Bolinger D, 2012, NEURON, V73, P333, DOI 10.1016/j.neuron.2011.10.039; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; da Silveira RA, 2011, CURR OPIN NEUROBIOL, V21, P664, DOI 10.1016/j.conb.2011.05.007; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FREED MA, 1988, J NEUROSCI, V8, P2303; Garcia-Lazaro JA, 2007, EUR J NEUROSCI, V26, P2359, DOI 10.1111/j.1460-9568.2007.05847.x; Gaudry KS, 2007, J NEUROPHYSIOL, V98, P1287, DOI 10.1152/jn.00618.2006; Gollisch T, 2004, J NEUROSCI, V24, P7435, DOI 10.1523/JNEUROSCI.0398-04.2004; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jarsky T, 2011, J NEUROSCI, V31, P11003, DOI 10.1523/JNEUROSCI.2631-11.2011; Kastner DB, 2011, NAT NEUROSCI, V14, P1317, DOI 10.1038/nn.2906; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KOLB H, 1993, J COMP NEUROL, V329, P85, DOI 10.1002/cne.903290107; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Li GL, 2007, J NEUROSCI, V27, P7377, DOI 10.1523/JNEUROSCI.0410-07.2007; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Ozuysal Y, 2012, NEURON, V73, P1002, DOI 10.1016/j.neuron.2011.12.029; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Samengo I, 2013, J COMPUT NEUROSCI, V34, P137, DOI 10.1007/s10827-012-0411-y; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Weick M, 2011, NEURON, V71, P166, DOI 10.1016/j.neuron.2011.04.033; Werblin FS, 2010, VISUAL NEUROSCI, V27, P1, DOI 10.1017/S0952523810000076; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005; Zaghloul KA, 2007, J NEUROPHYSIOL, V97, P4327, DOI 10.1152/jn.01091.2006	59	30	31	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 6	2013	77	5					915	928		10.1016/j.neuron.2012.12.030	http://dx.doi.org/10.1016/j.neuron.2012.12.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473321	Bronze			2022-12-25	WOS:000316162600012
J	Campanac, E; Gasselin, C; Baude, A; Rama, S; Ankri, N; Debanne, D				Campanac, Emilie; Gasselin, Celia; Baude, Agnes; Rama, Sylvain; Ankri, Norbert; Debanne, Dominique			Enhanced Intrinsic Excitability in Basket Cells Maintains Excitatory-Inhibitory Balance in Hippocampal Circuits	NEURON			English	Article							CHOLINERGIC-RECEPTOR ACTIVATION; SPIKING GABAERGIC INTERNEURONS; TERM SYNAPTIC PLASTICITY; CA1 PYRAMIDAL NEURONS; BIDIRECTIONAL PLASTICITY; DENDRITIC INTEGRATION; TEMPORAL FIDELITY; TIME PRECISION; EXPERIENCE; LTP	The dynamics of inhibitory circuits in the cortex is thought to rely mainly on synaptic modifications. We challenge this view by showing that hippocampal parvalbumin-positive basket cells (PV-BCs) of the CA1 region express long-term (>30 min) potentiation of intrinsic neuronal excitability (LTP-IEPV-BC) upon brief repetitive stimulation of the Schaffer collaterals. LTP-IEPV-BC is induced by synaptic activation of metabotropic glutamate receptor subtype 5 (mGluR5) and mediated by the downregulation of Kv1 channel activity. LTP-IEPV-BC promotes spiking activity at the gamma frequency (similar to 35 Hz) and facilitates recruitment of PV-BCs to balance synaptic and intrinsic excitation in pyramidal neurons. In conclusion, activity-dependent modulation of intrinsic neuronal excitability in PV-BCs maintains excitatory-inhibitory balance and thus plays a major role in the dynamics of hippocampal circuits.	[Campanac, Emilie; Gasselin, Celia; Rama, Sylvain; Ankri, Norbert; Debanne, Dominique] INSERM, UMR S 1072, F-13344 Marseille, France; [Campanac, Emilie; Gasselin, Celia; Baude, Agnes; Rama, Sylvain; Ankri, Norbert; Debanne, Dominique] Aix Marseille Univ, UNIS, F-13344 Marseille, France; [Baude, Agnes] CNRS, UMR6231, F-13344 Marseille, France; [Baude, Agnes] INSERM, INMED, U901, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Debanne, D (corresponding author), INSERM, UMR S 1072, F-13344 Marseille, France.	dominique.debanne@univ-amu.fr	Debanne, Dominique/O-4673-2016; Baude, Agnès/M-7356-2016	Debanne, Dominique/0000-0001-8581-5695; Baude, Agnès/0000-0002-7025-364X; Rama, Sylvain/0000-0002-0190-5448	INSERM; CNRS; ANR MNPS [P-007071]; FRM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR MNPS(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale)	We thank P. Giraud for help with some experiments, J.M. Goaillard, G. Maccaferri, C. McBain, K.A. Pelkey, and M. Seagar for helpful comments on the manuscript. This work was supported by INSERM, CNRS, ANR MNPS P-007071 "EPISOM," and FRM (to E.C. and C.G.). E.C. conceived and initiated the project, collected experimental data, carried out data analysis, and contributed to the manuscript. C.G. conceived part of the project, collected experimental data, and carried out data analysis. A.B. collected experimental data, carried out data analysis, and contributed to the manuscript. S.R. collected experimental data and carried out data analysis, N.A. carried out data analysis and computer simulation, and D.D. conceived and supervised the project, carried out data analysis, and wrote the manuscript.	Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Campanac E, 2008, J PHYSIOL-LONDON, V586, P779, DOI 10.1113/jphysiol.2007.147017; Cudmore RH, 2010, J NEUROSCI, V30, P12885, DOI 10.1523/JNEUROSCI.0740-10.2010; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Debanne Dominique, 2010, Front Synaptic Neurosci, V2, P21, DOI 10.3389/fnsyn.2010.00021; Desai NS, 2003, J PHYSIOL-PARIS, V97, P391, DOI 10.1016/j.jphysparis.2004.01.005; Fan W, 2010, J NEUROSCI, V30, P1471, DOI 10.1523/JNEUROSCI.5619-09.2010; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gastrein P, 2011, J PHYSIOL-LONDON, V589, P3753, DOI 10.1113/jphysiol.2011.209148; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MILES R, 1993, J PHYSIOL-LONDON, V463, P461, DOI 10.1113/jphysiol.1993.sp019605; Miller MN, 2011, DEV NEUROBIOL, V71, P62, DOI 10.1002/dneu.20811; Norenberg A, 2010, P NATL ACAD SCI USA, V107, P894, DOI 10.1073/pnas.0910716107; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Pelletier JG, 2008, PROG BRAIN RES, V169, P241, DOI 10.1016/S0079-6123(07)00014-3; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Sourdet V, 2003, J NEUROSCI, V23, P10238; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Szabo GG, 2010, EUR J NEUROSCI, V31, P2234, DOI 10.1111/j.1460-9568.2010.07292.x; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	42	74	75	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					712	722		10.1016/j.neuron.2012.12.020	http://dx.doi.org/10.1016/j.neuron.2012.12.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439123	Green Submitted, Bronze			2022-12-25	WOS:000315561300013
J	Wang, M; Yang, Y; Wang, CJ; Gamo, NJ; Jin, LE; Mazer, JA; Morrison, JH; Wang, XJ; Arnsten, AFT				Wang, Min; Yang, Yang; Wang, Ching-Jung; Gamo, Nao J.; Jin, Lu E.; Mazer, James A.; Morrison, John H.; Wang, Xiao-Jing; Arnsten, Amy F. T.			NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex	NEURON			English	Article							CORTICAL NETWORK MODEL; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PYRAMIDAL NEURONS; SPINE DENSITY; EYE-MOVEMENTS; SCHIZOPHRENIA; GLUTAMATE; KETAMINE; TASK	Neurons in the primate dorsolateral prefrontal cortex (dIPFC) generate persistent firing in the absence of sensory stimulation, the foundation of mental representation. Persistent firing arises from recurrent excitation within a network of pyramidal Delay cells. Here, we examined glutamate receptor influences underlying persistent firing in primate dIPFC during a spatial working memory task. Computational models predicted dependence on NMDA receptor (NMDAR) NR2B stimulation, and Delay cell persistent firing was abolished by local NR2B NMDAR blockade or by systemic ketamine administration. AMPA receptors (AMPARs) contributed background depolarization to sustain network firing. In contrast, many Response cells were sensitive to AMPAR blockade and increased firing after systemic ketamine, indicating that models of ketamine actions should be refined to reflect neuronal heterogeneity. The reliance of Delay cells on NMDAR may explain why insults to NMDARs in schizophrenia or Alzheimer's disease profoundly impair cognition.	[Wang, Min; Yang, Yang; Gamo, Nao J.; Jin, Lu E.; Mazer, James A.; Wang, Xiao-Jing; Arnsten, Amy F. T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Wang, Ching-Jung; Morrison, John H.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA	Yale University; Icahn School of Medicine at Mount Sinai	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Wang, Xiao-Jing/D-2722-2009	Yang, Yang/0000-0001-6612-8865	NIH [PO1 AG030004, RL1 AA017536, U54RR024350, AG016765, AG06647, MH062349, MH 09335401]; Alzheimer's Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349, R01MH093354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006647, R37AG006647, P01AG030004, P01AG016765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RL1AA017536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH grants PO1 AG030004 and RL1 AA017536 within U54RR024350 to A.F.T.A., AG016765 and AG06647 to J.H.M., MH062349 to X.-J.W., and MH 09335401 to MW., as well as a New Investigator Research Grant from the Alzheimer's Association to M.W., and a gift to honor the memory of Percy S. Arnsten. We are grateful to L. Ciavarella, T. Sad Ion, S. Johnson, and J. Thomas for their invaluable technical support and thank Dr. Bao-Ming Li, Dr. Naomi Dreisen, Dr. John Krystal, and Dr. Phil Corlett for their inspiration.	Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Bai L, 2004, NEUROBIOL AGING, V25, P201, DOI 10.1016/S0197-4580(03)00091-5; Banerjee A, 2010, BRAIN RES BULL, V83, P132, DOI 10.1016/j.brainresbull.2010.04.011; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Bitanihirwe BKY, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-71; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Bustillo JR, 2011, BIOL PSYCHIAT, V69, P19, DOI 10.1016/j.biopsych.2010.08.024; Caetano MS, 2012, J NEUROSCI, V32, P3765, DOI 10.1523/JNEUROSCI.6011-11.2012; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Dalton GL, 2011, PSYCHOPHARMACOLOGY, V216, P525, DOI 10.1007/s00213-011-2246-z; Dawson N., 2011, SCHIZOPHR B; Driesen NR, 2008, BIOL PSYCHIAT, V64, P1026, DOI 10.1016/j.biopsych.2008.07.029; Dumas TC, 2005, PROG NEUROBIOL, V76, P189, DOI 10.1016/j.pneurobio.2005.08.002; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Fitzgerald PJ, 2012, BEHAV BRAIN RES, V230, P291, DOI 10.1016/j.bbr.2012.01.057; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goff DC, 2007, J CLIN PSYCHOPHARM, V27, P582, DOI 10.1097/jcp.0b013e31815abf34; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Honey RAE, 2004, NEUROPSYCHOPHARMACOL, V29, P1203, DOI 10.1038/sj.npp.1300438; Jackson M, 2004, ANN BOT-LONDON, V93, P1, DOI 10.1093/aob/mch033; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Jentsch JD, 1997, J NEUROSCI, V17, P1769; Keedy SK, 2006, PSYCHIAT RES-NEUROIM, V146, P199, DOI 10.1016/j.pscychresns.2006.01.003; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kristiansen LV, 2010, SCHIZOPHR RES, V119, P198, DOI 10.1016/j.schres.2010.02.1069; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Krystal JH, 2005, PSYCHOPHARMACOLOGY, V179, P303, DOI 10.1007/s00213-004-1982-8; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; Lieberman JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1322, DOI 10.1038/npp.2008.200; Linn GS, 1999, NEUROREPORT, V10, P2789, DOI 10.1097/00001756-199909090-00017; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo CC, 2009, J NEUROSCI, V29, P9059, DOI 10.1523/JNEUROSCI.6164-08.2009; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; Murray JD, 2012, CEREB CORTEX; Paspalas C. D., 2012, CEREB CORTEX, V2012, P12, DOI DOI 10.1093/CERC0R/BHS152; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Roberts BM, 2010, NEUROREPORT, V21, P390, DOI 10.1097/WNR.0b013e3283381a4e; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Salvadore G, 2009, BIOL PSYCHIAT, V65, P289, DOI 10.1016/j.biopsych.2008.08.014; SAWAGUCHI T, 1989, J NEUROPHYSIOL, V61, P435, DOI 10.1152/jn.1989.61.2.435; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Selemon L.D., 1995, ARCH GEN PSYCHIAT, V52, P819; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Skoblenick K, 2012, J NEUROSCI, V32, P12018, DOI 10.1523/JNEUROSCI.1510-12.2012; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Stefani MR, 2003, BEHAV NEUROSCI, V117, P728, DOI 10.1037/0735-7044.117.4.728; van Dyck CH, 2004, CNS SPECTRUMS, V9, P24, DOI 10.1017/S1092852900024780; Verma A, 1996, J NEUROSCI, V16, P373; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; Weickert C.S., 2012, MOL PSYCHIAT; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	85	299	302	1	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					736	749		10.1016/j.neuron.2012.12.032	http://dx.doi.org/10.1016/j.neuron.2012.12.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439125	Green Accepted, Bronze			2022-12-25	WOS:000315561300015
J	Tian, Y; Li, T; Sun, MK; Wan, DD; Li, Q; Li, PP; Zhang, ZC; Han, JH; Xie, W				Tian, Yao; Li, Tao; Sun, Mingkuan; Wan, Didi; Li, Qian; Li, Peipei; Zhang, Zi Chao; Han, Junhai; Xie, Wei			Neurexin Regulates Visual Function via Mediating Retinoid Transport to Promote Rhodopsin Maturation	NEURON			English	Article							ACID-BINDING GLYCOPROTEIN; CYCLOPHILIN HOMOLOG NINAA; VITAMIN-A; DROSOPHILA RHODOPSIN; GENETIC DISSECTION; SYNAPSE FORMATION; PROTEIN; TRANSDUCTION; EXPRESSION; RECEPTOR	Neurexins are cell adhesion molecules involved in synapse formation and synaptic regulation. Mutations in the neurexin genes are linked to a number of neurodevelopmental disorders such as autism. Here, we show that the Drosophila homolog of alpha-Neurexin is critical for fly visual function. Lack of Neurexin leads to significantly impaired visual function due to reduced rhodopsin levels. We show that the decreased chromophore levels cause deficits in rhodopsin maturation and that Neurexin is required for retinoid transport. Using yeast two-hybrid screening, we identify that Neurexin interacts with apolipoprotein I (ApoL I), a product generated by cleavage of retinoid- and fatty acid-binding glycoprotein (RFABG) that function's in retinoid transport. Finally, we demonstrate that Neurexin is essential for the apolipoproteins level. Our results reveal a role for Neurexin in mediating retinoid transport and subsequent rhodopsin maturation and suggest that Neurexin regulates lipoprotein function.	[Tian, Yao; Li, Tao; Sun, Mingkuan; Wan, Didi; Li, Qian; Li, Peipei; Zhang, Zi Chao; Han, Junhai; Xie, Wei] Southeast Univ, Key Lab Dev Genes & Human Dis, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China	Southeast University - China	Han, JH (corresponding author), Southeast Univ, Key Lab Dev Genes & Human Dis, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China.	junhaihan@seu.edu.cn; wei.xie@seu.edu.cn	Sun, Mingkuan/H-6191-2019; ZHANG, ZICHAO/C-1764-2014; SUN, Mingkuan/I-7186-2016	Sun, Mingkuan/0000-0002-4511-5894; ZHANG, ZICHAO/0000-0003-3402-7757; SUN, Mingkuan/0000-0002-4511-5894; Tian, Yao/0000-0002-0367-6239; Zhang, Zi Chao/0000-0001-5769-948X	National Natural Science Foundation of China [30930051, 30970663, 91132706]; National Basic Research Program (973 Program) [2012CB517903]; New-Century Training Program Foundation for Talent by the State Education Commission; Youth Foundation of Southeast University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); New-Century Training Program Foundation for Talent by the State Education Commission; Youth Foundation of Southeast University	We thank Dr. C.S. Zuker for providing ninaA<SUP>269</SUP> flies, anti-INAD antibody, and anti-NINAA antibody; Dr. Hong-sheng Li for providing anti-TRP antibody and anti-Arr2 antibody; Dr. Suzanne Eaton for providing anti-ApoL I antibody, anti-ApoL II antibody, and p[UAS-RFABG] transgenic flies; Bloomington Stock Center for the flies; Dr. Zhengping Jia, Dr. Li-Yang Chiang, Dr. Zikai Zhou, and members of the Han laboratory for their critical comments on the manuscript. This work was supported by the National Natural Science Foundation of China (Key program 30930051) and the National Basic Research Program (973 Program) Grant (2012CB517903) to W.X. and the National Natural Science Foundation of China (30970663 and 91132706) and the New-Century Training Program Foundation for Talent by the State Education Commission and Youth Foundation of Southeast University to J.H.	BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Cunningham LL, 1999, EXP EYE RES, V68, P399, DOI 10.1006/exer.1998.0633; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DUNCAN T, 1994, ARCH BIOCHEM BIOPHYS, V312, P158, DOI 10.1006/abbi.1994.1294; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Gu G, 2004, J BIOL CHEM, V279, P18608, DOI 10.1074/jbc.M400323200; Han J, 2007, EMBO J, V26, P4966, DOI 10.1038/sj.emboj.7601929; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Mosedale M, 2012, J BIOL CHEM, V287, P6350, DOI 10.1074/jbc.M111.299081; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OZAKI K, 1993, NEURON, V10, P1113, DOI 10.1016/0896-6273(93)90059-Z; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Pak W.L., 1979, P67; Palczewski K, 1997, CURR OPIN NEUROBIOL, V7, P500, DOI 10.1016/S0959-4388(97)80029-3; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Paraoanu LE, 2006, NEUROSCI LETT, V395, P114, DOI 10.1016/j.neulet.2005.10.076; PUSCHEL AW, 1995, J NEUROSCI, V15, P2849; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Shim K, 1997, EXP EYE RES, V65, P717, DOI 10.1006/exer.1997.0383; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; SUNG CH, 1994, J NEUROSCI, V14, P5818; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Voolstra O, 2010, J BIOL CHEM, V285, P2130, DOI 10.1074/jbc.M109.056101; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wang T, 2005, J NEUROSCI, V25, P5187, DOI 10.1523/JNEUROSCI.0995-05.2005; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Wiest MM, 2009, PROSTAG LEUKOTR ESS, V80, P221, DOI 10.1016/j.plefa.2009.01.007; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	67	28	35	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					311	322		10.1016/j.neuron.2012.11.012	http://dx.doi.org/10.1016/j.neuron.2012.11.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352167	Bronze			2022-12-25	WOS:000314199400013
J	Lee, BR; Ma, YY; Huang, YHH; Wang, XS; Otaka, M; Ishikawa, M; Neumann, PA; Graziane, NM; Brown, TE; Suska, A; Guo, CY; Lobo, MK; Sesack, SR; Wolf, ME; Nestler, EJ; Shaham, Y; Schluter, OM; Dong, Y				Lee, Brian R.; Ma, Yao-Ying; Huang, Yanhua H.; Wang, Xiusong; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Brown, Travis E.; Suska, Anna; Guo, Changyong; Lobo, Mary Kay; Sesack, Susan R.; Wolf, Marina E.; Nestler, Eric J.; Shaham, Yavin; Schlueter, Oliver M.; Dong, Yan			Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving	NATURE NEUROSCIENCE			English	Article							PERMEABLE AMPA RECEPTORS; NUCLEUS-ACCUMBENS; REINSTATEMENT MODEL; DRUG RELAPSE; EXPOSURE; TRANSMISSION; PLASTICITY; WITHDRAWAL; SEEKING; ADAPTATIONS	In rat models of drug relapse and craving, cue-induced cocaine seeking progressively increases after withdrawal from the drug. This 'incubation of cocaine craving' is partially mediated by time-dependent adaptations at glutamatergic synapses in nucleus accumbens (NAc). However, the circuit-level adaptations mediating this plasticity remain elusive. We studied silent synapses, often regarded as immature synapses that express stable NMDA receptors with AMPA receptors being either absent or labile, in the projection from the basolateral amygdala to the NAc in incubation of cocaine craving. Silent synapses were detected in this projection during early withdrawal from cocaine. As the withdrawal period progressed, these silent synapses became unsilenced, a process that involved synaptic insertion of calcium-permeable AMPA receptors (CP-AMPARs). In vivo optogenetic stimulation-induced downregulation of CP-AMPARs at amygdala-to-NAc synapses, which re-silenced some of the previously silent synapses after prolonged withdrawal, decreased incubation of cocaine craving. Our findings indicate that silent synapse-based reorganization of the amygdala-to-NAc projection is critical for persistent cocaine craving and relapse after withdrawal.	[Lee, Brian R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Lee, Brian R.; Brown, Travis E.; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Ma, Yao-Ying; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Guo, Changyong; Sesack, Susan R.; Dong, Yan] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Huang, Yanhua H.; Wang, Xiusong] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Suska, Anna; Schlueter, Oliver M.] European Neurosci Inst, Gottingen, Germany; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA; [Shaham, Yavin] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH, Baltimore, MD USA	Scripps Research Institute; Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Dong, Y (corresponding author), Washington State Univ, Program Neurosci, Pullman, WA 99164 USA.	yandong@pitt.edu	Sesack, Susan R/H-8013-2018; shaham, yavin/G-1306-2014; Dong, Yan/A-4154-2016; Beroun, Anna/P-6322-2016; Huang, Yanhua/P-1583-2015; Lobo, Mary Kay/K-7734-2015	Sesack, Susan R/0000-0002-2852-7440; Dong, Yan/0000-0003-0016-9028; Beroun, Anna/0000-0003-4376-5241; Huang, Yanhua/0000-0003-1770-0196; Lobo, Mary Kay/0000-0002-9419-2079; Graziane, Nicholas/0000-0002-7055-7029; Lee, Brian/0000-0002-3210-5638	National Institute on Drug Abuse [DA028020, DA029565, DA036303, DA030379, DA009621, DA029099, DA007359, DA014133, DA023206, DA031551, DA034856]; German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society;  [SCHL592/4]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031551, R01DA009621, F31DA028020, R37DA015835, R01DA015835, R01DA023206, R01DA030379, R01DA034856, ZIADA000434, P01DA008227, R00DA029565, R01DA014133, K99DA029565, R37DA007359, R01DA007359, K05DA029099, R21DA036303] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society(Max Planck SocietyFoundation CELLEX); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Sorg, D. Dietz, R.L. Brown and H. Jansen for technical consultations. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse (Y.S.), extramural funds DA028020 (B.R.L.), DA029565 and DA036303 (Y.H.H.), DA030379 (M.E.W. and Y.D.), DA009621 and DA029099 (M.E.W.), DA007359 and DA014133 (E.J.N.), DA023206, DA031551 and DA034856 (Y.D.) from the National Institute on Drug Abuse, the German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain" and grant SCHL592/4 (O.M.S.). The European Neuroscience Institute Gottingen is jointly funded by the Gottingen University Medical School and the Max Planck Society.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Koya E, 2012, NAT NEUROSCI, V15, P1556, DOI 10.1038/nn.3232; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marchant NJ, 2013, CURR OPIN NEUROBIOL, V23, P675, DOI 10.1016/j.conb.2013.01.003; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Otaka M, 2013, J NEUROSCI, V33, P6753, DOI 10.1523/JNEUROSCI.4577-12.2013; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Purgianto A, 2013, NEUROPSYCHOPHARMACOL, V38, P1789, DOI 10.1038/npp.2013.78; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sorge RE, 2005, PSYCHOPHARMACOLOGY, V183, P210, DOI 10.1007/s00213-005-0160-y; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suska A, 2013, P NATL ACAD SCI USA, V110, P713, DOI 10.1073/pnas.1206287110; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013	50	207	207	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1644	1651		10.1038/nn.3533	http://dx.doi.org/10.1038/nn.3533			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077564	Green Accepted			2022-12-25	WOS:000326205700022
J	Li, YT; Ibrahim, LA; Liu, BH; Zhang, LI; Tao, HW				Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua; Zhang, Li I.; Tao, Huizhong Whit			Linear transformation of thalamocortical input by intracortical excitation	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; ORIENTATION SELECTIVITY; SIMPLE CELLS; RECEPTIVE-FIELDS; RESPONSE PROPERTIES; GABA(B) RECEPTORS; THALAMIC INPUT; NEURONS	Neurons in thalamorecipient layers of sensory cortices integrate thalamocortical and intracortical inputs. Although we know that their functional properties can arise from the convergence of thalamic inputs, intracortical circuits could also be involved in thalamocortical transformations of sensory information. We silenced intracortical excitatory circuits with optogenetic activation of parvalbumin-positive inhibitory neurons in mouse primary visual cortex and compared visually evoked thalamocortical input with total excitation in the same layer 4 pyramidal neurons. We found that intracortical excitatory circuits preserved the orientation and direction tuning of thalamocortical excitation, with a linear amplification of thalamocortical signals of about threefold. The spatial receptive field of thalamocortical input was slightly elongated and was expanded by intracortical excitation in an approximately proportional manner. Thus, intracortical excitatory circuits faithfully reinforce the representation of thalamocortical information and may influence the size of the receptive field by recruiting additional inputs.	[Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua; Zhang, Li I.; Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Tao, HW (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	htao@usc.edu	Li, Ya-tang/AAF-2573-2020; Tao, Huizhong W/HDM-9767-2022; Li, Ya-tang/A-9583-2011	Ibrahim, Leena Ali/0000-0001-8255-3423; Li, Ya-tang/0000-0003-2763-1534	US National Institutes of Health [EY019049, EY022478]; Kirchgessner Foundation; NATIONAL EYE INSTITUTE [R21EY022478, R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirchgessner Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Scanziani for the help on viral injection setup. This work was supported by grants to H.W.T. from the US National Institutes of Health (EY019049 and EY022478) and the Kirchgessner Foundation.	Adorjan P, 1999, VISUAL NEUROSCI, V16, P303, DOI 10.1017/S0952523899162114; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BenYishai R, 1997, J COMPUT NEUROSCI, V4, P57, DOI 10.1023/A:1008816611284; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Khibnik LA, 2010, NEURON, V66, P493, DOI 10.1016/j.neuron.2010.04.012; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li YT, 2012, J NEUROSCI, V32, P16466, DOI 10.1523/JNEUROSCI.3221-12.2012; Li YT, 2012, J NEUROSCI, V32, P3981, DOI 10.1523/JNEUROSCI.5514-11.2012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PFRIEGER FW, 1994, NEURON, V12, P97, DOI 10.1016/0896-6273(94)90155-4; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011	59	104	104	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1324	U216		10.1038/nn.3494	http://dx.doi.org/10.1038/nn.3494			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933750	Green Accepted			2022-12-25	WOS:000323597500025
J	Cao, R; Robinson, B; Xu, HY; Gkogkas, C; Khoutorsky, A; Alain, T; Yanagiya, A; Nevarko, T; Liu, AC; Amir, S; Sonenberg, N				Cao, Ruifeng; Robinson, Barry; Xu, Haiyan; Gkogkas, Christos; Khoutorsky, Arkady; Alain, Tommy; Yanagiya, Akiko; Nevarko, Tatiana; Liu, Andrew C.; Amir, Shimon; Sonenberg, Nahum			Translational Control of Entrainment and Synchrony of the Suprachiasmatic Circadian Clock by mTOR/4E-BP1 Signaling	NEURON			English	Article							VPAC(2) RECEPTOR; GENE-EXPRESSION; MESSENGER-RNA; NUCLEUS; MOUSE; CELLS; OSCILLATORS; RHYTHMICITY; LIGHT; VIP	Protein synthesis is critical for circadian clock function, but little is known of how translational regulation controls the master pacemaker in mammals, the suprachiasmatic nucleus (SCN). Here we demonstrate that the pivotal translational repressor, the eukaryotic translational initiation factor 4E binding protein 1 (4E-BP1), is rhythmically regulated via the mechanistic target of rapamycin (mTOR) signaling in the SCN and preferentially represses vasoactive intestinal peptide (Vip) nnRNA translation. Knockout (KO) of Eif4ebp1 (gene encoding 4E-BP1) leads to upregulation of VIP and higher amplitude of molecular rhythms in the SCN. Consequently, the 4E-BP1 null mice exhibit accelerated re-entrainment to a shifted light/dark cycle and are more resistant to the rhythm-disruptive effects of constant light. Conversely, in Mtor(+/-) mice VIP expression is decreased and susceptibility to the effects of constant light is increased. These results reveal a key role for mTOR/4E-BP1-mediated translational control in regulating entrainment and synchrony of the master clock.	[Cao, Ruifeng; Gkogkas, Christos; Khoutorsky, Arkady; Alain, Tommy; Yanagiya, Akiko; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Cao, Ruifeng; Gkogkas, Christos; Khoutorsky, Arkady; Alain, Tommy; Yanagiya, Akiko; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Robinson, Barry; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H4B 1R6, Canada; [Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	McGill University; McGill University; Concordia University - Canada; University of Memphis	Amir, S (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H4B 1R6, Canada.	shimon.amir@concordia.ca; nahum.sonenberg@mcgill.ca	Cao, Ruifeng/P-3819-2019; Gkogkas, Christos/GQH-2659-2022; Amir, Shimon/AAE-4635-2022; Cao, Ruifeng/K-8894-2013; Liu, Andrew C/B-3548-2009; Gkogkas, Christos/GLR-5348-2022	Cao, Ruifeng/0000-0001-5105-7726; Gkogkas, Christos/0000-0001-6281-3419; Liu, Andrew C/0000-0003-1927-0900; Khoutorsky, Arkady/0000-0003-3846-8728; Yanagiya, Akiko/0000-0002-5553-0311	Canadian Institute of Health Research (CIHR) [MOP 114994, MOP 13625]; National Science Foundation (NSF) [IOS-0920417]; Fonds de recherche du Quebec - Sante (FRQS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066157] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF)(National Science Foundation (NSF)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Rosbash, Isaac Edery, Erik Herzog, and Jane Stewart for advice and critical reading of the manuscript and Maritza Jaramillo, Alex Gavrila, Annie Sylvestre, and Isabelle Harvey for excellent technical assistance. We are indebted to Joseph Takahashi for his generous gift of the mPER2::LUC transgenic mice, Sara C. Kozma for the mtor floxed mice, and Linda Penn and Manfred Schwab for the SHEP neuroblastoma cell line. This work was supported by Canadian Institute of Health Research (CIHR) Grants MOP 114994 to N.S. and MOP 13625 to S.A. and by National Science Foundation (NSF) Grant IOS-0920417 to A.C.L.. N.S. is a senior international research scholar of the Howard Hughes Medical Institute (HHMI). R.C. is a Fonds de recherche du Quebec - Sante (FRQS) Postdoctoral Training Award recipient.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; An S., 2011, THESIS WASH U; An S, 2012, J COMP NEUROL, V520, P2730, DOI 10.1002/cne.23078; An SW, 2011, J NEUROPHYSIOL, V105, P2289, DOI 10.1152/jn.00966.2010; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao Ruifeng, 2010, Mol Cell Pharmacol, V2, P125; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cao RF, 2009, J NEUROSCI, V29, P12372, DOI 10.1523/JNEUROSCI.3486-09.2009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; GOZES I, 1989, MOL NEUROBIOL, V3, P201, DOI 10.1007/BF02740606; GOZES I, 1995, J PHARMACOL EXP THER, V273, P161; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings M H, 1999, J Neurosci, V19, pRC11; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee Choogon, 2007, Methods Mol Biol, V362, P385; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meyer-Spasche A, 2004, NEUROSCI LETT, V358, P91, DOI 10.1016/j.neulet.2003.12.114; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rohling JHT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025437; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Shen SB, 2000, P NATL ACAD SCI USA, V97, P11575, DOI 10.1073/pnas.97.21.11575; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TAKAHASHI Y, 1989, BRAIN RES, V497, P374, DOI 10.1016/0006-8993(89)90283-7; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Topisirovic I, 2011, COLD SH Q B, V76, P355, DOI 10.1101/sqb.2011.76.010785; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; VanderLeest HT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004976; WASCHEK JA, 1988, P NATL ACAD SCI USA, V85, P9547, DOI 10.1073/pnas.85.24.9547; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027	72	108	109	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					712	724		10.1016/j.neuron.2013.06.026	http://dx.doi.org/10.1016/j.neuron.2013.06.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972597	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000323587000011
J	Anjos-Afonso, F; Currie, E; Palmer, HG; Foster, KE; Taussig, DC; Bonnet, D				Anjos-Afonso, Fernando; Currie, Erin; Palmer, Hector G.; Foster, Katie E.; Taussig, David C.; Bonnet, Dominique			CD34(-) Cells at the Apex of the Human Hematopoietic Stem Cell Hierarchy Have Distinctive Cellular and Molecular Signatures	CELL STEM CELL			English	Article							BONE-MARROW; CORD BLOOD; IN-VIVO; DYE EFFLUX; ACTIVATION; DIFFERENTIATION; EXPRESSION; INJECTION; RISE	In addition to well-characterized CD34(+) hematopoietic stem and progenitor cells (HSPCs), the human hematopoietic stem cell (HSC) hierarchy contains a rare CD34(-) population with severe combined immunodeficiency-repopulating capacity. However, little is known about the molecular characteristics of these CD34(-) cells or their relationship to the CD34(+) populations. Here, we show that the self-renewing Lin(-)CD34(-)CD38(-)CD93(hi) population contains cells that not only function as HSCs, but can also be placed above the CD34(+) populations in the hematopoietic hierarchy. These cells have an active Notch pathway, in which signaling through Delta4 is crucial for maintenance of the primitive state, and combined signals from Jagged1 and TGF-beta are important in controlling its quiescence. They are also refractory to proliferative signals and show a repressed canonical Wnt pathway, in part regulated by Notch. Overall, therefore, CD34(-) cells represent an immature and quiescent human HSC population maintained through a distinctive network of cellular signaling interactions.	[Anjos-Afonso, Fernando; Currie, Erin; Foster, Katie E.; Bonnet, Dominique] Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, London WC2A 3LY, England; [Palmer, Hector G.] Vall dHebron Inst Oncol, Stem Cells & Canc Lab, Barcelona 08035, Spain; [Taussig, David C.] Queen Mary Univ London, Barts Canc Inst, Dept Haematooncol, London EC1M 6BQ, England	Cancer Research UK; Vall d'Hebron Institut d'Oncologia (VHIO); University of London; Queen Mary University London	Anjos-Afonso, F (corresponding author), Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	fernando.afonso@cancer.org.uk; d.bonnet@cancer.org.uk	Palmer, Héctor G./AAG-8332-2019; Seoane, Joan/AAG-9173-2019	Anjos-Afonso, Fernando/0000-0003-4392-488X; Palmer, Hector/0000-0002-9823-5638; Seoane, Joan/0000-0002-6541-5974	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK (to D. B.). Authors are grateful to the staff at the Biological Resources Unit and Flow Cytometry core facilities for their valuable technical help. We would like to thank Dr. Stuart Horswell for his valuable help with the statistical analysis and Dr. Elena Siapati for her valuable comments. We are thankful to Drs. Evelyne Lauret (Cochin University Hospital, Paris, France) and Anne-Marie Buckle (Univeristy of Manchester, Manchester, UK) for providing different S17 stroma cell lines. F.A.-A. designed and performed all experiments, analyzed data, and wrote the manuscript. E. C. helped perform experiments and wrote the manuscript. K. E. F. and D. C. T. helped perform experiments; H. G. P. helped design experiments and provided reagents. D. B. supervised the project, provided resources, and edited the manuscript.	Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dao MA, 2003, BLOOD, V101, P112, DOI 10.1182/blood-2002-01-0025; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kuci S, 2003, BLOOD, V101, P869, DOI 10.1182/blood-2002-03-0711; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Lemoli RM, 2003, BRIT J HAEMATOL, V123, P720, DOI 10.1046/j.1365-2141.2003.04673.x; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Storms RW, 2000, BLOOD, V96, P2125; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995; Zanjani ED, 1998, EXP HEMATOL, V26, P353	22	59	62	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					161	174		10.1016/j.stem.2013.05.025	http://dx.doi.org/10.1016/j.stem.2013.05.025			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910083	hybrid			2022-12-25	WOS:000329570600010
J	Krupp, JJ; Billeter, JC; Wong, A; Choi, C; Nitabach, MN; Levine, JD				Krupp, Joshua J.; Billeter, Jean-Christophe; Wong, Amy; Choi, Charles; Nitabach, Michael N.; Levine, Joel D.			Pigment-Dispersing Factor Modulates Pheromone Production in Clock Cells that Influence Mating in Drosophila	NEURON			English	Article							MALE SEX DRIVE; CIRCADIAN CLOCK; SOCIAL EXPERIENCE; NEUROPEPTIDE PDF; HNRNP-Q; MELANOGASTER; RHYTHMS; NEURONS; GENE; BEHAVIOR	Social cues contribute to the circadian entrainment of physiological and behavioral rhythms. These cues supplement the influence of daily and seasonal cycles in light and temperature. In Drosophila, the social environment modulates circadian mechanisms that regulate sex pheromone production and mating behavior. Here we demonstrate that a neuroendocrine pathway, defined by the neuropeptide Pigment-Dispersing Factor (PDF), couples the CNS to the physiological output of peripheral clock cells that produce pheromones, the oenocytes. PDF signaling from the CNS modulates the phase of the oenocyte clock. Despite its requirement for sustaining free-running locomoter activity rhythms, PDF is not necessary to sustain molecular rhythms in the oenocytes. Interestingly, disruption of the PDF signaling pathway reduces male sex pheromones and results in sex-specific differences in mating behavior. Our findings highlight the role of neuropeptide signaling and the circadian system in synchronizing the physiological and behavioral processes that govern social interactions.	[Krupp, Joshua J.; Billeter, Jean-Christophe; Wong, Amy; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Billeter, Jean-Christophe] Univ Groningen, Ctr Behav & Neurosci, NL-9700 CC Groningen, Netherlands; [Choi, Charles; Nitabach, Michael N.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, Dept Genet,Program Cellular Neurosci Neurodegener, New Haven, CT 06520 USA	University of Toronto; University Toronto Mississauga; University of Groningen; Yale University	Levine, JD (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	joel.levine@utoronto.ca		Choi, Hyun Chul/0000-0001-5231-6320; Billeter, Jean-Christophe/0000-0001-7796-4068	Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Canada Research Chair Program; Child and Brain Development Program of the Canadian Institute for Advanced Research; Sleep and Biological Rhythms Toronto; CIHR; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH) [R01NS055035, R01NS056443, R01GM098931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083875, R01NS056443, R56NS055035, R01NS055035] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Child and Brain Development Program of the Canadian Institute for Advanced Research; Sleep and Biological Rhythms Toronto; CIHR(Canadian Institutes of Health Research (CIHR)); National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to J. Atallah, J. Schneider, A. Rooke, and R. Rooke for comments on the text and to S. Jagadeesh for assistance with the mating experiments. This work was supported by grants to J.D.L. from the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council, the Canada Research Chair Program, and the Child and Brain Development Program of the Canadian Institute for Advanced Research. J.J.K. was supported by Sleep and Biological Rhythms Toronto, a CIHR-funded transdisciplinary research and training program at the University of Toronto. Work in the laboratory of M.N.N. was supported in part by the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH) (R01NS055035, R01NS056443, R01GM098931).	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bloch G, 2011, PHILOS T R SOC B, V366, P2155, DOI 10.1098/rstb.2010.0346; Chatterjee A, 2010, CURR BIOL, V20, P300, DOI 10.1016/j.cub.2009.12.055; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; HARDELAND R, 1972, ANIM BEHAV, V20, P170, DOI 10.1016/S0003-3472(72)80188-X; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Immonen E, 2012, P ROY SOC B-BIOL SCI, V279, P1359, DOI 10.1098/rspb.2011.1644; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Krupp Joshua J, 2010, J Vis Exp, DOI 10.3791/2242; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Ovadia A, 2010, PLANT MOL BIOL, V72, P659, DOI 10.1007/s11103-010-9605-8; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park D, 2011, CURR BIOL, V21, P1515, DOI 10.1016/j.cub.2011.08.015; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Talsma AD, 2012, P NATL ACAD SCI USA, V109, P12177, DOI 10.1073/pnas.1200247109; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	59	54	55	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					54	68		10.1016/j.neuron.2013.05.019	http://dx.doi.org/10.1016/j.neuron.2013.05.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23849197	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000321802000009
J	Liston, C; Cichon, JM; Jeanneteau, F; Jia, ZP; Chao, MV; Gan, WB				Liston, Conor; Cichon, Joseph M.; Jeanneteau, Freddy; Jia, Zhengping; Chao, Moses V.; Gan, Wen-Biao			Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; GENE-EXPRESSION; IN-VIVO; NORADRENERGIC ACTIVATION; PYRAMIDAL NEURONS; MEMORY STORAGE; STRESS; RECEPTOR; PLASTICITY	Excessive glucocorticoid exposure during chronic stress causes synapse loss and learning impairment. Under normal physiological conditions, glucocorticoid activity oscillates in synchrony with the circadian rhythm. Whether and how endogenous glucocorticoid oscillations modulate synaptic plasticity and learning is unknown. Here we show that circadian glucocorticoid peaks promote postsynaptic dendritic spine formation in the mouse cortex after motor skill learning, whereas troughs are required for stabilizing newly formed spines that are important for long-term memory retention. Conversely, chronic and excessive exposure to glucocorticoids eliminates learning-associated new spines and disrupts previously acquired memories. Furthermore, we show that glucocorticoids promote rapid spine formation through a non-transcriptional mechanism by means of the LIM kinase-cofilin pathway and increase spine elimination through transcriptional mechanisms involving mineralocorticoid receptor activation. Together, these findings indicate that tightly regulated circadian glucocorticoid oscillations are important for learning-dependent synaptic formation and maintenance. They also delineate a new signaling mechanism underlying these effects.	[Liston, Conor; Cichon, Joseph M.; Chao, Moses V.; Gan, Wen-Biao] NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA; [Liston, Conor] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Jeanneteau, Freddy] CNRS, INSERM, Inst Genom Fonct, UMR 5203,U661, Montpellier, France; [Jia, Zhengping] Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada	New York University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Liston, C (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA.	cliston@stanford.edu; gan@saturn.med.nyu.edu	Jia, zhengping/AAZ-4190-2021; , Conor Liston/GQH-8931-2022; Jeanneteau, Freddy/AAC-7052-2021	Chao, Moses/0000-0002-6969-3744; Jeanneteau, freddy/0000-0002-9606-2892	US National Institutes of Health [R01 NS047325, R01MH085324, MH086651, NS21072]; US National Institute of Mental Health [K99 MH097822]; DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086651, K99MH097822, R00MH097822, R01MH085324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325, R56NS021072, R01NS021072] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.S. McEwen and Gan laboratory members for critical comments on this manuscript. This work was supported by grants from the US National Institutes of Health (R01 NS047325 and a subcontract of R01MH085324) to W.-B.G.C.L. is supported by grants from the US National Institute of Mental Health (K99 MH097822) and the DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College. F.J. and M.V.C. are supported by grants from the US National Institutes of Health (MH086651 and NS21072).	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bangasser DA, 2007, NAT NEUROSCI, V10, P1401, DOI 10.1038/nn1973; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dailey ME, 1996, J NEUROSCI, V16, P2983; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Di S, 2003, J NEUROSCI, V23, P4850; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Karssen AM, 2005, ENDOCRINOLOGY, V146, P5587, DOI 10.1210/en.2005-0501; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller NL, 2012, SLEEP, V35, P1123, DOI 10.5665/sleep.2002; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	60	240	242	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					698	+		10.1038/nn.3387	http://dx.doi.org/10.1038/nn.3387			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624512	Green Accepted			2022-12-25	WOS:000319509600011
J	Inoue, W; Baimoukhametova, DV; Fuzesi, T; Wamsteeker Cusulin, JI; Koblinger, K; Whelan, PJ; Pittman, QJ; Bains, JS				Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.			Noradrenaline is a stress-associated metaplastic signal at GABA synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; BETA-ADRENERGIC-RECEPTORS; PARVOCELLULAR NEURONS; PROTEIN-KINASE; PHYSIOLOGICAL-RESPONSE; GENE-EXPRESSION; PLASTICITY; ACTIVATION	Exposure to a stressor sensitizes behavioral and hormonal responses to future stressors. Stress-associated release of noradrenaline enhances the capacity of central synapses to show plasticity (metaplasticity). We found noradrenaline-dependent metaplasticity at GABA synapses in the paraventricular nucleus of the hypothalamus in rat and mouse that controls the hypothalamic-pituitary-adrenal axis. In vivo stress exposure was required for these synapses to undergo activity-dependent long-term potentiation (LTPGABA). The activation of beta-adrenergic receptors during stress functionally upregulated metabotropic glutamate receptor 1 (mGluR1), allowing for mGluR1-dependent LTPGABA during afferent bursts. LTPGABA was expressed postsynaptically and manifested as the emergence of new functional synapses. Our findings provide, to the best of our knowledge, the first demonstration that noradrenaline release during an in vivo challenge alters information storage capacity at GABA synapses. Because these GABA synapses become excitatory following acute stress, this metaplasticity may contribute to neuroendocrine sensitization to stress.	[Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Bains, JS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca	Inoue, Wataru/M-2163-2015	Inoue, Wataru/0000-0002-2438-5123; Whelan, Patrick/0000-0002-1234-5415; Bains, Jaideep/0000-0002-3634-6463; Pittman, Quentin/0000-0003-0984-7665	Alberta Innovates-Health Solutions (AI-HS); Hotchkiss Brain Institute; Canadian Institute for Health Research; Alberta Innovates [201100359] Funding Source: researchfish	Alberta Innovates-Health Solutions (AI-HS); Hotchkiss Brain Institute; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	We thank members of the Bains laboratory for comments and discussion regarding the manuscript and C. Sank for technical assistance. We are grateful to the Hotchkiss Brain Institute for providing optogenetics core resources. AAV vectors carrying the ChR2 gene were developed by K. Deisseroth (Stanford University) and distributed by Addgene. W.I. and T.F. are supported by a postdoctoral fellowship, and J.I.W.C. and K.K. by a PhD scholarship from the Alberta Innovates-Health Solutions (AI-HS). W.I., K.K. and J.I.W.C. also received fellowship and/or scholarship support from the Hotchkiss Brain Institute. J.S.B. and P.J.W. are AI-HS Senior Scholars. Q.J.P. is an AI-HS Scientist. This work was funded by operating grants from the Canadian Institute for Health Research (J.S.B., P.J.W. and Q.J.P.).	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Armario A, 2004, STRESS, V7, P157, DOI 10.1080/10253890400010721; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Crosby KM, 2011, NEURON, V71, P529, DOI 10.1016/j.neuron.2011.06.006; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Daftary SS, 2000, NEUROSCIENCE, V96, P743, DOI 10.1016/S0306-4522(00)00003-8; Day HEW, 1999, J NEUROSCI, V19, P10098; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Flak JN, 2009, J COMP NEUROL, V517, P156, DOI 10.1002/cne.22142; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; ITOI K, 1994, ENDOCRINOLOGY, V135, P2177, DOI 10.1210/en.135.5.2177; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kocsis K, 1998, NEUROREPORT, V9, P4029, DOI 10.1097/00001756-199812210-00008; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Kwon MS, 2006, NEUROSCIENCE, V142, P1281, DOI 10.1016/j.neuroscience.2006.07.027; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Miklos IH, 2012, BIOL PSYCHIAT, V71, P301, DOI 10.1016/j.biopsych.2011.10.027; Mundell SJ, 2004, MOL PHARMACOL, V65, P1507, DOI 10.1124/mol.65.6.1507; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pacak K, 1995, ANN NY ACAD SCI, V771, P115, DOI 10.1111/j.1749-6632.1995.tb44675.x; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; SAPHIER D, 1991, BRAIN RES BULL, V26, P863, DOI 10.1016/0361-9230(91)90250-N; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Sugiyama Y, 2008, EUR J NEUROSCI, V27, P884, DOI 10.1111/j.1460-9568.2008.06063.x; TAKANO T, 1989, BRAIN RES, V499, P174, DOI 10.1016/0006-8993(89)91149-9; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Verkuyl JM, 2005, EUR J NEUROSCI, V21, P113, DOI 10.1111/j.1460-9568.2004.03846.x; Verkuyl JM, 2004, EUR J NEUROSCI, V20, P1665, DOI 10.1111/j.1460-9568.2004.03568.x; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wamsteeker Cusulin JI, 2013, NAT NEUROSCI, V16, P596, DOI 10.1038/nn.3374; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao JP, 2006, J NEUROSCI, V26, P12647, DOI 10.1523/JNEUROSCI.3678-06.2006	51	68	68	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					605	+		10.1038/nn.3373	http://dx.doi.org/10.1038/nn.3373			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563580	Green Accepted			2022-12-25	WOS:000318029300017
J	Dillman, AA; Hauser, DN; Gibbs, JR; Nalls, MA; McCoy, MK; Rudenko, IN; Galter, D; Cookson, MR				Dillman, Allissa A.; Hauser, David N.; Gibbs, J. Raphael; Nalls, Michael A.; McCoy, Melissa K.; Rudenko, Iakov N.; Galter, Dagmar; Cookson, Mark R.			mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex	NATURE NEUROSCIENCE			English	Article							GLOBAL REGULATION; GENOME; POINT	The complexity of the adult brain is a result of both developmental processes and experience-dependent circuit formation. One way to look at the differences between embryonic and adult brain is to examine gene expression. Previous studies have used microarrays to address this in a global manner. However, the transcriptome is more complex than gene expression levels alone, as alternative splicing and RNA editing generate a diverse set of mature transcripts. Here we report a high-resolution transcriptome data set of mouse cerebral cortex at embryonic and adult stages using RNA sequencing (RNA-Seq). We found many differences in gene expression, splicing and RNA editing between embryonic and adult cerebral cortex. Each data set was validated technically and biologically, and in each case we found our RNA-Seq observations to have predictive validity. We provide this data set and analysis as a resource for understanding gene expression in the embryonic and adult cerebral cortex.	[Dillman, Allissa A.; Hauser, David N.; McCoy, Melissa K.; Rudenko, Iakov N.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Dillman, Allissa A.; Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Hauser, David N.] Brown Univ, Natl Inst Hlth Grad Partnership Program, Dept Neurosci, Providence, RI 02912 USA; [Gibbs, J. Raphael] NIA, Computat Biol Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Gibbs, J. Raphael] UCL, Inst Neurol, Reta Lila Weston Labs, London, England; [Gibbs, J. Raphael] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Nalls, Michael A.] NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Karolinska Institutet; Brown University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Cookson, Mark/AAW-2516-2021; Hauser, David/AAJ-1536-2020; Galter, Dagmar/C-4826-2011; Gibbs, J. Raphael/A-3984-2010; Hauser, David/I-4933-2012	Cookson, Mark/0000-0002-1058-3831; Galter, Dagmar/0000-0001-6485-6244; Gibbs, J. Raphael/0000-0002-6985-0658; Hauser, David/0000-0002-9500-5255	US National Institutes of Health, National Institute on Aging [AG000947]; Swedish Research Council; Swedish Brain Power; NATIONAL INSTITUTE ON AGING [ZIAAG000947, K01AG000947] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank E. Lindquist for excellent technical assistance. We would also like to thank M. Do for assistance with cloning experiments. This research was supported in part by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging (project AG000947) and by the Swedish Research Council and Swedish Brain Power.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Blanc V, 2010, WIRES SYST BIOL MED, V2, P594, DOI 10.1002/wsbm.82; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; DeCerbo J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-216; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Kagami Yoshihiro, 2001, Gene Expression Patterns, V1, P39, DOI 10.1016/S1567-133X(01)00007-2; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Matsuki T, 2005, MOL BRAIN RES, V136, P231, DOI 10.1016/j.molbrainres.2005.02.008; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Semeralul MO, 2006, J NEUROBIOL, V66, P1646, DOI 10.1002/neu.20302; Serra MJ, 2004, NUCLEIC ACIDS RES, V32, P1824, DOI 10.1093/nar/gkh501; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	40	104	106	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					499	U178		10.1038/nn.3332	http://dx.doi.org/10.1038/nn.3332			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416452	Green Accepted			2022-12-25	WOS:000316723700022
J	Graziane, NM; Polter, AM; Briand, LA; Pierce, RC; Kauer, JA				Graziane, Nicholas M.; Polter, Abigail M.; Briand, Lisa A.; Pierce, R. Christopher; Kauer, Julie A.			Kappa Opioid Receptors Regulate Stress-Induced Cocaine Seeking and Synaptic Plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINERGIC-NEURONS; CONDITIONED PLACE PREFERENCE; INDUCED REINSTATEMENT; PRODYNORPHIN GENE; NUCLEUS-ACCUMBENS; STRIA TERMINALIS; IMMUNOHISTOCHEMICAL LOCALIZATION; INHIBITORY SYNAPSES	Stress facilitates reinstatement of addictive drug seeking in animals and promotes relapse in humans. Acute stress has marked and long-lasting effects on plasticity at both inhibitory and excitatory synapses on dopamine neurons in the ventral tegmental area (VTA), a key region necessary for drug reinforcement. Stress blocks long-term potentiation at GABAergic synapses on dopamine neurons in the VTA (LTPGABA), potentially removing a normal brake on activity. Here we show that blocking kappa opioid receptors (KORs) prior to forced-swim stress rescues LTPGABA. In contrast, blocking KORs does not prevent stress-induced potentiation of excitatory synapses nor morphine-induced block of LTPGABA. Using a kappa receptor antagonist as a selective tool to test the role of LTPGABA in vivo, we find that blocking KORs within the VTA prior to forced-swim stress prevents reinstatement of cocaine seeking. These results suggest that KORs may represent a useful therapeutic target for treatment of stress-triggered relapse in substance abuse.	[Graziane, Nicholas M.; Polter, Abigail M.; Kauer, Julie A.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Briand, Lisa A.; Pierce, R. Christopher] Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA	Brown University; University of Pennsylvania; Pennsylvania Medicine	Kauer, JA (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	julie_kauer@brown.edu	Briand, Lisa/P-4877-2018	Briand, Lisa/0000-0002-1228-5061; Kauer, Julie/0000-0002-3362-1642; Graziane, Nicholas/0000-0002-7055-7029	 [DA011289];  [MH019118];  [AA007459];  [DA026660];  [DA15214];  [DA18678]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281, R01DA011289, F32DA026660, K02DA018678, R01DA015214] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Drs. Jane Sullivan, Jonathan Ting, Pavel Ortinski, and Pierce and Kauer lab members for their help and suggestions. This research was supported by DA011289 (J.A.K.), MH019118 (N.M.G. and A.M.P.), AA007459 (AMP.) DA026660 (L.A.B.), DA15214 (R.C.P.), and DA18678 (R.C.P.).	Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Anstrom KK, 2005, NEUROPSYCHOPHARMACOL, V30, P1832, DOI 10.1038/sj.npp.1300730; ARVIDSSON U, 1995, P NATL ACAD SCI USA, V92, P5062, DOI 10.1073/pnas.92.11.5062; BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; Beardsley PM, 2010, PSYCHOPHARMACOLOGY, V210, P189, DOI 10.1007/s00213-010-1846-3; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Bonci A, 1999, J NEUROSCI, V19, P3723; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; BROWN SA, 1995, J STUD ALCOHOL, V56, P538, DOI 10.15288/jsa.1995.56.538; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Carey AN, 2007, EUR J PHARMACOL, V569, P84, DOI 10.1016/j.ejphar.2007.05.007; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chartoff EH, 2009, MOL PHARMACOL, V75, P704, DOI 10.1124/mol.108.051417; Chen ACH, 2002, AM J MED GENET, V114, P429, DOI 10.1002/ajmg.10362; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Ciccocioppo R, 2002, NEUROPSYCHOPHARMACOL, V27, P391, DOI 10.1016/S0893-133X(02)00302-0; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; COMER SD, 1993, J PHARMACOL EXP THER, V267, P1470; Conrad KL, 2010, BIOL PSYCHIAT, V68, P303, DOI 10.1016/j.biopsych.2010.03.030; Covington HE, 2008, PSYCHOPHARMACOLOGY, V197, P203, DOI 10.1007/s00213-007-1024-4; Dahl JP, 2005, AM J MED GENET B, V139B, P106, DOI 10.1002/ajmg.b.30238; DOHERTY K, 1995, PSYCHOPHARMACOLOGY, V119, P171, DOI 10.1007/BF02246158; Dong HW, 2003, J COMP NEUROL, V463, P434, DOI 10.1002/cne.10758; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FALLON JH, 1985, NEUROPEPTIDES, V5, P457, DOI 10.1016/0143-4179(85)90053-8; Famous KR, 2008, J NEUROSCI, V28, P11061, DOI 10.1523/JNEUROSCI.1221-08.2008; Ford CP, 2007, J NEUROPHYSIOL, V97, P883, DOI 10.1152/jn.00963.2006; GLICK SD, 1995, BRAIN RES, V681, P147, DOI 10.1016/0006-8993(95)00306-B; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; Guan YZ, 2010, NEUROPSYCHOPHARMACOL, V35, P1841, DOI 10.1038/npp.2010.51; HURD YL, 1993, SYNAPSE, V13, P357, DOI 10.1002/syn.890130408; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Kreek MJ, 2009, CURR OPIN PHARMACOL, V9, P74, DOI 10.1016/j.coph.2008.12.016; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Le AD, 1999, NEUROPSYCHOPHARMACOL, V21, P435, DOI 10.1016/S0893-133X(99)00024-X; Leri F, 2002, J NEUROSCI, V22, P5713; Lewanowitsch T, 2003, BRAIN RES, V964, P302, DOI 10.1016/S0006-8993(02)04117-3; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; MANLEY LD, 1992, J NEUROCHEM, V58, P1491, DOI 10.1111/j.1471-4159.1992.tb11369.x; Mansour A, 1996, NEUROSCIENCE, V71, P671, DOI 10.1016/0306-4522(95)00464-5; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P787, DOI 10.1038/sj.npp.1300860; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Meredith GE, 1999, ANN NY ACAD SCI, V877, P140, DOI 10.1111/j.1749-6632.1999.tb09266.x; MIGNAT C, 1995, LIFE SCI, V56, P793, DOI 10.1016/0024-3205(95)00010-4; MOTT DD, 1990, NEUROSCI LETT, V113, P222, DOI 10.1016/0304-3940(90)90307-U; NABESHIMA T, 1992, LIFE SCI, V51, P211, DOI 10.1016/0024-3205(92)90077-3; Nawata Y, 2012, PHARMACOL BIOCHEM BE, V101, P297, DOI 10.1016/j.pbb.2012.01.003; Negus SS, 1997, J PHARMACOL EXP THER, V282, P44; Niehaus JL, 2010, EUR J NEUROSCI, V32, P108, DOI 10.1111/j.1460-9568.2010.07256.x; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Nugent FS, 2009, NEUROPSYCHOPHARMACOL, V34, P1829, DOI 10.1038/npp.2009.5; Paladini CA, 1999, SYNAPSE, V32, P165, DOI 10.1002/(SICI)1098-2396(19990601)32:3<165::AID-SYN3>3.0.CO;2-N; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Poulin JF, 2009, PROG NEURO-PSYCHOPH, V33, P1356, DOI 10.1016/j.pnpbp.2009.06.021; Redila VA, 2008, PSYCHOPHARMACOLOGY, V200, P59, DOI 10.1007/s00213-008-1122-y; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 1996, PSYCHOPHARMACOLOGY, V125, P385, DOI 10.1007/BF02246022; Shippenberg TS, 2009, NEUROPSYCHOPHARMACOL, V34, P247, DOI 10.1038/npp.2008.165; Simmons D, 2009, NEUROPSYCHOPHARMACOL, V34, P1946, DOI 10.1038/npp.2009.28; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2007, DRUG ALCOHOL REV, V26, P25, DOI 10.1080/09595230601036960; Smith JS, 2012, J NEUROSCI, V32, P1488, DOI 10.1523/JNEUROSCI.2980-11.2012; Sorge RE, 2005, PSYCHOPHARMACOLOGY, V183, P210, DOI 10.1007/s00213-005-0160-y; SPECIALE SG, 1993, J NEURAL TRANSM-GEN, V91, P53, DOI 10.1007/BF01244918; Sperling RE, 2010, PSYCHOPHARMACOLOGY, V210, P199, DOI 10.1007/s00213-010-1844-5; Stewart J, 2000, J PSYCHIATR NEUROSCI, V25, P125; Sun WL, 2010, PSYCHOPHARMACOLOGY, V210, P179, DOI 10.1007/s00213-010-1812-0; TAKAHASHI M, 1990, JPN J PHARMACOL, V53, P487, DOI 10.1254/jjp.53.487; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Valdez GR, 2007, J PHARMACOL EXP THER, V323, P525, DOI 10.1124/jpet.107.125484; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Williams TJ, 2007, ADDICT BIOL, V12, P496, DOI 10.1111/j.1369-1600.2007.00069.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf Marina E, 2002, Mol Interv, V2, P146, DOI 10.1124/mi.2.3.146	94	84	86	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 6	2013	77	5					942	954		10.1016/j.neuron.2012.12.034	http://dx.doi.org/10.1016/j.neuron.2012.12.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473323	Green Accepted, Bronze			2022-12-25	WOS:000316162600014
J	Watrous, AJ; Tandon, N; Conner, CR; Pieters, T; Ekstrom, AD				Watrous, Andrew J.; Tandon, Nitin; Conner, Chris R.; Pieters, Thomas; Ekstrom, Arne D.			Frequency-specific network connectivity increases underlie accurate spatiotemporal memory retrieval	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY-LEARNING-SYSTEMS; HUMAN NEOCORTICAL OSCILLATIONS; THETA OSCILLATIONS; PARIETAL CORTEX; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; PHASE-LOCKING; HIPPOCAMPAL	The medial temporal lobes, prefrontal cortex and parts of parietal cortex form the neural underpinnings of episodic memory, which includes remembering both where and when an event occurred. However, the manner in which these three regions interact during retrieval of spatial and temporal context remains untested. We employed simultaneous electrocorticographical recordings across multilobular regions in patients undergoing seizure monitoring while they retrieved spatial and temporal context associated with an episode, and we used phase synchronization as a measure of network connectivity. Successful memory retrieval was characterized by greater global connectivity compared with incorrect retrieval, with the medial temporal lobe acting as a hub for these interactions. Spatial versus temporal context retrieval resulted in prominent differences in both the spectral and temporal patterns of network interactions. These results emphasize dynamic network interactions as being central to episodic memory retrieval, providing insight into how multiple contexts underlying a single event can be recreated in the same network.	[Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif, Ctr Neurosci, Davis, CA USA; [Tandon, Nitin; Conner, Chris R.; Pieters, Thomas] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Tandon, Nitin] Memorial Hermann Hosp, Texas Med Ctr, Houston, TX USA; [Ekstrom, Arne D.] Univ Calif, Dept Psychol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Davis	Ekstrom, AD (corresponding author), Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA.	adekstrom@ucdavis.edu	Ekstrom, Arne/A-1329-2013	Tandon, Nitin/0000-0002-2752-2365; Ekstrom, Arne/0000-0002-6812-2368; Conner, Christopher R/0000-0003-0176-9025	Sloan Foundation; Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke [RO1NS076856]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076856] Funding Source: NIH RePORTER	Sloan Foundation(Alfred P. Sloan Foundation); Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Ranganath and A. Yonelinas, as well as members of their laboratories, for helpful comments on this manuscript. This work was supported by the Sloan Foundation, a Hellman Young Investigator Award and National Institute of Neurological Disorders and Stroke grant RO1NS076856.	Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2011, NEUROIMAGE, V56, P1803, DOI 10.1016/j.neuroimage.2011.02.033; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Maris E, 2011, NEUROIMAGE, V54, P836, DOI 10.1016/j.neuroimage.2010.09.029; Marshuetz C, 2006, NEUROSCIENCE, V139, P311, DOI 10.1016/j.neuroscience.2005.04.071; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mormann F, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.003.2008; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Watrous AJ, 2011, J NEUROPHYSIOL, V105, P1747, DOI 10.1152/jn.00921.2010; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Zhang H, 2013, HUM BRAIN MAPP, V34, P1070, DOI 10.1002/hbm.21494	47	189	193	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					349	356		10.1038/nn.3315	http://dx.doi.org/10.1038/nn.3315			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354333	Green Submitted, Green Accepted			2022-12-25	WOS:000315474800018
J	Chang, L; Breuninger, T; Euler, T				Chang, Le; Breuninger, Tobias; Euler, Thomas			Chromatic Coding from Cone-type Unselective Circuits in the Mouse Retina	NEURON			English	Article							RECEPTIVE-FIELD STRUCTURE; MIDGET GANGLION-CELLS; PRIMATE RETINA; COLOR-VISION; PARVOCELLULAR PATHWAY; VISUAL PIGMENTS; AMACRINE CELLS; GENE-THERAPY; M OPSINS; PHOTORECEPTORS	Retinal specializations such as cone-photoreceptor opsin-expression gradients, as found in several vertebrate species, are intuitively considered detrimental to color vision. In mice, the majority of cones coexpress both "blue" and "green" opsin. The coexpression ratio changes along the dorsoventral axis, resulting in a "green"-dominant dorsal and a "blue"-dominant ventral retina. Here, we asked how these specializations affect chromatic processing, especially with respect to the opsin transitional zone, the band where opsin coexpression shifts from "green" to "blue." Using electrophysiology, modeling, and calcium imaging, we found that "alpha-like" retinal ganglion cells, which previously have not been implicated in chromatic processing, display color-opponent responses when located in the vicinity of the opsin transitional zone. Moreover, direction-selective ganglion cells within this zone respond differentially to color sequences. Our data suggest that the dorsoventral opsin distribution, in combination with conventional spatiotemporal processing, renders mouse ganglion cell responses color-opponent without requiring cone-type selective connectivity.	[Chang, Le; Breuninger, Tobias; Euler, Thomas] Univ Tubingen, Ctr Ophthalmol, CIN, D-72076 Tubingen, Germany; [Chang, Le] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Chang, Le] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Euler, T (corresponding author), Univ Tubingen, Ctr Ophthalmol, CIN, Otfried Muller Str 25, D-72076 Tubingen, Germany.	thomas.euler@cin.uni-tuebingen.de		Euler, Thomas/0000-0002-4567-6966	DFG [EXC 307, FOR 701]	DFG(German Research Foundation (DFG))	We thank Gordon Eske for excellent technical assistance, Tom Baden, Christian Puller, and Martin Greschner for helpful discussions, and Silke Haverkamp for providing GFP-O mice. This work was supported by the DFG (EXC 307 to T.E., FOR 701 to L.C. and T.B.).	Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Lin B, 2006, J COMP NEUROL, V499, P797, DOI 10.1002/cne.21126; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Briggman KL, 2011, J NEUROPHYSIOL, V105, P2601, DOI 10.1152/jn.00722.2010; Buzas P, 2006, J NEUROSCI, V26, P11148, DOI 10.1523/JNEUROSCI.3237-06.2006; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Crook JD, 2011, J NEUROSCI, V31, P1762, DOI 10.1523/JNEUROSCI.4385-10.2011; Crook JD, 2009, J NEUROSCI, V29, P8372, DOI 10.1523/JNEUROSCI.1218-09.2009; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Daniele LL, 2011, VISION RES, V51, P447, DOI 10.1016/j.visres.2010.12.017; Demb JB, 1999, J NEUROSCI, V19, P9756; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Ekesten B, 2005, VISUAL NEUROSCI, V22, P893, DOI 10.1017/S0952523805226172; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Gouras P, 2004, EXP EYE RES, V79, P887, DOI 10.1016/j.exer.2004.06.031; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Jusuf PR, 2006, J NEUROSCI, V26, P3908, DOI 10.1523/JNEUROSCI.4891-05.2006; Jusuf PR, 2006, J COMP NEUROL, V494, P260, DOI 10.1002/cne.20804; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; Makous W, 2007, SCIENCE, V318, DOI 10.1126/science.1146084; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Neitz J, 2008, CURR BIOL, V18, pR700, DOI 10.1016/j.cub.2008.06.062; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neitz M, 2001, TRENDS NEUROSCI, V24, P248, DOI 10.1016/S0166-2236(00)01773-2; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Odermatt B, 2012, NEURON, V73, P758, DOI 10.1016/j.neuron.2011.12.023; PAULUS W, 1983, VISION RES, V23, P529, DOI 10.1016/0042-6989(83)90128-1; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Puller C, 2011, VISUAL NEUROSCI, V28, P51, DOI 10.1017/S0952523810000271; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Shapley R, 2009, NATURE, V461, P737, DOI 10.1038/461737a; Sher A, 2012, NAT NEUROSCI, V15, P952, DOI 10.1038/nn.3127; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Wei W, 2010, NAT PROTOC, V5, P1347, DOI 10.1038/nprot.2010.106; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009; ZRENNER E, 1981, VISION RES, V21, P1605, DOI 10.1016/0042-6989(81)90042-0	64	60	61	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					559	571		10.1016/j.neuron.2012.12.012	http://dx.doi.org/10.1016/j.neuron.2012.12.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395380	Bronze			2022-12-25	WOS:000317030800016
J	Flavahan, WA; Wu, QL; Hitomi, M; Rahim, N; Kim, Y; Sloan, AE; Weil, RJ; Nakano, I; Sarkaria, JN; Stringer, BW; Day, BW; Li, MZ; Lathia, JD; Rich, JN; Hjelmeland, AB				Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Sloan, Andrew E.; Weil, Robert J.; Nakano, Ichiro; Sarkaria, Jann N.; Stringer, Brett W.; Day, Bryan W.; Li, Meizhang; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.			Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake	NATURE NEUROSCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; GENE-EXPRESSION; STEM-CELLS; GLIOMA; CANCER; GLIOBLASTOMA; GLUT3; IDH1; CARCINOMA; SURVIVAL	Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.	[Flavahan, William A.; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA; [Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA; [Sloan, Andrew E.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH USA; [Weil, Robert J.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Cleveland, OH 44106 USA; [Weil, Robert J.] Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Nakano, Ichiro] Ohio State Univ, Med Ctr, Dardinger Lab Neurosci, Dept Neurol Surg, Columbus, OH 43210 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Brain Canc Res Unit, Brisbane, Qld 4006, Australia; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Res Unit, Leukaemia Fdn, Brisbane, Qld 4006, Australia; [Li, Meizhang; Lathia, Justin D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Mayo Clinic; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Cleveland Clinic Foundation	Rich, JN (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA.	richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Nakano, Ichiro/F-2076-2014; Day, Bryan/AAV-6170-2020; Nakano, Ichiro/AAR-9562-2020; Stringer, Brett/GZB-1390-2022; Day, Bryan/O-4469-2015; Sloan, Andrew/AAE-9842-2020	Nakano, Ichiro/0000-0002-6734-3468; Nakano, Ichiro/0000-0002-0916-3207; Hjelmeland, Anita/0000-0003-2200-3248; Stringer, Brett/0000-0003-4552-9736; Day, Bryan/0000-0002-8948-9089	NCI NIH HHS [P30 CA016058, K99 CA157948, UM1 CA137443, K08 CA101954, CA116257, R01 CA116659, U01 CA137443, R01 CA169117, R42 CA128269, CA128269, CA157948, CA137443, R01 CA154130, R00 CA157948, R01 CA116257, CA151522, R01 CA151522, CA116659, CA101954, CA129958, CA154130, R01 CA129958] Funding Source: Medline; NINDS NIH HHS [R01 NS063971, NS063971] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154130, R01CA151522, U01CA137443, K08CA101954, K99CA157948, P30CA016058, R01CA129958, R00CA157948, R42CA128269, R01CA116257, R01CA116659, R01CA169117, UM1CA137443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063971] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baer S, 2002, LARYNGOSCOPE, V112, P393, DOI 10.1097/00005537-200202000-00034; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; BURGESS EA, 1962, CANCER RES, V22, P581; Charnley N, 2008, ONCOL REP, V20, P537, DOI 10.3892/or_00000039; Chen YJ, 2013, ENDOCRINOLOGY, V154, P1598, DOI 10.1210/en.2012-2076; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung JK, 2004, NUCL MED COMMUN, V25, P11, DOI 10.1097/00006231-200401000-00003; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; FELLOWS LK, 1993, BRAIN RES, V604, P225, DOI 10.1016/0006-8993(93)90373-U; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mathews EH, 2011, MED HYPOTHESES, V76, P157, DOI 10.1016/j.mehy.2010.09.006; NAGAMATSU S, 1993, J NEUROCHEM, V61, P2048, DOI 10.1111/j.1471-4159.1993.tb07441.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Nutt CL, 2003, CANCER RES, V63, P1602; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Younes M, 1997, ANTICANCER RES, V17, P2747; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	52	309	316	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1373	+		10.1038/nn.3510	http://dx.doi.org/10.1038/nn.3510			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995067	Green Accepted			2022-12-25	WOS:000324795300009
J	Gupta, VK; Scheunemann, L; Eisenberg, T; Mertel, S; Bhukel, A; Koemans, TS; Kramer, JM; Liu, KSY; Schroeder, S; Stunnenberg, HG; Sinner, F; Magnes, C; Pieber, TR; Dipt, S; Fiala, A; Schenck, A; Schwaerzel, M; Madeo, F; Sigrist, SJ				Gupta, Varun K.; Scheunemann, Lisa; Eisenberg, Tobias; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Kramer, Jamie M.; Liu, Karen S. Y.; Schroeder, Sabrina; Stunnenberg, Hendrik G.; Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.; Dipt, Shubham; Fiala, Andre; Schenck, Annette; Schwaerzel, Martin; Madeo, Frank; Sigrist, Stephan J.			Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; LIFE-SPAN; ORNITHINE-DECARBOXYLASE; DIETARY RESTRICTION; C-ELEGANS; MICE; BRAIN; SPERMIDINE; LONGEVITY; DISEASE	Age-dependent memory impairment is known to occur in several organisms, including Drosophila, mouse and human. However, the fundamental cellular mechanisms that underlie these impairments are still poorly understood, effectively hampering the development of pharmacological strategies to treat the condition. Polyamines are among the substances found to decrease with age in the human brain. We found that levels of polyamines (spermidine, putrescine) decreased in aging fruit flies, concomitant with declining memory abilities. Simple spermidine feeding not only restored juvenile polyamine levels, but also suppressed age-induced memory impairment. Ornithine decarboxylase-1, the rate-limiting enzyme for de novo polyamine synthesis, also protected olfactory memories in aged flies when expressed specifically in Kenyon cells, which are crucial for olfactory memory formation. Spermidine-fed flies showed enhanced autophagy (a form of cellular self-digestion), and genetic deficits in the autophagic machinery prevented spermidine-mediated rescue of memory impairments. Our findings indicate that autophagy is critical for suppression of memory impairments by spermidine and that polyamines, which are endogenously present, are candidates for pharmacological intervention.	[Gupta, Varun K.; Scheunemann, Lisa; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Liu, Karen S. Y.; Schwaerzel, Martin; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Berlin, Germany; [Gupta, Varun K.; Bhukel, Anuradha; Liu, Karen S. Y.; Sigrist, Stephan J.] NeuroCure Charite, Berlin, Germany; [Eisenberg, Tobias; Schroeder, Sabrina; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Koemans, Tom S.; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.] Joanneum Res Forsch GesmBH, Hlth Inst Biomed & Hlth Sci, Graz, Austria; [Sinner, Frank; Pieber, Thomas R.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [Dipt, Shubham; Fiala, Andre] Univ Gottingen, D-37073 Gottingen, Germany	Free University of Berlin; University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; Medical University of Graz; University of Gottingen	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de	Gupta, Varun/ABE-1876-2020; Bhukel, Anuradha/AAU-8586-2020; Schenck, Annette/E-4514-2012; Eisenberg, Tobias/AAV-7806-2021; Fiala, André/AAA-3852-2019; Stunnenberg, Hendrik G./D-6875-2012	Bhukel, Anuradha/0000-0002-4269-1466; Schenck, Annette/0000-0002-6918-3314; Fiala, André/0000-0002-9745-5145; Stunnenberg, Hendrik G./0000-0002-0066-1576; Pieber, Thomas/0000-0003-3554-0405; Magnes, Christoph/0000-0002-5153-7444; Kramer, Jamie/0000-0002-0924-1279; Sinner, Frank Michael/0000-0002-9292-4512; Eisenberg, Tobias/0000-0003-3559-1130; Madeo, Frank/0000-0002-5070-1329	Deutsche Forschungsgemeinschaft [Exc257, FOR1363]; DynAge Focus Area (Freie Universitat Berlin); European Union [HEALTH-241995]; Netherlands Organization for Scientific Research [917-96-346]; BMBF (BCCNII) [01GQ1005A]; Emmy Noether Program; FWF [LIPOTOX, P23490, P24381, I1000]; Austrian Academy of Sciences;  [A6/SFB 958]; Austrian Science Fund (FWF) [P 23490, P 24381] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DynAge Focus Area (Freie Universitat Berlin); European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BMBF (BCCNII)(Federal Ministry of Education & Research (BMBF)); Emmy Noether Program(German Research Foundation (DFG)); FWF(Austrian Science Fund (FWF)); Austrian Academy of Sciences; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank T. Neufeld (University of Minnesota), L. Luo (Stanford University) and the Bloomington Stock Center for fly stocks, and S. Gaumer (University Versailles) for ref(2) P antibody. We are also grateful to M.G. Holt and B. Gerber for critically reading the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft to S.J.S. (Exc257, FOR1363), as well as A6/SFB 958 and DynAge Focus Area (Freie Universitat Berlin) to S.J.S., the European Union (FP7 Gencodys HEALTH-241995) to H.G.S. and A.S., a VIDI grant from the Netherlands Organization for Scientific Research (917-96-346) to A.S., the BMBF (BCCNII, grant number 01GQ1005A) to A.F., and the Emmy Noether Program to M.S. F.M. is grateful to the FWF for grants LIPOTOX, P23490, P24381 and I1000 (DACH). T.E. is recipient of an APART fellowship of the Austrian Academy of Sciences.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Estes PS, 1996, J NEUROSCI, V16, P5443; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee J.A., 2012, EXP NEUROBIOL, V21, P1, DOI DOI 10.5607/EN.2012.21.1.1; Liu P, 2008, NEUROSCIENCE, V155, P789, DOI 10.1016/j.neuroscience.2008.06.033; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saitoe M, 2005, REV NEUROSCIENCE, V16, P137; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tonoki A, 2012, P NATL ACAD SCI USA, V109, P6319, DOI 10.1073/pnas.1118126109; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vivo M, 2001, NEUROSCI LETT, V304, P107, DOI 10.1016/S0304-3940(01)01776-1; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	60	213	224	5	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1453	+		10.1038/nn.3512	http://dx.doi.org/10.1038/nn.3512			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995066				2022-12-25	WOS:000324795300018
J	Habibi, E; Brinkman, AB; Arand, J; Kroeze, LI; Kerstens, HHD; Matarese, F; Lepikhov, K; Gut, M; Brun-Heath, I; Hubner, NC; Benedetti, R; Altucci, L; Jansen, JH; Walter, J; Gut, IG; Marks, H; Stunnenberg, HG				Habibi, Ehsan; Brinkman, Arie B.; Arand, Julia; Kroeze, Leonie I.; Kerstens, Hindrik H. D.; Matarese, Filomena; Lepikhov, Konstantin; Gut, Marta; Brun-Heath, Isabelle; Hubner, Nina C.; Benedetti, Rosaria; Altucci, Lucia; Jansen, Joop H.; Walter, Joern; Gut, Ivo G.; Marks, Hendrik; Stunnenberg, Hendrik G.			Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							GROUND-STATE; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; HYPOMETHYLATION; PLURIPOTENCY; HETEROGENEITY; ENHANCERS; UHRF1; TET1	The use of two kinase inhibitors (2i) enables derivation of mouse embryonic stem cells (ESCs) in the pluripotent ground state. Using whole-genome bisulfite sequencing (WGBS), we show that male 2i ESCs are globally hypomethylated compared to conventional ESCs maintained in serum. In serum, female ESCs are hypomethyated similarly to male ESCs in 2i, and DNA methylation is further reduced in 2i. Regions with elevated DNA methylation in 2i strongly correlate with the presence of H3K9me3 on endogenous retroviruses (ERVs) and imprinted loci. The methylome of male ESCs in serum parallels post-implantation blastocyst cells, while 2i stalls ESCs in a hypomethylated, ICM-like state. WGBS analysis during adaptation of 2i ESCs to serum suggests that deposition of DNA methylation is largely random, while loss of DNA methylation during reversion to 2i occurs passively, initiating at TET1 binding sites. Together, our analysis provides insight into DNA methylation dynamics in cultured ESCs paralleling early developmental processes.	[Habibi, Ehsan; Brinkman, Arie B.; Kerstens, Hindrik H. D.; Matarese, Filomena; Hubner, Nina C.; Marks, Hendrik; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Arand, Julia; Lepikhov, Konstantin; Walter, Joern] Univ Saarland, Dept Genet Epigenet, D-66123 Saarbrucken, Germany; [Kroeze, Leonie I.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [Kroeze, Leonie I.; Jansen, Joop H.] Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gut, Marta; Brun-Heath, Isabelle; Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Benedetti, Rosaria; Altucci, Lucia] Univ Naples 2, Dipartimento Biochim Biofis & Patol Gen, I-80138 Naples, Italy; [Altucci, Lucia] IGB, I-80131 Naples, Italy	Radboud University Nijmegen; Saarland University; Radboud University Nijmegen; Radboud University Nijmegen; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Marks, H (corresponding author), Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands.	h.marks@ncmls.ru.nl; h.stunnenberg@ncmls.ru.nl	Gut, Ivo/ABF-3188-2020; Habibi, Ehsan/R-7756-2019; Habibi, Ehsan/E-3196-2016; Arand, Julia/AFQ-8652-2022; Kroeze, Leonie/D-9673-2016; Jansen, J.H./H-8054-2014; Marks, Hendrik/E-2801-2012; Habibi, Ehsan/AAE-6053-2021; Arand, Julia/AAD-8640-2020; Stunnenberg, Hendrik G./D-6875-2012; Walter, Jörn/AFN-6428-2022; Brun-Heath, Isabelle/G-9844-2013; Brinkman, Arie/V-1533-2018; Lepikhov, Konstantin/AAN-3634-2021; Altucci, Lucia/S-8031-2019; Arand, Julia/AAU-9679-2020; Hubner, Nina C/C-4298-2008; Benedetti, Rosaria/AAF-2398-2020; Benedetti, Rosaria/AHE-8039-2022	Gut, Ivo/0000-0001-7219-632X; Habibi, Ehsan/0000-0002-7208-7999; Jansen, J.H./0000-0001-9459-568X; Marks, Hendrik/0000-0002-4198-3731; Stunnenberg, Hendrik G./0000-0002-0066-1576; Walter, Jörn/0000-0003-0563-7417; Brun-Heath, Isabelle/0000-0002-5828-0020; Brinkman, Arie/0000-0002-9875-1835; Arand, Julia/0000-0002-2357-1119; Hubner, Nina C/0000-0002-7864-2877; Benedetti, Rosaria/0000-0001-5517-5519; Kroeze, Leonie/0000-0002-2666-1742; altucci, lucia/0000-0002-7312-5387	Dutch KWF [KUN2008-4130]; Netherlands National Computing Facilities foundation [MP-266-13]; Netherlands Institute for Regenerative Medicine (NIRM); Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR); Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming'' [WA1029]; European Union [NWO/Zoom 90201134, FP7/2008: 235447, FP7/2011: 282510, FP7/2009: 223485];  [PON_0101227]	Dutch KWF; Netherlands National Computing Facilities foundation; Netherlands Institute for Regenerative Medicine (NIRM); Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR)(Consiglio Nazionale delle Ricerche (CNR)); Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming''(German Research Foundation (DFG)); European Union(European Commission); 	We thank Eva Janssen-Megens, Anita Kaan, and Yan Tan for sequencing, Kees-Jan Francoijs and Simon van Heeringen for bioinformatic assistance, Roberta Menafra and Gianluigi Franci for general practical advice, and Pascal Giehr, Christina LoPorto, Jasmin Gries, and Karl Nordstrom for help with hairpin BS-seq. Felix Krueger helped with preprocessing of the sequencing data, and Andrew Smith, Qiang Song, Fang Fang, and Meng Zhou helped with the WGBS analysis. Yuanxin Xi provided advice for RRBSMAP data analysis. Joost Martens and Colin Logie gave useful comments on the manuscript. Tuzer Kalkan and Austin Smith provided the Rex/GFP-2i cells, and Alice Jouneau provided the EpiSCs. The research leading to these results has received funding from the Dutch KWF (KUN2008-4130), Netherlands National Computing Facilities foundation grant MP-266-13, the Netherlands Institute for Regenerative Medicine (NIRM), the Epigenomics Flagship Project "EPIGEN'' (MIUR-CNR), PON_0101227, Deutsche Forschungsgemeinschaft (DFG) priority program SPP1356 "Pluripotency and Cellular Reprogramming'' (grant number WA1029), and the European Union grants SYNERGY (NWO/Zoom 90201134; within ERASYSBIO+, FP7/2008: 235447), BLUEPRINT (FP7/2011: 282510), and PluriSys (FP7/2009: 223485). E.H. and H.M. carried out most of the wet-lab experiments and F. M. helped with western blots and DNA isolation. M.G., I.B.H., and I.G.G. performed bisulfite conversion and sequencing of the samples. E.H. and H.H.D.K. mapped sequencing data and determined methylation levels. E.H. and A.B.B. performed bioinformatic analysis. J.A., K.L., and J.W. performed hairpin-bisulfite amplicon sequencing and cell stainings. N.C.H. performed MS analysis of DNMT1 and L.I.K. and J.H.J. performed MS analysis of DNA (hydroxy) methylation. R.B. and L.A. measured DNMT1 activity. H.M., E.H., A.B.B., and H.G.S. wrote the manuscript. H.M. and H.G.S. designed and supervised the experiments.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; MONK M, 1987, DEVELOPMENT, V99, P371; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	309	314	5	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					360	369		10.1016/j.stem.2013.06.002	http://dx.doi.org/10.1016/j.stem.2013.06.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850244	Bronze			2022-12-25	WOS:000329570800013
J	Gu, BN; Watanabe, K; Sun, P; Fallahi, M; Dai, X				Gu, Bingnan; Watanabe, Kazuhide; Sun, Peng; Fallahi, Magid; Dai, Xing			Chromatin Effector Pygo2 Mediates Wnt-Notch Crosstalk to Suppress Luminal/Alveolar Potential of Mammary Stem and Basal Cells	CELL STEM CELL			English	Article							GENOME-WIDE MAPS; SIGNALING PATHWAY; EPITHELIAL-CELLS; BETA-CATENIN; GLAND DEVELOPMENT; COMMITTED CELLS; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; EXPRESSION	Epigenetic mechanisms regulating lineage differentiation of mammary stem cells (MaSCs) remain poorly understood. Pygopus 2 (Pygo2) is a histone methylation reader and a context-dependent Wnt/beta-catenin coactivator. Here we provide evidence for Pygo2's function in suppressing luminal/alveolar differentiation of MaSC-enriched basal cells. We show that Pygo2-deficient MaSC/basal cells exhibit partial molecular resemblance to luminal cells, such as elevated Notch signaling and reduced mammary repopulating capability upon transplantation. Inhibition of Notch signaling suppresses basal-level and Pygo2-deficiency-induced luminal/alveolar differentiation of MaSC/basal cells, whereas activation of Wnt/beta-catenin signaling suppresses luminal/alveolar differentiation and Notch3 expression in a Pygo2-dependent manner. We show that Notch3 is a direct target of Pygo2 and that Pygo2 is required for beta-catenin binding and maintenance of a poised/ repressed chromatin state at the Notch3 locus in MaSC/basal cells. Together, our data support a model where Pygo2-mediated chromatin regulation connects Wnt signaling and Notch signaling to restrict the luminal/alveolar differentiation competence of MaSC/basal cells.	[Gu, Bingnan; Watanabe, Kazuhide; Sun, Peng; Fallahi, Magid; Dai, Xing] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dai, X (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	xdai@uci.edu	Watanabe, Kazuhide/C-9667-2017; Sun, Peng/P-6099-2014	Watanabe, Kazuhide/0000-0002-5331-0593; Dai, Xing/0000-0001-8134-1365	Susan G. Komen grant [KG110897]; NSF [DMS-1161621]; NIH [R01-GM083089]; CBCRP Postdoctoral Fellowship [14FB-0129]; U.S. DOD BCRP Postdoctoral Fellowship [W81XWH-10-1-0383]; Division Of Mathematical Sciences [1161621] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083089] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBCRP Postdoctoral Fellowship; U.S. DOD BCRP Postdoctoral Fellowship; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Eva Lee, Wen-Hwa Lee, and Bogi Andersen for discussions and the UCI Genomics High Throughput Facility (GHTF) and Sue and Bill Gross Stem Cell Research Center Core Facility for expert service. This work was supported by Susan G. Komen grant KG110897, NSF grant DMS-1161621, and NIH grant R01-GM083089 (to X. D.). B. G. and K. W. were supported by CBCRP Postdoctoral Fellowship (14FB-0129) and U.S. DOD BCRP Postdoctoral Fellowship (W81XWH-10-1-0383), respectively.	Andrews PGP, 2009, BIOCHEM J, V422, P493, DOI 10.1042/BJ20090134; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; BARTEK J, 1985, INT J CANCER, V36, P299, DOI 10.1002/ijc.1985.36.3.299; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; GUGLIOTTA P, 1988, J HISTOCHEM CYTOCHEM, V36, P659, DOI 10.1177/36.6.3367051; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kessler R, 2009, MECH DEVELOP, V126, P752, DOI 10.1016/j.mod.2009.04.003; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Pal B, 2013, CELL REP, V3, P411, DOI 10.1016/j.celrep.2012.12.020; Parker DS, 2002, DEVELOPMENT, V129, P2565; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Raafat A, 2011, J CELL PHYSIOL, V226, P1940, DOI 10.1002/jcp.22526; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watanabe K., 2013, ONCOGENE IN PRESS; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	63	60	63	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					48	61		10.1016/j.stem.2013.04.012	http://dx.doi.org/10.1016/j.stem.2013.04.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23684539	Green Accepted, Bronze			2022-12-25	WOS:000329570100012
J	Korb, E; Wilkinson, CL; Delgado, RN; Lovero, KL; Finkbeiner, S				Korb, Erica; Wilkinson, Carol L.; Delgado, Ryan N.; Lovero, Kathryn L.; Finkbeiner, Steven			Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; EARLY GENE ARC/ARG3.1; SYNAPTIC PLASTICITY; MESSENGER-RNA; ACTIN POLYMERIZATION; DENTATE GYRUS; EXPRESSION; CONSOLIDATION; TRANSLATION	The activity-regulated cytoskeletal protein Arc (also known as Arg3.1) is required for long-term memory formation and synaptic plasticity. Arc expression is robustly induced by activity, and Arc protein localizes to both active synapses and the nucleus. Whereas its synaptic function has been examined, it is not clear why or how Arc is localized to the nucleus. We found that murine Arc nuclear expression is regulated by synaptic activity in vivo and in vitro. We identified distinct regions of Arc that control its localization, including a nuclear localization signal, a nuclear retention domain and a nuclear export signal. Arc localization to the nucleus promotes an activity-induced increase in the expression of promyelocytic leukemia nuclear bodies, which decreases GluA1 (also called Gria1) transcription and synaptic strength. We further show that Arc nuclear localization regulates homeostatic plasticity. Thus, Arc mediates the homeostatic response to increased activity by translocating to the nucleus, increasing promyelocytic leukemia protein expression and decreasing GluA1 transcription, ultimately downscaling synaptic strength.	[Korb, Erica; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Korb, Erica; Wilkinson, Carol L.; Lovero, Kathryn L.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Delgado, Ryan N.; Finkbeiner, Steven] Univ Calif San Francisco, Biomed Sci Program, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Gladstone Inst, Taube Koret Ctr Neurodegenerat Dis, San Francisco, CA USA; [Finkbeiner, Steven] Gladstone Inst, Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu		Korb, Erica/0000-0002-7064-8123	Ruth L. Kirschstein Fellowship [5 F31 MH087009]; National Institute of Neurological Disease and Stroke [2 R01 NS39074)]; National Institute on Aging [2 P01 AG022074]; J. David Gladstone Institutes; Keck Foundation; US National Institutes of Health Extramural Research Facilities Improvement Project [RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH087009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045191, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Ruth L. Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); J. David Gladstone Institutes(University of California System); Keck Foundation(W.M. Keck Foundation); US National Institutes of Health Extramural Research Facilities Improvement Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Truant (McMaster University) for the GFP-beta-gal construct, B. Henderson (University of Sydney) for the GFP-NLS-NES construct, R. Dingledine (Emory University) for the GluA1-luciferase and GluA2-luciferase constructs, P. Pandolfi (Sloan-Kettering Institute) for the eGFP-PML construct, D. Bredt (University of California San Francisco) for the eGFP-PSD95 construct, R. Everett (MRC-Universit of Glasgow Centre for Virus Research) for the PML and ICP0 construct and J. Ahn (Sungkyunkwan University School of Medicine) for the IE1 constructs. We thank members of the Finkbeiner lab, L. Jan, R. Edwards and N. Krogan for helpful suggestions and G. Howard for editorial input. E. K. was supported by a Ruth L. Kirschstein Fellowship (5 F31 MH087009). Primary support for this work was provided by the National Institute of Neurological Disease and Stroke (2 R01 NS39074), the National Institute on Aging (2 P01 AG022074) and the J. David Gladstone Institutes (S.F.), as well as the Keck Foundation (S.F.). The animal care facility was partly supported by a US National Institutes of Health Extramural Research Facilities Improvement Project (RR018928).	Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Bramham CR, 2011, EXP BRAIN RES, V209, P317, DOI 10.1007/s00221-011-2570-x; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brough D, 2005, J CELL SCI, V118, P3019, DOI 10.1242/jcs.02426; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	54	96	97	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					874	U266		10.1038/nn.3429	http://dx.doi.org/10.1038/nn.3429			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749147	Green Accepted, Green Submitted			2022-12-25	WOS:000321180900020
J	Christian, CA; Herbert, AG; Holt, RL; Peng, K; Sherwood, KD; Pangratz-Fuehrer, S; Rudolph, U; Huguenard, JR				Christian, Catherine A.; Herbert, Anne G.; Holt, Rebecca L.; Peng, Kathy; Sherwood, Kyla D.; Pangratz-Fuehrer, Susanne; Rudolph, Uwe; Huguenard, John R.			Endogenous Positive Allosteric Modulation of GABA(A) Receptors by Diazepam binding inhibitor	NEURON			English	Article							THALAMIC RETICULAR NEURONS; CHILDHOOD ABSENCE EPILEPSY; ACYL-COA-BINDING; ADULT-RAT BRAIN; OCTADECANEUROPEPTIDE ODN; BENZODIAZEPINE RECEPTORS; SYNAPTIC CURRENTS; NETWORK SYNCHRONY; FEBRILE SEIZURES; RELAY NEURONS	Benzodiazepines (BZs) allosterically modulate gamma-aminobutyric acid type-A receptors (GABA(A)Rs) to increase inhibitory synaptic strength. Diazepam binding inhibitor (DBI) protein is a BZ site ligand expressed endogenously in the brain, but functional evidence for BZ-mimicking positive modulatory actions has been elusive. We demonstrate an endogenous potentiation of GABAergic synaptic transmission and responses to GABA uncaging in the thalamic reticular nucleus (nRT) that is absent in both nm1054 mice, in which the Dbi gene is deleted, and mice in which BZ binding to alpha 3 subunit-containing GABA(A)Rs is disrupted. Viral transduction of DBI into nRT is sufficient to rescue the endogenous potentiation of GABAergic transmission in nm1054 mice. Both mutations enhance thalamocortical spike-and-wave discharges characteristic of absence epilepsy. Together, these results indicate that DBI mediates endogenous nucleus-specific BZ-mimicking ("endozepine") roles to modulate nRT function and suppress thalamocortical oscillations. Enhanced DBI signaling might serve as a therapy for epilepsy and other neurological disorders.	[Christian, Catherine A.; Herbert, Anne G.; Holt, Rebecca L.; Peng, Kathy; Sherwood, Kyla D.; Pangratz-Fuehrer, Susanne; Huguenard, John R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rudolph, Uwe] Harvard Univ, Sch Med, McLean Hosp, Lab Genet Neuropharmacol, Belmont, MA 02478 USA; [Rudolph, Uwe] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	Stanford University; Harvard University; McLean Hospital; Harvard University	Christian, CA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	cchristian@stanford.edu; john.huguenard@stanford.edu	Pangratz-Fuehrer, Susanne/AAF-2332-2021; Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Christian-Hinman, Catherine A./0000-0003-3475-2166	NIH [NS034774, NS005477, T32 NS007280]; Epilepsy Foundation Research Fellowship; Katharine McCormick Advanced Postdoctoral Fellowship from Stanford School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS006477, R37NS034774, R01NS034774, T32NS007280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation Research Fellowship; Katharine McCormick Advanced Postdoctoral Fellowship from Stanford School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Isabel Parada for expert assistance with histology experiments, Lance Lee and Mark Fleming for providing nm1054 founder mice, Richard Reimer for providing the DBI-T2A-GFP plasmid and helpful discussions, Craig Garner and Michael Lochrie for helpful discussions regarding virus generation, and Istvan Mody and Stefano Vicini for useful critiques of the manuscript. This work was supported by NIH grants NS034774 (J.R.H.), NS005477 (J.R.H.), T32 NS007280 (C.A.C.), an Epilepsy Foundation Research Fellowship (C.A.C.), and a Katharine McCormick Advanced Postdoctoral Fellowship from Stanford School of Medicine (C.A.C.). C.A.C. and J.R.H. designed the studies, analyzed EEG data, and wrote the manuscript; C.A.C. performed and analyzed the in vitro electrophysiology and virus experiments and prepared the figures; C.A.C., A.G.H., R.L.H., K.P, and K.D.S. performed the EEG experiments; S.P.-F. performed pilot studies; U.R. provided alpha 3(H126R) founder mice and edited the manuscript.	Alfonso J, 2012, CELL STEM CELL, V10, P76, DOI 10.1016/j.stem.2011.11.011; ALHO H, 1989, J CHEM NEUROANAT, V2, P301; ALHO H, 1985, SCIENCE, V229, P179, DOI 10.1126/science.3892688; Allen TGJ, 1997, TRENDS NEUROSCI, V20, P192, DOI 10.1016/S0166-2236(96)01039-9; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; Beenhakker MP, 2010, J NEUROSCI, V30, P15262, DOI 10.1523/JNEUROSCI.3243-10.2010; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; BORMANN J, 1985, REGUL PEPTIDES, P33; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Conigrave AD, 2003, PROG BIOPHYS MOL BIO, V81, P219, DOI 10.1016/S0079-6107(03)00020-8; Cox CL, 1996, J COMP NEUROL, V366, P416; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; De Mateos-Verchere JG, 1998, PEPTIDES, V19, P841; de Mateos-Verchere JG, 1999, PEPTIDES, V20, P1431, DOI 10.1016/S0196-9781(99)00153-9; DEDEYN PP, 1987, J PHARMACOL EXP THER, V242, P48; Dong EB, 1999, LIFE SCI, V64, P1779, DOI 10.1016/S0024-3205(99)00116-2; FERRERO P, 1986, P NATL ACAD SCI USA, V83, P827, DOI 10.1073/pnas.83.3.827; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Galarreta M, 1997, J NEUROSCI, V17, P7220; GAVISH M, 1980, NATURE, V287, P651, DOI 10.1038/287651a0; Gibbs JW, 1996, J NEUROPHYSIOL, V76, P2568, DOI 10.1152/jn.1996.76.4.2568; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hadingham KL, 1996, MOL PHARMACOL, V49, P253; Hentschke H, 2009, J NEUROPHYSIOL, V102, P3643, DOI 10.1152/jn.00651.2009; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; Huguenard J R, 1999, Adv Neurol, V79, P991; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; HUGUENARD JR, 1994, J NEUROPHYSIOL, V71, P2576, DOI 10.1152/jn.1994.71.6.2576; HUNKELER W, 1981, NATURE, V290, P514, DOI 10.1038/290514a0; Huntsman MM, 2006, J PHYSIOL-LONDON, V572, P459, DOI 10.1113/jphysiol.2006.106617; Huntsman MM, 2000, J NEUROPHYSIOL, V83, P350, DOI 10.1152/jn.2000.83.1.350; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; IVERSEN L, 1977, NATURE, V266, P678, DOI 10.1038/266678a0; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; KAVALIERS M, 1986, BRAIN RES, V383, P343, DOI 10.1016/0006-8993(86)90037-5; KING GL, 1985, NEUROSCIENCE, V15, P371, DOI 10.1016/0306-4522(85)90219-2; Knoflach F, 1996, MOL PHARMACOL, V50, P1253; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; KNUDSEN J, 1991, NEUROPHARMACOLOGY, V30, P1405, DOI 10.1016/S0028-3908(11)80009-2; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leprince J, 1998, J MED CHEM, V41, P4433, DOI 10.1021/jm980275d; LIHRMANN I, 1994, P NATL ACAD SCI USA, V91, P6899, DOI 10.1073/pnas.91.15.6899; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MACDONALD RL, 1986, ADV BIOCHEM PSYCHOPH, V41, P67; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; MOHLER H, 1977, SCIENCE, V198, P849, DOI 10.1126/science.918669; Mozrzymas JW, 2007, EUR J NEUROSCI, V26, P657, DOI 10.1111/j.1460-9568.2007.05693.x; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; PAPADOPOULOS V, 1991, ENDOCRINOLOGY, V129, P1481, DOI 10.1210/endo-129-3-1481; Peden DR, 2008, J PHYSIOL-LONDON, V586, P965, DOI 10.1113/jphysiol.2007.145375; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Ramerstorfer J, 2010, EUR J PHARMACOL, V636, P18, DOI 10.1016/j.ejphar.2010.03.015; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; RYAN LJ, 1979, EXP NEUROL, V66, P493, DOI 10.1016/0014-4886(79)90197-3; Rye DB, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004685; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Shu YS, 2002, J NEUROPHYSIOL, V87, P2571, DOI 10.1152/jn.00850.2001; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SKERRITT JH, 1983, NEUROSCI LETT, V43, P321, DOI 10.1016/0304-3940(83)90208-2; SLOBODYANSKY E, 1992, J CHEM NEUROANAT, V5, P169, DOI 10.1016/0891-0618(92)90042-O; Snead OC, 1998, ANN NEUROL, V44, P688, DOI 10.1002/ana.410440417; Sohal VS, 2003, J NEUROSCI, V23, P8978; Sohal VS, 2003, J NEUROSCI, V23, P3649; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; VICINI S, 1986, P NATL ACAD SCI USA, V83, P9269, DOI 10.1073/pnas.83.23.9269; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Weiss M, 2002, NEUROCHEM RES, V27, P1605, DOI 10.1023/A:1021674708556; Whittemore ER, 1996, MOL PHARMACOL, V50, P1364; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001; Zhang SLJ, 1997, J NEUROPHYSIOL, V78, P2280, DOI 10.1152/jn.1997.78.5.2280	83	64	66	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 19	2013	78	6					1063	1074		10.1016/j.neuron.2013.04.026	http://dx.doi.org/10.1016/j.neuron.2013.04.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23727119	Green Accepted, Bronze			2022-12-25	WOS:000321026900012
J	Bahl, A; Ammer, G; Schilling, T; Borst, A				Bahl, Armin; Ammer, Georg; Schilling, Tabea; Borst, Alexander			Object tracking in motion-blind flies	NATURE NEUROSCIENCE			English	Article							FIGURE-GROUND DISCRIMINATION; VISUAL ORIENTATION BEHAVIOR; DROSOPHILA-MELANOGASTER; RELATIVE MOTION; NEURONAL BASIS; MOVEMENT DETECTORS; MUSCA-DOMESTICA; NEURAL CIRCUIT; FLIGHT TORQUE; LOBULA PLATE	Different visual features of an object, such as its position and direction of motion, are important elements for animal orientation, but the neural circuits extracting them are generally not well understood. We analyzed this problem in Drosophila, focusing on two well-studied behaviors known as optomotor response and fixation response. In the neural circuit controlling the optomotor response, columnar T4 and T5 cells are thought to be crucial. We found that blocking T4 and T5 cells resulted in a complete loss of the optomotor response. Nevertheless, these flies were still able to fixate a black bar, although at a reduced performance level. Further analysis revealed that flies in which T4 and T5 cells were blocked possess an intact position circuit that is implemented in parallel to the motion circuit; the optomotor response is exclusively controlled by the motion circuit, whereas the fixation response is supported by both the position and the motion circuit.	[Bahl, Armin; Ammer, Georg; Schilling, Tabea; Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Bahl, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	bahl@neuro.mpg.de; borst@neuro.mpg.de		Bahl, Armin/0000-0001-7591-5860				Aptekar JW, 2012, CURR BIOL, V22, P482, DOI 10.1016/j.cub.2012.01.044; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; EGELHAAF M, 1985, BIOL CYBERN, V52, P195; EGELHAAF M, 1985, BIOL CYBERN, V52, P123, DOI 10.1007/BF00364003; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; GEIGER G, 1981, NATURE, V293, P398, DOI 10.1038/293398a0; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Gotz KG, 1980, DEV NEUROBIOLOGY DRO, P391; HAUSEN K, 1990, J NEUROSCI, V10, P351; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; Heisenberg M., 1984, VISION DROSOPHILA GE; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Liang P, 2012, J NEUROPHYSIOL, V107, P3446, DOI 10.1152/jn.00530.2011; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; PICK B, 1974, Z NATURFORSCH C, VC 29, P310; POGGIO T, 1973, KYBERNETIK, V12, P185, DOI 10.1007/BF00270572; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Tammero LF, 2002, J EXP BIOL, V205, P327; WARZECHA AK, 1992, NEUROSCI LETT, V141, P119, DOI 10.1016/0304-3940(92)90348-B; WEHRHAHN C, 1978, BIOL CYBERN, V29, P237, DOI 10.1007/BF00337281; WEHRHAHN C, 1981, BIOL CYBERN, V40, P213, DOI 10.1007/BF00453371; WOLF R, 1986, NATURE, V323, P154, DOI 10.1038/323154a0	43	98	98	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					730	+		10.1038/nn.3386	http://dx.doi.org/10.1038/nn.3386			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624513				2022-12-25	WOS:000319509600015
J	Gipson, CD; Kupchik, YM; Shen, HW; Reissner, KJ; Thomas, CA; Kalivas, PW				Gipson, Cassandra D.; Kupchik, Yonatan M.; Shen, Haowei; Reissner, Kathryn J.; Thomas, Charles A.; Kalivas, Peter W.			Relapse Induced by Cues Predicting Cocaine Depends on Rapid, Transient Synaptic Potentiation	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; DRUG-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; DENDRITIC SPINE; PLASTICITY; NEURONS; CORE; REINSTATEMENT	Cocaine addiction is characterized by long-lasting vulnerability to relapse arising because neutral environmental stimuli become associated with drug use and then act as cues that induce relapse. It is not known how cues elicit cocaine seeking, and why cocaine seeking is more difficult to regulate than seeking a natural reward. We found that cocaine-associated cues initiate cocaine seeking by inducing a rapid, transient increase in dendritic spine size and synaptic strength in the nucleus accumbens. These changes required neural activity in the prefrontal cortex. This is not the case when identical cues were associated with obtaining sucrose, which did not elicit changes in spine size or synaptic strength. The marked cue-induced synaptic changes in the accumbens were correlated with the intensity of cocaine, but not sucrose seeking, and may explain the difficulty addicts experience in managing relapse to cocaine use.	[Gipson, Cassandra D.; Kupchik, Yonatan M.; Reissner, Kathryn J.; Thomas, Charles A.; Kalivas, Peter W.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Shen, Haowei] Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China	Medical University of South Carolina; Peking University	Gipson, CD (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	gipson@musc.edu; kalivasp@musc.edu	Kupchik, Yonatan/O-5998-2019; Gipson, Cassandra/AAN-7470-2021; Gipson, Cassandra D/L-8359-2017; Reissner, Kathryn J/K-7187-2015	Kupchik, Yonatan/0000-0003-3732-4933; Gipson, Cassandra/0000-0003-2372-9323; Shen, Hao-wei/0000-0002-2766-5139	National Institutes of Health [DA007288, DA033690, DA003906, DA012513, DA015369]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003906, T32DA007288, F32DA033690, R01DA012513, P50DA015369, R37DA003906, K99DA031790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Rachel Smith, Dr. Joshua Beckmann, Megan Hensley, Brenton Mahaffey, Rebecca Szer, and Phong Do for technical assistance. This work was supported by DA007288, DA033690 (C.D.G.), DA003906, DA012513, and DA015369 (P.W.K.) grants from the National Institutes of Health.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gorelova N, 1997, NEUROSCIENCE, V76, P689, DOI 10.1016/S0306-4522(96)00380-6; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Luscher C., 2011, NEURON, V69, P650; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McFarland K, 2001, J NEUROSCI, V21, P8655; Miller CA, 2004, J NEUROSCI, V24, P6889, DOI 10.1523/JNEUROSCI.1685-04.2004; Moussawi K, 2011, P NATL ACAD SCI USA, V108, P385, DOI 10.1073/pnas.1011265108; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Shen HW, 2011, P NATL ACAD SCI USA, V108, P19407, DOI 10.1073/pnas.1112052108; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sun X, 2008, J NEUROSCI, V28, P4216, DOI 10.1523/JNEUROSCI.0258-08.2008; Vocci F, 2005, PHARMACOL THERAPEUT, V108, P94, DOI 10.1016/j.pharmthera.2005.06.010; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Yang YL, 2009, NEUROSCIENTIST, V15, P464, DOI 10.1177/1073858409340800; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	39	152	153	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 6	2013	77	5					867	872		10.1016/j.neuron.2013.01.005	http://dx.doi.org/10.1016/j.neuron.2013.01.005			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473317	Green Accepted, Bronze			2022-12-25	WOS:000316162600008
J	Deng, PY; Rotman, Z; Blundon, JA; Cho, Y; Cui, J; Cavalli, V; Zakharenko, SS; Klyachko, VA				Deng, Pan-Yue; Rotman, Ziv; Blundon, Jay A.; Cho, Yongcheol; Cui, Jianmin; Cavalli, Valeria; Zakharenko, Stanislav S.; Klyachko, Vitaly A.			FMRP Regulates Neurotransmitter Release and Synaptic Information Transmission by Modulating Action Potential Duration via BK Channels	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; SHORT-TERM PLASTICITY; MOUSE MODEL; POTASSIUM CHANNELS; MESSENGER-RNAS; BETA-SUBUNITS; REPOLARIZATION; SYNAPSES; DYNAMICS; REVEALS	Loss of FMRP causes fragile X syndrome (FXS), but the physiological functions of FMRP remain highly debatable. Here we show that FMRP regulates neurotransmitter release in CA3 pyramidal neurons by modulating action potential (AP) duration. Loss of FMRP leads to excessive AP broadening during repetitive activity, enhanced presynaptic calcium influx, and elevated neurotransmitter release. The AP broadening defects caused by FMRP loss have a cell-autonomous presynaptic origin and can be acutely rescued in postnatal neurons. These presynaptic actions of FMRP are translation independent and are mediated selectively by BK channels via interaction of FMRP with BK channel's regulatory beta 4 subunits. Information-theoretical analysis demonstrates that loss of these FMRP functions causes marked dysregulation of synaptic information transmission. FMRP-dependent AP broadening is not limited to the hippocampus, but also occurs in cortical pyramidal neurons. Our results thus suggest major translation-independent presynaptic functions of FMRP that may have important implications for understanding FXS neuropathology.	[Deng, Pan-Yue; Rotman, Ziv; Cui, Jianmin; Klyachko, Vitaly A.] Washington Univ, CIMED, Dept Biomed Engn, St Louis, MO 63110 USA; [Deng, Pan-Yue; Rotman, Ziv; Cui, Jianmin; Klyachko, Vitaly A.] Washington Univ, CIMED, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Cho, Yongcheol; Cavalli, Valeria] Washington Univ, CIMED, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Blundon, Jay A.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital	Klyachko, VA (corresponding author), Washington Univ, CIMED, Dept Biomed Engn, St Louis, MO 63110 USA.	klyachko@wustl.edu	Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X	NINDS [R01 NS081972, RO1 NS060709, R01 NS060706]; FRAXA Foundation; Edward Mallinckrodt Jr. Foundation; McDonnell Center for Systems Neuroscience; NIMH [R01 MH079079, R01 MH095810]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079079, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060709, R01NS060706, R01NS081972] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FRAXA Foundation; Edward Mallinckrodt Jr. Foundation; McDonnell Center for Systems Neuroscience; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the NINDS R01 NS081972, FRAXA Foundation, Edward Mallinckrodt Jr. Foundation, and McDonnell Center for Systems Neuroscience to V.A.K.; by NIMH R01 MH079079 and R01 MH095810 to S.S.Z.; by NINDS RO1 NS060709 to V.C.; and by NINDS R01 NS060706 to J.C. We thank Dr. Brenner (University of Texas-San Antonio) for providing slo beta 4 KO mice and Drs. Blumer, O'Malley, and Owyoung for their constructive comments.	Akins MR, 2012, J COMP NEUROL, V520, P3687, DOI 10.1002/cne.23123; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng Pan-Yue, 2011, Commun Integr Biol, V4, P543, DOI 10.4161/cib.4.5.15870; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Earls LR, 2010, J NEUROSCI, V30, P15843, DOI 10.1523/JNEUROSCI.1425-10.2010; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kandaswamy U, 2010, J NEUROSCI, V30, P15904, DOI 10.1523/JNEUROSCI.4050-10.2010; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nelson ED, 2011, J NEUROPHYSIOL, V106, P193, DOI 10.1152/jn.00751.2010; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Poage RE, 2002, SYNAPSE, V46, P189, DOI 10.1002/syn.10135; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Rotman Z, 2011, J NEUROSCI, V31, P14800, DOI 10.1523/JNEUROSCI.3231-11.2011; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	39	228	233	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2013	77	4					696	711		10.1016/j.neuron.2012.12.018	http://dx.doi.org/10.1016/j.neuron.2012.12.018			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439122	Bronze, Green Accepted			2022-12-25	WOS:000315561300012
J	Liu, JC; Guan, X; Ryan, JA; Rivera, AG; Mock, C; Agarwal, V; Letai, A; Lerou, PH; Lahav, G				Liu, Julia C.; Guan, Xiao; Ryan, Jeremy A.; Rivera, Ana G.; Mock, Caroline; Agarwal, Vishesh; Letai, Anthony; Lerou, Paul H.; Lahav, Galit			High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; BCL-2 FAMILY; SELF-RENEWAL; P53; DIFFERENTIATION; PUMA; ACTIVATION; EXPRESSION; RADIATION; RESPONSES	Human embryonic stem cells (hESCs) are highly sensitive to DNA damage and have low survival ability relative to differentiated cells. We investigated the source of this difference by comparing damage response pathways in hESCs and differentiated cells. We found that hESCs undergo more rapid p53-dependent apoptosis after DNA damage than differentiated cells do. However, p53 localization and function are similar between hESCs and differentiated cells, suggesting that p53 alone cannot explain the difference in sensitivity. Instead, we show that mitochondrial readiness for apoptosis, known as mitochondrial priming, differs between hESCs and differentiated cells. Specifically, the balance between proapoptotic and antiapoptotic proteins is shifted closer to the apoptotic threshold in hESCs than in differentiated cells. Altering this balance in differentiated cells increases their sensitivity and results in cell death, suggesting that manipulation of mitochondrial priming could potentially alter the sensitivity of other stem cells, including cancer stem cells.	[Liu, Julia C.; Rivera, Ana G.; Mock, Caroline; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Letai, Anthony] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Guan, Xiao; Agarwal, Vishesh; Lerou, Paul H.] Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA; [Guan, Xiao; Agarwal, Vishesh; Lerou, Paul H.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Ryan, Jeremy A.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lerou, Paul H.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Lerou, Paul H.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University	Lerou, PH (corresponding author), Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA.	plerou@partners.org; galit@hms.harvard.edu		Liu, Julia/0000-0002-8604-1633; Mock, Charles/0000-0002-0564-568X; Ryan, Jeremy/0000-0002-3327-1283	Molecular Biophysics Training Grant [NIH/NIGMS T32008313]; National Science Foundation; Harvard College Program for Research in Science and Engineering; FAS Center for Systems Biology; Charles H. Hood Foundation; NIH/NICHD [HD061981]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD061981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	Molecular Biophysics Training Grant; National Science Foundation(National Science Foundation (NSF)); Harvard College Program for Research in Science and Engineering; FAS Center for Systems Biology; Charles H. Hood Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Agami for the p53shRNA construct; G. Daley for the CHB8 cell line; D. Melton for the HUES9 cell line; Y. Xu for the HUES9 p53<SUP>-/-</SUP> cell line; A. Baccei, B. Gorman, and K. Karhohs for assistance with IF imaging and analysis; J. Moore and J. Stewart-Ornstein for assistance with flow cytometry and analysis; J. Reyes for assistance with illustration; and E. Batchelor and all members of our laboratory for comments and discussions. J. C. L. was supported by the Molecular Biophysics Training Grant (NIH/NIGMS T32008313) and the National Science Foundation Graduate Research Fellowship. A. G. R. was supported by the Harvard College Program for Research in Science and Engineering and the FAS Center for Systems Biology. P. H. L. was supported by the Charles H. Hood Foundation and NIH/NICHD HD061981.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robles AI, 2001, CANCER RES, V61, P6660; SHILOH Y, 1983, CARCINOGENESIS, V4, P917, DOI 10.1093/carcin/4.7.917; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238	33	107	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					483	491		10.1016/j.stem.2013.07.018	http://dx.doi.org/10.1016/j.stem.2013.07.018			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	23954752	Green Accepted, Bronze			2022-12-25	WOS:000329571100016
J	De Martino, B; O'Doherty, JP; Ray, D; Bossaerts, P; Camerer, C				De Martino, Benedetto; O'Doherty, John P.; Ray, Debajyoti; Bossaerts, Peter; Camerer, Colin			In the Mind of the Market: Theory of Mind Biases Value Computation during Financial Bubbles	NEURON			English	Article							DECISION-MAKING; GENDER-DIFFERENCES; NEURAL BASIS; RISK-TAKING; CORTEX	The ability to infer intentions of other agents, called theory of mind (ToM), confers strong advantages for individuals in social situations. Here, we show that ToM can also be maladaptive when people interact with complex modern institutions like financial markets. We tested participants who were investing in an experimental bubble market, a situation in which the price of an asset is much higher than its underlying fundamental value. We describe a mechanism by which social signals computed in the dorsomedial prefrontal cortex affect value computations in ventromedial prefrontal cortex, thereby increasing an individual's propensity to 'ride' financial bubbles and lose money. These regions compute a financial metric that signals variations in order flow intensity, prompting inference about other traders' intentions. Our results suggest that incorporating inferences about the intentions of others when making value judgments in a complex financial market could lead to the formation of market bubbles.	[De Martino, Benedetto; O'Doherty, John P.; Bossaerts, Peter; Camerer, Colin] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [De Martino, Benedetto] Royal Holloway Univ London, Dept Psychol, Egham TW20 0EX, Surrey, England; [O'Doherty, John P.; Ray, Debajyoti; Bossaerts, Peter; Camerer, Colin] CALTECH, Pasadena, CA 91125 USA; [Bossaerts, Peter] Univ Utah, Dept Finance, David Eccles Sch Business, Salt Lake City, UT 84112 USA	California Institute of Technology; University of London; Royal Holloway University London; California Institute of Technology; Utah System of Higher Education; University of Utah	De Martino, B (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	benedettodemartino@gmail.com	Bossaerts, Peter/O-9964-2015; O'Doherty, John P/F-1204-2013; Bossaerts, Peter/AAZ-9851-2020	Bossaerts, Peter/0000-0003-2308-2603	Sir Henry Wellcome Fellowship; Betty and Gordon Moore Foundation; Lipper Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Sir Henry Wellcome Fellowship; Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Lipper Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to David Porter for sharing the behavioral data, Antonio Rangel for help during the initial design of the experiment, and Jessica Hughes for commenting on the manuscript. Support came from the Sir Henry Wellcome Fellowship (B.D.M.), the Betty and Gordon Moore Foundation (C.F.C., J.O.D., P.B.), and the Lipper Family Foundation (C.F.C.). None of the authors of this manuscript have a financial interest related to this work.	Abreu D, 2003, ECONOMETRICA, V71, P173, DOI 10.1111/1468-0262.00393; Akerlof G., 2009, ANIMAL SPIRITS; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baker M, 2007, J ECON PERSPECT, V21, P129, DOI 10.1257/jep.21.2.129; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bertrand M., 2011, HDB LABOR EC, P1545; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bossaerts P, 2009, ANNU REV FINANC ECON, V1, P383, DOI 10.1146/annurev.financial.102708.141514; Brown LD., 2002, SANKHYA, V64, P611; Bruguier AJ, 2010, J FINANC, V65, P1703, DOI 10.1111/j.1540-6261.2010.01591.x; Brunnermeier M. K., 2013, HDB EC FINANCE; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; CAMERER C, 1991, J BUS, V64, P463, DOI 10.1086/296548; Camerer C, 1993, DOUBLE AUCTION MARKE; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; DeCarlo LT, 2003, BEHAV RES METH INS C, V35, P49, DOI 10.3758/BF03195496; Easley D, 1997, REV FINANC STUD, V10, P805, DOI 10.1093/rfs/10.3.805; Easley D, 2002, J FINANC, V57, P2185, DOI 10.1111/1540-6261.00493; Eckel Catherine, 2008, HDB EXPT EC RESULTS; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kindleberger CP, 2005, MANIAS, PANICS AND CRASHES: A HISTORY OF FINANCIAL CRISES, 5TH EDITION, P1, DOI 10.1057/9780230628045; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Kuhnen CM, 2011, J FINANC QUANT ANAL, V46, P605, DOI 10.1017/S0022109011000123; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lei V, 2001, ECONOMETRICA, V69, P831, DOI 10.1111/1468-0262.00222; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Nagelkerke N.J.D., 1991, MAXIMUM LIKELIHOOD E; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Porter D. P., 2003, J BEHAV FINANC, V4, P7, DOI DOI 10.1207/S15427579JPFM0401\_03; Powell M, 1997, J ECON PSYCHOL, V18, P605, DOI 10.1016/S0167-4870(97)00026-3; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Shiller R.J., 2005, IRRATIONAL EXUBERANC; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; SMITH VL, 1988, ECONOMETRICA, V56, P1119, DOI 10.2307/1911361; Suzuki S, 2012, NEURON, V74, P1125, DOI 10.1016/j.neuron.2012.04.030; Weber B, 2009, P NATL ACAD SCI USA, V106, P5025, DOI 10.1073/pnas.0901490106; Wu CC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00159; Xiong W, 2013, HANDBOOK ON SYSTEMIC RISK, P663; Xiong W, 2011, AM ECON REV, V101, P2723, DOI 10.1257/aer.101.6.2723	56	60	60	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1222	1231		10.1016/j.neuron.2013.07.003	http://dx.doi.org/10.1016/j.neuron.2013.07.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	298NC	24050407	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330329600018
J	Ficz, G; Hore, TA; Santos, F; Lee, HJ; Dean, W; Arand, J; Krueger, F; Oxley, D; Paul, YL; Walter, J; Cook, SJ; Andrews, S; Branco, MR; Reik, W				Ficz, Gabriella; Hore, Timothy A.; Santos, Fatima; Lee, Heather J.; Dean, Wendy; Arand, Julia; Krueger, Felix; Oxley, David; Paul, Yu-Lee; Walter, Joern; Cook, Simon J.; Andrews, Simon; Branco, Miguel R.; Reik, Wolf			FGF Signaling Inhibition in ESCs Drives Rapid Genome-wide Demethylation to the Epigenetic Ground State of Pluripotency	CELL STEM CELL			English	Article							DNA METHYLATION; NAIVE PLURIPOTENCY; ERASURE; CELLS; 5-HYDROXYMETHYLCYTOSINE; IMPRINTS; PROTEINS; DYNAMICS	Genome-wide erasure of DNA methylation takes place in primordial germ cells (PGCs) and early embryos and is linked with pluripotency. Inhibition of Erk1/2 and Gsk3 beta signaling in mouse embryonic stem cells (ESCs) by small-molecule inhibitors (called 2i) has recently been shown to induce hypomethylation. We show by whole-genome bisulphite sequencing that 2i induces rapid and genome-wide demethylation on a scale and pattern similar to that in migratory PGCs and early embryos. Major satellites, intracisternal A particles (IAPs), and imprinted genes remain relatively resistant to erasure. Demethylation involves oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), impaired maintenance of 5mC and 5hmC, and repression of the de novo methyltransferases (Dnmt3a and Dnmt3b) and Dnmt3L. We identify a Prdm14- and Nanog-binding cis-acting regulatory region in Dnmt3b that is highly responsive to signaling. These insights provide a framework for understanding how signaling pathways regulate reprogramming to an epigenetic ground state of pluripotency.	[Ficz, Gabriella; Hore, Timothy A.; Santos, Fatima; Lee, Heather J.; Dean, Wendy; Paul, Yu-Lee; Branco, Miguel R.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Krueger, Felix; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Oxley, David] Babraham Inst, Prote Res Grp, Cambridge CB22 3AT, England; [Cook, Simon J.] Babraham Inst, Signalling Programme, Cambridge CB22 3AT, England; [Arand, Julia; Walter, Joern] Univ Saarland, Inst Genet Epigenet, Dept Biol Sci, D-66123 Saarbrucken, Germany; [Branco, Miguel R.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Saarland University; University of Cambridge; Wellcome Trust Sanger Institute	Ficz, G (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	gabriella.ficz@babraham.ac.uk; wolf.reik@babraham.ac.uk	Arand, Julia/AAD-8640-2020; Branco, Miguel/H-9509-2019; Arand, Julia/AAU-9679-2020; Ficz, Gabriella/HCH-3771-2022; Lee, Heather/M-2670-2019; Reik, Wolf/I-6794-2012; Arand, Julia/AFQ-8652-2022; Walter, Jörn/AFN-6428-2022; Dean, Wendy/GSE-3948-2022; Krueger, Felix/J-3340-2019	Branco, Miguel/0000-0001-9447-1548; Arand, Julia/0000-0002-2357-1119; Lee, Heather/0000-0002-6482-0337; Walter, Jörn/0000-0003-0563-7417; Dean, Wendy/0000-0001-9441-5044; Ficz, Gabriella/0000-0001-9313-9578; Krueger, Felix/0000-0002-5513-3324; Reik, Wolf/0000-0003-0216-9881; Cook, Simon/0000-0001-9087-1616; Hore, Timothy/0000-0002-6735-225X; Santos, Fatima/0000-0002-3854-4084	Wellcome Trust; BBSRC; MRC; EU NoE Epigenesys; EU BLUEPRINT; Human Frontier Science Program; BBSRC [BBS/E/B/0000H334, BBS/E/B/0000S266, BBS/E/B/000C0419, BBS/E/B/000C0417] Funding Source: UKRI; MRC [G0801156, G0801727] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0419, BBS/E/B/0000S266, BBS/E/B/0000H334, BBS/E/B/000C0417, BBS/E/B/0000C199] Funding Source: researchfish; Cancer Research UK [14867] Funding Source: researchfish; Medical Research Council [G0801727, G0801156] Funding Source: researchfish; Worldwide Cancer Research [12-1259] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE Epigenesys; EU BLUEPRINT; Human Frontier Science Program(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	We thank Kristina Tabbada for help with epigenomics and transcriptomics sequencing, Kristian Helin for providing the TET1 antibody, Shoji Tajima for providing the DNMT3L antibody, Guoliang Xu for providing Tet1<SUP>-/-</SUP> and Tet1wt ESCs, Tony Green for providing Tet2 <SUP>/</SUP> and Tet2wt ESCs, and Kiyoe Ura for providing the p3b -8615/+93 construct. We would like to thank Stefanie Seisenberger for discussions and Cambridge Epigenetix for a prototype oxBS kit to process our samples. This work was funded by the Wellcome Trust, BBSRC, MRC, EU NoE Epigenesys, EU BLUEPRINT, and the Human Frontier Science Program (T.H.).	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Grabole N., 2013, EMBO REP; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	295	299	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					351	359		10.1016/j.stem.2013.06.004	http://dx.doi.org/10.1016/j.stem.2013.06.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23850245	Green Published, hybrid			2022-12-25	WOS:000329570800012
J	Li, LY; Li, YT; Zhou, M; Tao, HZW; Zhang, LI				Li, Ling-yun; Li, Ya-tang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.			Intracortical multiplication of thalamocortical signals in mouse auditory cortex	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; SIMPLE CELLS; LAYER 6; CIRCUITS; NEURONS; INHIBITION; TECHNOLOGIES; CONVERGENCE	Cortical processing of sensory information begins with the transformation of thalamically relayed signals. We optogenetically silenced intracortical circuits to isolate thalamic inputs to layer 4 neurons and found that intracortical excitation linearly amplified thalamocortical responses underlying frequency and direction selectivity, with spectral range and tuning preserved, and prolonged the response duration. This signal pre-amplification and prolongation enhanced the salience of thalamocortically relayed information and ensured its robust, faithful and more persistent representation.	[Li, Ling-yun; Li, Ya-tang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Ling-yun; Li, Ya-tang; Zhou, Mu] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Zhou, Mu/K-8137-2016; Li, Ya-tang/AAF-2573-2020; Tao, Huizhong W/HDM-9767-2022; Li, Ya-tang/A-9583-2011	Zhou, Mu/0000-0001-5326-4884; Li, Lingyun/0000-0002-0616-6074; Li, Ya-tang/0000-0003-2763-1534	US National Institutes of Health [DC008983, EY019049]; David and Lucile Packard Foundation; NATIONAL EYE INSTITUTE [R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institutes of Health (DC008983 to L.I.Z., EY019049 to H.W.T.) and the David and Lucile Packard Foundation (L.I.Z.).	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Li YT, 2012, J NEUROSCI, V32, P16466, DOI 10.1523/JNEUROSCI.3221-12.2012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011; Zhou M, 2012, J NEUROSCI, V32, P18068, DOI 10.1523/JNEUROSCI.3647-12.2012; Zhou Y, 2012, J NEUROSCI, V32, P9969, DOI 10.1523/JNEUROSCI.1384-12.2012; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	30	79	79	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1179	U25		10.1038/nn.3493	http://dx.doi.org/10.1038/nn.3493			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933752	Green Accepted			2022-12-25	WOS:000323597500006
J	Merkle, FT; Eggan, K				Merkle, Florian T.; Eggan, Kevin			Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function	CELL STEM CELL			English	Review							DEPENDENT ADENOVIRAL VECTORS; PATIENT-SPECIFIC IPSCS; GENE-EXPRESSION; DEFINED FACTORS; DIRECT CONVERSION; HUMAN FIBROBLASTS; MOTOR-NEURONS; BIOMEDICAL-RESEARCH; ALZHEIMERS-DISEASE; RETT-SYNDROME	Mechanistic insights into human disease may enable the development of treatments that are effective in broad patient populations. The confluence of gene-editing technologies, induced pluripotent stem cells, and genome-wide association as well as DNA sequencing studies is enabling new approaches for illuminating the molecular basis of human disease. We discuss the opportunities and challenges of combining these technologies and provide a workflow for interrogating the contribution of disease-associated candidate genetic variants to disease-relevant phenotypes. Finally, we discuss the potential utility of human pluripotent stem cells for placing disease-associated genetic variants into molecular pathways.	[Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Eggan, Kevin/P-7119-2018	Merkle, Florian/0000-0002-8513-2998	Harvard Stem Cell Institute	Harvard Stem Cell Institute	We thank L. Williams, S. Han, B. Davis-Dusenbery, and A. Pauli for comments and discussions that improved this manuscript. F.T.M. is supported by a grant from the Harvard Stem Cell Institute. K.E. is an investigator with the Howard Hughes Medical Institute.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Colten HR, 2006, SLEEP DISORDERS SLEE; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Dyken ME, 2005, PRIMARY CARE, V32, P389, DOI 10.1016/j.pop.2005.02.012; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Gotter AL, 2012, PROG BRAIN RES, V198, P163, DOI 10.1016/B978-0-444-59489-1.00010-0; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Larsson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049874; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Prigodich AE, 2009, ACS NANO, V3, P2147, DOI 10.1021/nn9003814; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Seok J., 2013, P NATL ACAD SCI; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Williams LA, 2012, CELL, V149, P1174, DOI 10.1016/j.cell.2012.05.015; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu DX, 2013, CELL STEM CELL, V12, P678, DOI 10.1016/j.stem.2013.05.018; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	89	134	139	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					656	668		10.1016/j.stem.2013.05.016	http://dx.doi.org/10.1016/j.stem.2013.05.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746975	Bronze			2022-12-25	WOS:000329569900009
J	Freeman, GM; Krock, RM; Aton, SJ; Thaben, P; Herzog, ED				Freeman, G. Mark, Jr.; Krock, Rebecca M.; Aton, Sara J.; Thaben, Paul; Herzog, Erik D.			GABA Networks Destabilize Genetic Oscillations in the Circadian Pacemaker	NEURON			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CLOCK NEURONS; SYNCHRONIZATION; RHYTHMS; MODELS; PHASE	Systems of coupled oscillators abound in nature. How they establish stable phase relationships under diverse conditions is fundamentally important. The mammalian suprachiasmatic nucleus (SCN) is a self-sustained, synchronized network of circadian oscillators that coordinates daily rhythms in physiology and behavior. To elucidate the underlying topology and signaling mechanisms that modulate circadian synchrony, we discriminated the firing of hundreds of SCN neurons continuously over days. Using an analysis method to identify functional interactions between neurons based on changes in their firing, we characterized a GABAergic network comprised of fast, excitatory, and inhibitory connections that is both stable over days and changes in strength with time of day. By monitoring PERIOD2 protein expression, we provide the first evidence that these millisecond-level interactions actively oppose circadian synchrony and inject jitter into daily rhythms. These results provide a mechanism by which circadian oscillators can tune their phase relationships under different environmental conditions.	[Freeman, G. Mark, Jr.; Krock, Rebecca M.; Aton, Sara J.; Herzog, Erik D.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Thaben, Paul] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany	Washington University (WUSTL); Humboldt University of Berlin	Herzog, ED (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	herzog@wustl.edu		Herzog, Erik/0000-0001-7209-5174; Aton, Sara/0000-0002-2921-0509	NIH [MH63104, F30NS070376]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS070376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Carlson, T. Holy, J. Huettner, P. Taghert, C. Zorumski, H. Herzel and members of the Herzog lab for helpful discussions. This work was supported by NIH grants MH63104 (to E.D.H.) and F30NS070376 (to G.M.F.).	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Aton SJ, 2006, P NATL ACAD SCI USA, V103, P19188, DOI 10.1073/pnas.0607466103; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Belenky MA, 2008, J COMP NEUROL, V506, P708, DOI 10.1002/cne.21553; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buxton OM, 2000, SLEEP, V23, P915; Cayetanot F, 2005, EUR J NEUROSCI, V22, P902, DOI 10.1111/j.1460-9568.2005.04268.x; Choi HJ, 2008, J NEUROSCI, V28, P5450, DOI 10.1523/JNEUROSCI.5750-07.2008; De Jeu M, 2002, J NEUROPHYSIOL, V87, P834, DOI 10.1152/jn.00241.2001; Diekman CO, 2009, J BIOL RHYTHM, V24, P322, DOI 10.1177/0748730409337601; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; GULDNER FH, 1976, CELL TISSUE RES, V165, P509; Hafner M., 2012, PLOS COMPUT BIOL, V8; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Mordel J, 2011, J PHYSIOL-LONDON, V589, P2287, DOI 10.1113/jphysiol.2010.204693; MULLER JM, 1995, MOL NEUROBIOL, V10, P115, DOI 10.1007/BF02740671; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vasalou C, 2009, J BIOL RHYTHM, V24, P243, DOI 10.1177/0748730409333220; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	35	82	83	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					799	806		10.1016/j.neuron.2013.04.003	http://dx.doi.org/10.1016/j.neuron.2013.04.003			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764285	Green Accepted, Bronze			2022-12-25	WOS:000320743400007
J	Kress, GJ; Yamawaki, N; Wokosin, DL; Wickersham, IR; Shepherd, GMG; Surmeier, DJ				Kress, Geraldine J.; Yamawaki, Naoki; Wokosin, David L.; Wickersham, Ian R.; Shepherd, Gordon M. G.; Surmeier, D. James			Convergent cortical innervation of striatal projection neurons	NATURE NEUROSCIENCE			English	Article							MOUSE MOTOR CORTEX; CORTICOSTRIATAL NEURONS; BASAL GANGLIA; CONNECTIVITY; MORPHOLOGY; PATHWAYS; RATS	Anatomical studies have led to the assertion that intratelencephalic and pyramidal tract cortical neurons innervate different striatal projection neurons. To test this hypothesis, we measured the responses of mouse striatal neurons to optogenetic activation of intratelencephalic and pyramidal tract axons. Contrary to expectation, direct and indirect pathway striatal spiny projection neurons responded to both intratelencephalic and pyramidal tract activation, arguing that these cortical networks innervate both striatal projection neurons.	[Kress, Geraldine J.; Yamawaki, Naoki; Wokosin, David L.; Shepherd, Gordon M. G.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Wickersham, Ian R.] MIT, Media Lab, Cambridge, MA 02139 USA	Northwestern University; Feinberg School of Medicine; Massachusetts Institute of Technology (MIT)	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Yamawaki, Naoki/AAD-5044-2022	Yamawaki, Naoki/0000-0001-8253-2059; Kress, Geraldine/0000-0001-9442-8734	National Institute of Neurological Disorders and Stroke [T32NS041234, R01NS034696, R01NS061963, P30NS054850]; CHDI Foundation; JPB Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, R01NS034696, P30NS054850, R01NS061963] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CHDI Foundation; JPB Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Ulrich, K. Saporito, Y. Chen and L. Fisher for animal husbandry and genotyping, as well as members of the Shepherd and Surmeier laboratories for helpful discussions. We thank H.S. Seung (Massachusetts Institute of Technology) for providing the virus. This work is supported by grants from the National Institute of Neurological Disorders and Stroke (T32NS041234 to G.J.K., R01NS034696 to D.J.S., R01NS061963 to G.M.G.S. and P30NS054850 to D.L.W.), the CHDI Foundation and the JPB Foundation.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Apicella AJ, 2012, J NEUROSCI, V32, P7021, DOI 10.1523/JNEUROSCI.0011-12.2012; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Morita K, 2012, TRENDS NEUROSCI, V35, P457, DOI 10.1016/j.tins.2012.04.009; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408	17	99	103	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					665	+		10.1038/nn.3397	http://dx.doi.org/10.1038/nn.3397			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666180	Green Accepted			2022-12-25	WOS:000319509600006
J	Brancaccio, M; Maywood, ES; Chesham, JE; Loudon, ASI; Hastings, MH				Brancaccio, Marco; Maywood, Elizabeth S.; Chesham, Johanna E.; Loudon, Andrew S. I.; Hastings, Michael H.			A Gq-Ca2+ Axis Controls Circuit-Level Encoding of Circadian Time in the Suprachiasmatic Nucleus	NEURON			English	Article							VPAC(2) RECEPTOR; CELL AUTONOMY; RHYTHMICITY; SYNCHRONY; ROBUSTNESS; PACEMAKING; GENERATION; CLOCKWORK; DYNAMICS; NEURONS	The role of intracellular transcriptional/post-translational feedback loops (TTFL) within the circadian pacemaker of the suprachiasmatic nucleus (SCN) is well established. In contrast, contributions from G-coupled pathways and cytosolic rhythms to the intercellular control of SCN pacemaking are poorly understood. We therefore combined viral transduction of SCN slices with fluorescence/bioluminescence imaging to visualize GCaMP3-reported circadian oscillations of intracellular calcium [Ca2+](i) alongside activation of Ca2+/cAMP-responsive elements. We phase-mapped them to the TTFL, in time and SCN space, and demonstrated their dependence upon G-coupled vasoactive intestinal peptide (VIP) signaling. Pharmacogenetic manipulation revealed the individual contributions of Gq, Gs, and Gi to cytosolic and TTFL circadian rhythms. Importantly, activation of Gq-dependent (but not Gs or Gi) pathways in a minority of neurons reprogrammed [Ca2+](i) and TTFL rhythms across the entire SCN. This reprogramming was mediated by intrinsic VIPergic signaling, thus revealing a Gq/[Ca2+](i)-VIP leitmotif and unanticipated plasticity within network encoding of SCN circadian time.	[Brancaccio, Marco; Maywood, Elizabeth S.; Chesham, Johanna E.; Hastings, Michael H.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England; [Loudon, Andrew S. I.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	MRC Laboratory Molecular Biology; University of Manchester	Hastings, MH (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England.	mha@mrc-lmb.cam.ac.uk	Brancaccio, Marco/ABD-8086-2021; Core, Vector/CAF-4832-2022	Brancaccio, Marco/0000-0001-8053-5221; Loudon, Andrew/0000-0003-3648-445X; Hastings, Michael Harvey/0000-0001-8576-6651	MRC UK; BBSRC UK [BB/E023223/1]; BBSRC [BB/E023223/1, BB/E022553/1] Funding Source: UKRI; MRC [MC_U105170643] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022553/1, BB/E023223/1] Funding Source: researchfish; Medical Research Council [MC_U105170643] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC UK and the BBSRC UK (BB/E023223/1). The authors thank the Biomedical Staff at the MRC Ares facility, Drs. Leon Lagnado and Federico Esposti (MRC Laboratory of Molecular Biology) for image analysis, and Professor Bryan L. Roth (University of North Carolina) for DREADD plasmids.	An SW, 2011, J NEUROPHYSIOL, V105, P2289, DOI 10.1152/jn.00966.2010; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atkinson SE, 2011, J BIOL RHYTHM, V26, P210, DOI 10.1177/0748730411402810; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Brancaccio M, 2010, STEM CELLS, V28, P1206, DOI 10.1002/stem.443; Butler MP, 2009, J BIOL RHYTHM, V24, P340, DOI 10.1177/0748730409344800; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; Enoki R, 2012, J NEUROSCI METH, V207, P72, DOI 10.1016/j.jneumeth.2012.03.004; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hong JH, 2012, EUR J NEUROSCI, V35, P1417, DOI 10.1111/j.1460-9568.2012.08069.x; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Kori H, 2012, J THEOR BIOL, V297, P61, DOI 10.1016/j.jtbi.2011.12.007; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Mizrak D, 2012, CURR BIOL, V22, P1871, DOI 10.1016/j.cub.2012.07.070; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian Lin, 2012, Cold Spring Harb Protoc, V2012, P647, DOI 10.1101/pdb.top069609; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	45	129	129	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2013	78	4					714	728		10.1016/j.neuron.2013.03.011	http://dx.doi.org/10.1016/j.neuron.2013.03.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151WN	23623697	Green Published, hybrid			2022-12-25	WOS:000319491200014
J	Yamaguchi, T; Danjo, T; Pastan, I; Hikida, T; Nakanishi, S				Yamaguchi, Takashi; Danjo, Teruko; Pastan, Ira; Hikida, Takatoshi; Nakanishi, Shigetada			Distinct Roles of Segregated Transmission of the Septo-Habenular Pathway in Anxiety and Fear	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; PLUS-MAZE; RECEPTOR; RAT; CONNECTIONS; LESIONS; CIRCUITS; COMPLEX; MEDIATE; MGLUR2	The posterior septum consisting of the triangular septum (TS) and the bed nucleus of the anterior commissure (BAG) is predominantly linked with the medial habenula (MHb) and has been implicated in the control of anxiety and fear responses. However, its anatomical and functional linkage has largely remained elusive. We established a transgenic mouse model in which the TS and BAG projection neurons were visualized by GFP fluorescence and selectively eliminated by immunotoxin-mediated cell targeting. The linkage between the TS/BAC and the MHb constitutes two parallel pathways composed of the TS-ventral MHb, the core part of the interpeduncular nucleus (IPN), and the BAG-dorsal MHb, the peripheral part of the IPN. Ablation of the TS and BAG projection neurons selectively impaired anxiety and enhanced fear responses and learning, respectively. Inputs from the TS and BAC to the MHb are thus segregated by two parallel pathways and play specialized roles in controlling emotional behaviors.	[Yamaguchi, Takashi; Danjo, Teruko; Hikida, Takatoshi; Nakanishi, Shigetada] Osaka Biosci Inst, Dept Syst Biol, Suita, Osaka 5650874, Japan; [Yamaguchi, Takashi] Osaka Univ, Grad Sch Med, Dept Aging Sci, Suita, Osaka 5650871, Japan; [Pastan, Ira] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Osaka University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakanishi, S (corresponding author), Osaka Biosci Inst, Dept Syst Biol, Suita, Osaka 5650874, Japan.	snakanis@obi.or.jp	pastan, ira/P-9319-2019; Hikida, Takatoshi/J-5561-2017	pastan, ira/0000-0002-9223-0270; Hikida, Takatoshi/0000-0002-8653-311X; Yamaguchi, Takashi/0000-0001-5153-940X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22220005, 23120011, 23680034]; JST PRESTO Program; Takeda Science Foundation; Naito Foundation; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST PRESTO Program; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Chaki and T. Shimazaki for technical advice on the behavioral analysis. This work was supported by Research Grants-in-Aid 22220005 (S.N.), 23120011 (T.H. and S.N.), and 23680034 (T.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants from the JST PRESTO Program (T.H.), the Takeda Science Foundation (S.N.), and the Naito Foundation (T.H.).	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; CONTESTABILE A, 1987, NEUROSCIENCE, V21, P253, DOI 10.1016/0306-4522(87)90337-X; Damsa C, 2009, CURR OPIN PSYCHIATR, V22, P96, DOI 10.1097/YCO.0b013e328319bd10; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Jesuthasan S, 2012, DEV NEUROBIOL, V72, P395, DOI 10.1002/dneu.20873; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Menard J, 1996, PHYSIOL BEHAV, V60, P845; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Ohishi H, 1998, NEUROSCI RES, V30, P65, DOI 10.1016/S0168-0102(97)00120-X; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Okamoto H, 2012, DEV NEUROBIOL, V72, P386, DOI 10.1002/dneu.20913; PESOLD C, 1992, PHYSIOL BEHAV, V52, P37, DOI 10.1016/0031-9384(92)90431-Z; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Quina LA, 2009, J NEUROSCI, V29, P14309, DOI 10.1523/JNEUROSCI.2430-09.2009; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; Risold P.Y., 2004, RAT NERVOUS SYSTEM, P605, DOI DOI 10.1016/B978-012547638-6/50021-3; Shin J, 2009, J NEUROSCI, V29, P15375, DOI 10.1523/JNEUROSCI.3126-09.2009; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Sylvers P, 2011, CLIN PSYCHOL REV, V31, P122, DOI 10.1016/j.cpr.2010.08.004; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; WILCOX KS, 1986, PHYSIOL BEHAV, V36, P413, DOI 10.1016/0031-9384(86)90307-0; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	41	121	123	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					537	544		10.1016/j.neuron.2013.02.035	http://dx.doi.org/10.1016/j.neuron.2013.02.035			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23602500	Green Accepted, Bronze			2022-12-25	WOS:000318961700014
J	Maroof, AM; Keros, S; Tyson, JA; Ying, SW; Ganat, YM; Merkle, FT; Liu, B; Goulburn, A; Stanley, EG; Elefanty, AG; Widmer, HR; Eggan, K; Goldstein, PA; Anderson, SA; Studer, L				Maroof, Asif M.; Keros, Sotirios; Tyson, Jennifer A.; Ying, Shui-Wang; Ganat, Yosif M.; Merkle, Florian T.; Liu, Becky; Goulburn, Adam; Stanley, Edouard G.; Elefanty, Andrew G.; Widmer, Hans Ruedi; Eggan, Kevin; Goldstein, Peter A.; Anderson, Stewart A.; Studer, Lorenz			Directed Differentiation and Functional Maturation of Cortical Interneurons from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							MEDIAL GANGLIONIC EMINENCE; HUMAN CEREBRAL-CORTEX; NEURAL DEVELOPMENT; BASAL FOREBRAIN; HUMAN NEOCORTEX; FLOOR PLATE; MOUSE-BRAIN; HUMAN ES; NEURONS; EXPRESSION	Human pluripotent stem cells are a powerful tool for modeling brain development and disease. The human cortex is composed of two major neuronal populations: projection neurons and local interneurons. Cortical interneurons comprise a diverse class of cell types expressing the neurotransmitter GABA. Dysfunction of cortical interneurons has been implicated in neuropsychiatric diseases, including schizophrenia, autism, and epilepsy. Here, we demonstrate the highly efficient derivation of human cortical interneurons in an NKX2.1::GFP human embryonic stem cell reporter line. Manipulating the timing of SHH activation yields three distinct GFP+ populations with specific transcriptional profiles, neurotransmitter phenotypes, and migratory behaviors. Further differentiation in a murine cortical environment yields parvalbumin- and somatostatin-expressing neurons that exhibit synaptic inputs and electrophysiological properties of cortical interneurons. Our study defines the signals sufficient for modeling human ventral forebrain development in vitro and lays the foundation for studying cortical interneuron involvement in human disease pathology.	[Maroof, Asif M.; Ganat, Yosif M.; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Maroof, Asif M.; Ganat, Yosif M.; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Tyson, Jennifer A.; Goulburn, Adam; Anderson, Stewart A.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10021 USA; [Keros, Sotirios; Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10021 USA; [Keros, Sotirios] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY 10021 USA; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Widmer, Hans Ruedi] Univ Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland; [Maroof, Asif M.; Merkle, Florian T.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Anderson, Stewart A.] Childrens Hosp Philadelphia, Dept Psychiat, Philadelphia, PA 19104 USA; [Anderson, Stewart A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Monash University; University of Bern; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Anderson, SA (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.	andersons3@email.chop.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021; Stanley, Ed G/A-2985-2013; Ritter, Stefanie L/D-9312-2012; Eggan, Kevin/P-7119-2018; Widmer, Hans R./AAC-8948-2022; Widmer, Hans Rudolf/O-5172-2017; Elefanty, Andrew G/A-6066-2008	Studer, Lorenz/0000-0003-0741-7987; Stanley, Ed G/0000-0002-6389-3665; Widmer, Hans Rudolf/0000-0003-3378-8765; Merkle, Florian/0000-0002-8513-2998; Keros, Sotirios/0000-0001-9264-9824; Goldstein, Peter/0000-0002-5973-9104; Elefanty, Andrew/0000-0001-6448-8314	NIMH [2RO1 MH066912, 1RC1MH089690]; Swiss National Science Foundation [31003A_135565]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089690, R01MH066912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, K12NS066274] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. Hendrikx (Sloan-Kettering Institute [SKI] Flow Cytometry Core), A. Viale (SKI Genomics Core laboratory), M. Leversha (Molecular Cytogenetics Core), and E. Tu and M. Tomishima (SKI Stem Cell Facility) for excellent technical support. We further thank the Department of Gynecology (directors: M. Mueller and D. Surbek), University of Bern, Switzerland for providing us with the human fetal tissue. Studies using the NKX2.1::GFP hESC line were supported by grants from NYSTEM (S.A.), the European Commission project NeuroStemcell (L.S.), and the C.V. Starr Foundation (S.A. and L.S.). Experiments using hESC line WA-09 or iPSC lines were supported by NIMH grants 2RO1 MH066912 (S.A.) and 1RC1MH089690 (S.A. and L.S.) and by the Swiss National Science Foundation grant no. 31003A_135565 (H.R.W.).	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kerwin J, 2010, J ANAT, V217, P289, DOI 10.1111/j.1469-7580.2010.01290.x; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marin O, 2000, J NEUROSCI, V20, P6063; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Rakic S, 2003, CEREB CORTEX, V13, P1072, DOI 10.1093/cercor/13.10.1072; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812	54	384	396	0	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					559	572		10.1016/j.stem.2013.04.008	http://dx.doi.org/10.1016/j.stem.2013.04.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642365	Green Accepted, Bronze			2022-12-25	WOS:000329569600012
J	Pucci, F; Gardano, L; Harrington, L				Pucci, Fabio; Gardano, Laura; Harrington, Lea			Short Telomeres in ESCs Lead to Unstable Differentiation	CELL STEM CELL			English	Article							SELF-RENEWAL; STEM-CELLS; DNA METHYLATION; NANOG; PLURIPOTENCY; EXPRESSION; CHROMATIN; DNMT3A; LENGTH; GENE	Functional telomeres are critical for stem cell proliferation; however, whether they are equally important for the stability of stem cell differentiation is not known. We found that mouse embryonic stem cells (ESCs) with critically short telomeres (Tert(-/-) ESCs) initiated normal differentiation after leukemia inhibitory factor (LIF) withdrawal but, unlike control ESCs, failed to maintain stable differentiation when LIF was reintroduced to the growth medium. Tert(-/-) ESCs expressed higher levels of Nanog and, overall, had decreased genomic CpG methylation levels, which included the promoters of Oct4 and Nanog. This unstable differentiation phenotype could be rescued by telomere elongation via reintroduction of Tert, via suppression of Nanog by small hairpin RNA (shRNA) knockdown, or via enforced expression of the de novo DNA methyltransferase 3b. These results demonstrate an unexpected role of functional telomeres in the genome-wide epigenetic regulation of cell differentiation and suggest a potentially important role of telomere instability in cell fate during development or disease.	[Pucci, Fabio; Gardano, Laura; Harrington, Lea] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Pucci, Fabio; Gardano, Laura; Harrington, Lea] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Harrington, Lea] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3T 1J4, Canada	University of Edinburgh; University of Edinburgh; Universite de Montreal	Harrington, L (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	lea.harrington@umontreal.ca		Gardano, Laura/0000-0003-4333-9891	Wellcome Trust [086580, 084637]; MRC [G0800081] Funding Source: UKRI; Medical Research Council [G0800081] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Bird, K. Kaji, I. Stancheva, and L. H. Wong for discussion and input; C. Furlan, S. Catania, D. Kelly, N. Martins, M. Robson, A. Termanis, M. Waterfall, and G. Vargiu for technical assistance; and K. Kaji for the pCAG-MKOSiE plasmid. This work was funded by Wellcome Trust grants 086580 and 084637 to L.H.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2011, STEM CELLS, V29, P1705, DOI 10.1002/stem.736; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YQ, 2010, CELL REPROGRAM, V12, P3, DOI 10.1089/cell.2009.0033; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658	33	66	68	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 4	2013	12	4					479	486		10.1016/j.stem.2013.01.018	http://dx.doi.org/10.1016/j.stem.2013.01.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VD	23561444	Green Published, hybrid			2022-12-25	WOS:000329569500014
J	Ben-David, U; Gan, QF; Golan-Lev, T; Arora, P; Yanuka, O; Oren, YS; Leikin-Frenkel, A; Graf, M; Garippa, R; Boehringer, M; Gromo, G; Benvenisty, N				Ben-David, Uri; Gan, Qing-Fen; Golan-Lev, Tamar; Arora, Payal; Yanuka, Ofra; Oren, Yifat S.; Leikin-Frenkel, Alicia; Graf, Martin; Garippa, Ralph; Boehringer, Markus; Gromo, Gianni; Benvenisty, Nissim			Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen	CELL STEM CELL			English	Article							STEAROYL-COA DESATURASE; TERATOMA FORMATION; STRESS; GENE; DIFFERENTIATION; TUMORIGENICITY; DISRUPTION; ANTIBODY	The use of human pluripotent stem cells (hPSCs) in cell therapy is hindered by the tumorigenic risk from residual undifferentiated cells. Here we performed a high-throughput screen of over 52,000 small molecules and identified 15 pluripotent cell-specific inhibitors (PluriSIns), nine of which share a common structural moiety. The PluriSIns selectively eliminated hPSCs while sparing a large array of progenitor and differentiated cells. Cellular and molecular analyses demonstrated that the most selective compound, PluriSIn #1, induces ER stress, protein synthesis attenuation, and apoptosis in hPSCs. Close examination identified this molecule as an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs. PluriSIn #1 was also cytotoxic to mouse blastocysts, indicating that the dependence on oleate is inherent to the pluripotent state. Finally, application of PluriSIn #1 prevented teratoma formation from tumorigenic undifferentiated cells. These findings should increase the safety of hPSC-based treatments.	[Ben-David, Uri; Golan-Lev, Tamar; Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Ben-David, Uri; Golan-Lev, Tamar; Yanuka, Ofra; Oren, Yifat S.; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Gan, Qing-Fen; Arora, Payal; Garippa, Ralph] Hoffmann La Roche Inc, Nutley, NJ 07110 USA; [Leikin-Frenkel, Alicia] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel; [Leikin-Frenkel, Alicia] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Graf, Martin; Boehringer, Markus; Gromo, Gianni] F Hoffmann La Roche & Cie AG, CH-4070 Basel, Switzerland	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Roche Holding; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Roche Holding	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378	Hoffmann La Roche-Yissum collaboration	Hoffmann La Roche-Yissum collaboration	The authors would like to thank Hong Ma and Adva Maimon for their assistance with tissue culture; Dr. Eric Chiao, Dr. Josh Babiarz, Dr. Jenny Cohen, and Sei Kameoka for their assistance with assay development; Sean Walker for his assistance with the liquid handler; Dr. Ann Hoffman for her assistance with microscopy imaging; Dr. Rachel Eiges for her assistance with the in vitro embryonic development assay and for critically reading the manuscript; Dr. Sonia Steiner-Mordoch and Professor Oded Meyuhas for their assistance with the protein synthesis inhibition assay; Dr. Simona Ceccarelli for her assistance with the chemical analysis of compounds; Tamar Shiloach for her assistance with apoptosis assays; Dr. Eran Meshorer for the mouse ESCs and for critically reading the manuscript; Oded Kopper for the CSES2-SO2/3 cells; Professor Batsheva Kerem, Dr. Kyle Kolaja, Dr. Jacques Mizrahi, and Dr. David Mark for fruitful discussions and helpful suggestions. N.B. is the Herbert Cohn Chair in Cancer Research. U.B.-D. is a Clore Fellow. This work was supported by a grant from Hoffmann La Roche-Yissum collaboration. Q. F. G., M. G., M. B., and G. G. are employees of the company. R. G. and P. A. are former employees of the company.	Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Germain ND, 2012, CELL TRANSPLANT, V21, P1603, DOI 10.3727/096368912X647243; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kopper O, 2012, STEM CELL RES, V8, P335, DOI 10.1016/j.scr.2011.12.006; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Liu LH, 2012, BIOCHEM BIOPH RES CO, V417, P738, DOI 10.1016/j.bbrc.2011.12.026; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Menendez S, 2012, AGING CELL, V11, P41, DOI 10.1111/j.1474-9726.2011.00754.x; Minville-Walz M., 2010, PLOS ONE, V5; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032	35	226	238	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					167	179		10.1016/j.stem.2012.11.015	http://dx.doi.org/10.1016/j.stem.2012.11.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23318055	Bronze			2022-12-25	WOS:000329569300008
J	Jang, MH; Bonaguidi, MA; Kitabatake, Y; Sun, JQ; Song, J; Kang, EC; Jun, H; Zhong, C; Su, YJ; Guo, JJU; Wang, MX; Sailor, KA; Kim, JY; Gao, Y; Christian, KM; Ming, GL; Song, HJ				Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Sun, Jiaqi; Song, Juan; Kang, Eunchai; Jun, Heechul; Zhong, Chun; Su, Yijing; Guo, Junjie U.; Wang, Marie Xun; Sailor, Kurt A.; Kim, Ju-Young; Gao, Yuan; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Secreted Frizzled-Related Protein 3 Regulates Activity-Dependent Adult Hippocampal Neurogenesis	CELL STEM CELL			English	Article							DNA DEMETHYLATION; RAT HIPPOCAMPUS; BRAIN; SEIZURES; WNT; INTEGRATION; EXPRESSION; NEURONS; MEMORY; CELLS	Adult neurogenesis, the process of generating mature neurons from adult neural stem cells, proceeds concurrently with ongoing neuronal circuit activity and is modulated by various physiological and pathological stimuli. The niche mechanism underlying the activity-dependent regulation of the sequential steps of adult neurogenesis remains largely unknown. Here, we report that neuronal activity decreases the expression of secreted frizzled-related protein 3 (sFRP3), a naturally secreted Wnt inhibitor highly expressed by adult dentate gyrus granule neurons. Sfrp3 deletion activates quiescent radial neural stem cells and promotes newborn neuron maturation, dendritic growth, and dendritic spine formation in the adult mouse hippocampus. Furthermore, sfrp3 reduction is essential for activity-induced adult neural progenitor proliferation and the acceleration of new neuron development. Our study identifies sFRP3 as an inhibitory niche factor from local mature dentate granule neurons that regulates multiple phases of adult hippocampal neurogenesis and suggests an interesting activity-dependent mechanism governing adult neurogenesis via the acute release of tonic inhibition.	[Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Sun, Jiaqi; Song, Juan; Kang, Eunchai; Jun, Heechul; Zhong, Chun; Su, Yijing; Guo, Junjie U.; Wang, Marie Xun; Sailor, Kurt A.; Kim, Ju-Young; Gao, Yuan; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Bonaguidi, Michael A.; Kitabatake, Yasuji; Song, Juan; Kang, Eunchai; Zhong, Chun; Su, Yijing; Kim, Ju-Young; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Guo, Junjie U.; Sailor, Kurt A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Yuan] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Jun, Heechul] Mayo Coll Med, Dept Neurol Surg, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kitabatake, Yasuji] Osaka Univ, Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Sun, Jiaqi] Tsinghua Univ, Sch Life Sci, Beijing 100081, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Osaka University; Tsinghua University	Jang, MH (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	jang.mihyeon@mayo.edu; shongju1@jhmi.edu	Sailor, Kurt Andrew/AFN-4046-2022; Jun, Heechul/K-7623-2013; Sailor, Kurt/GSO-2237-2022	Sailor, Kurt Andrew/0000-0002-9574-6838; Jun, Heechul/0000-0002-5905-2716; Sailor, Kurt/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Kang, Eunchai/0000-0001-6884-622X	NIH [NS047344, MH087874, ES021957, NS048271, HD069184, MH090115, NS080913]; NARSAD; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH090115, R33MH087874, R21MH087874, R00MH090115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS080913, R56NS047344, R01NS048271, R37NS047344, R01NS047344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. D. Ginty, S. Jessberger, X. He, and members of the Song and Ming laboratories for their suggestions, A. Rattner and J. Nathans for generating sfrp3 KO mice, J. H. Shin and B. Xie for help with RNA-seq, and P. Worley for Arc antibodies and initial help with ECS. This work was supported by the NIH (NS047344, MH087874, and ES021957 to H. S; NS048271 and HD069184 to G. M.; MH090115 to M.-H. J.; and NS080913 to M. A. B) and NARSAD (Independent Investigator awards to H. S. and G.-I. M., and a Young Investigator award to M.-H.J.) and by postdoctoral fellowship awards from MSCRF to J.S., E. K., Y.S., and K.C.	Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Zhao CM, 2012, DEV NEUROBIOL, V72, P937, DOI 10.1002/dneu.20986	28	144	152	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					215	223		10.1016/j.stem.2012.11.021	http://dx.doi.org/10.1016/j.stem.2012.11.021			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395446	Green Accepted, Bronze			2022-12-25	WOS:000329569300012
J	Sachidhanandam, S; Sreenivasan, V; Kyriakatos, A; Kremer, Y; Petersen, CCH				Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.			Membrane potential correlates of sensory perception in mouse barrel cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; AUDITORY-CORTEX; BEHAVING MICE; CORTICAL MICROSTIMULATION; GABAERGIC NEURONS; NEURAL ACTIVITY; VISUAL-CORTEX; SINGLE NEURON; MOTOR CORTEX; LAYER 2/3	Neocortical activity can evoke sensory percepts, but the cellular mechanisms remain poorly understood. We trained mice to detect single brief whisker stimuli and report perceived stimuli by licking to obtain a reward. Pharmacological inactivation and optogenetic stimulation demonstrated a causal role for the primary somatosensory barrel cortex. Whole-cell recordings from barrel cortex neurons revealed membrane potential correlates of sensory perception. Sensory responses depended strongly on prestimulus cortical state, but both slow-wave and desynchronized cortical states were compatible with task performance. Whisker deflection evoked an early (<50 ms) reliable sensory response that was encoded through cell-specific reversal potentials. A secondary late (50-400 ms) depolarization was enhanced on hit trials compared to misses. Optogenetic inactivation revealed a causal role for late excitation. Our data reveal dynamic processing in the sensory cortex during task performance, with an early sensory response reliably encoding the stimulus and later secondary activity contributing to driving the subjective percept.	[Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Sreenivasan, Varun/0000-0003-0559-9713; Sachidhanandam, Shankar/0000-0002-9359-6653; Kremer, Yves/0000-0002-2319-1394	Swiss National Science Foundation [31003A-116027, 310030-146252, BaCoFun 310030E-147486]; Deutsche Forschungsgemeinschaft [BaCoFun 310030E-147486]; Human Frontier Science Program [RGP0041/2009]; SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council [ERC-2011-AdG-293660]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council(European Research Council (ERC)European Commission)	This work was funded by grants from the Swiss National Science Foundation (31003A-116027 and 310030-146252), a joint grant between the Swiss National Science Foundation and the Deutsche Forschungsgemeinschaft (BaCoFun 310030E-147486), the Human Frontier Science Program (RGP0041/2009), SystemsX.ch (Neurochoice), the National Competence Centre for Research (Synapsy) and the European Research Council (ERC-2011-AdG-293660 Sensorimotor).	Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Miyashita T, 2013, CEREB CORTEX, V23, P1655, DOI 10.1093/cercor/bhs155; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	216	216	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1671	1677		10.1038/nn.3532	http://dx.doi.org/10.1038/nn.3532			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097038				2022-12-25	WOS:000326205700025
J	Scott, BB; Brody, CD; Tank, DW				Scott, Benjamin B.; Brody, Carlos D.; Tank, David W.			Cellular Resolution Functional Imaging in Behaving Rats Using Voluntary Head Restraint	NEURON			English	Article							FREELY MOVING ANIMALS; RECEPTIVE-FIELD PROPERTIES; HIPPOCAMPAL PLACE CELLS; NEURAL ACTIVITY; VIRTUAL-NAVIGATION; VISUAL-CORTEX; KNOCKOUT RATS; EMBRYO MICROINJECTION; 2-PHOTON MICROSCOPE; BRAIN	High-throughput operant conditioning systems for rodents provide efficient training on sophisticated behavioral tasks. Combining these systems with technologies for cellular resolution functional imaging would provide a powerful approach to study neural dynamics during behavior. Here we describe an integrated two-photon microscope and behavioral apparatus that allows cellular resolution functional imaging of cortical regions during epochs of voluntary head restraint. Rats were trained to initiate periods of restraint up to 8 s in duration, which provided the mechanical stability necessary for in vivo imaging while allowing free movement between behavioral trials. A mechanical registration system repositioned the head to within a few microns, allowing the same neuronal populations to be imaged on each trial. In proof-of-principle experiments, calcium-dependent fluorescence transients were recorded from GCaMP-labeled cortical neurons. In contrast to previous methods for head restraint, this system can be incorporated into high-throughput operant conditioning systems.	[Scott, Benjamin B.; Brody, Carlos D.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Scott, Benjamin B.; Brody, Carlos D.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Brody, Carlos D.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Scott, Benjamin B.; Brody, Carlos D.; Tank, David W.] Princeton Univ, Bezos Ctr Neural Circuit Dynam, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu			NIH [RC1NS068148, R21NS082956]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148, F32NS078913, R21NS082956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Osorio and J. Teran for animal training, D. Aronov for translation of Girman (1980), and S. Lowe for assistance with hardware fabrication. This work was supported by NIH challenge grant number RC1NS068148 and by NIH grant number R21NS082956.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dolgin E, 2010, NAT MED, V16, P254, DOI 10.1038/nm0310-254; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dwinell MR, 2010, BRIEF BIOINFORM, V11, P431, DOI 10.1093/bib/bbp069; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Girman S V, 1985, Neurosci Behav Physiol, V15, P379, DOI 10.1007/BF01184022; GIRMAN SV, 1980, ZH VYSSH NERV DEYAT+, V30, P1087; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huang GY, 2011, CELL CYCLE, V10, P1059, DOI 10.4161/cc.10.7.15233; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Kornblum HI, 2000, NAT BIOTECHNOL, V18, P655, DOI 10.1038/76509; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/NMETH.1641, 10.1038/nmeth.1641]; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P731, DOI 10.1146/annurev-cellbio-100109-104051; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; PARNAVELAS JG, 1981, NEUROSCI LETT, V27, P291, DOI 10.1016/0304-3940(81)90445-6; Piyawattanametha W, 2009, OPT LETT, V34, P2309, DOI 10.1364/OL.34.002309; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Winter Y, 2011, J NEUROSCI METH, V196, P276, DOI 10.1016/j.jneumeth.2011.01.017; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	43	57	58	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					371	384		10.1016/j.neuron.2013.08.002	http://dx.doi.org/10.1016/j.neuron.2013.08.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24055015	Bronze, Green Accepted			2022-12-25	WOS:000326196400019
J	Rao, M				Rao, Mahendra			iPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening	CELL STEM CELL			English	Editorial Material								A key to tapping the potential of iPSCs is the establishment of readily accessible well-characterized panels of lines for custom screening. Here, we propose a crowdsourcing strategy to rapidly develop a large repository of iPSCs and provide a model for how the NIH could support this effort.			Rao, M (corresponding author), 50 South Dr,Suite 1140, Bethesda, MD 20892 USA.	mahendra.rao@nih.gov						Brewer GJ, 2009, TRANSL RES, V154, P314, DOI 10.1016/j.trsl.2009.03.008; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Prebula Randy J, 2010, J Contemp Health Law Policy, V26, P343; Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	20	20	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					389	391		10.1016/j.stem.2013.09.005	http://dx.doi.org/10.1016/j.stem.2013.09.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094321	Bronze			2022-12-25	WOS:000329571100008
J	Stacey, GN; Crook, JM; Hei, D; Ludwig, T				Stacey, Glyn N.; Crook, Jeremy M.; Hei, Derek; Ludwig, Tenneille			Banking Human Induced Pluripotent Stem Cells: Lessons Learned from Embryonic Stem Cells?	CELL STEM CELL			English	Editorial Material							GUIDANCE; LINES	The generation of human embryonic stem cell banking networks has ensured that well-characterized and quality controlled stem cell lines are broadly accessible to researchers worldwide. Here, we provide recommendations for engaging these established networks in efforts to build similar resources for the distribution and collection of induced pluripotent stem cells.	[Stacey, Glyn N.] Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England; [Crook, Jeremy M.] Univ Wollongong, Australian Inst Innovat Mat, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Wollongong, AIIM Facil, Intelligent Polymer Res Inst, ARC Ctr Excellence Elect Sci ACES, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, East Melbourne, Vic 3002, Australia; [Hei, Derek] Univ Wisconsin, Waisman Biomfg, Madison, WI 53705 USA; [Ludwig, Tenneille] WiCell Res Inst, Madison, WI 53726 USA	National Institute for Biological Standards & Control; University of Wollongong; University of Wollongong; University of Wollongong; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute	Stacey, GN (corresponding author), Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England.	glyn.stacey@nibsc.org	Crook, Jeremy Micah/AAH-8441-2020	Crook, Jeremy Micah/0000-0002-6415-1639	Medical Research Council [G1001045] Funding Source: Medline; MRC [G1001045] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Crook JM, 2010, IN VITRO CELL DEV-AN, V46, P169, DOI 10.1007/s11626-010-9301-7; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Luong M.X., 2011, HUMAN STEM CELL MANU, P106; MacLeod RAF, 1999, INT J CANCER, V83, P555; Podolac E., 2010, BIOTECHNIQUES; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	9	49	50	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					385	388		10.1016/j.stem.2013.09.007	http://dx.doi.org/10.1016/j.stem.2013.09.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094320	Bronze			2022-12-25	WOS:000329571100007
J	Jakkamsetti, V; Tsai, NP; Gross, C; Molinaro, G; Collins, KA; Nicoletti, F; Wang, KH; Osten, P; Bassell, GJ; Gibson, JR; Huber, KM				Jakkamsetti, Vikram; Tsai, Nien-Pei; Gross, Christina; Molinaro, Gemma; Collins, Katie A.; Nicoletti, Ferdinando; Wang, Kuan H.; Osten, Pavel; Bassell, Gary J.; Gibson, Jay R.; Huber, Kimberly M.			Experience-Induced Arc/Arg3.1 Primes CA1 Pyramidal Neurons for Metabotropic Glutamate Receptor-Dependent Long-Term Synaptic Depression	NEURON			English	Article							FRAGILE-X-SYNDROME; IMMEDIATE-EARLY GENE; MENTAL-RETARDATION; NOVELTY ACQUISITION; PROTEIN EXPRESSION; MOUSE MODEL; IN-VIVO; HIPPOCAMPAL; ARC; PLASTICITY	A novel experience induces the Arc/Arg3.1 gene as well as plasticity of CA1 neural networks. To understand how these are linked, we briefly exposed GFP reporter mice of Arc transcription to a novel environment. Excitatory synaptic function of CA1 neurons with recent in vivo Arc induction (ArcGFP+) was similar to neighboring noninduced neurons. However, in response to group 1 metabotropic glutamate receptor (mGluR) activation, ArcGFP+ neurons preferentially displayed long-term synaptic depression (mGluR-LTD) and robust increases in dendritic Arc protein. mGluR-LTD in ArcGFP+ neurons required rapid protein synthesis and Arc, suggesting that dendritic translation of Arc underlies the priming of mGluR-LTD. In support of this idea, novelty exposure increased Arc messenger RNA in CA1 dendrites and promoted mGluR-induced translation of Arc in hippocannpal synaptoneurosomes. Repeated experience suppressed synaptic transmission onto ArcGFP+ neurons and occluded mGluR-LTD ex vivo. mGluR-LTD priming in neurons with similar Arc activation history may contribute to encoding a novel environment.	[Jakkamsetti, Vikram; Tsai, Nien-Pei; Molinaro, Gemma; Collins, Katie A.; Gibson, Jay R.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Gross, Christina; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Molinaro, Gemma; Nicoletti, Ferdinando] IRCCS Neuromed, I-80077 Pozzilli, Italy; [Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Wang, Kuan H.] NIMH, Bethesda, MD 20892 USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; IRCCS Neuromed; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Cold Spring Harbor Laboratory	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Nicoletti, Ferdinando/K-4410-2016; Nicoletti, Ferdinando/T-4898-2019; Wang, Kuan Hong/J-1150-2016; Huber, Kimberly/X-5534-2019; Jakkamsetti, Vikram/AAJ-8744-2020; Nicoletti, Ferdinando/A-2446-2010	Wang, Kuan Hong/0000-0002-2249-5417; Jakkamsetti, Vikram/0000-0001-6524-2893; NICOLETTI, Ferdinando/0000-0003-3366-7269; Nicoletti, Ferdinando/0000-0003-0917-443X	National Institutes of Health [NS045711, HD052731, HD056370, MH085617]; Emory Neuroscience NINDS [P30NS055077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, R01HD056370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085617, ZIAMH002897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS045711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Neuroscience NINDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the grants from the National Institutes of Health grants NS045711, HD052731 (to K.M.H.), HD056370 (to J.R.G.), and MH085617 (to G.J.B.) and Emory Neuroscience NINDS Core Facilities grant P30NS055077 (to G.J.B. and C.G.). We would like to thank Dr. John Isaac for discussions and sending us the ArcGFP-BAC mice; Darya Fakhretdinova, Lorea Ormazabal, and Nicole Cabalo for technical assistance; and members of the Huber lab for discussions and comments on the manuscript. We thank Dr. Darrin Brager and Dr. Daniel Johnston for technical assistance with whole-cell recordings in mice.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Dong ZF, 2012, J NEUROSCI, V32, P11980, DOI 10.1523/JNEUROSCI.0984-12.2012; Fletcher BR, 2006, J NEUROSCI, V26, P1507, DOI 10.1523/JNEUROSCI.4441-05.2006; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Grinevich V, 2009, J NEUROSCI METH, V184, P25, DOI 10.1016/j.jneumeth.2009.07.015; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HAGERMAN R, 1985, AM J DIS CHILD, V139, P674, DOI 10.1001/archpedi.1985.02140090036021; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Popkirov SG, 2011, CEREB CORTEX, V21, P501, DOI 10.1093/cercor/bhq093; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011	38	72	75	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					72	79		10.1016/j.neuron.2013.07.020	http://dx.doi.org/10.1016/j.neuron.2013.07.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094104	Green Accepted, Bronze			2022-12-25	WOS:000326305300009
J	Novak, P; Gorelik, J; Vivekananda, U; Shevchuk, AI; Ermolyuk, YS; Bailey, RJ; Bushby, AJ; Moss, GWJ; Rusakov, DA; Klenerman, D; Kullmann, DM; Volynski, KE; Korchev, YE				Novak, Pavel; Gorelik, Julia; Vivekananda, Umesh; Shevchuk, Andrew I.; Ermolyuk, Yaroslav S.; Bailey, Russell J.; Bushby, Andrew J.; Moss, Guy W. J.; Rusakov, Dmitri A.; Klenerman, David; Kullmann, Dimitri M.; Volynski, Kirill E.; Korchev, Yuri E.			Nanoscale-Targeted Patch-Clamp Recordings of Functional Presynaptic Ion Channels	NEURON			English	Article							TRANSMITTER RELEASE; CA2+ CHANNELS; TERMINALS; TRANSMISSION; MODULATION; MICROSCOPY; MEMBRANES	Direct electrical access to presynaptic ion channels has hitherto been limited to large specialized terminals such as the calyx of Held or hippocampal mossy fiber bouton. The electrophysiology and ion-channel complement of far more abundant small synaptic terminals (<= 1 mu m) remain poorly understood. Here we report a method based on superresolution scanning ion conductance imaging of small synapses in culture at approximately 100-150 nm 3D resolution, which allows presynaptic patch-clamp recordings in all four configurations (cell-attached, inside-out, outside-out, and whole-cell). Using this technique, we report presynaptic recordings of K+, Na+, Cl-, and Ca2+ channels. This semiautomated approach allows direct investigation of the distribution and properties of presynaptic ion channels at small central synapses.	[Novak, Pavel; Shevchuk, Andrew I.; Korchev, Yuri E.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Novak, Pavel; Bailey, Russell J.; Bushby, Andrew J.] Univ London, Sch Mat Sci & Engn, London E1 4NS, England; [Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiac Med, London W12 0NN, England; [Vivekananda, Umesh; Ermolyuk, Yaroslav S.; Rusakov, Dmitri A.; Kullmann, Dimitri M.; Volynski, Kirill E.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Shevchuk, Andrew I.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Moss, Guy W. J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Moss, Guy W. J.] UCL, Ctr Math & Phys Life Sci & Expt Biol, London WC1E 6BT, England; [Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Imperial College London; University of London; Queen Mary University London; Imperial College London; University of London; University College London; University of Southampton; University of London; University College London; University of London; University College London; University of Cambridge	Novak, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England.	p.novak@qmul.ac.uk; k.volynski@ucl.ac.uk; y.korchev@imperial.ac.uk	Bushby, Andy/AAJ-8342-2020; Novak, Pavel/J-4264-2012; Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri/AAH-4529-2021; Bailey, Russell/H-7007-2012; Novak, Pavel/P-8154-2019; Rusakov, Dmitri A/E-1987-2011	Novak, Pavel/0000-0002-5461-0344; Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri/0000-0001-9539-9947; Bailey, Russell/0000-0003-3789-168X; Novak, Pavel/0000-0002-5461-0344; Rusakov, Dmitri A/0000-0001-9539-9947; Volynski, Kirill/0000-0001-8208-1905; Korchev, Yuri/0000-0002-4872-8696; Klenerman, David/0000-0001-7116-6954; Gorelik, Julia/0000-0003-1148-9158	BBSRC; MRC; Wellcome Trust; European Research Council; Action Medical Research; Ionscope; BBSRC [BB/D020816/1, BB/D018595/1, BB/D020875/1, BB/D01817X/1] Funding Source: UKRI; MRC [MR/K000608/1, G0600089, G116/147, G0200373, G0802216, G0801316, G0501424, G0900613] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01817X/1, C19021, BB/D020816/1, BB/D018595/1, BB/D020875/1] Funding Source: researchfish; Medical Research Council [G0801316, G0501424, G0200373, G0600089, G116/147, MR/K000608/1, G0900613, G0802216] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Action Medical Research; Ionscope; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	We are grateful to D. Benton and M. Cano for technical help with preparation of the hippocampal cultures. This study was supported by the BBSRC, the MRC, the Wellcome Trust, the European Research Council, and Action Medical Research. P.N., A.I.S., Y.E.K., and D.K. hold shares of Ionscope, a small spin-out company manufacturing scanning ion conductance microscopes. G.M. has a CASE studentship supported by Ionscope. D.M.K, K.E.V., D.A.R., J.G., Y.S.E, U.V, R.J.B., and A.J.B. declare no competing interests.	Ariel P, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00018; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; BOHLE T, 1994, PFLUG ARCH EUR J PHY, V427, P487, DOI 10.1007/BF00374265; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Delmas P, 2000, NAT NEUROSCI, V3, P670, DOI 10.1038/76621; Ermolyuk YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001396; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7; Gorelik J, 2002, P NATL ACAD SCI USA, V99, P16018, DOI 10.1073/pnas.252458399; Gu YC, 2002, FASEB J, V16, P748, DOI 10.1096/fj.01-1024fje; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; HOSOKAWA Y, 1994, NEUROSCI LETT, V169, P167, DOI 10.1016/0304-3940(94)90382-4; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Korchev YE, 1997, BIOPHYS J, V73, P653, DOI 10.1016/S0006-3495(97)78100-1; Li HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00034; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; NOMURA K, 1991, J MEMBRANE BIOL, V124, P53, DOI 10.1007/BF01871364; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Oltedal L, 2007, J NEUROPHYSIOL, V97, P1171, DOI 10.1152/jn.01010.2006; Rheinlaender J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3122007; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; Sasaki T, 2012, NAT PROTOC, V7, P1228, DOI 10.1038/nprot.2012.061; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun L, 2006, EUR J NEUROSCI, V23, P1391, DOI 10.1111/j.1460-9568.2006.04653.x; Sun XP, 1999, J PHYSIOL-LONDON, V518, P639, DOI 10.1111/j.1469-7793.1999.0639p.x; Ying LM, 2002, ANAL CHEM, V74, P1380, DOI 10.1021/ac015674m	41	74	76	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1067	1077		10.1016/j.neuron.2013.07.012	http://dx.doi.org/10.1016/j.neuron.2013.07.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050398	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000330329600006
J	Li, H; Fertuzinhos, S; Mohns, E; Hnasko, TS; Verhage, M; Edwards, R; Sestan, N; Crair, MC				Li, Hong; Fertuzinhos, Sofia; Mohns, Ethan; Hnasko, Thomas S.; Verhage, Matthijs; Edwards, Robert; Sestan, Nenad; Crair, Michael C.			Laminar and Columnar Development of Barrel Cortex Relies on Thalamocortical Neurotransmission	NEURON			English	Article							MOUSE SOMATOSENSORY CORTEX; NEURONAL-ACTIVITY; GENE-EXPRESSION; CEREBRAL-CORTEX; CRITICAL PERIOD; NERVOUS-SYSTEM; LAYER-IV; IN-VIVO; MAP DEVELOPMENT; VISUAL-CORTEX	A dynamic interplay between intrinsic regional molecular cues and extrinsic factors from the thalamus shape multiple features of early cortical development. It remains uncertain and controversial, however, whether the initial formation of cortical columns depends on neuronal activity, and there is little evidence that cortical lamination or neuronal differentiation is influenced by extrinsic activity. We examined the role of thalamic-derived factors in cortical development by selectively eliminating glutamatergic synaptic transmission from thalamocortical neurons in mice and found that eliminating thalamocortical neurotransmission prevented the formation of "barrel" columns in somatosensory cortex. Interestingly, based on cytoarchitectonic criteria and genetic markers, blocking thalamocortical neurotransmission also perturbed the development of superficial cortical lamina and the morphologic development of neurons. These experiments demonstrate that barrels and aspects of the layer-dependent pattern of cortical cytoarchitecture, gene expression, and neuronal differentiation depend on thalamocortical neurotransmission, extending the apparent influence of extrinsic, presumably activity-dependent factors, on cortical development.	[Li, Hong; Fertuzinhos, Sofia; Mohns, Ethan; Sestan, Nenad; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Crair, Michael C.] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Sestan, Nenad; Crair, Michael C.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Hnasko, Thomas S.; Edwards, Robert] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Hnasko, Thomas S.; Edwards, Robert] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Verhage, Matthijs] VU, CNCR, Dept Funct Genom Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands	Yale University; Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Crair, MC (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	michael.crair@yale.edu		Hnasko, Thomas/0000-0001-6176-8513; verhage, matthijs/0000-0002-6085-7503	Brown-Coxe fellowship; NIH [K01 DA026504, R01 MH50712, R01 NS054273, R01 EY015788, T32 NS007224, R01 MH062639]; family of William Ziegler III; NATIONAL EYE INSTITUTE [R01EY023105, R01EY015788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, R37MH050712, R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273, T32NS007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, K01DA026504] Funding Source: NIH RePORTER	Brown-Coxe fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of William Ziegler III; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Zhang for her excellent technical support and members of the Crair lab for their continual feedback and valuable comments on the manuscript. This work was supported by a Brown-Coxe fellowship to H.L.; NIH grants K01 DA026504 to T.H..; R01 MH50712 to R.E.; R01 NS054273 to N.S.; R01 EY015788, T32 NS007224, and R01 MH062639 to M.C.C.; and by the family of William Ziegler III.	Abe H, 2012, P NATL ACAD SCI USA, V109, P8734, DOI 10.1073/pnas.1206418109; Barroso-Chinea P, 2008, J CHEM NEUROANAT, V35, P101, DOI 10.1016/j.jchemneu.2007.08.001; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Dudok JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028137; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; Hayano Y, 2008, NEUROSCIENTIST, V14, P359, DOI 10.1177/1073858408317272; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 2008, J NEUROSCI, V28, P5931, DOI 10.1523/JNEUROSCI.0815-08.2008; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lebrand C, 1998, J COMP NEUROL, V401, P506; Li H, 2011, ANN NY ACAD SCI, V1225, P119, DOI 10.1111/j.1749-6632.2011.06024.x; LOMBARDO A, 1995, NEUROSCIENCE, V65, P997, DOI 10.1016/0306-4522(94)00538-G; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Lu W, 2013, NEURON, V78, P433, DOI 10.1016/j.neuron.2013.02.030; LUND JS, 1984, CEREB CORTEX, V1, P255; Mataga N, 2001, J NEUROSCI, V21, P9724, DOI 10.1523/JNEUROSCI.21-24-09724.2001; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; MCMULLEN NT, 1988, J COMP NEUROL, V267, P92, DOI 10.1002/cne.902670107; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; O'Leary DDM, 2008, CURR OPIN NEUROBIOL, V18, P90, DOI 10.1016/j.conb.2008.05.011; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Patra RC, 2004, J NEUROSCI RES, V78, P235, DOI 10.1002/jnr.20243; Quairiaux C, 2007, J NEUROPHYSIOL, V97, P2130, DOI 10.1152/jn.00338.2006; Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007; Sato H, 2012, J NEUROSCI, V32, P15388, DOI 10.1523/JNEUROSCI.0293-12.2012; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Wang Y, 2011, NEUROSCIENCE, V190, P398, DOI 10.1016/j.neuroscience.2011.06.010; WELKER E, 1986, J NEUROSCI, V6, P3355; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wijetunge LS, 2008, J NEUROSCI, V28, P13028, DOI 10.1523/JNEUROSCI.2600-08.2008; Windrem MS, 1991, CEREB CORTEX, V1, P230, DOI 10.1093/cercor/1.3.230; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Zhou LB, 2010, J NEUROSCI, V30, P7928, DOI 10.1523/JNEUROSCI.6005-09.2010; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	62	99	101	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					970	986		10.1016/j.neuron.2013.06.043	http://dx.doi.org/10.1016/j.neuron.2013.06.043			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012009	Bronze, Green Accepted			2022-12-25	WOS:000330269100014
J	Matsumoto, M; Takada, M				Matsumoto, Masayuki; Takada, Masahiko			Distinct Representations of Cognitive and Motivational Signals in Midbrain Dopamine Neurons	NEURON			English	Article							PRIMATE PREFRONTAL CORTEX; FRONTO-EXECUTIVE FUNCTION; DELAYED-RESPONSE TASK; WORKING-MEMORY; REWARD PREDICTION; STIMULI; ATTENTION; MODULATION; STRIATUM; DISSOCIATION	Dopamine is essential to cognitive functions. However, despite abundant studies demonstrating that dopamine neuron activity is related to reinforcement and motivation, little is known about what signals dopamine neurons convey to promote cognitive processing. We therefore examined dopamine neuron activity in monkeys performing a delayed matching-to-sample task that required working memory and visual search. We found that dopamine neurons responded to task events associated with cognitive operations. A subset of dopamine neurons were activated by visual stimuli if the monkey had to store the stimuli in working memory. These neurons were located dorsolaterally in the substantia nigra pars compacta, whereas ventromedial dopamine neurons, some in the ventral tegmental area, represented reward prediction signals. Furthermore, dopamine neurons monitored visual search performance, becoming active when the monkey made an internal judgment that the search was successfully completed. Our findings suggest an anatomical gradient of dopamine signals along the dorsolateral-ventromedial axis of the ventral midbrain.	[Matsumoto, Masayuki; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Syst Neurosci Sect, Inuyama, Aichi 4848506, Japan; [Matsumoto, Masayuki] Univ Tsukuba, Fac Med, Div Biomed Sci, Tsukuba, Ibaraki 3058577, Japan; [Matsumoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	Kyoto University; University of Tsukuba; University of Tsukuba	Matsumoto, M (corresponding author), Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Syst Neurosci Sect, Inuyama, Aichi 4848506, Japan.	mmatsumoto@md.tsukuba.ac.jp			Cabinet Office, Government of Japan [LS074]; Ministry of Education, Science, Sports, Culture, and Technology of Japan [22800036]; Takeda Science Foundation; Uehara Memorial Foundation	Cabinet Office, Government of Japan; Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank E. Bromberg-Martin and K. McCairn for comments on the earlier version of the manuscript, and D. Takahara for technical assistance. This research was supported by Funding Program for Next Generation World-Leading Researchers (LS074) to M.M. from Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research (22800036) to M.M. from the Ministry of Education, Science, Sports, Culture, and Technology of Japan; the Takeda Science Foundation to M.M.; and the Uehara Memorial Foundation to M.M.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; de Lafuente V, 2011, P NATL ACAD SCI USA, V108, P19767, DOI 10.1073/pnas.1117636108; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Faure A, 2008, J NEUROSCI, V28, P7184, DOI 10.1523/JNEUROSCI.4961-07.2008; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Haber SN, 2000, J NEUROSCI, V20, P2369; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; PORRINO LJ, 1982, J COMP NEUROL, V205, P63, DOI 10.1002/cne.902050107; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Satoh T, 2003, J NEUROSCI, V23, P9913; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; STEINFELS GF, 1983, BRAIN RES, V258, P217, DOI 10.1016/0006-8993(83)91145-9; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Ullsperger M, 2010, NEUROSCI BIOBEHAV R, V34, P649, DOI 10.1016/j.neubiorev.2009.06.009; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Vezoli J, 2009, J NEUROSCI, V29, P15675, DOI 10.1523/JNEUROSCI.4943-09.2009; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	61	83	84	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					1011	1024		10.1016/j.neuron.2013.07.002	http://dx.doi.org/10.1016/j.neuron.2013.07.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	23932490	Bronze			2022-12-25	WOS:000330269100017
J	Hermanson, DJ; Hartley, ND; Gamble-George, J; Brown, N; Shonesy, BC; Kingsley, PJ; Colbran, RJ; Reese, J; Marnett, LJ; Patel, S				Hermanson, Daniel J.; Hartley, Nolan D.; Gamble-George, Joyonna; Brown, Naoko; Shonesy, Brian C.; Kingsley, Phillip J.; Colbran, Roger J.; Reese, Jeffrey; Marnett, Lawrence J.; Patel, Sachin			Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation	NATURE NEUROSCIENCE			English	Article							AMIDE HYDROLASE INHIBITION; REPEATED HOMOTYPIC STRESS; MOLECULAR CHARACTERIZATION; MONOACYLGLYCEROL LIPASE; CATABOLIC ENZYMES; ARACHIDONIC-ACID; MOUSE-BRAIN; SYSTEM; 2-ARACHIDONOYLGLYCEROL; CYCLOOXYGENASE-2	Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for in vivo eCB augmentation has not been explored. Using medicinal chemistry and in vivo analytical and behavioral pharmacological approaches, we found that COX-2 is important for the regulation of eCB levels in vivo. We used a pharmacological strategy involving substrate-selective inhibition of COX-2 to augment eCB signaling without affecting related non-eCB lipids or prostaglandin synthesis. Behaviorally, substrate-selective inhibition of COX-2 reduced anxiety-like behaviors in mice via increased eCB signaling. Our data suggest a key role for COX-2 in the regulation of eCB signaling and indicate that substrate-selective pharmacology represents a viable approach for eCB augmentation with broad therapeutic potential.	[Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Biochem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Chem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Pharmacol, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Hartley, Nolan D.; Gamble-George, Joyonna; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Brown, Naoko; Reese, Jeffrey] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Shonesy, Brian C.; Colbran, Roger J.; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Biochem, Nashville, TN 37212 USA.	larry.marnett@vanderbilt.edu; sachin.patel@vanderbilt.edu	Gamble-George, Joyonna/AAM-7598-2021; Colbran, Roger/AAU-7708-2021; Shonesy, Brian/AAP-7569-2021; Gamble-George, Joyonna Carrie/GQA-7423-2022	Gamble-George, Joyonna/0000-0002-5492-9216; Colbran, Roger/0000-0001-7401-8244; Reese, Jeff/0000-0001-8751-6146; Shonesy, Brian/0000-0003-3791-9339	US National Institutes of Health [MH090412, MH100096, CA89450, GM15431, NS064278, DA031572, HL96967, HL109199, NS078291, T32-MH065215]; A.B. Hancock Jr. Memorial Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109199, R01HL096967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, R25GM062459, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100096, K08MH090412, R01MH063232, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291, R01NS064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA031572] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.B. Hancock Jr. Memorial Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Masuda, M. Brown, R. Stevens and B. Cravatt (Scripps Research Institute) for FAAH knockout mice. This work was supported by US National Institutes of Health grants MH090412 and MH100096 (S.P.), CA89450, GM15431, NS064278 (L.J.M.), DA031572 (D.J.H.), HL96967, HL109199 (J.R.), NS078291 (R.J.C.) and T32-MH065215 (B.C.S.), and the A.B. Hancock Jr. Memorial Laboratory for Cancer Research. Analytical studies were conducted in the Vanderbilt University Mass Spectrometry Core facility and all behavioral experiments were conducted in the Vanderbilt University Medical Center Mouse Neurobehavioral Core facility. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Bifulco M, 2007, ONCOL REP, V17, P813; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Fride E, 2006, METH MOLEC MED, V123, P269; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hohmann AG, 2006, AAPS J, V8, pE693, DOI 10.1208/aapsj080479; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kingsley PJ, 2007, METHOD ENZYMOL, V433, P91, DOI 10.1016/s0076-6879(07)33005-X; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kunos G, 2007, AM J MED, V120, P18, DOI 10.1016/j.amjmed.2007.06.007; Lichtman AH, 2002, PROSTAG LEUKOTR ESS, V66, P269, DOI 10.1054/plef.2001.0351; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lopez-Rodriguez ML, 2005, MINI-REV MED CHEM, V5, P97, DOI 10.2174/1389557053402819; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Makriyannis A, 2005, NEUROPHARMACOLOGY, V48, P1068, DOI 10.1016/j.neuropharm.2005.03.012; Mangleri RA, 2007, PHARMACOL RES, V56, P360, DOI 10.1016/j.phrs.2007.09.003; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Muller N, 2008, CURR PHARM DESIGN, V14, P1452, DOI 10.2174/138161208784480243; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Pan B, 2008, J NEUROSCI, V28, P14018, DOI 10.1523/JNEUROSCI.4035-08.2008; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Patrignani Paola, 2011, Expert Rev Clin Pharmacol, V4, P605, DOI 10.1586/ecp.11.36; Pedicord DL, 2011, BIOCHEM BIOPH RES CO, V411, P809, DOI 10.1016/j.bbrc.2011.07.037; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Rouzer CA, 2006, PROSTAG OTH LIPID M, V79, P146; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sciolino NR, 2011, PHARMACOL RES, V64, P226, DOI 10.1016/j.phrs.2011.04.010; Staniaszek LE, 2010, BRIT J PHARMACOL, V160, P669, DOI 10.1111/j.1476-5381.2010.00703.x; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Uddin MJ, 2011, CANCER PREV RES, V4, P1536, DOI 10.1158/1940-6207.CAPR-11-0120; Yu Y., 2012, SCI TRANSL MED, V4	56	90	92	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1291	U176		10.1038/nn.3480	http://dx.doi.org/10.1038/nn.3480			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912944	Green Accepted			2022-12-25	WOS:000323597500021
J	Lim, S; Goldman, MS				Lim, Sukbin; Goldman, Mark S.			Balanced cortical microcircuitry for maintaining information in working memory	NATURE NEUROSCIENCE			English	Article							PERSISTENT NEURAL ACTIVITY; RAT PREFRONTAL CORTEX; SHORT-TERM-MEMORY; NMDA RECEPTORS; DECISION-MAKING; IN-VIVO; NEURONS; NETWORK; INTEGRATOR; MODEL	Persistent neural activity in the absence of a stimulus has been identified as a neural correlate of working memory, but how such activity is maintained by neocortical circuits remains unknown. We used a computational approach to show that the inhibitory and excitatory microcircuitry of neocortical memory-storing regions is sufficient to implement a corrective feedback mechanism that enables persistent activity to be maintained stably for prolonged durations. When recurrent excitatory and inhibitory inputs to memory neurons were balanced in strength and offset in time, drifts in activity triggered a corrective signal that counteracted memory decay. Circuits containing this mechanism temporally integrated their inputs, generated the irregular neural firing observed during persistent activity and were robust against common perturbations that severely disrupted previous models of short-term memory storage. These results reveal a mechanism for the accumulation and storage of memories in neocortical circuits based on principles of corrective negative feedback that are widely used in engineering applications.	[Lim, Sukbin; Goldman, Mark S.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Ophthalmol & Visual Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Goldman, MS (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	msgoldman@ucdavis.edu			US National Institutes of Health [R01 MH069726, R01 MH065034]; Sloan Foundation fellowship; University of California Davis Ophthalmology Research to Prevent Blindness grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069726, R01MH065034] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation fellowship(Alfred P. Sloan Foundation); University of California Davis Ophthalmology Research to Prevent Blindness grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Fisher for valuable discussions and E. Aksay, K. Britten, N. Brunel, D. Butts, J. Ditterich, R. Froemke, A. Goddard, D. Kastner, B. Lankow, S. Luck, B. Mulloney, J. Raymond, J. Rinzel and M. Usrey for valuable discussions and feedback on the manuscript. We thank A. Lerchner for providing code for our initial simulations of spiking network models. This research was supported by US National Institutes of Health grants R01 MH069726 and R01 MH065034, a Sloan Foundation fellowship, and a University of California Davis Ophthalmology Research to Prevent Blindness grant.	Barbieri F, 2008, FRONT NEUROSCI-SWITZ, V2, P114, DOI 10.3389/neuro.01.003.2008; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hansel D, 1998, NEURAL COMPUT, V10, P467, DOI 10.1162/089976698300017845; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nikitchenko M, 2008, NEURAL COMPUT, V20, P2379, DOI 10.1162/neco.2008.12-06-416; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang HX, 2009, NEUROPSYCHOPHARMACOL, V34, P2028, DOI 10.1038/npp.2009.20; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wilson H.R., 1999, SPIKES DECISIONS ACT; Xiang ZX, 1998, J PHYSIOL-LONDON, V506, P715, DOI 10.1111/j.1469-7793.1998.715bv.x; Xie XH, 2000, ADV NEUR IN, V12, P199	54	113	115	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1306	U196		10.1038/nn.3492	http://dx.doi.org/10.1038/nn.3492			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955560	Green Accepted			2022-12-25	WOS:000323597500023
J	Hunt, DL; Puente, N; Grandes, P; Castillo, PE				Hunt, David L.; Puente, Nagore; Grandes, Pedro; Castillo, Pablo E.			Bidirectional NMDA receptor plasticity controls CA3 output and heterosynaptic metaplasticity	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; FEEDFORWARD INHIBITION; MEDIATED TRANSMISSION; RAT HIPPOCAMPUS; MEMORY	NMDA receptors (NMDARs) are classically known as coincidence detectors for the induction of long-term synaptic plasticity and have been implicated in hippocampal CA3 cell-dependent spatial memory functions that likely rely on dynamic cellular ensemble encoding of space. The unique functional properties of both NMDARs and mossy fiber projections to CA3 pyramidal cells place mossy fiber NMDARs in a prime position to influence CA3 ensemble dynamics. By mimicking presynaptic and postsynaptic activity patterns observed in vivo, we found a burst timing-dependent pattern of activity that triggered bidirectional long-term NMDAR plasticity at mossy fiber-CA3 synapses in rat hippocampal slices. This form of plasticity imparts bimodal control of mossy fiber-driven CA3 burst firing and spike temporal fidelity. Moreover, we found that mossy fiber NMDARs mediate heterosynaptic metaplasticity between mossy fiber and associational-commissural synapses. Thus, bidirectional NMDAR plasticity at mossy fiber-CA3 synapses could substantially contribute to the formation, storage and recall of CA3 cell assembly patterns.	[Hunt, David L.; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain	Yeshiva University; Albert Einstein College of Medicine; University of Basque Country	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	pablo.castillo@einstein.yu.edu	Grandes, Pedro/H-7494-2015; Puente, Nagore/H-7054-2015; Grandes, Pedro/AAA-1627-2019	Grandes, Pedro/0000-0003-3947-4230; Puente, Nagore/0000-0003-0866-5747; Hunt, David/0000-0002-7567-5649; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [R01 MH081935, R01 DA017392]; Ministerio de Economia y Competitividad [BFU2012-33334]; Basque Country Government [IT764-13]; University of the Basque Country; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government); Basque Country Government(Basque Government); University of the Basque Country; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Castillo lab (in particular, A. Chavez, T. Younts, P. Haeger and S. Makani) for their constructive discussions on the data and helpful comments on the manuscript. This work was supported by US National Institutes of Health grants to P.E.C. (R01 MH081935 and R01 DA017392). Funding for P.G.'s laboratory is provided by Ministerio de Economia y Competitividad (BFU2012-33334), Basque Country Government (IT764-13) and University of the Basque Country.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Astori S, 2010, J PHYSIOL-LONDON, V588, P4475, DOI 10.1113/jphysiol.2010.198366; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Frausto SF, 2011, J NEUROSCI, V31, P16897, DOI 10.1523/JNEUROSCI.1264-11.2011; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hulme SR, 2012, J NEUROSCI, V32, P6785, DOI 10.1523/JNEUROSCI.0634-12.2012; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ireland DR, 2009, J NEUROPHYSIOL, V101, P1375, DOI 10.1152/jn.90643.2008; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kapur A, 2001, NEUROSCIENCE, V107, P59, DOI 10.1016/S0306-4522(01)00293-7; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mateos JM, 1998, J COMP NEUROL, V390, P225, DOI 10.1002/(SICI)1096-9861(19980112)390:2<225::AID-CNE5>3.0.CO;2-3; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Rebola N, 2011, NAT NEUROSCI, V14, P691, DOI 10.1038/nn.2809; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Torborg CL, 2010, J NEUROSCI, V30, P15628, DOI 10.1523/JNEUROSCI.3099-10.2010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387	51	36	36	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1049	U109		10.1038/nn.3461	http://dx.doi.org/10.1038/nn.3461			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852115	Green Accepted			2022-12-25	WOS:000322323000015
J	Liu, GM; Gu, B; He, XP; Joshi, RB; Wackerle, HD; Rodriguiz, RM; Wetsel, WC; McNamara, JO				Liu, Gumei; Gu, Bin; He, Xiao-Ping; Joshi, Rasesh B.; Wackerle, Harold D.; Rodriguiz, Ramona Marie; Wetsel, William C.; McNamara, James O.			Transient Inhibition of TrkB Kinase after Status Epilepticus Prevents Development of Temporal Lobe Epilepsy	NEURON			English	Article							NEUROTROPHIC FACTOR; MAMMALIAN TARGET; KAINIC ACID; EPILEPTOGENESIS; SEIZURES; ANXIETY	Temporal lobe epilepsy is the most common and often devastating form of human epilepsy. The molecular mechanism underlying the development of temporal lobe epilepsy remains largely unknown. Emerging evidence suggests that activation of the BDNF receptor TrkB promotes epileptogenesis caused by status epilepticus. We investigated a mouse model in which a brief episode of status epilepticus results in chronic recurrent seizures, anxiety-like behavior, and destruction of hippocannpal neurons. We used a chemical-genetic approach to selectively inhibit activation of TrkB. We demonstrate that inhibition of TrkB commencing after status epilepticus and continued for 2 weeks prevents recurrent seizures, ameliorates anxiety-like behavior, and limits loss of hippocampal neurons when tested weeks to months later. That transient inhibition commencing after status epilepticus can prevent these long-lasting devastating consequences establishes TrkB signaling as an attractive target for developing preventive treatments of epilepsy in humans.	[Liu, Gumei; He, Xiao-Ping; Wetsel, William C.; McNamara, James O.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Gu, Bin; McNamara, James O.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Rodriguiz, Ramona Marie; Wetsel, William C.] Duke Univ, Mouse Behav & Neuroendocrine Anal Core Facil, Med Ctr, Durham, NC 27710 USA; [Rodriguiz, Ramona Marie; Wetsel, William C.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Dept Cell Biol, Med Ctr, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Dept Med Neurol, Med Ctr, Durham, NC 27710 USA; [Joshi, Rasesh B.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27710 USA; [Wackerle, Harold D.] Duke Univ, Neurosci Program, Trinity Coll Arts & Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	jmc@neuro.duke.edu	Gu, Bin/E-3409-2014	Gu, Bin/0000-0002-6846-5563	NINDS [NS56217, NS060728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217, R01NS060728] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. David Ginty for providing TrkB<SUP>F616A</SUP> mice. We thank Dr. J. Victor Nadler and Dr. Richard D. Mooney for critical discussions and reading of the manuscript. Danielle Cordero assisted in EEG and video reading. Wei-Hua Qian assisted in animal breeding and genotyping. This work was supported by NINDS grants NS56217 and NS060728 (J.O.M.).	Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; BENARI Y, 1980, NEUROSCIENCE, V5, P515, DOI 10.1016/0306-4522(80)90049-4; Beyenburg S, 2005, EPILEPSY BEHAV, V7, P161, DOI 10.1016/j.yebeh.2005.05.014; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Boulle F, 2012, PROG NEUROBIOL, V98, P197, DOI 10.1016/j.pneurobio.2012.06.002; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Cascino G. D., 1998, EPILEPSY COMPREHENSI, P937; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; ENGEL J, 1998, EPILEPSY COMPREHENSI, P2417; Ferreira T, 2011, IMAGEJ USER GUIDE; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Helgager J, 2013, J COMP NEUROL, V521, P499, DOI 10.1002/cne.23225; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Lehmkuhle MJ, 2009, J NEUROPHYSIOL, V101, P1660, DOI 10.1152/jn.91062.2008; Mathern GW, 1998, EPILEPSY COMPREHENSI, P133; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Pitkanen A, 2004, EPILEPSY RES, V61, P119, DOI 10.1016/j.eplepsyres.2004.07.005; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Torta R, 1999, EPILEPSIA, V40, pS2, DOI 10.1111/j.1528-1157.1999.tb00883.x; Tsai MH, 2009, QJM-INT J MED, V102, P57, DOI 10.1093/qjmed/hcn149; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x	32	150	152	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2013	79	1					31	38		10.1016/j.neuron.2013.04.027	http://dx.doi.org/10.1016/j.neuron.2013.04.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23790754	Bronze, Green Accepted, Green Submitted			2022-12-25	WOS:000321802000007
J	Olulade, OA; Napoliello, EM; Eden, GF				Olulade, Olumide A.; Napoliello, Eileen M.; Eden, Guinevere F.			Abnormal Visual Motion Processing Is Not a Cause of Dyslexia	NEURON			English	Article							DORSAL STREAM FUNCTION; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; PHONOLOGICAL AWARENESS; CONTRAST SENSITIVITY; EYE-MOVEMENTS; CHILDREN; BRAIN; DEFICITS; SKILLS	Developmental dyslexia is a reading disorder, yet deficits also manifest in the magnocellular-dominated dorsal visual system. Uncertainty about whether visual deficits are causal or consequential to reading disability encumbers accurate identification and appropriate treatment of this common learning disability. Using fMRI, we demonstrate in typical readers a relationship between reading ability and activity in area V5/MT during visual motion processing and, as expected, also found lower V5/MT activity for dyslexic children compared to age-matched controls. However, when dyslexics were matched to younger controls on reading ability, no differences emerged, suggesting that weakness in V5/MT may not be causal to dyslexia. To further test for causality, dyslexics underwent a phonological-based reading intervention. Surprisingly, V5/MT activity increased along with intervention-driven reading gains, demonstrating that activity here is mobilized through reading. Our results provide strong evidence that visual magnocellular dysfunction is not causal to dyslexia but may instead be consequential to impoverished reading.	[Olulade, Olumide A.; Napoliello, Eileen M.; Eden, Guinevere F.] Georgetown Univ, Med Ctr, Ctr Study Learning, Washington, DC 20057 USA	Georgetown University	Eden, GF (corresponding author), Georgetown Univ, Med Ctr, Ctr Study Learning, Washington, DC 20057 USA.	edeng@georgetown.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [P50 HD40095, R01 HD056107]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056107] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD040095] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank Corinna Moore, Emily Curran, lain DeWitt, Megan Luetje, Alison Merikangas, Ashley Wall-Piche, Robert Twomey, Jenni Rosenberg, and staff at the Center for Functional and Molecular Imaging for their assistance in fMRI data collection; Emma Cole, Martha Miranda, Gina Smith, and Kelly Crain for collection of behavioral psychometric measures; and careful supervision of these assessments by Dr. Lynn Flowers. We thank our subjects for their participation, and the students, parents, and staff at the Jemicy School for their involvement. We thank Peter Turkeltaub and three anonymous reviewers for providing constructive comments on the manuscript. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD40095 and R01 HD056107).	Alexander AW, 2004, J CHILD NEUROL, V19, P744, DOI 10.1177/08830738040190100401; Atkinson J, 1997, NEUROREPORT, V8, P1919, DOI 10.1097/00001756-199705260-00025; Bell N., 1997, CLOUD 9 VISUALIZING; Bell N., 1997, SEEING STARS; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Boden C, 2007, PSYCHOL BULL, V133, P346, DOI 10.1037/0033-2909.133.2.346; Boets B, 2011, CHILD DEV, V82, P854, DOI 10.1111/j.1467-8624.2010.01527.x; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Conners CK, 2000, CONNERS RATING SCALE; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; Danelli L., 2012, HUM BRAIN MAPP, V2012, P27; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Eden GF, 1998, NEURON, V21, P279, DOI 10.1016/S0896-6273(00)80537-1; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Frith U., 1983, BRIT J DEV PSYCHOL, V1, P329, DOI 10.1111/j.2044-835X.1983.tb00906.x; Gaillard WD, 2003, HUM BRAIN MAPP, V18, P176, DOI 10.1002/hbm.10091; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; Hansen PC, 2001, NEUROREPORT, V12, P1527, DOI 10.1097/00001756-200105250-00045; Heim S, 2010, DYSLEXIA, V16, P258, DOI 10.1002/dys.409; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; HULME C, 1988, COGNITIVE NEUROPSYCH, V5, P369, DOI 10.1080/02643298808252942; Kang E, 2004, NEUROIMAGE, V22, P1173, DOI 10.1016/j.neuroimage.2004.02.036; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kwok V, 2011, P NATL ACAD SCI USA, V108, P6686, DOI 10.1073/pnas.1103217108; Lindamood P. C., 2004, LINDAMOOD BEEL AUDIT; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Mendola JD, 1999, J NEUROSCI, V19, P8560; Meng XZ, 2011, ANN DYSLEXIA, V61, P161, DOI 10.1007/s11881-010-0049-2; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Mitchell TV, 2004, J COGNITIVE NEUROSCI, V16, P1363, DOI 10.1162/0898929042304750; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1093/neucas/8.5.345; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Rauschecker AM, 2011, NEURON, V71, P941, DOI 10.1016/j.neuron.2011.06.036; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; SNOWLING MJ, 1980, J EXP CHILD PSYCHOL, V29, P294, DOI 10.1016/0022-0965(80)90021-1; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Szwed M, 2012, DEVELOPMENTAL SCI, V15, P139, DOI 10.1111/j.1467-7687.2011.01102.x; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Talcott JB, 2003, BRAIN LANG, V87, P259, DOI 10.1016/S0093-934X(03)00105-6; Temereanca S, 2012, J NEUROSCI, V32, P4482, DOI 10.1523/JNEUROSCI.5571-11.2012; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vanni S, 1997, NEUROREPORT, V8, P1939, DOI 10.1097/00001756-199705260-00029; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wechsler D., 1999, WECHSLER ABBREVIATED; Wilmer JB, 2004, J COGNITIVE NEUROSCI, V16, P528, DOI 10.1162/089892904323057272; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	69	99	103	1	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					180	190		10.1016/j.neuron.2013.05.002	http://dx.doi.org/10.1016/j.neuron.2013.05.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23746630	Bronze, Green Accepted			2022-12-25	WOS:000321802000018
J	Hyun, I				Hyun, Insoo			Therapeutic Hope, Spiritual Distress, and the Problem of Stem Cell Tourism	CELL STEM CELL			English	Editorial Material							PHYSICIANS	Managing patients' therapeutic hope and spiritual distress-in addition to tighter regulation of commercial therapies and improved patient understanding-may offer a more comprehensive approach to reducing the overall incidence of stem cell tourism. Such patient support must occur early in the clinical relationship after appropriate assessment and discussion.	Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.	insoo.hyun@case.edu						Anandarajah G, 2001, AM FAM PHYSICIAN, V63, P81; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Caulfield T, 2012, CAN FAM PHYSICIAN, V58, P365; Caulfield T, 2012, CAN FAM PHYSICIAN, V58, pE182; Feudtner C, 2009, NEW ENGL J MED, V361, P2306, DOI 10.1056/NEJMp0906516; Levine AD, 2012, J LAW MED ETHICS, V40, P122, DOI 10.1111/j.1748-720X.2012.00650.x; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; Murdoch CE, 2010, AM J BIOETHICS, V10, P16, DOI 10.1080/15265161003728860; Petersen A, 2011, NEW GENET SOC, V30, P329, DOI 10.1080/14636778.2011.592003; ROSS L, 1995, INT J NURS STUD, V32, P457, DOI 10.1016/0020-7489(95)00007-K; Snyder C. R., 2000, HDB HOPE THEORY MEAS, P3, DOI DOI 10.1016/B978-012654050-5/50003-8	11	28	28	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					505	507		10.1016/j.stem.2013.04.010	http://dx.doi.org/10.1016/j.stem.2013.04.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642359	Bronze			2022-12-25	WOS:000329569600005
J	Marcos, E; Pani, P; Brunamonti, E; Deco, G; Ferraina, S; Verschure, P				Marcos, Encarni; Pani, Pierpaolo; Brunamonti, Emiliano; Deco, Gustavo; Ferraina, Stefano; Verschure, Paul			Neural Variability in Premotor Cortex Is Modulated by Trial History and Predicts Behavioral Performance	NEURON			English	Article							STOP-SIGNAL PARADIGM; DECISION-MAKING; MOVEMENT INITIATION; REACHING MOVEMENTS; PREFRONTAL CORTEX; CORTICAL NETWORKS; CONNECTIVITY; ALTERNATIVES; UNCERTAINTY; NEURONS	In the study of decision making, emphasis is placed on different forms of perceptual integration, while the influence of other factors, such as memory, is ignored. In addition, it is believed that the information underlying decision making is carried in the rate of the neuronal response, while its variability is considered unspecific. Here we studied the influence of recent experience on motor decision making by analyzing the activity of neurons in the dorsal premotor area of two monkeys performing a countermanding arm task. We observe that the across-trial variability of the neural response strongly correlates with trial history-dependent changes in reaction time. Using a theoretical model of decision making, we show that a trial history-monitoring signal can explain the observed behavioral and neural modulation. Our study reveals that, in the neural processes that culminate in motor plan maturation, the evidence provided by perception and memory is reflected in mean rate and variance respectively.	[Marcos, Encarni; Verschure, Paul] Univ Pompeu Fabra, Ctr Autonomous Syst & Neurorobot NRAS, Lab Synthet Percept Emot & Cognit Syst SPECS, Barcelona 08018, Spain; [Deco, Gustavo] Univ Pompeu Fabra, Lab Computat Neurosci, Ctr Brain & Cognit, Dept Technol, Barcelona 08018, Spain; [Pani, Pierpaolo; Brunamonti, Emiliano; Ferraina, Stefano] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Deco, Gustavo; Verschure, Paul] ICREA, Barcelona 08010, Spain	Pompeu Fabra University; Pompeu Fabra University; University of Barcelona; Sapienza University Rome; ICREA	Verschure, P (corresponding author), Univ Pompeu Fabra, Ctr Autonomous Syst & Neurorobot NRAS, Lab Synthet Percept Emot & Cognit Syst SPECS, Roc Boronat 138, Barcelona 08018, Spain.	paul.verschure@upf.edu	Verschure, Paul/AAR-2340-2021; ferraina, stefano/M-5230-2018; Marcos, Encarni/AAE-4144-2019; DECO, GUSTAVO/A-6341-2008	Verschure, Paul/0000-0003-3643-9544; ferraina, stefano/0000-0001-6100-2438; Marcos, Encarni/0000-0001-6518-4734; DECO, GUSTAVO/0000-0002-8995-7583; Brunamonti, Emiliano/0000-0002-5119-6950; Pani, Pierpaolo/0000-0001-6825-1162	European Community [270490, 270108]; ICREA Funding Source: Custom	European Community(European Commission); ICREA(ICREA)	We thank G. Mirabella for the help in setting up the behavioral apparatus and in data collection of monkey L. We also thank I. Herreros and C. Renno-Costa for the valuable discussions. and comments. This work was supported by European Community FP7/2007-2013 Grant 270490 - EFAA and Grant 270108 - Goal-Leaders.	Albantakis L, 2009, P NATL ACAD SCI USA, V106, P10308, DOI 10.1073/pnas.0901621106; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Domenech P, 2010, J NEUROSCI, V30, P14305, DOI 10.1523/JNEUROSCI.2371-10.2010; Emeric EE, 2007, VISION RES, V47, P35, DOI 10.1016/j.visres.2006.08.032; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Johnson PB, 1996, EUR J NEUROSCI, V8, P1358, DOI 10.1111/j.1460-9568.1996.tb01598.x; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luppino G, 2003, EUR J NEUROSCI, V17, P559, DOI 10.1046/j.1460-9568.2003.02476.x; Mirabella G, 2011, J NEUROPHYSIOL, V106, P1454, DOI 10.1152/jn.00995.2010; Mirabella G, 2006, EXP BRAIN RES, V174, P240, DOI 10.1007/s00221-006-0456-0; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Nelson MJ, 2010, ATTEN PERCEPT PSYCHO, V72, P1913, DOI 10.3758/APP.72.7.1913; Pare M, 2003, J NEUROSCI, V23, P6480; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Pouget P, 2011, J NEUROSCI, V31, P12604, DOI 10.1523/JNEUROSCI.1868-11.2011; Rieger M, 1999, BRIT J PSYCHOL, V90, P509, DOI 10.1348/000712699161585; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Scangos KW, 2010, J NEUROSCI, V30, P1968, DOI 10.1523/JNEUROSCI.4509-09.2010; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	37	64	64	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					249	255		10.1016/j.neuron.2013.02.006	http://dx.doi.org/10.1016/j.neuron.2013.02.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622062	Bronze			2022-12-25	WOS:000318202200006
J	Levitz, J; Pantoja, C; Gaub, B; Janovjak, H; Reiner, A; Hoagland, A; Schoppik, D; Kane, B; Stawski, P; Schier, AF; Trauner, D; Isacoff, EY				Levitz, Joshua; Pantoja, Carlos; Gaub, Benjamin; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Schoppik, David; Kane, Brian; Stawski, Philipp; Schier, Alexander F.; Trauner, Dirk; Isacoff, Ehud Y.			Optical control of metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; HETEROLOGOUS EXPRESSION; REMOTE-CONTROL; ACTIVATION; INHIBITION; RHODOPSIN; CHANNELS; ROLES; TRANSGENESIS; MECHANISMS	G protein-coupled receptors (GPCRs), the largest family of membrane signaling proteins, respond to neurotransmitters, hormones and small environmental molecules. The neuronal function of many GPCRs has been difficult to resolve because of an inability to gate them with subtype specificity, spatial precision, speed and reversibility. To address this, we developed an approach for opto-chemical engineering of native GPCRs. We applied this to the metabotropic glutamate receptors (mGluRs) to generate light-agonized and light-antagonized mGluRs (LimGluRs). The light-agonized LimGluR2, on which we focused, was fast, bistable and supported multiple rounds of on/off switching. Light gated two of the primary neuronal functions of mGluR2: suppression of excitability and inhibition of neurotransmitter release. We found that the light-antagonized tool LimGluR2-block was able to manipulate negative feedback of synaptically released glutamate on transmitter release. We generalized the optical control to two additional family members: mGluR3 and mGluR6. This system worked in rodent brain slices and in zebrafish in vivo, where we found that mGluR2 modulated the threshold for escape behavior. These light-gated mGluRs pave the way for determining the roles of mGluRs in synaptic plasticity, memory and disease.	[Levitz, Joshua; Isacoff, Ehud Y.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pantoja, Carlos; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gaub, Benjamin; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Grad Program, Berkeley, CA 94720 USA; [Schoppik, David; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kane, Brian; Trauner, Dirk] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of California System; University of California Berkeley; University of Munich; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Trauner, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dirk.trauner@lmu.de; ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Reiner, Andreas/AGK-2170-2022; Janovjak, Harald/O-9070-2016	Reiner, Andreas/0000-0003-0802-7278; Janovjak, Harald/0000-0002-8023-9315; Schoppik, David/0000-0001-7969-9632; Erdmann, Philipp/0000-0001-8289-9133; Isacoff, Ehud Y./0000-0003-4775-9359; Schier, Alexander Franz/0000-0001-7645-5325	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health [PN2EY018241, R01HL109525]; Human Frontier Science Program [RGP0013/2010]; Deutsche Forschungsgemeinschaft [FOR 1279]; Fond der Chemischen Industrie; National Science Foundation [CHE-0233882, CHE-0840505]; European Molecular Biology Organization; Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028971] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; Direct For Biological Sciences [1041078] Funding Source: National Science Foundation	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A.P. Mariani (National Eye Institute) for 11-cis retinal, J.P. Pin (University of Montpellier) for the mGluR plasmids and E. Reuveny (Weizmann Institute) for the GIRK1 plasmid, K. Durkin, K. Dubay, T. Berger, G. Sandoz and S. Berlin for helpful discussions, A. Guyon, Z. Fu and S. Szobota for help with slice cultures, Z. Fu for molecular biology assistance, K. McDaniel, J. Maxfield, J. Saint-Hillaire and D. Weinman for fish care, E. Carroll for discussion and help with zebrafish set up, P. Gut (University of California, San Francisco) for zebrafish plasmids, H. Baier (University of California, San Francisco) for fish lines, and the College of Chemistry (University of California, Berkeley) for computing resources for the Monte Carlo simulations. Support for the work was provided by the Nanomedicine Development Center for the Optical Control of Biological Function, US National Institutes of Health grant PN2EY018241 (D.T. and E.Y.I.), the Human Frontier Science Program (RGP0013/2010 to E.Y.I.), the Deutsche Forschungsgemeinschaft (FOR 1279, D.T.), the Fond der Chemischen Industrie (Kekule fellowship to P.S.), National Science Foundation grants CHE-0233882 and CHE-0840505 (to the College of Chemistry at the University of California, Berkeley), a postdoctoral fellowship of the European Molecular Biology Organization (H.J.), a Helen Hay Whitney postdoctoral fellowship (D.S.), the McKnight Endowment Fund for Neuroscience and US National Institutes of Health grant R01HL109525 (A.F.S.), and a predoctoral fellowship from the Fulbright Foundation (B.G.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Altinbilek B, 2009, NEUROSCIENCE, V158, P149, DOI 10.1016/j.neuroscience.2008.07.045; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Bailes HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030774; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley SJ, 2012, BIOCHEM PHARMACOL, V84, P249, DOI 10.1016/j.bcp.2012.04.009; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Grauer SM, 1999, PSYCHOPHARMACOLOGY, V141, P405, DOI 10.1007/s002130050850; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; Hanna L, 2013, NEUROPHARMACOLOGY, V66, P114, DOI 10.1016/j.neuropharm.2012.02.023; Haug MF, 2013, J COMP NEUROL, V521, P1533, DOI 10.1002/cne.23240; Iacovelli L, 2009, MOL PHARMACOL, V75, P991, DOI 10.1124/mol.108.052316; IKEDA SR, 1995, NEURON, V14, P1029, DOI 10.1016/0896-6273(95)90341-0; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Marek GJ, 2004, CURR OPIN PHARMACOL, V4, P18, DOI 10.1016/j.coph.2003.10.003; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tsuji T, 2001, J PHYS CHEM A, V105, P9347, DOI 10.1021/jp004418v; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yamashita T, 2001, J BIOCHEM-TOKYO, V130, P149, DOI 10.1093/oxfordjournals.jbchem.a002954; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	58	152	171	0	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					507	U190		10.1038/nn.3346	http://dx.doi.org/10.1038/nn.3346			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455609	Green Submitted, Green Accepted			2022-12-25	WOS:000316723700023
J	Khuong, TM; Habets, RLP; Kuenen, S; Witkowska, A; Kasprowicz, J; Swerts, J; Jahn, R; van den Bogaart, G; Verstreken, P				Thang Manh Khuong; Habets, Ron L. P.; Kuenen, Sabine; Witkowska, Agata; Kasprowicz, Jaroslaw; Swerts, Jef; Jahn, Reinhard; van den Bogaart, Geert; Verstreken, Patrik			Synaptic PI(3,4,5)P-3 Is Required for Syntaxin1A Clustering and Neurotransmitter Release	NEURON			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTION; SNARE COMPLEX; ACTIVE ZONE; PROTEIN; ENDOCYTOSIS; PI(4,5)P-2; HOMOLOGY	PI(3,4,5)P-3 is a low-abundance lipid thought to play a role in the regulation of synaptic activity; however, the mechanism remains obscure. We have constructed novel split Venus-based probes and used superresolution imaging to localize PI(3,4,5)P-3 at Drosophila larval neuromuscular synapses. We find the lipid in membrane domains at neurotransmitter release sites, where it concentrates with Syntaxin1A, a protein essential for vesicle fusion. Reducing PI(3,4,5)P-3 availability disperses Syntaxin1A clusters and increasing PI(3,4,5)P-3 levels rescues this defect. In artificial giant unilamellar vesicles, PI(3,4,5)P-3 also induces Syntaxin1A domain formation and this clustering, in vitro and in vivo, is dependent on positively charged residues in the Syntaxin1A-juxtannembrane domain. Functionally, reduced PI(3,4,5)P-3 causes temperature-sensitive paralysis and reduced neurotransmitter release, a phenotype also seen in animals expressing a Syntaxin1A with a mutated juxtamembrane domain. Thus, our data indicate that PI(3,4,5)P-3, based on electrostatic interactions, clusters Syntaxin1A at release sites to regulate neurotransmitter release.	[Thang Manh Khuong; Habets, Ron L. P.; Kuenen, Sabine; Kasprowicz, Jaroslaw; Swerts, Jef; Verstreken, Patrik] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Thang Manh Khuong; Habets, Ron L. P.; Kuenen, Sabine; Kasprowicz, Jaroslaw; Swerts, Jef; Verstreken, Patrik] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Thang Manh Khuong; Habets, Ron L. P.; Kuenen, Sabine; Kasprowicz, Jaroslaw; Swerts, Jef; Verstreken, Patrik] Leuven Res Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Witkowska, Agata; Jahn, Reinhard; van den Bogaart, Geert] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; Max Planck Society	Verstreken, P (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	patrik.verstreken@cme.vib-kuleuven.be	Witkowska, Agata/AAR-3442-2020; van den Bogaart, Geert/A-1089-2014; Witkowska, Agata/K-2637-2013; Verstreken, Patrik/AAC-7591-2022; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; Witkowska, Agata/0000-0001-6926-4707; Verstreken, Patrik/0000-0002-5073-5393; van den Bogaart, Geert/0000-0003-2180-6735; Jahn, Reinhard/0000-0003-1542-3498	Marie Curie Excellence grant [MEXT-CT-2006-042267]; ERC [260678]; FWO; IUAP by BELSPO; Research Fund KU Leuven; Francqui Foundation; Hercules Foundation; VIB	Marie Curie Excellence grant(European Commission); ERC(European Research Council (ERC)European Commission); FWO(FWO); IUAP by BELSPO; Research Fund KU Leuven(KU Leuven); Francqui Foundation; Hercules Foundation; VIB	We thank the Bloomington, VDRC, and Harvard Drosophila stock centers and the Developmental Studies Hybridoma bank and Bruno Andre, Hugo Bellen, Chris Brown, Carlos Dotti, Bassem Hassan, Matthew Holt, Elsa Lauwers, and Tobias Meyer for reagents, help, or discussions, as well as members of the Verstreken laboratory for comments. We thank Sebastian Munck from the VIB Bio Imaging Core and LiMoNe facility and KU Leuven cell imaging core facility. Support was provided by a Marie Curie Excellence grant (MEXT-CT-2006-042267), an ERC Starting Grant (260678), FWO grants to P.V., an IUAP by BELSPO, the Research Fund KU Leuven, the Francqui Foundation, the Hercules Foundation, and VIB.	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P9264, DOI 10.1021/bi025934+; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin Thomas F J, 2012, Subcell Biochem, V59, P111, DOI 10.1007/978-94-007-3015-1_4; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Merhi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018457; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Munck S, 2012, J CELL SCI, V125, P2257, DOI 10.1242/jcs.098939; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Schulze KL, 1996, GENETICS, V144, P1713; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Slabbaert JR, 2012, METHOD CELL BIOL, V108, P227, DOI 10.1016/B978-0-12-386487-1.00012-2; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	58	71	73	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 20	2013	77	6					1097	1108		10.1016/j.neuron.2013.01.025	http://dx.doi.org/10.1016/j.neuron.2013.01.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522045	Green Published, Bronze			2022-12-25	WOS:000316645000011
J	Zhu, YH; Huang, YF; Kek, C; Bulavin, DV				Zhu, Yunhua; Huang, Yi-Fu; Kek, Calvina; Bulavin, Dmitry V.			Apoptosis Differently Affects Lineage Tracing of Lgr5 and Bmi1 Intestinal Stem Cell Populations	CELL STEM CELL			English	Article							IN-VIVO; TUMORIGENESIS	Emerging lineage-tracing data support the existence of several pools of intestinal stem cells (ISCs) in the adult mouse. The +4 location is known to harbor proliferative cells undergoing robust apoptosis in response to irradiation, but their relationship with recently reported ISC models is unclear. Here, we found that tamoxifen, at doses commonly used to induce lineage tracing, mimics the irradiation-induced apoptotic response of the +4 cells. We found that about 40% of apoptotic cells were Lgr5-positive whereas Bmi1-positive ISCs became sensitive to tamoxifen upon entering a proliferative state. In turn, when we suppressed apoptosis by either Bcl2 overexpression or Chk2 deletion, we found that lineage tracing of Lgr5-positive cells was efficiently reduced. In contrast, lineage tracing from Bmi1-positive ISCs was substantially increased in apoptosis-deficient backgrounds. We propose that apoptosis plays an important role in controlling lineage tracing from different ISC populations in the mouse intestine.	[Zhu, Yunhua; Huang, Yi-Fu; Kek, Calvina; Bulavin, Dmitry V.] Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bulavin, DV (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	dvbulavin@imcb.a-star.edu.sg			Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	The research for D. V. B. was supported by the Agency for Science, Technology and Research (Singapore). We are extremely grateful to Dr. Natalia Gunko for her help with transmission electron microscopy. All animal protocols used in this study were approved by the Institute of Molecular and Cell Biology Animal Safety and Use Committee.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Demidov ON, 2012, CELL DEATH DIFFER, V19, P1761, DOI 10.1038/cdd.2012.57; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Zhu JJ, 2012, GENESIS, V50, P102, DOI 10.1002/dvg.20799	18	69	69	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					298	303		10.1016/j.stem.2013.01.003	http://dx.doi.org/10.1016/j.stem.2013.01.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23415913	Bronze			2022-12-25	WOS:000329569400008
J	Tao, YM; Chen, YJ; Shen, CY; Luo, ZY; Bates, CR; Lee, D; Marchetto, S; Gao, TM; Borg, JP; Xiong, WC; Mei, L				Tao, Yanmei; Chen, Yong-Jun; Shen, Chengyong; Luo, Zhengyi; Bates, C. Ryan; Lee, Daehoon; Marchetto, Sylvie; Gao, Tian-Ming; Borg, Jean-Paul; Xiong, Wen-Cheng; Mei, Lin			Erbin interacts with TARP gamma-2 for surface expression of AMPA receptors in cortical interneurons	NATURE NEUROSCIENCE			English	Article							BASOLATERAL PDZ PROTEIN; RAT PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; REGULATORY PROTEINS; AUXILIARY SUBUNITS; GABAERGIC NEURONS; NMDA RECEPTORS; HIPPOCAMPAL; TRAFFICKING; STARGAZIN	Inhibitory neurons control the firing of glutamatergic neurons and synchronize brain activity. However, little is known about mechanisms of excitatory synapse formation in inhibitory neurons. Here we demonstrate that Erbin is specifically expressed in cortical inhibitory neurons. It localizes at excitatory synapses and regulates AMPA receptor (AMPAR) surface expression. Erbin mutation reduced mEPSCs and AMPAR currents specifically in parvalbumin (PV)-positive interneurons but not in pyramidal neurons. We found that the AMPAR auxiliary protein TARP gamma-2 was specifically expressed in cortical interneurons. Erbin interacts with TARP gamma-2 and is crucial for its stability. Deletion of the gamma-2-interacting domain in Erbin attenuated surface AMPAR and excitatory transmission in PV-positive interneurons. Furthermore, we observed behavioral deficits in Erbin-null mice and in mice expressing an Erbin truncation mutant that is unable to interact with TARP gamma-2. These observations demonstrate a crucial function for Erbin in AMPAR surface expression in cortical PV-positive interneurons and may contribute to a better understanding of psychiatric disorders.	[Tao, Yanmei] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou, Zhejiang, Peoples R China; [Tao, Yanmei; Chen, Yong-Jun; Shen, Chengyong; Bates, C. Ryan; Lee, Daehoon; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA USA; [Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Luo, Zhengyi; Gao, Tian-Ming; Mei, Lin] So Med Univ, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China; [Marchetto, Sylvie; Borg, Jean-Paul] Aix Marseille Univ, Inst Paoli Calmettes, CNRS, CRCM,Inserm,U1068,UMR 7258, Marseille, France; [Xiong, Wen-Cheng; Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA USA	Hangzhou Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Southern Medical University - China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mei, L (corresponding author), Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA USA.	lmei@grc.edu	Lee, Daehoon/AAP-3260-2020; Tao, Yanmei/AFL-9494-2022; Tao, Yanmei/AAH-1601-2022; Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Tao, Yanmei/0000-0002-4456-5447	VA Merit Awards; US National Institutes of Health (NIH); La Ligue Contre le Cancer; National Nature Sciences foundation of China [NSFC 31271137]; NSFC [81030022, U1201225]	VA Merit Awards; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Ligue Contre le Cancer(Ligue nationale contre le cancer); National Nature Sciences foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	We thank S. Tomita (Yale University) and R.A. Nicoll (University of California, San Francisco) for TARP subunit constructs, Y. Yanagawa (National Institute for Physiological Sciences) for Gad-GFP mice, R. Huganir (John Hopkins University) for rabbit polyclonal antibodies to GluA1, GluA2/3 and GluN1, B.-S. Chen (Georgia Regents University) for the GluA1 antibody and A. Terry and K. Bouchard (Georgia Regents University) for assistance on behavioral tests. This work is supported in part by grants from VA Merit Awards and the US National Institutes of Health (NIH) (L.M. and W.-C.X.). L.M. is the Georgia Research Alliance Eminent Scholar in Neuroscience. J.-P.B. is supported by La Ligue Contre le Cancer (Label Ligue 2010). Y.T. is supported by National Nature Sciences foundation of China (NSFC 31271137). T.-M.G. is supported by NSFC 81030022, U1201225.	Apperson ML, 1996, J NEUROSCI, V16, P6839; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Huang YZ, 2003, J BIOL CHEM, V278, P1108, DOI 10.1074/jbc.M205413200; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Inamura M, 2006, NEUROSCI RES, V55, P45, DOI 10.1016/j.neures.2006.01.004; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Knight HM, 2008, EUR J HUM GENET, V16, P750, DOI 10.1038/ejhg.2008.11; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li XB, 2004, EUR J NEUROSCI, V19, P2132, DOI 10.1111/j.0953-816X.2004.03283.x; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Menuz K, 2008, J NEUROSCI, V28, P10599, DOI 10.1523/JNEUROSCI.2732-08.2008; Menuz K, 2009, NEUROPHARMACOLOGY, V56, P22, DOI 10.1016/j.neuropharm.2008.06.037; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Silberberg G, 2008, PHARMACOGENET GENOM, V18, P403, DOI 10.1097/FPC.0b013e3282f974ca; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tao YM, 2009, P NATL ACAD SCI USA, V106, P9477, DOI 10.1073/pnas.0901844106; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591; Wang HX, 2009, NEUROPSYCHOPHARMACOL, V34, P2028, DOI 10.1038/npp.2009.20; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	50	38	39	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					290	299		10.1038/nn.3320	http://dx.doi.org/10.1038/nn.3320			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354328				2022-12-25	WOS:000315474800011
J	Bao, XM; Tang, J; Lopez-Pajares, V; Tao, SY; Qu, K; Crabtree, GR; Khavari, PA				Bao, Xiaomin; Tang, Jiong; Lopez-Pajares, Vanessa; Tao, Shiying; Qu, Kun; Crabtree, Gerald R.; Khavari, Paul A.			ACTL6a Enforces the Epidermal Progenitor State by Suppressing SWI/SNF-Dependent Induction of KLF4	CELL STEM CELL			English	Article							CHROMATIN REMODELING COMPLEX; TRANSCRIPTION FACTORS; C-MYC; TERMINAL DIFFERENTIATION; NEURAL DEVELOPMENT; STEM-CELLS; TISSUE; SKIN; ACTIN; BRG1	Somatic progenitors suppress differentiation to maintain tissue self-renewal. The mammalian SWI/SNF chromatin-remodeling complex regulates nucleosome packaging to control differentiation in embryonic and adult stem cells. Catalytic Brg1 and Brm subunits are required for these processes; however, the roles of SWI/SNF regulatory subunits are not fully understood. Here, we show that ACTL6a/BAF53A modulates the SWI/SNF complex to suppress differentiation in epidermis. Conditional loss of ACTL6a resulted in terminal differentiation, cell-cycle exit, and hypoplasia, whereas ectopic expression of ACTL6a promoted the progenitor state. A significant portion of genes regulated by ACTL6a were found to also be targets of KLF4, a known activator of epidermal differentiation. Mechanistically, we show that ACTL6a prevents SWI/SNF complex binding to promoters of KLF4 and other differentiation genes and that SWI/SNF catalytic subunits are required for full induction of KLF4 targets. Thus, ACTL6a controls the epidermal progenitor state by sequestering SWI/SNF to prevent activation of differentiation programs.	[Bao, Xiaomin; Lopez-Pajares, Vanessa; Tao, Shiying; Qu, Kun; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Tang, Jiong; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu	Qu, Kun/G-3359-2012	Bao, Xiaomin/0000-0002-8845-5012; Crabtree, Robert/0000-0002-6639-8707	U.S. Department of Veterans Affairs Office of Research and Development; NIAMS NIH [R01 AR45192]; F32 Award [AR061230]; NATIONAL CANCER INSTITUTE [R01CA163915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045192, F32AR061230] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); NIAMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); F32 Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Chang and A. Oro for their presubmission review, B. Zarnegar for the FPLC fractions of undifferentiated human keratinocytes, D. Johnston for technical support, and L. Boxer for suggestions and reagents. We thank L. Morcom and P. Bernstein for their administrative assistance. This work is supported by the U.S. Department of Veterans Affairs Office of Research and Development, by NIAMS NIH R01 AR45192 (P. A. K), and by an F32 Award (AR061230) to X. B.	Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Kuroda Y, 2002, BIOCHEM BIOPH RES CO, V299, P328, DOI 10.1016/S0006-291X(02)02637-2; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee JH, 2003, MOL CELLS, V16, P78; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nishimoto N, 2012, J CELL SCI, V125, P3870, DOI 10.1242/jcs.104349; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vangapandu H, 2009, GENE THER MOL BIOL, V13A, P194; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Visa N., 2010, COLD SPRING HARB PER, V2; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang JM, 2010, EUR J CELL BIOL, V89, P537, DOI 10.1016/j.ejcb.2010.01.005; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	49	77	78	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 7	2013	12	2					193	203		10.1016/j.stem.2012.12.014	http://dx.doi.org/10.1016/j.stem.2012.12.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VB	23395444	Green Accepted, Bronze			2022-12-25	WOS:000329569300010
J	Doyon, WM; Dong, Y; Ostroumov, A; Thomas, AM; Zhang, TA; Dani, JA				Doyon, William M.; Dong, Yu; Ostroumov, Alexey; Thomas, Alyse M.; Zhang, Tao A.; Dani, John A.			Nicotine Decreases Ethanol-Induced Dopamine Signaling and Increases Self-Administration via Stress Hormones	NEURON			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ALCOHOL-USE; NEUROACTIVE STEROIDS; CIGARETTE-SMOKING; YOUNG-ADULTS; NEURONS; REWARD; MECHANISMS; DRINKING	Tobacco smoking is a well-known risk factor for subsequent alcohol abuse, but the neural events underlying this risk remain largely unknown. Alcohol and nicotine reinforcement involve common neural circuitry, including the mesolimbic dopamine system. We demonstrate in rodents that pre-exposure to nicotine increases alcohol self-administration and decreases alcohol-induced dopamine responses. The blunted dopamine response was due to increased inhibitory synaptic transmission onto dopamine neurons. Blocking stress hormone receptors prior to nicotine exposure prevented all interactions with alcohol that we measured, including the increased inhibition onto dopamine neurons, the decreased dopamine responses, and the increased alcohol self-administration. These results indicate that nicotine recruits neuroendocrine systems to influence neurotransmission and behavior associated with alcohol reinforcement.	[Doyon, William M.; Dong, Yu; Ostroumov, Alexey; Thomas, Alyse M.; Zhang, Tao A.; Dani, John A.] Baylor Coll Med, Ctr Addict, Houston, TX 77030 USA; [Doyon, William M.; Dong, Yu; Ostroumov, Alexey; Thomas, Alyse M.; Zhang, Tao A.; Dani, John A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Ctr Addict, Houston, TX 77030 USA.	jdani@bcm.edu		Thomas, Alyse/0000-0002-6070-4769	National Institutes of Health; NIDA [DA09411]; NINDS [NS21229]; Cancer Prevention and Research Institute of Texas; Diana Hells Henry Medical Research Foundation through Baylor College of Medicine; "Genomic, Neural, Preclinical Analysis for Smoking Cessation" Project for the Cancer Program; NRSA [F32 AA016709]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS021229, R01NS021229, R37NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA016709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Prevention and Research Institute of Texas; Diana Hells Henry Medical Research Foundation through Baylor College of Medicine; "Genomic, Neural, Preclinical Analysis for Smoking Cessation" Project for the Cancer Program; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Rueben A. Gonzales at the University of Texas for the generous use of his gas chromatograph for the analysis of brain ethanol samples. The authors are supported by grants from the National Institutes of Health, NIDA DA09411, NINDS NS21229, and the Cancer Prevention and Research Institute of Texas. The authors also acknowledge the support arising from the joint participation of the Diana Hells Henry Medical Research Foundation through its direct engagement with Baylor College of Medicine and the "Genomic, Neural, Preclinical Analysis for Smoking Cessation" Project for the Cancer Program. W.M.D. was also supported by an NRSA (F32 AA016709).	Al-Rejaie S, 2006, ALCOHOL CLIN EXP RES, V30, P1223, DOI 10.1111/j.1530-0277.2006.00143.x; Armario A, 2010, TRENDS PHARMACOL SCI, V31, P318, DOI 10.1016/j.tips.2010.04.005; Barrett SP, 2006, DRUG ALCOHOL DEPEN, V81, P197, DOI 10.1016/j.drugalcdep.2005.06.009; Barrot M, 2000, EUR J NEUROSCI, V12, P973, DOI 10.1046/j.1460-9568.2000.00996.x; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; Brodie MS, 2000, ALCOHOL CLIN EXP RES, V24, P1120, DOI 10.1111/j.1530-0277.2000.tb04658.x; BRODIE MS, 1990, BRAIN RES, V508, P65, DOI 10.1016/0006-8993(90)91118-Z; Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108; Cadepond F, 1997, ANNU REV MED, V48, P129; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen XG, 2002, ADDICT BEHAV, V27, P799, DOI 10.1016/S0306-4603(01)00211-8; Chester JA, 2002, ALCOHOL, V26, P131, DOI 10.1016/S0741-8329(02)00199-4; Collins AC, 1996, ALCOHOL CLIN EXP RES, V20, P990, DOI 10.1111/j.1530-0277.1996.tb01936.x; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Di S, 2009, J NEUROSCI, V29, P393, DOI 10.1523/JNEUROSCI.4546-08.2009; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Dong Y, 2010, J MOL NEUROSCI, V40, P164, DOI 10.1007/s12031-009-9231-6; Doyon WM, 2005, J NEUROCHEM, V93, P1469, DOI 10.1111/j.1471-4159.2005.03137.x; Foddai M, 2004, NEUROPSYCHOPHARMACOL, V29, P530, DOI 10.1038/sj.npp.1300326; Funk D, 2006, ALCOHOL RES HEALTH, V29, P186; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; GESSA GL, 1985, BRAIN RES, V348, P201, DOI 10.1016/0006-8993(85)90381-6; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Grant BF, 1998, J SUBST ABUSE, V10, P59, DOI 10.1016/S0899-3289(99)80141-2; Gulick D, 2008, PSYCHOPHARMACOLOGY, V196, P483, DOI 10.1007/s00213-007-0982-x; Gunn BG, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00131; Harrison ELR, 2008, ALCOHOL CLIN EXP RES, V32, P2081, DOI 10.1111/j.1530-0277.2008.00796.x; HEIKINHEIMO O, 1993, ANN MED, V25, P71, DOI 10.3109/07853899309147861; Helms Christa M, 2012, Front Endocrinol (Lausanne), V3, P10, DOI 10.3389/fendo.2012.00010; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Howard EC, 2008, NEUROSCIENCE, V154, P1042, DOI 10.1016/j.neuroscience.2008.04.014; Hurley LL, 2012, NEUROTOX RES, V21, P57, DOI 10.1007/s12640-011-9275-6; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kenna GA, 2012, NEUROPSYCHOL REV, V22, P211, DOI 10.1007/s11065-012-9209-y; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Le AD, 2003, PSYCHOPHARMACOLOGY, V168, P216, DOI 10.1007/s00213-002-1330-9; LESTER RAJ, 1995, J NEUROPHYSIOL, V74, P195, DOI 10.1152/jn.1995.74.1.195; Lopez-Moreno JA, 2008, NEUROSCI LETT, V433, P1, DOI 10.1016/j.neulet.2007.11.074; Lutfy K, 2012, J NEUROCHEM, V120, P1108, DOI 10.1111/j.1471-4159.2011.07633.x; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McKee SA, 2007, ARCH INTERN MED, V167, P716, DOI 10.1001/archinte.167.7.716; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Morgen CS, 2008, ALCOHOL ALCOHOLISM, V43, P371, DOI 10.1093/alcalc/agn001; Morrow AL, 2009, ALCOHOL, V43, P521, DOI 10.1016/j.alcohol.2009.04.002; Nashmi R, 2006, J MOL NEUROSCI, V30, P181, DOI 10.1385/JMN:30:1:181; Nie H, 2011, P NATL ACAD SCI USA, V108, P4459, DOI 10.1073/pnas.1016156108; Okamoto T, 2006, J NEUROPHYSIOL, V95, P619, DOI 10.1152/jn.00682.2005; Palmatier MI, 2008, NEUROPHARMACOLOGY, V55, P1425, DOI 10.1016/j.neuropharm.2008.09.002; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Richards JM, 2011, BIOL PSYCHOL, V88, P1, DOI 10.1016/j.biopsycho.2011.06.009; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Roberts AJ, 1999, ALCOHOL CLIN EXP RES, V23, P1151, DOI 10.1097/00000374-199907000-00003; Rotter A, 2012, BRAIN RES BULL, V88, P519, DOI 10.1016/j.brainresbull.2012.05.007; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schlaepfer Isabel R, 2008, Curr Drug Abuse Rev, V1, P124; Schorling J B, 1994, J Subst Abuse, V6, P105, DOI 10.1016/S0899-3289(94)90143-0; Segev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029988; Sher KJ, 1996, ALCOHOL CLIN EXP RES, V20, P485, DOI 10.1111/j.1530-0277.1996.tb01079.x; Sinha R, 2011, ARCH GEN PSYCHIAT, V68, P942, DOI 10.1001/archgenpsychiatry.2011.49; Smith BR, 1999, PSYCHOPHARMACOLOGY, V142, P408, DOI 10.1007/s002130050906; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Theile JW, 2008, ALCOHOL CLIN EXP RES, V32, P1040, DOI 10.1111/j.1530-0277.2008.00665.x; TORABI MR, 1993, J SCHOOL HEALTH, V63, P302, DOI 10.1111/j.1746-1561.1993.tb06150.x; Ungless MA, 2010, NEUROSCI BIOBEHAV R, V35, P151, DOI 10.1016/j.neubiorev.2010.04.006; Vendruscolo LF, 2012, J NEUROSCI, V32, P7563, DOI 10.1523/JNEUROSCI.0069-12.2012; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Wanat MJ, 2009, BIOL PSYCHIAT, V65, P646, DOI 10.1016/j.biopsych.2008.10.042; Weitzman ER, 2005, DRUG ALCOHOL DEPEN, V80, P377, DOI 10.1016/j.drugalcdep.2005.05.008; Wirth Michelle M, 2011, Front Endocrinol (Lausanne), V2, P19, DOI 10.3389/fendo.2011.00019; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Xiao C, 2009, NEUROPSYCHOPHARMACOL, V34, P307, DOI 10.1038/npp.2008.99; Zhang LF, 2012, BIOL PSYCHIAT, V71, P184, DOI 10.1016/j.biopsych.2011.07.024; Zhang TA, 2010, NEUROPHARMACOLOGY, V59, P431, DOI 10.1016/j.neuropharm.2010.06.004	87	63	63	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 7	2013	79	3					530	540		10.1016/j.neuron.2013.06.006	http://dx.doi.org/10.1016/j.neuron.2013.06.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23871233	Green Accepted, Bronze			2022-12-25	WOS:000323085100013
J	Zagha, E; Casale, AE; Sachdev, RNS; McGinley, MJ; McCormick, DA				Zagha, Edward; Casale, Amanda E.; Sachdev, Robert N. S.; McGinley, Matthew J.; McCormick, David A.			Motor Cortex Feedback Influences Sensory Processing by Modulating Network State	NEURON			English	Article							BARREL CORTEX; IN-VIVO; SELECTIVE ATTENTION; BEHAVIORAL STATE; THALAMIC CONTROL; HZ OSCILLATION; UNIT-ACTIVITY; RAT; RESPONSES; DYNAMICS	Long-range corticocortical communication may have important roles in context-dependent sensory processing, yet we know very little about how these pathways influence their target regions. We studied the influence of primary motor cortex activity on primary somatosensory cortex in the mouse whisker system. We show that primary motor and somatosensory cortices undergo coherent, context-dependent changes in network state. Moreover, we show that motor cortex activity can drive changes in somatosensory cortex network state. A series of experiments demonstrate the involvement of the direct corticocortical feedback pathway, providing temporally precise and spatially targeted modulation of network dynamics. Cortically mediated changes in network state significantly impact sensory coding, with activated states increasing the reliability of responses to complex stimuli. By influencing network state, corticocortical communication from motor cortex may ensure that during active exploration the relevant sensory region is primed for enhanced sensory discrimination.	[Zagha, Edward; Casale, Amanda E.; Sachdev, Robert N. S.; McGinley, Matthew J.; McCormick, David A.] Yale Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [McCormick, David A.] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Yale University	McCormick, DA (corresponding author), Yale Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	david.mccormick@yale.edu		Sachdev, Robert/0000-0002-6627-0199	NIH [NS026143, NS007224, F32NS077816]; Kavli Institute for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077816, R37NS026143, R01NS026143, T32NS007224, R29NS026143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Matthew Krause and James Mazer for many helpful discussions. We thank Flavio Frohlich for guidance on multielectrode recordings and analysis and Peter O'Brien for technical guidance. We thank Babak Tahvildari and Renata Batista-Brito for comments on the manuscript. This work was supported by NIH NS026143, NS007224 and Kavli Institute for Neuroscience (D.A.M.) and NIH F32NS077816 (E.Z.).	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Borisovska M, 2011, J PHYSIOL-LONDON, V589, P1927, DOI 10.1113/jphysiol.2011.206276; Brecht M, 2011, NEURON, V72, P193, DOI 10.1016/j.neuron.2011.10.002; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Friedman WA, 2012, J NEUROPHYSIOL, V107, P551, DOI 10.1152/jn.01132.2010; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; SHARP FR, 1982, J COMP NEUROL, V208, P255, DOI 10.1002/cne.902080305; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	60	161	161	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					567	578		10.1016/j.neuron.2013.06.008	http://dx.doi.org/10.1016/j.neuron.2013.06.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23850595	Bronze, Green Accepted			2022-12-25	WOS:000323085100016
J	Amiry-Moghaddam, M; Ottersen, OP				Amiry-Moghaddam, Mahmood; Ottersen, Ole Petter			Immunogold cytochemistry in neuroscience	NATURE NEUROSCIENCE			English	Review							POSTSYNAPTIC DENSITY; ELECTRON-MICROSCOPE; NMDA RECEPTORS; RAT CEREBELLUM; AMPA RECEPTORS; GLUTAMATE; IMMUNOCYTOCHEMISTRY; SYNAPSES; ANTIBODY; BRAIN	The complexity of the central nervous system calls for immunocytochemical procedures that allow target proteins to be localized with high precision and with opportunities for quantitation. Immunogold procedures stand out as particularly powerful in this regard. Although these procedures have found wide application in the neuroscience community, they present limitations and pitfalls that must be taken into account. At the same time, these procedures offer potentials that remain to be fully realized.	[Amiry-Moghaddam, Mahmood; Ottersen, Ole Petter] Univ Oslo, Inst Basic Med Sci, Lab Mol Neurosci, Oslo, Norway	University of Oslo	Ottersen, OP (corresponding author), Univ Oslo, Inst Basic Med Sci, Lab Mol Neurosci, Oslo, Norway.	o.p.ottersen@medisin.uio.no		Amiry-Moghaddam, Mahmood/0000-0003-1071-1247	Norwegian Research Council; European Union framework programmes; Letten Fund	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Union framework programmes; Letten Fund	We thank G. Lothe and C. Knudsen for technical assistance, P. Laake for comments, and D. Frydenlund for providing Figure 5. We gratefully acknowledge support from the Norwegian Research Council, the European Union framework programmes and the Letten Fund.	Alelu-Paz R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003378; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Baleviciute I, 2013, BIOSENS BIOELECTRON, V39, P170, DOI 10.1016/j.bios.2012.07.017; Bergersen LH, 2012, CEREB CORTEX, V22, P1690, DOI 10.1093/cercor/bhr254; BLACKSTAD TW, 1990, COMPUT BIOL MED, V20, P15, DOI 10.1016/0010-4825(90)90041-M; Bloss EB, 2013, NEUROBIOL AGING, V34, P200, DOI 10.1016/j.neurobiolaging.2012.05.014; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; CAMPAGNE MV, 1991, J HISTOCHEM CYTOCHEM, V39, P1267, DOI 10.1177/39.9.1833448; CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; COONS AH, 1951, FED PROC, V10, P558; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; D'Amico F, 2008, J MICROSC-OXFORD, V230, P9, DOI 10.1111/j.1365-2818.2008.01949.x; DALE N, 1986, NATURE, V324, P255, DOI 10.1038/324255a0; DAVANGER S, 1994, GASTROENTEROLOGY, V107, P137, DOI 10.1016/0016-5085(94)90071-X; DUTTON AH, 1979, P NATL ACAD SCI USA, V76, P3392, DOI 10.1073/pnas.76.7.3392; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Franciosi S, 2007, J NEUROSCI METH, V163, P76, DOI 10.1016/j.jneumeth.2007.02.020; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; GINGRAS D, 1994, BIOL CELL, V81, P153, DOI 10.1016/S0248-4900(94)80006-5; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Hayat M.A., 1990, COLLOIDAL GOLD PRINC, V3; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; JI ZQ, 1991, J COMP NEUROL, V307, P296, DOI 10.1002/cne.903070210; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; KRAEHENBUHL JP, 1980, HISTOCHEM J, V12, P317, DOI 10.1007/BF01006953; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Matsubara A, 1996, J NEUROSCI, V16, P4457; Maunsbach A, 1999, BIOMEDICAL ELECT MIC; Mayer G, 2001, PROG HISTOCHEM CYTO, V36, P11, DOI 10.1016/S0079-6336(01)80002-4; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Newman G.R., 1993, RESIN MICROSCOPY ON; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; OTTERSEN OP, 1987, EXP BRAIN RES, V69, P167; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Pool C.W., 1983, NEUROIMMUNOCYTOCHEMI, V3, P1; POSTHUMA G, 1987, J HISTOCHEM CYTOCHEM, V35, P405, DOI 10.1177/35.4.2434559; POSTHUMA G, 1988, EUR J CELL BIOL, V46, P327; Pradidarcheep W, 2008, J HISTOCHEM CYTOCHEM, V56, P1099, DOI 10.1369/jhc.2008.952101; PRASAD BVV, 1990, NATURE, V343, P476, DOI 10.1038/343476a0; REMACLE J, 1976, J CELL BIOL, V71, P551, DOI 10.1083/jcb.71.2.551; Rhodes KJ, 2008, J GEN PHYSIOL, V131, P407, DOI 10.1085/jgp.200709926; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Roth J, 1996, HISTOCHEM CELL BIOL, V106, P131; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; SESACK SR, 1995, NEUROSCIENCE, V67, P993, DOI 10.1016/0306-4522(95)00087-Y; SHUPLIAKOV O, 1992, J NEUROSCI, V12, P3789; SINGER SJ, 1959, NATURE, V183, P1523, DOI 10.1038/1831523a0; SLOT JW, 1989, AM J ANAT, V185, P271, DOI 10.1002/aja.1001850220; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; STERNBERGER LA, 1965, EXP MOL PATHOL, V4, P112, DOI 10.1016/0014-4800(65)90027-4; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tonnesen J, 2013, EXP NEUROL, V242, P33, DOI 10.1016/j.expneurol.2012.10.004; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; VANDENPOL AN, 1989, J MICROSC-OXFORD, V155, P27, DOI 10.1111/j.1365-2818.1989.tb04297.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x	73	42	42	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					798	804		10.1038/nn.3418	http://dx.doi.org/10.1038/nn.3418			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799472				2022-12-25	WOS:000321180900009
J	Wang, AY; Miura, K; Uchida, N				Wang, Alice Y.; Miura, Keiji; Uchida, Naoshige			The dorsomedial striatum encodes net expected return, critical for energizing performance vigor	NATURE NEUROSCIENCE			English	Article							REACTION-TIME PERFORMANCE; NUCLEUS-ACCUMBENS; VENTRAL STRIATUM; ACTION SELECTION; DECISION-MAKING; CAUDATE-NUCLEUS; DORSAL STRIATUM; BASAL GANGLIA; REWARD; DOPAMINE	Decision making requires an actor to not only steer behavior toward specific goals but also determine the optimal vigor of performance. Current research and models have largely focused on the former problem of how actions are directed while overlooking the latter problem of how they are energized. Here we designed a self-paced decision-making paradigm, which showed that rats' performance vigor globally fluctuates with the net value of their options, suggesting that they maintain long-term estimates of the value of their current state. Lesions of the dorsomedial striatum (DMS) and, to a lesser degree, in the ventral striatum impaired such state-dependent modulation of vigor, rendering vigor to depend more exclusively on the outcomes of immediately preceding trials. The lesions, however, spared choice biases. Neuronal recordings showed that the DMS is enriched in net value-coding neurons. In sum, the DMS encodes one's net expected return, which drives the general motivation to perform.	[Wang, Alice Y.; Miura, Keiji; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Miura, Keiji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Miura, Keiji] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Harvard University; Japan Science & Technology Agency (JST); Tohoku University	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Uchida, Naoshige/0000-0002-5755-9409	National Science Foundation; Precursory Research for Embryonic Science and Technology; Smith Family New Investigator Award; Alfred Sloan Foundation; Milton Fund; Startup Fund from Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095953] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Precursory Research for Embryonic Science and Technology; Smith Family New Investigator Award; Alfred Sloan Foundation(Alfred P. Sloan Foundation); Milton Fund; Startup Fund from Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Assad, K. Blum, O. Hikosaka, D. Lee, M. Livingstone, J. Maunsell and M. Meister for their comments on the manuscript; R. Born and the members of the Uchida laboratory for discussions; and S. Kim for support in behavioral experiments. This work was supported by a fellowship from National Science Foundation (A.Y.W.), Precursory Research for Embryonic Science and Technology (K.M.), a Smith Family New Investigator Award, the Alfred Sloan Foundation, the Milton Fund and the Startup Fund from Harvard University (N.U.).	AMALRIC M, 1987, J NEUROSCI, V7, P2129; Bailey KR, 2006, J NEUROSCI, V26, P1016, DOI 10.1523/JNEUROSCI.3883-05.2006; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; BROWN VJ, 1989, J NEUROSCI, V9, P3760; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Guitart-Masip M, 2011, J COGNITIVE NEUROSCI, V23, P3933, DOI 10.1162/jocn_a_00090; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; HAUBER W, 1994, BEHAV BRAIN RES, V60, P211, DOI 10.1016/0166-4328(94)90149-X; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Jongen-Relo AL, 2002, PHYSIOL BEHAV, V76, P449, DOI 10.1016/S0031-9384(02)00732-1; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; MOGENSON GJ, 1979, BRAIN RES, V171, P247, DOI 10.1016/0006-8993(79)90331-7; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; NEWMAN R, 1980, J COMP NEUROL, V191, P167, DOI 10.1002/cne.901910203; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	44	78	78	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					639	+		10.1038/nn.3377	http://dx.doi.org/10.1038/nn.3377			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23584742	Green Accepted, Green Submitted			2022-12-25	WOS:000318029300021
J	Bartolome, F; Wu, HC; Burchell, VS; Preza, E; Wray, S; Mahoney, CJ; Fox, NC; Calvo, A; Canosa, A; Moglia, C; Mandrioli, J; Chio, A; Orrell, RW; Houlden, H; Hardy, J; Abramov, AY; Plun-Favreau, H				Bartolome, Fernando; Wu, Hsiu-Chuan; Burchell, Victoria S.; Preza, Elisavet; Wray, Selina; Mahoney, Colin J.; Fox, Nick C.; Calvo, Andrea; Canosa, Antonio; Moglia, Cristina; Mandrioli, Jessica; Chio, Adriano; Orrell, Richard W.; Houlden, Henry; Hardy, John; Abramov, Andrey Y.; Plun-Favreau, Helene			Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels	NEURON			English	Article							SPINAL-CORD PATHOLOGY; LIPID-PEROXIDATION; PAGET-DISEASE; MOUSE MODEL; DYSFUNCTION; REVEALS; DEFICIENCY; METABOLISM; MUSCLE; DEFECT	Valosin-containing protein (VCP) is a highly expressed member of the type II AAA+ ATPase family. VCP mutations are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (IBMPFD) and they account for 1%-2% of familial amyotrophic lateral sclerosis (ALS). Using fibroblasts from patients carrying three independent pathogenic mutations in the VCP gene, we show that VCP deficiency causes profound mitochondrial uncoupling leading to decreased mitochondrial membrane potential and increased mitochondrial oxygen consumption. This mitochondrial uncoupling results in a significant reduction of cellular ATP production. Decreased ATP levels in VCP-deficient cells lower their energy capacity, making them more vulnerable to high energy-demanding processes such as ischemia. Our findings propose a mechanism by which pathogenic VCP mutations lead to cell death.	[Bartolome, Fernando; Wu, Hsiu-Chuan; Burchell, Victoria S.; Preza, Elisavet; Wray, Selina; Houlden, Henry; Hardy, John; Abramov, Andrey Y.; Plun-Favreau, Helene] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Mahoney, Colin J.; Fox, Nick C.] UCL Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Hardy, John] UCL Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Orrell, Richard W.] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Calvo, Andrea; Canosa, Antonio; Moglia, Cristina; Chio, Adriano] Univ Turin, Dept Neurosci, I-10126 Turin, Italy; [Mandrioli, Jessica] S Agostino Estense Hosp, Dept Neurosci, I-41126 Modena, Italy; [Mandrioli, Jessica] Univ Modena, I-41126 Modena, Italy	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Turin; Universita di Modena e Reggio Emilia	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	a.abramov@ucl.ac.uk; h.plun-favreau@ucl.ac.uk	Fox, Nick C/AAE-1849-2021; Mahoney, Colin/AAJ-5384-2021; Wray, Selina/C-3682-2009; Wu, Hsiu-Chuan/F-6365-2010; CALVO, Andrea/K-4141-2016; Mandrioli, Jessica/ABW-3887-2022; Fox, Nick C/B-1319-2009; Plun-Favreau, Helene/Q-4111-2016; Moglia, Cristina/AAB-9643-2019; Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Hardy, John/C-2451-2009; Bartolome, Fernando/D-4618-2011; Orrell, Richard/L-2123-2013; Mandrioli, Jessica/K-7235-2016; Houlden, Henry J/C-1532-2008; Chio, Adriano/K-3425-2016; moglia, cristina/K-4142-2016	Fox, Nick C/0000-0002-6660-657X; Mahoney, Colin/0000-0002-5878-3859; Wray, Selina/0000-0003-3062-7050; CALVO, Andrea/0000-0002-5122-7243; Fox, Nick C/0000-0002-6660-657X; Plun-Favreau, Helene/0000-0002-1401-9656; Moglia, Cristina/0000-0001-7377-7222; Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Hardy, John/0000-0002-3122-0423; Bartolome, Fernando/0000-0001-9322-8933; Mandrioli, Jessica/0000-0002-9244-9782; Houlden, Henry J/0000-0002-2866-7777; Chio, Adriano/0000-0001-9579-5341; moglia, cristina/0000-0001-7377-7222; PREZA, ELISAVET/0000-0003-4082-4621	Spanish Ministerio de Educacion through FECYT; MRC [G0700183]; ALS Association Initiated award [2109]; Motor Neuron Disease Association; Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; European Community [259867, 278611]; Motor Neuron Disease Association [6040]; MRC [G1001253, G0701075, MR/K000608/1, MR/J004758/1, G0802760, MC_G1000735, G108/638] Funding Source: UKRI; Medical Research Council [G1001253, G0700183, MC_G1000735, MR/J004758/1, G0802760, MR/K000608/1, G0701075, G108/638] Funding Source: researchfish	Spanish Ministerio de Educacion through FECYT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ALS Association Initiated award; Motor Neuron Disease Association; Wellcome Trust/MRC Joint Call in Neurodegeneration award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); European Community(European Commission); Motor Neuron Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to all patients and donors who helped make this work possible. F.B. is supported by a fellowship from the Spanish Ministerio de Educacion through the FECYT. This work was supported by a career development award from the MRC (G0700183), ALS Association Initiated award (ID 2109), Motor Neuron Disease Association, partially by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC), and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. A.C., A.C., C.J.M., J.M., and A.C. are funded by European Community's Health Seventh Framework Programme (FP7/2007-2013) (grant agreements 259867 and 278611). R.W.O. is funded by the Motor Neuron Disease Association (Grant 6040). Thanks to Dr. M. Cano who kindly provided us the mouse littermates, Dr. H. Imamura who provided us with the FRET-based ATP sensor, Dr. K. Wanish who provided us the Hek293T cell line used for the generation of lentiviral particles, and Dr. K.M. Holmstrom for her help in the experimental procedures and her advice in the writing of the manuscript. F.B. performed all the experiments and wrote the first draft of the manuscript. A.Y.A., H.P.-F., and J.H. directed the research. Other authors helped with the cell cultures and provided the patient fibroblasts. R.W.O. and J.H. obtained part of the funding for this project.	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Bolanos JP, 2009, ADV DRUG DELIVER REV, V61, P1299, DOI 10.1016/j.addr.2009.05.009; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bradley LJ, 2009, EXP NEUROL, V218, P92, DOI 10.1016/j.expneurol.2009.04.007; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brookes PS, 1998, J NEUROCHEM, V70, P2195; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Chan HT, 2012, MOL BIOSYST, V8, P1730, DOI 10.1039/c2mb25037c; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Ghiasi P, 2012, NEUROL RES, V34, P297, DOI 10.1179/1743132812Y.0000000012; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Smittkamp SE, 2010, BEHAV BRAIN RES, V211, P48, DOI 10.1016/j.bbr.2010.03.007; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; White MG, 2011, NEUROSCI RES, V70, P220, DOI 10.1016/j.neures.2011.01.013; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115	38	99	101	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2013	78	1					57	64		10.1016/j.neuron.2013.02.028	http://dx.doi.org/10.1016/j.neuron.2013.02.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23498975	Green Published, hybrid			2022-12-25	WOS:000317556000007
J	Itoh, Y; Moriyama, Y; Hasegawa, T; Endo, TA; Toyoda, T; Gotoh, Y				Itoh, Yasuhiro; Moriyama, Yasunobu; Hasegawa, Tsuyoshi; Endo, Takaho A.; Toyoda, Tetsuro; Gotoh, Yukiko			Scratch regulates neuronal migration onset via an epithelial-mesenchymal transition-like mechanism	NATURE NEUROSCIENCE			English	Article							OUTER SUBVENTRICULAR ZONE; NEURAL STEM; E-CADHERIN; TRANSCRIPTION FACTORS; ASYMMETRIC DIVISION; ADHERENS JUNCTIONS; PLANAR DIVISIONS; PROGENITOR CELLS; RADIAL GLIA; NEUROGENESIS	During neocortical development, the neuroepithelial or neural precursor cells that commit to neuronal fate need to delaminate and start migration toward the pial surface. However, the mechanism that couples neuronal fate commitment to detachment from the neuroepithelium remains largely unknown. Here we show that Scratch1 and Scratch2, members of the Snail superfamily of transcription factors, are expressed upon neuronal fate commitment under the control of proneural genes and promote apical process detachment and radial migration in the developing mouse neocortex. Scratch-induced delamination from the apical surface was mediated by transcriptional repression of the adhesion molecule E-cadherin. These findings suggest that Scratch proteins constitute a molecular link between neuronal fate commitment and the onset of neuronal migration. On the basis of their similarity to proteins involved in the epithelial-mesenchymal transition (EMT), we propose that Scratch proteins mediate the conversion of neuroepithelial cells to migrating neurons or intermediate neuronal progenitors through an EMT-related mechanism.	[Itoh, Yasuhiro; Moriyama, Yasunobu; Hasegawa, Tsuyoshi; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Endo, Takaho A.; Toyoda, Tetsuro] RIKEN Bioinformat & Syst Engn Div, Kanagawa, Japan	University of Tokyo; RIKEN	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	yasu-itoh@iam.u-tokyo.ac.jp; ygotoh@iam.u-tokyo.ac.jp	Endo, Takaho/B-5763-2017	Endo, Takaho/0000-0002-2801-2463; Ito, Yasuhiro/0000-0001-8590-9122	"Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; CREST of the Japan Science and Technology Agency; MEXT	"Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; CREST of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank J.A. Cooper and R.N. Eisenman for critical reading of the manuscript; C.L. Cepko (Harvard University), T. Matsuda (Kyoto University), T. Kitamura (University of Tokyo), M. Nakafuku (University of Cincinnati), A. Nagafuchi (Kumamoto University), F. Matsuzaki (RIKEN Center for Developmental Biology), H. Okano (Keio University) and A. Garcia de Herreros (Institut Hospital del Mar d'Investigacions Mediques) for providing reagents; T. Sunabori for technical advice; H. Kosako and K. Ishiguro for generation of antibodies to Scratch1; Y. Hirabayashi, N. Masuyama, T. Yoshimatsu and T. Kato for technical assistance; K. Tyssowski for editing the manuscript; and members of the Gotoh laboratory for helpful discussion. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by CREST of the Japan Science and Technology Agency, and in part by the Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) of MEXT.	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fode C, 2000, GENE DEV, V14, P67; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kato TM, 2010, MOL CELL NEUROSCI, V45, P12, DOI 10.1016/j.mcn.2010.05.004; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Marin F, 2006, DEV DYNAM, V235, P2586, DOI 10.1002/dvdy.20869; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; ROCHA J, 1988, HUM GENET, V80, P299, DOI 10.1007/BF01790102; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sawamoto K, 2001, J NEUROSCI RES, V65, P220, DOI 10.1002/jnr.1145; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	56	90	91	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					416	U75		10.1038/nn.3336	http://dx.doi.org/10.1038/nn.3336			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434913				2022-12-25	WOS:000316723700011
J	Wanat, MJ; Bonci, A; Phillips, PEM				Wanat, Matthew J.; Bonci, Antonello; Phillips, Paul E. M.			CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; STRESS; COCAINE; ENHANCEMENT; DEPRESSION; NUCLEUS; NEURONS; PROTEIN	Stressors affect dopamine-dependent behaviors such as motivation, although the underlying neurobiological mechanism is not well defined. We report that corticotropin-releasing factor (CRF) acts in the ventral tegmental area (VTA) to reduce the motivation to work for food rewards. CRF in the VTA regulates dopamine output in a stimulus- and pathway-specific manner, offering a mechanism by which acute stress selectively regulates information transmission via the VTA to reprioritize motivated behavior.	[Wanat, Matthew J.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Wanat, Matthew J.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [R01-MH079292, R01-DA016782, T32-AA009455, F32-DA026273]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026273, K99DA033386, R01DA016782] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank S. Ng-Evans for invaluable technical support and C. Akers for technical assistance. We thank N. Hollon, J. Clark and S. Sandberg for scientific discussion. This work was funded by the US National Institutes of Health (R01-MH079292, P.E.M.P.; R01-DA016782, A.B. and P.E.M.P.; T32-AA009455 and F32-DA026273, M.J.W.) and NARSAD (P.E.M.P.).	Beckstead MJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1926, DOI 10.1038/npp.2009.25; Blacktop JM, 2011, J NEUROSCI, V31, P11396, DOI 10.1523/JNEUROSCI.1393-11.2011; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; KALIVAS PW, 1987, J PHARMACOL EXP THER, V242, P757; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Meyer SE, 2001, DEV PSYCHOPATHOL, V13, P565, DOI 10.1017/S095457940100308X; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SCARNATI E, 1984, BRAIN RES, V304, P351, DOI 10.1016/0006-8993(84)90339-1; Shafiei N, 2012, NEUROPSYCHOPHARMACOL, V37, P2194, DOI 10.1038/npp.2012.69; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wanat MJ, 2010, J NEUROSCI, V30, P12020, DOI 10.1523/JNEUROSCI.2691-10.2010; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; ZACHARKO RM, 1991, NEUROSCI BIOBEHAV R, V15, P391, DOI 10.1016/S0149-7634(05)80032-6; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	23	76	77	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					383	U191		10.1038/nn.3335	http://dx.doi.org/10.1038/nn.3335			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416448	Green Accepted			2022-12-25	WOS:000316723700005
J	Couey, JJ; Witoelar, A; Zhang, SJ; Zheng, K; Ye, J; Dunn, B; Czajkowski, R; Moser, MB; Moser, EI; Roudi, Y; Witter, MP				Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.			Recurrent inhibitory circuitry as a mechanism for grid formation	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; LAYER-II; PATH-INTEGRATION; DISYNAPTIC INHIBITION; RAT; NEURONS; CELLS; MODEL; DIRECTION; DYNAMICS	Grid cells in layer II of the medial entorhinal cortex form a principal component of the mammalian neural representation of space. The firing pattern of a single grid cell has been hypothesized to be generated through attractor dynamics in a network with a specific local connectivity including both excitatory and inhibitory connections. However, experimental evidence supporting the presence of such connectivity among grid cells in layer II is limited. Here we report recordings from more than 600 neuron pairs in rat entorhinal slices, demonstrating that stellate cells, the principal cell type in the layer II grid network, are mainly interconnected via inhibitory interneurons. Using a model attractor network, we demonstrate that stable grid firing can emerge from a simple recurrent inhibitory network. Our findings thus suggest that the observed inhibitory microcircuitry between stellate cells is sufficient to generate grid-cell firing patterns in layer II of the medial entorhinal cortex.	[Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Ctr Biol Memory, Norwegian Brain Ctr, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Witter, MP (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	yasser.roudi@ntnu.no; menno.witter@ntnu.no	Ye, Jing/M-3366-2017; Couey, Jonathan/GXG-6340-2022	Ye, Jing/0000-0002-6364-4124; Czajkowski, Rafal/0000-0002-9793-5421; Couey, Jonathan/0000-0003-2658-692X; Roudi, Yasser/0000-0002-6989-3420	Kavli Foundation; EU [200873]; Centre of Excellence from Norwegian Research Council [145993, 181676, 191929]; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; EU(European Commission); Centre of Excellence from Norwegian Research Council; European Research Council ('CIRCUIT')	We thank K. Deisseroth (Stanford University) for providing the ChR2(H134R) plasmid, I.E.J. Assebo for histological reconstructions, P. Gird for programming and A. Treves for comments on the manuscript. This work was supported by the Kavli Foundation, an EU 7th framework grant ('Spacebrain' grant agreement 200873), and Centre of Excellence (145993), equipment (181676) and research (191929) grants from the Norwegian Research Council, and an Advanced Investigator Grant from the European Research Council ('CIRCUIT', grant 232608).	Acsady L, 1998, J NEUROSCI, V18, P3386; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Boucheny C, 2005, J COMPUT NEUROSCI, V18, P205, DOI 10.1007/s10827-005-6559-y; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Gatome CW, 2010, NEUROSCIENCE, V170, P156, DOI 10.1016/j.neuroscience.2010.06.048; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klink R, 1997, HIPPOCAMPUS, V7, P571; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Morgan RJ, 2007, PROG BRAIN RES, V163, P639, DOI 10.1016/S0079-6123(07)63035-0; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sills JB, 2012, HIPPOCAMPUS, V22, P1912, DOI 10.1002/hipo.22026; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang K, 1996, J NEUROSCI, V16, P2112; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	46	240	244	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					318	324		10.1038/nn.3310	http://dx.doi.org/10.1038/nn.3310			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334580				2022-12-25	WOS:000315474800014
J	Kierdorf, K; Erny, D; Goldmann, T; Sander, V; Schulz, C; Perdiguero, EG; Wieghofer, P; Heinrich, A; Riemke, P; Holscher, C; Muller, DN; Luckow, B; Brocker, T; Debowski, K; Fritz, G; Opdenakker, G; Diefenbach, A; Biber, K; Heikenwalder, M; Geissmann, F; Rosenbauer, F; Prinz, M				Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Schulz, Christian; Perdiguero, Elisa Gomez; Wieghofer, Peter; Heinrich, Annette; Riemke, Pia; Hoelscher, Christoph; Mueller, Dominik N.; Luckow, Bruno; Brocker, Thomas; Debowski, Katharina; Fritz, Guenter; Opdenakker, Ghislain; Diefenbach, Andreas; Biber, Knut; Heikenwalder, Mathias; Geissmann, Frederic; Rosenbauer, Frank; Prinz, Marco			Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTORS; FRACTALKINE RECEPTOR; MYELOID CELLS; YOLK-SAC; MACROPHAGES; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; MONOCYTES; SURVIVAL	Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit(+) erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. These precursors developed into CD45(+) c-kit(lo) CX(3)CR1(-) immature (A1) cells and matured into CD45(+) c-kit(-) CX(3)CR1(+) (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia.	[Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Wieghofer, Peter; Fritz, Guenter; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Heinrich, Annette; Biber, Knut] Univ Freiburg, Dept Psychiat, D-79106 Freiburg, Germany; [Riemke, Pia; Rosenbauer, Frank] Univ Munster, Inst Mol Tumor Biol, D-48149 Munster, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Div Infect Immunol, Borstel, Germany; [Hoelscher, Christoph] Cluster Excellence Inflammat Interfaces Borstel K, Kiel, Germany; [Mueller, Dominik N.] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Mueller, Dominik N.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Luckow, Bruno] Klinikum Univ Munchen, Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany; [Brocker, Thomas] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Debowski, Katharina] German Primate Ctr, Cell Res Grp, Gottingen, Germany; [Opdenakker, Ghislain] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Diefenbach, Andreas] Univ Freiburg, Dept Microbiol, D-79106 Freiburg, Germany; [Biber, Knut] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of London; King's College London; University of London; King's College London; University of Freiburg; University of Munster; Forschungszentrum Borstel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; University of Munich; Deutsches Primatenzentrum (DPZ); KU Leuven; University of Freiburg; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Diefenbach, Andreas/T-2589-2018; Perdiguero, Elisa Gomez/U-2120-2018; Kierdorf, Katrin/AAO-6288-2021; Heikenwalder, Mathias/AAA-2269-2020; Opdenakker, Ghislain/V-8562-2019; Fritz, Guenter/E-2933-2013; Wieghofer, Peter/AAV-9572-2020; Schulz, Christian/J-8545-2012; Hölscher, Christoph/O-1732-2018; Erny, Daniel/AAU-7015-2020; Opdenakker, Ghislain/Q-3130-2017	Diefenbach, Andreas/0000-0002-9176-9530; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Opdenakker, Ghislain/0000-0003-1714-2294; Fritz, Guenter/0000-0002-4571-8812; Schulz, Christian/0000-0003-3878-7833; Hölscher, Christoph/0000-0002-7520-9146; Erny, Daniel/0000-0001-6000-8838; Opdenakker, Ghislain/0000-0003-1714-2294; Goldmann, Tobias/0000-0001-9754-9144; Masuch, Annette/0000-0002-8168-5042; Rosenbauer, Frank/0000-0001-7977-9421; geissmann, frederic/0000-0001-5029-2468; Brocker, Thomas/0000-0001-7060-5433; Muller, Dominik N/0000-0003-3650-5644; Kierdorf, Katrin/0000-0002-9272-4780	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung; Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG [SFB 620, PR 577/8-1]; Heisenberg fellowship [DFG FR 1488/3-2]; Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation; Geconcentreerde OnderzoeksActies [2012/017]; Fund for Scientific Research-Flanders; German National Academy of Sciences Leopoldina [LPDS 2009-31]; Medical Research Council [MRCG0900867]; European Research Council [ERC-2010-StG-261299]; Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG(German Research Foundation (DFG)); Heisenberg fellowship(German Research Foundation (DFG)); Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Geconcentreerde OnderzoeksActies; Fund for Scientific Research-Flanders(FWO); German National Academy of Sciences Leopoldina; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank M. Oberle, A. Holscher and U. Muller for excellent technical assistance, M. Mann for help with the heat map, A. Muller for assistance with the electron microscopy and S. Brendecke for critical reading and editing. The authors are indebted to S. McKercher (Sanford-Burnham Medical Research Institute) for providing Sfpi<SUP>+/-</SUP> mice and to J. Frampton (University of Birmingham) for providing Myb<SUP>+/-</SUP> mice. We thank S. Heck and the Flow facility of the Biomedical Research Centre at King's Health Partners. M.P., K.B. and ER. are supported by the Deutsche Forschungsgemeinschaft (DFG)-funded research unit 1336 "From monocytes to brain macrophages-conditions influencing the fate of myeloid cells in the brain". M.P. is supported by the Bundesministerium fur Bildung und Forschung-funded Competence Network of Multiple Sclerosis (Kompetenznetz Multiple Sklerose), the Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen), the Centre of Chronic Immunodeficiency and the DFG (SFB 620, PR 577/8-1). G.F. is supported by a Heisenberg fellowship (DFG FR 1488/3-2). M.H. is supported by the Helmholtz-Zentrum Munchen, a European Research Council starting grant and the Swiss National Foundation. G.O. is supported by the Geconcentreerde OnderzoeksActies 2012/017 and the Fund for Scientific Research-Flanders. CS. is supported by a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). F.G. is supported by grants MRCG0900867 from the Medical Research Council and ERC-2010-StG-261299 from the European Research Council.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hu JL, 2006, COMB CHEM HIGH T SCR, V9, P599, DOI 10.2174/138620706778249758; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0	30	869	895	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					273	280		10.1038/nn.3318	http://dx.doi.org/10.1038/nn.3318			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334579				2022-12-25	WOS:000315474800009
J	Mander, BA; Rao, V; Lu, B; Saletin, JM; Lindquist, JR; Ancoli-Israel, S; Jagust, W; Walker, MP				Mander, Bryce A.; Rao, Vikram; Lu, Brandon; Saletin, Jared M.; Lindquist, John R.; Ancoli-Israel, Sonia; Jagust, William; Walker, Matthew P.			Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging	NATURE NEUROSCIENCE			English	Article							GROWTH-HORMONE; EEG SLEEP; CONSOLIDATION; YOUNG; MEN; DYNAMICS; DECLINE; SCALE	Aging has independently been associated with regional brain atrophy, reduced slow wave activity (SWA) during non rapid eye movement (NREM) sleep and impaired long-term retention of episodic memories. However, whether the interaction of these factors represents a neuropatholgical pathway associated with cognitive decline in later life remains unknown. We found that age-related medial prefrontal cortex (mPFC) gray-matter atrophy was associated with reduced NREM SWA in older adults, the extent to which statistically mediated the impairment of overnight sleep dependent memory retention. Moreover, this memory impairment was further associated with persistent hippocampal activation and reduced task-related hippocampal-prefrontal cortex functional connectivity, potentially representing impoverished hippocampal-neocortical memory transformation. Together, these data support a model in which age-related mPFC atrophy diminishes SWA, the functional consequence of which is impaired long-term memory. Such findings suggest that sleep disruption in the elderly, mediated by structural brain changes, represents a contributing factor to age-related cognitive decline in later life	[Mander, Bryce A.; Rao, Vikram; Saletin, Jared M.; Lindquist, John R.; Walker, Matthew P.] Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Lu, Brandon] Calif Pacific Med Ctr, Div Pulm & Crit Care Med, San Francisco, CA USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jagust, William; Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; California Pacific Medical Center; University of California System; University of California San Diego; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mander, BA (corresponding author), Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA.	bamander@berkeley.edu; mpwalker@berkeley.edu	Jagust, William/ABE-6426-2020; Rao, Vikram/J-6931-2016	Saletin, Jared/0000-0002-8547-0161; Mander, Bryce/0000-0002-0831-7980	US National Institutes of Health [R01-AG031164, R01-AG034570, R01-AG08415, F32-AG039170]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031164, R01AG008415, F32AG039170, R01AG034570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Belshe, M. Shatter, M. Binod, S. Bowditch, C. Dang, A. Hayenga, A. Horn, E. Hur, C. Markeley, E. Mormino, M. Nicholas, L. Zhang and A. Zhu for their assistance, A. Mander for his aid in task design, and M. Rubens and A. Gazzaley for use of their aging template brain. This work was supported by awards R01-AG031164 (M.P.W.), R01-AG034570 (W.J.), R01-AG08415 (S.A.-I.) and F32-AG039170 (B.A.M.) from the US National Institutes of Health.	Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Davis HP, 2003, CORTEX, V39, P1063, DOI 10.1016/S0010-9452(08)70878-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marzano C, 2010, J SLEEP RES, V19, P260, DOI 10.1111/j.1365-2869.2009.00776.x; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; Naylor E, 2000, SLEEP, V23, P87; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Otten LJ, 2007, J COGNITIVE NEUROSCI, V19, P1776, DOI 10.1162/jocn.2007.19.11.1776; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X	34	302	312	6	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					357	364		10.1038/nn.3324	http://dx.doi.org/10.1038/nn.3324			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354332	Green Accepted, Green Submitted			2022-12-25	WOS:000315474800019
J	Zhou, MO; Li, WD; Huang, S; Song, J; Kim, JY; Tian, XL; Kang, EC; Sano, Y; Liu, C; Balaji, J; Wu, SM; Zhou, Y; Zhou, Y; Parivash, SN; Ehninger, D; He, L; Song, HJ; Ming, GL; Silva, AJ				Zhou, Miou; Li, Weidong; Huang, Shan; Song, Juan; Kim, Ju Young; Tian, Xiaoli; Kang, Eunchai; Sano, Yoshitake; Liu, Cindy; Balaji, J.; Wu, Shumin; Zhou, Yu; Zhou, Ying; Parivash, Sherveen N.; Ehninger, Dan; He, Lin; Song, Hongjun; Ming, Guo-li; Silva, Alcino J.			mTOR Inhibition Ameliorates Cognitive and Affective Deficits Caused by Disc1 Knockdown in Adult-Born Dentate Granule Neurons	NEURON			English	Article							TERM SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; PROGENITOR PROLIFERATION; REVERSIBLE INACTIVATION; GENERATED NEURONS; SCHIZOPHRENIA; BRAIN; MICE; DISRUPTED-IN-SCHIZOPHRENIA-1; PHENOTYPES	Abnormalities during brain development are thought to cause psychiatric illness and other neurodevelopmental disorders. However, developmental processes such as neurogenesis continue in restricted brain regions of adults, and disruptions of these processes could contribute to the phenotypes of neurodevelopmental disorders. As previously reported, we show that Disc1 knockdown specifically in adult-born dentate gyrus (DG) neurons results in increased mTOR signaling, hyperexcitability, and neuronal structure deficits. Disc1 knockdown also resulted in pronounced cognitive and affective deficits, which could be reversed when the affected DG neurons were inactivated. Importantly, reversing increases in mTOR signaling with an FDA-approved inhibitor both prevented and treated these behavioral deficits, even when associated structural deficits were not reversed. Our findings suggest that a component of the affective and cognitive phenotypes in neurodevelopmental disorders may be caused by disruptions in adult-born neurons. Consequently, treatments directed at this cell population may have a significant impact on these phenotypes.	[Zhou, Miou; Li, Weidong; Huang, Shan; Sano, Yoshitake; Balaji, J.; Zhou, Yu; Parivash, Sherveen N.; Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zhou, Miou; Li, Weidong; Huang, Shan; Sano, Yoshitake; Balaji, J.; Zhou, Yu; Parivash, Sherveen N.; Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA 90095 USA; [Zhou, Miou; Li, Weidong; Huang, Shan; Sano, Yoshitake; Balaji, J.; Zhou, Yu; Parivash, Sherveen N.; Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Dept Psychiat, Los Angeles, CA 90095 USA; [Zhou, Miou; Li, Weidong; Huang, Shan; Sano, Yoshitake; Balaji, J.; Zhou, Yu; Parivash, Sherveen N.; Ehninger, Dan; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Li, Weidong; Zhou, Ying; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200240, Peoples R China; [Li, Weidong; Zhou, Ying] Wuxi Mental Hlth Ctr, Wuxi 214151, Peoples R China; [Tian, Xiaoli] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Wu, Shumin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Song, Juan; Kim, Ju Young; Kang, Eunchai; Liu, Cindy; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Song, Juan; Kim, Ju Young; Kang, Eunchai; Liu, Cindy; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Song, Juan; Song, Hongjun] Johns Hopkins Univ, Sch Med, Human Genet Program, Baltimore, MD 21205 USA; [Zhou, Yu] Qingdao Univ, Coll Med, Dept Psychol, Qingdao 266071, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shanghai Jiao Tong University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Qingdao University	Li, WD (corresponding author), Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90095 USA.	liwd@sjtu.edu.cn; silvaa@mednet.ucla.edu	Zhou, Miou/AAK-1515-2021; Silva, Alcino/ABD-7684-2021; Ming, Guo-li/J-7880-2013	Zhou, Miou/0000-0001-8188-7392; Silva, Alcino/0000-0002-1587-4558; Sano, Yoshitake/0000-0001-5188-3104; Li, Weidong/0000-0001-5384-4838; Kang, Eunchai/0000-0001-6884-622X; Huang, Shan/0000-0002-9230-8680; Silva, Alcino/0000-0001-5525-0494	National Institutes of Mental Health [P50-MH0779720]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Staglin IMHRO Center for Cognitive Neuroscience at UCLA; National Institute of Health [NS048271, HD069184, NS047344]; NARSAD; China 973 Program [2010CB529604]; National Scientific Foundation of China [81271511, 30900432]; National Science & Technology Pillar Program [2012BAI01B08, 2012BAI01B09]; Shanghai Pujiang Program [11PJ1405100]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [10SG14]; National Major Scientific Instruments Development Project [2012YQ03026007]; NSFC [NSFC31222027, NSFC3117107]; SD NSF [SDNSF JQ201209]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R37NS047344, R01NS048271, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Staglin IMHRO Center for Cognitive Neuroscience at UCLA; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); China 973 Program(National Basic Research Program of China); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; National Major Scientific Instruments Development Project; NSFC(National Natural Science Foundation of China (NSFC)); SD NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Denise Cai for help with statistical analysis, Yong-Seok Lee and Justin Shobe for helpful advice, and Tawnie Silva, Aida Amin, and Katie Cai for technical support. This work was supported by grants from the National Institutes of Mental Health (P50-MH0779720), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and the Staglin IMHRO Center for Cognitive Neuroscience at UCLA to A.J.S., National Institute of Health (NS048271, HD069184) and NARSAD Investigator Award to G.L.M., National Institute of Health (NS047344) to H.J.S., China 973 Program (2010CB529604), National Scientific Foundation of China (81271511, 30900432), National Science & Technology Pillar Program (2012BAI01B08, 2012BAI01B09), Shanghai Pujiang Program (11PJ1405100), "Eastern Scholar," "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (10SG14), "National Major Scientific Instruments Development Project" (2012YQ03026007), and NARSAD Young Investigator Award to W.L., NSFC (NSFC31222027, NSFC3117107) and SD NSF (SDNSF JQ201209) to Y.Z., and NARSAD Young Investigator Awards to M.Z. M.Z., W.L., and A.J.S. designed the experiments. M.Z., S.H., and W.L. performed the behavioral experiments. M.Z. did immunostaining and data analysis. J.S. did eletrophysiological recording. E.K. carried out the axonal targeting experiment. J.Y.K. provided the virus. H.S. and G.M. helped with paper writing. M.Z. and A.J.S. wrote the paper.	Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Cleary C, 2008, BRAIN RES BULL, V76, P469, DOI 10.1016/j.brainresbull.2008.03.005; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Rinehart NJ, 2002, AUST NZ J PSYCHIAT, V36, P762, DOI 10.1046/j.1440-1614.2002.01097.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsiouris JA, 2004, CNS DRUGS, V18, P687, DOI 10.2165/00023210-200418110-00001	26	75	80	1	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					647	654		10.1016/j.neuron.2012.12.033	http://dx.doi.org/10.1016/j.neuron.2012.12.033			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439118	Green Accepted, Bronze			2022-12-25	WOS:000315561300008
J	Ogawa, M; van der Meer, MAA; Esber, GR; Cerri, DH; Stalnaker, TA; Schoenbaum, G				Ogawa, Masaaki; van der Meer, Matthijs A. A.; Esber, Guillem R.; Cerri, Domenic H.; Stalnaker, Thomas A.; Schoenbaum, Geoffrey			Risk-Responsive Orbitofrontal Neurons Track Acquired Salience	NEURON			English	Article							PERSISTENT LATENT INHIBITION; BASOLATERAL AMYGDALA; CORTEX; UNCERTAINTY; ATTENTION; LESIONS; MODEL; DISTINCT; IMPACT	Decision making is impacted by uncertainty and risk (i.e., variance). Activity in the orbitofrontal cortex, an area implicated in decision making, covaries with these quantities. However, this activity could reflect the heightened salience of situations in which multiple outcomes-reward and reward omission-are expected. To resolve these accounts, rats were trained to respond to cues predicting 100%, 67%, 33%, or 0% reward. Consistent with prior reports, some orbitofrontal neurons fired differently in anticipation of uncertain (33% and 67%) versus certain (100% and 0%) reward. However, over 90% of these neurons also fired differently prior to 100% versus 0% reward (or baseline) or prior to 33% versus 67% reward. These responses are inconsistent with risk but fit well with the representation of acquired salience linked to the sum of cue-outcome and cue-no-outcome associative strengths. These results expand our understanding of how the orbitofrontal cortex might regulate learning and behavior.	[Ogawa, Masaaki; Cerri, Domenic H.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [van der Meer, Matthijs A. A.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [van der Meer, Matthijs A. A.] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada; [Esber, Guillem R.; Stalnaker, Thomas A.; Schoenbaum, Geoffrey] NIDA, Intramural Res Program, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland Baltimore; University of Waterloo; University of Waterloo; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Ogawa, M (corresponding author), MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA.	seri0722@gmail.com; geoffrey.schoenbaum@nih.gov	Esber, Guillem/AAL-9246-2020	Esber, Guillem/0000-0001-8874-4255; Ogawa, Masaaki/0000-0003-4615-8412; van der Meer, Matthijs/0000-0002-2206-4473; Cerri, Domenic/0000-0003-4322-5827	Uehara Memorial Foundation; National Science and Engineering Research Council; Netherlands Organization for Scientific Research [VENI 863.10.013]; NIDA; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027742, R01DA015718, ZIADA000587] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Reza Ramezan for comments on the statistical analysis. This work was supported by funding from the Uehara Memorial Foundation to M.O., the National Science and Engineering Research Council and the Netherlands Organization for Scientific Research (VENI 863.10.013) to M.A.A.vdM., and NIDA to G.S and M.O. This work was conducted while G.S. and T.A.S. were employed at the University of Maryland. The opinions expressed in this article are the authors' own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government. M.O. and G.S. conceived the experiments; M.O. and D.H.C. carried out the experiment. M.O. and M.A.A.vdM. analyzed the data with assistance from G.R.E., T.A.S., and G.S. The manuscript was prepared by M.O. and G.S. with assistance from M.A.A.vdM. and G.R.E.	Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Chase EA, 2012, EUR J NEUROSCI, V36, P2368, DOI 10.1111/j.1460-9568.2012.08141.x; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Haselgrove M, 2010, J EXP PSYCHOL ANIM B, V36, P456, DOI 10.1037/a0018528; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kahnt T., 2013, J NEUROSCI; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Konorski J., 1967, INTEGRATIVE ACTIVITY; Le Pelley ME, 2004, Q J EXP PSYCHOL-B, V57, P193, DOI 10.1080/02724990344000141; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Ramus SJ, 2000, J NEUROSCI, V20, P8199, DOI 10.1523/jneurosci.20-21-08199.2000; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schiller D, 2006, J PSYCHIATR RES, V40, P167, DOI 10.1016/j.jpsychires.2005.03.002; Schiller D, 2004, NEUROSCIENCE, V128, P15, DOI 10.1016/j.neuroscience.2004.06.020; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027	28	49	52	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					251	258		10.1016/j.neuron.2012.11.006	http://dx.doi.org/10.1016/j.neuron.2012.11.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352162	Green Accepted, Bronze			2022-12-25	WOS:000314199400008
J	Porlan, E; Morante-Redolat, JM; Marques-Torrejon, MA; Andreu-Agullo, C; Carneiro, C; Gomez-Ibarlucea, E; Soto, A; Vidal, A; Ferron, SR; Farinas, I				Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo; Ferron, Sacri R.; Farinas, Isabel			Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; GFAP-EXPRESSING CELLS; ADULT NEUROGENESIS; SUBVENTRICULAR ZONE; LINEAGE COMMITMENT; PROGENITOR CELLS; GENE-EXPRESSION; INHIBITOR; DIFFERENTIATION; MICE	Relative quiescence and self renewal are defining features of adult stem cells, but their potential coordination remains unclear. Subependymal neural stem cells (NSCs) lacking cyclin-dependent kinase (CDK) inhibitor (CKI) 1a (p21) exhibit rapid expansion that is followed by their permanent loss later in life. Here we demonstrate that transcription of the gene encoding bone morphogenetic protein 2 (Bmp2) in NSCs is under the direct negative control of p21 through actions that are independent of CDK. Loss of p21 in NSCs results in increased levels of secreted BMP2, which induce premature terminal differentiation of multipotent NSCs into mature non-neurogenic astrocytes in an autocrine and/or paracrine manner. We also show that the cell-nonautonomous p21-null phenotype is modulated by the Noggin-rich environment of the subependymal niche. The dual function that we describe here provides a physiological example of combined cell-autonomous and cell-nonautonomous functions of p21 with implications in self renewal, linking the relative quiescence of adult stem cells to their longevity and potentiality.	[Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Farinas, Isabel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Ferron, Sacri R.; Farinas, Isabel] Univ Valencia, Dept Biol Celular, Valencia, Spain; [Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo] Univ Santiago de Compostela, Dept Fisiol, Santiago De Compostela, Spain; [Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Fac Med, Inst Invest Sanitaria Santiago IDIS, Santiago De Compostela, Spain	CIBERNED; University of Valencia; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Ferron, SR (corresponding author), Univ Valencia, Dept Biol Celular, Valencia, Spain.	sacramento.rodriguez@uv.es; isabel.farinas@uv.es	Ferrón, Sacri R./I-2958-2015; Marques, Maria Angeles/AAH-2720-2019; Vidal, Anxo/B-5010-2015; Gómez-Ibarlucea, Esther/AAA-8536-2020; porlan, Eva/AAE-6561-2022; Morante-Redolat, Jose Manuel/L-9397-2014; Farinas, Isabel/L-7118-2014	Ferrón, Sacri R./0000-0003-0854-8575; Vidal, Anxo/0000-0002-0866-4202; porlan, Eva/0000-0003-0934-9711; Morante-Redolat, Jose Manuel/0000-0003-0610-1665; Farinas, Isabel/0000-0003-2903-4960	Ministerio de Economia y Competitividad (MINECO) (SAF program); Ministerio de Sanidad (Red TerCel); Ministerio de Sanidad (CIBERNED); Generalitat Valenciana (Programas Prometeo); Generalitat Valenciana (ISIC); Generalitat Valenciana (ACOMP); Ministerio de Educacion y Ciencia (FPI program); Ministerio de Educacion y Ciencia (FPU program); Xunta de Galicia	Ministerio de Economia y Competitividad (MINECO) (SAF program); Ministerio de Sanidad (Red TerCel); Ministerio de Sanidad (CIBERNED); Generalitat Valenciana (Programas Prometeo)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ISIC)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ACOMP)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia (FPI program)(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Ministerio de Educacion y Ciencia (FPU program)(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	We thank C. Gallego (Institut de Biologia Molecular de Barcelona), M.R. Campanero (Instituto de Investigaciones Biomedicas Alberto Sols, Madrid), S. Harris (University of Texas Health Science Center at San Antonio), S. Hitoshi (Shiga University of Medical Science), D. van der Kooy (University of Toronto) and W Zhang (The Johns Hopkins University School of Medicine) for generously providing constructs. We also thank the Servicios Centrales de Soporte a la Investigacion Experimental of the Universidad de Valencia for technical support. This work was supported by grants from the Ministerio de Economia y Competitividad (MINECO) (SAF program) to I.F., S.R.F. and A.V. and the Ministerio de Sanidad (Red TerCel and CIBERNED) and Generalitat Valenciana (Programas Prometeo, ISIC and ACOMP) to LE M.A.M.-T. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (FPI program), CA-A. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (FPU program), E.G.-I. is supported by a predoctoral fellowship from Xunta de Galicia, and C.C. was a 'Parga Pondal' investigator supported by Xunta de Galicia.	Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fern A.L., 2004, DEVELOPMENT, V131, P3805; Ferrandiz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037759; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Le Dreau G, 2012, DEVELOPMENT, V139, P259, DOI 10.1242/dev.074948; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lin JY, 1996, MOL CELL BIOL, V16, P1786; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Mabie PC, 1997, J NEUROSCI, V17, P4112; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tevosian SG, 1996, CELL GROWTH DIFFER, V7, P43; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	51	51	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1567	1575		10.1038/nn.3545	http://dx.doi.org/10.1038/nn.3545			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097040				2022-12-25	WOS:000326205700014
J	Contreras, EJB; Schjetnan, AGP; Muhammad, A; Bartho, P; McNaughton, BL; Kolb, B; Gruber, AJ; Luczak, A				Contreras, Edgar J. Bermudez; Schjetnan, Andrea Gomez Palacio; Muhammad, Arif; Bartho, Peter; McNaughton, Bruce L.; Kolb, Bryan; Gruber, Aaron J.; Luczak, Artur			Formation and Reverberation of Sequential Neural Activity Patterns Evoked by Sensory Stimulation Are Enhanced during Cortical Desynchronization	NEURON			English	Article							AUDITORY-CORTEX; NMDA RECEPTORS; MEMORY CONSOLIDATION; DISCHARGE PROPERTIES; HIPPOCAMPAL RIPPLES; PREFRONTAL CORTEX; ANESTHETIZED RATS; BASAL FOREBRAIN; VISUAL-CORTEX; REACTIVATION	Memory formation is hypothesized to involve the generation of event-specific neural activity patterns during learning and the subsequent spontaneous reactivation of these patterns. Here, we present evidence that these processes can also be observed in urethane-anesthetized rats and are enhanced by desynchronized brain state evoked by tail pinch, subcortical carbachol infusion, or systemic amphetamine administration. During desynchronization, we found that repeated tactile or auditory stimulation evoked unique sequential patterns of neural firing in somatosensory and auditory cortex and that these patterns then reoccurred during subsequent spontaneous activity, similar to what we have observed in awake animals. Furthermore, the formation of these patterns was blocked by an NMDA receptor antagonist, suggesting that the phenomenon depends on synaptic plasticity. These results suggest that anesthetized animals with a desynchronized brain state could serve as a convenient model for studying stimulus-induced plasticity to improve our understanding of memory formation and replay in the brain.	[Contreras, Edgar J. Bermudez; Schjetnan, Andrea Gomez Palacio; Muhammad, Arif; McNaughton, Bruce L.; Kolb, Bryan; Gruber, Aaron J.; Luczak, Artur] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Bartho, Peter] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Bartho, Peter] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary	University of Lethbridge; Rutgers State University Newark; Rutgers State University New Brunswick; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Luczak, A (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	luczak@uleth.ca	Contreras, Edgar Bermudez/AAB-2566-2019	Contreras, Edgar Bermudez/0000-0002-4937-1780; Gomez Palacio Schjetnan, Andrea/0000-0002-4319-7689; Luczak, Artur/0000-0002-4929-5781; Gruber, Aaron/0000-0003-2700-5429	NSERC; AIHS; HSRF [NF-101773]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); AIHS; HSRF	We thank David Euston and Masami Tatsuno for insightful comments on the manuscript and Kenneth D. Harris for supporting recordings from awake animals. We also thank Zak Stinson, Simone Cherry-Delisle, Adam Neumann, Montserrat Villanueva Borbolla, and Hiroe Yamazaki for help with experiments. This work was supported by NSERC (to A.L., A.J.G., B.L.M., and B.K.), AIHS (to A.L., A.J.G., and B.L.M.), and HSRF NF-101773 (P.B.). P.B is a Bolyai fellow.	Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; BLAND BH, 1994, HIPPOCAMPUS, V4, P649, DOI 10.1002/hipo.450040604; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; Boucetta S, 2009, J NEUROSCI, V29, P4664, DOI 10.1523/JNEUROSCI.5502-08.2009; BUZSAKI G, 1984, BRAIN RES, V300, P179, DOI 10.1016/0006-8993(84)91356-8; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; CREESE I, 1983, STIMULANTS NEUROCHEM; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Duque A, 2000, J NEUROPHYSIOL, V84, P1627, DOI 10.1152/jn.2000.84.3.1627; Dykes RW, 1997, CAN J PHYSIOL PHARM, V75, P535, DOI 10.1139/cjpp-75-5-535; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; GRILLY DM, 1989, PHARMACOL BIOCHEM BE, V33, P733, DOI 10.1016/0091-3057(89)90463-2; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hebb Donald O., 1949, ORG BEHAV; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jablonska B, 1999, CEREB CORTEX, V9, P222, DOI 10.1093/cercor/9.3.222; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson LA, 2010, J NEUROSCI, V30, P2650, DOI 10.1523/JNEUROSCI.1617-09.2010; KARLER R, 1994, BRAIN RES, V658, P8, DOI 10.1016/S0006-8993(09)90003-8; KELLEY AE, 1992, BRAIN RES BULL, V29, P247, DOI 10.1016/0361-9230(92)90034-U; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kruskal PB, 2007, STAT MED, V26, P3997, DOI 10.1002/sim.2946; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LEONARD BJ, 1987, BRAIN RES, V425, P174; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Luczak A, 2012, EUR J NEUROSCI, V36, P2830, DOI 10.1111/j.1460-9568.2012.08201.x; Luczak A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00030; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Manns ID, 2000, J NEUROSCI, V20, P1505; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McLin DE, 2002, P NATL ACAD SCI USA, V99, P4002, DOI 10.1073/pnas.062057099; METHERATE R, 1990, SYNAPSE, V6, P133, DOI 10.1002/syn.890060204; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Schicknick H, 2006, NEUROPHARMACOLOGY, V50, P671, DOI 10.1016/j.neuropharm.2005.11.013; Schicknick H, 2012, EUR J NEUROSCI, V35, P763, DOI 10.1111/j.1460-9568.2012.07994.x; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; Tegenthoff M, 2004, ACTA NEUROL SCAND, V109, P330, DOI 10.1046/j.1600-0404.2003.00235.x; Tronel S, 2003, J NEUROSCI, V23, P5472; van Wingerden M, 2012, NEURON, V76, P813, DOI 10.1016/j.neuron.2012.09.039; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036	61	60	60	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 7	2013	79	3					555	566		10.1016/j.neuron.2013.06.013	http://dx.doi.org/10.1016/j.neuron.2013.06.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200QX	23932001	Bronze			2022-12-25	WOS:000323085100015
J	Specht, CG; Izeddin, I; Rodriguez, PC; El Beheiry, M; Rostaing, P; Darzacq, X; Dahan, M; Triller, A				Specht, Christian G.; Izeddin, Ignacio; Rodriguez, Pamela C.; El Beheiry, Mohamed; Rostaing, Philippe; Darzacq, Xavier; Dahan, Maxime; Triller, Antoine			Quantitative Nanoscopy of Inhibitory Synapses: Counting Gephyrin Molecules and Receptor Binding Sites	NEURON			English	Article							GLYCINE RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION; SUBUNIT; NUMBER; KINASE; DYNAMICS; MOBILITY; SIZE	The strength of synaptic transmission is controlled by the number and activity of neurotransmitter receptors. However, little is known about absolute numbers and densities of receptor and scaffold proteins and the stoichiometry of molecular interactions at synapses. Here, we conducted three-dimensional and quantitative nanoscopic imaging based on single-molecule detections to characterize the ultrastructure of inhibitory synapses and to count scaffold proteins and receptor binding sites. We observed a close correspondence between the spatial organization of gephyrin scaffolds and glycine receptors at spinal cord synapses. Endogenous gephyrin was clustered at densities of 5,00010,000 molecules/mu m(2). The stoichiometry between gephyrin molecules and receptor binding sites was approximately 1:1, consistent with a two-dimensional scaffold in which all gephyrin molecules can contribute to receptor binding. The competition of glycine and GABA(A) receptor complexes for synaptic binding sites highlights the potential of single-molecule imaging to quantify synaptic plasticity on the nanoscopic scale.	[Specht, Christian G.; Rodriguez, Pamela C.; Rostaing, Philippe; Triller, Antoine] ENS, INSERM, U1024, Inst Biol, F-75005 Paris, France; [Izeddin, Ignacio; El Beheiry, Mohamed; Dahan, Maxime] Univ Paris 06, ENS, Lab Kastler Brossel, CNRS,UMR 8552,Dept Phys, F-75005 Paris, France; [Izeddin, Ignacio; El Beheiry, Mohamed; Dahan, Maxime] Univ Paris 06, ENS, Inst Biol, F-75005 Paris, France; [Izeddin, Ignacio; Darzacq, Xavier] ENS, CNRS, UMR 8197, Inst Biol, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Triller, A (corresponding author), ENS, INSERM, U1024, Inst Biol, 46 Rue Ulm, F-75005 Paris, France.	triller@biologie.ens.fr	Izeddin, Ignacio/H-2628-2013; Dahan, Maxime/F-1740-2010	Izeddin, Ignacio/0000-0002-8476-3915; Dahan, Maxime/0000-0002-4943-2491; Rodriguez, Pamela/0000-0002-7529-0992; Specht, Christian G/0000-0001-6038-7735; TRILLER, Antoine/0000-0002-7530-1233; Darzacq, Xavier/0000-0003-2537-8395	Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale; Agence Nationale pour la Recherche; Lamonica; Netherlands Organisation for Scientific Research; Marie Curie International Incoming Fellowship; European Community	Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Lamonica; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie International Incoming Fellowship(European Commission); European Community(European Commission)	The authors thank Alain Bessis, Yasmine Cantaut-Belarif, and Andrea Dumoulin (Institut de Biologie de l'Ecole Normale Superieure) as well as Christophe Zimmer and Mickael Lelek (Institut Pasteur) for technical help. This project was funded by the Fondation Pierre-Gilles de Gennes through a research contract with Nikon France, the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale, and by grants TRIDIMIC and MorphoSynDiff from the Agence Nationale pour la Recherche. C.G.S. acknowledges grant Lamonica, and l.l. acknowledges the Netherlands Organisation for Scientific Research for financial support. P.C.R. was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme. C.G.S., l.l., M.D., and A.T. designed the experiments; C.G.S., l.l., P.C.R., P.R., and M.E.B. conducted the experiments and analyzed the data; C.G.S. and l.l. wrote the manuscript.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; BEHEIRY ME, 2013, NAT METHODS, V10, P689, DOI DOI 10.1038/NMETH.2566; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Hoyer P, 2011, NANO LETT, V11, P245, DOI 10.1021/nl103639f; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Izeddin I, 2012, OPT EXPRESS, V20, P4957, DOI 10.1364/OE.20.004957; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Lushnikova I, 2011, NEUROPHARMACOLOGY, V60, P757, DOI 10.1016/j.neuropharm.2010.12.014; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Rigo JM, 2003, J PHYSIOL-LONDON, V553, P819, DOI 10.1113/jphysiol.2003.049577; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; TRILLER A, 1982, J NEUROPHYSIOL, V48, P708, DOI 10.1152/jn.1982.48.3.708; TRILLER A, 1986, P101; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vlachos A, 2013, CEREB CORTEX, V23, P2700, DOI 10.1093/cercor/bhs260; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	49	148	148	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					308	321		10.1016/j.neuron.2013.05.013	http://dx.doi.org/10.1016/j.neuron.2013.05.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889935	Bronze			2022-12-25	WOS:000322426200010
J	Lyst, MJ; Ekiert, R; Ebert, DH; Merusi, C; Nowak, J; Selfridge, J; Guy, J; Kastan, NR; Robinson, ND; Alves, FD; Rappsilber, J; Greenberg, ME; Bird, A				Lyst, Matthew J.; Ekiert, Robert; Ebert, Daniel H.; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Alves, Flavia de Lima; Rappsilber, Juri; Greenberg, Michael E.; Bird, Adrian			Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REPRESSION; METHYLATED DNA; CHROMATIN; BRAIN; MICE; PHOSPHORYLATION; GENERATION; NEURONS	Rett syndrome (RTT) is a severe neurological disorder that is caused by mutations in the MECP2 gene. Many missense mutations causing RTT are clustered in the DNA-binding domain of MeCP2, suggesting that association with chromatin is critical for its function. We identified a second mutational cluster in a previously uncharacterized region of MeCP2. We found that RTT mutations in this region abolished the interaction between MeCP2 and the NCoR/SMRT co-repressor complexes. Mice bearing a common missense RTT mutation in this domain exhibited severe RTT-like phenotypes. Our data are compatible with the hypothesis that brain dysfunction in RTT is caused by a loss of the MeCP2 'bridge' between the NCoR/SMRT co-repressors and chromatin.	[Lyst, Matthew J.; Ekiert, Robert; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Alves, Flavia de Lima; Rappsilber, Juri; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Ebert, Daniel H.; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Harvard Medical School	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Nowak, Jakub Stanislaw/AFZ-0547-2022	Rappsilber, Juri/0000-0001-5999-1310; Nowak, Jakub Stanislaw/0000-0001-6536-2940; Lyst, Matthew/0000-0001-9018-4138; SELFRIDGE, JIM/0000-0003-2473-4386; Ekiert, Robert/0000-0002-8879-0646; Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372	Rett Syndrome Research Trust; Wellcome Trust; NIH [R01NS048276, K08MH90306]; NIHP30-HD [18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHP30-HD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harrison Gabel for advice and materials, and Martha Koerner, Thomas Clouaire and Sabine Lagger for comments on the manuscript. The work was supported by a grant to A.B. and M.E.G. from the Rett Syndrome Research Trust and by grants from the Wellcome Trust (to A.B.) and the NIH R01NS048276 (to M.E.G.). D.H.E. was supported by NIH grant K08MH90306. The Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) was supported by grant NIHP30-HD 18655. R.E. and J.N. were funded by Wellcome Trust 4 year PhD studentships and J.R. holds a Wellcome Trust Senior Fellowship.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; COOPER DN, 1990, HUM GENET, V85, P55; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Fyfe S, 2003, J CHILD NEUROL, V18, P709, DOI 10.1177/08830738030180100301; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	239	243	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					898	U268		10.1038/nn.3434	http://dx.doi.org/10.1038/nn.3434			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23770565	Green Accepted			2022-12-25	WOS:000321180900023
J	O'Connor, DH; Hires, SA; Guo, ZCV; Li, N; Yu, JN; Sun, QQ; Huber, D; Svoboda, K				O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel			Neural coding during active somatosensation revealed using illusory touch	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; SCANNING SENSORIMOTOR SYSTEM; OBJECT LOCALIZATION; CORTICAL MICROSTIMULATION; VIBRISSA CORTEX; TRANSGENIC MICE; MOTOR CORTEX; LAYER 5; WHISKER; BEHAVIOR	Active sensation requires the convergence of external stimuli with representations of body movements. We used mouse behavior, electrophysiology and optogenetics to dissect the temporal interactions among whisker movement, neural activity and sensation of touch. We photostimulated layer 4 activity in single barrels in a closed loop with whisking. Mimicking touch-related neural activity caused illusory perception of an object at a particular location, but scrambling the timing of the spikes over one whisking cycle (tens of milliseconds) did not abolish the illusion, indicating that knowledge of instantaneous whisker position is unnecessary for discriminating object locations. The illusions were induced only during bouts of directed whisking, when mice expected touch, and in the relevant barrel. Reducing activity biased behavior, consistent with a spike count code for object detection at a particular location. Our results show that mice integrate coding of touch with movement over timescales of a whisking bout to produce perception of active touch.	[O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	svobodak@janelia.hhmi.org	Hires, Samuel/E-4717-2015; Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Sun, Qian-Quan/0000-0002-5807-9327	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bagdasarian K, 2013, NAT NEUROSCI, V16, P622, DOI 10.1038/nn.3378; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2011, PHILOS T R SOC B, V366, P3037, DOI 10.1098/rstb.2011.0156; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Pammer L, 2013, J NEUROSCI, V33, P6726, DOI 10.1523/JNEUROSCI.4316-12.2013; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Slotnick B, 2009, J EXP ANAL BEHAV, V91, P253, DOI 10.1901/jeab.2009.91-253; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	147	148	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					958	U238		10.1038/nn.3419	http://dx.doi.org/10.1038/nn.3419			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727820	Green Published, Green Accepted			2022-12-25	WOS:000321180900031
J	Mikuni, T; Uesaka, N; Okuno, H; Hirai, H; Deisseroth, K; Bito, H; Kano, M				Mikuni, Takayasu; Uesaka, Naofumi; Okuno, Hiroyuki; Hirai, Hirokazu; Deisseroth, Karl; Bito, Haruhiko; Kano, Masanobu			Arc/Arg3.1 Is a Postsynaptic Mediator of Activity-Dependent Synapse Elimination in the Developing Cerebellum	NEURON			English	Article							LONG-TERM POTENTIATION; CLIMBING FIBER; PURKINJE-CELLS; POSTNATAL-DEVELOPMENT; MOTOR COORDINATION; CRITICAL PERIOD; NERVOUS-SYSTEM; VISUAL-CORTEX; NMDA RECEPTOR; CA2+ CHANNEL	Neural circuits are shaped by activity-dependent elimination of redundant synapses during postnatal development. In many systems, postsynaptic activity is known to be crucial, but the precise mechanisms remain elusive. Here, we report that the immediate early gene Arc/Arg3.1 mediates elimination of surplus climbing fiber (CF) to Purkinje cell (PC) synapses in the developing cerebellum. CF synapse elimination was accelerated when activity of channelrhodopsin-2-expressing PCs was elevated by 2-day photostimulation. This acceleration was suppressed by PC-specific knockdown of either the P/Q-type voltage-dependent Ca2+ channels (VDCCs) or Arc. PC-specific Arc knockdown had no appreciable effect until around postnatal day 11 but significantly impaired CF synapse elimination thereafter, leaving redundant CF terminals on PC somata. The effect of Arc knockdown was occluded by simultaneous knockdown of P/Q-type VDCCs in PCs. We conclude that Arc mediates the final stage of CF synapse elimination downstream of P/Q-type VDCCs by removing CF synapses from PC somata.	[Mikuni, Takayasu; Uesaka, Naofumi; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Okuno, Hiroyuki; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Tokyo 1130033, Japan; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Gunma 3718511, Japan; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Tokyo; University of Tokyo; Gunma University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	Hirai, Hirokazu/ABP-1143-2022; Uesaka, Naofumi/S-6072-2018; Bito, Haruhiko/A-8635-2008	Uesaka, Naofumi/0000-0002-9744-944X; Hirai, Hirokazu/0000-0002-0721-4293; Mikuni, Takayasu/0000-0002-9769-9369; Bito, Haruhiko/0000-0001-6315-9594; OKUNO, HIROYUKI/0000-0001-6237-6503; Kano, Masanobu/0000-0002-0725-3292	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17023021, 21220006, 23650204, 21500301, 24300117, 20670002]; Strategic Research Program for Brain Sciences (Development of biomarker candidates for social behavior) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour, and Welfare, Japan; CREST grant from the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Sciences (Development of biomarker candidates for social behavior) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); CREST grant from the Japan Science and Technology Agency	The authors thank A. Nienhuis, St. Jude Children's Research Hospital, and George Washington University for the gifts of the lentiviral backbone vector and the packaging plasmid, T. Nakazawa for helpful advice for real-time PCR, K. Kitamura and K. Hashimoto for helpful discussions, M. Mahoney for critically reading this manuscript, and K. Matsuyama, M. Sekiguchi, S. Tanaka, and A. Koseki for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (17023021, 21220006, and 23650204 to M.K., 21500301 and 24300117 to H.O., and 20670002 to H.B.), the Strategic Research Program for Brain Sciences (Development of biomarker candidates for social behavior), the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by a grant-in-aid from the Ministry of Health, Labour, and Welfare, Japan (to H.O. and H.B.), and a CREST grant from the Japan Science and Technology Agency (to H.B.).	Adams JP, 2009, NEUROREPORT, V20, P1429, DOI 10.1097/WNR.0b013e3283311db6; [Anonymous], P NATL ACAD SCI US, V94, P14089; Arsenault D, 2006, J PHYSIOL-LONDON, V573, P121, DOI 10.1113/jphysiol.2006.106542; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; Favero M, 2009, EUR J NEUROSCI, V29, P2327, DOI 10.1111/j.1460-9568.2009.06779.x; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 2009, NEUROSCIENCE, V162, P601, DOI 10.1016/j.neuroscience.2008.12.037; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Iizuka A, 2009, NEUROBIOL DIS, V35, P457, DOI 10.1016/j.nbd.2009.06.007; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Lorenzetto E, 2009, P NATL ACAD SCI USA, V106, P16475, DOI 10.1073/pnas.0907298106; Lu T, 2007, J NEUROSCI, V27, P808, DOI 10.1523/JNEUROSCI.4871-06.2007; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Ohtsuki G, 2008, EUR J NEUROSCI, V28, P2393, DOI 10.1111/j.1460-9568.2008.06539.x; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Uesaka N, 2012, J NEUROSCI, V32, P11657, DOI 10.1523/JNEUROSCI.1097-12.2012; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x; WOODWARD DJ, 1969, EXP NEUROL, V23, P120, DOI 10.1016/0014-4886(69)90039-9	54	68	72	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 19	2013	78	6					1024	1035		10.1016/j.neuron.2013.04.036	http://dx.doi.org/10.1016/j.neuron.2013.04.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791196	Green Accepted, Bronze			2022-12-25	WOS:000321026900009
J	Ratte, S; Hong, SG; De Schutter, E; Prescott, SA				Ratte, Stephanie; Hong, Sungho; De Schutter, Erik; Prescott, Steven A.			Impact of Neuronal Properties on Network Coding: Roles of Spike Initiation Dynamics and Robust Synchrony Transfer	NEURON			English	Review							PRIMARY VISUAL-CORTEX; MEMBRANE-POTENTIAL SYNCHRONY; RETINAL GANGLION-CELLS; HIGH-CONDUCTANCE STATE; CORTICAL-NEURONS; PYRAMIDAL NEURONS; IN-VIVO; NEOCORTICAL NEURONS; FIRING RATE; COINCIDENCE DETECTION	Neural networks are more than the sum of their parts, but the properties of those parts are nonetheless important. For instance, neuronal properties affect the degree to which neurons receiving common input will spike synchronously, and whether that synchrony will propagate through the network. Stimulus-evoked synchrony can help or hinder network coding depending on the type of code. In this Perspective, we describe how spike initiation dynamics influence neuronal input-output properties, how those properties affect synchronization, and how synchronization affects network coding. We propose that synchronous and asynchronous spiking can be used to multiplex temporal (synchrony) and rate coding and discuss how pyramidal neurons would be well suited for that task.	[Ratte, Stephanie; Prescott, Steven A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Ratte, Stephanie; Prescott, Steven A.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Hong, Sungho; De Schutter, Erik] Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa 9040495, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Okinawa Institute of Science & Technology Graduate University	Prescott, SA (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	steve.prescott@sickkids.ca	De Schutter, Erik/G-8460-2011; Hong, Sungho/D-3856-2015	De Schutter, Erik/0000-0001-8618-5138; Hong, Sungho/0000-0002-6905-7932	NIH [NS076706]; Okinawa Institute of Science and Technology School Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Okinawa Institute of Science and Technology School Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was support by NIH grant NS076706 (S.A.P) and the Okinawa Institute of Science and Technology School Corporation (E.D.S.). S.A.P. is also a Rita Allen Scholar in Pain and the 53rd Mallinckrodt Scholar. We thank Dan Simons for his constructive feedback.	ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Arsiero M, 2007, J NEUROSCI, V27, P3274, DOI 10.1523/JNEUROSCI.4937-06.2007; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; Barreiro AK, 2012, J NEUROPHYSIOL, V108, P1631, DOI 10.1152/jn.00928.2011; Barreiro AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011916; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Berry MJ, 1998, J NEUROSCI, V18, P2200; Billimoria CP, 2006, J NEUROSCI, V26, P5910, DOI 10.1523/JNEUROSCI.4659-05.2006; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Brunel N, 2009, COMPUT NEUROSCI-MIT, P161; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Burak Y, 2009, NEURAL COMPUT, V21, P2269, DOI 10.1162/neco.2009.07-08-830; Cecchi GA, 2000, P NATL ACAD SCI USA, V97, P5557, DOI 10.1073/pnas.100113597; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Cudmore RH, 2010, J NEUROSCI, V30, P12885, DOI 10.1523/JNEUROSCI.0740-10.2010; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; deCharms RC, 1998, P NATL ACAD SCI USA, V95, P15166, DOI 10.1073/pnas.95.26.15166; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Estebanez L, 2012, NAT NEUROSCI, V15, P1691, DOI 10.1038/nn.3258; Fernandez FR, 2011, J NEUROSCI, V31, P3880, DOI 10.1523/JNEUROSCI.5076-10.2011; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galan RF, 2008, J NEUROPHYSIOL, V99, P277, DOI 10.1152/jn.00563.2007; Gastrein P, 2011, J PHYSIOL-LONDON, V589, P3753, DOI 10.1113/jphysiol.2011.209148; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Goedeke S, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015007; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Grun S, 2009, J NEUROPHYSIOL, V101, P1126, DOI 10.1152/jn.00093.2008; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Higgs MH, 2006, J NEUROSCI, V26, P8787, DOI 10.1523/JNEUROSCI.1792-06.2006; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Hong S, 2007, NEURAL COMPUT, V19, P3133, DOI 10.1162/neco.2007.19.12.3133; Hong SH, 2012, J NEUROSCI, V32, P1413, DOI 10.1523/JNEUROSCI.3735-11.2012; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Josic K, 2009, NEURAL COMPUT, V21, P2774, DOI 10.1162/neco.2009.10-08-879; Kenyon GT, 2004, NEURAL COMPUT, V16, P2261, DOI 10.1162/0899766041941916; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lathi B.P., 2009, MODERN DIGITAL ANALO; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Lundstrom BN, 2008, NEURAL COMPUT, V20, P1239, DOI 10.1162/neco.2007.05-07-536; Lundstrom BN, 2009, J COMPUT NEUROSCI, V27, P277, DOI 10.1007/s10827-009-0142-x; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MASON A, 1991, J NEUROSCI, V11, P72; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Mato G, 2008, NEURAL COMPUT, V20, P2418, DOI 10.1162/neco.2008.10-07-632; Mazzoni A, 2011, J PHYSIOL-PARIS, V105, P2, DOI 10.1016/j.jphysparis.2011.07.014; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Perkel DH, 1969, NEUROSCI RES PROG SU, P405; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Prescott SA, 2005, J NEUROSCI, V25, P4743, DOI 10.1523/JNEUROSCI.0356-05.2005; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rieke F., 1997, SPIKES EXPLORING NEU; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Rossant C, 2011, J NEUROSCI, V31, P17193, DOI 10.1523/JNEUROSCI.2482-11.2011; Rudolph M, 2003, J COMPUT NEUROSCI, V14, P239, DOI 10.1023/A:1023245625896; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; SAYER RJ, 1989, J NEUROSCI, V9, P840; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Schultze-Kraft M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002904; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sharafi N, 2013, J COMPUT NEUROSCI, V34, P285, DOI 10.1007/s10827-012-0421-9; Shimazaki H, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002385; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stanley GB, 2013, NAT NEUROSCI, V16, P259, DOI 10.1038/nn.3330; Staude B, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00016; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STEVENS CF, 1994, CURR BIOL, V4, P268, DOI 10.1016/S0960-9822(00)00062-2; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Stiefel KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003947; Svirskis G, 2003, NETWORK-COMP NEURAL, V14, P137, DOI 10.1088/0954-898X/14/1/308; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Tchumatchenko T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058102; Temereanca S, 2008, J NEUROSCI, V28, P11153, DOI 10.1523/JNEUROSCI.1586-08.2008; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Yu JN, 2010, NEURON, V68, P1187, DOI 10.1016/j.neuron.2010.11.027; Yu S, 2011, J NEUROSCI, V31, P17514, DOI 10.1523/JNEUROSCI.3127-11.2011; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	130	97	97	4	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					758	772		10.1016/j.neuron.2013.05.030	http://dx.doi.org/10.1016/j.neuron.2013.05.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764282	Green Accepted, Bronze			2022-12-25	WOS:000320743400004
J	Roberts, MT; Seeman, SC; Golding, NL				Roberts, Michael T.; Seeman, Stephanie C.; Golding, Nace L.			A Mechanistic Understanding of the Role of Feedforward Inhibition in the Mammalian Sound Localization Circuitry	NEURON			English	Article							MEDIAL SUPERIOR OLIVE; INTERAURAL TIME DIFFERENCES; BINAURAL COINCIDENCE DETECTION; THRESHOLD POTASSIUM CURRENTS; AUDITORY BRAIN-STEM; COCHLEAR NUCLEUS; TRAPEZOID BODY; SYNAPTIC INHIBITION; PRINCIPAL NEURONS; GLYCINERGIC INHIBITION	Feedforward inhibition sharpens the precision of neurons throughout ascending auditory pathways, including the binaural neurons of the medial superior olive (MSO). However, the biophysical influence of inhibition is poorly understood, particularly at higher frequencies at which the relative phase of inhibition and excitation becomes ambiguous. Here, we show in gerbil MSO principal cells in vitro that feedforward inhibition precedes direct excitation, providing a concurrent hyperpolarization and conductance shunt during EPSP summation. We show with dual-patch recordings and dynamic clamp that both the linearity and temporal fidelity of synaptic integration is improved by reducing Kv1 potassium channel conductance during inhibition, which counters membrane shunting even at high frequencies at which IPSPs sum. The reduction of peak excitation by preceding inhibition lowers spike probability, narrowing but not shifting the window for detecting binaural coincidence. The interplay between inhibition and potassium conductances thus improves the consistency and resolution of ITD coding across different frequencies.	[Roberts, Michael T.; Seeman, Stephanie C.; Golding, Nace L.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Roberts, Michael T.; Seeman, Stephanie C.; Golding, Nace L.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Golding, NL (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	golding@austin.utexas.edu		Roberts, Michael/0000-0003-2835-8752	NIH [DC006877, DC011403]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC006788, R01DC006877, R21DC011403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to Jonathan Pillow for suggesting the use of bootstrap analysis. This work was supported by NIH grants DC006877 and DC011403 (N.L.G.).	Allen PD, 2012, J NEUROSCI, V32, P2538, DOI 10.1523/JNEUROSCI.1958-11.2012; Bal R, 2001, J NEUROPHYSIOL, V86, P2299, DOI 10.1152/jn.2001.86.5.2299; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; BROWNELL WE, 1975, BRAIN RES, V94, P413, DOI 10.1016/0006-8993(75)90226-7; CANT NB, 1992, HEARING RES, V58, P26, DOI 10.1016/0378-5955(92)90005-8; Chirila FV, 2007, J PHYSIOL-LONDON, V584, P167, DOI 10.1113/jphysiol.2007.137976; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; CLARK GM, 1969, BRAIN RES, V14, P293, DOI 10.1016/0006-8993(69)90111-5; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Couchman K, 2010, J NEUROSCI, V30, P17111, DOI 10.1523/JNEUROSCI.1760-10.2010; Day ML, 2011, J NEUROPHYSIOL, V106, P1985, DOI 10.1152/jn.00131.2011; Dodson PD, 2002, J NEUROSCI, V22, P6953; Economo MN, 2010, J NEUROSCI, V30, P2407, DOI 10.1523/JNEUROSCI.5954-09.2010; Fischl MJ, 2012, J PHYSIOL-LONDON, V590, P3047, DOI 10.1113/jphysiol.2011.226233; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; GROTHE B, 1993, J NEUROPHYSIOL, V69, P1192, DOI 10.1152/jn.1993.69.4.1192; Grothe B, 1998, J NEUROSCI, V18, P6608; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Howard MA, 2007, J NEUROSCI, V27, P2112, DOI 10.1523/JNEUROSCI.5266-06.2007; Howard MA, 2010, J NEUROSCI, V30, P12063, DOI 10.1523/JNEUROSCI.1840-10.2010; HYSON RL, 1995, BRAIN RES, V677, P117, DOI 10.1016/0006-8993(95)00130-I; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; Jercog PE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000406; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 2006, P NATL ACAD SCI USA, V103, P12917, DOI 10.1073/pnas.0601396103; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Khurana S, 2011, J NEUROSCI, V31, P8936, DOI 10.1523/JNEUROSCI.1079-11.2011; Kopp-Scheinpflug C, 2003, J NEUROSCI, V23, P9199, DOI 10.1523/jneurosci.23-27-09199.2003; Kopp-Scheinpflug C, 2011, HEARING RES, V279, P22, DOI 10.1016/j.heares.2011.02.007; Kuenzel T, 2011, J NEUROSCI, V31, P4260, DOI 10.1523/JNEUROSCI.5433-10.2011; Kuo SP, 2009, J NEUROSCI, V29, P9625, DOI 10.1523/JNEUROSCI.0103-09.2009; KUWABARA N, 1992, J COMP NEUROL, V324, P522, DOI 10.1002/cne.903240406; Leao R. M., 2005, J NEUROSCI, V25, P3724; Leibold C, 2010, J ACOUST SOC AM, V127, P931, DOI 10.1121/1.3282997; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Mc Laughlin M, 2008, J NEUROSCI, V28, P10206, DOI 10.1523/JNEUROSCI.2735-08.2008; Oertel D, 2008, NEUROSCIENCE, V154, P77, DOI 10.1016/j.neuroscience.2008.01.085; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Scott LL, 2010, J NEUROSCI, V30, P2039, DOI 10.1523/JNEUROSCI.2385-09.2010; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; SHAMMA SA, 1989, J ACOUST SOC AM, V86, P989, DOI 10.1121/1.398734; SHENG M, 1994, J NEUROSCI, V14, P2408; Spirou GA, 1998, J COMP NEUROL, V398, P257, DOI 10.1002/(SICI)1096-9861(19980824)398:2<257::AID-CNE7>3.0.CO;2-#; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Svirskis G, 2002, J NEUROSCI, V22, P11019; Tang ZQ, 2011, J NEUROSCI, V31, P6121, DOI 10.1523/JNEUROSCI.4733-10.2011; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; van der Heijden M, 2013, NEURON, V78, P936, DOI 10.1016/j.neuron.2013.04.028; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; WANG H, 1994, J NEUROSCI, V14, P4588; Yang LC, 1999, J NEUROSCI, V19, P2313; Zhou Y, 2005, J NEUROSCI, V25, P3046, DOI 10.1523/JNEUROSCI.3064-04.2005	72	67	67	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 5	2013	78	5					923	935		10.1016/j.neuron.2013.04.022	http://dx.doi.org/10.1016/j.neuron.2013.04.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	168YH	23764291	Bronze, Green Accepted			2022-12-25	WOS:000320743400017
J	Nicholas, CR; Chen, JD; Tang, YS; Southwell, DG; Chalmers, N; Vogt, D; Arnold, CM; Chen, YJJ; Stanley, EG; Elefanty, AG; Sasai, Y; Alvarez-Buylla, A; Rubenstein, JLR; Kriegstein, AR				Nicholas, Cory R.; Chen, Jiadong; Tang, Yunshuo; Southwell, Derek G.; Chalmers, Nadine; Vogt, Daniel; Arnold, Christine M.; Chen, Ying-Jiun J.; Stanley, Edouard G.; Elefanty, Andrew G.; Sasai, Yoshiki; Alvarez-Buylla, Arturo; Rubenstein, John L. R.; Kriegstein, Arnold R.			Functional Maturation of hPSC-Derived Forebrain Interneurons Requires an Extended Timeline and Mimics Human Neural Development	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TEMPORAL-LOBE EPILEPSY; HUMAN CEREBRAL-CORTEX; CORTICAL INTERNEURONS; HUMAN NEOCORTEX; RADIAL GLIA; HUMAN ES; NEURONS; PRECURSORS; INTEGRATE	Directed differentiation from human pluripotent stem cells (hPSCs) has seen significant progress in recent years. However, most differentiated populations exhibit immature properties of an early embryonic stage, raising concerns about their ability to model and treat disease. Here, we report the directed differentiation of hPSCs into medial ganglionic eminence (MGE)-like progenitors and their maturation into forebrain type interneurons. We find that early-stage progenitors progress via a radial glial-like stem cell enriched in the human fetal brain. Both in vitro and posttransplantation into the rodent cortex, the MGE-like cells develop into GABAergic interneuron subtypes with mature physiological properties along a prolonged intrinsic timeline of up to 7 months, mimicking endogenous human neural development. MGE-derived cortical interneuron deficiencies are implicated in a broad range of neurodevelopmental and degenerative disorders, highlighting the importance of these results for modeling human neural development and disease.	[Nicholas, Cory R.; Chen, Jiadong; Chalmers, Nadine; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol, San Francisco, CA 94158 USA; [Tang, Yunshuo; Southwell, Derek G.; Arnold, Christine M.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol Surg, San Francisco, CA 94158 USA; [Vogt, Daniel; Chen, Ying-Jiun J.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Vogt, Daniel; Chen, Ying-Jiun J.; Rubenstein, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, MISCL, Clayton, Vic 3800, Australia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; RIKEN; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Neurol, San Francisco, CA 94158 USA.	kriegsteina@stemcell.ucsf.edu	Ritter, Stefanie L/D-9312-2012; Elefanty, Andrew G/A-6066-2008; Stanley, Ed G/A-2985-2013	Stanley, Ed G/0000-0002-6389-3665; Southwell, Derek/0000-0001-6465-3869; Vogt, Daniel/0000-0003-1876-5936; Elefanty, Andrew/0000-0001-6448-8314; Alvarez-Buylla, Arturo/0000-0003-4426-8925	California Institute of Regenerative Medicine [RC1-00346, RB2-01602, TR2-01749]; National Institute of Neurological Disorders and Stroke; Osher Foundation; Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072630, R01NS075998] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Osher Foundation; Epilepsy Foundation of Greater Los Angeles; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baraban, R. Hunt, D. Wang, S. Gee, P. Parker, and M. Yang for electrophysiology guidance and discussion. We thank D. Hansen, J. Lui, M. Oldham, M. Paredes, C. Harwell, X. Wang, S. Wang, Y. Wang, S. Hart, R. Romero, T. Nguyen, and W. Walantus for helpful discussion, gene expression, cell culture, tissue procurement, processing, and technical assistance. We thank K. Probst for graphical design. We thank M. Ramalho-Santos and Y. Ohi for hiPSC lines, K. Deisseroth for the ChR2-EYFP plasmid, and K. Yoshikawa for the DLX2 antibody. We thank the staff and faculty at the San Francisco General Hospital Women's Options Center and at Advanced Bioscience Resources who assisted in human fetal tissue collection. This work was supported by the California Institute of Regenerative Medicine (RC1-00346 to A.R.K., RB2-01602 to J.L.R.R., and TR2-01749 to A.A.-B.), the National Institute of Neurological Disorders and Stroke, and the Osher Foundation. J.C. is a recipient of the CARE & CURE Pediatric Epilepsy Fellowship from Epilepsy Foundation of Greater Los Angeles. A.G.E. and E.G.S. are Senior Research Fellows of the National Health and Medical Research Council of Australia. C.R.N., A.A.-B., J.L.R.R., and A.R.K. are cofounders, board members, and shareholders of Neurona Therapeutics.	Anderson SA, 2001, DEVELOPMENT, V128, P353; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; de Lanerolle NC, 2003, EPILEPSIA, V44, P677, DOI 10.1046/j.1528-1157.2003.32701.x; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; Schmandt T, 2005, STEM CELLS DEV, V14, P55, DOI 10.1089/scd.2005.14.55; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	45	359	367	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					573	586		10.1016/j.stem.2013.04.005	http://dx.doi.org/10.1016/j.stem.2013.04.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642366	Green Accepted, Bronze			2022-12-25	WOS:000329569600013
J	Wang, CR; Liang, CC; Bian, ZC; Zhu, Y; Guan, JL				Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin			FIP200 is required for maintenance and differentiation of postnatal neural stem cells	NATURE NEUROSCIENCE			English	Article							SELF-RENEWAL; P53; AUTOPHAGY; NEUROGENESIS; SUPPRESSION; MECHANISMS; DELETION; NEURONS; ASTROCYTES; INDUCTION	Despite recent studies showing that inhibition of autophagy depletes the hematopoietic stem cell pool and increases intracellular reactive oxygen species (ROS), it remains unknown whether autophagy is essential in the maintenance of other stem cells. Moreover, it is unclear whether and how the aberrant ROS increase causes depletion of stem cells. Here we report that ablation of FIP200 (also known as Rb1cc1), a gene essential for autophagy induction in mammalian cells, results in a progressive loss of neural stem cells (NSCs) and impairment in neuronal differentiation specifically in the postnatal brain, but not the embryonic brain, in mice. The defect in maintaining the postnatal NSC pool was caused by p53-dependent apoptotic responses and cell cycle arrest. However, the impaired neuronal differentiation was rescued by treatment with the antioxidant N-acetylcysteine but not by p53 inactivation. These data reveal that FIP200-mediated autophagy contributes to the maintenance and functions of NSCs through regulation of oxidative state.	[Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Zhu, Yuan/ABF-8405-2020; wang, chenran/N-6629-2013; Liang, Chun-Chi/D-7986-2016	Liang, Chun-Chi/0000-0002-8345-8564	US National Institutes of Health [GM052890]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Yuan of Harvard Medical School for Spautin-1. We thank our laboratory colleagues for their discussions, help throughout the project and comments of the manuscript. This research was supported by US National Institutes of Health grant GM052890 to J.-L.G.	Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	52	118	121	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					532	+		10.1038/nn.3365	http://dx.doi.org/10.1038/nn.3365			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542691	Green Accepted			2022-12-25	WOS:000318029300009
J	Cruchaga, C; Kauwe, JSK; Harari, O; Jin, SC; Cai, YF; Karch, CM; Benitez, BA; Jeng, AT; Skorupa, T; Carrell, D; Bertelsen, S; Bailey, M; McKean, D; Shulman, JM; De Jager, PL; Chibnik, L; Bennett, DA; Arnold, SE; Harold, D; Sims, R; Gerrish, A; Williams, J; Van Deerlin, VM; Lee, VMY; Shaw, LM; Trojanowski, JQ; Haines, JL; Mayeux, R; Pericak-Vance, MA; Farrer, LA; Schellenberg, GD; Peskind, ER; Galasko, D; Fagan, AM; Holtzman, DM; Morris, JC; Goate, AM				Cruchaga, Carlos; Kauwe, John S. K.; Harari, Oscar; Jin, Sheng Chih; Cai, Yefei; Karch, Celeste M.; Benitez, Bruno A.; Jeng, Amanda T.; Skorupa, Tara; Carrell, David; Bertelsen, Sarah; Bailey, Matthew; McKean, David; Shulman, Joshua M.; De Jager, Philip L.; Chibnik, Lori; Bennett, David A.; Arnold, Steve E.; Harold, Denise; Sims, Rebecca; Gerrish, Amy; Williams, Julie; Van Deerlin, Vivianna M.; Lee, Virginia M. -Y.; Shaw, Leslie M.; Trojanowski, John Q.; Haines, Jonathan L.; Mayeux, Richard; Pericak-Vance, Margaret A.; Farrer, Lindsay A.; Schellenberg, Gerard D.; Peskind, Elaine R.; Galasko, Douglas; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.		GERAD Consortium; ADNI; ADGC	GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease	NEURON			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CSF; PROTEIN; ASSOCIATION; PHOSPHORYLATION; NEUROPATHOLOGY; EXPRESSION; BIOMARKERS; A-BETA(42); DIAGNOSIS	Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and A beta(42) are established biomarkers for Alzheimer's disease (AD) and have been used as quantitative traits for genetic analyses. We performed the largest genome-wide association study for cerebrospinal fluid (CSF) tau/ptau levels published to date (n = 1,269), identifying three genome-wide significant loci for CSF tau and ptau: rs9877502 (p = 4.89 x 10(-9) for tau) located at 3q28 between GEMC1 and OSTN, rs514716 (p = 1.07 x10(-8) and p = 3.22 x 10(-9) for tau and ptau, respectively), located at 9p24.2 within GLIS3 and rs6922617 (p = 3.58 x 10(-8) for CSF ptau) at 6p21.1 within the TREM gene cluster, a region recently reported to harbor rare variants that increase AD risk. In independent data sets, rs9877502 showed a strong association with risk for AD, tangle pathology, and global cognitive decline (p = 2.67 x 10(-4), 0.039, 4.86 x 10(-5), respectively) illustrating how this endophenotype-based approach can be used to identify new AD risk loci.	[Cruchaga, Carlos; Harari, Oscar; Jin, Sheng Chih; Cai, Yefei; Karch, Celeste M.; Benitez, Bruno A.; Jeng, Amanda T.; Skorupa, Tara; Carrell, David; Bertelsen, Sarah] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Cruchaga, Carlos; Fagan, Anne M.; Holtzman, David M.; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Kauwe, John S. K.; Bailey, Matthew; McKean, David] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shulman, Joshua M.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [De Jager, Philip L.; Chibnik, Lori] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.; Chibnik, Lori] Harvard Univ, Sch Med, Boston, MA 02115 USA; [De Jager, Philip L.; Chibnik, Lori] Broad Inst Harvard Univ & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60062 USA; [Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60062 USA; [Arnold, Steve E.] Univ Penn, Dept Psychiat & Neurol, Philadelphia, PA 19104 USA; [Harold, Denise; Sims, Rebecca; Gerrish, Amy; Williams, Julie] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AT, Wales; [Van Deerlin, Vivianna M.; Lee, Virginia M. -Y.; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Haines, Jonathan L.] Vanderbilt Univ, Vanderbilt Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Mayeux, Richard] Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY 10027 USA; [Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33124 USA; [Pericak-Vance, Margaret A.] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33124 USA; [Farrer, Lindsay A.] Boston Univ, Dept Biostat, Med Genet Program, Boston, MA 02118 USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat, Seattle, WA 99204 USA; [Peskind, Elaine R.] Univ Washington, Sch Med, Dept Behav Sci, Seattle, WA 99204 USA; [Peskind, Elaine R.] Mental Illness Res Educ & Clin Ctr, Vet Affairs Northwest Network, Seattle, WA 99204 USA; [Galasko, Douglas] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brigham Young University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University; University of Pennsylvania; Cardiff University; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Columbia University; Columbia University; University of Miami; University of Miami; Boston University; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Levey, Allan/F-2104-2011; Haines, Jonathan/C-3374-2012; Kauwe, John/AAC-6646-2021; Hsiung, Robin/AAT-1661-2021; , beccie/AAM-3770-2021; Farrer, Lindsay/AAS-1035-2020; Mayeux, Richard/E-9788-2013; Cruchaga, Carlos/ABF-4065-2020; Preda, Adrian/K-8889-2013; Benitez, Bruno A./E-7116-2014; Saykin, Andrew/A-1318-2007	Levey, Allan/0000-0002-3153-502X; Haines, Jonathan/0000-0002-4351-4728; Kauwe, John/0000-0001-8641-2468; Hsiung, Robin/0000-0002-8017-0856; , beccie/0000-0002-3885-1199; Mayeux, Richard/0000-0001-6519-9696; Cruchaga, Carlos/0000-0002-0276-2899; Preda, Adrian/0000-0003-3373-2438; Benitez, Bruno A./0000-0002-2699-3878; Farrer, Lindsay/0000-0001-5533-4225; Bailey, Matthew H./0000-0003-4526-9727; Chibnik, Lori/0000-0001-6293-806X; Saykin, Andrew/0000-0002-1376-8532; Williams, Julie/0000-0002-4069-0259; Harold, Denise/0000-0001-5195-0143; Jin, Sheng Chih/0000-0002-5777-7262; Goate, Alison/0000-0002-0576-2472; Karch, Celeste/0000-0002-6854-5547	NIH [P30 NS069329-01, R01 AG035083, R01 AG16208, P50 AG05681, P01 AG03991, P01 AG026276, AG05136, PO1 AG05131, U01AG032984, AG010124, R01 AG042611, PO1 AG026276, PO1 AG03991, RO1 AG16208, PO1 AGO5131, R01 AG30146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290]; AstraZeneca; Barnes-Jewish Hospital Foundation; Wellcome Trust [GR082604MA]; Medical Research Council [G0300429]; Alzheimer's Research Trust; Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland RD Office; Royal College of Physicians/Dunhill Medical Trust; Mercer's Institute for Research on Ageing; Bristol Research into Alzheimer's and Care of the Elderly (BRACE); Charles Wolfson Charitable Trust; NIA; Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Centre; UCLH/UCL Biomedical Centre; Lundbeck SA; German Federal Ministry of Education and Research (BMBF) [01GI0420]; Bundesministerium fur Bildung und Forschung; Competence Network Dementia (CND) Forderkennzeichen [01GI0102, 01GI0711]; Illinois Department of Public Health; Burroughs Wellcome Fund; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; Pfizer; Eli Lilly; C2N Diagnostics; Alzheimers Research UK [ARUK-PG2014-1] Funding Source: researchfish; Medical Research Council [MR/K013041/1, G0902227, G0801418B] Funding Source: researchfish; MRC [G0300429, G0902227, MR/K013041/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P01AG026276, K08AG034290, K25AG041906, P30AG010129, R01AG015819, P30AG010124, U01AG024904, R01AG017917, P50AG005136, P50AG005138, P30AG010161, P01AG003991, P50AG005681, R01AG035083, R01AG042611, P30AG013846, P30AG008051, U24AG021886, U01AG016976, P50AG005131, U01AG032984, U19AG010483, R01AG016208, R01AG030146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Barnes-Jewish Hospital Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; Northern Ireland RD Office; Royal College of Physicians/Dunhill Medical Trust(Dunhill Medical Trust); Mercer's Institute for Research on Ageing; Bristol Research into Alzheimer's and Care of the Elderly (BRACE); Charles Wolfson Charitable Trust; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Centre; UCLH/UCL Biomedical Centre; Lundbeck SA(Lundbeck Corporation); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Competence Network Dementia (CND) Forderkennzeichen; Illinois Department of Public Health; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pfizer(Pfizer); Eli Lilly(Eli Lilly); C2N Diagnostics; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from NIH (P30 NS069329-01, R01 AG035083, R01 AG16208, P50 AG05681, P01 AG03991, P01 AG026276, AG05136 and PO1 AG05131, U01AG032984, AG010124, and R01 AG042611), AstraZeneca, and the Barnes-Jewish Hospital Foundation. The authors thank the Clinical and Genetics Cores of the Knight ADRC at Washington University for clinical and cognitive assessments of the participants and for APOE genotypes and the Biomarker Core of the Adult Children Study at Washington University for the CSF collection and assays. We acknowledge use of genotype data from the "610 group," part of the GERAD1 consortium, who were supported by funding from the Wellcome Trust (including GR082604MA), Medical Research Council (including G0300429), Alzheimer's Research Trust, Welsh Assembly Government, Alzheimer's Society, Ulster Garden Villages, Northern Ireland R&D Office, Royal College of Physicians/Dunhill Medical Trust, Mercer's Institute for Research on Ageing, Bristol Research into Alzheimer's and Care of the Elderly (BRACE), Charles Wolfson Charitable Trust, NIH (including PO1 AG026276, PO1 AG03991, RO1 AG16208, and P50 AG05681), NIA, Barnes Jewish Hospital Foundation, Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Centre, the UCLH/UCL Biomedical Centre, Lundbeck SA, German Federal Ministry of Education and Research (BMBF): Kompetenznetz Demenzen (01GI0420), Bundesministerium fur Bildung und Forschung, and Competence Network Dementia (CND) Forderkennzeichen (01GI0102, 01GI0711). Recruitment and CSF studies at University of Washington and UCSD were supported by NIH PO1 AG05131. Replication analysis in the Religious Orders Study and Rush Memory and Aging Project cohorts was supported by grants from the National Institutes of Health (R01 AG30146, P30 AG10161, R01 AG17917, R01 AG15819, and K08 AG034290), the Illinois Department of Public Health, and the Burroughs Wellcome Fund. Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). D.M.H. is a cofounder of C2N Diagnostics and serves of the C2N Scientific Advisory Board. He also consults for Genentech, AstraZeneca, and Bristol Myers Squibb. His laboratory also receives research grants from Pfizer, Eli Lilly, AstraZeneca, and C2N Diagnostics.	Accardi G, 2012, REJUV RES, V15, P217, DOI 10.1089/rej.2011.1289; Andersson C., 2007, NEUROBIOL AGING; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Bertram L., ALZGENE DATABASE; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Cruchaga C, 2009, CEREB CORTEX, V19, P1751, DOI 10.1093/cercor/bhn202; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; de Leon MJ, 2004, J INTERN MED, V256, P205, DOI 10.1111/j.1365-2796.2004.01381.x; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dube MP, 2007, GENET EPIDEMIOL, V31, pS118, DOI 10.1002/gepi.20288; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Farias G, 2011, CURR ALZHEIMER RES, V8, P608, DOI 10.2174/156720511796717258; Gibb GM, 2000, FEBS LETT, V485, P99, DOI 10.1016/S0014-5793(00)02196-7; Guerreiro R., 2012, N ENGL J MED; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hu WT, 2011, PROG NEUROBIOL, V95, P636, DOI 10.1016/j.pneurobio.2011.04.012; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jia JP, 2005, NEUROSCI LETT, V383, P12, DOI 10.1016/j.neulet.2005.03.051; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Keenan BT, 2012, HUM MOL GENET, V21, P2377, DOI 10.1093/hmg/dds054; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Kraft P, 2008, ADV GENET, V60, P465, DOI 10.1016/S0065-2660(07)00417-8; Marcus JN, 2011, J NEUROGENET, V25, P127, DOI 10.3109/01677063.2011.626471; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Rohlfs Rori V, 2007, BMC Proc, V1 Suppl 1, pS137; Schneider JA, 2009, J ALZHEIMERS DIS, V18, P691, DOI 10.3233/JAD-2009-1227; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Shoji M, 1998, J NEUROL SCI, V158, P134, DOI 10.1016/S0022-510X(98)00122-1; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Welge V, 2009, J NEURAL TRANSM, V116, P203, DOI 10.1007/s00702-008-0177-6; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yoshida T, 2012, J NEUROSCI, V32, P2588, DOI 10.1523/JNEUROSCI.4637-11.2012; Zhou Jie, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P272; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	56	234	238	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					256	268		10.1016/j.neuron.2013.02.026	http://dx.doi.org/10.1016/j.neuron.2013.02.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23562540	Bronze, Green Accepted			2022-12-25	WOS:000318202200007
J	Wang, XD; Zhang, J; Eberhart, D; Urban, R; Meda, K; Solorzano, C; Yamanaka, H; Rice, D; Basbaum, AI				Wang, Xidao; Zhang, Jie; Eberhart, Derek; Urban, Rochelle; Meda, Karuna; Solorzano, Carlos; Yamanaka, Hiroki; Rice, Dennis; Basbaum, Allan I.			Excitatory Superficial Dorsal Horn Interneurons Are Functionally Heterogeneous and Required for the Full Behavioral Expression of Pain and Itch	NEURON			English	Article							RAT SPINAL-CORD; GASTRIN-RELEASING-PEPTIDE; ORPHAN NUCLEAR RECEPTOR-4; CEREBELLAR DEVELOPMENT; NEUROPATHIC PAIN; MUTANT MICE; SUBSTANCE-P; LAMINAE I; NEURONS; POPULATIONS	To what extent dorsal horn interneurons contribute to the modality specific processing of pain and itch messages is not known. Here, we report that loxp/cre-mediated CNS deletion of TR4, a testicular orphan nuclear receptor, results in loss of many excitatory interneurons in the superficial dorsal horn but preservation of primary afferents and spinal projection neurons. The interneuron loss is associated with a near complete absence of supraspinally integrated pain and itch behaviors, elevated mechanical withdrawal thresholds and loss of nerve injury-induced mechanical hypersensitivity, but reflex responsiveness to noxious heat, nerve injury-induced heat hypersensitivity, and tissue injury-induced heat and mechanical hypersensitivity are intact. We conclude that different subsets of dorsal horn excitatory interneurons contribute to tissue and nerve injury-induced heat and mechanical pain and that the full expression of supraspinally mediated pain and itch behaviors cannot be generated solely by nociceptor and pruritoceptor activation of projection neurons; concurrent activation of excitatory interneurons is essential.	[Wang, Xidao; Zhang, Jie; Urban, Rochelle; Meda, Karuna; Solorzano, Carlos; Yamanaka, Hiroki; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Wang, Xidao; Zhang, Jie; Urban, Rochelle; Meda, Karuna; Solorzano, Carlos; Yamanaka, Hiroki; Basbaum, Allan I.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Eberhart, Derek; Rice, Dennis] Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Lexicon Pharmaceuticals	Basbaum, AI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	allan.basbaum@ucsf.edu			NIH [NS R37 NS014627, R01AR059402]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS079066, R01NS014627, R37NS014627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants NS R37 NS014627 and R01AR059402. We thank members of the Neurobehavioral Core for Rehabilitation Research at UCSF for their assistance with many of the behavioral tests and members of the Basbaum lab for their comments on the manuscript. We are also grateful for the use of various Cre lines: alpha CamKII-Cre from John Rubenstein, Nestin-Cre from Nirao Shah, Pax3-Cre from David Rowitch, Peripherin-Cre from David Donovan, and SF1-Cre from Holly Ingraham.	Ahn AH, 2006, J NEUROSCI, V26, P8332, DOI 10.1523/JNEUROSCI.1989-06.2006; Akiyama T, 2013, J NEUROPHYSIOL, V109, P742, DOI 10.1152/jn.00539.2012; Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; Akopians AL, 2008, EUR J NEUROSCI, V27, P523, DOI 10.1111/j.1460-9568.2008.06056.x; Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chen YT, 2007, BRAIN RES, V1168, P72, DOI 10.1016/j.brainres.2007.06.069; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; CLIFFER KD, 1988, BRAIN RES, V460, P356, DOI 10.1016/0006-8993(88)90381-2; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jankowski MP, 2012, PAIN, V153, P410, DOI 10.1016/j.pain.2011.10.042; LANGERMAN L, 1995, J PHARMACOL TOX MET, V34, P23, DOI 10.1016/1056-8719(94)00077-H; Le Bars D, 2001, PHARMACOL REV, V53, P597; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Martin WJ, 2004, J NEUROPHYSIOL, V91, P1945, DOI 10.1152/jn.00945.2003; Mazario J, 2007, J NEUROSCI, V27, P762, DOI 10.1523/JNEUROSCI.2992-06.2007; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003	46	95	97	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2013	78	2					312	324		10.1016/j.neuron.2013.03.001	http://dx.doi.org/10.1016/j.neuron.2013.03.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622066	Bronze, Green Accepted			2022-12-25	WOS:000318202200011
J	Mairet-Coello, G; Courchet, J; Pieraut, S; Courchet, V; Maximov, A; Polleux, F				Mairet-Coello, Georges; Courchet, Julien; Pieraut, Simon; Courchet, Virginie; Maximov, Anton; Polleux, Franck			The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of A beta Oligomers through Tau Phosphorylation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; ALZHEIMERS-DISEASE; AMYLOID-BETA; DIABETES-MELLITUS; UPSTREAM KINASE; ENDOGENOUS TAU; MOUSE MODELS; SYNAPSE LOSS; AMPK; LKB1	Amyloid-beta 1-42 (A beta 42) oligomers are synaptotoxic for excitatory cortical and hippocampal neurons and might play a role in early stages of Alzheimer's disease (AD) progression. Recent results suggested that A beta 42 oligomers trigger activation of AMP-activated kinase (AMPK), and its activation is increased in the brain of patients with AD. We show that increased intracellular calcium [Ca2+](i) induced by NMDA receptor activation or membrane depolarization activates AMPK in a CAMKK2-dependent manner. CAMKK2 or AMPK overactivation is sufficient to induce dendritic spine loss. Conversely, inhibiting their activity protects hippocampal neurons against synaptotoxic effects of A beta 42 oligomers in vitro and against the loss of dendritic spines observed in the human APP(SWE,IND)-expressing transgenic mouse model in vivo. AMPK phosphorylates Tau on KxGS motif S262, and expression of Tau S262A inhibits the synaptotoxic effects of A beta 42 oligomers. Our results identify a CAMKK2-AMPK-Tau pathway as a critical mediator of the synaptotoxic effects of A beta 42 oligomers.	[Mairet-Coello, Georges; Courchet, Julien; Pieraut, Simon; Courchet, Virginie; Maximov, Anton; Polleux, Franck] Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Scripps Research Institute	Polleux, F (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	polleux@scripps.edu	Polleux, Franck/H-9948-2014; Courchet, Virginie/G-9431-2017; Karakhanov, Edward/P-1660-2015; COURCHET, JULIEN/E-9645-2016	Courchet, Virginie/0000-0002-7186-3669; COURCHET, JULIEN/0000-0002-1199-9329; Polleux, Franck/0000-0003-4313-0481	NIH [RO1 AG031524]; ADI Novartis funds; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADI Novartis funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank members of the F.P. lab for discussions, Dr. Reuben Shaw (Salk Institute, La Jolla, CA, USA) for the AMPK constructs, Dr. Pascal Lacor (Northwestern University School of Medicine, Chicago, IL, USA) for initial advice on A beta oligomer production, Dr. Benoit Viollet (INSERM, Institut Cochin, Paris, France) for providing AMPK alpha 1 knockout mice, and Dr. Talal Chatila (Harvard Medical School, Boston, MA, USA) for providing CAMKK2 knockout mice. This work was partially supported by NIH RO1 AG031524 (to F.P.) and ADI Novartis funds (to F.P.).	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Chatterjee S, 2009, HUM MOL GENET, V18, P164, DOI 10.1093/hmg/ddn326; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hassing LB, 2002, INT PSYCHOGERIATR, V14, P239, DOI 10.1017/S104161020200844X; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lim MA, 2012, J NEUROSCI, V32, P1123, DOI 10.1523/JNEUROSCI.6554-10.2012; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lopez-Lopez C, 2007, J NEUROSCI, V27, P824, DOI 10.1523/JNEUROSCI.4345-06.2007; MacKnight C, 2002, DEMENT GERIATR COGN, V14, P77, DOI 10.1159/000064928; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024; Yoshida H, 2012, J NEUROCHEM, V120, P165, DOI 10.1111/j.1471-4159.2011.07523.x; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	76	251	257	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2013	78	1					94	108		10.1016/j.neuron.2013.02.003	http://dx.doi.org/10.1016/j.neuron.2013.02.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583109	Bronze, Green Accepted, Green Submitted			2022-12-25	WOS:000317556000010
J	Zhang, Y; Emery, P				Zhang, Yong; Emery, Patrick			GW182 Controls Drosophila Circadian Behavior and PDF-Receptor Signaling	NEURON			English	Article							CLOCK NEURONS; TEMPERATURE ENTRAINMENT; TARGET PREDICTIONS; TRANSGENIC RNAI; RHYTHMS; LIGHT; MICRORNA; BRAIN; DORSAL; PERIOD	The neuropeptide PDF is crucial for Drosophila circadian behavior: it keeps circadian neurons synchronized. Here, we identify GW182 as a key regulator of PDF signaling. Indeed, GW182 downregulation results in phenotypes similar to those of Pdf and Pdf-receptor (Pdfr) mutants. gw182 genetically interacts with Pdfr and cAMP signaling, which is essential for PDFR function. GW182 mediates miRNA-dependent gene silencing through its interaction with AG01. Consistently, GW182's AGO1 interaction domain is required for GW182's circadian function. Moreover, our results indicate that GW182 modulates PDFR signaling by silencing the expression of the cAMP phosphodiesterase DUNCE. Importantly, this repression is under photic control, and GW182 activity level which is limiting in circadian neurons influences the responses of the circadian neural network to light. We propose that GW182's gene silencing activity functions as a rheostat for PDFR signaling and thus profoundly impacts the circadian neural network and its response to environmental inputs.	[Zhang, Yong; Emery, Patrick] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Emery, Patrick] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			NIH [GM066777, GM079182, GM100091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079182, R01GM066777, R01GM100091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Diana Wentworth and Diane Szydlik for technical support and the Emery, Weaver, and Reppert lab, as well as V. Ambros, E. Izaurralde, and M. Ramaswami for helpful discussions. We also thank the VDRC and TRiP stock centers for RNAi transgenic flies, as well as M. Nitabach, R. Allada, P. Zamore, S. Waddell, and V. Budnik for various fly strains. We are very grateful to E. Izaurralde for the pAc5-GW182 and pAc5-GW182AA plasmids, as well as the anti-GW182 antibodies; and to P. Hardin for anti-VRI antibodies. This work was supported by NIH Grants GM066777, GM079182, and GM100091 to P.E. P.E. supervised the project. Y.Z. and P.E. designed the experiments. Y.Z. performed the experiments and analysis. Y.Z. and P.E. wrote the manuscript.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Choi C, 2012, CELL REP, V2, P332, DOI 10.1016/j.celrep.2012.06.021; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Dahdal D, 2010, NEURON, V68, P964, DOI 10.1016/j.neuron.2010.11.017; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dubruille R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000787; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Duvall LB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001337; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Helfrich-Forster C, 2005, NEURON, V48, P161, DOI 10.1016/j.neuron.2005.10.004; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; McGuire S.E., 2004, SCI STKE, V220, P116; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; Wulbeck C, 2008, J BIOL RHYTHM, V23, P409, DOI 10.1177/0748730408322699; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P513, DOI 10.1016/B978-0-12-384747-8.10015-7; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	58	31	32	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2013	78	1					152	165		10.1016/j.neuron.2013.01.035	http://dx.doi.org/10.1016/j.neuron.2013.01.035			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583112	Green Accepted, Bronze			2022-12-25	WOS:000317556000014
J	Singer, AC; Carr, MF; Karlsson, MP; Frank, LM				Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.			Hippocampal SWR Activity Predicts Correct Decisions during the Initial Learning of an Alternation Task	NEURON			English	Article							SPATIAL MEMORY; AWAKE STATE; EXPERIENCE; REPLAY; REACTIVATION; RIPPLES; CONSOLIDATION; SEQUENCES	The hippocampus frequently replays memories of past experiences during sharp-wave ripple (SWR) events. These events can represent spatial trajectories extending from the animal's current location to distant locations, suggesting a role in the evaluation of upcoming choices. While SWRs have been linked to learning and memory, the specific role of awake replay remains unclear. Here we show that there is greater coordinated neural activity during SWRs preceding correct, as compared to incorrect, trials in a spatial alternation task. As a result, the proportion of cell pairs coactive during SWRs was predictive of subsequent correct or incorrect responses on a trial-by-trial basis. This effect was seen specifically during early learning, when the hippocampus is essential for task performance. SWR activity preceding correct trials represented multiple trajectories that included both correct and incorrect options. These results suggest that reactivation during awake SWRs contributes to the evaluation of possible choices during memory-guided decision making.	[Singer, Annabelle C.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Singer, Annabelle C.] MIT, MIT Media Lab, Cambridge, MA 02139 USA; [Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Singer, Annabelle C.; Carr, Margaret F.; Karlsson, Mattias P.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Carr, Margaret F.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Karlsson, Mattias P.] HHMI, Ashburn, VA 20147 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute	Frank, LM (corresponding author), Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		Singer, Annabelle C./0000-0001-6003-0488; /0000-0003-4111-1535; Frank, Loren/0000-0002-1752-5677	John Merck Scholars Program; U.S. National Institutes of Health [RO1MH090188, F31093067]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283, R01MH090188] Funding Source: NIH RePORTER	John Merck Scholars Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Frank laboratory for comments on the manuscript. This work was supported by the John Merck Scholars Program and the U.S. National Institutes of Health research grants RO1MH090188 and F31093067.	Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	26	141	144	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 20	2013	77	6					1163	1173		10.1016/j.neuron.2013.01.027	http://dx.doi.org/10.1016/j.neuron.2013.01.027			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113CX	23522050	Bronze, Green Accepted			2022-12-25	WOS:000316645000016
J	Yamaji, M; Ueda, J; Hayashi, K; Ohta, H; Yabuta, Y; Kurimoto, K; Nakato, R; Yamada, Y; Shirahige, K; Saitou, M				Yamaji, Masashi; Ueda, Jun; Hayashi, Katsuhiko; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Nakato, Ryuichiro; Yamada, Yasuhiro; Shirahige, Katsuhiko; Saitou, Mitinori			PRDM14 Ensures Naive Pluripotency through Dual Regulation of Signaling and Epigenetic Pathways in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; DNA METHYLATION; GROUND-STATE; ES CELLS; DIFFERENTIATION; LINEAGE; CULTURE; TARGET; DNMT3B; GENES	In serum, mouse embryonic stem cells (mESCs) fluctuate between a naive inner cell mass (ICM)-like state and a primed epiblast-like state, but when cultured with inhibitors of the mitogen-activated protein kinase (MAPK) and glycogen synthase kinase 3 pathways (2i), they are harnessed exclusively in a distinct naive pluropotent state, the ground state, that more faithfully recapitulates the ICM. Understanding the mechanism underlying this naive pluripotent state will be critical for realizing the full potential of ESCs. We show here that PRDM14, a PR-domain-containing transcriptional regulator, ensures naive pluripotency through a dual mechanism: antagonizing activation of the fibroblast growth factor receptor (FGFR) signaling by the core pluripotency transcriptional circuitry, and repressing expression of de novo DNA methyltransferases that modify the epigenome to a primed epiblast-like state. PRDM14 exerts these effects by recruiting polycomb repressive complex 2 (PRC2) specifically to key targets and repressing their expression.	[Yamaji, Masashi; Hayashi, Katsuhiko; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Yamaji, Masashi; Ohta, Hiroshi; Yabuta, Yukihiro; Kurimoto, Kazuki; Saitou, Mitinori] CREST ERATO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Ueda, Jun; Saitou, Mitinori] RIKEN Ctr Dev Biol, Lab Mammalian Germ Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Jun] Osaka Univ, Microbial Dis Res Inst, Ctr Genet Anal Biol Responses, Suita, Osaka 5650871, Japan; [Hayashi, Katsuhiko] PRESTO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Yamada, Yasuhiro; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Sakyo Ku, Kyoto 6068507, Japan; [Nakato, Ryuichiro; Shirahige, Katsuhiko] Univ Tokyo, Lab Genome Struct & Funct, Res Ctr Epigenet Dis, Inst Mol & Cellular Biosci,Bunkyo Ku, Tokyo 1130032, Japan; [Yamada, Yasuhiro; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Osaka University; Japan Science & Technology Agency (JST); Kyoto University; University of Tokyo; Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Yamaji, Masashi/ABA-5267-2020; Nakato, Ryuichiro/AAV-6405-2020; Ueda, Jun/AAX-9704-2020	Yamaji, Masashi/0000-0002-8215-2184; Nakato, Ryuichiro/0000-0003-3019-5817; Ueda, Jun/0000-0002-9766-203X; Shirahige, Katsuhiko/0000-0002-7862-1144	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST/ERATO; Takeda Science Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to S. Yamanaka and M. Koyanagi for the anti-DNMT3L antibody, H. Kimura for the anti-H3K27Ac antibody, H. Niwa for the pBRPyCAG and pPyCAG-IRESneo/pac plasmids, M. Okano for the Dnmt3a2 and Dnmt3b1 expression plasmids and Dnmt TKO ESCs, K. Hata for the Dnmt3l expression plasmid, M. S. H. Ko for the Tcl1 expression plasmid, Y. Katou and S. Fukuzawa for assistance, and I. Oinuma and H. Harada for their comments and suggestions. We also thank R. Kabata, S. Ohsako, N. Konishi, K. Nakagawa, and K. Osugi for assistance. The authors were supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by JST-CREST/ERATO, by the Takeda Science Foundation, by the Uehara Memorial Foundation, and by the Mitsubishi Foundation.	[Anonymous], 2010, R LANG ENV STAT COMP; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cull MG, 2000, METHOD ENZYMOL, V326, P430; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rossant J, 2011, DEV CELL, V21, P20, DOI 10.1016/j.devcel.2011.06.010; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smithies O, 2005, NAT REV GENET, V6, P419, DOI 10.1038/nrg1605; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	48	218	227	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 7	2013	12	3					368	382		10.1016/j.stem.2012.12.012	http://dx.doi.org/10.1016/j.stem.2012.12.012			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VC	23333148	Bronze			2022-12-25	WOS:000329569400014
J	Deck, M; Lokmane, L; Chauvet, S; Mailhes, C; Keita, M; Niquille, M; Yoshida, M; Yoshida, Y; Lebrand, C; Mann, F; Grove, EA; Garel, S				Deck, Marie; Lokmane, Ludmilla; Chauvet, Sophie; Mailhes, Caroline; Keita, Maryama; Niquille, Mathieu; Yoshida, Michio; Yoshida, Yutaka; Lebrand, Cecile; Mann, Fanny; Grove, Elizabeth A.; Garel, Sonia			Pathfinding of Corticothalamic Axons Relies on a Rendezvous with Thalamic Projections	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CAJAL-RETZIUS CELLS; CEREBRAL-CORTEX; THALAMOCORTICAL AXONS; CHICK HINDLIMB; CORTICAL AXONS; SEMAPHORIN 3E; MUTANT MICE; GUIDANCE; GROWTH	Major outputs of the neocortex are conveyed by corticothalamic axons (CTAs), which form reciprocal connections with thalamocortical axons, and corticosubcerebral axons (CSAs) headed to more caudal parts of the nervous system. Previous findings establish that transcriptional programs define cortical neuron identity and suggest that CTAs and thalamic axons may guide each other, but the mechanisms governing CTA versus CSA pathfinding remain elusive. Here, we show that thalamocortical axons are required to guide pioneer CTAs away from a default CSA-like trajectory. This process relies on a hold in the progression of cortical axons, or waiting period, during which thalamic projections navigate toward cortical axons. At the molecular level, Sema3E/PlexinD1 signaling in pioneer cortical neurons mediates a "waiting signal" required to orchestrate the mandatory meeting with reciprocal thalamic axons. Our study reveals that temporal control of axonal progression contributes to spatial pathfinding of cortical projections and opens perspectives on brain wiring.	[Deck, Marie; Lokmane, Ludmilla; Mailhes, Caroline; Keita, Maryama; Garel, Sonia] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Deck, Marie; Lokmane, Ludmilla; Mailhes, Caroline; Keita, Maryama; Garel, Sonia] INSERM, U1024, F-75005 Paris, France; [Deck, Marie; Lokmane, Ludmilla; Mailhes, Caroline; Keita, Maryama; Garel, Sonia] CNRS, UMR 8197, F-75005 Paris, France; [Chauvet, Sophie; Mann, Fanny] Aix Marseille Univ, CNRS, IBDML UMR 7288, F-13288 Marseille, France; [Niquille, Mathieu; Lebrand, Cecile] Univ Lausanne, DBCM, CH-1005 Lausanne, Switzerland; [Yoshida, Michio; Grove, Elizabeth A.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Lebrand, Cecile] Ecole Polytech Fed Lausanne, NCCR Robot, CH-1015 Lausanne, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Lausanne; University of Chicago; Cincinnati Children's Hospital Medical Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Garel, S (corresponding author), Ecole Normale Super, Inst Biol, F-75005 Paris, France.	garel@biologie.ens.fr	Lebrand, Cecile/G-1394-2015; Mann, Fanny/G-2786-2016; Garel, Sonia/P-4538-2017; Lokmane, Ludmilla/AAA-7973-2019	Lebrand, Cecile/0000-0002-2750-3164; Mann, Fanny/0000-0003-4839-4347; Garel, Sonia/0000-0003-2984-3645; Mailhes-Hamon, Caroline/0000-0002-7009-7798; Lokmane, Ludmilla/0000-0002-5999-2855; deck, marie/0000-0002-1838-1193	NIH [37 MH059962]; NINDS [065048]; Fond National Suisse (FNS) [31003A_122550]; CNRS; Aix-Marseille Universite; Federation pour la Recherche sur le Cerveau; Institut Universitaire de France; INSERM "Avenir" Program; City of Paris Start-up Program; EURYI program; French Ministry of Research and Fondation ARC pour la recherche sur le cancer; Fondation ARC pour la recherche sur le cancer; EMBO YIP; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fond National Suisse (FNS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Federation pour la Recherche sur le Cerveau; Institut Universitaire de France; INSERM "Avenir" Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); City of Paris Start-up Program(Region Ile-de-France); EURYI program(European Science Foundation (ESF)); French Ministry of Research and Fondation ARC pour la recherche sur le cancer; Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); EMBO YIP(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Jean-Francois Brunet, Valerie Castellani, Marion Wassef, Guillermina Lopez-Bendito, and Christo Goridis for insightful discussions and input on the manuscript. We are grateful to Benjamin Mathieu, Christophe Auger, and Deborah Souchet for excellent technical assistance. We thank members from the Garel laboratory for discussions and members of the Brunet, Pierani, and Wassef laboratories for discussions and the gift of reagents. This work was supported by grants from the NIH (R, 37 MH059962) to E.A.G.; the NINDS (NS, 065048) to Y.Y.; the Fond National Suisse (FNS, 31003A_122550) to C.L.; the CNRS, Aix-Marseille Universite and the Federation pour la Recherche sur le Cerveau to F.M.; the Institut Universitaire de France to S.C.; and the INSERM "Avenir" Program, the City of Paris Start-up Program, and the EURYI program to S.G. M.D. was supported by PhD fellowships from the French Ministry of Research and Fondation ARC pour la recherche sur le cancer, L.L. was supported by a postdoctoral fellowship from the Fondation ARC pour la recherche sur le cancer, and S.G is a recipient of the EMBO YIP.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bagnard D, 2001, CEREB CORTEX, V11, P278, DOI 10.1093/cercor/11.3.278; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bellion A, 2003, CEREB CORTEX, V13, P203, DOI 10.1093/cercor/13.2.203; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Bielle F, 2011, CURR BIOL, V21, P1748, DOI 10.1016/j.cub.2011.09.008; Bielle F, 2011, NEURON, V69, P1085, DOI 10.1016/j.neuron.2011.02.026; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033105; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; Del Rio JA, 2000, CEREB CORTEX, V10, P784, DOI 10.1093/cercor/10.8.784; Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Heydemann A, 2001, DEV BRAIN RES, V128, P83, DOI 10.1016/S0165-3806(01)00137-7; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Jones L, 2002, DEVELOPMENT, V129, P5041; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Louvi A, 2007, J COMP NEUROL, V504, P550, DOI 10.1002/cne.21461; Magnani D, 2010, J NEUROSCI, V30, P13883, DOI 10.1523/JNEUROSCI.3650-10.2010; Marin O, 2002, DEVELOPMENT, V129, P761; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; MCCONNELL SK, 1994, J NEUROSCI, V14, P1892; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Metin C, 1997, DEVELOPMENT, V124, P5063; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Richards LJ, 1997, J NEUROSCI, V17, P2445; SHARMA K, 1994, DEVELOPMENT, V120, P1315; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Wang L, 2011, NEURON, V71, P263, DOI 10.1016/j.neuron.2011.06.021; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	62	72	72	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					472	484		10.1016/j.neuron.2012.11.031	http://dx.doi.org/10.1016/j.neuron.2012.11.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395374	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000317030800010
J	MacLeod, DA; Rhinn, H; Kuwahara, T; Zolin, A; Di Paolo, G; MacCabe, BD; Marder, KS; Honig, LS; Clark, LN; Small, SA; Abeliovich, A				MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa			RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson's Disease Risk	NEURON			English	Article							GENE-EXPRESSION; RETROMER; ALPHA; MICE; NEURODEGENERATION; LOCALIZATION; TRAFFICKING; TRANSPORT; COMPLEX; KINASE	Recent genome-wide association studies have linked common variants in the human genome to Parkinson's disease (PD) risk. Here we show that the consequences of variants at 2 such loci, PARK16 and LRRK2, are highly interrelated, both in terms of their broad impacts on human brain transcriptomes of unaffected carriers, and in terms of their associations with PD risk. Deficiency of the PARK16 locus gene RAB7L1 in primary rodent neurons, or of a RAB7L1 ortholog in Drosophila dopamine neurons, recapitulated degeneration observed with expression of a familial PD mutant form of LRRK2, whereas RAB7L1 overexpression rescued the LRRK2 mutant phenotypes. PD-associated defects in RAB7L1 or LRRK2 led to endolysosomal and Golgi apparatus sorting defects and deficiency of the VPS35 component of the retromer complex. Expression of wildtype VPS35, but not a familial PD-associated mutant form, rescued these defects. Taken together, these studies implicate retromer and lysosomal pathway alterations in PD risk.	[MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Marder, Karen S.; Honig, Lawrence S.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Taub Inst, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [MacLeod, David A.; Rhinn, Herve; Kuwahara, Tomoki; Zolin, Ari; Di Paolo, Gilbert; MacCabe, Brian D.; Clark, Lorraine N.; Small, Scott A.; Abeliovich, Asa] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Marder, Karen S.; Honig, Lawrence S.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ, Dept Neurol, Black Bldg 1208,650 West 168th St, New York, NY 10032 USA.	aa900@columbia.edu	Kuwahara, Tomoki/AAX-2459-2020; Kuwahara, Tomoki/AAT-7119-2021	Kuwahara, Tomoki/0000-0003-1788-7018; McCabe, Brian/0000-0003-1620-0501; Zolin, Aryeh/0000-0002-0752-9770	Michael J. Fox Foundation; NIH [NS064433, NS060876, NS060113, NS063660, UL1 TR000040, AG025161, AG08702-21, P50AG08702]; Daiichi-Sankyo Foundation; Japan Society for the Promotion of Science; Parkinson's Disease Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433, R01NS060113, R01NS036630, R01NS060876, R01NS056049, R56NS036630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025161, P50AG008702] Funding Source: NIH RePORTER	Michael J. Fox Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi-Sankyo Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Parkinson's Disease Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the New York Brain Bank and Jean Paul Vonsattel for banked tissue samples. We are grateful to all the contributors who made their data publicly available at the Gene Expression Omnibus. We thank Oliver Hobert for reviewing the manuscript. The work was supported by grants from the Michael J. Fox Foundation (A.A.), the NIH (NS064433 and NS060876 to A.A.; NS060113 to L.N.C.; NS063660 and UL1 TR000040 to K.S.M.; AG025161 to S.A.S.; AG08702-21 to B.D.M.; and P50AG08702 to L.S.H.), the Daiichi-Sankyo Foundation and the Japan Society for the Promotion of Science (T.K.), and the Parkinson's Disease Foundation (L. N. C. and K.S.M.). A.A. designed studies and interpreted data. H.R. designed and performed the human genetics analyses, and performed the bioinformatics and the splicing experiments. D.A.M. performed the Drosophila and mouse experiments. D.A.M., T. K., and A.Z performed the cell culture experiments. B.D.M. helped designing and interpreting the Drosophila experiments, L.N.C. the human genetics, G.D.P. and S.A.S. the retromer and trafficking experiments. A.A. and H.R wrote the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Kim E, 2010, BIOCHEM BIOPH RES CO, V403, P167, DOI 10.1016/j.bbrc.2010.10.121; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Latourelle JC, 2011, MOVEMENT DISORD, V26, P2039, DOI 10.1002/mds.23781; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shimizu F, 1997, CYTOGENET CELL GENET, V77, P261, DOI 10.1159/000134591; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skinner CF, 2009, RES PER ALZ, P125, DOI 10.1007/978-3-540-87941-1_10; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; St George-Hyslop P., 2009, INTRACELLULAR TRAFFI; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	46	395	405	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2013	77	3					425	439		10.1016/j.neuron.2012.11.033	http://dx.doi.org/10.1016/j.neuron.2012.11.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395371	Green Accepted, Bronze			2022-12-25	WOS:000317030800007
J	Gunther, S; Kim, J; Kostin, S; Lepper, C; Fan, CM; Braun, T				Guenther, Stefan; Kim, Johnny; Kostin, Sawa; Lepper, Christoph; Fan, Chen-Ming; Braun, Thomas			Myf5-Positive Satellite Cells Contribute to Pax7-Dependent Long-Term Maintenance of Adult Muscle Stem Cells	CELL STEM CELL			English	Article							PAX7; DISTINCT; MYF5; SPECIFICATION; REGENERATION; POPULATION; EXPRESSION; EFFICIENT; RENEWAL; GENES	Skeletal muscle contains Pax7-expressing muscle stem or satellite cells, enabling muscle regeneration throughout most of adult life. Here, we demonstrate that induced inactivation of Pax7 in Pax7-expressing cells of adult mice leads to loss of muscle stem cells and reduced heterochromatin condensation in rare surviving satellite cells. Inactivation of Pax7 in Myf5-expressing cells revealed that the majority of adult muscle stem cells originate from myogenic lineages, which express the myogenic regulators Myf5 or MyoD. Likewise, the majority of muscle stem cells are replenished from Myf5-expressing myogenic cells during adult life, and inactivation of Pax7 in Myf5-expressing cells after muscle damage leads to a complete arrest of muscle regeneration. Finally, we demonstrate that a relatively small number of muscle stem cells are sufficient for efficient repair of skeletal muscles. We conclude that Pax7 acts at different levels in a nonhierarchical regulatory network controlling muscle-satellite-cell-mediated muscle regeneration.	[Guenther, Stefan; Kim, Johnny; Kostin, Sawa; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Lepper, Christoph; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Max Planck Society; Carnegie Institution for Science	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Kim, Johnny/AAY-2149-2020; Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Kim, Johnny/0000-0002-5226-5460	DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS] [Br1416, SFB TR81]; LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Universities of Giessen and Marburg Lung Center (UGMLC); NIH [RO1AR060042, R21AR063847];  [DP5OD009208]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063847, R01AR060042] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009208] Funding Source: NIH RePORTER	DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS](German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy; German Center for Cardiovascular Research; Universities of Giessen and Marburg Lung Center (UGMLC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are indebted to Dr. Frank Constanini, Dr. Charles Keller, and Dr. Phil Soriano for the contribution of mouse strains. T.B. was supported by the DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS], Br1416, and SFB TR81), the LOEWE Center for Cell and Gene Therapy, the German Center for Cardiovascular Research, and the Universities of Giessen and Marburg Lung Center (UGMLC). C.-M.F. is supported by the NIH (RO1AR060042 and R21AR063847). C.L. is supported by DP5OD009208 and R21AR063847).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cooper RN, 1999, J CELL SCI, V112, P2895; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Krauss V, 2008, GENETICA, V133, P93, DOI 10.1007/s10709-007-9184-z; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Massuda ES, 1997, P NATL ACAD SCI USA, V94, P14701, DOI 10.1073/pnas.94.26.14701; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	33	167	176	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					590	601		10.1016/j.stem.2013.07.016	http://dx.doi.org/10.1016/j.stem.2013.07.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	23933088	Bronze, Green Accepted			2022-12-25	WOS:000329571500011
J	Shang, YH; Donelson, NC; Vecsey, CG; Guo, F; Rosbash, M; Griffith, LC				Shang, Yuhua; Donelson, Nathan C.; Vecsey, Christopher G.; Guo, Fang; Rosbash, Michael; Griffith, Leslie C.			Short Neuropeptide F Is a Sleep-Promoting Inhibitory Modulator	NEURON			English	Article							VENTRAL LATERAL NEURONS; DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; REGULATES SLEEP; NERVOUS-SYSTEM; NEURAL CIRCUIT; CLOCK NEURONS; PDF CELLS; DOPAMINE; AROUSAL	To advance the understanding of sleep regulation, we screened for sleep-promoting cells and identified neurons expressing neuropeptide Y-like short neuropeptide F (sNPF). Sleep induction by sNPF meets all relevant criteria. Rebound sleep following sleep deprivation is reduced by activation of sNPF neurons, and flies experience negative sleep rebound upon cessation of sNPF neuronal stimulation, indicating that sNPF provides an important signal to the sleep homeostat. Only a subset of sNPF-expressing neurons, which includes the small ventrolateral clock neurons, is sleep promoting. Their release of sNPF increases sleep consolidation in part by suppressing the activity of wake-promoting large ventrolateral clock neurons, and suppression of neuronal firing may be the general response to sNPF receptor activation. sNPF acutely increases sleep without altering feeding behavior, which it affects only on a much longer time scale. The profound effect of sNPF on sleep indicates that it is an important sleep-promoting molecule.	[Shang, Yuhua; Donelson, Nathan C.; Vecsey, Christopher G.; Guo, Fang; Rosbash, Michael; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Shang, Yuhua; Donelson, Nathan C.; Vecsey, Christopher G.; Guo, Fang; Rosbash, Michael; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Guo, Fang; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02545 USA	Brandeis University; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Rosbash, M (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	rosbash@brandeis.edu; griffith@brandeis.edu	Vecsey, Christopher/AAP-6002-2020; Guo, Fang/H-4067-2014	Guo, Fang/0000-0003-2219-2886; Griffith, Leslie/0000-0003-3164-9876	NIH [R01 MH067284, P01 NS044232-06];  [T32 NS007292];  [F32 MH090711]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284, F32MH090711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, T32NS007292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Paul Garrity, Ron Davis, Paul Taghert, Kweon Yu, Ping Shen, and Ulrike Heberlein for kindly providing transgenic flies. We also obtained fly lines from Bloomington Stock Center and DGRC. We thank E. Dougherty for assistance in confocal microscopy and Kristyna Palm and Patricia Parmenter for administrative assistance. The work was supported by grants from the NIH: R01 MH067284 (to L.C.G.) and P01 NS044232-06 (to M.R.). N.C.D. was supported by postdoctoral training grant T32 NS007292, and C.G.V. was supported by F32 MH090711. Y.S. conceived the project. Y.S., N.C.D., C.G.V., and F.G. performed the experiments. Y.S., M.R., and L.C.G. wrote the paper.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Antonijevic IA, 2000, NEUROPHARMACOLOGY, V39, P1474, DOI 10.1016/S0028-3908(00)00057-5; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Cayre M, 1999, J NEUROPHYSIOL, V81, P1, DOI 10.1152/jn.1999.81.1.1; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Dyzma M, 2010, SLEEP MED REV, V14, P161, DOI 10.1016/j.smrv.2009.09.001; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Howell MJ, 2009, SLEEP MED REV, V13, P23, DOI 10.1016/j.smrv.2008.07.005; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Lee KS, 2009, FEBS LETT, V583, P2573, DOI 10.1016/j.febslet.2009.07.024; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; MACFADYEN UM, 1973, J APPL PHYSIOL, V35, P391, DOI 10.1152/jappl.1973.35.3.391; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Penev Plamen D, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P374, DOI 10.1097/MED.0b013e3282be9093; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Shang YH, 2011, NAT NEUROSCI, V14, P889, DOI 10.1038/nn.2860; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x	54	86	86	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					171	183		10.1016/j.neuron.2013.07.029	http://dx.doi.org/10.1016/j.neuron.2013.07.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094110	Green Accepted, Bronze			2022-12-25	WOS:000326305300016
J	Wang, L; Tu, P; Bonet, L; Aubrey, KR; Supplisson, S				Wang, Lu; Tu, Peng; Bonet, Laurine; Aubrey, Karin R.; Supplisson, Stephane			Cytosolic Transmitter Concentration Regulates Vesicle Cycling at Hippocampal GABAergic Terminals	NEURON			English	Article							NEUROTRANSMITTER GABA SYNTHESIS; EMPTY SYNAPTIC VESICLES; GAMMA-AMINOBUTYRIC-ACID; QUANTAL SIZE; GLUTAMATE TRANSPORTER; SUPPORTS NEUROTRANSMISSION; CORTICAL INTERNEURONS; NERVE-TERMINALS; CEREBRAL-CORTEX; NEURONS	Sustained synaptic transmission requires vesicle recycling and refilling with transmitter, two processes considered to proceed independently. Contrary to this assumption, we show here that depletion of cytosolic transmitter at GABAergic synapses reversibly reduces the number of recycling vesicles. Using paired recordings in hippocampal cultures, we show that repetitive activity causes two phases of reduction of the postsynaptic response. The first involves the classical depletion of the readily releasable and recycling pools, while the second reflects impairment of vesicle filling as GABA is consumed, since it can only be reversed by uptake of GABA or its precursors, glutamate or glutamine. Surprisingly, this second phase is associated with reduced quantal release, a faster depression, rate and lower FM5-95 labeling, suggesting that the size of the cycling vesicular pool is regulated by cytosolic transmitter availability. Regulation of vesicular cycling may represent a general mechanism of presynaptic plasticity, matching synaptic release to transmitter supply.	[Wang, Lu; Tu, Peng; Bonet, Laurine; Aubrey, Karin R.; Supplisson, Stephane] INSERM, U1024, F-75005 Paris, France; [Wang, Lu; Tu, Peng; Bonet, Laurine; Aubrey, Karin R.; Supplisson, Stephane] CNRS, UMR 8197, F-75005 Paris, France; [Wang, Lu; Tu, Peng; Bonet, Laurine; Aubrey, Karin R.; Supplisson, Stephane] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Wang, Lu] E China Normal Univ, Shanghai Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); East China Normal University	Supplisson, S (corresponding author), INSERM, U1024, F-75005 Paris, France.	stephane.supplisson@biologie.ens.fr	Aubrey, Karin/J-6526-2012; SUPPLISSON, Stéphane/AAD-7482-2019; , Karin/R-3241-2019; SUPPLISSON, Stéphane/L-6658-2017	Aubrey, Karin/0000-0002-1808-4041; SUPPLISSON, Stéphane/0000-0002-0062-9752; , Karin/0000-0002-1808-4041; SUPPLISSON, Stéphane/0000-0002-0062-9752; Wang, Lu/0000-0002-4244-5687	CNRS; INSERM; Association Francaise contre les Myopathies (AFM); East China Normal University; CHINA Scholarship Council; Fondation pour la Recherche Medicale; Region Ile de France; Neuroscience pole of Research in Ile de France (NeRF); Fondation Pierre-Gilles de Gennes; Ministere de la Recherche et de la Technologie PhD fellowship	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); East China Normal University; CHINA Scholarship Council(China Scholarship Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile de France(Region Ile-de-France); Neuroscience pole of Research in Ile de France (NeRF); Fondation Pierre-Gilles de Gennes; Ministere de la Recherche et de la Technologie PhD fellowship	We thank Gabor Szabo for the generous gift of the EGFP-GAD65 mice. We thank Boris Barbour, Philippe Ascher, and Mariano Casado for critical reading and suggestions; Stephane Dieudonne, Paikan Marcaggi, and Bernard Poulain for stimulating discussions; Guillaume Dugue and Charly Rousseau for SpAcAn development; and Pr Yinghe Hu for his interest. This project is supported by the CNRS, INSERM, and a grant from the Association Francaise contre les Myopathies (AFM). L.W. was supported by fellowships from East China Normal University, the CHINA Scholarship Council, the Fondation pour la Recherche Medicale, and a grant from the Region Ile de France. P.T. was supported by postdoctoral fellowships from the Neuroscience pole of Research in Ile de France (NeRF) and the Fondation Pierre-Gilles de Gennes. L.B. is a recipient of Ministere de la Recherche et de la Technologie PhD fellowship. K.A. was supported by a postdoctoral fellowship from the Association Francaise contre les Myopathies (AFM).	Apostolides PF, 2013, J NEUROSCI, V33, P4768, DOI 10.1523/JNEUROSCI.5555-12.2013; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Aubrey KR, 2007, J NEUROSCI, V27, P6273, DOI 10.1523/JNEUROSCI.1024-07.2007; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Bragina L, 2008, J NEUROCHEM, V105, P1781, DOI 10.1111/j.1471-4159.2008.05273.x; Brown MN, 2010, J NEUROCHEM, V114, P909, DOI 10.1111/j.1471-4159.2010.06823.x; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Fish KN, 2011, CEREB CORTEX, V21, P2450, DOI 10.1093/cercor/bhr007; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; He Y, 2000, J COMP NEUROL, V418, P255; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Kavalali ET, 2006, NEUROSCIENTIST, V12, P57, DOI 10.1177/1073858405281852; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Mathews GC, 2003, J NEUROSCI, V23, P2040; Neher Erwin, 2010, Front Synaptic Neurosci, V2, P144, DOI 10.3389/fnsyn.2010.00144; Obata K, 2008, BIOCHEM BIOPH RES CO, V370, P429, DOI 10.1016/j.bbrc.2008.03.110; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; POULAIN B, 1986, P NATL ACAD SCI USA, V83, P170, DOI 10.1073/pnas.83.1.170; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tabares L, 2001, J BIOL CHEM, V276, P39974, DOI 10.1074/jbc.M106498200; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Walls AB, 2011, J CEREBR BLOOD F MET, V31, P494, DOI 10.1038/jcbfm.2010.115; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	53	28	28	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					143	158		10.1016/j.neuron.2013.07.021	http://dx.doi.org/10.1016/j.neuron.2013.07.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094108	Bronze			2022-12-25	WOS:000326305300014
J	Vigano, F; Mobius, W; Gotz, M; Dimou, L				Vigano, Francesca; Moebius, Wiebke; Goetz, Magdalena; Dimou, Leda			Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; NERVOUS-SYSTEM; WHITE-MATTER; RAT CNS; CELLS; PROGENITORS; LINEAGE; MOUSE; MICE; EXPRESSION	To examine the role of gray and white matter niches for oligodendrocyte differentiation, we used homo- and heterotopic transplantations into the adult mouse cerebral cortex. White matter-derived cells differentiated into mature oligodendrocytes in both niches with equal efficiency, whereas gray matter-derived cells did not. Thus, white matter promotes oligodendrocyte differentiation, and cells from this niche differentiate more easily, even in the less supportive gray matter environment.	[Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] HelmholtzZentrum, Inst Stem Cell Res, Neuherberg, Germany; [Vigano, Francesca] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Moebius, Wiebke] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Moebius, Wiebke] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Milan; Max Planck Society; University of Munich	Dimou, L (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	leda.dimou@lrz.uni-muenchen.de	Dimou, Leda/E-7968-2012	/0000-0002-2902-7165; Gotz, Magdalena/0000-0003-1551-9203	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain; University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft [SFB 596, SFB 870]; Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	We thank J. Trotter (Johannes Gutenberg-University) for the NG2-EYFP and F. Kirchhoff (University of Saarland) for the PLP-DsRed mouse lines, K. Karram for advice regarding cell isolation procedures, J. Ninkovic for help with the statistics, and E. Violette and S. Sirko for carefully reading the manuscript. We are also grateful to B. Sadowski for technical help with the electron microscope, as well as the technical assistants in the Physiological Genomics. W.M. is funded by the European Research Council Advanced Investigator Grant AXOGLIA to K.-A. Nave and is supported by the Cluster of Excellence and DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain. F.V. was, in part, supported by a doctorate fellowship from the University of Milan and an International Brain Research Organization InEurope grant. This work was mainly supported by the SFB 596 and the SFB 870 of the Deutsche Forschungsgemeinschaft, the Helmholtz Association of Mental Aging and the Friedrich Bauer Stiftung.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peters PJ, 2008, METHOD CELL BIOL, V88, P131, DOI [10.1016/S0091-679X(08)00409-1, 10.1016/S0091-679X(08)00408-1]; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	18	125	126	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1370	+		10.1038/nn.3503	http://dx.doi.org/10.1038/nn.3503			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995069				2022-12-25	WOS:000324795300008
J	Beed, P; Gundlfinger, A; Schneiderbauer, S; Song, J; Bohm, C; Burgalossi, A; Brecht, M; Vida, I; Schmitz, D				Beed, Prateep; Gundlfinger, Anja; Schneiderbauer, Sophie; Song, Jie; Boehm, Claudia; Burgalossi, Andrea; Brecht, Michael; Vida, Imre; Schmitz, Dietmar			Inhibitory Gradient along the Dorsoventral Axis in the Medial Entorhinal Cortex	NEURON			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; GAMMA-OSCILLATIONS; PYRAMIDAL CELLS; GRID CELLS; RAT; ORGANIZATION; DYNAMICS; MICROCIRCUITS; FREQUENCY; DORSAL	Local inhibitory microcircuits in the medial entorhinal cortex (MEG) and their role in network activity are little investigated. Using a combination of electrophysiological, optical, and morphological circuit analysis tools, we find that layer II stellate cells are embedded in a dense local inhibitory microcircuit. Specifically, we report a gradient of inhibitory inputs along the dorsoventral axis of the MEG, with the majority of this local inhibition arising from parvalbumin positive (PV+) interneurons. Finally, the gradient of PV+ fibers is accompanied by a gradient in the power of extracellular network oscillations in the gamma range, measured both in vitro and in vivo. The reported differences in the inhibitory microcircuitry in layer II of the MEG may therefore have a profound functional impact on the computational working principles at different locations of the entorhinal network and influence the input pathways to the hippocampus.	[Beed, Prateep; Gundlfinger, Anja; Boehm, Claudia; Schmitz, Dietmar] Charite, Neurowissensch Forschungszentrum, D-10117 Berlin, Germany; [Vida, Imre] Charite, Inst Integrat Neuroanat, D-10117 Berlin, Germany; [Schneiderbauer, Sophie; Burgalossi, Andrea; Brecht, Michael; Schmitz, Dietmar] Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Song, Jie; Vida, Imre; Schmitz, Dietmar] NeuroCure, Cluster Excellence, D-10117 Berlin, Germany; [Schmitz, Dietmar] DZNE German Ctr Neurodegenerat Dis, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmitz, D (corresponding author), Charite, Neurowissensch Forschungszentrum, D-10117 Berlin, Germany.	dietmar.schmitz@charite.de	Vida, Imre/F-8275-2012	Vida, Imre/0000-0003-3214-2233; Brecht, Michael/0000-0002-5387-0953; Bohm, Claudia/0000-0002-9802-1162; Schmitz, Dietmar/0000-0003-2741-5241	Deutsche Forschungsgemeinschen [SFB 618, 665, Exc 257]; Bundesministerium fur Bildung und Forschung (Bernstein Centers Berlin) [01GQ0410]; Bundesministerium fur Bildung und Forschung (Bernstein Fokus) [01GQ0981, 01GQ0972]; Human Frontier Science Program (LTF)	Deutsche Forschungsgemeinschen; Bundesministerium fur Bildung und Forschung (Bernstein Centers Berlin)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (Bernstein Fokus)(Federal Ministry of Education & Research (BMBF)); Human Frontier Science Program (LTF)(Human Frontier Science Program)	This study was supported by grants from the Deutsche Forschungsgemeinschen (SFB 618, 665; Exc 257), the Bundesministerium fur Bildung und Forschung (Bernstein Centers Berlin 01GQ0410, Bernstein Fokus 01GQ0981, 01GQ0972), and the Human Frontier Science Program (LTF to A.G.). The authors thank Susanne Rieckmann and Anke Schonherr for excellent technical assistance. The authors are indebted to Michael Bendels for help with the software, Friedrich Johenning for technical assistance with the optics, and Richard Kempter for advice regarding analysis and his helpful comments on the manuscript. P.S.B. and D.S. designed the study. P.S.B., A.G., A.B., S.S., and C.B. performed electrophysiological experiments. P.S.B., A.G., S.S., and M.T.K. analyzed the electrophysiological data. S.J. and I.V. performed the morphological experiments and analyzed the data. P.S.B., A.G., I.V., and D.S. wrote the paper.	ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Beed PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005576; Bendels MHK, 2008, J NEUROSCI METH, V175, P44, DOI 10.1016/j.jneumeth.2008.08.010; Bendels MHK, 2010, J NEUROSCI METH, V192, P286, DOI 10.1016/j.jneumeth.2010.08.006; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krook-Magnuson E, 2011, J NEUROSCI, V31, P14861, DOI 10.1523/JNEUROSCI.2269-11.2011; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Luna VM, 2010, NAT NEUROSCI, V13, P533, DOI 10.1038/nn.2524; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556	39	59	60	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1197	1207		10.1016/j.neuron.2013.06.038	http://dx.doi.org/10.1016/j.neuron.2013.06.038			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050405	Bronze			2022-12-25	WOS:000330329600016
J	Montserrat, N; Nivet, E; Sancho-Martinez, I; Hishida, T; Kumar, S; Miquel, L; Cortina, C; Hishida, Y; Xia, Y; Esteban, CR; Belmonte, JCI				Montserrat, Nuria; Nivet, Emmanuel; Sancho-Martinez, Ignacio; Hishida, Tomoaki; Kumar, Sachin; Miquel, Laia; Cortina, Carme; Hishida, Yuriko; Xia, Yun; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos			Reprogramming of Human Fibroblasts to Pluripotency with Lineage Specifiers	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; TRANSCRIPTION FACTORS; SOMATIC-CELLS; DIFFERENTIATION; OCT4; MOUSE; STATE; INDUCTION; FAMILY; CDX2	Since the initial discovery that OCT4, SOX2, KLF4, and c-MYC overexpression sufficed for the induction of pluripotency in somatic cells, methodologies replacing the original factors have enhanced our understanding of the reprogramming process. However, unlike in mouse, OCT4 has not been replaced successfully during reprogramming of human cells. Here we report on a strategy to accomplish this replacement. Through a combination of transcriptome and bioinformatic analysis we have identified factors previously characterized as being lineage specifiers that are able to replace OCT4 and SOX2 in the reprogramming of human fibroblasts. Our results show that it is possible to replace OCT4 and SOX2 simultaneously with alternative lineage specifiers in the reprogramming of human cells. At a broader level, they also support a model in which counteracting lineage specification networks underlies the induction of pluripotency.	[Montserrat, Nuria; Sancho-Martinez, Ignacio; Miquel, Laia; Cortina, Carme; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Montserrat, Nuria] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08003, Spain; [Nivet, Emmanuel; Sancho-Martinez, Ignacio; Hishida, Tomoaki; Kumar, Sachin; Hishida, Yuriko; Xia, Yun; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Cortina Duran, Carme/K-7203-2017; Xia, Yun/K-4128-2015; Montserrat, Nuria/F-3136-2016; Nivet, Emmanuel/C-2729-2014	Cortina Duran, Carme/0000-0003-3477-4322; Xia, Yun/0000-0003-2184-4870; Montserrat, Nuria/0000-0002-1603-1755; Nivet, Emmanuel/0000-0001-7903-4059; Miquel Serra, Laia/0000-0001-8382-3341; Sancho-Martinez, Ignacio/0000-0003-4348-1038	Nomis Foundation; F.M. Kirby Foundation; Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Ministerio de Economia y Competitividad (MINECO); CIBER-BBN; TERCEL-ISCIII- MINECO; Cardiocel	Nomis Foundation; F.M. Kirby Foundation; Fundacion Cellex(Foundation CELLEX); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Ministerio de Economia y Competitividad (MINECO); CIBER-BBN; TERCEL-ISCIII- MINECO; Cardiocel	We thank M. Schwarz for administrative support. We also thank Montserrat Barragan, Lola Mulero, Cristina Morera, Rafaella Fazzina, Kelly Herbert, and Krystal Moon for expert technical assistance and Lara Nonell and Eulalia Puigdecanet at the Microarray Service (SAM) of IMIM-Hospital del Mar for microarray processing and analysis. I.S.M. was partially supported by a Nomis Foundation postdoctoral fellowship. E.N. was partially supported by a F.M. Kirby Foundation postdoctoral fellowship. Work in the laboratory of J.C.I.B. was supported by grants from Fundacion Cellex, the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and Ministerio de Economia y Competitividad (MINECO), CIBER-BBN, TERCEL-ISCIII- MINECO, and Cardiocel.	Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	30	110	116	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 5	2013	13	3					341	350		10.1016/j.stem.2013.06.019	http://dx.doi.org/10.1016/j.stem.2013.06.019			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VQ	23871606	Bronze			2022-12-25	WOS:000329570800011
J	Kim, HF; Hikosaka, O				Kim, Hyoung F.; Hikosaka, Okihide			Distinct Basal Ganglia Circuits Controlling Behaviors Guided by Flexible and Stable Values	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; PARKINSONS-DISEASE; CAUDATE-NUCLEUS; ORBITOFRONTAL CORTEX; RHESUS-MONKEY; HUNTINGTONS-DISEASE; STRIATAL NEURONS; HABIT FORMATION; INFORMATION; RESPONSES	Choosing valuable objects is critical for survival, but their values may change flexibly or remain stable. Therefore, animals should be able to update the object values flexibly by recent experiences and retain them stably by long-term experiences. However, it is unclear how the brain encodes the two conflicting forms of values and controls behavior accordingly. We found that distinct circuits of the primate caudate nucleus control behavior selectively in the flexible and stable value conditions. Single caudate neurons encoded the values of visual objects in a regionally distinct manner: flexible value coding in the caudate head and stable value coding in the caudate tail. Monkeys adapted in both conditions by looking at objects with higher values. Importantly, inactivation of each caudate subregion disrupted the high-low value discrimination selectively in the flexible or stable context. This parallel complementary mechanism enables animals to choose valuable objects in both flexible and stable conditions.	[Kim, Hyoung F.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Kim, HF (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	hyoung.f.kim@gmail.com			Intramural Research Program at the National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Yasuda, S. Yamamoto, A. Ghazizadeh, I. Monosov, and E. Bromberg-Martin for discussions and D. Parker, B. Nagy, M.K. Smith, G.Tansey, J.W. McClurkin, A.M. Nichols, T.W. Ruffner, and A.V. Hays for technical assistance. This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson P, 2007, ADMIN SCI QUART, V52, P333, DOI 10.2189/asqu.52.2.333; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barto Andrew G., 1994, Current Opinion in Neurobiology, V4, P888, DOI 10.1016/0959-4388(94)90138-4; BROWN RG, 1990, TRENDS NEUROSCI, V13, P21, DOI 10.1016/0166-2236(90)90058-I; BROWN VJ, 1995, J NEUROPHYSIOL, V74, P1083, DOI 10.1152/jn.1995.74.3.1083; CAAN W, 1984, BRAIN RES, V290, P53, DOI 10.1016/0006-8993(84)90735-2; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; COOLS AR, 1984, J NEUROL NEUROSUR PS, V47, P443, DOI 10.1136/jnnp.47.5.443; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Gottlieb J, 2012, NEURON, V76, P281, DOI 10.1016/j.neuron.2012.09.034; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Kim SJ, 2012, PHYS STATUS SOLIDI-R, V6, P108, DOI 10.1002/pssr.201105516; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Liljenstrom H, 2003, NEUROPSYCHOPHARMACOL, V28, pS64, DOI 10.1038/sj.npp.1300137; Mishkin M., 1984, NEUROBIOL LEARN MEM, P65, DOI DOI 10.1523/JNEUROSCI.0840-16.2016; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; SELEMON LD, 1985, J NEUROSCI, V5, P776; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shohamy D, 2004, BEHAV NEUROSCI, V118, P676, DOI 10.1037/0735-7044.118.4.676; SZABO J, 1972, EXP NEUROL, V37, P562, DOI 10.1016/0014-4886(72)90099-4; SZABO J, 1970, EXP NEUROL, V27, P1, DOI 10.1016/0014-4886(70)90196-2; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Yamamoto S, 2013, J NEUROSCI, V33, P11227, DOI 10.1523/JNEUROSCI.0318-13.2013; Yamamoto S, 2012, J NEUROSCI, V32, P11005, DOI 10.1523/JNEUROSCI.0828-12.2012; Yasuda M, 2012, J NEUROSCI, V32, P16917, DOI 10.1523/JNEUROSCI.3438-12.2012; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	51	112	113	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					1001	1010		10.1016/j.neuron.2013.06.044	http://dx.doi.org/10.1016/j.neuron.2013.06.044			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	23954031	Green Accepted, Bronze			2022-12-25	WOS:000330269100016
J	Betti, V; Della Penna, S; de Pasquale, F; Mantini, D; Marzetti, L; Romanis, GL; Corbetta, M				Betti, Viviana; Della Penna, Stefania; de Pasquale, Francesco; Mantini, Dante; Marzetti, Laura; Romanis, Gian Luca; Corbetta, Maurizio			Natural Scenes Viewing Alters the Dynamics of Functional Connectivity in the Human Brain	NEURON			English	Article							RESTING-STATE ACTIVITY; DEFAULT-MODE; NEURONAL OSCILLATIONS; VISUAL-CORTEX; NETWORKS; FLUCTUATIONS; SYNCHRONIZATION; VARIABILITY; MECHANISM; MODULATION	Spontaneous fMRI fluctuations are organized in large-scale spatiotemporal structures, or resting-state networks (RSN). However, it is unknown how task performance affects RSN dynamics. We use MEG to measure slow (similar to 0.1 Hz) coherent fluctuations of band-limited power (BLP), a robust correlate of RSN, during rest and movie observation and compare them to fMRI-RSN. BLP correlation, especially in a band, dropped in multiple RSN during movie although overall topography was maintained. Variability of power correlation increased in visual occipital cortex, and transient decrements corresponded to scenes perceived as "event boundaries." Additionally, stronger task-dependent interactions developed between vision and language networks in theta and beta bands, and default and language networks in gamma band. The topography of fMRI connectivity and relative changes induced by the movie were well matched to MEG. We conclude that resting-state and task network interactions are clearly different in the frequency domain despite maintenance of underlying network topography.	[Betti, Viviana; Della Penna, Stefania; de Pasquale, Francesco; Marzetti, Laura; Romanis, Gian Luca; Corbetta, Maurizio] G dAnnunzio Univ Chieti Pescara, Dept Neurosci & Imaging, I-66013 Chieti, Italy; [Betti, Viviana; Della Penna, Stefania; de Pasquale, Francesco; Marzetti, Laura; Romanis, Gian Luca; Corbetta, Maurizio] Univ G dAnnunzio, Inst Adv Biomed Technol, I-66013 Chieti, Italy; [Mantini, Dante] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Mantini, Dante] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, CH-8057 Zurich, Switzerland; [Corbetta, Maurizio] Washington Univ, Dept Neurol Radiol & Anat & Neurobiol, St Louis, MO 63101 USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Washington University (WUSTL)	Betti, V (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Neurosci & Imaging, I-66013 Chieti, Italy.	v.betti@unich.it; mau@npg.wustl.edu	Marzetti, Laura/ABC-9763-2021; Marzetti, Laura/AAA-4231-2020; Corbetta, Maurizio/AAZ-5219-2020; Mantini, Dante/D-6989-2014; de Pasquale, Francesco/AAB-3440-2019; Marzetti, Laura/Q-2909-2016; Betti, Viviana/K-5516-2016	Marzetti, Laura/0000-0002-6481-3743; Mantini, Dante/0000-0001-6485-5559; Marzetti, Laura/0000-0002-6481-3743; Betti, Viviana/0000-0003-3429-2104; Della Penna, Stefania/0000-0001-5067-4327; DE PASQUALE, Francesco/0000-0003-1109-3305	European Community's Seventh Framework Programme [HEALTH-F2-2008-200728]; Human Connectome Project [1U54MH091657-01]; University of Chieti; NIMH [R01 MH096482-01]; NICHD [5R01HD061117-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657, R01MH096482] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme; Human Connectome Project; University of Chieti; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the European Community's Seventh Framework Programme Grant Agreement HEALTH-F2-2008-200728 (BrainSynch) and by the Human Connectome Project (1U54MH091657-01).V.B. was additionally supported by a fellowship from the University of Chieti. M.C. was supported by R01 MH096482-01 (NIMH) and 5R01HD061117-08 (NICHD).	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Betti V, 2009, J NEUROSCI, V29, P12384, DOI 10.1523/JNEUROSCI.2759-09.2009; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Della Penna S, 2000, PHILOS MAG B, V80, P937, DOI 10.1080/01418630008221960; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Mantini D, 2013, J NEUROSCI, V33, P3259, DOI 10.1523/JNEUROSCI.4392-12.2013; Mantini D, 2011, BRAIN CONNECT, V1, P49, DOI 10.1089/brain.2011.0001; Mantini D, 2012, NAT METHODS, V9, P277, DOI [10.1038/nmeth.1868, 10.1038/NMETH.1868]; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marzetti L, 2013, NEUROIMAGE, V79, P172, DOI 10.1016/j.neuroimage.2013.04.062; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Morgan VL, 2004, MAGN RESON IMAGING, V22, P1069, DOI 10.1016/j.mri.2004.07.002; Nauhaus I, 2012, J NEUROSCI, V32, P3088, DOI 10.1523/JNEUROSCI.5827-11.2012; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sauseng P, 2013, NEUROIMAGE, V65, P52, DOI 10.1016/j.neuroimage.2012.09.048; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O., 2016, NETWORKS BRAIN; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2007, NEURON, V55, P521, DOI 10.1016/j.neuron.2007.07.003; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zacks JM, 2007, CURR DIR PSYCHOL SCI, V16, P80, DOI 10.1111/j.1467-8721.2007.00480.x; Zacks JM, 2007, PSYCHOL BULL, V133, P273, DOI 10.1037/0033-2909.133.2.273; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	85	118	119	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					782	797		10.1016/j.neuron.2013.06.022	http://dx.doi.org/10.1016/j.neuron.2013.06.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23891400	Green Accepted, Bronze			2022-12-25	WOS:000323587000016
J	Fang, WQ; Chen, WW; Fu, AKY; Ip, NY				Fang, Wei-Qun; Chen, Wei-Wei; Fu, Amy K. Y.; Ip, Nancy Y.			Axin Directs the Amplification and Differentiation of Intermediate Progenitors in the Developing Cerebral Cortex	NEURON			English	Article							WNT SIGNALING PATHWAY; NEURAL STEM-CELLS; BETA-CATENIN; NEGATIVE REGULATOR; NEURONAL DIFFERENTIATION; PROTEIN STABILITY; GROWTH-FACTOR; RADIAL GLIA; PHOSPHORYLATION; NEUROGENESIS	The expansion of the mammalian cerebral cortex is safeguarded by a concerted balance between amplification and neuronal differentiation of intermediate progenitors (IPs). Nonetheless, the molecular controls governing these processes remain unclear. We found that the scaffold protein Axin is a critical regulator that determines the IP population size and ultimately the number of neurons during neurogenesis in the developing cerebral cortex. The increase of the IP pool is mediated by the interaction between Axin and GSK-3 in the cytoplasmic compartments of the progenitors. Importantly, as development proceeds, Axin becomes enriched in the nucleus to trigger neuronal differentiation via beta-catenin activation. The nuclear localization of Axin and hence the switch of IPs from proliferative to differentiative status are strictly controlled by the Cdk5-dependent phosphorylation of Axin at Thr485. Our results demonstrate an important Axin-dependent regulatory mechanism in neurogenesis, providing potential insights into the evolutionary expansion of the cerebral cortex.	[Fang, Wei-Qun; Chen, Wei-Wei; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Fang, Wei-Qun/AAW-5945-2020	Fang, Weiqun/0000-0002-6741-860X; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907	Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; National Key Basic Research Program of China [2013CB530900]; Research Grants Council of Hong Kong SAR [HKUST661109, HKUST660110, HKUST660610, HKUST660810, HKUST661111]; Innovation and Technology Fund for State Key Laboratory [ITCPT/17-9]; Shenzhen Peacock Plan; SH Ho Foundation	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); Innovation and Technology Fund for State Key Laboratory; Shenzhen Peacock Plan; SH Ho Foundation	We are grateful to Drs. Franck Polleux (The Scripps Research Institute, CA, USA), Anjen Chenn (Northwestern University, IL, USA), and Peter S. Klein (University of Pennsylvania, PA, USA) for their generous gifts of expression constructs. We also thank Dr. Kwok-On Lai for critical reading of the manuscript; Dr. Wei Qian, Ying Dai, Busma Butt, Cara Kwong, and William Chau for their excellent technical assistance; and other members of the N.Y.I. laboratory for many helpful discussions. This study was supported in part by the Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), the National Key Basic Research Program of China (2013CB530900), the Research Grants Council of Hong Kong SAR (HKUST661109, HKUST660110, HKUST660610, HKUST660810, and HKUST661111), the Innovation and Technology Fund for State Key Laboratory (ITCPT/17-9), the Shenzhen Peacock Plan, and the SH Ho Foundation.	Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Brooks BP, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-2; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fang WQ, 2011, J NEUROSCI, V31, P13613, DOI 10.1523/JNEUROSCI.3120-11.2011; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; Kavaslar GN, 2000, AM J HUM GENET, V66, P1705, DOI 10.1086/302898; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Komada M, 2008, DEVELOPMENT, V135, P2717, DOI 10.1242/dev.015891; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; McCaffery P, 2005, PROG NEUROBIOL, V77, P38, DOI 10.1016/j.pneurobio.2005.10.005; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munoz-Descalzo S, 2011, DEVELOPMENT, V138, P1501, DOI 10.1242/dev.061309; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zheng YL, 2010, MOL BIOL CELL, V21, P3601, DOI 10.1091/mbc.E10-01-0054	66	43	45	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					665	679		10.1016/j.neuron.2013.06.017	http://dx.doi.org/10.1016/j.neuron.2013.06.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972596	Bronze			2022-12-25	WOS:000323587000008
J	Barak, S; Liu, F; Ben Hamida, S; Yowell, QV; Neasta, J; Kharazia, V; Janak, PH; Ron, D				Barak, Segev; Liu, Feng; Ben Hamida, Sami; Yowell, Quinn V.; Neasta, Jeremie; Kharazia, Viktor; Janak, Patricia H.; Ron, Dorit			Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse	NATURE NEUROSCIENCE			English	Article							RAPAMYCIN SIGNALING PATHWAY; AMYGDALA CENTRAL NUCLEUS; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; FEAR MEMORY; TRANSLATIONAL CONTROL; PLACE PREFERENCE; NMDA RECEPTORS; RECONSOLIDATION; HIPPOCAMPUS	Relapse to alcohol abuse is an important clinical issue that is frequently caused by cue-induced drug craving. Therefore, disruption of the memory for the cue-alcohol association is expected to prevent relapse. It is increasingly accepted that memories become labile and erasable soon after their reactivation through retrieval during a memory reconsolidation process that depends on protein synthesis. Here we show that reconsolidation of alcohol-related memories triggered by the sensory properties of alcohol itself (odor and taste) activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions in rats, resulting in increased levels of several synaptic proteins. Furthermore, systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse. Our findings provide evidence that the mTORC1 pathway and its downstream substrates are crucial in alcohol-related memory reconsolidation and highlight this pathway as a therapeutic target to prevent relapse.	[Barak, Segev; Liu, Feng; Ben Hamida, Sami; Yowell, Quinn V.; Neasta, Jeremie; Kharazia, Viktor; Janak, Patricia H.; Ron, Dorit] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Ron, D (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Res Ctr, San Francisco, CA 94143 USA.	pjanak@gallo.ucsf.edu; dron@gallo.ucsf.edu	Hamida, Sami Ben/V-1010-2017; Barak, Segev/ABG-4080-2020; Hamida, Sami Ben/AAB-4767-2021	Hamida, Sami Ben/0000-0001-9636-9432; Barak, Segev/0000-0002-3143-6777; Hamida, Sami Ben/0000-0001-9636-9432; Neasta, Jeremie/0000-0002-7801-4176; Kharazia, Viktor/0000-0003-0642-6080; Janak, Patricia/0000-0002-3333-9049	US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [P50 AA017072]; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism grant P50 AA017072 (D.R. and P.H.J.) and funds from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (D.R. and P.H.J.). We thank S. Carnicella for critical review of the manuscript.	[Anonymous], 2004, WHO GLOB STAT REP AL; Bailey J, 2012, ADDICT BIOL, V17, P248, DOI 10.1111/j.1369-1600.2010.00311.x; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barak S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.57; Barak S, 2011, J NEUROSCI, V31, P9885, DOI 10.1523/JNEUROSCI.1750-11.2011; Besheer J, 2010, BIOL PSYCHIAT, V67, P812, DOI 10.1016/j.biopsych.2009.09.016; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Calu DJ, 2010, NEURON, V68, P991, DOI 10.1016/j.neuron.2010.11.019; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carnicella S, 2008, P NATL ACAD SCI USA, V105, P8114, DOI 10.1073/pnas.0711755105; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Everitt B.J., 2000, AMYGDALA FUNCTIONAL, P353; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Glover EM, 2010, LEARN MEMORY, V17, P577, DOI 10.1101/lm.1908310; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Jobim PFC, 2012, BEHAV BRAIN RES, V228, P151, DOI 10.1016/j.bbr.2011.12.004; Jobim PFC, 2012, NEUROBIOL LEARN MEM, V97, P105, DOI 10.1016/j.nlm.2011.10.002; Johnson BA, 2008, BIOCHEM PHARMACOL, V75, P34, DOI 10.1016/j.bcp.2007.08.005; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lingawi NW, 2012, J NEUROSCI, V32, P1073, DOI 10.1523/JNEUROSCI.4806-11.2012; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Milton A., 2012, CURR OPIN NEUROBIOL, DOI DOI 10.1016/J.C0NB.2012.11.008; Milton AL, 2012, PSYCHOPHARMACOLOGY, V219, P751, DOI 10.1007/s00213-011-2399-9; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Neasta J, 2010, P NATL ACAD SCI USA, V107, P20093, DOI 10.1073/pnas.1005554107; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Purgert RJ, 2012, J NEUROSCI, V32, P2461, DOI 10.1523/JNEUROSCI.5090-11.2012; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sinha R, 2011, CURR PSYCHIAT REP, V13, P398, DOI 10.1007/s11920-011-0224-0; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang J, 2010, J NEUROSCI, V30, P10187, DOI 10.1523/JNEUROSCI.2268-10.2010; Wang X, 2010, J NEUROSCI, V30, P12632, DOI 10.1523/JNEUROSCI.1264-10.2010; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070	52	116	121	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1111	U185		10.1038/nn.3439	http://dx.doi.org/10.1038/nn.3439			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792945	Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000322323000022
J	Gire, DH; Whitesell, JD; Doucette, W; Restrepo, D				Gire, David H.; Whitesell, Jennifer D.; Doucette, Wilder; Restrepo, Diego			Information for decision-making and stimulus identification is multiplexed in sensory cortex	NATURE NEUROSCIENCE			English	Article							FALSE DISCOVERY RATE; OLFACTORY-BULB; ODOR REPRESENTATIONS; PERCEPTION; RESPONSES; PHASE	In recordings from anterior piriform cortex in awake behaving mice, we found that neuronal firing early in the olfactory pathway simultaneously conveyed fundamentally different information: odor value (is the odor rewarded?) and identity (what is the smell?). Thus, this sensory system performs early multiplexing of information reflecting stimulus-specific characteristics with that used for decision-making.	[Gire, David H.; Doucette, Wilder; Restrepo, Diego] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA; [Gire, David H.; Whitesell, Jennifer D.; Doucette, Wilder; Restrepo, Diego] Univ Colorado, Sch Med, Neurosci Program, Aurora, CO USA; [Whitesell, Jennifer D.] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Restrepo, D (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA.	diego.restrepo@ucdenver.edu	Doucette, Wilder/S-2019-2016	Doucette, Wilder/0000-0003-2249-0461; Gire, David/0000-0003-4119-4270; Whitesell, Jennifer/0000-0002-2961-5207	US National Institutes of Health; National Institute on Deafness and Other Communication Disorders [F32 DC011980, F31 DC011202, F30 DC008066, R01 DC00566, P30 DC04657]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS099042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011202, F32DC011980, P30DC004657, F30DC008066, R01DC000566] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank G. Felsen and N. Schoppa for discussions. This work was funded by grants from the US National Institutes of Health and the National Institute on Deafness and Other Communication Disorders (F32 DC011980 to D. H. G., F31 DC011202 to J.D.W., F30 DC008066 to W.D., R01 DC00566 to D.R. and P30 DC04657 to D.R.).	Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gschwend O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030155; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Piette CE, 2012, J NEUROSCI, V32, P9981, DOI 10.1523/JNEUROSCI.0669-12.2012; Rennaker RL, 2007, J NEURAL ENG, V4, pL1, DOI 10.1088/1741-2560/4/2/L01; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Slotnick B., 2005, CURR PROTOC NEUROSCI, V33, P8, DOI [10.1002/0471142301.ns0820s33., DOI 10.1002/0471142301.NS0820S33]; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Zhang XH, 2009, RESULTS PROBL CELL D, V47, P25, DOI 10.1007/400_2008_28	22	54	54	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					991	U25		10.1038/nn.3432	http://dx.doi.org/10.1038/nn.3432			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792942	Green Accepted			2022-12-25	WOS:000322323000006
J	Akrouh, A; Kerschensteiner, D				Akrouh, Alejandro; Kerschensteiner, Daniel			Intersecting Circuits Generate Precisely Patterned Retinal Waves	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVITY-DEPENDENT REFINEMENT; INNER PLEXIFORM LAYER; BIPOLAR CELL NETWORK; GANGLION-CELLS; AMACRINE CELLS; MOUSE RETINA; MAMMALIAN RETINA; RABBIT RETINA	The developing retina generates spontaneous glutamatergic (stage III) waves of activity that sequentially recruit neighboring ganglion cells with opposite light responses (ON and OFF RGCs). This activity pattern is thought to help establish parallel ON and OFF pathways in downstream visual areas. The circuits that produce stage III waves and desynchronize ON and OFF RGC firing remain obscure. Using dual patch-clamp recordings, we find that ON and OFF RGCs receive sequential excitatory input from ON and OFF cone bipolar cells (CBCs), respectively. This input sequence is generated by crossover circuits, in which ON CBCs control glutamate release from OFF CBCs via diffusely stratified inhibitory amacrine cells. In addition, neighboring ON CBCs communicate directly and indirectly through lateral glutamatergic transmission and gap junctions, both of which are required for wave initiation and propagation. Thus, intersecting lateral excitatory and vertical inhibitory circuits give rise to precisely patterned stage III retinal waves.	[Akrouh, Alejandro; Kerschensteiner, Daniel] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Akrouh, Alejandro] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO 63110 USA; [Kerschensteiner, Daniel] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Kerschensteiner, Daniel] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kerschensteiner, D (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63110 USA.	dkerschensteiner@wustl.edu			Whitehall Foundation; Edward Mallinckrodt Jr. Foundation; Alfred P. Sloan Foundation; Research to Prevent Blindness Foundation; NIH [R01 EY021855, P30 EY0268]; NSF [DGE1143954]; NATIONAL EYE INSTITUTE [T32EY013360, R01EY021855] Funding Source: NIH RePORTER	Whitehall Foundation; Edward Mallinckrodt Jr. Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Kerschensteiner Lab and Dr. Peter Lukasiewicz for helpful discussions and comments on the manuscript. We are grateful to Dr. Peter Lukasiewicz for lending us equipment for focal agonist applications and to Dr. Felice Dunn for advice on bipolar cell recordings in retinal flat mount preparations. This work was supported by grants from the Whitehall Foundation (D.K.), Edward Mallinckrodt Jr. Foundation (D.K.), Alfred P. Sloan Foundation (D.K.), Research to Prevent Blindness Foundation (Career Development Award to D.K. and unrestricted grant to the Department of Ophthalmology and Visual Sciences at Washington University), the NIH (R01 EY021855 to D.K.; P30 EY0268 to the Department of Ophthalmology and Visual Sciences at Washington University), and the NSF (DGE1143954, A.A.). A.A. and D.K. planned and performed the experiments, analyzed the data, and wrote the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Arai I, 2010, J NEUROSCI, V30, P9260, DOI 10.1523/JNEUROSCI.1590-10.2010; Blankenship AG, 2011, J NEUROSCI, V31, P9998, DOI 10.1523/JNEUROSCI.5640-10.2011; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Firl A, 2013, J NEUROPHYSIOL, V109, P1969, DOI 10.1152/jn.00039.2013; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kamphuis W, 2003, J COMP NEUROL, V455, P172, DOI 10.1002/cne.10469; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; Liang ZY, 2010, J NEUROSCI, V30, P5533, DOI 10.1523/JNEUROSCI.4733-09.2010; Liets LC, 2003, J NEUROSCI, V23, P7343; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; MILLER KD, 1994, J NEUROSCI, V14, P409; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; MORGAN J, 1993, VISUAL NEUROSCI, V10, P303, DOI 10.1017/S0952523800003709; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Pang JJ, 2012, VISION RES, V68, P48, DOI 10.1016/j.visres.2012.07.012; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pow DV, 2000, NEUROCHEM INT, V37, P191, DOI 10.1016/S0197-0186(00)00022-X; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Veruki ML, 2009, J NEUROPHYSIOL, V101, P2339, DOI 10.1152/jn.00112.2009; Veruki ML, 2002, J NEUROSCI, V22, P10558; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 1998, J NEUROSCI, V18, P8839; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhang LL, 2006, J NEUROPHYSIOL, V95, P2404, DOI 10.1152/jn.00578.2005; Zhou CW, 2004, VISUAL NEUROSCI, V21, P181, DOI 10.1017/S0952523804042099	72	31	31	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					322	334		10.1016/j.neuron.2013.05.012	http://dx.doi.org/10.1016/j.neuron.2013.05.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23830830	Bronze, Green Accepted			2022-12-25	WOS:000322426200011
J	Chen, HY; Chen, X; Zheng, YX				Chen, Haiyang; Chen, Xin; Zheng, Yixian			The Nuclear Lamina Regulates Germline Stem Cell Niche Organization via Modulation of EGFR Signaling	CELL STEM CELL			English	Article							SOMATIC SUPPORT CELLS; B-TYPE LAMINS; DROSOPHILA TESTIS; SELF-RENEWAL; MAP KINASE; EYE DEVELOPMENT; DIFFERENTIATION; RECEPTOR; SPERMATOGENESIS; PROLIFERATION	Stem cell niche interactions have been studied extensively with regard to cell polarity and extracellular signaling. Less is known about the way in which signals and polarity cues integrate with intracellular structures to ensure appropriate niche organization and function. Here, we report that nuclear lamins function in the cyst stem cells (CySCs) of Drosophila testes to control the interaction of CySCs with the hub. This interaction is important for regulation of CySC differentiation and organization of the niche that supports the germline stem cells (GSCs). Lamin promotes nuclear retention of phosphorylated ERK in the CySC lineage by regulating the distribution of specific nucleoporins within the nuclear pores. Lamin-regulated nuclear epidermal growth factor (EGF) receptor signaling in the CySC lineage is essential for proliferation and differentiation of the GSCs and the transient amplifying germ cells. Thus, we have uncovered a role for the nuclear lamina in the integration of EGF signaling to regulate stem cell niche function.	[Chen, Haiyang; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Chen, Xin; Zheng, Yixian] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu			NIH [R01 GM056312, R01 HD065816]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Allan Spradling and members of his group for valuable support; Drs. Mark Van Doren, Mitchell Dushay, Lori Wallrath, Kristen Johansen, Erica Selva, Silvia Gigliotti, and Ruth Lehmann for fly strains and antibodies; and Matthew Sieber, Alexis Marianes, William Yarosh, and members of the Zheng lab for critical comments. This work was supported by NIH grants R01 GM056312 (to Y.Z.) and R01 HD065816 (to X.C.).	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Al-Haboubi T, 2011, NUCLEUS-PHILA, V2, P500, DOI 10.4161/nucl.2.5.17913; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Herranz H, 2012, GENE DEV, V26, P1602, DOI 10.1101/gad.192021.112; Hime GR, 1996, J CELL SCI, V109, P2779; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kim Y, 2012, NUCLEUS-PHILA, V3, P256, DOI 10.4161/nucl.20392; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lim JGY, 2012, P NATL ACAD SCI USA, V109, P18477, DOI 10.1073/pnas.1215516109; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Parrott BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036460; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pignoni F, 1997, DEVELOPMENT, V124, P271; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2002, DEVELOPMENT, V129, P4523; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tarayrah L, 2013, DEVELOPMENT, V140, P1014, DOI 10.1242/dev.089433; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; XU T, 1993, DEVELOPMENT, V117, P1223; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Zhao DB, 2000, J CELL SCI, V113, P3781; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919; Zoller Richard, 2012, Spermatogenesis, V2, P145	58	55	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					73	86		10.1016/j.stem.2013.05.003	http://dx.doi.org/10.1016/j.stem.2013.05.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23827710	Green Accepted, Bronze			2022-12-25	WOS:000329570100014
J	Roberson, DP; Gudes, S; Sprague, JM; Patoski, HAW; Robson, VK; Blasl, F; Duan, B; Oh, SB; Bean, BP; Ma, QF; Binshtok, AM; Woolf, CJ				Roberson, David P.; Gudes, Sagi; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Blasl, Felix; Duan, Bo; Oh, Seog Bae; Bean, Bruce P.; Ma, Qiufu; Binshtok, Alexander M.; Woolf, Clifford J.			Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNEL BLOCKERS; DRY SKIN ITCH; BEHAVIORAL-RESPONSES; PAR-2 AGONIST; HISTAMINE H1; SPINAL-CORD; NOCICEPTORS; RECEPTOR; MICE; MOUSE	The peripheral terminals of primary sensory neurons detect histamine and non-histamine itch-provoking ligands through molecularly distinct transduction mechanisms. It remains unclear, however, whether these distinct pruritogens activate the same or different afferent fibers. Using a strategy of reversibly silencing specific subsets of murine pruritogen-sensitive sensory axons by targeted delivery of a charged sodium-channel blocker, we found that functional blockade of histamine itch did not affect the itch evoked by chloroquine or SLIGRL-NH2, and vice versa. Notably, blocking itch-generating fibers did not reduce pain-associated behavior. However, silencing TRPV1(+) or TRPA1(+) neurons allowed allyl isothiocyanate or capsaicin, respectively, to evoke itch, implying that certain peripheral afferents may normally indirectly inhibit algogens from eliciting itch. These findings support the presence of functionally distinct sets of itch-generating neurons and suggest that targeted silencing of activated sensory fibers may represent a clinically useful anti-pruritic therapeutic approach for histaminergic and non-histaminergic pruritus.	[Roberson, David P.; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Oh, Seog Bae; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Roberson, David P.; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Oh, Seog Bae; Woolf, Clifford J.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Roberson, David P.; Duan, Bo; Bean, Bruce P.; Ma, Qiufu; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Gudes, Sagi; Blasl, Felix; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Gudes, Sagi; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Sprague, Jared M.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Duan, Bo; Ma, Qiufu] Dana Farber Canc Inst, Boston, MA 02115 USA; [Oh, Seog Bae] Seoul Natl Univ, Natl Res Lab Pain, Dent Res Inst, Seoul, South Korea; [Oh, Seog Bae] Seoul Natl Univ, Sch Dent, Dept Neurobiol & Physiol, Seoul, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Harvard School of Dental Medicine; Harvard University; Dana-Farber Cancer Institute; Seoul National University (SNU); Seoul National University (SNU)	Binshtok, AM (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel.	alexanderb@ekmd.huji.ac.il; clifford.woolf@childrens.harvard.edu	OH, Seog Bae/AAQ-2478-2020; Woolf, Clifford/A-9784-2010	Bradford, Victoria/0000-0003-1825-0035; Binshtok, Alexander/0000-0002-3620-8116; Oh, Seog Bae/0000-0001-7975-6895	US National Institutes of Health [NS072040, NS047710]; Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047710, P01NS072040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ghasemlou and S. Ross for discussion and O. Viramontes for technical assistance. This study was supported by the US National Institutes of Health (NS072040 to B.P.B., Q.M., B.D. and C.J.W.; NS047710 to B.D. and Q.M.). J.M.S. is a recipient of a Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research.	Akiyama T, 2012, NEUROSCIENCE, V226, P305, DOI 10.1016/j.neuroscience.2012.09.019; Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Akiyama T, 2010, PAIN, V151, P378, DOI 10.1016/j.pain.2010.07.024; Akiyama T, 2011, J NEUROPHYSIOL, V105, P2811, DOI 10.1152/jn.01124.2010; Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Grundmann S, 2011, ANN DERMATOL, V23, P1, DOI 10.5021/ad.2011.23.1.1; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Khalil IF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-249; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; KOPPERT W, 1993, NEUROSCI LETT, V152, P117, DOI 10.1016/0304-3940(93)90497-9; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu T, 2012, NEUROSCI BULL, V28, P145, DOI 10.1007/s12264-012-1207-9; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Namer B, 2013, NAT NEUROSCI, V16, P117, DOI 10.1038/nn.3316; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Patel KN, 2011, ACS CHEM NEUROSCI, V2, P17, DOI 10.1021/cn100085g; Petersen LJ, 1997, ALLERGY, V52, P547, DOI 10.1111/j.1398-9995.1997.tb02598.x; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Roberson DP, 2011, BRIT J PHARMACOL, V164, P48, DOI 10.1111/j.1476-5381.2011.01391.x; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yosipovitch G, 2008, CURR ALLERGY ASTHM R, V8, P306, DOI 10.1007/s11882-008-0049-z	46	98	100	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					910	U176		10.1038/nn.3404	http://dx.doi.org/10.1038/nn.3404			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685721	Green Submitted, Green Accepted			2022-12-25	WOS:000321180900025
J	Izuma, K; Adolphs, R				Izuma, Keise; Adolphs, Ralph			Social Manipulation of Preference in the Human Brain	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; MULTISOURCE INTERFERENCE TASK; ERROR-RELATED NEGATIVITY; COGNITIVE-DISSONANCE; DECISION-MAKING; ATTITUDE-CHANGE; NEURAL SYSTEM; REWARD; FMRI	Our preferences are influenced by what other people like, but depend critically on how we feel about those people, a classical psychological effect called "cognitive balance." Here, we manipulated preferences for goods by telling participants the preferences of strongly liked or disliked groups of other people. Participants' preferences converged to those of the liked group, but diverged from the disliked group. Activation of dorsomedial prefrontal cortex (dmPFC) tracked the discrepancy between one's own preference and its social ideal and was associated with subsequent preference change (toward the liked and away from the disliked group), even several months later. A follow-up study found overlapping activation in this same region of dmPFC with negative monetary outcomes, but no overlap with nearby activations induced by response conflict. A single social encounter can thus result in long-lasting preference change, a mechanism that recruits dmPFC and that may reflect the aversive nature of cognitive imbalance.	[Izuma, Keise; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology	Izuma, K (corresponding author), CALTECH, Div Humanities & Social Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	izuma@caltech.edu			Japan Society for the Promotion of Science Fellows; National Science Foundation; National Institute of Mental Health; Gordon and Betty Moore Foundation; Tamagawa University Global Centers of Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER; Direct For Biological Sciences [0922982] Funding Source: National Science Foundation	Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Tamagawa University Global Centers of Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank John P. O'Doherty and Dan Kennedy for helpful comments on the manuscript, and the staff of the Caltech Brain Imaging Center for their assistance in conducting the fMRI. This work was funded by the Japan Society for the Promotion of Science Fellows (K.I.), as well as the National Science Foundation, a Conte Center grant from the National Institute of Mental Health, the Gordon and Betty Moore Foundation, and the Tamagawa University Global Centers of Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (R.A.).	Abelson R.P., 1968, THEORIES COGNITIVE C; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Berns GS, 2010, NEUROIMAGE, V49, P2687, DOI 10.1016/j.neuroimage.2009.10.070; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Campbell-Meiklejohn DK, 2012, NEUROPSYCHOPHARMACOL, V37, P1517, DOI 10.1038/npp.2011.337; Campbell-Meiklejohn DK, 2012, CURR BIOL, V22, pR123, DOI 10.1016/j.cub.2012.01.012; Campbell-Meiklejohn DK, 2010, CURR BIOL, V20, P1165, DOI 10.1016/j.cub.2010.04.055; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gawronski B., 2012, COGNITIVE CONSISTENC; Gawronski B, 2012, SOC COGNITION, V30, P652, DOI 10.1521/soco.2012.30.6.652; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Henson R, 2006, TRENDS COGN SCI, V10, P64, DOI 10.1016/j.tics.2005.12.005; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; INSKO CA, 1984, ADV EXP SOC PSYCHOL, V18, P89, DOI 10.1016/S0065-2601(08)60143-4; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Klucharev V, 2011, J NEUROSCI, V31, P11934, DOI 10.1523/JNEUROSCI.1869-11.2011; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; OSGOOD CE, 1955, PSYCHOL REV, V62, P42, DOI 10.1037/h0048153; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Ullsperger M, 2004, TRENDS COGN SCI, V8, P445, DOI 10.1016/j.tics.2004.08.013; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413; Walther E., 2012, COGNITIVE CONSISTENC, P351; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Zajonc R.B., 1968, HDB SOCIAL PSYCHOL, P320; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057	56	121	123	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2013	78	3					563	573		10.1016/j.neuron.2013.03.023	http://dx.doi.org/10.1016/j.neuron.2013.03.023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	144SW	23664619	Green Accepted, Bronze			2022-12-25	WOS:000318961700017
J	Suberbielle, E; Sanchez, PE; Kravitz, AV; Wang, X; Ho, K; Eilertson, K; Devidze, N; Kreitzer, AC; Mucke, L				Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Eilertson, Kirsten; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart			Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-beta	NATURE NEUROSCIENCE			English	Article							SYNTHETIC SUPEROXIDE-DISMUTASE; ALZHEIMERS-DISEASE; MOUSE MODELS; COGNITIVE IMPAIRMENTS; OXIDATIVE STRESS; HISTONE H2A.X; DAMAGE; DYSFUNCTION; REPAIR; PHOSPHORYLATION	We show that a natural behavior, exploration of a novel environment, causes DNA double-strand breaks (DSBs) in neurons of young adult wild-type mice. DSBs occurred in multiple brain regions, were most abundant in the dentate gyrus, which is involved in learning and memory, and were repaired within 24 h. Increasing neuronal activity by sensory or optogenetic stimulation increased neuronal DSBs in relevant but not irrelevant networks. Mice transgenic for human amyloid precursor protein (hAPP), which simulate key aspects of Alzheimer's disease, had increased neuronal DSBs at baseline and more severe and prolonged DSBs after exploration. Interventions that suppress aberrant neuronal activity and improve learning and memory in hAPP mice normalized their levels of DSBs. Blocking extrasynaptic NMDA-type glutamate receptors prevented amyloid-beta (A beta)-induced DSBs in neuronal cultures. Thus, transient increases in neuronal DSBs occur as a result of physiological brain activity, and A beta exacerbates DNA damage, most likely by eliciting synaptic dysfunction.	[Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Kreitzer, Anatol C.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Eilertson, Kirsten] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu	Suberbielle, Elsa/K-5416-2014	Suberbielle, Elsa/0000-0002-4554-471X; Eilertson, Kirsten/0000-0003-4850-1210; Kravitz, Alexxai/0000-0001-5983-0218	US National Institutes of Health [AG011385, AG022074, NS065780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG011385, R01AG011385] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.J. Selkoe (Harvard Medical School) and D.M. Walsh (Conway Institute and University College Dublin) for CHO-7PA2 cells; N. Sakane, E. Verdin and L. Verret for comments on the manuscript; H. Kassler for advice on gamma-irradiation; D. Davalos for advice on confocal imaging; D. Pathak for advice on live cell imaging; H. Solanoy, M. Thwin, C. Wang and G.-Q. Yu for technical support; A.L. Lucido for editorial review; J. Carroll, T. Roberts, G. Maki and C. Goodfellow for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by US National Institutes of Health grants AG011385, AG022074 and NS065780 to L.M. and a gift from the S.D. Bechtel, Jr. Foundation.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Canugovi C, 2012, P NATL ACAD SCI USA, V109, P14948, DOI 10.1073/pnas.1204156109; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crowe SL, 2006, EUR J NEUROSCI, V23, P2351, DOI 10.1111/j.1460-9568.2006.04768.x; Crowe SL, 2011, J NEUROSCI, V31, P7648, DOI 10.1523/JNEUROSCI.0092-11.2011; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee SY, 2010, J BIOL CHEM, V285, P29525, DOI 10.1074/jbc.M110.127233; Li Luming, 2011, Int J Alzheimers Dis, V2011, P171464, DOI 10.4061/2011/171464; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Roberson E.D., 2007, NAT REV NEUROSCI, V316, P750; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000	55	293	307	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					613	+		10.1038/nn.3356	http://dx.doi.org/10.1038/nn.3356			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525040	Green Accepted, Green Submitted			2022-12-25	WOS:000318029300018
J	Jeanne, JM; Sharpee, TO; Gentner, TQ				Jeanne, James M.; Sharpee, Tatyana O.; Gentner, Timothy Q.			Associative Learning Enhances Population Coding by Inverting Interneuronal Correlation Patterns	NEURON			English	Article							NEURONAL POPULATIONS; INHIBITORY NEURONS; SONG; CORTEX; CELLS; CONNECTIVITY; ACCURACY; MOTOR; REPRESENTATIONS; INFORMATION	Learning-dependent cortical encoding has been well described in single neurons. But behaviorally relevant sensory signals drive the coordinated activity of millions of cortical neurons; whether learning produces stimulus-specific changes in population codes is unknown. Because the pattern of firing rate correlations between neurons-an emergent property of neural populations-can significantly impact encoding fidelity, we hypothesize that it is a target for learning. Using an associative learning procedure, we manipulated the behavioral relevance of natural acoustic signals and examined the evoked spiking activity in auditory cortical neurons in songbirds. We show that learning produces stimulus-specific changes in the pattern of interneuronal correlations that enhance the ability of neural populations to recognize signals relevant for behavior. This learning-dependent enhancement increases with population size. The results identify the pattern of interneuronal correlation in neural populations as a target of learning that can selectively enhance the representations of specific sensory signals.	[Jeanne, James M.; Sharpee, Tatyana O.; Gentner, Timothy Q.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Jeanne, James M.; Gentner, Timothy Q.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Sharpee, Tatyana O.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Gentner, Timothy Q.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Jeanne, James M.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Gentner, TQ (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	tgentner@ucsd.edu		Sharpee, Tatyana/0000-0002-7483-5081; Jeanne, James/0000-0001-7657-202X	NIH [R01DC008358, R01EY019493]; Alfred P. Sloan Foundation; Searle Scholars Program; Center for Theoretical Biological Physics (NSF); W.M. Keck Foundation; Ray Thomas Edwards Career award in Biomedical Sciences; McKnight Scholar Award; NSF; Institute for Neural Computation (UCSD); NATIONAL EYE INSTITUTE [R01EY019493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008358] Funding Source: NIH RePORTER; Division Of Physics [1308264] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholars Program; Center for Theoretical Biological Physics (NSF); W.M. Keck Foundation(W.M. Keck Foundation); Ray Thomas Edwards Career award in Biomedical Sciences; McKnight Scholar Award; NSF(National Science Foundation (NSF)); Institute for Neural Computation (UCSD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank W. Kristan and D. Margoliash for comments on an earlier version of this manuscript and the members of the Gentner and Sharpee laboratories for conversations. This work was supported by a grant from the NIH (R01DC008358) to T.Q.G., grants from the NIH (R01EY019493), the Alfred P. Sloan Foundation, the Searle Scholars Program, the Center for Theoretical Biological Physics (NSF), the W.M. Keck Foundation, the Ray Thomas Edwards Career award in Biomedical Sciences, and the McKnight Scholar Award to T.O.S., and by an NSF Graduate Research Fellowship and an Institute for Neural Computation (UCSD) Fellowship to J.M.J. J.M.J., T.O.S., and T.Q.G. designed research. J.M.J. performed research. J.M.J., T.O.S., and T.Q.G. analyzed data and wrote the paper.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001111; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jeanne JM, 2011, J NEUROSCI, V31, P2595, DOI 10.1523/JNEUROSCI.3930-10.2011; Knudsen D.P., 2013, J NEUROPHYSIOL; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Long JS, 1997, REGRESSION MODELS CA; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Meliza CD, 2012, J NEUROSCI, V32, P15158, DOI 10.1523/JNEUROSCI.0845-12.2012; Meliza CD, 2010, J NEUROPHYSIOL, V103, P1195, DOI 10.1152/jn.00464.2009; MICHALSKI A, 1983, EXP BRAIN RES, V51, P97; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Schmajuk N., 1998, OCCASION SETTING ASS, V1, DOI [10.1037/10298-000, DOI 10.1037/10298-000]; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Tamura H, 2004, J NEUROPHYSIOL, V91, P2782, DOI 10.1152/jn.01267.2003; Thompson JV, 2013, J NEUROPHYSIOL, V109, P721, DOI 10.1152/jn.00262.2012; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	51	84	84	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2013	78	2					352	363		10.1016/j.neuron.2013.02.023	http://dx.doi.org/10.1016/j.neuron.2013.02.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134HY	23622067	Bronze, Green Accepted			2022-12-25	WOS:000318202200014
J	Peck, CJ; Lau, B; Salzman, CD				Peck, Christopher J.; Lau, Brian; Salzman, C. Daniel			The primate amygdala combines information about space and value	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AVERSIVE STIMULI; PARIETAL CORTEX; RHESUS-MONKEY; NEURAL BASES; ATTENTION; REWARD; EMOTION; NEURONS	A stimulus predicting reinforcement can trigger emotional responses, such as arousal, and cognitive ones, such as increased attention toward the stimulus. Neuroscientists have long appreciated that the amygdala mediates spatially nonspecific emotional responses, but it remains unclear whether the amygdala links motivational and spatial representations. To test whether amygdala neurons encode spatial and motivational information, we presented reward-predictive cues in different spatial configurations to monkeys and assessed how these cues influenced spatial attention. Cue configuration and predicted reward magnitude modulated amygdala neural activity in a coordinated fashion. Moreover, fluctuations in activity were correlated with trial-to-trial variability in spatial attention. Thus, the amygdala integrates spatial and motivational information, which may influence the spatial allocation of cognitive resources. These results suggest that amygdala dysfunction may contribute to deficits in cognitive processes normally coordinated with emotional responses, such as the directing of attention toward the location of emotionally relevant stimuli.	[Peck, Christopher J.; Lau, Brian; Salzman, C. Daniel] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Salzman, C. Daniel] Columbia Univ, Dept Psychiat, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, WM Keck Ctr Brain Plast & Cognit, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY USA; [Salzman, C. Daniel] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Salzman, CD (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	cds2005@columbia.edu	Lau, Brian/D-6991-2011	Lau, Brian/0000-0001-8615-8244	US National Institute of Mental Health (NIMH) [R01 MH082017]; US National Institute on Drug Abuse [R01 DA020656]; US National Eye Institute (NEI) [P30-EY19007]; NIH [T32-HD07430, T32-NS06492, T32-EY139333]; NIMH [T32-MH015144]; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015144, R01MH082017, T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020656] Funding Source: NIH RePORTER	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Eye Institute (NEI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Kandel and K. Louie for discussions and comments on the manuscript, S. Dashnaw for MRI support, G. Asfaw for veterinary support, and K. Marmon and N. Macfarlane for technical support. This research was supported by grants to C.D.S. from the US National Institute of Mental Health (NIMH) (R01 MH082017) and the US National Institute on Drug Abuse (R01 DA020656), and by a core grant from the US National Eye Institute (NEI) (P30-EY19007) to Columbia University; C.J.P. received support from NIH (T32-HD07430, T32-NS06492 and T32-EY139333); B.L. received support from the NIMH (T32-MH015144) and the Helen Hay Whitney Foundation.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DEMETER S, 1990, J COMP NEUROL, V302, P29, DOI 10.1002/cne.903020104; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Freese J.L., 2009, HUMAN AMYGDALA; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kaping D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001224; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kennerley SW, 2009, J NEUROSCI, V29, P3259, DOI 10.1523/JNEUROSCI.5353-08.2009; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Ohman A., 2003, HDB AFFECTIVE SCI; Padmala S, 2008, J NEUROSCI, V28, P6202, DOI 10.1523/JNEUROSCI.1233-08.2008; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reason J. T., 1984, VARIETIES ATTENTION; Roesch MR, 2010, J NEUROPHYSIOL, V104, P587, DOI 10.1152/jn.00173.2010; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; URSIN H, 1960, ELECTROEN CLIN NEURO, V12, P1, DOI 10.1016/0013-4694(60)90058-4; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341	50	94	94	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					340	348		10.1038/nn.3328	http://dx.doi.org/10.1038/nn.3328			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23377126	Green Accepted			2022-12-25	WOS:000315474800017
J	Kozar, S; Morrissey, E; Nicholson, AM; van der Heijden, M; Zecchini, HI; Kemp, R; Tavare, S; Vermeulen, L; Winton, DJ				Kozar, Sarah; Morrissey, Edward; Nicholson, Anna M.; van der Heijden, Maartje; Zecchini, Heather I.; Kemp, Richard; Tavare, Simon; Vermeulen, Louis; Winton, Douglas J.			Continuous Clonal Labeling Reveals Small Numbers of Functional Stem Cells in Intestinal Crypts and Adenomas	CELL STEM CELL			English	Article							IN-VIVO; MOUSE; EXPRESSION; LGR5; PROLIFERATION; PATTERN; COLON; BMI1	Lineage-tracing approaches, widely used to characterize stem cell populations, rely on the specificity and stability of individual markers for accurate results. We present a method in which genetic labeling in the intestinal epithelium is acquired as a mutation-induced clonal mark during DNA replication. By determining the rate of mutation in vivo and combining this data with the known neutral-drift dynamics that describe intestinal stem cell replacement, we quantify the number of functional stem cells in crypts and adenomas. Contrary to previous reports, we find that significantly lower numbers of "working" stem cells are present in the intestinal epithelium (five to seven per crypt) and in adenomas (nine per gland), and that those stem cells are also replaced at a significantly lower rate. These findings suggest that the bulk of tumor stem cell divisions serve only to replace stem cell loss, with rare clonal victors driving gland repopulation and tumor growth.	[Kozar, Sarah; Morrissey, Edward; Nicholson, Anna M.; van der Heijden, Maartje; Zecchini, Heather I.; Kemp, Richard; Tavare, Simon; Vermeulen, Louis; Winton, Douglas J.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [van der Heijden, Maartje; Vermeulen, Louis] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Winton, DJ (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	doug.winton@cruk.cam.ac.uk	Vermeulen, Louis/B-7488-2008	Vermeulen, Louis/0000-0002-6066-789X; Kemp, Richard/0000-0002-0121-7709; Morrissey, Edward/0000-0003-1021-5358	Cancer Research UK; KWF fellowship from the Dutch Cancer Society; Cancer Research UK [19556, 17044, 22310] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF fellowship from the Dutch Cancer Society; Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK, and L.V. is the recipient of a KWF fellowship from the Dutch Cancer Society. We gratefully acknowledge the following core facilities at the Cancer Research UK Cambridge Institute: the Transgenic Laboratory, the Biological Resources Unit, and Histopathology.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Humphries A, 2013, P NATL ACAD SCI USA, V110, pE2490, DOI 10.1073/pnas.1220353110; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; McCutcheon SC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-89; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nygren JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003710; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wasan HS, 1998, J PATHOL, V185, P246; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yamada NA, 2002, MUTAT RES-FUND MOL M, V499, P213, DOI 10.1016/S0027-5107(01)00282-2; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	29	151	155	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 7	2013	13	5					626	633		10.1016/j.stem.2013.08.001	http://dx.doi.org/10.1016/j.stem.2013.08.001			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VX	24035355	Bronze			2022-12-25	WOS:000329571500014
J	Ali, F; Otchy, TM; Pehlevan, C; Fantana, AL; Burak, Y; Olveczky, BP				Ali, Farhan; Otchy, Timothy M.; Pehlevan, Cengiz; Fantana, Antoniu L.; Burak, Yoram; Oelveczky, Bence P.			The Basal Ganglia Is Necessary for Learning Spectral, but Not Temporal, Features of Birdsong	NEURON			English	Article							ZEBRA FINCH SONG; AUDITORY-FEEDBACK; ADULT BIRDSONG; TELENCEPHALIC NUCLEUS; SEQUENCE GENERATION; FOREBRAIN CIRCUIT; VOCAL PLASTICITY; SOCIAL-CONTEXT; MOTOR PATHWAY; NEURONS	Executing a motor skill requires the brain to control which muscles to activate at what times. How these aspects of control-motor implementation and timing-are acquired, and whether the learning processes underlying them differ, is not well understood. To address this, we used a reinforcement learning paradigm to independently manipulate both spectral and temporal features of birdsong, a complex learned motor sequence, while recording and perturbing activity in underlying circuits. Our results uncovered a striking dissociation in how neural circuits underlie learning in the two domains. The basal ganglia was required for modifying spectral, but not temporal, structure. This functional dissociation extended to the descending motor pathway, where recordings from a premotor cortex analog nucleus reflected changes to temporal, but not spectral, structure. Our results reveal a strategy in which the nervous system employs different and largely independent circuits to learn distinct aspects of a motor skill.	[Ali, Farhan; Fantana, Antoniu L.; Oelveczky, Bence P.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Ali, Farhan; Otchy, Timothy M.; Pehlevan, Cengiz; Fantana, Antoniu L.; Burak, Yoram; Oelveczky, Bence P.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Otchy, Timothy M.] Harvard Univ, Program Neurosci, Cambridge, MA 02138 USA; [Pehlevan, Cengiz; Burak, Yoram] Harvard Univ, Swartz Program Theoret Neurosci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Olveczky, BP (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	olveczky@fas.harvard.edu	Burak, Yoram/AAC-9112-2019; Ali, Farhan/AAA-6193-2019	Ali, Farhan/0000-0003-4519-7903; Olveczky, Bence/0000-0003-2499-2705; Pehlevan, Cengiz/0000-0001-9767-6063	NINDS [R01 NS066408]; McKnight Scholar Award; Klingenstein Fellowship; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066408] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKnight Scholar Award; Klingenstein Fellowship(Klingenstein Philanthropies); Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ed Soucy for assistance with the OAF software and Stephen Turney and the Harvard University Neurobiology Department and the Neurobiology Imaging Facility for imaging consultation and equipment use. We acknowledge Jesse Goldberg, Aaron Andalman, Rajesh Poddar, Naoshige Uchida, Markus Meister, Evan Feinberg, Maurice Smith, and Kenneth Blum for helpful discussions and feedback on the manuscript. This work was supported by a grant from NINDS (R01 NS066408), a McKnight Scholar Award and Klingenstein Fellowship to B.P.O., and a Swartz Foundation postdoctoral fellowship to C.P.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Aronov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047856; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Cai SQ, 2011, J NEUROSCI, V31, P16483, DOI 10.1523/JNEUROSCI.3653-11.2011; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Crandall SR, 2007, J NEUROPHYSIOL, V97, P806, DOI 10.1152/jn.00907.2006; Diuk C, 2013, J NEUROSCI, V33, P5797, DOI 10.1523/JNEUROSCI.5445-12.2013; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 1996, ADV NEURAL INFORMATI, P101; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Farries MA, 2002, J NEUROSCI, V22, P3776; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Foster EF, 2001, J NEUROBIOL, V46, P142, DOI 10.1002/1097-4695(20010205)46:2<142::AID-NEU60>3.0.CO;2-R; GENTNER DR, 1987, PSYCHOL REV, V94, P255, DOI 10.1037/0033-295X.94.2.255; Glaze CM, 2013, J NEUROPHYSIOL, V109, P1025, DOI 10.1152/jn.00578.2012; Glaze CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037616; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goldberg JH, 2011, J NEUROPHYSIOL, V105, P2729, DOI 10.1152/jn.00823.2010; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hamaguchi K, 2012, J NEUROSCI, V32, P11671, DOI 10.1523/JNEUROSCI.1666-12.2012; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Immelmann K., 1969, P61; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2008, J NEUROSCI, V28, P13232, DOI 10.1523/JNEUROSCI.2250-08.2008; Kojima S, 2013, P NATL ACAD SCI USA, V110, P4756, DOI 10.1073/pnas.1216308110; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Konishi M, 2010, BRAIN LANG, V115, P18, DOI 10.1016/j.bandl.2010.05.001; Kopuchian C, 2004, ANIM BEHAV, V68, P551, DOI 10.1016/j.anbehav.2003.10.025; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Lipkind D, 2011, P NATL ACAD SCI USA, V108, P15572, DOI 10.1073/pnas.1012941108; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Olveczky BP, 2011, J NEUROPHYSIOL, V106, P386, DOI 10.1152/jn.00018.2011; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Person AL, 2008, J COMP NEUROL, V508, P840, DOI 10.1002/cne.21699; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Sizemore M, 2011, P NATL ACAD SCI USA, V108, P17492, DOI 10.1073/pnas.1104255108; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Stepanek L, 2010, J NEUROPHYSIOL, V104, P2474, DOI 10.1152/jn.00977.2009; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Thompson JA, 2011, J NEUROSCI, V31, P322, DOI 10.1523/JNEUROSCI.5967-09.2011; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; VU ET, 1994, J NEUROSCI, V14, P6924; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032178; Wonke G, 2009, J ORNITHOL, V150, P117, DOI 10.1007/s10336-008-0326-6; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	71	85	86	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					494	506		10.1016/j.neuron.2013.07.049	http://dx.doi.org/10.1016/j.neuron.2013.07.049			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24075977	Green Accepted, Bronze			2022-12-25	WOS:000326196400028
J	Li, Y; Wang, HY; Muffat, J; Cheng, AW; Orlando, DA; Loven, J; Kwok, SM; Feldman, DA; Bateup, HS; Gao, Q; Hockemeyer, D; Mitalipova, M; Lewis, CA; Vander Heiden, MG; Sur, M; Young, RA; Jaenisch, R				Li, Yun; Wang, Haoyi; Muffat, Julien; Cheng, Albert W.; Orlando, David A.; Loven, Jakob; Kwok, Show-ming; Feldman, Danielle A.; Bateup, Helen S.; Gao, Qing; Hockemeyer, Dirk; Mitalipova, Maisam; Lewis, Caroline A.; Vander Heiden, Matthew G.; Sur, Mriganka; Young, Richard A.; Jaenisch, Rudolf			Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons	CELL STEM CELL			English	Article							MOUSE MODEL; MITOCHONDRIAL ABNORMALITIES; NEURAL CONVERSION; MUTANT MICE; MECP2; DISEASE; EXPRESSION; GENES; DYSFUNCTION; DEFICIENCY	Rett syndrome (RTT) is caused by mutations of MECP2, a methyl CpG binding protein thought to act as a global transcriptional repressor. Here we show, using an isogenic human embryonic stem cell model of RTT, that MECP2 mutant neurons display key molecular and cellular features of this disorder. Unbiased global gene expression analyses demonstrate that MECP2 functions as a global activator in neurons but not in neural precursors. Decreased transcription in neurons was coupled with a significant reduction in nascent protein synthesis and lack of MECP2 was manifested as a severe defect in the activity of the AKT/mTOR pathway. Lack of MECP2 also leads to impaired mitochondrial function in mutant neurons. Activation of AKT/mTOR signaling by exogenous growth factors or by depletion of PTEN boosted protein synthesis and ameliorated disease phenotypes in mutant neurons. Our findings indicate a vital function for MECP2 in maintaining active gene transcription in human neuronal cells.	[Li, Yun; Wang, Haoyi; Muffat, Julien; Cheng, Albert W.; Orlando, David A.; Loven, Jakob; Gao, Qing; Hockemeyer, Dirk; Mitalipova, Maisam; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Kwok, Show-ming; Feldman, Danielle A.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Bateup, Helen S.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Lewis, Caroline A.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Muffat, Julien/P-2298-2014; Li, Yun/C-3367-2011; Young, Richard A/F-6495-2012	Li, Yun/0000-0002-5849-5910; Young, Richard A/0000-0001-8855-8647; Muffat, Julien/0000-0003-1889-7023; Hockemeyer, Dirk/0000-0002-5598-5092; Cheng, Albert/0000-0003-2653-5743	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; IRSF; Croucher scholarship; Swedish Research Council [VR-B0086301]; NIH [R01-HG002668, HD 045022, R37-CA084198]; Koch Institute; Curt Marble Cancer Research Fund; SFARI; ELA foundation;  [P30-CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation(NARSAD); IRSF; Croucher scholarship; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute; Curt Marble Cancer Research Fund; SFARI; ELA foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Ping Xu, Raaji Alagappan, Tenzin Lungjangwa, Dongdong Fu, Daniel B. Dadon, Kibibi Ganz, and Ruth Flannery for technical support; Drs. Bryan Luikart and David Sabatini for PTEN shRNA lentivirus constructs and access to Seahorse XF24; Dr. Carson Thoreen for advice on the protein synthesis assay; Drs. Peter Rahl, Bingbing Yuan, and Jeong-Ah Kwon for assistance with microarray; and members of the Jaenisch lab for helpful discussions. Y.L. was a Simons Postdoctoral Fellow. Y.L. was supported in part by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation and the IRSF. A. W. C. was supported by a Croucher scholarship. J.L. was supported by a Swedish Research Council Postdoctoral Fellowship (VR-B0086301). D.O. and R.Y. were supported by NIH grant R01-HG002668. M. V. H and C. A. L. acknowledge support from P30-CA14051, the Koch Institute, and Curt Marble Cancer Research Fund. R.J. was supported by NIH grants HD 045022 and R37-CA084198, SFARI, and the ELA foundation.	Akbarian S, 2002, AM J PSYCHIAT, V159, P1103, DOI 10.1176/appi.ajp.159.7.1103; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Su D, 2012, EPIGENETICS-US, V7, P146, DOI 10.4161/epi.7.2.18907; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	59	208	213	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					446	458		10.1016/j.stem.2013.09.001	http://dx.doi.org/10.1016/j.stem.2013.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094325	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000329571100013
J	Kang, ZH; Wang, CH; Zepp, J; Wu, L; Sun, K; Zhao, JJ; Chandrasekharan, U; DiCorleto, PE; Trapp, BD; Ransohoff, RM; Li, XX				Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Chandrasekharan, Unni; DiCorleto, Paul E.; Trapp, Bruce D.; Ransohoff, Richard M.; Li, Xiaoxia			Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; ADULT BRAIN; T-CELLS; OLIGODENDROCYTE; MYELIN; CNS	Interleukin 17 (IL-17) is a signature cytokine of Th17 cells. We previously reported that deletion of NF-kappa B activator 1 (Act1), the key transducer of IL-17 receptor signaling, from the neuroectodermal lineage in mice (neurons, oligodendrocytes and astrocytes) results in attenuated severity of experimental autoimmune encephalomyelitis (EAE). Here we examined the cellular basis of this observation. EAE disease course was unaffected by deletion of Act1 in neurons or mature oligodendrocytes, and Act1 deletion in astrocytes only modestly affected disease course. Deletion of Act1 in NG2(+) glia resulted in markedly reduced EAE severity. Furthermore, IL-17 induced characteristic inflammatory mediator expression in NG2(+) glial cells. IL-17 also exhibited strong inhibitory effects on the maturation of oligodendrocyte lineage cells in vitro and reduced their survival. These data identify NG2(+) glia as the major CNS cellular target of IL-17 in EAE. The sensitivity of oligodendrocyte lineage cells to IL-17-mediated toxicity further suggests a direct link between inflammation and neurodegeneration in multiple sclerosis.	[Kang, Zizhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA; [Chandrasekharan, Unni; DiCorleto, Paul E.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Trapp, Bruce D.; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Mississippi Treatment & Res, Cleveland, OH 44106 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021	, Zizhen/0000-0001-5621-8912; Wang, Chenhui/0000-0002-3186-3066	US National Institutes of Health [R01NS071996, P01HL103453]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM088088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG046399] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge W.B. Stallcup (Burnham Institute for Medical Research) for providing antibodies to NG2 and K.-A. Nave for providing Cnp1-cre transgenic mice (Max Planck Institute of Experimental Medicine). We also thank the Dana-Farber Cancer Institute for providing the Olig2-cre transgenic mice. This investigation was supported by grants from the US National Institutes of Health (R01NS071996 and P01HL103453).	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hara H, 2011, J NEUROIMMUNOL, V233, P135, DOI 10.1016/j.jneuroim.2010.12.011; Hisahara S, 2003, NEUROSCI RES, V46, P387, DOI 10.1016/S0168-0102(03)00127-5; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Kaga Y, 2006, J NEUROSCI, V26, P12339, DOI 10.1523/JNEUROSCI.3573-06.2006; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Lev N, 2004, NEUROSCI LETT, V359, P139, DOI 10.1016/j.neulet.2004.01.076; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mc Guire C, 2011, TRENDS NEUROSCI, V34, P619, DOI 10.1016/j.tins.2011.09.002; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Patel J, 2012, INT J MOL SCI, V13, P10647, DOI 10.3390/ijms130810647; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	55	132	137	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1401	+		10.1038/nn.3505	http://dx.doi.org/10.1038/nn.3505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995070	Green Accepted			2022-12-25	WOS:000324795300012
J	Zhang, RR; Cui, QY; Murai, K; Lim, YC; Smith, ZD; Jin, SN; Ye, P; Rosa, L; Lee, YK; Wu, HP; Liu, W; Xu, ZM; Yang, L; Ding, YQ; Tang, FC; Meissner, A; Ding, CM; Shi, YH; Xu, GL				Zhang, Run-Rui; Cui, Qing-Yan; Murai, Kiyohito; Lim, Yen Ching; Smith, Zachary D.; Jin, Shengnan; Ye, Peng; Rosa, Luis; Lee, Yew Kok; Wu, Hai-Ping; Liu, Wei; Xu, Zhi-Mei; Yang, Lu; Ding, Yu-Qiang; Tang, Fuchou; Meissner, Alexander; Ding, Chunming; Shi, Yanhong; Xu, Guo-Liang			Tet1 Regulates Adult Hippocampal Neurogenesis and Cognition	CELL STEM CELL			English	Article							ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; MAMMALIAN DNA; NEURAL STEM; 5-HYDROXYMETHYLCYTOSINE; BRAIN; NEURONS; 5-METHYLCYTOSINE	DNA hydroxylation catalyzed by Tet dioxygenases occurs abundantly in embryonic stem cells and neurons in mammals. However, its biological function in vivo is largely unknown. Here, we demonstrate that Tet1 plays an important role in regulating neural progenitor cell proliferation in adult mouse brain. Mice lacking Tet1 exhibit impaired hippocampal neurogenesis accompanied by poor learning and memory. In adult neural progenitor cells deficient in Tet1, a cohort of genes involved in progenitor proliferation were hypermethylated and downregulated. Our results indicate that Tet1 is positively involved in the epigenetic regulation of neural progenitor cell proliferation in the adult brain.	[Zhang, Run-Rui; Cui, Qing-Yan; Wu, Hai-Ping; Liu, Wei; Xu, Zhi-Mei; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Murai, Kiyohito; Ye, Peng; Rosa, Luis; Shi, Yanhong] City Hope Natl Med Ctr, Beckman Res Inst, Ctr Gene Express & Drug Discovery, Dept Neurosci, Duarte, CA 91010 USA; [Lim, Yen Ching; Jin, Shengnan; Lee, Yew Kok; Ding, Chunming] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Smith, Zachary D.; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yang, Lu; Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Ding, Yu-Qiang] East Hosp, Minist Educ China, Key Lab Arrhythmias, Shanghai 200120, Peoples R China; [Ding, Yu-Qiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; City of Hope; Beckman Research Institute of City of Hope; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Peking University; Ministry of Education, China; Tongji University	Ding, CM (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore.	ding_chunming@sics.a-star.edu.sg; yshi@coh.org; glxu@sibs.ac.cn	Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594; Ding, Yu-Qiang/0000-0003-1202-4635; Shi, Yanhong/0000-0002-3938-5839; Cui, Qingyan/0000-0002-5029-4436	Ministry of Sciences and Technology of China [2012CB966903, 2009CB941101]; National Science Foundation of China [90919061, 31221001]; Chinese Academy of Sciences [XDA01010301]; NIH NINDS [R01 NS059546, RC1 NS068370]; California Institute for Regenerative Medicine [TR2-01832, RB4-06277]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059546, RC1NS068370] Funding Source: NIH RePORTER	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chun-Li Zhang and Qin Shen for comments; Hongjun Song, Haikun Liu, and Guoping Fan for discussions; Jianwei Jiao for Nestin-GFP and Nestin-Cre ERT2 mouse strains; Yujiang Shi for Tet1shRNA; Desmond Ng for help with sequencing; and Chenyan Ma, Ying Huang, Zelan Hu, Ningning Song, and Yingyu Zhang for technical assistance. This work was supported by grants from the Ministry of Sciences and Technology of China (2012CB966903 and 2009CB941101), the National Science Foundation of China (90919061 and 31221001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010301) (to G.-L. X.), NIH NINDS (R01 NS059546 and RC1 NS068370), and the California Institute for Regenerative Medicine (TR2-01832 and RB4-06277) (to Y.S.).	Abbosh C, 2011, J NEUROCHEM, V117, P425, DOI 10.1111/j.1471-4159.2011.07204.x; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Moens L, 2000, NATURE, V407, P461, DOI 10.1038/35035181; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	49	234	251	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					237	245		10.1016/j.stem.2013.05.006	http://dx.doi.org/10.1016/j.stem.2013.05.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23770080	Bronze, Green Accepted			2022-12-25	WOS:000329570600016
J	Choudhury, S; Almendro, V; Merino, VF; Wu, ZH; Maruyama, R; Su, Y; Martins, FC; Fackler, MJ; Bessarabova, M; Kowalczyk, A; Conway, T; Beresford-Smith, B; Macintyre, G; Cheng, YK; Lopez-Bujanda, Z; Kaspi, A; Hu, R; Robens, J; Nikolskaya, T; Haakensen, VD; Schnitt, SJ; Argani, P; Ethington, G; Panos, L; Grant, M; Clark, J; Herlihy, W; Lin, SJ; Chew, G; Thompson, EW; Greene-Colozzi, A; Richardson, AL; Rosson, GD; Pike, M; Garber, JE; Nikolsky, Y; Blum, JL; Au, A; Hwang, ES; Tamimi, RM; Michor, F; Haviv, I; Liu, XS; Sukumar, S; Polyak, K				Choudhury, Sibgat; Almendro, Vanessa; Merino, Vanessa F.; Wu, Zhenhua; Maruyama, Reo; Su, Ying; Martins, Filipe C.; Fackler, Mary Jo; Bessarabova, Marina; Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff; Cheng, Yu-Kang; Lopez-Bujanda, Zoila; Kaspi, Antony; Hu, Rong; Robens, Judith; Nikolskaya, Tatiana; Haakensen, Vilde D.; Schnitt, Stuart J.; Argani, Pedram; Ethington, Gabrielle; Panos, Laura; Grant, Michael; Clark, Jason; Herlihy, William; Lin, S. Joyce; Chew, Grace; Thompson, Erik W.; Greene-Colozzi, April; Richardson, Andrea L.; Rosson, Gedge D.; Pike, Malcolm; Garber, Judy E.; Nikolsky, Yuri; Blum, Joanne L.; Au, Alfred; Hwang, E. Shelley; Tamimi, Rulla M.; Michor, Franziska; Haviv, Izhak; Liu, X. Shirley; Sukumar, Saraswati; Polyak, Kornelia			Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics	CELL STEM CELL			English	Article							HORMONE-INDUCED PROTECTION; GENE-EXPRESSION; STEM-CELLS; MUTATION CARRIERS; GENOMIC SIGNATURE; PREGNANCY; P27(KIP1); INHIBITOR; GROWTH; TUMORIGENESIS	Early full-term pregnancy is one of the most effective natural protections against breast cancer. To investigate this effect, we have characterized the global gene expression and epigenetic profiles of multiple cell types from normal breast tissue of nulliparous and parous women and carriers of BRCA1 or BRCA2 mutations. We found significant differences in CD44(+) progenitor cells, where the levels of many stem cell-related genes and pathways, including the cell-cycle regulator p27, are lower in parous women without BRCA1/BRCA2 mutations. We also noted a significant reduction in the frequency of CD44(+)p27(+) cells in parous women and showed, using explant cultures, that parity-related signaling pathways play a role in regulating the number of p27(+) cells and their proliferation. Our results suggest that pathways controlling p27(+) mammary epithelial cells and the numbers of these cells relate to breast cancer risk and can be explored for cancer risk assessment and prevention.	[Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Martins, Filipe C.; Garber, Judy E.; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Wu, Zhenhua; Cheng, Yu-Kang; Michor, Franziska; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Greene-Colozzi, April; Richardson, Andrea L.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Garber, Judy E.] Dana Farber Canc Inst, Ctr Clin Canc Genet, Boston, MA 02215 USA; [Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Hu, Rong; Garber, Judy E.; Tamimi, Rulla M.; Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Choudhury, Sibgat; Almendro, Vanessa; Maruyama, Reo; Su, Ying; Garber, Judy E.; Polyak, Kornelia] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Robens, Judith; Schnitt, Stuart J.; Richardson, Andrea L.] Harvard Univ, Dept Pathol, Boston, MA 02115 USA; [Wu, Zhenhua; Cheng, Yu-Kang; Tamimi, Rulla M.; Michor, Franziska; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Almendro, Vanessa] Hosp Clin Barcelona, Dept Med, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Merino, Vanessa F.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Argani, Pedram] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Rosson, Gedge D.] Johns Hopkins Univ, Sch Med, Dept Plast Surg, Baltimore, MD 21231 USA; [Martins, Filipe C.] Coimbra Univ Hosp, Dept Obstet & Gynaecol, P-3000354 Coimbra, Portugal; [Martins, Filipe C.] Programa Gulbenkian Formacao Med Avancada, P-1067001 Lisbon, Portugal; [Bessarabova, Marina; Nikolskaya, Tatiana; Nikolsky, Yuri] Thomson Reuters Healthcare & Sci, Encinitas, CA 92024 USA; [Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff; Haviv, Izhak] Univ Melbourne, NICTA Victoria Res Lab, Parkville, Vic 3010, Australia; [Kowalczyk, Adam] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Kowalczyk, Adam; Conway, Thomas; Beresford-Smith, Bryan; Macintyre, Geoff] Univ Melbourne, Dept Comp Sci & Software Engn, Parkville, Vic 3010, Australia; [Lin, S. Joyce; Haviv, Izhak] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Chew, Grace; Thompson, Erik W.] Univ Melbourne, Dept Surg, Parkville, Vic 3010, Australia; [Thompson, Erik W.] Univ Melbourne, Dept Biochem, Parkville, Vic 3010, Australia; [Kaspi, Antony; Haviv, Izhak] Baker IDI Heart & Diabet Inst, Prahran, Vic 3004, Australia; [Robens, Judith; Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Haakensen, Vilde D.] Univ Oslo, Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0424 Oslo, Norway; [Haakensen, Vilde D.] Univ Oslo, Oslo Univ Hosp, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0424 Oslo, Norway; [Ethington, Gabrielle; Panos, Laura; Grant, Michael; Clark, Jason; Herlihy, William; Blum, Joanne L.] Baylor Charles A Sammons Canc Ctr, Dallas, TX 75246 USA; [Thompson, Erik W.] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Pike, Malcolm] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Au, Alfred; Hwang, E. Shelley] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Haviv, Izhak] Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Clarivate; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Baker Heart and Diabetes Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Oslo; University of Oslo; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; St. Vincent's Institute of Medical Research; University of Southern California; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Peter Maccallum Cancer Center; Harvard University	Sukumar, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.	saras@jhmi.edu; kornelia_polyak@dfci.harvard.edu	Nikolskaya, Tatiana/M-5008-2013; Thompson, Erik/GPK-2067-2022; Haviv, Izhak/E-3782-2015; Thompson, Erik W/A-1425-2009	Thompson, Erik/0000-0002-9723-4924; Haviv, Izhak/0000-0002-0837-5005; Thompson, Erik W/0000-0002-9723-4924; Lopez Bujanda, Zoila/0000-0001-5729-7309; Rosson, Gedge/0000-0003-1817-9443; Su, Ying/0000-0003-0462-3865; Kaspi, Antony/0000-0001-6576-5862; Macintyre, Geoff/0000-0003-3906-467X; Haakensen, Vilde Drageset/0000-0003-0864-3628; Correia Martins, Filipe/0000-0001-6459-8206	Avon Foundation; National Cancer Institute [P50 CA89383, P01 CA080111, CA116235-04S1, CA087969]; Susan G. Komen Foundation; Terri Brodeur Foundation; US Army Congressionally Directed Research [W81XWH-07-1-0294]; Victorian Breast Cancer Research Consortium; St. Vincent's Hospital Research Endowment Fund; Victorian Government's OIS Program; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian; Cellex Foundation; NATIONAL CANCER INSTITUTE [P01CA080111, P50CA089393, R01CA116235, P01CA087969] Funding Source: NIH RePORTER	Avon Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Terri Brodeur Foundation; US Army Congressionally Directed Research; Victorian Breast Cancer Research Consortium; St. Vincent's Hospital Research Endowment Fund; Victorian Government's OIS Program; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian(European Commission); Cellex Foundation(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Lisa Cameron in the DFCI Confocal and Light Microscopy Core Facility, members of Dr. Massimo Loda's lab for technical assistance, members of our laboratories and Drs. Elgene Lim and David Livingston for their critical reading of this manuscript, Jonathan Yingling (Eli Lilly) for providing the LY2109761 TGF-beta receptor kinase inhibitor, Drs. Sally Knox, Jeffrey Lamont, and Dao Tuoc (Baylor University Medical Center-Baylor Sammons Cancer Center), Erin Bowlby (University of California San Francisco, San Francisco), and Drs. Eli Golomg and Pikarski (Hadassah Medical Centre) for their help with collecting tissue samples from patients with BRCA1/BRCA2 germline mutation. Samples from the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center were used in this study. We thank contributors, including Indiana University who collected samples used in this study, as well as donors and their families, whose help and participation made this work possible. This work was supported by the Avon Foundation (to K. P. and S. S.), the National Cancer Institute P50 CA89383 and P01 CA080111 (to S.J.S., K. P., and A. L. R.), CA116235-04S1 (to K. P.), and CA087969 (to R. M. T.), the Susan G. Komen Foundation (to R. M., Y.S., I. H., J.E.G., and K. P.), the Terri Brodeur Foundation (to S. C.), US Army Congressionally Directed Research W81XWH-07-1-0294 (to K. P.), the Victorian Breast Cancer Research Consortium (to S.J.L., G. C., and E. W. T.), the St. Vincent's Hospital Research Endowment Fund and the Victorian Government's OIS Program (to E. W. T.), the Programme for Advanced Medical Education funded by Fundacao Calouste Gulbenkian (to F. M.), and the Cellex Foundation (to V.A.).	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Belitskaya-Levy I, 2011, CANCER PREV RES, V4, P1457, DOI 10.1158/1940-6207.CAPR-11-0021; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blakely CM, 2006, CANCER RES, V66, P6421, DOI 10.1158/0008-5472.CAN-05-4235; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boyd NF, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2423; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Chung K, 2012, BREAST CANCER RES TR, V132, P653, DOI 10.1007/s10549-011-1870-y; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Davison EA, 2003, MOL ENDOCRINOL, V17, P2436, DOI 10.1210/me.2003-0199; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Ginger MR, 2003, BREAST CANCER RES, V5, P192, DOI 10.1186/bcr603; GOING JJ, 1988, AM J PATHOL, V130, P193; Haakensen VD, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-77; Haakensen VD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-332; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kowalczyk A, 2011, J COMPUT BIOL, V18, P391, DOI 10.1089/cmb.2010.0272; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Muraoka RS, 2001, J CELL BIOL, V153, P917, DOI 10.1083/jcb.153.5.917; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Poynter JN, 2010, CANCER CAUSE CONTROL, V21, P839, DOI 10.1007/s10552-010-9510-0; Rebbeck TR, 1999, AM J HUM GENET, V64, P1371, DOI 10.1086/302366; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Russo J, 2001, Breast J, V7, P278, DOI 10.1046/j.1524-4741.2001.21033.x; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Russo J, 2008, CANCER EPIDEM BIOMAR, V17, P51, DOI 10.1158/1055-9965.EPI-07-0678; Russo J, 2012, INT J CANCER, V131, P1059, DOI 10.1002/ijc.27323; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shinde SS, 2010, CANCER-AM CANCER SOC, V116, P4933, DOI 10.1002/cncr.25443; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sivaraman L, 2002, J MAMMARY GLAND BIOL, V7, P77, DOI 10.1023/A:1015774524076; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Taylor D, 2009, BREAST CANCER RES TR, V118, P161, DOI 10.1007/s10549-009-0322-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110	58	65	65	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					117	130		10.1016/j.stem.2013.05.004	http://dx.doi.org/10.1016/j.stem.2013.05.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23770079	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000329570100017
J	Goncalves, JT; Anstey, JE; Golshani, P; Portera-Cailliau, C				Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos			Circuit level defects in the developing neocortex of Fragile X mice	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD PLASTICITY; BARREL CORTEX; MOUSE MODEL; MENTAL-RETARDATION; GABA(A) RECEPTOR; VISUAL-CORTEX; STATES; NETWORK; NEURONS; SLEEP	Subtle alterations in how cortical network dynamics are modulated by different behavioral states could disrupt normal brain function and underlie symptoms of neuropsychiatric disorders, including Fragile X syndrome (FXS). Using two-photon calcium imaging and electrophysiology, we recorded spontaneous neuronal ensemble activity in mouse somatosensory cortex. Unanesthetized Fmr1(-/-) mice exhibited abnormally high synchrony of neocortical network activity, especially during the first two postnatal weeks. Neuronal firing rates were threefold higher in Fmr1(-/-) mice than in wild-type mice during whole-cell recordings manifesting Up/Down states (slow-wave sleep, quiet wakefulness), probably as a result of a higher firing probability during Up states. Combined electroencephalography and calcium imaging experiments confirmed that neurons in mutant mice had abnormally high firing and synchrony during sleep. We conclude that cortical networks in FXS are hyperexcitable in a brain state-dependent manner during a critical period for experience-dependent plasticity. These state-dependent network defects could explain the intellectual, sleep and sensory integration dysfunctions associated with FXS.	[Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Portera-Cailliau, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	cpcailliau@mednet.ucla.edu		Anstey, James/0000-0001-6422-0086; Goncalves, J. Tiago/0000-0003-2303-1822	National Institute of Child Health and Human Development [R01HD054453]; National Institute of Neurological Disorders and Stroke [RC1NS068093]; FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068093] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Buonomano, C. Houser, I. Mody and R. Mostany, as well as D. Cantu for helpful discussions and/or valuable comments on the manuscript. We also thank A. Bragin and M. Blumberg for help with EEG recordings and interpretation, J. Gornbein and D. Markovich for help with statistical analyses, and W. Greenough for providing the Fmr1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Child Health and Human Development (R01HD054453), the National Institute of Neurological Disorders and Stroke (RC1NS068093), the FRAXA Research Foundation and the Dana Foundation.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Golshani Peyman, 2008, J Vis Exp, DOI 10.3791/681; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Meredith RM, 2012, TRENDS NEUROSCI, V35, P335, DOI 10.1016/j.tins.2012.03.005; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Mitra P., 2007, OBSERVED BRAIN DYNAM; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2012, NEUROSCIENTIST, V18, P28, DOI 10.1177/1073858410395322; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Testa-Silva G, 2012, CEREB CORTEX, V22, P1333, DOI 10.1093/cercor/bhr224; Van der Molen MJW, 2013, BIOL PSYCHOL, V92, P216, DOI 10.1016/j.biopsycho.2012.11.013; Veasey SC, 2000, SLEEP, V23, P1025; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	56	190	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					903	U166		10.1038/nn.3415	http://dx.doi.org/10.1038/nn.3415			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727819	Green Accepted, Green Submitted			2022-12-25	WOS:000321180900024
J	Steinberg, EE; Keiflin, R; Boivin, JR; Witten, IB; Deisseroth, K; Janak, PH				Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Witten, Ilana B.; Deisseroth, Karl; Janak, Patricia H.			A causal link between prediction errors, dopamine neurons and learning	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ORBITOFRONTAL CORTEX; OPTICAL CONTROL; REWARD; RESPONSES; RAT; REINFORCEMENT; BEHAVIOR; MODULATION	Situations in which rewards are unexpectedly obtained or withheld represent opportunities for new learning. Often, this learning includes identifying cues that predict reward availability. Unexpected rewards strongly activate midbrain dopamine neurons. This phasic signal is proposed to support learning about antecedent cues by signaling discrepancies between actual and expected outcomes, termed a reward prediction error. However, it is unknown whether dopamine neuron prediction error signaling and cue-reward learning are causally linked. To test this hypothesis, we manipulated dopamine neuron activity in rats in two behavioral procedures, associative blocking and extinction, that illustrate the essential function of prediction errors in learning. We observed that optogenetic activation of dopamine neurons concurrent with reward delivery, mimicking a prediction error, was sufficient to cause long-lasting increases in cue-elicited reward-seeking behavior. Our findings establish a causal role for temporally precise dopamine neuron signaling in cue-reward learning, bridging a critical gap between experimental evidence and influential theoretical frameworks.	[Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Steinberg, Elizabeth E.; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Deisseroth, Karl] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Crack Neural Code Program, Stanford, CA 94305 USA; [Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Princeton University; Princeton University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Janak, PH (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	pjanak@gallo.ucsf.edu		Boivin, Josiah/0000-0001-9895-4141; Keiflin, Ronald/0000-0001-5347-7337; Janak, Patricia/0000-0002-3333-9049	US National Institutes of Health [DA015096, AA17072]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; National Science Foundation Graduate Research Fellowship; National Institute of Mental Health; National Institute on Drug Abuse; Michael J Fox Foundation; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149, R01DA015096] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Michael J Fox Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical assistance of M. Olsman, L. Sahuque and R. Reese, and for critical feedback from H. Fields during manuscript preparation. This research was supported by the US National Institutes of Health (grants DA015096 and AA17072 to P.H.J. and a New Innovator award to I.B.W.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (P.H.J.), a National Science Foundation Graduate Research Fellowship (E.E.S.), and grants from the National Institute of Mental Health, the National Institute on Drug Abuse, the Michael J Fox Foundation, the Howard Hughes Medical Institute, and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program (K.D.).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; HOLLAND PC, 1984, J EXP PSYCHOL ANIM B, V10, P476, DOI 10.1037/0097-7403.10.4.476; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Iordanova MD, 2006, EUR J NEUROSCI, V24, P3265, DOI 10.1111/j.1460-9568.2006.05195.x; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Karim BO, 2003, COMPARATIVE MED, V53, P532; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suri RE, 2002, NEURAL NETWORKS, V15, P523, DOI 10.1016/S0893-6080(02)00046-1; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	48	495	500	6	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					966	U248		10.1038/nn.3413	http://dx.doi.org/10.1038/nn.3413			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708143	Green Submitted, Green Accepted			2022-12-25	WOS:000321180900032
J	Nandy, AS; Sharpee, TO; Reynolds, JH; Mitchell, JF				Nandy, Anirvan S.; Sharpee, Tatyana O.; Reynolds, John H.; Mitchell, Jude F.			The Fine Structure of Shape Tuning in Area V4	NEURON			English	Article							MONKEY STRIATE CORTEX; RECEPTIVE-FIELDS; VISUAL-CORTEX; ORIENTATION SELECTIVITY; ATTENTIONAL MODULATION; RESPONSE NORMALIZATION; MULTIPLE STIMULI; MACAQUE; NEURONS; SINGLE	Previous studies have shown that neurons in area V4 are involved in the processing of shapes of intermediate complexity and are sensitive to curvature. These studies also suggest that curvature-tuned neurons are position invariant. We sought to examine the mechanisms that endow V4 neurons with these properties. Consistent with previous studies, we found that response rank order to the most- and least-preferred stimuli was preserved throughout the receptive field. However, a fine-grained analysis of shape tuning revealed a surprising result: V4 neurons tuned to highly curved shapes exhibit very limited translation invariance. At a fine spatial scale, these neurons exhibit local variation in orientation. In contrast, neurons that prefer straight contours exhibit spatially invariant orientation-tuning and homogenous fine-scale orientation maps. Both of these patterns are consistent with a simple orientation-pooling model, with tuning for straight or curved shapes resulting, respectively, from pooling of homogenous or heterogeneous orientation signals inherited from early visual areas.	[Nandy, Anirvan S.; Reynolds, John H.; Mitchell, Jude F.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Nandy, Anirvan S.; Sharpee, Tatyana O.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Nandy, AS (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nandy@salk.edu; jude@salk.edu		Nandy, Anirvan/0000-0002-4225-5349; Sharpee, Tatyana/0000-0002-7483-5081; Mitchell, Jude/0000-0003-0197-7545	NIH [R01 EY019493, R01 EY013802]; Alfred P. Sloan Foundation; W.M. Keck Foundation; Ray Thomas Edward career award in Biomedical Sciences; McKnight Scholar Award; Gatsby Charitable Foundation; Swartz Foundation; Pioneer Fund postdoctoral fellowship; NATIONAL EYE INSTITUTE [R01EY019493, R01EY013802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); W.M. Keck Foundation(W.M. Keck Foundation); Ray Thomas Edward career award in Biomedical Sciences; McKnight Scholar Award; Gatsby Charitable Foundation; Swartz Foundation; Pioneer Fund postdoctoral fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the NIH (R01 EY019493), the Alfred P. Sloan Foundation, the W.M. Keck Foundation, the Ray Thomas Edward career award in Biomedical Sciences, and the McKnight Scholar Award (to T.O.S.); NIH grant R01 EY013802 and the Gatsby Charitable Foundation (to J.H.R.); NIH grant R01 EY013802 and the Swartz Foundation (to J.F.M.); and by a Pioneer Fund postdoctoral fellowship (to A.S.N.). A.S.N. and J.F.M. designed the experiments, collected data, and developed the model and the statistical methods; A.S.N analyzed the data and ran the model simulations; A.S.N., J.F.M., J.H.R., and T.O.S. wrote the manuscript.	Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Bushnell BN, 2011, J NEUROSCI, V31, P12398, DOI 10.1523/JNEUROSCI.1890-11.2011; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carlson ET, 2011, CURR BIOL, V21, P288, DOI 10.1016/j.cub.2011.01.013; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Cox DD, 2008, J NEUROSCI, V28, P10045, DOI 10.1523/JNEUROSCI.2142-08.2008; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Efron B., 1993, INTRO BOOTSTRAP, V57; Feldman J, 2005, PSYCHOL REV, V112, P243, DOI 10.1037/0033-295X.112.1.243; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Lee J, 2010, J NEUROSCI, V30, P3058, DOI 10.1523/JNEUROSCI.3766-09.2010; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Motter BC, 2009, J NEUROSCI, V29, P5749, DOI 10.1523/JNEUROSCI.4496-08.2009; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; SAHANI M, 2003, ADV NEURAL INFORM PR, V15; Tanigawa H, 2010, NAT NEUROSCI, V13, P1542, DOI 10.1038/nn.2676; Tao X, 2012, J NEUROPHYSIOL, V107, P1094, DOI 10.1152/jn.00640.2011; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Yau JM, 2013, CEREB CORTEX, V23, P198, DOI 10.1093/cercor/bhs004; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	42	54	54	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2013	78	6					1102	1115		10.1016/j.neuron.2013.04.016	http://dx.doi.org/10.1016/j.neuron.2013.04.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791199	Bronze, Green Accepted			2022-12-25	WOS:000321026900015
J	Tulpule, A; Kelley, JM; Lensch, MW; McPherson, J; Park, IH; Hartung, O; Nakamura, T; Schlaeger, TM; Shimamura, A; Daley, GQ				Tulpule, Asmin; Kelley, James M.; Lensch, M. William; McPherson, Jade; Park, In Hyun; Hartung, Odelya; Nakamura, Tomoka; Schlaeger, Thorsten M.; Shimamura, Akiko; Daley, George Q.			Pluripotent Stem Cell Models of Shwachman-Diamond Syndrome Reveal a Common Mechanism for Pancreatic and Hematopoietic Dysfunction	CELL STEM CELL			English	Article							MARROW FAILURE SYNDROMES; SBDS GENE; MUTATIONS; DIFFERENTIATION; GENERATION; FEATURES; PROTEIN; DEATH; RNA	Shwachman-Diamond syndrome (SDS), a rare autosomal- recessive disorder characterized by exocrine pancreatic insufficiency and hematopoietic dysfunction, is caused by mutations in the Shwachman-Bodian- Diamond syndrome (SBDS) gene. We created human pluripotent stem cell models of SDS through knockdown of SBDS in human embryonic stem cells (hESCs) and generation of induced pluripotent stem cell (iPSC) lines from two patients with SDS. SBDS-deficient hESCs and iPSCs manifest deficits in exocrine pancreatic and hematopoietic differentiation in vitro, enhanced apoptosis, and elevated protease levels in culture supernatants, which could be reversed by restoring SBDS protein expression through transgene rescue or by supplementing culture media with protease inhibitors. Protease-mediated autodigestion provides a mechanistic link between the pancreatic and hematopoietic phenotypes in SDS, highlighting the utility of hESCs and iPSCs in obtaining novel insights into human disease.	[Tulpule, Asmin; Lensch, M. William; McPherson, Jade; Hartung, Odelya; Schlaeger, Thorsten M.; Shimamura, Akiko; Daley, George Q.] Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Tulpule, Asmin; Daley, George Q.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kelley, James M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Tulpule, Asmin; Lensch, M. William; McPherson, Jade; Hartung, Odelya; Schlaeger, Thorsten M.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lensch, M. William; Daley, George Q.] Howard Hughes Med Inst, New Haven, CT 06520 USA; [Park, In Hyun] Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Nakamura, Tomoka; Shimamura, Akiko] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA; [Shimamura, Akiko] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Shimamura, Akiko] Univ Washington, Seattle, WA 98105 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Yale University; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Daley, GQ (corresponding author), Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Schlaeger, Thorsten/0000-0002-1599-9908	Manton Center for Orphan Disease Research (BCH); NIH [P30 DK056465-10, R01 HL079582-11, R24 DK092760, RC4 DK09091, U01 HL100001, UL1 DE019582]; Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079582, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090913, P30DK056465, R24DK092760] Funding Source: NIH RePORTER	Manton Center for Orphan Disease Research (BCH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shuibing Chen (Weill Cornell Medical College) and Doug Melton (Harvard University) for their help with pancreatic differentiation protocols and Roderick Bronson (Harvard University) for his histopathological expertise. Harry Kozakewich (Boston Children's Hospital [BCH]) provided SDS patient slides. This work was supported by the Manton Center for Orphan Disease Research (BCH); NIH grants P30 DK056465-10, R01 HL079582-11, R24 DK092760, RC4 DK09091, U01 HL100001, and UL1 DE019582; and the Roche Foundation for Anemia Research. G.Q.D. is an investigator of the Howard Hughes Medical Institute.	Austin KM, 2008, J CLIN INVEST, V118, P1511, DOI 10.1172/JCI33764; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Calado RT, 2007, BLOOD, V110, P1141, DOI 10.1182/blood-2007-03-080044; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Hashmi SK, 2011, CLIN GENET, V79, P448, DOI 10.1111/j.1399-0004.2010.01468.x; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Minelli A, 2009, LEUKEMIA, V23, P708, DOI 10.1038/leu.2008.369; Nakashima E, 2004, HUM GENET, V114, P345, DOI 10.1007/s00439-004-1081-2; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rujkijyanont P, 2008, HAEMATOLOGICA, V93, P363, DOI 10.3324/haematol.11579; Shah N, 2010, J CLIN PATHOL, V63, P592, DOI 10.1136/jcp.2010.077677; Shimamura A, 2006, SEMIN HEMATOL, V43, P178, DOI 10.1053/j.seminhematol.2006.04.006; Stormon MO, 2010, J PEDIATR GASTR NUTR, V51, P8, DOI 10.1097/MPG.0b013e3181d67e78; Toiviainen-Salo S, 2007, BONE, V41, P965, DOI 10.1016/j.bone.2007.08.035; Tourlakis ME, 2012, GASTROENTEROLOGY, V143, P481, DOI 10.1053/j.gastro.2012.04.012; Tsangaris E, 2011, J MED GENET, V48, P618, DOI 10.1136/jmg.2011.089821; Woloszynek JR, 2004, BLOOD, V104, P3588, DOI 10.1182/blood-2004-04-1516; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Yamaguchi M, 2007, EXP HEMATOL, V35, P579, DOI 10.1016/j.exphem.2006.12.010; Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06	32	60	62	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					727	736		10.1016/j.stem.2013.04.002	http://dx.doi.org/10.1016/j.stem.2013.04.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23602541	Green Accepted, Bronze			2022-12-25	WOS:000329569900015
J	Hall, DD; Dai, SP; Tseng, PY; Malik, Z; Nguyen, M; Matt, L; Schnizler, K; Shephard, A; Mohapatra, DP; Tsuruta, F; Dolmetsch, RE; Christel, CJ; Lee, A; Burette, A; Weinberg, RJ; Hell, JW				Hall, Duane D.; Dai, Shuiping; Tseng, Pang-Yen; Malik, Zulfiqar; Minh Nguyen; Matt, Lucas; Schnizler, Katrin; Shephard, Andrew; Mohapatra, Durga P.; Tsuruta, Fuminori; Dolmetsch, Ricardo E.; Christel, Carl J.; Lee, Amy; Burette, Alain; Weinberg, Richard J.; Hell, Johannes W.			Competition between alpha-actinin and Ca2+-Calmodulin Controls Surface Retention of the L-type Ca2+ Channel Ca(v)1.2	NEURON			English	Article							PROTEIN-KINASE-II; NEURONAL CLASS-C; CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; HIPPOCAMPAL-NEURONS; SIGNALING COMPLEX; IQ DOMAIN; CALMODULIN; NMDA; SUBUNIT	Regulation of neuronal excitability and cardiac excitation-contraction coupling requires the proper localization of L-type Ca2+ channels. We show that the actin-binding protein a-actinin binds to the C-terminal surface targeting motif of alpha(1)1.2, the central pore-forming Ca(v)1.2 subunit, in order to foster its surface expression. Disruption of alpha-actinin function by dominant-negative or small hairpin RNA constructs reduces Ca(v)1.2 surface localization in human embryonic kidney 293 and neuronal cultures and dendritic spine localization in neurons. We demonstrate that calnnodulin displaces a-actinin from their shared binding site on alpha(1)1.2 upon Ca2+ influx through L-type channel's, but not through NMDAR, thereby triggering loss of Ca(v)1.2 from spines. Coexpression of a Ca2+-(b)inding-deficient calmodulin mutant does not affect basal Ca(v)1.2 surface expression but inhibits its internalization upon Ca2+ influx. We conclude that alpha-actinin stabilizes Ca(v)1.2 at the plasma membrane and that its displacement by Ca2+-calnnodulin triggers Ca(2+-)induced endocytosis of Cav1.2, thus providing an important negative feedback mechanism for Ca2+ influx.	[Hall, Duane D.; Dai, Shuiping; Malik, Zulfiqar; Schnizler, Katrin; Shephard, Andrew; Mohapatra, Durga P.; Hell, Johannes W.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Christel, Carl J.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Tseng, Pang-Yen; Malik, Zulfiqar; Minh Nguyen; Matt, Lucas; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95615 USA; [Tsuruta, Fuminori; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Burette, Alain; Weinberg, Richard J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Iowa; University of Iowa; University of California System; University of California Davis; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Hell, JW (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	jwhell@ucdavis.edu	TSENG, PANG-YEN/B-3218-2013; Hell, Johannes W./P-5085-2019; Mohapatra, Durga/M-2133-2017; Hall, Duane/ACD-6815-2022; Weinberg, Richard/AAC-1898-2020	Mohapatra, Durga/0000-0001-5016-1281; Hall, Duane/0000-0003-2228-0966; Weinberg, Richard/0000-0001-9689-7278; Lee, Amy/0000-0001-8021-0443; Shepherd, Andrew/0000-0002-8440-6192; Matt, Lucas/0000-0003-3235-5140	NIH [HL07121, DK07759, AG00213, AG017502, NS35527, HL087120, DC009433]; American Heart Association [0535235N]; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433, R55DC009433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH training grants HL07121, DK07759, and AG00213 to D.D.H.; AG017502 to J.W.H.; NS35527 to R.J.W.; DC009433 and HL087120 to A.L.; and the American Heart Association grant 0535235N to D.D.H.. The authors thank J. Ulrich, A. Dickey, I. Stein, and C. Cowan for technical support, M. C. Home for input and advice, and M. Navedo, UC Davis, for critically reading the manuscript. K.S. holds stock in Bayer, who produces, among other drugs, Ca channel antagonists for clinical use. K.A. will also join Bayer as an employee in April 2013. R.J.W. is a recipient of a grant from Pfizer for a project that is not directly related to the work in this article.	Allison DW, 1998, J NEUROSCI, V18, P2423; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; Disterhoft J.F., 1994, CALCIUM HYPOTHESIS A; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dzhura I, 2002, J PHYSIOL-LONDON, V545, P399, DOI 10.1113/jphysiol.2002.021881; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Halling D Brent, 2006, Sci STKE, V2006, per1; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; Kepplinger KJF, 2000, FEBS LETT, V477, P161, DOI 10.1016/S0014-5793(00)01791-9; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; LIU J, 1994, MOL PHARMACOL, V45, P1198; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Merrill MA, 2007, BIOCHEMISTRY-US, V46, P8485, DOI 10.1021/bi0623025; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nakamura M, 2000, AM J PHYSIOL-CELL PH, V279, pC480, DOI 10.1152/ajpcell.2000.279.2.C480; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Tavalin SJ, 2004, J NEUROPHYSIOL, V92, P824, DOI 10.1152/jn.00700.2003; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang GQ, 2007, J HYDRO-ENVIRON RES, V1, P1, DOI 10.1016/j.jher.2007.03.001; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Xu XH, 2010, CIRC RES, V107, P620, DOI 10.1161/CIRCRESAHA.110.224717; Zhang J, 2011, J NEUROSCI, V31, P7199, DOI 10.1523/JNEUROSCI.4446-10.2011; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	69	70	70	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					483	497		10.1016/j.neuron.2013.02.032	http://dx.doi.org/10.1016/j.neuron.2013.02.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664615	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000318961700010
J	Lu, W; Bushong, EA; Shih, TP; Ellisman, MH; Nicoll, RA				Lu, Wei; Bushong, Eric A.; Shih, Tiffany P.; Ellisman, Mark H.; Nicoll, Roger A.			The Cell-Autonomous Role of Excitatory Synaptic Transmission in the Regulation of Neuronal Structure and Function	NEURON			English	Article							DENDRITIC SPINE DENSITY; SPONTANEOUS RETINAL ACTIVITY; OCULAR DOMINANCE COLUMNS; VISUAL-CORTEX; ENVIRONMENTAL ENRICHMENT; INTRINSIC EXCITABILITY; STEREOTYPED BEHAVIOR; CRITICAL PERIOD; ADULT-RATS; PLASTICITY	The cell-autonomous role of synaptic transmission in the regulation of neuronal structural and electrical properties is unclear. We have now employed a genetic approach to eliminate glutamatergic synaptic transmission onto individual CA1 pyramidal neurons in a mosaic fashion in vivo. Surprisingly, while electrical properties are profoundly affected in these neurons, as well as inhibitory synaptic transmission, we found little perturbation of neuronal morphology, demonstrating a functional segregation of excitatory synaptic transmission from neuronal morphological development.	[Lu, Wei; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lu, Wei] NINDS, Synapse & Neural Circuit Res Unit, NIH, Bethesda, MD 20892 USA; [Bushong, Eric A.; Shih, Tiffany P.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Bushong, Eric A.; Shih, Tiffany P.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California San Diego; University of California System; University of California San Diego	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	roger.nicoll@ucsf.edu	Lu, Wei/S-5617-2018	Lu, Wei/0000-0001-6668-8432	NIH Pathway to Independence Award from NIMH; NINDS Intramural Research Program; NIMH; NIH NCRR [P41 GM103412]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103412-24]; NIH NIGMS [R01 GM082949]; Maryann Martone; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM082949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH063981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003136] Funding Source: NIH RePORTER	NIH Pathway to Independence Award from NIMH; NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Maryann Martone; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Bjorgan and M. Cerpas for technical assistance and all members from the Nicoll laboratory and Ellisman laboratory for helpful discussions. We are also grateful to the generosity of Professors Peter Seeburg and Rolf Sprengel at Max Planck Institute for Medical Research, Heidelberg, Germany, for sharing individual gene-targeted conditional mice for GluA1, GluA2, or GluA3, from which we were able to make the triple-floxed Gria1-3<SUP>fl/fl</SUP> mice. W.L. was funded by an NIH Pathway to Independence Award from NIMH and is supported by the NINDS Intramural Research Program. R.A.N. is funded by grants from NIMH. The microscopy studies were carried out at the National Center for Microscopy and Imaging Research at UCSD supported by an award from NIH NCRR (P41 GM103412) and the National Institute of General Medical Sciences (8 P41 GM103412-24) from the National Institutes of Health to M.H.E. The image data obtained for this project are available in the Cell Image Library/Cell Centered Database supported by grants from the NIH NIGMS (R01 GM082949) to M.H.E. and Maryann Martone.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; CONNOR JR, 1982, J COMP NEUROL, V210, P99, DOI 10.1002/cne.902100111; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Galante M, 2000, J PHYSIOL-LONDON, V523, P639, DOI 10.1111/j.1469-7793.2000.t01-1-00639.x; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Lu W, 2011, J NEUROPHYSIOL, V105, P923, DOI 10.1152/jn.00725.2010; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Murphy DD, 1996, J NEUROSCI, V16, P4059; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Owens DF, 1996, J NEUROSCI, V16, P6414; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tropea Daniela, 2011, Commun Integr Biol, V4, P216, DOI 10.4161/cib.4.2.14505; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Turner CA, 2002, BRAIN RES, V938, P15, DOI 10.1016/S0006-8993(02)02472-1; Turner CA, 2003, DEV PSYCHOBIOL, V43, P20, DOI 10.1002/dev.10116; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	78	57	58	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					433	439		10.1016/j.neuron.2013.02.030	http://dx.doi.org/10.1016/j.neuron.2013.02.030			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664612	Green Accepted, Bronze			2022-12-25	WOS:000318961700006
J	Akbik, FV; Bhagat, SM; Patel, PR; Cafferty, WBJ; Strittmatter, SM				Akbik, Feras V.; Bhagat, Sarah M.; Patel, Pujan R.; Cafferty, William B. J.; Strittmatter, Stephen M.			Anatomical Plasticity of Adult Brain Is Titrated by Nogo Receptor 1	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; OCULAR-DOMINANCE PLASTICITY; DENDRITIC SPINE STABILITY; NEOCORTEX IN-VIVO; VISUAL-CORTEX; STRUCTURAL PLASTICITY; AXONAL REGENERATION; CORTICAL CIRCUITS; TRANSGENIC MICE; CORD CONTUSION	Experience rearranges anatomical connectivity in the brain, but such plasticity is suppressed in adulthood. We examined the turnover of dendritic spines and axonal varicosities in the somatosensory cortex of mice lacking Nogo Receptor 1 (NgR1). Through adolescence, the anatomy and plasticity of ngr1 null mice are indistinguishable from control, but suppression of turnover after age 26 days fails to occur in ngr1-/- mice. Adolescent anatomical plasticity can be restored to 1-year-old mice by conditional deletion of ngr1. Suppression of anatomical dynamics by NgR1 is cell autonomous and is phenocopied by deletion of Nogo-A ligand. Whisker removal deprives the somatosensory cortex of experience-dependent input and reduces dendritic spine turnover in adult ngr1-/- mice to control levels, while an acutely enriched environment increases dendritic spine dynamics in control mice to the level of ngr1-/- mice in a standard environment. Thus, NgR1 determines the low set point for synaptic turnover in adult cerebral cortex.	[Akbik, Feras V.; Bhagat, Sarah M.; Patel, Pujan R.; Cafferty, William B. J.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06536 USA; [Akbik, Feras V.; Bhagat, Sarah M.; Patel, Pujan R.; Cafferty, William B. J.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurobiol, New Haven, CT 06536 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Bhagat, Sarah M/0000-0003-1108-6244	Institutional N.I.H. Medical Scientist Training Program; N.I.H.; Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020, R01NS080388] Funding Source: NIH RePORTER	Institutional N.I.H. Medical Scientist Training Program; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W.B. Gan for instruction on thin skull techniques, C. Portera-Cailliau for instruction on open skull surgeries, S. Tomita for instruction on subcellular fractionation, A. Holtmaat and A. McGee for helpful discussion, and S. Sodi and Y. Fu for technical assistance. F.V.A. is supported by an Institutional N.I.H. Medical Scientist Training Program grant. S.M.S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge research support from the N.I.H. and the Falk Medical Research Trust to S.M.S. S.M.S. is a cofounder of Axerion Therapeutics, seeking to develop PrP- and NgR-based therapeutics.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; Wang XX, 2002, J NEUROSCI, V22, P5505; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	43	87	89	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 6	2013	77	5					859	866		10.1016/j.neuron.2012.12.027	http://dx.doi.org/10.1016/j.neuron.2012.12.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473316	Green Accepted, Bronze			2022-12-25	WOS:000316162600007
J	Suh, J; Choi, SH; Romano, DM; Gannon, MA; Lesinski, AN; Kim, DY; Tanzi, RE				Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.			ADAM10 Missense Mutations Potentiate beta-Amyloid Accumulation by Impairing Prodomain Chaperone Function	NEURON			English	Article							ALPHA-SECRETASE ADAM10; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; DISINTEGRIN; BRAIN; APP; PROLIFERATION; DOMAIN; DEFICIENT; PATHOLOGY	The generation of A beta, the main component of senile plaques in Alzheimer's disease (AD), is precluded by alpha-secretase cleavage within the A beta domain of the amyloid precursor protein (APP). We identified two rare mutations (Q170H and R181G) in the prodomain of the metalloprotease, ADAM10, that cosegregate with late-onset AD (LOAD). Here, we addressed the pathogenicity of these mutations in transgenic mice expressing human ADAM10 in brain. In Tg2576 AD mice, both mutations attenuated alpha-secretase activity of ADAM10 and shifted APP processing toward beta-secretase-mediated cleavage, while enhancing A beta plaque load and reactive gliosis. We also demonstrated ADAM10 expression potentiates adult hippocampal neurogenesis, which is reduced by the LOAD mutations. Mechanistically, both LOAD mutations impaired the molecular chaperone activity of ADAM10 prodomain. Collectively, these findings suggest that diminished alpha-secretase activity, owing to LOAD ADAM10 prodomain mutations, leads to AD-related pathology, strongly supporting ADAM10 as a promising therapeutic target for this devastating disease.	[Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Boston, MA 02129 USA; [Suh, Jaehong; Choi, Se Hoon; Romano, Donna M.; Gannon, Moira A.; Lesinski, Andrea N.; Kim, Doo Yeon; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	Cure Alzheimer's Fund; NIA, NIMH; American Health Assistance Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG041856] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; NIA, NIMH; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Lin Wu for her scientific expertise and technical assistance in generating ADAM10 transgenic mice. We also thank Dr. Jorg Bartsch for providing ADAM10 prodomain antibody; Dr. Sam Sisodia for providing MoPrP.Xhol plasmid; Dr. Matthew Frosch for providing Tg2576 mice; Dr. Basavaraj Hooli and Dr. Can Zhang for helpful discussions; and William Wisdom for mouse tail genotyping. This study was supported by the Cure Alzheimer's Fund, grants from the NIA, NIMH (R.E.T.), and the American Health Assistance Foundation (J.S.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao J, 2000, J BIOL CHEM, V275, P29648, DOI 10.1074/jbc.M001920200; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gaultier A, 2002, J BIOL CHEM, V277, P23336, DOI 10.1074/jbc.M201792200; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kang TB, 2002, J BIOL CHEM, V277, P48514, DOI 10.1074/jbc.M208961200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	44	135	140	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 16	2013	80	2					385	401		10.1016/j.neuron.2013.08.035	http://dx.doi.org/10.1016/j.neuron.2013.08.035			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241VI	24055016	Bronze, Green Accepted			2022-12-25	WOS:000326196400020
J	Doulatov, S; Vo, LT; Chou, SS; Kim, PG; Arora, N; Li, H; Hadland, BK; Bernstein, ID; Collins, JJ; Zon, LI; Daley, GQ				Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Li, Hu; Hadland, Brandon K.; Bernstein, Irwin D.; Collins, James J.; Zon, Leonard I.; Daley, George Q.			Induction of Multipotential Hematopoietic Progenitors from Human Pluripotent Stem Cells via Respecification of Lineage-Restricted Precursors	CELL STEM CELL			English	Article							RED-BLOOD-CELLS; REPOPULATING ABILITY; IN-VITRO; DIFFERENTIATION; GENERATION; EXPRESSION; MACROPHAGES; PATIENT	Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. However, the inability to derive engraftable human hematopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34(+)CD45(+) myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34(+)CD38(-) cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells.	[Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Doulatov, Sergei; Vo, Linda T.; Chou, Stephanie S.; Kim, Peter G.; Arora, Natasha; Zon, Leonard I.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Hadland, Brandon K.; Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Hadland, Brandon K.; Bernstein, Irwin D.] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Zon, Leonard I.] Childrens Hosp, Howard Hughes Med Inst, Div Pediat Hematol Oncol, Stem Cell Program, Boston, MA 02115 USA; [Zon, Leonard I.; Daley, George Q.] Broad Inst, Cambridge, MA 02141 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Hadland, Brandon/0000-0003-3999-9002	US National Institute of Diabetes and Digestive and Kidney Diseases [R24-DK092760]; National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium [UO1-HL100001]; Alex's Lemonade Stand; Doris Duke Medical Foundation; Helen Hay Whitney Foundation; NSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R24DK092760] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium; Alex's Lemonade Stand; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Helen Hay Whitney Foundation; NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Thorsten Schlaeger and the BCH ESC core, Ronald Mathieu from the flow cytometry core, and Norman Gerry from the Coriell Genotyping and Microarray Center for assistance. Andrea Ditadi and Gordon Keller provided reagents and advice. Band3 antibody was a gift from the Narla Mohandas lab. This work is supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (R24-DK092760) and the National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium (UO1-HL100001); Alex's Lemonade Stand; and the Doris Duke Medical Foundation. G. Q. D. is an associate member of the Broad Institute and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. S. D. is supported by a fellowship from the Helen Hay Whitney Foundation. L. T. V. is supported by the NSF Graduate Research Fellowship.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Anstee DJ, 2012, CURR OPIN HEMATOL, V19, P163, DOI 10.1097/MOH.0b013e328352240a; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Dias J, 2011, STEM CELLS DEV, V20, P1639, DOI 10.1089/scd.2011.0078; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Hu Z, 2011, BLOOD, V118, P5938, DOI 10.1182/blood-2010-11-321414; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lee GS, 2008, MOL CELLS, V25, P487; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Martin CH, 2008, BLOOD, V112, P2730, DOI 10.1182/blood-2008-01-133801; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Migliaccio AR, 2012, CELL STEM CELL, V10, P115, DOI 10.1016/j.stem.2012.01.001; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	47	183	189	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 3	2013	13	4					459	470		10.1016/j.stem.2013.09.002	http://dx.doi.org/10.1016/j.stem.2013.09.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VT	24094326	Green Accepted, Bronze			2022-12-25	WOS:000329571100014
J	Burchell, VS; Nelson, DE; Sanchez-Martinez, A; Delgado-Camprubi, M; Ivatt, RM; Pogson, JH; Randle, SJ; Wray, S; Lewis, PA; Houlden, H; Abramov, AY; Hardy, J; Wood, NW; Whitworth, AJ; Laman, H; Plun-Favreau, H				Burchell, Victoria S.; Nelson, David E.; Sanchez-Martinez, Alvaro; Delgado-Camprubi, Marta; Ivatt, Rachael M.; Pogson, Joe H.; Randle, Suzanne J.; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Whitworth, Alexander J.; Laman, Heike; Plun-Favreau, Helene			The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy	NATURE NEUROSCIENCE			English	Article							F-BOX PROTEIN; MITOCHONDRIAL PATHOLOGY; MONITORING AUTOPHAGY; TARGETING SEQUENCES; PYRAMIDAL SYNDROME; DROSOPHILA; PINK1; COMPLEX; CELLS; PROTEASOME	Compelling evidence indicates that two autosomal recessive Parkinson's disease genes, PINK1 (PARK6) and Parkin (PARK2), cooperate to mediate the autophagic clearance of damaged mitochondria (mitophagy). Mutations in the F-box domain-containing protein Fbxo7 (encoded by PARK15) also cause early-onset autosomal recessive Parkinson's disease, by an unknown mechanism. Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy. Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria, ubiquitination of mitofusin 1 and mitophagy. In Drosophila, ectopic overexpression of Fbxo7 rescued loss of Parkin, supporting a functional relationship between the two proteins. Parkinson's disease-causing mutations in Fbxo7 interfered with this process, emphasizing the importance of mitochondrial dysfunction in Parkinson's disease pathogenesis.	[Burchell, Victoria S.; Delgado-Camprubi, Marta; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Plun-Favreau, Helene] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Nelson, David E.; Randle, Suzanne J.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Ctr Dev & Biomed Genet, MRC, Sheffield, S Yorkshire, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Cambridge; University of Sheffield	Plun-Favreau, H (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	a.whitworth@sheffield.ac.uk; hl316@cam.ac.uk; h.plun-favreau@ucl.ac.uk	Plun-Favreau, Helene/Q-4111-2016; Wray, Selina/C-3682-2009; Lewis, Patrick A./C-3674-2009; Abramov, Andrey Y/H-9053-2012; Nelson, David/AAX-5648-2021; Sanchez-Martinez, Alvaro/L-3851-2019; Houlden, Henry J/C-1532-2008; Wood, Nicholas W/C-2505-2009; Abramov, Andrey/AAC-6712-2019; Sanchez-Martinez, Alvaro/L-1395-2013; Hardy, John/C-2451-2009	Plun-Favreau, Helene/0000-0002-1401-9656; Wray, Selina/0000-0003-3062-7050; Abramov, Andrey Y/0000-0002-7646-7235; Nelson, David/0000-0002-5034-0885; Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Houlden, Henry J/0000-0002-2866-7777; Wood, Nicholas W/0000-0002-9500-3348; Abramov, Andrey/0000-0002-7646-7235; Hardy, John/0000-0002-3122-0423; Laman, Heike/0000-0002-6089-171X; Whitworth, Alexander/0000-0002-1154-6629; Lewis, Patrick/0000-0003-4537-0489	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; MRC Career Development Award [G0700183]; European Union; ERC Starting Grant [309742]; UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account; Biotechnology and Biological Sciences Research Council [BB/F012764/1, BB/J007846/1]; University of Sheffield;  [G070091]; BBSRC [BB/J007846/1] Funding Source: UKRI; MRC [MC_G1000735, MR/J004758/1, G0701075, G0802760, G108/638, G0700183, G1001253] Funding Source: UKRI; Medical Research Council [G0802760, G0700183, G1001253, MR/J004758/1, G0701075, MC_G1000735, G108/638, G0700091B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [F-1002, H-1006] Funding Source: researchfish	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); ERC Starting Grant(European Research Council (ERC)); UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Sheffield; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to thank M. Mehrabian and E. Elahi for obtaining patient biopsies, H. Ardley (Leeds Institute of Molecular Medicine) for donating the Flag-Parkin construct and cell line, K. Holmstrpom and A. Isaacs for discussions and M. Gegg for technical advice. We thank C. Hill for technical assistance within the University of Sheffield Electron Microscopy Facility. We thank the H. Steller (Rockefeller University) laboratory for kind provision of the ntc mutant lines. The work was funded by a Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant to the University College London Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (grant number WT089698), an MRC Career Development Award (G0700183; H.P.-F.), the MEFOPA project funded through the European Union FP7 research program (A.J.W.), and an ERC Starting Grant (no. 309742; A.J.W.). This research was supported by the UK National Institute for Health Research University College London Hospitals Biomedical Research Centre. V.S.B. is funded by the MRC Doctoral Training Account. D.E.N. is funded by the Biotechnology and Biological Sciences Research Council (BB/F012764/1; BB/J007846/1). The Wellcome Trust is acknowledged for support of the Sheffield Light Microscopy Facility (GR077544AIA). The MRC Centre for Developmental and Biomedical Genetics is supported by grant G070091.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lee SJ, 2010, EMBO REP, V11, P226, DOI 10.1038/embor.2010.7; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Sullivan W., 2000, DROSOPHILA PROTOCOLS, P240; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	47	213	219	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1257	U135		10.1038/nn.3489	http://dx.doi.org/10.1038/nn.3489			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933751	Green Accepted, Green Submitted			2022-12-25	WOS:000323597500017
J	Polack, PO; Friedman, J; Golshani, P				Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman			Cellular mechanisms of brain state-dependent gain modulation in visual cortex	NATURE NEUROSCIENCE			English	Article							BASAL FOREBRAIN; BARREL CORTEX; GABAERGIC NEURONS; BEHAVIORAL STATE; ACETYLCHOLINE; ACTIVATION; NOREPINEPHRINE; OSCILLATIONS; SELECTIVITY; INHIBITION	Visual cortical neurons fire at higher rates to visual stimuli during locomotion than during immobility, while maintaining orientation selectivity. The mechanisms underlying this change in gain are not understood. We performed whole-cell recordings from layer 2/3 and layer 4 visual cortical excitatory neurons and from parvalbumin-positive and somatostatin-positive inhibitory neurons in mice that were free to rest or run on a spherical treadmill. We found that the membrane potential of all cell types became more depolarized and (with the exception of somatostatin-positive interneurons) less variable during locomotion. Cholinergic input was essential for maintaining the unimodal membrane potential distribution during immobility, whereas noradrenergic input was necessary for the tonic depolarization associated with locomotion. Our results provide a mechanism for how neuromodulation controls the gain and signal-to-noise ratio of visual cortical neurons during changes in the state of vigilance.	[Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Polack, Pierre-Olivier; Golshani, Peyman] W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Golshani, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	pgolshani@mednet.ucla.edu		Polack, Pierre-Olivier/0000-0003-1716-6595	US National Institutes of Health [KO8 NS0562101]; Whitehall Foundation [2012-05-83]; Veterans Affairs Merit Review Award [1I01BX001524-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS056210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001524] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge R. Gruver for technical assistance on visual stimulation, Z. Peng and C. Houser for histology, and D. Contreras, M. Einstein, T. Indersmitten, M. Javaherian, C. Kaba, S. Mahon, A. Silva and S. Singh for their thoughtful comments on the manuscript. This work was supported by the US National Institutes of Health (KO8 NS0562101), the Whitehall Foundation (grant 2012-05-83) and a Veterans Affairs Merit Review Award (1I01BX001524-01A1).	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bereshpolova Y, 2007, J NEUROSCI, V27, P9392, DOI 10.1523/JNEUROSCI.2218-07.2007; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Botly LCP, 2012, CEREB CORTEX, V22, P2441, DOI 10.1093/cercor/bhr331; Buchanan JAM, 1997, BRAIN RES, V771, P63, DOI 10.1016/S0006-8993(97)00778-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Langlois M, 2010, J NEUROSCI, V30, P16523, DOI 10.1523/JNEUROSCI.1109-10.2010; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rodriguez R, 2010, NEUROSCIENCE, V165, P944, DOI 10.1016/j.neuroscience.2009.10.059; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sarter M, 2000, NEUROSCIENCE, V95, P933; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; WANG Z, 1993, J NEUROSCI, V13, P2199; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	53	354	354	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1331	U227		10.1038/nn.3464	http://dx.doi.org/10.1038/nn.3464			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872595	Green Submitted, Green Accepted			2022-12-25	WOS:000323597500026
J	Siddiqui, TJ; Tari, PK; Connor, SA; Zhang, P; Dobie, FA; She, K; Kawabe, H; Wang, YT; Brose, N; Craig, AM				Siddiqui, Tabrez J.; Tari, Parisa Karimi; Connor, Steven A.; Zhang, Peng; Dobie, Frederick A.; She, Kevin; Kawabe, Hiroshi; Wang, Yu Tian; Brose, Nils; Craig, Ann Marie			An LRRTM4-HSPG Complex Mediates Excitatory Synapse Development on Dentate Gyrus Granule Cells	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; REPEAT TRANSMEMBRANE PROTEINS; AMPA RECEPTOR TRAFFICKING; TRANSSYNAPTIC INTERACTION; HIPPOCAMPAL-NEURONS; MENTAL-RETARDATION; DENDRITIC SPINES; NMDA RECEPTORS; NERVOUS-SYSTEM; NEUROLIGINS	Selective synapse development determines how complex neuronal networks in the brain are formed. Complexes of postsynaptic neuroligins and LRRTMs with presynaptic neurexins contribute widely to excitatory synapse development, and mutations in these gene families increase the risk of developing psychiatric disorders. We find that LRRTM4 has distinct presynaptic binding partners, heparan sulfate proteoglycans (HSPGs). HSPGs are required to mediate the synaptogenic activity of LRRTM4. LRRTM4 shows highly selective expression in the brain. Within the hippocampus, we detected LRRTM4 specifically at excitatory postsynaptic sites on dentate gyrus granule cells. LRRTM4(-/-) dentate gyrus granule cells, but not CA1 pyramidal cells, exhibit reductions in excitatory synapse density and function. Furthermore, LRRTM4(-/-) dentate gyrus granule cells show impaired activity-regulated AMPA receptor trafficking. These results identifying cell-type-specific functions and multiple presynaptic binding partners for different LRRTM family members reveal an unexpected complexity in the design and function of synapse-organizing proteins.	[Siddiqui, Tabrez J.; Tari, Parisa Karimi; Connor, Steven A.; Zhang, Peng; Dobie, Frederick A.; She, Kevin; Wang, Yu Tian; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Siddiqui, Tabrez J.; Tari, Parisa Karimi; Connor, Steven A.; Zhang, Peng; Dobie, Frederick A.; She, Kevin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Connor, Steven A.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada; [Kawabe, Hiroshi; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Brose, Nils] Ctr Nanoscale Microscopy & Mol Physiol Brain CNM, D-37073 Gottingen, Germany	University of British Columbia; University of British Columbia; University of British Columbia; Max Planck Society	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de; acraig@mail.ubc.ca	Connor, Steven/AAD-6261-2021; Wang, Yu Tian/J-8255-2015; Craig, Ann Marie/M-2054-2014; Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696; Dobie, Frederick/0000-0002-0550-8095; Siddiqui, Tabrez/0000-0002-6938-7827	Canadian Institutes of Health Research [MOP-84241, MOP-125967]; Canada Research Chair; Michael Smith Foundation; EMBO; German Research Foundation [SPP1365/KA3423/1-1]; European Commission EUROSPIN; SynSys Consortia [FP7-HEALTH-F2-2009-241498, FP7-HEALTH-F2-2009-242167]; European Commission Innovative Medicines Initiative [EU-AIMS FP7-115300]; Fritz Thyssen Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation(Michael Smith Foundation for Health Research); EMBO(European Molecular Biology Organization (EMBO)); German Research Foundation(German Research Foundation (DFG)); European Commission EUROSPIN; SynSys Consortia; European Commission Innovative Medicines Initiative; Fritz Thyssen Foundation	We thank Xi ling Zhou and Nazarine Fernandes for excellent technical assistance, Sarah Au-Yeung for contributions to the western blot analysis, Michiko Takeda for contributions to mouse colony management, Andrea Betz for advice on ES cell culture and Southern blotting, and Suzanne Perry and the team at the Proteomics Core Facility at the University of British Columbia. This work was supported by Canadian Institutes of Health Research Grants MOP-84241 and MOP-125967 and a Canada Research Chair salary award (A.M.C.), by a Michael Smith Foundation for Health Research Fellowship and an EMBO Short-Term Fellowship (T.J.S.), by the German Research Foundation (SPP1365/KA3423/1-1; H.K and N.B.), by the European Commission EUROSPIN and SynSys Consortia (FP7-HEALTH-F2-2009-241498; FP7-HEALTH-F2-2009-242167; N.B.), by the European Commission Innovative Medicines Initiative (EU-AIMS FP7-115300; N.B.), and by the Fritz Thyssen Foundation (H.K.).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; DeNardo LA, 2012, NEURON, V76, P762, DOI 10.1016/j.neuron.2012.10.013; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hong L, 2002, J HUM GENET, V47, P262, DOI 10.1007/s100380200036; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Johnston D., 1995, FDN CELLULAR NEUROPH; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lauri SE, 1999, J NEUROSCI, V19, P1226; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Ohmi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027461; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; She K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024423; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Trommald M, 1997, J COMP NEUROL, V377, P15, DOI 10.1002/(SICI)1096-9861(19970106)377:1<15::AID-CNE3>3.0.CO;2-M; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Westerink RHS, 2012, BRAIN RES, V1450, P1, DOI 10.1016/j.brainres.2012.02.036; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Yoshida T, 2012, J NEUROSCI, V32, P2588, DOI 10.1523/JNEUROSCI.4637-11.2012; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Yuzaki M, 2011, CURR OPIN NEUROBIOL, V21, P215, DOI 10.1016/j.conb.2011.01.010	60	114	114	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					680	695		10.1016/j.neuron.2013.06.029	http://dx.doi.org/10.1016/j.neuron.2013.06.029			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23911104	Bronze			2022-12-25	WOS:000323587000009
J	Yoon, KJ; Buice, MA; Barry, C; Hayman, R; Burgess, N; Fiete, IR				Yoon, KiJung; Buice, Michael A.; Barry, Caswell; Hayman, Robin; Burgess, Neil; Fiete, Ila R.			Specific evidence of low-dimensional continuous attractor dynamics in grid cells	NATURE NEUROSCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; MEDIAL ENTORHINAL CORTEX; PERSISTENT ACTIVITY; PATH-INTEGRATION; HEAD-DIRECTION; OSCILLATORY INTERFERENCE; NEURAL INTEGRATOR; PREFRONTAL CORTEX; VISUAL-CORTEX; NETWORK MODEL	We examined simultaneously recorded spikes from multiple rat grid cells, to explain mechanisms underlying their activity. Among grid cells with similar spatial periods, the population activity was confined to lie close to a two-dimensional (2D) manifold: grid cells differed only along two dimensions of their responses and otherwise were nearly identical. Relationships between cell pairs were conserved despite extensive deformations of single-neuron responses. Results from novel environments suggest such structure is not inherited from hippocampal or external sensory inputs. Across conditions, cell-cell relationships are better conserved than responses of single cells. Finally, the system is continually subject to perturbations that, were the 2D manifold not attractive, would drive the system to inhabit a different region of state space than observed. These findings have strong implications for theories of grid-cell activity and substantiate the general hypothesis that the brain computes using low-dimensional continuous attractors.	[Yoon, KiJung; Buice, Michael A.; Fiete, Ila R.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Barry, Caswell; Burgess, Neil] UCL, Inst Cognit Neurosci, London, England; [Burgess, Neil] UCL, Inst Neurol, London, England; [Barry, Caswell; Hayman, Robin] UCL, Div Psychol & Language Sci, Inst Behav Neurosci, London, England	University of Texas System; University of Texas Austin; University of London; University College London; University of London; University College London; University of London; University College London	Fiete, IR (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	ilafiete@mail.clm.utexas.edu	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Fiete, Ila/0000-0003-4738-2539	Sloan Foundation; Searle Scholar; McKnight Scholar; Wellcome Trust, UK; Office of Naval Research through ONR MURI [N00014-10-1-0936]; ONR-Young Investigator Program; MRC [G1000854] Funding Source: UKRI; Medical Research Council [G1000854] Funding Source: researchfish	Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholar; McKnight Scholar; Wellcome Trust, UK(Wellcome Trust); Office of Naval Research through ONR MURI; ONR-Young Investigator Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to D. Tank for insightful comments. We thank members of the Moser laboratory for public release of some of their data sets, which we used in this study. I. R. F. is funded as a Sloan Foundation Fellow, a Searle Scholar and a McKnight Scholar. We acknowledge funding from the Wellcome Trust, UK and the Office of Naval Research through ONR MURI N00014-10-1-0936 and the ONR-Young Investigator Program to I.R.F.	Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Artin M, 2011, ALGEBRA; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2012, P NATL ACAD SCI USA, V109, P17645, DOI 10.1073/pnas.1117386109; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, SCIENCE, V290, P2268, DOI 10.1126/science.290.5500.2268; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAUBE JS, 1990, J NEUROSCI, V10, P436; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang K, 1996, J NEUROSCI, V16, P2112	50	147	147	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1077	U141		10.1038/nn.3450	http://dx.doi.org/10.1038/nn.3450			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852111	Green Accepted			2022-12-25	WOS:000322323000018
J	Xie, YL; Juschke, C; Esk, C; Hirotsune, S; Knoblich, JA				Xie, Yunli; Jueschke, Christoph; Esk, Christopher; Hirotsune, Shinji; Knoblich, Juergen A.			The Phosphatase PP4c Controls Spindle Orientation to Maintain Proliferative Symmetric Divisions in the Developing Neocortex	NEURON			English	Article							NEURAL STEM-CELLS; RADIAL GLIA; ASYMMETRIC DIVISION; PROGENITOR CELLS; NEURONS ARISE; NOTCH; NEUROGENESIS; FATE; LIS1; SPECIFICATION	In the developing neocortex, progenitor cells expand through symmetric division before they generate cortical neurons through multiple rounds of asymmetric cell division. Here, we show that the orientation of the mitotic spindle plays a crucial role in regulating the transition between those two division modes. We demonstrate that the protein phosphatase PP4c regulates spindle orientation in early cortical progenitor cells. Upon removing PP4c, mitotic spindles fail to orient in parallel to the neuroepithelial surface and progenitors divide with random orientation. As a result, their divisions become asymmetric and neurogenesis starts prematurely. Biochemical and genetic experiments show that PP4c acts by dephosphorylating the microtubule binding protein Ndel1, thereby enabling complex formation with Lis1 to form a functional spindle orientation complex. Our results identify a key regulator of cortical development and demonstrate that changes in the orientation of progenitor division are responsible for the transition between symmetric and asymmetric cell division.	[Xie, Yunli; Jueschke, Christoph; Esk, Christopher; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Hirotsune, Shinji] Osaka City Univ, Dept Genet Dis Res, Grad Sch Med, Osaka 5458586, Japan	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Osaka Metropolitan University	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Xie, Yunli/J-4638-2019; Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Xie, Yunli/0000-0002-7126-0972; Juschke, Christoph/0000-0001-5842-4824; Esk, Christopher/0000-0003-1833-0801	Lise Meitner postdoctoral fellowship (FWF) [M1147-B09]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Z153-B09, I552-B19]; European Research Council (ERC) [PN 250342]; Austrian Science Fund (FWF) [I 552, Z 153] Funding Source: researchfish	Lise Meitner postdoctoral fellowship (FWF); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Angela Peer for excellent technical assistance, Karin Paiha and Pawel Pasierbek for excellent bio-optics support and image analysis, and N. Gaiano for providing the CBFRE-GFP construct. We are grateful to all members of the J.A.K. laboratory for discussions and particularly to Madeline Lancaster for comments on the manuscript. Y.X. was supported by a Lise Meitner postdoctoral fellowship (FWF, M1147-B09). Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF, Z153-B09, I552-B19), and an advanced grant from the European Research Council (ERC, NeuroSystem PN 250342). Experiments were conceived and designed by Y.X. and J.A.K. and carried out by Y.X. S.H. provided the PP4c knockout mice and reagents. C.J. performed 3D spindle analysis. C.E. and Y.X. performed ultrasound-guided in utero electroporation. The manuscript was written by Y.X. and J.A.K.	Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Helps NR, 1998, J CELL SCI, V111, P1331; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Iulianella A, 2009, DEVELOPMENT, V136, P2329, DOI 10.1242/dev.032128; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Mapelli M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120102; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026	55	57	58	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					254	265		10.1016/j.neuron.2013.05.027	http://dx.doi.org/10.1016/j.neuron.2013.05.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23830831	Green Published, hybrid			2022-12-25	WOS:000322426200006
J	Schubert, T; Hoon, M; Euler, T; Lukasiewicz, PD; Wong, ROL				Schubert, Timm; Hoon, Mrinalini; Euler, Thomas; Lukasiewicz, Peter D.; Wong, Rachel O. L.			Developmental Regulation and Activity-Dependent Maintenance of GABAergic Presynaptic Inhibition onto Rod Bipolar Cell Axonal Terminals	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; RETINAL GANGLION-CELLS; RECEPTOR RHO SUBUNITS; GABA(A) RECEPTORS; MAMMALIAN RETINA; MOUSE RETINA; CAT RETINA; RAT RETINA; IMMUNOCYTOCHEMICAL LOCALIZATION; SYNAPTIC-TRANSMISSION	Presynaptic inhibition onto axons regulates neuronal output, but how such inhibitory synapses develop and are maintained in vivo remains unclear. Axon terminals of glutamatergic retinal rod bipolar cells (RBCs) receive GABA(A) and GABA(C) receptor-mediated synaptic inhibition. We found that perturbing GABAergic or glutamatergic neurotransmission does not prevent GABAergic synaptogenesis onto RBC axons. But, GABA release is necessary for maintaining axonal GABA receptors. This activity-dependent process is receptor subtype specific: GABA(C) receptors are maintained, whereas GABA(A) receptors containing alpha 1, but not alpha 3, subunits decrease over time in mice with deficient GABA synthesis. GABA(A) receptor distribution on RBC axons is unaffected in GABA(C) receptor knockout mice. Thus, GABA(A) and GABA(C) receptor maintenance are regulated separately. Although immature RBCs elevate their glutamate release when GABA synthesis is impaired, homeostatic mechanisms ensure that the RBC output operates within its normal range after eye opening, perhaps to regain proper visual processing within the scotopic pathway.	[Schubert, Timm; Hoon, Mrinalini; Wong, Rachel O. L.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Schubert, Timm; Euler, Thomas] Univ Tubingen, Inst Ophthalm Res, Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Lukasiewicz, Peter D.] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Lukasiewicz, Peter D.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Washington University (WUSTL); Washington University (WUSTL)	Wong, ROL (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, 1959 Northeast Pacific St, Seattle, WA 98195 USA.	wongr2@u.washington.edu		Euler, Thomas/0000-0002-4567-6966	National Institutes of Health [EY10699, EY08922, EY02687, EY01730]; Research to Prevent Blindness; Deutsche Forschungsgemeinschaft [SCHU2243/1-1, EXC 307]; NATIONAL EYE INSTITUTE [R01EY010699, R01EY008922, P30EY001730, P30EY002687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (EY10699 to ROW., EY08922 to P.D.L., EY02687 to the Department of Ophthalmology, Washington University and EY01730 to the Department of Ophthalmology, University of Washington), Research to Prevent Blindness (to P.D.L.), and Deutsche Forschungsgemeinschaft (SCHU2243/1-1 to T.S and EXC 307 to T.E.). We thank A. Barria and W. Cerpa for help with western blots and E. Parker for assistance with electron microscopy. We are grateful to R. Sinha, H. Okawa, and L. Della Santina for helpful comments on the manuscript.	Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chavez AE, 2006, NATURE, V443, P705, DOI 10.1038/nature05123; Chavez AE, 2010, J NEUROSCI, V30, P2330, DOI 10.1523/JNEUROSCI.5574-09.2010; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Eggers ED, 2006, J NEUROSCI, V26, P9413, DOI 10.1523/JNEUROSCI.2591-06.2006; Enz R, 1996, J NEUROSCI, V16, P4479; FEIGENSPAN A, 1994, EUR J PHARM-MOLEC PH, V288, P97, DOI 10.1016/0922-4106(94)90014-0; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fu Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00057; Gingrich KJ, 1995, J PHYSIOL-LONDON, V489, P529, DOI 10.1113/jphysiol.1995.sp021070; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; Koulen P, 1996, J NEUROSCI, V16, P2127; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lukasiewicz PD, 1996, MOL NEUROBIOL, V12, P181, DOI 10.1007/BF02755587; LUKASIEWICZ PD, 1995, J NEUROSCI, V15, P4592; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rosato-Siri M, 2002, EUR J NEUROSCI, V16, P2123, DOI 10.1046/j.1460-9568.2002.02291.x; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; Schubert T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-15; Shields CR, 2000, J NEUROSCI, V20, P2673; Soto F, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-31; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wu XY, 2012, J NEUROSCI, V32, P331, DOI 10.1523/JNEUROSCI.3189-11.2012	63	21	21	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 10	2013	78	1					124	137		10.1016/j.neuron.2013.01.037	http://dx.doi.org/10.1016/j.neuron.2013.01.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125QI	23583111	Bronze, Green Accepted			2022-12-25	WOS:000317556000012
J	Li, SM; Jin, M; Zhang, DN; Yang, T; Koeglsperger, T; Fu, HJ; Selkoe, DJ				Li, Shaomin; Jin, Ming; Zhang, Dainan; Yang, Ting; Koeglsperger, Thomas; Fu, Hongjun; Selkoe, Dennis J.			Environmental Novelty Activates beta(2)-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by A beta Oligomers	NEURON			English	Article							LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; ADRENERGIC-RECEPTOR ACTIVATION; ENRICHMENT IMPROVES COGNITION; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; MOUSE MODEL; SYNAPTIC PLASTICITY; LEISURE ACTIVITIES; PKA-DEPENDENCE	A central question about human brain aging is whether cognitive enrichment slows the development of Alzheimer changes. Here, we show that prolonged exposure to an enriched environment (EE) facilitated signaling in the hippocampus of wildtype mice that promoted long-term potentiation. A key feature of the EE effect was activation of beta(2)-adrenergic receptors and downstream cAMP/PKA signaling. This EE pathway prevented LTP inhibition by soluble oligomers of amyloid beta-protein (A beta) isolated from AD cortex. Protection by EE occurred in both young and middle-aged wild-type mice. Exposure to novelty afforded greater protection than did aerobic exercise. Mice chronically fed a beta-adrenergic agonist without EE were protected from hippocampal impairment by A beta oligomers. Thus, EE enhances hippocampal synaptic plasticity by activating beta-adrenoceptor signaling and mitigating synaptotoxicity of human A beta oligomers. These mechanistic insights support using prolonged exposure to cognitive novelty and/or oral beta-adrenergic agonists to lessen the effects of A beta accumulation during aging.	[Li, Shaomin; Jin, Ming; Zhang, Dainan; Yang, Ting; Koeglsperger, Thomas; Fu, Hongjun; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Li, Shaomin; Jin, Ming; Zhang, Dainan; Yang, Ting; Koeglsperger, Thomas; Fu, Hongjun; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhang, Dainan] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Koeglsperger, Thomas] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Zhengzhou University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Li, SM (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	sli11@partners.org; dselkoe@rics.bwh.harvard.edu	Fu, Hongjun/ABB-3558-2021; Meijer, Anna/K-5118-2016; FU, HONGJUN/H-4498-2011	FU, HONGJUN/0000-0001-5346-7075	NIH [AG 027443, AG 036694]; Massachusetts Alzheimer's Disease Research Center [5P50 AG 005134]; MGH Neurology Clinical Trials Units; Harvard NeuroDiscovery Center; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG027443, R01AG006173, P01AG036694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Alzheimer's Disease Research Center; MGH Neurology Clinical Trials Units; Harvard NeuroDiscovery Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Walsh (BWH/HMS) for providing synthetic A beta(S26C)<INF>2</INF> dimers and N. Shepardson for preparing the 7PA2 CM and CHO-CM. We thank Huixin Xu (HMS) for technical assistance in some of the biochemical assays. This work was supported by NIH grants AG 027443 and AG 036694 (to D.J.S.) and a grant (to S.L.) from the Massachusetts Alzheimer's Disease Research Center (5P50 AG 005134), the MGH Neurology Clinical Trials Units, and the Harvard NeuroDiscovery Center.	Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; Cahill L, 2000, NEUROBIOL LEARN MEM, V74, P259, DOI 10.1006/nlme.1999.3950; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Chamberlain SR, 2006, PSYCHOPHARMACOLOGY, V188, P397, DOI 10.1007/s00213-006-0391-6; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; ESCORIHUELA RM, 1994, BEHAV BRAIN RES, V61, P169, DOI 10.1016/0166-4328(94)90157-0; ESCORIHUELA RM, 1995, NEUROBIOL LEARN MEM, V64, P49, DOI 10.1006/nlme.1995.1043; Foster TC, 1996, BRAIN RES, V736, P243, DOI 10.1016/0006-8993(96)00707-X; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gelinas JN, 2008, LEARN MEMORY, V15, P281, DOI 10.1101/lm.829208; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Grudzien A, 2007, NEUROBIOL AGING, V28, P327, DOI 10.1016/j.neurobiolaging.2006.02.007; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kemp A, 2008, CEREB CORTEX, V18, P1326, DOI 10.1093/cercor/bhm164; King SO, 2009, LEARN MEMORY, V16, P625, DOI 10.1101/lm.1513109; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lemon N, 2009, CEREB CORTEX, V19, P2827, DOI 10.1093/cercor/bhp065; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Malik R, 2012, J NEUROPHYSIOL, V107, P1366, DOI 10.1152/jn.01009.2011; Manaye KF, 2013, AGE, V35, P139, DOI 10.1007/s11357-011-9343-0; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Naka F, 2002, BRAIN RES, V924, P124, DOI 10.1016/S0006-8993(01)03257-7; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; O'Dell TJ, 2010, CELL SIGNAL, V22, P728, DOI 10.1016/j.cellsig.2009.12.004; Paradise M, 2009, INT PSYCHOGERIATR, V21, P25, DOI 10.1017/S1041610208008053; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; SARA SJ, 1994, BRAIN RES BULL, V35, P457, DOI 10.1016/0361-9230(94)90159-7; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; Valero J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016832; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang QW, 2009, NEUROBIOL AGING, V30, P1608, DOI 10.1016/j.neurobiolaging.2007.12.004; Weinshenker D, 2008, CURR ALZHEIMER RES, V5, P342, DOI 10.2174/156720508784533286; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004	53	122	131	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2013	77	5					929	941		10.1016/j.neuron.2012.12.040	http://dx.doi.org/10.1016/j.neuron.2012.12.040			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106RO	23473322	Bronze, Green Accepted			2022-12-25	WOS:000316162600013
J	Sylantyev, S; Savtchenko, LP; Ermolyuk, Y; Michaluk, P; Rusakov, DA				Sylantyev, Sergiy; Savtchenko, Leonid P.; Ermolyuk, Yaroslav; Michaluk, Piotr; Rusakov, Dmitri A.			Spike-Driven Glutamate Electrodiffusion Triggers Synaptic Potentiation via a Homer-Dependent mGluR-NMDAR Link	NEURON			English	Article							CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; EXCITATORY TRANSMISSION; MULTIVESICULAR RELEASE; DENDRITIC SPINES; RECEPTORS; NEURONS; ACTIVATION; CLEFT; EPSCS	Electric fields of synaptic currents can influence diffusion of charged neurotransmitters, such as glutamate, in the synaptic cleft. However, this phenomenon has hitherto been detected only through sustained depolarization of large principal neurons, and its adaptive significance remains unknown. Here, we find that in cerebellar synapses formed on electrically compact granule cells, a single postsynaptic action potential can retard escape of glutamate released into the cleft. This retardation boosts activation of perisynaptic group I metabotropic glutamate receptors (mGluRs), which in turn rapidly facilitates local NMDA receptor currents. The underlying mechanism relies on a Homer-containing protein scaffold, but not GPCR- or Ca2+-dependent signaling. Through the mGluR-NMDAR interaction, the coincidence between a postsynaptic spike and glutamate release triggers a lasting enhancement of synaptic transmission that alters the basic integrate-and-spike rule in the circuitry. Our results thus reveal an electrodiffusion-driven synaptic memory mechanism that requires high-precision coincidence detection suitable for high-fidelity circuitries.	[Sylantyev, Sergiy; Savtchenko, Leonid P.; Ermolyuk, Yaroslav; Michaluk, Piotr; Rusakov, Dmitri A.] UCL, UCL Inst Neurol, London WC1N 3BG, England	University of London; University College London	Rusakov, DA (corresponding author), UCL, UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.rusakov@ucl.ac.uk	Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021; Michaluk, Piotr/AAR-5238-2021	Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Michaluk, Piotr/0000-0003-2306-3314; Sylantyev, Sergiy/0000-0002-1358-0601	Wellcome Trust; MRC; BBSRC; ERC; Foundation for Polish Science; MRC [G0900613, G0802216] Funding Source: UKRI; Medical Research Council [G0802216, G0900613] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, MRC, BBSRC, and ERC Advanced Grant (D.A.R.) and the Foundation for Polish Science (P.M.). The authors thank Angus Silver, Dimitri Kullmann, Kirill Volynski, and the anonymous referees for their valuable comments and Mykola Stryebkov and Ksenia Redunova for help with data processing software.	BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Contractor A, 1998, P NATL ACAD SCI USA, V95, P8969, DOI 10.1073/pnas.95.15.8969; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KINNEY GA, 1993, J NEUROPHYSIOL, V69, P585, DOI 10.1152/jn.1993.69.2.585; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Marcaggi P, 2009, P NATL ACAD SCI USA, V106, P11388, DOI 10.1073/pnas.0901290106; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Moutin E, 2012, J CELL BIOL, V198, P251, DOI 10.1083/jcb.201110101; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; POO MM, 1985, ANNU REV NEUROSCI, V8, P369; Raman IM, 1995, BIOPHYS J, V69, P1868, DOI 10.1016/S0006-3495(95)80057-3; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rossi P, 1996, EUR J NEUROSCI, V8, P1182, DOI 10.1111/j.1460-9568.1996.tb01286.x; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Savtchenko LP, 2000, BIOPHYS J, V78, P1119, DOI 10.1016/S0006-3495(00)76670-7; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Sylantyev S, 2008, SCIENCE, V319, P1845, DOI 10.1126/science.1154330; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	44	36	37	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 6	2013	77	3					528	541		10.1016/j.neuron.2012.11.026	http://dx.doi.org/10.1016/j.neuron.2012.11.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	118MY	23395378	hybrid, Green Published			2022-12-25	WOS:000317030800014
J	Sarkar, C; Chandra, G; Peng, SY; Zhang, ZJ; Liu, AY; Mukherjee, AB				Sarkar, Chinmoy; Chandra, Goutam; Peng, Shiyong; Zhang, Zhongjian; Liu, Aiyi; Mukherjee, Anil B.			Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA: therapeutic implications for INCL	NATURE NEUROSCIENCE			English	Article							PALMITOYL-PROTEIN THIOESTERASE; NEURONAL CEROID-LIPOFUSCINOSIS; ENZYME REPLACEMENT THERAPY; MOUSE MODEL; LYSOSOMAL STORAGE; HYDROXYLAMINE; ACTIVATION; EXPRESSION; BRAIN; NEURODEGENERATION	Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating childhood neurodegenerative lysosomal storage disease (LSD) that has no effective treatment. It is caused by inactivating mutations in the palmitoyl-protein thioesterase-1 (PPT1) gene. PPT1 deficiency impairs the cleavage of thioester linkage in palmitoylated proteins (constituents of ceroid), preventing degradation by lysosomal hydrolases. Consequently, accumulation of lysosomal ceroid leads to INCL. Thioester linkage is cleaved by nucleophilic attack. Hydroxylamine, a potent nucleophilic cellular metabolite, may have therapeutic potential for INCL, but its toxicity precludes clinical application. We found that a hydroxylamine derivative, N-(tert-Butyl) hydroxylamine (NtBuHA), was non-toxic, cleaved thioester linkage in palmitoylated proteins and mediated lysosomal ceroid depletion in cultured cells from INCL patients. In Ppt1(-/-) mice, which mimic INCL, NtBuHA crossed the blood-brain barrier, depleted lysosomal ceroid, suppressed neuronal apoptosis, slowed neurological deterioration and extended lifespan. Our findings provide a proof of concept that thioesterase-mimetic and antioxidant small molecules such as NtBuHA are potential drug targets for thioesterase deficiency diseases such as INCL.	[Sarkar, Chinmoy; Chandra, Goutam; Peng, Shiyong; Zhang, Zhongjian; Mukherjee, Anil B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Liu, Aiyi] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	mukherja@exchange.nih.gov	Sarkar, Chinmoy/AAI-2461-2019; Peng, Shiyong/D-6391-2014	Peng, Shiyong/0000-0003-0697-3674; Liu, Aiyi/0000-0002-6618-5082	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S.L. Hofmann (University of Texas Southwestern Medical Center) for the generous gift of Ppt1<SUP>-/-</SUP> mice and for a sample of recombinant human PPT1 enzyme that we used as a positive control. M. Sands (Washington University School of Medicine) provided a pair of C57 congenic Ppt1<SUP>-/-</SUP> mice that we used to establish our colony at the US National Institutes of Health. We thank S.W. Levin, J.Y. Chou and I. Owens for critical review of the manuscript and helpful suggestions. We also thank A. Bouchelion and A. Chen for editorial assistance. We thank L. Dye at the Microscopy and Imaging Core facility for his expert assistance in performing TEM of cultured lymphoblasts and mouse brain tissues. We are grateful to H.-S. fun for helping us with the FACS analysis. The mass spectrometric analyses for the detection of NtBuHA in brain tissues were performed in the laboratory of A.K. Cheema (Georgetown University School of Medicine). This research was supported in whole by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Atamna H, 2001, FASEB J, V15, P2196, DOI 10.1096/fj.01-0134com; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Greaves J, 2012, J BIOL CHEM, V287, P37330, DOI 10.1074/jbc.M112.389098; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; GROSS P, 1985, CRC CR REV TOXICOL, V14, P87, DOI 10.3109/10408448509023765; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; HOFMANN SL, 2001, METABOLIC MOL BASES, P3877; Hu J, 2012, MOL GENET METAB, V107, P213, DOI 10.1016/j.ymgme.2012.05.009; Isosomppi J, 1999, DEV BRAIN RES, V118, P1, DOI 10.1016/S0165-3806(99)00115-7; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jocelyn P.C., 1972, BIOCH SH GROUPS; Kaur P, 2012, INT J MASS SPECTROM, V310, P44, DOI 10.1016/j.ijms.2011.11.005; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093/hmg/ddl078; Kirby AJ, 2006, J AM CHEM SOC, V128, P12374, DOI 10.1021/ja065147q; Kohan R, 2011, CURR PHARM BIOTECHNO, V12, P867, DOI 1389-2010/11 $58.00+.00; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Lonnqvist T, 2001, NEUROLOGY, V57, P1411, DOI 10.1212/WNL.57.8.1411; Lu JY, 2010, MOL GENET METAB, V99, P374, DOI 10.1016/j.ymgme.2009.12.002; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munasinghe J, 2012, NEURODEGENER DIS, V9, P159, DOI 10.1159/000334838; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Riikonen R, 2000, NEUROLOGY, V54, P1828, DOI 10.1212/WNL.54.9.1828; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Srikanth M, 2012, NAT REV NEUROL, V8, P307, DOI 10.1038/nrneurol.2012.76; Tamaki SJ, 2009, CELL STEM CELL, V5, P310, DOI 10.1016/j.stem.2009.05.022; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; Zhang ZJ, 1999, GENE, V231, P203, DOI 10.1016/S0378-1119(99)00050-5	49	49	50	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1608	1617		10.1038/nn.3526	http://dx.doi.org/10.1038/nn.3526			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056696	Green Accepted			2022-12-25	WOS:000326205700018
J	Simmons, WK; Rapuano, KM; Kallman, SJ; Ingeholm, JE; Miller, B; Gotts, SJ; Avery, JA; Hall, KD; Martin, A				Simmons, W. Kyle; Rapuano, Kristina M.; Kallman, Seth J.; Ingeholm, John E.; Miller, Bernard; Gotts, Stephen J.; Avery, Jason A.; Hall, Kevin D.; Martin, Alex			Category-specific integration of homeostatic signals in caudal but not rostral human insula	NATURE NEUROSCIENCE			English	Article							HUMAN AWARENESS; ACTIVATION; FEELINGS; NUCLEUS; FOODS; TASTE; BODY	Prevailing theories hold that the insula is functionally organized along its caudal-to-rostral axis, with posterior regions coding lower-level sensory information and anterior regions coding higher-level stimulus significance relative to the body's homeostatic needs. Contrary to predictions of this model, the response of the taste-sensitive region of the caudal, but not rostral, insula to food images was directly related to the body's homeostatic state as indexed by levels of peripheral glucose.	[Simmons, W. Kyle; Avery, Jason A.] Laureate Inst Brain Res, Tulsa, OK USA; [Simmons, W. Kyle] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Simmons, W. Kyle; Rapuano, Kristina M.; Kallman, Seth J.; Ingeholm, John E.; Gotts, Stephen J.; Martin, Alex] NIHM, Lab Brain & Cognit, NIH, Bethesda, MD USA; [Miller, Bernard; Hall, Kevin D.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Avery, Jason A.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Laureate Institute for Brain Research, Inc.; University of Tulsa; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Tulsa	Simmons, WK (corresponding author), Laureate Inst Brain Res, Tulsa, OK USA.	wksimmons@laureateinstitute.org	Simmons, William/K-8925-2015; Rapuano, Kristina/J-6489-2019; Simmons, W. Kyle/V-6846-2019; Hall, Kevin/F-2383-2010	Simmons, William/0000-0002-0399-9003; Simmons, W. Kyle/0000-0002-0399-9003; Hall, Kevin/0000-0003-4062-3133; Avery, Jason/0000-0003-4097-2819	NIMH [K01MH096175-01]; NIDDK; Oklahoma Center for the Advancement of Science and Technology [OCAST HR10-141]; NARSAD; Oklahoma Tobacco Research Center; William K. Warren Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH096175, ZIAMH002588] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oklahoma Center for the Advancement of Science and Technology; NARSAD(NARSAD); Oklahoma Tobacco Research Center; William K. Warren Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank K. Burrows for help with data management and analysis of the high-sweetness and low-sweetness food pictures. This research supported by the Intramural Research Programs of the NIMH and the NIDDK, as well as by NIMH grant K01MH096175-01 to W.K.S., a grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST HR10-141) to W.K.S., a NARSAD Young Investigator Award to W.K.S., a grant to W.K.S. from the Oklahoma Tobacco Research Center, and The William K. Warren Foundation. The study was conducted under NIH Clinical Study Protocol 09-DK-0081 (ClinicalTrials.gov ID NCT00846040).	BECKSTEAD RM, 1980, J COMP NEUROL, V190, P259, DOI 10.1002/cne.901900205; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Philippi CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038413; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Yettefti K, 1997, PHYSIOL BEHAV, V61, P93, DOI 10.1016/S0031-9384(96)00358-7	16	67	68	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1551	1552		10.1038/nn.3535	http://dx.doi.org/10.1038/nn.3535			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077565	Green Accepted			2022-12-25	WOS:000326205700011
J	Ercsey-Ravasz, M; Markov, NT; Lamy, C; Van Essen, DC; Knoblauch, K; Toroczkai, Z; Kennedy, H				Ercsey-Ravasz, Maria; Markov, Nikola T.; Lamy, Camille; Van Essen, David C.; Knoblauch, Kenneth; Toroczkai, Zoltan; Kennedy, Henry			A Predictive Network Model of Cerebral Cortical Connectivity Based on a Distance Rule	NEURON			English	Article							SMALL-WORLD; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; COMPLEX NETWORKS; BRAIN; OPTIMIZATION; ORGANIZATION; ARCHITECTURE; DYNAMICS; ECONOMY	Recent advances in neuroscience have engendered interest in large-scale brain networks. Using a consistent database of cortico-cortical connectivity, generated from hemisphere-wide, retrograde tracing experiments in the macaque, we analyzed interareal weights and distances to reveal an important organizational principle of brain connectivity. Using appropriate graph theoretical measures, we show that although very dense (66%), the interareal network has strong structural specificity. Connection weights exhibit a heavy-tailed lognormal distribution spanning five orders of magnitude and conform to a distance rule reflecting exponential decay with interareal separation. A single-parameter random graph model based on this rule predicts numerous features of the cortical network: (1) the existence of a network core and the distribution of cliques, (2) global and local binary properties, (3) global and local weight-based communication efficiencies modeled as network conductance, and (4) overall wire-length minimization. These findings underscore the importance of distance and weight-based heterogeneity in cortical architecture and processing.	[Ercsey-Ravasz, Maria; Toroczkai, Zoltan] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Ercsey-Ravasz, Maria; Toroczkai, Zoltan] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Ercsey-Ravasz, Maria] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania; [Markov, Nikola T.; Lamy, Camille; Knoblauch, Kenneth; Kennedy, Henry] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Markov, Nikola T.; Lamy, Camille; Knoblauch, Kenneth; Kennedy, Henry] Univ Lyon 1, F-69003 Lyon, France; [Markov, Nikola T.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Van Essen, David C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Toroczkai, Zoltan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	University of Notre Dame; University of Notre Dame; Babes Bolyai University from Cluj; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Yale University; Washington University (WUSTL); Max Planck Society	Toroczkai, Z (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	toro@nd.edu; henry.kennedy@inserm.fr	Knoblauch, Kenneth/H-8156-2014; Van Essen, David/ABA-8888-2020; Markov, Nikola/AAI-9680-2020; Ravasz, Maria Ercsey/E-2098-2017; Markov, Nikola T./AFO-2802-2022; Toroczkai, Zoltan/AAC-8446-2019; Kennedy, Henry/B-9636-2013	Knoblauch, Kenneth/0000-0002-4681-4638; Ravasz, Maria Ercsey/0000-0003-4428-9953; Markov, Nikola T./0000-0003-1417-1161; Toroczkai, Zoltan/0000-0002-6602-2849; Kennedy, Henry/0000-0002-2796-7663	Lab Ex CORTEX [ANR-11-LABX-0042]; NIH [R01-MH-60974];  [FP6-2005 IST-1583];  [FP7-2007 ICT-216593];  [ANR-11-BSV4-501];  [HDTRA 1-09-1-0039];  [FP7-PEOPLE-2011-IIF-299915]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974] Funding Source: NIH RePORTER	Lab Ex CORTEX; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Giroud, P. Misery, L. Magrou, and A.R. Ribeiro Games for data analysis and B. Beneyton, M. Sean, and M. Valdebenito for animal husbandry. We thank C. Dehay, R. Douglas, K.A.C. Martin, W. Maass, and M. Cook for critical reading of the manuscript. This work was supported by FP6-2005 IST-1583 (H.K.); FP7-2007 ICT-216593 (H.K.); ANR-11-BSV4-501 (H.K.); Lab Ex CORTEX (ANR-11-LABX-0042) (H.K.), and in part by HDTRA 1-09-1-0039 (Z.T.), NIH R01-MH-60974 (D.C.V.E.), and by FP7-PEOPLE-2011-IIF-299915 (M.E.-R.).	Aflalo TN, 2011, J NEUROPHYSIOL, V105, P305, DOI 10.1152/jn.00795.2010; Alvarez-Hamelin J.I., 2005, K CORE DECOMPOSITION; Bakker R, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00030; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Braitenberg V, 1998, CORTEX STAT GEOMETRY; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brouwer AE, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-1939-6; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; Cherniak C, 2012, PROG BRAIN RES, V195, P361, DOI 10.1016/B978-0-444-53860-4.00017-9; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Chung F. R.-K., 1996, CBMS REGIONAL C SERI, V92; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Douglas RJ, 2012, CURR BIOL, V22, pR1033, DOI 10.1016/j.cub.2012.11.017; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gallos LK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00123; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jouve B, 1998, CEREB CORTEX, V8, P28, DOI 10.1093/cercor/8.1.28; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Kaas JonH., 2000, BRAIN MIND, V1, P7, DOI DOI 10.1023/A:1010028405318; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kennedy H, 2013, NEUROIMAGE, V80, P37, DOI 10.1016/j.neuroimage.2013.04.031; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Markov N., 2013, CEREB CORTEX, DOI DOI 10.1093/CERC0R/BHS1270; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; Meyer K, 2009, TRENDS NEUROSCI, V32, P376, DOI 10.1016/j.tins.2009.04.002; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Rockland KS, 1997, CEREBR CORT, V12, P243; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Schuz A, 2002, CORTICAL AREAS UNITY; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O., 2016, NETWORKS BRAIN; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; Vragovic I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036122; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wang W, 2005, BIOL CYBERN, V92, P38, DOI 10.1007/s00422-004-0527-x; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zeki S, 2005, PHILOS T R SOC B, V360, P651, DOI 10.1098/rstb.2005.1632; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	85	224	224	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					184	197		10.1016/j.neuron.2013.07.036	http://dx.doi.org/10.1016/j.neuron.2013.07.036			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094111	Bronze, Green Accepted			2022-12-25	WOS:000326305300017
J	Kaas, GA; Zhong, C; Eason, DE; Ross, DL; Vachhani, RV; Ming, GI; King, JR; Song, HJ; Sweatt, JD				Kaas, Garrett A.; Zhong, Chun; Eason, Dawn E.; Ross, Daniel L.; Vachhani, Raj V.; Ming, Guo-Ii; King, Jennifer R.; Song, Hongjun; Sweatt, J. David			TET1 Controls CNS 5-Methylcytosine Hydroxylation, Active DNA Demethylation, Gene Transcription, and Memory Formation	NEURON			English	Article							METHYLATION; BRAIN; 5-HYDROXYMETHYLCYTOSINE; NEUROGENESIS; GLYCOSYLASE; CHROMATIN; EXPRESSION; PLASTICITY; CONVERSION; PROTEINS	Dynamic changes in 5-methylcytosine (5mC) have been implicated in the regulation of gene expression critical for consolidation of memory. However, little is known about how these changes in 5mC are regulated in the adult brain. The enzyme methylcytosine dioxygenase TET1 (TET1) has been shown to promote active DNA demethylation in the nervous system. Therefore, we took a viral-mediated approach to overexpress the protein in the hippocampus and examine its potential involvement in memory formation. We found that Tet1 is a neuronal activity-regulated gene and that its overexpression leads to global changes in modified cytosine levels. Furthermore, expression of TET1 or a catalytically inactive mutant (TET1m) resulted in the upregulation of several neuronal memory-associated genes and impaired contextual fear memory. In summary, we show that neuronal Tet1 regulates DNA methylation levels and that its expression, independent of its catalytic activity, regulates the expression of CNS activity-dependent genes and memory formation.	[Kaas, Garrett A.; Eason, Dawn E.; Vachhani, Raj V.; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Kaas, Garrett A.; Eason, Dawn E.; Vachhani, Raj V.; Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; [Ross, Daniel L.; King, Jennifer R.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Zhong, Chun; Ming, Guo-Ii; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurosci,Dept Neurol, Baltimore, MD 21205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu		Ming, Guo-li/0000-0002-2517-6075; Sweatt, J. David/0000-0003-3567-485X	NIH [MH091122, MH57014, NR012686, NS07344, ES021957]; McKnight Brain Research Foundation; SFARI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014, R01MH091122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Brain Research Foundation; SFARI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Stephen Moore, Alison Margolies, and Faraz Sultan for experimental assistance and Adam Petterson at Zymo Research for technical support regarding measurement of 5mC and 5hmC. This work was supported by NIH grants MH091122, MH57014, and NR012686 to J.D.S. and the McKnight Brain Research Foundation. Further support was provided by NIH grants NS07344, ES021957, and SFARI to H.S.	Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Celikel T, 2007, FRONT NEUROSCI-SWITZ, V1, P97, DOI 10.3389/neuro.01.1.1.007.2007; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Datson NA, 2004, EUR J NEUROSCI, V20, P2541, DOI 10.1111/j.1460-9568.2004.03738.x; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Kemmerich K, 2012, NUCLEIC ACIDS RES, V40, P6016, DOI 10.1093/nar/gks259; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Sultan FA, 2011, EPIGENOMICS-UK, V3, P157, DOI [10.2217/EPI.11.6, 10.2217/epi.11.6]; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	32	297	312	4	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 18	2013	79	6					1086	1093		10.1016/j.neuron.2013.08.032	http://dx.doi.org/10.1016/j.neuron.2013.08.032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298NC	24050399	Bronze, Green Accepted			2022-12-25	WOS:000330329600008
J	Ma, T; Trinh, MA; Wexler, AJ; Bourbon, C; Gatti, E; Pierre, P; Cavener, DR; Klann, E				Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe; Cavener, Douglas R.; Klann, Eric			Suppression of eIF2 alpha kinases alleviates Alzheimer's disease-related plasticity and memory deficits	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; OXIDATIVE STRESS; EIF2 KINASES; PHOSPHORYLATION; ACTIVATION; PERK; MECHANISMS; DISRUPTION; EXPRESSION	Expression of long-lasting synaptic plasticity and long-term memory requires protein synthesis, which can be repressed by phosphorylation of eukaryotic initiation factor 2 alpha-subunit (eIF2 alpha). Elevated phosphorylation of eIF2 alpha has been observed in the brains of Alzheimer's disease patients and Alzheimer's disease model mice. Therefore, we tested whether suppressing eIF2 alpha kinases could alleviate synaptic plasticity and memory deficits in Alzheimer's disease model mice. Genetic deletion of eIF2 alpha kinase PERK prevented enhanced phosphorylation of eIF2 alpha and deficits in protein synthesis, synaptic plasticity and spatial memory in mice that express familial Alzheimer's disease-related mutations in APP and PSEN1. Similarly, deletion of another eIF2 alpha kinase, GCN2, prevented impairments of synaptic plasticity and defects in spatial memory exhibited by the Alzheimer's disease model mice. Our findings implicate aberrant eIF2 alpha phosphorylation as a previously unidentified molecular mechanism underlying Alzheimer's disease-related synaptic pathophysioloy and memory dysfunction and suggest that PERK and GCN2 are potential therapeutic targets for treatment of individuals with Alzheimer's disease.	[Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, Unite Mixte Rech 6102, Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] INSERM, U1104, F-13258 Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] CNRS, Unite Mixte Rech 7280, Marseille, France; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	New York University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Gatti, Evelina/B-7941-2012	Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255	US National Institutes of Health [NS034007, NS047834]; Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R37NS034007, R01NS034007, R21NS078718, R29NS034007] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the late Dr. Mark A. Smith (Case Western Reserve University) for providing postmortem Alzheimer's disease brain samples, R.C. Wek (Indiana University School of Medicine) for providing the ATF4 antibody, C.A. Hoeffer for help with the design of the mouse breeding, H. Bowling and M.V. Chao (New York University School of Medicine) for providing primary cultured neurons, E. Santini for advice on the statistical analyses for the mouse behavioral tests, Y. Chen for technical help, M. Dorsey for keeping colonies of transgenic mice, and all members of the Klann laboratory for comments on the manuscript. This work was supported by US National Institutes of Health grants NS034007 and NS047834, and Alzheimer's Association Investigator grant to E. K.	Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bonda DJ, 2010, REDOX REP, V15, P161, DOI 10.1179/174329210X12650506623645; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kim SM, 2010, NEUROSCIENCE, V169, P1831, DOI 10.1016/j.neuroscience.2010.06.016; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	48	374	384	10	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1299	U185		10.1038/nn.3486	http://dx.doi.org/10.1038/nn.3486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933749	Green Accepted			2022-12-25	WOS:000323597500022
J	Mathur, BN; Tanahira, C; Tamamaki, N; Lovinger, DM				Mathur, Brian N.; Tanahira, Chiyoko; Tamamaki, Nobuaki; Lovinger, David M.			Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; PARVALBUMIN-IMMUNOREACTIVE NEURONS; DIACYLGLYCEROL LIPASE-ALPHA; FAST-SPIKING INTERNEURONS; MEDIUM SPINY NEURONS; MICE LACKING; SYNAPTIC CONNECTIONS; PROJECTION NEURONS; RAT NEOSTRIATUM; BASAL GANGLIA	The dorsolateral striatum and cannabinoid type 1 receptor (CB1) signaling mediate habitual action learning, which is thought to require a balance of activity in the direct and indirect striatal output pathways. However, very little is known about how the high CB1-expressing striatal inhibitory microcircuitry might contribute to long-term plasticity capable of sculpting direct and indirect pathway output. Using optogenetic and molecular interrogation of striatal GABAergic microcircuits, we examined voltage-dependent long-term depression of inhibitory synapses (iLTD) onto mouse and rat medium spiny projection neurons (MSNs). The observed iLTD involved recruitment of different endocannabinoid types and showed both presynaptic and postsynaptic selectivity for MSN subtypes, ultimately resulting in a powerful disinhibition of direct pathway MSNs. These results suggest a new role for voltage states in gating circuit-specific forms of synaptic plasticity and illuminate possible circuit dynamics underlying action control.	[Mathur, Brian N.; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Tanahira, Chiyoko; Tamamaki, Nobuaki] Kumamoto Univ, Grad Sch Med, Dept Morphol Neural Sci, Honjo, Kumamoto, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Kumamoto University	Lovinger, DM (corresponding author), NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	lovindav@mail.nih.gov	Mathur, Brian/P-5986-2018	Mathur, Brian/0000-0003-2912-8625	Intramural NIH HHS [Z99 AA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Adermark L, 2009, J NEUROSCI, V29, P1375, DOI 10.1523/JNEUROSCI.3842-08.2009; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bracci E, 2006, J NEUROPHYSIOL, V95, P1285, DOI 10.1152/jn.00598.2005; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Freiman I, 2006, J PHYSIOL-LONDON, V575, P789, DOI 10.1113/jphysiol.2006.114272; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Maccarrone M, 2003, J NEUROCHEM, V85, P1018, DOI 10.1046/j.1471-4159.2003.01759.x; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Malone DT, 2008, NEUROSCIENCE, V152, P265, DOI 10.1016/j.neuroscience.2007.10.043; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mathur BN, 2008, NEUROSCI LETT, V435, P90, DOI 10.1016/j.neulet.2008.01.082; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Plenz D, 2003, TRENDS NEUROSCI, V26, P436, DOI 10.1016/S0166-2236(03)00196-6; Plenz D, 1998, J NEUROSCI, V18, P266; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Watts A, 2012, J NEUROSCI, V32, P13411, DOI 10.1523/JNEUROSCI.0170-12.2012; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; Winters BD, 2012, P NATL ACAD SCI USA, V109, pE2717, DOI 10.1073/pnas.1206303109; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	44	44	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1275	U157		10.1038/nn.3478	http://dx.doi.org/10.1038/nn.3478			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892554	Green Accepted			2022-12-25	WOS:000323597500019
J	Lacroix, JJ; Campos, FV; Frezza, L; Bezanilla, F				Lacroix, Jerome J.; Campos, Fabiana V.; Frezza, Ludivine; Bezanilla, Francisco			Molecular Bases for the Asynchronous Activation of Sodium and Potassium Channels Required for Nerve Impulse Generation	NEURON			English	Article							VOLTAGE-SENSOR; GATING CURRENTS; CONDUCTANCE CHANGES; RESTING STATE; CONFORMATIONS; MOVEMENT; TRACKING; CHARGE	Most action potentials are produced by the sequential activation of voltage-gated sodium (Nav) and potassium (Kv) channels. This is mainly achieved by the rapid conformational rearrangement of voltage-sensor (VS) modules in Nay channels, with activation kinetics up to 6-fold faster than Shaker-type Kv channels. Here, using mutagenesis and gating current measurements, we show that a 3-fold acceleration of the VS kinetics in Nav versus Shaker Kv channels is produced by the hydrophilicity of two "speed-control" residues located in the S2 and S4 segments in Nay domains I-III. An additional 2-fold acceleration of the Nay VS kinetics is provided by the coexpression of the beta 1 subunit, ubiquitously found in mammal tissues. This study uncovers the molecular bases responsible for the differential activation of Nay versus Kv channels, a fundamental prerequisite for the genesis of action potentials.	[Lacroix, Jerome J.; Campos, Fabiana V.; Frezza, Ludivine; Bezanilla, Francisco] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Bezanilla, F (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th, Chicago, IL 60637 USA.	fbezanilla@uchicago.edu	Campos, Fabiana V/F-5601-2016	Campos, Fabiana V/0000-0002-1132-3257	National Institutes of Health [GM030376]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030376, R37GM030376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Allan Drummond and Dr. Ramon Latorre for their insightful comments on the manuscript, Dr. Christopher Ahern and Dr. Stephan Pless for providing us with a plasmid encoding the human Nav1.5, and Dr. Ernesto Vargas for providing the pdb files for the all-atom simulation of the consensus resting state model. This work was supported by National Institutes of Health grant GM030376.	ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1982, NATURE, V296, P657, DOI 10.1038/296657a0; BEZANILLA F, 1970, J PHYSIOL-LONDON, V211, P729, DOI 10.1113/jphysiol.1970.sp009301; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Goldschen-Ohm MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2356; Gosselin-Badaroudine P, 2012, P NATL ACAD SCI USA, V109, P19250, DOI 10.1073/pnas.1217990109; Henrion U, 2012, P NATL ACAD SCI USA, V109, P8552, DOI 10.1073/pnas.1116938109; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; ROJAS E, 1970, NATURE, V225, P747, DOI 10.1038/225747a0; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	30	42	43	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					651	657		10.1016/j.neuron.2013.05.036	http://dx.doi.org/10.1016/j.neuron.2013.05.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972594	Green Accepted, Bronze			2022-12-25	WOS:000323587000006
J	Palaniyappan, L; Simmonite, M; White, TP; Liddle, EB; Liddle, PF				Palaniyappan, Lena; Simmonite, Molly; White, Thomas P.; Liddle, Elizabeth B.; Liddle, Peter F.			Neural Primacy of the Salience Processing System in Schizophrenia	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC CONNECTIVITY NETWORKS; FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; PREFRONTAL CORTEX; LIKELIHOOD ESTIMATION; INHIBITORY NEURONS; INSULAR CORTEX; WORKING-MEMORY; METAANALYSIS	For effective information processing, two large-scale distributed neural networks appear to be critical: a multimodal executive system anchored on the dorsolateral prefrontal cortex (DLPFC) and a salience system anchored on the anterior insula. Aberrant interaction among distributed networks is a feature of psychiatric disorders such as schizophrenia. We used whole-brain Granger causal modeling using resting fMRI and observed a significant failure of both the feedforward and reciprocal influence between the insula and the DLPFC in schizophrenia. Further, a significant failure of directed influence from bilateral visual cortices to the insula was also seen in patients. These findings provide compelling evidence for a breakdown of the salience-execution loop in the clinical expression of psychosis. In addition, this offers a parsimonious explanation for the often-observed "frontal inefficiency," the failure to recruit prefrontal system when salient or novel information becomes available in patients with schizophrenia.	[Palaniyappan, Lena; Simmonite, Molly; Liddle, Elizabeth B.; Liddle, Peter F.] Univ Nottingham, Div Psychiat, Ctr Translat Neuroimaging Mental Hlth, Nottingham NG7 2TU, England; [White, Thomas P.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London SE5 8AF, England; [Palaniyappan, Lena] Nottinghamshire Healthcare NHS Trust, Nottingham NG3 6AA, England	University of Nottingham; University of London; King's College London	Palaniyappan, L (corresponding author), Univ Nottingham, Div Psychiat, Ctr Translat Neuroimaging Mental Hlth, Nottingham NG7 2TU, England.	lena.palaniyappan@nottingham.ac.uk	Simmonite, Molly/ABF-6121-2020; Liddle, Peter/AAU-7939-2020; PALANIYAPPAN, LENA/L-8911-2016; Liddle, Elizabeth/A-2034-2015	PALANIYAPPAN, LENA/0000-0003-1640-7182; Liddle, Elizabeth/0000-0002-9299-094X; Simmonite, Molly/0000-0001-7181-8094	Wellcome Trust [WT096002/Z/11/Z]; Medical Research Council, UK [G0601442]; Eli Lilly; MRC [G0601442] Funding Source: UKRI; Medical Research Council [G0601442] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eli Lilly(Eli Lilly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	L.P. is supported by the Wellcome Trust (Research Training Fellowship WT096002/Z/11/Z). We are grateful to all volunteers who participated in this study. We gratefully acknowledge Dr. Vijender Balain for contributing to the recruitment and clinical assessment. Our sincere thanks to Dr. Marije Jansen, Dr. Bert Park, Dr. Raj Dangi, Dr. Debasis Das, Dr. Anna Cheetham, Dr. Hazel Johnson, and Dr. Eileen O'Reagan for their assistance. This work was funded by Medical Research Council, UK; grant number G0601442. L.P. received a travel fellowship sponsored by Eli Lilly in 2011. P.F.L. received honoraria for an academic meeting from Bristol Myers-Squibb in the last 3 years.	Barbas H, 2000, ADV NEUROL, V84, P87; Brookes MJ, 2012, NEUROIMAGE, V63, P1918, DOI 10.1016/j.neuroimage.2012.08.012; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Cole DM, 2013, CEREB CORTEX, V23, P1509, DOI 10.1093/cercor/bhs136; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dichter GS, 2010, SCHIZOPHRENIA BULL, V36, P595, DOI 10.1093/schbul/sbn118; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Dickinson D, 2011, SCHIZOPHRENIA BULL, V37, P1157, DOI 10.1093/schbul/sbq018; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Forget B, 2010, BIOL PSYCHIAT, V68, P265, DOI 10.1016/j.biopsych.2010.01.029; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Guller Y, 2012, ARCH GEN PSYCHIAT, V69, P662, DOI 10.1001/archgenpsychiatry.2012.23; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hasenkamp W, 2011, SCHIZOPHR RES, V125, P169, DOI 10.1016/j.schres.2010.08.041; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Kasparek T, 2013, HUM BRAIN MAPP, V34, P726, DOI 10.1002/hbm.21469; Klein TA, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00014, 10.3389/fnins.2013.00113]; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liddle PF, 2002, BRIT J PSYCHIAT, V180, P45, DOI 10.1192/bjp.180.1.45; Rodriguez-Sanchez JM, 2007, BRIT J PSYCHIAT, V191, pS107, DOI 10.1192/bjp.191.51.s107; Mars RB, 2011, NEURAL BASIS OF MOTIVATIONAL AND COGNITIVE CONTROL, P1; Medalla M, 2009, NEURON, V61, P609, DOI 10.1016/j.neuron.2009.01.006; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Molina V, 2009, PSYCHIAT RES-NEUROIM, V173, P88, DOI 10.1016/j.pscychresns.2008.09.009; Nygard M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00149; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Palaniyappan L, 2012, CURR TOP MED CHEM, V12, P2324, DOI 10.2174/156802612805289881; Palaniyappan L, 2013, NEUROPSYCHOPHARMACOL, V38, P1808, DOI 10.1038/npp.2013.80; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pu WD, 2012, SCHIZOPHR RES, V141, P15, DOI 10.1016/j.schres.2012.07.017; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Rose D, 2003, RES GUIDE NATL STAT; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Slotema CW, 2012, SCHIZOPHR RES, V142, P40, DOI 10.1016/j.schres.2012.08.025; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Su L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00348; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Van Snellenberg JX, 2006, NEUROPSYCHOLOGY, V20, P497, DOI 10.1037/0894-4105.20.5.497; Vercammen A, 2010, J PSYCHIATR RES, V44, P725, DOI 10.1016/j.jpsychires.2009.12.011; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; White TP, 2010, SCHIZOPHR RES, V123, P105, DOI 10.1016/j.schres.2010.07.020; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	66	227	231	4	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 21	2013	79	4					814	828		10.1016/j.neuron.2013.06.027	http://dx.doi.org/10.1016/j.neuron.2013.06.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207GN	23972602	Green Published, hybrid			2022-12-25	WOS:000323587000018
J	Higginbotham, H; Guo, JM; Yokota, Y; Umberger, NL; Su, CY; Li, JJ; Verma, N; Hirt, J; Ghukasyan, V; Caspary, T; Anton, ES				Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Umberger, Nicole L.; Su, Chen-Ying; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Caspary, Tamara; Anton, E. S.			Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; JOUBERT-SYNDROME; CEREBROSPINAL-FLUID; BASAL PROGENITORS; CORTICAL-NEURONS; ARL13B; DIFFERENTIATION; PROTEIN; NEUROGENESIS; CILIOGENESIS	The construction of cerebral cortex begins with the formation of radial glia. Once formed, polarized radial glial cells divide either symmetrically or asymmetrically to balance appropriate production of progenitor cells and neurons. Following birth, neurons use the processes of radial glia as scaffolding for oriented migration. Radial glia therefore provide an instructive structural matrix to coordinate the generation and placement of distinct groups of cortical neurons in the developing cerebral cortex. We found that Arl13b, a cilia-enriched small GTPase that is mutated in Joubert syndrome, was critical for the initial formation of the polarized radial progenitor scaffold. Using developmental stage-specific deletion of Arl13b in mouse cortical progenitors, we found that early neuroepithelial deletion of ciliary Arl13b led to a reversal of the apical-basal polarity of radial progenitors and aberrant neuronal placement. Arl13b modulated ciliary signaling necessary for radial glial polarity. Our findings indicate that Arl13b signaling in primary cilia is crucial for the initial formation of a polarized radial glial scaffold and suggest that disruption of this process may contribute to aberrant neurodevelopment and brain abnormalities in Joubert syndrome-related ciliopathies.	[Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Umberger, Nicole L.; Su, Chen-Ying; Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University	Caspary, T (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	tcaspar@emory.edu; anton@med.unc.edu	Caspary, Tamara/AAH-5625-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Caspary, Tamara/0000-0002-6579-7589; 	US National Institutes of Health [MH060929, NS056380]; NARSAD Young Investigator Award; US National Institutes of Health predoctoral training grant [T32GM008490]; National Institute of Neurological Disorders and Stroke [P30 NS045892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977, R01MH060929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS056380] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); US National Institutes of Health predoctoral training grant; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.-S. Lamantia, L. Pevny, M. Deshmukh and W. Snider for helpful comments and C. T. Strauss for editing. This research was supported by US National Institutes of Health grants MH060929 to E. S. A. and NS056380 to T. C., a NARSAD Young Investigator Award to H. H., a US National Institutes of Health predoctoral training grant to N.L.U. (T32GM008490) and the confocal imaging core of a National Institute of Neurological Disorders and Stroke institutional center core grant (P30 NS045892).	Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Aruga J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-79; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Horner VL, 2011, DEV BIOL, V355, P43, DOI 10.1016/j.ydbio.2011.04.019; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reiter JF, 2008, DEV CELL, V14, P635, DOI 10.1016/j.devcel.2008.04.011; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	47	128	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1000	U44		10.1038/nn.3451	http://dx.doi.org/10.1038/nn.3451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817546	Green Accepted, Green Submitted			2022-12-25	WOS:000322323000009
J	Yoshioka, N; Gros, E; Li, HR; Kumar, S; Deacon, DC; Maron, C; Muotri, AR; Chi, NC; Fu, XD; Yu, BD; Dowdy, SF				Yoshioka, Naohisa; Gros, Edwige; Li, Hai-Ri; Kumar, Shantanu; Deacon, Dekker C.; Maron, Cornelia; Muotri, Alysson R.; Chi, Neil C.; Fu, Xiang-Dong; Yu, Benjamin D.; Dowdy, Steven F.			Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; EQUINE ENCEPHALITIS-VIRUS; SENDAI-VIRUS; INDUCTION	The generation of human induced pluripotent stem cells (iPSCs) holds great promise for the development of regenerative medicine therapies to treat a wide range of human diseases. However, the generation of iPSCs in the absence of integrative DNA vectors remains problematic. Here, we report a simple, highly reproducible RNA-based iPSC generation approach that utilizes a single, synthetic self-replicating VEE-RF RNA replicon that expresses four reprogramming factors (OCT4, KLF4, and SOX2, with c-MYC or GLIS1) at consistent high levels prior to regulated RNA degradation. A single VEE-RF RNA transfection into newborn or adult human fibroblasts resulted in efficient generation of iPSCs with all the hallmarks of stem cells, including cell surface markers, global gene expression profiles, and in vivo pluripotency, to differentiate into all three germ layers. The VEE-RF RNA-based approach has broad applicability for the generation of iPSCs for ultimate use in human stem cell therapies in regenerative medicine.	[Yoshioka, Naohisa; Gros, Edwige; Li, Hai-Ri; Maron, Cornelia; Muotri, Alysson R.; Fu, Xiang-Dong; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kumar, Shantanu; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Deacon, Dekker C.; Chi, Neil C.] Univ Calif San Diego, Sch Med, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Muotri, Alysson R.; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Stem Cell Program, La Jolla, CA 92093 USA; [Chi, Neil C.; Fu, Xiang-Dong; Yu, Benjamin D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu		Yu, Benjamin/0000-0001-6663-6616	California Institute for Regenerative Medicine; National Institutes of Health [U01HL107442]; Department of Defense; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Frolov (UAB) for VEE vector and T. Kogiso for valuable input. This work was supported by grants from the California Institute for Regenerative Medicine (to A. R. M., B.D.Y., D. C. D., and S. F. D.), National Institutes of Health (# U01HL107442 to N.C.C.), Department of Defense (to X.-D.F.), and the Howard Hughes Medical Institute (to S. F. D.).	Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Davis NL, 2002, IUBMB LIFE, V53, P209, DOI 10.1080/15216540212657; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hussein SMI, 2011, CLIN PHARMACOL THER, V89, P741, DOI 10.1038/clpt.2011.37; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mochiduki Y, 2012, BIOTECHNOL J, V7, P789, DOI 10.1002/biot.201100356; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Schelle B., 2007, T7 RIBOMAX EXPRESS G; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	194	218	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					246	254		10.1016/j.stem.2013.06.001	http://dx.doi.org/10.1016/j.stem.2013.06.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910086	Bronze, Green Accepted			2022-12-25	WOS:000329570600017
J	Lin, JY; Sann, SB; Zhou, KM; Nabavi, S; Proulx, CD; Malinow, R; Jin, YS; Tsien, RY				Lin, John Y.; Sann, Sharon B.; Zhou, Keming; Nabavi, Sadegh; Proulx, Christophe D.; Malinow, Roberto; Jin, Yishi; Tsien, Roger Y.			Optogenetic Inhibition of Synaptic Release with Chromophore-Assisted Light Inactivation (CALI)	NEURON			English	Article							OPTICAL CONTROL; SINGLET OXYGEN; EXPRESSION; NEUROTRANSMITTER; SYNAPTOPHYSIN; RECEPTOR; SECRETION; REPORTER	Optogenetic techniques provide effective ways of manipulating the functions of selected neurons with light. In the current study, we engineered an optogenetic technique that directly inhibits neurotransmitter release. We used a genetically encoded singlet oxygen generator, miniSOG, to conduct chromophore assisted light inactivation (CALI) of synaptic proteins. Fusions of miniSOG to VAMP2 and synaptophysin enabled disruption of presynaptic vesicular release upon illumination with blue light. In cultured neurons and hippocampal organotypic slices, synaptic release was reduced up to 100%. Such inhibition lasted >1 hr and had minimal effects on membrane electrical properties. When miniSOG-VAMP2 was expressed panneuronally in Caenorhabditis elegans, movement of the worms was reduced after illumination, and paralysis was often observed. The movement of the worms recovered overnight. We name this technique Inhibition of Synapses with CALI (InSynC). InSynC is a powerful way to silence genetically specified synapses with light in a spatially and temporally precise manner.	[Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Sann, Sharon B.; Zhou, Keming; Malinow, Roberto; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Jin, Yishi; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Lin, JY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j8lin@ucsd.edu		Proulx, Christophe/0000-0001-6484-9677; Lin, John/0000-0002-1723-4597; Nabavi, Sadegh/0000-0002-3940-1210; Jin, Yishi/0000-0002-9371-9860	Foundation of Research, Science and Technology New Zealand; Ruth L. Kirschstein National Research Service Awards (NIH NINDS) [NS067891]; Instituts de Recherche en Sante du Canada; National Institutes of Health [MH091119, NS035546, NS027177]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R01NS035546, F32NS067891, R37NS027177, R37NS035546] Funding Source: NIH RePORTER	Foundation of Research, Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology); Ruth L. Kirschstein National Research Service Awards (NIH NINDS); Instituts de Recherche en Sante du Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.Y.L. was funded by Foundation of Research, Science and Technology New Zealand. S.B.S. was funded by Ruth L. Kirschstein National Research Service Awards (NIH NINDS NS067891). C.D.P. was funded by Instituts de Recherche en Sante du Canada. The project was supported by National Institutes of Health grants to R.M. (MH091119), Y.J. (NS035546), and R.Y.T. (NS027177). R.Y.T. and Y.J. are Investigators of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. J.Y.L. and S.B.S. designed the InSynC constructs. J.Y.L. conducted and analyzed the hippocampal microisland recordings. J.Y.L. and S.B.S. conducted and analyzed the worm movement and imaging experiments. K.Z. conducted and analyzed the electrophysiological recordings from C. elegans muscle cells. S.N. conducted and analyzed the organotypic slice experiments. R.Y.T., C.D.P., R.M., and Y.J. contributed to the design and analysis of the experiments. All authors contributed to the writing and discussion of the manuscript.	ALDER J, 1995, J NEUROSCI, V15, P511; Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Bekkers JM, 2005, J NEUROSCI, V25, P4031, DOI 10.1523/JNEUROSCI.4969-04.2005; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Cousin Michael A, 2008, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0206s43; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Han WP, 2005, J BIOL CHEM, V280, P5089, DOI 10.1074/jbc.M408757200; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hatz S, 2007, PHOTOCH PHOTOBIO SCI, V6, P1106, DOI 10.1039/b707313e; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; Kim S, 2000, BRAIN RES, V877, P209, DOI 10.1016/S0006-8993(00)02641-X; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Malinow R, 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5406, DOI 10.1101/PDB.PR0T5406]; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; MARQUEZE-POUEY B, 1991, J NEUROSCI, V11, P3388; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Smith SM, 2012, CELL CALCIUM, V52, P226, DOI 10.1016/j.ceca.2012.06.001; Stawicki TM, 2011, CURR BIOL, V21, P883, DOI 10.1016/j.cub.2011.03.070; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Takemoto K, 2011, ACS CHEM BIOL, V6, P401, DOI 10.1021/cb100431e; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Wyart C, 2005, J NEUROPHYSIOL, V93, P3370, DOI 10.1152/jn.00530.2004	46	127	134	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 24	2013	79	2					241	253		10.1016/j.neuron.2013.05.022	http://dx.doi.org/10.1016/j.neuron.2013.05.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191PX	23889931	Green Accepted, Bronze			2022-12-25	WOS:000322426200005
J	Beurg, M; Tan, XD; Fettiplace, R				Beurg, Maryline; Tan, Xiaodong; Fettiplace, Robert			A Prestin Motor in Chicken Auditory Hair Cells: Active Force Generation in a Nonmammalian Species	NEURON			English	Article							MECHANOELECTRICAL-TRANSDUCTION CHANNELS; OTOACOUSTIC EMISSIONS; BASILAR PAPILLA; PERILYMPHATIC APPLICATION; BULLFROGS SACCULUS; BUNDLE MOVEMENTS; GUINEA-PIG; COCHLEA; MOTILITY; SALICYLATE	Active force generation by outer hair cells (OHCs) underlies amplification and frequency tuning in the mammalian cochlea but whether such a process exists in nonmammals is unclear. Here, we demonstrate that hair cells of the chicken auditory papilla possess an electromechanical force generator in addition to active hair bundle motion due to mechanotransducer channel gating. The properties of the force generator, its voltage dependence and susceptibility to salicylate, as well as an associated chloride-sensitive nonlinear capacitance, suggest involvement of the chicken homolog of prestin, the OHC motor protein. The presence of chicken prestin in the hair cell lateral membrane was confirmed by immunolabeling studies. The hair bundle and prestin motors together create sufficient force to produce fast lateral displacements of the tectorial membrane. Our results imply that the first use of prestin as a motor protein occurred early in amniote evolution and was not a mammalian invention as is usually supposed.	[Beurg, Maryline; Tan, Xiaodong; Fettiplace, Robert] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53706 USA; [Beurg, Maryline] Univ Bordeaux Segalen, CHU, INSERM, U587, F-33076 Bordeaux, France	University of Wisconsin System; University of Wisconsin Madison; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53706 USA.	fettiplace@wisc.edu		Beurg, Maryline/0000-0003-3069-267X; Tan, Xiaodong/0000-0003-0251-2774	National Institutes on Deafness and other Communication Disorders [RO1 DC01362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER	National Institutes on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was supported by grant RO1 DC01362 from the National Institutes on Deafness and other Communication Disorders to R.F. We thank Dan Yee for constructing electrical equipment, Ana Garic for assistance with molecular biology, Lance Rodenkirch for advice on confocal imaging, Dominik Oliver for the pEGFP-N1 plasmid containing chicken prestin, and Jeff Corwin for the HCS-1 antibody.	Amann R, 2002, EUR J PHARMACOL, V447, P1, DOI 10.1016/S0014-2999(02)01828-9; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Benser ME, 1996, J NEUROSCI, V16, P5629; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BRIX J, 1994, HEARING RES, V76, P147, DOI 10.1016/0378-5955(94)90096-5; Burkard R, 1996, Audiol Neurootol, V1, P197; Chen L, 2001, HEARING RES, V161, P54, DOI 10.1016/S0378-5955(01)00353-7; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; DIELER R, 1994, HEARING RES, V74, P85, DOI 10.1016/0378-5955(94)90178-3; FISCHER FP, 1992, HEARING RES, V61, P167, DOI 10.1016/0378-5955(92)90048-R; FUCHS PA, 1988, J NEUROSCI, V8, P2460; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; GUMMER AW, 1987, HEARING RES, V29, P63, DOI 10.1016/0378-5955(87)90206-1; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; HIROKAWA N, 1978, J COMP NEUROL, V181, P361, DOI 10.1002/cne.901810208; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; KETTEMBEIL S, 1995, HEARING RES, V86, P47, DOI 10.1016/0378-5955(95)00053-7; Koppl C, 2011, HEARING RES, V273, P65, DOI 10.1016/j.heares.2010.03.095; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Mahendrasingam S, 2010, EUR J NEUROSCI, V31, P1595, DOI 10.1111/j.1460-9568.2010.07182.x; Manley GA, 1998, CURR OPIN NEUROBIOL, V8, P468, DOI 10.1016/S0959-4388(98)80033-0; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; Martin P, 2003, J NEUROSCI, V23, P4533; MURROW BW, 1994, J PHYSIOL-LONDON, V480, P247, DOI 10.1113/jphysiol.1994.sp020357; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ricci AJ, 2000, J NEUROSCI, V20, P7131; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; SHEHATADIELER WE, 1994, HEARING RES, V74, P77, DOI 10.1016/0378-5955(94)90177-5; Stewart CE, 2000, P NATL ACAD SCI USA, V97, P454, DOI 10.1073/pnas.97.1.454; Sul B, 2009, BIOPHYS J, V97, P2653, DOI 10.1016/j.bpj.2009.08.039; SZYMKO YM, 1992, HEARING RES, V59, P241, DOI 10.1016/0378-5955(92)90120-C; TAKASAKA T, 1971, J ULTRA MOL STRUCT R, V35, P20, DOI 10.1016/S0022-5320(71)80141-7; Tan XD, 2013, J NEUROPHYSIOL, V109, P2007, DOI 10.1152/jn.01028.2012; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; TILNEY LG, 1983, J CELL BIOL, V96, P807, DOI 10.1083/jcb.96.3.807; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	47	48	50	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2013	79	1					69	81		10.1016/j.neuron.2013.05.018	http://dx.doi.org/10.1016/j.neuron.2013.05.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	23746629	Green Accepted, Bronze			2022-12-25	WOS:000321802000010
J	Gross, GG; Junge, JA; Mora, RJ; Kwon, HB; Olson, CA; Takahashi, TT; Liman, ER; Ellis-Davies, GCR; Mcgee, AW; Sabatini, BL; Roberts, RW; Arnold, DB				Gross, Garrett G.; Junge, Jason A.; Mora, Rudy J.; Kwon, Hyung-Bae; Olson, C. Anders; Takahashi, Terry T.; Liman, Emily R.; Ellis-Davies, Graham C. R.; McGee, Aaron W.; Sabatini, Bernardo L.; Roberts, Richard W.; Arnold, Don B.			Recombinant Probes for Visualizing Endogenous Synaptic Proteins in Living Neurons	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEINS; IMMUNOGLOBULIN LIGHT-CHAIN; GREEN FLUORESCENT PROTEIN; MESSENGER-RNA DISPLAY; IN-VIVO; TRANSCRIPTIONAL REPRESSION; GABAERGIC SYNAPSES; CONSTANT FRAGMENT; DENDRITIC SPINES; ANTIBODY MIMICS	The ability to visualize endogenous proteins in living neurons provides a powerful means to interrogate neuronal structure and function. Here we generate recombinant antibody-like proteins, termed Fibronectin intrabodies generated with mRNA display (FingRs), that bind endogenous neuronal proteins PSD-95 and Gephyrin with high affinity and that, when fused to GFP, allow excitatory and inhibitory synapses to be visualized in living neurons. Design of the FingR incorporates a transcriptional regulation system that ties FingR expression to the level of the target and reduces background fluorescence. In dissociated neurons and brain slices, FingRs generated against PSD-95 and Gephyrin did not affect the expression patterns of their endogenous target proteins or the number or strength of synapses. Together, our data indicate that PSD-95 and Gephyrin FingRs can report the localization and amount of endogenous synaptic proteins in living neurons and thus may be used to study changes in synaptic strength in vivo.	[Gross, Garrett G.; Takahashi, Terry T.; Roberts, Richard W.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Junge, Jason A.; Mora, Rudy J.; Liman, Emily R.; Arnold, Don B.] Univ So Calif, Dept Biol, Los Angeles, CA 90089 USA; [Kwon, Hyung-Bae; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Olson, C. Anders] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90090 USA; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [McGee, Aaron W.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; Children's Hospital Los Angeles	Roberts, RW (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	richrob@usc.edu; darnold@usc.edu	Liman, Emily/AAC-7383-2021; Takahashi, Terry T/F-3463-2010	Junge, Jason/0000-0002-9886-1751; Roberts, Richard/0000-0002-8587-5097	 [GM-083898];  [MH-086381];  [GM 060416];  [OD 006117];  [GM53395];  [NS69720];  [NS-046579]; NATIONAL CANCER INSTITUTE [R01CA170820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395, R01GM083898, R01GM060416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081678, R37NS046579, R01NS046579, R01NS069720] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Liana Asatryan (USC, Lentivirus Core Facility) for producing lentivirus, Aaron Nichols for help in producing the naive FingR library, Samantha Ancona-Esselmann for technical assistance and help in data analysis, Jerardo Viramontes Garcia for help in data analysis, and Ryan Kast for technical help with in vivo two-photon imaging. We thank Matthew Pratt, David McKemy, Samantha Butler, and members of the Arnold and Roberts laboratories for helpful suggestions on the manuscript. D.B.A. was supported by grants GM-083898 and MH-086381. R.W.R. was supported by GM-083898, GM 060416, and OD 006117. G.C.R.E.-D. was supported by GM53395 and NS69720. B.L.S. was supported by NS-046579. G.C.R.E.-D. has filed a preliminary patent declaration on the synthesis of dinitroindolinyl-caged neurotransmitters.	Andersson AM, 1997, J VIROL, V71, P4717, DOI 10.1128/JVI.71.6.4717-4727.1997; [Anonymous], NEURON, V23, P583; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Brenman JE, 1998, J NEUROSCI, V18, P8805; Brenman JE, 1996, J NEUROSCI, V16, P7407; Burkhalter A, 2006, J NEUROSCI, V26, P12274, DOI 10.1523/JNEUROSCI.2599-06.2006; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiu CS, 2002, J NEUROSCI, V22, P10251; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Coons AH, 1942, J IMMUNOL, V45, P159; Craig AM, 1996, J NEUROSCI, V16, P3166; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; El-Hussein AE, 2000, SCIENCE, V290, P1364; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; GOTO Y, 1987, J BIOCHEM, V101, P319, DOI 10.1093/oxfordjournals.jbchem.a121916; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Ishikawa FN, 2009, ACS NANO, V3, P1219, DOI 10.1021/nn900086c; Jinno S, 2005, NEUROSCIENCE, V134, P483, DOI 10.1016/j.neuroscience.2005.04.065; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009; Kistner U., 1996, NEURON, V17, P255; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mani M, 2005, BIOCHEM BIOPH RES CO, V335, P447, DOI 10.1016/j.bbrc.2005.07.089; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Olson CA, 2008, ACS CHEM BIOL, V3, P480, DOI 10.1021/cb800069c; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; TAKAGI T, 1992, FEBS LETT, V303, P178, DOI 10.1016/0014-5793(92)80513-G; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Varley ZK, 2011, J BIOL CHEM, V286, P20942, DOI 10.1074/jbc.M111.234641; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	56	156	158	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 19	2013	78	6					971	985		10.1016/j.neuron.2013.04.017	http://dx.doi.org/10.1016/j.neuron.2013.04.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172TD	23791193	Green Accepted, Bronze			2022-12-25	WOS:000321026900005
J	Roberts, MJ; Lowet, E; Brunet, NM; Ter Wal, M; Tiesinga, P; Fries, P; De Weerd, P				Roberts, Mark J.; Lowet, Eric; Brunet, Nicolas M.; Ter Wal, Marije; Tiesinga, Paul; Fries, Pascal; De Weerd, Peter			Robust Gamma Coherence between Macaque V1 and V2 by Dynamic Frequency Matching	NEURON			English	Article							PRIMARY VISUAL-CORTEX; BAND ACTIVITY; NEURONAL OSCILLATIONS; FEATURE INTEGRATION; IN-VITRO; AREA 17; MONKEY; SYNCHRONY; RESPONSES; STRIATE	Current theories propose that coherence of oscillatory brain activity in the gamma band (30-80 Hz) constitutes an avenue for communication among remote neural populations. However, reports documenting stimulus dependency and time variability of gamma frequency suggest that distant neuronal populations may, at any one time, operate at different frequencies precluding synchronization. To test this idea, we recorded from macaque V1 and V2 simultaneously while presenting gratings of varying contrast. Although gamma frequency increased with stimulus contrast in V1 and V2 (by similar to 25 Hz), V1-V2 gamma coherence was maintained for all contrasts. Moreover, while gamma frequency fluctuated by similar to 15 Hz during constant contrast stimulation, this fluctuation was highly correlated between V1 and V2. The strongest coherence connections showed a layer-specific pattern, matching feedforward anatomical connectivity. Hence, gamma coherence among remote populations can occur despite large stimulus-induced and time-dependent changes in gamma frequency, allowing communication through coherence to operate without a stimulus independent, fixed-frequency gamma channel.	[Roberts, Mark J.; Lowet, Eric; Brunet, Nicolas M.; Ter Wal, Marije; Tiesinga, Paul; Fries, Pascal; De Weerd, Peter] Radboud Univ Nijmegen, Donders Inst Brain Behav & Cognit, NL-6500 HC Nijmegen, Netherlands; [Roberts, Mark J.; Lowet, Eric; De Weerd, Peter] Maastricht Univ, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands; [Fries, Pascal] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, D-60528 Frankfurt, Germany; [Brunet, Nicolas M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA	Radboud University Nijmegen; Maastricht University; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, MJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Behav & Cognit, NL-6500 HC Nijmegen, Netherlands.	mark.roberts@maastrichtuniversity.nl	Fries, Pascal/E-3196-2010; Roberts, Mark/C-7011-2018; Tiesinga, Paul/D-1901-2010	Fries, Pascal/0000-0002-4270-1468; Roberts, Mark/0000-0001-7513-1281; ter Wal, Marije/0000-0003-4922-3435	NWO VICI grant [453-04-002]; NWO VENI grant [451-09-025]; Maastricht University; Donders Institute for Brain Behavior and Cognition	NWO VICI grant(Netherlands Organization for Scientific Research (NWO)); NWO VENI grant; Maastricht University; Donders Institute for Brain Behavior and Cognition	This research was supported by NWO VICI grant 453-04-002 (to P.D.W.), NWO VENI grant 451-09-025 (to M.R.), and Maastricht University graduate funding in cooperation with the Donders Institute for Brain Behavior and Cognition (to P.D.W.). Experiments were designed by P.D.W. and M.R. Measurements were carried out by M.R. and E.L. with assistance from N.B. Analysis was carried out by M.R. and E.L. and modeling by M.T.W. with guidance from P.T., P.F., and P.D.W. The paper was written by M.R., E.L., and P.D.W. in collaboration with the other authors.	Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Burns SP, 2011, J NEUROSCI, V31, P9658, DOI 10.1523/JNEUROSCI.0660-11.2011; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; de Sousa AA, 2010, CEREB CORTEX, V20, P966, DOI 10.1093/cercor/bhp158; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feng WJ, 2010, NEUROREPORT, V21, P680, DOI 10.1097/WNR.0b013e32833ae9d1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Lund JS, 2003, CEREB CORTEX, V13, P15, DOI 10.1093/cercor/13.1.15; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maier A, 2011, J NEUROSCI, V31, P1971, DOI 10.1523/JNEUROSCI.5300-09.2011; MANJUNATH BS, 1993, IEEE T NEURAL NETWOR, V4, P96, DOI 10.1109/72.182699; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nowak LG, 1999, J NEUROPHYSIOL, V81, P1057, DOI 10.1152/jn.1999.81.3.1057; Oostenveld R., 2011, NEUROSCIENCE, DOI [10.1155/2011/156869, DOI 10.1155/2011/156869]; Palanca BJA, 2005, NEURON, V46, P333, DOI 10.1016/j.neuron.2005.03.002; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Rosenblum M., 2001, CAMBRIDGE NONLINEAR; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Smith MA, 2013, J NEUROPHYSIOL, V109, P940, DOI 10.1152/jn.00846.2012; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Tiesinga PHE, 2002, NETWORK-COMP NEURAL, V13, P41, DOI 10.1088/0954-898X/13/1/302; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wildie M, 2012, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00062; Xing DJ, 2012, J NEUROSCI, V32, P13873, DOI 10.1523/JNEUROSCI.5644-11.2012; Xing DJ, 2012, P NATL ACAD SCI USA, V109, P13871, DOI 10.1073/pnas.1201478109	52	161	161	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2013	78	3					523	536		10.1016/j.neuron.2013.03.003	http://dx.doi.org/10.1016/j.neuron.2013.03.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144SW	23664617	Bronze			2022-12-25	WOS:000318961700013
J	Bu, PC; Chen, KY; Chen, JH; Wang, LH; Walters, J; Shin, YJ; Goerger, JP; Sun, J; Witherspoon, M; Rakhilin, N; Li, JH; Yang, H; Milsom, J; Lee, S; Zipfel, W; Jin, MM; Gumus, ZH; Lipkin, SM; Shen, XL				Bu, Pengcheng; Chen, Kai-Yuan; Chen, Joyce Huan; Wang, Lihua; Walters, Jewell; Shin, Yong Jun; Goerger, Julian P.; Sun, Jian; Witherspoon, Mavee; Rakhilin, Nikolai; Li, Jiahe; Yang, Herman; Milsom, Jeff; Lee, Sang; Zipfel, Warren; Jin, Moonsoo M.; Guemues, Zeynep H.; Lipkin, Steven M.; Shen, Xiling			A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells	CELL STEM CELL			English	Article							TUMOR-INITIATING CELLS; INTESTINAL CRYPTS; MAMMALIAN-CELLS; SELF-RENEWAL; DIVISION; METASTASIS; RNAS; DIFFERENTIATION; MODULATION; REGULATORS	microRNAs regulate developmental cell-fate decisions, tissue homeostasis, and oncogenesis in distinct ways relative to proteins. Here, we show that the tumor suppressor microRNA miR-34a is a cell-fate determinant in early-stage dividing colon cancer stem cells (CCSCs). In pair-cell assays, miR-34a distributes at high levels in differentiating progeny, whereas low levels of miR-34a demarcate self-renewing CCSCs. Moreover, miR-34a loss of function and gain of function alter the balance between self-renewal versus differentiation both in vitro and in vivo. Mechanistically, miR-34a sequesters Notch1 mRNA to generate a sharp threshold response where a bimodal Notch signal specifies the choice between self-renewal and differentiation. In contrast, the canonical cell-fate determinant Numb regulates Notch levels in a continuously graded manner. Altogether, our findings highlight a unique microRNA-regulated mechanism that converts noisy input into a toggle switch for robust cell-fate decisions in CCSCs.	[Bu, Pengcheng; Chen, Kai-Yuan; Wang, Lihua; Shin, Yong Jun; Rakhilin, Nikolai; Yang, Herman; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA; [Bu, Pengcheng; Chen, Joyce Huan; Goerger, Julian P.; Li, Jiahe; Zipfel, Warren; Jin, Moonsoo M.; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Wang, Lihua; Rakhilin, Nikolai; Shen, Xiling] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10021 USA; [Walters, Jewell; Witherspoon, Mavee; Milsom, Jeff; Lee, Sang; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA; [Sun, Jian; Guemues, Zeynep H.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Jin, Moonsoo M.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10021 USA; [Guemues, Zeynep H.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Guemues, Zeynep H.] Weill Cornell Med Coll, Computat Biomed & Canc Ctr, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Lipkin, SM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA.	stl2012@med.cornell.edu; xs66@cornell.edu	Bu, Pengcheng/N-4134-2013; Zipfel, Warren/B-4059-2016	Gumus, Zeynep/0000-0002-7364-2202; Zipfel, Warren/0000-0003-2640-329X; Bu, Pengcheng/0000-0002-3208-0354	Cornell Nanobiotechnology Center, the Cornell Stem Cell Program;  [NIGMS R01GM95990];  [NSF 1137269];  [DARPA 19-1091726];  [NCI R21CA162483];  [NCI R21CA153049]; NATIONAL CANCER INSTITUTE [R21CA153049, R21CA162483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095990] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1106153] Funding Source: National Science Foundation	Cornell Nanobiotechnology Center, the Cornell Stem Cell Program; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Michael Elowitz and members of the Shen, Lipkin, Elowitz, and Jin laboratories for discussions and advice. We also thank Harley McAdams, Kenneth Kemphues, Tudorita Tumbar, and Robert Weiss for their comments on the manuscript. This work was supported by grants NIGMS R01GM95990, NSF 1137269, DARPA 19-1091726, NCI R21CA162483, and NCI R21CA153049 as well as the Cornell Nanobiotechnology Center, the Cornell Stem Cell Program, and a generous gift from Matthew Bell.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DEYGUHA I, 2011, P NATL ACAD SCI US; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EMELO FD, 2011, CELL STEM CELL, V9, P476; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; JAHID S, 2012, CANC DISCOVERY; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Potten CS, 2002, J CELL SCI, V115, P2381; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Taketo MM, 2011, CANCER PREV RES, V4, P324, DOI 10.1158/1940-6207.CAPR-11-0046; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vohradsky J, 2010, NUCLEIC ACIDS RES, V38, P4579, DOI 10.1093/nar/gkq220; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Youn BS, 2001, BLOOD, V98, P925, DOI 10.1182/blood.V98.4.925	53	282	294	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					602	615		10.1016/j.stem.2013.03.002	http://dx.doi.org/10.1016/j.stem.2013.03.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642368	Green Accepted, Bronze			2022-12-25	WOS:000329569600015
J	Takatoh, J; Nelson, A; Zhou, X; Bolton, MM; Ehlers, MD; Arenkiel, BR; Mooney, R; Wang, F				Takatoh, Jun; Nelson, Anders; Zhou, Xiang; Bolton, M. McLean; Ehlers, Michael D.; Arenkiel, Benjamin R.; Mooney, Richard; Wang, Fan			New Modules Are Added to Vibrissal Premotor Circuitry with the Emergence of Exploratory Whisking	NEURON			English	Article							MOTOR CORTEX; RABIES VIRUS; TRANSNEURONAL TRACER; RODENT WHISKING; RAT; MOVEMENT; ORGANIZATION; NUCLEUS; MICROSTIMULATION; INNERVATION	Rodents begin to use bilaterally coordinated, rhythmic sweeping of their vibrissae ("whisking") for environmental exploration around 2 weeks after birth. Whether (and how) the vibrissal control circuitry changes after birth is unknown, and the relevant premotor circuitry remains poorly characterized. Using a modified rabies virus transsynaptic tracing strategy, we labeled neurons synapsing directly onto vibrissa facial motor neurons (vFMNs). Sources of potential excitatory, inhibitory, and modulatory vFMN premotor neurons, and differences between the premotor circuitry for vFMNs innervating intrinsic versus extrinsic vibrissal muscles were systematically characterized. The emergence of whisking is accompanied by the addition of new sets of bilateral excitatory inputs to vFMNs from neurons in the lateral paragigantocellu-laris (LPGi). Furthermore, descending axons from the motor cortex directly innervate LPGi premotor neurons. Thus, neural modules that are well suited to facilitate the bilateral coordination and cortical control of whisking are added to the premotor circuitry in parallel with the emergence of this exploratory behavior.	[Takatoh, Jun; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Nelson, Anders; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Zhou, Xiang] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bolton, M. McLean] Max Planck Inst Florida, Jupiter, FL 33458 USA; [Ehlers, Michael D.] Pfizer Worldwide Res & Dev, Neurosci Res Unit, Cambridge, MA 02139 USA; [Arenkiel, Benjamin R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Duke University; Duke University; University of Chicago; Max Planck Society; Pfizer; Baylor College of Medicine	Wang, F (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	fan.wang@duke.edu		Mooney, Richard/0000-0002-3308-1367; Takatoh, Jun/0000-0002-0976-7684; Arenkiel, Benjamin/0000-0001-9047-2420; Nelson, Anders/0000-0003-1460-9848	NIH [DA028302, DE019440, NS079929, NS078294]; McNair Foundation; Duke Institute of Brain Sciences; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078294, R21NS079929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair Foundation; Duke Institute of Brain Sciences; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Ed Callaway for providing various Delta G rabies viruses and Yingchun Ni and Zhigang He for help with producing viruses. We thank Bao-Xia Han for general technical support and members of the Wang laboratory and Mooney laboratory for discussions and suggestions. We thank Martin Deschenes, Jeff Moore, and David Kleinfeld for sharing results prior to publication. We thank Drs. Stephen Lisberger, Rebecca Yang, Martin Deschenes, Jeff Moore, and David Kleinfeld for critically reading the manuscript. This work was supported by NIH grants DA028302 and DE019440 to F.W., NS079929 to R.M., and NS078294 to B.R.A., who was also supported by the McNair Foundation. J.T. was supported in part by an incubator award from Duke Institute of Brain Sciences. Correspondence for the R Phi GT (rosa26-CAG-IoxP-5TOP-Iox-Prabies-G-TVA) mouse should be addressed to B.R.A. (arenkiel@bcm.edu).	Arenkiel BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029423; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; ASHWELL KW, 1983, J EMBRYOL EXP MORPH, V77, P117; Berg RW, 2005, J NEUROPHYSIOL, V94, P699, DOI 10.1152/jn.01125.2004; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; DORFL J, 1985, J ANAT, V142, P173; DORFL J, 1982, J ANAT, V135, P147; Dutschmann M, 2004, RESP PHYSIOL NEUROBI, V143, P155, DOI 10.1016/j.resp.2004.04.015; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; EZURE K, 1990, PROG NEUROBIOL, V35, P429, DOI 10.1016/0301-0082(90)90030-K; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Gerber RJ, 2010, PEDIATR REV, V31, P267, DOI 10.1542/pir.31-7-267; Grant RA, 2012, DEV PSYCHOBIOL, V54, P151, DOI 10.1002/dev.20591; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Immelmann K., 1969, P61; ISOKAWAAKESSON M, 1987, EXP BRAIN RES, V65, P385; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; KLEIN BG, 1985, J COMP NEUROL, V232, P55, DOI 10.1002/cne.902320106; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; MOONEY R, 1994, J NEUROSCI, V14, P6532; MOONEY R, 1992, J NEUROSCI, V12, P2464; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Sellien H, 2005, SOMATOSENS MOT RES, V22, P97, DOI 10.1080/08990220400015375; SEMBA K, 1986, J COMP NEUROL, V247, P144, DOI 10.1002/cne.902470203; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Wallace PS, 2003, NEUROPSYCHOLOGIA, V41, P1912, DOI 10.1016/S0028-3932(03)00128-3; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; WINESKI LE, 1985, J MORPHOL, V183, P199, DOI 10.1002/jmor.1051830208	56	77	77	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2013	77	2					346	360		10.1016/j.neuron.2012.11.010	http://dx.doi.org/10.1016/j.neuron.2012.11.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079VD	23352170	Bronze, Green Accepted			2022-12-25	WOS:000314199400016
J	Hearing, M; Kotecki, L; de Velasco, EMF; Fajardo-Serrano, A; Chung, HJ; Lujan, R; Wickman, K				Hearing, Matthew; Kotecki, Lydia; de Velasco, Ezequiel Marron Fernandez; Fajardo-Serrano, Ana; Chung, Hee Jung; Lujan, Rafael; Wickman, Kevin			Repeated Cocaine Weakens GABA(B)-Girk Signaling in Layer 5/6 Pyramidal Neurons in the Prelimbic Cortex	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA; INDUCED BEHAVIORAL SENSITIZATION; RECTIFYING POTASSIUM CHANNELS; DRUG-SEEKING BEHAVIOR; RAT FRONTAL-CORTEX; DOPAMINE MODULATION; GABA TRANSMISSION; IN-VITRO; RECEPTORS	Repeated cocaine exposure triggers adaptations in layer 5/6 glutamatergic neurons in the medial prefrontal cortex (mPFC) that promote behavioral sensitization and drug-seeking behavior. While suppression of metabotropic inhibitory signaling has been implicated in these behaviors, underlying mechanisms are unknown. Here, we show that Girk/K(IR)3 channels mediate most of the GABA(B) receptor (GABA(B)R)-dependent inhibition of layer 5/6 pyramidal neurons in the nnPFC and that repeated cocaine suppresses this pathway. This adaptation was selective for GABA(B)R-dependent Girk signaling in layer 5/6 pyramidal neurons of the prelimbic cortex (PrLC) and involved a D-1/5 dopamine receptor-and phosphorylation-dependent internalization of GABA(B)R and Girk channels. Persistent suppression of Girk signaling in layer 5/6 of the dorsal mPFC enhanced cocaine-induced locomotor activity and occluded behavioral sensitization. Thus, the cocaine-induced suppression of GABA(B)R-Girk signaling in layer 5/6 pyramidal neurons of the prelimbic cortex appears to represent an early adaptation critical for promoting addiction-related behavior.	[Hearing, Matthew; Kotecki, Lydia; de Velasco, Ezequiel Marron Fernandez; Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Fajardo-Serrano, Ana; Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Albacete 02071, Spain; [Chung, Hee Jung] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Minnesota System; University of Minnesota Twin Cities; Universidad de Castilla-La Mancha; University of Illinois System; University of Illinois Urbana-Champaign	Wickman, K (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	wickm002@umn.edu	Lujan, Rafael/G-2555-2015; Fajardo-Serrano, Ana/AAB-4166-2021	Fajardo-Serrano, Ana/0000-0003-0645-8808; Marron Fernandez de Velasco, Ezequiel/0000-0003-0257-4457; Wickman, Kevin/0000-0002-5179-9540; Lujan Miras, Rafael/0000-0003-2001-9545	NIH [MH061933, DA011806, DA034696, DA007097]; Spanish Ministry of Science and Innovation [BFU2012-38348]; CONSOLIDER-Ingenio [CSD2008-0000]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034696, T32DA007097, R21DA029343, T32DA007234, P50DA011806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants to KW (MH061933, DA011806, DA034696), MH (DA007097), LK (DA007097), and the Spanish Ministry of Science and Innovation BFU2012-38348 and CONSOLIDER-Ingenio CSD2008-0000 (RL). The authors thank Kelsey Mirkovic, Daniele Young, Matt Novitch, and Edward Kim for excellent technical support.	Aoki C, 1998, Adv Pharmacol, V42, P777; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Arora D, 2011, J NEUROSCI, V31, P12251, DOI 10.1523/JNEUROSCI.0494-11.2011; Arora D, 2010, J NEUROCHEM, V114, P1487, DOI 10.1111/j.1471-4159.2010.06864.x; Beyer CE, 2002, CEREB CORTEX, V12, P526, DOI 10.1093/cercor/12.5.526; Briand LA, 2008, NEUROPSYCHOPHARMACOL, V33, P2969, DOI 10.1038/npp.2008.18; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Harte M, 2005, NEUROSCIENCE, V130, P215, DOI 10.1016/j.neuroscience.2004.08.045; Hearing MC, 2012, REV NEUROSCIENCE, V23, P325, DOI 10.1515/revneuro-2012-0045; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jayaram P, 2006, EUR J PHARMACOL, V531, P74, DOI 10.1016/j.ejphar.2005.11.056; Jayaram P, 2005, EUR J NEUROSCI, V21, P2035, DOI 10.1111/j.1460-9568.2005.04000.x; Jayaram P, 2004, J NEUROCHEM, V90, P839, DOI 10.1111/j.1471-4159.2004.02525.x; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Karschin C, 1996, J NEUROSCI, V16, P3559; Kase Daisuke, 2012, J Signal Transduct, V2012, P619747, DOI 10.1155/2012/619747; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kroener S, 2010, NEUROPSYCHOPHARMACOL, V35, P2292, DOI 10.1038/npp.2010.107; Kulik A, 2003, J NEUROSCI, V23, P11026; Kushner SA, 2001, LIFE SCI, V69, P1093, DOI 10.1016/S0024-3205(01)01203-6; Li JY, 2002, J NEUROSCI RES, V68, P241, DOI 10.1002/jnr.10206; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marquis JP, 2007, EUR J NEUROSCI, V25, P559, DOI 10.1111/j.1460-9568.2006.05295.x; McFarland K, 2001, J NEUROSCI, V21, P8655; Nasif FJ, 2005, J PHARMACOL EXP THER, V312, P1305, DOI 10.1124/jpet.104.075184; Nogueira L, 2006, J NEUROSCI, V26, P12308, DOI 10.1523/JNEUROSCI.3206-06.2006; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pierce R.C., 1998, NEUROSCIENCE, V82, P1103; RETAUX S, 1993, BRAIN RES, V611, P187, DOI 10.1016/0006-8993(93)90502-E; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Steketee JD, 2005, PSYCHOPHARMACOLOGY, V180, P352, DOI 10.1007/s00213-005-2149-y; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; STRIPLIN CD, 1992, BRAIN RES, V579, P181, DOI 10.1016/0006-8993(92)90049-F; Sun WL, 2006, J NEUROSCI, V26, P8004, DOI 10.1523/JNEUROSCI.1413-06.2006; TABER MT, 1995, J NEUROSCI, V15, P3896; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Tzschentke TM, 2000, CEREB CORTEX, V10, P488, DOI 10.1093/cercor/10.5.488; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; VINCENT SL, 1993, J NEUROSCI, V13, P2551, DOI 10.1523/JNEUROSCI.13-06-02551.1993; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Wang Y, 2010, EUR J NEUROSCI, V31, P1582, DOI 10.1111/j.1460-9568.2010.07191.x; Wang Z, 2001, BRAIN RES, V901, P303, DOI 10.1016/S0006-8993(01)02350-2; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; Witkowski G, 2012, J PHYSIOL PHARMACOL, V63, P457; WOLF ME, 1987, NEUROPHARMACOLOGY, V26, P1053, DOI 10.1016/0028-3908(87)90248-6; Yang CR, 1996, J NEUROSCI, V16, P1904	65	81	82	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 2	2013	80	1					159	170		10.1016/j.neuron.2013.07.019	http://dx.doi.org/10.1016/j.neuron.2013.07.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243GQ	24094109	Green Accepted, Bronze			2022-12-25	WOS:000326305300015
J	Lucin, KM; O'Brien, CE; Bieri, G; Czirr, E; Mosher, KI; Abbey, RJ; Mastroeni, DF; Rogers, J; Spencer, B; Masliah, E; Wyss-Coray, T				Lucin, Kurt M.; O'Brien, Caitlin E.; Bieri, Gregor; Czirr, Eva; Mosher, Kira I.; Abbey, Rachelle J.; Mastroeni, Diego F.; Rogers, Joseph; Spencer, Brian; Masliah, Eliezer; Wyss-Coray, Tony			Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer's Disease	NEURON			English	Article							AUTOPHAGY GENE; EMBRYONIC-DEVELOPMENT; RETROGRADE TRANSPORT; GLUTAMATE-RECEPTOR; PARKINSON DISEASE; TRANSGENIC MICE; TYRO-3 FAMILY; MOUSE MODEL; PATHOLOGY; PROTEIN	Phagocytosis controls CNS homeostasis by facilitating the removal of unwanted cellular debris. Accordingly, impairments in different receptors or proteins involved in phagocytosis result in enhanced inflammation and neurodegeneration. While various studies have identified extrinsic factors that modulate phagocytosis in health and disease, key intracellular regulators are less understood. Here we show that the autophagy protein beclin 1 is required for efficient phagocytosis in vitro and in mouse brains. Furthermore, we show that beclin 1-mediated impairments in phagocytosis are associated with dysfunctional recruitment of retromer to phagosomal membranes, reduced retromer levels, and impaired recycling of phagocytic receptors CD36 and Trem2. Interestingly, microglia isolated from human Alzheimer's disease (AD) brains show significantly reduced beclin 1 and retromer protein levels. These findings position beclin 1 as a link between autophagy, retromer trafficking, and receptor-mediated phagocytosis and provide insight into mechanisms by which phagocytosis is regulated and how it may become impaired in AD.	[Lucin, Kurt M.; O'Brien, Caitlin E.; Bieri, Gregor; Czirr, Eva; Mosher, Kira I.; Abbey, Rachelle J.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [O'Brien, Caitlin E.] Stanford Univ, Sch Med, Cell & Mol Biol Program, Stanford, CA 94305 USA; [Bieri, Gregor; Mosher, Kira I.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Neurosci IDP Program, Stanford, CA 94305 USA; [Lucin, Kurt M.; O'Brien, Caitlin E.; Bieri, Gregor; Czirr, Eva; Mosher, Kira I.; Abbey, Rachelle J.; Wyss-Coray, Tony] Vet Adm Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA; [Mastroeni, Diego F.] Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Ctr, Sun City, AZ 85351 USA; [Rogers, Joseph] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA; [Spencer, Brian; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Stanford University; Stanford University; Stanford University; Banner Research; Banner Health; Banner Sun Health Research Institute; SRI International; University of California System; University of California San Diego; University of California System; University of California San Diego	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Mosher, Kira/0000-0002-3041-3186; Lipton, Stuart/0000-0002-3490-1259	NINDS [P30 NS069375-01A1]; Department of Veterans Affairs; National Institutes of Health Institute on Aging [R01 AG030144, R01 AG18440, R01 AG10435]; California Initiative for Regenerative Medicine Award; Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; National Science Foundation predoctoral fellowship; Kirschstein NRSA predoctoral fellowship; National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders) [U24 NS072026]; National Institute on Aging (Arizona Alzheimer's Disease Core Center) [P30 AG19610]; Arizona Department of Health Services (Arizona Alzheimer's Research Center) [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS078865, P30NS069375, U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440, R01AG020603, P30AG019610, R01AG030144, R01AG045034, R01AG043384, P50AG005131, R01AG018440, F31AG040877] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001319] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Initiative for Regenerative Medicine Award; Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); Kirschstein NRSA predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders); National Institute on Aging (Arizona Alzheimer's Disease Core Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services (Arizona Alzheimer's Research Center); Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Saul Villeda and Dr. Joseph Castellano for critical review of the manuscript, Zhaoqing Ding for assistance with flow cytometry, Dr. Manuel Buttini for assistance with the ex vivo phagocytosis assay, Dr. Sergio Grinstein for providing the 2xFYVE-mRFP construct, the Stanford Virus Core (supported by NINDS P30 NS069375-01A1) for producing the lentiviruses used in this study, and Dr. Philipp Jaeger and Dr. Scott Small for helpful discussions of the manuscript. Funding for these studies was provided by the Department of Veterans Affairs (T.W.-C.), the National Institutes of Health Institute on Aging (R01 AG030144, T.W.-C. R01 AG18440, E.M.; R01 AG10435, E.M.), a California Initiative for Regenerative Medicine Award (T.W.-C.), The Larry L. Hillblom Foundation (K.M.L., T.W.-C.), The John Douglas French Alzheimer's Foundation (K.M.L.), a National Science Foundation predoctoral fellowship (K.I.M.), and a Kirschstein NRSA predoctoral fellowship (1 F31 AG040877-01A1, K.I.M.). We are also grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, AZ for the provision of human microglia. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Ma CY, 2012, J BIOL CHEM, V287, P18359, DOI 10.1074/jbc.M112.367060; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Marr RA, 2003, J NEUROSCI, V23, P1992; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ruck A, 2011, AUTOPHAGY, V7, P386, DOI 10.4161/auto.7.4.14391; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Smale S.T., 2010, COLD SPRING HARB PRO, V2010, pt5374; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	59	245	257	3	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 4	2013	79	5					873	886		10.1016/j.neuron.2013.06.046	http://dx.doi.org/10.1016/j.neuron.2013.06.046			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297QD	24012002	Green Accepted, Bronze			2022-12-25	WOS:000330269100007
J	Sun, XN; Xu, J; Lu, HX; Liu, W; Miao, ZC; Sui, X; Liu, HS; Su, L; Du, WC; He, QH; Chen, FY; Shi, Y; Deng, HK				Sun, Xiaoning; Xu, Jun; Lu, Hongxia; Liu, Wang; Miao, Zhenchuan; Sui, Xin; Liu, Haisong; Su, Li; Du, Weichao; He, Qihua; Chen, Fangyuan; Shi, Yan; Deng, Hongkui			Directed Differentiation of Human Embryonic Stem Cells into Thymic Epithelial Progenitor-like Cells Reconstitutes the Thymic Microenvironment In Vivo	CELL STEM CELL			English	Article							ENDODERM; MICE; ORGANOGENESIS; GENERATION; LUNG; IDENTIFICATION; INHIBITION; MECHANISMS; EXPRESSION; TISSUE	Thymus transplantation has great clinical potential for treating immunological disorders, but the shortage of transplant donors limits the progress of this therapy. Human embryonic stem cells (hESCs) are promising cell sources for generating thymic epithelial cells. Here, we report a stepwise protocol to direct the differentiation of hESCs into thymic epithelial progenitor-like cells (TEPLCs) by mimicking thymus organogenesis with sequential regulation of Activin, retinoic acid, BMP, and WNT signals. The hESC-derived TEPLCs expressed the key thymic marker gene FOXN1 and could further develop in vivo into thymic epithelium expressing the functional thymic markers MHC II and AIRE upon transplantation. Moreover, the TEPLC-derived thymic epithelium could supportmouse thymopoiesis in T-cell-deficient mice and promote human T cell generation in NOD/SCID mice engrafted with human hematopoietic stem cells (hHSCs). These findings could facilitate hESC-based replacement therapy and provide a valuable in vitro platform for studying human thymus organogenesis and regeneration.	[Sun, Xiaoning; Sui, Xin; Liu, Haisong; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China; [Xu, Jun; Lu, Hongxia; Liu, Wang; Miao, Zhenchuan; Sui, Xin; Du, Weichao; Chen, Fangyuan; Deng, Hongkui] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Deng, Hongkui] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Su, Li; He, Qihua] Peking Univ, Ctr Med & Hlth Anal, Beijing 100191, Peoples R China	Peking University; University Town of Shenzhen; Peking University; Peking University; Peking University	Shi, Y (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	shiyan@pkusz.edu.cn; hongkui_deng@pku.edu.cn		liu, Haisong/0000-0002-7645-0855	National Basic Research Program of China (973 program) [2012CB966401]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Science and Technology Major Project [2012ZX10001-008, 2013ZX10001003]; Ministry of Science and Technology [2011DFA30730, 2013DFG30680]; 111 project; Bill & Melinda Gates Foundation [37871]; National Natural Science Foundation of China [30900855]; China Postdoctoral Science Foundation [20080440269]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Science and Technology Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 project(Ministry of Education, China - 111 Project); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Dr. D. S. Li for critical reading of the manuscript and Dr. Y. Zhao for advice on experimental design. We also thank Y.Z. Zhang, T. Yang, and W.F. Lai for the Q-PCR analysis; S. G. Duo, M. Liu, and D. C. Zhu for the animal experiments; and Y.X. Liu, C.Y. Wang, D. X. Zhao, S. Chen, H. F. Xie, and Y. Liu for discussion in the preparation of this manuscript. H. D. conceived the project and X. Sun, H. Lu, and J.X. designed the experiments. X. Sun performed the in vitro experiments with the technical help and advice of J.X, W. L., H. Liu, L. S., Q. H., and W. D.; X. Sun, J.X.; and H. Lu performed the in vivo experiments in the help of Z.M., W. L., X. Sui, and F. C.; X. Sun and J.X. analyzed the data and wrote the manuscript with the assistance and advice of H. D., H. Lu, Y. S., and Z.M.; X. Sun, J.X., and H. Lu contributed equally to this work. This work was supported by the National Basic Research Program of China (973 program 2012CB966401), the Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), the National Science and Technology Major Project (2012ZX10001-008, 2013ZX10001003), the Ministry of Science and Technology (2011DFA30730, 2013DFG30680) and 111 project, Bill & Melinda Gates Foundation Grant (37871), the National Natural Science Foundation of China (30900855), and the China Postdoctoral Science Foundation (20080440269).	Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chinn IK, 2011, J ALLERGY CLIN IMMUN, V127, P1351, DOI 10.1016/j.jaci.2011.03.033; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Green MD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-51; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nowell Craig S, 2007, Methods Mol Biol, V380, P125; ROCHA B, 1990, EUR J IMMUNOL, V20, P919, DOI 10.1002/eji.1830200430; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Tsai PT, 2003, BLOOD, V102, P3947, DOI 10.1182/blood-2003-05-1657; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Zhao Y, 1997, J IMMUNOL, V158, P1641; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	32	78	86	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 1	2013	13	2					230	236		10.1016/j.stem.2013.06.014	http://dx.doi.org/10.1016/j.stem.2013.06.014			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VO	23910085	Bronze			2022-12-25	WOS:000329570600015
J	Wei, Z; Gao, F; Kim, S; Yang, HZ; Lyu, J; An, WJ; Wang, K; Lu, WG				Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; Lyu, Jungmook; An, Woojin; Wang, Kai; Lu, Wange			Klf4 Organizes Long-Range Chromosomal Interactions with the Oct4 Locus inReprogramming andPluripotency	CELL STEM CELL			English	Article							GENOME-WIDE; CHROMATIN INTERACTIONS; GENE-EXPRESSION; NANOG LOCUS; STEM-CELLS; PLURIPOTENCY; TRANSCRIPTION; REVEALS; DOMAINS; MOUSE	Epigenetic mechanisms underlying somatic reprogramming have been extensively studied, but little is known about the nuclear architecture of pluripotent stem cells (PSCs). Using circular chromosome conformation capture with high-throughput sequencing (4C-seq) and fluorescence in situ hybridization (FISH), we identified chromosomal regions that colocalize frequently with the Oct4 locus in PSCs. These PSC-specific long-range interactions are established prior to transcriptional activation of endogenous Oct4 during reprogramming to induced PSCs and are facilitated by Klf4-mediated recruitment of cohesin. Depletion of Klf4 leads to unloading of cohesin at the Oct4 enhancer and disrupts long-range interactions prior to loss of Oct4 transcription and subsequent PSC differentiation, suggesting a causative role for Klf4 in facilitating long-range interactions independent of its transcriptional activity. Taken together, our results delineate the basic nuclear organization at the Oct4 locus in PSCs and suggest a functional role for Klf4-mediated higherorder chromatin structure in maintaining and inducing pluripotency.	[Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; Lu, Wange] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wei, Zong; Gao, Fan; Kim, Sewoon; Yang, Hongzhen; An, Woojin; Lu, Wange] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Gao, Fan; Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Gao, Fan; Wang, Kai] Univ So Calif, Dept Prevent Med & Psychiat, Los Angeles, CA 90033 USA; [Lyu, Jungmook] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Catholic Inst Visual Sci, Seoul 137040, South Korea	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Catholic University of Korea	Lu, WG (corresponding author), Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu		Wei, Zong/0000-0002-4691-0101	CIRM [RB1-01353]	CIRM(California Institute for Regenerative Medicine)	We thank all members of the Lu laboratory for discussion, C. Yang for providing the inducible shRNA construct, G. Coetzee and M. Pera for critical comments, and L. Barsky for FACS sorting. This work was partially supported by a grant from CIRM (RB1-01353).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	63	153	156	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 3	2013	13	1					36	47		10.1016/j.stem.2013.05.010	http://dx.doi.org/10.1016/j.stem.2013.05.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VJ	23747203	Bronze			2022-12-25	WOS:000329570100011
J	Kisiswa, L; Osorio, C; Erice, C; Vizard, T; Wyatt, S; Davies, AM				Kisiswa, Lilian; Osorio, Catarina; Erice, Clara; Vizard, Thomas; Wyatt, Sean; Davies, Alun M.			TNF alpha reverse signaling promotes sympathetic axon growth and target innervation	NATURE NEUROSCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; NEURITE GROWTH; MONOCYTIC CELLS; FACTOR-RECEPTOR; NERVOUS-SYSTEM; ACTIVATION; NEURONS; DEATH; NGF; SURVIVAL	Reverse signaling via members of the tumor necrosis factor (TNF) superfamily controls multiple aspects of immune function. Here we document TNF alpha reverse signaling in the nervous system to our knowledge for the first time and show that it has a crucial role in establishing sympathetic innervation. During postnatal development, sympathetic axons express TNF alpha as they grow and branch in their target tissues, which in turn express TNF receptor 1 (TNFR1). In culture, soluble forms of TNFR1 act directly on postnatal sympathetic axons to promote growth and branching by a mechanism that depends on membrane-integrated TNF alpha and on downstream activation of ERK. Sympathetic innervation density is substantially lower in several tissues in postnatal and adult mice lacking either TNF alpha or TNFR1. These findings reveal that target-derived TNFR1 acts as a reverse-signaling ligand for membrane- integrated TNF alpha to promote growth and branching of sympathetic axons.	[Kisiswa, Lilian; Osorio, Catarina; Erice, Clara; Vizard, Thomas; Wyatt, Sean; Davies, Alun M.] Cardiff Univ, Sch Biosci, Div Mol Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Davies, AM (corresponding author), Cardiff Univ, Sch Biosci, Div Mol Biosci, Cardiff CF10 3AX, S Glam, Wales.	daviesalun@cf.ac.uk	Davies, Alun M/A-4334-2010; Osorio, Catarina/G-1700-2017; Wyatt, Sean/A-5266-2010; Erice, Clara/ABI-5816-2020	Davies, Alun M/0000-0001-5841-8176; Wyatt, Sean/0000-0002-0572-234X; Erice, Clara/0000-0001-9681-6861; Osorio, Catarina/0000-0002-5228-0599; Kisiswa, Lilian/0000-0002-1800-0645	Wellcome Trust [085984]; Fundacao para a Ciencia e a Tecnologia; Neuroscience and Mental Health Research Institute of Cardiff University	Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Neuroscience and Mental Health Research Institute of Cardiff University	We thank M. White for providing RNA samples and K. Fox (Cardiff University), A. Dick (Bristol University) and the late S. Korsmeyer for providing Tnf, Tnfrsf1a and Bax mutant mice, respectively. This work was supported by a Wellcome Trust grant (grant no. 085984). C.O. was supported by a grant from the Fundacao para a Ciencia e a Tecnologia. C.E. was supported by a studentship from the Neuroscience and Mental Health Research Institute of Cardiff University.	Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Davies AM, 2009, AUTON NEUROSCI-BASIC, V151, P39, DOI 10.1016/j.autneu.2009.07.011; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Gavalda N, 2009, J NEUROSCI, V29, P1599, DOI 10.1523/JNEUROSCI.3566-08.2009; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; Gutierrez H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120150; Harashima S, 2001, J IMMUNOL, V166, P130, DOI 10.4049/jimmunol.166.1.130; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Kirchner S, 2004, J LEUKOCYTE BIOL, V75, P324, DOI 10.1189/jlb.0703343; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; O'Keeffe GW, 2008, NAT NEUROSCI, V11, P135, DOI 10.1038/nn2034; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Takei Y, 2008, MOL BIOL CELL, V19, P855, DOI 10.1091/mbc.E07-06-0624; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Xin LJ, 2006, INT J MOL MED, V18, P885; Yu MX, 2009, EUR J CELL BIOL, V88, P181, DOI 10.1016/j.ejcb.2008.09.001; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	40	46	48	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					865	U264		10.1038/nn.3430	http://dx.doi.org/10.1038/nn.3430			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749144	Green Accepted			2022-12-25	WOS:000321180900019
J	Yu, DX; Marchetto, MC; Gage, FH				Yu, Diana X.; Marchetto, Maria C.; Gage, Fred H.			Therapeutic Translation of iPSCs for Treating Neurological Disease	CELL STEM CELL			English	Review							PLURIPOTENT STEM-CELLS; FAMILIAL ALZHEIMERS-DISEASE; DIRECTED DIFFERENTIATION; FUNCTIONAL MATURATION; PARKINSONS-DISEASE; LONG-TERM; NEURONS; BRAIN; GENERATION; TRANSPLANTATION	Somatic cellular reprogramming is a fast-paced and evolving field that is changing the way scientists approach neurological diseases. For the first time in the history of neuroscience, it is feasible to study the behavior of live neurons from patients with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, and neuropsychiatric diseases, such as autism and schizophrenia. In this Perspective, we will discuss reprogramming technology in the context of its potential use for modeling and treating neurological and psychiatric diseases and will highlight areas of caution and opportunities for improvement.	[Yu, Diana X.; Marchetto, Maria C.; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Freeman T B, 2000, Prog Brain Res, V127, P405; Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hai A, 2010, J NEUROPHYSIOL, V104, P559, DOI 10.1152/jn.00265.2010; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Jiang M, 2011, MOL CELL BIOCHEM, V354, P67, DOI 10.1007/s11010-011-0806-5; Kanagasabapathi Thirukumaran T, 2011, Front Neuroeng, V4, P13, DOI 10.3389/fneng.2011.00013; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lindvall Olle, 2004, NeuroRx, V1, P382; Lopez-Bendito G, 2012, DEV NEUROBIOL, V72, P145, DOI 10.1002/dneu.20897; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Musick K, 2009, LAB CHIP, V9, P2036, DOI 10.1039/b820596e; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Peng J., 2013, J BIOMOL SCREEN; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Porteus M., 2010, COLD SPRING HARB PRO, V2010; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Scott CW, 2013, TOXICOL LETT, V219, P49, DOI 10.1016/j.toxlet.2013.02.020; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f; Weinacht KG, 2012, CURR OPIN IMMUNOL, V24, P617, DOI 10.1016/j.coi.2012.07.001; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	89	76	79	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 6	2013	12	6					678	688		10.1016/j.stem.2013.05.018	http://dx.doi.org/10.1016/j.stem.2013.05.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VH	23746977	Bronze			2022-12-25	WOS:000329569900011
J	Sasai, Y				Sasai, Yoshiki			Next-Generation Regenerative Medicine: Organogenesis from Stem Cells in 3D Culture	CELL STEM CELL			English	Review							IN-VITRO; 3-DIMENSIONAL CULTURE; ES CELLS; EFFICIENT DIFFERENTIATION; DIRECTED DIFFERENTIATION; DEFINITIVE ENDODERM; SELF-ORGANIZATION; SMALL-INTESTINE; MOUSE; PROGENITORS	The behavior of stem cells, when they work collectively, can be much more sophisticated than one might expect from their individual programming. This Perspective covers recent discoveries about the dynamic patterning and structural self-formation of complex organ buds in 3D stem cell culture, including the generation of various neuroectodermal and endodermal tissues. For some tissues, epithelial-mesenchymal interactions can also be manipulated in coculture to guide organogenesis. This new area of stem cell research-the spatiotemporal control of dynamic cellular interactions-will open a new avenue for next-generation regenerative medicine.	RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp						Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Camazine S., 2001, SELF ORG BIOL SYSTEM, P7; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Carlone DL, 2012, CELL STEM CELL, V10, P2, DOI 10.1016/j.stem.2011.12.012; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Dobrescu R, 2011, J Med Life, V4, P82; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Mao JJ, 2012, CELL STEM CELL, V11, P291, DOI 10.1016/j.stem.2012.08.010; Meng Q, 2010, EXPERT OPIN DRUG MET, V6, P733, DOI 10.1517/17425251003674356; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nakamura H, 2005, BRAIN RES REV, V49, P120, DOI 10.1016/j.brainresrev.2004.10.005; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Rizzoti K, 2005, REV ENDOCR METAB DIS, V6, P161, DOI 10.1007/s11154-005-3047-7; Saito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028209; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Ueda T, 2010, BIOCHEM BIOPH RES CO, V391, P38, DOI 10.1016/j.bbrc.2009.10.157; Wang XL, 2009, TISSUE ENG PT A, V15, P1941, DOI 10.1089/ten.tea.2008.0181; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodford C, 2012, CURR OPIN BIOTECH, V23, P810, DOI 10.1016/j.copbio.2012.03.003; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zervas M, 2005, CURR TOP DEV BIOL, V69, P101, DOI 10.1016/S0070-2153(05)69005-9	73	255	270	3	85	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 2	2013	12	5					520	530		10.1016/j.stem.2013.04.009	http://dx.doi.org/10.1016/j.stem.2013.04.009			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	287VE	23642363	Bronze			2022-12-25	WOS:000329569600009
J	Kang, SH; Li, Y; Fukaya, M; Lorenzini, I; Cleveland, DW; Ostrow, LW; Rothstein, JD; Bergles, DE				Kang, Shin H.; Li, Ying; Fukaya, Masahiro; Lorenzini, Ileana; Cleveland, Don W.; Ostrow, Lyle W.; Rothstein, Jeffrey D.; Bergles, Dwight E.			Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; SPINAL-CORD; SUPEROXIDE-DISMUTASE; PROGENITOR CELLS; TRANSGENIC MICE; IFN-GAMMA; EXPRESSION; MODEL; ALS; ASTROCYTES	Oligodendrocytes associate with axons to establish myelin and provide metabolic support to neurons. In the spinal cord of amyotrophic lateral sclerosis (ALS) mice, oligodendrocytes downregulate transporters that transfer glycolytic substrates to neurons and oligodendrocyte progenitors (NG2(+) cells) exhibit enhanced proliferation and differentiation, although the cause of these changes in oligodendroglia is unknown. We found extensive degeneration of gray matter oligodendrocytes in the spinal cord of SOD1 (G93A) ALS mice prior to disease onset. Although new oligodendrocytes were formed, they failed to mature, resulting in progressive demyelination. Oligodendrocyte dysfunction was also prevalent in human ALS, as gray matter demyelination and reactive changes in NG2(+) cells were observed in motor cortex and spinal cord of ALS patients. Selective removal of mutant SOD1 from oligodendroglia substantially delayed disease onset and prolonged survival in ALS mice, suggesting that ALS-linked genes enhance the vulnerability of motor neurons and accelerate disease by directly impairing the function of oligodendrocytes.	[Kang, Shin H.; Lorenzini, Ileana; Rothstein, Jeffrey D.; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Li, Ying; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Fukaya, Masahiro] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan; [Lorenzini, Ileana; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins University; Kitasato University; Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	jrothstein@jhmi.edu; dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Cleveland, Don/AAN-9783-2021	Bergles, Dwight/0000-0002-7133-7378; Cleveland, Don/0000-0002-1934-3682; Ostrow, Lyle/0000-0001-7158-5243	P2ALS; US National Institutes of Health [NS27036, NS33958, NS051509]; ALS Association [4ZMUDE]; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS051509, R01NS027036, R01NS033958] Funding Source: NIH RePORTER	P2ALS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ye, I. Srivastava, S. Singh and T. Le for their excellent technical support, M. Pucak for help with Imaris software operation and quantitative analysis, J. Carmen for her contributions to the Cre/lox animal study, and H. Zhang at the Johns Hopkins University School of Public Health FACS core for assistance with NG2<SUP>+</SUP> cell isolation. We thank B. Trapp (Cleveland Clinic Lerner Research Institute) for advice regarding human NG2<SUP>+</SUP> cell staining, R. Dutta (Cleveland Clinic Lerner Research Institute) for advice regarding protein extraction from human tissues and B. Popko (University of Chicago) for providing Plp1-creER mice. Human samples were provided by R. Bowser (Barrow Neurological Institute), K. Trevor (SACTL-VA Biorepository Trust), T. Hyde (Lieber Institute for Brain Development and the Johns Hopkins School of Medicine), J. Glass (Emory Alzheimer's Disease Research Center, 5P50AG025688-07), and the Johns Hopkins School of Medicine Department of Neuropathology. We thank E. Mosmiller for helping with patient demographic information. We also thank A. Agarwal and A. Langseth for critical discussions. This work was supported by grants from P<SUP>2</SUP>ALS (D.E.B. and J.D.R.), the US National Institutes of Health (NS27036 to D.W.C., NS33958 to J.D.R. and NS051509 to D.E.B.), the ALS Association (4ZMUDE to Y.L.), the Robert Packard Center for ALS Research at Johns Hopkins, and the Brain Science Institute.	Aebischer J, 2012, EUR J NEUROL, V19, P752, DOI 10.1111/j.1468-1331.2011.03623.x; Bauer J, 2002, J NEUROPATH EXP NEUR, V61, P12, DOI 10.1093/jnen/61.1.12; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Buntinx M, 2004, J NEUROSCI RES, V76, P834, DOI 10.1002/jnr.20118; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cosottini M, 2011, AM J NEURORADIOL, V32, P704, DOI 10.3174/ajnr.A2356; Coutts M, 2010, J NEUROTRAUM, V27, P1333, DOI 10.1089/neu.2010.1285; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jamin N, 2001, EXP NEUROL, V172, P17, DOI 10.1006/exnr.2001.7752; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Komori T, 1999, BRAIN PATHOL, V9, P663; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Niebroj-Dobosz I, 2007, FOLIA NEUROPATHOL, V45, P236; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Pouly S, 1999, GLIA, V27, P259, DOI 10.1002/(SICI)1098-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rudick RA, 2009, NEW ENGL J MED, V361, P1505, DOI 10.1056/NEJMcibr0905482; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wu Yu-Huan, 2008, P3; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	54	365	381	7	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					571	+		10.1038/nn.3357	http://dx.doi.org/10.1038/nn.3357			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542689	Green Accepted, Green Submitted			2022-12-25	WOS:000318029300013
J	Silson, EH; McKeefry, DJ; Rodgers, J; Gouws, AD; Hymers, M; Morland, AB				Silson, Edward H.; McKeefry, Declan J.; Rodgers, Jessica; Gouws, Andre D.; Hymers, Mark; Morland, Antony B.			Specialized and independent processing of orientation and shape in visual field maps LO1 and LO2	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; OCCIPITAL CORTEX; EXTRASTRIATE CORTEX; OBJECTS; DISSOCIATION; PERCEPTION; FMRI	We identified human visual field maps, LO1 and LO2, in object-selective lateral occipital cortex. Using transcranial magnetic stimulation (TMS), we assessed the functions of these maps in the perception of orientation and shape. TMS of LO1 disrupted orientation, but not shape, discrimination, whereas TMS of LO2 disrupted shape, but not orientation, discrimination. This double dissociation suggests that specialized and independent processing of different visual attributes occurs in LO1 and LO2.	[Silson, Edward H.; Rodgers, Jessica; Gouws, Andre D.; Hymers, Mark; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [McKeefry, Declan J.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Morland, Antony B.] Hull York Med Sch, Ctr Neurosci, York, N Yorkshire, England	University of York - UK; University of Bradford; University of Hull; University of York - UK	Morland, AB (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	antony.morland@york.ac.uk		Gouws, Andre/0000-0003-0674-7829; Morland, Antony/0000-0002-6754-5545	Department of Psychology, University of York	Department of Psychology, University of York	We are grateful to T. Andrews, H. Baseler and A. Wade for their useful discussion of the study and earlier drafts of the manuscript. We also thank R. Baker, J. Blake, C. Breare, E. Cooper, E. Reeves, E. Shah and S. Strong for their assistance in performing the experiments. We thank the Department of Psychology, University of York, which funds the PhD studentship award to E.H.S. and summer bursary award to J.R.	Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Ellison A, 2009, NEUROPSYCHOLOGIA, V47, P1609, DOI 10.1016/j.neuropsychologia.2008.12.013; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weiner KS, 2012, TRENDS COGN SCI, V16, P251, DOI 10.1016/j.tics.2012.03.003; ZEKI S, 1990, COLD SPRING HARB SYM, V55, P651	19	43	43	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					267	269		10.1038/nn.3327	http://dx.doi.org/10.1038/nn.3327			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23377127				2022-12-25	WOS:000315474800007
J	Chubykin, AA; Roach, EB; Bear, MF; Shuler, MGH				Chubykin, Alexander A.; Roach, Emma B.; Bear, Mark F.; Shuler, Marshall G. Hussain			A Cholinergic Mechanism for Reward Timing within Primary Visual Cortex	NEURON			English	Article							RAT CEREBRAL-CORTEX; BASAL FOREBRAIN; CORTICAL PLASTICITY; PYRAMIDAL NEURONS; NUCLEUS BASALIS; INTRACORTICAL INFUSION; SYNAPTIC PLASTICITY; PERSISTENT ACTIVITY; INDUCTION; EXCITABILITY	Neurons in rodent primary visual cortex (V1) relate operantly conditioned stimulus-reward intervals with modulated patterns of spiking output, but little is known about the locus or mechanism of this plasticity. Here we show that cholinergic basal forebrain projections to V1 are necessary for the neural acquisition, but not the expression, of reward timing in the visual cortex of awake, behaving animals. We then mimic reward timing in vitro by pairing white matter stimulation with muscarinic receptor activation at a fixed interval and show that this protocol results in the prolongation of electrically evoked spike train durations out to the conditioned interval. Together, these data suggest that V1 possesses the circuitry and plasticity to support reward time prediction learning and the cholinergic system serves as an important reinforcement signal which, in vivo, conveys to the cortex the outcome of behavior.	[Chubykin, Alexander A.; Bear, Mark F.] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Roach, Emma B.; Shuler, Marshall G. Hussain] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Johns Hopkins University	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu; shuler@jhmi.edu		Bear, Mark/0000-0002-9903-2541; Chubykin, Alexander/0000-0001-8224-9296	NIMH [R01 MH084911]; Johns Hopkins University; NIDA [F31 DA026687]; NEI [R01 EYO12309]; NICHD [R01 HD046943]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046943] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203, R01EY012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA026687] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins University(Johns Hopkins University); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Harel Shouval, Jeff Gavornik, and Arnold Heynen for insightful comments and critiques. We are grateful to Jill McGaughy, Weidong Hu, and Peter Holland for sharing their histological expertise. We thank Tanya Marton, Vijay M.K. Namboodiri, and Camila Zold for helpful discussions of the experimental design. We also thank Hannah Joo and Shelby Hecht for their assistance with data collection, electrode drive assembly, and histology and Kathleen Oram, Erik Sklar, and Suzanne Meagher for technical and administrative support. This work was funded by NIMH (R01 MH084911) and start-up funds provided by the Johns Hopkins University to M.G.H.S, NIDA (F31 DA026687) to E.B.R., and grants from NEI (R01 EYO12309) and NICHD (R01 HD046943) to M.F.B.	BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; Breton JD, 2009, J PHYSIOL-LONDON, V587, P5107, DOI 10.1113/jphysiol.2009.180943; BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; CAREY RG, 1987, BRAIN RES, V424, P205, DOI 10.1016/0006-8993(87)91463-6; Cho KH, 2012, J NEUROSCI, V32, P4520, DOI 10.1523/JNEUROSCI.4577-11.2012; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Di Terlizzi R, 2006, VET J, V172, P422, DOI 10.1016/j.tvjl.2005.07.021; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gavornik JP, 2011, J COMPUT NEUROSCI, V30, P501, DOI 10.1007/s10827-010-0275-y; Gavornik JP, 2009, P NATL ACAD SCI USA, V106, P6826, DOI 10.1073/pnas.0901835106; Genovesio A, 2009, NEURON, V63, P254, DOI 10.1016/j.neuron.2009.06.018; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; Gu Q, 2003, NEUROBIOL LEARN MEM, V80, P291, DOI 10.1016/S1074-7427(03)00073-X; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Gulledge AT, 2009, J NEUROSCI, V29, P9888, DOI 10.1523/JNEUROSCI.1366-09.2009; HOLLEY LA, 1994, BRAIN RES, V663, P277, DOI 10.1016/0006-8993(94)91274-2; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; LYSAKOWSKI A, 1989, NEUROSCIENCE, V28, P291, DOI 10.1016/0306-4522(89)90180-2; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Mechawar N, 2000, J COMP NEUROL, V428, P305, DOI 10.1002/1096-9861(20001211)428:2<305::AID-CNE9>3.0.CO;2-Y; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Obuchowski NA, 1998, ACAD RADIOL, V5, P561, DOI 10.1016/S1076-6332(98)80208-0; Origlia N, 2008, ARCH ITAL BIOL, V146, P165; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Pennartz CMA, 1995, BRAIN RES REV, V21, P219, DOI 10.1016/0165-0173(95)00014-3; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rahman J, 2011, EUR J NEUROSCI, V34, P22, DOI 10.1111/j.1460-9568.2011.07736.x; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; Saar D, 2009, MOL NEUROBIOL, V39, P171, DOI 10.1007/s12035-009-8060-5; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SANTOSBENITEZ H, 1995, BRAIN RES BULL, V37, P507, DOI 10.1016/0361-9230(95)00033-B; Shouval HZ, 2011, J COMPUT NEUROSCI, V30, P489, DOI 10.1007/s10827-010-0273-0; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TAGO H, 1986, J HISTOCHEM CYTOCHEM, V34, P1431, DOI 10.1177/34.11.2430009; WAITE JJ, 1994, NEUROSCI LETT, V169, P154, DOI 10.1016/0304-3940(94)90379-4; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Wickens T.D., 2001, ELEMENTARY SIGNAL DE; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; WILSON FAW, 1990, BRAIN RES, V509, P213, DOI 10.1016/0006-8993(90)90546-N; Woolf NJ, 1996, NEUROSCIENCE, V74, P625, DOI 10.1016/0306-4522(96)00163-7; Zilles K., 1985, CORTEX RAT STEREOTAX	60	106	108	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 20	2013	77	4					723	735		10.1016/j.neuron.2012.12.039	http://dx.doi.org/10.1016/j.neuron.2012.12.039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098PN	23439124	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000315561300014
